PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Nawa, K; Yajima, T; Okamoto, Y; Hiroi, Z				Nawa, Kazuhiro; Yajima, Takeshi; Okamoto, Yoshihiko; Hiroi, Zenji			Orbital Arrangements and Magnetic Interactions in the Quasi-One-Dimensional Cuprates ACuMoO(4)(OH) (A = Na, K)	INORGANIC CHEMISTRY			English	Article							FIELD-INDUCED GAP; S=1/2 ANTIFERROMAGNET; CU BENZOATE; CHAINS; EXCHANGE	A new spin-1/2 quasi-one-dimensional antiferromagnet KCu-MoO4(OH) is prepared by the hydrothermal method. The crystal structures of KCuMoO4(OH) and the already-known Na-analogue NaCuMoO4(OH) are iotypic, comprising chains of Cu2+-known in edge-sharing CuO4(OH)(2) octahedra Despite the structural similarity, their magnetic properties are quite different: because of the different arrangements of d(x2-y2) orbitals carrying spills. For NaCuMoO4(OH), d(x2-y2) orbitals are linked by superexchange couplings via two bridging oxide ions, which gives a ferromagnetic nearest-neighbor interaction J(1) of -51 K and an antiferromagnetic next-nearest-neighbor interaction J(2) of 315 k in the chain. In contrast, a staggered d(x2-y2) orbital arrangement in KCuMoO4(OH) results in superexchange couplings via only one bridging oxide ion, which makes J(1), antiferromagnetic as as 238 K and 12 negligible: This comparison between the two isotypic compounds,demonstrates an Important role of orbital arrangements in determining the magnetic properties of cuprates.	[Nawa, Kazuhiro; Yajima, Takeshi; Okamoto, Yoshihiko; Hiroi, Zenji] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan	Nawa, K (reprint author), Nagoya Univ, Grad Sch Engn, Dept Appl Sci, Nagoya, Aichi 4648603, Japan.	knawa@issp.u-tokyo.ac.jp					Mizuno Y, 1998, PHYS REV B, V57, P5326, DOI 10.1103/PhysRevB.57.5326; Okamoto Y, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.033701; Hikihara T, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.144404; Hiroi Z, 2001, J PHYS SOC JPN, V70, P3377, DOI 10.1143/JPSJ.70.3377; Dender DC, 1997, PHYS REV LETT, V79, P1750, DOI 10.1103/PhysRevLett.79.1750; CRAWFORD VH, 1976, INORG CHEM, V15, P2107, DOI 10.1021/ic50163a019; Kecke L, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.060407; Morisaki R, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.063706; Kohgi M, 2001, PHYS REV LETT, V86, P2439, DOI 10.1103/PhysRevLett.86.2439; Mikeska HJ, 2004, LECT NOTES PHYS, V645, P1; Oshikawa M, 1997, PHYS REV LETT, V79, P2883, DOI 10.1103/PhysRevLett.79.2883; Affleck I, 1999, PHYS REV B, V60, P1038, DOI 10.1103/PhysRevB.60.1038; Vekua T, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.174420; Shores MP, 2005, J AM CHEM SOC, V127, P13462, DOI 10.1021/ja053891p; Johnston DC, 2000, PHYS REV B, V61, P9558, DOI 10.1103/PhysRevB.61.9558; Dender DC, 1996, PHYS REV B, V53, P2583, DOI 10.1103/PhysRevB.53.2583; BONNER JC, 1964, PHYS REV, V135, pA640, DOI 10.1103/PhysRev.135.A640; Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Banks MG, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.024404; Baran M, 2006, PHYS STATUS SOLIDI C, V3, P220, DOI 10.1002/pssc.200562523; Buttgen N, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.134401; de Haas W. J., 1931, COMMUN LEIDEN, p215a; Dunitz J. D., 1957, ACTA CRYSTALLOGR, V10, P307, DOI DOI 10.1107/S0365110X57000894; GEBALLE TH, 1952, J AM CHEM SOC, V74, P3513, DOI 10.1021/ja01134a017; GIESTER G, 1989, Z KRISTALLOGR, V187, P239, DOI 10.1524/zkri.1989.187.3-4.239; Giester G., 1987, KRISTALLOGRAFIYA, V179, P431; Ishikawa H., 2012, ACTA CRYSTALLOGR C, VC68, pi41; KOIZUMI H, 1963, J PHYS SOC JPN, V18, P117, DOI 10.1143/JPSJ.18.117; LAFONTAINE MA, 1989, ACTA CRYSTALLOGR C, V45, P1205, DOI 10.1107/S0108270189001551; MARSHALL W, 1958, J PHYS CHEM SOLIDS, V7, P159, DOI 10.1016/0022-3697(58)90257-9; MOINI A, 1986, INORG CHEM, V25, P3782, DOI 10.1021/ic00241a016; Nawa K, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.103702; Nojiri H, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/9/218; Palache C., 1951, SYSTEM MINERALOGY JD, V2, P804; Schmitt M, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.245119; Starr C, 1940, PHYS REV, V58, P977, DOI 10.1103/PhysRev.58.977; Sudan J, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.140402; TAKEDA K, 1971, J PHYS SOC JPN, V30, P1330, DOI 10.1143/JPSJ.30.1330; Takeda S, 2002, MOL CRYST LIQ CRYST, V376, P443, DOI 10.1080/10587250210791; VANDENHANDEL J, 1952, PHYSICA, V18, P862, DOI 10.1016/S0031-8914(52)80221-6; Vollenkle H., 1967, MONTASH CHEM, V98, P1352; Yoshida H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1875	42	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0020-1669	1520-510X		INORG CHEM	Inorg. Chem.	JUN 1	2015	54	11					5566	5570		10.1021/acs.inorgchem.5b00686		5	Chemistry, Inorganic & Nuclear	Chemistry	CJ6XI	WOS:000355638100063		
J	Kawahara, M; Nemoto, M; Nakata, T; Kondo, S; Takahashi, H; Kimura, B; Kuda, T				Kawahara, Miho; Nemoto, Maki; Nakata, Toru; Kondo, Saya; Takahashi, Hajime; Kimura, Bon; Kuda, Takashi			Anti-inflammatory properties of fermented soy milk with Lactococcus lactis subsp lactis S-SU2 in murine macrophage RAW264.7 cells and DSS-induced IBD model mice	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Anti-inflammation; Lactococcus lactis subsp lactis; murine macrophage RAW264.7; Inflammation bowl disease; Dextran sodium sulfate; Mice	INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SULFATE SODIUM; ULCERATIVE-COLITIS; ANTIOXIDANT PROPERTIES; BACTEROIDES-FRAGILIS; GENE-EXPRESSION; CROHNS-DISEASE; ACID BACTERIA; AJI-NAREZUSHI; C57BL/6 MICE	Six lactic acid bacteria strains (four Lactobacillus plantarum strains and one each of Lactococcus lactis subsp. lactis and Pediococcus pentosaceus) have been isolated and shown to possess anti-oxidant activity. In this study, we determined their acid, bile, salt resistance, and adhesion activity on human enterocyte-like HT-29-Luc and Caco-2 cells. An isolate Lc. lactis S-SU2 showed highest bile resistance and adhesion activity compared to type strains. S-SU2 could ferment both 10% skimmed milk and soy milk while the type strain could not ferment soy milk. Soy milk fermented with S-SU2 showed an increased nitric oxide (NO) secretion in the mouse macrophage RAW264.7 cells without bacterial lipopolysaccharide (LPS). Furthermore, the inhibitory effects of the fermented soy milk on Escherichia coil 0111 LPS-induced NO secretion were higher than those of fresh soy milk. Inflammatory bowel disease (IBD) was induced in mice fed either 5% (w/v) dextran sodium sulfate (DSS) in drinking water or 50% soy milk in drinking water. Shortening of colon length, breaking of epithelial cells, lowering liver and thymus weights, and enlargement of spleen are some of the characteristics observed in the IBD, which were prevented by the use of soy milk fermented with Lc. lactis S-SU2. (C) 2015 Elsevier B.V. All rights reserved.	[Kawahara, Miho; Nemoto, Maki; Nakata, Toru; Kondo, Saya; Takahashi, Hajime; Kimura, Bon; Kuda, Takashi] Tokyo Univ Marine Sci & Technol, Dept Food Sci & Technol, Minato City, Tokyo 1088477, Japan	Kuda, T (reprint author), Tokyo Univ Marine Sci & Technol, Dept Food Sci & Technol, 4-5-7 Konan, Minato City, Tokyo 1088477, Japan.	kuda@kaiyodai.ac.jp	KUDA, Takashi/O-1974-2014; Kimura, Bon/O-1879-2014	Kimura, Bon/0000-0002-3071-1343	Ministry of Education, Science, Sports and Culture, Japan [25450300]; Organization of Revitalization for Sanriku-region (Iwate University, Japan)	This research was partially supported by the Ministry of Education, Science, Sports and Culture, Japan: Grant-in-Aid for Scientific Research (C), 25450300, 2013-2015 and was also supported by the Organization of Revitalization for Sanriku-region (Iwate University, Japan).	Kuda T, 2010, FOOD CHEM, V120, P517, DOI 10.1016/j.foodchem.2009.10.046; Peloquin JM, 2013, ANAEROBE, V24, P102, DOI 10.1016/j.anaerobe.2013.04.006; Lebeer S, 2009, APPL ENVIRON MICROB, V75, P3554, DOI 10.1128/AEM.02919-08; Nakamura S, 2012, ANAEROBE, V18, P19, DOI 10.1016/j.anaerobe.2011.11.006; Heyman MB, 2006, PEDIATRICS, V118, P1279, DOI 10.1542/peds.2006-1721; Shigeshiro M, 2013, J FUNCT FOODS, V5, P949, DOI 10.1016/j.jff.2013.02.008; Kuda T, 2014, FOOD RES INT, V64, P248, DOI 10.1016/j.foodres.2014.06.028; Kappelman MD, 2013, DIGEST DIS SCI, V58, P519, DOI 10.1007/s10620-012-2371-5; Ito R, 2006, CLIN EXP IMMUNOL, V146, P330, DOI 10.1111/j.1365-2249.2006.03214.x; Goto H, 2010, J NUTR, V140, P2121, DOI 10.3945/jn.110.125948; Simin N, 2013, LWT-FOOD SCI TECHNOL, V54, P139, DOI 10.1016/j.lwt.2013.05.023; Wu MH, 2010, INT J FOOD MICROBIOL, V144, P104, DOI 10.1016/j.ijfoodmicro.2010.09.003; Itoi S, 2008, INT J FOOD MICROBIOL, V121, P116, DOI 10.1016/j.ijfoodmicro.2007.11.031; Foligne B, 2013, CURR OPIN MICROBIOL, V16, P284, DOI 10.1016/j.mib.2013.06.008; Jonkers D, 2012, DRUGS, V72, P803, DOI 10.2165/11632710-000000000-00000; Rhee KJ, 2009, INFECT IMMUN, V77, P1708, DOI 10.1128/IAI.00814-08; Perez T, 2011, INT J SYST EVOL MICR, V61, P1894, DOI 10.1099/ijs.0.023945-0; Kanno T, 2012, LWT-FOOD SCI TECHNOL, V47, P25, DOI 10.1016/j.lwt.2012.01.007; Asakura K, 2009, J GASTROENTEROL, V44, P659, DOI 10.1007/s00535-009-0057-3; Solieri L, 2014, FOOD MICROBIOL, V38, P240, DOI 10.1016/j.fm.2013.10.003; Eadala P, 2011, ALIMENT PHARM THER, V34, P735, DOI 10.1111/j.1365-2036.2011.04799.x; Kumar-Roine S, 2008, NITRIC OXIDE-BIOL CH, V19, P21, DOI 10.1016/j.niox.2008.03.001; Ko IK, 2010, MOL THER, V18, P1365, DOI 10.1038/mt.2010.54; Mishkin S, 1997, AM J CLIN NUTR, V65, P564; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Mazzei JC, 2011, J NUTR BIOCHEM, V22, P1160, DOI 10.1016/j.jnutbio.2010.09.017; Kuda T, 2013, LETT APPL MICROBIOL, V57, P187, DOI 10.1111/lam.12094; Kuda T, 2006, FOOD CHEM, V98, P545, DOI 10.1016/j.foodchem.2005.06.023; Mack DR, 2011, NUTRIENTS, V3, P245, DOI 10.3390/nu3020245; Ciszek-Lenda M, 2011, INT J EXP PATHOL, V92, P382, DOI 10.1111/j.1365-2613.2011.00788.x; Kuda T, 2014, J FUNCT FOODS, V6, P631, DOI 10.1016/j.jff.2013.11.017; Kuda T, 2009, FOOD CHEM, V112, P575, DOI 10.1016/j.foodchem.2008.06.008; Blum S, 1999, TRENDS FOOD SCI TECH, V10, P405, DOI 10.1016/S0924-2244(00)00028-5; da Silva E.C., 2014, WORLD J GASTROENTERO, V20, P9458; Hovede O., 2012, WORLD J GASTROENTERO, V18, P1723; Ishiwatari Mikio, 2014, DISASTER RECOVERY, V77, P88; Jiang H., 2001, J NUTR, V141, P1239; Karlsson A, 2008, INT IMMUNOPHARMACOL, V8, P20, DOI 10.1016/j.intimp.2007.10.007; Kuda T, 2012, APPL BIOCHEM BIOTECH, V168, P928, DOI 10.1007/s12010-012-9831-4; Kuda T, 2011, MAR POLLUT BULL, V62, P1622, DOI 10.1016/j.marpolbul.2011.06.015; Kuda T, 2014, J FUNCT FOODS, V11, P269, DOI 10.1016/j.jff.2014.09.017; Kuda T, 2004, FOOD CHEM, V88, P543, DOI 10.1016/j.foodchem.2004.01.069; Lakics V, 1998, J IMMUNOL, V161, P2490; Lea MA, 2007, ANTICANCER RES, V27, P741; Lewandowska M., 2005, BIOTECHNOLOGIA, V2, P215; Liao CL, 2010, J FOOD DRUG ANAL, V18, P202; Mao YK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2478; Matsumoto S, 2008, IMMUNOLOGY, V128, pe170; Mellor C.E., 2009, APPL ENVIRON MICROB, V75, P1796; Okada Y, 2009, INT J EXP PATHOL, V90, P131, DOI 10.1111/j.1365-2613.2008.00632.x; Olendzki BC, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-5; Sartor RB, 2012, AM J GASTROENTEROL S, V1, P15; Sasaki S, 2008, INFLAMMATION, V31, P319, DOI 10.1007/s10753-008-9081-3; Steur D. J., 1989, J EXP MED, V169, P1543; Strijbis K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112472; Wells CL, 1999, J NUTR, V129, P634; Yang SK, 2000, J GASTROEN HEPATOL, V15, P1037, DOI 10.1046/j.1440-1746.2000.02252.x	57	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	JUN	2015	26	2					295	303		10.1016/j.intimp.2015.04.004		9	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	CK3JW	WOS:000356113400003		
J	Yoshioka, K; Tanaka, R; Muranaka, K; Sasaki, T; Ueda, T; Chiba, T; Takeda, K; Sugawara, T				Yoshioka, Kunihiro; Tanaka, Ryoichi; Muranaka, Kenta; Sasaki, Tadashi; Ueda, Takanori; Chiba, Takuya; Takeda, Kouta; Sugawara, Tsuyoshi			Subtraction coronary CT angiography using second-generation 320-detector row CT	INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING			English	Article						Cardiac computed tomography; 320-Detector row CT; Angiography; Coronary artery calcification; Subtraction	COMPUTED-TOMOGRAPHY; DIAGNOSTIC-ACCURACY; ARTERY-DISEASE	The purpose of this study was to explore the feasibility of subtraction coronary computed tomography angiography (CCTA) by second-generation 320-detector row CT in patients with severe coronary artery calcification using invasive coronary angiography (ICA) as the gold standard. This study was approved by the institutional board, and all subjects provided written consent. Twenty patients with calcium scores of > 400 underwent conventional CCTA and subtraction CCTA followed by ICA. A total of 82 segments were evaluated for image quality using a 4-point scale and the presence of significant (> 50 %) luminal stenosis by two independent readers. The average image quality was 2.3 +/- A 0.8 with conventional CCTA and 3.2 +/- A 0.6 with subtraction CCTA (P < 0.001). The percentage of segments with non-diagnostic image quality was 43.9 % on conventional CCTA versus 8.5 % on subtraction CCTA (P = 0.004). The segment-based diagnostic accuracy for detecting significant stenosis according to ICA revealed an area under the receiver operating characteristics curve of 0.824 (95 % confidence interval [CI], 0.750-0.899) for conventional CCTA and 0.936 (95 % CI 0.889-0.936) for subtraction CCTA (P = 0.001). The sensitivity, specificity, positive predictive value, and negative predictive value for conventional CCTA were 88.2, 62.5, 62.5, and 88.2 %, respectively, and for subtraction CCTA they were 94.1, 85.4, 82.1, and 95.3 %, respectively. As compared to conventional, subtraction CCTA using a second-generation 320-detector row CT showed improvement in diagnostic accuracy at segment base analysis in patients with severe calcifications.	[Yoshioka, Kunihiro; Tanaka, Ryoichi] Iwate Med Univ, Dept Radiol, Div Cardiovasc Radiol, Morioka, Iwate 0208505, Japan; [Muranaka, Kenta; Sasaki, Tadashi; Ueda, Takanori; Chiba, Takuya; Takeda, Kouta; Sugawara, Tsuyoshi] Iwate Med Univ Hosp, Ctr Radiol Sci, Morioka, Iwate 0208505, Japan	Yoshioka, K (reprint author), Iwate Med Univ, Dept Radiol, Div Cardiovasc Radiol, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	kyoshi@iwate-med.ac.jp			Japan Society for the Promotion of Science (JSPS KAKENHI) [26461803]	Dr. Joanne Schuijf and Mrs. Yukie Osawa from Toshiba Medical Systems gave support and suggestions in writing and technical subjects, especially for the dedicated subtraction algorithms. This work was supported by the Japan Society for the Promotion of Science (JSPS KAKENHI, Grant Number 26461803).	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827; Arbab-Zadeh A, 2012, J AM COLL CARDIOL, V59, P379, DOI 10.1016/j.jacc.2011.06.079; Yoshioka K, 2012, CARDIOL CLIN, V30, P93, DOI 10.1016/j.ccl.2011.10.004; Tanaka R, 2013, INT J CARDIOVAS IMAG, V29, P75, DOI 10.1007/s10554-013-0316-5; Zhang CC, 2011, INT J CARDIOVAS IMAG, V27, P1059, DOI 10.1007/s10554-010-9754-5; Taylor AJ, 2010, J AM COLL CARDIOL, V56, P1864, DOI 10.1016/j.jacc.2010.07.005; Vavere AL, 2011, RADIOLOGY, V261, P100, DOI 10.1148/radiol.11110537; Abdulla J, 2012, INT J CARDIOVAS IMAG, V28, P943, DOI 10.1007/s10554-011-9902-6; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058; Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031; Chen MY, 2013, RADIOLOGY, V267, P76, DOI 10.1148/radiol.13122621; Razeto M, 2013, P SOC PHOTO-OPT INS, V8768; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; YOSHIOKA K, 1983, NEUROSCIENCE, V9, P437, DOI 10.1016/0306-4522(83)90306-8	14	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1569-5794	1573-0743		INT J CARDIOVAS IMAG	Int. J. Cardiovasc. Imaging	JUN	2015	31			1			51	58		10.1007/s10554-015-0630-1		8	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CK1QY	WOS:000355983300005		
J	Kohgo, Y				Kohgo, Yutaka			Recent advances in multiple myeloma	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Editorial Material							DEXAMETHASONE		Asahikawa Med Univ, Div Gastroenterol & Hematol Oncol, Dept Internal Med, Asahikawa, Hokkaido 0788510, Japan	Kohgo, Y (reprint author), Asahikawa Med Univ, Div Gastroenterol & Hematol Oncol, Dept Internal Med, 2-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	yk1950@asahikawa-med.ac.jp					Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Dimopoulos M, 2007, NEW ENGL J MED, V357, P2123, DOI 10.1056/NEJMoa070594; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445	4	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	JUN	2015	20	3					411	412		10.1007/s10147-015-0809-4		2	Oncology	Oncology	CK0WV	WOS:000355927200001		
J	Furukawa, Y; Kikuchi, J				Furukawa, Yusuke; Kikuchi, Jiro			Molecular pathogenesis of multiple myeloma	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Review						Genetic architecture; Linear clonal evolution; Branching evolution; Intra-clonal heterogeneity; Drug resistance	BONE-MARROW; MONOCLONAL GAMMOPATHY; INTRACLONAL HETEROGENEITY; UNDETERMINED SIGNIFICANCE; PROGNOSTIC-FACTOR; DRUG-RESISTANCE; C-MAF; TRANSLOCATION; RISK; MMSET	Multiple myeloma (MM), one of the most intractable malignancies, is characterized by the infiltration and growth of plasma cells, the most differentiated cells in the B-cell lineage, in the bone marrow. Despite the introduction of novel therapeutic agents, including proteasome inhibitors and immunomodulatory drugs, the prognosis of patients with MM is still worse than that of most hematological malignancies. A better understanding of the molecular pathogenesis of the disease is essential to achieve any improvement of treatment outcome of MM patients. All MM cases pass through the phase of asymptomatic expansion of clonal plasma cells, referred to as monoclonal gammopathy of undetermined significance (MGUS). It has long been believed that MM evolves linearly from MGUS to terminal phases, such as extramedullary tumors and plasma cell leukemia via the accumulation of novel mutations. However, recent studies using next-generation sequencing have disclosed the complex genomic architecture of the disease. At each step of progression, the acquisition of novel mutations is accompanied by subclonal evolution from reservoir clones with branching patterns. Each subclone may carry novel mutations and distinct phenotypes, including drug sensitivity. In addition, minor clones already exist at the MGUS stage, which could expand later in the clinical course, resulting in relapse and/or leukemic conversion. The ultimate goal of treatment is to eradicate all clones, including subclonal populations with distinct biological characteristics. This goal could be achieved by further improving treatment strategies that reflect the genomic landscape of the disease.	[Furukawa, Yusuke; Kikuchi, Jiro] Jichi Med Univ, Div Stem Cell Regulat, Ctr Mol Med, Shimotsuke, Tochigi 3290498, Japan	Furukawa, Y (reprint author), Jichi Med Univ, Div Stem Cell Regulat, Ctr Mol Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	furuyu@jichi.ac.jp					Walker BA, 2014, LEUKEMIA, V28, P384, DOI 10.1038/leu.2013.199; Kikuchi J, 2014, INT J HEMATOL, V99, P726, DOI 10.1007/s12185-014-1573-3; Lauring J, 2008, BLOOD, V111, P856, DOI 10.1182/blood-2007-05-088674; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Avet-Loiseau H, 2012, J CLIN ONCOL, V30, P1949, DOI 10.1200/JCO.2011.36.5726; Boyd KD, 2012, LEUKEMIA, V26, P349, DOI 10.1038/leu.2011.204; Bahlis NJ, 2012, BLOOD, V120, P927, DOI 10.1182/blood-2012-06-430645; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; Bringhen S, 2013, HAEMATOLOGICA, V98, P980, DOI 10.3324/haematol.2012.075051; Mitsiades CS, 2011, J CLIN ONCOL, V29, P1916, DOI 10.1200/JCO.2010.34.0760; Hebraud B, 2014, LEUKEMIA, V28, P675, DOI 10.1038/leu.2013.225; Mateos MV, 2013, NEW ENGL J MED, V369, P438, DOI 10.1056/NEJMoa1300439; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Smadja NV, 2001, BLOOD, V98, P2229, DOI 10.1182/blood.V98.7.2229; Meads MB, 2008, CLIN CANCER RES, V14, P2519, DOI 10.1158/1078-0432.CCR-07-2223; Kumar SK, 2014, LEUKEMIA, V28, P1122, DOI 10.1038/leu.2013.313; Weiss BM, 2009, BLOOD, V113, P5418, DOI 10.1182/blood-2008-12-195008; Chesi M, 1998, BLOOD, V92, P3025; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Chesi M, 1996, BLOOD, V88, P674; LAI JL, 1995, BLOOD, V85, P2490; Nutt SL, 2011, SEMIN IMMUNOL, V23, P341, DOI 10.1016/j.smim.2011.08.010; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Chesi M, 1997, NAT GENET, V16, P260, DOI 10.1038/ng0797-260; Keats JJ, 2012, BLOOD, V120, P1067, DOI 10.1182/blood-2012-01-405985; Rajkumar SV, 2013, LEUKEMIA, V27, P1738, DOI 10.1038/leu.2013.86; Noborio-Hatano K, 2009, ONCOGENE, V28, P231, DOI 10.1038/onc.2008.385; Corre J, 2015, BLOOD, V125, P1870, DOI 10.1182/blood-2014-10-567370; Walker BA, 2012, BLOOD, V120, P1077, DOI 10.1182/blood-2012-03-412981; Iida S, 1997, NAT GENET, V17, P226, DOI 10.1038/ng1097-226; Pieper K, 2013, J ALLERGY CLIN IMMUN, V131, P959, DOI 10.1016/j.jaci.2013.01.046; Bergsagel PL, 2005, BLOOD, V106, P296, DOI 10.1182/blood-2005-01-0034; SAWYER JR, 1995, CANCER GENET CYTOGEN, V82, P41, DOI 10.1016/0165-4608(94)00284-I; Gonzalez D, 2007, BLOOD, V110, P3112, DOI 10.1182/blood-2007-02-069625; Chesi M, 1998, BLOOD, V91, P4457; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Egan JB, 2012, BLOOD, V120, P1060, DOI 10.1182/blood-2012-01-405977; Hurt EM, 2004, CANCER CELL, V5, P191, DOI 10.1016/S1535-6108(04)00019-4; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Demchenko YN, 2010, BLOOD, V115, P3541, DOI 10.1182/blood-2009-09-243535; Gay F, 2011, BLOOD, V117, P3025, DOI 10.1182/blood-2010-09-307645; Agarwal A, 2013, CLIN CANCER RES, V19, P985, DOI 10.1158/1078-0432.CCR-12-2922; Sonneveld P, 2013, J CLIN ONCOL, V31, P3279, DOI 10.1200/JCO.2012.48.4626; Affer M, 2014, LEUKEMIA, V28, P1725, DOI 10.1038/leu.2014.70; Magrangeas F, 2013, LEUKEMIA, V27, P473, DOI 10.1038/leu.2012.226; Mikhael JR, 2013, MAYO CLIN PROC, V88, P360, DOI 10.1016/j.mayocp.2013.01.019; Walker BA, 2013, BLOOD, V121, P3413, DOI 10.1182/blood-2012-12-471888; Bolli N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3997; Calasanz MJ, 1997, GENE CHROMOSOME CANC, V18, P84, DOI 10.1002/(SICI)1098-2264(199702)18:2<84::AID-GCC2>3.0.CO;2-X; Chiecchio L, 2009, HAEMATOL-HEMATOL J, V94, P1708, DOI 10.3324/haematol.2009.011064; Ghobrial IM, 2014, BLOOD, V124, P3380, DOI 10.1182/blood-2014-08-551549; Hebraud B, 2013, CLIN CANCER RES, V19, P4634, DOI 10.1158/1078-0432.CCR-12-3866; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Mateos MV, 2014, 56 ASH ANN M AM SOC; Pineda-Roman M, 2007, BRIT J HAEMATOL, V136, P393, DOI 10.1111/j.1365-2141.2006.06441.x; Rajkumar SV, 2012, AM J HEMATOL, V87, P79, DOI 10.1002/ajh.22237; Sawyer JR, 2014, BLOOD, V123, P2504, DOI 10.1182/blood-2013-12-546077; Walker BA, 2014, BLOOD CANC J, V4, pe191	60	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	JUN	2015	20	3					413	422		10.1007/s10147-015-0837-0		10	Oncology	Oncology	CK0WV	WOS:000355927200002		
J	Torimoto, Y; Shindo, M; Ikuta, K; Kohgo, Y				Torimoto, Yoshihiro; Shindo, Motohiro; Ikuta, Katsuya; Kohgo, Yutaka			Current therapeutic strategies for multiple myeloma	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Review						Multiple myeloma; Autologous stem cell transplantation; Immunomodulatory agents; Proteasome inhibitors; Histone deacetylase inhibitors	STEM-CELL TRANSPLANTATION; BORTEZOMIB-MELPHALAN-PREDNISONE; RANDOMIZED CONTROLLED-TRIAL; TERM-FOLLOW-UP; LENALIDOMIDE PLUS DEXAMETHASONE; HIGH-DOSE DEXAMETHASONE; INDIVIDUAL PATIENT DATA; NEWLY-DIAGNOSED MYELOMA; ELDERLY-PATIENTS; PHASE-III	The introduction of novel molecular targeting agents against multiple myeloma has dramatically and rapidly changed the therapeutic strategies for this incurable hematologic disease. Novel agents such as thalidomide, bortezomib and lenalidomide have significantly improved the response rate, progression-free survival, and overall survival compared with conventional chemotherapies, and made it easy to control the disease for longer periods of time. Initial therapies for newly diagnosed myeloma patients depend on the individual's clinical condition. Induction therapy with novel agents and high-dose chemotherapy followed by autologous stem cell transplantation is a standard therapy for newly diagnosed younger myeloma patients. On the other hand, several combinations of novel agents and other drugs (melphalan, prednisone, dexamethasone, etc.) are widely used as initial therapy for transplantation-ineligible myeloma patients. Although the clinical advantage of maintenance therapy after induction therapy has been reported, it is not recommend in routine practice. Maintenance therapy would be an option for some patients. Despite the significant improvements with the use of novel agents, the majority of patients eventually relapse. A number of treatment options including novel agents, which demonstrated marked clinical effects, are reported in the setting of salvage therapy. The choice of appropriate therapy for relapsed or refractory patients must take the disease status or patient status in consideration. Furthermore, a new generation of novel agents such as pomalidomide, carfilzomib or panobinostat has recently become available for relapsed or refractory myeloma. It is necessary to determine the optimal combination of drugs, administration timing and patients to be treated in future clinical trials.	[Torimoto, Yoshihiro] Asahikawa Med Univ Hosp, Ctr Oncol, Asahikawa, Hokkaido 0788510, Japan; [Shindo, Motohiro; Ikuta, Katsuya; Kohgo, Yutaka] Asahikawa Med Univ, Div Gastroenterol & Hematol Oncol, Dept Internal Med, Asahikawa, Hokkaido 0788510, Japan	Torimoto, Y (reprint author), Asahikawa Med Univ Hosp, Ctr Oncol, 2-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	tori@asahikawa-med.ac.jp; m-shindo@asahikawa-med.ac.jp; ikuta@asahikawa-med.ac.jp; yk1950@asahikawa-med.ac.jp					ALEXANIA.R, 1968, BLOOD, V31, P1; Rajkumar SV, 2010, LANCET ONCOL, V11, P29, DOI 10.1016/S1470-2045(09)70284-0; Patriarca F, 2012, BIOL BLOOD MARROW TR, V18, P617, DOI 10.1016/j.bbmt.2011.07.026; Cavo M, 2010, LANCET, V376, P2075, DOI 10.1016/S0140-6736(10)61424-9; Stewart AK, 2015, NEW ENGL J MED, V372, P142, DOI 10.1056/NEJMoa1411321; Palumbo A, 2007, J CLIN ONCOL, V25, P4459, DOI 10.1200/JCO.2007.12.3463; Dimopoulos MA, 2009, LEUKEMIA, V23, P2147, DOI 10.1038/leu.2009.147; Wijermans P, 2010, J CLIN ONCOL, V28, P3160, DOI 10.1200/JCO.2009.26.1610; Zonder JA, 2010, BLOOD, V116, P5838, DOI 10.1182/blood-2010-08-303487; Attal M, 2006, BLOOD, V108, P3289, DOI 10.1182/bloos-2006-05-022962; Morgan GJ, 2012, BLOOD, V119, P7, DOI 10.1182/blood-2011-06-357038; Roussel M, 2010, BLOOD, V115, P32, DOI 10.1182/blood-2009-06-229658; Mateos MV, 2010, J CLIN ONCOL, V28, P2259, DOI 10.1200/JCO.2009.26.0638; Palumbo A, 2014, LANCET ONCOL, V15, P333, DOI 10.1016/S1470-2045(13)70609-0; Madan S, 2011, BLOOD, V118, P1763, DOI 10.1182/blood-2011-04-350009; Attal M, 1996, NEW ENGL J MED, V335, P91, DOI 10.1056/NEJM199607113350204; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Dimopoulos M, 2007, NEW ENGL J MED, V357, P2123, DOI 10.1056/NEJMoa070594; Cavo M, 2007, J CLIN ONCOL, V25, P2434, DOI 10.1200/JCO.2006.10.2509; Mark TM, 2013, BIOL BLOOD MARROW TR, V19, P831, DOI 10.1016/j.bbmt.2013.02.013; Cavo M, 2005, BLOOD, V106, P35, DOI 10.1182/blood-2005-02-0522; Palumbo A, 2014, NEW ENGL J MED, V371, P895, DOI 10.1056/NEJMoa1402888; Facon T, 2007, LANCET, V370, P1209, DOI 10.1016/S0140-6736(07)61537-2; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Attal M, 2012, NEW ENGL J MED, V366, P1782, DOI 10.1056/NEJMoa1114138; Rosinol L, 2012, BLOOD, V120, P1589, DOI 10.1182/blood-2012-02-408922; Kumar SK, 2014, LEUKEMIA, V28, P1122, DOI 10.1038/leu.2013.313; Palumbo A, 2010, J CLIN ONCOL, V28, P5101, DOI 10.1200/JCO.2010.29.8216; Blanes M, 2013, BIOL BLOOD MARROW TR, V19, P69, DOI 10.1016/j.bbmt.2012.08.009; Koreth J, 2007, BIOL BLOOD MARROW TR, V13, P183, DOI 10.1016/j.bbmt.2006.09.010; Palumbo A, 2006, LANCET, V367, P825, DOI 10.1016/S0140-6736(06)68338-4; Palumbo A, 2012, NEW ENGL J MED, V366, P1759, DOI 10.1056/NEJMoa1112704; Mellqvist UH, 2013, BLOOD, V121, P4647, DOI 10.1182/blood-2012-11-464503; Palumbo A, 2014, J CLIN ONCOL, V32, P587, DOI 10.1200/JCO.2013.48.7934; Benboubker L, 2014, NEW ENGL J MED, V371, P906, DOI 10.1056/NEJMoa1402551; McCarthy PL, 2012, NEW ENGL J MED, V366, P1770, DOI 10.1056/NEJMoa1114083; Spencer A, 2009, J CLIN ONCOL, V27, P1788, DOI 10.1200/JCO.2008.18.8573; Moreau P, 2002, BLOOD, V99, P731, DOI 10.1182/blood.V99.3.731; Beksac M, 2011, EUR J HAEMATOL, V86, P16, DOI 10.1111/j.1600-0609.2010.01524.x; Richardson PG, 2010, BLOOD, V116, P679, DOI 10.1182/blood-2010-02-268862; San Miguel JF, 2013, J CLIN ONCOL, V31, P448, DOI 10.1200/JCO.2012.41.6180; Waage A, 2010, BLOOD, V116, P1405, DOI 10.1182/blood-2009-08-237974; Anagnostopoulos A, 2003, BRIT J HAEMATOL, V121, P768, DOI 10.1046/j.1365-2141.2003.04345.x; Attal M, 2003, NEW ENGL J MED, V349, P2495, DOI 10.1056/NEJMoa032290; Moreau P, 2011, LANCET ONCOL, V12, P431, DOI 10.1016/S1470-2045(11)70081-X; Fayers PM, 2011, BLOOD, V118, P1239, DOI 10.1182/blood-2011-03-341669; Palumbo A, 2008, BLOOD, V112, P3107, DOI 10.1182/blood-2008-04-149427; Morgan GJ, 2012, HAEMATOL-HEMATOL J, V97, P442, DOI 10.3324/haematol.2011.043372; Rajkumar SV, 2008, J CLIN ONCOL, V26, P2171, DOI 10.1200/JCO.2007.14.1853; Palumbo A, 2014, J CLIN ONCOL, V32, P634, DOI 10.1200/JCO.2013.52.0023; Richardson P, 2009, BLOOD, V114, P772, DOI 10.1182/blood-2008-12-196238; Ladetto M, 2010, J CLIN ONCOL, V28, P2077, DOI 10.1200/JCO.2009.23.7172; Harousseau JL, 2010, J CLIN ONCOL, V28, P4621, DOI 10.1200/JCO.2009.27.9158; Bringhen S, 2010, BLOOD, V116, P4745, DOI 10.1182/blood-2010-07-294983; Hulin C, 2009, J CLIN ONCOL, V27, P3664, DOI 10.1200/JCO.2008.21.0948; Sonneveld P, 2012, J CLIN ONCOL, V30, P2946, DOI 10.1200/JCO.2011.39.6820; Cook G, 2011, BIOL BLOOD MARROW TR, V17, P1638, DOI 10.1016/j.bbmt.2011.04.005; Morgan GJ, 2013, CLIN CANCER RES, V19, P6030, DOI 10.1158/1078-0432.CCR-12-3211; Mateos MV, 2010, LANCET ONCOL, V11, P934, DOI 10.1016/S1470-2045(10)70187-X; Nooka AK, 2013, CANCER-AM CANCER SOC, V119, P4119, DOI 10.1002/cncr.28325; Sonneveld P, 2013, J CLIN ONCOL, V31, P3279, DOI 10.1200/JCO.2012.48.4626; Cavo M, 2012, BLOOD, V120, P9, DOI 10.1182/blood-2012-02-408898; Kumar S, 2012, BLOOD, V119, P4375, DOI 10.1182/blood-2011-11-395749; Ludwig H, 2014, ONCOLOGIST, V19, P829, DOI 10.1634/theoncologist.2014-0042; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Knopf KB, 2014, CL LYMPH MYELOM LEUK, V14, P380, DOI 10.1016/j.clml.2014.03.005; Kropff M, 2012, HAEMATOL-HEMATOL J, V97, P784, DOI 10.3324/haematol.2011.044271; Mehta J, 2007, BONE MARROW TRANSPL, V40, P1101, DOI 10.1038/sj.bmt.1705799; Pasquali S, 1998, J CLIN ONCOL, V16, P3832; National Cancer Institute, SURV EP END RES PROG; San Miguel Jesus, 2013, Lancet Oncol, V14, P1055, DOI 10.1016/S1470-2045(13)70380-2; San-Miguel JF, 2014, LANCET ONCOL, V15, P1195, DOI 10.1016/S1470-2045(14)70440-1; Sonneveld P, 2007, HAEMATOL-HEMATOL J, V92, P928, DOI 10.3324/haematol.11168	73	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	JUN	2015	20	3					423	430		10.1007/s10147-015-0826-3		8	Oncology	Oncology	CK0WV	WOS:000355927200003		
J	Mizumachi, T; Homma, A; Kakizaki, T; Sakashita, T; Kano, S; Hatakeyama, H; Tsuchiya, K; Yasuda, K; Onimaru, R; Shirato, H; Taguchi, J; Shimizu, Y; Kinoshita, I; Akita, H; Fukuda, S				Mizumachi, Takatsugu; Homma, Akihiro; Kakizaki, Tomohiko; Sakashita, Tomohiro; Kano, Satoshi; Hatakeyama, Hiromitsu; Tsuchiya, Kazuhiko; Yasuda, Koichi; Onimaru, Rikiya; Shirato, Hiroki; Taguchi, Jun; Shimizu, Yasushi; Kinoshita, Ichiro; Akita, Hirotoshi; Fukuda, Satoshi			Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with concurrent weekly cisplatin chemoradiotherapy for locally advanced head and neck squamous cell carcinoma	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Head and neck cancer; Induction chemotherapy; Chemoradiotherapy	CONCOMITANT WEEKLY CISPLATIN; PHASE-II; LARYNX PRESERVATION; JAPANESE PATIENTS; RANDOMIZED-TRIAL; CANCER; RADIOTHERAPY; FLUOROURACIL	The aim of this study was to evaluate the feasibility of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy followed by concurrent weekly cisplatin chemoradiotherapy for patients with locally advanced head and neck squamous cell carcinoma (HNSCC). Between 2010 and 2013, 30 patients with Stage IV HNSCC were treated in Hokkaido University Hospital with three cycles of induction chemotherapy (docetaxel 75 mg/m(2) and cisplatin 75 mg/m(2), day 1; and 5-fluorouracil 750 mg/m(2)/day 120 h continuous infusion, every 3 weeks) followed by concurrent weekly cisplatin (40 mg/m(2), on weeks 1, 2, 3, 5, 6 and 7) chemoradiotherapy. Three courses of induction chemotherapy were performed in 25 patients (83 %) with grade 3-4 toxicities during induction chemotherapy observed in 22 patients (73 %). The major toxicities were hematologic, with 22 cases (73 %) showing grade 3-4 neutropenia. Radiotherapy was completed (70 Gy) in 29 patients (97 %), while a total of 19 patients (63 %) completed five (13 patients) or six (6 patients) courses of chemotherapy. During concurrent chemoradiotherapy, no grade 4 hematological toxicities were observed. Grade 4 dermatitis was observed in one patient, and grade 3 mucositis was observed in 12 patients. There were no treatment-related deaths during the induction chemotherapy or concurrent chemoradiotherapy. The 1- and 2-year progression-free survival rates and the 1- and 2-year overall survival rates were 86 %, 72 %, and 89 %, 81 %, respectively. Sequential therapy composed of induction chemotherapy followed by concurrent weekly cisplatin chemoradiotherapy is feasible, showing encouraging results in patients with locally advanced HNSCC. Concurrent weekly cisplatin chemoradiotherapy following induction chemotherapy appears to be a suitable alternative to three-weekly high-dose cisplatin therapy.	[Mizumachi, Takatsugu; Homma, Akihiro; Kakizaki, Tomohiko; Sakashita, Tomohiro; Kano, Satoshi; Hatakeyama, Hiromitsu; Fukuda, Satoshi] Hokkaido Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Tsuchiya, Kazuhiko; Yasuda, Koichi; Onimaru, Rikiya; Shirato, Hiroki] Hokkaido Univ, Dept Radiat Med, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan; [Taguchi, Jun; Shimizu, Yasushi; Kinoshita, Ichiro; Akita, Hirotoshi] Hokkaido Univ, Dept Med Oncol, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan	Mizumachi, T (reprint author), Hokkaido Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	mizumati@med.hokudai.ac.jp	Onimaru, Rikiya/C-9805-2012	Onimaru, Rikiya/0000-0002-4768-2358	Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Adelstein DJ, 2009, HEAD NECK-J SCI SPEC, V32, P221; Lefebvre JL, 2013, J CLIN ONCOL, V31, P853, DOI 10.1200/JCO.2012.42.3988; Prestwich RJ, 2011, INT J RADIAT ONCOL, V81, pE237, DOI 10.1016/j.ijrobp.2011.03.043; Mizumachi T, 2013, INT J CLIN ONCOL, V18, P824, DOI 10.1007/s10147-012-0469-6; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; Newlin HE, 2010, CANCER-AM CANCER SOC, V116, P4533, DOI 10.1002/cncr.25189; Homma A, 2011, JPN J CLIN ONCOL, V41, P980, DOI 10.1093/jjco/hyr086; Sharma A, 2010, ANN ONCOL, V21, P2272, DOI 10.1093/annonc/mdq219; Pignon JP, 2009, RADIOTHER ONCOL, V92, P4, DOI 10.1016/j.radonc.2009.04.014; Pointreau Y, 2009, J NATL CANCER I, V101, P498, DOI 10.1093/jnci/djp007; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Adelstein DJ, 2003, J CLIN ONCOL, V21, P92, DOI 10.1200/JCO.2003.01.008; Paccagnella A, 2010, ANN ONCOL, V21, P1515, DOI 10.1093/annonc/mdp573; Hitt R, 2005, J CLIN ONCOL, V23, P8636, DOI 10.1200/JCO.2004.00.1990; Haddad R, 2013, LANCET ONCOL, V14, P257, DOI 10.1016/S1470-2045(13)70011-1; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Rutter CE, 2011, HEAD NECK-J SCI SPEC, V33, P1441, DOI 10.1002/hed.21624; Spector ME, 2012, HEAD NECK-J SCI SPEC, V34, P1727, DOI 10.1002/hed.21997; Traynor AM, 2009, HEAD NECK-J SCI SPEC, V32, P599; Zenda S, 2011, RADIOTHER ONCOL, V101, P410, DOI 10.1016/j.radonc.2011.09.016; Zenda S, 2007, JPN J CLIN ONCOL, V37, P725, DOI 10.1093/jjco/hym106	21	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	JUN	2015	20	3					431	437		10.1007/s10147-014-0726-y		7	Oncology	Oncology	CK0WV	WOS:000355927200004		
J	Yazama, H; Kitatani, K; Fujiwara, K; Kato, M; Hashimoto-Nishimura, M; Kawamoto, K; Hasegawa, K; Kitano, H; Bielawska, A; Bielawski, J; Okazaki, T				Yazama, Hiroaki; Kitatani, Kazuyuki; Fujiwara, Kazunori; Kato, Misaki; Hashimoto-Nishimura, Mayumi; Kawamoto, Katsuyuki; Hasegawa, Kensaku; Kitano, Hiroya; Bielawska, Alicja; Bielawski, Jacek; Okazaki, Toshiro			Dietary glucosylceramides suppress tumor growth in a mouse xenograft model of head and neck squamous cell carcinoma by the inhibition of angiogenesis through an increase in ceramide	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Angiogenesis; Dietary glucosylceramides; Head and neck cancer; VEGF; VEGFR-2; HIF-1 alpha	INTESTINAL TRACT; SPHINGOID BASES; IN-VIVO; CANCER; METASTASIS; METABOLISM; VEGF; SPHINGOLIPIDS; EXPRESSION; SPHINGOSINE-1-PHOSPHATE	We previously reported that dietary glucosylceramides show cancer-prevention activity in a mouse xenograft model of human head and neck cancer cells (SCCKN). However, the mechanism was unclear. Ceramides, metabolites of glucosylceramides, induce apoptotic cell death in various malignancies. Here, we investigated the inhibitory effects of dietary glucosylceramides on tumor growth in vivo and in vitro. SCCKN were subcutaneously inoculated into the right flanks of NOD/SCID mice. Mice were treated with or without dietary glucosylceramides (300 mg/kg) daily for 14 consecutive days after confirmation of tumor progression. Microvessel areas around the tumor were assessed by hematoxylin-eosin staining and immunohistochemistry of CD31, and, as markers for angiogenesis, protein levels of VEGF, VEGF receptor-2, and HIF-1 alpha were assessed by Western blotting. Mass spectrometry was performed to measure the levels of sphingolipids in mouse serum after treatment with dietary glucosylceramides. Oral administration of glucosylceramides significantly decreased SCCKN growth in the xenograft model with inhibition of angioinvasion. In tumor-invasive areas, VEGF and HIF-1 alpha in the tumor cells, and VEGF receptor-2 in endothelial cells decreased after treatment with dietary glucosylceramides. Dietary glucosylceramides increased serum levels of sphingosine-based ceramides as compared to the control. In SCCKN and UVa (TM) Euro2 cells, C6-ceramide suppressed the expressions of VEGF, VEGF receptor-2, and HIF-1 alpha in vitro. These results suggest that dietary glucosylceramides trigger the de novo pathway of ceramide synthesis, indicating that sphingosine-based ceramide suppresses the growth of head and neck tumors through the inhibition of pro-angiogenic signals such as VEGF, VEGF receptor-2, and HIF-1 alpha.	[Yazama, Hiroaki; Fujiwara, Kazunori; Kawamoto, Katsuyuki; Hasegawa, Kensaku; Kitano, Hiroya] Tottori Univ, Dept Otolaryngol Head & Neck Surg, Fac Med, Yonago, Tottori 6838503, Japan; [Kitatani, Kazuyuki] Tottori Univ, Div Clin Lab Med, Fac Med, Yonago, Tottori 6838503, Japan; [Kato, Misaki; Hashimoto-Nishimura, Mayumi] Tottori Univ Hosp Canc Ctr, Yonago, Tottori 6838504, Japan; [Bielawska, Alicja; Bielawski, Jacek] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Okazaki, Toshiro] Kanazawa Med Univ, Div Hematol & Immunol, Uchinada, Ishikawa 9200293, Japan	Okazaki, T (reprint author), Kanazawa Med Univ, Div Hematol & Immunol, Uchinada, Ishikawa 9200293, Japan.	hkitano@med.tottori-u.ac.jp; toshiroo@kanazawa-med.ac.jp		Kitatani, Kazuyuki/0000-0002-8516-6135	Takeda Science Foundation; Strategic Research Foundation; Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT) [S1201004]; Kanazawa Medical University [H2012-15]; SENSHIN Medical Research Foundation; Mizutani Foundation for Glycoscience; Collaborative Research from Kanazawa Medical University [C2012-4, C2013-1]; Chieko Sakurai Commemorative Grant	This work was partly supported by Takeda Science Foundation and performed under a joint research project with Shalome Co. Ltd. and Ono Pharmaceutical Co. Ltd. This study was supported in part by a grant of the Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT) (No. S1201004) from Kanazawa Medical University (H2012-15), 2012-2016, from the SENSHIN Medical Research Foundation, from the Mizutani Foundation for Glycoscience; from the Collaborative Research from Kanazawa Medical University (C2012-4, C2013-1); and from the Chieko Sakurai Commemorative Grant.	Sugawara T, 2010, J LIPID RES, V51, P1761, DOI 10.1194/jlr.M002204; Bielawski J, 2009, METHODS MOL BIOL, V579, P443, DOI 10.1007/978-1-60761-322-0_22; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Grothey A, 2009, NAT REV CLIN ONCOL, V6, P507, DOI 10.1038/nrclinonc.2009.110; NILSSON A, 1969, BIOCHIM BIOPHYS ACTA, V187, P113, DOI 10.1016/0005-2760(69)90138-6; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Ikeda N, 1999, BRIT J CANCER, V79, P1553, DOI 10.1038/sj.bjc.6690248; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Vesper H, 1999, J NUTR, V129, P1239; Oku H, 2007, CANCER CHEMOTH PHARM, V60, P767, DOI 10.1007/s00280-007-0422-y; Yabu T, 2005, BLOOD, V106, P125, DOI 10.1182/blood-2004-09-3679; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gaengel K, 2012, DEV CELL, V23, P587, DOI 10.1016/j.devcel.2012.08.005; Tanigawa N, 1997, J CLIN ONCOL, V15, P826; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; Menaldino DS, 2003, PHARMACOL RES, V47, P373, DOI 10.1016/S1043-6618(03)00054-9; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; NILSSON A, 1968, BIOCHIM BIOPHYS ACTA, V164, P575, DOI 10.1016/0005-2760(68)90187-2; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Sugawara T, 2004, BIOSCI BIOTECH BIOCH, V68, P2541, DOI 10.1271/bbb.68.2541; Jemal A, 2007, CA-CANCER J CLIN, V57, P43; BRADY RO, 1965, J BIOL CHEM, V240, P39; ASANO M, 1995, CANCER RES, V55, P5296; Bansode RR, 2011, INT J BIOL SCI, V7, P629; Barth BM, 2010, CANCER BIOL THER, V10, P1126, DOI 10.4161/cbt.10.11.13438; Chaigneau L, 2006, B CANCER, V93, P677; Che XM, 1998, ANN SURG ONCOL, V5, P585; Fujiwara K, 2011, INT J CLIN ONCOL, V16, P133, DOI 10.1007/s10147-010-0141-y; Her C, 2001, AM FAM PHYSICIAN, V63, P1776; Ideta R, 2011, BIOSCI BIOTECH BIOCH, V75, P1516, DOI 10.1271/bbb.110215; Inafuku M, 2012, LIPIDS, V47, P581, DOI 10.1007/s11745-012-3666-1; Linder S, 2001, PANCREAS, V22, P240, DOI 10.1097/00006676-200104000-00003; Neuchrist C, 2001, LARYNGOSCOPE, V111, P1834, DOI 10.1097/00005537-200110000-00031; Ramos B, 2003, MOL PHARMACOL, V64, P502, DOI 10.1124/mol.64.2.502	39	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	JUN	2015	20	3					438	446		10.1007/s10147-014-0734-y		9	Oncology	Oncology	CK0WV	WOS:000355927200005		
J	Zenda, S; Kawashima, M; Arahira, S; Kohno, R; Nishio, T; Tahara, M; Hayashi, R; Akimoto, T				Zenda, Sadamoto; Kawashima, Mitsuhiko; Arahira, Satoko; Kohno, Ryosuke; Nishio, Teiji; Tahara, Makoto; Hayashi, Ryuichi; Akimoto, Tetsuo			Late toxicity of proton beam therapy for patients with the nasal cavity, para-nasal sinuses, or involving the skull base malignancy: importance of long-term follow-up	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Proton beam therapy; Late toxicity; Followup; Head and neck cancer	PARANASAL SINUSES; CEREBRAL RADIONECROSIS; NECK-CANCER; RADIOTHERAPY; CARCINOMA; OUTCOMES; SURGERY; VOLUME; HEAD	Although several reports have shown that proton beam therapy (PBT) offers promise for patients with skull base cancer, little is known about the frequency of late toxicity in clinical practice when PBT is used for these patients. Here, we conducted a retrospective analysis to clarify the late toxicity profile of PBT in patients with malignancies of the nasal cavity, para-nasal sinuses, or involving the skull base. Entry to this retrospective study was restricted to patients with (1) malignant tumors of the nasal cavity, para-nasal sinuses, or involving the skull base; (2) definitive or postoperative PBT (> 50 GyE) from January 1999 through December 2008; and (3) more than 1 year of follow-up. Late toxicities were graded according to the common terminology criteria for adverse events v4.0 (CTCAE v4.0). From January 1999 through December 2008, 90 patients satisfied all criteria. Median observation period was 57.5 months (range, 12.4-162.7 months), median time to onset of grade 2 or greater late toxicity except cataract was 39.2 months (range, 2.7-99.8 months), and 3 patients had toxicities that occurred more than 5 years after PBT. Grade 3 late toxicities occurred in 17 patients (19 %), with 19 events, and grade 4 late toxicities in 6 patients (7 %), with 6 events (encephalomyelitis infection 2, optic nerve disorder 4). In conclusion, the late toxicity profile of PBT in patients with malignancy involving the nasal cavity, para-nasal sinuses, or skull base malignancy was partly clarified. Because late toxicity can still occur at 5 years after treatment, long-term follow-up is necessary.	[Zenda, Sadamoto; Kawashima, Mitsuhiko; Arahira, Satoko; Kohno, Ryosuke; Nishio, Teiji; Akimoto, Tetsuo] Natl Canc Ctr Hosp East, Div Radiat Oncol, Kashiwa, Chiba 2778577, Japan; [Tahara, Makoto] Natl Canc Ctr Hosp East, Div Head & Neck Med Oncol, Kashiwa, Chiba 2778577, Japan; [Hayashi, Ryuichi] Natl Canc Ctr Hosp East, Div Head & Neck Surg, Kashiwa, Chiba 2778577, Japan	Zenda, S (reprint author), Natl Canc Ctr Hosp East, Div Radiat Oncol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	szenda@east.ncc.go.jp					KETCHAM AS, 1963, AM J SURG, V106, P698; Hotta K, 2010, PHYS MED BIOL, V55, P3545, DOI 10.1088/0031-9155/55/12/018; Zenda S, 2011, INT J RADIAT ONCOL, V81, P1473, DOI 10.1016/j.ijrobp.2010.08.009; SHELINE GE, 1980, INT J RADIAT ONCOL, V6, P1215; Dulguerov P, 2001, CANCER, V92, P3012, DOI 10.1002/1097-0142(20011215)92:12<3012::AID-CNCR10131>3.0.CO;2-E; Jansen EPM, 2000, INT J RADIAT ONCOL, V48, P27, DOI 10.1016/S0360-3016(00)00594-0; Mizoe J, 2012, RADIOTHER ONCOL, V103, P32, DOI 10.1016/j.radonc.2011.12.013; Nutting CM, 2011, LANCET ONCOL, V12, P127, DOI 10.1016/S1470-2045(10)70290-4; Hoppe BS, 2008, INT J RADIAT ONCOL, V72, P763, DOI 10.1016/j.ijrobp.2008.01.038; Nishimura H, 2007, INT J RADIAT ONCOL, V68, P758, DOI 10.1016/j.ijrobp.2006.12.071; Debus J, 2001, J CLIN ONCOL, V19, P3547; MARKS JE, 1981, INT J RADIAT ONCOL, V7, P243; Blanco AI, 2004, INT J RADIAT ONCOL, V59, P51, DOI 10.1016/j.ijrobp.2003.09.101; Dirix P, 2007, INT J RADIAT ONCOL, V69, P1042, DOI 10.1016/j.ijrobp.2007.04.044; Fuji H, 2011, SKULL BASE-INTERD AP, V21, P201, DOI 10.1055/s-0031-1275636; Hoppe BS, 2007, INT J RADIAT ONCOL, V67, P691, DOI 10.1016/j.ijrobp.2006.09.023; Lee DS, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-85; Snyers A, 2009, INT J RADIAT ONCOL, V73, P1343, DOI 10.1016/j.ijrobp.2008.07.040; Stelzer KJ, 2000, NEUROSURG CLIN N AM, V11, P597; WOO E, 1987, J NEUROL NEUROSUR PS, V50, P1407, DOI 10.1136/jnnp.50.11.1407	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	JUN	2015	20	3					447	454		10.1007/s10147-014-0737-8		8	Oncology	Oncology	CK0WV	WOS:000355927200006		
J	Izawa, N; Onozawa, Y; Hikosaka, T; Hamauchi, S; Tsushima, T; Todaka, A; Machida, N; Haraguchi, Y; Ogawa, H; Nishimura, T; Nakagawa, M; Fuke, T; Iida, Y; Kamijo, T; Onitsuka, T; Boku, N; Yasui, H; Yokota, T				Izawa, Naoki; Onozawa, Yusuke; Hikosaka, Tomomi; Hamauchi, Satoshi; Tsushima, Takahiro; Todaka, Akiko; Machida, Nozomu; Haraguchi, Yutaka; Ogawa, Hirofumi; Nishimura, Tetsuo; Nakagawa, Masahiro; Fuke, Tomohito; Iida, Yoshiyuki; Kamijo, Tomoyuki; Onitsuka, Tetsuro; Boku, Narikazu; Yasui, Hirofumi; Yokota, Tomoya			Efficacy and feasibility of docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy for locally advanced head and neck squamous cell carcinoma classified as clinical nodal stage N2c, N3, or N2b with supraclavicular lymph node metastases	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						TPF; Induction chemotherapy; Chemoradiotherapy	PHASE-III TRIAL; DISTANT METASTASES; CONCURRENT CHEMORADIOTHERAPY; PROGNOSTIC-FACTORS; UNRESECTABLE HEAD; CANCER; PRESERVATION; FLUOROURACIL; RADIOTHERAPY; SURVIVAL	We evaluated the efficacy and feasibility of docetaxel, cisplatin, and 5-fluorouracil (TPF) induction chemotherapy followed by concurrent chemoradiotherapy (CRT) for locally advanced head and neck squamous cell carcinoma (HNSCC) with a high risk of distant metastases compared with CRT alone. We retrospectively analyzed 29 HNSCC patients with clinical nodal stage N2c, N3, or N2b disease and supraclavicular lymph node metastases receiving CRT alone (CRT group; n = 16) or TPF induction chemotherapy followed by CRT (TPF group; n = 13) between April 2008 and May 2012. The median follow-up periods were 14.5 (range 5.0-65.0) and 25.0 (range 14.0-32.0) months for CRT and TPF groups, respectively. A greater proportion of patient characteristics in the CRT group had advanced T and N stages. The overall response rate to induction TPF was 50.0 %; grade 3-4 toxicities included neutropenia, febrile neutropenia, anorexia, and hyponatremia. Complete response rates after CRT completion were 55.5 % in the TPF and 42.9 % in the CRT group; median overall survival was not reached in the TPF group and was 14.0 months in the CRT group (p = 0.037). Multivariate analysis revealed that induction TPF and T stage were independent prognostic factors [hazard ratio (HR) = 0.196; 95 % confidence interval (CI) 0.043-0.898; p = 0.036, HR = 9.966; 95 % CI 2.270-43.75; p = 0.002, respectively). TPF followed by CRT is tolerated and may be an option for the treatment of locally advanced stage N2c, N3, or N2b HNSCC.	[Izawa, Naoki; Onozawa, Yusuke; Hikosaka, Tomomi; Hamauchi, Satoshi; Tsushima, Takahiro; Todaka, Akiko; Machida, Nozomu; Haraguchi, Yutaka; Yasui, Hirofumi; Yokota, Tomoya] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka 4118777, Japan; [Izawa, Naoki; Boku, Narikazu] St Marianna Univ, Sch Med, Div Clin Oncol, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan; [Onozawa, Yusuke] Shizuoka Canc Ctr, Div Med Oncol, Shizuoka 4118777, Japan; [Ogawa, Hirofumi; Nishimura, Tetsuo] Shizuoka Canc Ctr, Div Radiat Oncol, Shizuoka 4118777, Japan; [Nakagawa, Masahiro] Shizuoka Canc Ctr, Div Plast & Reconstruct Surg, Shizuoka 4118777, Japan; [Fuke, Tomohito; Iida, Yoshiyuki; Kamijo, Tomoyuki; Onitsuka, Tetsuro] Shizuoka Canc Ctr, Div Head & Neck Surg, Shizuoka 4118777, Japan	Yokota, T (reprint author), Shizuoka Canc Ctr, Div Gastrointestinal Oncol, 1007 Shimonagakubo Nagaizumi, Shizuoka 4118777, Japan.	t.yokota@scchr.jp			Taiho; Chugai; Shionogi; Merck Serono; Bristol-Myers Squibb	Narikazu Boku received a research grant from Taiho and Chugai and lecture fees from Taiho, Chugai, and Shionogi. Tomoya Yokota serves as a consultant to AstraZeneca and receives lecture fees from Merck Serono and Bristol-Myers Squibb. The other authors have no conflict of interest.	Garavello W, 2006, ARCH OTOLARYNGOL, V132, P762, DOI 10.1001/archotol.132.7.762; Leon X, 2000, HEAD NECK-J SCI SPEC, V22, P680, DOI 10.1002/1097-0347(200010)22:7<680::AID-HED7>3.0.CO;2-J; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Denis F, 2004, J CLIN ONCOL, V22, P69, DOI 10.1200/JCO.2004.08.021; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; Hitt R, 2014, ANN ONCOL, V25, P216, DOI 10.1093/annonc/mdt461; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; Brockstein B, 2004, ANN ONCOL, V15, P1179, DOI 10.1093/annonc/mdh308; Matsuo JMS, 2003, ANN SURG, V238, P412, DOI 10.1097/01.sla.0000086660.35809.8a; Hara H, 2013, CANCER SCI, V104, P1455, DOI 10.1111/cas.12274; Lefebvre JL, 1996, J NATL CANCER I, V88, P890, DOI 10.1093/jnci/88.13.890; Pignon JP, 2009, RADIOTHER ONCOL, V92, P4, DOI 10.1016/j.radonc.2009.04.014; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Adelstein DJ, 2003, J CLIN ONCOL, V21, P92, DOI 10.1200/JCO.2003.01.008; de Bree R, 2000, LARYNGOSCOPE, V110, P397, DOI 10.1097/00005537-200003000-00012; CEREZO L, 1992, CANCER, V69, P1224; Haddad R, 2013, LANCET ONCOL, V14, P257, DOI 10.1016/S1470-2045(13)70011-1; Cohen EE, 2012, J CLIN ONCOL S, V30, p356s; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Ura T, 2010, 2010 ASCO GASTR CANC; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306	21	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	JUN	2015	20	3					455	462		10.1007/s10147-014-0749-4		8	Oncology	Oncology	CK0WV	WOS:000355927200007		
J	Kutomi, G; Ohmura, T; Satomi, F; Maeda, H; Shima, H; Kameshima, H; Okazaki, M; Masuoka, H; Sasaki, K; Hirata, K				Kutomi, Goro; Ohmura, Tousei; Satomi, Fukino; Maeda, Hideki; Shima, Hiroaki; Kameshima, Hidekazu; Okazaki, Minoru; Masuoka, Hideji; Sasaki, Kenichi; Hirata, Koichi			A phase I study of combination therapy with nanoparticle albumin-bound paclitaxel and cyclophosphamide in patients with metastatic or recurrent breast cancer	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Breast cancer; nab-paclitaxel; Cyclophosphamide; Phase I	CREMOPHOR-FREE; ABI-007; TRIAL; WOMEN	The objective of the present clinical study is to determine the maximum tolerated dose (MTD)/recommended dose (RD) of combination therapy with nanoparticle albumin-bound paclitaxel (nab-PTX) and cyclophosphamide (CPA) in patients with metastatic or recurrent breast cancer. nab-PTX and CPA were administered on the first day of each 21-day treatment cycle. The dose of CPA was fixed at 600 mg/m(2), while the dose of nab-PTX was increased from 180 mg/m(2) (Level 1) to 220 mg/m(2) (Level 2) and then to 260 mg/m(2) (Level 3). A total of 11 patients from two institutions were enrolled in the present study. At Level 3, a dose-limiting toxicity (DLT) was observed in 1 patient. Considering treatment continuity and the risk of adverse events in Cycle 2 and thereafter at this level, further subject enrollment at Level 3 was discontinued after two patients had been enrolled. Since the doses used at Level 3 were considered the MTD of nab-PTX and CPA and the doses used at Level 2 were considered the RD of nab-PTX and CPA, three additional subjects were enrolled at Level 2. No DLTs were observed at Level 2. The RD of combination therapy with nab-PTX and CPA was 220 mg/m(2) and 600 mg/m(2), respectively, in patients with metastatic or recurrent breast cancer.	[Kutomi, Goro; Satomi, Fukino; Maeda, Hideki; Shima, Hiroaki; Hirata, Koichi] Sapporo Med Univ, Sch Med, Dept Surg Surg Oncol & Sci, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Ohmura, Tousei; Kameshima, Hidekazu] Higashi Sapporo Hosp, Dept Surg, Sapporo, Hokkaido, Japan; [Okazaki, Minoru] Sapporo Breast Surg Clin, Sapporo, Hokkaido, Japan; [Masuoka, Hideji] Sapporo Kotoni Breast Clin, Sapporo, Hokkaido, Japan; [Sasaki, Kenichi] Muroran City Gen Hosp, Dept Surg, Muroran, Hokkaido, Japan	Kutomi, G (reprint author), Sapporo Med Univ, Sch Med, Dept Surg Surg Oncol & Sci, Chuo Ku, Minami 1 Jo,Nishi 17 Chome, Sapporo, Hokkaido 0608556, Japan.	kutomi@sapmed.ac.jp					Ibrahim NK, 2002, CLIN CANCER RES, V8, P1038; Gradishar WJ, 2006, EXPERT OPIN PHARMACO, V7, P1041, DOI 10.1517/14656566.7.8.1041; Gradishar WJ, 2005, J CLIN ONCOL, V23, P7794, DOI 10.1200/JCO.2005.04.937; Elsadek B, 2012, J CONTROL RELEASE, V157, P4, DOI 10.1016/j.jconrel.2011.09.069; Desai N, 2006, CLIN CANCER RES, V12, P1317, DOI 10.1158/1078-0432.CCR-05-1634; Sparreboom A, 1999, CANCER RES, V59, P1454; Ibrahim NK, 2005, J CLIN ONCOL, V23, P6019, DOI 10.1200/JCO.2005.11.013; VONHOFF DD, 1979, ANN INTERN MED, V91, P710; Bissery MC, 1995, SEMIN ONCOL, V22, P3; Denise Y, 2010, BREAST CANC RES TREA, V123, P471; Hortobagyi GN, 1998, NEW ENGL J MED, V339, P974; John TA, 2003, AM J PHYSIOL-LUNG C, V284, P187; Jonathan CTr, 2003, CLIN CANCER RES, V9, P2426; Stephen EJ, 2006, J CLIN ONCOL, V34, P5381; The Japanese Breast Cancer Society, 2013, BREAST CANC GUID; William JG, 2009, J CLIN ONCOL, V27, P3611	16	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	JUN	2015	20	3					474	479		10.1007/s10147-014-0725-z		6	Oncology	Oncology	CK0WV	WOS:000355927200009		
J	Horii, R; Matsuura, M; Dan, S; Ushijima, M; Uehiro, N; Ogiya, A; Honma, N; Ito, Y; Iwase, T; Yamori, T; Akiyama, F				Horii, Rie; Matsuura, Masaaki; Dan, Shingo; Ushijima, Masaru; Uehiro, Natsue; Ogiya, Akiko; Honma, Naoko; Ito, Yoshinori; Iwase, Takuji; Yamori, Takao; Akiyama, Futoshi			Extensive analysis of signaling pathway molecules in breast cancer: association with clinicopathological characteristics	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Breast cancer; Pathology; Classification; p-p70S6 K; Signaling pathway; Survival	CYCLIN D1; CELLS; CARCINOMA; GROWTH; METASTASIS; EXPRESSION; INHIBITOR; ESTROGEN; RECEPTOR; THERAPY	The aim of this study was to extensively analyze the signaling pathway molecules in breast cancer and to explore candidate biomarkers for clinicopathological relevance. We assessed the expression of key factors in cell signaling, namely p-AKT, cyclin D1, P27, p-p70S6 K, p-4EBP1, and p-MAPK/ERK, within 338 invasive breast cancer patients. These factors were immunohistochemically examined in tumor tissues and assessed by staining score. Staining scores were analyzed by a clustering method to devise a new classification based on pathway activity. We investigated the relationships among staining scores, the clustering classification, and patient characteristics. The proportion of patients displaying high expression levels were as fol lows: p-AKT, 75 %; cyclin D1, 12 %; P27, 53 %; p-p70S6 K, 37 %; p-4EBP1, 19 %; and p-MAPK/ERK, 3 %. Patients were classified into two groups on the basis of staining scores. Group 1 (39 %) included more positive cases for p-4EBP1, p-MAPK/ERK, and p-p70S6 K and fewer positive cases for P27 and cyclin D1 than Group 2 (61 %). The clustering classification was significantly related to subgrouping by hormone receptor and HER2 (P < 0.001), nuclear grade (P < 0.001) and histological subtype (P = 0.034). A strong positive correlation was identified between p-AKT and P27, cyclin D1 and P27, p-p70S6 K and p-4EBP1, p-p70S6 K and p-MAPK/ERK, and between p-4EBP1 and p-MAPK/ERK. Levels of p-p70S6 K were significantly related to recurrence in both univariate (RR = 0.75, P < 0.001) and multivariate (RR = 0.71, P = 0.049) analyses. The present study helps us to understand the characteristics of signaling pathway status in breast cancers. Moreover, p-p70S6 K expression may be of use in predicting clinical outcome.	[Horii, Rie; Honma, Naoko; Akiyama, Futoshi] Japanese Fdn Canc Res, Inst Canc, Dept Pathol, Koto Ku, Tokyo 1358550, Japan; [Horii, Rie; Akiyama, Futoshi] Japanese Fdn Canc Res, Inst Canc, Dept Pathol, Tokyo 1358550, Japan; [Matsuura, Masaaki] Japanese Fdn Canc Res, Inst Canc, Dept Canc Genom, Tokyo 1358550, Japan; [Matsuura, Masaaki; Ushijima, Masaru] Japanese Fdn Canc Res, Genome Ctr, Bioinformat Grp, Tokyo 1358550, Japan; [Dan, Shingo; Yamori, Takao] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Dept Mol Pharmacol, Tokyo 1358550, Japan; [Uehiro, Natsue; Ogiya, Akiko; Ito, Yoshinori; Iwase, Takuji] Japanese Fdn Canc Res, Canc Inst Hosp, Breast Oncol Ctr, Tokyo 1358550, Japan; [Honma, Naoko] Tokyo Metropolitan Inst Gerontol, Res Team Geriatr Pathol, Tokyo, Japan	Horii, R (reprint author), Japanese Fdn Canc Res, Inst Canc, Dept Pathol, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	rhorii-pathology@jfcr.or.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors would like to thank Ms. Tomoyo Kakita, Ms. Mayumi Ogawa, Mr. Genkichi Iwakoshi and the technical staff of the Department of Pathology, Cancer Institute, for their excellent technical support.	Aleskandarany MA, 2011, BREAST CANCER RES TR, V127, P407, DOI 10.1007/s10549-010-1012-y; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Klos KS, 2006, CANCER RES, V66, P2028, DOI 10.1158/0008-5472.CAN-04-4559; Esteva FJ, 2010, AM J PATHOL, V177, P1647, DOI 10.2353/ajpath.2010.090885; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Dan S, 2010, CANCER RES, V70, P4982, DOI 10.1158/0008-5472.CAN-09-4172; Akar U, 2010, MOL CANCER THER, V9, P1180, DOI 10.1158/1535-7163.MCT-09-1025; Di Nicolantonio F, 2010, J CLIN INVEST, V120, P2858, DOI 10.1172/JCI37539; Tsuda H, 1998, JPN J CLIN ONCOL, V28, P486, DOI 10.1093/jjco/28.8.486; Bareford MD, 2011, CANCER RES, V71, P4955, DOI 10.1158/0008-5472.CAN-11-0898; Kong D, 2008, CANCER SCI, V99, P1734, DOI 10.1111/j.1349-7006.2008.00891.x; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Rojo F, 2007, CLIN CANCER RES, V13, P81, DOI 10.1158/1078-0432.CCR-06-1560; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Capodanno A, 2009, HUM PATHOL, V40, P1408, DOI 10.1016/j.humpath.2009.02.005; Elkabets M, 2013, SCI TRANSL IN PRESS, DOI [10.1126/scitranslmed.300574710.1126/scitranslmed.3005747, DOI 10.1126/SCITRANSLMED.300574710.1126/SCITRANSLMED.3005747]; Karlsson E, 2011, GENE CHROMOSOME CANC, V50, P775, DOI 10.1002/gcc.20900; Kim EK, 2011, BREAST CANCER RES TR, V126, P93, DOI 10.1007/s10549-010-1315-z; Lee A, 2007, JPN J CLIN ONCOL, V37, P708, DOI 10.1093/jjco/hym082; Page DL, 1987, DIAGNOSTIC HISTOPATH, P193; Reed W, 1999, VIRCHOWS ARCH, V435, P116, DOI 10.1007/s004280050408; Sakamoto Goi, 2005, Breast Cancer, V12 Suppl, pS1; Stendahl M, 2010, INT J CANCER, V127, P2851, DOI 10.1002/ijc.25297; van der Hage JA, 2004, BRIT J CANCER, V90, P1543, DOI 10.1038/sj.bjc.6601741	24	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	JUN	2015	20	3					490	498		10.1007/s10147-014-0753-8		9	Oncology	Oncology	CK0WV	WOS:000355927200011		
J	Ochiai, S; Yamakado, K; Kodama, H; Nomoto, Y; Ii, N; Takaki, H; Sakuma, H				Ochiai, Satoru; Yamakado, Koichiro; Kodama, Hiroshi; Nomoto, Yoshihito; Ii, Noriko; Takaki, Haruyuki; Sakuma, Hajime			Comparison of therapeutic results from radiofrequency ablation and stereotactic body radiotherapy in solitary lung tumors measuring 5 cm or smaller	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Lung tumors; Radiofrequency ablation; Stereotactic body radiotherapy; Prognosis; Complication	RADIATION-THERAPY; PHASE-II; CLINICAL-OUTCOMES; RISK-FACTORS; CANCER; COMPLICATIONS; PNEUMOTHORAX; FEASIBILITY; CANDIDATES; EXPERIENCE	This retrospective study was conducted to compare the clinical outcomes of radiofrequency ablation (RFA) with those of stereotactic body radiotherapy (SBRT) in patients with lung tumors. Local tumor progression, adverse events, and overall survival were compared in patients who underwent either RFA or SBRT for a single lung tumor measuring 5 cm or smaller. This study was approved by the institutional review boards of two institutions. Informed consent was waived. During September 2009 to June 2012, 48 patients [30 males and 18 females, with a mean age +/- A standard deviation (SD) of 75.0 +/- A 7.5 years] underwent RFA at one institution and 47 patients (21 males and 26 females, with a mean age +/- A SD of 77.0 +/- A 7.5 years) underwent SBRT in another. The mean maximum tumor diameter +/- A SD was 2.0 +/- A 0.8 cm (range 0.6-3.9 cm) in the RFA group, and 2.1 +/- A 0.9 cm (range 0.8-4.7 cm, p = 0.539) in the SBRT group. The RFA and SBRT groups showed similar 3-year local tumor progression [9.6 %, 95 % confidence interval (CI) 3.6-23.9 % vs. 7.0 %, 95 % CI 0.2-20.2 %, p = 0.746] and overall survival rates (86.4 %, 95 % CI 69.2-94.3 % vs. 79.6 %, 95 % CI 60.6-90.1 %, p = 0.738). No factor significantly affected local tumor progression. A maximum tumor size of 2 cm was identified as a prognostic factor in both univariate and multivariate analyses. No death was related to treatment procedures. Major complication rates (Grade 3 adverse events) of the RFA (10.4 %, 5/48) and SBRT (8.5 %, 4/47, p > 0.999) groups were similar. For lung tumor patients, lung RFA provided local tumor control and survival that were similar to those achieved using SBRT, with equal safety.	[Ochiai, Satoru] Matsusaka Cent Hosp, Dept Radiat Oncol, Matsusaka, Mie 5158566, Japan; [Yamakado, Koichiro; Nomoto, Yoshihito; Ii, Noriko; Takaki, Haruyuki; Sakuma, Hajime] Mie Univ, Sch Med, Dept Radiol, Tsu, Mie 5148507, Japan; [Kodama, Hiroshi] Suzuka Cent Hosp, Dept Radiol, Suzuka, Mie 5130818, Japan	Yamakado, K (reprint author), Mie Univ, Sch Med, Dept Radiol, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	yama@clin.medic.mie-u.ac.jp					Goldberg SN, 2005, RADIOLOGY, V235, P728, DOI 10.1148/radiol.2353042205; de Baere T, 2006, RADIOLOGY, V240, P587, DOI 10.1148/radiol.2402050807; Pennathur A, 2009, ANN THORAC SURG, V88, P1601, DOI 10.1016/j.athoracsur.2009.05.012; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Fernando HC, 2005, J THORAC CARDIOV SUR, V129, P639, DOI 10.1016/j.jtevs.2004.10.019; Nagata Y, 2009, INT J RADIAT ONCOL, V75, P343, DOI 10.1016/j.ijrobp.2009.02.087; Hiraki T, 2007, J THORAC CARDIOV SUR, V134, P1306, DOI 10.1016/j.jtcvs.2007.07.013; Steinke K, 2004, ANTICANCER RES, V24, P339; Baumann P, 2009, J CLIN ONCOL, V27, P3290, DOI 10.1200/JCO.2008.21.5681; Sano Y, 2007, CANCER, V109, P1397, DOI 10.1002/cncr.22541; Simon CJ, 2007, RADIOLOGY, V243, P268, DOI 10.1148/radiol.2431060088; Donington J, 2012, CHEST, V142, P1620, DOI 10.1378/chest.12-0790; Kashima M, 2011, AM J ROENTGENOL, V197, pW576, DOI 10.2214/AJR.11.6408; Uematsu M, 2001, INT J RADIAT ONCOL, V51, P666, DOI 10.1016/S0360-3016(01)01703-5; Dupuy DE, 2013, J VASC INTERV RADIOL, V24, P1139, DOI 10.1016/j.jvir.2013.04.021; Nomura M, 2008, BRIT J RADIOL, V81, P244, DOI 10.1259/bjr/84269673; Dunlap NE, 2010, J THORAC CARDIOV SUR, V140, P583, DOI 10.1016/j.jtcvs.2010.01.046; Okuma T, 2009, ANN THORAC SURG, V87, P948, DOI 10.1016/j.athoracsur.2008.07.069; Beland MD, 2010, RADIOLOGY, V254, P301, DOI 10.1148/radiol.2541090174; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Nagata Y, 2005, INT J RADIAT ONCOL, V63, P1427, DOI 10.1016/j.ijrobp.2005.05.034; Lee JM, 2004, RADIOLOGY, V230, P125, DOI 10.1148/radiol.2301020934; Onishi H, 2004, CANCER-AM CANCER SOC, V101, P1623, DOI 10.1002/cncr.20539; Shibamoto Y, 2012, CANCER-AM CANCER SOC, V118, P2078, DOI 10.1002/cncr.26470; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Haasbeek CJA, 2010, CANCER, V116, P406, DOI 10.1002/cncr.24759; Sakurai J, 2007, J VASC INTERV RADIOL, V18, P141, DOI 10.1016/j.jvir.2006.10.011; Asamura H, 2008, J THORAC ONCOL, V3, P46, DOI 10.1097/JTO.0b013e31815e8577; Mery CM, 2005, CHEST, V128, P237, DOI 10.1378/chest.128.1.237; Zhu JC, 2009, ANN THORAC SURG, V87, P1023, DOI 10.1016/j.athoracsur.2008.11.017; Koto M, 2007, RADIOTHER ONCOL, V85, P429, DOI 10.1016/j.radonc.2007.10.017; Kodama H, 2012, CARDIOVASC INTER RAD, V35, P563, DOI 10.1007/s00270-011-0220-0; Timmerman R, 2006, J CLIN ONCOL, V24, P4833, DOI 10.1200/JCO.2006.07.5937; Grutters JPC, 2010, RADIOTHER ONCOL, V95, P32, DOI 10.1016/j.radonc.2009.08.003; Hiraki T, 2006, RADIOLOGY, V241, P275, DOI 10.1148/radiol.2411051087; Yamakado K, 2005, CARDIOVASC INTER RAD, V28, P530, DOI 10.1007/s00270-004-0246-7; Huang LJ, 2011, EUR J CARDIO-THORAC, V39, P348, DOI 10.1016/j.ejcts.2010.06.004; Howington JA, 2013, CHEST S, V143, pe278S; Takeda A, 2009, INT J RADIAT ONCOL, V73, P442, DOI 10.1016/j.ijrobp.2008.04.043	39	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	JUN	2015	20	3					499	507		10.1007/s10147-014-0741-z		9	Oncology	Oncology	CK0WV	WOS:000355927200012		
J	Ishikawa, K; Nakamatsu, K; Shiraishi, O; Yasuda, T; Nishimura, Y				Ishikawa, Kazuki; Nakamatsu, Kiyoshi; Shiraishi, Osamu; Yasuda, Takushi; Nishimura, Yasumasa			Clinical results of definitive-dose (50 Gy/25 fractions) preoperative chemoradiotherapy for unresectable esophageal cancer	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Unresectable esophageal cancer; Preoperative treatment; Chemoradiotherapy	SQUAMOUS-CELL CARCINOMA; PHASE-III TRIAL; NEOADJUVANT CHEMORADIOTHERAPY; TRIMODALITY THERAPY; RADIATION-THERAPY; SURGERY; CISPLATIN; 5-FLUOROURACIL; CHEMOTHERAPY; CHEMORADIATION	The clinical results of definitive-dose preoperative chemoradiotherapy (CRT) of 50 Gy/25 fractions/5 weeks for unresectable esophageal cancer were analyzed. Inclusion criteria were unresectable esophageal squamous cell carcinoma with T4b or mediastinal lymph nodes invading to the trachea or aorta. Radiation therapy of 50 Gy/25 fractions/5 weeks was combined concurrently with two courses of FP therapy (CDDP 70 mg/m(2) + 5-FU 700 mg/m(2)/d x 5 days: day 1-5, day 29-33). Tumor response was evaluated 4 weeks after completion of RT. Subtotal esophagectomy was planned 6-8 weeks after RT. Thirty patients (26 male and 4 female) aged from 50-78 years (median 66) were enrolled between 2008 and 2011. The clinical stages according to the 7th edition of UICC were stages II/III/IV, 1/23/6; T1/2/3/4, 1/1/4/24; and N0/1/2/3, 3/25/1/1. All 30 patients completed RT of 50 Gy/25 fractions. Initial tumor responses were 21 patients with resectable disease, 7 with unresectable disease, and 2 with progressive disease. Subtotal esophagectomy was performed in 18 (60 %) of the 30 patients. Pathological complete response was obtained in five (28 %) patients. There were two patients with hospitalization death after surgery (11 %). Six of the 7 patients who still had unresectable disease were treated with 1-3 courses of docetaxel, CDDP and 5-FU. Three patients treated without surgery showed long-term survival. The 3-year loco-regional control rate and the 3-year overall survival rate for the 30 patients were 70 and 49 %, respectively. Definitive-dose preoperative CRT was feasible, and is a promising treatment strategy for unresectable esophageal cancer.	[Ishikawa, Kazuki; Nakamatsu, Kiyoshi; Nishimura, Yasumasa] Kinki Univ, Fac Med, Dept Radiat Oncol, Osaka, Osaka 5898511, Japan; [Shiraishi, Osamu; Yasuda, Takushi] Kinki Univ, Fac Med, Dept Surg, Osaka, Osaka 5898511, Japan	Ishikawa, K (reprint author), Kinki Univ, Fac Med, Dept Radiat Oncol, Osaka, Osaka 5898511, Japan.	k-ishi@med.kindai.ac.jp					Bedenne L, 2007, J CLIN ONCOL, V25, P1160, DOI 10.1200/JCO.2005.04.7118; Ohtsu A, 1999, J CLIN ONCOL, V17, P2915; Minsky BD, 2002, J CLIN ONCOL, V20, P1167, DOI 10.1200/JCO.20.5.1167; Fiorica F, 2004, GUT, V53, P925, DOI 10.1136/gut.2003.025080; Dahn D, 2010, INT J RADIAT ONCOL, V77, P44, DOI 10.1016/j.ijrobp.2009.04.053; Tepper J, 2008, J CLIN ONCOL, V26, P1086, DOI 10.1200/JCO.2007.12.9593; Bosset JF, 1997, NEW ENGL J MED, V337, P161, DOI 10.1056/NEJM199707173370304; Jin HL, 2009, WORLD J GASTROENTERO, V15, P5983, DOI 10.3748/wjg.15.5983; PICUS D, 1983, RADIOLOGY, V146, P433; Fujiwara Y, 2012, ONCOL REP, V28, P446, DOI 10.3892/or.2012.1847; Geh JI, 2006, RADIOTHER ONCOL, V78, P236, DOI 10.1016/j.radonc.2006.01.009; Ishida K, 2004, JPN J CLIN ONCOL, V34, P615, DOI 10.1093/jjco/hyh107; Nishimura Y, 2002, INT J RADIAT ONCOL, V53, P134, DOI 10.1016/S0360-3016(01)02813-9; Yano M, 1999, J SURG ONCOL, V70, P25, DOI 10.1002/(SICI)1096-9098(199901)70:1<25::AID-JSO5>3.0.CO;2-M; Shimoji H, 2013, WORLD J SURG, V37, P2180, DOI 10.1007/s00268-013-2074-x; Walsh TN, 1996, NEW ENGL J MED, V335, P462, DOI 10.1056/NEJM199608153350702; Nishimura Y, 2012, INT J CLIN ONCOL, V17, P48, DOI 10.1007/s10147-011-0254-y; Cooper J, 1999, JAMA-J AM MED ASSOC, V17, P1623; Staal EFWC, 2010, BRIT J SURG, V97, P1482, DOI 10.1002/bjs.7175; De Manzoni G, 2007, J SURG ONCOL, V95, P261, DOI 10.1002/jso.20640; Hurmuzlu M, 2010, RADIOTHER ONCOL, V97, P60, DOI 10.1016/j.radonc.2010.06.008; Japan Esophageal Society, 2012, GUID DIAGN TREATM CA; Tachimori Y, 2014, ESOPHAGUS-TOKYO, V11, P21, DOI 10.1007/s10388-013-0393-5	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	JUN	2015	20	3					531	537		10.1007/s10147-014-0736-9		7	Oncology	Oncology	CK0WV	WOS:000355927200016		
J	Nishizawa, K; Shimada, H; Ito, M; Oshima, Y; Yajima, S; Kikuchi, Y; Sumino, Y; Kaneko, H; Nishizawa, K; Obayashi, M				Nishizawa, Kosuke; Shimada, Hideaki; Ito, Masaaki; Oshima, Yoko; Yajima, Satoshi; Kikuchi, Yoshinori; Sumino, Yasukiyo; Kaneko, Hironori; Nishizawa, Kenji; Obayashi, Masahiko			The correlation between plasma aprepitant concentration and antiemetic effect in Japanese gastric or esophageal cancer patients	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Chemotherapy; Nausea; Vomiting; Aprepitant	CHEMOTHERAPY-INDUCED NAUSEA; PHARMACOKINETICS; CISPLATIN; TRIAL	Chemotherapy-induced nausea and vomiting (CINV) are significant problems in cancer patients, but a correlation between plasma aprepitant concentration and antiemetic effect has not been reported. This study aimed to characterize the correlation between plasma aprepitant concentration and clinical antiemetic effect in a limited group of Japanese gastric or esophageal cancer patients. Thirty-three Japanese cancer patients receiving cisplatin-based chemotherapy for the first time following oral aprepitant (125 mg on day 1 and 80 mg on days 2 and 3) were enrolled. The plasma aprepitant concentrations 48 h after the first administration were determined using liquid chromatography-mass spectrometry. Patients were allocated to the high-concentration group (plasma aprepitant concentration was > 331.1 ng/ml) or the low-concentration group (plasma aprepitant concentration was a parts per thousand currency sign331.1 ng/ml) to investigate the relationship between plasma aprepitant concentration and antiemetic effects. No significant differences were found between the two groups in terms of percentage of CINV prevention. Of 13 patients who experienced CINV [MASCC Antiemesis Tool (MAT) score > 3], those in the high-concentration group showed a significant improvement in CINV following aprepitant administration (days 1-3). The present study suggests that the antiemetic effect of aprepitant is associated with plasma aprepitant concentration. A plasma aprepitant concentration of 331.1 ng/ml may be a valid threshold for identifying its optimal antiemetic effects in Japanese gastric or esophageal cancer patients.	[Nishizawa, Kosuke; Nishizawa, Kenji] Toho Univ, Dept Pharm, Omori Med Ctr, Ota Ku, Tokyo 1438541, Japan; [Shimada, Hideaki; Ito, Masaaki; Oshima, Yoko; Yajima, Satoshi; Kaneko, Hironori] Toho Univ, Sch Med, Dept Surg, Ota Ku, Tokyo 1438541, Japan; [Kikuchi, Yoshinori; Sumino, Yasukiyo] Toho Univ, Sch Med, Div Gastroenterol & Hepatol, Dept Internal Med Omori,Ota Ku, Tokyo 1438540, Japan; [Obayashi, Masahiko] Toho Univ, Sch Pharmaceut Sci, Dept Clin Pharmaceut, Funabashi, Chiba 2748510, Japan	Nishizawa, K (reprint author), Toho Univ, Dept Pharm, Omori Med Ctr, Ota Ku, 6-11-1 Omori Nishi, Tokyo 1438541, Japan.	k-nishizawa@med.toho-u.ac.jp					Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Bergstrom M, 2004, BIOL PSYCHIAT, V55, P1007, DOI 10.1016/j.biopsych.2004.02.007; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; Kato H, 2009, JPN J CLIN ONCOL, V39, P638, DOI 10.1093/jjco/hyp069; Takahashi T, 2011, CANCER CHEMOTH PHARM, V68, P653, DOI 10.1007/s00280-010-1519-2; [Anonymous], 2014, INT FORM EM CAPS 125; Majumdar AK, 2006, J CLIN PHARMACOL, V46, P291, DOI 10.1177/0091270005283467; Molassiotis A, 2007, J PAIN SYMPTOM MANAG, V34, P148, DOI 10.1016/j.jpainsymman.2006.10.018; Motohashi S, 2013, BIOL PHARM BULL, V36, P676; Nakade S, 2008, CANCER CHEMOTH PHARM, V63, P75, DOI 10.1007/s00280-008-0713-y; Rolia F, 1989, J CLIN ONCOL, V7, P1693; Sanchez RI, 2004, DRUG METAB DISPOS, V32, P1287, DOI 10.1124/dmd.104.000216	12	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	JUN	2015	20	3					538	542		10.1007/s10147-014-0747-6		5	Oncology	Oncology	CK0WV	WOS:000355927200017		
J	Sato, H; Shimada, M; Kurita, N; Iwata, T; Yoshikawa, K; Higashigima, J; Chikakio, M; Kashihara, H; Takasu, C; Matsumoto, N; Eto, S				Sato, Hirohiko; Shimada, Mitsuo; Kurita, Nobuhiro; Iwata, Takashi; Yoshikawa, Kozo; Higashigima, Jun; Chikakio, Motoya; Kashihara, Hideya; Takasu, Chie; Matsumoto, Noriko; Eto, Shozo			Phase I trial of neoadjuvant preoperative chemotherapy with S-1, oxaliplatin, and bevacizumab plus radiation in patients with locally advanced rectal cancer	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Bevacizumab; Neoadjuvant chemoradiotherapy; Oxaliplatin; Phase I study; Rectal cancer; S-1	CAPECITABINE; RADIOTHERAPY; CHEMORADIOTHERAPY; RADIOCHEMOTHERAPY; LEUCOVORIN; IRINOTECAN; RESECTION; EXCISION	This phase I study was performed to determine the maximum tolerated dose (MTD), recommended dose (RD), and dose-limiting toxicities (DLTs) of oxaliplatin combined with preoperative chemoradiotherapy with S-1, oxaliplatin, and bevacizumab in locally advanced rectal cancer. Eligible patients had a newly diagnosed clinical stage T1-4 N0-3 M0 rectal adenocarcinoma within 12 cm of the anal verge suitable for curative resection. Conformal radiation therapy was given (4 fields, 2 Gy daily fractions, 5 days/week, total dose 40 Gy) with concurrent S-1 (80 mg/m(2)/day orally, days 1-5, 8-12, 15-19, and 22-26), bevacizumab (90 min continuous intravenous infusion at 5 mg/kg, days 1 and 15), and oxaliplatin (120 min continuous intravenous infusion, days 1, 8, 15, and 22). The initial oxaliplatin dose (40 mg/m(2)/day) was gradually increased to determine the MTD and RD. Surgery was performed 6 weeks after completion of preoperative chemoradiotherapy. 11 patients were enrolled. The MTD of oxaliplatin was considered to be 60 mg/m(2), because three of five patients developed DLTs such as diarrhea and hives. The recommended dose of oxaliplatin was set at 50 mg/m(2). Of the patients who received oxaliplatin at a parts per thousand currency sign RD, 5 (83.3 %) had a clinical response [four pathological responses and one pathological complete response (Grade 3)]. With this new regimen, the MTD of oxaliplatin was 60 mg/m(2), and the RD for phase II studies was 50 mg/m(2). This new regimen appears to provide worthwhile outcomes for locally advanced rectal cancer and merits a phase II study.	[Sato, Hirohiko; Shimada, Mitsuo; Kurita, Nobuhiro; Iwata, Takashi; Yoshikawa, Kozo; Higashigima, Jun; Chikakio, Motoya; Kashihara, Hideya; Takasu, Chie; Matsumoto, Noriko; Eto, Shozo] Univ Tokushima, Inst Hlth Biosci, Dept Surg, Tokushima 7708503, Japan	Sato, H (reprint author), Univ Tokushima, Inst Hlth Biosci, Dept Surg, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	hiko03363@festa.ocn.ne.jp; mitsuo.shimada@tokushima-u.ac.jp			TAIHO Pharmaceutical Co., Ltd.; Yakult Co., Ltd.; Chugai Co., Ltd.	This study was supported by a grant-in-aid from a cooperative cancer research project between TAIHO Pharmaceutical Co., Ltd., Yakult Co., Ltd. and Chugai Co., Ltd..	Wong SJ, 2012, INT J RADIAT ONCOL, V82, P1367, DOI 10.1016/j.ijrobp.2011.05.027; An X, 2013, EUR J CANCER, V49, P843, DOI 10.1016/j.ejca.2012.09.026; ENKER WE, 1995, J AM COLL SURGEONS, V181, P335; Bosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829; Sato T, 2007, INT J RADIAT ONCOL, V69, P1442, DOI 10.1016/j.ijrobp.2007.05.081; Landry JC, 2013, CANCER-AM CANCER SOC, V119, P1521, DOI 10.1002/cncr.27890; Aschele C, 2011, J CLIN ONCOL, V29, P2773, DOI 10.1200/JCO.2010.34.4911; Gerard JP, 2006, J CLIN ONCOL, V24, P4620, DOI 10.1200/JCO.2006.06.7629; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; QUIRKE P, 1986, LANCET, V2, P996; Kennecke H, 2012, EUR J CANCER, V48, P37, DOI 10.1016/j.ejca.2011.05.016; Stipa F, 2006, ANN SURG ONCOL, V13, P1047, DOI 10.1245/ASO.2006.03.053; Hong YS, 2012, LANCET ONCOL, V13, P1125, DOI 10.1016/S1470-2045(12)70363-7; Gavioli M, 2005, DIS COLON RECTUM, V48, P1851, DOI 10.1007/s10350-005-0133-6; Rodel C, 2014, ASCO ANN M; Rullier A, 2013, EUR J CANCER, V49, P82, DOI 10.1016/j.ejca.2012.06.028; Van Gijn W, 2011, NEW ENGL J MED, V12, P575	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	JUN	2015	20	3					543	548		10.1007/s10147-014-0733-z		6	Oncology	Oncology	CK0WV	WOS:000355927200018		
J	Morimoto, A; Ueda, Y; Egawa-Takata, T; Yagi, A; Terai, Y; Ohmichi, M; Ichimura, T; Sumi, T; Murata, H; Kanzaki, H; Nakai, H; Mandai, M; Yoshino, K; Fujita, M; Kimura, T; Saito, J; Sobue, T; Nishikawa, N; Sekine, M; Enomoto, T; Horikoshi, Y; Takagi, T				Morimoto, Akiko; Ueda, Yutaka; Egawa-Takata, Tomomi; Yagi, Asami; Terai, Yoshito; Ohmichi, Masahide; Ichimura, Tomoyuki; Sumi, Toshiyuki; Murata, Hiromi; Kanzaki, Hideharu; Nakai, Hidekatsu; Mandai, Masaki; Yoshino, Kiyoshi; Fujita, Masami; Kimura, Tadashi; Saito, Junko; Sobue, Tomotaka; Nishikawa, Nobumichi; Sekine, Masayuki; Enomoto, Takayuki; Horikoshi, Yorihiko; Takagi, Tetsu			Effect on HPV vaccination in Japan resulting from news report of adverse events and suspension of governmental recommendation for HPV vaccination	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						HPV vaccine; Adverse events; Media reports; Governmental suspension of vaccination; Japan	HUMAN-PAPILLOMAVIRUS VACCINATION; INVASIVE CERVICAL-CANCER; WOMEN; PREVALENCE; ATTITUDES; WORLDWIDE; MOTHERS; ADOLESCENTS; PHYSICIANS; GIRLS	Administration of the human papillomavirus (HPV) vaccine decreased dramatically in Japan after extensive news of adverse vaccine events and suspension of the governmental recommendation for the vaccine. In this study, we investigated the knowledge and acceptance of vaccinated adolescents concerning cervical cancer, cancer screening and the HPV vaccine. Furthermore, we analyzed whether and by how much the news affected acceptance of the vaccination. This study was conducted as a part of Osaka Clinical resEArch of HPV vacciNe (OCEAN) study. A questionnaire was distributed to 2,777 study registrants. The response rate was 38 %. The recognition rate of the news of the vaccine's adverse events was 80 %; it was 68 % for awareness of the government's announcement of the suspension of its recommendation for the vaccine. Among those who had a chance to hear or see the negative news during their vaccination period, 46 (60 %) continued vaccination while knowing of the news, 22 (29 %) discontinued vaccination, and 9 (11 %) continued vaccination without an awareness of the news. Reports of the vaccine's adverse events were the main reason for not continuing the vaccination series. Those who consulted doctors after hearing the adverse news were significantly more likely to continue their vaccinations than those who did not. Our results should help in understanding the need for a strong promotion of vaccine usage and cancer screening after future retraction of the recommendation suspension. This may apply to other countries with an unsatisfactory rate of HPV vaccination due to fears of adverse vaccine events.	[Morimoto, Akiko; Ueda, Yutaka; Egawa-Takata, Tomomi; Terai, Yoshito; Ohmichi, Masahide; Ichimura, Tomoyuki; Sumi, Toshiyuki; Murata, Hiromi; Kanzaki, Hideharu; Nakai, Hidekatsu; Mandai, Masaki; Yoshino, Kiyoshi; Fujita, Masami; Kimura, Tadashi; Saito, Junko; Enomoto, Takayuki; Horikoshi, Yorihiko; Takagi, Tetsu] Obstetr Gynecol Soc Osaka, Chuo Ku, Osaka 5410048, Japan; [Morimoto, Akiko; Ueda, Yutaka; Egawa-Takata, Tomomi; Yagi, Asami; Yoshino, Kiyoshi; Fujita, Masami; Kimura, Tadashi] Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka 5650871, Japan; [Terai, Yoshito; Ohmichi, Masahide] Osaka Med Coll, Grad Sch Med Sci, Dept Obstet & Gynecol, Takatsuki, Osaka 5698686, Japan; [Ichimura, Tomoyuki; Sumi, Toshiyuki] Osaka City Univ, Grad Sch, Dept Obstet & Gynecol, Abeno Ku, Osaka 5458585, Japan; [Ichimura, Tomoyuki; Sumi, Toshiyuki] Osaka City Univ, Fac Med, Abeno Ku, Osaka 5458585, Japan; [Murata, Hiromi; Kanzaki, Hideharu] Kansai Med Univ, Grad Sch Med, Dept Obstet & Gynecol, Hirakata, Osaka 5731191, Japan; [Nakai, Hidekatsu; Mandai, Masaki] Kinki Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Osaka, Osaka 5898511, Japan; [Saito, Junko] Saito Womens Clin, Yodogawa Ku, Osaka 5320003, Japan; [Sobue, Tomotaka] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Suita, Osaka 5650871, Japan; [Nishikawa, Nobumichi; Sekine, Masayuki; Enomoto, Takayuki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Obstet & Gynecol, Chuo Ku, Niigata 9518510, Japan	Ueda, Y (reprint author), Obstetr Gynecol Soc Osaka, Chuo Ku, 4-4-3 Kawaramachi, Osaka 5410048, Japan.	ZVF03563@nifty.ne.jp			Ministry of Health, Labour and Welfare, Japan	The present study was financially supported in part by Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare, Japan.	American Academy of Pediatrics, PED CAN LAY OUT EV A; Sotiriadis A, 2012, ARCH GYNECOL OBSTET, V285, P1719, DOI 10.1007/s00404-011-2208-z; Darden PM, 2013, PEDIATRICS, V131, P645, DOI 10.1542/peds.2012-2384; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Miura S, 2006, INT J CANCER, V119, P2713, DOI 10.1002/ijc.22195; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; Kessels SJM, 2012, VACCINE, V30, P3546, DOI 10.1016/j.vaccine.2012.03.063; Dempsey AF, 2009, ANN EPIDEMIOL, V19, P531, DOI 10.1016/j.annepidem.2009.03.011; Holman DM, 2014, JAMA PEDIATR, V168, P76, DOI 10.1001/jamapediatrics.2013.2752; Onuki M, 2009, CANCER SCI, V100, P1312, DOI 10.1111/j.1349-7006.2009.01161.x; Gilmour S, 2013, LANCET, V382, P768, DOI [10.1016/S0140-6736(13)61831-0, 10.1016/S0140-6736(13)61529-9]; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Daley MF, 2010, PEDIATRICS, V126, P425, DOI 10.1542/peds.2009-3500; Franceschi S, 2006, INT J CANCER, V119, P2677, DOI 10.1002/ijc.22241; Jacobs MV, 2000, INT J CANCER, V87, P221, DOI 10.1002/1097-0215(20000715)87:2<221::AID-IJC11>3.3.CO;2-U; Bodemer N, 2012, VACCINE, V30, P3747, DOI 10.1016/j.vaccine.2012.03.005; Chow SN, 2010, VACCINE, V28, P3809, DOI 10.1016/j.vaccine.2010.03.027; Dinh TA, 2007, J ADOLESCENT HEALTH, V40, P559, DOI 10.1016/j.jadohealth.2007.02.003; Hanley SJB, 2012, VACCINE, V30, P5740, DOI 10.1016/j.vaccine.2012.07.003; Japanese Ministry of Health, 2012, VIT STAT JAP TAB CTR; Japanese Ministry of Health, HEALTHC SERV HPV VAC; The Global Advisory Committee on Vaccine Safety (GACVS), 2013, GACVS SAF UPD HPV VA; Wong MCS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071827	26	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	JUN	2015	20	3					549	555		10.1007/s10147-014-0723-1		7	Oncology	Oncology	CK0WV	WOS:000355927200019		
J	Deura, I; Shimada, M; Hirashita, K; Sugimura, M; Sato, S; Sato, S; Oishi, T; Itamochi, H; Harada, T; Kigawa, J				Deura, Imari; Shimada, Muneaki; Hirashita, Keiko; Sugimura, Maki; Sato, Seiya; Sato, Shinya; Oishi, Tetsuro; Itamochi, Hiroaki; Harada, Tasuku; Kigawa, Junzo			Incidence and risk factors for lower limb lymphedema after gynecologic cancer surgery with initiation of periodic complex decongestive physiotherapy	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Lower limb lymphedema; Gynecologic cancer; Lymphadenectomy; Complex decongestive physiotherapy	LOWER-EXTREMITY LYMPHEDEMA; CERVICAL-CANCER; LYMPHADENECTOMY; MALIGNANCIES; COMPLICATIONS; RADIOTHERAPY; LIFE	Lower limb lymphedema (LLL) is one of the most frequent postoperative complications of retroperitoneal lymphadenectomy for gynecologic cancer. LLL often impairs quality of life, activities of daily living, sleep, and sex in patients with gynecologic cancer. We conducted this study to evaluate the incidence and risk factors for LLL after gynecologic cancer surgery in patients who received assessment and periodic complex decongestive physiotherapy (CDP). We retrospectively reviewed 126 cases of gynecologic cancer that underwent surgery involving retroperitoneal lymphadenectomy at Tottori University Hospital between 2009 and 2012. All patients received physical examinations to detect LLL and underwent CDP by nurse specialists within several months after surgery. The International Society of Lymphology staging of lymphedema severity was used as the diagnostic criteria. Of 126 patients, 57 (45.2 %) had LLL, comprising 45 and 12 patients with stage 1 and stage 2 LLL, respectively. No patient had stage 3 LLL. LLL was present in 37 (29.4 %) patients at the initial physical examination. Multivariate analysis revealed that adjuvant concurrent chemoradiotherapy and age a parts per thousand yen55 years were independent risk factors for a parts per thousand yenstage 2 LLL. To minimize the incidence of a parts per thousand yenstage 2 LLL, gynecologic oncologists should be vigilant for this condition in patients who are a parts per thousand yen55 years and in those who undergo adjuvant chemoradiotherapy. Patients should be advised to have a physical assessment for LLL and to receive education about CDP immediately after surgery involving retroperitoneal lymphadenectomy for gynecologic cancer.	[Deura, Imari; Shimada, Muneaki; Sato, Seiya; Sato, Shinya; Oishi, Tetsuro; Itamochi, Hiroaki; Harada, Tasuku] Tottori Univ, Sch Med, Dept Obstet & Gynecol, Yonago, Tottori 6838504, Japan; [Hirashita, Keiko; Sugimura, Maki] Tottori Univ Hosp, Dept Nursing, Yonago, Tottori 6838504, Japan; [Kigawa, Junzo] Matsue City Hosp, Matsue, Shimane 6908508, Japan	Deura, I (reprint author), Tottori Univ, Sch Med, Dept Obstet & Gynecol, 36-1 Nishimachi, Yonago, Tottori 6838504, Japan.	imari@med.tottori-u.ac.jp					Achouri A, 2013, EJSO-EUR J SURG ONC, V39, P81, DOI 10.1016/j.ejso.2012.10.011; Hareyama H, 2012, ANN SURG ONCOL, V19, P268, DOI 10.1245/s10434-011-1863-4; Dunberger G, 2013, SUPPORT CARE CANCER, V21, P3063, DOI 10.1007/s00520-013-1879-3; Konno Y, 2011, INT J GYNECOL CANCER, V21, P385, DOI 10.1097/IGC.0b013e3182094e09; Liao SF, 2012, GYNECOL ONCOL, V125, P712, DOI 10.1016/j.ygyno.2012.03.017; Tanaka T, 2007, INT J GYNECOL CANCER, V17, P460, DOI 10.1111/j.1525-1438.2007.00869.x; Kim SJ, 2008, EUR J CANCER CARE, V17, P463, DOI 10.1111/j.1365-2354.2007.00877.x; Abu-Rustum NR, 2006, GYNECOL ONCOL, V103, P714, DOI 10.1016/j.ygyno.2006.03.055; Ohba Y, 2011, INT J CLIN ONCOL, V16, P238, DOI 10.1007/s10147-010-0171-5; Beesley V, 2007, CANCER, V109, P2607, DOI 10.1002/cncr.22684; Todo Y, 2010, GYNECOL ONCOL, V119, P60, DOI 10.1016/j.ygyno.2010.06.018; Graf N, 2013, EUR J GYNAECOL ONCOL, V34, P23; Halaska MJ, 2010, INT J GYNECOL CANCER, V20, P900, DOI 10.1111/IGC.0b013e3181da29d0; Kim JH, 2012, INT J GYNECOL CANCER, V22, P686, DOI 10.1097/IGC.0b013e3182466950; Kim YB, 2012, GYNECOL ONCOL, V127, P638, DOI 10.1016/j.ygyno.2012.09.015; Kwan ML, 1996, RADIOLOGY, V198, P279; Nielsen I, 2008, CANCER TREAT REV, V34, P621, DOI 10.1016/j.ctrv.2007.11.002; Oremus M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-6; The diagnosis and treatment of peripheral lymphedema, 2009, LYMPHOLOGY, V42, P51	19	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	JUN	2015	20	3					556	560		10.1007/s10147-014-0724-0		5	Oncology	Oncology	CK0WV	WOS:000355927200020		
J	Tokunaga, H; Nakanishi, T; Iwata, T; Aoki, D; Saito, T; Nagase, S; Takahashi, F; Yaegashi, N; Watanabe, Y				Tokunaga, Hideki; Nakanishi, Toru; Iwata, Takashi; Aoki, Daisuke; Saito, Toshiaki; Nagase, Satoru; Takahashi, Fumiaki; Yaegashi, Nobuo; Watanabe, Yoh			Effects of chemotherapy on patients with recurrent cervical cancer previously treated with concurrent chemoradiotherapy: a retrospective multicenter survey in Japan	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Cervical cancer; Concurrent chemoradiotherapy; Multicenter survey; Chemotherapy; Recurrent cervical cancer	GYNECOLOGIC-ONCOLOGY-GROUP; HIGH-DOSE-RATE; UTERINE CERVIX; PHASE-III; ADJUVANT CHEMOTHERAPY; RADICAL HYSTERECTOMY; SQUAMOUS CARCINOMA; RADIATION-THERAPY; PELVIC RADIATION; RANDOMIZED-TRIAL	Predictive factors of the efficacy of chemotherapy for Japanese patients with recurrent cervical cancer who have been previously treated with concurrent chemoradiotherapy (CCRT) are currently unknown, and hence we aimed to investigate this. We retrospectively studied the prognostic outcomes of patients with recurrent cervical cancer treated with CCRT between 2002 and 2010 at four medical facilities. A total of 64 patients were included in this study. Forty-two patients received definitive CCRT and 22 patients received postoperative adjuvant CCRT, with 55 receiving platinum-based combination chemotherapy and nine receiving single-agent chemotherapy. The overall response rate (ORR) was 12.5 %, with one complete response. The median survival period was 12 months. The ORR and overall survival rate did not differ significantly according to recurrence site, post-CCRT interval, or chemotherapy regimen. None of the factors analyzed in this study were identified as positive predictive factors for the efficacy of chemotherapy in patients with recurrent cervical cancer after CCRT. Based on the results of previous studies, in order to improve long-term prognosis in recurrent cases, adjuvant chemotherapy should be considered as a potential treatment option for selected patients, especially as postoperative adjuvant therapy.	[Tokunaga, Hideki; Nagase, Satoru; Yaegashi, Nobuo; Watanabe, Yoh] Tohoku Grad Sch Med, Dept Obstet & Gynecol, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Nakanishi, Toru] Aichi Canc Ctr, Dept Gynecol, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Iwata, Takashi; Aoki, Daisuke] Keio Univ, Sch Med, Dept Obstet & Gynecol, Shinjuku Ku, Tokyo 1608582, Japan; [Saito, Toshiaki] Kyushu Natl Canc Ctr, Dept Gynecol, Minami Ku, Fukuoka 8111395, Japan; [Takahashi, Fumiaki; Watanabe, Yoh] Tohoku Univ Hosp, Dept Clin Res Network, Clin Res Innovat & Educ Ctr, Aoba Ku, Sendai, Miyagi 9808574, Japan	Tokunaga, H (reprint author), Tohoku Grad Sch Med, Dept Obstet & Gynecol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	tokunagahideki@med.tohoku.ac.jp					Rose PG, 1999, NEW ENGL J MED, V340, P1144, DOI 10.1056/NEJM199904153401502; Peters WA, 2000, J CLIN ONCOL, V18, P1606; Tewari KS, 2014, NEW ENGL J MED, V370, P734, DOI 10.1056/NEJMoa1309748; Moore DH, 2004, J CLIN ONCOL, V22, P3113, DOI 10.1200/JCO.2004.04.170; Bloss JD, 2002, J CLIN ONCOL, V20, P1832, DOI 10.1200/JCO.2002.07.045; Green JA, 2001, LANCET, V358, P781, DOI 10.1016/S0140-6736(01)05965-7; Moore DH, 2010, GYNECOL ONCOL, V116, P44, DOI 10.1016/j.ygyno.2009.09.006; Takeshima N, 2006, GYNECOL ONCOL, V103, P618, DOI 10.1016/j.ygyno.2006.04.019; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Rose PG, 2000, DRUGS, V60, P1239, DOI 10.2165/00003495-200060060-00001; Monk BJ, 2009, J CLIN ONCOL, V27, P4649, DOI 10.1200/JCO.2009.21.8909; TESHIMA T, 1993, CANCER, V72, P2409, DOI 10.1002/1097-0142(19931015)72:8<2409::AID-CNCR2820720819>3.0.CO;2-N; Whitney CW, 1999, J CLIN ONCOL, V17, P1339; Long HJ, 2005, J CLIN ONCOL, V23, P4626, DOI 10.1200/JCO.2005.10.021; Omura GA, 1997, J CLIN ONCOL, V15, P165; Rao GG, 2005, GYNECOL ONCOL, V96, P168, DOI 10.1016/j.ygyno.2004.09.009; Ikushima Hitoshi, 2006, Radiat Med, V24, P115, DOI 10.1007/BF02493277; Lee Tae Yeon, 2013, Obstet Gynecol Sci, V56, P15, DOI 10.5468/OGS.2013.56.1.15; Lukka H, 2002, CLIN ONCOL-UK, V14, P203, DOI 10.1053/clon.2002.0076; Morris M, 1999, NEW ENGL J MED, V340, P1137, DOI 10.1056/NEJM199904153401501; Pignata S, 2000, ANN ONCOL, V11, P455, DOI 10.1023/A:1008379922120; Schefter TE, 2011, INT J RADIAT ONCOL, V83, P1179; Sehouli J, 2012, ANN ONCOL, V23, P2259, DOI 10.1093/annonc/mdr628; Shimada M, 2013, EUR J GYNAECOL ONCOL, V34, P425; Toita T, 2012, INT J GYNECOL CANCER, V22, P1420, DOI 10.1097/IGC.0b013e3182647265; Watanabe Yoh, 2006, Int J Clin Oncol, V11, P309, DOI 10.1007/s10147-006-0567-4	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	JUN	2015	20	3					561	565		10.1007/s10147-014-0728-9		5	Oncology	Oncology	CK0WV	WOS:000355927200021		
J	Takase, N; Matsumoto, K; Onoe, T; Kitao, A; Tanioka, M; Kikukawa, Y; Yamaguchi, S; Fujiwara, K; Negoro, S				Takase, Naoto; Matsumoto, Koji; Onoe, Takuma; Kitao, Akihito; Tanioka, Maki; Kikukawa, Yoshitaka; Yamaguchi, Satoshi; Fujiwara, Kiyoshi; Negoro, Shunichi			4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Ovarian cancer; Desensitization; Carboplatin; Hypersensitivity reaction; Gynecological malignancy	RECURRENT OVARIAN-CANCER; DOCETAXEL-CARBOPLATIN; TRIAL; CHEMOTHERAPY; PACLITAXEL; CISPLATIN; NEDAPLATIN; THERAPY; SAFETY	Platinum agents are essential for treating gynecological malignancies, particularly ovarian cancer. However, multiple carboplatin doses may cause hypersensitivity reactions (HSRs). Carboplatin desensitization prevents life-threatening HSRs and promotes the successful completion of planned chemotherapy. Since January 2010, carboplatin desensitization was performed at our institution. Solutions with 1/1000, 1/100, and 1/10 dilutions of carboplatin and an undiluted solution were prepared in 250 mL of 5 % glucose. Each solution was administered as a 1-h intravenous infusion (4-step 4-h protocol). This retrospective analysis was approved by the institutional review board. From January 2010 to December 2013, 20 patients with gynecological malignancies (median age 62 years, range 43-74 years) received desensitization treatment. The International Federation of Gynecology and Obstetrics stages at presentation were I, II, III, and IV in 1, 1, 15, 13 patients, respectively. During first-line and second-line treatments, 3 and 17 patients, respectively, experienced carboplatin-induced HSRs. The median carboplatin cycle number was 11 (range 2-16). In the first desensitization cycle, 17 (85 %) patients completed treatment without adverse events, 2 experienced Grade 1 HSRs but completed treatment, and 1 experienced Grade 3 HSR and discontinued treatment. The first desensitization cycle completion rate was 95 %. Of 83 desensitization cycles administered, 79 (95.2 %) were completed. No treatment-related deaths occurred. Most patients completed the planned chemotherapy. Our protocol could be conducted safely with shorter duration and simpler procedures than previous protocols. Carboplatin desensitization seems beneficial for patients with a history of carboplatin-induced HSRs; however, the risk of HSR recurrence still remains. Desensitization should therefore be performed only by well-trained staff.	[Takase, Naoto; Matsumoto, Koji; Onoe, Takuma; Tanioka, Maki; Negoro, Shunichi] Hyogo Canc Ctr, Dept Med Oncol, Akashi, Hyogo 6738558, Japan; [Kitao, Akihito] Publ Toyooka Hosp, Dept Gen Med, Toyooka, Hyogo 6688501, Japan; [Kikukawa, Yoshitaka] Kumamoto Univ, Sch Med, Dept Hematol, Kumamoto 8608556, Japan; [Yamaguchi, Satoshi; Fujiwara, Kiyoshi] Hyogo Canc Ctr, Dept Gynecol, Akashi, Hyogo 6738558, Japan	Takase, N (reprint author), Hyogo Canc Ctr, Dept Med Oncol, 13-70 Kitaoji Cho, Akashi, Hyogo 6738558, Japan.	ntakase@hp.pref.hyogo.jp		Tanioka, Maki/0000-0002-6558-2246			Lee CW, 2005, GYNECOL ONCOL, V99, P393, DOI 10.1016/j.ygyno.2005.06.028; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Gomez R, 2009, INT J GYNECOL CANCER, V19, P1284, DOI 10.1111/IGC.0b013e3181a418ff; Castells MC, 2008, J ALLERGY CLIN IMMUN, V122, P574, DOI 10.1016/j.jaci.2008.02.044; MARKMAN M, 1991, J CLIN ONCOL, V9, P389; Vasey PA, 2004, J NATL CANCER I, V96, P1682, DOI 10.1093/jnci/djh323; Polyzos A, 2001, ONCOLOGY-BASEL, V61, P129, DOI 10.1159/000055363; Rose PG, 2003, GYNECOL ONCOL, V89, P429, DOI 10.1016/S0090-8258(03)00178-1; du Bois A, 2003, J NATL CANCER I, V95, P1320, DOI 10.1093/jnci/djg036; Confino-Cohen R, 2005, CANCER, V104, P640, DOI 10.1002/cncr.21168; Markman M, 1999, J CLIN ONCOL, V17, P1141; Hesterberg PE, 2009, J ALLERGY CLIN IMMUN, V123, P1262, DOI 10.1016/j.jaci.2009.02.042; Pfisterer J, 2006, J CLIN ONCOL, V24, P4699, DOI 10.1200/JCO.2006.06.0913; Parmar MKB, 2003, LANCET, V361, P2099; Arimoto T, 2013, J OBSTET GYNAECOL RE, V39, P336, DOI 10.1111/j.1447-0756.2012.01917.x; Cantu MG, 2002, J CLIN ONCOL, V20, P1232, DOI 10.1200/JCO.20.5.1232; Makrilia Nektaria, 2010, Metal-Based Drugs, P207084, DOI 10.1155/2010/207084; Michikami H, 2013, J OBSTET GYNAECOL RE, V39, P330, DOI 10.1111/j.1447-0756.2012.01893.x; Shoji T, 2010, ONCOL LETT, V1, P1021, DOI 10.3892/ol.2010.192; ZWEIZIG S, 1994, GYNECOL ONCOL, V53, P121, DOI 10.1006/gyno.1994.1098	20	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	JUN	2015	20	3					566	573		10.1007/s10147-014-0731-1		8	Oncology	Oncology	CK0WV	WOS:000355927200022		
J	Otsuki, A; Otsuki, T; Tokunaga, H; Niikura, H; Nagase, S; Sugiyama, T; Toyoshima, M; Utsunomiya, H; Yokoyama, Y; Mizunuma, H; Sato, N; Terada, Y; Shoji, T; Sugiyama, T; Nakahara, K; Ohta, T; Yamada, H; Tase, T; Nishiyama, H; Fujimori, K; Takano, T; Takahashi, F; Watanabe, Y; Yaegashi, N				Otsuki, Ai; Otsuki, Takeo; Tokunaga, Hideki; Niikura, Hitoshi; Nagase, Satoru; Sugiyama, Takashi; Toyoshima, Masafumi; Utsunomiya, Hiroki; Yokoyama, Yoshihito; Mizunuma, Hideki; Sato, Naoki; Terada, Yukihiro; Shoji, Tadahiro; Sugiyama, Toru; Nakahara, Kenji; Ohta, Tsuyoshi; Yamada, Hidekazu; Tase, Toru; Nishiyama, Hiroshi; Fujimori, Keiya; Takano, Tadao; Takahashi, Fumiaki; Watanabe, Yoh; Yaegashi, Nobuo			Evaluation of postoperative chemotherapy in patients with uterine carcinosarcoma: a retrospective survey of the Tohoku Gynecologic Cancer Unit	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Uterine carcinosarcoma; Prognostic factor; Chemotherapy; Retrospective study	MIXED MULLERIAN TUMORS; PHASE-III TRIAL; ONCOLOGY-GROUP; PROGNOSTIC-FACTORS; STAGE-I; UTERUS; IFOSFAMIDE; THERAPY; PACLITAXEL; EXPERIENCE	The aim of this study was to evaluate prognostic factors including efficacy of postoperative chemotherapy in Japanese patients with uterine carcinosarcoma. We conducted a retrospective survey of seven medical facilities in the Tohoku Gynecologic Cancer Unit. A total of 45 patients who had undergone hysterectomy and bilateral salpingo-oophorectomy were enrolled. No significant difference was observed in overall survival according to patient age (a parts per thousand currency sign50 years vs > 50 years) or retroperitoneal lymphadenectomy (performed vs. not performed). However, the International Federation of Gynecology and Obstetrics stage (stage I/II vs stage III/IV) and postoperative chemotherapy (provided vs not provided) were significant prognostic factors in both univariate and multivariate analyses for the 25-month median follow-up period. Our results revealed that postoperative chemotherapy should be considered for all uterine carcinosarcoma stages in Japanese patients.	[Otsuki, Ai; Otsuki, Takeo; Tokunaga, Hideki; Niikura, Hitoshi; Nagase, Satoru; Sugiyama, Takashi; Toyoshima, Masafumi; Utsunomiya, Hiroki; Takano, Tadao; Watanabe, Yoh; Yaegashi, Nobuo] Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi 980, Japan; [Yokoyama, Yoshihito; Mizunuma, Hideki] Hirosaki Univ, Grad Sch Med, Dept Obstet & Gynecol, Hirosaki, Aomori, Japan; [Sato, Naoki; Terada, Yukihiro] Akita Univ, Grad Sch Med, Dept Obstet & Gynecol, Akita 010, Japan; [Shoji, Tadahiro; Sugiyama, Toru] Iwate Med Univ, Dept Obstet & Gynecol, Morioka, Iwate 020, Japan; [Nakahara, Kenji; Ohta, Tsuyoshi] Yamagata Univ, Fac Med, Dept Obstet & Gynecol, Yamagata 990, Japan; [Yamada, Hidekazu; Tase, Toru] Miyagi Canc Ctr, Dept Gynecol, Sendai, Miyagi, Japan; [Nishiyama, Hiroshi; Fujimori, Keiya] Fukushima Med Univ, Dept Obstet & Gynecol, Fukushima, Japan; [Takano, Tadao; Takahashi, Fumiaki; Watanabe, Yoh] Tohoku Univ Hosp, Dept Clin Res Network, Clin Res Innovat & Educ Ctr, Aoba Ku, Sendai, Miyagi 9808574, Japan	Watanabe, Y (reprint author), Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi 980, Japan.	watanabe@med.tohoku.ac.jp					Akahira J, 2007, ONCOLOGY, V71, P333; Inthasorn P, 2002, INT J GYNECOL CANCER, V12, P348, DOI 10.1046/j.1525-1438.2002.01117.x; Bansal N, 2008, OBSTET GYNECOL, V112, P64, DOI 10.1097/AOG.0b013e318176157c; SILVERBERG SG, 1990, INT J GYNECOL PATHOL, V9, P1, DOI 10.1097/00004347-199001000-00001; Callister M, 2004, INT J RADIAT ONCOL, V58, P786, DOI 10.1016/S0360-3016(03)01561-X; Amant F, 2005, GYNECOL ONCOL, V98, P274, DOI 10.1016/j.ygyno.2005.04.027; Cantrell LA, 2012, GYNECOL ONCOL, V127, P22, DOI 10.1016/j.ygyno.2012.06.020; Park JY, 2010, ANN SURG ONCOL, V17, P861, DOI 10.1245/s10434-009-0833-6; Reed NS, 2008, EUR J CANCER, V44, P808, DOI 10.1016/j.ejca.2008.01.019; Mancari R, 2014, GYNECOL ONCOL, V133, P531, DOI 10.1016/j.ygyno.2014.03.001; Wolfson AH, 2007, GYNECOL ONCOL, V107, P177, DOI 10.1016/j.ygyno.2007.07.070; Homesley HD, 2007, J CLIN ONCOL, V25, P526, DOI 10.1200/JCO.2006.06.4907; Todo Y, 2010, LANCET, V375, P1165, DOI 10.1016/S0140-6736(09)62002-X; Sutton G, 2000, GYNECOL ONCOL, V79, P147, DOI 10.1006/gyno.2000.6001; Toyoshima M, 2004, GYNECOL ONCOL, V94, P774, DOI 10.1016/j.ygyno.2004.05.048; Sartori E, 1997, GYNECOL ONCOL, V67, P70, DOI 10.1006/gyno.1997.4827; Galaal K, 2009, EUR J OBSTET GYN R B, V143, P88, DOI 10.1016/j.ejogrb.2008.12.014; Galaal K, 2013, COCHRANE DB SYST REV, V28; GALLUP DG, 1989, AM J OBSTET GYNECOL, V161, P533; MAJOR FJ, 1993, CANCER, V71, P1702, DOI 10.1002/cncr.2820710440; Nordal RR, 1997, GYNECOL ONCOL, V67, P316, DOI 10.1006/gyno.1997.4875; Panici PB, 2014, AM J OBSTET GYNECOL, V210, pe1; SPANOS WJ, 1984, CANCER, V53, P311, DOI 10.1002/1097-0142(19840115)53:2<311::AID-CNCR2820530222>3.0.CO;2-X; Takano T, 2014, INT J CLIN ONCOL, DOI [10.1007/s101470130658, DOI 10.1007/S101470130658]	24	0	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	JUN	2015	20	3					574	578		10.1007/s10147-014-0732-0		5	Oncology	Oncology	CK0WV	WOS:000355927200023		
J	Nakamura, Y; Matsumoto, K; Satoh, T; Nishide, K; Nozue, A; Shimabukuro, K; Endo, S; Nagai, K; Oki, A; Minaguchi, T; Morishita, Y; Noguchi, M; Yoshikawa, H				Nakamura, Yuko; Matsumoto, Koji; Satoh, Toyomi; Nishide, Ken; Nozue, Akiko; Shimabukuro, Koji; Endo, Seiichi; Nagai, Kimihiro; Oki, Akinori; Minaguchi, Takeo; Morishita, Yukio; Noguchi, Masayuki; Yoshikawa, Hiroyuki			Optimizing biopsy procedures during colposcopy for women with abnormal cervical cancer screening results: a multicenter prospective study	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Colposcopy; Biopsy; CIN; Cervical cancer	ENDOCERVICAL CURETTAGE; INTRAEPITHELIAL NEOPLASIA; CYTOLOGY; TERMINOLOGY; GUIDELINES; SOCIETY	In cervical cancer screening programs, women with abnormal cytology results are referred to colposcopy for histological diagnosis. This study was designed to evaluate the sensitivity of colposcopic procedures for detecting cervical cancer and its precursor, cervical intraepithelial neoplasia (CIN). Women referred to colposcopy for abnormal cytology were enrolled from four hospitals. Gynecologists were required to take a colposcopy-guided biopsy from the worst of the abnormal-looking areas as a first biopsy. They were also asked to take a parts per thousand yen3 cervical specimens including by endocervical curettage (ECC). Random biopsies were performed at the gynecologist's discretion. We analyzed 827 biopsy results from 255 women who were diagnosed by central pathologists as having histology of CIN or cancer. In this study, 78.1 % of diagnoses of CIN grade 2 or worse (CIN2+) (the threshold that would trigger intensive management) were obtained from a first colposcopy-guided biopsy. The additional diagnostic utility of second and third colposcopy-guided biopsies was 16.4 and 1.8 %, respectively. The combined sensitivity of two colposcopy-directed biopsies for CIN2+ detection was > 90 %, regardless of the colposcopist. Random biopsies and ECC increased the diagnostic yield of CIN2+ lesions otherwise missed by colposcopy-guided biopsies alone, but only by 1.2 and 2.4 %, respectively. Random biopsies were more useful for women referred after low-grade abnormal cytology (P = 0.01). The utility of ECC was greatest among women with unsatisfactory colposcopy (P = 0.03) or aged a parts per thousand yen40 years (P = 0.02). Our data suggest that at least two colposcopy-directed biopsies should be taken for histological diagnosis. Random biopsies and ECC are recommended for special populations.	[Nakamura, Yuko; Matsumoto, Koji; Satoh, Toyomi; Oki, Akinori; Minaguchi, Takeo; Yoshikawa, Hiroyuki] Univ Tsukuba, Fac Med, Dept Obstet & Gynecol, Tsukuba, Ibaraki 3058575, Japan; [Nakamura, Yuko; Morishita, Yukio; Noguchi, Masayuki] Univ Tsukuba, Dept Pathol, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Nishide, Ken; Nozue, Akiko] Tsukuba Med Ctr Hosp, Dept Gynecol, Tsukuba, Ibaraki 3058558, Japan; [Shimabukuro, Koji; Endo, Seiichi] Tsuchiura Kyodo Gen Hosp, Dept Obstet & Gynecol, Tsuchiura, Ibaraki 3000053, Japan; [Nagai, Kimihiro; Oki, Akinori] Ibaraki Cent Hosp, Dept Gynecol, Kasama, Ibaraki 3091793, Japan	Matsumoto, K (reprint author), Univ Tsukuba, Fac Med, Dept Obstet & Gynecol, Tsukuba, Ibaraki 3058575, Japan.	matsumok@mui.biglobe.ne.jp			Ministry of Education, Science, Sports and Culture of Japan [25462585]; Ibaraki Clinical and Epidemiological Cancer Research Project	The authors thank Chizuko Fukui and Yoko Kuno for technical assistance; Kokoro Hirai and Chieko Abe for assistance in data collection; many other researchers who facilitated this study; and all the women who participated in the study. This work was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan (Grant # 25462585) and the Ibaraki Clinical and Epidemiological Cancer Research Project. The supporting organizations played no role in the design and implementation of the study; the collection, management, analysis and interpretation of the data; or the preparation, review or approval of the manuscript.	Moniak CW, 2000, J REPROD MED, V45, P285; Solomon D, 2007, OBSTET GYNECOL, V110, P288, DOI 10.1097/01.AOG.0000270154.69879.09; Darragh TM, 2012, ARCH PATHOL LAB MED, V136, P1266; Massad LS, 2013, OBSTET GYNECOL, V121, P829, DOI 10.1097/AOG.0b013e3182883a34; Pretorius RG, 2004, AM J OBSTET GYNECOL, V191, P430, DOI 10.1016/j.ajog.2004.02.065; Massad LS, 2003, J REPROD MED, V48, P1; Takeda T, 2012, J OBSTET GYNAECOL RE, V38, P615, DOI 10.1111/j.1447-0756.2012.01858.x; Gage JC, 2006, OBSTET GYNECOL, V108, P264, DOI 10.1097/01.AOG.0000220505.18525.85; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Stoler MH, 2011, INT J CANCER, V128, P1354, DOI 10.1002/ijc.25470; Chase DM, 2009, AM J OBSTET GYNECOL, V200, P472, DOI 10.1016/j.ajog.2008.12.025; Fine BA, 1998, GYNECOL ONCOL, V71, P46, DOI 10.1006/gyno.1998.5120; Gage JC, 2010, AM J OBSTET GYNECOL, V203; HATCH KD, 1985, OBSTET GYNECOL, V65, P403; Jeronimo J, 2006, AM J OBSTET GYNECOL, V195, P349, DOI 10.1016/j.ajog.2006.01.091; Oyama IA, 2003, AM J OBSTET GYNECOL, V188, P1164, DOI 10.1067/mob.2003.290	16	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	JUN	2015	20	3					579	585		10.1007/s10147-014-0739-6		7	Oncology	Oncology	CK0WV	WOS:000355927200024		
J	Miyake, H; Furukawa, J; Hinata, N; Muramaki, M; Tanaka, K; Fujisawa, M				Miyake, Hideaki; Furukawa, Junya; Hinata, Nobuyuki; Muramaki, Mototsugu; Tanaka, Kazushi; Fujisawa, Masato			Significant impact of RENAL nephrometry score on changes in postoperative renal function early after robot-assisted partial nephrectomy	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Robot-assisted partial nephrectomy; RENAL nephrometry score; Renal function	LAPAROSCOPIC PARTIAL NEPHRECTOMY; WARM ISCHEMIA TIME; SPARING SURGERY; CELL CARCINOMA; OUTCOMES; SYSTEM; UTILITY; MASS	Our objective was to evaluate the significance of the R.E.N.A.L. nephrometry score (RNS)-developed to quantitatively evaluate the complexity of renal tumors in a reproducible manner-in perioperative and renal functional outcomes following robot-assisted partial nephrectomy (RAPN). This study assessed 48 consecutive patients with renal tumors who underwent RAPN. Preoperative RNS for each patient was calculated, and its impact on several parameters associated with perioperative outcomes, including postoperative renal function, was investigated with Spearman's rank correlation test. Mean RNS in the 48 patients was 6.8; of these 48 patients, 21 (43.7 %), 24 (50.0 %), and three (6.3 %) were classified into low-, moderate-, and high-complexity groups, respectively. The RNS was significantly correlated with resected tumor weight and postoperative changes in estimated glomerular filtration rate (eGFR) at both 1 and 4 weeks-but not age, body mass index (BMI), preoperative eGFR, operative time, warm ischemia time, estimated blood loss, postoperative complications, or eGFR- after RAPN. No component of the RNS (R: radius; E: exophytic/endophytic properties; N: nearness of tumor to the collecting system or sinus; A: anterior/posterior; L: location relative to polar lines) alone had a significant impact on postoperative changes in eGFR at 1 and 4 weeks, whereas resected tumor weight was significantly associated with the R and E subcategories. Measurement of total RNS is useful for predicting renal functional outcomes early after RAPN.	[Miyake, Hideaki; Furukawa, Junya; Hinata, Nobuyuki; Muramaki, Mototsugu; Tanaka, Kazushi; Fujisawa, Masato] Kobe Univ, Grad Sch Med, Div Urol, Chuo Ku, Kobe, Hyogo 6500017, Japan	Miyake, H (reprint author), Kobe Univ, Grad Sch Med, Div Urol, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	hideakimiyake@hotmail.com	Hinata, Nobuyuki/M-9421-2015	Hinata, Nobuyuki/0000-0001-7014-6812			Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Simmons MN, 2010, J UROLOGY, V183, P1708, DOI 10.1016/j.juro.2010.01.005; Thompson RH, 2008, J UROLOGY, V179, P468, DOI 10.1016/j.juro.2007.09.077; Long JA, 2013, BJU INT, V111, P233, DOI 10.1111/j.1464-410X.2012.11339.x; Sea JC, 2013, J ENDOUROL, V27, P1471, DOI 10.1089/end.2013.0202; Ficarra V, 2009, EUR UROL, V56, P786, DOI 10.1016/j.eururo.2009.07.040; Rosevear HM, 2012, BJU INT, V109, P700, DOI 10.1111/j.1464-410X.2011.10452.x; Aboumarzouk OM, 2012, EUR UROL, V62, P1023, DOI 10.1016/j.eururo.2012.06.038; Png KS, 2013, J ENDOUROL, V27, P304, DOI 10.1089/end.2012.0182; Kutikov A, 2009, J UROLOGY, V182, P844, DOI 10.1016/j.juro.2009.05.035; Levey AS, 2009, ANN INTERN MED, V150, P604; Mufarrij PW, 2011, J ENDOUROL, V25, P1649, DOI 10.1089/end.2011.0003; Kural AR, 2009, J ENDOUROL, V23, P1491, DOI 10.1089/end.2009.0377; Altunrende F, 2013, WORLD J UROL, V31, P1165, DOI 10.1007/s00345-012-0867-4; Gill IS, 2010, NEW ENGL J MED, V362, P624, DOI 10.1056/NEJMcp0910041; Marszalek M, 2012, EUR UROL, V61, P757, DOI 10.1016/j.eururo.2011.11.028; Tanaka K, 2013, J ENDOUROL, V27, P1384, DOI 10.1089/end.2012.0641; Canter D, 2011, UROLOGY, V78, P1089, DOI 10.1016/j.urology.2011.04.035; Castilla EA, 2002, UROLOGY, V60, P993, DOI 10.1016/S0090-4295(02)01983-0; Scoll BJ, 2010, UROLOGY, V75, P1328, DOI 10.1016/j.urology.2009.10.040; Liu ZW, 2013, WORLD J UROL, V31, P1183, DOI 10.1007/s00345-012-0876-3; Hayn MH, 2011, BJU INT, V108, P876, DOI 10.1111/j.1464-410X.2010.09940.x; Mayer WA, 2012, UROLOGY, V79, P1052, DOI 10.1016/j.urology.2012.01.048; Furukawa J, 2014, INT J MED ROBOT COMP, V10, P385, DOI 10.1002/rcs.1574; Gong Y, 2010, WORLD J UROL, V28, P111, DOI 10.1007/s00345-009-0427-8; Patel MN, 2010, EUR UROL, V57, P310, DOI 10.1016/j.eururo.2009.11.024	26	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	JUN	2015	20	3					586	592		10.1007/s10147-014-0751-x		7	Oncology	Oncology	CK0WV	WOS:000355927200025		
J	Naya, Y; Oishi, M; Yamada, Y; Ueda, T; Fujihara, A; Nakanishi, H; Naito, Y; Nakamura, T; Hongo, F; Kamoi, K; Okihara, K; Miki, T				Naya, Yoshio; Oishi, Masakastu; Yamada, Yasunori; Ueda, Takashi; Fujihara, Atsuko; Nakanishi, Hiroyuki; Naito, Yasuyuki; Nakamura, Terukazu; Hongo, Fumiya; Kamoi, Kazumi; Okihara, Koji; Miki, Tsuneharu			Initial experience of combined use of photodynamic diagnosis and narrow band imaging for detection of flat urothelial lesion	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Carcinoma in situ of bladder; Photodynamic diagnosis; Narrow band imaging	TRANSITIONAL-CELL CARCINOMA; INVASIVE BLADDER-CANCER; 5-AMINOLEVULINIC ACID; FLUORESCENCE CYSTOSCOPY; TRANSURETHRAL RESECTION; FOLLOW-UP; RECURRENCE; BENEFIT; RISK	This preliminary study is the first report to compare photodynamic diagnosis (PDD) with narrow band imaging (NBI) in the same patients with flat urothelial lesions suspicious of carcinoma in situ (CIS) of the bladder. Between November 26, 2012 and April 1, 2013, 10 patients underwent transurethral resection of bladder tumor using PDD and NBI simultaneously because of suspicion of CIS. The bladder was mapped first under white light (WL), then under NBI, and subsequently under blue light in odd-numbered patients. The bladder was mapped first under WL, then under blue light, and subsequently under NBI in even-numbered patients. Biopsies were carried out from all suspicious areas, noting whether NBI, PDD or both detected lesions. Random cold cup biopsies from healthy mucosa of bladder were performed from lesions negative on PDD and NBI. The sensitivity and specificity of PDD for detection of CIS and dysplasia were 0.916 and 0.827, respectively. The sensitivity and specificity of NBI for detection of CIS and dysplasia were 0.625 and 0.879. The area under the curve (AUC) for detection of CIS and dysplasia was 0.872 with PDD and 0.752 with NBI. The AUC with combined use of PDD and NBI was 0.918. There was no cancer or dysplasia identified in 43 lesions that were both PDD- and NBI-negative. When both PDD and NBI are negative, the possibility of CIS or dysplasia might be very low. The usefulness of the combination of PDD with NBI was suggested in this study.	[Naya, Yoshio; Oishi, Masakastu; Yamada, Yasunori; Ueda, Takashi; Fujihara, Atsuko; Nakanishi, Hiroyuki; Naito, Yasuyuki; Nakamura, Terukazu; Hongo, Fumiya; Kamoi, Kazumi; Okihara, Koji; Miki, Tsuneharu] Kyoto Prefectural Univ Med, Dept Urol, Kyoto, Japan	Naya, Y (reprint author), Kyoto Prefectural Univ Med, Dept Urol, Kyoto, Japan.	ynaya@koto.kpu-m.ac.jp					Bryan RT, 2008, BJU INT, V101, P702, DOI 10.1111/j.1464-410X.2007.07317.07471.x; Tatsugami K, 2010, J ENDOUROL, V24, P1807, DOI 10.1089/end.2010.0055; Lapini A, 2012, SURG ENDOSC, V26, P3634, DOI 10.1007/s00464-012-2387-0; Stenzl A, 2010, J UROLOGY, V184, P1907, DOI 10.1016/j.juro.2010.06.148; Brausi M, 2002, EUR UROL, V41, P523, DOI 10.1016/S0302-2838(02)00068-4; Krammer B, 2008, PHOTOCH PHOTOBIO SCI, V7, P283, DOI 10.1039/b712847a; Mowatt G, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14040; Montironi R, 2005, INT J SURG PATHOL, V13, P143, DOI 10.1177/106689690501300203; Matsuda T, 2011, JPN J CLIN ONCOL, V41, P139, DOI 10.1093/jjco/hyq169; Cauberg ECC, 2010, UROLOGY, V76, P658, DOI 10.1016/j.urology.2009.11.075; Patel P, 2011, THESCIENTIFICWORLDJO, V11, P2550, DOI 10.1100/2011/412739; Denzinger S, 2007, UROLOGY, V69, P675, DOI 10.1016/j.urology.2006.12.023; Daniltchenko DI, 2005, J UROLOGY, V174, P2129, DOI 10.1097/01.ju.0000181814.73466.14; Blanco S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-122; Ferlay J, 2010, GLOBOCAN 2008 V1 2 C; Hermann GG, 2011, BJU INT, V108, P297; Hungerhuber E, 2007, UROLOGY, V69, P260, DOI 10.1016/j.urology.2006.10.015; Inoue K, 2012, CANCER-AM CANCER SOC, V118, P1062, DOI 10.1002/cncr.26378; Richterstetter M, 2012, BJU INT, V110, pE76, DOI 10.1111/j.1464-410X.2011.10904.x; Schumacher MC, 2010, EUR UROL, V57, P293, DOI 10.1016/j.eururo.2009.10.030; Zaak D, 2001, UROLOGY, V57, P690, DOI 10.1016/S0090-4295(00)01053-0; Zheng C, 2012, BJU INT, V110, P680	22	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	JUN	2015	20	3					593	597		10.1007/s10147-014-0748-5		5	Oncology	Oncology	CK0WV	WOS:000355927200026		
J	Shigeta, K; Kosaka, T; Yazawa, S; Yasumizu, Y; Mizuno, R; Nagata, H; Shinoda, K; Morita, S; Miyajima, A; Kikuchi, E; Nakagawa, K; Hasegawa, S; Oya, M				Shigeta, Keisuke; Kosaka, Takeo; Yazawa, Satoshi; Yasumizu, Yota; Mizuno, Ryuichi; Nagata, Hirohiko; Shinoda, Kazunobu; Morita, Shinya; Miyajima, Akira; Kikuchi, Eiji; Nakagawa, Ken; Hasegawa, Shintaro; Oya, Mototsugu			Predictive factors for severe and febrile neutropenia during docetaxel chemotherapy for castration-resistant prostate cancer	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Severe neutropenia; Febrile neutropenia; Docetaxel; Predictive factor; Castration-resistant prostate cancer	CLINICAL-PRACTICE GUIDELINE; GROWTH-FACTORS; OPEN-LABEL; PHASE-II; MITOXANTRONE; MULTICENTER; PREDNISONE; UPDATE; TRIAL; JAPAN	The aim of this study is to identify factors that increase the occurrence of severe neutropenia (SN) and febrile neutropenia (FN) during docetaxel treatment for castration-resistant prostate cancer (CRPC). We retrospectively reviewed 258 courses during the first three cycles among 95 patients. Docetaxel at a dose of 75 mg/m(2) was administered every 3 or 4 weeks. Patient background, laboratory data, and bone scan results were collected to assess predictive factors for SN and FN. We defined SN as an absolute neutrophil count (ANC) of < 500/mm(3) and defined FN as an ANC of < 1000/mm(3) with a body temperature of > 38.3 A degrees C. The mean age of the patients was 72.6 +/- A 6.4 years and the mean prostate-specific antigen was 135.4 +/- A 290.9 ng/ml. During the first three courses of treatment, SN occurred in 72.6 % of patients and FN occurred in 9.5 % of patients. Univariate analysis demonstrated that age a parts per thousand yen75 years (p = 0.002), number of comorbidities a parts per thousand yen1.2 (p = 0.008 and p = 0.006) and previous external beam radiation therapy (EBRT) (p = 0.001) were predictive factors for the development of SN or FN. In multivariate analysis, significant predictors of SN or FN were age a parts per thousand yen75 years (hazard ratio [HR] 5.77; p = 0.004) and previous EBRT (HR 14.5; p = 0.012). According to the subgroup analysis dividing SN and FN separately, multivariate analysis also revealed that age a parts per thousand yen75 years and previous EBRT were also significant predictors for developing SN (HR 5.09; p = 0.023, HR 12.7; p = 0.020, respectively) and for developing FN (HR 5.45; p = 0.042, HR 7.72; p = 0.015, respectively). Patients aged a parts per thousand yen75 years and with a history of localized radiation therapy are at higher risk for significant neutropenic events and require closer surveillance.	[Shigeta, Keisuke; Kosaka, Takeo; Yazawa, Satoshi; Yasumizu, Yota; Mizuno, Ryuichi; Nagata, Hirohiko; Shinoda, Kazunobu; Morita, Shinya; Miyajima, Akira; Kikuchi, Eiji; Nakagawa, Ken; Hasegawa, Shintaro; Oya, Mototsugu] Keio Univ, Sch Med, Dept Urol, Shinjuku Ku, Tokyo 1608582, Japan; [Hasegawa, Shintaro] Natl Hosp Org Tochigi Med Ctr, Dept Urol, Utsunomiya, Tochigi, Japan	Kosaka, T (reprint author), Keio Univ, Sch Med, Dept Urol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	takemduro@gmail.com			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24890230]	This work was supported in part by a Grant-in-Aid for Young Scientists (Start-up # 24890230 to Takeo Kosaka) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACS, 2013, CANC FACTS FIG 2013; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Naito S, 2008, JPN J CLIN ONCOL, V38, P365, DOI 10.1093/jjco/hyn029; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Hosmer W, 2011, SUPPORT CARE CANCER, V19, P333, DOI 10.1007/s00520-010-0821-1; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Hurria A, 2011, J CLIN ONCOL, V29, P3457, DOI 10.1200/JCO.2011.34.7625; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; SOLOWAY MS, 1988, CANCER, V61, P195, DOI 10.1002/1097-0142(19880101)61:1<195::AID-CNCR2820610133>3.0.CO;2-Y; Crawford J, 2011, J NATL COMPR CANC NE, V9, P914; Intragumtornchai T, 2000, LEUKEMIA LYMPHOMA, V37, P351; Jiang N, 2013, SUPPORT CARE CANCER, V21, P785, DOI 10.1007/s00520-012-1580-y; Karlsson C, 2012, PROSTATE CANCER P D, V15, P303; Laskey RA, 2012, GYNECOL ONCOL, V125, P625, DOI 10.1016/j.ygyno.2012.03.015; Nishimura K, 2013, INT J CLIN ONCOL, V18, P306, DOI 10.1007/s10147-012-0380-1; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Shiozawa T, 2013, JPN J CLIN ONCOL, V43, P483, DOI 10.1093/jjco/hyt040	18	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	JUN	2015	20	3					605	612		10.1007/s10147-014-0746-7		8	Oncology	Oncology	CK0WV	WOS:000355927200028		
J	Yonemoto, T; Hosono, A; Iwata, S; Kamoda, H; Hagiwara, Y; Fujiwara, T; Kawai, A; Ishii, T				Yonemoto, Tsukasa; Hosono, Ako; Iwata, Shintaro; Kamoda, Hiroto; Hagiwara, Yoko; Fujiwara, Tomohiro; Kawai, Akira; Ishii, Takeshi			The prognosis of osteosarcoma occurring as second malignancy of childhood cancers may be favorable: experience of two cancer centers in Japan	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Osteosarcoma; Second malignant neoplasm; Childhood cancer; Multiple primary cancers	GERMLINE P53 MUTATION; ADRENOCORTICAL CARCINOMA; NEOPLASMS; CHILDREN; SURVIVORS; RADIOTHERAPY; SARCOMAS; TUMORS; RISK; GENE	Osteosarcoma as second malignancy of childhood cancers rarely occurs, and its clinical characteristics are unclear. Patients with osteosarcoma occurring as second malignancy of childhood cancers were retrospectively surveyed. Of 323 patients with osteosarcoma registered in the database, 10 (3.1 %) had a past history of childhood cancers. The mean age at the onset of the first childhood cancer was 2.7 years, and the diagnosis of the first childhood cancer was adrenocortical carcinoma, malignant teratoma, ovarian carcinoma, Ewing's sarcoma, and rhabdomyosarcoma in 1 patient each, and retinoblastoma in 5 patients. Osteosarcoma as second malignancy occurred 14.6 years after the first childhood cancer on average. Seven patients were alive and 3 died. In 1 patient, the cause of death was related to a complication of treatment for the first childhood cancer. Except for this patient, 7 (77.8 %) of 9 patients survived with no disease (mean follow-up period: 10.9 years). Attention should be paid to complications of treatment for the first childhood cancer in the treatment for osteosarcoma occurring as second malignancy. The prognosis of osteosarcoma as second malignancy of childhood cancers may be more favorable than that of conventional osteosarcoma.	[Yonemoto, Tsukasa; Iwata, Shintaro; Kamoda, Hiroto; Hagiwara, Yoko; Ishii, Takeshi] Chiba Canc Ctr, Div Orthopaed Surg, Chuo Ku, Chiba 2608717, Japan; [Yonemoto, Tsukasa; Iwata, Shintaro; Kamoda, Hiroto; Hagiwara, Yoko; Ishii, Takeshi] Chiba Pediat Orthopaed Grp, Chiba, Japan; [Hosono, Ako] Natl Canc Ctr, Div Pediat, Chuo Ku, Tokyo 1040045, Japan; [Fujiwara, Tomohiro; Kawai, Akira] Natl Canc Ctr, Div Musculoskeletal Oncol, Chuo Ku, Tokyo 1040045, Japan	Yonemoto, T (reprint author), Chiba Canc Ctr, Div Orthopaed Surg, Chuo Ku, 666-2 Nitona Cho, Chiba 2608717, Japan.	tyonemot@chiba-cc.jp					Henderson TO, 2007, J NATL CANCER I, V99, P300, DOI 10.1093/jnci/djk052; Turaka K, 2012, PEDIATR BLOOD CANCER, V59, P121, DOI 10.1002/pbc.23278; TOGUCHIDA J, 1992, NEW ENGL J MED, V326, P1301, DOI 10.1056/NEJM199205143262001; Nathan PC, 2010, ANN INTERN MED, V153, P442, DOI 10.7326/0003-4819-153-7-201010050-00007; Smith MA, 2010, J CLIN ONCOL, V28, P2625, DOI 10.1200/JCO.2009.27.0421; Doi K, 2009, PAEDIATR PERINAT EP, V23, P370, DOI 10.1111/j.1365-3016.2009.01047.x; BECHLER JR, 1992, J BONE JOINT SURG AM, V74A, P1079; Bielack SS, 1999, J CLIN ONCOL, V17, P1164; Bielack SS, 2003, BONE MARROW TRANSPL, V31, P353, DOI 10.1038/sj.bmt.1703864; Cho Yool, 2011, Clin Orthop Surg, V3, P48, DOI 10.4055/cios.2011.3.1.48; Delaney HM, 2008, J PEDIAT HEMATOL ONC, V30, P803, DOI 10.1097/MPH.0b013e31818ab288; Iwata A, 2001, PEDIATR HEMAT ONCOL, V18, P465, DOI 10.1080/088800101750476050; Khayat CM, 2004, PEDIATR BLOOD CANCER, V43, P683, DOI 10.1002/pbc.20142; Makis A, 2004, J PEDIAT HEMATOL ONC, V26, P444, DOI 10.1097/00043426-200407000-00009; MEADOWS AT, 1985, J CLIN ONCOL, V3, P532; MEADOWS AT, 1980, CANCER-AM CANCER SOC, V46, P2603, DOI 10.1002/1097-0142(19801215)46:12<2603::AID-CNCR2820461212>3.0.CO;2-4; Moll AC, 1997, OPHTHALMIC GENET, V18, P27, DOI 10.3109/13816819709057880; NEWTON WA, 1991, CANCER, V67, P193, DOI 10.1002/1097-0142(19910101)67:1<193::AID-CNCR2820670132>3.0.CO;2-B; Nguyen F, 2008, INT J RADIAT ONCOL, V70, P908, DOI 10.1016/j.ijrobp.2007.10.034; Okada A, 2009, UPSALA J MED SCI, V114, P249, DOI 10.3109/03009730903177340; Radig K, 1998, HUM PATHOL, V29, P1310, DOI 10.1016/S0046-8177(98)90263-5; Renard M, 2011, PEDIATR BLOOD CANCER, V57, P119, DOI 10.1002/pbc.23083; Yonemoto T, 1999, ANTICANCER RES, V19, P5563	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	JUN	2015	20	3					613	616		10.1007/s10147-014-0729-8		4	Oncology	Oncology	CK0WV	WOS:000355927200029		
J	Ito, T; Hanafusa, N; Iwase, S; Noiri, E; Nangaku, M; Nakagawa, K; Miyagawa, K				Ito, Tetsuya; Hanafusa, Norio; Iwase, Satoru; Noiri, Eisei; Nangaku, Masaomi; Nakagawa, Keiichi; Miyagawa, Kiyoshi			Effects of cell-free and concentrated ascites reinfusion therapy (CART) on symptom relief of malignancy-related ascites	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Cell-free and concentrated ascites reinfusion therapy; Numerical rating scale; Ascites; Malignancy; Symptom relief; MDASI-J	CHRONIC-FATIGUE-SYNDROME; CANCER-PATIENTS; INVENTORY; CHEMOTHERAPY; VALIDATION; BURDEN; TRIAL	It is expected that cell-free and concentrated ascites reinfusion therapy (CART) will relieve the symptoms caused by ascites. To date, however, no report of objective changes in patients' symptoms has been published. We have therefore evaluated symptom management by CART. From April 2011 to July 2012, 37 patients at our hospital, most of whom had malignancies, received CART. Symptom severity was evaluated in each patient 24 h before and after the first CART procedure using a numerical rating scale for abdominal tension and the Japanese version of the M. D. Anderson Symptom Inventory (MDASI-J) for various symptoms. CART significantly improved the scores for abdominal tension and the symptom and interference scores of the MDASI-J within 24 h of the procedure. The abdominal tension scores decreased from 7.19 to 3.81 (p < 0.001), the symptom scores of the MDASI-J decreased from 4.73 to 2.75 and the interference scores of the MDASI-J decreased from 7.05 to 5.12. Detailed investigation revealed many symptoms, including fatigue and gastric symptoms, which are the usual targets of paracentesis, as well as general symptoms. No significant correlation between improved scores and the amount of reinfused protein or ascites removed was observed. Patients experienced no severe adverse event. Among the 37 patients receiving CART, various symptoms related to malignant ascites, especially fatigue, improved within the 24-h period following CART. Factors that ameliorate these symptoms remain to be elucidated.	[Ito, Tetsuya; Iwase, Satoru; Nakagawa, Keiichi] Tokyo Univ Hosp, Dept Palliat Med, Bunkyo Ku, Tokyo 1138655, Japan; [Ito, Tetsuya; Hanafusa, Norio; Noiri, Eisei; Nangaku, Masaomi] Tokyo Univ Hosp, Dept Hemodialysis & Apheresis, Bunkyo Ku, Tokyo 1138655, Japan; [Miyagawa, Kiyoshi] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Lab Mol Radiol,Bunkyo Ku, Tokyo 1138655, Japan	Ito, T (reprint author), Tokyo Univ Hosp, Dept Palliat Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	rachmaninov0531@aol.com					Cleeland CS, 2000, CANCER, V89, P1634, DOI 10.1002/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO;2-V; Peterson PK, 1998, ARCH INTERN MED, V158, P908, DOI 10.1001/archinte.158.8.908; Okuyama T, 2003, J PAIN SYMPTOM MANAG, V26, P1093, DOI 10.1016/j.jpainsymman.2003.05.003; BRUERA E, 1985, CANCER TREAT REP, V69, P751; Guirimand F, 2010, J PAIN SYMPTOM MANAG, V39, P721, DOI 10.1016/j.jpainsymman.2009.08.014; Bruera E, 2004, J PAIN SYMPTOM MANAG, V28, P381, DOI 10.1016/j.jpainsymman.2004.01.009; Campagnaro E, 2008, CANCER-AM CANCER SOC, V112, P1617, DOI [10.1002/cncr.23299, 10.1002/cncr23299]; Davis Mellar P, 2006, Curr Pain Headache Rep, V10, P260, DOI 10.1007/s11916-006-0030-2; Gabrilove JL, 2007, CANCER, V110, P1629, DOI 10.1002/cncr.22943; GARRISON RN, 1986, ANN SURG, V203, P644, DOI 10.1097/00000658-198606000-00009; Ito T, 2013, ARCHIT REV, V233, P18; Keen J, 2010, OXFORD TXB PALLIATIV, V4th, P863; Matsusaki K, 2011, INT J CLIN ONCOL, V16, P395, DOI 10.1007/s10147-011-0199-1; Van Houdenhove B, 2010, EXPERT OPIN PHARMACO, V11, P215, DOI 10.1517/14656560903487744; Yamagishi A, 2009, J PAIN SYMPTOM MANAG, V37, P823, DOI 10.1016/j.jpainsymman.2008.04.015	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	JUN	2015	20	3					623	628		10.1007/s10147-014-0750-y		6	Oncology	Oncology	CK0WV	WOS:000355927200031		
J	Matsuoka, K; Yasuno, F; Taguchi, A; Yamamoto, A; Kajimoto, K; Kazui, H; Kudo, T; Sekiyama, A; Kitamura, S; Kiuchi, K; Kosaka, J; Kishimoto, T; Iida, H; Nagatsuka, K				Matsuoka, Kiwamu; Yasuno, Fumihiko; Taguchi, Akihiko; Yamamoto, Akihide; Kajimoto, Katsufumi; Kazui, Hiroaki; Kudo, Takashi; Sekiyama, Atsuo; Kitamura, Soichiro; Kiuchi, Kuniaki; Kosaka, Jun; Kishimoto, Toshifumi; Iida, Hidehiro; Nagatsuka, Kazuyuki			Delayed atrophy in posterior cingulate cortex and apathy after stroke	INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY			English	Article						stroke; apathy; magnetic resonance imaging; voxel-based morphometric analysis; posterior cingulate cortex	DEFAULT MODE NETWORK; COGNITIVE CONTROL; ISCHEMIC-STROKE; GLOBAL BURDEN; DEPRESSION; SCALE; LIFE	Objective: A few studies have been performed on chronic structural changes after stroke. The primary purpose of the present study was to investigate regional cortical volume changes after the onset of stroke and to examine how the cortical volume changes affected neuropsychiatric symptoms. Methods: Participants were 20 stroke patients and 14 control subjects. T1-MRI was performed twice, once at the subacute stage and again 6 months later, and whole brain voxel-based morphometric (VBM) analysis was used to detect significant cortical gray matter volume changes in patients. We also assessed the correlation between changes in cortical volumes and changes in neuropsychiatric symptoms during the 6 months following a stroke. Results: In the present study, we found significant volume reductions in the anterior part of the posterior cingulate cortex (PCC) over the 6 months following a stroke by exploratory VBM analysis. We also found that the amount of volume change was significantly correlated with the change in apathy-scale scores during the 6 months poststroke. Conclusions: The present study suggests that delayed atrophic change is evident in the PCC 6 months after a stroke. There was greater apathetic change in the stroke patients with the larger volume reductions. The delayed atrophy of the PCC may reflect degeneration secondary to neuronal loss due to stroke. Such degeneration might have impaired control of goal-directed behavior, leading to the observed increase in apathy. Copyright (C) 2014 John Wiley & Sons, Ltd.	[Matsuoka, Kiwamu; Yasuno, Fumihiko; Kitamura, Soichiro; Kiuchi, Kuniaki; Kosaka, Jun; Kishimoto, Toshifumi] Nara Med Univ, Dept Psychiat, Kashihara, Nara 634, Japan; [Yasuno, Fumihiko; Yamamoto, Akihide; Iida, Hidehiro] Natl Cerebral & Cardiovasc Ctr, Dept Investigat Radiol, Suita, Osaka, Japan; [Taguchi, Akihiko; Kajimoto, Katsufumi; Nagatsuka, Kazuyuki] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Suita, Osaka, Japan; [Taguchi, Akihiko] Fdn Biomed Res & Innovat, Inst Biomed Res & Innovat, Kobe, Hyogo, Japan; [Kazui, Hiroaki; Kudo, Takashi] Osaka Univ, Sch Med, Dept Neuropsychiat, Suita, Osaka 565, Japan; [Sekiyama, Atsuo] Osaka City Univ, Sch Med, Dept Brain Sci, Osaka 545, Japan	Yasuno, F (reprint author), Nara Med Univ, Dept Psychiat, Kashihara, Nara 634, Japan.	ejm86rp@yahoo.co.jp			Japan Society for the Promotion of Science;  [24591740]	This research was supported by the Japan Society for the Promotion of Science and Grant-in-Aid for Scientific Research (C), 24591740.	Hama S, 2007, INT J GERIATR PSYCH, V22, P1046, DOI 10.1002/gps.1866; STARKSTEIN SE, 1993, STROKE, V24, P1625; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63; Thomalla G, 2004, NEUROIMAGE, V22, P1767, DOI 10.1016/j.neuroimage.2004.03.041; Kraemer M, 2004, J NEUROIMAGING, V14, P265, DOI 10.1177/1051228404264950; Alexopoulos GS, 2012, J AFFECT DISORDERS, V139, P56, DOI 10.1016/j.jad.2011.12.002; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Samus QM, 2005, GERONTOLOGIST, V45, P19; BROTT T, 1989, STROKE, V20, P864; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Hackett ML, 2005, STROKE, V36, P1330, DOI 10.1161/01.STR.0000165928.19135.35; van Dalen JW, 2013, STROKE, V44, P851, DOI 10.1161/STROKEAHA.112.674614; Goldstein LB, 1997, STROKE, V28, P307; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Mukherjee D, 2011, WORLD NEUROSURG, V76, pS85, DOI 10.1016/j.wneu.2011.07.023; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243	20	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-6230	1099-1166		INT J GERIATR PSYCH	Int. J. Geriatr. Psychiatr.	JUN	2015	30	6					566	572		10.1002/gps.4185		7	Geriatrics & Gerontology; Gerontology; Psychiatry	Geriatrics & Gerontology; Psychiatry	CK1RT	WOS:000355985600003		
J	Kobayashi, K; Nakano, H; Akiyama, N; Maeda, T; Yamamori, S				Kobayashi, Katsuji; Nakano, Hiroyuki; Akiyama, Noriko; Maeda, Takashi; Yamamori, Sanae			Pure psychiatric presentation of the Lewy body disease is depression-an analysis of 60 cases verified with myocardial meta-iodobenzylguanidine study	INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY			English	Article						depression; pure psychiatric presentation; Lewy body disease; MIBG	CARDIAC SYMPATHETIC DENERVATION; PARKINSONS-DISEASE; DEMENTIA; BODIES; DISORDER; DIAGNOSIS; SYMPTOMS; SCINTIGRAPHY; DLB; AD	Objective: Parkinson's disease (PD), Parkinson's disease with dementia (PDD) and dementia with Lewy bodies (DLB) were collectively termed Lewy body disease (LBD). Pure psychiatric presentation (PPP) of the LBD may be the fourth subtype in which psychiatric symptoms without definite parkinsonism and cognitive disturbance lasted for many years. The aim of this study is to localize the presence of the PPP in subjects with low uptake of myocardial meta-iodobenzylguanidine (MIBG). Methods: Sixty MIBG-verified patients (28 women and 32 men) were classified into three psychiatric pictures; depression (Group D: 27 patients), isolated visual hallucinations (Group V: 16 patients) and psychosis (Group P: 17 patients). Fifty six cases were examined with single photon emission tomography (SPECT) study of the brains in which hypoperfusion lobes were identified in 37 cases and 19 cases showed no abnormality. After that, we determined final diagnoses; PD, PDD, DLB and PPP with an aid of the DSM-IV, the unified Parkinson's disease rating scale (UPDRS) and Mini-mental state examination (MMSE). Results: Of Group D patients 40% remained depressive without parkinsonism and about 50% had or developed typical parkinsonism. Most Group P patients developed clinical pictures of PDD or DLB. Statistics provided four combinations: Group V-DLB-occipital lobe hypoperfusion, Group D-PD without SPECT abnormality, Group P-PDD with temporal lobe hypoperfusion and Group D-PPP without SPECT abnormality. Conclusions: PPP featured major depressive disorder and can be preparative of incidental LBD and prodromal depression of PD. Psychosis and dementia were of the same quality that characterizes the PDD. Copyright (C) 2014 John Wiley & Sons, Ltd.	[Kobayashi, Katsuji; Nakano, Hiroyuki; Akiyama, Noriko; Maeda, Takashi] Awazu Neuropsychiat Sanat, Psychiat, Komatsu, Ishikawa, Japan; [Kobayashi, Katsuji] Kanazawa Univ, Grad Sch Med Psychiat & Neurobiol Kanazawa, Kanazawa, Ishikawa 9201192, Japan; [Yamamori, Sanae] Yawata Med Ctr, Radiol Komatsu, Komatsu, Ishikawa, Japan	Kobayashi, K (reprint author), Awazu Neuropsychiat Sanat, Psychiat, Komatsu, Ishikawa, Japan.	k-koba@ta2.so-net.ne.jp					American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Orimo S, 2008, BRAIN, V131, P642, DOI 10.1093/brain/awm302; Yoshita M, 2006, NEUROLOGY, V66, P1850, DOI 10.1212/01.wnl.0000219640.59984.a7; Lemke MR, 2008, EUR J NEUROL, V15, P21, DOI 10.1111/j.1468-1331.2008.02058.x; Adler CH, 2010, MOVEMENT DISORD, V25, P642, DOI 10.1002/mds.22971; Navarro-Otano J, 2013, PARKINSONISM RELAT D, V19, P27, DOI 10.1016/j.parkreldis.2012.07.005; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Fujishiro H, 2008, MOVEMENT DISORD, V23, P1085, DOI 10.1002/mds.21989; Iritani S, 2008, NEUROPATHOLOGY, V28, P652, DOI 10.1111/j.1440-1789.2008.00905.x; Alves G, 2006, MOVEMENT DISORD, V21, P1123, DOI 10.1002/mds.20897; Tateno F, 2011, PARKINSONISM RELAT D, V17, P395, DOI 10.1016/j.parkreldis.2011.02.001; Courbon F, 2003, MOVEMENT DISORD, V18, P890, DOI 10.1002/mds.10461; Dubois B, 2007, MOVEMENT DISORD, V22, P2314, DOI 10.1002/mds.21844; Reijnders JSAM, 2009, PARKINSONISM RELAT D, V15, P379, DOI 10.1016/j.parkreldis.2008.09.003; Dijkstra AA, 2014, MOVEMENT DISORD, V29, P1244, DOI 10.1002/mds.25952; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Jellinger KA, 2012, CLIN NEUROPATHOL, V31, P87, DOI 10.5414/NP300418; Lieberman A, 2006, ACTA NEUROL SCAND, V113, P1, DOI 10.1111/j.1600-0404.2006.00536.x; Ballard CG, 2004, AM J PSYCHIAT, V161, P843, DOI 10.1176/appi.ajp.161.5.843; Borroni B, 2008, ARCH GERONTOL GERIAT, V47, P53, DOI 10.1016/j.archger.2007.07.005; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Forno LS, 1971, RECENT ADV PARKINSON, P119; Fritze F, 2011, DEMENT GERIATR COGN, V32, P143, DOI 10.1159/000332016; Huang Yue, 2013, Transl Neurodegener, V2, P4, DOI 10.1186/2047-9158-2-4; Hughes A, 1992, J NEUROL NEUROSUR PS, V66, P181, DOI DOI 10.1136/JNNP.55.3.181; Kobayashi K, 2010, INT J GERIATR PSYCH, V25, P55, DOI 10.1002/gps.2297; LENNOX GG, 1998, BLUE BOOK PRACT NEUR, V19, P67; Lobotesis K, 2001, NEUROLOGY, V56, P643; MCSHANE R, 1995, J NEUROL NEUROSUR PS, V59, P185, DOI 10.1136/jnnp.59.2.185; Moretti R, 2012, AM J ALZHEIMERS DIS, V27, P196, DOI 10.1177/1533317512445502; Pfeiffer RF, 2007, PARKINSONISM RELA S3, V13, P211; Sakakibara Ryuji, 2012, Am J Neurodegener Dis, V1, P146	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-6230	1099-1166		INT J GERIATR PSYCH	Int. J. Geriatr. Psychiatr.	JUN	2015	30	6					663	668		10.1002/gps.4214		6	Geriatrics & Gerontology; Gerontology; Psychiatry	Geriatrics & Gerontology; Psychiatry	CK1RT	WOS:000355985600015		
J	Miyazaki, K; Yoshihiro, E; Tenma, N; Yamaguchi, T				Miyazaki, Kuniyuki; Yoshihiro, Endo; Tenma, Norio; Yamaguchi, Tsutomu			Effects of Particle-Size Distribution on the Viscoelasticity of Artificial Methane-Hydrate-Bearing Sand	INTERNATIONAL JOURNAL OF OFFSHORE AND POLAR ENGINEERING			English	Article						Methane hydrate; triaxial compression; viscoelasticity; strain rate; creep; particle-size distribution	TRIAXIAL COMPRESSION TEST; STRAIN-RATE DEPENDENCE; MECHANICAL-BEHAVIOR; CONFINING PRESSURE; SEDIMENT; STRENGTH; ROCK; RESERVOIR	The viscoelastic behaviors of gas-hydrate-bearing sediments have great significance in the long-term prediction of the geomechanical response to gas extraction from a gas-hydrate reservoir. Two types of triaxial compression tests were conducted on artificial methane-hydrate-bearing sand specimens to clarify their viscoelasticity: constant-strain-rate and creep tests. The specimens were formed by using two types of sand with different particle-size distributions. The particle-size distribution was found to affect the viscoelasticity of the methane-hydrate-bearing sand specimen in the early stage of axial loading, although it did not have much effect in the late stage of axial loading.	[Miyazaki, Kuniyuki] Natl Inst Adv Ind Sci & Technol, Inst Georesources & Environm, Tsukuba, Ibaraki, Japan; [Yoshihiro, Endo] Toho Univ, Grad Sch Sci, Funabashi, Chiba 274, Japan; [Tenma, Norio] Natl Inst Adv Ind Sci & Technol, Methane Hydrate Res Ctr, Tsukuba, Ibaraki, Japan; [Yamaguchi, Tsutomu] Toho Univ, Dept Environm Sci, Funabashi, Chiba 274, Japan	Miyazaki, K (reprint author), Natl Inst Adv Ind Sci & Technol, Inst Georesources & Environm, Tsukuba, Ibaraki, Japan.				Research Consortium for Methane Hydrate Resources in Japan (MH21 Research Consortium) in the Methane Hydrate Research and Development Program; Ministry of Economy, Trade and Industry of the Government of Japan	This work was financially supported by the Research Consortium for Methane Hydrate Resources in Japan (MH21 Research Consortium) in the Methane Hydrate Research and Development Program established by the Ministry of Economy, Trade and Industry of the Government of Japan. We would like to thank Akira Masui, Takao Ohno, and Shigenori Nagase for their experimental assistance.	Hyodo M, 2005, SOILS FOUND, V45, P75; Miyazaki K, 2010, INT J OFFSHORE POLAR, V20, P256; Durham WB, 2003, CAN J PHYS, V81, P373, DOI 10.1139/P03-042; Miyazaki K, 2010, INT J OFFSHORE POLAR, V20, P61; Miyazaki K, 2011, INT J OFFSHORE POLAR, V21, P148; KVENVOLDEN KA, 1993, GEO-MAR LETT, V13, P32, DOI 10.1007/BF01204390; Sakamoto Y, 2009, INT J OFFSHORE POLAR, V19, P124; KVENVOLDEN KA, 1988, CHEM GEOL, V71, P41, DOI 10.1016/0009-2541(88)90104-0; GRAHAM J, 1983, GEOTECHNIQUE, V33, P327; BUGGE T, 1988, PHILOS T R SOC A, V325, P357, DOI 10.1098/rsta.1988.0055; Benedetto HD, 2002, SOILS FOUND, V42, P1; Collett TS, 2002, P 4 INT C GAS HYDR Y, V1, P47; Durham WB, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001872; Hashiba K, 2006, INT J ROCK MECH MIN, V43, P894, DOI 10.1016/j.ijrmms.2005.12.005; Hayano K, 2001, SOILS FOUND, V41, P21; Hyodo M, 2002, P 12 INT OFFSH POL E, V1, P422; Kleinberg RL, 2005, P 5 INT C GAS HYDR T, V3, P736; Magistris FS, 1999, GEOTECH TEST J, V22, P44; Makogon Y.F., 1981, HYDRATES NATURAL GAS; Makogon YF, 1982, P 4 CAN PERM C CALG, P299; Masui A, 2005, P 15 INT OFFSH POL E, V1, P364; Miyazaki K, 2012, INT J OFFSHORE POLAR, V22, P90; Miyazaki K., 2011, INT J JCRM, V7, P43; Miyazaki K, 2011, P 12 ISRM INT C ROCK, P747; OKUBO S, 1990, INT J ROCK MECH MIN, V27, P559, DOI 10.1016/0148-9062(90)91007-T; PARAMESWARAN VR, 1980, CAN GEOTECH J, V17, P74; Tatsuoka F, 2002, SOILS FOUND, V42, P103	27	0	0	INT SOC OFFSHORE POLAR ENGINEERS	CUPERTINO	PO BOX 189, CUPERTINO, CA 95015-0189 USA	1053-5381			INT J OFFSHORE POLAR	Int. J. Offshore Polar Eng.	JUN	2015	25	2					112	119				8	Engineering, Civil; Engineering, Ocean; Engineering, Mechanical	Engineering	CK3KI	WOS:000356114600005		
J	Sobue, T				Sobue, Tomotaka			Recent progress and future direction of cancer epidemiological research in Japan	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Review						cancer epidemiology; research funding; cancer control	LUNG-CANCER; FOLLOW-UP; RISK; POPULATION; REGISTRIES; TRIAL	In 2006, the Cancer Control Act was approved and a Basic Plan, to Promote the Cancer Control Program at the national level, was developed in 2007. Cancer research is recognized as a fundamental component to provide evidence in cancer control program. Cancer epidemiology plays central role in connecting research and policy, since it directly deals with data from humans. Research for cancer epidemiology in Japan made substantial progress, in the field of descriptive studies, cohort studies, intervention studies and activities for summarizing evidences. In future, promoting high-quality large-scale intervention studies, individual-level linkage studies, simulation models and studies for elderly population will be of great importance, but at the same time research should be promoted in well-balanced fashion not placing too much emphasis on one particular research field.	Osaka Univ, Grad Sch Med, Dept Prevent Med & Populat Sci, Osaka 5650871, Japan	Sobue, T (reprint author), Osaka Univ, Grad Sch Med, Dept Prevent Med & Populat Sci, 2-2 F1 Yamadaoka Suita, Osaka 5650871, Japan.	tsobue@envi.med.osaka-u.ac.jp					Tamakoshi A, 2013, J EPIDEMIOL, V23, P227, DOI 10.2188/jea.JE20120161; HIRAYAMA T, 1981, BRIT MED J, V282, P183; Meza R, 2014, CANCER-AM CANCER SOC, V120, P1713, DOI 10.1002/cncr.28623; Higashi T, 2014, JPN J CLIN ONCOL, V44, P2, DOI 10.1093/jjco/hyt013; Katanoda K, 2011, J EPIDEMIOL, V21, P132, DOI 10.2188/jea.JE20100098; Hamashima C, 2010, JPN J CLIN ONCOL, V40, P485, DOI 10.1093/jjco/hyq036; Inoue M, 2012, ANN ONCOL, V23, P1362, DOI 10.1093/annonc/mdr437; Ishida T, 2014, JPN J CLIN ONCOL, V44, P134, DOI 10.1093/jjco/hyt199; Matsuda T, 2015, INT J CLIN ONCOL, V20, P11, DOI 10.1007/s10147-014-0765-4; Sakata R, 2012, MATURITAS, V72, P99, DOI 10.1016/j.maturitas.2012.02.009; Tanaka H, 2014, INT J CANCER, V134, P747, DOI 10.1002/ijc.28519; Tanaka K, 2014, JPN J CLIN ONCOL, V44, P986, DOI 10.1093/jjco/hyu108; Tsugane S, 2014, JPN J CLIN ONCOL, V44, P777, DOI 10.1093/jjco/hyu096; World Health Organization (WHO), 2002, NAT CANC CONTR PROGR; Zhu CS, 2013, JNCI-J NATL CANCER I, V105, P1684, DOI 10.1093/jnci/djt281	15	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	JUN	2015	45	6					509	512		10.1093/jjco/hyv015		4	Oncology	Oncology	CK5DL	WOS:000356242300001		
J	Umemura, S; Tsuchihara, K; Goto, K				Umemura, Shigeki; Tsuchihara, Katsuya; Goto, Koichi			Genomic profiling of small-cell lung cancer: the era of targeted therapies	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Review						lung cancer; small cell; genome; profiling; targeted therapy	PHASE-II-TRIAL; PLACEBO-CONTROLLED TRIAL; C-KIT PROTEIN; DOUBLE-BLIND; 1ST-LINE TREATMENT; INDUCTION CHEMOTHERAPY; CD117 IMMUNOREACTIVITY; NEUROENDOCRINE TUMORS; PI3K/AKT/MTOR PATHWAY; THERAPEUTIC TARGETS	The molecular profiling of small-cell lung cancer is challenging because of the difficulty in obtaining suitable tumor samples for integrative genomic analysis. While an urgent need exists for well-defined and effective therapeutic targets in small-cell lung cancer, no significant improvement has been made in treating this disease over the past 30 years. Recently, three reports describing comprehensive genomic analyses of small-cell lung cancer have been published. These reports have provided a framework of biologically relevant genes in small-cell lung cancer and have demonstrated that the genomic landscape of small-cell lung cancer was almost equivalent between Asian and Caucasian populations. Of note, these three comprehensive genomic analyses and other molecular analyses of small-cell lung cancer have contributed to the identification of patient populations that may benefit from promising targeted agents, such as those affecting the PI3K/AKT/mTOR pathway, FGFR1, RET or AURORA kinase inhibitors. Targeting small-cell lung cancer cells with tumor suppressor gene alteration based on synthetic lethality is also promising. The present review provides an overview of the biologically relevant genetic alterations and targeted therapies of small-cell lung cancer focusing on recent discoveries that could impact the management of small-cell lung cancer.	[Umemura, Shigeki; Goto, Koichi] Natl Canc Ctr Hosp East, Div Thorac Oncol, Kashiwa, Chiba, Japan; [Tsuchihara, Katsuya] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan	Umemura, S (reprint author), Natl Canc Ctr Hosp, Div Thorac Oncol, East 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	sumemura@east.ncc.go.jp					Gitlitz BJ, 2010, J THORAC ONCOL, V5, P1835, DOI 10.1097/JTO.0b013e3181f0bd78; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Umemura S, 2014, J THORAC ONCOL, V9, P1324, DOI 10.1097/JTO.0000000000000250; Borges M, 1997, NATURE, V386, P852, DOI 10.1038/386852a0; William WN, 2011, NAT REV CLIN ONCOL, V8, P611, DOI 10.1038/nrclinonc.2011.90; Spigel DR, 2009, J THORAC ONCOL, V4, P1555, DOI 10.1097/JTO.0b013e3181bbc540; Enomoto H, 2001, DEVELOPMENT, V128, P3963; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Dy GK, 2005, ANN ONCOL, V16, P1811, DOI 10.1093/annonc/mdi365; Dabir S, 2014, J THORAC ONCOL, V9, P1316, DOI 10.1097/JTO.0000000000000234; Sos ML, 2012, P NATL ACAD SCI USA, V109, P17034, DOI 10.1073/pnas.1207310109; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Lee SM, 2009, J NATL CANCER I, V101, P1049, DOI 10.1093/jnci/djp200; Pietanza MC, 2012, NAT GENET, V44, P1074, DOI 10.1038/ng.2415; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; Pujol JL, 2007, J CLIN ONCOL, V25, P3945, DOI 10.1200/JCO.2007.11.8109; Allen JW, 2014, J CLIN ONCOL, V32, P2463, DOI 10.1200/JCO.2013.51.4109; Shepherd FA, 2002, J CLIN ONCOL, V20, P4434, DOI 10.1200/JCO.2002.02.108; Reck M, 2013, ANN ONCOL, V24, P75, DOI 10.1093/annonc/mds213; Schneider BJ, 2010, CLIN LUNG CANCER, V11, P223, DOI 10.3816/CLC.2010.n.028; Arriola E, 2008, CLIN TRANSL ONCOL, V10, P189, DOI 10.1007/s12094-008-0181-1; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Krug LM, 2005, CANCER, V103, P2128, DOI 10.1002/cncr.21000; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Pelosi G, 2004, MODERN PATHOL, V17, P711, DOI 10.1038/modpathol.3800110; Moore AM, 2006, LUNG CANCER-J IASLC, V52, P93, DOI 10.1016/j.lungcan.2005.12.002; Okamoto I, 2006, ANN ONCOL, V17, P1028, DOI 10.1093/annonc/mdj114; Rudin CM, 2012, CLIN CANCER RES, V18, P3163, DOI 10.1158/1078-0432.CCR-11-3090; Pandya KJ, 2007, J THORAC ONCOL, V2, P1036, DOI 10.1097/JTO.0b013e318155a439; Araki K, 2003, LUNG CANCER-J IASLC, V40, P173, DOI 10.1016/S0169-5002(03)00034-5; Gadgeel SM, 2013, CLIN LUNG CANCER, V14, P322, DOI 10.1016/j.cllc.2012.12.001; Rudin CM, 2008, J CLIN ONCOL, V26, P870, DOI 10.1200/JCO.2007.14.3461; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; Ross JS, 2014, J CLIN PATHOL, V67, P772, DOI 10.1136/jclinpath-2014-202447; Horiuchi D, 2012, J EXP MED, V209, P679, DOI 10.1084/jem.20111512; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Osada H, 2005, CANCER RES, V65, P10680, DOI 10.1158/0008-5472.CAN-05-1404; Johnson BE, 2003, CLIN CANCER RES, V9, P5880; Pelosi G, 2004, VIRCHOWS ARCH, V445, P449, DOI 10.1007/s00428-004-1106-1; Han JY, 2013, LUNG CANCER, V79, P137, DOI 10.1016/j.lungcan.2012.09.019; Horn L, 2009, J CLIN ONCOL, V27, P6006, DOI 10.1200/JCO.2009.23.7545; Shibata T, 2009, CANCER LETT, V283, P203, DOI 10.1016/j.canlet.2009.03.038; Augustyn A, 2014, P NATL ACAD SCI USA, V111, P14788, DOI 10.1073/pnas.1410419111; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Byers LA, 2012, CANCER DISCOV, V2, P798, DOI 10.1158/2159-8290.CD-12-0112; Jiang TY, 2009, CANCER RES, V69, P845, DOI 10.1158/0008-5472.CAN-08-2762; Lu HY, 2012, ONCOL LETT, V4, P89, DOI 10.3892/ol.2012.679; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Tarhini A, 2010, CLIN CANCER RES, V16, P5900, DOI 10.1158/1078-0432.CCR-10-0802; Spigel DR, 2011, J CLIN ONCOL, V29, P2215, DOI 10.1200/JCO.2010.29.3423; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Arnold AM, 2007, J CLIN ONCOL, V25, P4278, DOI 10.1200/JCO.2007.12.3083; Zakowski MF, 2006, NEW ENGL J MED, V355, P213, DOI 10.1056/NEJMc053610; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; Marinov M, 2009, CLIN CANCER RES, V15, P1277, DOI 10.1158/1078-0432.CCR-08-2166; Belani CK, 2013, J CLIN ONCOL, V31; Chau NG, 2013, CLIN CANCER RES, V19, P524, DOI 10.1158/1078-0432.CCR-12-2353; Christensen CL, 2014, CANCER CELL, V26, P909, DOI 10.1016/j.ccell.2014.10.019; Cirocchi R, 2010, TUMORI, V96, P392; Clinical Lung Cancer Genome Project Network Genomic Medicine, 2013, SCI TRANSL MED, V5; Eng C, 1996, JAMA-J AM MED ASSOC, V276, P1575, DOI 10.1001/jama.276.19.1575; Glisson B, 2013, J THORAC ONCOL, V8, pS220; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Havel L, 2013, J THORAC ONCOL, V8, pS221; Lu HY, 2012, NEOPLASMA, V59, P100, DOI 10.4149/neo_2012_013; Lucchi M, 2002, EUR J CARDIO-THORAC, V21, P1105, DOI 10.1016/S1010-7940(02)00112-4; Nickolich M, 2014, CLIN LUNG CANCER, V15, P207, DOI 10.1016/j.cllc.2013.12.001; Paik PK, 2011, LUNG CANCER, V74, P481, DOI 10.1016/j.lungcan.2011.05.005; Pourdehnada M, 2013, P NATL ACAD SCI USA, V110, P11988, DOI 10.1073/pnas.1310230110; REEVE JG, 1990, BRIT J CANCER, V61, P727, DOI 10.1038/bjc.1990.163; Reichardt P, 2010, ONCOLOGY-BASEL, V78, P130, DOI 10.1159/000312655; Rigas JR, 2003, LUNG CANCER, V41, pS34, DOI 10.1016/S0169-5002(03)91765-X; Rosell R, 2012, CANCER DISCOV, V2, P769, DOI 10.1158/2159-8290.CD-12-0346; Rudin CM, 2014, J THORAC ONCOL, V9, P1240, DOI 10.1097/JTO.0000000000000301; Searle JS, 2010, ONCOTARGET, V1, P228; Spigel DR, 2012, LUNG CANCER, V77, P359, DOI 10.1016/j.lungcan.2012.03.009; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Thomas A, 2014, J THORAC ONCOL, V9, P567, DOI 10.1097/JTO.0000000000000089; Von Pawel J, 2013, J CLIN ONCOL, V31; Voortman J, 2012, P NATL ACAD SCI USA, V107, P13040; Wakuda K, 2014, LUNG CANCER, V84, P139, DOI 10.1016/j.lungcan.2014.02.013; Wojtalla A, 2013, CLIN CANCER RES, V19, P96, DOI 10.1158/1078-0432.CCR-12-1138; Xuan Hong, 2014, Histol Histopathol, V29, P273; Yoshida C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059248	86	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	JUN	2015	45	6					513	519		10.1093/jjco/hyv017		7	Oncology	Oncology	CK5DL	WOS:000356242300002		
J	Fukazawa, S; Shinto, E; Tsuda, H; Ueno, H; Shikina, A; Kajiwara, Y; Yamamoto, J; Hase, K				Fukazawa, Satomi; Shinto, Eiji; Tsuda, Hitoshi; Ueno, Hideki; Shikina, Atsushi; Kajiwara, Yoshiki; Yamamoto, Junji; Hase, Kazuo			Laminin beta 3 expression as a prognostic factor and a predictive marker of chemoresistance in colorectal cancer	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						laminin beta 3; colorectal cancer; prognostic factor; chemoresistance	EPITHELIAL-MESENCHYMAL TRANSITION; GAMMA-2 CHAIN EXPRESSION; CARCINOMA CELL-LINES; TUMOR-CELLS; ADJUVANT CHEMOTHERAPY; DRUG-RESISTANCE; 5-FLUOROURACIL; INVASION; RECEPTOR; PATHWAY	Laminin-332, a marker of epithelial-mesenchymal transition, is composed of a heterotrimer of alpha 3, beta 3 and gamma 2 chains that regulates cell adhesion and migration. This study aimed to disclose the respective clinical significance of laminin beta 3 immunoexpression in colorectal cancer as a prognostic factor and a predictive marker of chemoresistance. Tissue specimens from 323 Stage II and 232 Stage III colorectal cancer patients who underwent curative resection were assessed using laminin beta 3 immunostaining. Among Stage III colorectal cancer patients, comparisons of 5-year disease-free survival rates revealed a poorer prognosis for the laminin beta 3-high group than for the laminin beta 3-low group (52.3 vs. 70.7%, P = 0.038), while there was no significant difference among Stage II patients. Among laminin beta 3-low Stage III patients, those who received adjuvant chemotherapy showed marginally better disease-free survival than those who did not receive it (75.8 vs. 62.8%; P = 0.096). Furthermore, multivariate analysis corroborated a distinct benefit of adjuvant chemotherapy in laminin beta 3-low patients (P = 0.035; hazard risk ratio = 1.66). Analyses of the laminin beta 3-high group, however, failed to show significance. Laminin beta 3 chain immunoreactivity was a poor prognostic factor for Stage III colorectal cancer patients, and laminin beta 3-high patients of Stage III colorectal cancer derived no survival benefit from adjuvant chemotherapy.	[Fukazawa, Satomi; Shinto, Eiji; Ueno, Hideki; Shikina, Atsushi; Kajiwara, Yoshiki; Yamamoto, Junji; Hase, Kazuo] Natl Def Med Coll, Dept Surg, Tokorozawa, Saitama 3598513, Japan; [Tsuda, Hitoshi] Natl Def Med Coll, Dept Pathol, Tokorozawa, Saitama 3598513, Japan	Fukazawa, S (reprint author), Natl Def Med Coll, Dept Surg, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	s-fukazawa2015@outlook.jp			National Cancer Center Research and Development Fund [23-A-11, 23-A-26]; Japan Society for the Promotion of Science KAKENHI [23501302, 25462074, 26462032]	This work was supported in part by a grant from the National Cancer Center Research and Development Fund (grant numbers 23-A-11 and 23-A-26) and the Japan Society for the Promotion of Science KAKENHI (grant numbers 23501302, 25462074 and 26462032).	Akimoto S, 2004, PATHOL INT, V54, P688, DOI 10.1111/j.1440-1827.2004.01681.x; Gray RG, 2000, LANCET, V355, P1588; Schenk S, 2003, J CELL BIOL, V161, P197, DOI 10.1083/jcb.200208145; Hoshino H, 2009, BIOCHEM BIOPH RES CO, V390, P1061, DOI 10.1016/j.bbrc.2009.10.117; Guo XX, 2008, ANTICANCER RES, V28, P9; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Ii M, 2011, INT J ONCOL, V39, P593, DOI 10.3892/ijo.2011.1048; Koshikawa N, 1999, CANCER RES, V59, P5596; Shah AN, 2007, ANN SURG ONCOL, V14, P3629, DOI 10.1245/s10434-007-9583-5; Hafsi S, 2012, INT J ONCOL, V40, P639, DOI 10.3892/ijo.2011.1312; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Pisani P, 1999, INT J CANCER, V83, P870; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Ueno H, 2002, HISTOPATHOLOGY, V40, P127, DOI 10.1046/j.1365-2559.2002.01324.x; Hlubek F, 2001, CANCER RES, V61, P8089; Zhang B, 2014, BRIT J CANCER, V110, P946, DOI 10.1038/bjc.2013.789; HASE K, 1993, DIS COLON RECTUM, V36, P627, DOI 10.1007/BF02238588; Hlubek F, 2004, INT J CANCER, V108, P321, DOI 10.1002/ijc.11522; PYKE C, 1995, CANCER RES, V55, P4132; Miyazaki K, 2006, CANCER SCI, V97, P91, DOI 10.1111/j.1349-7006.00150.x; Yasuda A, 2007, DIGEST DIS SCI, V52, P2292, DOI 10.1007/s10620-007-9759-7; Aoki S, 2002, DIS COLON RECTUM, V45, P1520, DOI 10.1097/01.DCR.0000029593.41892.62; De Angelis PM, 2004, INT J ONCOL, V24, P1279; He X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070858; Japanese Society for Cancer of the Colon and Rectum, 2009, JAP CLASS COL CARC; Kagesato Y, 2001, JPN J CANCER RES, V92, P184; Masaki T, 2003, DIGEST DIS SCI, V48, P272, DOI 10.1023/A:1021967108134; Masaki T, 2003, ANTICANCER RES, V23, P4113; MATSUI C, 1995, J BIOL CHEM, V270, P23496; Mizushima H, 2002, JPN J CANCER RES, V93, P652; Porschen R, 2001, J CLIN ONCOL, V19, P1787; Shinto E, 2005, HISTOPATHOLOGY, V47, P25, DOI 10.1111/j.1365-2559.2005.02162.x; Shinto E, 2005, LAB INVEST, V85, P257, DOI 10.1038/labinvest.3700199; Sordat I, 1998, J PATHOL, V185, P44, DOI 10.1002/(SICI)1096-9896(199805)185:1<44::AID-PATH46>3.0.CO;2-A; TOFFOLI G, 1992, CANCER CHEMOTH PHARM, V29, P283, DOI 10.1007/BF00685946; Tsubota Y, 2010, INT J CANCER, V127, P2031, DOI 10.1002/ijc.25231; Uchibori K, 2012, INT J ONCOL, V40, P1005, DOI 10.3892/ijo.2011.1300; Waterman EA, 2007, CANCER RES, V67, P4264, DOI 10.1158/0008-5472.CAN-06-4141; Xiao ZM, 2013, BIOTECHNOL APPL BIOC	43	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	JUN	2015	45	6					533	540		10.1093/jjco/hyv037		8	Oncology	Oncology	CK5DL	WOS:000356242300005		
J	Tanaka, K; Mizusawa, J; Fukuda, H; Araki, N; Chuman, H; Takahashi, M; Ozaki, T; Hiruma, T; Tsuchiya, H; Morioka, H; Hatano, H; Iwamoto, Y				Tanaka, Kazuhiro; Mizusawa, Junki; Fukuda, Haruhiko; Araki, Nobuhito; Chuman, Hirokazu; Takahashi, Mitsuru; Ozaki, Toshifumi; Hiruma, Toru; Tsuchiya, Hiroyuki; Morioka, Hideo; Hatano, Hiroshi; Iwamoto, Yukihide			Perioperative chemotherapy with ifosfamide and doxorubicin for high-grade soft tissue sarcomas in the extremities (JCOG0304)	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						chemotherapy; extremities; multicenter study; neoadjuvant therapy; sarcoma	ADJUVANT CHEMOTHERAPY; NEOADJUVANT CHEMOTHERAPY; TRIAL; METAANALYSIS; ADRIAMYCIN	The efficacy of perioperative chemotherapy for soft tissue sarcomas is controversial and only a few prospective studies of pre-operative chemotherapy for soft tissue sarcomas in the extremities have been reported. We therefore carried out Phase II study of perioperative chemotherapy for patients with soft tissue sarcomas in the extremities. Patients with Stage III non-round cell soft tissue sarcomas in the extremities were eligible. The patients were treated with pre-operative chemotherapy consisting doxorubicin 60 mg/m(2) and ifosfamide 10 g/m(2) for three courses. After the tumor resection, two additional courses of the same regimen were carried out. A total of 72 patients were enrolled and 70 patients were eligible. The median age of the patients was 49 years. The major pathological subtypes were synovial sarcoma in 20 and undifferentiated pleomorphic sarcoma in 17 patients. The protocol treatments were completed in 74% of the eligible cases. The 2 and 5-year progression-free survival rates were 75.7% (95% CI, 63.9-84.1%) and 63.8% (95% CI, 51.3-73.9%), respectively. The 5-year overall survival was 82.6% (95% CI, 71.3-89.7%). There was no treatment-related death. Grade 3 or 4 hematological toxicities (leukopenia and neutropenia) were observed in most of the patients. Although the toxicities of the regimen were significant, pre-operative chemotherapy followed by post-operative chemotherapy using doxorubicin and high-dose ifosfamide was feasible. The outcome of the trial for the patients with high-grade soft tissue sarcomas in the extremities was favorable, and this regimen is promising for further investigation. This trial was registered at the UMIN Clinical Trials Registry () as C000000096.	[Tanaka, Kazuhiro] Oita Univ, Dept Endoprosthet Surg, Oita 87011, Japan; [Mizusawa, Junki; Fukuda, Haruhiko] Natl Canc Ctr, Ctr Res Adm & Support, JCOG Data Ctr, Tokyo 104, Japan; [Araki, Nobuhito] Osaka Med Ctr, Dept Orthopaed Surg, Osaka, Japan; [Chuman, Hirokazu] Natl Canc Ctr, Dept Orthopaed Surg, Tokyo 104, Japan; [Takahashi, Mitsuru] Shizuoka Canc Ctr, Dept Orthopaed Surg, Shizuoka, Japan; [Ozaki, Toshifumi] Okayama Univ, Dept Orthopaed Surg, Okayama, Japan; [Hiruma, Toru] Kanagawa Canc Ctr, Dept Orthopaed Surg, Kanagawa, Japan; [Tsuchiya, Hiroyuki] Kanazawa Univ, Dept Orthopaed Surg, Kanazawa, Ishikawa 9201192, Japan; [Morioka, Hideo] Keio Univ, Dept Orthopaed Surg, Tokyo, Japan; [Hatano, Hiroshi] Niigata Canc Ctr Hosp, Dept Orthopaed Surg, Niigata, Japan; [Iwamoto, Yukihide] Kyushu Univ, Dept Orthopaed Surg, Fukuoka 8128582, Japan	Iwamoto, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yiwamoto@ortho.med.kyushu-u.ac.jp			National Cancer Center Research and Development Fund [23A-16, 23A-20, 26-A-4]; Health and Labour Sciences Research Grant [H14-Gan-033, H17-Gan-006]; Health and Labour Sciences Research Expenses for Commission, Applied Research for Innovative Treatment of Cancer from the Ministry of Health, Labour and Welfare, Japan [H26-084];  [14S-1];  [14S-4];  [17S-4];  [17S-5];  [20S-4];  [20S-6]	This work was supported in part by National Cancer Center Research and Development Fund (23A-16, 23A-20 and 26-A-4), the Grants-in-Aid for Cancer Research (14S-1, 14S-4, 17S-4, 17S-5, 20S-4 and 20S-6), the Health and Labour Sciences Research Grant (H14-Gan-033, H17-Gan-006), and the Health and Labour Sciences Research Expenses for Commission, Applied Research for Innovative Treatment of Cancer (H26-084) from the Ministry of Health, Labour and Welfare, Japan.	American Cancer Society, 2010, CANC FACT FIG 2010; Pervaiz N, 2008, CANCER, V113, P573, DOI [10.1002/cncr.23592, 10.1002/cncr23592]; Guillou L, 1997, J CLIN ONCOL, V15, P350; DeLaney TF, 2003, INT J RADIAT ONCOL, V56, P1117, DOI 10.1016/S0360-3016(03)00186-X; Issels RD, 2010, LANCET ONCOL, V11, P561, DOI 10.1016/S1470-2045(10)70071-1; Frustaci S, 2001, J CLIN ONCOL, V19, P1238; Edmonson JH, 2002, CANCER, V94, P786, DOI 10.1002/cncr.10259; Weitz J, 2003, J CLIN ONCOL, V21, P2719, DOI 10.1200/JCO.2003.02.026; Gronchi A, 2012, J CLIN ONCOL, V30, P850, DOI 10.1200/JCO.2011.37.7218; Biermann JS, 1997, SEMIN ONCOL, V24, P592; DEMETRI GD, 1995, HEMATOL ONCOL CLIN N, V9, P765; Figueredo Alvaro, 2002, Sarcoma, V6, P5, DOI 10.1080/13577140220127512; Japanese Orthopaedic Association Musculoskeletal Tumor Committee, 2009, SOFT TISS TUM REG JA; Kataoka K, 2014, JPN J CLIN ONCOL, V44, P765, DOI 10.1093/jjco/hyu080; Kawai A, 2005, J ORTHOP SCI, V10, P258, DOI 10.1007/s00776-05-0899-3; Tierney JF, 1997, LANCET, V350, P1647; Sobin LH, 2003, TNM CLASSIFICATION M, VSixth, P117; Tanaka K, 2009, JPN J CLIN ONCOL, V39, P271, DOI 10.1093/jjco/hyn153	18	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	JUN	2015	45	6					555	561		10.1093/jjco/hyv042		7	Oncology	Oncology	CK5DL	WOS:000356242300008		
J	Kataoka, Y; Yamamoto, Y; Otsuki, T; Shinomiya, M; Terada, T; Fukuma, S; Yamazaki, S; Hirabayashi, M; Nakano, T; Fukuhara, S				Kataoka, Yuki; Yamamoto, Yosuke; Otsuki, Taiichiro; Shinomiya, Mariko; Terada, Takayuki; Fukuma, Shingo; Yamazaki, Shin; Hirabayashi, Masataka; Nakano, Takashi; Fukuhara, Shunichi			A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						malignant pleural mesothelioma; pemetrexed; best supportive care; prognostic index; palliative care	CELL LUNG-CANCER; EARLY PALLIATIVE CARE; PREDICT SURVIVAL; PHASE-III; CHEMOTHERAPY; PREFERENCES; VALIDATION; CISPLATIN; THERAPY; TRIALS	Existing prognostic indices for malignant pleural mesothelioma do not incorporate the recent advances in oncology care. The purpose of this study was to provide a prognostic index for overall survival in malignant pleural mesothelioma patients treated with chemotherapy with pemetrexed or best supportive care in the recent clinical setting. A retrospective cohort study was performed in two hospitals in Japan (2007-13). The primary outcome was overall survival. The Cox proportional hazards model was used for multivariable analyses to identify prognostic factors. A final model was chosen based on both clinical and statistical significance. A total of 283 patients (chemotherapy: n = 228, best supportive care: n = 55) were enrolled in the study. On multivariate analysis, regimen including platinum plus pemetrexed, a performance status > 0, non-epithelial histological type and Stage IV disease predicted poor overall survival in chemotherapy patients. As hazard ratios of individual risk factors were approximately similar, a prognostic index for overall survival was constructed by counting the risk factors. Median overall survival in chemotherapy patients decreased by each one-point increase in this count: 1030 days for zero; 658 days for one; 373 days for two; 327 days for three; 125 days for four. Internal validation using the bootstrapping technique showed robustness of the model (c-index, 0.677; 95% confidence interval, 0.624-0.729). Further, the discrimination was consistent in best supportive care patients (c-index, 0.799; 95% confidence interval, 0.725-0.874). This novel index can provide clinicians and malignant pleural mesothelioma patients with a better framework for discussing prognosis at the time of diagnosis.	[Kataoka, Yuki; Yamamoto, Yosuke; Fukuma, Shingo; Yamazaki, Shin; Fukuhara, Shunichi] Kyoto Univ, Dept Healthcare Epidemiol, Grad Sch Med & Publ Hlth, Yoshida Konoe, Kyoto 6068501, Japan; [Kataoka, Yuki; Shinomiya, Mariko; Hirabayashi, Masataka] Hyogo Kenritsu Amagasaki Hosp, Dept Resp Med, Kobe, Hyogo, Japan; [Otsuki, Taiichiro] Hyogo Coll Med, Ctr Canc, Kobe, Hyogo, Japan; [Terada, Takayuki; Nakano, Takashi] Hyogo Coll Med, Div Resp Med, Kobe, Hyogo, Japan; [Fukuma, Shingo; Fukuhara, Shunichi] Fukushima Med Univ, Ctr Innovat Res Clin Evaluat Sci CiRCLE, Fukushima, Japan	Fukuhara, S (reprint author), Kyoto Univ, Dept Healthcare Epidemiol, Grad Sch Med & Publ Hlth, Sakyo Ku, Yoshida Konoe, Kyoto 6068501, Japan.	fukuhara.shunichi.6m@kyoto-u.ac.jp			Pfizer Health Research Foundation	This study was partially supported by the Pfizer Health Research Foundation without restriction of publication. We thank the following individuals for collecting data: Naoya Ito, Makio Kondo and Nobuko Maehashi.	Steinhauser KE, 2001, J PAIN SYMPTOM MANAG, V22, P727, DOI 10.1016/S0885-3924(01)00334-7; Francart J, 2009, EUR J CANCER, V45, P2304, DOI 10.1016/j.ejca.2009.04.028; Metintas M, 2001, RESP MED, V95, P829, DOI 10.1053/rmed.2001.1178; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Degner LF, 1997, JAMA-J AM MED ASSOC, V277, P1485, DOI 10.1001/jama.277.18.1485; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Kurumatani N, 2008, AM J RESP CRIT CARE, V178, P624, DOI 10.1164/rccm.200801-063OC; Cao CQ, 2010, J THORAC ONCOL, V5, P1692, DOI 10.1097/JTO.0b013e3181ed0489; Kao SCH, 2010, CLIN CANCER RES, V16, P5805, DOI 10.1158/1078-0432.CCR-10-2245; Temel JS, 2011, J CLIN ONCOL, V29, P2319, DOI 10.1200/JCO.2010.32.4459; Maione P, 2005, J CLIN ONCOL, V23, P6865, DOI 10.1200/JCO.2005.02.527; Pass HI, 2014, J THORAC ONCOL, V9, P856, DOI 10.1097/JTO.0000000000000181; Van Schil PE, 2014, EUR RESPIR J, V44, P754, DOI 10.1183/09031936.00207213; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Bovolato P, 2014, J THORAC ONCOL, V9, P390, DOI 10.1097/JTO.0000000000000064; Pinato DJ, 2012, J THORAC ONCOL, V7, P587, DOI 10.1097/JTO.0b013e31823f45c1; Tanrikulu AC, 2010, RESPIRATION, V80, P480, DOI 10.1159/000321370; [Anonymous], 1985, J R STAT SOC C, V34, P212; Curran D, 1998, J CLIN ONCOL, V16, P145; Herndon JE, 1998, CHEST, V113, P723, DOI 10.1378/chest.113.3.723; Husain AN, 2013, ARCH PATHOL LAB MED, V137, P647, DOI 10.5858/arpa.2012-0214-OA; [Anonymous], 1987, RUBIN MULTIPLE IMPUT; Boons CCLM, 2013, ANTICANCER RES, V33, P3553; Bottomley A, 2007, J CLIN ONCOL, V25, P5770, DOI 10.1200/JCO.2007.12.5294; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Gemba K, 2013, ACTA ONCOL, V52, P803, DOI 10.3109/0284186X.2012.709948; Muhlbcher AC, 2014, EUR J HEAL EC; Muska W, 2011, EUR RESPIR J, V38, P1420; Psaty BM, 2010, JAMA-J AM MED ASSOC, V304, P897, DOI 10.1001/jama.2010.1205; Robinson Benjamin M, 2012, Ann Cardiothorac Surg, V1, P491, DOI 10.3978/j.issn.2225-319X.2012.11.04; AISNER J, 1995, CHEST, V108, P1122; Ryan CW, 1998, CHEST, V113, p66S, DOI 10.1378/chest.113.1_Supplement.66S	34	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	JUN	2015	45	6					562	568		10.1093/jjco/hyv039		7	Oncology	Oncology	CK5DL	WOS:000356242300009		
J	Akaza, H; Naito, S; Ueno, N; Aoki, K; Houzawa, H; Lowenthal, SP; Lee, SY				Akaza, Hideyuki; Naito, Seiji; Ueno, Naomi; Aoki, Kouji; Houzawa, Hiroyuki; Lowenthal, Susan Pitman; Lee, Sang-Yoon			Real-world use of sunitinib in Japanese patients with advanced renal cell carcinoma: efficacy, safety and biomarker analyses in 1689 consecutive patients	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						renal cell carcinoma; Japanese; sunitinib; real world; biomarkers	INTERFERON-ALPHA; PHASE-II; TOXICITY; THERAPIES; TRIAL	This prospective, post-marketing study collected sunitinib safety and efficacy data in Japanese patients with unresectable/metastatic renal cell carcinoma. Retrospective analysis investigated adverse events as potential sunitinib efficacy biomarkers. Patients administered sunitinib, after its release, were registered until reaching a pre-specified number of cases. Primary starting dose was 50 mg/day orally on a 4-weeks-on and 2-weeks-off schedule. Physicians completed investigation forms at 6-week intervals for 24 weeks. Associations between baseline characteristics and adverse events were analyzed by Cox proportional hazards model and compared by chi(2) test. The log-rank test compared survival in subpopulations based on selected factors. Of note, 1689 patients receiving sunitinib were registered between June 2008 and November 2009. Most of them were males (75%), aged < 65 years (56%), and had Eastern Cooperative Oncology Group performance status 0/1 (90%), metastatic disease (88%) and previous systemic therapy (66%). Grade a parts per thousand yen3 adverse events occurred in 70%, with reduced platelet count the most common (34%). Characteristics significantly associated with Grade a parts per thousand yen3 adverse events were female sex, age a parts per thousand yen55 years, Eastern Cooperative Oncology Group performance status a parts per thousand yen2, history of several medical conditions and prior treatment. Objective response rate was 22%. Median progression-free survival was 22.7 weeks. Median overall survival was not reached; however, 24-week overall survival rate was 84%. Improved overall survival was associated with higher relative dose intensity during the first 6 weeks and specific adverse events: hypertension, hand-foot syndrome, hypothyroidism, leukopenia and thrombocytopenia. Sunitinib demonstrated acceptable safety and useful efficacy in Japanese patients with unresectable/metastatic renal cell carcinoma. Potential biomarkers associated with greater efficacy were relative dose intensity and specific adverse events.	[Akaza, Hideyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Naito, Seiji] Kyushu Univ, Grad Sch Med Sci, Dept Urol, Fukuoka 812, Japan; [Ueno, Naomi; Aoki, Kouji; Houzawa, Hiroyuki; Lee, Sang-Yoon] Pfizer Japan, Tokyo, Japan; [Lowenthal, Susan Pitman] Pfizer Oncol, New York, NY USA	Lee, SY (reprint author), Pfizer Japan, Shibuya Ku, 3-22-7 Yoyogi, Tokyo, Japan.	sang-yoon.lee@pfizer.com			Pfizer Inc; Pfizer	This work was supported by Pfizer Inc. Funding to pay the Open Access publication charges for this article was provided by Pfizer.	Dienstmann R, 2011, ONCOLOGIST, V16, P1729, DOI 10.1634/theoncologist.2011-0163; Rini BI, 2011, JNCI-J NATL CANCER I, V103, P763, DOI 10.1093/jnci/djr128; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Bjarnason GA, 2014, UROL ONCOL-SEMIN ORI, V32, P480, DOI 10.1016/j.urolonc.2013.10.004; Barrios CH, 2012, CANCER-AM CANCER SOC, V118, P1252, DOI 10.1002/cncr.26440; Uemura H, 2010, JPN J CLIN ONCOL, V40, P194, DOI 10.1093/jjco/hyp146; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Schmidinger M, 2011, CANCER-AM CANCER SOC, V117, P534, DOI 10.1002/cncr.25422; Gore ME, 2009, LANCET ONCOL, V10, P757, DOI 10.1016/S1470-2045(09)70162-7; Najjar YG, 2014, EUR J CANCER, V50, P1084, DOI 10.1016/j.ejca.2014.01.025; Houk BE, 2010, CANCER CHEMOTH PHARM, V66, P357, DOI 10.1007/s00280-009-1170-y; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2002, J CLIN ONCOL, V20, P289, DOI 10.1200/JCO.20.1.289; Yoo C, 2010, JPN J CLIN ONCOL, V40, P980, DOI 10.1093/jjco/hyq073; Barrios CH, 2010, EUR SOC MED ONC 35 E; Donskov F, 2011, 2011 EUR MULT CANC C; Lee S, 2009, JOINT 15 C EUR CANC; Li Xue-song, 2010, Zhonghua Wai Ke Za Zhi, V48, P375; Michaelson MD, 2011, J CLIN ONCOL S7, V29; Pharmaceutical and Food Safety Bureau Ministry of Health Labour and Welfare of Japan. Revision of the Standard Operating Procedure for Adverse Drug Reaction Infection and Defect Reports for Medicines or Medical Devices from Medical Institutions, 2010, REV STAND OP PROC AD; Shinohara N, 2012, J CLIN ONCOL S, V30; Tan HS, 2014, CLIN GENITOURIN CANC; Tomita HY, 2010, JPN J CLIN ONCOL, V40, P1166	23	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	JUN	2015	45	6					576	583		10.1093/jjco/hyv045		8	Oncology	Oncology	CK5DL	WOS:000356242300011		
J	Terabe, S; Nishiwaki, S; Koyama, D; Okuno, S; Harada, Y; Tomita, H; Yoshihara, H; Iwasaki, T; Sugiura, I				Terabe, Satomi; Nishiwaki, Satoshi; Koyama, Daisuke; Okuno, Shingo; Harada, Yasuhiko; Tomita, Hiroyuki; Yoshihara, Hisatake; Iwasaki, Toshihiro; Sugiura, Isamu			Cervical epidural hematoma in a healthy donor presenting stroke mimic symptoms: a rare adverse event following peripheral blood stem cell apheresis	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						PBSC apheresis; healthy donor; cervical epidural hematoma; adverse event	MARROW TRANSPLANTATION; PROGENITOR CELLS; G-CSF; MOBILIZATION; COLLECTION; DONATION	Peripheral blood stem cell apheresis from a healthy donor is indispensable for allogeneic peripheral blood stem cell transplantation. Here, we report a rare adverse event following peripheral blood stem cell apheresis. A female sibling donor, aged 61 years with an unremarkable medical history, complained of pain in the left neck and shoulder and numbness in the left upper limb 1 h after the end of peripheral blood stem cell apheresis. Paralysis of the left upper and lower limbs appeared consecutively. Computed tomography and magnetic resonance imaging of the head showed no abnormalities. Anticoagulant therapy was initiated according to the standard treatment of atherothrombotic brain infarction. Magnetic resonance imaging of the cervical cord on the following day revealed a cervical epidural hematoma. An emergency C4-C5 laminectomy was performed, and the paralysis was improved immediately after surgery. This report is the first case of cervical epidural hematoma in a healthy donor who underwent peripheral blood stem cell apheresis and presented symptoms confusingly similar to those of brain infarction.	[Terabe, Satomi; Nishiwaki, Satoshi; Koyama, Daisuke; Okuno, Shingo; Harada, Yasuhiko; Iwasaki, Toshihiro; Sugiura, Isamu] Toyohashi Municipal Hosp, Div Hematol & Oncol, Toyohashi, Aichi 4418570, Japan; [Tomita, Hiroyuki; Yoshihara, Hisatake] Toyohashi Municipal Hosp, Div Spine Surg, Toyohashi, Aichi 4418570, Japan	Terabe, S (reprint author), Toyohashi Municipal Hosp, Div Hematol & Oncol, 50 Aza Hachiken Nishi, Toyohashi, Aichi 4418570, Japan.	n-3104@tf7.so-net.ne.jp					Akimoto Tetsu, 2014, J Cent Nerv Syst Dis, V6, P15, DOI 10.4137/JCNSD.S13252; Groen RJM, 2004, ACTA NEUROCHIR, V146, P103, DOI 10.1007/s00701-003-0160-9; Holtas S, 1996, RADIOLOGY, V199, P409; Pulsipher MA, 2009, BLOOD, V113, P3604, DOI 10.1182/blood-2008-08-175323; Kodera Y, 2014, BONE MARROW TRANSPL, V49, P195, DOI 10.1038/bmt.2013.147; Halter JP, 2013, BONE MARROW TRANSPL, V48, P220, DOI 10.1038/bmt.2012.119; Di Nisio M, 2005, NEW ENGL J MED, V353, P1028, DOI 10.1056/NEJMra044440; Halter J, 2009, HAEMATOL-HEMATOL J, V94, P94, DOI 10.3324/haematol.13668; Kreppel D, 2003, NEUROSURG REV, V26, P1, DOI 10.1007/s10143-002-0224-y; Chanswangphuwana C, 2014, INT J HEMATOL, V99, P318, DOI 10.1007/s12185-014-1507-0; Chen SH, 2013, INT J HEMATOL, V97, P446, DOI 10.1007/s12185-013-1298-8; de Azevedo AM, 2001, BONE MARROW TRANSPL, V28, P311, DOI 10.1038/sj.bmt.1703138; Donmez A, 2011, TRANSFUS APHER SCI, V45, P13, DOI 10.1016/j.transci.2011.06.015; Falzetti F, 1999, LANCET, V353, P555, DOI 10.1016/S0140-6736(99)00268-8; Gasova Z, 2010, TRANSFUS APHER SCI, V43, P237, DOI 10.1016/j.transci.2010.07.015; LANE TA, 1995, BLOOD, V85, P275; RUSSELL NH, 1993, LANCET, V341, P1482, DOI 10.1016/0140-6736(93)90929-B	17	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	JUN	2015	45	6					584	587		10.1093/jjco/hyv034		4	Oncology	Oncology	CK5DL	WOS:000356242300012		
J	Mori, J; Tanimoto, T; Miura, Y; Kami, M				Mori, Jinichi; Tanimoto, Tetsuya; Miura, Yuji; Kami, Masahiro			Fatal adverse drug reactions of anticancer drugs detected by all-case post-marketing surveillance in Japan	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						post-marketing drug surveillance; adverse drug reaction reporting systems; antineoplastic agents	METASTATIC COLORECTAL-CANCER; INTERSTITIAL LUNG-DISEASE; 1ST-LINE THERAPY; PHASE-III; FLUOROURACIL; OXALIPLATIN; BEVACIZUMAB; LEUCOVORIN; PERSPECTIVES; GEFITINIB	All-case post-marketing surveillance of newly approved anticancer drugs is usually conducted on all patients in Japan. The present study investigates whether all-case post-marketing surveillance identifies fatal adverse drug reactions undetected before market entry. We examined fatal adverse drug reactions identified via all-case post-marketing surveillance by reviewing the disclosed post-marketing surveillance results, and determined the time points in which the fatal adverse drug reactions were initially reported by reviewing drug labels. We additionally scanned emergency alerts on the Japanese regulatory authority website to assess the relationship between all-case post-marketing surveillance and regulatory action. Twenty-five all-case post-marketing surveillances were performed between January 1999 and December 2009. Eight all-case post-marketing surveillances with final results included information on all fatal cases. Of these, the median number of patients was 1287 (range: 106-4998), the median number of fatal adverse drug reactions was 14.5 (range: 4-23). Of the 111 fatal adverse drug reactions detected in the eight post-marketing surveillances, only 28 (25.0%) and 22 (19.6%) were described on the initial global and the initial Japanese drug label, respectively, and 58 (52.3%) fatal adverse drug reactions were first described in the all-case post-marketing surveillance reports. Despite this, the regulatory authority issued only four warning letters, and two of these were prompted by case reports from the all-case post-marketing surveillance. All-case post-marketing surveillance of newly approved anticancer drugs in Japan was useful for the rigorous compilation of non-specific adverse drug reactions, but it rarely detected clinically significant fatal adverse drug reactions.	[Mori, Jinichi] Univ Tokyo, Ctr Human Genome, Inst Med Sci, Tokyo 1088639, Japan; [Mori, Jinichi; Tanimoto, Tetsuya] Jyoban Hosp, Div Internal Med, Tokiwakai, Japan; [Tanimoto, Tetsuya; Kami, Masahiro] Univ Tokyo, Inst Med Sci, Div Social Commun Syst Adv Clin Res, Minato Ku, Tokyo 1088639, Japan; [Miura, Yuji] Teikyo Univ, Chiba Med Ctr, Div Hematol, Chiba, Japan	Mori, J (reprint author), Univ Tokyo, Ctr Human Genome, Inst Med Sci, Minato Ku, 1-6-4 Shirokanedai, Tokyo 1088639, Japan.	jin_ichi@hotmail.com					Brewer T, 1999, JAMA-J AM MED ASSOC, V281, P824, DOI 10.1001/jama.281.9.824; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Inoue A, 2003, LANCET, V361, P137, DOI 10.1016/S0140-6736(03)12190-3; Min JH, 2011, CANCER CHEMOTH PHARM, V68, P1099, DOI 10.1007/s00280-011-1737-2; Seruga B, 2011, J CLIN ONCOL, V29, P174, DOI 10.1200/JCO.2010.31.9624; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Hazell L, 2006, DRUG SAFETY, V29, P385, DOI 10.2165/00002018-200629050-00003; Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215; Tsuji K, 2010, J CLIN PHARM THER, V35, P289, DOI 10.1111/j.1365-2710.2009.01099.x; Huang SM, 2008, CLIN PHARMACOL THER, V84, P287, DOI 10.1038/clpt.2008.144; Kabbinavar FF, 2005, J CLIN ONCOL, V23, P3706, DOI 10.1200/JCO.2005.00.232; Breckenridge A, 2012, NAT REV DRUG DISCOV, V11, P501, DOI 10.1038/nrd3787; Huang RS, 2009, CA-CANCER J CLIN, V59, P42, DOI 10.3322/caac.20002; Harmark L, 2008, EUR J CLIN PHARMACOL, V64, P743, DOI 10.1007/s00228-008-0475-9; Cassidy J, 2008, J CLIN ONCOL, V26, P2006, DOI 10.1200/JCO.2007.14.9898; Fournier A, 2012, PHARMACOEPIDEM DR S, V21, P343, DOI 10.1002/pds.3213; Murashige N, 2010, NEW ENGL J MED, V363, P1579; Murashige N, 2010, NEW ENGL J MED, V363, P1578, DOI 10.1056/NEJMc1008506; Pharmaceuticals and Medical Devices Agency, 2015, INF APPR DRUGS; Srba J, 2012, EUR J CLIN PHARMACOL, V68, P1057, DOI 10.1007/s00228-012-1219-4; Wood AJJ, 2000, NEW ENGL J MED, V342, P1824, DOI 10.1056/NEJM200006153422410; Yamada Y, 2006, JPN J CLIN ONCOL, V36, P218, DOI 10.1093/jjco/hyl020	23	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	JUN	2015	45	6					588	594		10.1093/jjco/hyv030		7	Oncology	Oncology	CK5DL	WOS:000356242300013		
J	Satoh, T; Tsuda, H; Kanato, K; Nakamura, K; Shibata, T; Takano, M; Baba, T; Ishikawa, M; Ushijima, K; Yaegashi, N; Yoshikawa, H				Satoh, Toyomi; Tsuda, Hitoshi; Kanato, Keisuke; Nakamura, Kenichi; Shibata, Taro; Takano, Masashi; Baba, Tsukasa; Ishikawa, Mitsuya; Ushijima, Kimio; Yaegashi, Nobuo; Yoshikawa, Hiroyuki		Japan Clinical Oncology Grp	A non-randomized confirmatory study regarding selection of fertility-sparing surgery for patients with epithelial ovarian cancer: Japan Clinical Oncology Group Study (JCOG1203)	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						gynecology; gynecol-surg; ovarian cancer; early stage; fertility-sparing surgery	CARCINOMA; OUTCOMES	Fertility-sparing treatment has been accepted as a standard treatment for epithelial ovarian cancer in stage IA non-clear cell histology grade 1/grade 2. In order to expand an indication of fertility-sparing treatment, we have started a non-randomized confirmatory trial for stage IA clear cell histology and stage IC unilateral non-clear cell histology grade 1/grade 2. The protocol-defined fertility-sparing surgery is optimal staging laparotomy including unilateral salpingo-oophorectomy, omentectomy, peritoneal cytology and pelvic and para-aortic lymph node dissection or biopsy. After fertility-sparing surgery, four to six cycles of adjuvant chemotherapy with paclitaxel and carboplatin are administered. We plan to enroll 250 patients with an indication of fertility-sparing surgery, and then the primary analysis is to be conducted for 63 operated patients with pathologically confirmed stage IA clear cell histology and stage IC unilateral non-clear cell histology grade 1/grade 2. The primary endpoint is 5-year overall survival. Secondary endpoints are other survival endpoints and factors related to reproduction. This trial has been registered at the UMIN Clinical Trials Registry as UMIN000013380.	[Satoh, Toyomi; Yoshikawa, Hiroyuki] Univ Tsukuba, Dept Obstet & Gynecol, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Tsuda, Hitoshi] Natl Def Med Coll, Dept Pathol, Saitama, Japan; [Kanato, Keisuke; Nakamura, Kenichi; Shibata, Taro] Natl Canc Ctr, JCOG Data Ctr, Ctr Res Adm & Support, Tokyo, Japan; [Takano, Masashi] Natl Def Med Coll, Dept Obstet & Gynecol, Saitama, Japan; [Baba, Tsukasa] Kyoto Univ, Grad Sch Med, Dept Gynecol & Obstet, Kyoto, Japan; [Ishikawa, Mitsuya] Natl Canc Ctr, Dept Gynecol, Tokyo, Japan; [Ushijima, Kimio] Kurume Univ, Sch Med, Dept Obstet & Gynecol, Fukuoka, Japan; [Yaegashi, Nobuo] Tohoku Univ Hosp, Dept Obstet & Gynecol, Miyagi, Japan	Satoh, T (reprint author), Univ Tsukuba, Dept Obstet & Gynecol, Fac Med, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan.	toyomi-s@md.tsukuba.ac.jp			National Cancer Center Research and Development Fund [23-A-16, 23-A-17, 26-A-4]; Health and Labour Sciences Research Expenses for Commission from the Ministry of Health, Labour, and Welfare of Japan [H26-Applied Research for Innovative Treatment of Cancer-General-054]	This study was supported in part by the National Cancer Center Research and Development Fund (23-A-16, 23-A-17 and 26-A-4) and the Health and Labour Sciences Research Expenses for Commission from the Ministry of Health, Labour, and Welfare of Japan (H26-Applied Research for Innovative Treatment of Cancer-General-054).	Kajiyama H, 2014, EUR J OBSTET GYN R B, V175, P97, DOI 10.1016/j.ejogrb.2014.01.014; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; Satoh T, 2010, J CLIN ONCOL, V28, P1727, DOI 10.1200/JCO.2009.24.8617; Prat J, 2014, INT J GYNECOL OBSTET, V124, P1, DOI 10.1016/j.ijgo.2013.10.001; Fruscio R, 2013, ANN ONCOL, V24, P138, DOI 10.1093/annonc/mds241; Chan JK, 2008, GYNECOL ONCOL, V109, P370, DOI 10.1016/j.ygyno.2008.02.006; Zapardiel I, 2014, EJSO-EUR J SURG ONC, V40, P387, DOI 10.1016/j.ejso.2013.11.028; Kajiyama H, 2008, GYNECOL ONCOL, V111, P523, DOI 10.1016/j.ygyno.2008.04.001; Nam JH, 2013, GYNECOL OBSTET INVES, V76, P14, DOI 10.1159/000350797	9	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	JUN	2015	45	6					595	599		10.1093/jjco/hyv032		5	Oncology	Oncology	CK5DL	WOS:000356242300014		
J	Taira, N; Akiyama, I; Ishihara, S; Ishibe, Y; Kawasaki, K; Saito, M; Shien, T; Nomura, T; Hara, F; Mizoo, T; Mizota, Y; Yamamoto, S; Ohsumi, S; Doihara, H				Taira, Naruto; Akiyama, Ichiro; Ishihara, Setsuko; Ishibe, Youichi; Kawasaki, Kensuke; Saito, Makoto; Shien, Tadahiko; Nomura, Tsunehisa; Hara, Fumikata; Mizoo, Taeko; Mizota, Yuri; Yamamoto, Seiichiro; Ohsumi, Shozo; Doihara, Hiroyoshi		Executive Comm Setouchi Breast Can	Impact of modifiable lifestyle factors on outcomes after breast cancer diagnosis: the Setouchi Breast Cancer Cohort Study	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						breast cancer; cohort study; lifestyle; alternative medicine; prognosis; quality of life		The primary purpose of this large cohort study is to investigate the effects on breast cancer outcomes of modifiable lifestyle factors after breast cancer diagnosis. These factors include physical activity, smoking, alcohol consumption, obesity and weight gain after diagnosis, alternative medicine and dietary factors. Women diagnosed with Stage 0 to III breast cancer are eligible for participation to this study. Lifestyle, use of alternative medicine, psychosocial factors, reproductive factors and health-related quality of life will be assessed using a questionnaire at the time of breast cancer diagnosis (baseline), and 1, 2, 3 and 5 years after diagnosis. Clinical information and breast cancer outcomes will be obtained from a breast cancer database. The primary endpoint will be disease-free survival. Secondary endpoints are overall survival, health-related quality of life, breast cancer-related symptoms and adverse events. Patient recruitment commenced in February 2013. Enrollment of 2000 breast cancer patients is planned during the 5-year recruitment period. The concept of the study is described in this article.	[Taira, Naruto; Shien, Tadahiko; Mizoo, Taeko; Doihara, Hiroyoshi] Okayama Univ Hosp, Dept Breast & Endocrine Surg, Kita Ku, Okayama 7008558, Japan; [Akiyama, Ichiro] Okayama Med Ctr, Dept Surg, Okayama, Japan; [Ishihara, Setsuko] Okayama Saiseikai Gen Hosp, Dept Radiol, Okayama, Japan; [Ishibe, Youichi] Mizushima Kyodo Hosp, Dept Surg, Okayama, Japan; [Kawasaki, Kensuke] Kagawa Prefectural Cent Hosp, Dept Surg, Kagawa, Japan; [Saito, Makoto] Yashima Gen Hosp, Dept Surg, Kagawa, Japan; [Nomura, Tsunehisa] Kawasaki Med Sch Hosp, Dept Breast & Thyroid Surg, Okayama, Japan; [Hara, Fumikata; Ohsumi, Shozo] Shikoku Canc Ctr, Dept Breast Oncol, Matsuyama, Ehime, Japan; [Mizota, Yuri; Yamamoto, Seiichiro] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Tokyo, Japan	Taira, N (reprint author), Okayama Univ Hosp, Dept Breast & Endocrine Surg, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	ntaira@md.okayama-u.ac.jp			SBP-CS; Ministry of Health, Labour and Welfare of Japan; National Cancer Center [25-A-16]; Ministry of Education, Culture, Sports, Science and Technology of Japan [24591906]	This study was funded by the SBP-CS; grants from the Ministry of Health, Labour and Welfare of Japan; the research and development funds of the National Cancer Center (25-A-16) and a Grant-in-Aid for Scientific Research (C, No. 24591906) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. All decisions concerning the planning, implementation and publication of this study were made by the clinical research committee of SBP-CS and the executive committee of the SBCCS.	Matsuda A, 2014, JPN J CLIN ONCOL, V44, P388, DOI 10.1093/jjco/hyu003; Ligibel J, 2012, J CLIN ONCOL, V30, P3697, DOI 10.1200/JCO.2012.42.0638; Kellen E, 2009, BREAST CANCER RES TR, V114, P13, DOI 10.1007/s10549-008-9990-8; Taira N, 2015, BREAST CANCER-TOKYO, V22, P16, DOI 10.1007/s12282-014-0555-x	4	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	JUN	2015	45	6					600	602		10.1093/jjco/hyv033		3	Oncology	Oncology	CK5DL	WOS:000356242300015		
J	Hotta, K; Ninomiya, K; Takigawa, N; Tanimoto, M; Kiura, K				Hotta, Katsuyuki; Ninomiya, Kiichiro; Takigawa, Nagio; Tanimoto, Mitsune; Kiura, Katsuyuki			Reappraisal of short-term low-volume hydration in cisplatin-based chemotherapy; hoping for it as a public domain	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Letter							CELL LUNG-CANCER; CARBOPLATIN; TRIALS		[Hotta, Katsuyuki; Ninomiya, Kiichiro; Kiura, Katsuyuki] Okayama Univ Hosp, Dept Resp & Allergy Med, Okayama 7008558, Japan; [Hotta, Katsuyuki; Tanimoto, Mitsune] Okayama Univ Hosp, Dept Hematol & Oncol, Okayama 7008558, Japan; [Takigawa, Nagio] Kawasaki Med Univ, Dept Gen Internal Med 4, Okayama, Japan	Hotta, K (reprint author), Okayama Univ Hosp, Dept Hematol & Oncol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	khotta@md.okayama-u.ac.jp					Hotta K, 2004, J CLIN ONCOL, V22, P3852, DOI 10.1200/JCO.2004.02.109; Horinouchi H, 2013, JPN J CLIN ONCOL, V43, P1105, DOI 10.1093/jjco/hyt122; Hotta K, 2007, J THORAC ONCOL, V2, P96, DOI 10.1097/JTO.0b013e31802bb010; Hotta K, 2007, CANCER, V109, P939, DOI 10.1002/cncr.22478; Hotta K, 2013, JPN J CLIN ONCOL, V43, P1115, DOI 10.1093/jjco/hyt128	5	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	JUN	2015	45	6					603	604		10.1093/jjco/hyv065		2	Oncology	Oncology	CK5DL	WOS:000356242300016		
J	Nagata, H; Hayashi, K; Mike, M				Nagata, Hiroshi; Hayashi, Ken; Mike, Makio			An exophytic hepatic metastasis of mucinous colon cancer	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Editorial Material									[Nagata, Hiroshi; Hayashi, Ken; Mike, Makio] Kameda Med Ctr, Dept Gen Surg, Kamogawa, Chiba, Japan; [Nagata, Hiroshi] Tokyo Univ Hosp, Dept Surg Oncol, Bunkyo Ku, Tokyo 113, Japan	Nagata, H (reprint author), Kameda Med Ctr, Dept Gen Surg, Kamogawa, Chiba, Japan.	hinagata-tky@umin.ac.jp						0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	JUN	2015	45	6					605	606		10.1093/jjco/hyv059		2	Oncology	Oncology	CK5DL	WOS:000356242300017		
J	Katanoda, K; Hori, M				Katanoda, Kota; Hori, Megumi			Morphological distribution of liver cancer from Cancer Incidence in Five Continents Vol. X	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Editorial Material									[Katanoda, Kota; Hori, Megumi] Natl Canc Ctr, Div Surveillance, Ctr Canc Control & Informat Serv, Tokyo, Japan	Katanoda, K (reprint author), Natl Canc Ctr, Div Surveillance, Ctr Canc Control & Informat Serv, Tokyo, Japan.							0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	JUN	2015	45	6					607	607		10.1093/jjco/hyv084		1	Oncology	Oncology	CK5DL	WOS:000356242300018		
J	Fukumitsu, N; Numajiri, H; Ohnishi, K; Mizumoto, M; Aihara, T; Ishikawa, H; Okumura, T; Tsuboi, K; Terunuma, T; Sakae, T; Sakurai, H				Fukumitsu, Nobuyoshi; Numajiri, Haruko; Ohnishi, Kayoko; Mizumoto, Masashi; Aihara, Teruhito; Ishikawa, Hitoshi; Okumura, Toshiyuki; Tsuboi, Koji; Terunuma, Toshiyuki; Sakae, Takeji; Sakurai, Hideyuki			Prediction error and required internal margin provided for irregular respiratory movements: a phantom study	JAPANESE JOURNAL OF RADIOLOGY			English	Article						4D CT; Respiratory-gated imaging technique; Phantom imaging; Movement; Image analysis	COMPUTED-TOMOGRAPHY; GATED RADIOTHERAPY; IMAGE QUALITY; TUMOR MOTION; 4DCT; LUNG; REPRODUCIBILITY; REGISTRATION; SIMULATION; ARTIFACTS	To estimate the prediction error and required internal margin provided for irregular respiratory movements. Twenty-eight patterns of irregular movement were prepared using a moving phantom. For irregular cycle movement, a cycle of 2.0-5.0 s was inserted into the baseline movement data (3.5-s cycle, 6-mm amplitude) every four cycles. In addition, a cycle of 2.5-4.5 s was further inserted into one of the irregular data points every four cycles to produce more complicated irregularity. For irregular amplitude movement, an amplitude of 3.0-9.0 mm was inserted into the baseline respiratory movement data. In addition, an amplitude of 4.0-8.0 mm was further inserted into one of the irregular data points every four cycles to produce more complicated irregularity. Images of the moving target were acquired using a real-time position management (RPM) and four-dimensional CT (4DCT) system. The displacement from the baseline image and required margin to compensate for irregular movement were calculated. Amplitude irregularity tended to lose stable placement and need larger margins to compensate for the reduction of image reproducibility than cycle irregularity. There was a large displacement and required margin when the target moved with more complicated irregular amplitude. The RPM and 4DCT system has a risk of prediction error, which may result from the complicated amplitude irregularity of respiratory movement.	[Fukumitsu, Nobuyoshi; Numajiri, Haruko; Ohnishi, Kayoko; Mizumoto, Masashi; Aihara, Teruhito; Ishikawa, Hitoshi; Okumura, Toshiyuki; Tsuboi, Koji; Terunuma, Toshiyuki; Sakae, Takeji; Sakurai, Hideyuki] Univ Tsukuba, Proton Med Res Ctr, Tsukuba, Ibaraki 3058575, Japan	Fukumitsu, N (reprint author), Univ Tsukuba, Proton Med Res Ctr, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan.	fukumitsun@yahoo.co.jp					Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Cai J, 2010, MED PHYS, V37, P3927, DOI 10.1118/1.3457329; Vedam SS, 2003, MED PHYS, V30, P505, DOI 10.1118/1.1558675; Li XA, 2006, MED PHYS, V33, P145, DOI 10.1118/1.2147743; Persson GF, 2010, RADIOTHER ONCOL, V96, P61, DOI 10.1016/j.radonc.2010.04.019; Lujan AE, 1999, MED PHYS, V26, P715, DOI 10.1118/1.598577; Ford EC, 2002, INT J RADIAT ONCOL, V52, P522, DOI 10.1016/S0360-3016(01)02681-5; Hertanto A, 2012, MED PHYS, V39, P3070, DOI 10.1118/1.4711802; Sarker J, 2010, MED PHYS, V37, P1254, DOI 10.1118/1.3298007; Vedam SS, 2001, MED PHYS, V28, P2139, DOI 10.1118/1.1406524; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583; Mutaf YD, 2007, MED PHYS, V34, P1615, DOI 10.1118/1.2717404; Seppenwoolde Y, 2002, INT J RADIAT ONCOL, V53, P822, DOI 10.1016/S0360-3016(02)02803-1; Brady SL, 2010, PHYS MED BIOL, V55, P2187, DOI 10.1088/0031-9155/55/8/005; Fukumitsu N, 2012, J RADIAT RES, V53, P945, DOI 10.1093/jrr/rrs039; Fukumitsu N, 2014, JPN J RADIOL, V32, P700, DOI 10.1007/s11604-014-0369-y; Gianoli C, 2011, MED PHYS, V38, P656, DOI 10.1118/1.3538921; Kyriakou E, 2011, PHYS MED BIOL, V56, P2999, DOI 10.1088/0031-9155/56/10/007; Matney Jason E, 2011, J Appl Clin Med Phys, V12, P3296; Rietzel E, 2006, MED PHYS, V33, P377, DOI 10.1118/1.2150780; Spadea MF, 2010, TECHNOL CANCER RES T, V9, P307; Vedam S, 2007, MED PHYS, V34, P4247, DOI 10.1118/1.2794169; Wells W M 3rd, 1996, Med Image Anal, V1, P35, DOI 10.1016/S1361-8415(96)80004-1	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	JUN	2015	33	6					303	310		10.1007/s11604-015-0418-1		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CK5OD	WOS:000356273800001		
J	Tanaka, N; Emoto, T; Suda, H; Matsumoto, T; Matsunaga, N				Tanaka, Nobuyuki; Emoto, Takuya; Suda, Hiroki; Matsumoto, Tsuneo; Matsunaga, Naofumi			Community-acquired pneumonia: a correlative study between chest radiographic and HRCT findings	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Thorax; CT-high resolution; Lung; Comparative study; Infection	INFILTRATIVE LUNG-DISEASE; RESOLUTION CT FINDINGS; MYCOPLASMA-PNEUMONIAE; CHLAMYDIA-PNEUMONIAE; VIRAL PNEUMONIAS; BACTERIAL; RADIOLOGY; DIAGNOSIS; ACCURACY	To elucidate what kinds of lesions tend to be overlooked or misinterpreted and why they were overlooked or misinterpreted on chest radiographs in the diagnosis of community-acquired pneumonia (CAP) by comparing radiographic findings with HRCT findings. In 129 patients with CAP (107 bacterial and 22 atypical) and 105 healthy subjects, the chest radiographic findings were correlated with the HRCT findings. The diagnostic accuracy of each chest radiographic finding was evaluated by comparing it with the HRCT finding. The false negative rate of radiographic interpretation tended to be higher for nodules and thickening of the bronchial wall, especially in patients with atypical pneumonia. The most frequent reason for false negative interpretations of nodules and bronchial wall thickening was the overlapping of these findings with airspace consolidation or ground-glass opacity (GGO). Thin lesions were the most frequent reasons for the false negative interpretation of airspace consolidation and GGO. The chest radiographic interpretations of GGO and airspace consolidation were influenced by the thickness of lesions, and those of nodules and thickening of bronchial walls were influenced by coexisting GGO and airspace consolidation and may contribute to a misinterpretation of these lesions and an incorrect diagnosis of CAP.	[Tanaka, Nobuyuki] Saiseikai Yamaguchi Gen Hosp, Dept Radiol, Yamaguchi, Yamaguchi 7538517, Japan; [Tanaka, Nobuyuki; Matsunaga, Naofumi] Yamaguchi Univ, Dept Radiol, Grad Sch Med, Ube, Yamaguchi 7558505, Japan; [Emoto, Takuya] Fukuoka Wajiro Hosp, Dept Radiol, Higashi Ku, Fukuoka, Fukuoka 8110213, Japan; [Suda, Hiroki] Nagato Gen Hosp, Dept Radiol, Nagato, Yamaguchi 7594194, Japan; [Matsumoto, Tsuneo] Natl Hosp Org, Yamaguchi Ube Med Ctr, Dept Lab Med, Ube, Yamaguchi 7550241, Japan	Tanaka, N (reprint author), Saiseikai Yamaguchi Gen Hosp, Dept Radiol, 2-11 Midorimachi, Yamaguchi, Yamaguchi 7538517, Japan.	ntanaka@yamaguchi.saiseikai.or.jp; t-emoto@tf6.so-net.ne.jp; radiology@nagato-hp.jp; matumoto@yamaguchi-hosp.jp; matsuna@yamaguchi-u.ac.jp					Syrjala H, 1998, CLIN INFECT DIS, V27, P358, DOI 10.1086/514675; [Anonymous], 2007, NIHON KOKYUKI GAKK S, V2, P2; Reittner P, 2000, AM J ROENTGENOL, V174, P37; MATHIESON JR, 1989, RADIOLOGY, V171, P111; Vilar J, 2004, EUR J RADIOL, V51, P102, DOI 10.1016/j.ejrad.2004.03.010; TEW J, 1977, RADIOLOGY, V124, P607; Kim EA, 2002, RADIOGRAPHICS, V22, pS137; MCLOUD TC, 1983, RADIOLOGY, V149, P353; Nambu A, 2006, RADIOLOGY, V238, P330, DOI 10.1148/radiol.2381040088; Albaum MN, 1996, CHEST, V110, P343, DOI 10.1378/chest.110.2.343; British Thoracic Society Standards of Care Committee, 2001, THORAX, V56, piv1, DOI DOI 10.1136/THX.56.SUPPL_1.I1; Hansell DM, 2008, RADIOLOGY, V3, P697, DOI DOI 10.1148/RADI0L.2462070712; LEVY M, 1988, CHEST, V93, P43, DOI 10.1378/chest.93.1.43; LYNCH DA, 1991, CLIN CHEST MED, V12, P203; Miyashita Naoyuki, 2009, BMC Med Imaging, V9, P7, DOI 10.1186/1471-2342-9-7; MURRAY HW, 1980, MED CLIN N AM, V64, P507; Okada F, 2005, J COMPUT ASSIST TOMO, V29, P626, DOI 10.1097/01.rct.0000167809.89352.93; Reittner P, 2003, EUR RADIOL, V13, P515, DOI 10.1007/s00330-002-1490-3; SCANLON GT, 1973, RADIOL CLIN N AM, V11, P317; Tanaka N, 1996, J COMPUT ASSIST TOMO, V20, P600, DOI 10.1097/00004728-199607000-00019	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	JUN	2015	33	6					317	328		10.1007/s11604-015-0420-7		12	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CK5OD	WOS:000356273800003		
J	Kenjo, M; Yamasaki, F; Takayasu, T; Nosaka, R; Murakami, Y; Kimura, T; Doi, Y; Okabe, T; Sugiyama, K; Nagata, Y				Kenjo, Masahiro; Yamasaki, Fumiyuki; Takayasu, Takeshi; Nosaka, Ryo; Murakami, Yuji; Kimura, Tomoki; Doi, Yoshiko; Okabe, Tomoyuki; Sugiyama, Kazuhiko; Nagata, Yasushi			Results of sequential chemoradiotherapy for intracranial germinoma	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Intracranial germinoma; Radiotherapy; Chemotherapy; Magnetic resonance imaging	INVOLVED-FIELD RADIOTHERAPY; GERM-CELL TUMORS; NERVOUS-SYSTEM GERMINOMA; RADIATION-THERAPY; INDUCTION CHEMOTHERAPY; BRAIN-TUMORS; IRRADIATION; VOLUME; CHILDREN; MEDULLOBLASTOMA	To evaluate the efficacy of sequential chemoradiotherapy (CRT) for intracranial germinoma by long-term follow-up. We retrospectively evaluated 23 consecutive intracranial germinoma patients without spinal dissemination, who had been treated by sequential CRT. All patients except for one were biopsied or surgically resected before treatment and all patients received both cranial and spinal magnetic resonance imaging. Three cycles of induction chemotherapy composed of etoposide and platinum agents were administered. The prescription of radiotherapy was 24 Gy per 12 fractions. No patients received spinal irradiation. All patients accomplished CRT and achieved complete remission. No severe acute and late toxicities were observed. Median follow-up time was 11.8 years. The 5- and 10-year overall survival rates were 100 and 100 %, and relapse-free survival rates were 96 and 89 %, respectively. Three patients developed intracranial recurrence and all of them were successfully salvaged by additional CRT. All patients were alive without disease at final follow-up. Treatment of 24 Gy of sequential CRT for intracranial germinoma might be promising as an alternative to radiotherapy alone. Spinal irradiation may not be necessary for patients who had no spinal dissemination and who were treated with CRT.	[Kenjo, Masahiro; Murakami, Yuji; Kimura, Tomoki; Doi, Yoshiko; Okabe, Tomoyuki; Nagata, Yasushi] Hiroshima Univ Hosp, Dept Radiat Oncol, Minami Ku, Hiroshima 7348551, Japan; [Yamasaki, Fumiyuki; Takayasu, Takeshi; Nosaka, Ryo] Hiroshima Univ Hosp, Dept Neurosurg, Minami Ku, Hiroshima 7348551, Japan; [Sugiyama, Kazuhiko] Hiroshima Univ Hosp, Dept Med Oncol, Minami Ku, Hiroshima 7348551, Japan	Kenjo, M (reprint author), Hiroshima Univ Hosp, Dept Radiat Oncol, Minami Ku, Kasumi 1-2-3, Hiroshima 7348551, Japan.	kenjom@hiroshima-u.ac.jp					Palmer SL, 2001, J CLIN ONCOL, V19, P2302; Merchant TE, 2002, INT J RADIAT ONCOL, V54, P45, DOI 10.1016/S0360-3016(02)02888-2; Darzy Ken H., 2009, V15, P1, DOI 10.1159/000207607; Ogawa K, 2004, INT J RADIAT ONCOL, V58, P705, DOI 10.1016/j.ijrobp.2003.07.001; Kretschmar C, 2007, PEDIATR BLOOD CANCER, V48, P285, DOI 10.1002/pbc.20815; Grill J, 1999, INT J RADIAT ONCOL, V45, P137, DOI 10.1016/S0360-3016(99)00177-7; Jensen AW, 2010, INT J RADIAT ONCOL, V77, P1449, DOI 10.1016/j.ijrobp.2009.06.077; Laughton SJ, 2008, J CLIN ONCOL, V26, P1112, DOI 10.1200/JCO.2008.13.5293; Aoyama H, 2002, J CLIN ONCOL, V20, P857, DOI 10.1200/JCO.20.3.857; Baranzelli MC, 1998, J NEURO-ONCOL, V37, P229, DOI 10.1023/A:1005863601481; BLEWS DE, 1990, J COMPUT ASSIST TOMO, V14, P730, DOI 10.1097/00004728-199009000-00009; Douglas JG, 2006, J PEDIAT HEMATOL ONC, V28, P36; Eom KY, 2008, INT J RADIAT ONCOL, V71, P667, DOI 10.1016/j.ijrobp.2008.01.061; Geyer JR, 2009, RADIOTHER ONCOL, V91, P75; Kawabata Y, 2008, J NEURO-ONCOL, V88, P161, DOI 10.1007/s11060-008-9542-4; Mulhern RK, 2001, J CLIN ONCOL, V19, P472; Ogawa K, 2008, INT J RADIAT ONCOL, V72, P1347, DOI 10.1016/j.ijrobp.2008.03.055; Rohrer TR, 2009, J ENDOCRINOL INVEST, V32, P294; Sawamura Y, 1998, J NEUROSURG, V88, P66, DOI 10.3171/jns.1998.88.1.0066; Schoenfeld GO, 2006, INT J RADIAT ONCOL, V65, P481, DOI 10.1016/j.ijrobp.2005.12.012; Shibamoto Y, 1997, INT J RADIAT ONCOL, V37, P505, DOI 10.1016/S0360-3016(96)00611-6; Shibamoto Y, 1999, J NEURO-ONCOL, V44, P181, DOI 10.1023/A:1006367316168; Shibamoto Y, 2001, RADIOLOGY, V218, P452; Shikama N, 2005, CANCER, V104, P126, DOI 10.1002/cncr.21169; Shirato H, 1997, INT J RADIAT ONCOL, V37, P511, DOI 10.1016/S0360-3016(96)00607-4; Shirato H, 2004, INT J RADIAT ONCOL, V60, P214, DOI 10.1016/j.ijrob.2004.02.024; Sugiyama K, 2009, PROG NEUROL SURG, V23, P130, DOI 10.1159/000210059	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	JUN	2015	33	6					336	343		10.1007/s11604-015-0424-3		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CK5OD	WOS:000356273800005		
J	Hamaguchi, S; Lohman, BD; Ogawa, Y; Arai, Y; Hashimoto, K; Matsumoto, J; Nakajima, Y				Hamaguchi, Shingo; Lohman, Brandon D.; Ogawa, Yukihisa; Arai, Yasunori; Hashimoto, Kazuki; Matsumoto, Junichi; Nakajima, Yasuo			Preliminary findings of arterial embolization with balloon-occluded and flow-dependent histoacryl glue embolization in a swine model	JAPANESE JOURNAL OF RADIOLOGY			English	Article						NBCA; B-glue; Embolization; Balloon occlusion	N-BUTYL-CYANOACRYLATE; POSTPARTUM HEMORRHAGE; EXPERIENCE; FISTULAS	To evaluate the potential usefulness of the balloon-occluded histoacryl glue embolization (B-glue) technique. Both flow-dependent (no balloon occlusion) and B-glue techniques were used for 24 intercostal arteries of two female swine. N-butyl 2-cyanoacrylate (NBCA) was diluted with lipiodol to a 50 % solution, which was infused after occluding the arteries with microballoon catheters. The embolization range, fragmentation, reflux, adhesion, and glue particle attachment were compared between flow-dependent and B-glue techniques. The B-glue technique was performed in a controlled fashion resulting in successful arterial occlusion without fragmented migration of the injected glue cast. Reflux occurred less frequently with the B-glue technique and was significantly different (p = 0.012) from that for the flow-dependent technique. Catheters were safely removed from the arterial walls, although in one instance (8.3 %), large glue particles were found to be attached to the catheter tip on removal. Conversely, the flow-dependent technique was more difficult to control and resulted in several instances of higher rates of fragmentation. The B-glue technique can efficiently control NBCA delivery with lower rates of reflux.	[Hamaguchi, Shingo; Lohman, Brandon D.; Ogawa, Yukihisa; Arai, Yasunori; Hashimoto, Kazuki; Nakajima, Yasuo] St Marianna Univ, Dept Radiol, Sch Med, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan; [Lohman, Brandon D.; Matsumoto, Junichi] St Marianna Univ, Dept Emergency & Crit Care Med, Sch Med, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan	Hamaguchi, S (reprint author), St Marianna Univ, Dept Radiol, Sch Med, Miyamae Ku, Sugao 2-16-1, Kawasaki, Kanagawa 2168511, Japan.	hal29120@me.com					Frodsham A, 2009, J VASC INTERV RADIOL, V20, P1312, DOI 10.1016/j.jvir.2009.06.031; Yonemitsu T, 2009, J VASC INTERV RADIOL, V20, P1176, DOI 10.1016/j.jvir.2009.06.005; Soyer P, 2011, EUR J RADIOL, V80, P729, DOI 10.1016/j.ejrad.2010.07.018; Mavili E, 2007, CARDIOVASC INTER RAD, V30, P1124, DOI 10.1007/s00270-007-9142-2; Li MH, 2008, ACTA NEUROCHIR, V150, P1149, DOI 10.1007/s00701-008-0133-0; Kish JW, 2004, J VASC INTERV RADIOL, V15, P689, DOI 10.1097/01.RVI.0000133505.84588.8C; Nelson PK, 2003, J NEUROSURG, V98, P498, DOI 10.3171/jns.2003.98.3.0498; Maassen MS, 2009, BJOG-INT J OBSTET GY, V116, P55, DOI 10.1111/j.1471-0528.2008.01939.x; Hamaguchi S, 2013, JPN J RADIOL, V31, P538, DOI 10.1007/s11604-013-0207-7; Igarashi S, 2011, FERTIL STERIL, V95, p290 e9; Iizuka Y, 2001, NEURORADIOLOGY, V43, P677; Kanematsu M, 2011, J VASC INTERV RADIOL, V22, P1773, DOI 10.1016/j.jvir.2011.08.016; Pollak JS, 2001, J VASC INTERV RADIOL, V12, P907, DOI 10.1016/S1051-0443(07)61568-1; Razavi Mahmood K, 2007, Tech Vasc Interv Radiol, V10, P276, DOI 10.1053/j.tvir.2008.03.006; STOESSLEIN F, 1982, CARDIOVASC INTER RAD, V5, P264, DOI 10.1007/BF02565409; Thomas A, 2002, AM J NEURORADIOL, V23, P748; Yoo DH, 2012, CARDIOVASC INTER RAD, V35, P292, DOI 10.1007/s00270-011-0162-6	17	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	JUN	2015	33	6					344	351		10.1007/s11604-015-0426-1		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CK5OD	WOS:000356273800006		
J	Hamaguchi, S; Lohman, BD; Ogawa, Y; Arai, Y; Hashimoto, K; Matsumoto, J; Nakajima, Y				Hamaguchi, Shingo; Lohman, Brandon D.; Ogawa, Yukihisa; Arai, Yasunori; Hashimoto, Kazuki; Matsumoto, Junichi; Nakajima, Yasuo			Preliminary findings of arterial embolization with balloon-occluded and flow-dependent histoacryl glue embolization in a swine model (vol 33, pg 344, 2015)	JAPANESE JOURNAL OF RADIOLOGY			English	Correction									[Hamaguchi, Shingo; Lohman, Brandon D.; Ogawa, Yukihisa; Arai, Yasunori; Hashimoto, Kazuki; Nakajima, Yasuo] St Marianna Univ, Dept Radiol, Sch Med, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan; [Lohman, Brandon D.; Matsumoto, Junichi] St Marianna Univ, Dept Emergency & Crit Care Med, Sch Med, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan	Hamaguchi, S (reprint author), St Marianna Univ, Dept Radiol, Sch Med, Miyamae Ku, Sugao 2-16-1, Kawasaki, Kanagawa 2168511, Japan.	hal29120@me.com					Hamaguchi S, 2015, JPN J RADIOL, V33, P344, DOI 10.1007/s11604-015-0426-1	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	JUN	2015	33	6					352	352		10.1007/s11604-015-0438-x		1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CK5OD	WOS:000356273800007		
J	Kidoh, M; Hirai, T; Oda, S; Utsunomiya, D; Kawano, T; Yano, S; Nakamura, H; Makino, K; Iryo, Y; Azuma, M; Hayashida, E; Nakaura, T; Yamashita, Y				Kidoh, Masafumi; Hirai, Toshinori; Oda, Seitaro; Utsunomiya, Daisuke; Kawano, Takayuki; Yano, Shigetoshi; Nakamura, Hideo; Makino, Keishi; Iryo, Yasuhiko; Azuma, Minako; Hayashida, Eri; Nakaura, Takeshi; Yamashita, Yasuyuki			Can CT angiography reconstructed from CT perfusion source data on a 320-section volume CT scanner replace conventional CT angiography for the evaluation of intracranial arteries?	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Computed tomography (CT); CT Angiography (CTA); Perfusion CTA; Diagnosis	ACUTE STROKE; SUBARACHNOID HEMORRHAGE; DOSE REDUCTION; IMAGE QUALITY; VASOSPASM; EXPOSURE; 320-MDCT; DISEASE; PHASE	To compare conventional CT angiography (CTA) and CTA reconstructed from CT perfusion source data (perfusion CTA) acquired on a 320-section CT scanner for the evaluation of intracranial arteries. Our study included 7 patients who had undergone trapping of an intracranial aneurysm and placement of a bypass. All underwent conventional and perfusion CTA and digital subtraction angiography (DSA). Using DSA as the gold standard, 2 radiologists evaluated 10 arterial segments on conventional and perfusion CTA images. On a 4-point scale they independently scored the image quality and vascular visualization of the intracranial arteries on the conventional and perfusion CTA images. The effective radiation dose to each patient was also recorded. A total of 65 arterial segments without apparent abnormalities were assessed. While the mean image quality score tended to be slightly higher for conventional than perfusion CTA, there was no significant difference. The effective dose for perfusion and conventional CTA with unenhanced CT was 4.2 mSv and 3.1 mSv, respectively, for all patients. For the evaluation of intracranial arteries using DSA as the gold standard, perfusion CTA yields image quality and vascular visualization similar to conventional CTA at an acceptable radiation dose.	[Kidoh, Masafumi; Oda, Seitaro; Utsunomiya, Daisuke; Iryo, Yasuhiko; Azuma, Minako; Hayashida, Eri; Nakaura, Takeshi; Yamashita, Yasuyuki] Kumamoto Univ, Dept Diagnost Radiol, Fac Life Sci, Kumamoto 8608556, Japan; [Kawano, Takayuki; Yano, Shigetoshi; Nakamura, Hideo; Makino, Keishi] Kumamoto Univ, Dept Neurosurg, Fac Life Sci, Kumamoto 8608556, Japan; [Hirai, Toshinori] Miyazaki Univ, Sch Med, Dept Radiol, Miyazaki, Japan	Kidoh, M (reprint author), Kumamoto Univ, Dept Diagnost Radiol, Fac Life Sci, 1-1-1 Honjo, Kumamoto 8608556, Japan.	masafkidoh@yahoo.co.jp					Cohnen M, 2006, AM J NEURORADIOL, V27, P1741; Christner JA, 2010, AM J ROENTGENOL, V194, P881, DOI 10.2214/AJR.09.3462; Frolich AMJ, 2012, STROKE, V43, P97, DOI 10.1161/STROKEAHA.111.630954; Turk A, 2012, J NEUROINTERV SURG, V4, P261, DOI 10.1136/neurintsurg-2011-010067; Wang R, 2014, EUR RADIOL, V24, P1135, DOI 10.1007/s00330-014-3098-9; Konstas AA, 2011, NEUROIMAG CLIN N AM, V21, P215, DOI 10.1016/j.nic.2011.01.008; Funama Y, 2014, PHYS MEDICA, V30, P385, DOI 10.1016/j.ejmp.2013.10.003; Sanelli PC, 2011, NEURORADIOLOGY, V53, P425, DOI 10.1007/s00234-010-0752-z; Saake M, 2012, AM J NEURORADIOL, V33, P2068, DOI 10.3174/ajnr.A3155; Silvennoinen HM, 2008, AM J NEURORADIOL, V29, P1118, DOI 10.3174/ajnr.A1039; Siebert E, 2009, BRIT J RADIOL, V82, P561, DOI 10.1259/bjr/27721218; Ding B, 2006, NEURORADIOLOGY, V48, P773, DOI 10.1007/s00234-006-0120-1; Wintermark M, 2006, AM J NEURORADIOL, V27, P26; Hayashida E, 2013, JPN J RADIOL, V31, P600, DOI 10.1007/s11604-013-0228-2; Hulme KW, 2011, AM J ROENTGENOL, V196, pW144, DOI 10.2214/AJR.10.4470; Nitta N, 2014, AM J ROENTGENOL, V202, P2, DOI 10.2214/AJR.12.10364; Provenzale JM, 2008, AM J NEURORADIOL, V29, P1476, DOI 10.3174/ajnr.A1161; Ramli N, 2009, Biomed Imaging Interv J, V5, pe6, DOI 10.2349/biij.5.1.e6; Tabuchi Sadaharu, 2013, Case Rep Oncol, V6, P362, DOI 10.1159/000353929; Tomizawa N, 2014, JPN J RADIOL, V32, P391, DOI 10.1007/s11604-014-0321-1; Yamashiro T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105735	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	JUN	2015	33	6					353	359		10.1007/s11604-015-0429-y		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CK5OD	WOS:000356273800008		
J	Kimura, K; Tomita, N; Shimizu, A; Sato, Y; Makita, C; Kodaira, T				Kimura, Kana; Tomita, Natsuo; Shimizu, Arisa; Sato, Yozo; Makita, Chiyoko; Kodaira, Takeshi			A case of severe hemoptysis after stereotactic body radiotherapy for peripherally located stage I non-small cell lung cancer	JAPANESE JOURNAL OF RADIOLOGY			English	Article						SBRT; Lung cancer; Toxicity; Bronchial hemorrhage; BAE	RADIATION-THERAPY; PHASE-II	In stereotactic body radiotherapy (SBRT) for centrally located non-small cell lung carcinoma (NSCLC), severe hemoptysis has been reported in several studies. We report here a rare case of hemoptysis after SBRT even though the lung tumor was peripherally located. A lung nodule of a 79-year-old man was accidentally found at the periphery of the left upper lobe. A computed tomography-guided biopsy of this nodule provided confirmation of the diagnosis of poorly differentiated adenocarcinoma. The clinical diagnosis was T1bN0M0, stage I primary lung cancer. The patient was treated with SBRT using helical tomotherapy at a dose of 60 Gy in 6 fractions (i.e., BED10 = 120). He obtained a complete response and did not experience recurrence. However, the patient suffered massive hemoptysis 4.5 years after SBRT. As hypervascularity of a left bronchial artery was observed at the left lung in accordance with SBRT field on bronchial arteriography, a bronchial artery embolization (BAE) procedure was performed. The patient has had no episodes of hemoptysis after BAE. Although SBRT for early stage NSCLC is usually safe and efficient, it is necessary to be careful for late-onset bronchial hemorrhage in SBRT, even for a peripheral tumor.	[Kimura, Kana; Tomita, Natsuo; Shimizu, Arisa; Makita, Chiyoko; Kodaira, Takeshi] Aichi Canc Ctr Hosp, Dept Radiat Oncol, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Sato, Yozo] Aichi Canc Ctr Hosp, Dept Diagnost & Intervent Radiol, Chikusa Ku, Nagoya, Aichi 4648681, Japan	Kimura, K (reprint author), Aichi Canc Ctr Hosp, Dept Radiat Oncol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	k-kimura@aichi-cc.jp					Song SY, 2009, LUNG CANCER, V66, P89, DOI 10.1016/j.lungcan.2008.12.016; Fakiris AJ, 2009, INT J RADIAT ONCOL, V75, P677, DOI 10.1016/j.ijrobp.2008.11.042; Nagai A, 2014, BIOMED RES INT, DOI 10.1155/2014/473173; Chun JY, 2010, CARDIOVASC INTER RAD, V33, P240, DOI 10.1007/s00270-009-9788-z; Timmerman R, 2006, J CLIN ONCOL, V24, P4833, DOI 10.1200/JCO.2006.07.5937; Chi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035809; Onishi H, 2013, JPN J CLIN ONCOL, V43, P345, DOI 10.1093/jjco/hyt014; Tomita N, 2014, JPN J CLIN ONCOL, V44, P579, DOI 10.1093/jjco/hyu041; Tomita N, 2010, TECHNOL CANCER RES T, V9, P407	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	JUN	2015	33	6					370	374		10.1007/s11604-015-0423-4		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CK5OD	WOS:000356273800011		
J	Takeuchi, M; Cho, H; Sugimoto, M; Ohira, T; Usuki, N; Morimoto, Y				Takeuchi, Makiko; Cho, Hisayuki; Sugimoto, Michiko; Ohira, Tomohiro; Usuki, Noriaki; Morimoto, Yoshikazu			CT and MRI findings for Brunner's gland hamartoma: report of three cases	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Brunner's gland hamartoma; Computed tomography; Magnetic resonance imaging; Internal cystic changes; Stalk		Brunner's gland hamartoma (BGH) is an uncommon, benign, tumor-like lesion of the duodenum. Endoscopic diagnosis of larger BGH is sometimes difficult. We describe computed tomography (CT) and magnetic resonance imaging (MRI) findings for three patients with BGH. In all three cases, CT and MRI revealed internal cystic changes within the mass and a stalk originating in the duodenal bulb. These findings may be useful for diagnosis of BGH.	[Takeuchi, Makiko; Cho, Hisayuki; Sugimoto, Michiko; Ohira, Tomohiro; Usuki, Noriaki] Japan Community Healthcare Org, Dept Diagnost Radiol, Osaka Hosp, Fukushima Ku, Osaka 5530003, Japan; [Morimoto, Yoshikazu] Japan Community Healthcare Org, Dept Surg, Osaka Hosp, Osaka 5530003, Japan	Takeuchi, M (reprint author), Japan Community Healthcare Org, Dept Diagnost Radiol, Osaka Hosp, Fukushima Ku, 4-2-78 Fukushima, Osaka 5530003, Japan.	m-takeuchi@okn.gr.jp					Hur S, 2010, J COMPUT ASSIST TOMO, V34, P543, DOI 10.1097/RCT.0b013e3181d472dc; Bayan K, 2009, TURK J GASTROENTEROL, V20, P52; Changchien CS, 2001, J CLIN ULTRASOUND, V29, P243, DOI 10.1002/jcu.1027; Gokhale Uday, 2009, Oman Med J, V24, P41, DOI 10.5001/omj.2009.11; Gupta Vishal, 2011, JOP, V12, P413; LEVINE JA, 1995, AM J GASTROENTEROL, V90, P290; Limi L, 2010, Med J Malaysia, V65, P311; Park BJ, 2009, WORLD J GASTROENTERO, V15, P4980, DOI 10.3748/wjg.15.4980; Stewart ZA, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-68; Walden DT, 1998, GASTROINTEST ENDOSC, V47, P403, DOI 10.1016/S0016-5107(98)70228-7	10	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	JUN	2015	33	6					375	379		10.1007/s11604-015-0425-2		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CK5OD	WOS:000356273800012		
J	Hirosawa, S				Hirosawa, Satoshi			Permanent Magnets Beyond Nd-Dy-Fe-B	JOM			English	Editorial Material									Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan	Hirosawa, S (reprint author), Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan.	HIROSAWA.Satoshi@nims.go.jp						0	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1047-4838	1543-1851		JOM-US	JOM	JUN	2015	67	6					1304	1305		10.1007/s11837-015-1439-z		2	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering; Mineralogy; Mining & Mineral Processing	Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy; Mining & Mineral Processing	CK1DY	WOS:000355947400005		
J	Hirayama, Y; Miyake, T; Hono, K				Hirayama, Yusuke; Miyake, Takashi; Hono, Kazuhiro			Rare-Earth Lean Hard Magnet Compound NdFe12N	JOM			English	Article							ANISOTROPY-FIELD; FE; ND; MAGNETIZATION; COERCIVITY; TI	Among various ThMn12-type rare-earth iron compounds, NdFe11TiN has been known for its large magnetization and high anisotropy field, although their values are smaller than those of Nd2Fe14B and Sm2Fe17N3. Recent first-principles calculations predicted that NdFe12N has a substantially larger magnetization than NdFe11TiN with a comparable anisotropy field. To validate this prediction, the NdFe12N (x) phase was successfully synthesized by nitriding the NdFe12 film that was grown on a W underlayer on a MgO(001) substrate. The NdFe12N (x) phase was found to have a saturation magnetization, anisotropy field, and Curie temperature superior to those of Nd2Fe14B.	[Hirayama, Yusuke; Miyake, Takashi; Hono, Kazuhiro] Natl Inst Mat Sci, ESICMM, Tsukuba, Ibaraki 3050047, Japan; [Miyake, Takashi] AIST, Nanosyst Res Inst, Tsukuba, Ibaraki 3058568, Japan	Hirayama, Y (reprint author), Natl Inst Mat Sci, ESICMM, Tsukuba, Ibaraki 3050047, Japan.	kazuhiro.hono@nims.go.jp	Hono, Kazuhiro/B-9202-2008	Hono, Kazuhiro/0000-0001-7367-0193	Elements Strategy Initiative Project under MEXT; JST, CREST	This work was supported in part by the Elements Strategy Initiative Project under the auspice of MEXT and JST, CREST. We thank Mr. Bumjin Bae for his help in coordinating the data for Fig. 5 and Dr. Takahiro Akiya for his permission to use the unpublished data on HA(T) of Sm<INF>2</INF>Fe<INF>17</INF>N<INF>3</INF>.	Akiya T., 2014, J APPL PHYS, V115; Akiya T., 2014, UNPUB; IRIYAMA T, 1992, IEEE T MAGN, V28, P2326, DOI 10.1109/20.179482; SAGAWA M, 1984, J APPL PHYS, V55, P2083, DOI 10.1063/1.333572; Lao B, 2014, IEEE T MAGN, V50, DOI 10.1109/TMAG.2014.2322936; SAGAWA M, 1987, JPN J APPL PHYS 1, V26, P785, DOI 10.1143/JJAP.26.785; YANG YC, 1991, SOLID STATE COMMUN, V78, P317, DOI 10.1016/0038-1098(91)90205-A; Miyake T, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.043702; YANG YC, 1991, J APPL PHYS, V70, P6001, DOI 10.1063/1.350074; HIROSAWA S, 1986, J APPL PHYS, V59, P873, DOI 10.1063/1.336611; SAGAWA M, 1987, J APPL PHYS, V61, P3559, DOI 10.1063/1.338725; SAGAWA M, 1985, J APPL PHYS, V57, P4094, DOI 10.1063/1.334629; Suzuki S, 2014, AIP ADV, V4, DOI 10.1063/1.4902176; COEY JMD, 1990, J MAGN MAGN MATER, V87, pL251, DOI 10.1016/0304-8853(90)90756-G; DEMOOIJ DB, 1988, J LESS-COMMON MET, V136, P207, DOI 10.1016/0022-5088(88)90424-9; FELNER I, 1980, J LESS-COMMON MET, V72, P241, DOI 10.1016/0022-5088(80)90143-5; FELNER I, 1981, J PHYS CHEM SOLIDS, V42, P369, DOI 10.1016/0022-3697(81)90044-5; Ferner I., 1983, J MAGN MAGN MATER, V38, P172; Hirayama Y, 2015, SCRIPTA MATER, V95, P70, DOI 10.1016/j.scriptamat.2014.10.016; Kojima T, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/6/064207; OHASHI K, 1988, J LESS-COMMON MET, V139, pL1, DOI 10.1016/0022-5088(88)90020-3; OHASHI K, 1987, IEEE T MAGN, V23, P3101, DOI 10.1109/TMAG.1987.1065256; Sakurada S, 1996, J APPL PHYS, V79, P4611, DOI 10.1063/1.361679; Sepehri-Amin H, 2010, SCRIPTA MATER, V63, P1124, DOI 10.1016/j.scriptamat.2010.08.021	24	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1047-4838	1543-1851		JOM-US	JOM	JUN	2015	67	6					1344	1349		10.1007/s11837-015-1421-9		6	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering; Mineralogy; Mining & Mineral Processing	Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy; Mining & Mineral Processing	CK1DY	WOS:000355947400010		
J	Oyoshi, MK; Beaupre, J; Venturelli, N; Lewis, CN; Lwakura, Y; Geha, RS				Oyoshi, Michiko K.; Beaupre, Jacqueline; Venturelli, Nicholas; Lewis, Christopher N.; Lwakura, Yoichiro; Geha, Raif S.			Filaggrin deficiency promotes the dissemination of cutaneously inoculated vaccinia virus	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Vaccinia virus; filaggrin; IL-17A	ALLERGIC SKIN INFLAMMATION; HUMAN ATOPIC-DERMATITIS; IMMUNE-RESPONSE; EPICUTANEOUS SENSITIZATION; ECZEMA HERPETICUM; FLAKY TAIL; T-CELLS; BARRIER; DISEASE; MOUSE	Background: Eczema vaccinatum is a life-threatening complication of smallpox vaccination in patients with atopic dermatitis (AD) characterized by dissemination of vaccinia virus (VV) in the skin and internal organs. Mutations in the filaggrin (FLG) gene, the most common genetic risk factor for AD, confer a greater risk for eczema herpeticum in patients with AD, suggesting that it impairs the response to cutaneous viral infections. Objective: We sought to determine the effects of FLG deficiency on the response of mice to cutaneous VV inoculation. Methods: VV was inoculated by means of scarification of unsensitized skin or skin topically sensitized with ovalbumin in FLG-deficient flaky tail (ft/ft) mice or wild-type (WT) control mice. The sizes of primary and satellite skin lesions were measured, and hematoxylin and eosin staining was performed. VV genome copy numbers and cytokine mRNA levels were measured by using quantitative PCR. Results: VV inoculation in unsensitized skin of ft/ft mice, independent of the matted hair mutation, resulted in larger primary lesions, more abundant satellite lesions, heavier viral loads in internal organs, greater epidermal thickness, dermal cellular infiltration, and higher local Il17a, Il4, Il13, and Ifng mRNA levels than in WT control mice. VV inoculation at sites of topical ovalbumin application amplified all of these features in ft/ft mice but had no detectable effect in WT control mice. The number of satellite lesions and the viral loads in internal organs after cutaneous VV inoculation were significantly reduced in both unsensitized and topically sensitized ft/ft mice. Conclusion: FLG deficiency predisposes to eczema vaccinatum. This is mediated primarily through production of IL-17A.	[Oyoshi, Michiko K.; Beaupre, Jacqueline; Venturelli, Nicholas; Lewis, Christopher N.; Geha, Raif S.] Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Oyoshi, Michiko K.; Beaupre, Jacqueline; Venturelli, Nicholas; Lewis, Christopher N.; Geha, Raif S.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Lwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Chiba, Japan	Oyoshi, MK (reprint author), Boston Childrens Hosp, Div Immunol, Karp 10,300 Longwood Ave, Boston, MA 02115 USA.	michiko.oyoshi@childrens.harvard.edu			National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIAID) [HHSN272201000020C]; Boston Children's Hospital Faculty Career Development Fellowship; Children's Hospital Pediatric Associates Award	Supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIAID) contract no. HHSN272201000020C (to R.S.G.). M.K.O. was supported by the Boston Children's Hospital Faculty Career Development Fellowship and the Children's Hospital Pediatric Associates Award.	Irvine AD, 2006, J INVEST DERMATOL, V126, P1200, DOI 10.1038/sj.jid.5700365; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Scott JE, 2007, J ALLERGY CLIN IMMUN, V120, P1382, DOI 10.1016/j.jaci.2007.08.004; Silverberg JI, 2014, J ALLERGY CLIN IMMUN, V133, P1041, DOI 10.1016/j.jaci.2013.08.012; Jin HL, 2009, J ALLERGY CLIN IMMUN, V123, P875, DOI 10.1016/j.jaci.2009.02.007; Reed JL, 2012, CLIN INFECT DIS, V54, P832, DOI 10.1093/cid/cir952; He R, 2008, P NATL ACAD SCI USA, V105, P11875, DOI 10.1073/pnas.0801532105; Fallon PG, 2009, NAT GENET, V41, P602, DOI 10.1038/ng.358; Laouini D, 2003, J ALLERGY CLIN IMMUN, V112, P981, DOI 10.1067/mai.2003.1789; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Kuo IH, 2013, J ALLERGY CLIN IMMUN, V131, P266, DOI 10.1016/j.jaci.2012.12.1563; Engler RJM, 2002, J ALLERGY CLIN IMMUN, V110, P357, DOI 10.1067/mai.2002.128052; Combadiere B, 2004, J EXP MED, V199, P1585, DOI 10.1084/jem.20032083; Oyoshi MK, 2009, P NATL ACAD SCI USA, V106, P14954, DOI 10.1073/pnas.0904021106; Oyoshi MK, 2009, J ALLERGY CLIN IMMUN, V124, P485, DOI 10.1016/j.jaci.2009.05.042; Harper EG, 2009, J INVEST DERMATOL, V129, P2175, DOI 10.1038/jid.2009.65; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Eyerich K, 2009, J ALLERGY CLIN IMMUN, V123, P59, DOI [10.1016/j.jaci.2008.10.031, 10.1016/j.jaci.2009.10.031]; Kawasaki H, 2012, J ALLERGY CLIN IMMUN, V129, P1538, DOI 10.1016/j.jaci.2012.01.068; He R, 2007, P NATL ACAD SCI USA, V104, P15817, DOI 10.1073/pnas.0706942104; Wollenberg A, 2003, J ALLERGY CLIN IMMUN, V112, P667, DOI 10.1067/mai.2003.1775; Scharschmidt TC, 2009, J ALLERGY CLIN IMMUN, V124, P496, DOI 10.1016/j.jaci.2009.06.046; McAleer MA, 2013, J ALLERGY CLIN IMMUN, V131, P280, DOI 10.1016/j.jaci.2012.12.668; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; Cole C, 2014, J ALLERGY CLIN IMMUN, V134, P82, DOI 10.1016/j.jaci.2014.04.021; Laouini D, 2003, J CLIN INVEST, V112, P1058, DOI 10.1172/JCI200318246; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P214, DOI 10.1016/j.jaci.2006.05.004; Leung DYM, 2011, J ALLERGY CLIN IMMUN, V127, P965, DOI 10.1016/j.jaci.2011.02.010; Moniaga CS, 2010, AM J PATHOL, V176, P2385, DOI 10.2353/ajpath.2010.090957; Kanda N, 2005, J ALLERGY CLIN IMMUN, V116, P1144, DOI 10.1016/j.jaci.2005.08.014; Basu R, 2013, IMMUNOL REV, V252, P89, DOI 10.1111/imr.12035; Gao PS, 2009, J ALLERGY CLIN IMMUN, V124, P507, DOI 10.1016/j.jaci.2009.07.034; Bin L, 2014, J ALLERGY CLIN IMMUN, V134, P848; Cooney LA, 2013, CRIT REV IMMUNOL, V33, P379; Freyschmidt EJ, 2007, J ALLERGY CLIN IMMUN, V119, P671, DOI 10.1016/j.jaci.2006.12.645; Gao PS, 2009, J ALLERGY CLIN IMMUN, V124, pe1; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Jin HL, 2009, J CLIN INVEST, V119, P47, DOI 10.1172/JCI32310; LANE PW, 1972, J HERED, V63, P135; Leung DYM, 2014, J ALLERGY CLIN IMMUN, V134, P769, DOI 10.1016/j.jaci.2014.08.008; Saunders SP, 2013, J ALLERGY CLIN IMMUN, V132, P1121, DOI 10.1016/j.jaci.2013.08.046; Scharschmidt TC, 2009, J ALLERGY CLIN IMMUN, V124, pe1; Slifka MK, 2014, J ALLERGY CLIN IMMUN, V133, P439, DOI 10.1016/j.jaci.2013.10.037; Thyssen JP, 2014, J ALLERGY CLIN IMMUN, V134, P792, DOI 10.1016/j.jaci.2014.06.014; Tian T, 2009, J INVEST DERMATOL, V129, P70, DOI 10.1038/jid.2008.191; Ziegler SF, 2012, J ALLERGY CLIN IMMUN, V130, P845, DOI 10.1016/j.jaci.2012.07.010	46	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2015	135	6					1511	U188		10.1016/j.jaci.2014..12.1923		14	Allergy; Immunology	Allergy; Immunology	CK0ZC	WOS:000355933400014		
J	Ueta, M; Sawai, H; Sotozono, C; Hitomi, Y; Kaniwa, N; Kim, MK; Seo, KY; Yoon, KC; Joo, CK; Kannabiran, C; Wakamatsu, TH; Sangwan, V; Rathi, V; Basu, S; Ozeki, T; Mushiroda, T; Sugiyama, E; Maekawa, K; Nakamura, R; Aihara, M; Matsunaga, K; Sekine, A; Gomes, JAP; Hamuro, J; Saito, Y; Kubo, M; Kinoshita, S; Tokunaga, K				Ueta, Mayumi; Sawai, Hiromi; Sotozono, Chie; Hitomi, Yuki; Kaniwa, Nahoko; Kim, Mee Kum; Seo, Kyoung Yul; Yoon, Kyung-Chul; Joo, Choun-Ki; Kannabiran, Chitra; Wakamatsu, Tais Hitomi; Sangwan, Virender; Rathi, Varsha; Basu, Sayan; Ozeki, Takeshi; Mushiroda, Taisei; Sugiyama, Emiko; Maekawa, Keiko; Nakamura, Ryosuke; Aihara, Michiko; Matsunaga, Kayoko; Sekine, Akihiro; Pereira Gomes, Jose Alvaro; Hamuro, Junji; Saito, Yoshiro; Kubo, Michiaki; Kinoshita, Shigeru; Tokunaga, Katsushi			IKZF1, a new susceptibility gene for cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis with severe mucosal involvement	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Stevens-Johnson syndrome; toxic epidermal necrolysis; cold medicine; severe mucosal involvement; genome-wide association study; IKZFl; alternative splicing	OCULAR SURFACE COMPLICATIONS; GENOME-WIDE ASSOCIATION; DNA-BINDING PROTEINS; ERYTHEMA MULTIFORME; IKAROS GENE; JAPANESE; POLYMORPHISMS; POPULATION; DRUGS; RISK	Background: Stevens-Johnson syndrome (SJS) and its severe form, toxic epidermal necrolysis (TEN), are acute inflammatory vesiculobullous reactions of the skin and mucous membranes, including the ocular surface, oral cavity, and genitals. These reactions are very rare but are often associated with inciting drugs, infectious agents, or both. Objective: We sought to identify susceptibility loci for cold medicine related SJS/TEN (CM-SJS/TEN) with severe mucosal involvement (SMI). Methods: A genome-wide association study was performed in 808 Japanese subjects (117 patients with CM-SJS/TEN with SMI and 691 healthy control subjects), and subsequent replication studies were performed in 204 other Japanese subjects (16 cases and 188 control subjects), 117 Korean subjects (27 cases and 90 control subjects), 76 Indian subjects (20 cases and 56 control subjects), and 174 Brazilian subjects (39 cases and 135 control subjects). Results: In addition to the most significant susceptibility region, HLA-A, we identified IKZF1, which encodes Ikaros, as a novel susceptibility gene (meta-analysis, rs4917014 [G vs T]; odds ratio, 0.5; P = 8.5 x 10(-11)). Furthermore, quantitative ratios of the IKZF1 alternative splicing isoforms Ik1 and Ik2 were significantly associated with rs4917014 genotypes. Conclusion: We identified IKZF1 as a susceptibility gene for CM-SJS/TEN with SMI not only in Japanese subjects but also in Korean and Indian subjects and showed that the Ik2/1k1 ratio might be influenced by IKZF1 single nucleotide polymorphisms, which were significantly associated with susceptibility to CM-SJS/TEN with SMI.	[Ueta, Mayumi; Sotozono, Chie] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto 60020841, Japan; [Ueta, Mayumi] Doshisha Univ, Fac Life & Med Sci, Res Ctr Inflammat & Regenerat Med, Kyoto 602, Japan; [Ueta, Mayumi; Sawai, Hiromi; Hitomi, Yuki; Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo, Japan; [Kaniwa, Nahoko; Sugiyama, Emiko; Maekawa, Keiko; Nakamura, Ryosuke; Saito, Yoshiro] Natl Inst Hlth Sci, Div Med Safety Sci, Tokyo, Japan; [Kim, Mee Kum] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Seo, Kyoung Yul] Yonsei Univ, Coll Med, Severance Hosp, Dept Ophthalmol,Inst Vis Res, Seoul, South Korea; [Yoon, Kyung-Chul] Chonnam Natl Univ, Dept Ophthalmol, Gwagju, South Korea; [Joo, Choun-Ki] Cathol Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Kannabiran, Chitra] Prof Brien Holden Eye Res Ctr, Hyderabad, Andhra Pradesh, India; [Sangwan, Virender; Rathi, Varsha; Basu, Sayan] LV Prasad Eye Inst, Cornea & Anterior Segment Serv, Hyderabad, Andhra Pradesh, India; [Wakamatsu, Tais Hitomi; Pereira Gomes, Jose Alvaro] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil; [Ozeki, Takeshi; Mushiroda, Taisei; Kubo, Michiaki] RIKEN, Ctr Integrat Med Sci, Res Grp Pharmacogen, Yokohama, Kanagawa, Japan; [Aihara, Michiko] Yokohama City Univ, Grad Sch Med, Dept Environm Immuno Dermatol, Yokohama, Kanagawa 232, Japan; [Matsunaga, Kayoko] Fujita Hlth Univ, Sch Med, Dept Dermatol, Toyoake, Aichi 47011, Japan; [Sekine, Akihiro] Kyoto Univ, Grad Sch Med, EBM Res Ctr, Kyoto, Japan	Tokunaga, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Human Genet, Bunkyo Ku, 7-3-1 Hong, Tokyo 1130033, Japan.	tokunaga@m.u-tokyo.ac.jp		Sangwan, Virender/0000-0002-8229-4158	Ministry of Education, Culture, Sports, Science, and Technology of the Japanese government (Scientific Research on Innovative Areas "Genome Science" and BioBank Japan Project); Japanese Ministry of Health, Labor and Welfare; Kyoto Foundation for the Promotion of Medical Science; Intramural Research Fund of Kyoto Prefectural University of Medicine; Department of Science and Technology, Government of India, under the India-Japan S&T cooperation (to Hyderabad Eye Research Foundation)	Supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of the Japanese government (Scientific Research on Innovative Areas "Genome Science" and BioBank Japan Project) and also partly by grants-in-aid for scientific research from the Japanese Ministry of Health, Labor and Welfare and a research grant from the Kyoto Foundation for the Promotion of Medical Science and the Intramural Research Fund of Kyoto Prefectural University of Medicine. This project was funded by the Department of Science and Technology, Government of India, under the India-Japan S&T cooperation (to Hyderabad Eye Research Foundation).	Ueta M, 2012, PROG RETIN EYE RES, V31, P551, DOI 10.1016/j.preteyeres.2012.05.003; YETIV JZ, 1980, SOUTHERN MED J, V73, P599; Ueta M, 2008, INVEST OPHTH VIS SCI, V49, P1809, DOI 10.1167/iovs.07-1401; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Nishida N, 2007, ANAL BIOCHEM, V364, P78, DOI 10.1016/j.ab.2007.02.005; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; ROUJEAU JC, 1995, NEW ENGL J MED, V333, P1600, DOI 10.1056/NEJM199512143332404; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; Ueta M, 2008, MOL VIS, V14, P550; Lonjou C, 2008, PHARMACOGENET GENOM, V18, P99, DOI 10.1097/FPC.0b013e3282f3ef9c; Hung SL, 2005, P NATL ACAD SCI USA, V102, P4134, DOI 10.1073/pnas.0409500102; Merkenschlager M, 2010, FEBS LETT, V584, P4910, DOI 10.1016/j.febslet.2010.09.042; POWER WJ, 1995, OPHTHALMOLOGY, V102, P1669; Leaute-Labreze C, 2000, ARCH DIS CHILD, V83, P347, DOI 10.1136/adc.83.4.347; Ueta M, 2007, BRIT J OPHTHALMOL, V91, P962, DOI 10.1136/bjo.2006.113449; Tohkin M, 2013, PHARMACOGENOMICS J, V13, P60, DOI 10.1038/tpj.2011.41; BASTUJIGARIN S, 1993, ARCH DERMATOL, V129, P92, DOI 10.1001/archderm.129.1.92; Ozeki T, 2011, HUM MOL GENET, V20, P1034, DOI 10.1093/hmg/ddq537; Sotozono C, 2007, OPHTHALMOLOGY, V114, P1294, DOI 10.1016/j.ophtha.2006.10.029; Mockenhaupt M, 2008, J INVEST DERMATOL, V128, P35, DOI 10.1038/sj.jid.5701033; Sotozono C, 2009, OPHTHALMOLOGY, V116, P685, DOI 10.1016/j.ophtha.2008.12.048; Ueta M, 2010, J ALLERGY CLIN IMMUN, V126, P1218, DOI 10.1016/j.jaci.2010.08.007; CHAN HL, 1990, ARCH DERMATOL, V126, P43, DOI 10.1001/archderm.126.1.43; Ueta M, 2007, J ALLERGY CLIN IMMUN, V120, P1457, DOI 10.1016/j.jaci.2007.07.048; Sun L, 1996, EMBO J, V15, P5358; Forman R, 2002, DRUG SAFETY, V25, P965, DOI 10.2165/00002018-200225130-00006; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Ueta M, 2012, J ALLERGY CLIN IMMUN, V129, P1413, DOI 10.1016/j.jaci.2012.01.069; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Ueta M, 2008, BRIT J OPHTHALMOL, V92, P989, DOI 10.1136/bjo.2007.136796; Fang CM, 2012, GENES IMMUN, V13, P421, DOI 10.1038/gene.2012.10; HAHM KM, 1994, MOL CELL BIOL, V14, P7111; Hu SJ, 2013, MOD RHEUMATOL, V23, P205, DOI 10.1007/s10165-012-0706-x; Molnar A, 1996, J IMMUNOL, V156, P585; Nishida N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029967; Ueta M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05981; Ueta M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04862; Ueta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043650; Ueta M, 2007, AM J OPHTHALMOL, V143, P367, DOI 10.1016/j.ajo.2006.09.029; Yamane Yumiko, 2007, Allergol Int, V56, P419, DOI 10.2332/allergolint.O-07-483	41	3	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2015	135	6					1538	U240		10.1016/j.jaci.2014.12.1916		25	Allergy; Immunology	Allergy; Immunology	CK0ZC	WOS:000355933400017		
J	Yamamoto, Y; Sakisaka, T				Yamamoto, Yasunori; Sakisaka, Toshiaki			The emerging role of calcium-modulating cyclophilin ligand in posttranslational insertion of tail-anchored proteins into the endoplasmic reticulum membrane	JOURNAL OF BIOCHEMISTRY			English	Review						CAML; GET complex; tail-anchored protein; TRC40; WRB	SIGNAL RECOGNITION PARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; CYTOSOLIC QUALITY-CONTROL; ER MEMBRANE; PHOSPHOLIPID-BILAYERS; MISLOCALIZED PROTEINS; NASCENT POLYPEPTIDES; GET4/GET5 COMPLEX; CRYSTAL-STRUCTURE; TARGETING FACTOR	Tail-anchored (TA) proteins, a class of membrane proteins having an N-terminal cytoplasmic region anchored to the membrane by a single C-terminal transmembrane domain, are posttranslationally inserted into the endoplasmic reticulum (ER) membrane. In yeasts, the posttranslational membrane insertion is mediated by the Guided Entry of TA Proteins (GET) complex. Get3, a cytosolic ATPase, targets newly synthesized TA proteins to the ER membrane, where Get2 and Get3 constitute the Get3 receptor driving the membrane insertion. While mammalian cells employ TRC40 and WRB, mammalian homologs of Get3 and Get1, respectively, they lack the gene homologous to Get2. We recently identified calcium-modulating cyclophilin ligand (CAML) as a TRC40 receptor, indicating that CAML was equivalent to Get2 in the context of the membrane insertion. On the other hand, CAML has been well characterized as a signaling molecule that regulates various biological processes, raising the question of how the two distinct actions of CAML, the membrane insertion and the signal transduction, are assembled. In this review, we summarize recent progress of the molecular mechanism of the membrane insertion of TA proteins and discuss the possibility that CAML could sense the various signals at the ER membrane, thereby controlling TA protein biogenesis.	[Yamamoto, Yasunori; Sakisaka, Toshiaki] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Membrane Dynam, Kobe, Hyogo 6500017, Japan	Sakisaka, T (reprint author), Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Membrane Dynam, Kobe, Hyogo 6500017, Japan.	sakisaka@med.kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [24570157, 25293071, 25640036, 26117513]; Takeda Science Foundation; Naito Foundation; Kanae Foundation for the Promotion of Medical Sciences; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Ono Medical Research Foundation; Uehara Memorial Foundation; Sumitomo Foundation	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (grant numbers 24570157, 25293071, 25640036, 26117513), and in part by The Takeda Science Foundation, The Naito Foundation, The Kanae Foundation for the Promotion of Medical Sciences, The Mochida Memorial Foundation for Medical and Pharmaceutical Research, Ono Medical Research Foundation, The Uehara Memorial Foundation, and The Sumitomo Foundation.	Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Stefer S, 2011, SCIENCE, V333, P758, DOI 10.1126/science.1207125; Denic V, 2012, TRENDS BIOCHEM SCI, V37, P411, DOI 10.1016/j.tibs.2012.07.004; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Chang YW, 2010, J BIOL CHEM, V285, P9962, DOI 10.1074/jbc.M109.087098; Suloway CJM, 2009, P NATL ACAD SCI USA, V106, P14849, DOI 10.1073/pnas.0907522106; Yan MH, 2001, NAT IMMUNOL, V2, P638, DOI 10.1038/89790; Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Chartron JW, 2012, CURR OPIN STRUC BIOL, V22, P217, DOI 10.1016/j.sbi.2012.03.001; Mariappan M, 2011, NATURE, V477, P61, DOI 10.1038/nature10362; Johnson N, 2013, BBA-MOL CELL RES, V1833, P2403, DOI 10.1016/j.bbamcr.2012.12.008; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; vonBulow GU, 1997, SCIENCE, V278, P138, DOI 10.1126/science.278.5335.138; Holloway MP, 1998, J BIOL CHEM, V273, P16346, DOI 10.1074/jbc.273.26.16346; Chartron JW, 2010, P NATL ACAD SCI USA, V107, P12127, DOI 10.1073/pnas.1006036107; BRAM RJ, 1994, NATURE, V371, P355, DOI 10.1038/371355a0; Vilardi F, 2011, J CELL SCI, V124, P1301, DOI 10.1242/jcs.084277; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Tran DD, 2003, DEV CELL, V5, P245, DOI 10.1016/S1534-5807(03)00207-7; Shan SO, 2005, FEBS LETT, V579, P921, DOI 10.1016/j.febslet.2004.11.049; Colombo SF, 2009, J CELL SCI, V122, P2383, DOI 10.1242/jcs.049460; Novak AJ, 2004, BLOOD, V103, P689, DOI 10.1182/blood-2003-06-2043; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600; Ng LG, 2004, J IMMUNOL, V173, P807; GILMORE R, 1982, J CELL BIOL, V95, P470, DOI 10.1083/jcb.95.2.470; Seshasayee D, 2003, IMMUNITY, V18, P279, DOI 10.1016/S1074-7613(03)00025-6; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; Brambillasca S, 2005, EMBO J, V24, P2533, DOI 10.1038/sj.emboj.7600730; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Kalbfleisch T, 2007, TRAFFIC, V8, P1687, DOI 10.1111/j.1600-0854.2007.00661.x; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; Rome ME, 2013, P NATL ACAD SCI USA, V110, P7666, DOI 10.1073/pnas.1222054110; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633; Yamamoto Y, 2012, MOL CELL, V48, P387, DOI 10.1016/j.molcel.2012.08.028; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Bozkurt G, 2009, P NATL ACAD SCI USA, V106, P21131, DOI 10.1073/pnas.0910223106; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Kriechbaumer V, 2009, TRAFFIC, V10, P1753, DOI 10.1111/j.1600-0854.2009.00991.x; Aviram N, 2014, CURR OPIN CELL BIOL, V29, P8, DOI 10.1016/j.ceb.2014.02.004; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Gristick HB, 2014, NAT STRUCT MOL BIOL, V21, P437, DOI 10.1038/nsmb.2813; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Wang F, 2011, MOL CELL, V43, P738, DOI 10.1016/j.molcel.2011.07.020; Suloway CJM, 2012, EMBO J, V31, P707, DOI 10.1038/emboj.2011.433; GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G; Guo SD, 2005, J BIOL CHEM, V280, P12536, DOI 10.1074/jbc.M500296200; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Wang F, 2014, NATURE, V512, P441, DOI 10.1038/nature13471; Liu Y, 2009, CELL CYCLE, V8, P940, DOI 10.4161/cc.8.6.7948; Yamagata A, 2010, GENES CELLS, V15, P29, DOI 10.1111/j.1365-2443.2009.01362.x; Rodrigo-Brenni MC, 2014, MOL CELL, V55, P227, DOI 10.1016/j.molcel.2014.05.025; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Battle A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.27; BLOBEL G, 1970, J CELL BIOL, V45, P130, DOI 10.1083/jcb.45.1.130; Chang YW, 2012, J BIOL CHEM, V287, P4783, DOI 10.1074/jbc.M111.318329; Chartron JW, 2012, J BIOL CHEM, V287, P8310, DOI 10.1074/jbc.M111.333252; Egeo A, 1998, HUM GENET, V102, P289, DOI 10.1007/s004390050693; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Hu JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008061; Leznicki P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059590; Leznicki P, 2012, P NATL ACAD SCI USA, V109, P19214, DOI 10.1073/pnas.1209997109; MEYER DI, 1982, NATURE, V297, P647, DOI 10.1038/297647a0; Mock JY, 2015, P NATL ACAD SCI USA, V112, P106, DOI 10.1073/pnas.1402745112; Murata K, 2009, DEV GROWTH DIFFER, V51, P95, DOI 10.1111/j.1440-169X.2008.01084.x; Peng Z, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-41; Rome ME, 2014, P NATL ACAD SCI USA, V111, pE4929, DOI 10.1073/pnas.1411284111; Tran David D, 2005, Immunity, V23, P139, DOI 10.1016/j.immuni.2005.06.006; Vilardi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085033; Voth W, 2014, MOL CELL, V56, P116, DOI 10.1016/j.molcel.2014.08.017; Wunderley L, 2014, J CELL SCI, V127, P4728, DOI 10.1242/jcs.155648; Yuan X, 2008, MOL CELL NEUROSCI, V38, P277, DOI 10.1016/j.mcn.2008.03.002; Zhang W, 2010, BIOINFORMATICS BIOME, V1, P1	84	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	JUN	2015	157	6					419	429		10.1093/jb/mvv035		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CK5BW	WOS:000356238100001		
J	Oneyama, C; Okada, M				Oneyama, Chitose; Okada, Masato			MicroRNAs as the fine-tuners of Src oncogenic signalling	JOURNAL OF BIOCHEMISTRY			English	Review						cancer signalling; microRNA; mTOR; proto-oncogene; Src	INTEGRIN-LINKED KINASE; CELL LUNG-CANCER; TUMOR-SUPPRESSOR; PROSTATE-CANCER; TYROSINE PHOSPHORYLATION; GEFITINIB RESISTANCE; MIRNA EXPRESSION; ADAPTER PROTEIN; FAMILY KINASES; C-SRC	The cellular Src (c-Src) tyrosine kinase is upregulated and believed to play a pivotal role in various human cancers. However, the molecular mechanism underlying c-Src-mediated tumour progression remains elusive. Recent studies have revealed that several microRNAs (miRNAs) function as tumour suppressors by regulating the malignant expression of signalling molecules. Aberrant expression of miRNAs is frequently observed in human cancers and should be exploited to seek related molecular targets. In this review, we focus on miRNAs found to be involved in Src signalling in various cancers. We summarize recent findings on Src-related miRNAs, their target genes, mechanisms behind their interplay and their implications for cancer therapeutics.	[Oneyama, Chitose] Aichi Canc Ctr Res Inst, Div Microbiol & Oncol, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Oneyama, Chitose; Okada, Masato] Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, Suita, Osaka 5650871, Japan	Oneyama, C (reprint author), Aichi Canc Ctr Res Inst, Div Microbiol & Oncol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	coneyama@aichi-cc.jp			Exciting Leading-Edge Research Project at Osaka University (Japan); MEXT KAKENHI [25293077]; MEXT	We appreciate that this work was supported by The Exciting Leading-Edge Research Project at Osaka University (Japan) to C.O; Grants-in-Aid for Scientific Research (B) from MEXT KAKENHI Grant Number 25293077 to C.O.; and Grant-in-aid for P-DIRECT from the MEXT to C.O.	Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Martin GS, 2004, ONCOGENE, V23, P7910, DOI 10.1038/sj.onc.1208077; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Fornari F, 2010, CANCER RES, V70, P5184, DOI 10.1158/0008-5472.CAN-10-0145; Kao CJ, 2014, ONCOGENE, V33, P2495, DOI 10.1038/onc.2013.200; Oom AL, 2014, BIOMED RES INT, DOI 10.1155/2014/959461; Arcaroli JJ, 2010, CLIN CANCER RES, V16, P4165, DOI 10.1158/1078-0432.CCR-10-0066; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Majid S, 2011, CANCER RES, V71, P2611, DOI 10.1158/0008-5472.CAN-10-3666; Park KS, 2014, J CLIN INVEST, V124, P3003, DOI 10.1172/JCI73048; Cao Q, 2011, CANCER CELL, V20, P187, DOI 10.1016/j.ccr.2011.06.016; Donadelli M, 2014, CANCER LETT, V349, P107, DOI 10.1016/j.canlet.2014.04.012; Garofalo M, 2012, NAT MED, V18, P74, DOI 10.1038/nm.2577; Rothschild SI, 2010, CLIN LUNG CANCER, V11, P238, DOI 10.3816/CLC.2010.n.030; Benedettini E, 2010, AM J PATHOL, V177, P415, DOI 10.2353/ajpath.2010.090863; Laszlo GS, 2009, CURR BIOL, V19, P157, DOI 10.1016/j.cub.2008.12.007; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Fong S, 2004, TRENDS MOL MED, V10, P387, DOI 10.1016/j.molmed.2004.06.008; Uesugi A, 2011, CANCER RES, V71, P5765, DOI 10.1158/0008-5472.CAN-11-0368; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Ochi N, 2014, EXP CELL RES, V322, P168, DOI 10.1016/j.yexcr.2014.01.007; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cb.03.110187.000335; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Augoff K, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-5; Tatarov O, 2009, CLIN CANCER RES, V15, P3540, DOI 10.1158/1078-0432.CCR-08-1857; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Edwards J, 2010, EXPERT OPIN INV DRUG, V19, P605, DOI 10.1517/13543781003789388; Bianco C, 2010, EXPERT OPIN THER PAT, V20, P1739, DOI 10.1517/13543776.2010.530659; Okada M, 2012, INT J BIOL SCI, V8, P1385, DOI 10.7150/ijbs.5141; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Senga T, 2000, ONCOGENE, V19, P273, DOI 10.1038/sj.onc.1203296; Azuma K, 2005, ONCOGENE, V24, P4754, DOI 10.1038/sj.onc.1208654; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Tsuruta T, 2011, CANCER RES, V71, P6450, DOI 10.1158/0008-5472.CAN-11-0364; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Majid S, 2012, CANCER RES, V72, P6435, DOI 10.1158/0008-5472.CAN-12-2181; Hakak Y, 1999, CURR BIOL, V9, P1039, DOI 10.1016/S0960-9822(99)80453-9; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Di Leva G, 2013, CURR OPIN GENET DEV, V23, P3, DOI 10.1016/j.gde.2013.01.004; Oneyama C, 2012, ONCOGENE, V31, P1623, DOI 10.1038/onc.2011.367; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Asangani IA, 2012, ONCOTARGET, V3, P1011; Yu EY, 2009, CLIN CANCER RES, V15, P7421, DOI 10.1158/1078-0432.CCR-09-1691; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Yoshida T, 2014, CLIN CANCER RES, V20, P4059, DOI 10.1158/1078-0432.CCR-13-1559; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Kunej T, 2012, CANCER J, V18, P223, DOI 10.1097/PPO.0b013e318258b771; Oneyama C, 2011, ONCOGENE, V30, P3489, DOI 10.1038/onc.2011.63; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Krishnan Harini, 2012, Genes Cancer, V3, P426, DOI 10.1177/1947601912458583; Li X, 2009, ONCOGENE, V28, P4272, DOI 10.1038/onc.2009.278; Liu Q., 2009, DRUG DISCOV TODAY TH, V6, P47, DOI DOI 10.1016/J.DDSTR.2009.12.001; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; Oneyama C, 2008, GENES CELLS, V13, P1, DOI 10.1111/j.1365-2443.2007.01145.x; Oneyama C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080300; Oneyama C, 2009, MOL CELL BIOL, V29, P6462, DOI 10.1128/MCB.00941-09; Rothschild SI, 2012, ONCOGENE, V31, P4221, DOI 10.1038/onc.2011.578; Shi JN, 2010, J ORAL PATHOL MED, V39, P548, DOI 10.1111/j.1600-0714.2009.00859.x; Tsuda Masumi, 2012, Genes Cancer, V3, P334, DOI 10.1177/1947601912458687; Wang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105570; Yamada H, 2008, GENE CHROMOSOME CANC, V47, P810, DOI 10.1002/gcc.20582; Yonezawa Y, 2005, MOL CARCINOGEN, V43, P188, DOI 10.1002/mc.20109	77	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	JUN	2015	157	6					431	438		10.1093/jb/mvv036		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CK5BW	WOS:000356238100002		
J	Goto, Y; Ogawa, K; Nakamura, TJ; Hattori, A; Tsujimoto, M				Goto, Yoshikuni; Ogawa, Kenji; Nakamura, Takahiro J.; Hattori, Akira; Tsujimoto, Masafumi			Substrate-dependent nitric oxide synthesis by secreted endoplasmic reticulum aminopeptidase 1 in macrophages	JOURNAL OF BIOCHEMISTRY			English	Article						aminopeptidase; arginine; lipopolysaccharide; macrophage; nitric oxide	PLACENTAL LEUCINE AMINOPEPTIDASE/OXYTOCINASE; INSULIN-REGULATED AMINOPEPTIDASE; LEUCYL-SPECIFIC AMINOPEPTIDASE; GENOME-WIDE ASSOCIATION; ANGIOTENSIN-IV; MEMBRANE AMINOPEPTIDASE; PULMONARY TUBERCULOSIS; OXYTOCINASE SUBFAMILY; SUSCEPTIBILITY LOCI; ENDOTHELIAL-CELLS	In this study, we examined the role of aminopeptidases with reference to endoplasmic reticulum aminopeptidase 1 (ERAP1) in nitric oxide (NO) synthesis employing murine macrophage cell line RAW264.7 cells activated by lipopolysaccharide (LPS) and interferon (IFN)-gamma and LPS-activated peritoneal macrophages derived from ERAP1 knockout mouse. When NO synthesis was measured in the presence of peptides having N-terminal Arg, comparative NO synthesis was seen with that measured in the presence of Arg. In the presence of an aminopeptidase inhibitor amastatin, NO synthesis in activated RAW264.7 cells was significantly decreased. These results suggest that aminopeptidases are involved in the NO synthesis in activated RAW264.7 cells. Subsequently, significant reduction of NO synthesis was observed in ERAP1 knockdown cells compared with wild-type cells. This reduction was rescued by exogenously added ERAP1. Furthermore, when peritoneal macrophages prepared from ERAP1 knockout mouse were employed, reduction of NO synthesis in knockout mouse macrophages was also attributable to ERAP1. In the presence of amastatin, further reduction was observed in knockout mouse-derived macrophages. Taken together, these results suggest that several aminopeptidases play important roles in the maximum synthesis of NO in activated macrophages in a substrate peptide-dependent manner and ERAP1 is one of the aminopeptidases involved in the NO synthesis.	[Goto, Yoshikuni; Nakamura, Takahiro J.; Tsujimoto, Masafumi] Teikyo Heisei Univ, Fac Pharmaceut Sci, Tokyo 1648530, Japan; [Ogawa, Kenji] RIKEN, Chem Genet Lab, Wako, Saitama 3510198, Japan; [Nakamura, Takahiro J.] Meiji Univ, Sch Agr, Dept Life Sci, Kawasaki, Kanagawa 2148571, Japan; [Hattori, Akira] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Syst Chemotherapy & Mol Sci, Kyoto 6068501, Japan	Goto, Y (reprint author), Teikyo Heisei Univ, Fac Pharmaceut Sci, 4-21-2 Nakano, Tokyo 1648530, Japan.	y.goto@thu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24659153, 24790083, 25293083]; Suzuken Memorial Foundation	This work was supported by a Grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (project number: 24659153, 24790083 and 25293083) and a grant from the Suzuken Memorial Foundation.	ADAMS LB, 1991, J IMMUNOL, V147, P1642; Alvarez-Navarro C, 2013, CURR OPIN RHEUMATOL, V25, P419, DOI 10.1097/BOR.0b013e328362042f; van de Wal RMA, 2006, INT J CARDIOL, V106, P367, DOI 10.1016/j.ijcard.2005.02.016; Goto Y, 2011, J BIOL CHEM, V286, P21906, DOI 10.1074/jbc.M111.239111; Ogawa Y, 2014, BBA-GEN SUBJECTS, V1840, P1872, DOI 10.1016/j.bbagen.2014.01.002; Sato Y, 2004, BIOL PHARM BULL, V27, P772, DOI 10.1248/bpb.27.772; Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P443, DOI 10.1111/j.1574-695X.2007.00329.x; Choi HS, 2002, AM J RESP CRIT CARE, V166, P178, DOI 10.1164/rccm.2201023; Cui XL, 2003, J IMMUNOL, V171, P6814; Tanioka T, 2003, J BIOL CHEM, V278, P32275, DOI 10.1074/jbc.M305076200; Saveanu L, 2009, SCIENCE, V325, P213, DOI 10.1126/science.1172845; TAYLOR A, 1993, FASEB J, V7, P290; Cui XL, 2003, J BIOL CHEM, V278, P28677, DOI 10.1074/jbc.M300456200; Closs EI, 2000, MOL PHARMACOL, V57, P68; Yamahara N, 2000, LIFE SCI, V66, P1401, DOI 10.1016/S0024-3205(00)00451-3; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; TSUJIMOTO M, 1992, ARCH BIOCHEM BIOPHYS, V292, P388, DOI 10.1016/0003-9861(92)90007-J; Weimershaus M, 2013, CURR OPIN IMMUNOL, V25, P90, DOI 10.1016/j.coi.2012.10.001; Nomura S, 2005, BBA-PROTEINS PROTEOM, V1751, P19, DOI 10.1016/j.bbapap.2005.04.006; Zini S, 1996, P NATL ACAD SCI USA, V93, P11968, DOI 10.1073/pnas.93.21.11968; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Hadkar V, 2001, MOL PHARMACOL, V59, P1324; Matsumoto H, 2000, EUR J BIOCHEM, V267, P46, DOI 10.1046/j.1432-1327.2000.00949.x; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Yan JB, 2006, J EXP MED, V203, P647, DOI 10.1084/jem.20052271; Haroon N, 2010, NAT REV RHEUMATOL, V6, P461, DOI 10.1038/nrrheum.2010.85; Goto Y, 2006, FEBS LETT, V580, P1833, DOI 10.1016/j.febslet.2006.02.041; Wearsch PA, 2008, CURR OPIN CELL BIOL, V20, P624, DOI 10.1016/j.ceb.2008.09.005; Hattori A, 2012, BIOL PHARM BULL, V35, P601; Stragier B, 2006, J NEUROCHEM, V98, P1100, DOI 10.1111/j.1471-4159.2006.03942.x; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Tsujimoto M, 2005, BBA-PROTEINS PROTEOM, V1751, P9, DOI 10.1016/j.bbapap.2004.09.011; Alam MS, 2002, INFECT IMMUN, V70, P3130, DOI 10.1128/IAI.70.6.3130-3142.2002; Stragier B, 2007, BRAIN RES, V1131, P97, DOI 10.1016/j.brainres.2006.11.010; Albiston AL, 2001, J BIOL CHEM, V276, P48623, DOI 10.1074/jbc.C100512200; BOGLE RG, 1992, BIOCHEM J, V284, P15; Cui XL, 2002, J CLIN INVEST, V110, P515, DOI 10.1172/JCI200213847; Ross SA, 1996, J BIOL CHEM, V271, P3328; Maruyama M, 2007, J BIOL CHEM, V282, P20088, DOI 10.1074/jbc.M702650200; Asai Y, 2008, J NUTR SCI VITAMINOL, V54, P460, DOI 10.3177/jnsv.54.460; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Cifaldi L, 2012, INT J MOL SCI, V13, P8338, DOI 10.3390/ijms13078338; Gabrilovac J, 2011, IMMUNOBIOLOGY, V216, P132, DOI 10.1016/j.imbio.2010.06.005; Genetic Analysis of Psoriasis Consorsium and the Wellcome Trust Case Control Consorsium, 2010, NAT GENET, V42, P985; Goto Y, 2014, J IMMUNOL, V192, P4443, DOI 10.4049/jimmunol.1300935; Hattori A, 1999, J BIOCHEM-TOKYO, V125, P931; Hattori A, 2013, J BIOCHEM, V154, P219, DOI 10.1093/jb/mvt066; Hui M, 2003, NEUROCHEM RES, V28, P855, DOI 10.1023/A:1023263123911; Miyashita H, 2002, BLOOD, V99, P3241, DOI 10.1182/blood.V99.9.3241; Morris Jr S. M., 2009, NITRIC OXIDE BIOL PA, P187; NIHIRA S, 1982, J BIOCHEM-TOKYO, V92, P1567; NIHIRA S, 1983, J BIOCHEM-TOKYO, V94, P565; Nikolaou A, 2014, J RENIN-ANGIO-ALDO S, V15, P466, DOI 10.1177/1470320313507621; PALMIERI FE, 1985, BIOCHEM PHARMACOL, V34, P2309, DOI 10.1016/0006-2952(85)90787-7; Reaux A, 1999, P NATL ACAD SCI USA, V96, P13415, DOI 10.1073/pnas.96.23.13415; Schomburg L, 2000, EUR J BIOCHEM, V267, P3198, DOI 10.1046/j.1432-1327.2000.01348.x; Wang CH, 2001, INT J TUBERC LUNG D, V5, P283; Yamamoto N, 2002, HUM MUTAT, V19, P251, DOI 10.1002/humu.10047	60	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	JUN	2015	157	6					439	449		10.1093/jb/mvv001		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CK5BW	WOS:000356238100003		
J	Makino, Y; Fujii, Y; Taniguchi, M				Makino, Yasushi; Fujii, Yuta; Taniguchi, Motoi			Properties and functions of the storage sites of glycogen phosphorylase	JOURNAL OF BIOCHEMISTRY			English	Article						cyclodextrin; glycogen phosphorylase; high-performance liquid chromatography; pyridylamination; storage site	AMINO-ACID-SEQUENCE; DEBRANCHING ENZYME; LIVER-GLYCOGEN; CYCLODEXTRIN DIALDEHYDE; MUSCLE GLYCOGEN; BINDING; RABBIT; OLIGOSACCHARIDES; CHROMATOGRAPHY; POLYSACCHARIDE	Glycogen phosphorylase (GP) is biologically active as a dimer of identical subunits. Each subunit has two distinct maltooligosaccharide binding sites: a storage site and a catalytic site. Our characterization of the properties of these sites suggested that GP activity consists of two activities: (i) binding to the glycogen molecule and (ii) phosphorolysis of the non-reducing-end glucose residues. Activity (i) is mainly due to the activities of the two storage sites, which depended on the ionic strength of the medium and were directly inhibited by cyclodextrins (CDs). Activity (i) is of benefit to GP because a high concentration of non-reducing-end glucose residues is localized on the surface of the glycogen molecule. Activity (ii), the total activity of the two catalytic sites, exhibited relatively little ionic strength dependence. Because the combined activity of (i) and (ii) is deduced using glycogen as an assay substrate, the sole activity of (ii) must be measured using small maltooligosyl-substrates. By using a very low concentration of pyridylaminated maltohexaose, we demonstrated that the GP catalytic sites are active even in the presence of CDs, and that the actions of the catalytic site and the storage site are independent of each other.	[Makino, Yasushi; Fujii, Yuta; Taniguchi, Motoi] Osaka Prefecture Univ, Dept Chem, Grad Sch Sci, Naka Ku, Sakai, Osaka 5998531, Japan	Makino, Y (reprint author), Osaka Prefecture Univ, Dept Chem, Grad Sch Sci, Naka Ku, Gakuen Cho 1-1, Sakai, Osaka 5998531, Japan.	ymakino@c.s.osakafu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [23651241]	This research was supported by a Grant-in-Aid for Challenging Exploratory Research (23651241 to Y.M.) from The Japan Society for the Promotion of Science (JSPS).	HASE S, 1978, BIOCHEM BIOPH RES CO, V85, P257, DOI 10.1016/S0006-291X(78)80037-0; Reed MC, 2010, BIOESSAYS, V32, P422, DOI 10.1002/bies.200900167; Cheng A, 2007, GENE DEV, V21, P2399, DOI 10.1101/gad.1553207; Melendez R, 1999, BIOPHYS J, V77, P1327, DOI 10.1016/S0006-3495(99)76982-1; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Pinotsis N, 2003, PROTEIN SCI, V12, P1914, DOI 10.1110/ps.03149503; GEDDES R, 1977, BIOCHEM J, V163, P201; MELENDEZHEVIA E, 1993, BIOCHEM J, V295, P477; NAKANO K, 1980, J BIOCHEM-TOKYO, V87, P919; BIRKEL G, 1986, INT J BIOCHEM, V18, P79, DOI 10.1016/0020-711X(86)90012-1; Brokordt K, 2004, MAR ECOL PROG SER, V268, P141, DOI 10.3354/meps268141; CHEETHAM NWH, 1991, CARBOHYD RES, V215, P59, DOI 10.1016/0008-6215(91)84007-2; ENGERS HD, 1968, BIOCHEM BIOPH RES CO, V33, P49, DOI 10.1016/0006-291X(68)90253-2; FUKUI T, 1987, J PROTEIN CHEM, V6, P47; GORDON RB, 1972, BIOCHIM BIOPHYS ACTA, V289, P97, DOI 10.1016/0005-2744(72)90112-X; HAJDU J, 1987, EMBO J, V6, P539; HU HY, 1975, BIOCHEMISTRY-US, V14, P2224, DOI 10.1021/bi00681a028; Ishimizu T, 2007, J BIOCHEM, V142, P721, DOI 10.1093/jb/mvm186; Kasvinsky P.J., 1977, J BIOL CHEM, V253, P1290; KOBAYASHI M, 1988, AGR BIOL CHEM TOKYO, V52, P2703; KURAYA N, 1992, J BIOCHEM, V112, P122; LIU W, 1991, BIOCHEMISTRY-US, V30, P1419, DOI 10.1021/bi00219a036; MADSEN NB, 1983, BIOCHEMISTRY-US, V22, P4460, DOI 10.1021/bi00288a017; Makino Y, 2009, J BIOCHEM, V146, P71, DOI 10.1093/jb/mvp044; Makino Y, 2006, J BIOCHEM, V139, P535, DOI 10.1093/jb/mvj056; MATSUI M, 1993, BIOSCI BIOTECH BIOCH, V57, P623; Misaki A., 1994, J TRACE NUTR ELEMENT, V11, P1; MORANGE M, 1976, EUR J BIOCHEM, V65, P553, DOI 10.1111/j.1432-1033.1976.tb10373.x; NAKANO K, 1986, J BIOL CHEM, V261, P8230; Nakayama A, 2001, J BIOL CHEM, V276, P28824, DOI 10.1074/jbc.M102192200; Natsuka S, 2011, FEBS J, V278, P452, DOI 10.1111/j.1742-4658.2010.07966.x; Natsuka S, 2012, BIOSCI BIOTECH BIOCH, V76, P1982, DOI 10.1271/bbb.120388; Ohashi T, 2007, BIOSCI BIOTECH BIOCH, V71, P2291, DOI 10.1271/bbb.70311; Oikonomakos NG, 2008, CURR OPIN INVEST DR, V9, P379; PHILIP G, 1982, BIOCHEMISTRY-US, V21, P3043, DOI 10.1021/bi00256a002; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Sandhya-Rani M.R., 1992, CARBOHYD RES, V227, P183, DOI 10.1016/0008-6215(92)85070-G; Segel I.H., 1975, ENZYME KINETICS, P170; Shearer J, 2002, CAN J APPL PHYSIOL, V27, P179; SHIMOMURA S, 1980, BIOCHEMISTRY-US, V19, P2287, DOI 10.1021/bi00552a001; SHIMOMURA S, 1982, J BIOCHEM-TOKYO, V91, P703; SORENSEN NB, 1975, BIOCHEM BIOPH RES CO, V67, P883, DOI 10.1016/0006-291X(75)90759-7; SOTIROUDIS TG, 1978, EUR J BIOCHEM, V88, P573, DOI 10.1111/j.1432-1033.1978.tb12483.x; TAGAYA M, 1984, J BIOL CHEM, V259, P4860; TAKAGI S, 1988, AGR BIOL CHEM TOKYO, V52, P2709; TITANI K, 1977, P NATL ACAD SCI USA, V74, P4762, DOI 10.1073/pnas.74.11.4762; Watanabe Y, 2006, J BIOCHEM, V140, P135, DOI 10.1093/jb/mvj129; WEBER IT, 1978, NATURE, V274, P433, DOI 10.1038/274433a0; Yamamoto E, 2009, J BIOCHEM, V145, P585, DOI 10.1093/jb/mvp012; Yang Z., 2009, J BIOTECHNOL, V144, P49	50	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	JUN	2015	157	6					451	458		10.1093/jb/mvv007		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CK5BW	WOS:000356238100004		
J	Hanai, R; Arai, Y				Hanai, Ryo; Arai, Yui			New roles of DNA and SopB in polymerization of SopA of Escherichia coli F plasmid	JOURNAL OF BIOCHEMISTRY			English	Article						ATPase; DNA-protein interaction; plasmid partitioning; protein polymerization; protein-protein interaction	PARTITION; PROTEIN; SEGREGATION; ATPASE; GENES; PRODUCTS	Active equi-paritioning of the F plasmid is achieved by its sopABC gene. SopA binds to the sopAB promoter region and SopB binds to sopC. SopA also polymerizes in the presence of ATP and Mg(II), which is stimulated by SopB. Non-specific DNA is known to inhibit SopA polymerization and disassemble SopA polymer. This study followed kinetics of polymerization and de-polymerization of SopA by turbidity measurement and found new effects by DNA and SopB. Plasmid DNA, at low concentrations, shortened the lag (nucleation) phase of SopA polymerization and also caused an initial 'burst' of turbidity. Results with two non-specific 20-bp DNAs indicated sequence/length dependence of these effects. sopAB operator DNA only showed inhibition of SopA polymerization. Results of turbidity decrease of pre-formed SopA polymer in the presence of ethylenediaminetetraacetic acid showed that SopB also accelerates disassembly of the SopA polymer. The steady-state level of turbidity in the presence of SopB and plasmid DNA indicated synergy between SopB and DNA in the disassembly. SopB protein showed no effect on SopA polymerization, when SopB was specifically bound to DNA. This result and others with truncation mutants of SopB suggested that a proper configuration of the domains of SopB is important for SopA-SopB interactions.	[Hanai, Ryo] Rikkyo Univ, Dept Life Sci, Coll Sci, Toshima Ku, Tokyo 1718501, Japan; Rikkyo Univ, Res Ctr Life Sci, Coll Sci, Toshima Ku, Tokyo 1718501, Japan	Hanai, R (reprint author), Rikkyo Univ, Dept Life Sci, Coll Sci, Toshima Ku, 3-34-1 Nishi Ikebukuro, Tokyo 1718501, Japan.	hanai@rikkyo.ac.jp			Rikkyo University; Strategic Research Foundation Grant for Private Universities from Ministry of Education, Culture, Sports, Science and Technology, Japan [S1201003]	This work was supported by basal research funding from Rikkyo University and by a Strategic Research Foundation Grant for Private Universities (S1201003) from Ministry of Education, Culture, Sports, Science and Technology, Japan.	Ah-Seng Y, 2009, J BIOL CHEM, V284, P30067, DOI 10.1074/jbc.M109.044800; LYNCH AS, 1995, P NATL ACAD SCI USA, V92, P1896, DOI 10.1073/pnas.92.6.1896; PACE CN, 1995, PROTEIN SCI, V4, P2411; Hatano T, 2007, MOL MICROBIOL, V64, P1198, DOI 10.1111/j.1365-2958.2007.05728.x; Ravin NV, 2003, J MOL BIOL, V329, P875, DOI 10.1016/S0022-2836(03)00525-4; Castaing JP, 2008, MOL MICROBIOL, V70, P1000, DOI 10.1111/j.1365-2958.2008.06465.x; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Bouet JY, 2007, MOL MICROBIOL, V63, P468, DOI 10.1111/j.1365-2958.2006.05537.x; Dunham T. D., 2009, EMBO J, V28, P792; Hanai R, 1996, J BIOL CHEM, V271, P17469; Hirano M, 1998, MOL GEN GENET, V257, P392; Komai M, 2011, J BIOCHEM, V149, P455, DOI 10.1093/jb/mvq151; Lim GE, 2005, P NATL ACAD SCI USA, V102, P17658, DOI 10.1073/pnas.0507222102; MORI H, 1989, J BIOL CHEM, V264, P15535; MORI H, 1986, J MOL BIOL, V192, P1, DOI 10.1016/0022-2836(86)90459-6; OGURA T, 1983, CELL, V32, P351, DOI 10.1016/0092-8674(83)90454-3; Schumacher MA, 2010, NUCLEIC ACIDS RES, V38, P4514, DOI 10.1093/nar/gkq161; WATANABE E, 1992, MOL GEN GENET, V234, P346, DOI 10.1007/BF00538693; WEBB MR, 1980, J BIOL CHEM, V255, P8629; Yamaichi Y, 2000, P NATL ACAD SCI USA, V97, P14656, DOI 10.1073/pnas.97.26.14656	20	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	JUN	2015	157	6					459	466		10.1093/jb/mvv003		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CK5BW	WOS:000356238100005		
J	Kawato, T; Mizohata, E; Shimizu, Y; Meshizuka, T; Yamamoto, T; Takasu, N; Matsuoka, M; Matsumura, H; Kodama, T; Kanai, M; Doi, H; Inoue, T; Sugiyama, A				Kawato, Tatsuya; Mizohata, Eiichi; Shimizu, Yohei; Meshizuka, Tomohiro; Yamamoto, Tomohiro; Takasu, Noriaki; Matsuoka, Masahiro; Matsumura, Hiroyoshi; Kodama, Tatsuhiko; Kanai, Motomu; Doi, Hirofumi; Inoue, Tsuyoshi; Sugiyama, Akira			Structure-based design of a streptavidin mutant specific for an artificial biotin analogue	JOURNAL OF BIOCHEMISTRY			English	Article						endogenous biotin; molecular design; pre-targeting; streptavidin; X-ray structural analysis	NON-HODGKIN-LYMPHOMA; B-CELL LYMPHOMAS; TAG II PEPTIDE; PRETARGETED RADIOIMMUNOTHERAPY; ESCHERICHIA-COLI; ANTIBODY-RESPONSE; FUSION PROTEIN; BINDING; AFFINITY; CANCER	For a multistep pre-targeting method using antibodies, a streptavidin mutant with low immunogenicity, termed low immunogenic streptavidin mutant No. 314 (LISA-314), was produced previously as a drug delivery tool. However, endogenous biotins (BTNs) with high affinity (K-d < 10(-10) M) for the binding pocket of LISA-314 prevents access of exogenous BTN-labelled anticancer drugs. In this study, we improve the binding pocket of LISA-314 to abolish its affinity for endogenous BTN species, therefore ensuring that the newly designed LISA-314 binds only artificial BTN analogue. The replacement of three amino acid residues was performed in two steps to develop a mutant termed V212, which selectively binds to 6-(5-((3aS,4S,6aR)-2-iminohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)hexanoic acid (iminobiotin long tail, IMNtail). Surface plasmon resonance results showed that V212 has a K-d value of 5.9 x 10(-7) M towards IMNtail, but no binding affinity for endogenous BTN species. This V212/IMNtail system will be useful as a novel delivery tool for anticancer therapy.	[Kawato, Tatsuya; Mizohata, Eiichi; Meshizuka, Tomohiro; Matsumura, Hiroyoshi; Inoue, Tsuyoshi] Osaka Univ, Grad Sch Engn, Div Appl Chem, Suita, Osaka 5650871, Japan; [Shimizu, Yohei; Yamamoto, Tomohiro; Takasu, Noriaki; Kanai, Motomu] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Matsuoka, Masahiro; Kodama, Tatsuhiko; Doi, Hirofumi] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo 1538904, Japan; [Sugiyama, Akira] Univ Tokyo, Radioisotope Ctr, Bunkyo Ku, Tokyo 1130032, Japan	Kawato, T (reprint author), Osaka Univ, Grad Sch Engn, Div Appl Chem, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	doi-h@lsbm.org; inouet@chem.eng.osaka-u.ac.jp; sugiyama@lsbm.org			Cabinet Office, Government of Japan; Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy (CSTP); JST-ERATO, Lipid Active Structure Project; MEXT; JSPS KAKENHI [25282230, 24770096, 22550152]	This work was carried out under the Japanese research project Molecular Dynamics for Antibody Drug Development (MDADD), which is supported by the Cabinet Office, Government of Japan and the Japan Society for the Promotion of Science (JSPS) through the Funding Programme for World-Leading Innovative R&D on Science and Technology (FIRST Programme) initiated by the Council for Science and Technology Policy (CSTP). This work was partly supported by the JST-ERATO, Lipid Active Structure Project, the Grant-in-Aid for Scientific Research on Innovative Areas, the X-ray Free-Electron Laser Priority Strategy Programme (MEXT) and the JSPS KAKENHI Grant Numbers 25282230, 24770096 and 22550152.	Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Knox SJ, 2000, CLIN CANCER RES, V6, P406; Palanca-Wessels MC, 2014, BLOOD, V123, P2293, DOI 10.1182/blood-2013-10-492223; WEBER PC, 1992, J AM CHEM SOC, V114, P3197, DOI 10.1021/ja00035a004; Yumura K, 2013, PROTEIN SCI, V22, P213, DOI 10.1002/pro.2203; CHAIET L, 1964, ARCH BIOCHEM BIOPHYS, V106, P1, DOI 10.1016/0003-9861(64)90150-X; [Anonymous], ACTA CRYSTALLOGR D, V50, P760; DIAMANDIS EP, 1991, CLIN CHEM, V37, P625; Chang CH, 2002, MOL CANCER THER, V1, P553; Goldenberg DM, 2006, J CLIN ONCOL, V24, P823, DOI 10.1200/JCO.2005.03.8471; Stayton PS, 1999, BIOMOL ENG, V16, P39, DOI 10.1016/S1050-3862(99)00042-X; Freitag S, 1997, PROTEIN SCI, V6, P1157; SANO T, 1995, P NATL ACAD SCI USA, V92, P3180, DOI 10.1073/pnas.92.8.3180; Zeglis BM, 2013, J NUCL MED, V54, P1389, DOI 10.2967/jnumed.112.115840; Orcutt KD, 2011, NUCL MED BIOL, V38, P223, DOI 10.1016/j.nucmedbio.2010.08.013; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Boerman OC, 2003, J NUCL MED, V44, P400; Voss S, 1997, PROTEIN ENG, V10, P975, DOI 10.1093/protein/10.8.975; Axworthy DB, 2000, P NATL ACAD SCI USA, V97, P1802, DOI 10.1073/pnas.97.4.1802; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Korndorfer IP, 2002, PROTEIN SCI, V11, P883, DOI 10.1110/ps.4150102; Athappilly FK, 1997, PROTEIN SCI, V6, P1338; BAKER H, 1985, ANN NY ACAD SCI, V447, P129, DOI 10.1111/j.1749-6632.1985.tb18432.x; Baugh L, 2012, BIOCHEMISTRY-US, V51, P597, DOI 10.1021/bi201221j; Forero A, 2004, BLOOD, V104, P227, DOI 10.1182/blood-2003-09-3284; Forster GJ, 2006, J NUCL MED, V47, P140; Gallizia A, 1998, PROTEIN EXPRES PURIF, V14, P192, DOI 10.1006/prep.1998.0930; Goldenberg DM, 2007, CANC THER, V2, P19, DOI DOI 10.1016/J.UCT.2007.04.003; GOODWIN D, 1984, EUR J NUCL MED, V9, P209, DOI 10.1007/BF00448541; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; Hamblett KJ, 2002, BIOCONJUGATE CHEM, V13, P588, DOI 10.1021/bc010087t; Hytonen VP, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-8; Kawato T, 2015, J BIOSCI BIOENG, V119, P642, DOI 10.1016/j.jbiosc.2014.10.025; Meyer DL, 2001, PROTEIN SCI, V10, P491, DOI 10.1110/ps.19901; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Paganelli G, 1997, EUR J NUCL MED, V24, P350, DOI 10.1007/BF01728778; Pagel JM, 2003, BLOOD, V101, P2340, DOI 10.1182/blood-2002-03-0874; Pantelias A, 2007, BLOOD, V109, P4980, DOI 10.1182/blood-2006-11-056895; Park SI, 2011, CLIN CANCER RES, V17, P7373, DOI 10.1158/1078-0432.CCR-11-1204; Press OW, 2001, BLOOD, V98, P2535, DOI 10.1182/blood.V98.8.2535; Reichert JM, 2007, NAT REV DRUG DISCOV, V6, P349, DOI 10.1038/nrd2241; Reznik GO, 1998, P NATL ACAD SCI USA, V95, P13525, DOI 10.1073/pnas.95.23.13525; SANO T, 1990, P NATL ACAD SCI USA, V87, P142, DOI 10.1073/pnas.87.1.142; Shi HB, 2009, CHEM COMMUN, P5030, DOI 10.1039/b910611a; THOMPSON LD, 1993, GENE, V136, P243, DOI 10.1016/0378-1119(93)90472-F; WEBER PC, 1989, SCIENCE, V243, P85, DOI 10.1126/science.2911722; Wilbur DS, 1997, BIOCONJUGATE CHEM, V8, P572, DOI 10.1021/bc9700852; Zhang ML, 2003, P NATL ACAD SCI USA, V100, P1891, DOI 10.1073/pnas.0437788100	48	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	JUN	2015	157	6					467	475		10.1093/jb/mvv004		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CK5BW	WOS:000356238100006		
J	Yoshida, R; Kawahara, M; Nagamune, T				Yoshida, Rie; Kawahara, Masahiro; Nagamune, Teruyuki			Domain structure of growth signalobodies critically affects the outcome of antibody library selection	JOURNAL OF BIOCHEMISTRY			English	Article						antibody selection; chimeric protein; cytokine receptor; growth signalobody; single-chain Fv	YEAST SURFACE DISPLAY; GENETICALLY-MODIFIED CELLS; ERYTHROPOIETIN RECEPTOR; ENGINEERING ANTIBODIES; TRANSMEMBRANE DOMAIN; SIGNAL-TRANSDUCTION; MAMMALIAN-CELLS; CHIMERA; PROTEINS; PLATFORM	Wide applications of antibodies have demanded rapid and easy methods for isolating high-affinity antibodies. We recently developed an antibody screening system in mammalian cells using a growth signalobody, which is a single-chain Fv (scFv) library/cytokine receptor chimera that can transduce a growth signal in response to a target oligomeric antigen. However, we have never investigated how the domain structure of signalobodies affects the outcome of library screening. In this study, we screened na < ve scFv library-inserted signalobodies having distinct extracellular and transmembrane (TM) domains. Although the previously constructed signalobody with the extracellular D1/D2 domains of erythropoietin receptor had recovered the clones with high affinity against a target antigen and with low background cell growth, its D1/D2-deficient variant which was tested in this study recovered the clones with low affinity against a target antigen and with considerable background cell growth. In addition, mutagenesis in the TM domain lowered the level of the background cell growth. These results suggest that the D1/D2 domains increase a threshold to activate signalobodies, thereby selecting clones with high affinity against a target antigen and that the TM domain could be engineered to minimize background growth signalling.	[Yoshida, Rie; Nagamune, Teruyuki] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Tokyo 1138656, Japan; [Kawahara, Masahiro; Nagamune, Teruyuki] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan	Kawahara, M (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	kawahara@bio.t.u-tokyo.ac.jp			JSPS, Japan [21686077, 23656516]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; Global COE Program for Chemistry Innovation	This work was supported by Grants-in-Aid for Young Scientists (A) 21686077 (M.K.) and for Challenging Exploratory Research 23656516 (M.K.) from the JSPS, Japan, by the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry (M.K.) and by the Global COE Program for Chemistry Innovation.	Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Forsyth CM, 2013, MABS-AUSTIN, V5, P523, DOI 10.4161/mabs.24979; Ho M, 2009, METHODS MOL BIOL, V562, P99, DOI 10.1007/978-1-60327-302-2_8; Tillotson BJ, 2013, METHODS, V60, P27, DOI 10.1016/j.ymeth.2012.03.010; Bowers PM, 2014, METHODS, V65, P44, DOI 10.1016/j.ymeth.2013.06.010; Lipovsek D, 2004, J IMMUNOL METHODS, V290, P51, DOI 10.1016/j.jim.2004.04.008; Zhou C, 2010, MABS-AUSTIN, V2, P508, DOI 10.4161/mabs.2.5.12970; Rothe A, 2006, FASEB J, V20, P1599, DOI 10.1096/fj.05-5650rev; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; de Wildt RMT, 2000, NAT BIOTECHNOL, V18, P989, DOI 10.1038/79494; Chen G, 2001, NAT BIOTECHNOL, V19, P537, DOI 10.1038/89281; Onishi M, 1996, EXP HEMATOL, V24, P324; Gai SA, 2007, CURR OPIN STRUC BIOL, V17, P467, DOI 10.1016/j.sbi.2007.08.012; Feldhaus MJ, 2004, J IMMUNOL METHODS, V290, P69, DOI 10.1016/j.jim.2004.04.009; Kaneko E, 2012, J BIOSCI BIOENG, V113, P641, DOI 10.1016/j.jbiosc.2011.12.005; Daugherty PS, 2007, CURR OPIN STRUC BIOL, V17, P474, DOI 10.1016/j.sbi.2007.07.004; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Daugherty PS, 1998, PROTEIN ENG, V11, P825, DOI 10.1093/protein/11.9.825; Boder ET, 2012, ARCH BIOCHEM BIOPHYS, V526, P99, DOI 10.1016/j.abb.2012.03.009; Geyer C Ronald, 2012, Methods Mol Biol, V901, P11, DOI 10.1007/978-1-61779-931-0_2; Kawahara M, 2004, BIOCHEM BIOPH RES CO, V315, P132, DOI 10.1016/j.bbrc.2004.01.030; Kawahara M, 2004, PROTEIN ENG DES SEL, V17, P715, DOI 10.1093/protein/gzh088; Kawahara M, 2011, CYTOKINE, V55, P402, DOI 10.1016/j.cyto.2011.05.024; Kubatzky KF, 2001, CURR BIOL, V11, P110, DOI 10.1016/S0960-9822(01)00018-5; Li F, 2012, APPL MICROBIOL BIOT, V96, P1233, DOI 10.1007/s00253-012-4243-5; Li F, 2012, MOL CELL BIOCHEM, V365, P77, DOI 10.1007/s11010-012-1245-7; Liu W, 2008, BIOTECHNOL BIOENG, V101, P975, DOI 10.1002/bit.21961; Liu WH, 2009, J BIOCHEM, V145, P575, DOI 10.1093/jb/mvp013; Nakabayashi H, 2013, CYTOTECHNOLOGY, V65, P945, DOI 10.1007/s10616-013-9571-5; Prudencio M, 2004, J MOL RECOGNIT, V17, P524, DOI 10.1002/jmr.686; Qin J, 2014, FEBS J, V281, P1948, DOI 10.1111/febs.12744; Sogo T, 2009, CYTOKINE, V46, P127, DOI 10.1016/j.cyto.2008.12.020; Tanaka K, 2009, BIOTECHNOL PROGR, V25, P1138, DOI 10.1002/btpr.185; Vaynberg J, 2005, MOL CELL, V17, P513, DOI 10.1016/j.molcel.2004.12.031; Venturi M, 2002, J MOL BIOL, V315, P1, DOI 10.1006/jmbi.2001.5221; Yoshida R, 2014, BIOTECHNOL BIOENG, V111, P1170, DOI 10.1002/bit.25173; Zhou Chen, 2012, Methods Mol Biol, V907, P293, DOI 10.1007/978-1-61779-974-7_17	38	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	JUN	2015	157	6					497	506		10.1093/jb/mvv008		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CK5BW	WOS:000356238100009		
J	Kong, QQ; Nakai, Y; Kuroda, N; Shiratsuchi, A; Nagaosa, K; Nakanishi, Y				Kong, Qingquan; Nakai, Yuji; Kuroda, Nanae; Shiratsuchi, Akiko; Nagaosa, Kaz; Nakanishi, Yoshinobu			Peptidoglycan recognition protein-triggered induction of Escherichia coli gene in Drosophila melanogaster	JOURNAL OF BIOCHEMISTRY			English	Article						bacteria; Drosophila; gene regulation; immunology cellular response; transcription regulation	STAPHYLOCOCCUS-AUREUS; IMMUNE-RESPONSE; PGRP-LC; BACTERIAL PATHOGENS; 2-COMPONENT SYSTEM; INNATE IMMUNITY; VIRULENCE; LIPOPROTEIN; ACTIVATION; EXPRESSION	Interaction between the host and pathogen determines the fate of both organisms during the infectious state. The host is equipped with a battery of immune reactions, while the pathogen displays a variety of mechanisms to compromise host immunity. Although bacteria alter their pattern of gene expression in host organisms, studies to elucidate the mechanism behind this are only in their infancy. We here examined the possibility that host immune proteins directly participate in the change of gene expression in bacteria. Escherichia coli was treated with a mixture of the extracellular region of peptidoglycan recognition protein (PGRP)-LC and the antimicrobial peptide attacin of Drosophila, and subjected to DNA microarray analysis for mRNA repertoire. We identified 133 annotated genes whose mRNA increased after the treatment, and at least four of them were induced in response to PGRP-LC. One such gene, lipoprotein-encoding nlpI, showed a transient increase of mRNA in adult flies depending on PGRP-LC but not PGRP-LE. NlpI-lacking E. coli had a lowered growth rate and/or viability in flies than the parental strain. These results suggest that a host immune receptor triggers a change of gene expression in bacteria simultaneously with their recognition and induction of immune responses.	[Kong, Qingquan; Shiratsuchi, Akiko; Nagaosa, Kaz; Nakanishi, Yoshinobu] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan; [Nakai, Yuji] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138675, Japan; [Kuroda, Nanae; Shiratsuchi, Akiko; Nagaosa, Kaz; Nakanishi, Yoshinobu] Kanazawa Univ, Sch Pharm, Kanazawa, Ishikawa 9201192, Japan	Nakai, Y (reprint author), Hirosaki Univ, Inst Food Sci, Aomori 0380012, Japan.	nakanaka@p.kanazawa-u.ac.jp	Nakanishi, Yoshinobu/D-4602-2014; NAKAI, Yuji/G-3433-2014; Shiratsuchi, Akiko/D-8391-2015	Nakanishi, Yoshinobu/0000-0002-8767-3587; Shiratsuchi, Akiko/0000-0002-7811-4409	Japan Society for the Promotion of Science [23570160, 26440049, 25291021]	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science [grant numbers 23570160 and 26440049 to A.S., and 25291021 to Y.N.].	Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Janeway CA, 2001, P NATL ACAD SCI USA, V98, P7461, DOI 10.1073/pnas.131202998; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Ephrussi B, 1936, AM NAT, V70, P218, DOI 10.1086/280658; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Kurokawa K, 2009, J BIOL CHEM, V284, P8406, DOI 10.1074/jbc.M809618200; Diacovich L, 2010, NAT REV MICROBIOL, V8, P117, DOI 10.1038/nrmicro2295; Louwen R, 2014, MICROBIOL MOL BIOL R, V78, P74, DOI 10.1128/MMBR.00039-13; Shiratsuchi A, 2012, J BIOL CHEM, V287, P21663, DOI 10.1074/jbc.M111.333807; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Hanada Y, 2011, J BIOL CHEM, V286, P39360, DOI 10.1074/jbc.M111.278416; Pukklay P, 2013, BIOCHEM BIOPH RES CO, V438, P306, DOI 10.1016/j.bbrc.2013.07.062; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; LaSarre B, 2013, MICROBIOL MOL BIOL R, V77, P73, DOI 10.1128/MMBR.00046-12; Malone AS, 2006, APPL ENVIRON MICROB, V72, P2661, DOI 10.1128/AEM.72.4.2661-2671.2006; Kurata S, 2014, DEV COMP IMMUNOL, V42, P36, DOI 10.1016/j.dci.2013.06.006; Choe KM, 2005, P NATL ACAD SCI USA, V102, P1122, DOI 10.1073/pnas.0404952102; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Chen ZX, 2007, BIOINFORMATICS, V23, P321, DOI 10.1093/bioinformatics/btl609; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Clarke MB, 2006, P NATL ACAD SCI USA, V103, P10420, DOI 10.1073/pnas.0604343103; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Takehana A, 2004, EMBO J, V23, P4690, DOI 10.1038/sj.emboj.7600466; Avet-Rochex A, 2005, CELL MICROBIOL, V7, P799, DOI 10.1111/j.1462-5822.2005.00512.x; Baba Tomoya, 2006, Mol Syst Biol, V2; Barnich N, 2004, INFECT IMMUN, V72, P2484, DOI 10.1128/IAI.72.5.2484-2493.2004; Brokx SJ, 2004, J BACTERIOL, V186, P3254, DOI 10.1128/JB.186.10.3254-3258.2004; Chang CI, 2005, P NATL ACAD SCI USA, V102, P10279, DOI 10.1073/pnas.0504547102; Coombes BK, 2004, CURR BIOL, V14, pR856, DOI 10.1016/j.cub.2004.09.043; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hashimoto Y, 2009, J IMMUNOL, V183, P7451, DOI 10.4049/jimmunol.0901032; Hughes DT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000553; Kashyap DR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004280; Nguyen Y., 2013, MICROBE, V8, P111; Ohara M, 1999, J BACTERIOL, V181, P4318; Omae Y, 2013, J BIOL CHEM, V288, P25542, DOI 10.1074/jbc.M113.495051; Pacheco AR, 2009, CURR OPIN MICROBIOL, V12, P192, DOI 10.1016/j.mib.2009.01.006; R Development Core Team R, 2006, R LANG ENV STAT COMP; Reading NC, 2009, P NATL ACAD SCI USA, V106, P5889, DOI 10.1073/pnas.0811409106; Shiratsuchi A, 2014, J IMMUNOL, V192, P666, DOI 10.4049/jimmunol.1300968; Tabuchi Y, 2010, J IMMUNOL, V185, P2424, DOI 10.4049/jimmunol.1000625	57	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	JUN	2015	157	6					507	517		10.1093/jb/mvv002		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CK5BW	WOS:000356238100010		
J	Yoshida, S; Takahashi, M; Ikeda, A; Fukuda, H; Kitazaki, C; Asayama, M				Yoshida, Satomi; Takahashi, Masatoshi; Ikeda, Ayae; Fukuda, Hirofumi; Kitazaki, Chifumi; Asayama, Munehiko			Overproduction and easy recovery of biofuels from engineered cyanobacteria, autolyzing multicellular cells	JOURNAL OF BIOCHEMISTRY			English	Article						Alkane; autolysis; biofuel; cyanobacteria; expression vector	SP STRAIN ABRG5-3; MICROCYSTIS; BACTERIA; ALKANES; GROWTH	The semi-filamentous multicellular cyanobacterium Limnothrix/Pseudanabaena sp. strain ABRG5-3 undergoes autolysis, which involves the accumulation of polyphosphate compounds and disintegration of thylakoid membranes in cells, as a unique feature that occurs due to growth conditions. In this study, the overexpression and easy recovery of alkane (a saturated hydrocarbon, C17H36) as a biofuel were examined in recombinants of the cyanobacteria ABRG5-3 and Synechocystis sp. strain PCC6803. The results obtained indicated that the accumulated mass of alkane accounted for similar to 50 or 60% of the dry weight of ABRG5-3 or PCC6803 recombinant cells, respectively. Furthermore, cultivating cells in liquid medium BG11 in which the nitrogen resource had been depleted promoted the production of alkane and cell lysis, resulting in the easy recovery of target products from the supernatant.	[Yoshida, Satomi; Takahashi, Masatoshi; Ikeda, Ayae; Fukuda, Hirofumi; Kitazaki, Chifumi; Asayama, Munehiko] Ibaraki Univ, Coll Agr, Ibaraki 3000393, Japan; [Kitazaki, Chifumi; Asayama, Munehiko] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Saitama 3320012, Japan	Asayama, M (reprint author), Ibaraki Univ, Coll Agr, 3-21-1 Ami, Ibaraki 3000393, Japan.	asam@mx.ibaraki.ac.jp			PRESTO (SAKIGAKE project) of the Japan Science and Technology Agency	This work was partially supported by PRESTO (SAKIGAKE project) of the Japan Science and Technology Agency (to M.A.).	Tan XM, 2011, METAB ENG, V13, P169, DOI 10.1016/j.ymben.2011.01.001; Hein S, 1998, ARCH MICROBIOL, V170, P162, DOI 10.1007/s002030050629; Hu P, 2013, APPL ENERG, V102, P850, DOI 10.1016/j.apenergy.2012.08.047; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Quintana N, 2011, APPL MICROBIOL BIOT, V91, P471, DOI 10.1007/s00253-011-3394-0; Parmar A, 2011, BIORESOURCE TECHNOL, V102, P10163, DOI 10.1016/j.biortech.2011.08.030; SHIRAI M, 1989, APPL ENVIRON MICROB, V55, P2569; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; MEYER RJ, 1980, J BACTERIOL, V143, P1362; Nishizawa T, 1999, J BIOCHEM-TOKYO, V126, P520; Kitazaki C, 2013, BIOSCI BIOTECH BIOCH, V77, P2339, DOI 10.1271/bbb.130409; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Nishizawa T, 2010, BIOSCI BIOTECH BIOCH, V74, P1827, DOI 10.1271/bbb.100216; Machado IMP, 2012, J BIOTECHNOL, V162, P50, DOI 10.1016/j.jbiotec.2012.03.005; Asayama M, 2012, APPL MICROBIOL BIOT, V95, P683, DOI 10.1007/s00253-012-3989-0; Asayama M, 2006, BIOSCI BIOTECH BIOCH, V70, P565, DOI 10.1271/bbb.70.565; Castenholz R. W., 2001, BERGEYS MANUAL SYSTE, P554; Ducat C. D., 2011, TRENDS BIOTECHNOL, V29, P95; Imamura S., 2009, GENE REGUL SYST BIO, V22, P65; Matsunaga T, 2009, BIOTECHNOL LETT, V31, P1367, DOI 10.1007/s10529-009-0029-y; Nguyen A. V., 2010, EUKARYOT CELL, V7, P1965; Rippka R., 1989, METHOD ENZYMOL, V167, P3; Tanoi T, 2011, J APPL PHYCOL, V23, P25, DOI 10.1007/s10811-010-9528-4; Xin Li, 2010, Bioresour Technol, V101, P5494, DOI 10.1016/j.biortech.2010.02.016	24	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	JUN	2015	157	6					519	527		10.1093/jb/mvv011		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CK5BW	WOS:000356238100011		
J	Aramaki, T; Abe, Y; Furutani, K; Katayama, T; Ueda, T				Aramaki, Takahiko; Abe, Yoshito; Furutani, Kaori; Katayama, Tsutomu; Ueda, Tadashi			Basic and aromatic residues in the C-terminal domain of PriC are involved in ssDNA and SSB binding	JOURNAL OF BIOCHEMISTRY			English	Article						PriC; primosome; protein-DNA interactions; replication restart; SSB	SINGLE-STRANDED-DNA; STALLED REPLICATION FORKS; RESTART PRIMOSOME FACTOR; ESCHERICHIA-COLI K-12; STRUCTURAL BASIS; PROTEIN; HELICASE; RECOGNITION; MUTATIONS; COMPLEXES	In bacterial organisms, the oriC-independent primosome plays an essential role in replication restart after dissociation of the replication DNA-protein complex following DNA damage. PriC is a key protein component in the oriC-independent replication restart primosome. Our previous study suggested that PriC was divided into an N-terminal domain and a C-terminal domain, with the latter domain being the major contributor to single-stranded DNA (ssDNA) binding capacity. In this study, we prepared several PriC mutants in which basic and aromatic amino acid residues were mutated to alanine. Five of these residues, Arg107, Lys111, Phe118, Arg121 and Lys165 in the C-terminal domain, were shown to be involved in ssDNA binding. Moreover, we evaluated the binding of the PriC mutants to the ssDNA-binding protein (SSB) complex. Five residues, Phe118, Arg121, Arg129, Tyr152 and Arg155 in the C-terminal domain of PriC, were shown to be involved in SSB binding in the presence of ssDNA. On the basis of these results, we propose a structural model of the C-terminal domain of PriC and discuss how the interactions of PriC with SSB and ssDNA may contribute to the regulation of PriC-dependent replication restart.	[Aramaki, Takahiko; Abe, Yoshito; Furutani, Kaori; Ueda, Tadashi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Prot Struct Funct & Design, Fukuoka 8128582, Japan; [Katayama, Tsutomu] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Fukuoka 8128582, Japan	Aramaki, T (reprint author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Prot Struct Funct & Design, Fukuoka 8128582, Japan.	ueda@phar.kyushu-u.ac.jp	Abe, Yoshito/D-8370-2012	Abe, Yoshito/0000-0002-0016-8490	JSPS KAKENHI [23570140, 26440031]; Japan Foundation for Applied Enzymology	This work was supported by JSPS KAKENHI (Grant Numbers 23570140 and 26440031) to Y.A. and T.K and a grant from the Japan Foundation for Applied Enzymology to Y.A.	Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Kozlov AG, 2010, BIOCHEMISTRY-US, V49, P3555, DOI 10.1021/bi100069s; Boivin S, 2013, PROTEIN EXPRES PURIF, V91, P192, DOI 10.1016/j.pep.2013.08.002; Zhou RB, 2011, CELL, V146, P222, DOI 10.1016/j.cell.2011.06.036; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI 10.1080/10409230802341296 ; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Sandler SJ, 2000, J BACTERIOL, V182, P9; George NP, 2012, J BIOL CHEM, V287, P22123, DOI 10.1074/jbc.M112.367573; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; Cox MM, 2000, NATURE, V404, P37; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; LEE EH, 1991, P NATL ACAD SCI USA, V88, P3029, DOI 10.1073/pnas.88.8.3029; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Aramaki T, 2013, PROTEIN SCI, V22, P1279, DOI 10.1002/pro.2314; Aramaki T, 2013, GENES CELLS, V18, P723, DOI 10.1111/gtc.12069; Cadman CJ, 2005, J BIOL CHEM, V280, P39693, DOI 10.1074/jbc.M508521200; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; Chen HW, 2004, J BIOL CHEM, V279, P38503, DOI 10.1074/jbc.M404769200; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; Inoue J, 2011, J BIOL CHEM, V286, P6720, DOI 10.1074/jbc.M110.164210; Kozlov AG, 2010, J BIOL CHEM, V285, P17246, DOI 10.1074/jbc.M110.118273; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; Lecointe F, 2007, EMBO J, V26, P4239, DOI 10.1038/sj.emboj.7601848; Lopper M, 2007, MOL CELL, V26, P781, DOI 10.1016/j.molcel.2007.05.012; Lovett ST, 2005, MOL CELL, V17, P751, DOI 10.1016/j.molcel.2005.03.002; Lu D, 2008, P NATL ACAD SCI USA, V105, P9169, DOI 10.1073/pnas.0800741105; Marceau AH, 2011, EMBO J, V30, P4236, DOI 10.1038/emboj.2011.305; MEYER RR, 1979, P NATL ACAD SCI USA, V76, P1702, DOI 10.1073/pnas.76.4.1702; Ryzhikov M, 2011, NUCLEIC ACIDS RES, V39, P6305, DOI 10.1093/nar/gkr199; Sandler SJ, 2000, GENETICS, V155, P487; Sandler SJ, 1999, MOL MICROBIOL, V34, P91, DOI 10.1046/j.1365-2958.1999.01576.x; Sandler SJ, 2001, MOL MICROBIOL, V41, P697, DOI 10.1046/j.1365-2958.2001.02547.x; Sasaki K, 2007, EMBO J, V26, P2584, DOI 10.1038/sj.emboj.7601697; Tanaka T, 2007, J BIOL CHEM, V282, P19917, DOI 10.1074/jbc.M701848200; Wessel SR, 2013, J BIOL CHEM, V288, P17569, DOI 10.1074/jbc.M113.478156	37	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	JUN	2015	157	6					529	537		10.1093/jb/mvv014		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CK5BW	WOS:000356238100012		
J	Wu, CC; Chen, W; Chen, J; Han, B; Peng, Z; Ge, F; Wei, B; Liu, MX; Zhang, MY; Qian, CW; Hou, ZB; Liu, G; Guo, CW; Wang, YF; Kitazato, K; Yu, GY; Zou, CB; Xiong, S				Wu, Chongchao; Chen, Wei; Chen, Jia; Han, Bo; Peng, Zhou; Ge, Feng; Wei, Bo; Liu, Mingxian; Zhang, Meiying; Qian, Chuiwen; Hou, Zhibo; Liu, Ge; Guo, Chaowan; Wang, Yifei; Kitazato, Kaio; Yu, Guoying; Zou, Chunbin; Xiong, Sheng			Preparation of monoPEGylated Cyanovirin-N's derivative and its anti-influenza A virus bioactivity in vitro and in vivo	JOURNAL OF BIOCHEMISTRY			English	Article						Cyanovirin-N; influenza A virus; mice; PEGylation; polypeptide linker	TRANSFERRIN FUSION PROTEIN; COLONY-STIMULATING FACTOR; MICROBICIDE DEVELOPMENT; INACTIVATING PROTEIN; INFLUENZA VACCINES; PEGYLATION; EXPRESSION; EFFICACY; HIV	Influenza A virus (IAV) has been raising public health and safety concerns worldwide. Cyanovirin-N (CVN) is a prominent anti-IAV candidate, but both cytotoxicity and immunogenicity have hindered the development of this protein as a viable therapy. In this article, linker-CVN (LCVN) with a flexible and hydrophilic polypeptide at the N-terminus was efficiently produced from the cytoplasm of Escherichia coli at a > 15-l scale. PEGylation at the N-terminal alpha-amine of LCVN was also reformed as 20 kDa PEGylated linkered Cyanovirin-N (PEG(20k)-LCVN). The 50% effective concentrations of PEG(20k)-LCVN were 0.43 +/- 0.11 A mu M for influenza A/HK/8/68 (H3N2) and 0.04 +/- 0.02 A mu M for A/Swan/Hokkaido/51/96 (H5N3), dramatically lower than that of the positive control, Ribavirin (2.88 +/- 0.66 x 10(3) A mu M and 1.79 +/- 0.62 x 10(3) A mu M, respectively). A total of 12.5 A mu M PEG(20k)-LCVN effectively inactivate the propagation of H3N2 in chicken embryos. About 2.0 mg/kg/day PEG(20k)-LCVN increased double the survival rate (66.67%, P = 0.0378) of H3N2 infected mice, prolonged the median survival period, downregulated the mRNA level of viral nuclear protein and decreased (attenuated) the pathology lesion in mice lung. A novel PEGylated CVN derivative, PEG(20k)-LCVN, exhibited potent and strain-dependent anti-IAV activity in nanomolar concentrations in vitro, as well as in micromolar concentration in vivo.	[Wu, Chongchao; Chen, Wei; Chen, Jia; Han, Bo; Ge, Feng; Wei, Bo; Liu, Mingxian; Zhang, Meiying; Qian, Chuiwen; Hou, Zhibo; Wang, Yifei; Xiong, Sheng] Jinan Univ, Inst Biomedicine Natl Engn Res Ctr Genet Med, Dept Cellular Biol, Guangzhou 510632, Guangdong, Peoples R China; [Wu, Chongchao; Han, Bo] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Minist Educ, Key Lab Syst Biomed, Shanghai 200240, Peoples R China; [Peng, Zhou] Zhejiang Ocean Univ, Dept Pharm, Coll Food & Pharm Med, Zhoushan 316002, Peoples R China; [Ge, Feng] Chinese Acad Sci, Inst Hydrobiol, Wuhan 430072, Peoples R China; [Liu, Ge; Guo, Chaowan; Kitazato, Kaio; Yu, Guoying] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Div Mol Pharmacol Infect Agents, Nagasaki, Nagasaki Prefec 8528521, Japan; [Zou, Chunbin] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15213 USA	Xiong, S (reprint author), Jinan Univ, Biomed R&D Ctr, 5-F,Bldg Biol, Guangzhou 510632, Guangdong, Peoples R China.	xiongsheng@jnu.edu.cn			Ministry of Science and Technology of China [2012ZX09103-301-033, 2012ZX09202301-001]; Central University Scientific Research Funding of Jinan University [11611206]; National Natural Science Foundation of China [30873082]	This work was supported by grants from the 'National Project for Significant New Drugs Development' of the Ministry of Science and Technology of China (2012ZX09103-301-033, 2012ZX09202301-001), the Central University Scientific Research Funding of Jinan University (11611206) and the National Natural Science Foundation of China (30873082) to X.S.	Fiore Anthony E., 2010, Morbidity and Mortality Weekly Report, V59, P1; Cheng HY, 2002, ANTIVIR RES, V55, P447, DOI 10.1016/S0166-3542(02)00077-3; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; Zhao HL, 2008, PROTEIN EXPRES PURIF, V61, P73, DOI 10.1016/j.pep.2008.04.013; Bai Y, 2005, P NATL ACAD SCI USA, V102, P7292, DOI 10.1073/pnas.0500062102; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Monto AS, 2009, NEW ENGL J MED, V361, P1260, DOI 10.1056/NEJMoa0808652; Shaw A, 2012, VACCINE, V30, P4927, DOI 10.1016/j.vaccine.2012.04.095; Amet N, 2009, PHARM RES-DORD, V26, P523, DOI 10.1007/s11095-008-9767-0; Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4; Pasut G, 2012, J CONTROL RELEASE, V161, P461, DOI 10.1016/j.jconrel.2011.10.037; O'Keefe BR, 2003, ANTIMICROB AGENTS CH, V47, P2518, DOI 10.1128/AAC.47.8.2518-2525.2003; Smee DF, 2008, ANTIVIR RES, V80, P266, DOI 10.1016/j.antiviral.2008.06.003; Uyeki TM, 2009, CLIN INFECT DIS, V49, P279, DOI 10.1086/600035; Bai Y, 2006, PHARM RES, V23, P2116, DOI 10.1007/s11095-006-9059-5; Zappe H, 2008, ADV DRUG DELIVER REV, V60, P79, DOI 10.1016/j.addr.2007.05.016; Chen J., 2014, INT J ANTENN PROPAG, V2014, P1; Colleluori DM, 2005, PROTEIN EXPRES PURIF, V39, P229, DOI 10.1016/j.pep.2004.10.009; Gao XL, 2010, APPL MICROBIOL BIOT, V85, P1051, DOI 10.1007/s00253-009-2078-5; Li M, 2011, JAIDS-J ACQ IMM DEF, V58, P379, DOI 10.1097/QAI.0b013e31823643fe; Mori T, 2002, PROTEIN EXPRES PURIF, V26, P42, DOI 10.1016/S1046-5928(02)00513-2; Mori T, 1998, PROTEIN EXPRES PURIF, V12, P151, DOI 10.1006/prep.1997.0838; Reid AH, 2001, MICROBES INFECT, V3, P81, DOI 10.1016/S1286-4579(00)01351-4	24	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	JUN	2015	157	6					539	548		10.1093/jb/mvv013		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CK5BW	WOS:000356238100013		
J	Amano, M; Mizuguchi, H; Sano, T; Kondo, H; Shinyashiki, K; Inagaki, J; Tamura, T; Kawaguchi, T; Kusakabe, H; Imada, K; Inagaki, K				Amano, Marie; Mizuguchi, Haruka; Sano, Tadahisa; Kondo, Hiroki; Shinyashiki, Kengo; Inagaki, Junko; Tamura, Takashi; Kawaguchi, Tatsuya; Kusakabe, Hitoshi; Imada, Katsumi; Inagaki, Kenji			Recombinant expression, molecular characterization and crystal structure of antitumor enzyme, l-lysine alpha-oxidase from Trichoderma viride*	JOURNAL OF BIOCHEMISTRY			English	Article						antitumor enzyme; cDNA cloning; crystal structure; L-lysine alpha-oxidase; recombinant expression	AMINO-ACID OXIDASE; ROCKFISH SEBASTES-SCHLEGELI; CALLOSELASMA-RHODOSTOMA; PURIFICATION; SUBSTRATE; INSIGHTS; PROTEIN; SIMPLEX; CLONING; VENOM	L-Lysine alpha-oxidase (LysOX) from Trichoderma viride is a homodimeric 112 kDa flavoenzyme that catalyzes the oxidative deamination of L-lysine to form alpha-keto-epsilon-aminocaproate. LysOX severely inhibited growth of cancer cells but showed relatively low cytotoxicity for normal cells. We have determined the cDNA nucleotide sequence encoding LysOX from T. viride. The full-length cDNA consists of 2,119 bp and encodes a possible signal peptide (Met1-Arg77) and the mature protein (Ala78-Ile617). The LysOX gene have been cloned and heterologously expressed in Streptomyces lividans TK24 with the enzyme activity up to 9.8 U/ml. The enzymatic properties of the purified recombinant LysOX, such as substrate specificity and thermal stability, are same as those of native LysOX. The crystal structure of LysOX at 1.9 <remove> resolution revealed that the overall structure is similar to that of snake venom L-amino acid oxidase (LAAO), and the residues involved in the interaction with the amino or carboxy group of the substrate are structurally conserved. However, the entrance and the inner surface structures of the funnel to the active site, as well as the residues involved in the substrate side-chain recognition, are distinct from LAAOs. These structural differences well explain the unique substrate specificity of LysOX.	[Amano, Marie; Mizuguchi, Haruka; Shinyashiki, Kengo; Tamura, Takashi; Inagaki, Kenji] Okayama Univ, Grad Sch Environm & Life Sci, Dept Biofunct Chem, Okayama 7008530, Japan; [Sano, Tadahisa; Kondo, Hiroki; Kawaguchi, Tatsuya; Imada, Katsumi] Osaka Univ, Grad Sch Sci, Dept Macromol Sci, Toyonaka, Osaka 5600043, Japan; [Inagaki, Junko] Okayama Univ, Grad Sch Med, Dent & Pharmaceut Sci, Okayama 7008558, Japan; [Kusakabe, Hitoshi] Enzyme Sensor Co Ltd, Tsukuba, Ibaraki 3050047, Japan	Amano, M (reprint author), Okayama Univ, Grad Sch Environm & Life Sci, Dept Biofunct Chem, Okayama 7008530, Japan.	kimada@chem.sci.osaka-u.ac.jp; kinagaki@okayama-u.ac.jp			ministry of Education, Science and Culture of Japan [24560962]	This work is supported by Grants-in-Aid for scientific research from the ministry of Education, Science and Culture of Japan Grants 24560962 to K.I.	Arima J, 2009, FEBS J, V276, P4318, DOI 10.1111/j.1742-4658.2009.07103.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Nagashima Y, 2003, COMP BIOCHEM PHYS C, V136, P63, DOI 10.1016/S1532-0456(03)00174-1; Moustafa IM, 2006, J MOL BIOL, V364, P991, DOI 10.1016/j.jmb.2006.09.032; Zhang HM, 2004, ACTA CRYSTALLOGR D, V60, P974, DOI 10.1107/S0907444904000046; Yang HC, 2005, J EXP BIOL, V208, P3609, DOI 10.1242/jeb.01795; GRIFFITH RS, 1978, DERMATOLOGICA, V156, P257; POHLMANN A, 1990, ANAL CHIM ACTA, V235, P329, DOI 10.1016/S0003-2670(00)82091-7; KUSAKABE H, 1980, J BIOL CHEM, V255, P976; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Pollegioni L, 2013, APPL MICROBIOL BIOT, V97, P9323, DOI 10.1007/s00253-013-5230-1; Herai S, 2004, P NATL ACAD SCI USA, V101, P14031, DOI 10.1073/pnas.0406058101; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Fung J., 2009, ADV DRUG DELIV REV, V61, P290; Georgieva D, 2011, MOL BIOSYST, V7, P379, DOI 10.1039/c0mb00101e; Jung SK, 2000, J IMMUNOL, V165, P1491; Kitani Y, 2007, FISH SHELLFISH IMMUN, V23, P1178, DOI 10.1016/j.fsi.2007.04.005; KUSAKABE H, 1980, AGR BIOL CHEM TOKYO, V44, P387; Leslie A. G. W., 1992, NEWSL PROTEIN CRYSTA, V26, P27; Macheroux P, 2001, EUR J BIOCHEM, V268, P1679, DOI 10.1046/j.1432-1327.2001.02042.x; Pawelek PD, 2000, EMBO J, V19, P4204, DOI 10.1093/emboj/19.16.4204; Ullah A, 2012, BIOCHEM BIOPH RES CO, V421, P124, DOI 10.1016/j.bbrc.2012.03.129	22	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	JUN	2015	157	6					549	559		10.1093/jb/mvv012		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CK5BW	WOS:000356238100014		
J	Ishimi, Y; Irie, D				Ishimi, Yukio; Irie, Daiki			G364R mutation of MCM4 detected in human skin cancer cells affects DNA helicase activity of MCM4/6/7 complex	JOURNAL OF BIOCHEMISTRY			English	Article						cancer; DNA binding; DNA helicase; DNA replication; gene mutation	MINICHROMOSOME MAINTENANCE PROTEINS; REPLICATION FORKS; MAMMALIAN-CELLS; BINDING; INSTABILITY; SUBUNITS; MOUSE; CDC45	A number of gene mutations are detected in cells derived from human cancer tissues, but roles of these mutations in cancer cell development are largely unknown. We examined G364R mutation of MCM4 detected in human skin cancer cells. Formation of MCM4/6/7 complex is not affected by the mutation. Consistent with this notion, the binding to MCM6 is comparable between the mutant MCM4 and wild-type MCM4. Nuclear localization of this mutant MCM4 expressed in HeLa cells supports this conclusion. Purified MCM4/6/7 complex containing the G364R MCM4 exhibited similar levels of single-stranded DNA binding and ATPase activities to the complex containing wild-type MCM4. However, the mutant complex showed only 30-50% of DNA helicase activity of the wild-type complex. When G364R MCM4 was expressed in HeLa cells, it was fractionated into nuclease-sensitive chromatin fraction, similar to wild-type MCM4. These results suggest that this mutation does not affect assembly of MCM2-7 complex on replication origins but it interferes some step at function of MCM2-7 helicase. Thus, this mutation may contribute to cancer cell development by disturbing DNA replication.	[Ishimi, Yukio; Irie, Daiki] Ibaraki Univ, Coll Sci, Mito, Ibaraki 3518511, Japan	Ishimi, Y (reprint author), Ibaraki Univ, Coll Sci, 2-1-1 Bunkyo, Mito, Ibaraki 3518511, Japan.	ishimi@ibaraki.ac.jp			Ministry of Education, Science, Sports and Culture of Japan	This study was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports and Culture of Japan.	Abbas T, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012914; Brewster AS, 2008, P NATL ACAD SCI USA, V105, P20191, DOI 10.1073/pnas.0808037105; Sakakibara N, 2008, NUCLEIC ACIDS RES, V36, P1309, DOI 10.1093/nar/gkm1160; Yu ZL, 2004, J MOL BIOL, V340, P1197, DOI 10.1016/jmb.2004.05.024; Shima N, 2007, NAT GENET, V39, P93, DOI 10.1038/ng1936; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Kawabata T, 2011, MOL CELL, V41, P543, DOI 10.1016/j.molcel.2011.02.006; Labib K, 2007, TRENDS CELL BIOL, V17, P271, DOI 10.1016/j.tcb.2007.04.002; Aguilera A, 2013, ANNU REV GENET, V47, P1, DOI 10.1146/annurev-genet-111212-133232; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Chuang CH, 2012, NUCLEIC ACIDS RES, V40, P4914, DOI 10.1093/nar/gks176; Bochman M., 2007, J BIOL CHEM, V282, P33759; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Ishimi Y, 1996, J BIOL CHEM, V271, P24115; Kusunoki S, 2014, FEBS J, V281, P1057, DOI 10.1111/febs.12668; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Takaya J, 2013, J BIOCHEM, V153, P381, DOI 10.1093/jb/mvt004; Uno S, 2011, GENES CELLS, V16, P842, DOI 10.1111/j.1365-2443.2011.01535.x; Watanabe E, 2012, J BIOCHEM, V152, P191, DOI 10.1093/jb/mvs060; You ZY, 2002, J BIOL CHEM, V277, P42471, DOI 10.1074/jbc.M205769200	26	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	JUN	2015	157	6					561	569		10.1093/jb/mvv015		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CK5BW	WOS:000356238100015		
J	Imamura, T; Kinugawa, K; Nitta, D; Hatano, M; Komuro, I				Imamura, Teruhiko; Kinugawa, Koichiro; Nitta, Daisuke; Hatano, Masaru; Komuro, Issei			Should Cardiac Resynchronization Therapy Be a Rescue Therapy for Inotrope-Dependent Patients With Advanced Heart Failure?	JOURNAL OF CARDIAC FAILURE			English	Article						INTERMACS; ventricular assist device; catecholamine; reverse remodeling	QRS COMPLEX	Background: Although the "off-label usage" of cardiac resynchronization therapy with defibrillator (CRT-D) has spread recently in advanced heart failure (HF) patients in the real-world practice, its clinical effect remained uncertain. Methods and Results: A total of 84 in-hospital <65-year old patients with advanced HF undergoing CRT-D were enrolled. Seventeen patients (20%) had been dependent on inotropes at the time of CRT-D implantation, and 17 suffered cardiac death within a year. Both inotrope dependence and elevated plasma levels of B-type natriuretic peptide (BNP) (>690 pg/mL) at the time of CRT-D implantation were independent predictors of cardiac death within a year by Cox regression analyses (P < 0.05 for both). These 2 parameters could significantly stratify 1-year ventricular assist device (VAD)-free survival: inotrope-free low (1) or high BNP (2), or inotrope-dependent low (3) or high BNP groups (4) (98, 77, 57, and 17%, respectively, P < 0.001). In contrast, there were no significant differences in actual 1-year survival among the four groups. Conclusion: Patients dependent on inotropes sometimes receive CRT-D therapy as the last treatment resort in clinical practice, but LVAD implantation should be considered instead of CRT-D in advanced HF patients because of their poor prognosis with CRT-D therapy.	[Imamura, Teruhiko; Kinugawa, Koichiro] Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Tokyo 1138655, Japan; [Nitta, Daisuke; Hatano, Masaru; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1138655, Japan	Kinugawa, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kinugawa-tky@umin.ac.jp					Imamura T, 2014, CIRC J, V78, P1396, DOI 10.1253/circj.CJ-14-0077; Kutyifa V, 2013, JACC-CARDIOVASC IMAG, V6, P432, DOI 10.1016/j.jcmg.2012.12.008; Kinugawa K, 2011, CIRC J, V75, P2038, DOI 10.1253/circj.CJ-11-0621; Epstein AE, 2013, CIRCULATION, V127, pE283, DOI 10.1161/CIR.0b013e318276ce9b; Kirklin JK, 2014, J HEART LUNG TRANSPL, V33, P555, DOI 10.1016/j.healun.2014.04.010; Ruschitzka F, 2013, NEW ENGL J MED, V369, P1395, DOI 10.1056/NEJMoa1306687; Khazanie P, 2014, CIRC-HEART FAIL, V7, P926, DOI 10.1161/CIRCHEARTFAILURE.113.000838; Russo Andrea M, 2013, J Am Coll Cardiol, V61, P1318, DOI 10.1016/j.jacc.2012.12.017; Thibault B, 2013, CIRCULATION, V127, P873, DOI 10.1161/CIRCULATIONAHA.112.001239	9	1	1	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	JUN	2015	21	6					535	538		10.1016/j.cardfail.2015.04.009		4	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CK3GP	WOS:000356104900012		
J	Ogi, M; Taguchi, B; Honda, M; Barber, DG; Rysgaard, S				Ogi, Masayo; Taguchi, Bunmei; Honda, Meiji; Barber, David G.; Rysgaard, Soren			Summer-to-Winter Sea-Ice Linkage between the Arctic Ocean and the Okhotsk Sea through Atmospheric Circulation	JOURNAL OF CLIMATE			English	Article							INTERANNUAL VARIABILITY; NORTHERN-HEMISPHERE; TEMPERATURE; OSCILLATION; AMPLIFICATION; ANOMALIES	Contemporary climate science seeks to understand the rate and magnitude of a warming global climate and how it impacts regional variability and teleconnections. One of the key drivers of regional climate is the observed reduction in end of summer sea-ice extent over the Arctic. Here the authors show that interannual variations between the September Arctic sea-ice concentration, especially in the East Siberian Sea, and the maximum Okhotsk sea-ice extent in the following winter are positively correlated, which is not explained by the recent warming trend only. An increase of sea ice both in the East Siberian Sea and the Okhotsk Sea and corresponding atmospheric patterns, showing a seesaw between positive anomalies of sea level pressures over the Arctic Ocean and negative anomalies over the midlatitudes, are related to cold anomalies over the high-latitude Eurasian continent. The patterns of atmospheric circulation and air temperatures are similar to those of the annually integrated Arctic Oscillation (AO). The negative annual AO forms colder anomalies in autumn sea surface temperatures both over the East Siberian Sea and the Okhotsk Sea, which causes heavy sea-ice conditions in both seas through season-to-season persistence.	[Ogi, Masayo; Barber, David G.; Rysgaard, Soren] Univ Manitoba, Ctr Earth Observat Sci, Winnipeg, MB R3T 2N2, Canada; [Taguchi, Bunmei] Japan Agcy Marine Earth Sci & Technol, Applicat Lab, Yokohama, Kanagawa, Japan; [Honda, Meiji] Niigata Univ, Fac Sci, Niigata 95021, Japan; [Rysgaard, Soren] Greenland Inst Nat Resources, Greenland Climate Res Ctr, Nuuk, Greenland; [Rysgaard, Soren] Aarhus Univ, Arctic Res Ctr, Aarhus, Denmark	Ogi, M (reprint author), Univ Manitoba, Ctr Earth Observat Sci, 530 Wallace Bldg,125 Dysart Rd, Winnipeg, MB R3T 2N2, Canada.	Masayo.Ogi@umanitoba.ca			Japan Society for Promotion for Science through KAKENHI [24540476]; Institute of Low Temperature Science, Hokkaido University; Canada Excellence Research Chairs (CERC) program; Canada Research Chairs (CRC) program; "Green Network of Excellence" Program (GRENE Program) Arctic Climate Change Research Project;  [22106010]	This study was in part supported by Grant-in-Aid for Scientific Research on Innovative Areas (22106010), the Japan Society for Promotion for Science through KAKENHI (24540476), and the Grant for Joint Research Program of the Institute of Low Temperature Science, Hokkaido University. This study is also supported by the Canada Excellence Research Chairs (CERC) program, the Canada Research Chairs (CRC) program, and the "Green Network of Excellence" Program (GRENE Program) Arctic Climate Change Research Project. We thank three reviewers for their sound criticisms and constructive suggestions. We are also grateful to Prof. John Walsh for his helpful comments as an editor.	Ukita J, 2007, TELLUS A, V59, P261, DOI 10.1111/j.1600-0870.2006.00223.x; Screen JA, 2010, NATURE, V464, P1334, DOI 10.1038/nature09051; Wu BY, 2006, J CLIMATE, V19, P210, DOI 10.1175/JCLI3619.1; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; FANG ZF, 1994, J CLIMATE, V7, P1897, DOI 10.1175/1520-0442(1994)007<1897:ASIVOA>2.0.CO;2; Kistler R, 2001, B AM METEOROL SOC, V82, P247, DOI 10.1175/1520-0477(2001)082<0247:TNNYRM>2.3.CO;2; Serreze MC, 2009, CRYOSPHERE, V3, P11; Thompson DWJ, 1998, GEOPHYS RES LETT, V25, P1297, DOI 10.1029/98GL00950; Alexander MA, 2004, J CLIMATE, V17, P890, DOI 10.1175/1520-0442(2004)017<0890:TARTRA>2.0.CO;2; Honda M, 1999, J CLIMATE, V12, P3347, DOI 10.1175/1520-0442(1999)012<3347:DATCOA>2.0.CO;2; Balmaseda MA, 2010, Q J ROY METEOR SOC, V136, P1655, DOI 10.1002/qj.661; Parkinson CL, 1999, J GEOPHYS RES-OCEANS, V104, P20837, DOI 10.1029/1999JC900082; Bhatt S. U., 2013, REMOTE SENS, V5, P4229, DOI [10.3390/rs5094229, DOI 10.3390/RS5094229]; Doblas-Reyes FJ, 2013, WIRES CLIM CHANGE, V4, P245, DOI 10.1002/wcc.217; Honda M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037079; L'Heureux ML, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035205; Ogi M, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004514; Ogi M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029897; Ogi M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025838; Ogi M, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042356; Ogi M, 2001, J METEOROL SOC JPN, V79, P123, DOI 10.2151/jmsj.79.123; Ohshima KI, 2006, J METEOROL SOC JPN, V84, P907, DOI 10.2151/jmsj.84.907; Orsolini YJ, 2012, CLIM DYNAM, V114, DOI [10.1007/s00382-011-1169-z, DOI 10.1007/S00382-011-1169-Z]; Rigor IG, 2002, J CLIMATE, V15, P2648, DOI 10.1175/1520-0442(2002)015<2648:ROSITT>2.0.CO;2; Sasaki YN, 2007, J OCEANOGR, V63, P255, DOI 10.1007/s10872-007-0026-5; Screen JA, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044015; Tachibana Y, 1996, J METEOROL SOC JPN, V74, P579; Tachibana Y, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009555	28	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	JUN	2015	28	12					4971	4979		10.1175/JCLI-D-14-00297.1		9	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CK5RR	WOS:000356283900021		
J	Imajo, Y; Komasawa, N; Minami, T				Imajo, Yukihiro; Komasawa, Nobuyasu; Minami, Toshiaki			Efficacy of bronchofiberscope double-lumen tracheal tube intubation combined with McGRATH MAC for difficult airway	JOURNAL OF CLINICAL ANESTHESIA			English	Letter									[Imajo, Yukihiro; Komasawa, Nobuyasu; Minami, Toshiaki] Osaka Med Coll, Dept Anesthesiol, Takatsuki, Osaka 5698686, Japan	Komasawa, N (reprint author), Osaka Med Coll, Dept Anesthesiol, Daigaku Machi 2-7, Takatsuki, Osaka 5698686, Japan.	ane078@poh.osaka-med.ac.jp					Campos JH, 2006, ANESTHESIOLOGY, V104, P261, DOI 10.1097/00000542-200602000-00010; Taylor AM, 2013, ANAESTHESIA, V68, P142, DOI 10.1111/anae.12075	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0952-8180	1873-4529		J CLIN ANESTH	J. Clin. Anesth.	JUN	2015	27	4					362	362		10.1016/j.jclinane.2015.03.012		1	Anesthesiology	Anesthesiology	CK0LJ	WOS:000355896400015		
J	Mizutani, K; Suwa, K; Tsuchiya, M				Mizutani, Koh; Suwa, Kunio; Tsuchiya, Masahiko			Illustration of O-2 and CO2 recirculation to interpret respiratory and circulatory physiology	JOURNAL OF CLINICAL ANESTHESIA			English	Letter									[Mizutani, Koh] Osaka Rosai Hosp, Operating Theater, Sakai, Osaka 5918025, Japan; [Suwa, Kunio] Teikyo Jr Coll, Fac Life Care, Dept Clin Engn, Tokyo 1510071, Japan; [Tsuchiya, Masahiko] Osaka City Univ, Sch Med, Dept Anesthesiol, Osaka 5458586, Japan	Mizutani, K (reprint author), Osaka Rosai Hosp, Operating Theater, Kita Ku, 1179-3 Nagasonecho, Sakai, Osaka 5918025, Japan.	youshookme40@yahoo.co.jp					FARHI LE, 1955, J APPL PHYSIOL, V7, P472; Farhi LE, 1964, HDB PHYSL RESPIRATIO, VI, P873	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0952-8180	1873-4529		J CLIN ANESTH	J. Clin. Anesth.	JUN	2015	27	4					363	365		10.1016/j.jclinane.2015.03.014		3	Anesthesiology	Anesthesiology	CK0LJ	WOS:000355896400017		
J	Ueshima, H; Kitamura, A				Ueshima, Hironobu; Kitamura, Akira			A needle with sand-blasted steel at the tip of the bevel is valid for ultrasound-guided deep nerve block	JOURNAL OF CLINICAL ANESTHESIA			English	Letter									[Ueshima, Hironobu; Kitamura, Akira] Saitama Med Univ, Int Med Ctr, Dept Anesthesiol, Saitama, Japan	Ueshima, H (reprint author), Saitama Med Univ, Int Med Ctr, Dept Anesthesiol, Yamane 1397-1, Saitama, Japan.	ueshimhi@yahoo.co.jp					MacLennan N, 2014, EUR J ANAESTH, V31, P244, DOI 10.1097/EJA.0000000000000021; Piccioni F, 2014, J CLIN ANESTH, V26, P271, DOI 10.1016/j.jclinane.2013.11.019; Uppal V, 2014, CAN J ANESTH, V61, P909, DOI 10.1007/s12630-014-0207-9	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0952-8180	1873-4529		J CLIN ANESTH	J. Clin. Anesth.	JUN	2015	27	4					363	363		10.1016/j.jclinane.2015.03.019		1	Anesthesiology	Anesthesiology	CK0LJ	WOS:000355896400016		
J	Ueshima, H; Kitamura, A				Ueshima, Hironobu; Kitamura, Akira			A patient-controlled analgesia device equipped with 2 flow controllers is effective for bilateral trunk nerve blocks	JOURNAL OF CLINICAL ANESTHESIA			English	Letter									[Ueshima, Hironobu; Kitamura, Akira] Saitama Med Univ, Int Med Ctr, Dept Anesthesiol, Saitama, Japan	Ueshima, H (reprint author), Saitama Med Univ, Int Med Ctr, Dept Anesthesiol, Yamane 1397-1, Saitama, Japan.	ueshimhi@yahoo.co.jp					Bhatia N, 2014, J CLIN ANESTH, V26, P294, DOI 10.1016/j.jclinane.2013.11.023; Maeda A, 2014, EUR J ANAESTH, V31, P1; Piccioni F, 2014, J CLIN ANESTH, V26, P271, DOI 10.1016/j.jclinane.2013.11.019	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0952-8180	1873-4529		J CLIN ANESTH	J. Clin. Anesth.	JUN	2015	27	4					365	366		10.1016/j.jclinane.2015.03.009		2	Anesthesiology	Anesthesiology	CK0LJ	WOS:000355896400018		
J	Kinoshita, H; Hatakeyama, N; Fujita, Y; Fujiwara, Y				Kinoshita, Hiroyuki; Hatakeyama, Noboru; Fujita, Yoshihito; Fujiwara, Yoshihiro			Leak in Perseus workstation after complete check sequences	JOURNAL OF CLINICAL ANESTHESIA			English	Letter									[Kinoshita, Hiroyuki; Hatakeyama, Noboru; Fujita, Yoshihito; Fujiwara, Yoshihiro] Aichi Med Univ, Sch Med, Dept Anesthesiol, Nagakute, Aichi 4801195, Japan	Kinoshita, H (reprint author), Aichi Med Univ, Sch Med, Dept Anesthesiol, 1-1 Yazako Karimata, Nagakute, Aichi 4801195, Japan.	hkinoshi@aichi-med-u.ac.jp					[Anonymous], 2013, INSTR US DRAG PERS A; Singh M, 2014, J CLIN ANESTH, V26, P245, DOI 10.1016/j.jclinane.2013.11.010	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0952-8180	1873-4529		J CLIN ANESTH	J. Clin. Anesth.	JUN	2015	27	4					367	368		10.1016/j.jclinane.2015.03.016		2	Anesthesiology	Anesthesiology	CK0LJ	WOS:000355896400020		
J	Gulshan, F; Okada, K				Gulshan, Fahmida; Okada, Kiyoshi			Preparation of alumina-iron oxide compounds by coprecipitation and gel evaporation methods and their characterization	JOURNAL OF ENGINEERING RESEARCH			English	Article						Coprecipitation; Fe2O3-Al2O3 compounds; gel evaporation; hematite; maghemite	SYSTEM	Fe2O3-Al2O3 compounds were synthesized by coprecipitation (CP) and gel evaporation (GE) method with different Fe/Al compositions and calcined at high temperatures (300 degrees C-1000 degrees C). The crystalline phases in the samples were determined by XRD, the lattice parameters of the resulting crystalline phases were calculated by a least-square method. The properties were also characterized by magnetization measurements. The formation of crystalline phases (e.g., maghemite, hematite), transformation temperature, magnetic properties of iron oxide were all affected by the component ratio and thermal treatment.	[Gulshan, Fahmida] Bangladesh Univ Engn & Technol, Mat & Met Engn Dept, Dhaka, Bangladesh; [Okada, Kiyoshi] Tokyo Inst Technol, AMDII Div, Mat & Struct Lab, Tokyo 152, Japan	Gulshan, F (reprint author), Bangladesh Univ Engn & Technol, Mat & Met Engn Dept, Dhaka, Bangladesh.	fahmidagulshan@mme.buet.ac.bd					Li FB, 2007, J HAZARD MATER, V149, P199, DOI 10.1016/j.jhazmat.2007.03.069; El-Sharkawy EA, 2000, MATER LETT, V42, P331, DOI 10.1016/S0167-577X(99)00209-8; Filho M.F.D.J., 1992, P 6 INT C FERR TOK, P126; Gulshan F., 2013, AM J MAT SCI ENG, V1, P6; Gulshan F, 2009, J HAZARD MATER, V169, P697, DOI 10.1016/j.jhazmat.2009.04.009; Gulshan F, 2010, WATER RES, V44, P2876, DOI 10.1016/j.watres.2010.01.040; MICHEL A, 1951, J PHYS-PARIS, V12, P189, DOI 10.1051/jphysrad:01951001203018900; Pownceby MI, 2003, J AM CERAM SOC, V86, P975; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; WOLSKA E, 1989, SOLID STATE IONICS, V32-3, P214, DOI 10.1016/0167-2738(89)90224-5	10	0	0	ACADEMIC PUBLICATION COUNCIL	KHALDIYA	PO BOX 17225, KHALDIYA 72453, KUWAIT	2307-1877	2307-1885		J ENG RES-KUWAIT	J. Eng. Res.	JUN	2015	3	2					1	8				8	Engineering, Multidisciplinary	Engineering	CK3HF	WOS:000356106500001		
J	Take, S; Mizuno, M; Ishiki, K; Hamada, F; Yoshida, T; Yokota, K; Okada, H; Yamamoto, K				Take, Susumu; Mizuno, Motowo; Ishiki, Kuniharu; Hamada, Fumihiro; Yoshida, Tomowo; Yokota, Kenji; Okada, Hiroyuki; Yamamoto, Kazuhide			Seventeen-year effects of eradicating Helicobacter pylori on the prevention of gastric cancer in patients with peptic ulcer; a prospective cohort study	JOURNAL OF GASTROENTEROLOGY			English	Article						Helicobacter pylori; Eradication therapy; Gastric cancer	REFLUX ESOPHAGITIS; MUCOSAL ATROPHY; INFECTION; THERAPY; JAPAN; CLASSIFICATION; METAANALYSIS; PREVALENCE; CARCINOMA; REDUCE	We previously reported that eradication of Helicobacter pylori in our cohort of patients with peptic ulcer disease reduced their risk of developing gastric cancer to approximately one-third after a mean follow-up period of 3.4 years (up to 8.6 years). We have now followed these patients for a longer period. A total of 1,222 consecutive patients with peptic ulcer diseases who completed more than 1-year follow-up after receiving H. pylori eradication therapy were followed with annual endoscopic surveillance for a mean of 9.9 years (as long as 17.4 years). H. pylori infection was judged cured in 1,030 patients (eradication-success group) but persisted in 192 (eradication-failure group) after initial eradication therapy. In the eradication-failure group, 114 patients received re-treatment at a mean of 4.4 years after the start of follow-up, and 105 of these were cured of infection. Gastric cancer developed in 21 of the 1,030 patients in the eradication-success group and in nine of the 192 in the failure group (p = 0.04). The risk of developing gastric cancer in the eradication-success group (0.21 %/year) was significantly lower than that in the failure group (0.45 %, p = 0.049). The longest interval between the initial H. pylori eradication and the occurrence of gastric cancer was 14.5 years in the eradication-success group and 13.7 years in the eradication-failure group. A prophylactic effect for gastric cancer persists for more than 10 years after H. pylori eradication therapy, but we should be aware that cancer can develop even after that interval.	[Take, Susumu] Fukuwatari Municipal Hosp, Dept Internal Med, Okayama, Japan; [Take, Susumu; Ishiki, Kuniharu; Yoshida, Tomowo] Nippon Kokan Fukuyama Hosp, Dept Internal Med, Fukuyama, Hiroshima, Japan; [Mizuno, Motowo] Hiroshima City Hosp, Dept Internal Med, Naka Ku, Hiroshima 7308518, Japan; [Hamada, Fumihiro] Nippon Kokan Fukuyama Hosp, Dept Surg, Fukuyama, Hiroshima, Japan; [Yokota, Kenji] Okayama Univ, Dept Bacteriol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Okada, Hiroyuki; Yamamoto, Kazuhide] Okayama Univ, Dept Med & Med Sci, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan	Mizuno, M (reprint author), Hiroshima City Hosp, Dept Internal Med, Naka Ku, 7-33 Motomachi, Hiroshima 7308518, Japan.	mmizuno@isis.ocn.ne.jp			Health Labour Sciences Research Grant, The Ministry of Health Labour and Welfare, Tokyo, Japan	S. Take and M. Mizuno contributed principally and equally to the study. The authors thank to Drs. Tsuyoshi Okamoto, Tomomi, Hakoda, Takayuki Imada, Masako Kataoka, Yoshimi Itoh and Hideaki Inoue (Nippon Kokan Fukuyama Hospital) for support of this work and Dr. William R. Brown (Denver, Colorado) for assistance in preparation of the manuscript. This work was supported in part by Health Labour Sciences Research Grant, The Ministry of Health Labour and Welfare, Tokyo, Japan.	Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Ma JL, 2012, J NATL CANCER I, V104, P488, DOI 10.1093/jnci/djs003; You WC, 2006, J NATL CANCER I, V98, P974, DOI 10.1093/jnci/djj264; Ito S, 1996, GUT, V39, P800, DOI 10.1136/gut.39.6.800; Konno M, 2008, PEDIATR INFECT DIS J, V27, P999, DOI 10.1097/INF.0b013e31817d756e; Take S, 2005, AM J GASTROENTEROL, V100, P1037, DOI 10.1111/j.1572-0241.2005.41384.x; [Anonymous], 2009, ANN INTERN MED, V151, P516; Take S, 2011, J GASTROENTEROL, V46, P318, DOI 10.1007/s00535-010-0347-9; Satoh K, 1996, AM J GASTROENTEROL, V91, P963; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Fuccio L, 2009, ANN INTERN MED, V151, P121; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31; Take S, 2007, J GASTROENTEROL, V42, P21, DOI 10.1007/s00535-006-1924-9; Graham DY, 2005, GUT, V54, P735, DOI 10.1136/gut.2004.056549; Asaka M, 2014, J GASTROENTEROL, V49, P1, DOI 10.1007/s00535-013-0897-8; Ford AC, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3174; Graham David Y., 2000, Journal of Gastroenterology, V35, P90; Ishiki K, 2004, CLIN GASTROENTEROL H, V2, P474, DOI 10.1053/S1542-3565(04)00165-X; Kimura K, 1969, ENDOSCOPY, V3, P87, DOI DOI 10.1055/S-0028-1098086; Nagahara Y, 2003, HEPATO-GASTROENTEROL, V50, P1700; Sakaki N, 1997, J GASTROENTEROL, V32, P19, DOI 10.1007/BF01213291; Take S, 2012, REINFECTION RATE HEL, V47, P641; Take S, 2003, AM J GASTROENTEROL, V98, P2403, DOI 10.1016/S0002-9270(03)00713-5; Take S, 2009, J GASTROEN HEPATOL, V24, P107, DOI 10.1111/j.1440-1746.2008.05606.x; Wu CY, 2009, GASTROENTEROLOGY, V137, pel	26	3	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	JUN	2015	50	6					638	644		10.1007/s00535-014-1004-5		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CK0YK	WOS:000355931500004		
J	Okita, K; Izumi, N; Ikeda, K; Osaki, Y; Numata, K; Ikeda, M; Kokudo, N; Imanaka, K; Nishiguchi, S; Kondo, S; Nishigaki, Y; Shiomi, S; Ueshima, K; Isoda, N; Karino, Y; Kudo, M; Tanaka, K; Kaneko, S; Moriwaki, H; Makuuchi, M; Okusaka, T; Hayashi, N; Ohashi, Y; Kumada, H				Okita, Kiwamu; Izumi, Namiki; Ikeda, Kenji; Osaki, Yukio; Numata, Kazushi; Ikeda, Masafumi; Kokudo, Norihiro; Imanaka, Kazuho; Nishiguchi, Shuhei; Kondo, Shunsuke; Nishigaki, Yoichi; Shiomi, Susumu; Ueshima, Kazuomi; Isoda, Norio; Karino, Yoshiyasu; Kudo, Masatoshi; Tanaka, Katsuaki; Kaneko, Shuichi; Moriwaki, Hisataka; Makuuchi, Masatoshi; Okusaka, Takuji; Hayashi, Norio; Ohashi, Yasuo; Kumada, Hiromitsu		Peretinoin Study Grp	Survey of survival among patients with hepatitis C virus-related hepatocellular carcinoma treated with peretinoin, an acyclic retinoid, after the completion of a randomized, placebo-controlled trial	JOURNAL OF GASTROENTEROLOGY			English	Article						Hepatocellular carcinoma; Hepatitis C virus; Multicentric carcinogenesis; Overall survival; Peretinoin	2ND PRIMARY TUMORS; UNITED-STATES; INTRAHEPATIC RECURRENCE; INTERFERON; PREVENTION; RESECTION; THERAPY; METAANALYSIS; ABLATION; CANCER	This study examined the effects of peretinoin, an acyclic retinoid, on the survival of patients with hepatitis C virus-related hepatocellular carcinoma (HCC) who had completed curative therapy and participated in a randomized, placebo-controlled trial. This study was an investigator-initiated retrospective cohort study. Subjects were all patients who were administered the investigational drug (peretinoin 600 mg/day, peretinoin 300 mg/day, or placebo) in the randomized trial. Survivals between the groups were compared using the log-rank test, and hazard ratios were estimated by Cox regression. Survey data were collected from all patients (n = 392) who participated in the randomized trial, all of whom were then divided into the peretinoin 600 mg/day (n = 132), peretinoin 300 mg/day (n = 131), and placebo (n = 129) groups. At the median follow-up of 4.9 years, 5-year cumulative survival rates for patients in the 600 mg/day, 300 mg/day, and placebo groups were 73.9, 56.8, and 64.3 %, respectively. Comparison of overall survival among patients classified as Child-Pugh A revealed that survival of the 600 mg/day group (n = 105) was significantly longer than that of the placebo group (n = 108) (hazard ratio 0.575, 95 % CI 0.341-0.967; P = 0.0347). Administration of 600 mg/day peretinoin to patients with hepatitis C virus-related HCC who have completed curative therapy may improve survival for those classified as Child-Pugh A, for whom liver function is relatively stable.	[Okita, Kiwamu] Shimonoseki Kohsei Hosp, Shimonoseki, Yamaguchi 7500061, Japan; [Izumi, Namiki] Musashino Red Cross Hosp, Musashino, Tokyo 1808610, Japan; [Ikeda, Kenji; Kumada, Hiromitsu] Toranomon Gen Hosp, Minato Ku, Tokyo 1058470, Japan; [Osaki, Yukio] Osaka Red Cross Hosp, Tennoji Ku, Osaka 5438555, Japan; [Numata, Kazushi; Tanaka, Katsuaki] Yokohama City Univ, Med Ctr, Minami Ku, Yokohama, Kanagawa 2320024, Japan; [Ikeda, Masafumi] Natl Canc Ctr Hosp East, Kashiwa, Chiba 2778577, Japan; [Kokudo, Norihiro] Tokyo Univ Hosp, Bunkyo Ku, Tokyo 1138655, Japan; [Imanaka, Kazuho] Osaka Med Ctr Canc & Cardiovasc Dis, Higashinari Ku, Osaka 5378511, Japan; [Nishiguchi, Shuhei] Hyogo Coll Med Hosp, Nishinomiya, Hyogo 6638501, Japan; [Kondo, Shunsuke; Okusaka, Takuji] Natl Canc Ctr, Chuo Ku, Tokyo 1040045, Japan; [Nishigaki, Yoichi] Gifu Municipal Hosp, Gifu 5008513, Japan; [Shiomi, Susumu] Osaka City Univ Hosp, Abeno Ku, Osaka 5458585, Japan; [Ueshima, Kazuomi; Kudo, Masatoshi] Kinki Univ, Sch Med, Osaka 5898511, Japan; [Isoda, Norio] Jichi Med Univ, Shimotsuke, Tochigi 3290498, Japan; [Karino, Yoshiyasu] Sapporo Kosei Gen Hosp, Chuo Ku, Sapporo, Hokkaido 0600033, Japan; [Kaneko, Shuichi] Kanazawa Univ Hosp, Kanazawa, Ishikawa 9208641, Japan; [Moriwaki, Hisataka] Gifu Univ Hosp, Gifu 5011194, Japan; [Makuuchi, Masatoshi] Japanese Red Cross Med Ctr, Shibuya Ku, Tokyo 1508935, Japan; [Hayashi, Norio] Kansai Rosai Hosp, Amagasaki, Hyogo 6608511, Japan; [Ohashi, Yasuo] Chuo Univ, Bunkyo Ku, Tokyo 1128551, Japan	Okita, K (reprint author), Shimonoseki Kohsei Hosp, Kamishinchi Machi 3-3-8, Shimonoseki, Yamaguchi 7500061, Japan.	icb68895@nifty.com			Comprehensive Support Project (CSP) of the Public Health Research Foundation	The authors would like to thank all patients and their families who participated in this study. We also thank all who were involved in the research and would like to acknowledge Non-Profit Organization Japan Clinical Research Support Unit for their assistance in data management and statistical analyses, and Statcom Co., Ltd. for their assistance in preparing and editing this manuscript. This study was presented in part at the seventh annual conference of the International Liver Cancer Association, Washington, D.C., September 13-15, 2013. This study was funded by the Comprehensive Support Project (CSP) of the Public Health Research Foundation. The corporate and individual sponsors of this study are listed on the CSPOR website (http://www.csp.or.jp/cspor/kyousan_e.html). The pharmaceutical manufacturer/distributor who provided financial contribution as a corporate sponsor took no part in this study other than providing information relevant to proper use of the study drug(s). The following institutions provided data: Ehime University Hospital, Fukuoka University Hospital, Gifu Municipal Hospital, Gifu University Hospital, Hiroshima Prefectural Hospital, Hiroshima University Hospital, Hokkaido University Hospital, Hyogo College of Medicine, Iwate Medical University Hospital, Jichi Medical University Hospital, Kagoshima University Medical And Dental Hospital, Kansai Medical University Takii Hospital, Kinki University Hospital, Kitano Hospital, Kitasato University East Hospital, Kokura Memorial Hospital, Kumamoto University Hospital, Musashino Red Cross Hospital, Nagasaki University Hospital, National Cancer Center Hospital, National Cancer Center Hospital East, National Hospital Organization Nagasaki Medical Center, Oita University Hospital, Osaka City General Hospital, Osaka City University Hospital, Osaka General Medical Center, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka Red Cross Hospital, Osaka Rosai Hospital, Saiseikai Fukuoka General Hospital, Sapporo Kosei General Hospital, Shimonoseki Kosei Hospital, Showa University Hospital, Teine-Keijinkai Hospital, The University of Tokyo Hospital, Tokyo Medical And Dental University Hospital Faculty of Medicine, Tokyo Medical University Hospital, Toranomon Hospital, Toyohashi Municipal Hospital, Yamaguchi University Hospital and Yokohama City University Medical Center.	Nakashima Y, 2003, HEPATOL RES, V26, P142, DOI 10.1016/S1386-6346(03)00007-X; Breitenstein S, 2009, BRIT J SURG, V96, P975, DOI 10.1002/bjs.6731; ARAKI H, 1995, BIOCHEM BIOPH RES CO, V209, P66, DOI 10.1006/bbrc.1995.1471; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Shiratori Y, 2003, ANN INTERN MED, V138, P299; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; Muto Y, 1999, NEW ENGL J MED, V340, P1046, DOI 10.1056/NEJM199904013401315; Ikeda K, 2000, HEPATOLOGY, V32, P228, DOI 10.1053/jhep.2000.9409; Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Kubo S, 2001, ANN INTERN MED, V134, P963; Okada H, 2012, CANCER RES, V72, P4459, DOI 10.1158/0008-5472.CAN-12-0028; El-Serag H, 2003, ANN INTERN MED, V139, P817; Llovet JM, 2008, J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Mathurin P, 2003, ALIMENT PHARM THERAP, V17, P1247, DOI 10.1046/j.0269-2813.2003.01580.x; Armstrong GL, 2006, ANN INTERN MED, V144, P705; Honda M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-191; Muto Y, 1996, NEW ENGL J MED, V334, P1561, DOI 10.1056/NEJM199606133342402; Okita K, 2015, J GASTROENTEROL, V50, P191, DOI 10.1007/s00535-014-0956-9; Okusaka T, 2011, HEPATOL RES, V41, P542, DOI 10.1111/j.1872-034X.2011.00800.x; Samuel M, 2009, COCHRANE DB SYST REV, V1; SPORN MB, 1979, FED PROC, V38, P2528; Suou T, 2001, HEPATOL RES, V20, P301, DOI 10.1016/S1386-6346(00)00148-0; Takai K, 2005, INTERVIROLOGY, V48, P39, DOI 10.1159/000082093	23	3	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	JUN	2015	50	6					667	674		10.1007/s00535-014-0996-1		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CK0YK	WOS:000355931500007		
J	Tanaka, A; Hirohara, J; Nakanuma, Y; Tsubouchi, H; Takikawa, H				Tanaka, Atsushi; Hirohara, Junko; Nakanuma, Yasuni; Tsubouchi, Hirohito; Takikawa, Hajime			Biochemical responses to bezafibrate improve long-term outcome in asymptomatic patients with primary biliary cirrhosis refractory to UDCA	JOURNAL OF GASTROENTEROLOGY			English	Article						Bezafibrate; Ursodeoxycholic acid; Outcome; Liver enzymes	URSODEOXYCHOLIC ACID; COMBINATION THERAPY; PROGNOSIS; PROGRESSION; JAPAN; PBC	Bezafibrate is reported to have biochemical efficacy for patients with primary biliary cirrhosis (PBC) refractory to ursodeoxycholic acid (UDCA), yet the long-term effect is still unknown. In Japan, nationwide surveys of PBC have been performed since 1980. In the current study, we retrospectively examined whether response to bezafibrate treatment is associated with the long-term outcomes using this large-scale database. Among 7,376 patients in the database, we enrolled patients who were treated with UDCA at 13-15 mg/kg per day and followed up for at least 2 years after diagnosis. Bezafibrate (400 mg/day) was administered in addition to UDCA when biochemical response to UDCA was not optimal. Response to bezafibrate treatment was determined by serum alanine transaminase (ALT) levels within 2-3 years or at the earliest point thereafter from the commencement of bezafibrate treatment. We enrolled 1,121 PBC patients, and the observational period was 6.1 +/- A 3.4 years. Among the PBC patients, 835 were asymptomatic, defined as no liver-related symptoms at the baseline. In asymptomatic PBC patients, multivariate analysis indicated that ALT response to bezafibrate treatment was significantly associated with the presence of liver-related symptoms at the end of observation [hazard ratio 1.46 (95 % confidence interval 1.01-2.13), P = 0.048]. The cumulative liver-related-symptoms-free rate of patients treated with bezafibrate and who had a normal ALT level was significantly higher than that of those treated with bezafibrate and who had an elevated ALT level (P < 0.001), and was comparable to that of those who received UDCA monotherapy. These results suggested that normalization of ALT levels with additional bezafibrate treatment significantly decreased the rate of occurrence of liver-related symptoms in asymptomatic PBC patients with suboptimal response to UDCA.	[Tanaka, Atsushi; Takikawa, Hajime] Teikyo Univ, Dept Med, Sch Med, Itabashi Ku, Tokyo 1738605, Japan; [Hirohara, Junko] Kansai Med Univ, Dept Internal Med 3, Osaka, Japan; [Nakanuma, Yasuni] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa, Japan; [Tsubouchi, Hirohito] Kagoshima City Hosp, Kagoshima, Japan	Tanaka, A (reprint author), Teikyo Univ, Dept Med, Sch Med, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	a-tanaka@med.teikyo-u.ac.jp			Health and Labor Sciences Research Grants from Research on Measures for Intractable Diseases, the Japanese Intractable Hepatobiliary Disease Study Group	This study was conducted and supported by Health and Labor Sciences Research Grants from Research on Measures for Intractable Diseases, the Japanese Intractable Hepatobiliary Disease Study Group.	Kumagi T, 2010, AM J GASTROENTEROL, V105, P2186, DOI 10.1038/ajg.2010.216; Azemoto N, 2009, J GASTROENTEROL, V44, P630, DOI 10.1007/s00535-009-0051-9; Kita R, 2006, J GASTROENTEROL, V41, P686, DOI 10.1007/s00535-006-1831-0; Kanda T, 2003, J GASTROENTEROL, V38, P573, DOI 10.1007/s00535-002-1102-7; Pares A, 2006, GASTROENTEROLOGY, V130, P715, DOI 10.1053/j.gastro.2005.12.029; Nakai S, 2000, AM J GASTROENTEROL, V95, P326; Corpechot C, 2011, J HEPATOL, V55, P1361, DOI 10.1016/j.jhep.2011.02.031; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Iwasaki S, 2008, HEPATOL RES, V38, P557, DOI 10.1111/j.1872-034X.2007.00305.x; Hazzan R, 2010, J CLIN GASTROENTEROL, V44, P371, DOI 10.1097/MCG.0b013e3181c115b3; Takeuchi Y, 2011, J GASTROEN HEPATOL, V26, P1395, DOI 10.1111/j.1440-1746.2011.06737.x; Iwasaki S, 1999, HEPATOL RES, V16, P12, DOI 10.1016/S1386-6346(99)00033-9; Kurihara T, 2000, AM J GASTROENTEROL, V95, P2990, DOI 10.1016/S0002-9270(00)02013-X; Ohmoto K, 2006, J GASTROENTEROL, V41, P502, DOI 10.1007/s00535-006-1778-1; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Yano K, 2002, AM J GASTROENTEROL, V97, P1075; Itakura J, 2004, HEPATOL RES, V29, P216, DOI 10.1016/j.hepres.2004.04.001; Lens S, 2014, LIVER INT, V34, P197, DOI 10.1111/liv.12290; Marschall HU, 2005, GASTROENTEROLOGY, V129, P476, DOI 10.1053/j.gastro.2005.05.009; Poupon R, 2010, J HEPATOL, V52, P745, DOI 10.1016/j.jhep.2009.11.027; Invernizzi P, 2014, LIVER INT, V34, P167, DOI 10.1111/liv.12354; Kuiper EMM, 2009, GASTROENTEROLOGY, V136, P1281, DOI 10.1053/j.gastro.2009.01.003; Corpechot C, 2008, HEPATOLOGY, V48, P871, DOI 10.1002/hep.22428; Honda A, 2013, HEPATOLOGY, V57, P1931, DOI 10.1002/hep.26018; Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology, 2014, HEPATOLOGY RES S1, V44, P1, DOI 10.1111/hepr.12269; Drafting Committee for Hepatitis Management Guidelines the Japan Society of Hepatology, 2014, HEPATOL RES SS1, V44, P59; European Association for the Study of the Liver, 2009, J HEPATOL, V51, P237, DOI DOI 10.1016/J.JHEP.2009.04.009; Harada K, 2013, HEPATOLOGY, V57, P1942, DOI 10.1002/hep.26176; Miyaguchi S, 2000, HEPATO-GASTROENTEROL, V47, P1518; Nakano T, 2002, HEPATOL RES, V22, P250, DOI 10.1016/S1386-6346(01)00148-6; Ohmoto K, 2001, LIVER, V21, P223, DOI 10.1034/j.1600-0676.2001.021003223.x; Tanaka Atsushi, 2013, Nihon Shokakibyo Gakkai Zasshi, V110, P16; Working Subgroup (English Version) for Clinical Practice Guidelines for Primary Biliary Cirrhosis, 2014, HEPATOL RES SS1, V44, P71	33	3	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	JUN	2015	50	6					675	682		10.1007/s00535-014-0998-z		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CK0YK	WOS:000355931500008		
J	Kuroda, T; Hirooka, M; Koizumi, M; Ochi, H; Hisano, Y; Bando, K; Matsuura, B; Kumagi, T; Hiasa, Y				Kuroda, Taira; Hirooka, Masashi; Koizumi, Mitsuhito; Ochi, Hironori; Hisano, Yoshiko; Bando, Kenji; Matsuura, Bunzo; Kumagi, Teru; Hiasa, Yoichi			Pancreatic congestion in liver cirrhosis correlates with impaired insulin secretion	JOURNAL OF GASTROENTEROLOGY			English	Article						Portal hypertension; Pancreas; Congestion; Liver cirrhosis; Contrast-enhanced ultrasound	RETROGRADE TRANSVENOUS OBLITERATION; SCANNING-ELECTRON-MICROSCOPY; PORTAL-HYPERTENSION; GLUCOSE-TOLERANCE; RESISTANCE; RATS; ULTRASONOGRAPHY; TRANSPLANTATION; METABOLISM; INFECTION	Although impaired glucose tolerance is common in cirrhosis, this condition's pathogenesis remains undefined. This study aimed to clarify pathogenesis related to the pancreas in cirrhotic patients, and to evaluate associations between insulin secretion and pancreatic congestion due to portal hypertension. Pancreatic perfusion parameters were analyzed by dynamic contrast-enhanced ultrasound (CE-US) in 41 patients (20 cirrhotic, 21 non-cirrhotic; age, 67.9 +/- A 13.3; female, 19), and prospectively compared to delta C-peptide immunoreactivity (Delta CPR). In a separate study, a retrospective chart review with human autopsy specimens was conducted, and vessels and islets of the pancreas were analyzed in 43 patients (20 cirrhotic, 23 controls; age, 71.5 +/- A 11.6; female, 15). In the CE-US study, the clinical characteristics indicative of portal hypertension (e.g., ascites and varices) had significantly higher incidences in the cirrhotic group than in the control group. Pancreatic drainage times were greater in the cirrhotic group (p < 0.0001), and had a significant negative correlation with Delta CPR (R = 0.42, p = 0.0069). In the histopathological study, the islets were enlarged in the cirrhotic group (p < 0.0001). However, the percentage of insulin-positive area per islet was decreased in the cirrhotic group (p < 0.0001), and had a significant negative correlation with the wall thickness of the pancreatic vein (R = 0.63, p < 0.0001). Pancreatic congestion was present in cirrhotic patients. Moreover, pancreatic congestion and insulin secretion were significantly correlated. This pathogenesis could be a key factor underlying the development of hepatogenous diabetes in cirrhotic patients.	[Kuroda, Taira; Hirooka, Masashi; Koizumi, Mitsuhito; Ochi, Hironori; Matsuura, Bunzo; Kumagi, Teru; Hiasa, Yoichi] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime 7910295, Japan; [Hisano, Yoshiko] Ehime Univ, Grad Sch Med, Dept Pathogen, Toon, Ehime 7910295, Japan; [Bando, Kenji] Saiseikai Imabari Hosp, Dept Diagnost Pathol, Imabari, Ehime, Japan	Hiasa, Y (reprint author), Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime 7910295, Japan.	hiasa@m.ehime-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology [JSPS KAKENHI 24590980, 23591014]; Japanese Ministry of Health, Labor and Welfare	This work was supported in part by a Grant-in-Aid for Scientific Research (JSPS KAKENHI 24590980, 23591014) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (to Y. Hiasa and T. Kumagi) and by a Grant-in-Aid for Scientific Research and Development from the Japanese Ministry of Health, Labor and Welfare (to Y. Hiasa). The authors are grateful to Mr. Kenji Tanimoto (Department of Gastroenterology and Hepatology, Ehime University Graduate School of Medicine) for his valuable technical assistance.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; D'Onofrio M, 2007, ABDOM IMAGING, V32, P171, DOI 10.1007/s00261-006-9010-6; Kersting S, 2009, GASTROENTEROLOGY, V137, P1903, DOI 10.1053/j.gastro.2009.08.049; Akahane T, 1997, AM J GASTROENTEROL, V92, P1026; Merli M, 1999, HEPATOLOGY, V30, P649, DOI 10.1002/hep.510300306; KRUSZYNSKA YT, 1993, DIABETOLOGIA, V36, P121, DOI 10.1007/BF00400692; IVERSEN J, 1984, GASTROENTEROLOGY, V87, P1138; Resch M, 2009, AM J PHYSIOL-GASTR L, V297, pG849, DOI 10.1152/ajpgi.00084.2009; Imai J, 2008, SCIENCE, V322, P1250, DOI 10.1126/science.1163971; Bellot P, 2013, LIVER INT, V33, P31, DOI 10.1111/liv.12021; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; GOMIS R, 1994, HEPATOLOGY, V19, P1257, DOI 10.1016/0270-9139(94)90875-3; Quigley EMM, 2010, INFECT DIS CLIN N AM, V24, P943, DOI 10.1016/j.idc.2010.07.007; PETRIDES AS, 1989, J HEPATOL, V8, P107, DOI 10.1016/0168-8278(89)90169-4; Hirota S, 1999, RADIOLOGY, V211, P349; CAVALLI G, 1984, PATHOL RES PRACT, V178, P590; Collins BS, 2010, DIGEST DIS SCI, V55, P124, DOI 10.1007/s10620-009-1026-7; Ishikawa T, 2013, J GASTROENT IN PRESS; Johnson-Neitman JL, 2012, AM J VET RES, V73, P385, DOI 10.2460/ajvr.73.3.385; Konrad T, 2000, DIGESTION, V62, P52, DOI 10.1159/000007778; Lamps LW, 1999, LIVER TRANSPLANT SUR, V5, P57, DOI 10.1002/lt.500050110; Li T, 2006, WORLD J GASTROENTERO, V12, P2737; Manenti A., 1993, Pathologica (Genoa), V85, P721; MURAKAMI T, 1992, ARCH HISTOL CYTOL, V55, P381, DOI 10.1679/aohc.55.381; Murakami T, 1997, MICROSC RES TECHNIQ, V37, P478, DOI 10.1002/(SICI)1097-0029(19970601)37:5/6<478::AID-JEMT10>3.0.CO;2-N; Narita R, 2004, J HEPATOL, V41, P132, DOI 10.1016/j.jhep.2004.03.020; Ouwehand A., 2002, European Journal of Nutrition, V41; PETRIDES AS, 1993, HEPATOLOGY, V18, P284, DOI 10.1016/0270-9139(93)90009-C; Rasband WS, 1997, IMAGEJ; RE G, 1986, Applied Pathology, V4, P98; Ripolles T, 2010, EUR RADIOL, V20, P2518, DOI 10.1007/s00330-010-1824-5; Sakata M, 2013, J GASTROENTEROL, V48, P277, DOI 10.1007/s00535-012-0633-9; Sherwin RS, 1978, GASTROENTEROLOGY, V74, P1244; Tanabe N, 2000, DIGEST DIS SCI, V45, P581, DOI 10.1023/A:1005461611262; TERAYAMA N, 1994, PATHOL INT, V44, P753; VonGlahn WC, 1925, AM J PATHOL, V1, P373; WU J, 1994, J HEPATOL, V21, P332, DOI 10.1016/S0168-8278(05)80310-1; Yang Z, 2002, CHINESE MED J-PEKING, V115, P559	38	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	JUN	2015	50	6					683	693		10.1007/s00535-014-1001-8		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CK0YK	WOS:000355931500009		
J	Sho, M; Murakami, Y; Motoi, F; Satoi, S; Matsumoto, I; Kawai, M; Honda, G; Uemura, K; Yanagimoto, H; Kurata, M; Fukumoto, T; Akahori, T; Kinoshita, S; Nagai, M; Nishiwada, S; Unno, M; Yamaue, H; Nakajima, Y				Sho, Masayuki; Murakami, Yoshiaki; Motoi, Fuyuhiko; Satoi, Sohei; Matsumoto, Ippei; Kawai, Manabu; Honda, Goro; Uemura, Kenichiro; Yanagimoto, Hiroaki; Kurata, Masanao; Fukumoto, Takumi; Akahori, Takahiro; Kinoshita, Shoichi; Nagai, Minako; Nishiwada, Satoshi; Unno, Michiaki; Yamaue, Hiroki; Nakajima, Yoshiyuki			Postoperative prognosis of pancreatic cancer with para-aortic lymph node metastasis: a multicenter study on 822 patients	JOURNAL OF GASTROENTEROLOGY			English	Article						Pancreatic cancer; Para-aortic lymph node metastasis; Postoperative prognosis	RANDOMIZED PHASE-III; GEMCITABINE PLUS S-1; LONG-TERM SURVIVAL; DUCTAL ADENOCARCINOMA; SURGICAL RESECTION; CARCINOMA; TRIAL; HEAD; PANCREATICODUODENECTOMY; CHEMOTHERAPY	The prognosis of pancreatic cancer patients with metastatic para-aortic lymph node (PALN) has been reported to be extremely poor. In general, PALN metastasis has been considered as a contraindication for pancreatic resection. The aim of this study was to reevaluate the postoperative prognostic value of PALN metastasis in pancreatic cancer and to determine the validity of pancreatic surgery. Retrospective multicenter analysis of 882 patients who have undergone curative-intent pancreatic resection with pathological evaluation of PALNs for pancreatic ductal adenocarcinoma between 2001 and 2012 was conducted. Clinicopathological data and outcomes were evaluated with univariate and multivariate analysis. In total, 102 (12.4 %) patients had positive metastasis in PALN. Patients with metastatic PALN had significantly poorer survival than those without (17 vs. 23 months; p < 0.001). Multivariable analysis of 822 patients identified adjuvant chemotherapy, primary tumor status, regional lymph node metastasis, portal vein invasion, pre- and post-operative serum CA19-9 levels, and tumor grade as independent prognostic factors. In contrast, PALN metastasis did not have a significant prognostic value. Furthermore, the multivariate prognostic analysis in patients with PALN metastasis revealed that adjuvant chemotherapy and the number of metastatic PALN were significantly associated with long-term survival. Lung metastasis as initial recurrence was observed more often in patients with PALN metastasis in comparison with those without. Some pancreatic cancer patients with metastatic PALN may survive for longer than expected after pancreatectomy. Adjuvant chemotherapy and the number of metastatic PALN were critical factors for long-term survival of those patients.	[Sho, Masayuki; Akahori, Takahiro; Kinoshita, Shoichi; Nagai, Minako; Nishiwada, Satoshi; Nakajima, Yoshiyuki] Nara Med Univ, Dept Surg, Kashihara, Nara 6348522, Japan; [Murakami, Yoshiaki; Uemura, Kenichiro] Hiroshima Univ, Dept Surg, Inst Biomed & Hlth Sci, Hiroshima, Japan; [Motoi, Fuyuhiko; Unno, Michiaki] Tohoku Univ, Dept Surg, Div Gastroenterol Surg, Sendai, Miyagi 980, Japan; [Satoi, Sohei; Yanagimoto, Hiroaki] Kansai Med Univ, Dept Surg, Osaka, Japan; [Matsumoto, Ippei; Fukumoto, Takumi] Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg, Kobe, Hyogo 657, Japan; [Kawai, Manabu; Yamaue, Hiroki] Wakayama Med Univ, Dept Surg 2, Wakayama, Japan; [Honda, Goro; Kurata, Masanao] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Surg, Tokyo, Japan	Sho, M (reprint author), Nara Med Univ, Dept Surg, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	m-sho@naramed-u.ac.jp	Unno, Michiaki/A-8633-2010	Unno, Michiaki/0000-0002-2145-6416			Ueno H, 2013, J CLIN ONCOL, V31, P1640, DOI 10.1200/JCO.2012.43.3680; Sakai M, 2005, SURGERY, V137, P606, DOI 10.1016/j.surg.2005.02.009; Imai H, 2010, INT J CLIN ONCOL, V15, P294, DOI 10.1007/s10147-010-0066-5; Bickenbach KA, 2012, ANN SURG ONCOL, V19, P1663, DOI 10.1245/s10434-011-2156-7; Schnelldorfer T, 2008, ANN SURG, V247, P456, DOI 10.1097/SLA.0b013e3181613142; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Ueno H, 2009, BRIT J CANCER, V101, P908, DOI 10.1038/sj.bjc.6605256; Hirono S, 2012, DIGEST SURG, V29, P132, DOI 10.1159/000337306; Ma JM, 2013, JNCI-J NATL CANCER I, V105, P1694, DOI 10.1093/jnci/djt292; Doi R, 2007, WORLD J SURG, V31, P147, DOI 10.1007/s00268-005-0730-5; Kanda M, 2011, PANCREAS, V40, P951, DOI 10.1097/MPA.0b013e3182148342; Schwarz L, 2014, BRIT J SURG, V101, P530, DOI 10.1002/bjs.9444; Shimada K, 2006, J AM COLL SURGEONS, V203, P345, DOI 10.1016/j.jamcollsurg.2006.05.289; Tamm EP, 2012, RADIOL CLIN N AM, V50, P407, DOI 10.1016/j.rcl.2012.03.008; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Sho M, 2011, J HEPATO-BIL-PAN SCI, V18, P235, DOI 10.1007/s00534-010-0336-7; Egawa S, 2012, PANCREAS, V41, P985, DOI 10.1097/MPA.0b013e318258055c; Murakami Y, 2010, WORLD J SURG, V34, P1900, DOI 10.1007/s00268-010-0577-2; Murakami Y, 2012, J SURG ONCOL, V106, P174, DOI 10.1002/jso.23068; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Yamada S, 2009, PANCREAS, V38, pE13, DOI 10.1097/MPA.0b013e3181889e2d; Konstantinidis IT, 2013, ANN SURG, V257, P731, DOI 10.1097/SLA.0b013e318263da2f; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Paulson AS, 2013, GASTROENTEROLOGY, V144, P1316, DOI 10.1053/j.gastro.2013.01.078; Aristu J, 2003, AM J CLIN ONCOL-CANC, V26, P30, DOI 10.1097/00000421-200302000-00007; Japan Pancreas Society, 2003, CLASS PANCR CARC; Masui T, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-195; Matsumoto I, 2013, CLIN GASTROENTEROL H, V11, P712, DOI 10.1016/j.cgh.2012.12.033; NAGAI H, 1986, ANN SURG, V204, P65, DOI 10.1097/00000658-198607000-00009; Satoi S, 2013, J HEPATO-BIL-PAN SCI, V20, P590, DOI 10.1007/s00534-013-0616-0; Sho M, 2011, J HEPATOBILIARY PANC, V18, P9; Sobin LH, 2010, TNM CLASSIFICATION M	33	3	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	JUN	2015	50	6					694	702		10.1007/s00535-014-1005-4		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CK0YK	WOS:000355931500010		
J	Nouso, K				Nouso, Kazuhiro			How do we conquer the recurrence of HCC?	JOURNAL OF GASTROENTEROLOGY			English	Editorial Material							HEPATOCELLULAR-CARCINOMA		[Nouso, Kazuhiro] Okayama Univ, Dept Gastroenterol & Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan	Nouso, K (reprint author), Okayama Univ, Dept Gastroenterol & Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	nouso@cc.okayama-u.ac.jp					Okita K, 2015, J GASTROENTEROL, V50, P667, DOI 10.1007/s00535-014-0996-1; Hasegawa K, 2006, HEPATOLOGY, V44, P891, DOI 10.1002/hep.21341; Honda M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-191; Muto Y, 1996, NEW ENGL J MED, V334, P1561, DOI 10.1056/NEJM199606133342402; Okita K, 2015, J GASTROENTEROL, V50, P191, DOI 10.1007/s00535-014-0956-9	5	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	JUN	2015	50	6					703	704		10.1007/s00535-014-1003-6		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CK0YK	WOS:000355931500011		
J	Morishita, N; Hiramatsu, N; Oze, T; Harada, N; Yamada, R; Miyazaki, M; Yakushijin, T; Miyagi, T; Yoshida, Y; Tatsumi, T; Kanto, T; Takehara, T				Morishita, Naoki; Hiramatsu, Naoki; Oze, Tsugiko; Harada, Naoki; Yamada, Ryoko; Miyazaki, Masanori; Yakushijin, Takayuki; Miyagi, Takuya; Yoshida, Yuichi; Tatsumi, Tomohide; Kanto, Tatsuya; Takehara, Tetsuo			Liver stiffness measurement by acoustic radiation force impulse is useful in predicting the presence of esophageal varices or high-risk esophageal varices among patients with HCV-related cirrhosis (vol 49, pg 1175, 2014)	JOURNAL OF GASTROENTEROLOGY			English	Correction									[Morishita, Naoki; Hiramatsu, Naoki; Oze, Tsugiko; Harada, Naoki; Yamada, Ryoko; Miyazaki, Masanori; Yakushijin, Takayuki; Miyagi, Takuya; Yoshida, Yuichi; Tatsumi, Tomohide; Takehara, Tetsuo] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka 5650871, Japan; [Kanto, Tatsuya] Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Ichikawa, Japan	Morishita, N (reprint author), Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	n.morishita@gh.med.osaka-u.ac.jp; hiramatsu@gh.med.osaka-u.ac.jp					Morishita N, 2014, J GASTROENTEROL, V49, P1175, DOI 10.1007/s00535-013-0877-z	1	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	JUN	2015	50	6					705	705		10.1007/s00535-015-1072-1		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CK0YK	WOS:000355931500012		
J	Zhang, YQ; Kono, RT; Wang, W; Harrison, T; Takai, M; Ciochon, RL; Jin, CZ				Zhang, Yingqi; Kono, Reiko T.; Wang, Wei; Harrison, Terry; Takai, Masanaru; Ciochon, Russell L.; Jin, Changzhu			Evolutionary trend in dental size in Gigantopithecus blacki revisited	JOURNAL OF HUMAN EVOLUTION			English	Article						Sexual dimorphism; Chronology; ANOVA; Silverman's test	MOLAR ENAMEL THICKNESS; SOUTH CHINA; EARLY PLEISTOCENE; CHUIFENG CAVE; BUBING BASIN; GUANGXI; CHONGZUO; FAUNA; EXTINCTION; MORPHOLOGY	Previous analyses of dental size in Gigantopithecus blacki indicated marked sexual dimorphism and a trend towards increasing size through time. These studies were based on a sample of over 700 teeth from five localities excavated prior to 1990. Since then, 12 additional cave sites have been discovered in southern China, yielding hundreds of isolated teeth of G. blacki. Most of these sites are well dated by a combination of biochronology and absolute dating methods, so we now have a much better understanding of the chronology of G. blacki. Here, we reexamine the degree of sexual dimorphism and the question of dental size increase through time in G. blacki based on the expanded collections now available. Our results show that sexual dimorphism is not as marked as indicated in previous studies and confirm earlier analyses suggesting that the postcanine teeth of G. blacki tend to become larger through time from the beginning of the Early Pleistocene to the Middle Pleistocene. (C) 2015 Elsevier Ltd. All rights reserved.	[Zhang, Yingqi; Jin, Changzhu] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China; [Kono, Reiko T.] Natl Museum Nat & Sci, Dept Anthropol, Div Human Evolut, Tsukuba, Ibaraki 3050005, Japan; [Wang, Wei] Guangxi Museum Nationalities, Nanning 530021, Peoples R China; [Harrison, Terry] NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA; [Takai, Masanaru] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 4848506, Japan; [Ciochon, Russell L.] Univ Iowa, Dept Anthropol, Iowa City, IA 52242 USA	Zhang, YQ (reprint author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China.	zhangyingqi@ivpp.ac.cn; rtkono@kahaku.go.jp			Chinese Academy of Sciences [kzzd-ew-03]; National Science Fund for Talent Training in Basic Science [J1210008]; National Natural Science Foundation of China [41072013, 41202017]; Program of China Geological Survey [1212011220519]; Cooperation Research Program of Primate Research Institute, Kyoto University [H25-B46, H26-B7];  [22770242];  [24000015];  [26304019]	We thank Dr. Nao Kusuhashi for helpful discussion about the Silverman's test, and Professor Chaorong Li for providing information about G. blacki specimens from Hainan. We are grateful to Mr. Tobias Avalos for helpful editing. We extend our gratitude to Sarah Elton, an Associate Editor, Eric Delson, and an anonymous reviewer for their helpful comments and constructive feedback on an earlier version of the manuscript. The research was supported by the Key Research Program of the Chinese Academy of Sciences (kzzd-ew-03), the National Science Fund for Talent Training in Basic Science (J1210008), National Natural Science Foundation of China (41072013, 41202017), and the Program of China Geological Survey (1212011220519), Grants-in-Aid for Scientific Research (22770242, 24000015, 26304019), and the Cooperation Research Program of Primate Research Institute, Kyoto University (H25-B46, H26-B7).	Zhao LX, 2013, QUATERN INT, V286, P69, DOI 10.1016/j.quaint.2011.12.016; Jin CZ, 2009, CHINESE SCI BULL, V54, P788, DOI 10.1007/s11434-008-0531-y; Wang W, 2009, J HUM EVOL, V57, P229, DOI 10.1016/j.jhevol.2009.05.004; SILVERMAN BW, 1981, J ROY STAT SOC B MET, V43, P97; Jin CZ, 2014, QUATERN INT, V354, P4, DOI 10.1016/j.quaint.2013.12.051; Ciochon R, 1996, P NATL ACAD SCI USA, V93, P3016, DOI 10.1073/pnas.93.7.3016; Sun L, 2014, QUATERN INT, V354, P15, DOI 10.1016/j.quaint.2013.08.049; Takai M, 2014, QUATERN INT, V354, P75, DOI 10.1016/j.quaint.2014.02.021; Rink WJ, 2008, QUATERNARY RES, V69, P377, DOI 10.1016/j.yqres.2008.02.008; Shao QF, 2014, QUATERNARY RES, V82, P270, DOI 10.1016/j.yqres.2014.04.009; Suwa G, 2009, SCIENCE, V326, P94, DOI 10.1126/science.1175824; HUANG WP, 1995, NATURE, V378, P275; Wang W, 2005, CHINESE SCI BULL, V50, P2777, DOI 10.1360/982004-614; WHITE TD, 1977, AM J PHYS ANTHROPOL, V46, P197, DOI 10.1002/ajpa.1330460203; Harrison T, 2014, QUATERN INT, V354, P59, DOI 10.1016/j.quaint.2014.01.013; Olejniczak AJ, 2008, AM J PHYS ANTHROPOL, V135, P85, DOI 10.1002/ajpa.20711; Zhang YQ, 2014, QUATERN INT, V354, P35, DOI 10.1016/j.quaint.2013.12.008; Chang Yin-yun, 1975, Vertebrata Palasiatica, V13, P148; Chang Y, 1973, CHINESE SCI BULL, V18, P130; Figueirido B, 2011, NATURWISSENSCHAFTEN, V98, P107, DOI 10.1007/s00114-010-0748-x; Harrison T., 2000, B INDOPACIFIC PREHIS, V20, P133; Huang W.-P., 1991, WUSHAN HOMINID SITE; Jin CZ, 2007, P NATL ACAD SCI USA, V104, P10932, DOI 10.1073/pnas.0704198104; Kono RT, 2014, QUATERN INT, V354, P46, DOI 10.1016/j.quaint.2014.02.012; Kupczik K, 2008, J HUM EVOL, V54, P196, DOI 10.1016/j.jhevol.2007.09.013; KUSUHASHI N, 2015, KASEKI, P23; Mahler P. E., 1973, THESIS U MICHIGAN; Pei W. C., 1957, Vertebrata Palasiatica, V1, P65; Pei W. C, 1965, Memoirs Institute of Vertebrate Paleontology Peking, V7, P1; Pei W. C., 1956, Acta Palaeontologica Sinica, V4, P477; Qu YT, 2014, QUATERN INT, V354, P52, DOI 10.1016/j.quaint.2013.10.053; R Core Team, 2014, R LANG ENV STAT COMP; Silverman B.W., 1983, LONDON MATH SOC LECT, V79, P248; Suwa G., 1990, THESIS U CALIFORNIA; von Koenigswald GHR, 1935, P K AKAD WET-AMSTERD, V38, P872; Woo J. K., 1962, Palaeontologia Sinica New Ser D, V11, P1; Xu C., 1974, VERTEBRAT PALASIATIC, V12, P293; Yan YL, 2014, QUATERN INT, V354, P110, DOI 10.1016/j.quaint.2014.01.004; Zhang Li-zhao, 2013, Acta Anthropologica Sinica, V32, P365; ZHANG YY, 1982, AM J PHYS ANTHROPOL, V59, P21; Zhang Yinyun, 1983, Acta Anthropologica Sinica, V2, P205; Zhang YQ, 2014, J HUM EVOL, V75, P166, DOI 10.1016/j.jhevol.2014.06.010; Zhao Lingxia, 2008, Disiji Yanjiu, V28, P1138; [赵凌霞 Zhao Lingxia], 2006, [第四纪研究, Quaternary Sciences], V26, P548; Zheng SH., 2004, JIANSHI HOMINID SITE	45	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0047-2484			J HUM EVOL	J. Hum. Evol.	JUN	2015	83						91	100		10.1016/j.jhevol.2015.03.005		10	Anthropology; Evolutionary Biology	Anthropology; Evolutionary Biology	CK3IQ	WOS:000356110200007		
J	Sun, XC; Onda, Y; Kato, H; Gomi, T; Komatsu, H				Sun, Xinchao; Onda, Yuichi; Kato, Hiroaki; Gomi, Takashi; Komatsu, Hikaru			Effect of strip thinning on rainfall interception in a Japanese cypress plantation	JOURNAL OF HYDROLOGY			English	Article						Interception; Chamaecyparis obtusa; Revised Gash model; Rainfall partitioning; Thinning	CANOPY INTERCEPTION; WATER-BALANCE; VEGETATION CHANGES; ANALYTICAL-MODEL; DOUGLAS-FIR; PINE FOREST; THROUGHFALL; GROWTH; STAND; TRANSPIRATION	We examined the effect of strip thinning on rainfall interception (Et) in a 32-year-old Japanese cypress plantation in central Japan. Strip thinning was conducted in the catchment in October 2011; that removed 50% of the stems. The gross precipitation (Pg), throughfall (TF) and stemflow (SF) were monitored in a 12-m x 13-m plot before and after thinning. Et was calculated as the difference between Pg and the sum of TF and SF. The interception processes were illustrated using the revised Gash model with quantifying interception parameters. The results showed that the Gash model successfully predicted Et on a rainy-season basis in both pre- and post-thinning periods. Thinning altered the interception components whereas the largest part during and after rainfall accounted for similar proportion in both periods. Additionally, after thinning, the annual TF rate was increased from 61.4% to 73.0%, whereas the annual SF rate was decreased from 9.8% to 6.1%, and the annual E-i rate was decreased from 28.7% to 20.8%. The summarized findings of previous studies indicate that the degree of decline in the Ei caused by thinning is related to Pg and the thinning ratio. These results provide useful information for understanding the changes in interception processes induced by thinning, and for acquiring a more accurate forecast of the effects of forest management practices on water resources in the watershed. The response in rainfall partitioning to strip thinning can also help us to acquire an integrated understanding of the changes in canopy water balance under different forest practices. (C) 2015 Elsevier B.V. All rights reserved.	[Sun, Xinchao; Onda, Yuichi; Kato, Hiroaki] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Gomi, Takashi] Tokyo Univ Agr & Technol, Dept Int Environm & Agr Sci, Fuchu, Tokyo 1838509, Japan; [Komatsu, Hikaru] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto 6068302, Japan	Sun, XC (reprint author), Univ Tsukuba, Fac Life & Environm Sci, Ten Nodai 1-1-1, Tsukuba, Ibaraki 3058572, Japan.	xinchao.sun@gmail.com	Onda, Yuichi/N-6527-2014; Sun, Xinchao/K-4119-2015; Gomi, Takashi/E-3504-2010	Onda, Yuichi/0000-0001-8753-0378; 	Japan Science and Technology Agency (JST) through the Core Research for Evolutional Science and Technology (CREST); China Scholarship Council [2010635146]	We acknowledge Dr. Teramage Tesfaye and Nahyun Brianne Yoo (Tsukuba University, Japan) for their help with discussion. We also appreciate the anonymous referees whose critical comments significantly improved the manuscript. This study was supported by the Japan Science and Technology Agency (JST) through the Core Research for Evolutional Science and Technology (CREST) project entitled "Development of innovative technologies for increasing watershed runoff and improving river environments by management practices on devastated forest plantations". The first author is sponsored by the China Scholarship Council (File No.: 2010635146).	Simonin K, 2007, AGR FOREST METEOROL, V143, P266, DOI 10.1016/j.agrformet.2007.01.003; Link TE, 2004, AGR FOREST METEOROL, V124, P171, DOI 10.1016/j.agrformet.2004.01.010; Zhang L, 2001, WATER RESOUR RES, V37, P701, DOI 10.1029/2000WR900325; Pypker TG, 2005, AGR FOREST METEOROL, V130, P113, DOI 10.1016/j.agrformet.2005.03.003; Molina AJ, 2012, FOREST ECOL MANAG, V269, P206, DOI 10.1016/j.foreco.2011.12.037; Andreassian V, 2004, J HYDROL, V291, P1, DOI 10.1016/j.jhydrol.2003.12.015; Llorens P, 2007, J HYDROL, V335, P37, DOI 10.1016/j.jhydrol.2006.10.032; Crockford RH, 2000, HYDROL PROCESS, V14, P2903, DOI 10.1002/1099-1085(200011/12)14:16/17<2903::AID-HYP126>3.3.CO;2-Y; Aboal JR, 2000, J HYDROL, V238, P218, DOI 10.1016/S0022-1694(00)00329-2; Limousin JM, 2008, J HYDROL, V357, P57, DOI 10.1016/j.jhydrol.2008.05.001; Dodson EK, 2008, FOREST ECOL MANAG, V255, P3130, DOI 10.1016/j.foreco.2008.01.026; Hormann G, 1996, AGR FOREST METEOROL, V79, P131, DOI 10.1016/0168-1923(95)02275-9; Ganatsios HP, 2010, FOREST ECOL MANAG, V260, P1367, DOI 10.1016/j.foreco.2010.07.033; Saito T, 2013, J HYDROL, V507, P287, DOI 10.1016/j.jhydrol.2013.09.053; GASH JHC, 1979, Q J ROY METEOR SOC, V105, P43, DOI 10.1002/qj.49710544304; Dung BX, 2012, J HYDROL, V444, P51, DOI 10.1016/j.jhydrol.2012.03.040; BREDA N, 1995, TREE PHYSIOL, V15, P295; CROCKFORD RH, 1990, HYDROL PROCESS, V4, P169, DOI 10.1002/hyp.3360040207; Komatsu H, 2007, J HYDROL, V336, P361, DOI 10.1016/j.jhydrol.2007.01.009; Thomas SC, 1999, ECOL APPL, V9, P864, DOI 10.1890/1051-0761(1999)009[0864:PDIMFU]2.0.CO;2; Deguchi A, 2006, J HYDROL, V318, P80, DOI 10.1016/j.jhydrol.2005.06.005; AUSSENAC G, 1988, CAN J FOREST RES, V18, P100, DOI 10.1139/x88-015; AUSSENAC G, 1982, CAN J FOREST RES, V12, P222; BOSCH JM, 1982, J HYDROL, V55, P3, DOI 10.1016/0022-1694(82)90117-2; Calder IR, 1996, J HYDROL, V185, P379, DOI 10.1016/0022-1694(95)02999-0; GASH JHC, 1995, J HYDROL, V170, P79, DOI 10.1016/0022-1694(95)02697-N; Hattori S., 1988, Journal of the Japanese Forestry Society, V70, P529; LOUSTAU D, 1992, J HYDROL, V138, P449, DOI 10.1016/0022-1694(92)90130-N; Maleque MA, 2007, J FOREST RES-JPN, V12, P14, DOI 10.1007/s10310-006-0243-6; Maleque MA, 2007, ARTHROPOD-PLANT INTE, V1, P175, DOI 10.1007/s11829-007-9016-1; Mazza G, 2011, ANN FOREST SCI, V68, P1323, DOI 10.1007/s13595-011-0142-7; Monteith J.L., 1990, PRINCIPLES ENV PHYS, P291; Murai H., 1970, JPN FORESTRY SOC, V232, P25; Murai H., 1989, B SHIZUOKA U FOR, V13, P1; Murakami S, 2007, J HYDROL, V342, P305, DOI 10.1016/j.jhydrol.2007.05.032; Nagaike T, 2006, J FOREST RES-JPN, V11, P215, DOI 10.1007/s10310-006-0220-0; Sado S., 2004, TEST REPORT YAMAGUCH, V17, P14; Sun X., 2015, HYDROL PROC IN PRESS; Sun XC, 2014, AGR FOREST METEOROL, V197, P123, DOI 10.1016/j.agrformet.2014.06.011; Sun XC, 2014, J FOREST RES-JPN, V19, P317, DOI 10.1007/s10310-013-0421-2; Sun XC, 2014, ECOHYDROLOGY, V7, P1042, DOI 10.1002/eco.1428; Taniguchi S., 1999, APPL FOR SCI, P181; TEKLEHAIMANOT Z, 1991, J HYDROL, V123, P261, DOI 10.1016/0022-1694(91)90094-X; WHITEHEAD D, 1991, AGR FOREST METEOROL, V55, P109, DOI 10.1016/0168-1923(91)90025-L	44	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-1694	1879-2707		J HYDROL	J. Hydrol.	JUN	2015	525						607	618		10.1016/j.jhydrol.2015.04.023		12	Engineering, Civil; Geosciences, Multidisciplinary; Water Resources	Engineering; Geology; Water Resources	CK0HF	WOS:000355885600051		
J	Hattori, Y; Yamashita, J; Sakaida, C; Kawano, K; Yonemochi, E				Hattori, Yoshiyuki; Yamashita, Jun; Sakaida, Chisato; Kawano, Kumi; Yonemochi, Etsuo			Evaluation of antitumor effect of zoledronic acid entrapped in folate-linked liposome for targeting to tumor-associated macrophages	JOURNAL OF LIPOSOME RESEARCH			English	Article						Folate receptor; folic acid; liposomes; tumor-associated macrophages; zoledronic acid	BISPHOSPHONATES INDUCE APOPTOSIS; IN-VITRO; BREAST-CANCER; CELL-LINES; PROGRESSION; EXPRESSION; DEPLETION; GROWTH; MODEL; ANGIOGENESIS	In this study, we investigated the possibility of whether depletion of tumor-associated macrophages (TAMs) by zoledronic acid (ZOL) entrapped in folate-linked liposome could inhibit tumor angiogenesis and consequently tumor growth. Abundant expression of folate receptor beta (FR beta) mRNA was detected in tumor tissues from subcutaneously implanted FR-negative tumor cells in mice, indicating that FR beta mRNA was expressed in TAMs, not in tumor cells. When fluorescent-labeled folic acid was intravenously injected into mice bearing FR-positive human nasopharyngeal tumor KB, and FR-negative human prostate tumor PC-3 and mouse colon adenocarcinoma Colon 26, fluorescence was strongly detected in KB and Colon 26 tumors, and moderately in PC-3 tumor, indicating that folic acid was taken up by TAMs via FR beta in PC-3 and Colon 26 tumors. For evaluation of ZOL delivery to TAMs, folate-linked liposomal ZOL (FL-ZOL) for TAM targeting and non-folate-linked liposomal ZOL (L-ZOL) as a control were prepared by incorporation with 0.5 mol% folate-PEG(2000)-DSPE and 0.5 mol% PEG(2000)-DSPE, respectively, into the liposomal formulation of egg phosphatidylcholine and cholesterol. FL-ZOL showed high cytotoxicity for KB and murine macrophage RAW264.7 cells, but not for Colon 26 cells, suggested that FL-ZOL was selectively taken up via FR-mediated endocytosis. However, injections of FL-ZOL and L-ZOL did not induce antitumor activities for KB and Colon 26 tumor-bearing mice, and had a lethal effect by high toxicity. From these findings, the severe in vivo toxicity of liposomal ZOL limited its utility for in vivo TAM targeting, although FL-ZOL could selectively induce in vitro cytotoxicity via FR.	[Hattori, Yoshiyuki; Yamashita, Jun; Sakaida, Chisato; Kawano, Kumi; Yonemochi, Etsuo] Hoshi Univ, Inst Med Chem, Shinagawa Ku, Tokyo 1428501, Japan	Hattori, Y (reprint author), Hoshi Univ, Inst Med Chem, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.	yhattori@hoshi.ac.jp		Hattori, Yoshiyuki/0000-0002-4731-0407	Ministry of Education, Culture, Sports, Science, and Technology of Japan, KAKENHI [23790203]; Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan	This project was supported in part by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, KAKENHI (23790203), and by the Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan.	Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Bak SP, 2007, CANCER RES, V67, P4783, DOI 10.1158/0008-5472.CAN-06-4410; Marra M, 2011, NANOMED-NANOTECHNOL, V7, P955, DOI 10.1016/j.nano.2011.03.004; Nagai T, 2009, CANCER IMMUNOL IMMUN, V58, P1577, DOI 10.1007/s00262-009-0667-x; Yamada A, 2008, CLIN CANCER RES, V14, P8161, DOI 10.1158/1078-0432.CCR-08-0159; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240; Kobayashi N, 2010, CANCER RES, V70, P7073, DOI 10.1158/0008-5472.CAN-09-4687; Kono Y, 2014, BIOL PHARM BULL, V37, P137; Shmeeda H, 2013, J CONTROL RELEASE, V167, P265, DOI 10.1016/j.jconrel.2013.02.003; Chen JJW, 2005, J CLIN ONCOL, V23, P953, DOI 10.1200/JCO.2005.12.172; Zhang W, 2010, CLIN CANCER RES, V16, P3420, DOI 10.1158/1078-0432.CCR-09-2904; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Lee MV, 2001, CANCER RES, V61, P2602; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Antony AC, 1996, ANNU REV NUTR, V16, P501; Gazzaniga S, 2007, J INVEST DERMATOL, V127, P2031, DOI 10.1038/sj.jid.5700827; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Aparicio A, 1998, LEUKEMIA, V12, P220, DOI 10.1038/sj.leu.2400892; Bacman D, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-156; Bolat F, 2006, J EXP CLIN CANC RES, V25, P365; Deininger MH, 2003, ACTA NEUROPATHOL, V106, P271, DOI 10.1007/s00401-003-0727-9; Hattori Y, 2006, BIOL PHARM BULL, V29, P1516, DOI 10.1248/bpb.29.1516; Kagaya T, 2006, CANCER GENE THER, V13, P357, DOI 10.1038/sj.cgt.7700908; Ottewell PD, 2008, J NATL CANCER I, V100, P1167, DOI 10.1093/jnci/djn240; Rogers Michael J., 2000, Cancer, V88, P2961, DOI 10.1002/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L; Senaratne SG, 2000, BRIT J CANCER, V82, P1459; Shiokawa T, 2005, CLIN CANCER RES, V11, P2018, DOI 10.1158/1078-0432.CCR-04-1129; Shipman CM, 1997, BRIT J HAEMATOL, V98, P665, DOI 10.1046/j.1365-2141.1997.2713086.x; Sica A, 2007, EXPERT OPIN THER TAR, V11, P1219, DOI 10.1517/14728222.11.9.1219; Smith AE, 2007, HYBRIDOMA, V26, P281, DOI 10.1089/hyb.2007.0512; Thompson K, 2006, MOL PHARMACOL, V69, P1624, DOI 10.1124/mol.105.020776; Wollack JB, 2008, J NEUROCHEM, V104, P1494, DOI 10.1111/j.1471-4159.2007.05095.x; Ross J R, 2004, Health Technol Assess, V8, P1	35	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0898-2104	1532-2394		J LIPOSOME RES	J. Liposome Res.	JUN	2015	25	2					131	140		10.3109/08982104.2014.954128		10	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	CK4QJ	WOS:000356208000005		
J	Ko, JH; Kwon, HU				Ko, Jun-Hyung; Kwon, Hyeog Ug			Do technology shocks lower hours worked? - Evidence from Japanese industry level data	JOURNAL OF MACROECONOMICS			English	Article						Technology shocks; Composition shocks; Hours worked; Japanese economy; VAR	BUSINESS-CYCLE; EMPIRICAL-ANALYSIS; AGGREGATE FLUCTUATIONS; MONETARY-POLICY; IMPROVEMENTS; GROWTH; FIRMS	We examine the response of productivity and hours worked to technology and nontechnology shocks using the Japan Industrial Productivity (JIP) Database. We find that, at the aggregate level, positive technology shocks increase hours worked both in the manufacturing and the nonmanufacturing sector, accounting for a large fraction in the variances of hours worked. At the two- and three-digit industry levels, in contrast, we find that the correlation between productivity and hours worked in response to sectoral technology shocks tends to be negative. Further, we find that neither aggregate nor sectoral technology shocks appear to be the dominant factor underlying fluctuations in hours worked at the disaggregate level. The productivity decline in response to nontechnology shocks is not related to a permanent change in the relative size of industries. (C) 2015 Elsevier Inc. All rights reserved.	[Ko, Jun-Hyung] Aoyama Gakuin Univ, Shibuya Ku, Tokyo 1508366, Japan; [Kwon, Hyeog Ug] Nihon Univ, Chiyoda Ku, Tokyo 1028360, Japan	Ko, JH (reprint author), Aoyama Gakuin Univ, Shibuya Ku, 4-4-25 Shibuya, Tokyo 1508366, Japan.	kojunhyung@aoyamagakuin.jp; kwon.hyeogug@nihon-u.ac.jp			JSPS (Japan Society for the Promotion of Science) [23243050]; JSPS [22330092]; National Research Foundation of South Korea Grant - Korean Government [NRF-2013S1A3A2053312]	This research was conducted as a part of the RIETI research project "Research on Measuring Productivity in the Service Industries and Identifying the Driving Factors for Productivity Growth." Ko and Kwon are grateful to the Grant-in-Aid for Scientific Research (Grant No. 23243050) from JSPS (Japan Society for the Promotion of Science). Kwon also gratefully acknowledges financial support from the Grant-in-Aid for Scientific Research (Grant No. 22330092) from the JSPS and the National Research Foundation of South Korea Grant Funded by the Korean Government (NRF-2013S1A3A2053312). The authors would like to thank Masahisa Fujita, Kyoji Fukao, Keiko Ito, Tsutomu Miyagawa, Masayuki Morikawa, Atsushi Nakajima, Makoto Nirei, and Keiichiro Oda for helpful comments and suggestions. All remaining mistakes are ours.	Abe N, 2004, JPN ECON REV, V55, P101, DOI 10.1111/j.1468-5876.2004.00296.x; Ahearne A., 2005, INT EC EC POLICY, V2, P363, DOI 10.1007/s10368-005-0041-1; Alexius A, 2007, ECON LETT, V96, P259, DOI 10.1016/j.econlet.2007.01.001; Alexius A, 2005, REV ECON STAT, V87, P299, DOI 10.1162/0034653053970285; Caballero RJ, 2008, AM ECON REV, V98, P1943, DOI 10.1257/aer.98.5.1943; LONG JB, 1983, J POLIT ECON, V91, P39; Lastrapes WD, 2005, ECON LETT, V87, P75, DOI 10.1016/j.econlet.2004.10.004; Gabaix X, 2011, ECONOMETRICA, V79, P733, DOI 10.3982/ECTA8769; Cantore C, 2014, J EUR ECON ASSOC, V12, P108, DOI 10.1111/jeea.12038; Francis N, 2009, J MONEY CREDIT BANK, V41, P1071, DOI 10.1111/j.1538-4616.2009.00247.x; Fukao K, 2006, JPN ECON REV, V57, P195, DOI 10.1111/j.1468-5876.2006.00359.x; Basu S, 2006, AM ECON REV, V96, P1418, DOI 10.1257/aer.96.5.1418; Bernanke BS, 2005, Q J ECON, V120, P387, DOI 10.1162/0033553053327452; Braun R. A., 2004, KEIZAI KENKYUU, V55, P289; Carlsson M, 2007, J MONEY CREDIT BANK, V39, P1509, DOI 10.1111/j.1538-4616.2007.00076.x; Chang YS, 2006, AM ECON REV, V96, P352, DOI 10.1257/000282806776157687; Christiano L., 2003, 763 INT FIN; Cooley T. F., 1995, FRONTIERS BUSINESS C; Dotsey M., 2002, EC Q FEDERAL RESERVE, V88, P37; Franco F, 2007, REV ECON STAT, V89, P587, DOI 10.1162/rest.89.4.587; Fukao K., 2006, RIETI DISCUSSION PAP, V07-E-003; Gali J, 2005, FED RESERVE BANK ST, V87, P459; Gali J., 1999, AM ECON REV, V89, P249; Horvath M, 2000, J MONETARY ECON, V45, P69, DOI 10.1016/S0304-3932(99)00044-6; Horvath M, 1998, REV ECON DYNAM, V1, P781, DOI DOI 10.1006/REDY.1998.0028; Kiley M., 1998, LABOR PRODUCTI UNPUB; Kim J. W., 2011, B E J MACROECON, V11, P1; Ko JH, 2013, JPN WORLD ECON, V27, P10, DOI 10.1016/j.japwor.2013.03.001; Linde J, 2009, J ECON DYN CONTROL, V33, P597, DOI 10.1016/j.jedc.2008.08.011; Marchetti DJ, 2007, J MONEY CREDIT BANK, V39, P1587, DOI 10.1111/j.1538-4616.2007.00080.x; Miyagawa T, 2006, JPN WORLD ECON, V18, P401, DOI 10.1016/j.japwor.2006.04.004; Nirei M., 2012, AUTONOMOUS FLU UNPUB; Shea J., 1998, NBER MACROECONOMICS; Uhlig H, 2005, J MONETARY ECON, V52, P381, DOI 10.1016/j.jmoneco.2004.05.007	34	0	0	LOUISIANA STATE UNIV PR	BATON ROUGE	BATON ROUGE, LA 70893 USA	0164-0704			J MACROECON	J. Macroecon.	JUN	2015	44						138	157		10.1016/j.jmacro.2015.01.004		20	Economics	Business & Economics	CK0HR	WOS:000355886800011		
J	Doan, VP; Nishi, Y				Viet-Phan Doan; Nishi, Yoshiki			Modeling of fluid-structure interaction for simulating vortex-induced vibration of flexible riser: finite difference method combined with wake oscillator model	JOURNAL OF MARINE SCIENCE AND TECHNOLOGY			English	Article						Vortex-induced vibration; Riser pipe; Wake oscillator model; Finite difference method	NONLINEAR DYNAMICS; VIV; FLOW	This paper proposes a numerical simulation method for the dynamic motion of a flexible riser pipe undergoing vortex-induced vibration (VIV). The method is based on a finite difference scheme for solving nonlinear structural dynamics of the pipe and wake oscillator model for quantifying vortex-induced forces acting on the pipe, the combination of which can offer a very efficient and stable computation. To investigate the accuracy of the method, we performed simulations of the VIV of riser pipes under uniform flow and sheared flow conditions; and then compared obtained results with experiments of preceding works. We consequently confirmed that the present method can simulate a couple of important aspects of the VIV of the pipes: frequency, mode shape, and amplitude of displacement of cross-flow displacement.	[Viet-Phan Doan; Nishi, Yoshiki] Yokohama Natl Univ, Grad Sch Engn, Fac Engn, Dept Syst Design Ocean Space, Yokohama, Kanagawa 2408501, Japan	Doan, VP (reprint author), Yokohama Natl Univ, Grad Sch Engn, Fac Engn, Dept Syst Design Ocean Space, 79-5 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	doan-phan-jk@ynu.ac.jp					Srinil N, 2009, OCEAN ENG, V36, P1404, DOI 10.1016/j.oceaneng.2009.08.010; Facchinetti ML, 2004, EUR J MECH B-FLUID, V23, P199, DOI 10.1016/j.euromechflu.2003.04.004; Lie H, 2006, J FLUID STRUCT, V22, P557, DOI 10.1016/j.jfluidstructs.2006.01.002; Xu WH, 2008, OCEAN ENG, V35, P1769, DOI 10.1016/j.oceaneng.2008.08.015; Facchinetti ML, 2004, J FLUID STRUCT, V19, P123, DOI 10.1016/j.jfluidstructs.2003.12.004; Violette R, 2007, COMPUT STRUCT, V85, P1134, DOI 10.1016/j.compstruc.2006.08.005; Chen WM, 2012, OCEAN ENG, V42, P7, DOI 10.1016/j.oceaneng.2011.12.019; Chatjigeorgiou IK, 2008, OCEAN ENG, V35, P616, DOI 10.1016/j.oceaneng.2008.01.006; Song JN, 2011, OCEAN ENG, V38, P1308, DOI 10.1016/j.oceaneng.2011.05.020; Trim AD, 2005, J FLUID STRUCT, V21, P335, DOI 10.1016/j.jfluidstructs.2005.07.014; Gabbai RD, 2005, J SOUND VIB, V282, P575, DOI 10.1016/j.jsv.2004.04.017; Chatjigeorgiou IK, 2010, INT J NONLIN MECH, V45, P667, DOI 10.1016/j.ijnonlinmec.2010.04.001; Chatjigeorgiou IK, 2010, ENG STRUCT, V32, P3313, DOI 10.1016/j.engstruct.2010.07.004; Constantinides Y, 2007, P OMAE2007 ASME; di Silvio G, 1969, J ENGINEERING MECHAN, V95, P347; Hartlen R. T., 1970, J ENG MECH DIV ASCE, V96, P577; Hoffman J.D., 1993, NUMERICAL METHODS EN; Holmes S, 2006, P OMAE2006 ASME; Howell C.T., 1992, THESIS MIT CAMBRIDGE; Kuchnicki SN, 2002, J SOUND VIB, V257, P903, DOI 10.1006/jsvi.5067; Nishi Y, 2009, J MAR SCI TECHNOL, V14, P285, DOI 10.1007/s00773-008-0036-z; Press W. H., 1986, NUMERICAL RECIPES; Tamura Y., 1979, P 5 INT C WIND ENG F, P1085; Tamura Y, 1978, T ARCHIT I JPN, V266, P87; Tjavaras AA, 1998, J SOUND VIB, V213, P709, DOI 10.1006/jsvi.1998.1526	25	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0948-4280	1437-8213		J MAR SCI TECH-JAPAN	J. Mar. Sci. Technol.	JUN	2015	20	2					309	321		10.1007/s00773-014-0284-z		13	Engineering, Marine; Engineering, Civil	Engineering	CK5VW	WOS:000356295000009		
J	Rahman, MM; Hasan, ABMT; Islam, AKMS; Matsuo, S; Setoguchi, T				Rahman, M. Mostaqur; Hasan, A. B. M. Toufique; Islam, A. K. M. Sadrul; Matsuo, S.; Setoguchi, T.			Computation of transonic internal flow around a biconvex airfoil with cavity	JOURNAL OF MECHANICAL SCIENCE AND TECHNOLOGY			English	Article						Shock control; Shock induced oscillation; Shock wave; Transonic flow	NONEQUILIBRIUM CONDENSATION; SHOCK OSCILLATIONS; BUFFET	At transonic flow conditions, unsteady self-excited shock waves are frequently observed in several modern internal aeronautical applications such as in turbine cascades, compressor blades, butterfly valves, fans, nozzles, diffusers and so on. The appearance of shock oscillation often causes serious problems such as aero-acoustic noise, non-synchronous vibration (NSV), intense drag rise, high cycle fatigue failure (HCF) and buffeting. In recent years, the effect of various passive means on the airfoil are investigated both experimentally and numerically to find the effectiveness as a shock control device. In the present study, the transonic internal flow around an airfoil using a cavity as a passive means of shock control was investigated numerically. Computational results are validated with available experimental data. Results showed that the airfoil with cavity significantly reduced the flow field unsteadiness such as the amplitude of pressure oscillation and root mean square of pressure oscillation.	[Rahman, M. Mostaqur; Matsuo, S.; Setoguchi, T.] Saga Univ, Fac Sci & Engn, Saga 8408502, Japan; [Hasan, A. B. M. Toufique] Bangladesh Univ Engn & Technol, Dept Mech Engn, Dhaka 1000, Bangladesh; [Islam, A. K. M. Sadrul] IUT, Dept Mech & Chem Engn, Gazipur 1704, Bangladesh	Hasan, ABMT (reprint author), Bangladesh Univ Engn & Technol, Dept Mech Engn, Dhaka 1000, Bangladesh.	toufiquehasan@me.buet.ac.bd			Higher Education Quality Enhancement Project (HEQEP), AIF (2nd Round)-Sub-Project CP, UGC, MoE, Government of Bangladesh [2099, 28/2012]	The present work has been carried out with computational resource support from Higher Education Quality Enhancement Project (HEQEP), AIF (2nd Round)-Sub-Project CP 2099, UGC, MoE, Government of Bangladesh (Contract No. 28/2012).	Alfano D., 2006, 20062840 AIAA; Lee BHK, 2001, PROG AEROSP SCI, V37, P147, DOI 10.1016/S0376-0421(01)00003-3; Xiao Q, 2006, AIAA J, V44, P620, DOI 10.2514/1.16658; Rowley CW, 2006, ANNU REV FLUID MECH, V38, P251, DOI 10.1146/annurev.fluid.38.050304.092057; Chen LW, 2010, J FLUID MECH, V643, P97, DOI 10.1017/S0022112009991960; Sanders AJ, 2005, J TURBOMACH, V127, P412, DOI 10.1115/1.1811091; Caruana D., 2005, AEROSP SCI TECHNOL, V9, P606; Choi SM, 2013, J MECH SCI TECHNOL, V27, P1671, DOI 10.1007/s12206-013-0415-1; Hasan ABMT, 2009, INT J TURBO JET ENG, V26, P33; Hasan ABMT, 2012, INT J MECH SCI, V54, P249, DOI 10.1016/j.ijmecsci.2011.11.004; Lee S, 2013, J MECH SCI TECHNOL, V27, P3309, DOI 10.1007/s12206-013-0853-9; Lepicovsky J, 2008, EXP FLUIDS, V44, P939, DOI 10.1007/s00348-007-0452-6; Lepicovsky J., 2002, TM2002211375 NASA; Mabey D. G., 1981, RAETR81059; MCDEVITT JB, 1976, AIAA J, V14, P606, DOI 10.2514/3.61402; MENTER FR, 1994, AIAA J, V32, P1598, DOI 10.2514/3.12149; Olsman WFJ, 2011, AIAA J, V49, P143, DOI 10.2514/1.J050542; Raghunathan S, 1999, AEROSP SCI TECHNOL, V3, P1, DOI 10.1016/S1270-9638(99)80017-0; Raghunathan S, 2008, AERONAUT J, V112, P1; Raghunathan SR, 1997, AIAA J, V35, P1890, DOI 10.2514/2.50; Tijdeman H., 1977, TR77090U NLR; Xiong J., 2010, 20105109 AIAA	22	0	0	KOREAN SOC MECHANICAL ENGINEERS	SEOUL	KSTC NEW BLD. 7TH FLOOR, 635-4 YEOKSAM-DONG KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	1738-494X	1976-3824		J MECH SCI TECHNOL	J. Mech. Sci. Technol.	JUN	2015	29	6					2415	2421		10.1007/s12206-015-0540-0		7	Engineering, Mechanical	Engineering	CK1FN	WOS:000355952400016		
J	Khokhlova, O; Tomita, Y; Hung, WC; Takano, T; Iwao, Y; Higuchi, W; Nishiyama, A; Reva, I; Yamamoto, T				Khokhlova, Olga; Tomita, Yusuke; Hung, Wei-Chun; Takano, Tomomi; Iwao, Yasuhisa; Higuchi, Wataru; Nishiyama, Akihito; Reva, Ivan; Yamamoto, Tatsuo			Elderly infection in the community due to ST5/SCCmecII methicillin-resistant Staphylococcus aureus (the New York/Japan clone) in Japan: Panton-Valentine leukocidin-negative necrotizing pneumonia	JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION			English	Article						Community-acquired necrotizing pneumonia; Elderly infection; Methicillin-resistant Staphylococcus aureus (MRSA); New York/Japan clone	MOLECULAR CHARACTERIZATION; VIRULENCE DETERMINANTS; MRSA; STRAINS; TRANSMISSION; HOSPITALS; THREAT	An 89-year-old man suffered from and died of necrotizing pneumonia with rapid progression and cavity formation due to methicillin-resistant Staphylococcus aureus (MRSA). He was at no risk for hospital-acquired MRSA infection. His MRSA exhibited genotype ST5/spa2(t002)/agr2/SCCmecII/coagulaseII and was negative for Panton-Valentine leukocidin, indicating the New York/Japan clone (the predominant epidemic hospital-acquired MRSA clone in Japan). However, this strain expressed the cytolytic peptide (phenol-soluble modulin or delta-hemolysin) genes at high level, similar to USA300 (the most common community-acquired MRSA in the United States), indicating a variant of the New York/Japan clone with an important feature of community-acquired MRSA. Copyright (C) 2012, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.	[Khokhlova, Olga; Hung, Wei-Chun; Takano, Tomomi; Iwao, Yasuhisa; Higuchi, Wataru; Nishiyama, Akihito; Reva, Ivan; Yamamoto, Tatsuo] Niigata Univ, Grad Sch Med & Dent Sci, Dept Infect Dis Control & Int Med, Div Bacteriol, Niigata 9518510, Japan; [Tomita, Yusuke] Kumamoto Univ, Fac Life Sci, Dept Resp Med, Kumamoto, Japan	Yamamoto, T (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Infect Dis Control & Int Med, Div Bacteriol, 757 Ichibanchou, Niigata 9518510, Japan.	tatsuoy@med.niigata-u.ac.jp					Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Yanagihara K, 2012, DIAGN MICR INFEC DIS, V72, P253, DOI 10.1016/j.diagmicrobio.2011.11.010; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Defres S, 2009, EUR RESPIR J, V34, P1470, DOI 10.1183/09031936.00122309; Yamamoto T, 2012, J INFECT CHEMOTHER, V18, P187, DOI 10.1007/s10156-011-0316-0; Oliveira DC, 2002, LANCET INFECT DIS, V2, P180, DOI 10.1016/S1473-3099(02)00227-X; Zaraket H, 2007, MICROBIOL IMMUNOL, V51, P171; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Chongtrakool P, 2006, ANTIMICROB AGENTS CH, V50, P1001, DOI 10.1128/AAC.50.3.1001-1012.2006; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Iwao Y, 2012, MICROBIOL IMMUNOL, V56, P76, DOI 10.1111/j.1348-0421.2011.00397.x; Takano T, 2008, ANTIMICROB AGENTS CH, V52, P837, DOI 10.1128/AAC.01001-07; Harinstein L, 2011, J HOSP INFECT, V79, P194, DOI 10.1016/j.jhin.2011.03.017; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Clinical and Laboratory Standards Institute, 2011, M100MS21 CLSI S; Iwao Y, 2012, J INFECT CHEMOTHER, V18, P228, DOI 10.1007/s10156-012-0379-6; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Ohkura T, 2009, J MED MICROBIOL, V58, P1329, DOI 10.1099/jmm.0.010173-0; Ozaki K, 2009, J INFECT CHEMOTHER, V15, P84, DOI 10.1007/s10156-009-0668-x; Strandberg KL, 2010, J INFECT DIS, V202, P1690, DOI 10.1086/657156; Yamamoto T, 2010, J INFECT CHEMOTHER, V16, P225, DOI 10.1007/s10156-010-0045-9	25	1	1	ELSEVIER TAIWAN	TAIPEI	RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2, TAIPEI, 10449, TAIWAN	1684-1182	1995-9133		J MICROBIOL IMMUNOL	J. Microbiol. Immunol. Infect.	JUN	2015	48	3					335	339		10.1016/j.jmii.2012.09.004		5	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CK1GB	WOS:000355954200015		
J	Yamamoto, W; Sasaki, K; Kita, R; Yagihara, S; Shinyashiki, N				Yamamoto, Wataru; Sasaki, Kaito; Kita, Rio; Yagihara, Shin; Shinyashiki, Naoki			Dielectric study on temperature-concentration superposition of liquid to glass in fructose-water mixtures	JOURNAL OF MOLECULAR LIQUIDS			English	Article							GOLDSTEIN BETA-RELAXATION; AQUEOUS-SOLUTIONS; SECONDARY RELAXATIONS; GLUCOSE; DYNAMICS; TRANSITION; SPECTROSCOPY; VISCOSITY	Broadband dielectric measurements of fructose-water mixtures with various fructose concentrations, C-f (wt.%), in the range of 5-94.6 wt.% were carried out in the frequency range of 2 mHz-50 GHz at 25 and 0 degrees C, to clarify the dynamics of water and fructose molecules in the mixtures from liquid to glass states as a function of C-f. For the mixtures with C-f below 45 wt.%, a single relaxation process originating from the reorientational motion of water, i.e., v relaxation, was observed. In contrast, in the mixtures with C-f above 45 wt.%, in addition to the v relaxation, a relaxation resulting from the cooperative motion of two components appears at a lower frequency than that of the v relaxation. The temperature dependences of the relaxation time and strength of the alpha and v relaxations are governed by the deviation from the glass transition temperature. Similarly, the concentration dependences of the relaxation time and strength are governed by the deviation from the glass transition concentration, which was defined as the concentration at which the relaxation time is 100 s. This means that the temperature-concentration superposition appears to be valid for the v and alpha relaxations. (C) 2015 Elsevier B.V. All rights reserved.	[Yamamoto, Wataru; Sasaki, Kaito; Kita, Rio; Yagihara, Shin; Shinyashiki, Naoki] Tokai Univ, Dept Phys, Hiratsuka, Kanagawa 2591292, Japan	Shinyashiki, N (reprint author), Tokai Univ, Dept Phys, Hiratsuka, Kanagawa 2591292, Japan.	naoki-ko@keyaki.cc.u-tokai.ac.jp			Tokai University Educational System General Research Organization	This work was supported in part by the Research and Study Project of Tokai University Educational System General Research Organization.	MASHIMO S, 1992, J CHEM PHYS, V97, P6759, DOI 10.1063/1.463653; Kessairi K, 2008, J PHYS CHEM B, V112, P4470, DOI 10.1021/jp800764w; Capaccioli S, 2007, J PHYS CHEM B, V111, P8197, DOI 10.1021/jp071857m; Ngai KL, 2004, J CHEM PHYS, V120, P857, DOI 10.1063/1.1630295; Fuchs K, 2001, J PHYS CHEM B, V105, P2036, DOI 10.1021/jp0030084; Mahawanich T, 2004, FOOD CHEM, V84, P169, DOI 10.1016/S0308-8146(03)00197-3; Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906; JOHARI GP, 1970, J CHEM PHYS, V53, P2372, DOI 10.1063/1.1674335; Sudo S, 2002, J PHYS CHEM A, V106, P458, DOI 10.1021/jp013117y; Shinyashiki N, 2008, J PHYS CHEM B, V112, P15470, DOI 10.1021/jp807038r; Bohmer R, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.135701; Ngai KL, 2013, CHEM PHYS, V424, P37, DOI 10.1016/j.chemphys.2013.05.018; WILLIAMS G, 1970, T FARADAY SOC, V66, P80, DOI 10.1039/tf9706600080; Mierzwa M, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2828496; Lelong G, 2009, J PHYS CHEM B, V113, P13079, DOI 10.1021/jp905001q; Fulcher GS, 1925, J AM CERAM SOC, V8, P339, DOI 10.1111/j.1151-2916.1925.tb16731.x; Buchner R, 1999, CHEM PHYS LETT, V306, P57, DOI 10.1016/S0009-2614(99)00455-8; Vogel H, 1921, PHYS Z, V22, P645; Ngai KL, 1998, J CHEM PHYS, V109, P6982, DOI 10.1063/1.477334; Kaminski K, 2006, J PHYS CHEM B, V110, P25045, DOI 10.1021/jp064710o; Behrends R, 2004, BIOPHYS CHEM, V111, P89, DOI 10.1016/j.bpc.2004.03.011; Bertolini D, 1998, J CHEM PHYS, V108, P6416, DOI 10.1063/1.476048; Cerveny S, 2008, PHYS REV E, V77; Fuchs K, 2002, J CHEM PHYS, V116, P7137, DOI 10.1063/1.1463426; Hill N.E., 1969, DIELECTRIC PROPERTIE, P1; Jansson H, 2005, J NON-CRYST SOLIDS, V351, P2858, DOI 10.1016/j.jnoncrysol.2005.04.086; Kohlrausch R., 1854, POGG ANN PHYS CHEM, V91, P179; Moran GR, 2000, CARBOHYD RES, V328, P573, DOI 10.1016/S0008-6215(00)00125-7; Oh J, 2006, J NON-CRYST SOLIDS, V352, P4679, DOI 10.1016/j.jnoncrysol.2006.02.167; Pomata MHH, 2009, J PHYS CHEM B, V113, P12999, DOI 10.1021/jp904019c; Sasaki K, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4869346; Seo JA, 2006, CARBOHYD RES, V341, P2516, DOI 10.1016/j.carres.2006.08.014; Shinyashiki N, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/20/205113; Sonoda MT, 2007, J PHYS CHEM B, V111, P11948, DOI 10.1021/jp0749120; Sudo S, 2001, J MOL LIQ, V90, P113, DOI 10.1016/S0167-7322(01)00113-1; Tammann G., 1926, Z ANORG ALLG CHEM, V156, P245, DOI DOI 10.1002/ZAAC.19261560121; Tombari E, 2001, J MOL STRUCT, V559, P245, DOI 10.1016/S0022-2860(00)00702-X; Tyagi M, 2006, CARBOHYD RES, V341, P650, DOI 10.1016/j.carres.2006.01.006	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7322	1873-3166		J MOL LIQ	J. Mol. Liq.	JUN	2015	206						39	46		10.1016/j.molliq.2015.01.057		8	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CJ5ZC	WOS:000355571800006		
J	Yoshimura, Y; Takekiyo, T; Abe, H; Hamaya, N				Yoshimura, Yukihiro; Takekiyo, Takahiro; Abe, Hiroshi; Hamaya, Nozomu			High-pressure phase behavior of the room temperature ionic liquid 1-ethyl-3-methylimidazolium nitrate	JOURNAL OF MOLECULAR LIQUIDS			English	Article						High pressure; Ionic liquid; Raman spectroscopy; Crystal polymorphism; Conformation	1-BUTYL-3-METHYLIMIDAZOLIUM HEXAFLUOROPHOSPHATE; GLASS-TRANSITION; TETRAFLUOROBORATE; DYNAMICS; DENSITY; SULFATE	The phase behavior of 1-ethyl-3-methylimidazolium nitrate ([emim][NO3]) was investigated at 298 K under high pressures, reaching 8.6 GPa, by Raman spectroscopy. This compound was found to crystallize at 0.4 GPa. The crystalline state of [emim][NO3] seems to undergo, at least, three more phase changes under the present experimental conditions. The conformational isomerism of the [emim](+) cation between planar and nonplanar forms was also investigated. Remarkably, these crystals showed drastic conformational changes upon phase changes, concomitant with the appearance of a new Raman peak attributable to the planar [emim](+) cation. This behavior contrasts markedly with previous results obtained for 1-ethyl-3-methylimidazolium tetrafluoroborate ([emim][BF4]), which showed pressure-induced amorphization at 2.8 GPa. (C) 2015 Elsevier B.V. All rights reserved.	[Yoshimura, Yukihiro; Takekiyo, Takahiro] Natl Def Acad, Dept Appl Chem, Yokosuka, Kanagawa 2398686, Japan; [Abe, Hiroshi] Natl Def Acad, Dept Mat Sci & Engn, Yokosuka, Kanagawa 2398686, Japan; [Hamaya, Nozomu] Ochanornizu Univ, Grad Sch Humanities & Sci, Tokyo 1128610, Japan	Yoshimura, Y (reprint author), Natl Def Acad, Dept Appl Chem, Yokosuka, Kanagawa 2398686, Japan.	muki@nda.ac.jp					Chang HC, 2007, J PHYS CHEM A, V111, P9201, DOI 10.1021/jp071055r; Umebayashi Y, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3100099; MAO HK, 1978, J APPL PHYS, V49, P3276, DOI 10.1063/1.325277; Yoshimura Y, 2013, J PHYS CHEM B, V117, P12296, DOI 10.1021/jp4055507; Ribeiro MCC, 2012, J PHYS CHEM B, V116, P7281, DOI 10.1021/jp302091d; Imanari M, 2008, CHEM PHYS LETT, V459, P89, DOI 10.1016/j.cplett.2008.05.012; Takekiyo T, 2011, CHEM PHYS LETT, V511, P241, DOI 10.1016/j.cplett.2011.06.022; Garcia-Saiz A, 2013, J PHYS CHEM B, V117, P3198, DOI 10.1021/jp3114623; Umebayashi Y, 2005, J PHYS CHEM A, V109, P8976, DOI 10.1021/jp053476j; Heimer NE, 2006, J MOL LIQ, V124, P84, DOI 10.1016/j.molliq.2005.08.004; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; KATO M, 1991, J CHEM PHYS, V94, P4440; Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t; MAO HK, 1986, J GEOPHYS RES-SOLID, V91, P4673, DOI 10.1029/JB091iB05p04673; Endo T, 2010, J PHYS CHEM B, V114, P407, DOI 10.1021/jp909256j; Sturlaugson AL, 2012, J PHYS CHEM B, V116, P1777, DOI 10.1021/jp209942r; Abe H, 2014, J PHYS CHEM B, V118, P1138, DOI 10.1021/jp409924h; Su L, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3127363; Chang HC, 2006, J PHYS CHEM B, V110, P3302, DOI 10.1021/jp0560009; Xu W, 2003, J PHYS CHEM B, V107, P6170, DOI 10.1021/jp0275894; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Frisch M. J., 2003, GAUSSIAN 03; Habasaki J., 2008, J CHEM PHYS, V129; Habasaki J, 2008, ANAL SCI, V24, P1321, DOI 10.2116/analsci.24.1321; Kabo GJ, 2004, J CHEM ENG DATA, V49, P453, DOI 10.1021/je034102r; Nestor J. R., 1973, Journal of Raman Spectroscopy, V1, DOI 10.1002/jrs.1250010309; Shigemi M, 2014, J SOLUTION CHEM, V43, P1614, DOI 10.1007/s10953-014-0233-9; Wasserscheid P., 2002, IONIC LIQUIDS SYNTHE; WILKES JS, 1992, J CHEM SOC CHEM COMM, P965, DOI 10.1039/c39920000965; Yamamuro O, 2006, CHEM PHYS LETT, V423, P371, DOI 10.1016/j.cplett.2006.03.074	30	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7322	1873-3166		J MOL LIQ	J. Mol. Liq.	JUN	2015	206						89	94		10.1016/j.molliq.2015.02.010		6	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CJ5ZC	WOS:000355571800012		
J	Rauma, PH; Pasco, JA; Berk, M; Stuart, AL; Koivumaa-Honkanen, H; Honkanen, RJ; Hodge, JM; Williams, LJ				Rauma, P. H.; Pasco, J. A.; Berk, M.; Stuart, A. L.; Koivumaa-Honkanen, H.; Honkanen, R. J.; Hodge, J. M.; Williams, L. J.			The association between major depressive disorder, use of antidepressants and bone mineral density (BMD) in men	JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS			English	Article						Antidepressants; Bone Mineral Density; Depression; Osteoporosis; Selective Serotonin Reuptake Inhibitor	SEROTONIN REUPTAKE INHIBITORS; QUANTITATIVE HEEL ULTRASOUND; POSTMENOPAUSAL WOMEN; OLDER MEN; GEELONG OSTEOPOROSIS; PREMENOPAUSAL WOMEN; FRACTURE RISK; LEPTIN LEVELS; HIP FRACTURE; YOUNG-ADULTS	Objective: Both depression and use of antidepressants have been negatively associated with bone mineral density (BMD) but mainly in studies among postmenopausal women. Therefore, the aim of this study was to investigate these relationships in men. Methods: Between 2006 and 2011, 928 men (aged 24-98 years) from the Geelong Osteoporosis Study completed a comprehensive questionnaire, clinical measurements and had BMD assessments at the forearm, spine, total hip and total body. Major depressive disorder (MDD) was identified using a structured clinical interview (SCID-I/NP). The cross-sectional associations between BMD and both MDD and antidepressant use were analyzed using multivariable linear regression. Results: Of the study population, 84 (9.1%) men had a single MDD episode, 50 (5.4%) had recurrent episodes and 65 (7.0%) were using antidepressants at the time of assessment. Following adjustments, recurrent MDD was associated with lower BMD at the forearm and total body (-6.5%, P=0.033 and -2.5%, P=0.033, respectively compared to men with no history of MDD), while single MDD episodes were associated with higher BMD at the total hip (+3.4%, P=0.030). Antidepressant use was associated with lower BMD only in lower-weight men (<75-110 kg depending on bone site). Conclusions: Both depression and use of antidepressants should be taken into account as possible risk factors for osteoporosis in men.	[Rauma, P. H.] UEF, Fac Hlth Sci, Sch Pharm, Social Pharm, Kuopio, Finland; [Rauma, P. H.; Honkanen, R. J.] UEF, Inst Clin Med, Surg, Bone & Cartilage Res Unit, Kuopio, Finland; [Pasco, J. A.; Berk, M.; Stuart, A. L.; Hodge, J. M.; Williams, L. J.] Deakin Univ, Sch Med, Geelong, Vic 3217, Australia; [Pasco, J. A.] Univ Melbourne, North West Acad Ctr, Dept Med, St Albans, Australia; [Berk, M.] Univ Melbourne, Orygen Youth Hlth Res Ctr, Parkville, Vic 3052, Australia; [Berk, M.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Koivumaa-Honkanen, H.] UEF, Inst Clin Med, Psychiat, Kuopio, Finland; [Koivumaa-Honkanen, H.] Univ Oulu, Inst Clin Med, Dept Child Psychiat, Oulu, Finland; [Koivumaa-Honkanen, H.] KUH, Dept Psychiat, Miki, Kagawa, Japan; [Koivumaa-Honkanen, H.] North Karelia Cent Hosp, Joensuu, Finland; [Koivumaa-Honkanen, H.] SOSTERI, Savonlinna, Finland; [Koivumaa-Honkanen, H.] SOTE, Iisalmi, Finland; [Koivumaa-Honkanen, H.] Lapland Hosp Dist, Rovaniemi, Finland; [Hodge, J. M.] Geelong Hosp, Barwon Biomed Res, Geelong, Vic, Australia	Williams, LJ (reprint author), Deakin Univ, IMPACT Strateg Res Ctr, Sch Med, POB 281, Geelong, Vic 3220, Australia.	lanaw@barwonhealth.org.au			National Health and Medical Research Council (NHMRC) [299831, 628582, 1009367]; Saastamoinen Foundation; National Doctoral Programme of Musculoskeletal Disorders and Biomaterials; Finnish Concordia Fund; North Savo Regional Fund of Finnish Cultural Foundation; Lapland Hospital District; NHMRC [1059660, 1064272]	The GOS is supported by grants from the National Health and Medical Research Council (NHMRC 299831, 628582 and 1009367). PHR received a travel grant and research support from the Saastamoinen Foundation, research support from National Doctoral Programme of Musculoskeletal Disorders and Biomaterials, Finnish Concordia Fund, North Savo Regional Fund of Finnish Cultural Foundation and an EVO grant from Lapland Hospital District. MB is supported by a NHMRC Senior Principal Research Fellowship (1059660). HK-H and RJH received an EVO grant from Lapland Hospital District. JMH is supported by a NHMRC. LJW is supported by a NHMRC Career Development Fellowship (1064272).	Pasco JA, 2012, INT J EPIDEMIOL, V41, P1565, DOI 10.1093/ije/dyr148; Spangler L, 2008, J GEN INTERN MED, V23, P567, DOI 10.1007/s11606-008-0525-0; Mussolino ME, 2004, PSYCHOSOM MED, V66, P533, DOI 10.1097/01.psy.0000132873.50734.7d; Wronska A, 2012, ACTA PHYSIOL, V205, P194, DOI 10.1111/j.1748-1716.2012.02409.x; Oikonen M, 2014, INT J BEHAV MED, V21, P464, DOI 10.1007/s12529-013-9327-9; Thomas T, 1999, ENDOCRINOLOGY, V140, P1630, DOI 10.1210/en.140.4.1630; Pasco JA, 2006, JAMA-J AM MED ASSOC, V296, P1353, DOI 10.1001/jama.296.11.1353; Altindag O, 2007, INT J CLIN PRACT, V61, P416, DOI 10.1111/j.1742-1241.2006.01276.x; Cizza G, 2009, TRENDS ENDOCRIN MET, V20, P367, DOI 10.1016/j.tem.2009.05.003; Bjarnason I, 1997, GUT, V40, P228; Schilling C, 2013, J CLIN PSYCHOPHARM, V33, P99, DOI 10.1097/JCP.0b013e31827cb179; Bolton JM, 2011, J CLIN PSYCHOPHARM, V31, P56, DOI 10.1097/JCP.0b013e3182075587; POOR G, 1995, CLIN ORTHOP RELAT R, P260; Zupan J, 2013, BIOCHEM MEDICA, V23, P43, DOI 10.11613/BM.2013.007; Wauquier F, 2009, TRENDS MOL MED, V15, P468, DOI 10.1016/j.molmed.2009.08.004; Williams LJ, 2011, J AFFECT DISORDERS, V131, P164, DOI 10.1016/j.jad.2010.11.019; Williams LJ, 2008, INT CLIN PSYCHOPHARM, V23, P84, DOI 10.1097/YIC.0b013e3282f2b3bb; Stunes AK, 2011, DIABETES OBES METAB, V13, P551, DOI 10.1111/j.1463-1326.2011.01378.x; Laimer M, 2006, J CLIN PSYCHIAT, V67, P421; Gilsanz V, 2009, J CLIN ENDOCR METAB, V94, P3387, DOI 10.1210/jc.2008-2422; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; de Paula FJA, 2010, DIABETES-METAB RES, V26, P622, DOI 10.1002/dmrr.1135; Kiebzak GM, 2002, ARCH INTERN MED, V162, P2217, DOI 10.1001/archinte.162.19.2217; Kinoshita M, 2010, MOL ENDOCRINOL, V24, P1978, DOI 10.1210/me.2010-0054; Haney EM, 2007, ARCH INTERN MED, V167, P1246, DOI 10.1001/archinte.167.12.1246; Kanis JA, 1997, OSTEOPOROSIS INT, V7, P390, DOI 10.1007/BF01623782; Reid IR, 2010, ARCH BIOCHEM BIOPHYS, V503, P20, DOI 10.1016/j.abb.2010.06.027; Diem SJ, 2007, ARCH INTERN MED, V167, P1240, DOI 10.1001/archinte.167.12.1240; Pasco JA, 2008, ACTA NEUROPSYCHIATR, V20, P112, DOI 10.1111/j.1601-5215.2008.00283.x; Cauley JA, 2005, OSTEOPOROSIS INT, V16, P1525, DOI 10.1007/s00198-005-1866-8; Moylan S, 2013, MOL PSYCHIATR, V18, P595, DOI 10.1038/mp.2012.33; Goldman LS, 1999, J GEN INTERN MED, V14, P569, DOI 10.1046/j.1525-1497.1999.03478.x; Oh SM, 2012, MATURITAS, V71, P142, DOI 10.1016/j.maturitas.2011.11.007; Eskandari F, 2007, ARCH INTERN MED, V167, P2329, DOI 10.1001/archinte.167.21.2329; Hodge JM, 2013, BIOL PSYCHIAT, V74, P32, DOI 10.1016/j.biopsych.2012.11.003; Atteritano M, 2013, INTERN EMERG MED, V8, P485, DOI 10.1007/s11739-011-0628-1; Calarge CA, 2010, J CLIN PSYCHIAT, V71, P338, DOI 10.4088/JCP.08m04595gre; Charles Luenda E, 2012, Glob J Health Sci, V4, P39, DOI 10.5539/gjhs.v4n3p39; Cornish J, 2002, J ENDOCRINOL, V175, P405, DOI 10.1677/joe.0.1750405; Dryden S, 1999, HORM METAB RES, V31, P363, DOI 10.1055/s-2007-978755; Erez Hany Burstein, 2012, Arch Osteoporos, V7, P247; First M. B., 2002, STRUCTURED CLIN INTE; Giles C, 1996, DIETARY QUESTIONNAIR; Henry MJ, 2011, MED J AUSTRALIA, V195, P321, DOI 10.5694/mja11.10571; Hernlund E, 2013, Arch Osteoporos, V8, P136, DOI 10.1007/s11657-013-0136-1; Jacka FN, 2007, JMHG, V4, P292, DOI 10.1016/j.jmhg.2007.05.008; Kishimoto T, 2012, CURR OPIN PSYCHIATR, V25, P415, DOI 10.1097/YCO.0b013e328355e1ac; Mezuk B, 2008, J GERONTOL A-BIOL, V63, P1410; Otmar R, 2013, J MENS HEALTH, V10, P22, DOI 10.1016/j.jomh.2012.10.006; Pasco JA, 2001, J CLIN ENDOCR METAB, V86, P1884, DOI 10.1210/jc.86.5.1884; Rauma PH, 2015, AUST NZ J PSYCHIAT, V49, P437, DOI 10.1177/0004867414565475; Rauma PH, 2014, PSYCHOSOM MED, V76, P709, DOI 10.1097/PSY.0000000000000114; Taylor VH, 2010, J OBES; Singh Tanvir, 2006, Psychiatry (Edgmont), V3, P33; Williams LJ, 2013, J AFFECT DISORDERS, V146, P395, DOI 10.1016/j.jad.2012.09.025; Williams LJ, 2011, BONE, V48, P1277, DOI 10.1016/j.bone.2011.03.435; Williams LJ, 2009, PSYCHOTHER PSYCHOSOM, V78, P16, DOI 10.1159/000162297; Wong SYS, 2005, OSTEOPOROSIS INT, V16, P610, DOI 10.1007/s00198-004-1730-2	58	0	0	JMNI	NAFPLION	7 SPILIADOU SQ, NAFPLION, 21 100, GREECE	1108-7161			J MUSCULOSKEL NEURON	J. Musculoskelet. Neuronal Interact.	JUN	2015	15	2					177	185				9	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	CK1XF	WOS:000356001800008		
J	Oh, H; Hirano, J; Takai, H; Ogata, Y				Oh, Hyun; Hirano, Jiro; Takai, Hideki; Ogata, Yorimasa			Effects of initial periodontal therapy on interleukin-1 beta level in gingival crevicular fluid and clinical periodontal parameters	JOURNAL OF ORAL SCIENCE			English	Article						chronic periodontitis; IL-1 beta; gingival crevicular fluid; initial periodontal therapy	SECRETION; MONOCYTES	Inflammatory cytokines may have important roles in periodontitis. We assessed the effects of initial periodontal therapy on clinical periodontal parameters and interleukin-1 beta (IL-1 beta) level in gingival crevicular fluid (GCF) from chronic periodontitis (CP) patients. After initial screening, baseline periodontal parameters such as probing pocket depth (PPD) and bleeding on probing (BOP) were measured. GCF samples were collected from 13 shallow (<= 3 mm) and deep (>= 5 mm) PPD sites from 13 CP patients, and GCF volume and IL-1 beta concentration were determined at baseline (before scaling and root planning) and at 2 and 4 months after initial therapy. Baseline BOP rate, GCF volume, and IL-1 beta level were significantly higher at deep PPD sites than at shallow PPD sites. Significant improvements in PPD and BOP were observed at 2 and 4 months after periodontal initial therapy in deep PPD sites only. In contrast, GCF volume and IL-1 beta concentration were lower at 2 and 4 months after initial therapy at all sites. These results suggest that GCF volume and IL-1 beta level in samples reflect disease severity and that these variables are better than PPD and BOP as markers of gingival inflammation.	[Oh, Hyun; Hirano, Jiro; Takai, Hideki; Ogata, Yorimasa] Nihon Univ Sch Dent Matsudo, Dept Periodontol, Matsudo, Chiba 2718587, Japan; [Hirano, Jiro] Hirano Dent Off, Hiratsuka, Kanagawa, Japan; [Takai, Hideki; Ogata, Yorimasa] Nihon Univ Sch Dent Matsudo, Res Inst Oral Sci, Matsudo, Chiba 2718587, Japan	Ogata, Y (reprint author), Nihon Univ Sch Dent Matsudo, Dept Periodontol, 2-870-1 Sakaecho Nishi, Matsudo, Chiba 2718587, Japan.	ogata.yorimasa@nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT) [25862057, 25463229, S1001024]; Nihon University from Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT)	This work was supported in part by a Grant-in-Aid for Scientific Research (Young Scientists (B); 25862057, (C); No. 25463229), a Nihon University President's Grant for Specified Multidisciplinary Research, and a grant of Strategic Research Base Development Program for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT), 2010-2014 (S1001024).	HOU LT, 1995, J CLIN PERIODONTOL, V22, P162; Al-Shammari KF, 2001, J PERIODONTOL, V72, P1045, DOI 10.1902/jop.2001.72.8.1045; RICHARDS D, 1988, ARCH ORAL BIOL, V33, P237, DOI 10.1016/0003-9969(88)90184-7; Fiola S, 2010, J IMMUNOL, V185, P3620, DOI 10.4049/jimmunol.0903736; Ishihara Y, 1997, J PERIODONTAL RES, V32, P524, DOI 10.1111/j.1600-0765.1997.tb00568.x; AKATSU T, 1991, J BONE MINER RES, V6, P183; Faizuddin M, 2003, J PERIODONTAL RES, V38, P111, DOI 10.1034/j.1600-0765.2003.01649.x; Tuter G, 2001, J PERIODONTOL, V72, P883, DOI 10.1902/jop.2001.72.7.883; Gaudreault E, 2007, J VIROL, V81, P8016, DOI 10.1128/JVI.00403-07; Slots J, 2010, PERIODONTOL 2000, V52, P117, DOI 10.1111/j.1600-0757.2009.00308.x; Engebretson SP, 1999, J PERIODONTOL, V70, P567, DOI 10.1902/jop.1999.70.6.567; Figueredo CMS, 1999, J PERIODONTOL, V70, P1457, DOI 10.1902/jop.1999.70.12.1457; WILTON JMA, 1992, J CLIN PERIODONTOL, V19, P53, DOI 10.1111/j.1600-051X.1992.tb01149.x; Armitage G C, 1996, Ann Periodontol, V1, P37, DOI 10.1902/annals.1996.1.1.37; Kato A, 2015, CLIN ORAL INVEST, V19, P1605, DOI 10.1007/s00784-014-1387-y; Kato A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071990; Reddy M S, 1997, Ann Periodontol, V2, P113, DOI 10.1902/annals.1997.2.1.113; REINHARDT RA, 1993, J CLIN PERIODONTOL, V20, P514, DOI 10.1111/j.1600-051X.1993.tb00400.x; WILTON JMA, 1993, ARCH ORAL BIOL, V38, P55, DOI 10.1016/0003-9969(93)90155-F	19	0	0	NIHON UNIV, SCHOOL DENTISTRY	TOYKO	1--13 KANDA-SURUGADAI, CHIYODA-KU, TOYKO, 101-8310, JAPAN	1343-4934	1880-4926		J ORAL SCI	J. Oral Sci.	JUN	2015	57	2					67	71		10.2334/josnusd.57.67		5	Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials	Dentistry, Oral Surgery & Medicine; Materials Science	CK4OP	WOS:000356203400001		
J	Motoyoshi, M; Sanuki-Suzuki, R; Uchida, Y; Saiki, A; Shimizu, N				Motoyoshi, Mitsuru; Sanuki-Suzuki, Rina; Uchida, Yasuki; Saiki, Akari; Shimizu, Noriyoshi			Maxillary sinus perforation by orthodontic anchor screws	JOURNAL OF ORAL SCIENCE			English	Article						temporary anchorage devices; TAD; mini implant	BEAM COMPUTED-TOMOGRAPHY; MINI-IMPLANTS; TITANIUM SCREWS; ROOT PROXIMITY; MEMBRANE; INSERTION; PREVALENCE; THICKNESS; STABILITY	To facilitate safe placement of orthodontic anchor screws (miniscrews), we investigated the frequency of maxillary sinus perforation after screw placement and the effect of sinus perforation on screw stability. Maxillary sinus perforations involving 82 miniscrews (diameter, 1.6 mm; length, 8 mm) were evaluated using cone-beam computed tomography. All miniscrews were placed in maxillary alveolar bone between the second premolar and first molar for anchorage for anterior retraction in patients undergoing first premolar extraction. The placement torque and screw mobility of each implant were determined using a torque tester and a Periotest device, and variability in these values in relation to sinus perforation was evaluated. Eight of the 82 miniscrews perforated the maxillary sinus. There was no case of sinusitis in patients with miniscrew perforation and no significant difference in screw mobility or placement torque between perforating and non-perforating miniscrews. The sinus floor was significantly thinner in perforated cases than in non-perforated cases. A sinus floor thickness of 6.0 mm or more is recommended in order to avoid miniscrew perforation of the maxillary sinus.	[Motoyoshi, Mitsuru; Sanuki-Suzuki, Rina; Uchida, Yasuki; Shimizu, Noriyoshi] Nihon Univ Sch Dent, Dept Orthodont, Tokyo 1018310, Japan; [Motoyoshi, Mitsuru; Sanuki-Suzuki, Rina; Uchida, Yasuki; Shimizu, Noriyoshi] Nihon Univ Sch Dent, Dent Res Ctr, Div Clin Res, Tokyo 1018310, Japan; [Saiki, Akari] Nihon Univ Grad Sch Dent, Oral Struct & Funct Biol, Tokyo, Japan	Motoyoshi, M (reprint author), Nihon Univ Sch Dent, Dept Orthodont, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018310, Japan.	motoyoshi.mitsuru@nihon-u.ac.jp					Aimetti M, 2001, INT J PERIODONT REST, V21, P581; Kim TW, 2006, AM J ORTHOD DENTOFAC, V130, P676, DOI 10.1016/j.ajodo.2005.07.013; Kravitz ND, 2007, AM J ORTHOD DENTOFAC, V131, pS43, DOI 10.1016/j.ajodo.2006.04.027; Motoyoshi M, 2007, INT J ORAL MAX IMPL, V22, P779; Hernandez-Alfaro F, 2008, CLIN ORAL IMPLAN RES, V19, P91, DOI 10.1111/j.1600-0501.2007.01372.x; Pikos MA, 2008, IMPLANT DENT, V17, P24, DOI 10.1097/ID.0b013e318166d934; Ardekian L, 2006, J ORAL MAXIL SURG, V64, P277, DOI 10.1016/j.joms.2005.10.031; BRANEMARK PI, 1984, J ORAL MAXIL SURG, V42, P497, DOI 10.1016/0278-2391(84)90008-9; Miyawaki S, 2003, AM J ORTHOD DENTOFAC, V124, P373, DOI 10.1016/S0889-5406(03)00565-1; Liou EJW, 2007, AM J ORTHOD DENTOFAC, V131, P352, DOI 10.1016/j.ajodo.2005.04.044; Herman RJ, 2006, AM J ORTHOD DENTOFAC, V130, P228, DOI 10.1016/j.ajodo.2006.02.029; Freudenthaler JW, 2001, CLIN ORAL IMPLAN RES, V12, P358, DOI 10.1034/j.1600-0501.2001.012004358.x; Bae Seong-Min, 2002, J Clin Orthod, V36, P298; Baumgaertel S, 2009, CLIN ORAL IMPLAN RES, V20, P638, DOI 10.1111/j.1600-0501.2008.01691.x; Gracco A, 2012, KOREAN J ORTHOD, V42, P329, DOI 10.4041/kjod.2012.42.6.329; Gracco Antonio, 2010, J Clin Orthod, V44, P439; Kanomi R, 1997, J Clin Orthod, V31, P763; Kuroda S, 2007, AM J ORTHOD DENTOFAC, V131, pS68, DOI 10.1016/j.ajodo.2006.06.017; Laursen MG, 2013, ANGLE ORTHOD, V83, P222, DOI 10.2319/042512-344.1; Lee J S, 2001, J Clin Orthod, V35, P643; Motoyoshi Mitsuru, 2011, J Oral Sci, V53, P407; Motoyoshi M, 2014, CLIN ORAL INVEST, V18, P321, DOI 10.1007/s00784-013-0965-8; Park Hyo-Sang, 2002, J Clin Orthod, V36, P592; Pazera P, 2011, ORTHOD CRANIOFAC RES, V14, P17, DOI 10.1111/j.1601-6343.2010.01502.x	24	0	0	NIHON UNIV, SCHOOL DENTISTRY	TOYKO	1--13 KANDA-SURUGADAI, CHIYODA-KU, TOYKO, 101-8310, JAPAN	1343-4934	1880-4926		J ORAL SCI	J. Oral Sci.	JUN	2015	57	2					95	100		10.2334/josnusd.57.95		6	Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials	Dentistry, Oral Surgery & Medicine; Materials Science	CK4OP	WOS:000356203400005		
J	Kurokawa, H; Takamizawa, T; Rikuta, A; Tsubota, K; Miyazaki, M				Kurokawa, Hiroyasu; Takamizawa, Toshiki; Rikuta, Akitomo; Tsubota, Keishi; Miyazaki, Masashi			Three-year clinical evaluation of posterior composite restorations placed with a single-step self-etch adhesive	JOURNAL OF ORAL SCIENCE			English	Article						single-step self-etch adhesive; posterior composite restoration; S-PRG filler	RESIN COMPOSITE; MARGINAL QUALITY; PRG FILLERS; IN-VITRO; DEMINERALIZATION; SYSTEMS; ENAMEL; DURABILITY; INLAYS; DENTIN	In this clinical study, we evaluated the 3-year clinical performance of a resin composite containing a surface-prereacted glass ionomer (S-PRG) filler (Beautifil II; Shofu Inc., Kyoto, Japan) placed with a single-step self-etch adhesive (Beauti-Bond; Shofu Inc.) in posterior restorations. Using modified US Public Health Service criteria, two experienced investigators performed clinical evaluations at the baseline, 6 months, 18 months, and 3 years. Color match, marginal adaptation, anatomical form, surface roughness, marginal discoloration, postoperative sensitivity, and secondary caries were evaluated. After 3 years, 26 patients attended the recall and 31 restorations were evaluated. No postoperative sensitivity or secondary caries was observed at any time point, and no restorations failed during the follow-up period. However, surface roughness, marginal adaptation, and marginal discoloration showed deterioration after 3 years. In conclusion, although some clinical changes were observed, resin composite containing S-PRG filler placed with self-etch adhesive exhibited acceptable clinical behavior in posterior restorations.	[Kurokawa, Hiroyasu; Takamizawa, Toshiki; Rikuta, Akitomo; Tsubota, Keishi; Miyazaki, Masashi] Nihon Univ Sch Dent, Dept Operat Dent, Tokyo 1018310, Japan; [Kurokawa, Hiroyasu; Takamizawa, Toshiki; Rikuta, Akitomo; Tsubota, Keishi; Miyazaki, Masashi] Nihon Univ Sch Dent, Dent Res Ctr, Div Biomat Sci, Tokyo 1018310, Japan	Kurokawa, H (reprint author), Nihon Univ Sch Dent, Dept Operat Dent, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018310, Japan.	kurokawa.hiroyasu@nihon-u.ac.jp			Japan Society for the Promotion of Science [26462896, 25462967, 24592883]; Sato Fund; Dental Research Center of the Nihon University School of Dentistry, Japan	This work was supported in part by a Grant-in-Aid for Scientific Research (C) 26462896, 25462967, 24592883 from the Japan Society for the Promotion of Science. This project was also supported in part by the Sato Fund and by a grant from the Dental Research Center of the Nihon University School of Dentistry, Japan (2014).	Van Meerbeek B, 2010, DENT MATER, V26, pE100, DOI 10.1016/j.dental.2009.11.148; Ferracane JL, 2011, DENT MATER, V27, P29, DOI 10.1016/j.dental.2010.10.020; Adebayo OA, 2012, OPER DENT, V37, P137, DOI 10.2341/11-172-L; Carvalho RM, 2012, DENT MATER, V28, P72, DOI 10.1016/j.dental.2011.09.011; Miyazaki M, 2014, J ORAL SCI, V56, P1, DOI 10.2334/josnusd.56.1; Dawson V, 2014, J ENDODONT, V40, P1303, DOI 10.1016/j.joen.2014.05.002; Akimoto N, 2011, DENT MATER J, V30, P411, DOI 10.4012/dmj.2010-205; Van Meerbeek B, 2011, DENT MATER, V27, P17, DOI 10.1016/j.dental.2010.10.023; Manuja N, 2012, J CLIN PEDIATR DENT, V36, P223; Barabanti N, 2013, J DENT, V41, P436, DOI 10.1016/j.jdent.2013.02.009; Chee B, 2012, J DENT, V40, P443, DOI 10.1016/j.jdent.2012.02.007; Fujimoto Y, 2010, DENT MATER J, V29, P392, DOI 10.4012/dmj.2010-015; Saito T, 2003, CARIES RES, V37, P445, DOI 10.1159/000073398; van Meerbeek B, 2005, DENT MATER J, V24, P1; Cvar JF, 2005, CLIN ORAL INVEST, V9, P215, DOI 10.1007/s00784-005-0018-z; Cardoso MV, 2011, AUST DENT J, V56, P31, DOI 10.1111/j.1834-7819.2011.01294.x; Asano K, 2014, OPER DENT, V39, P159; Attin T, 2000, OPER DENT, V25, P259; Dejak B, 2015, DENT MATER, V31, pE77, DOI 10.1016/j.dental.2014.11.016; Ferraris Federico, 2014, Int J Esthet Dent, V9, P70; Haller B, 2013, QUINTESSENCE INT, V44, P645, DOI 10.3290/j.qi.a30182; Han JM, 2014, DENT MATER J, V33, P725, DOI 10.4012/dmj.2013-339; Han LL, 2006, DENT MATER J, V25, P509; Hanabusa M, 2011, DENT MATER, V27, P818, DOI 10.1016/j.dental.2011.04.007; Iino M, 2014, DENT MATER J, V33, P48, DOI 10.4012/dmj.2013-202; Ikemura K, 2008, DENT MATER J, V27, P315; Ikemura K, 2003, DENT MATER, V19, P137, DOI 10.1016/S0109-5641(02)00022-2; Kaga M, 2014, EUR J ORAL SCI, V122, P78, DOI 10.1111/eos.12107; Mine A, 2010, J DENT RES, V89, P1505, DOI 10.1177/0022034510384871; Mukai Y, 2009, EUR J ORAL SCI, V117, P750, DOI 10.1111/j.1600-0722.2009.00678.x; Murayama R, 2012, DENT MATER J, V31, P954, DOI 10.4012/dmj.2012-153; Opdam NJM, 2014, J DENT RES, V93, P943, DOI 10.1177/0022034514544217; Roggendorf MJ, 2012, J DENT, V40, P1068, DOI 10.1016/j.jdent.2012.08.019; Seemann R, 2011, INT DENT J, V61, P252, DOI 10.1111/j.1875-595X.2011.00068.x; Thuy Tran Thu, 2008, Arch Oral Biol, V53, P1017, DOI 10.1016/j.archoralbio.2008.06.005	35	0	0	NIHON UNIV, SCHOOL DENTISTRY	TOYKO	1--13 KANDA-SURUGADAI, CHIYODA-KU, TOYKO, 101-8310, JAPAN	1343-4934	1880-4926		J ORAL SCI	J. Oral Sci.	JUN	2015	57	2					101	108		10.2334/josnusd.57.101		8	Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials	Dentistry, Oral Surgery & Medicine; Materials Science	CK4OP	WOS:000356203400006		
J	Tsunori, K				Tsunori, Katsuyoshi			Effects of parathyroid hormone dosage and schedule on bone regeneration	JOURNAL OF ORAL SCIENCE			English	Article						parathyroid hormone; administration protocol; bone regeneration therapy; rat calvaria; micro-CT	DEFECT MODEL; RATS; FRAGMENT; DENSITY; REPAIR	This study investigated the effects of administration of parathyroid hormone (PTH) at different dosages and schedules on bone regeneration in critical-size bone defects in rat calvariae. After calvarial defects had been prepared in 50 rats, they were divided into five treatment groups: 15 mu g/kg PTH daily (PTH-15), 35 mu g/kg PTH three times per week (PTH-35), 105 mu g/kg once per week (PTH-105-1), 105 mu g/kg three times per week (PTH-105-3), and controls given vehicle alone. Bone regeneration was evaluated radiographically using micro-computed tomography (micro-CT) or histologically. The amount of newly generated bone in the calvarial defects was found to be significantly greater in the PTH groups than in the control group, and did not differ significantly among the PTH-15, PTH-35, and PTH-105-1 groups, whereas the PTH-105-3 group showed a significantly greater degree of new bone formation than the other PTH groups. It appeared that a higher dose of PTH stimulated a greater degree of bone regeneration in this experimental setting. The present results also suggest that the total dose of PTH administered is significantly related to the amount of bone regenerated within a defined period, indicating that less frequent administration of PTH might be a feasible protocol for bone regeneration therapy.	[Tsunori, Katsuyoshi] Nihon Univ Grad Sch Dent, Div Appl Oral Sci, Tokyo, Japan	Tsunori, K (reprint author), Care of Sato S, Nihon Univ Sch Dent, Dept Periodontol, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018310, Japan.	satou.shuuichi@nihon-u.ac.jp					Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Yun JI, 2010, J CLIN PERIODONTOL, V37, P419, DOI 10.1111/j.1600-051X.2010.01547.x; Stancoven BW, 2013, J PERIODONTAL RES, V48, P243, DOI 10.1111/jre.12001; Andreassen TT, 2004, J CRANIOFAC SURG, V15, P424, DOI 10.1097/00001665-200405000-00014; Retzepi M, 2010, CLIN ORAL IMPLAN RES, V21, P567, DOI 10.1111/j.1600-0501.2010.01922.x; Skripitz R, 2004, ACTA ORTHOP SCAND, V75, P654, DOI 10.1080/00016470410004012; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Chan HL, 2013, J DENT RES, V92, P18, DOI 10.1177/0022034512464779; EJERSTED C, 1993, J BONE MINER RES, V8, P1097; Nozaka K, 2008, BONE, V42, P90, DOI 10.1016/j.bone.2007.08.041; Ramseier CA, 2012, PERIODONTOL 2000, V59, P185, DOI 10.1111/j.1600-0757.2011.00432.x; Iida-Klein A, 2005, J ENDOCRINOL, V186, P549, DOI 10.1677/joe.1.06270; DOBNIG H, 1995, ENDOCRINOLOGY, V136, P3632, DOI 10.1210/en.136.8.3632; Dobnig H, 1997, ENDOCRINOLOGY, V138, P4607, DOI 10.1210/en.138.11.4607; Mitlak BH, 2002, CURR OPIN PHARMACOL, V2, P694, DOI 10.1016/S1471489202002084; Tang ZL, 2014, J ORAL MAXIL SURG, V72, P419, DOI 10.1016/j.joms.2013.07.037	16	0	0	NIHON UNIV, SCHOOL DENTISTRY	TOYKO	1--13 KANDA-SURUGADAI, CHIYODA-KU, TOYKO, 101-8310, JAPAN	1343-4934	1880-4926		J ORAL SCI	J. Oral Sci.	JUN	2015	57	2					131	136		10.2334/josnusd.57.131		6	Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials	Dentistry, Oral Surgery & Medicine; Materials Science	CK4OP	WOS:000356203400010		
J	Tsurumachi, T; Hirano, Y; Hira, A; Aida, Y; Ogiso, B				Tsurumachi, Tamotsu; Hirano, Yoriyuki; Hira, Akiko; Aida, Yasuyo; Ogiso, Bunnai			Developmental disturbance of a mandibular central incisor following trauma to the primary predecessor	JOURNAL OF ORAL SCIENCE			English	Article						crown dilaceration; dental trauma; developmental disturbance; mandibular incisor; primary tooth	PERMANENT SUCCESSORS; PRIMARY DENTITION; TEETH	When a primary tooth sustains a traumatic injury, development of the permanent tooth can be disturbed, leading to various malformations. This case report details the 7-year follow-up of a developmental anomaly of a central mandibular incisor in a 10-year-old Japanese girl with a history of dental trauma that had occurred at age 4. The trauma had resulted in unusual crown dilaceration in the permanent successor, which exhibited a discoloured and abnormal crown morphology. Radiographic examination revealed crown dilaceration of the tooth, which had a curved root canal.	[Tsurumachi, Tamotsu; Hirano, Yoriyuki; Hira, Akiko; Aida, Yasuyo; Ogiso, Bunnai] Nihon Univ Sch Dent, Dept Endodont, Tokyo 1018310, Japan; [Tsurumachi, Tamotsu; Ogiso, Bunnai] Nihon Univ Sch Dent, Dent Res Ctr, Div Adv Dent Treatment, Tokyo 1018310, Japan	Tsurumachi, T (reprint author), Nihon Univ Sch Dent, Dept Endodont, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018310, Japan.	tsurumachi.tamotsu@nihon-u.ac.jp			Sato Fund, Nihon University School of Dentistry	This study was supported by the Sato Fund, Nihon University School of Dentistry (2013).	ANDREASEN J O, 1971, Scandinavian Journal of Dental Research, V79, P284; Signore A, 2009, J DENT, V37, P115, DOI 10.1016/j.jdent.2008.10.007; Christophersen P, 2005, DENT TRAUMATOL, V21, P320, DOI 10.1111/j.1600-9657.2005.00323.x; Coutinho T, 2011, INT ENDOD J, V44, P688, DOI 10.1111/j.1365-2591.2010.01842.x; LONEY RW, 1990, J PROSTHET DENT, V63, P506, DOI 10.1016/0022-3913(90)90066-L; Nelson P, 2005, DENT TRAUMATOL, V21, P309, DOI 10.1111/j.1600-9657.2005.00333.x; Sennhenn-Kirchner S, 2006, DENT TRAUMATOL, V22, P237, DOI 10.1111/j.1600-9657.2006.00383.x; SMITH RJ, 1980, J DENT CHILD, V47, P36; Turgut MD, 2006, DENT TRAUMATOL, V22, P283, DOI 10.1111/j.1600-9657.2006.00357.x; VONARX T, 1993, AUST DENT J, V38, P1	10	0	0	NIHON UNIV, SCHOOL DENTISTRY	TOYKO	1--13 KANDA-SURUGADAI, CHIYODA-KU, TOYKO, 101-8310, JAPAN	1343-4934	1880-4926		J ORAL SCI	J. Oral Sci.	JUN	2015	57	2					157	160		10.2334/josnusd.57.157		4	Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials	Dentistry, Oral Surgery & Medicine; Materials Science	CK4OP	WOS:000356203400014		
J	Takada, A; Endo, T				Takada, Akira; Endo, Tomoko			Object transfer in request-accept sequence in Japanese caregiver-child interactions	JOURNAL OF PRAGMATICS			English	Article						Directives; Interaction; Japanese; Language socialization; Young children	COMMUNICATION	Requesting an object or information is a basic and ubiquitous activity in human interactions, but the sequential organization of this activity varies considerably across speech communities. In line with the Language Socialization approach, this paper inquires into (1) how children formulate their acceptance of object requests made by caregivers, (2) the role of the requested object in request accept sequences, and (3) the distinctive features of object requests in Japanese caregiver child interactions (CCIs). Based on video data of Japanese caregiver child (aged 0-5 years) interactions, we conducted an interaction analysis of conversations involving object transfer. The results revealed that the features of request acceptance sequences are shaped by (1) the trigger of the object request, (2) the features of the requested object, (3) timing, bodily orientation, and the manner of transferring the requested object. By engaging in object request sequences, caregivers not only made reciprocal communication more effective but also set and modified the frame of their activity. The study also revealed that object request sequences are the place of negotiation for both children and caregivers with respect to (re)constructing the appropriate morality of Japanese culture. (C) 2015 Elsevier B.V. All rights reserved.	[Takada, Akira] Kyoto Univ, Grad Sch Asian & African Area Studies, Sakyo, Kyoto 6068501, Japan; [Endo, Tomoko] Univ Tsukuba, Fac Human & Social Sci, Tsukuba, Ibaraki 3058571, Japan	Takada, A (reprint author), Kyoto Univ, Grad Sch Asian & African Area Studies, 46 Yoshida Shimoadachi, Sakyo, Kyoto 6068501, Japan.	takada@jambo.africa.kyoto-u.ac.jp; endotomoko@gmail.com			JSPS [19672002, 24242035, 25-40090]	This work is financially supported by JSPS Grant-in-Aid for Young Scientists (S) "Cultural formation of responsibility in caregiver-child interactions" (Project No. 19672002 headed by Akira Takada) and JSPS Grant-in-Aid for Scientific Research (A) "Cultural and ecological foundations of education and learning: An anthropological study on rhythm, imitation, and exchange" (Project No. 24242035 headed by Akira Takada), and JSPS Grant-in-Aid for Postdoctoral Researchers "Pursuing response in child-caregiver interactions" (Project No. 25-40090 headed by Tomoko Endo).	Adamson L., 1995, COMMUNICATION DEV IN; Akita K, 2012, COGN LINGUIST, V23, P67, DOI 10.1515/cog-2012-0003; Hutchins E, 2005, J PRAGMATICS, V37, P1555, DOI 10.1016/j.pragma.2004.06.008; Curl TS, 2008, RES LANG SOC INTERAC, V41, P129, DOI 10.1080/08351810802028613; Liszkowski U, 2012, COGNITIVE SCI, V36, P698, DOI 10.1111/j.1551-6709.2011.01228.x; Goodwin C, 2000, J PRAGMATICS, V32, P1489, DOI 10.1016/S0378-2166(99)00096-X; Cartmill EA, 2010, ANIM COGN, V13, P793, DOI 10.1007/s10071-010-0328-7; Brown P., 1987, POLITENESS SOME UNIV; Bruner J., 1983, CHILDS TALK LEARNING; Burdelski Matthew J., 2006, THESIS U CALIFORNIA; Cartmill EA, 2012, PHILOS T R SOC B, V367, P129, DOI 10.1098/rstb.2011.0162; Clancy P., 1986, LANGUAGE SOCIALIZATI, P213; Duranti Alessandro, 2012, HDB LANGUAGE SOCIALI; Endo Tomoko, 2013, WORKSH JAP LANG INT; Goffman E., 1981, FORMS TALK; Goodwin Charles, 2010, MCDONALD I MONOGRAPH, P103; Goodwin M. H., 2006, HIDDEN LIFE GIRLS GA; Goodwin Marjorie Harness, 2006, TEXT TALK, V26, P513; Goodwin MH, 2012, EMOTION INTERACTION, P16, DOI DOI 10.1093/ACPROF:OSO/9780199730735.003.0002; Heritage J, 1984, STRUCTURES SOCIAL AC, P299, DOI DOI 10.1017/CB09780511665868; Hymes D., 1972, SOCIOLINGUISTICS, P269; Ingold T, 2011, BEING ALIVE: ESSAYS ON MOVEMENT, KNOWLEDGE AND DESCRIPTION, P1; Ingold Tim, 2001, DEBATED MIND EVOLUTI, P113; Lemer Gene H., 2011, EMBODIED INTERACTION, P44; Moore Leslie C., 2012, HDB LANGUAGE SOCIALI, P209; Nishizaka Aug, 1997, PERSPECTIVE LINTERAC; Ochs E, 2005, DISCOURSE STUD, V7, P547, DOI 10.1177/1461445605054406; Schegloff Emanuel A., 2007, SEQUENCE ORG INTERAC, V1; Searle J. R., 1975, LANGUAGE MIND KNOWLE, P344; Shibatani Masayoshi, 1996, GRAMMATICAL CONSTRUC, P157; Suzuki Yoko, 2013, SOUND SYMBOLISM MIME, P167; Takada Akira, 2014, REV PRIMATOL, V5; Takada A, 2013, LANG COMMUN, V33, P420, DOI 10.1016/j.langcom.2013.03.012; Tomasello M., 1999, CULTURAL ORIGINS HUM; Tulbert E, 2011, EMBODIED INTERACTION, P79; Yamada Toshihiro, 2004, BENEFACTIVES JAPANES	36	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-2166	1879-1387		J PRAGMATICS	J. Pragmat.	JUN	2015	82				SI		52	66		10.1016/j.pragma.2015.03.011		15	Linguistics; Language & Linguistics	Linguistics	CK3OT	WOS:000356126100005		
J	Zhu, W; Hu, J; Wang, X; Tian, JK; Komatsu, S				Zhu, Wei; Hu, Jin; Wang, Xin; Tian, Jingkui; Komatsu, Setsuko			Organ-Specific Analysis of Mahonia Using Gel-Free/Label-Free Proteomic Technique	JOURNAL OF PROTEOME RESEARCH			English	Article						Mahonia; organ; gel-free/label-free proteomics; alkaloid; polyethylene glycol fractionation	POLYETHYLENE-GLYCOL FRACTIONATION; AQUIFOLIUM STEM BARK; ANTIMICROBIAL ACTIVITY; MASS-SPECTROMETRY; OPIUM POPPY; ANTIINFLAMMATORY ACTIVITIES; ISOQUINOLINE ALKALOIDS; ENDOPLASMIC-RETICULUM; CRUDE EXTRACT; BIOSYNTHESIS	Mahonia is an important medicinal plant used for the treatment of human diseases. To explore the molecular mechanism's underlying the different pharmacological functions of Mahonia, organ-specific proteomics was performed. Protein profiles of leaves, stems, and roots from 2-year-old Mahonia plants were determined using gel-free/label-free proteomic technique, and totals of 304, 314, and 182 proteins were identified, respectively, and included 36 common proteins. In leaves, the most abundant proteins related to photosynthesis. Furthermore, polyethylene glycol fractionation was used to identify low-abundance proteins in leaves. With this approach, oxidative pentose phosphate-related proteins were identified in leaves. In stems, the main functional categories of proteins were protein synthesis and redox ascorbate/glutathione metabolism. In roots, proteins were mainly related to protein synthesis, stress, and amino acid metabolism. Of the proteins identified, the abundance of calreticulin was markedly higher in roots than that detected in stems and leaves. Many roots-specific proteins, including S-adenosylmethionine synthetase and (S)-tetrahydroprotoberberine oxidase, involved in the biosynthesis of alkaloids, were identified. Consistent with this finding, levels of the alkaloids, which were columbamine, jatrorrhizine, palmatine, tetrandrine, and berberine, were markedly higher in roots compared to those detected in stems and leaves. Taken together, these results suggest that alkaloid biosynthesis is an important function in Mahonia roots.	[Zhu, Wei; Hu, Jin; Tian, Jingkui] Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Hangzhou 310027, Zhejiang, Peoples R China; [Wang, Xin; Komatsu, Setsuko] Natl Agr & Food Res Org, Natl Inst Crop Sci, Tsukuba, Ibaraki 3058518, Japan	Tian, JK (reprint author), Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Hangzhou 310027, Zhejiang, Peoples R China.	tjk@zju.edu.cn; skomatsu@affrc.go.jp			Zhejiang Provincial Natural Science Foundation of China [LZ14H280001]	We thank Dr. Y. Nanjo, Dr. K. Nishizawa, and Mr. X. Yin at the National Institute of Crop Science for experimental support and guidance during this research. This work was supported by the Zhejiang Provincial Natural Science Foundation of China (LZ14H280001).	Aghaei K, 2013, FRONT PLANT SCI, V4, P1; Alcantara J, 2005, PLANT PHYSIOL, V138, P173, DOI 10.1104/pp.105.059287; Chao J, 2009, J ETHNOPHARMACOL, V125, P297, DOI 10.1016/j.jep.2009.06.024; Zhang SL, 2014, PHYTOMEDICINE, V21, P1356, DOI 10.1016/j.phymed.2014.07.007; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Aryal UK, 2012, J PROTEOME RES, V11, P425, DOI 10.1021/pr200917t; Ahsan N, 2007, PHYSIOL PLANTARUM, V131, P555, DOI 10.1111/j.1399-3054.2007.00980.x; Zhang Y, 2009, ANAL CHEM, V81, P6317, DOI 10.1021/ac9004887; Slobodnikova L, 2004, PHYTOTHER RES, V18, P674, DOI 10.1002/ptr.1517; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Li AR, 2007, FITOTERAPIA, V78, P379, DOI 10.1016/j.fitote.2007.03.001; Zhang L, 2011, J AGR FOOD CHEM, V59, P12361, DOI 10.1021/jf203146e; Klovekorn W, 2007, INT J CLIN PHARM TH, V45, P583; Valpuesta V, 2004, TRENDS PLANT SCI, V9, P573, DOI 10.1016/j.tplants.2004.10.002; Dowdle J, 2007, PLANT J, V52, P673, DOI 10.1111/j.1365-313X.2007.03266.x; GIELER U, 1995, J DERMATOL TREAT, V6, P31, DOI 10.3109/09546639509080587; HASSAN AM, 1995, BIOCHEM BIOPH RES CO, V211, P54, DOI 10.1006/bbrc.1995.1777; AMANN M, 1988, EUR J BIOCHEM, V175, P17, DOI 10.1111/j.1432-1033.1988.tb14160.x; Alam I, 2013, BIOTECH HISTOCHEM, V88, P61, DOI 10.3109/10520295.2012.729863; Chao J, 2013, INT J MOL SCI, V14, P2928, DOI 10.3390/ijms14022928; ROBERTS MF, 1983, ARCH BIOCHEM BIOPHYS, V222, P599, DOI 10.1016/0003-9861(83)90558-1; Vollekova A, 2001, FOLIA MICROBIOL, V46, P107, DOI 10.1159/000050777; Hu WC, 2011, FOOD CHEM TOXICOL, V49, P799, DOI 10.1016/j.fct.2010.12.001; Zeng XY, 2006, J ETHNOPHARMACOL, V108, P317, DOI 10.1016/j.jep.2006.05.014; Shinoda K, 2010, BIOINFORMATICS, V26, P576, DOI 10.1093/bioinformatics/btp700; Bajpai D, 2007, FIBER POLYM, V8, P487, DOI 10.1007/BF02875870; Wong BS, 2009, CHEM-BIOL INTERACT, V180, P165, DOI 10.1016/j.cbi.2009.02.011; Wolucka BA, 2005, J EXP BOT, V56, P2527, DOI 10.1093/jxb/eri246; Wyatt SE, 2002, TRANSGENIC RES, V11, P1, DOI 10.1023/A:1013917701701; Miflin BJ, 2002, J EXP BOT, V53, P979, DOI 10.1093/jexbot/53.370.979; Hashimoto M, 2007, PROTEOMICS, V7, P1293, DOI 10.1002/pmic.200600921; Brosch M, 2009, J PROTEOME RES, V8, P3176, DOI 10.1021/pr800982s; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Roje S, 2006, PHYTOCHEMISTRY, V67, P1686, DOI 10.1016/j.phytochem.2006.04.019; Chao J, 2009, AM J CHINESE MED, V37, P1085, DOI 10.1142/S0192415X0900751X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; Nanjo Y, 2012, J PROTEOME RES, V11, P372, DOI 10.1021/pr200701y; Bock A, 2002, PLANTA, V216, P57, DOI 10.1007/s00425-002-0867-5; BRAMBLE JL, 1991, BIOTECHNOL BIOENG, V37, P859, DOI 10.1002/bit.260370910; BRUGGEMANN W, 1994, PLANTA, V194, P160, DOI 10.1007/BF01101674; Dulin MW, 2010, BOT REV, V76, P405, DOI 10.1007/s12229-010-9057-5; FACCHINI PJ, 1995, PLANT CELL, V7, P1811; Gulliver Wayne P, 2005, Am J Ther, V12, P398, DOI 10.1097/01.mjt.0000174350.82270.da; Guo XR, 2012, ACTA PHYSIOL PLANT, V34, P589, DOI 10.1007/s11738-011-0859-9; Hung YC, 2010, BBA-PROTEINS PROTEOM, V1804, P1310, DOI 10.1016/j.bbapap.2010.02.001; Irene A., 2013, J PROTEOMICS, V83, P160; Kalhori N, 2013, PROTEIN J, V32, P551, DOI 10.1007/s10930-013-9516-z; Kim ST, 2001, ELECTROPHORESIS, V22, P2103, DOI 10.1002/1522-2683(200106)22:10<2103::AID-ELPS2103>3.0.CO;2-W; Komatsu S, 1996, PLANT CELL PHYSIOL, V37, P748; Kost'alova D, 2001, FITOTERAPIA, V72, P802, DOI 10.1016/S0367-326X(01)00336-7; Li AR, 2008, WORLD J MICROB BIOT, V24, P569, DOI 10.1007/s11274-007-9494-4; Lirussi D, 2004, FITOTERAPIA, V75, P718, DOI 10.1016/j.fitote.2004.09.017; Lu H, 2010, CARBOHYD POLYM, V82, P136, DOI 10.1016/j.carbpol.2010.04.049; MURPHY DJ, 1982, PLANTA, V155, P316, DOI 10.1007/BF00429458; Nouri M. Z., 2010, PROTEOMICS, V10, P1930; Qiu Yongjian, 2012, Plant Signal Behav, V7, P907, DOI 10.4161/psb.20721; Samanani N, 2006, PLANT J, V47, P547, DOI 10.1111/j.1365-313X.2006.02801.x; Spelman K, 2011, PHYTOTHER RES, V25, P473, DOI 10.1002/ptr.3350; Tohge T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00062; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wagner D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080740; Wang XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071403; Xi JH, 2006, PHYTOCHEMISTRY, V67, P2341, DOI 10.1016/j.phytochem.2006.08.005; Zeng Xiangying, 2003, Zhong Yao Cai, V26, P29; Zhang L, 2014, J PROTEOMICS, V110, P59, DOI 10.1016/j.jprot.2014.07.036; Zheng W., 2015, PROTEOMICS	68	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	JUN	2015	14	6					2669	2685		10.1021/acs.jproteome.5b00208		17	Biochemical Research Methods	Biochemistry & Molecular Biology	CK1IW	WOS:000355962000029		
J	Bissen-Miyajima, H; Negishi, K; Hieda, O; Kinoshita, S				Bissen-Miyajima, Hiroko; Negishi, Kazuno; Hieda, Osamu; Kinoshita, Shigeru			Microincision Hydrophobic Acrylic Aspheric Toric Intraocular Lens for Astigmatism and Cataract Correction	JOURNAL OF REFRACTIVE SURGERY			English	Article							POSTERIOR CORNEAL ASTIGMATISM; ROTATIONAL STABILITY; CLINICAL-OUTCOMES; INTRAOPERATIVE IDENTIFICATION; REFERENCE POINT; SINGLE-PIECE; AXIS; IMPLANTATION; SURGERY; IOL	PURPOSE: To evaluate the efficacy and safety of a new acrylic one-piece toric intraocular lens (IOL). METHODS: This prospective multicenter clinical trial included 93 eyes of 61 patients that were implanted with a hydrophobic acrylic toric IOL from 2010 to 2012 and followed for 1 year. This IOL uses the platform of a microincision one-piece aspheric IOL, the NY-60 IOL (HOYA, Tokyo, Japan), with three increments in cylindrical power (NHT15, 1.5 diopters [D]; NHT23, 2.25 D; and NHT30, 3.0 D). The inclusion criterion was preoperative corneal astigmatism from 0.75 to 3.00 D. The primary endpoint was uncorrected distance visual acuity (UDVA) of 0.0 logMAR (20/20 Snellen) or better 6 months postoperatively. In addition to UDVA, corrected distance visual acuity (CDVA), residual astigmatism, stability of the IOL alignment, need of realignment, and the rate of Nd: YAG laser capsulotomy were evaluated up to 1 year postoperatively. Errors in astigmatic correction were assessed using Alpin's vector analysis. RESULTS: The primary endpoint was achieved in 54.8% of eyes. One year postoperatively, the logMAR UDVAs were 0.02 +/- 0.13, 0.05 +/- 0.17, and 0.09 +/- 0.14 with models NHT15, NHT23, and NHT30, which corresponds to 0.96 (19/20 Snellen), 0.89 (18/20 Snellen), and 0.82 (16/20 Snellen), respectively. One year postoperatively, the residual astigmatism was 0.66 +/- 0.58 D. In each evaluation, the mean absolute change in the position of the axis mark was between 1.93 degrees and 2.32 degrees. Three eyes required repositioning of the IOL axis and 2 eyes received Nd: YAG laser capsulotomy. The correction error showed an undercorrection with against-the-rule astigmatism and overcorrection with with-the-rule astigmatism. CONCLUSIONS: The new one-piece toric IOL provided desirable clinical outcomes and stability in eyes with corneal astigmatism.	[Bissen-Miyajima, Hiroko] Suidobashi Hosp, Tokyo Dent Coll, Dept Ophthalmol, Chiyoda Ku, Tokyo 1010061, Japan; [Negishi, Kazuno] Keio Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan; [Hieda, Osamu; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan	Bissen-Miyajima, H (reprint author), Suidobashi Hosp, Tokyo Dent Coll, Dept Ophthalmol, Chiyoda Ku, Misaki Cho 2-9-18, Tokyo 1010061, Japan.	bissen@tdc.ac.jp			HOYA, Tokyo, Japan	Supported by HOYA, Tokyo, Japan.	Hayashi K, 2010, OPHTHALMOLOGY, V117, P1313, DOI 10.1016/j.ophtha.2009.11.041; Ferreira TB, 2012, J REFRACT SURG, V28, P551, DOI 10.3928/1081597X-20120703-03; Koch DD, 2012, J CATARACT REFR SURG, V38, P2080, DOI 10.1016/j.jcrs.2012.08.036; Goggin M, 2011, ARCH OPHTHALMOL-CHIC, V129, P1004, DOI 10.1001/archophthalmol.2011.178; Holland E, 2010, OPHTHALMOLOGY, V117, P2104, DOI 10.1016/j.ophtha.2010.07.033; Sheppard AL, 2013, J CATARACT REFR SURG, V39, P41, DOI 10.1016/j.jcrs.2012.08.055; Zhang JY, 2013, CLIN EXP OPHTHALMOL, V41, P379, DOI 10.1111/j.1442-9071.2012.02868.x; Sanders DR, 2013, J CATARACT REFR SURG, V39, P1190, DOI 10.1016/j.jcrs.2013.06.006; Alpins N, 2001, J CATARACT REFR SURG, V27, P31, DOI 10.1016/S0886-3350(00)00798-7; Koch DD, 2013, J CATARACT REFR SURG, V39, P1803, DOI 10.1016/j.jcrs.2013.06.027; Suzuki A, 1997, J CATARACT REFR SURG, V23, P1491; Visser N, 2013, J CATARACT REFR SURG, V39, P624, DOI 10.1016/j.jcrs.2013.02.020; Hirnschall N, 2014, AM J OPHTHALMOL, V157, P405, DOI 10.1016/j.ajo.2013.09.032; Kobashi H, 2012, J CATARACT REFR SURG, V38, P1352, DOI 10.1016/j.jcrs.2012.03.032; Kwartz J, 2010, BRIT J OPHTHALMOL, V94, P1003, DOI 10.1136/bjo.2009.163485; Lee H, 2015, CURR OPIN OPHTHALMOL, V26, P34, DOI 10.1097/ICU.0000000000000119; Mencucci R, 2013, BRIT J OPHTHALMOL, V97, P578, DOI 10.1136/bjophthalmol-2013-303094; Miyake T, 2014, J CATARACT REFR SURG, V40, P1654, DOI 10.1016/j.jcrs.2014.01.044; Miyata K, 2011, J REFRACT SURG, V27, P339, DOI 10.3928/1081597X-20101005-02; Shah GD, 2012, J CATARACT REFR SURG, V38, P54, DOI 10.1016/j.jcrs.2011.08.028; SHIMIZU K, 1994, J CATARACT REFR SURG, V20, P523; Watanabe K, 2012, JPN J OPHTHALMOL, V56, P31, DOI 10.1007/s10384-011-0097-0; Wolffsohn JS, 2011, J CATARACT REFR SURG, V37, P454, DOI 10.1016/j.jcrs.2010.09.022	23	0	0	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	1081-597X	1938-2391		J REFRACT SURG	J. Refractive Surg.	JUN	2015	31	6					358	364		10.3928/1081597X-20150521-01		7	Ophthalmology; Surgery	Ophthalmology; Surgery	CK3WV	WOS:000356148200001		
J	Matsuno, A; Gai, ZQ; Tanaka, M; Kato, K; Kato, S; Katoh, T; Shimizu, T; Yoshioka, T; Kishimura, H; Tanaka, Y; Yao, M				Matsuno, Asuka; Gai, Zuoqi; Tanaka, Miyuki; Kato, Koji; Kato, Sanae; Katoh, Tsuyoshi; Shimizu, Takeshi; Yoshioka, Takeya; Kishimura, Hideki; Tanaka, Yoshikazu; Yao, Min			Crystallization and preliminary X-ray crystallographic study of a 3.8-MDa respiratory supermolecule hemocyanin	JOURNAL OF STRUCTURAL BIOLOGY			English	Article						Hemocyanin; Supermolecule; Decamer; Crystallization; Self-rotation function	SEPIA-OFFICINALIS HEMOCYANIN; CRYO-EM STRUCTURE; FUNCTIONAL UNITS; CRYOELECTRON MICROSCOPY; MOLECULAR-MODEL; INTERFACES; MECHANISM; REVEAL	Many molluscs transport oxygen using a very large cylindrical multimeric copper-containing protein named hemocyanin. The molluscan hemocyanin forms a decamer (cephalopods) or multidecamer (gastropods) of approximately 330-450 kDa subunits, resulting in a molecular mass >3.3 MDa. Therefore, molluscan hemocyanin is one of the largest proteins. The reason why these organisms use such a large supermolecule for oxygen transport remains unclear. Atomic-resolution X-ray crystallographic analysis is necessary to unveil the detailed molecular structure of this mysterious large molecule. However, its propensity to dissociate in solution has hampered the crystallization of its intact form. In the present study, we successfully obtained the first crystals of an intact decameric molluscan hemocyanin. The diffraction dataset at 3.0-angstrom resolution was collected by merging the datasets of two isomorphic crystals. Electron microscopy analysis of the dissolved crystals revealed cylindrical particles. Furthermore, self-rotation function analysis clearly showed the presence of a fivefold symmetry with several twofold symmetries perpendicular to the fivefold axis. The absorption spectrum of the crystals showed an absorption peak around 345 nm. These results indicated that the crystals contain intact hemocyanin decamers in the oxygen-bound form. (C) 2015 Elsevier Inc. All rights reserved.	[Matsuno, Asuka; Kato, Koji; Tanaka, Yoshikazu; Yao, Min] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0600810, Japan; [Gai, Zuoqi; Tanaka, Miyuki; Kato, Koji; Tanaka, Yoshikazu; Yao, Min] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan; [Kato, Sanae; Katoh, Tsuyoshi] Asahikawa Med Univ, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan; [Shimizu, Takeshi; Yoshioka, Takeya] Hokkaido Ind Technol Ctr, Hakodate, Hokkaido 0410801, Japan; [Kishimura, Hideki] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido 0418611, Japan	Tanaka, Y (reprint author), Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan.	tanaka@sci.hokudai.ac.jp	yao, min/F-5287-2011	yao, min/0000-0003-1687-5904	JSPS KAKENHI [26291008, 25450298]; Platform for Drug Discovery, Informatics, and Structural Life Science; Ministry of Education, Culture, Sports, Science, and Technology (Japan)	This work was supported by JSPS KAKENHI Grant number 26291008 (to Y.T.) and 25450298 (to S.K.), the Platform for Drug Discovery, Informatics, and Structural Life Science (to S.K. and Y.T.), and the Regional Innovation Strategy Support Program (to S.K., T.S., and T.Y.) of the Ministry of Education, Culture, Sports, Science, and Technology (Japan). The X-ray diffraction experiments were performed under the proposal numbers 2013G165 (Photon Factory), 2013A6829, 2013A1096, 2013B6829, 2013B1031, 2014A1193, 2014B6930, 2014B1295, 2014B1292 (SPring-8), and 20121296 (Swiss Light Source).	Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Geyer H, 2005, J BIOL CHEM, V280, P40731, DOI 10.1074/jbc.M505985200; Siddiqui NI, 2007, BIOCHEM BIOPH RES CO, V361, P705, DOI 10.1016/j.bbrc.2007.07.098; Jaenicke E, 2010, BIOCHEM J, V426, P373, DOI 10.1042/BJ20091501; Gatsogiannis C, 2009, J MOL BIOL, V385, P963, DOI 10.1016/j.jmb.2008.10.080; Perbandt M, 2003, BIOCHEMISTRY-US, V42, P6341, DOI 10.1021/bi020672x; Lamy J, 1998, J MOL BIOL, V284, P1051, DOI 10.1006/jmbi.1998.2235; Cuff ME, 1998, J MOL BIOL, V278, P855, DOI 10.1006/jmbi.1998.1647; Harris JR, 1999, MICRON, V30, P597, DOI 10.1016/S0968-4328(99)00036-0; Jaenicke E, 2011, IUBMB LIFE, V63, P183, DOI 10.1002/iub.435; Zhang QF, 2013, STRUCTURE, V21, P604, DOI 10.1016/j.str.2013.02.018; Gatsogiannis C, 2007, J MOL BIOL, V374, P465, DOI 10.1016/j.jmb.2007.09.036; Markl J, 2013, BBA-PROTEINS PROTEOM, V1834, P1840, DOI 10.1016/j.bbapap.2013.02.020; Meissner U, 2000, J MOL BIOL, V298, P21, DOI 10.1006/jmbi.2000.3631; Boisset N, 2000, J MOL BIOL, V296, P459, DOI 10.1006/jmbi.1999.3460; Becker M.I., 2014, IMMUNE RESPONSE ACTI; Gatsogiannis C, 2015, STRUCTURE, V23, P93, DOI 10.1016/j.str.2014.10.013; Zhu HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098766	19	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1047-8477	1095-8657		J STRUCT BIOL	J. Struct. Biol.	JUN	2015	190	3					379	382		10.1016/j.jsb.2015.04.015		4	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CK3KS	WOS:000356115600013		
J	Aye, HP; Nakamori, Y				Aye, Hnin Pwint; Nakamori, Yoshiteru			Constructing an access system for unbanked in Myanmar to a microfinance institution	JOURNAL OF SYSTEMS SCIENCE AND SYSTEMS ENGINEERING			English	Article						Legal policy; microfinance institution; unbanked; access system; obstacles	RURAL CREDIT MARKETS	In Myanmar, the formal financial institution does not provide uncollateralized credits. The rural unbanked under the poverty line is depending on the informal money-lenders with high interest rate. Private Agency Collaboration Together is only one microfinance institution providing the credits without collateral and with low interest rate to the unbanked in Myanmar. Half of the unbanked are unable to borrow the loans from the microfinance institution because of the weakness of the information contribution and the strict legal policies of the microfinance institution. Therefore, the objective of this study is to construct a system to improve the relationship between the microfinance institution and the unbanked by reducing the obstacles in the current system of microfinance institution. The legal policy is studied from the vision of the local unbanked as the originality of this research and the i-System methodology is applied to accomplish the research. The current system comprises the information contribution, loans and legal policies. The current system is only one relationship between the microfinance institution and unbanked. When the ten obstacles occurred in the current system, the unbanked cannot approach to the microfinance institution. An access system including four sub-systems is developed depending on the collected ideas to solve these obstacles and intend to improve the relationship between microfinance institution and the unbanked.	[Aye, Hnin Pwint; Nakamori, Yoshiteru] Japan Adv Inst Sci & Technol, Sch Knowledge Sci, Nomi, Ishikawa 9231292, Japan	Aye, HP (reprint author), Japan Adv Inst Sci & Technol, Sch Knowledge Sci, 1-1 Asahi Dai, Nomi, Ishikawa 9231292, Japan.	hninpwintaye24@gmail.com; nakamori0212@gmail.com					Adams D. W., 1983, EDI TRAINING MAT; Adams D. W., 1992, INFORMAL FINANCE LOW, P393; ATKINSON AB, 1987, ECONOMETRICA, V55, P749, DOI 10.2307/1911028; Binswanger H. P., 1995, ENV SUSTAINABLE DEV, V4; BRAVERMAN A, 1986, WORLD DEV, V14, P1253, DOI 10.1016/0305-750X(86)90104-X; Checkland P., 1999, SOFT SYSTEMS METHODO; Checkland P. B., 1981, SYSTEMS THINKING SYS; Chiumya C., 2006, THESIS U MANCHESTER; Gallardo J., 2001, FRAMEWORK REGULATING; Ghate P., 1992, INFORMAL FINANCE SOM; Hardy D.C., 2002, WP02159 INT MON FUND; HOFF K, 1990, WORLD BANK ECON REV, V4, P235, DOI 10.1093/wber/4.3.235; Johnson R.A., 1996, STAT PRINCIPLES METH; Khandker S., 1998, FIGHTING POVERTY MIC; King K., 2006, SKILLS DEV POVERTY R; Lhing NN, 2010, J FAC AGR KYUSHU U, V55, P173; Littlefield E, 2003, FOCUS NOTE, V24, P1; MacEwan A., 2007, MEANING POVERTY; Meagher P., 2002, MICROFINANCE REGULAT; Morduch J., 2002, 1014 NEW YORK U; Nakamori Y., 2013, KNOWLEDGE SYSTEMS SC; Nakamori Y., 2000, 1 INT S KNOWL SYST S, P57; Nakamori Y, 2012, KNOWLEDGE SCI MODELI; Nakamori Y., 2003, Journal of Systems Science and Systems Engineering, V12, DOI 10.1007/s11518-006-0120-z; Natke HG, 1999, INT J SYST SCI, V30, P283, DOI 10.1080/002077299292434; PACT (Private Agency Collaborations Together), 2012, PACT ANN REP 2012; PACT (Private Agency Collaborations Together), 2010, 40 YEARS ANN REP 201; PACT (Private Agency Collaborations Together), 2010, PACT ANN REP 2010; Ryoke M., 2007, INT J KNOWLEDGE SYST, V4, P31; The World Bank, 2012, WORLD DEV IND 2012; UNCTAD, 2011, LEAST DEV COUNTR REP; UNDP ( United Nations Development Program), 2011, POV DYN REP; UNDP (United Nations Development Program), 2011, MDG DAT REP; UNDP (United Nations Development Program), 2011, POV PROF; Wieerzbicki A.P., 2007, IFIP TC7 C KRAK POL; World Bank, 1990, WORLD DEV REP 1990 P; World Bank, 1992, 150 WORLD BANK; Yamashita Y., 2007, SYST MAN CYB 2007 IS, P332; Yunus M., 2007, CREATING WORLD POVER; Yunus M., 1984, P WORKSH BOGR BANGL	40	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1004-3756	1861-9576		J SYST SCI SYST ENG	J. Syst. Sci. Syst. Eng.	JUN	2015	24	2					229	257		10.1007/s11518-015-5272-2		29	Operations Research & Management Science	Operations Research & Management Science	CJ7UE	WOS:000355704400005		
J	Kohyama, K				Kohyama, Kaoru			Oral Sensing of Food Properties	JOURNAL OF TEXTURE STUDIES			English	Article						Heterogeneity; multiple sensing; tactile perception; taste receptors; texture	POINT SHEET SENSOR; BITTER TASTE RECEPTORS; MECHANICAL-PROPERTIES; SAMPLE THICKNESS; BITE FORCE; TEXTURE-PERCEPTION; ARTIFICIAL TONGUE; COMPRESSION TEST; ION CHANNELS; SWEET TASTE	Food properties are perceived through oral receptors during eating. In this review, various oral receptors involved in food oral processing of food are briefly described. Touch and taste are the most important senses in oral perception. Different tactile receptors are used to determine the mechanical properties, size, shape and their temporal/spatial changes of food materials in the oral cavity. Instrumental test results are often inconsistent with sensory-perceived food properties. A multiple-point pressure sensor inserted into the mouth with food can be used to mimic the human tactile systems and to relate instrumental and sensory results. Three evaluation systems of food properties with artificial tongues which were designed in different concepts are presented. Physiological research results are useful to simulate oral processing to design texture, flavor and appearance of diets for people with different eating functions. Practical ApplicationsFood oral processing is a dynamic process in which a mouthful of food is reduced in heterogeneity and converted into a more homogenized swallowable bolus. Human-mimetic sensing technologies have been recently developed to analyze the physical and chemical properties, these complex interactions and drastic changes of foodstuffs during oral processing. As practical applications, two current social topics are discussed in terms of homogenization of foods during oral processing. First, with the increase of elderly population, a need for texture-modified foods has emerged: hard food must be converted into paste-like, where the function of oral processing is partly done by pre-oral processing. Second, WASHOKU, the traditional dietary cultures of the Japanese, was added to UNESCO's Intangible Cultural Heritage list in 2013. Seasoning in the mouth, one of the features of oral processing of WASHOKU, is addressed. To improve food texture and flavor is needed for people with various ages and regions.	Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	Kohyama, K (reprint author), Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan.	kaoruk@affrc.go.jp					Adams S., 2012, Food oral processing: fundamentals of eating and sensory perception, P177; Caicedo A, 2001, SCIENCE, V291, P1557, DOI 10.1126/science.1056670; Verhagen JV, 2006, NEUROSCI BIOBEHAV R, V30, P613, DOI 10.1016/j.neubiorev.2005.11.003; Gao ZH, 2013, J TEXTURE STUD, V44, P387, DOI 10.1111/jtxs.12026; Ohsu T, 2010, J BIOL CHEM, V285, P1016, DOI 10.1074/jbc.M109.029165; Trulsson M, 2010, J NEUROPHYSIOL, V104, P2257, DOI 10.1152/jn.00565.2010; Engelen L, 2008, J TEXTURE STUD, V39, P83, DOI 10.1111/j.1745-4603.2007.00132.x; Kohyama K, 2004, ARCH ORAL BIOL, V49, P805, DOI 10.1016/j.archoralbio.2004.04.006; Dunkel A, 2007, J AGR FOOD CHEM, V55, P6712, DOI 10.1021/jf071276u; Foster KD, 2011, J FOOD SCI, V76, pR49, DOI 10.1111/j.1750-3841.2010.02029.x; Dan H, 2007, ARCH ORAL BIOL, V52, P455, DOI 10.1016/j.archoralbio.2006.11.005; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chen JS, 2009, FOOD HYDROCOLLOID, V23, P1, DOI 10.1016/j.foodhyd.2007.11.013; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Buettner A, 2010, FOOD QUAL PREFER, V21, P915, DOI 10.1016/j.foodqual.2010.01.008; Nishinari K, 2004, J TEXTURE STUD, V35, P113, DOI 10.1111/j.1745-4603.2004.tb00828.x; Forde CG, 2013, APPETITE, V60, P180, DOI 10.1016/j.appet.2012.10.002; Hayashi N, 2008, J AGR FOOD CHEM, V56, P7384, DOI 10.1021/jf800933x; Wilkinson C, 2000, TRENDS FOOD SCI TECH, V11, P442, DOI 10.1016/S0924-2244(01)00033-4; Scilingo EP, 2010, IEEE T HAPTICS, V3, P109, DOI [10.1109/TOH.2010.2, 10.1109/ToH.2010.2]; Ogasawara M, 2006, FOOD CHEM, V99, P736, DOI 10.1016/j.foodchem.2005.08.051; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; HUTCHINGS JB, 1988, J TEXTURE STUD, V19, P103, DOI 10.1111/j.1745-4603.1988.tb00928.x; Hayakawa F, 2013, J TEXTURE STUD, V44, P140, DOI 10.1111/jtxs.12006; Kohyama K, 2004, J ORAL REHABIL, V31, P327, DOI 10.1046/j.1365-2842.2003.01248.x; Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; SRINIVASAN MA, 1995, J NEUROPHYSIOL, V73, P88; Wadhera D, 2014, EAT BEHAV, V15, P132, DOI 10.1016/j.eatbeh.2013.11.003; Koc H, 2013, ANNU REV FOOD SCI T, V4, P237, DOI 10.1146/annurev-food-030212-182637; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Stevens JC, 1996, SOMATOSENS MOT RES, V13, P153, DOI 10.3109/08990229609051403; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Tunick MH, 2011, J AGR FOOD CHEM, V59, P1477, DOI 10.1021/jf1021994; Yamada Y, 2005, RESP PHYSIOL NEUROBI, V147, P177, DOI 10.1016/j.resp.2005.02.017; Small DM, 2012, PHYSIOL BEHAV, V107, P540, DOI 10.1016/j.physbeh.2012.04.011; Tahara Y, 2013, IEEE SENS J, V13, P3001, DOI 10.1109/JSEN.2013.2263125; Lucas PW, 2002, FOOD QUAL PREFER, V13, P203, DOI 10.1016/S0950-3293(00)00036-7; Szczesniak AS, 2002, FOOD QUAL PREFER, V13, P215, DOI 10.1016/S0950-3293(01)00039-8; Behrens M, 2006, CELL MOL LIFE SCI, V63, P1501, DOI 10.1109/s00018-006-6113-8; Bourne M, 2004, J TEXTURE STUD, V35, P125, DOI 10.1111/j.1745-4603.2004.tb00829.x; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Kohyama K, 2001, BIOSCI BIOTECH BIOCH, V65, P2597, DOI 10.1271/bbb.65.2597; Askwith CC, 2001, P NATL ACAD SCI USA, V98, P6459, DOI 10.1073/pnas.111155398; Bourne M., 2002, FOOD TEXTURE VISCOSI; BOURNE MC, 1966, J FOOD SCI, V31, P282, DOI 10.1111/j.1365-2621.1966.tb00494.x; Dan H, 2007, PHYSIOL BEHAV, V92, P601, DOI 10.1016/j.physbeh.2007.05.006; Dan H., 2007, APPETITE, V50, P158; Dan H, 2003, J TEXTURE STUD, V34, P287, DOI 10.1111/j.1745-4603.2003.tb01062.x; Engelen L., 2012, Food oral processing: fundamentals of eating and sensory perception, P15; Fujita K., 2001, P 5 WORLD MULT SYST, P78; Green B. G., 2002, FOOD QUAL PREFER, V14, P99; Hayashi M, 2014, FOOD CHEM, V145, P372, DOI 10.1016/j.foodchem.2013.08.067; Hayashi N., 2013, FOOD RES INT, V53, P813; Hayashi N, 2006, BIOSCI BIOTECH BIOCH, V70, P626, DOI 10.1271/bbb.70.626; Ikeda Y., 2004, T VIRTUAL REALITY SO, V9, P187; Ishihara S, 2013, J TEXTURE STUD, V44, P104, DOI 10.1111/jtxs.12002; Ishihara S, 2014, J TEXTURE STUD, V45, P354, DOI 10.1111/jtxs.12080; JACOBS R, 1994, J PERIODONTAL RES, V29, P153, DOI 10.1111/j.1600-0765.1994.tb01208.x; Kalantzis A, 2007, ARCH ORAL BIOL, V52, P149, DOI 10.1016/j.archoralbio.2006.09.001; Keast R. S. J., 2002, FOOD QUAL PREFER, V14, P111, DOI DOI 10.1016/S0950-3293(02)00110-6; Kimura F, 2013, ADV ROBOTICS, V27, P553, DOI 10.1080/01691864.2013.777016; Kohyama K, 2003, BIOSCI BIOTECH BIOCH, V67, P1492, DOI 10.1271/bbb.67.1492; Kohyama K, 1997, J TEXTURE STUD, V28, P605, DOI 10.1111/j.1745-4603.1997.tb00141.x; Kohyama K, 2005, J TEXTURE STUD, V36, P157, DOI 10.1111/j.1745-4603.2005.00009.x; Kohyama K., 2001, Food Science and Technology Research, V7, P290, DOI 10.3136/fstr.7.290; Kohyama K, 2003, Gerodontology, V20, P15, DOI 10.1111/j.1741-2358.2003.00015.x; Kohyama K, 2004, BIOSCI BIOTECH BIOCH, V68, P2104, DOI 10.1271/bbb.68.2104; Kusakabe Y., 2010, JPN J TASTE SMELL RE, V17, P5; Kusakabe Y., 2014, JPN J TASTE IN PRESS, V21; LEE WE, 1988, J TEXTURE STUD, V19, P27, DOI 10.1111/j.1745-4603.1988.tb00922.x; MAFF (Ministry of Agriculture Forestry and Fisheries Japan), 2012, WASH TRAD DIET CULT; Maruyama Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034489; MHLW (Ministry of Health Labour and Welfare Japan), 2014, JAP VIT STAT 2013; Nakatsu S, 2012, INNOV FOOD SCI EMERG, V16, P267, DOI 10.1016/j.ifset.2012.07.010; PELEG M, 1980, J TEXTURE STUD, V10, P245, DOI 10.1111/j.1745-4603.1980.tb00250.x; Sakamoto K, 2006, BIOSCI BIOTECH BIOCH, V70, P1564, DOI 10.1271/bbb.50562; Shiozawa K., 1993, J JPN SOC MASTICAT S, V3, P51; St John SJ, 2003, CHEM SENSES, V28, P33, DOI 10.1093/chemse/28.1.33; Strassburg J, 2009, FOOD QUAL PREFER, V20, P329, DOI 10.1016/j.foodqual.2009.02.004; Strassburg J, 2007, J BIOMECH, V40, P3533, DOI 10.1016/j.jbiomech.2007.04.012; van dersBilt A., 2012, FOOD ORAL PROCESSING, P63; van der Bilt A, 2009, WOODHEAD PUBL FOOD S, P3, DOI 10.1039/9781847556622-00003; vansBoven R W., 1994, NEUROLOGY, V44, P2361; vansVliet T., 2009, ADV COLLOID INTERFAC, V150, P27; vansVliet T., 2011, J TEXTURE STUD, V42, P82; WHO (World Health Organization), 2013, LIF EXP 2012; Xue SA, 2006, J VOICE, V20, P391, DOI 10.1016/j.jvoice.2005.05.001; Yagi K, 2006, PEDIAT DENT J, V16, P17	92	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4901	1745-4603		J TEXTURE STUD	J. Texture Stud.	JUN	2015	46	3					138	151		10.1111/jtxs.12099		14	Food Science & Technology	Food Science & Technology	CK6MT	WOS:000356342900003		
J	Funami, T; Isono, M; Ikegami, A; Nakao, S; Nakauma, M; Fujiwara, S; Minagi, Y; Hori, K; Ono, T				Funami, Takahiro; Isono, Mai; Ikegami, Akira; Nakao, Satomi; Nakauma, Makoto; Fujiwara, Shigehiro; Minagi, Yoshitomo; Hori, Kazuhiro; Ono, Takahiro			Throat Sensations of Beverages Evaluated by In Vivo Measurements of Swallowing	JOURNAL OF TEXTURE STUDIES			English	Article						Beverages; bodying sensation; in vivo measurements; laryngeal movement; sparkling sensation; swallowing sound	QUARTZ-CRYSTAL MICROBALANCE; PALATAL PRESSURE PATTERNS; PULSE DOPPLER METHOD; THICKENER SOLUTIONS; FOOD CONSISTENCY; TONGUE PRESSURE; MUSCLE-ACTIVITY; DRINKING BEER; TASTE SENSOR; GELATIN GELS	Relationship between throat sensations of beverages and some parameters from two types of in vivo measurements of swallowing was investigated. It was indicated using carbonated water that sparkling sensation can be assessed by the acoustic analysis of the swallowing sound, where both the intensity and the occurrence of the sound detected at a particular frequency of 4.0kHz during the bolus flow through the pharynx were increased by sparkling sensation. It was also indicated using beer that bodying sensation can be assessed by the kinetic analysis of the laryngeal movement, where both the duration and the activity of the larynx required for one swallowing cycle and detected on a bend sensor were increased by bodying sensation. Furthermore, it was demonstrated by these in vivo measurements that human swallowing behavior can be modified by the addition of flavor compounds, which was sometimes accompanied with enhanced perception in each sensation. Practical ApplicationsConsumers' palatability is becoming more diverse not only in solid or semi-solid foods but also liquid foods such as beverages. In the development of beverage products, including soft drinks and beers, throat sensations perceived during drinking should be designed proficiently because they can greatly impact the consumers' preference. Although the design of throat sensation of beverage products can be the key for the commercial success, the industry is still looking for any suitable measurement to quantify these human perceptions in an objective, reproducible and easy manner. Evaluation protocol established in the present study meets these requirements and should contribute to the development of high-value added products. In this aged society, usage of the protocol can be expanded to the development of beverage products for dysphagia patients in terms of prevented misleading, for example.	[Funami, Takahiro; Isono, Mai; Ikegami, Akira; Nakao, Satomi; Nakauma, Makoto] San Ei Gen FFI Inc, Toyonaka, Osaka 5618588, Japan; [Fujiwara, Shigehiro; Minagi, Yoshitomo; Ono, Takahiro] Osaka Univ, Grad Sch Dent, Suita, Osaka, Japan; [Hori, Kazuhiro] Niigata Univ, Grad Sch Med & Dent Sci, Chuo Ku, Niigata, Japan	Funami, T (reprint author), San Ei Gen FFI Inc, 1-1-11 Sanwa Cho, Toyonaka, Osaka 5618588, Japan.	tfunami@saneigenffi.co.jp					Gao ZH, 2013, J TEXTURE STUD, V44, P387, DOI 10.1111/jtxs.12026; Kaneda H, 2005, J AM SOC BREW CHEM, V63, P89, DOI 10.1094/ASBCJ-63-0089; Buettner A, 2001, CHEM SENSES, V26, P1211, DOI 10.1093/chemse/26.9.1211; Hasegawa A, 2005, J JPN SOC FOOD SCI, V52, P441; Chen JS, 2009, FOOD HYDROCOLLOID, V23, P1, DOI 10.1016/j.foodhyd.2007.11.013; Okada A, 2007, PHYSIOL BEHAV, V90, P172, DOI 10.1016/j.physbeh.2006.09.032; Taniguchi H, 2008, J APPL PHYSIOL, V105, P791, DOI 10.1152/japplphysiol.90485.2008; Nishinari K, 2008, J TEXTURE STUD, V39, P530, DOI 10.1111/j.1745-4603.2008.00157.x; Clave P, 2006, ALIMENT PHARM THERAP, V24, P1385, DOI 10.1111/j.1365-2036.2006.03118.x; Michou E, 2012, CHEM SENSES, V37, P799, DOI 10.1093/chemse/bjs061; Ding RY, 2003, J SPEECH LANG HEAR R, V46, P977, DOI 10.1044/1092-4388(2003/076); Saitoh E, 2007, DYSPHAGIA, V22, P100, DOI 10.1007/s00455-006-9060-5; Bulow M, 2003, ACTA RADIOL, V44, P366, DOI 10.1034/j.1600-0455.2003.00100.x; Nakauma M, 2011, FOOD HYDROCOLLOID, V25, P1165, DOI 10.1016/j.foodhyd.2010.11.003; TAKAHASHI J, 1991, J TEXTURE STUD, V22, P1, DOI 10.1111/j.1745-4603.1991.tb00001.x; Chee C, 2005, CHEM SENSES, V30, P393, DOI 10.1093/chemse/bji034; EVES A, 1987, DAIRY IND INT, V52, P23; Fukatsu H., 2010, JPN J DYSPHAGIA REHA, V14, P27; Hori K, 2015, FOOD HYDROCOLLOID, V44, P145, DOI 10.1016/j.foodhyd.2014.09.029; Inagaki D, 2009, J ORAL REHABIL, V36, P176, DOI 10.1111/j.1365-2842.2008.01927.x; Ishihara S, 2011, FOOD HYDROCOLLOID, V25, P1016, DOI 10.1016/j.foodhyd.2010.09.022; Kaneda H, 2002, J AM SOC BREW CHEM, V60, P71; Kaneda H., 2007, FFI J, V212, P666; Kojima H, 2009, J AM SOC BREW CHEM, V67, P1, DOI 10.1094/ASBCJ-2009-0107-01; Kojima H, 2009, J AM SOC BREW CHEM, V67, P217, DOI 10.1094/ASBCJ-2009-0910-01; Komai M., 2006, J JPN ASS ODOR ENV, V37, P408, DOI 10.2171/jao.37.408; Kumagai H, 2009, FOOD SCI TECHNOL RES, V15, P203; Li Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070850; Miura Y, 2009, CHEM SENSES, V34, P325, DOI 10.1093/chemse/bjp005; Moritaka H, 2014, CHEM SENSES, V39, P133, DOI 10.1093/chemse/bjt062; Okazawa M., 2008, J GIFU DENT SOC, V35, P7; Peleg M., 2012, Food oral processing: fundamentals of eating and sensory perception, P319; Shiozawa K., 1999, JPN J ORAL BIOL, V41, P27; TAKAHASHI J, 1992, J TEXTURE STUD, V23, P139, DOI 10.1111/j.1745-4603.1992.tb00516.x; TAKAHASHI J, 1991, J TEXTURE STUD, V22, P13, DOI 10.1111/j.1745-4603.1991.tb00002.x; Takahashi T, 2011, NIHON REOROJI GAKK, V39, P93; Tashiro A, 2010, BIOSCI BIOTECH BIOCH, V74, P1598, DOI 10.1271/bbb.100192; Yokoyama S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091920	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4901	1745-4603		J TEXTURE STUD	J. Texture Stud.	JUN	2015	46	3					187	199		10.1111/jtxs.12111		13	Food Science & Technology	Food Science & Technology	CK6MT	WOS:000356342900006		
J	Suzuki, T; Konishi, J; Yamamoto, K; Ogura, S; Fukutani, K				Suzuki, Toshio; Konishi, Junko; Yamamoto, Kiyoshi; Ogura, Shohei; Fukutani, Katsuyuki			IR Practical Extinction Coefficients of Water in Alkali Lime Silicate Glasses Determined by Nuclear Reaction Analysis	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							ALUMINOSILICATE GLASSES	Infrared spectroscopy (IR) is widely used to determine the water concentration in glasses, whereas determination of the IR practical extinction coefficient is necessary to deduce the absolute water concentration of glasses on the basis of Beer-Lambert law. From the nuclear reaction analysis data, the IR practical extinction coefficients of water were successfully determined for the alkali lime silicate glasses with different levels of sodium/potassium cation (Na/K) ratio. The two-band method is well-known to be useful for the determination of the water concentration in some alkali lime silicate glasses. It is proved here that the two-band method is not applicable to the variety of composition for alkali lime silicate and soda lime aluminosilicate glasses, whereas it is valid for the similar composition of soda lime silicate glasses [SLS: Composition (in mol%) 16Na(2)O10CaO74SiO(2)]. The single-band procedure with the IR practical extinction coefficient is crucial for the determination of the precise water concentration in the wide variety of glass composition although the determination of the IR practical extinction coefficient is troublesome. It also appears that the ion radius of alkali affects the IR practical extinction coefficient and the chemical state of OH group in glasses.	[Suzuki, Toshio; Konishi, Junko; Yamamoto, Kiyoshi] Asahi Glass Co Ltd, Res Ctr, Kanagawa Ku, Yokohama, Kanagawa 2218755, Japan; [Ogura, Shohei; Fukutani, Katsuyuki] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan	Suzuki, T (reprint author), Asahi Glass Co Ltd, Res Ctr, Kanagawa Ku, 1150 Hazawa Cho, Yokohama, Kanagawa 2218755, Japan.	toshio-suzuki@agc.com					Suzuki T, 2013, J NON-CRYST SOLIDS, V382, P66, DOI 10.1016/j.jnoncrysol.2013.10.011; Davis KM, 1996, J NON-CRYST SOLIDS, V203, P27, DOI 10.1016/0022-3093(96)00330-4; SHELBY JE, 1982, J AM CERAM SOC, V65, pC59, DOI 10.1111/j.1151-2916.1982.tb10420.x; MORROW BA, 1991, LANGMUIR, V7, P1695, DOI 10.1021/la00056a022; Fukutani K, 1999, PHYS REV B, V59, P13020, DOI 10.1103/PhysRevB.59.13020; Geotti-Bianchini F, 1999, GLASS SCI TECHNOL, V72, P103; GEOTTIBIANCHINI F, 1995, GLASTECH BER-GLASS, V68, P228; Harder U, 1998, FRESEN J ANAL CHEM, V361, P585, DOI 10.1007/s002160050956; Harder U, 1998, GLASTECH BER-GLASS, V71, P12; llievski S., 2000, GLASTECH BER, V73, P39; Peuker C, 2003, GLASS SCI TECHNOL, V76, P227; Shelby J. E., 2005, INTRO GLASS SCI TECH, P230; Sholze H., 1959, GLASTECH BER, V32, P81; Sholze H., 1959, GLASTECH BER, V32, P142; Suzuki T, 2014, BUNSEKI KAGAKU, V63, P831; Takai T., 1999, COLLOID SURFACE A, V150, P77	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	JUN	2015	98	6					1794	1798		10.1111/jace.13568		5	Materials Science, Ceramics	Materials Science	CK0FQ	WOS:000355881300017		
J	Roh, JY; Sato, Y; Ikuhara, Y				Roh, Ji-Young; Sato, Yukio; Ikuhara, Yuichi			Grain Boundary Plane Effect on Pr Segregation Site in ZnO sigma 13 [0001] Symmetric Tilt Grain Boundaries	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							CERAMICS; INTERFACE; ALUMINA	As grain boundary (GB) and GB segregation often have significant impact on various properties of polycrystalline materials, their atomic structures as well as the location of segregated dopant should be intensively investigated. We have thus reported several papers about segregation of Pr (praseodymium) in ZnO (zinc oxide) GBs for case study. In this study, we study the atomic structure of Pr-doped ZnO [0001]GB [Sato etal., Phys. Rev. B, 87,140101 (2013)]. Although atomic arrangements of these GBs can be characterized using the same kinds of structural units (SUs), Pr segregation sites relative to the SU vary with GBs. It is suggested that change in strain distribution for different GBs would cause the variation in the segregation sites and Pr would prefer the Zn site of locally highest tension.	[Roh, Ji-Young; Sato, Yukio; Ikuhara, Yuichi] Univ Tokyo, Inst Engn Innovat, Bunkyo Ku, Tokyo 1138656, Japan; [Ikuhara, Yuichi] Japan Fine Ceram Ctr, Nanostruct Res Lab, Atsuta Ku, Nagoya, Aichi 4568587, Japan; [Ikuhara, Yuichi] Tohoku Univ, World Premier Int Res Ctr Initiat, Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan	Ikuhara, Y (reprint author), Univ Tokyo, Inst Engn Innovat, Bunkyo Ku, Tokyo 1138656, Japan.	ikuhara@sigma.t.u-tokyo.ac.jp	Ikuhara, Yuichi/N-1001-2015; Ikuhara, Yuichi/F-3066-2010	Ikuhara, Yuichi/0000-0003-3886-005X; 	Japan Society for Promotion of Science (JSPS); MEXT [25106003]; G-COE program; Nihon Sheet Glass Foundation for Materials Science and Engineering; Kato Foundation for Promotion of Science; MEXT, Japan [12024046]	A part of this work is supported by the Grant-in-Aid for Young Scientists (B) from Japan Society for Promotion of Science (JSPS), the Grant-in-Aid for Scientific Research on Innovative Areas "Nano Informatics" (25106003) from MEXT, the G-COE program, Nihon Sheet Glass Foundation for Materials Science and Engineering, and Kato Foundation for Promotion of Science. A part of this work was conducted using supercomputer system in Institute of Solid State Physics of The University of Tokyo (UT) and user facilities in Research Hub for Advanced Nano Characterization in UT under the support of "Nanotechnology Platform" (12024046) by MEXT, Japan.	Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; PENNYCOOK SJ, 1990, PHYS REV LETT, V64, P938, DOI 10.1103/PhysRevLett.64.938; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Wang ZC, 2011, NATURE, V479, P380, DOI 10.1038/nature10593; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Shibata N, 2009, NAT MATER, V8, P654, DOI [10.1038/nmat2486, 10.1038/NMAT2486]; Sato Y, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.106802; Buban JP, 2006, SCIENCE, V311, P212, DOI 10.1126/science.1119839; BRANDON DG, 1964, ACTA METALL MATER, V12, P813, DOI 10.1016/0001-6160(64)90175-0; SUTTON AP, 1983, PHILOS T R SOC A, V309, P1, DOI 10.1098/rsta.1983.0020; Zhang ZL, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.094108; Browning ND, 1998, PHYSICA C, V294, P183, DOI 10.1016/S0921-4534(97)01689-4; LEWIS GV, 1985, J PHYS C SOLID STATE, V18, P1149, DOI 10.1088/0022-3719/18/6/010; Gale JD, 2003, MOL SIMULAT, V29, P291, DOI 10.1080/0892702031000104887; Sato Y, 2007, J AM CERAM SOC, V90, P337, DOI 10.1111/j.1551-2916.2006.01481.x; Clarke DR, 1999, J AM CERAM SOC, V82, P485; Elsasser C, 2003, J AM CERAM SOC, V86, P533; Herbert A., IMAGEJ FIND PEAKS PL; Ikuhara Y, 2001, J CERAM SOC JPN, V109, pS110, DOI 10.2109/jcersj.109.1271_S110; MUKAE K, 1977, JPN J APPL PHYS, V16, P1361, DOI 10.1143/JJAP.16.1361; Oba F, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.125415; Paxton A. T., 2005, J MATER SCI, V40, P3045; Roh J.-Y., 2014, AMTC LETT, V4, P26; Sakuma T., 2000, CERAM T, V118, P3; Sato Y, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.140101; Sato Y, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.094114; Sato Y, 2004, J APPL PHYS, V95, P1258, DOI 10.1063/1.1636816; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	JUN	2015	98	6					1932	1936		10.1111/jace.13536		5	Materials Science, Ceramics	Materials Science	CK0FQ	WOS:000355881300037		
J	Uchiyama, H				Uchiyama, Hiroaki			Evaporation-driven self-organization of sol-gel dip-coating films	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Thin film materials; Sol-gel method; Dip-coating; Surface patterns; Self-organization	SPONTANEOUS PATTERN-FORMATION; INORGANIC HYBRID FILMS; SURFACE-TENSION; RADIATIVE STRIATIONS; POLYMER-FILMS; NANOWIRE ARRAYS; CONTACT LINE; CONVECTION; LIQUID; EVOLUTION	In this review, we discuss the spontaneous pattern formation of sol-gel dip coating films induced by solvent evaporation, as a novel patterning technique. Linearly arranged striations and cell-like patterns were obtained upon withdrawing the substrate from the coating solution at increasing withdrawal rates. Such highly ordered micropatterns formed by the Benard-Marangoni convection mechanism triggered by solvent evaporation. In contrast, dip-coating at rates below 1.0 cm min(-1) generated periodic stripe patterns arranged on the surface of the films that were perpendicular to the substrate withdrawal direction. Such a formation design was attributed to the onset of capillary flow of the coating solution at the meniscus induced by solvent evaporation. (C)2015 The Ceramic Society of Japan. All rights reserved.	Kansai Univ, Dept Chem & Mat Engn, Suita, Osaka 5648680, Japan	Uchiyama, H (reprint author), Kansai Univ, Dept Chem & Mat Engn, 3-3-35 Yamate Cho, Suita, Osaka 5648680, Japan.	h_uchi@kansai-u.ac.jp			JSPS KAKENHI [24760554]; Izumi Science and Technology Foundation; Iketani Science and Technology Foundation; Sumitomo Foundation	The author thanks all co-workers for their contributions. This work was financially supported in part by JSPS KAKENHI Grant-in-Aid for Young Scientists (B) (No. 24760554), Izumi Science and Technology Foundation Grant-in-Aid, Iketani Science and Technology Foundation Grant-in-Aid, and The Sumitomo Foundation Grant-in-Aid for Basic Science Research.	PEARSON JRA, 1958, J FLUID MECH, V4, P489, DOI 10.1017/S0022112058000616; DISLICH H, 1971, ANGEW CHEM INT EDIT, V10, P363, DOI 10.1002/anie.197103631; Jeffreys H, 1926, PHILOS MAG, V2, P833; Pu G, 2008, LANGMUIR, V24, P4685, DOI 10.1021/la703790f; Uchiyama H, 2010, LANGMUIR, V26, P11479, DOI 10.1021/la1009708; Uchiyama H, 2014, COLLOID SURFACE A, V453, P1, DOI 10.1016/j.colsurfa.2014.03.066; Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827; Han W, 2012, ANGEW CHEM INT EDIT, V51, P12588, DOI 10.1002/anie.201207902; Yabu H, 2008, ADV MATER, V20, P4200, DOI 10.1002/adma.200801170; Haas DE, 2002, J MATER SCI, V37, P2109, DOI 10.1023/A:1015250120963; Chung JY, 2009, ADV MATER, V21, P1358, DOI 10.1002/adma.200803209; Yabu H, 2005, ADV FUNCT MATER, V15, P575, DOI 10.1002/adfm.200400315; Hong SW, 2009, ANGEW CHEM INT EDIT, V48, P8356, DOI 10.1002/anie.200903552; Rayleigh L, 1916, PHILOS MAG, V32, P529; Birnie DP, 2001, J MATER RES, V16, P1145, DOI 10.1557/JMR.2001.0158; Uchiyama H, 2012, LANGMUIR, V28, P10177, DOI 10.1021/la3020332; Ishow E, 2009, ADV FUNCT MATER, V19, P796, DOI 10.1002/adfm.200801497; Faustini M, 2010, J PHYS CHEM C, V114, P7637, DOI 10.1021/jp9114755; Landau L, 1942, ACTA PHYSICOCHIM URS, V17, P42; Xu J, 2007, ANGEW CHEM INT EDIT, V46, P1860, DOI 10.1002/anie.200604540; Kozuka H, 2004, J SOL-GEL SCI TECHN, V31, P245, DOI 10.1023/B:JSST.0000047996.53649.3d; Huang JX, 2007, ANGEW CHEM INT EDIT, V46, P2414, DOI 10.1002/anie.200604789; Grosso D, 2011, J MATER CHEM, V21, P17033, DOI 10.1039/c1jm12837j; Birnie DP, 2013, LANGMUIR, V29, P9072, DOI 10.1021/la401106z; Kim D, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2424671; Kozuka H, 2000, J SOL-GEL SCI TECHN, V19, P501, DOI 10.1023/A:1008772102546; Deegan RD, 2000, PHYS REV E, V62, P756, DOI 10.1103/PhysRevE.62.756; Yabu H, 2005, LANGMUIR, V21, P1709, DOI 10.1021/la046996z; Kozuka H, 2003, J CERAM SOC JPN, V111, P624, DOI 10.2109/jcersj.111.624; Liu NL, 2009, LANGMUIR, V25, P665, DOI 10.1021/la8036633; Chan EP, 2006, ADV MATER, V18, P3238, DOI 10.1002/adma.200601595; Zhang CY, 2008, ADV MATER, V20, P1716, DOI 10.1002/adma.200703142; Zhang NL, 1999, INT COMMUN HEAT MASS, V26, P1069, DOI 10.1016/S0735-1933(99)00098-6; Watanabe S, 2012, LANGMUIR, V28, P12982, DOI 10.1021/la302811y; Watanabe S, 2009, LANGMUIR, V25, P7287, DOI 10.1021/la900315h; Benard H, 1901, ANN CHIM PHYS, V23, P62; KOSCHMIEDER EL, 1986, J FLUID MECH, V167, P49, DOI 10.1017/S0022112086002720; Birnie DP, 2009, J SOL-GEL SCI TECHN, V49, P233, DOI 10.1007/s10971-008-1849-2; BLOCK MJ, 1956, NATURE, V178, P650, DOI 10.1038/178650a0; Daniels B. K., 1986, Proceedings of the SPIE - The International Society for Optical Engineering, V631; Innocenzi P, 2009, ANAL CHEM, V81, P551, DOI 10.1021/ac801518w; Karthaus O, 2000, MACROMOL SYMP, V160, P137, DOI 10.1002/1521-3900(200010)160:1<137::AID-MASY137>3.0.CO;2-1; Ohzono T., 2006, PHYS REV E, V73; Ohzono T, 2005, LANGMUIR, V21, P7230, DOI 10.1021/la0503449; Olgun U, 2008, POWDER TECHNOL, V183, P207, DOI 10.1016/j.powtec.2007.07.028; Stenzel-Rosenbaum MH, 2001, ANGEW CHEM INT EDIT, V40, P3428, DOI 10.1002/1521-3773(20010917)40:18<3428::AID-ANIE3428>3.0.CO;2-6; STRAWBRIDGE I, 1986, J NON-CRYST SOLIDS, V86, P381, DOI 10.1016/0022-3093(86)90026-8; Takahashi M, 2007, ADV MATER, V19, P4343, DOI 10.1002/adma.200701322; Takahashi M, 2014, J SOL-GEL SCI TECHN, V70, P272, DOI 10.1007/s10971-014-3301-0; Uchiyama H, 2012, RSC ADV, V2, P467, DOI 10.1039/c1ra00770j; Uchiyama H, 2012, SOFT MATTER, V8, P11318, DOI 10.1039/c2sm26328a	51	1	1	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	JUN	2015	123	1438					457	464		10.2109/jcersj2.123.457		8	Materials Science, Ceramics	Materials Science	CJ9UW	WOS:000355849700001		
J	Uehashi, A; Yoshida, H; Tokunaga, T; Sasaki, K; Yamamoto, T				Uehashi, Akinori; Yoshida, Hidehiro; Tokunaga, Tomoharu; Sasaki, Katsuhiro; Yamamoto, Takahisa			Enhancement of sintering rates in BaTiO3 by controlling of DC electric current	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Flash sintering; BaTiO3; Sintering; Fast; HRTEM	DEFECT STRUCTURE; ZIRCONIA 3Y-TZP; UNDOPED BATIO3; FIELD	DC electric fields ranged from 25 to 350V/cm enhanced the sintering rates of BaTiO3. At the field of 25V/cm, the sintering densification occurred by field-assisted sintering (FAST), and flash-sintering preceded by FAST was observed at the field strength of more than 75V/cm. Most of the densification, however, was produced by the FAST process. At high field strength of more than 250V/cm, the sintering densification was not finished owing to discharging during the flash-sintering. By means of FAST process at 100V/cm and the current limit of 100 mA, in contrast, relative density of 97% and a fine grain size about 500nm were achieved at 1020 degrees C in the present material. The FAST process, where the electric current was set to the transition current between FAST and flash-sintering, is highly effective to fabricate uniform and fine grained BaTiO3 polycrystal. (C)2015 The Ceramic Society of Japan. All rights reserved.	[Uehashi, Akinori; Tokunaga, Tomoharu; Sasaki, Katsuhiro; Yamamoto, Takahisa] Nagoya Univ, Dept Quantum Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Yoshida, Hidehiro] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan	Yamamoto, T (reprint author), Nagoya Univ, Dept Quantum Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan.	yamataka@k.u-tokyo.ac.jp			KAKENHI [25106004]	This work was supported in part by Grant-in-Aid for Scientific Research (KAKENHI) on Innovative Areas No. 25106004.	Karakuscu A, 2012, J AM CERAM SOC, V95, P2531, DOI 10.1111/j.1551-2916.2012.05240.x; Prette ALG, 2011, J POWER SOURCES, V196, P2061, DOI 10.1016/j.jpowsour.2010.10.036; Yang D, 2010, SCRIPTA MATER, V63, P328, DOI 10.1016/j.scriptamat.2010.04.030; CHAN NH, 1981, J AM CERAM SOC, V64, P556, DOI 10.1111/j.1151-2916.1981.tb10325.x; Cologna M, 2010, J AM CERAM SOC, V93, P3556, DOI 10.1111/j.1551-2916.2010.04089.x; Cologna M, 2011, J AM CERAM SOC, V94, P316, DOI 10.1111/j.1551-2916.2010.04267.x; Yang D, 2010, J AM CERAM SOC, V93, P2935, DOI 10.1111/j.1551-2916.2010.03905.x; Yoshida H, 2014, J EUR CERAM SOC, V34, P991, DOI 10.1016/j.jeurceramsoc.2013.10.031; Lee DK, 2002, SOLID STATE IONICS, V154, P189, DOI 10.1016/S0167-2738(02)00427-7; Cologna M, 2011, J EUR CERAM SOC, V31, P2827, DOI 10.1016/j.jeurceramsoc.2011.07.004; Francis J. S. C., 2013, J AM CERAM SOC, V96, P1342; M'Peko JC, 2014, J EUR CERAM SOC, V34, P3655, DOI 10.1016/j.jeurceramsoc.2014.04.041; Shikhar K. J., 2014, J AM CERAM SOC, V97, P527	13	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	JUN	2015	123	1438					465	468		10.2109/jcersj2.123.465		4	Materials Science, Ceramics	Materials Science	CJ9UW	WOS:000355849700002		
J	Komatsu, M; Ochi, A				Komatsu, Masao; Ochi, Akio			Tetragonal phase formed in liquid quenched ZrO2-9 mol % MgO and its thermal stability	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Mg-PSZ; Liquid-quench; TEM; XRD; EDS; t'-phase; Thermal stability	ZIRCONIA; PSZ; SYSTEM; MICROSTRUCTURE; TRANSFORMATION; TEMPERATURE; EVOLUTION	Ceramics were formed by the addition of magnesia to zirconia in the composition range of 0 to 50 mol%, and these ceramic materials were liquid quenched using an infrared image furnace and a twin roll process. The composition and structure of the liquid-quenched film samples were examined using X-ray diffraction and transmission electron microscopy. The results confirmed the formation of a high-temperature metastable phase (t'-phase) in ZrO2-9 mol% MgO partially stabilized zirconia (PSZ). The t'-phase that formed underwent a transition to the stable tetragonal phase (t-phase) during a suitable annealing treatment, but it was found not to undergo a phase transformation to the monoclinic phase (m-phase) in the presence of external stress. The t'-phase was confirmed to have three variants. (C)2015 The Ceramic Society of Japan. All rights reserved.	[Komatsu, Masao; Ochi, Akio] Hiroshima Inst Technol, Dept Intelligence Machine, Saeki Ku, Hiroshima 7315193, Japan	Komatsu, M (reprint author), Hiroshima Inst Technol, Dept Intelligence Machine, Saeki Ku, 2-1-1 Miyake, Hiroshima 7315193, Japan.	komatsu@cc.it-hiroshima.ac.jp					ALDEBERT P, 1985, J AM CERAM SOC, V68, P34, DOI 10.1111/j.1151-2916.1985.tb15247.x; Anderson C. A., 1984, ADV CERAM, V2, P78; SCOTT HG, 1975, J MATER SCI, V10, P1527, DOI 10.1007/BF01031853; TEUFER G, 1962, ACTA CRYSTALLOGR, V15, P1187, DOI 10.1107/S0365110X62003114; PORTER DL, 1979, J AM CERAM SOC, V62, P298, DOI 10.1111/j.1151-2916.1979.tb09484.x; SAKUMA T, 1985, J MATER SCI, V20, P2399, DOI 10.1007/BF00556069; PORTER DL, 1977, J AM CERAM SOC, V60, P183, DOI 10.1111/j.1151-2916.1977.tb15509.x; GRAIN CF, 1967, J AM CERAM SOC, V50, P288, DOI 10.1111/j.1151-2916.1967.tb15111.x; BENDER B, 1985, J MATER SCI LETT, V4, P1331, DOI 10.1007/BF00720094; BHATHENA N, 1984, SCRIPTA METALL MATER, V18, P179, DOI 10.1016/0036-9748(84)90501-5; BHATHENA N, 1984, J AM CERAM SOC, V67, P799, DOI 10.1111/j.1151-2916.1984.tb19704.x; CHAIM R, 1985, J AM CERAM SOC, V68, P427, DOI 10.1111/j.1151-2916.1985.tb10169.x; CHAIM R, 1984, J MATER SCI, V19, P2934, DOI 10.1007/BF01026970; Heuer A. H., 1984, ADV CERAM, V2, P1; HEUER AH, 1987, ACTA METALL MATER, V35, P661, DOI 10.1016/0001-6160(87)90189-1; Lankford J., 1983, J AM CERAM SOC, V66; LANKFORD J, 1985, J MATER SCI, V20, P53, DOI 10.1007/BF00555898; Lanteri V., 1986, J AM CERAM SOC, V69, P256; LANTERI V, 1986, J AM CERAM SOC, V69, P564, DOI 10.1111/j.1151-2916.1986.tb04793.x; Lanteri V., 1984, ADV CERAM, V2, P118; Miller R. A., 1981, SCI TECHNOLOGY ZIRCO, V3, P241; Noma T., 1986, P ANN M YOGYO KYOKAI, V2, P83; SAKUMA T, 1985, J MATER SCI LETT, V4, P29, DOI 10.1007/BF00719887; Sakuma T., 1986, P ANN M YOGYOU KYOKA, V2, P89; SAKUMA T, 1985, J MATER SCI, V20, P1085, DOI 10.1007/BF00585753; SAKUMA T, 1986, J MATER SCI, V21, P1436, DOI 10.1007/BF00553285; Shibata M., 1987, ZIRCONIA CERAMICS, P87; SIM SM, 1987, J AM CERAM SOC, V70, P521, DOI 10.1111/j.1151-2916.1987.tb05687.x; Sugiyama M., 1986, P INT C MARTENSITIC, P1155; Swain M. V., 1984, ZIRCONIA CERAMICS, P117; SWAIN MV, 1985, ACTA METALL MATER, V33, P2083, DOI 10.1016/0001-6160(85)90131-2; Urabe K., 1987, ZIRCONIA CERAMICS, P45; YOSHIMURA M, 1987, NIPPON SERAM KYO GAK, V95, P202; Yoshimura M., 1987, P ANN M YOGYO KYOKAI, V3, P887	34	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	JUN	2015	123	1438					492	500		10.2109/jcersj2.123.492		9	Materials Science, Ceramics	Materials Science	CJ9UW	WOS:000355849700007		
J	Niwa, E; Sato, T; Watanabe, Y; Toyota, Y; Hatakeyama, Y; Judai, K; Shozugawa, K; Matsuo, M; Hashimoto, T				Niwa, Eiki; Sato, Tsubasa; Watanabe, Yuki; Toyota, Yuichiro; Hatakeyama, Yoshikiyo; Judai, Ken; Shozugawa, Katsumi; Matsuo, Motoyuki; Hashimoto, Takuya			Dependence of crystal symmetry, electrical conduction property and electronic structure of LnFeO(3) (Ln: La, Pr, Nd, Sm) on kinds of Ln(3+)	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Perobskite-type oxide; X-ray diffraction; Electrical conductivity; Mossbauer spectroscopy; Diffuse reflecrance spectroscopy; Crystallite symmetry; Electrical conduction property; Electronic structure	RARE-EARTH ORTHOFERRITES; GAS SENSORS; OXYGEN NONSTOICHIOMETRY; LAFEO3 POWDERS; EXPANSION; CERAMICS; NDFEO3; FILMS	Dependence of crystal symmetry, electrical conductivity, chemical state of Fe and optical property of LnFeO(3) (Ln: La, Pr, Nd, Sm) on kinds of Ln(3+) was investigated. All the LnFeO(3) showed orthorhombic structure, with which order of high crystal symmetry was LaFeO3 > PrFeO3 > NdFeO3 > SmFeO3. Using tolerance factor, the order was successfully explained. The electrical conductivity of all the specimens could be explained by using small polaron hopping model. With increasing crystallite symmetry, electrical conductivity increased and activation energy for hopping conduction decreased. This can be ascribed to larger overlapping of Fe3d orbital and O2p orbital on nearly linear Fe-O-Fe bond in LnFeO(3) with higher crystal symmetry. The larger overlapping of Fe3d orbital and O2p orbital in LnFeO(3) with higher crystal symmetry can also be an origin of larger spin-spin interaction detected by Mossbauer spectroscopy and larger optical band gap observed by diffuse reflectance spectroscopy. Since chemical state of Fe, evaluated by Mossbauer spectroscopy, in LnFeO(3) is fundamentally constant at +3 regardless of kinds of Ln(3+), carrier concentration of LnFeO(3) was revealed to be constant. It is concluded that the predominant factor which determine the electrical property of LnFeO(3) is mobility affected by crystal symmetry. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Niwa, Eiki; Sato, Tsubasa; Watanabe, Yuki; Toyota, Yuichiro; Hatakeyama, Yoshikiyo; Judai, Ken; Hashimoto, Takuya] Nihon Univ, Coll Humanities & Sci, Dept Phys, Setagaya Ku, Tokyo 1568550, Japan; [Shozugawa, Katsumi; Matsuo, Motoyuki] Univ Tokyo, Grad Sch Arts & Sci, Dept Multidisciplinary Sci, Meguro Ku, Tokyo 1538902, Japan	Niwa, E (reprint author), Nihon Univ, Coll Humanities & Sci, Dept Phys, Setagaya Ku, 3-8-1 Sakurajousui, Tokyo 1568550, Japan.	e-niwa@phys.chs.nihon-u.ac.jp			"Strategic Research Base Development" Program for Private Universities - MEXT [S0901022]; Nihon University Strategic Projects for Academic Research "Nanothechnology Excellence-Nanomaterial based Photonic and Quantum Technologies"	This study was financially supported by grants from the "Strategic Research Base Development" Program for Private Universities (S0901022) subsidized by MEXT (2009) and from Nihon University Strategic Projects for Academic Research "Nanothechnology Excellence-Nanomaterial based Photonic and Quantum Technologies".	Fan K, 2013, SENSOR ACTUAT B-CHEM, V177, P265, DOI 10.1016/j.snb.2012.11.004; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Hashimoto S, 2011, SOLID STATE IONICS, V186, P37, DOI 10.1016/j.ssi.2011.01.014; MIZUSAKI J, 1985, J SOLID STATE CHEM, V58, P257, DOI 10.1016/0022-4596(85)90243-9; TRAVERSA E, 1995, SENSOR ACTUAT B-CHEM, V25, P661, DOI 10.1016/0925-4005(95)85146-1; Niwa E, 2013, MATER RES BULL, V48, P1, DOI 10.1016/j.materresbull.2012.09.055; Caronna T, 2009, MATER CHEM PHYS, V116, P645, DOI 10.1016/j.matchemphys.2009.05.020; Mir SA, 2014, OPTIK, V125, P6903, DOI 10.1016/j.ijleo.2014.08.050; Shivakumara C, 2006, SOLID STATE COMMUN, V139, P165, DOI 10.1016/j.ssc.2006.05.030; Sultan K, 2014, VACUUM, V99, P251, DOI 10.1016/j.vacuum.2013.06.014; Kuhn M, 2011, SOLID STATE IONICS, V195, P7, DOI 10.1016/j.ssi.2011.05.013; Carotta MC, 1997, SENSOR ACTUAT B-CHEM, V44, P590, DOI 10.1016/S0925-4005(97)00177-9; Li L, 2014, MATER RES BULL, V50, P18, DOI 10.1016/j.materresbull.2013.10.027; Martinelli G, 1999, SENSOR ACTUAT B-CHEM, V55, P99, DOI 10.1016/S0925-4005(99)00054-4; Ding JL, 2010, MATER SCI ENG B-ADV, V171, P31, DOI 10.1016/j.mseb.2010.03.050; Slawinski W, 2005, J PHYS-CONDENS MAT, V17, P4605, DOI 10.1088/0953-8984/17/29/002; Choi MB, 2012, SOLID STATE IONICS, V221, P22, DOI 10.1016/j.ssi.2012.06.012; Huang S, 2015, CERAM INT, V41, P691, DOI 10.1016/j.ceramint.2014.08.124; Koferstein R, 2013, SOLID STATE IONICS, V249, P1, DOI 10.1016/j.ssi.2013.07.001; Kortum G., 1958, J PHYS CHEM-US, V18, P110; Kubelka P., 1931, TECH PHYS A, V11, P593; MAREZIO M, 1970, ACTA CRYSTALL B-STRU, VB 26, P2008, DOI 10.1107/S0567740870005319; Niwa E., 2010, SOLID STATE IONICS, V201, P87; Pechini M. P., 1967, U. S. Pat., Patent No. [3330697, 3 330 697]; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Swierczek K, 2011, J POWER SOURCES, V196, P7110, DOI 10.1016/j.jpowsour.2010.08.063; Tuac J., 1968, MAT RES B, V3, P37; Wang SR, 2003, SOLID STATE IONICS, V159, P71, DOI 10.1016/S0167-2738(03)00027-4	28	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	JUN	2015	123	1438					501	506		10.2109/jcersj2.123.501		6	Materials Science, Ceramics	Materials Science	CJ9UW	WOS:000355849700008		
J	Hasegawa, T; Sato, N; Kim, SW; Ishigaki, T; Uematsu, K; Toda, K; Sato, M				Hasegawa, Takuya; Sato, Natsuki; Kim, Sun Woog; Ishigaki, Tadashi; Uematsu, Kazuyoshi; Toda, Kenji; Sato, Mineo			Synthesis and Luminescent Properties of Novel Ca3Y3Ge2BO13:Ln(3+) (Ln(3+) = Tb3+ and Eu3+) phosphors	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Rare earth doped germanate phosphor; Energy transfer; Cubic structure	LIGHT-EMITTING-DIODES; ENERGY-TRANSFER; 3-DIMENSIONAL VISUALIZATION; WHITE-LIGHT; BI3+; EMISSION; RED; GREEN; GLASS; DY3+	Novel Ln(3+)-doped (Ln(3+) = Tb3+ and Eu3+) and Eu3+, Bi3+ co-doped Ca3Y3Ge2BO13 phosphors were synthesized by a conventional solid-state reaction method. Tb3+- and Eu3+-doped phosphors showed strong narrow green and red emission due to 4f intra-shell transitions of the Tb3+ or Eu3+ ions under the excitation at 254 nm. Bi3+ co-doped Ca3Y3Ge2BO13:Eu3+ phosphor has a new broad strong excitation band appeared at around 302 nm due to S-1(0)-> P-3(1) transition of Bi3+, and presents red emission owing to 4f-4f transition of Eu3+ under excitation at 302 nm. (C)2015 The Ceramic Society of Japan. All rights reserved.	[Hasegawa, Takuya; Sato, Natsuki; Kim, Sun Woog; Ishigaki, Tadashi; Toda, Kenji] Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan; [Uematsu, Kazuyoshi; Sato, Mineo] Niigata Univ, Dept Chem & Chem Engn, Niigata 9502181, Japan	Toda, K (reprint author), Niigata Univ, Grad Sch Sci & Technol, 8050 Ikarashi 2-Nocho, Niigata 9502181, Japan.	ktoda@eng.niigata-u.ac.jp	KIM, Sun Woog/O-5366-2015		NEDO, New Energy and Industrial Technology Development Organization	This work was supported by a project from NEDO, New Energy and Industrial Technology Development Organization (Rare Metal Substitute Materials Development Project Development of Technology for Reducing Tb and Eu Usage in Phosphors for Fluorescent Lamp by High-speed Material Synthesis and Evaluation).	Chen L, 2010, J COMB CHEM, V12, P587, DOI 10.1021/cc100063x; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Xiao F, 2009, SPECTROCHIM ACTA A, V74, P498, DOI 10.1016/j.saa.2009.06.050; Zhou HP, 2015, DALTON T, V44, P1102, DOI 10.1039/c4dt02114b; Chen L, 2011, J MATER CHEM, V21, P3677, DOI 10.1039/c0jm02487b; Eliseeva SV, 2010, CHEM SOC REV, V39, P189, DOI 10.1039/b905604c; Yan SX, 2007, J PHYS CHEM C, V111, P13256, DOI 10.1021/jp073991c; Izumi F, 2007, SOL ST PHEN, V130, P15; Liu XM, 2007, J SOLID STATE CHEM, V180, P1421, DOI 10.1016/j.jssc.2007.01.034; Park JY, 2010, J LUMIN, V130, P478, DOI 10.1016/j.jlumin.2009.10.017; Kim GC, 2001, MATER RES BULL, V36, P1603, DOI 10.1016/S0025-5408(01)00556-6; Duan CK, 2011, CHEM PHYS LETT, V506, P179, DOI 10.1016/j.cplett.2011.03.002; DATTA RK, 1967, J ELECTROCHEM SOC, V114, P1137, DOI 10.1149/1.2426433; BLASSE G, 1967, J CHEM PHYS, V47, P1920, DOI 10.1063/1.1712219; Blasse 8. G., 1983, REV INORG CHEM, V5, P319; Brasse G., 1994, LUMINESCENT MAT; Brasse G., 1969, PHILIPS RES REP, V24, P131; CHENAVAS J, 1981, ACTA CRYSTALLOGR B, V37, P1343, DOI 10.1107/S056774088100589X; Huang MN, 2014, SPECTROCHIM ACTA A, V120, P55, DOI 10.1016/j.saa.2013.09.147; Huang XY, 2011, J APPL PHYS, V109, DOI 10.1063/1.3592889; JOSHI BC, 1989, J PHYS CHEM SOLIDS, V50, P599, DOI 10.1016/0022-3697(89)90453-8; JOSHI JC, 1977, J SOLID STATE CHEM, V22, P439, DOI 10.1016/0022-4596(77)90021-4; Kano T., 1999, PHOSPHOR HDB, P177; Lakshminarasimhan N, 2014, MATER RES BULL, V60, P238, DOI 10.1016/j.materresbull.2014.08.037; RONDE H, 1977, J ELECTROCHEM SOC, V124, P1276, DOI 10.1149/1.2133545; Sarantopoulou E, 1999, OPT COMMUN, V169, P263, DOI 10.1016/S0030-4018(99)00356-9; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Strohhofer C, 2000, J APPL PHYS, V88, P4486, DOI 10.1063/1.1311824; VENIKOUAS GE, 1978, J LUMIN, V16, P29, DOI 10.1016/0022-2313(78)90004-2; Yadav R, 2009, OPT EXPRESS, V17, P22023, DOI 10.1364/OE.17.022023	30	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	JUN	2015	123	1438					507	511		10.2109/jcersj2.123.507		5	Materials Science, Ceramics	Materials Science	CJ9UW	WOS:000355849700009		
J	Tominaga, Y; Sato, K; Yan, X; Shimamoto, D; Imai, Y; Hotta, Y				Tominaga, Yuichi; Sato, Kimiyasu; Yan, Xinlei; Shimamoto, Daisuke; Imai, Yusuke; Hotta, Yuji			Exfoliation of hexagonal boron nitride using wet-rotating disc milling	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Wet-rotating disc milling; Hexagonal boron nitride; Exfoliation	MECHANICAL-PROPERTIES; FABRICATION; COMPOSITES; NANOSHEETS	A wet-rotating disc milling was used as a novel method to investigate the exfoliation of laminated hexagonal boron nitride (h-BN) particles. The sedimentation test after the milling showed that the relative packing density of h-BN particles treated by the wet-rotating disc milling was much low compared to non-milled h-BN particles. Also, the particle size distributions showed that the particle size of exfoliated h-BN particle was relatively as similar as the initial particle size. Furthermore, SEM images of wet-rotating disc milled h-BN particles showed that the decrease of h-BN thickness was affected to the relative packing density after sedimentation test. The average aspect ratio of prepared h-BN particles was increased 1.8 times as compared to pristine h-BN particles. The wet-rotating disc milling process led to exfoliation of laminated h-BN particles without reducing the particle size and destroying the crystal structure. Moreover, the relative packing density of exfoliated h-BN particles was affected to rotation speed, number of pass, and distance between two rotation discs. Therefore, it was found that the exfoliation of laminated h-BN particles effectively was progressed by wet-rotating disc milling. (C)2015 The Ceramic Society of Japan. All rights reserved.	[Tominaga, Yuichi; Sato, Kimiyasu; Yan, Xinlei; Shimamoto, Daisuke; Imai, Yusuke; Hotta, Yuji] Natl Inst Adv Ind Sci & Technol, Moriyama Ku, Nagoya, Aichi 4638560, Japan	Tominaga, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Moriyama Ku, 2266-98 Anagahora, Nagoya, Aichi 4638560, Japan.	tominaga.yuichi@aist.go.jp					Kusunose T, 2002, J AM CERAM SOC, V85, P2678; Hernandez Y, 2008, NAT NANOTECHNOL, V3, P563, DOI 10.1038/nnano.2008.215; Marom N, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.046801; Trice RW, 1999, J AM CERAM SOC, V82, P2563; Sato K, 2010, J MATER CHEM, V20, P2749, DOI 10.1039/b924997d; Omura N, 2006, J AM CERAM SOC, V89, P2738, DOI 10.1111/j.1551-2916.2006.01142.x; Zhi CY, 2009, ADV MATER, V21, P2889, DOI 10.1002/adma.200900323; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Smith RJ, 2011, ADV MATER, V23, P3944, DOI 10.1002/adma.201102584; Li LH, 2011, J MATER CHEM, V21, P11862, DOI 10.1039/c1jm11192b; Pacile D, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2903702; Kume S, 2009, J AM CERAM SOC, V92, pS153, DOI 10.1111/j.1551-2916.2008.02650.x; Enomura M., 2002, J JAPAN SOC COLOUR M, V75, P586; Enomura M., 2004, J JPN SOC COLOUR MAT, V77, P110; Iyer KS, 2007, LAB CHIP, V7, P1800, DOI 10.1039/b709524d; JACHUCK RJJ, 1994, HEAT RECOV SYST CHP, V14, P475, DOI 10.1016/0890-4332(94)90051-5; Khan U., 2012, NANOSCALE, V5, P581; Lu HB, 2014, CHEM COMMUN, V50, P1478, DOI 10.1039/c3cc47354f; Nicolosi V, 2013, SCIENCE, V340, P1420, DOI 10.1126/science.1226419	19	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	JUN	2015	123	1438					512	515		10.2109/jcersj2.123.512		4	Materials Science, Ceramics	Materials Science	CJ9UW	WOS:000355849700010		
J	Onodera, H; Sasaki, S; Otake, S; Tomohiro, M; Shibuya, K; Nomura, M				Onodera, Hiroshi; Sasaki, Shoji; Otake, Seiji; Tomohiro, Masayuki; Shibuya, Kazumoto; Nomura, Mamoru			General considerations in ocular toxicity risk assessment from the toxicologists' viewpoints	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Review						Ocular toxicity; Risk assessment; Eye examinations; Ocular histopathology; Sight-threatening; Quality of vision	RETINAL-PIGMENT EPITHELIUM; BEAGLE DOGS; VISUAL TOXICITY; RATS; ETHAMBUTOL; ALBINO; LENS	Humans commonly obtain approximately 80% of external information from vision. Since loss of vision markedly decreases quality of life, risk assessments for visual toxicity of new drugs are extremely important. However, the ICH S4 guideline for nonclinical toxicity study of new drugs only indicates a brief instruction for ophthalmologic examinations, and submitted data for drug approval according only to this guideline are not always considered sufficient in light of ocular toxicity risk assessments. The eye is an assembly of many specialized sub-organs which have specific functions, and its integral maintenance of homeostasis plays an important role of visual function. When only a part of integrity of functions is lost, overall function of the eye might be commonly disturbed. Therefore, understanding of anatomy and physiology of these sub-organs may help know mechanisms of observed ocular changes. In ophthalmologic examinations in nonclinical toxicity studies, it is vital to understand the principles and features of each examination. Comparisons of findings between pre and post drug treatment as well as considerations of species differences, strain differences, age differences, and location/degree of abnormalities are essential. In addition, many kinds of spontaneous ocular findings are well known in experimental animals. To differentiate treatment-related changes from spontaneous findings, mastering basic skills for ophthalmologic examinations and taking advantage of collection of background data are necessary. For ocular toxicity risk assessments, while an evaluation of "sight-threatening" effects is most critical matter, "quality of vision" related findings also should be considered. To extrapolate animal data to human, clinical significances of ocular toxicity findings should be evaluated based on considerations for "species differences", "safety margins", "reversibility", and "risk-benefit balance". In addition, a detailed recording of features of lesions is also important for an appropriate judgment of clinical significance of ocular findings. For preparation of histopathological specimens, careful sampling of organs and suitable selection of fixatives are important. To accurately orient ocular lesions in the specimen for histopathological examinations, securing close communications prior to necropsy among ophthalmologists, gross necropsy pathologists and histopathology technicians should be effective and helpful. It is impossible to detect all ocular changes in histopathological examinations; that is, there is a limitation in histopathological examinations. Therefore, for ocular toxicity risk assessments, comprehensive evaluation with pathological findings as well as other results of various examinations in toxicity studies should be considered. In conclusion, for ocular toxicity risk assessments, integrated judgments from all examination data in nonclinical toxicity studies are required. To achieve appropriate risk assessments which can be extrapolated to human, close communications and sharing of data regarding the eye are most important among toxicologists, clinical sign investigators, histopathology technicians and pathologists.	[Onodera, Hiroshi] Pharmaceut & Med Devices Agcy, Chiyoda Ku, Tokyo 1000013, Japan; [Sasaki, Shoji] AbbVie GK, Global Pharmaceut Res & Dev Japan, Minato Ku, Tokyo 1086302, Japan; [Otake, Seiji] LSI Medience Corp, Dept Safety Assessment, Kamisu, Ibaraki 3140255, Japan; [Tomohiro, Masayuki] Alcon Japan Ltd, Clin & Regulatory Affairs, Minato Ku, Tokyo 1056333, Japan; [Shibuya, Kazumoto] Nippon Inst Biol Sci, Dept Res & Dev, Ome, Tokyo 1980024, Japan; [Nomura, Mamoru] Ina Res Inc, Ina, Nagano 3994501, Japan	Tomohiro, M (reprint author), Alcon Japan Ltd, Clin & Regulatory Affairs, Minato Ku, Toranomon Hills Mori Tower,1-23-1 Toranomon, Tokyo 1056333, Japan.	masayuki.tomohiro@alcon.com					MASSA T, 1984, TOXICOL APPL PHARM, V72, P195, DOI 10.1016/0041-008X(84)90303-X; Leblanc B, 1998, REGUL TOXICOL PHARM, V28, P124, DOI 10.1006/rtph.1998.1243; Gupta V, 2009, EXP EYE RES, V88, P248, DOI 10.1016/j.exer.2008.04.003; Holve DL, 2011, COMPARATIVE MED, V61, P436; Mecklenburg L, 2007, TOXICOL PATHOL, V35, P252, DOI 10.1080/01926230601178199; FORTNER JH, 1993, FUND APPL TOXICOL, V21, P164, DOI 10.1006/faat.1993.1086; CLOYD GG, 1978, TOXICOL APPL PHARM, V45, P771, DOI 10.1016/0041-008X(78)90169-2; Kamao H, 2014, STEM CELL REP, V2, P205, DOI 10.1016/j.stemcr.2013.12.007; Markwell EL, 2010, CLIN EXP OPTOM, V93, P137, DOI 10.1111/j.1444-0938.2010.00479.x; Li JP, 2008, DRUG SAFETY, V31, P127; HUBERT MF, 1994, LAB ANIM SCI, V44, P561; Ban Y., 2008, ANIM EYE RES, V27, P9; De Vera Mudry Maria Cristina, 2013, Toxicol Pathol, V41, P813, DOI 10.1177/0192623312469308; Hashimoto S, 2013, J TOXICOL PATHOL, V26, P275, DOI 10.1293/tox.26.275; Hosotani Y, 2008, J EYE, V25, P449; Imawaka M., 1997, ANIM EYE RES, V16, P11; Inagaki S., 2001, ANIM EYE RES, V20, P21; Japanese Maintenance Organization, 2007, JAP VERS MED DICT RE; Kashiwagi K., 2008, J EYE, V25, P437; Mimura O., 2008, J EYE, V25, P471; Ministry of Health and Welfare, 1999, PART REV GUID REP DO; Nakao Y., 2008, J EYE, V25, P455; Okamura T, 2011, J TOXICOL PATHOL, V24, P195, DOI 10.1293/tox.24.195; SAMUELSON D.A, 2007, VET OPHTHALMOLOGY, P37; Sasaki S, 2006, TOXICOL LETT, V166, P115, DOI 10.1016/j.toxlet.2006.06.003; Sasaki S, 2003, TOXICOL APPL PHARM, V189, P134, DOI 10.1016/S0041-008X(03)00097-8; Sasaki S, 2004, NEUROTOXICOL TERATOL, V26, P279, DOI 10.1016/j.ntt.2003.10.006; Shibuya K., 1997, ANIM EYE RES, V16, P1; Shibuya K., 2001, ANIM EYE RES, V20, P11; Shibuya K., 2001, ANIM EYE RES, V20, P15; Taradach C., 1981, LAB ANIM, V5, P285; Vezina M, 2013, ASSESSING OCULAR TOX, P1; Wasowicz M, 2002, INVEST OPHTH VIS SCI, V43, P813; Williams DL, 2002, VET OPHTHALMOL, V5, P183, DOI 10.1046/j.1463-5224.2002.00251.x	34	1	1	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	JUN	2015	40	3					295	307				13	Toxicology	Toxicology	CJ7VA	WOS:000355707200001		
J	Kohri, K; Yoshida, E; Yasuike, S; Fujie, T; Yamamoto, C; Kaji, T				Kohri, Kumiko; Yoshida, Elko; Yasuike, Shuji; Fujie, Tomoya; Yamamoto, Chika; Kaji, Toshiyuki			The cytotoxicity of organobismuth compounds with certain molecular structures can be diminished by replacing the bismuth atom with an antimony atom in the molecules	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Organobismuth; Organoantimony; Bio-organometallics; Cytotoxicity	ZINC TRANSPORTERS	Organic-inorganic hybrid molecules, which are composed of an organic structure and metal(s), are indispensable for synthetic chemical reactions; however, their toxicity has been incompletely understood. In the present study, we discovered two cytotoxic organobismuth compounds whose cytotoxicity diminished upon replacement of the intramolecular bismuth atom with an antimony atom. The intracellular accumulation of the organobismuth compounds was much higher than that of the organoantimony compounds with the corresponding organic structures. We also showed that both the organic structure and bismuth atom are required for certain organobismuth compounds to exert their cytotoxic effect, suggesting that the cytotoxicity of such a compound is a result of an interaction between the organic structure and the bismuth atom. The present data suggest that organobismuth compounds with certain molecular structures exhibit cytotoxicity via an interaction between the molecular structure and the bismuth atom, and this cytotoxicity can be diminished by replacing the bismuth atom with an antimony atom, resulting in lower intracellular accumulation.	[Kohri, Kumiko; Yoshida, Elko; Fujie, Tomoya; Kaji, Toshiyuki] Tokyo Univ Sci, Fac Pharmaceut Sci, Noda, Chiba 2788510, Japan; [Yasuike, Shuji] Aichi Gakuin Univ, Sch Pharm, Chikusa Ku, Nagoya, Aichi 4648650, Japan; [Yasuike, Shuji; Yamamoto, Chika; Kaji, Toshiyuki] Tokyo Univ Sci, Res Inst Sci & Technol, Div Bioorganometall, Noda, Chiba 2788510, Japan; [Yamamoto, Chika] Toho Univ, Fac Pharmaceut Sci, Funabashi, Chiba 2748510, Japan	Kaji, T (reprint author), Tokyo Univ Sci, Fac Pharmaceut Sci, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	t-kaji@rs.noda.tus.ac.jp			Japan Society for the Promotion of Science [24659058, 23590156]	This work was supported by a Grant-in-Aid for Challenging Exploratory Research #24659058 (to T. K.) and a Grant-in-Aid for Scientific Research (C) #23590156 (to C. Y.) from the Japan Society for the Promotion of Science.	Mackenzie B, 2007, BIOCHEM J, V403, P59, DOI 10.1042/BJ20061290; OHKATA K, 1989, TETRAHEDRON LETT, V30, P4841, DOI 10.1016/S0040-4039(01)80523-2; Gaither LA, 2001, BIOMETALS, V14, P251, DOI 10.1023/A:1012988914300; Fujiwara Y, 2005, J HEALTH SCI, V51, P333, DOI 10.1248/jhs.51.333; Grignard V, 1900, CR HEBD ACAD SCI, V130, P1322; Kakusawa N, 2006, HETEROCYCLES, V68, P1335; Kambe T, 2011, BIOSCI BIOTECH BIOCH, V75, P1036, DOI 10.1271/bbb.110056; Kawahata M, 2011, ACTA CRYSTALLOGR E, V67, pM25, DOI 10.1107/S1600536810043655; KISSANE JM, 1958, J BIOL CHEM, V233, P184; Mann KK, 2006, TOXICOL LETT, V160, P158, DOI 10.1016/j.toxlet.2005.06.017; SERFONTEIN WJ, 1979, RES COMMUN CHEM PATH, V26, P391; Tokunaga T, 2000, TETRAHEDRON, V56, P8833, DOI 10.1016/S0040-4020(00)00813-9; WITTIG G, 1954, CHEM BER-RECL, V87, P1318, DOI 10.1002/cber.19540870919	13	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	JUN	2015	40	3					321	327				7	Toxicology	Toxicology	CJ7VA	WOS:000355707200003		
J	Kurokawa, J; Sasano, T; Kodama, M; Li, M; Ebana, Y; Harada, N; Honda, S; Nakaya, H; Furukawa, T				Kurokawa, Junko; Sasano, Tetsuo; Kodama, Masami; Li, Min; Ebana, Yusuke; Harada, Nobuhiro; Honda, Shin-ichiro; Nakaya, Haruaki; Furukawa, Tetsushi			Aromatase knockout mice reveal an impact of estrogen on drug-induced alternation of murine electrocardiography parameters	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Estrogen; hERG channel; Cardiac electrophysiology; Cardiac toxicology; ECG	HORMONE REPLACEMENT THERAPY; SEX-STEROID-HORMONES; QT-INTERVAL; VENTRICULAR REPOLARIZATION; CARDIAC REPOLARIZATION; MOUSE HEART; PROLONGATION; HYPERTROPHY; CHANNELS; ATHEROSCLEROSIS	Our in vitro characterization showed that physiological concentrations of estrogen partially suppressed the I-Kr channel current in guinea pig ventricular myocytes and the human ether-a-go-go-related gene (hERG) channel currents in CHO-K1 cells regardless of estrogen receptor signaling and revealed that the partially suppressed hERG currents enhanced the sensitivity to the hERG blocker E-4031. To obtain in vivo proof-of-concept data to support the effects of estrogen on cardiac electrophysiology, we here employed an aromatase knockout mouse as an in vivo estrogen-null model and compared the acute effects of E-4031 on cardiac electrophysiological parameters with those in wild-type mice (C57/BL6J) by recording surface electrocardiogram (ECG). The ablation of circulating estrogens blunted the effects of E-4031 on heart rate and QT interval in mice under a denervation condition. Our result provides in vivo proof of principle and demonstrates that endogenous estrogens increase the sensitivity of E-4031 to cardiac electrophysiology.	[Kurokawa, Junko; Sasano, Tetsuo; Kodama, Masami; Li, Min; Ebana, Yusuke; Furukawa, Tetsushi] Tokyo Med Dent Univ, Med Res Inst, Dept Bioinformat Pharmacol, Bunkyo Ku, Tokyo 1138510, Japan; [Nakaya, Haruaki] Chiba Univ, Grad Sch Med, Dept Pharmacol, Chuo Ku, Chiba 2608670, Japan; [Harada, Nobuhiro; Honda, Shin-ichiro] Fujita Hlth Univ, Sch Med, Dept Biochem, Toyoake, Aichi 4701192, Japan	Kurokawa, J (reprint author), Tokyo Med Dent Univ, Med Res Inst, Dept Bioinformat Pharmacol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	junkokuro.bip@mri.tmd.ac.jp			Ministry of Education, Science, Culture, Sports and Technology of Japan [23136703, 25461045, 23390205, 25670126, 15H04684, 23390053]; Restart Postdoctoral Fellowship from Japan Society for the Promotion of Science (JSPS); Takeda Science Foundation; program of Activation of Gender Equity/Gender Medicine and Enrichment of Life of Tokyo Medical and Dental University	This work was supported by a grant-in-aid for scientific research on priority areas (23136703 to JK) and grants (25461045 to TS, 23390205 and 25670126 to TF, 15H04684 to JK, 23390053 to HN) from the Ministry of Education, Science, Culture, Sports and Technology of Japan (www.mext.go.jp/), Restart Postdoctoral Fellowship from Japan Society for the Promotion of Science (JSPS to MK) and Takeda Science Foundation (to JK, URL; www.takeda-sci.or.jp/). This work was also supported by a program of Activation of Gender Equity/Gender Medicine and Enrichment of Life of Tokyo Medical and Dental University (to JK and MK).	Skavdahl M, 2005, AM J PHYSIOL-HEART C, V288, pH469, DOI 10.1152/ajpheart.00723.2004; Charbit B, 2009, AM J CARDIOL, V103, P887, DOI 10.1016/j.amjcard.2008.11.041; Rodriguez I, 2001, JAMA-J AM MED ASSOC, V285, P1322, DOI 10.1001/jama.285.10.1322; Honda S, 1998, BIOCHEM BIOPH RES CO, V252, P445, DOI 10.1006/bbrc.1998.9672; Thum T, 2002, FASEB J, V16, P1537, DOI 10.1096/fj.02-0138com; Jeong JH, 2010, MOL CELL BIOL, V30, P2365, DOI 10.1128/MCB.00672-09; Kurokawa J, 2013, BIOL PHARM BULL, V36, P8; Carnethon MR, 2003, ANN EPIDEMIOL, V13, P530, DOI 10.1016/S1047-2797(03)00050-4; Kadish AH, 2004, ANN NONINVAS ELECTRO, V9, P366, DOI 10.1111/j.1542-474X.2004.94580.x; Cho HS, 2003, J PHYSIOL-LONDON, V550, P169, DOI 10.1113/jphysiol.2003.040501; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; Drici MD, 1998, JAMA-J AM MED ASSOC, V280, P1774, DOI 10.1001/jama.280.20.1774; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Miki T, 2002, NAT MED, V8, P466, DOI 10.1038/nm0502-466; Larsen JA, 1998, AM J CARDIOL, V82, P993, DOI 10.1016/S0002-9149(98)00523-2; MAKKAR RR, 1993, JAMA-J AM MED ASSOC, V270, P2590, DOI 10.1001/jama.270.21.2590; Saito T, 2009, CIRC RES, V105, P343, DOI 10.1161/CIRCRESAHA.108.190041; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Berul CI, 1996, CIRCULATION, V94, P2641; Suzuki M, 2002, J CLIN INVEST, V109, P509, DOI 10.1172/JC1200214270; Zhang YY, 2011, AM J EPIDEMIOL, V174, P403, DOI 10.1093/aje/kwr172; Bell JR, 2014, AM J PHYSIOL-HEART C, V306, pH1265, DOI 10.1152/ajpheart.00012.2014; Haines CD, 2012, ENDOCRINOLOGY, V153, P4480, DOI 10.1210/en.2012-1353; Hara M, 1998, J PHARMACOL EXP THER, V285, P1068; Jazbutyte V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042032; Kakusaka S, 2009, J PHARMACOL SCI, V109, P152, DOI 10.1254/jphs.08257SC; Knollmann BC, 2001, J CARDIOVASC ELECTR, V12, P1286, DOI 10.1046/j.1540-8167.2001.01286.x; Kurokawa J, 2009, J PHARMACOL SCI, V109, P334, DOI 10.1254/jphs.08R23FM; Kurokawa J., 2012, HDB EXP PHARM, V214, P237; Kurokawa J, 2008, J PHYSIOL-LONDON, V586, P2961, DOI 10.1113/jphysiol.2007.150367; Lande G, 2001, CARDIOVASC RES, V50, P328, DOI 10.1016/S0008-6363(01)00232-2; Liu G, 2004, J PHYSIOL-LONDON, V555, P267, DOI 10.1113/jphysiol.2003.054064; Marger L, 2011, CHANNELS, V5, P241, DOI 10.4161/chan.5.3.15264; Morani A, 2006, P NATL ACAD SCI USA, V103, P7165, DOI 10.1073/pnas.0602194103; Panama BK, 2007, AM J PHYSIOL-HEART C, V293, pH3558, DOI 10.1152/ajpheart.00419.2007; Giraldi FP, 2010, INT J ANDROL, V33, pE132, DOI 10.1111/j.1365-2605.2009.00985.x; Qin X, 2008, CELL MOL LIFE SCI, V65, P2752, DOI 10.1007/s00018-008-8273-1; Rissman EF, 1997, HORM BEHAV, V31, P232, DOI 10.1006/hbeh.1997.1390; Sasano T, 2004, J CARDIOVASC ELECTR, V15, P1250, DOI 10.1046/j.1540-8167.2004.03706.x; Trepanier-Boulay V, 2004, CARDIOVASC RES, V64, P84, DOI 10.1016/j.cardiores.2004.06.002	40	1	1	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	JUN	2015	40	3					339	348				10	Toxicology	Toxicology	CJ7VA	WOS:000355707200005		
J	Sakurai, K; Mikamoto, K; Shirai, M; Iguchi, T; Ito, K; Takasaki, W; Mori, K				Sakurai, Ken; Mikamoto, Kei; Shirai, Makoto; Iguchi, Takuma; Ito, Kazumi; Takasaki, Wataru; Mori, Kazuhiko			MicroRNA profiling in ethylene glycol monomethyl ether-induced monkey testicular toxicity model	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Testicular toxicity; Ethylene glycol monomethyl ether; Monkey; miRNA	MACACA-FASCICULARIS; SIRT1 EXPRESSION; MONOETHYL ETHERS; GROWTH ARREST; SPERMATOGENESIS; APOPTOSIS; RATS; PATHWAY; CANCER; TESTES	To establish and characterize ethylene glycol monomethyl ether (EGME)-induced testicular toxicity model in cynomolgus monkeys, EGME at 0 or 300 mg/kg was administered orally to sexually mature male cynomolgus monkeys (n = 3/group) for 4 consecutive days. Circulating and testicular microRNA (miRNA) profiles in this model were investigated using miRNA microarray or real-time quantitative reverse transcription-PCR methods. EGME at 300 mg/kg induced testicular toxicity in all the monkeys, which was characterized histopathologically by decreases in pachytene spermatocytes and round spermatids, without any severe changes in general conditions or clinical pathology. In microarray analysis, 16 down-regulated and 347 up-regulated miRNAs were detected in the testis, and 326 down-regulated but no up-regulated miRNAs were detected in plasma. Interestingly, miR-1228 and miR-2861 were identified as abundant miRNAs in plasma and the testis of control animals, associated presumably with apoptosis and cell differentiation, respectively, and were prominently increased in the testis of EGME-treated animals, reflecting the recovery from EGME-induced testicular damages via stimulating cell proliferation and differentiation of sperm. Furthermore, down-regulation of miR-34b-5p and miR-449a, which are enriched in meiotic cells like pachytene spermatocytes, was obvious in the testis, suggesting that these spermatogenic cells were damaged by the EGME treatment. In conclusion, EGME-induced testicular toxicity in cynomolgus monkeys was shown, and this model would be useful for investigating the mechanism of EGME-induced testicular toxicity and identifying testicular biomarkers. Additionally, testicular miR-34b-5p and miR-449a were suggested to be involved in damage of pachytene spermatocytes.	[Sakurai, Ken; Mikamoto, Kei; Shirai, Makoto; Iguchi, Takuma; Takasaki, Wataru; Mori, Kazuhiko] Daiichi Sankyo Co Ltd, Med Safety Res Labs, Edogawa Ku, Tokyo 1348630, Japan; [Ito, Kazumi] Daiichi Sankyo Co Ltd, Translat Med & Clin Pharmacol Dept, Shinagawa Ku, Tokyo 1408710, Japan	Sakurai, K (reprint author), Daiichi Sankyo Co Ltd, Med Safety Res Labs, Edogawa Ku, Tokyo 1348630, Japan.	sakurai.ken.t6@daiichisankyo.co.jp					Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Bouhallier F, 2010, RNA, V16, P720, DOI 10.1261/rna.1963810; McLachlan RI, 2002, RECENT PROG HORM RES, V57, P149, DOI 10.1210/rp.57.1.149; Wu JW, 2014, P NATL ACAD SCI USA, V111, pE2851, DOI 10.1073/pnas.1407777111; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Kawamoto Y, 2008, J MED PRIMATOL, V37, P45, DOI 10.1111/j.1600-0684.2007.00225.x; Papaioannou MD, 2009, DEV BIOL, V326, P250, DOI 10.1016/j.ydbio.2008.11.011; Lewis PJS, 2011, HEPATOLOGY, V54, P1767, DOI 10.1002/hep.24538; KU WW, 1995, TOXICOL APPL PHARM, V134, P100, DOI 10.1006/taap.1995.1173; Bao JQ, 2012, J BIOL CHEM, V287, P21686, DOI 10.1074/jbc.M111.328054; Smorag L, 2012, BIOL CELL, V104, P677, DOI 10.1111/boc.201200014; Johanson G, 2000, CRIT REV TOXICOL, V30, P307, DOI 10.1080/10408440091159220; Bagchi G, 2008, INT J ANDROL, V31, P269, DOI 10.1111/j.1365-2605.2007.00846.x; Lee J, 2010, AGING-US, V2, P527; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Saunders LR, 2010, AGING-US, V2, P415; FOSTER PMD, 1984, ENVIRON HEALTH PERSP, V57, P207, DOI 10.2307/3429918; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Lize M, 2010, CELL CYCLE, V9, P4579, DOI 10.4161/cc.9.22.13870; Lize M, 2011, CELL CYCLE, V10, P2874, DOI 10.4161/cc.10.17.17181; Dreef HC, 2007, TOXICOL PATHOL, V35, P395, DOI 10.1080/01926230701230346; FOSTER PMD, 1983, TOXICOL APPL PHARM, V69, P385, DOI 10.1016/0041-008X(83)90262-4; Fukushima T, 2011, J TOXICOL SCI, V36, P601; Higashino A, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r58; Li LH, 1996, J ANDROL, V17, P538; MILLER RR, 1983, FUND APPL TOXICOL, V3, P49, DOI 10.1016/S0272-0590(83)80172-9; NAGANO K, 1984, ENVIRON HEALTH PERSP, V57, P75, DOI 10.2307/3429901; Nagano K, 1979, Sangyo Igaku, V21, P29; Yan B, 2012, APOPTOSIS, V17, P717, DOI 10.1007/s10495-012-0710-9	31	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	JUN	2015	40	3					375	382				8	Toxicology	Toxicology	CJ7VA	WOS:000355707200008		
J	Kimura, T; Onodera, A; Okumura, F; Nakanishi, T; Itoh, N				Kimura, Tomoki; Onodera, Akira; Okumura, Fumika; Nakanishi, Tsuyoshi; Itoh, Norio			Chromium (VI)-induced transformation is enhanced by Zn deficiency in BALB/c 3T3 cells	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Zn; Cr; Metallothionein; Transformation	TRANSCRIPTION FACTOR MTF-1; METALLOTHIONEIN-I PROMOTER; GENE-TRANSCRIPTION; ZINC FINGERS; CELL-TRANSFORMATION; MOUSE; COMPLEX; SUPEROXIDE; MECHANISM; TOXICITY	Hexavalent chromium [Cr(VI)] is a carcinogenic heavy metal that is reduced to intermediate oxidation states, such as Cr(V) and Cr(IV), in the process of forming stable Cr(III) forms; it is these intermediate forms that are thought to be responsible for much of the DNA damage and mutations that are induced by Cr(VI). Metallothionein (MT), a heavy metal-binding protein, is induced by zinc and other heavy metals and protects cells from the toxic effects of these metals by sequestering them. MT cannot bind Cr, but by scavenging reactive oxygen species through its cysteine residues, it may act as a protective factor against Cr(VI)-induced DNA lesions by reducing Cr(VI) directly to Cr(III), thereby avoiding the creation of the toxic intermediates. Here, we showed that Zn deficiency decreased MT expression in BALB/3T3 clone A31-1-1 cells and caused them to become highly susceptible to Cr(VI)-induced transformation. To obtain Zn-deficient cultures, cells were cultured in medium supplemented with 10% Chelex (R)-100 chelating resin-treated FBS. The increase in susceptibility to transformation was abolished by culturing the cells with supplemental Zn (50 mu M). Previously, we reported that Cr(VI) inhibits MT transcription by preventing the zinc-dependent formation of a complex of metal response element-binding transcription factor-1 (MTF-1) and the co-activator p300. Our results suggest that the carcinogenicity of Cr(VI) is enhanced by MTF-1 dysfunction.	[Kimura, Tomoki; Okumura, Fumika] Setsunan Univ, Fac Pharmaceut Sci, Toxicol Lab, Hirakata, Osaka 5730101, Japan; [Onodera, Akira; Itoh, Norio] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Toxicol, Suita, Osaka 5650871, Japan; [Nakanishi, Tsuyoshi] Gifu Pharmaceut Univ, Lab Hygien Chem & Mol Toxicol, Gifu, Gifu 5028585, Japan	Kimura, T (reprint author), Setsunan Univ, Fac Pharmaceut Sci, Toxicol Lab, 45-1 Nagaotoge Cho, Hirakata, Osaka 5730101, Japan.	tomoki@pharm.setsunan.ac.jp			Long-range Research Initiative (LRI) of the Japan Chemical Industry Association (JCIA)	This research was supported in part by a grant from the Long-range Research Initiative (LRI) of the Japan Chemical Industry Association (JCIA).	ALCEDO JA, 1994, CARCINOGENESIS, V15, P1089, DOI 10.1093/carcin/15.5.1089; Jiang HM, 2003, J BIOL CHEM, V278, P30394, DOI 10.1074/jbc.M303598200; THORNALLEY PJ, 1985, BIOCHIM BIOPHYS ACTA, V827, P36, DOI 10.1016/0167-4838(85)90098-6; Li Y, 2006, MOL CELL BIOL, V26, P5580, DOI 10.1128/MCB.00471-06; Kelly EJ, 1996, J NUTR, V126, P1782; Li Y, 2008, MOL CELL BIOL, V28, P4275, DOI 10.1128/MCB.00369-08; HAMER DH, 1986, ANNU REV BIOCHEM, V55, P913, DOI 10.1146/annurev.biochem.55.1.913; Kimura T, 2011, J TOXICOL SCI, V36, P173; Zhitkovich A, 2005, CHEM RES TOXICOL, V18, P3, DOI 10.1021/tx049774+; MICHALSKA AE, 1993, P NATL ACAD SCI USA, V90, P8088, DOI 10.1073/pnas.90.17.8088; Li B, 2014, J CELL MOL MED, V18, P895, DOI 10.1111/jcmm.12239; Wang Y, 2004, FASEB J, V18, P1071, DOI 10.1096/fj.03-1282com; RADTKE F, 1993, EMBO J, V12, P1355; MASTERS BA, 1994, P NATL ACAD SCI USA, V91, P584, DOI 10.1073/pnas.91.2.584; Kabu K, 2006, J IMMUNOL, V177, P1296; BRUGNERA E, 1994, NUCLEIC ACIDS RES, V22, P3167, DOI 10.1093/nar/22.15.3167; Cho Young-Eun, 2007, Nutr Res Pract, V1, P29, DOI 10.4162/nrp.2007.1.1.29; Dalton T, 1996, J NUTR, V126, P825; FITZGERALD DJ, 1989, MUTAGENESIS, V4, P286, DOI 10.1093/mutage/4.4.286; Fujimoto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077445; Hirooka T, 2010, TOXICOL IN VITRO, V24, P835, DOI 10.1016/j.tiv.2009.12.009; IRAC, 2012, AG CLASS IARC MON C, V100C, P147; KAGI JHR, 1988, BIOCHEMISTRY-US, V27, P8509; Kimura T, 2008, BIOCHEM J, V415, P477, DOI 10.1042/BJ20081025; Klaassen Curtis D., 1998, Journal of Toxicological Sciences, V23, P97; Koizumi S, 2000, J CELL PHYSIOL, V185, P464, DOI 10.1002/1097-4652(200012)185:3<464::AID-JCP18>3.0.CO;2-4; Majumder S, 2003, J BIOL CHEM, V278, P26216, DOI 10.1074/jbc.M302887200; Murakami M, 2008, CANCER SCI, V99, P1515, DOI 10.1111/j.1349-7006.2008.00854.x; OTSUKA F, 1994, J BIOL CHEM, V269, P23700; Prasad AS, 2014, J TRACE ELEM MED BIO, V28, P364, DOI 10.1016/j.jtemb.2014.07.019; Sato M, 2002, CLIN EXP HYPERTENS, V24, P355, DOI 10.1081/CEH-120004797; YAMASAKI H, 1985, CANCER RES, V45, P2395; Yamasaki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039654	33	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	JUN	2015	40	3					383	387				5	Toxicology	Toxicology	CJ7VA	WOS:000355707200009		
J	Goto, S; Deguchi, J; Nishio, N; Nomura, N; Funabashi, H				Goto, Shima; Deguchi, Jiro; Nishio, Naoki; Nomura, Naruaki; Funabashi, Hitoshi			Hepatotoxicants induce cytokine imbalance in response to innate immune system	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Hepatotoxicity; Inflammation; Kupffer cells; Lipopolysaccharide; In vitro; Screening	INDUCED LIVER-INJURY; NECROSIS-FACTOR-ALPHA; MONOCYTE CHEMOATTRACTANT PROTEIN-1; INFLAMMATORY RESPONSE; INDUCED EXPRESSION; MICE; TOXICITY; CELLS; MACROPHAGES; STRESS	In recent years, attention has been paid to innate immune systems as mechanisms to initiate or promote drug-induced liver injury (DILI). Kupffer cells are hepatic resident macrophages and might be involved in the pathogenesis of DILI by release of pro- and anti-inflammatory mediators such as cytokines, chemokines, reactive oxygen species, and/or nitric oxides. The purpose of this study was to investigate alterations in mediator levels induced by hepatotoxic compounds in isolated Kupffer cells and discuss the relation between balance of each cytokine or chemokine and potential of innate immune-mediated DILI. Primary cultured rat Kupffer cells were treated with hepatotoxic (acetaminophen, troglitazone, trovafloxacin) or non-hepatotoxic (pioglitazone, levofloxacin) compounds with or without lipopolysaccharide (LPS). After 24 hr treatment, cell supernatants were collected and various levels of mediators released by Kupffer cells were examined. Although hepatotoxicants had no effect on the LPS-induced tumor necrosis factor-alpha (TNF-alpha) secretion, they enhanced the release of pro-inflammatory cytokine interleukin-1 beta (IL-1 beta) and suppressed the anti-inflammatory cytokines interleukin-6 (IL-6) and interleukin-10 (IL-10) induced by LPS. These cytokine shifts were not associated with switching the phenotypes of M1 and M2 macrophages in Kupffer cells. In conclusion, the present study suggested that the levels of some specific cytokines are affected by DILI-related drugs with LPS stimulation, and imbalance between pro- and anti-inflammatory cytokines, induced by the up-regulation of IL-1 beta and the down-regulation of IL-6 or IL-10, plays a key role in innate immune-mediated DILI.	[Goto, Shima; Deguchi, Jiro; Nishio, Naoki; Nomura, Naruaki; Funabashi, Hitoshi] Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, Osaka 5540022, Japan	Goto, S (reprint author), Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, Japan.	shima-goto@ds-pharma.co.jp					Ajuebor MN, 2004, EUR J IMMUNOL, V34, P2907, DOI 10.1002/eji.200425071; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Kubes P, 2012, GASTROENTEROLOGY, V143, P1158, DOI 10.1053/j.gastro.2012.09.008; Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; Deng XM, 2009, PHARMACOL REV, V61, P262, DOI 10.1124/pr.109.001727; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Njoku DB, 2014, INT J MOL SCI, V15, P6990, DOI 10.3390/ijms15046990; Pachkoria K, 2008, J HEPATOL, V49, P107, DOI 10.1016/j.jhep.2008.03.017; Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001; Tukov FF, 2007, TOXICOL SCI, V100, P267, DOI 10.1093/toxsci/kfm209; Lu JT, 2012, TOXICOL SCI, V125, P126, DOI 10.1093/toxsci/kfr266; Ohta MY, 2000, METABOLISM, V49, P163, DOI 10.1016/S0026-0495(00)91143-0; Adams DH, 2010, TOXICOL SCI, V115, P307, DOI 10.1093/toxsci/kfq009; Zhao XX, 2010, J SURG RES, V162, P264, DOI 10.1016/j.jss.2009.04.047; Laskin DL, 2009, CHEM RES TOXICOL, V22, P1376, DOI 10.1021/tx900086v; Lee WM, 2012, BEST PRACT RES CL GA, V26, P3, DOI 10.1016/j.bpg.2012.01.014; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Roberts RA, 2007, TOXICOL SCI, V96, P2, DOI 10.1093/toxsci/kfl173; Ju C, 2012, HEPATOLOGY, V56, P1599, DOI 10.1002/hep.25920; Bourdi M, 2002, HEPATOLOGY, V35, P289, DOI 10.1053/jhep.2002.30956; Gao B, 2012, J GASTROEN HEPATOL, V27, P89, DOI 10.1111/j.1440-1746.2011.07003.x; Ohta MY, 2000, DIABETES RES CLIN PR, V48, P171, DOI 10.1016/S0168-8227(00)00128-5; Botton T, 2011, CELL DEATH DIFFER, V18, P109, DOI 10.1038/cdd.2010.75; Cheng LL, 2009, HEPATOLOGY, V49, P215, DOI 10.1002/hep.22585; Chiu H, 2003, TOXICOL APPL PHARM, V193, P218, DOI 10.1016/S0041-008X(03)00369-7; Deng XM, 2006, J PHARMACOL EXP THER, V319, P1191, DOI 10.1124/jpet.106.110247; El-Assal O, 2004, CELL MOL IMMUNOL, V1, P205; Hadi M, 2012, CHEM RES TOXICOL, V25, P1938, DOI 10.1021/tx300248j; Hinson JA, 2010, HDB EXP PHARM, V196, P369, DOI DOI 10.1007/978-3-642-00663-0_12; Hogaboam CM, 1999, GENE THER, V6, P573, DOI 10.1038/sj.gt.3300858; Kumagai K, 2009, TOXICOL PATHOL, V37, P536, DOI 10.1177/0192623309336153; Maher JJ, 2009, J CLIN INVEST, V119, P246, DOI 10.1172/JCI38178; Ramm S, 2013, TOXICOLOGY, V312, P83, DOI 10.1016/j.tox.2013.08.002; Saiman Y, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00213; Shaw PJ, 2007, TOXICOL SCI, V100, P259, DOI 10.1093/toxsci/kfm218; Shaw PJ, 2009, J PHARMACOL EXP THER, V330, P72, DOI 10.1124/jpet.109.151068; Tanimoto N, 2007, BIOCHEM BIOPH RES CO, V361, P533, DOI 10.1016/j.bbrc.2007.07.060; Watkins PB, 2005, TOXICOL PATHOL, V33, P1, DOI 10.1080/01926230590888306; Yamada Y, 1998, AM J PATHOL, V152, P1577; Yumoto E, 2002, J GASTROEN HEPATOL, V17, P285, DOI 10.1046/j.1440-1746.2002.02690.x; Zimmermann HW, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00056	41	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	JUN	2015	40	3					389	404				16	Toxicology	Toxicology	CJ7VA	WOS:000355707200010		
J	Abiko, Y; Luong, NC; Kumagai, Y				Abiko, Yumi; Nho Cong Luong; Kumagai, Yoshito			A Biotin-PEAC(5)-maleimide labeling assay to detect electrophiles	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Electrophile; Thiol; Cysteine; S-arylation; Biotin-PEAC(5)-maleimide	ELEMENT-BINDING PROTEIN; COVALENT MODIFICATION; CHEMICAL-MODIFICATION; OUTDOOR AIR; 1,2-NAPHTHOQUINONE; NAPHTHALENE; ACTIVATION; QUINONES; INHIBITION; INDOOR	Recently, we established a biotin-PEAC(5)-maleimide (BPM)-labeling assay, which can be used to determine the modification of electrophilic metals to proteins (Toyama at al., J. Toxicol. Sci., 38, 477-484, 2013). In the present study, we applied a BPM-labeling assay to detect protein S-modification by environmental organic electrophiles. After exposing A431 cells to 1,2-naphthoquinone (1,2-NQ) and 1,4-naphthoquinone (1,4-NQ), there was an inverse correlation between Western blot analysis with specific antibody against these electrophiles and that with BPM on the blot intensity to detect protein modification. Similar results were also observed using enzyme-linked immunosorbent assay (ELISA) with BPM. Modification of proteins in mouse liver cytosol by 5-hydroxy-1,4-NQ, 5,8-dihydroxy-1,4-NQ, 1,4-benzoquinone (1,4-BQ), tert-butyl-1,4-BQ, and N-acetyl-p-benzoquinoneimine, an electrophilic metabolite of acetaminophen, was detected using ELISA, but not non-electrophilic quinones or hydroquinone. We also tested whether ELISA could be used to detect electrophiles contained in the vapor phase of ambient air samples collected in the midtown area of Los Angeles. Taken together, the results suggested that the ELISA, developed in this study, can detect the existence of electrophilic quinones that covalently modify cellular proteins, resulting in modulation of redox-signal transduction pathways or cell damage.	[Abiko, Yumi; Kumagai, Yoshito] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Nho Cong Luong; Kumagai, Yoshito] Univ Tsukuba, Grad Sch Comprehens Human Sci, Masters Program Med Sci, Tsukuba, Ibaraki 3058575, Japan	Kumagai, Y (reprint author), Univ Tsukuba, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	yk-em-tu@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25220103]	This work was supported by a Grant-in-Aid (#25220103 to Y.K.) for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Evans DC, 2004, CHEM RES TOXICOL, V17, P3, DOI 10.1021/tx034170b; Lind C, 2002, ARCH BIOCHEM BIOPHYS, V406, P229, DOI 10.1016/S0003-9861(02)00468-X; Cho AK, 2004, AEROSOL SCI TECH, V38, P68, DOI 10.1080/02786820390229471; Cho AK, 2005, ENVIRON RES, V99, P40, DOI 10.1016/j.envres.2005.01.003; Jia CR, 2010, INT J ENV RES PUB HE, V7, P2903, DOI 10.3390/ijerph7072903; Miura T, 2010, J TOXICOL SCI, V35, P843, DOI 10.2131/jts.35.843; Toyama T, 2013, J TOXICOL SCI, V38, P477; Jacobs AT, 2010, ACCOUNTS CHEM RES, V43, P673, DOI 10.1021/ar900286y; Abiko Y, 2011, TOXICOL APPL PHARM, V255, P32, DOI 10.1016/j.taap.2011.05.013; Jakober CA, 2007, ENVIRON SCI TECHNOL, V41, P4548, DOI 10.1021/es062967u; Iwamoto N, 2007, J BIOL CHEM, V282, P33396, DOI 10.1074/jbc.M705224200; Kumagai Y, 2012, ANNU REV PHARMACOL, V52, P221, DOI 10.1146/annurev-pharmtox-010611-134517; Miura T, 2011, CHEM RES TOXICOL, V24, P559, DOI 10.1021/tx100427p; Batterman S, 2012, INDOOR AIR, V22, P266, DOI 10.1111/j.1600-0668.2011.00760.x; OLLINGER K, 1991, J BIOL CHEM, V266, P21496; Kautzman KE, 2010, J PHYS CHEM A, V114, P913, DOI 10.1021/jp908530s; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Eiguren-Fernandez A, 2010, ENVIRON RES, V110, P207, DOI 10.1016/j.envres.2010.01.009; Eiguren-Fernandez A, 2008, AEROSOL SCI TECH, V42, P854, DOI 10.1080/02786820802339546; Endo A, 2011, CHEM-BIOL INTERACT, V192, P272, DOI 10.1016/j.cbi.2011.04.003; Endo A, 2007, BIOCHEM BIOPH RES CO, V361, P243, DOI 10.1016/j.bbrc.2007.07.024; Hinson JA, 2010, HDB EXP PHARM, V196, P369, DOI DOI 10.1007/978-3-642-00663-0_12; Hirose R, 2012, J TOXICOL SCI, V37, P891; Iwamoto N, 2010, ATMOS ENVIRON, V44, P1483, DOI 10.1016/j.atmosenv.2010.01.045; Kumagai Y., 2013, OXID MED CELL LONGEV, V2013; Kumagai Y, 1998, CHEM RES TOXICOL, V11, P608, DOI 10.1021/tx970119u; Muthuramalingam M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00054	27	2	2	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	JUN	2015	40	3					405	411				7	Toxicology	Toxicology	CJ7VA	WOS:000355707200011		
J	Tsubota, K; Kanki, M; Noto, T; Nakatsuji, S; Oishi, Y; Matsumoto, M; Nakayama, H				Tsubota, Kenjiro; Kanki, Masayuki; Noto, Takahisa; Nakatsuji, Shunji; Oishi, Yuji; Matsumoto, Masahiro; Nakayama, Hiroyuki			Altered gene expression profile in ovarian follicle in rats treated with indomethacin and RU486	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Indomethacin; RU486; Unruptured follicle; Gene expression profiling	ENDOTHELIAL GROWTH-FACTOR; COLLABORATIVE WORK; FEMALE RATS; PLASMINOGEN-ACTIVATOR; OVULATION; FERTILITY; MICE; TOXICITY; ANGIOGENESIS; MIFEPRISTONE	It is well-known that indomethacin (the cyclooxygenase 1 & 2 inhibitor) and RU486 (or mifepristone, the progesterone receptor antagonist) block follicular rupture in rats. To characterize genetic alterations in unruptured follicles, gene expression profiles in ovarian follicle were analyzed in indomethacin- and RU486-treated female Sprague-Dawley rats. Ovaries are collected at 22:00 on the proestrus day and 10:00 on the following estrus day after a single dose of indomethacin and RU486. Histopathologically, changes depicting responses to LH surge were observed in ovaries, uteri and vagina. Total RNA was extracted from pre-ovulatory follicles or unruptured follicles collected by laser microdissection and analyzed by Genechip (R). Among genes showing statistically significant changes compared to control groups, following changes were considered relevant to induction of unruptured follicles. In indomethacin-treated rats, Wnt4 was down-regulated, suggesting effect on tissue integrity and steroid genesis. In RU486-treated rats, Adamts1, Adamts9, Edn2, Ednra, Lyve1, Plat, and Pparg were down-regulated. These changes suggest effects on proteolysis for extra cellular matrix or surrounding tissue (Adamts1 & 9, and Plat), constriction of smooth muscle surrounding follicles (Edn2, Ednra, and Pparg), follicular fluid (Lyve1), and angiogenesis (Pparg). Down-regulation of angiogenesis related genes (Angpt2, Hmox1, and Vegfa) was observed in both treatment groups. Here, we clarify genetic alterations induced by the inhibition of cyclooxygenase or progesterone receptor.	[Tsubota, Kenjiro; Kanki, Masayuki; Noto, Takahisa; Nakatsuji, Shunji; Oishi, Yuji; Matsumoto, Masahiro] Astellas Pharma Inc, Drug Safety Res Labs, Yodogawa Ku, Osaka 5328514, Japan; [Nakayama, Hiroyuki] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pathol, Bunkyo Ku, Tokyo 1138657, Japan	Tsubota, K (reprint author), Astellas Pharma Inc, Drug Safety Res Labs, Yodogawa Ku, 1-6 Kashima 2 Chome, Osaka 5328514, Japan.	kenjiro.tsubota@astellas.com					Shindo T, 2000, J CLIN INVEST, V105, P1345, DOI 10.1172/JCI8635; Bridges PJ, 2010, REPROD FERT DEVELOP, V22, P780, DOI 10.1071/RD09194; Sanbuissho A, 2009, J TOXICOL SCI, V34, pSP1; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Tsubota K, 2009, J TOXICOL SCI, V34, pSP129; Boyer A, 2010, FASEB J, V24, P3010, DOI 10.1096/fj.09-145789; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Wulff C, 2002, ENDOCRINOLOGY, V143, P2797, DOI 10.1210/en.143.7.2797; Hsieh M, 2002, ENDOCRINOLOGY, V143, P898, DOI 10.1210/en.143.3.898; Ko C, 2006, ENDOCRINOLOGY, V147, P1770, DOI 10.1210/en.2005-1228; Komar CM, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-41; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Zenclussen ML, 2012, AM J REPROD IMMUNOL, V67, P376, DOI 10.1111/j.1600-0897.2011.01096.x; Gaytan F, 2003, BIOL REPROD, V69, P99, DOI 10.1095/biolreprod.102.013755; Richards JS, 1998, MOL CELL ENDOCRINOL, V145, P47, DOI 10.1016/S0303-7207(98)00168-3; Kim JY, 2008, MOL CELL BIOL, V28, P1770, DOI 10.1128/MCB.01556-07; Ny A, 1999, ENDOCRINOLOGY, V140, P5030, DOI 10.1210/en.140.11.5030; Brown HM, 2010, ENDOCRINOLOGY, V151, P5446, DOI 10.1210/en.2010-0629; Brown HM, 2006, DEV BIOL, V300, P699, DOI 10.1016/j.ydbio.2006.10.012; HAMEL RP, 1993, NEW ENGL J MED, V328, P354; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Ny A, 1997, EUR J BIOCHEM, V244, P487, DOI 10.1111/j.1432-1033.1997.00487.x; Robker R.L., 2009, NUCL RECEPT SIGNAL, V7; Robker RL, 2000, STEROIDS, V65, P559, DOI 10.1016/S0039-128X(00)00114-8; Tamura T, 2009, J TOXICOL SCI, V34, pSP31; TSAFRIRI A, 1989, ENDOCRINOLOGY, V124, P415; Tsubota K, 2011, TOXICOL PATHOL, V39, P641, DOI 10.1177/0192623311406932; Wiegand SJ, 2000, SERONO SYMP, P175	28	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	JUN	2015	40	3					413	425				13	Toxicology	Toxicology	CJ7VA	WOS:000355707200012		
J	Montenegro, FMU; Falbo, AR; Germano, EM; Correia, NB; Souza, ED; Nakagomi, O; Nakagomi, T; Cuevas, LE; Cunliffe, NA; Correia, JB				Ulisses Montenegro, Fernanda Maria; Falbo, Ana Rodrigues; Germano, Eliane Mendes; Correia, Nancy Barros; Souza, Edvaldo da Silva; Nakagomi, Osamu; Nakagomi, Toyoko; Cuevas, Luis E.; Cunliffe, Nigel A.; Correia, Jailson B.			Reduction in Rotavirus Disease and Sustained Predominance of G2P[4] Rotavirus Strain following Introduction of Rotavirus Vaccine in Recife, Brazil	JOURNAL OF TROPICAL PEDIATRICS			English	Article						rotavirus; gastroenteritis; rotavirus vaccine; genotype	GENOTYPE DISTRIBUTION; DIARRHEA; CHILDREN	Rotavirus vaccination was introduced in Brazil in March 2006. We describe the distribution of rotavirus genotypes in children with acute gastroenteritis in a hospital in Recife, Brazil, during pre- and post-vaccination periods. There was a 43.8% reduction in the proportion of diarrhea episodes due to rotavirus. Nevertheless, we observed a sustained predominance of G2P[4] as the main genotype identified in the post-vaccination period.	[Ulisses Montenegro, Fernanda Maria; Falbo, Ana Rodrigues; Germano, Eliane Mendes; Correia, Nancy Barros; Souza, Edvaldo da Silva; Correia, Jailson B.] Inst Med Integral Prof Fernando Figueira, Res Dept, Recife, PE, Brazil; [Nakagomi, Osamu; Nakagomi, Toyoko] Nagasaki Univ, Div Mol Epidemiol, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Nakagomi, Osamu; Nakagomi, Toyoko] Nagasaki Univ, Global Ctr Excellence, Nagasaki 852, Japan; [Nakagomi, Osamu; Nakagomi, Toyoko; Cunliffe, Nigel A.] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool L69 3BX, Merseyside, England; [Cuevas, Luis E.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Montenegro, FMU (reprint author), Av Cais de Santa Rita 595-3302, BR-50020360 Recife, PE, Brazil.	fmum@hotmail.com	Cuevas, Luis E./I-3697-2015	Cuevas, Luis E./0000-0002-6581-0587			Zeller M, 2010, VACCINE, V28, P7507, DOI 10.1016/j.vaccine.2010.09.004; Nakagomi T, 2008, ARCH VIROL, V153, P591, DOI 10.1007/s00705-007-0028-z; Kirkwood CD, 2011, PEDIATR INFECT DIS J, V30, pS48, DOI 10.1097/INF.0b013e3181fefd90; Correia JB, 2010, J INFECT DIS, V201, P363, DOI 10.1086/649843; Carvalho-Costa FA, 2009, EMERG INFECT DIS, V15, P95, DOI 10.3201/eid1501.071136; Safadi MAP, 2010, PEDIATR INFECT DIS J, V29, P1019, DOI 10.1097/INF.0b013e3181e7886a; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276; Montenegro FMU, 2007, J MED VIROL, V79, P335, DOI 10.1002/jmv.20803	9	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0142-6338	1465-3664		J TROP PEDIATRICS	J. Trop. Pediatr.	JUN	2015	61	3					206	209		10.1093/tropej/fmv006		4	Pediatrics; Tropical Medicine	Pediatrics; Tropical Medicine	CK2KR	WOS:000356039800008		
J	Ohta, T; Nishioka, M; Nakata, N; Fukuda, K; Kato, K				Ohta, Tomoyuki; Nishioka, Makiko; Nakata, Norio; Fukuda, Kunihiko; Kato, Kumiko			Five Cases of Axillary Lymph Node Metastatic Breast Cancer on Contrast-Enhanced Sonography	JOURNAL OF ULTRASOUND IN MEDICINE			English	Article						breast cancer; breast ultrasound; contrast-enhanced sonography; lymph node metastasis; perfusion defect		This study was performed to determine the importance of contrast-enhanced sonography for axillary lymph node metastatic breast cancer. Contrast-enhanced sonographic findings in 5 patients with breast cancer and axillary lymph node metastasis are discussed, and imaging-pathologic correlations are also presented in 3 cases. In all 5 cases, lymph nodes showed a perfusion defect in the late phase. Rapid arterial enhancement and wash-out were observed in 2 cases in which we performed second injections. Contrast-enhanced sonography may be effective for identifying metastatic lesions in lymph nodes, especially in the early stages.	[Ohta, Tomoyuki; Nishioka, Makiko; Nakata, Norio; Fukuda, Kunihiko] Jikei Univ, Dept Radiol, Sch Med, Tokyo 1540003, Japan; [Kato, Kumiko] Jikei Univ, Dept Surg, Sch Med, Tokyo 1540003, Japan	Ohta, T (reprint author), Jikei Univ, Dept Radiol, Sch Med, Setagaya Ku, Krevia Komazawadaigaku 804,Nozawa 4-23-12, Tokyo 1540003, Japan.	ohta.kent@nifty.com					Alvarez S, 2006, AM J ROENTGENOL, V186, P1342, DOI 10.1021/2214/AJR.05.0936; Ouyang QF, 2010, J ULTRAS MED, V29, P343; Miyamoto Y, 2014, AM J ROENTGENOL, V202, pW400, DOI 10.2214/AJR.12.10518; Rubaltelli L, 2004, J ULTRAS MED, V23, P829; Li L, 2013, CANCER RES, V73, P2082, DOI 10.1158/0008-5472.CAN-12-4200; Petralia Giuseppe, 2013, Ecancermedicalscience, V7, P328, DOI 10.3332/ecancer.2013.328	6	0	0	AMER INST ULTRASOUND MEDICINE	LAUREL	SUBSCRIPTION DEPT, 14750 SWEITZER LANE, STE 100, LAUREL, MD 20707-5906 USA	0278-4297	1550-9613		J ULTRAS MED	J. Ultrasound Med.	JUN	2015	34	6					1131	1137		10.7863/ultra.34.6.1131		7	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	CJ8QI	WOS:000355768200023		
J	Fujiwara, H; Gobara, H; Hiraki, T; Iguchi, T; Uchida, HA; Kanazawa, S				Fujiwara, Hiroyasu; Gobara, Hideo; Hiraki, Takao; Iguchi, Toshihiro; Uchida, Haruhito Adam; Kanazawa, Susumu			Retrograde Renal Ablation via the Renal Vein as a New Treatment Option for Renovascular Hypertension	JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY			English	Editorial Material									[Fujiwara, Hiroyasu; Gobara, Hideo; Hiraki, Takao; Iguchi, Toshihiro; Kanazawa, Susumu] Okayama Univ, Sch Med, Dept Radiol, Okayama, Okayama 7008558, Japan; [Uchida, Haruhito Adam] Okayama Univ, Sch Med, Dept Chron Kidney Dis, Okayama, Okayama 7008558, Japan; [Uchida, Haruhito Adam] Okayama Univ, Sch Med, Dept Cardiovasc Dis, Okayama, Okayama 7008558, Japan	Fujiwara, H (reprint author), Okayama Univ, Sch Med, Dept Radiol, 2-5-1 Shikatacho, Okayama, Okayama 7008558, Japan.	hirofujiwar@gmail.com						0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1051-0443	1535-7732		J VASC INTERV RADIOL	J. Vasc. Interv. Radiol.	JUN	2015	26	6					807	808		10.1016/j.jvir.2015.01.030		2	Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular Disease	Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System & Cardiology	CK1JO	WOS:000355963800005		
J	Shimohira, M; Kawai, T; Hashizume, T; Ohta, K; Nakagawa, M; Ozawa, Y; Sakurai, K; Shibamoto, Y				Shimohira, Masashi; Kawai, Tatsuya; Hashizume, Takuya; Ohta, Kengo; Nakagawa, Motoo; Ozawa, Yoshiyuki; Sakurai, Keita; Shibamoto, Yuta			Reperfusion Rates of Pulmonary Arteriovenous Malformations after Coil Embolization: Evaluation with Time-Resolved MR Angiography or Pulmonary Angiography	JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; VENOUS SAC EMBOLIZATION; TERM-FOLLOW-UP; PLATINUM COILS; EMBOLOTHERAPY; ANEURYSMS; RECANALIZATION; EFFICACY; SAFETY; EMBOLISM	Purpose: To assess reperfusion rates after coil embolization for pulmonary arteriovenous malformations (PAVMs) using time-resolved magnetic resonance (MR) angiography or pulmonary angiography. Materials and Methods: Patients with PAVMs who underwent embolization and met the following inclusion criteria were included: (a) embolization was performed using bare or fibered platinum microcoils or both, (b) the complete cessation of flow was confirmed by digital subtraction angiography, and (c) follow-up examinations were conducted with time-resolved MR angiography or pulmonary angiography. Coil embolization was performed in 16 patients with 24 untreated or reperfused PAVMs. Sac embolization was performed for 12 untreated PAVMs. Feeding artery embolization was performed as primary embolization in each of the 12 reperfused PAVMs. Five PAVMs were treated 2 to 4 times because of reperfusion. The study included 32 coil embolizations. Follow-up images were reviewed, and reperfusion rates were assessed. The relationships between reperfusion and the location of PAVM, size of PAVM (feeding artery and venous sac), coils (number and total length), timing of embolization (primary or repeat embolization), and types of coils used (with or without fibered coils) were examined. Results: Reperfusion rates at 3, 6, 12, and 24 months were 8%, 27%, 36%, and 49%, respectively, for the 12 untreated PAVMs (primary embolization) and 50%, 50%, 92%, and 100%, respectively, for the 12 reperfused PAVMs (repeat embolization) (P =.0062). No significant differences were observed in the other parameters measured. Conclusions: When evaluated with time-resolved MR angiography or pulmonary angiography, reperfusion rates after coil embolization for PAVM were considerably high, particularly with repeat embolization.	[Shimohira, Masashi; Kawai, Tatsuya; Hashizume, Takuya; Ohta, Kengo; Nakagawa, Motoo; Ozawa, Yoshiyuki; Sakurai, Keita; Shibamoto, Yuta] Nagoya City Univ, Grad Sch Med Sci, Dept Radiol, Mizuho Ku, Nagoya, Aichi 4678601, Japan	Shimohira, M (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Radiol, Mizuho Ku, Nagoya, Aichi 4678601, Japan.	mshimohira@gmail.com		Sakurai, Keita/0000-0002-8849-7335			Andersen PE, 2006, CARDIOVASC INTER RAD, V29, P70, DOI 10.1007/s00270-005-0101-5; Pollak JS, 2006, J VASC INTERV RADIOL, V17, P35, DOI 10.1097/01.RVI.0000191410.13974.B6; Canton G, 2005, AM J NEURORADIOL, V26, P904; Koganemaru M, 2014, DIAGN INTERV RADIOL, V20, P129, DOI 10.5152/dir.2013.13236; Trerotola SO, 2009, J VASC INTERV RADIOL, V20, P1287, DOI 10.1016/j.jvir.2009.06.026; Milic A, 2005, J VASC INTERV RADIOL, V16, P1675, DOI 10.1097/01.RVI.0000182163.25493.BB; ROSENBLATT M, 1992, RADIOLOGY, V185, P134; GRAVES VB, 1990, AM J NEURORADIOL, V11, P249; White PM, 2008, AM J NEURORADIOL, V29, P217, DOI 10.3174/ajnr.A0936; Woodward CS, 2013, RADIOLOGY, V269, P919, DOI 10.1148/radiol.13122153; Lee DW, 1997, ANN THORAC SURG, V64, P930, DOI 10.1016/S0003-4975(97)00815-1; Shovlin CL, 2008, THORAX, V63, P259, DOI 10.1136/thx.2007.087452; Yasumoto T, 2013, J VASC INTERV RADIOL, V24, P1798, DOI 10.1016/j.jvir.2013.04.030; Mager JJ, 2004, J VASC INTERV RADIOL, V15, P451, DOI 10.1097/01.RVI.0000126811.05229.B6; White PM, 2011, LANCET, V377, P1655, DOI 10.1016/S0140-6736(11)60408-X; Tapping CR, 2011, J VASC INTERV RADIOL, V22, P1740, DOI 10.1016/j.jvir.2011.08.029; Trerotola SO, 2010, AM J ROENTGENOL, V195, P837, DOI 10.2214/AJR.10.5230; Gunnarsson T, 2009, AM J NEURORADIOL, V30, P1657, DOI 10.3174/ajnr.A1691; Lee WL, 2003, CHEST, V123, P351, DOI 10.1378/chest.123.2.351; Hayashi S, 2012, J VASC INTERV RADIOL, V23, P1566, DOI 10.1016/j.jvir.2012.09.008; Boussel L, 2010, J MAGN RESON IMAGING, V32, P1110, DOI 10.1002/jmri.22384; HEWES RC, 1985, CARDIOVASC INTER RAD, V8, P151, DOI 10.1007/BF02552883; Kajiwara K, 2014, ACTA RADIOL, V55, P1093, DOI 10.1177/0284185113512123; Kawai T, 2014, J VASC INTERV RADIOL, V25, P1339, DOI 10.1016/j.jvir.2014.06.003; Koganemaru M, 2010, J VASC INTERV RADIOL, V21, P298, DOI 10.1016/j.jvir.2009.10.017; Lee DW, 1997, ANN THORAC SURG, V64, P939; Letourneau-Guillon L, 2010, J VASC INTERV RADIOL, V21, P649, DOI 10.1016/j.jvir.2010.01.026; Meek Mary E, 2011, Semin Intervent Radiol, V28, P24, DOI 10.1055/s-0031-1273937; Prasad V, 2004, J VASC INTERV RADIOL, V15, P153, DOI 10.1097/01.RVI.0000106390.63463.05; Remy-Jardin M, 2006, RADIOLOGY, V239, P576, DOI 10.1148/radiol.2391050333; Sagara K, 1998, AM J ROENTGENOL, V170, P727; Saouti N, 2010, Eur Respir Rev, V19, P197, DOI 10.1183/09059180.00002210; Spilberg G, 2012, AM J NEURORADIOL, V33, P655, DOI 10.3174/ajnr.A2831; Todo K, 2004, AM J NEURORADIOL, V25, P428; WHITE RI, 1994, ANN THORAC SURG, V57, P519	35	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1051-0443	1535-7732		J VASC INTERV RADIOL	J. Vasc. Interv. Radiol.	JUN	2015	26	6					856	864		10.1016/j.jvir.2015.02.016		9	Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular Disease	Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System & Cardiology	CK1JO	WOS:000355963800013		
J	Oguro, S; Nakatsuka, S; Yashiro, H; Hashimoto, S; Miyashita, K; Kurihara, I; Itoh, H; Jinzaki, M				Oguro, Sota; Nakatsuka, Seishi; Yashiro, Hideki; Hashimoto, Subaru; Miyashita, Kazutoshi; Kurihara, Isao; Itoh, Hiroshi; Jinzaki, Masahiro			CT during Arteriography to Visualize the Right Adrenal Vein for Adrenal Venous Sampling	JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article							PRIMARY ALDOSTERONISM; EXPERIENCE; ANATOMY	The present report describes 6 cases of adrenal venous sampling (AVS) in patients who underwent computed tomography (CT) during arteriography because cannulation of right adrenal veins was otherwise difficult. CT was performed during arteriography to obtain information on the location and direction of the right adrenal vein. Two right adrenal veins were visualized in I case. The right central adrenal vein was not visualized in 1 case owing to an injury from a previous unsuccessful AVS procedure, but the right renal capsular vein was well visualized. CT during arteriography could contribute to a high AVS success rate.	[Oguro, Sota; Nakatsuka, Seishi; Yashiro, Hideki; Jinzaki, Masahiro] Keio Univ, Sch Med, Dept Radiol, Tokyo, Japan; [Miyashita, Kazutoshi; Kurihara, Isao; Itoh, Hiroshi] Keio Univ Hosp, Dept Internal Med, Tokyo 1608582, Japan; [Hashimoto, Subaru] Tachikawa Hosp, Dept Radiol, Tokyo, Japan	Nakatsuka, S (reprint author), Keio Univ Hosp, Dept Radiol, 35 Shinanomachi, Tokyo 1608582, Japan.	nakatsuka@rad.med.keio.ac.jp					Scholten A, 2013, JAMA SURG, V148, P378, DOI 10.1001/jamasurg.2013.610; Young WF, 2009, CLIN ENDOCRINOL, V70, P14, DOI 10.1111/j.1365-2265.2008.03450.x; Busser WM, 2014, CARDIOVASC INTERVENT; Jones AK, 2012, AM COLL MED PHYS, V13, P3693; Kahn S Lowell, 2010, Tech Vasc Interv Radiol, V13, P110, DOI 10.1053/j.tvir.2010.02.006; Matsui O, 1997, RADIOLOGY, V205, P159; Matsuura T, 2008, AM J ROENTGENOL, V191, P402, DOI 10.2214/AJR.07.3338; Mulatero P, 2004, J CLIN ENDOCR METAB, V89, P1045, DOI 10.1210/jc.2003-031337; Oguro S, 2014, JPN J RADIOL	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1051-0443	1535-7732		J VASC INTERV RADIOL	J. Vasc. Interv. Radiol.	JUN	2015	26	6					910	914		10.1016/j.jvir.2015.02.008		5	Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular Disease	Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System & Cardiology	CK1JO	WOS:000355963800022		
J	Ogiso, M; Yomogida, K				Ogiso, Masashi; Yomogida, Kiyoshi			Estimation of locations and migration of debris flows on Izu-Oshima Island, Japan, on 16 October 2013 by the distribution of high frequency seismic amplitudes	JOURNAL OF VOLCANOLOGY AND GEOTHERMAL RESEARCH			English	Article						Seismic amplitude; Debris flow; Location estimation; Spatial migration; Scattering	PYROCLASTIC FLOWS; VOLCANO; ERUPTION; SIGNALS; RECORDS	In the early morning on 16 October 2013, large debris flows resulted in over 30 people dead on Izu-Oshima Island, Japan, which were induced by heavy rainfall from the approaching Typhoon 1326 (Wipha). We successfully estimated the locations and migration processes of five large events of the debris flows, using the spatial distribution of high-frequency seismic amplitudes recorded by a seismic network on the island. The flows occurred on the western flank of the island, almost at the same place as the site where large traces of debris flows were identified after the disaster. During each event of debris flows, the estimated locations migrated downstream with increasing time, from the caldera rim of Miharayama volcano in the center of the island to its western side with a speed of up to 30 m/s. The estimated time series of source amplitudes are different from event to event, exhibiting a large variety of flow sequences while they seem to have repeated at a relatively narrow area over several tens of minutes. The present approach may be utilized for early detection and warning for prevention and reduction of the present type of disasters in the future. (C) 2015 Elsevier B.V. All rights reserved.	[Ogiso, Masashi] Japan Meteorol Agcy, Meteorol Res Inst, Tsukuba, Ibaraki 3050052, Japan; [Yomogida, Kiyoshi] Hokkaido Univ, Grad Sch Sci, Earth & Planetaty Dynam, Kita Ku, Sapporo, Hokkaido 0600810, Japan	Ogiso, M (reprint author), Japan Meteorol Agcy, Meteorol Res Inst, Nagamine 1-1, Tsukuba, Ibaraki 3050052, Japan.	mogiso@mri-jma.go.jp					Yamada M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052174; KANAMORI H, 1982, J GEOPHYS RES, V87, P5422, DOI 10.1029/JB087iB07p05422; Takemura S, 2009, GEOPHYS J INT, V178, P950, DOI 10.1111/j.1365-246X.2009.04210.x; Ogiso M, 2012, J VOLCANOL GEOTH RES, V217, P8, DOI 10.1016/j.jvolgeores.2011.12.005; Kumagai H, 2013, J VOLCANOL GEOTH RES, V257, P57, DOI 10.1016/j.jvolgeores.2013.03.002; Yamasato H, 1997, J PHYS EARTH, V45, P397; Onizawa S, 2002, EARTH PLANETS SPACE, V54, P803; Kumagai H, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006889; Allstadt K, 2013, J GEOPHYS RES-EARTH, V118, P1472, DOI 10.1002/jgrf.20110; Kumagai H, 2009, J VOLCANOL GEOTH RES, V183, P112, DOI 10.1016/j.jvolgeores.2009.03.010; Yamamoto M, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB007109; Battaglia J, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002193; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; Kumagai H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045944; Geospatial Information Authority of Japan, 2013, PUBL REL AER PHOT SH; Ishihara Y, 2003, EARTH PLANETS SPACE, V55, pE9; Japan Meteorological Agency and the Volcanological Society of Japan, 2013, IZ OSH NAT CAT ACT V, Vfourth; Jolly AD, 2002, J VOLCANOL GEOTH RES, V118, P299, DOI 10.1016/S0377-0273(02)00299-8; Jolly AD, 2014, J VOLCANOL GEOTH RES, V286, P317, DOI 10.1016/j.jvolgeores.2014.04.008; Okada Y, 2004, EARTH PLANETS SPACE, V56, pXV; Phillips S., 1986, B SEISMOLOGICAL SOC, V76, P627; Sato H, 2012, SEISMIC WAVE PROPAGA; Tokyo Metropolitan Government, 2013, NEWS DIS PREV FY 201; Ueno H., 2002, Q J SEISMOL, V65, P123; WESSEL P, 1998, EOS T AGU, V0079; Yamada M, 2013, GEOPHYS RES LETT, V40, P2998, DOI 10.1002/grl.50437	26	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0377-0273	1872-6097		J VOLCANOL GEOTH RES	J. Volcanol. Geotherm. Res.	JUN 1	2015	298						15	26		10.1016/j.jvolgeores.2015.03.015		12	Geosciences, Multidisciplinary	Geology	CK4QK	WOS:000356208100002		
J	Matsuo, N; Yokoyama, K; Tanno, Y; Yamamoto, I; Yokoo, T				Matsuo, Nanae; Yokoyama, Keitaro; Tanno, Yudo; Yamamoto, Izumi; Yokoo, Takashi			Combined therapy using peritoneal dialysis and hemodialysis may increase the indications for peritoneal dialysis in the United States	KIDNEY INTERNATIONAL			English	Letter									[Matsuo, Nanae; Yokoyama, Keitaro; Tanno, Yudo; Yamamoto, Izumi; Yokoo, Takashi] Dept Internal Med, Div Nephrol & Hypertens, Tokyo, Japan	Yokoyama, K (reprint author), Jikei Univ, Div Nephrol & Hypertens, Dept Internal Med, Sch Med,Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058471, Japan.	keitaro@jikei.ac.jp					Kimura K, 2012, AM J KIDNEY DIS, V60, P327, DOI 10.1053/j.ajkd.2012.03.023; Kumar VA, 2014, KIDNEY INT, V86, P1016, DOI 10.1038/ki.2014.224; Matsuo N, 2010, CLIN NEPHROL, V74, P209	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	JUN	2015	87	6					1259	1260		10.1038/ki.2015.56		2	Urology & Nephrology	Urology & Nephrology	CK1IL	WOS:000355960900026		
J	Nishitani, T				Nishitani, Tatsuo			A simple proof of the existence of tangent bicharacteristics for noneffectively hyperbolic operators	KYOTO JOURNAL OF MATHEMATICS			English	Article								The behavior of orbits of the Hamilton vector field H-p of the principal symbol p of a second-order hyperbolic differential operator is discussed. In our previous paper, assuming that p is noneffectively hyperbolic on the doubly characteristic manifold Sigma of p, we have proved that if H(S)(3)p = 0 on Sigma with the Hamilton vector field H-S of some specified S, then there exists a bicharacteristic landing on Sigma tangentially. The aim of this paper is to provide a much more simple proof of this result since the previous proof was fairly long and rather complicated.	Osaka Univ, Dept Math, Toyonaka, Osaka 5600043, Japan	Nishitani, T (reprint author), Osaka Univ, Dept Math, Machikaneyama 1-1, Toyonaka, Osaka 5600043, Japan.						BERNARDI E, 1993, J FUNCT ANAL, V116, P62, DOI 10.1006/jfan.1993.1104; Hormander L., 1985, GRUND MATH WISS, V274; Hormander L., 1983, GRUND MATH WISS, V256, DOI 10.1007/978-3-642-96750-4; HORMANDER L, 1977, J ANAL MATH, V32, P118, DOI 10.1007/BF02803578; Ivrii V. J., 1979, T MOSCOW MATH SOC, V39, p[83, 235, 87]; Ivrii V. J., 1977, T MOSCOW MATH SOC, V34, P149; Ivrii V. J., 1974, USP MAT NAUK, V29, P3; Iwasaki N., 1984, HYPERBOLIC EQUATIONS, P89; KOMATSU G, 1989, P JPN ACAD A-MATH, V65, P109; Nishitani T., 2013, MATH SOC JAPAN MEM, V30, DOI 10.1142/e038; Nishitani T., 2004, KYOTO J MATH, V44, P55; Nishitani T., 1983, SCI REP COLL GEN ED, V32, P9; Nishitani T., 1984, HYPERBOLIC EQUATIONS, P235, DOI 10.1016/B978-0-12-501658-2.50017-8	13	0	0	DUKE UNIV PRESS	DURHAM	905 W MAIN ST, STE 18-B, DURHAM, NC 27701 USA	2156-2261	2154-3321		KYOTO J MATH	Kyoto J. Math.	JUN	2015	55	2					281	297		10.1215/21562261-2871758		17	Mathematics	Mathematics	CJ7XP	WOS:000355714000003		
J	Kariyama, K				Kariyama, Kazutoshi			Endo-class and the Jacquet-Langlands correspondence	KYOTO JOURNAL OF MATHEMATICS			English	Article							ZERO DISCRETE-SERIES; ADIC SIMPLE ALGEBRAS; UNIT GROUPS; REPRESENTATIONS; GL(N)	Let F be a non-archimedean local field. Recently, Broussous, Secherre, and Stevens extended the notion of an endo-class, introduced by Bushnell and Henniart for GL(N)(F) with N >= 1, to an inner form of GL(N) (F) over F, and conjectured that this endo-class for discrete series representations is preserved by the Jacquet-Langlands correspondence. Explicit realizations of the correspondence are given by Silberger and Zink for level-zero discrete series representations and by Bushnell and Henniart for totally ramified ones. In this paper, we show that these realizations confirm the conjecture.	Onomichi City Univ, Dept Econ Management & Informat Sci, Hiroshima 7228506, Japan	Kariyama, K (reprint author), Onomichi City Univ, Dept Econ Management & Informat Sci, Hiroshima 7228506, Japan.	Itariyama@onomichi-u.ac.jp					ROGAWSKI JD, 1983, DUKE MATH J, V50, P161, DOI 10.1215/S0012-7094-83-05006-8; Badulescu AI, 2010, AM J MATH, V132, P1365; Badulescu AI, 2002, ANN SCI ECOLE NORM S, V35, P695, DOI 10.1016/S0012-9593(02)01106-0; Broussous P, 2012, DOC MATH, V17, P23; Broussous P, 1998, P LOND MATH SOC, V77, P292, DOI 10.1112/S0024611598000471; Bushnell C. J., 1993, ANN MATH STUD, V129; Bushnell CJ, 2011, PURE APPL MATH Q, V7, P469; Bushnell CJ, 2005, J REINE ANGEW MATH, V580, P39; BUSHNELL CJ, 1996, PUBL MATH IHES, V83, P105, DOI 10.1007/BF02698646; Deligne P., 1984, REPRESENTATIONS GROU, P33; Grabitz M, 2001, J NUMBER THEORY, V91, P92, DOI 10.1006/jnth.2001.2684; Henniart G., 1993, PROGR MATH, V108, P85; Jacquet H., 1970, LECT NOTES MATH, V114; Secherre V, 2008, J INST MATH JUSSIEU, V7, P527, DOI 10.1017/S1474748008000078; Secherre V., 2005, ANN SCI ECOLE NORM S, V38, P951, DOI [10.1016/j.ansens.2005.10.003, DOI 10.1016/J.ANSENS.2005.10.003.(834)]; Secherre V., 2004, B SOC MATH FRANCE, V132, P327; Silberger AJ, 2005, J REINE ANGEW MATH, V585, P173; Silberger AJ, 2003, CAN J MATH, V55, P353, DOI 10.4153/CJM-2003-016-4; Stevens S, 2005, DUKE MATH J, V127, P123, DOI 10.1215/S0012-7094-04-12714-9	19	0	0	DUKE UNIV PRESS	DURHAM	905 W MAIN ST, STE 18-B, DURHAM, NC 27701 USA	2156-2261	2154-3321		KYOTO J MATH	Kyoto J. Math.	JUN	2015	55	2					299	320		10.1215/21562261-2871767		22	Mathematics	Mathematics	CJ7XP	WOS:000355714000004		
J	Katsurada, H				Katsurada, Hidenori			Koecher-Maass series of the Ikeda lift for U(m, m)	KYOTO JOURNAL OF MATHEMATICS			English	Article							HERMITIAN MODULAR-FORMS; DIRICHLET SERIES; EXPLICIT FORMULA; SPACE	Let K = Q(root-D) be an imaginary quadratic field with discriminant -D, and let chi be the Dirichlet character corresponding to the extension K/Q. Let m = 2n or 2n + 1 with n a positive integer. Let f be a primitive form of weight 2k + 1 and character chi for Gamma(0) (D) or a primitive form of weight 2k for SL2(Z) according to whether m = 2n or m = 2n + 1. For such an f let I-m (f) be the lift of f to the space of Hermitian modular forms constructed by Ikeda. We then give an explicit formula of the Koecher-Maass series L(s, I-m(f)) of I-m (f). This is a generalization of Mizuno.	Muroran Inst Technol, Muroran, Hokkaido 0508585, Japan	Katsurada, H (reprint author), Muroran Inst Technol, 27-1 Mizumoto, Muroran, Hokkaido 0508585, Japan.	hidenori@mmm.muroran-it.ac.jp			Japan Society for the Promotion of Science KAKENHI [24540005]	Author's work partly supported by Japan Society for the Promotion of Science KAKENHI Grant Number 24540005.	IBUKIYAMA T, 1995, AM J MATH, V117, P1097, DOI 10.2307/2374973; Ikeda T, 2001, ANN MATH, V154, P641, DOI 10.2307/3062143; Bocherer S., 1987, COMMENT MATH U ST PA, V36, P53; Gritsenko V. A., 1990, T MAT I STEKLOVA, V183, P68; Gritsenko V. A., 1991, P STEKLOV I MATH, P75; Ibukiyama T, 2004, ABH MATH SEM HAMBURG, V74, P101, DOI 10.1007/BF02941528; Ibukiyama T, 2006, Automorphic Forms and Zeta Functions, P170, DOI 10.1142/9789812774415_0009; Ikeda T, 2008, COMPOS MATH, V144, P1107, DOI 10.1112/S0010437X08003643; JACOBOWITZ R, 1962, AM J MATH, V84, P441, DOI 10.2307/2372982; Katsurada H., 2014, COMMENT MATH U ST PA, V63, P137; Katsurada H., ARXIV11024393V1MATHN; Kitaoka Y., 1993, CAMBRIDGE TRACTS MAT, V106, DOI 10.1017/CB09780511666155; KITAOKA Y, 1984, NAGOYA MATH J, V95, P73; KITAOKA Y, 1983, NAGOYA MATH J, V92, P145; KOJIMA H, 1982, INVENT MATH, V69, P217, DOI 10.1007/BF01399502; KRIEG A, 1991, MATH ANN, V289, P663, DOI 10.1007/BF01446595; Mizuno Y, 2006, MANUSCRIPTA MATH, V119, P159, DOI 10.1007/s00229-005-0613-y; Rehmann U., 1971, THESIS GEORG AUGUST; Saito H., 1997, COMMENT MATH U SANCT, V46, P175; Scharlau W., 1985, GRUND MATH WISS, V270; Shimura G., 1997, CBMS REG C SER MATH, V93; Sugano T., 1995, COMMENT MATH U ST PA, V44, P1; Weil A., 1982, PROGR MATH, V23	23	0	0	DUKE UNIV PRESS	DURHAM	905 W MAIN ST, STE 18-B, DURHAM, NC 27701 USA	2156-2261	2154-3321		KYOTO J MATH	Kyoto J. Math.	JUN	2015	55	2					321	364		10.1215/21562261-2871776		44	Mathematics	Mathematics	CJ7XP	WOS:000355714000005		
J	Yoshioka, K				Yoshioka, Kota			Perverse coherent sheaves and Fourier-Mukai transforms on surfaces, II	KYOTO JOURNAL OF MATHEMATICS			English	Article							STABLE SHEAVES; MODULI SPACES; K3 SURFACES; TWISTED STABILITY; SINGULARITIES; CATEGORIES; FLOPS	We study perverse coherent sheaves on the resolution of rational double points. As examples, we consider rational double points on 2-dimensional moduli spaces of stable sheaves on K3 and elliptic surfaces. Then we show that perverse coherent sheaves appear in the theory of Fourier-Mukai transforms. As an application, we generalize the Fourier-Mukai duality for K3 surfaces to our situation.	Kobe Univ, Fac Sci, Dept Math, Kobe, Hyogo 657, Japan	Yoshioka, K (reprint author), Kobe Univ, Fac Sci, Dept Math, Kobe, Hyogo 657, Japan.	yoshioka@math.kobe-u.ac.jp			Japan Society for the Promotion of Science [18340010, 22340010]	Author's work supported by the Grants-in-aid for Scientific Research (No. 18340010, No. 22340010) from the Japan Society for the Promotion of Science.	MUKAI S, 1981, NAGOYA MATH J, V81, P153; Bridgeland T, 2008, DUKE MATH J, V141, P241, DOI 10.1215/S0012-7094-08-14122-5; SESHADRI CS, 1977, ADV MATH, V26, P225, DOI 10.1016/0001-8708(77)90041-X; Yoshioka K, 1996, INT J MATH, V7, P411, DOI 10.1142/S0129167X96000244; MUKAI S, 1984, INVENT MATH, V77, P101, DOI 10.1007/BF01389137; Bridgeland T, 2002, INVENT MATH, V147, P613, DOI 10.1007/s002220100185; Van den Bergh M, 2004, DUKE MATH J, V122, P423, DOI 10.1215/S0012-7094-04-12231-6; Bridgeland T, 1999, B LOND MATH SOC, V31, P25, DOI 10.1112/S0024609398004998; Bridgeland T, 1998, J REINE ANGEW MATH, V498, P115; ESNAULT H, 1985, J REINE ANGEW MATH, V362, P63; Huybrechts D, 2008, J ALGEBRAIC GEOM, V17, P375; Inaba M, 2010, J MATH SOC JPN, V62, P395, DOI 10.2969/jmsj/06220395; Kac V., 1990, INFIN DIMENS ANAL QU; Minamide H., ARXIV11065217V2MATHA; Mukai S., 1987, TATA I FUNDAMENTAL R, V11, P341; Mumford D., 1994, ERGEBNISSE DER MATHE, V34; Onishi N, 2003, INT J MATH, V14, P837, DOI 10.1142/S0129167X03002022; Orlov D. O., 1997, J MATH SCI NEW YORK, V84, P1361, DOI 10.1007/BF02399195; Simpson CT, 1994, PUBL MATH-PARIS, P47; Yoshioka K, 2010, ADV STU P M, V58, P403; Yoshioka K, 2003, COMPOS MATH, V138, P261, DOI 10.1023/A:1027304215606; Yoshioka K, 2009, COMPOS MATH, V145, P112, DOI 10.1112/S0010437X08003758; Yoshioka K, 2003, MANUSCRIPTA MATH, V110, P433, DOI 10.1007/s00229-002-0340-6; Yoshioka K, 2013, KYOTO J MATH, V53, P261, DOI 10.1215/21562261-2081234; Yoshioka K., 2006, ADV STUD PURE MATH, V45, P1; Yoshioka K, 2001, MATH ANN, V321, P817, DOI 10.1007/s002080100255	26	0	0	DUKE UNIV PRESS	DURHAM	905 W MAIN ST, STE 18-B, DURHAM, NC 27701 USA	2156-2261	2154-3321		KYOTO J MATH	Kyoto J. Math.	JUN	2015	55	2					365	459		10.1215/21562261-2871785		95	Mathematics	Mathematics	CJ7XP	WOS:000355714000006		
J	Goto, S; O'Carroll, L; Planas-Vilanova, F				Goto, Shiro; O'Carroll, Liam; Planas-Vilanova, Francesc			Noncomplete intersection prime ideals in dimension 3	KYOTO JOURNAL OF MATHEMATICS			English	Article							GORENSTEIN RINGS	We describe prime ideals of height 2 minimally generated by three elements in a Gorenstein, Nagata local ring of Krull dimension 3 and multiplicity at most 3. This subject is related to a conjecture of Y. Shimoda and to a long-standing problem of J. Sally.	[Goto, Shiro] Meiji Univ, Dept Math, Sch Sci & Technol, Tama Ku, Kawasaki, Kanag 214, Japan; [O'Carroll, Liam] Univ Edinburgh, Sch Math, Maxwell Inst Math Sci, Edinburgh EH9 3JZ, Midlothian, Scotland; [Planas-Vilanova, Francesc] Univ Politecn Cataluna, Dept Matemat Aplicada 1, ETSEIB, E-08028 Barcelona, Spain	Goto, S (reprint author), Meiji Univ, Dept Math, Sch Sci & Technol, Tama Ku, Kawasaki, Kanag 214, Japan.	goto@math.meiji.ac.jp; L.O'Carroll@ed.ac.uk; francesc.planas@upc.edu	Planas-Vilanova, Francesc/O-4099-2014	Planas-Vilanova, Francesc/0000-0001-6200-1189	 [MTM2010-20279-C02-01]	Planas-Vilanova's work partially supported by grant MTM2010-20279-C02-01.	Barucci V, 1997, J ALGEBRA, V188, P418, DOI 10.1006/jabr.1996.6837; Barucci V., 1997, MEM AM MATH SOC, V125, P598; Bruns W., 1993, CAMBRIDGE STUDIES AD, V39; Goto S, 2013, NAGOYA MATH J, V211, P137, DOI 10.1215/00277630-2273397; Goto S, 2013, J ALGEBRA, V379, P355, DOI 10.1016/j.jalgebra.2013.01.025; Huneke Craig, 2006, LONDON MATH SOC LECT, V336; Matsumura H., 1980, MATH LECT NOTE SERIE, V56; Matsuoka T., 1971, KYOTO J MATH, V11, P485; MILLER M, 1980, J ALGEBRA, V64, P29, DOI 10.1016/0021-8693(80)90129-5; Nagata M., 1962, LOCAL RINGS; O'Carroll L, 2011, P EDINBURGH MATH SOC, V54, P161, DOI 10.1017/S0013091509001321; Rosales JC, 2009, DEV MATH, V20, P155, DOI 10.1007/978-1-4419-0160-6_11	12	0	0	DUKE UNIV PRESS	DURHAM	905 W MAIN ST, STE 18-B, DURHAM, NC 27701 USA	2156-2261	2154-3321		KYOTO J MATH	Kyoto J. Math.	JUN	2015	55	2					461	475		10.1215/21562261-2871794		15	Mathematics	Mathematics	CJ7XP	WOS:000355714000007		
J	Nakagome, S; Sato, T; Ishida, H; Hanihara, T; Yamaguchi, T; Kimura, R; Mano, S; Oota, H				Nakagome, Shigeki; Sato, Takehiro; Ishida, Hajime; Hanihara, Tsunehiko; Yamaguchi, Tetsutaro; Kimura, Ryosuke; Mano, Shuhei; Oota, Hiroki		Asian DNA Repository Consortium	Model-Based Verification of Hypotheses on the Origin of Modern Japanese Revisited by Bayesian Inference Based on Genome-Wide SNP Data	MOLECULAR BIOLOGY AND EVOLUTION			English	Article						origin of modern Japanese; Bayesian inference; genome-wide SNP data	POPULATION-STRUCTURE; DEMOGRAPHIC HISTORY; GENETIC DIVERSITY; RYUKYU ISLANDERS; JOMON JAPAN; AINU; ARCHIPELAGO; EVOLUTION; POLYMORPHISM; INDIVIDUALS	Various hypotheses for the peopling of the Japanese archipelago have been proposed, which can be classified into three models: transformation, replacement, and hybridization. In recent years, one of the hybridization models ("dual-structure model") has been widely accepted. According to this model, Neolithic hunter-gatherers known as Jomon, who are assumed to have originated in southeast Asia and lived in the Japanese archipelago greater than 10,000 years ago, admixed with an agricultural people known as Yayoi, whom were migrants from the East Asian continent 2,000-3,000 years ago. Meanwhile, some anthropologists propose that rather, morphological differences between the Jomon and Yayoi people can be explained by microevolution following the lifestyle change. To resolve this controversy, we compared three demographic models by approximate Bayesian computation using genome-wide single nucleotide polymorphism (gwSNP) data from the Ainu people who are thought to be direct descendants of indigenous Jomon. If we assume Chinese people sampled in Beijing from HapMap have the same ancestry as Yayoi, then the hybridization model is predicted to be between 29 and 63 times more likely than the replacement and transformation models, respectively. Furthermore, our data provide strong support for a model in which the Jomon lineages had population structure diversified in local areas before the admixture event. Initial divergence between the Jomon and Yayoi ancestries was dated to late Pleistocene, followed by the divergence of Jomon lineages at early Holocene. These results suggest gwSNP data provides a detailed picture of the complex hybridization model for Japanese population history.	[Nakagome, Shigeki; Mano, Shuhei] Inst Stat Math, Dept Math Anal & Stat Inference, Tokyo, Japan; [Sato, Takehiro; Ishida, Hajime; Kimura, Ryosuke] Univ Ryukyus, Grad Sch Med, Dept Human Biol & Anat, Nishihara, Okinawa 90301, Japan; [Hanihara, Tsunehiko; Oota, Hiroki] Kitasato Univ, Sch Med, Dept Anat, Minato, Kanagawa, Japan; [Yamaguchi, Tetsutaro] Showa Univ, Sch Dent, Dept Orthodont, Tokyo 142, Japan	Mano, S (reprint author), Inst Stat Math, Dept Math Anal & Stat Inference, Tokyo, Japan.	smano@ism.ac.jp; hiroki_oota@med.kitasato-u.ac.jp	Tajima, Atsushi/C-1053-2008	Tajima, Atsushi/0000-0001-6808-5491	 [24-3234];  [25-2544];  [21370108];  [24370099];  [22687023];  [22370087];  [22570220]	The authors thank two anonymous reviewers for valuable comments. S.N. and T.S were supported as a Grant-in-Aid for the Japan Society for the Promotion of Science (JSPS) Research Fellow (24-3234) and as a Grant-in-Aid for the JSPS Research Fellow (25-2544). This study was supported in part by Grant-in-Aid for the JSPS Nos. 21370108 and 24370099 to H.O., No. 22687023 to R.K., No. 22370087 to H.I., and No. 22570220 to T.H. The member list of the Asian DNA Repository Consortium: Keiichi Omoto, Katsushi Tokunaga, Naruya Saitou, Shoji Kawamura, Hideyuki Tanabe, Kazuo Umetsu, Atsushi Tajima, Shuhei Mano, Hiroki Oota, Naoki Osada, Ryosuke Kimura, Toshimitsu Yamamoto, Jun Ohashi, Yumiko Suto, Nao Nishida, Ryuichi Sakate, Hiromi Sawai, Shigeki Nakagome (March 8, 2014).	Ammerman A. J., 1984, NEOLITHIC TRANSITION; Omoto K, 1997, AM J PHYS ANTHROPOL, V102, P437; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Tajima A, 2004, J HUM GENET, V49, P187, DOI 10.1007/s10038-004-0131-x; Matsukusa H, 2010, AM J PHYS ANTHROPOL, V142, P211, DOI 10.1002/ajpa.21212; Nakagome S, 2013, STAT APPL GENET MOL, V12, P667, DOI 10.1515/sagmb-2012-0050; Craig OE, 2013, NATURE, V496, P351, DOI 10.1038/nature12109; Hammer MF, 2006, J HUM GENET, V51, P47, DOI 10.1007/s10038-005-0322-0; Fukumizu K, 2013, J MACH LEARN RES, V14, P3753; Lohmueller KE, 2009, GENETICS, V182, P217, DOI 10.1534/genetics.108.099275; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Osada N, 2013, GENETICS, V195, P1027, DOI 10.1534/genetics.113.156703; Nachman MW, 2000, GENETICS, V156, P297; Koganebuchi K, 2012, ANTHROPOL SCI, V120, P199, DOI 10.1537/ase.120322; Horai S, 1996, AM J HUM GENET, V59, P579; Jinam T, 2012, J HUM GENET, V57, P787, DOI 10.1038/jhg.2012.114; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Cavalli-Sforza L. L., 2000, GENES PEOPLES LANGUA; Fukase H, 2012, ANTHROPOL SCI, V120, P23, DOI 10.1537/ase.110411; Fukase H, 2012, AM J PHYS ANTHROPOL, V149, P125, DOI 10.1002/ajpa.22112; Habu J., 2004, ANCIENT JOMON JAPAN; Haga S, 2013, J HUM GENET, V58, P799, DOI 10.1038/jhg.2013.106; Hanihara K, 1991, JAPAN REV, V2, P1; Hanihara T, 2009, AM J PHYS ANTHROPOL, V139, P311, DOI 10.1002/ajpa.20985; Hasebe K, 1940, J ANTHROPOL SOC NIPP, V55, P27; He YG, 2012, SCI REP-UK, V2, DOI 10.1038/srep00355; Howells WW, 1966, PAP PEABODY MUS, V57, P1; Imamura K., 1996, PREHISTORIC JAPAN NE; Kaburagi M, 2010, ANTHROPOL SCI, V118, P95, DOI 10.1537/ase090603; Kiyono K, 1949, KODAIJINKOTSU NO KEN, P1; Mano SH, 2007, THEOR POPUL BIOL, V71, P95, DOI 10.1016/j.tpb.2006.07.003; Menozzi Paolo, 1994, HIST GEOGRAPHY HUMAN; Mizoguchi Y., 1986, PREHISTORIC HUNTER G, P107; Nakagome S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078813; Nakashima A, 2010, AM J HUM BIOL, V22, P782, DOI 10.1002/ajhb.21083; Nei M, 1995, ORIGIN PAST MODERN H, P71; Ono Y, 1995, MONGOROID CHIKYU, P33; Sato T, 2007, J HUM GENET, V52, P618, DOI 10.1007/s10038-007-0164-z; Sato T, 2014, MOL BIOL EVOL, V31, P2929, DOI 10.1093/molbev/msu230; Suzuki H., 1969, J FS U TOKYO, V3, P279; Suzuki H, 1981, RASSENGESCHICHTE MEN, V8, P7; Tuner C G 2nd, 1976, Science, V193, P911, DOI 10.1126/science.781841; Watson E, 1996, AM J HUM GENET, V59, P437; YAMAGUCHI B, 1982, J ANTHROPOL SOC NIP, V90, P77	51	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0737-4038	1537-1719		MOL BIOL EVOL	Mol. Biol. Evol.	JUN	2015	32	6					1533	1543		10.1093/molbev/msv045		11	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	CK5JJ	WOS:000356259600014		
J	Ruan, YB; Kovalchuk, A; Jayanthan, A; Lun, XQ; Nagashima, Y; Kovalchuk, O; Wright, JR; Pinto, A; Kirton, A; Anderson, R; Narendran, A				Ruan, Yibing; Kovalchuk, Anna; Jayanthan, Aarthi; Lun, Xueqing; Nagashima, Yoji; Kovalchuk, Olga; Wright, James R., Jr.; Pinto, Alfredo; Kirton, Adam; Anderson, Ronald; Narendran, Aru			Druggable targets in pediatric neurocutaneous melanocytosis: Molecular and drug sensitivity studies in xenograft and ex vivo tumor cell culture to identify agents for therapy	NEURO-ONCOLOGY			English	Article						molecular profiling; neurocutaneous melanocytosis; targeted therapy	KINASE ACTIVATION; MELANOMA; NEVI; EXPRESSION; CANCER; NRAS; PROGRESSION; MUTATIONS; APOPTOSIS; PROTEINS	Background. Neurocutaneous melanocytosis (NCM) is a rare congenital disorder that presents with pigmented cell lesions of the brain or leptomeninges in children with large or multiple congenital melanocytic nevi. Although the exact pathological processes involved are currently unclear, NCM appears to arise from an abnormal development of melanoblasts or melanocyte precursors. Currently, it has an extremely poor prognosis due to rapid disease progression and lack of effective treatment modalities. Methods. In this study, we report on an experimental approach to examining NCM cells by establishing subcutaneous tumors in nude mice, which can be further expanded for conducting molecular and drug sensitivity experiments. Results. Analysis of the NRAS gene-coding sequences of an established NCM cell line (YP-MEL) and NCM patient cells revealed heterogeneity in NRAS Q61K that activated mutation and possibly consequential differential sensitivity to MEK inhibition. Gene expression studies were performed to compare the molecular profiles of NCM cells with normal skin fibroblasts. In vitro cytotoxicity screens of libraries of targeted small-molecule inhibitors revealed prospective agents for further evaluation. Conclusions. Our studies provide an experimental platform for the generation of NCM cells for preclinical studies and the production of molecular and in vitro data with which to identify druggable targets for the treatment.	[Ruan, Yibing; Jayanthan, Aarthi; Lun, Xueqing; Anderson, Ronald; Narendran, Aru] Alberta Childrens Prov Gen Hosp, Div Pediat Oncol, Calgary, AB T3B 6A8, Canada; [Ruan, Yibing; Jayanthan, Aarthi; Lun, Xueqing; Anderson, Ronald; Narendran, Aru] Univ Calgary, POET Lab Preclin & Drug Discovery Studies, Calgary, AB, Canada; [Kovalchuk, Anna; Kovalchuk, Olga] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada; [Nagashima, Yoji] Yokohama City Univ, Sch Med, Dept Pathol, Tokyo, Japan; [Nagashima, Yoji] Tokyo Womens Med Univ Hosp, Div Diagnost Pathol, Tokyo, Japan; [Wright, James R., Jr.; Pinto, Alfredo] Alberta Childrens Prov Gen Hosp, Dept Pathol & Lab Med, Calgary, AB T3B 6A8, Canada; [Wright, James R., Jr.; Pinto, Alfredo] Calgary Lab Serv, Calgary, AB, Canada; [Kirton, Adam] Alberta Childrens Prov Gen Hosp, Dept Neurol, Calgary, AB T3B 6A8, Canada	Narendran, A (reprint author), Alberta Childrens Prov Gen Hosp, Div Pediat Oncol, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	a.narendran@ucalgary.ca			Alberta Children's Hospital Foundation; Kids Cancer Care Foundation of Alberta (KCCFA); POETIC Foundation	This study was supported in part by grants from the Alberta Children's Hospital Foundation, Kids Cancer Care Foundation of Alberta (KCCFA), and the POETIC Foundation.	Lindner DJ, 2013, MATRIX BIOL, V32, P123, DOI 10.1016/j.matbio.2012.11.010; Alajez NM, 2012, ONCOTARGET, V3, P1641; Agero ALC, 2005, J AM ACAD DERMATOL, V53, P959, DOI 10.1016/j.jaad.2005.0.046; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kazerounian S, 2008, CELL MOL LIFE SCI, V65, P700, DOI 10.1007/s00018-007-7486-z; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; KADONAGA JN, 1991, J AM ACAD DERMATOL, V24, P747, DOI 10.1016/0190-9622(91)70115-I; Kinsler VA, 2013, J INVEST DERMATOL, V133, P2229, DOI 10.1038/jid.2013.70; Satelli A, 2011, CANCER LETT, V301, P38, DOI 10.1016/j.canlet.2010.10.027; Singh A, 2013, MOL ONCOL, V7, P497, DOI 10.1016/j.molonc.2013.01.001; Sorolla A, 2008, BRIT J DERMATOL, V158, P496, DOI 10.1111/j.1365-2133.2007.08390.x; Anand N, 2002, NAT GENET, V31, P301, DOI 10.1038/ng904; Pedersen M, 2013, CANCER DISCOV, V3, P458, DOI 10.1158/2159-8290.CD-12-0464; Charbel C, 2014, J INVEST DERMATOL, V134, P1067, DOI 10.1038/jid.2013.429; Molhoek KR, 2011, MELANOMA RES, V21, P274, DOI 10.1097/CMR.0b013e328343a1d6; BALL NJ, 1994, J INVEST DERMATOL, V102, P285, DOI 10.1111/1523-1747.ep12371783; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Arneja Jugpal S, 2009, Plast Reconstr Surg, V124, p1e, DOI 10.1097/PRS.0b013e3181ab11be; CRAMER S F, 1988, Pediatric Pathology, V8, P253; Grimberg A, 2000, J CELL PHYSIOL, V183, P1, DOI 10.1002/(SICI)1097-4652(200004)183:1<1::AID-JCP1>3.0.CO;2-J; Hilmi C, 2008, J INVEST DERMATOL, V128, P1499, DOI 10.1038/sj.jid.5701185; Küsters-Vandevelde Heidi Vn, 2014, Acta Neuropathol Commun, V2, P41, DOI 10.1186/2051-5960-2-41; NAGASHIMA Y, 1994, PATHOL RES PRACT, V190, P178; Neudauer CL, 2003, EXP CELL RES, V286, P128, DOI 10.1016/S0014-4827(03)00049-1; Ortiz AG, 2010, CLIN TRANSL ONCOL, V12, P166, DOI 10.1007/s12094-010-0486-8; Shah KN, 2010, SEMIN CUTAN MED SURG, V29, P159, DOI 10.1016/j.sder.2010.06.007; Wu XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056134	27	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1522-8517	1523-5866		NEURO-ONCOLOGY	Neuro-Oncology	JUN	2015	17	6					822	831		10.1093/neuonc/nou310		10	Oncology; Clinical Neurology	Oncology; Neurosciences & Neurology	CK5LF	WOS:000356265100007		
J	Murakami, S; Miyazaki, I; Miyoshi, K; Asanuma, M				Murakami, Shinki; Miyazaki, Ikuko; Miyoshi, Ko; Asanuma, Masato			Long-Term Systemic Exposure to Rotenone Induces Central and Peripheral Pathology of Parkinson's Disease in Mice	NEUROCHEMICAL RESEARCH			English	Article						Parkinson's disease; Rotenone; Central nervous system; Peripheral nervous system; Glial cells	THERAPEUTIC TARGETS; SUBSTANTIA-NIGRA; ASTROCYTES; NEURONS; MODEL; RATS; PROGRESSION	Parkinson's disease (PD) is a progressive neurodegenerative disease with motor and non-motor symptoms that precede the onset of motor symptoms. Rotenone is often used to induce PD-like pathology in the central nervous system (CNS) and enteric nervous system (ENS). However, there is little or no information on the temporal changes in other neural tissues and the spread of pathology throughout the entire body organs. Here, we recorded the serial immunohistochemical changes in neurons and glial cells of the striatum, substantia nigra (SN), olfactory bulb (OB), thoracic cord (ThC) and ascending colon (AC) induced by 1-, 3- and 6-week administration of rotenone (50 mg/kg/day) infused subcutaneously in C57BL mice using an osmotic pump. Rotenone exposure for 3 or 6 weeks caused neurodegeneration in the striatum, whereas neuronal damage was seen in the SN and OB only after 6 weeks. Moreover, rotenone induced neurodegeneration in the myenteric plexus of AC but not in ThC. Rotenone also activated glial cells before any apparent neurodegeneration in the CNS but not in the ENS. Our results demonstrated that subcutaneous administration of rotenone can cause progressive neurodegeneration in the OB and AC, in addition to the nigrostriatal pathway, and temporal differential glial activation, and that these changes do not spread retrogradely from OB or ENS to nigrostriatal pathway. The results suggested that the different vulnerability of neurons to the neurotoxic effects of rotenone administrated subcutaneously are due to glial activation in these neural tissues.	[Murakami, Shinki; Miyazaki, Ikuko; Miyoshi, Ko; Asanuma, Masato] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Brain Sci, Kita Ku, Okayama 7008558, Japan; [Asanuma, Masato] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med Neurobiol, Okayama 7008558, Japan	Asanuma, M (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Brain Sci, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	asachan@cc.okayama-u.ac.jp			Japan Society for the Promotion of Science [21591082, 22590934, 25461279]; Japanese Ministry of Education, Culture, Sports, Science and Technology [24111533]; Okayama Medical Foundation	This work was supported by Grants-in-Aid for Scientific Research (C) (KAKENHI #21591082, #22590934, #25461279) from Japan Society for the Promotion of Science, by Grant-in Aid for Scientific Research on Innovative Areas "Brain Environment'' (KAKENHI #24111533) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, and by a Research Grant from the Okayama Medical Foundation. We thank T. Osato, M. Shigeyasu, M. Hori and R. Tsurubou for excellent technical assistance.	Murakami S, 2014, NEUROTOX RES, V26, P285, DOI 10.1007/s12640-014-9480-1; Mirza B, 2000, NEUROSCIENCE, V95, P425; Simuni T, 2008, ANN NEUROL, V64, pS65, DOI 10.1002/ana.21472; Miyazaki I, 2011, GLIA, V59, P435, DOI 10.1002/glia.21112; Fleming SM, 2004, EXP NEUROL, V187, P418, DOI 10.1016/j.expneurol.2004.01.023; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Miyazaki I, 2013, NEUROBIOL DIS, V59, P244, DOI 10.1016/j.nbd.2013.08.003; Hawkes CH, 2007, NEUROPATH APPL NEURO, V33, P599, DOI 10.1111/j.1365-2990.2007.00874.x; Ferrante RJ, 1997, BRAIN RES, V753, P157, DOI 10.1016/S0006-8993(97)00008-5; Greenamyre JT, 2003, PARKINSONISM RELAT D, V9, pS59, DOI 10.1016/S1353-8020(03)00023-3; Ferrer I, 2011, J NEURAL TRANSM, V118, P821, DOI 10.1007/s00702-010-0482-8; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Braak H, 2003, J NEURAL TRANSM, V110, P517, DOI 10.1007/s00702-002-0808-2; Brundin P, 2008, NAT REV NEUROSCI, V9, P741, DOI 10.1038/nrn2477; SEMCHUK KM, 1992, NEUROLOGY, V42, P1328; Samantaray S, 2007, NEUROSCIENCE, V146, P741, DOI 10.1016/j.neuroscience.2007.01.056; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; Hernandez-Romero MC, 2012, NEUROTOXICOLOGY, V33, P347, DOI 10.1016/j.neuro.2012.01.018; Greene JG, 2009, EXP NEUROL, V218, P154, DOI 10.1016/j.expneurol.2009.04.023; Arnold B, 2011, NEUROBIOL DIS, V41, P189, DOI 10.1016/j.nbd.2010.09.006; Sherer TB, 2003, NEUROSCI LETT, V341, P87, DOI 10.1016/S0304-3940(03)00172-1; SCHAPIRA AHV, 1989, LANCET, V1, P1269; Drolet RE, 2009, NEUROBIOL DIS, V36, P96, DOI 10.1016/j.nbd.2009.06.017; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Rojo AI, 2007, EXP NEUROL, V208, P120, DOI 10.1016/j.expneurol.2007.07.022; Zhu CN, 2004, J COMP NEUROL, V478, P418, DOI 10.1002/cne.20305; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Heneka MT, 2010, BRAIN RES REV, V63, P189, DOI 10.1016/j.brainresrev.2009.11.004; Dhillon Amanpreet S, 2008, J Agromedicine, V13, P37, DOI 10.1080/10599240801986215; Dickson Dennis W, 2009, Parkinsonism Relat Disord, V15 Suppl 3, pS1, DOI 10.1016/S1353-8020(09)70769-2; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; MCGEER PL, 1988, ACTA NEUROPATHOL, V76, P550; Pan-Montojo F, 2012, SCI REP-UK, V2, DOI 10.1038/srep00898; Pan-Montojo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008762; Schwarz M, 1996, J NEURAL TRANSM, V103, P581, DOI 10.1007/BF01273155; Smythies J, 1999, Neurotox Res, V1, P27; Viader A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027727; WONG GF, 1991, ARCH NEUROL-CHICAGO, V48, P287	40	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JUN	2015	40	6					1165	1178		10.1007/s11064-015-1577-2		14	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CK3DF	WOS:000356095700008		
J	Kuroda, M; Shimizu, M; Inoue, N; Ikeno, I; Nakagawa, H; Yokoi, A; Niida, Y; Konishi, M; Kaneda, H; Igarashi, N; Yamahana, J; Taneichi, H; Kanegane, H; Ito, M; Saito, S; Furuichi, K; Wada, T; Nakagawa, M; Yokoyama, H; Yachie, A				Kuroda, Mondo; Shimizu, Masaki; Inoue, Natsumi; Ikeno, Iku; Nakagawa, Hiroyasu; Yokoi, Ayano; Niida, Yo; Konishi, Michio; Kaneda, Hisashi; Igarashi, Noboru; Yamahana, Junya; Taneichi, Hiromichi; Kanegane, Hirokazu; Ito, Mika; Saito, Shigeru; Furuichi, Kengo; Wada, Takashi; Nakagawa, Masaru; Yokoyama, Hitoshi; Yachie, Akihiro			Serum tau protein as a marker of disease activity in enterohemorrhagic Escherichia coli O111-induced hemolytic uremic syndrome	NEUROCHEMISTRY INTERNATIONAL			English	Article						Tau protein; Enterohemorrhagic Escherichia coli; Hemolytic uremic syndrome; Encephalopathy	ALZHEIMERS-DISEASE; O111 OUTBREAK; CLEAVED-TAU; ENCEPHALOPATHY; INJURY; DAMAGE; LEVEL	Tau protein levels in cerebrospinal fluid (CSF) and serum are elevated in patients with various central nervous system diseases. We investigated whether serum tau protein levels are useful for predicting and assessing disease activity of acute encephalopathy (AE) in enterohemorrhagic Escherichia coli (EHEC) O111-induced hemolytic uremic syndrome (HUS; EHEC encephalopathy). Serum samples were obtained from 14 patients with EHEC O111/HUS, 20 patients with non-EHEC-related AE, and 20 age- and sex-matched healthy controls. CSF samples were obtained from 2 patients with EHEC encephalopathy and 20 patients with non-EHEC-related AE. Tau protein levels and levels of several proinflammatory cytokines were quantified by enzyme-linked immunosorbent assays. Results were compared with the clinical features of EHEC encephalopathy, including magnetic resonance image (MRI) findings. Serum tau levels in patients with EHEC encephalopathy were significantly elevated compared with those in patients with EHEC O111/HUS without encephalopathy, patients with non-EHEC-related AE, and healthy controls. The ratio of CSF tau levels to serum tau levels was >1.0 in all patients with non-EHEC-related AE but <1.0 in 2 patients with EHEC encephalopathy. Serum tau protein levels increased rapidly and markedly in patients with severe EHEC 0111/HUS and encephalopathy when HUS occurred, but were not elevated in mild patients, even in the HUS phase. Furthermore, changes in serum tau protein levels in patients with EHEC encephalopathy were consistent with abnormalities on brain MRI and were positively correlated with proinflammatory cytokine levels. Our results indicate that serum tau protein might be useful to predict and assess disease activity of EHEC encephalopathy. (C) 2015 Elsevier Ltd. All rights reserved.	[Kuroda, Mondo; Shimizu, Masaki; Inoue, Natsumi; Ikeno, Iku; Nakagawa, Hiroyasu; Yokoi, Ayano; Yachie, Akihiro] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Sch Med, Dept Pediat, Kanazawa, Ishikawa 9208641, Japan; [Niida, Yo] Kanazawa Med Univ, Med Res Inst, Dept Adv Med, Div Genom Med, Uchinada, Ishikawa 92002, Japan; [Konishi, Michio] Tonami Gen Hosp, Dept Pediat, Tonami, Toyama, Japan; [Kaneda, Hisashi] Toyama City Hosp, Dept Pediat, Toyama, Japan; [Igarashi, Noboru] Toyama Prefectural Cent Hosp, Dept Pediat, Toyama, Japan; [Yamahana, Junya] Toyama Prefectural Cent Hosp, Div Nephrol, Toyama, Japan; [Taneichi, Hiromichi; Kanegane, Hirokazu] Toyama Univ, Grad Sch Med, Dept Pediat, Toyama 930, Japan; [Ito, Mika; Saito, Shigeru] Toyama Univ, Sch Med, Dept Obstet & Gynecol, Toyama 930, Japan; [Furuichi, Kengo; Wada, Takashi] Kanazawa Univ Hosp, Div Nephrol, Kanazawa, Ishikawa, Japan; [Nakagawa, Masaru; Yokoyama, Hitoshi] Kanazawa Med Univ, Div Nephrol, Kanazawa, Ishikawa, Japan	Shimizu, M (reprint author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Sch Med, Dept Pediat, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	shimizum@staff.kanazawa-u.ac.jp			Ministry of Health, Labour and Welfare [H23-TOKUBETSUSHITEI-004]	We thank Harumi Matsukawa for technical assistance. We gratefully acknowledge the contribution of the attending physicians and staff nurses who collected clinical specimens. This work was partially supported by special research grant (H23-TOKUBETSUSHITEI-004) under a Health Labor Sciences Research Grant provided by the Ministry of Health, Labour and Welfare.	Banatvala N, 2001, J INFECT DIS, V183, P1063, DOI 10.1086/319269; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Takanashi J, 2014, NEUROLOGY, V82, P564, DOI 10.1212/WNL.0000000000000120; Gorath M, 2001, GLIA, V36, P89, DOI 10.1002/glia.1098; Flammer JR, 2011, MOL ENDOCRINOL, V25, P1075, DOI 10.1210/me.2011-0068; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Keepers TR, 2006, J AM SOC NEPHROL, V17, P3404, DOI 10.1681/ASN.2006050419; Piercefield EW, 2010, ARCH INTERN MED, V170, P1656, DOI 10.1001/archinternmed.2010.346; Tanuma N, 2010, BRAIN DEV-JPN, V32, P435, DOI 10.1016/j.braindev.2009.07.004; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Okumura A, 2009, BRAIN DEV-JPN, V31, P221, DOI 10.1016/j.braindev.2008.03.005; Bitsch A, 2002, EUR NEUROL, V47, P45, DOI 10.1159/000047946; Cleary Thomas G, 2004, Semin Pediatr Infect Dis, V15, P260, DOI 10.1053/j.spid.2004.07.007; Elliott E.J., 2005, CURR PROB PEDIATR AD, V35, P305; Fujii J, 1996, INFECT IMMUN, V64, P5053; Gallo E G, 1995, Pediatr Nephrol, V9, P117; Gawlikowski T, 2014, INHAL TOXICOL, V26, P885, DOI 10.3109/08958378.2014.970786; GIANANTO.CA, 1973, NEPHRON, V11, P174; Greinacher A, 2011, LANCET, V378, P1166, DOI 10.1016/S0140-6736(11)61253-1; Igarashi T, 2014, CLIN EXP NEPHROL, V18, P525, DOI 10.1007/s10157-014-0995-9; Kapaki E, 2001, J NEUROL NEUROSUR PS, V71, P401, DOI 10.1136/jnnp.71.3.401; Kilicaslan I, 2012, CLIN TOXICOL, V50, P497, DOI 10.3109/15563650.2012.698742; Matano S, 2012, J INFECT CHEMOTHER, V18, P558, DOI 10.1007/s10156-011-0336-9; Shaw GJ, 2002, ANN EMERG MED, V39, P254, DOI 10.1067/mem.2002.121214; Shimizu M, 2012, CYTOKINE, V60, P694, DOI 10.1016/j.cyto.2012.07.038; SHIN RW, 1991, LAB INVEST, V64, P693; Shiraishi M., 2008, J NEUROIMMUNOL, V196; SIEGLER RL, 1994, J PEDIATR-US, V125, P511, DOI 10.1016/S0022-3476(94)70001-X; The Research Committee on the Clarification of the Etiology and on the Establishment of Therapeutic and Preventive Measures for Influenza Encephalopathy Japan Ministry of Health Labor and Welfare, 2009, GUID INFL ENC, P23	29	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JUN-JUL	2015	85-86						24	30		10.1016/j.neuint.2015.04.003		7	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CK4QT	WOS:000356209000003		
J	Maldonado, M; Maeyama, K				Maldonado, Martin; Maeyama, Kazutaka			The metabolism of histamine in rat hypothalamus and cortex after reserpine treatment	NEUROCHEMISTRY INTERNATIONAL			English	Article						Histamine; N-tau-methylhistamine; Reserpine; Catecholamines; Ws/Ws rats; Histaminergic-neurons	CENTRAL-NERVOUS-SYSTEM; HISTIDINE-DECARBOXYLASE ACTIVITY; VESICULAR MONOAMINE TRANSPORTER; MOUSE-BRAIN; SUBCELLULAR LOCALIZATION; N-METHYLTRANSFERASE; NEURON SYSTEM; OXIDASE; RELEASE; CELLS	The effect of reserpine on histamine (HA) and tele-methylhistamine (N-tau-MHA) in hypothalamus and cortex of rats was analyzed and compared to catecholamines. IF injection of reserpine (5 mg/kg) confirmed the effectiveness of reserpine treatment on noradrenaline and dopamine levels. Our in-vitro experiment with synaptosomal/crude mitochondrial fraction from hypothalamus and cortex confirmed that while mono amine oxidase (MAO) is an efficient metabolic enzyme for catecholamines, HA is not significantly affected by its enzymatic action. HMT activity after reserpine, pargyline and L-histidine treatment showed no differences compared to the control values. However HDC was significantly increased in both hypothalamus and cortex. In this study, Ws/Ws rats with deficiency of mast cells were used to clarify aspects of HA metabolism in HAergic neurons by eliminating the contribution of mast cells. The irreversible MAO-B inhibitor Pargyline (65 mg/kg) failed to accumulate N-tau-MHA in the hypothalamus. However, when animals treated with reserpine and pargyline/reserpine were compared, the last group showed higher N-tau-MHA values (p < 0.01). Moreover, the precursor of HA, L-histidine (1 g/kg), produced an increase of HA in the hypothalamus to 166% and the cortex to 348%. In conclusion, our results suggest that the effect of reserpine on the HA pools in the brain might be different. The neuronal HA pools are more resistant to reserpine as compared to those of catecholamine. Moreover, the HAergic pool appears to be more resistant to depletion than mast cells' pool, and thus HDC/HMT activity and its localization may play a key role in the understanding of HA metabolism in brain after reserpine treatment. (C) 2015 Elsevier Ltd. All rights reserved.	[Maldonado, Martin; Maeyama, Kazutaka] Ehime Univ, Sch Med, Dept Pharmacol, Shigenobu, Ehime 79102, Japan	Maldonado, M (reprint author), Shantou Univ, Res Ctr Reprod Med, Med Coll, 22 Xinling Rd, Shantou 515041, Guangdong, Peoples R China.	w12martin@yahoo.com.ar			Department of Pharmacology, Informational Biomedicine, Ehime University Graduate School of Medicine, Japan	This research was supported by the Department of Pharmacology, Informational Biomedicine, Ehime University Graduate School of Medicine, Japan. The authors would like to thank Dr. Fritzie Celino for her contribution to the last stages of this work and Dr. Sima Sarvari on the final editing of the manuscript for publication.	ADAM HM, 1966, BRIT J PHARM CHEMOTH, V28, P137; Agundez JAG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047571; RENDON A, 1985, J NEUROSCI METH, V14, P41, DOI 10.1016/0165-0270(85)90113-X; BERRY MD, 1994, PROG NEUROBIOL, V42, P375, DOI 10.1016/0301-0082(94)90081-7; Lecklin A, 1998, BRAIN RES, V793, P279, DOI 10.1016/S0006-8993(98)00186-3; Busch AE, 1998, MOL PHARMACOL, V54, P342; Blandina P, 1996, BRIT J PHARMACOL, V119, P1656; ERICKSON JD, 1992, P NATL ACAD SCI USA, V89, P10993, DOI 10.1073/pnas.89.22.10993; CLAPHAM J, 1994, EUR J PHARMACOL, V259, P107, DOI 10.1016/0014-2999(94)90498-7; Yoshikawa T, 2013, GLIA, V61, P905, DOI 10.1002/glia.22484; Chu M, 2004, NEUROSCI RES, V49, P417, DOI 10.1016/j.neures.2004.05.001; Pang X, 1996, NEUROSCIENCE, V73, P889, DOI 10.1016/0306-4522(95)00606-0; Yoshimatsu H, 2008, NUTRITION, V24, P827, DOI 10.1016/j.nut.2008.06.014; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; TSUJIMURA T, 1991, BLOOD, V78, P1942; OWEN F, 1977, BIOCHEM PHARMACOL, V26, P289, DOI 10.1016/0006-2952(77)90179-4; SCHWARTZ JC, 1991, PHYSIOL REV, V71, P1; WATANABE T, 1984, BRAIN RES, V295, P13, DOI 10.1016/0006-8993(84)90811-4; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Liu YJ, 1997, ANNU REV NEUROSCI, V20, P125; Garcia-Martin E, 2009, PHARMACOGENOMICS, V10, P867, DOI [10.2217/pgs.09.26, 10.2217/PGS.09.26]; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; ATACK C, 1971, J PHARM PHARMACOL, V23, P992; BAUDRY M, 1973, J NEUROCHEM, V21, P1301, DOI 10.1111/j.1471-4159.1973.tb07583.x; BISCHOFF S, 1978, BRAIN RES, V141, P375, DOI 10.1016/0006-8993(78)90209-3; Cohen G, 1999, J NEUROCHEM, V73, P2310, DOI 10.1046/j.1471-4159.1999.0732310.x; DISMUKES K, 1974, BRAIN RES, V78, P467, DOI 10.1016/0006-8993(74)90929-9; Erikson J.D., 1996, P NATL ACAD SCI USA, V93, P5166; Frize E.D., 1954, NEW ENGL J MED, V251, P1006; Furtani K., 2003, J PHARMACOL EXP THER, V307, P331; GARBARG M, 1976, BRAIN RES, V106, P333, DOI 10.1016/0006-8993(76)91029-5; GREEN H, 1964, INT J NEUROPHARMACOL, V3, P315; HEBERT J, 1980, CELL IMMUNOL, V54, P49, DOI 10.1016/0008-8749(80)90188-4; HENRY JP, 1989, BIOCHEM PHARMACOL, V38, P2395, DOI 10.1016/0006-2952(89)90082-8; Holzbauer M., 1977, STRUCTURE FUNCTION M, P601; Imamura M, 1996, CIRC RES, V78, P863; Jahng JW, 1997, SYNAPSE, V25, P30; KUHAR MJ, 1971, J NEUROCHEM, V18, P1515, DOI 10.1111/j.1471-4159.1971.tb00014.x; MacIntosh FC, 1938, Q J EXP PHYSIOL CMS, V28, P87; Maldonado M, 2013, ANAL BIOCHEM, V432, P1, DOI 10.1016/j.ab.2012.09.022; Matsunaga T., 1991, HISTAMINERGIC NEURON, P315; MUROI N, 1991, J PHARMACOL EXP THER, V256, P967; Nagatsu T, 2004, NEUROTOXICOLOGY, V25, P11, DOI 10.1016/S0161-813X(03)00085-8; Nishibori M, 2000, EUR J NEUROSCI, V12, P415, DOI 10.1046/j.1460-9568.2000.00914.x; OISHI R, 1983, BRAIN RES, V280, P172, DOI 10.1016/0006-8993(83)91188-5; ORELAND L, 1983, ACTA NEUROL SCAND, V68, P81; Panula P., 1986, NEUROHISTOCHEMISTRY, V16, P424; POLLARD H, 1973, EUR J PHARMACOL, V24, P399, DOI 10.1016/0014-2999(73)90168-4; POLLARD H, 1974, J PHARMACOL EXP THER, V190, P88; PRELL GD, 1986, ANNU REV NEUROSCI, V9, P209; Sakata T., 1991, HISTAMINERGIC NEURON, P297; Schildkuart J.J., 1965, J PSYCHIAT, V122, P509; SCHWARTZ JC, 1975, LIFE SCI, V17, P503, DOI 10.1016/0024-3205(75)90083-1; Skidgel R.A., 2001, GOODMAN GILMANS PHAR; SUGIMOTO K, 1995, J NEUROCHEM, V65, P791; TAYLOR KM, 1971, J PHARMACOL EXP THER, V179, P619; TAYLOR KM, 1972, J NEUROCHEM, V19, P341, DOI 10.1111/j.1471-4159.1972.tb01344.x; Tipton K.F., 1976, MONOAMINE OXIDASE IT, P5; Tuomisto L, 1991, HISTAMINERGIC NEURON, P283; WADA H, 1991, TRENDS NEUROSCI, V14, P415, DOI 10.1016/0166-2236(91)90034-R; WATANABE T, 1979, BIOCHEM PHARMACOL, V28, P1149, DOI 10.1016/0006-2952(79)90321-6; WATANABE T, 1981, P NATL ACAD SCI-BIOL, V78, P4209, DOI 10.1073/pnas.78.7.4209; Watanabe T., 1983, NEUROSCI LETT, V39, P49; Yelin Rodrigo, 2002, P313; Youdim M.B.H., 1983, PSYCHOPHARMACOLOGY 1, V1, P38; Zheng G., 2006, AAPS J, V8, P682	66	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JUN-JUL	2015	85-86						31	39		10.1016/j.neuint.2015.04.005		9	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CK4QT	WOS:000356209000004		
J	Hatanaka, Y; Wada, K; Kabuta, T				Hatanaka, Yusuke; Wada, Keiji; Kabuta, Tomohiro			Abnormal instability, excess density, and aberrant morphology of dendritic spines in prenatally testosterone-exposed mice	NEUROCHEMISTRY INTERNATIONAL			English	Article						Dendritic spine; In vivo two-photon imaging; Autism; Polycystic ovary syndrome; Testosterone; Maternal environment	POLYCYSTIC-OVARY-SYNDROME; FRAGILE-X-SYNDROME; ADULT CORTEX; MOUSE MODEL; AUTISM; DISORDERS; EXPERIENCE; GENETICS; ETIOLOGY; INCREASE	Fetal brain development is programmed by the maternal intrauterine environment, and disturbance of the in utero environment leads to persisting deficits in brain functions of the offspring. Testosterone is an intrauterine environmental factor, and plays significant roles in fetal development. From human and animal model studies, it has been suggested that increased intrauterine testosterone concentration triggers subsequent autistic-like behavior of the offspring; however, the effects of maternal excess testosterone on synaptic development of the offspring remain unknown. In the present study, we employed prenatally testosterone-exposed mice, and by using in vivo two-photon imaging, we analyzed the dynamics, density, and morphology of the dendritic spine, an excitatory postsynaptic structure. We found that the offspring from testosterone-treated dams showed abnormal synaptic instability persisting into young adulthood, whereas dendritic spines in control mice became stabilized with normal synaptic maturation. In prenatally testosterone-exposed mice, the density of dendritic spines was excessively increased, and their morphology was abnormal. These results suggest that prenatally testosterone-exposed mice may have deficits in synaptic development, and furthermore that the observed pathological features of their dendritic spines may be the cause of the synaptic pathogenesis in prenatally testosterone-exposed mice. (C) 2015 Elsevier Ltd. All rights reserved.	[Hatanaka, Yusuke; Wada, Keiji; Kabuta, Tomohiro] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Kodaira, Tokyo 1878502, Japan; [Hatanaka, Yusuke; Wada, Keiji] JST, CREST, Kawaguchi, Saitama 3320012, Japan	Hatanaka, Y (reprint author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, 4-1-1 Ogawa Higashi, Kodaira, Tokyo 1878502, Japan.	hatanaka@ncnp.go.jp; kabuta@ncnp.go.jp			Intramural Research Grants for Neurological and Psychiatric Disorders of NCNP; Japan Society for the Promotion of Science, Japan [25871174]; Core Research for Evolutional Science and Technology, Japan Science and Technology Agency	We thank Hiromi Fujita, Yoshiko Hara, Masako Shikama, Tomoko Okada, and Hisae Kikuchi (NCNP) for technical assistance. This work was supported by Intramural Research Grants for Neurological and Psychiatric Disorders of NCNP [to T.K.]; by a Grants-in-Aid for Young Scientists (B) [25871174 to Y.H.], from the Japan Society for the Promotion of Science, Japan; and by a grant from Core Research for Evolutional Science and Technology, Japan Science and Technology Agency [to K.W.].	Abbout DH, 2005, HUM REPROD UPDATE, V11, P357, DOI 10.1093/humupd/dmi013; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; Gardener H, 2011, PEDIATRICS, V128, P344, DOI 10.1542/peds.2010-1036; Delorme R, 2013, NAT MED, V19, P685, DOI 10.1038/nm.3193; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Cruz-Martin A, 2010, J NEUROSCI, V30, P7793, DOI 10.1523/JNEUROSCI.0577-10.2010; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Lennartsson AK, 2012, INT J PSYCHOPHYSIOL, V84, P246, DOI 10.1016/j.ijpsycho.2012.03.001; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Jiang MH, 2013, J NEUROSCI, V33, P19518, DOI 10.1523/JNEUROSCI.1745-13.2013; Goodarzi MO, 2011, NAT REV ENDOCRINOL, V7, P219, DOI 10.1038/nrendo.2010.217; Azziz R, 2005, J CLIN ENDOCR METAB, V90, P4650, DOI 10.1210/jc.2005-0628; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Pan F, 2010, P NATL ACAD SCI USA, V107, P17768, DOI 10.1073/pnas.1012496107; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Hutsler JJ, 2010, BRAIN RES, V1309, P83, DOI 10.1016/j.brainres.2009.09.120; Palomba S, 2012, CLIN ENDOCRINOL, V77, P898, DOI 10.1111/j.1365-2265.2012.04443.x; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Xu XJ, 2015, PHYSIOL BEHAV, V138, P13, DOI 10.1016/j.physbeh.2014.09.014; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369; Bonthuis PJ, 2010, FRONT NEUROENDOCRIN, V31, P341, DOI 10.1016/j.yfrne.2010.05.001; Chichinadze K, 2008, PHYSIOL BEHAV, V94, P595, DOI 10.1016/j.physbeh.2008.03.020; Fernell E, 2010, RES DEV DISABIL, V31, P680, DOI 10.1016/j.ridd.2010.01.007; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; Hines M, 2011, FRONT NEUROENDOCRIN, V32, P170, DOI 10.1016/j.yfrne.2011.02.006; Isshiki M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5742; Keefe DL, 2002, ARCH SEX BEHAV, V31, P401, DOI 10.1023/A:1019883923346; Schuurmans C, 2013, CLIN GENET, V83, P108, DOI 10.1111/cge.12049; Walters KA, 2012, BIOL REPROD, V86, p[149, 1]; Walters KA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097808; Xu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074849	37	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JUN-JUL	2015	85-86						53	58		10.1016/j.neuint.2015.04.008		6	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CK4QT	WOS:000356209000007		
J	Nagamine, S; Fujiwara, Y; Shimizu, T; Kawata, A; Wada, K; Isozaki, E; Kabuta, T				Nagamine, Satoshi; Fujiwara, Yuuki; Shimizu, Toshio; Kawata, Akihiro; Wada, Keiji; Isozaki, Eiji; Kabuta, Tomohiro			Association of ubiquitin carboxy-terminal hydrolase-L1 in cerebrospinal fluid with clinical severity in a cohort of patients with Guillain-Barr, syndrome	NEUROLOGICAL SCIENCES			English	Article						Ubiquitin carboxy-terminal hydrolase-L1 (UCH-L1); Protein gene product 9.5 (PGP9.5); Guillain-Barre syndrome (GBS); Hughes functional grading scale	PARKINSONS-DISEASE; GM1 GANGLIOSIDE; BRAIN-INJURY; POLYNEUROPATHY; BIOMARKERS; ANTIBODIES; MODEL	Guillain-Barr, syndrome (GBS) is an acute immune-mediated polyneuropathy. Although its pathogenic mechanism has been revealed and various therapeutic trials have been performed, a proportion of patients experience the severe sequelae associated with GBS. In this paper, we investigated whether the amount of the neuron-specific protein, ubiquitin carboxy-terminal hydrolase-L1 (UCH-L1), in the cerebrospinal fluid of patients with GBS was correlated with the clinical course of the disease. UCH-L1 protein levels were greater in patients with GBS than in controls. The patients with GBS whose UCH-L1 protein levels were higher than those of the controls presented with more severe symptoms at peak. UCH-L1 protein levels tended to become elevated as the total protein levels were increased; however, elevated UCH-L1 without an increase in total protein might be correlated with severe disease course (bedridden or ventilator supported). These results suggest that UCH-L1 could be a biomarker associated with the severity of the disease at the acute phase of GBS.	[Nagamine, Satoshi; Shimizu, Toshio; Kawata, Akihiro; Isozaki, Eiji] Tokyo Metropolitan Neurol Hosp, Dept Neurol, Fuchu, Tokyo 1830042, Japan; [Fujiwara, Yuuki; Wada, Keiji; Kabuta, Tomohiro] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Tokyo, Japan	Nagamine, S (reprint author), Tokyo Metropolitan Neurol Hosp, Dept Neurol, 2-6-1 Musashidai, Fuchu, Tokyo 1830042, Japan.	satoshi_nagamine@tmhp.jp			Intramural Research Grants for Neurological and Psychiatric Disorders of the National Center of Neurology and Psychiatry [21-9, 24-11]	This work was supported by Intramural Research Grants (Nos. 21-9 and 24-11 to T.K.) for Neurological and Psychiatric Disorders of the National Center of Neurology and Psychiatry.	Petzold A, 2009, MUSCLE NERVE, V40, P42, DOI 10.1002/mus.21239; Wang XK, 2013, NEUROL SCI, V34, P655, DOI 10.1007/s10072-012-1092-z; HO TW, 1995, BRAIN, V118, P597, DOI 10.1093/brain/118.3.597; Day INM, 2010, PROG NEUROBIOL, V90, P327, DOI 10.1016/j.pneurobio.2009.10.020; Yuki N, 2001, ANN NEUROL, V49, P712, DOI 10.1002/ana.1012; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Arnaoutakis GJ, 2011, J THORAC CARDIOV SUR, V142, P902, DOI 10.1016/j.jtcvs.2011.06.027; Shahrizaila N, 2013, J NEUROL NEUROSUR PS, V84, P576, DOI 10.1136/jnnp-2012-302824; McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; HUGHES RAC, 1978, LANCET, V2, P750; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Massaro ME, 1998, NEUROLOGY, V51, P394; Bilguvar K, 2013, P NATL ACAD SCI USA, V110, P3489, DOI 10.1073/pnas.1222732110; YUKI N, 1990, NEUROLOGY, V40, P1900; Brettschneider J, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-0097-x; Kuwabara S, 2013, LANCET NEUROL, V12, P1180, DOI 10.1016/S1474-4422(13)70215-1; Kuwabara S, 2007, CURR NEUROL NEUROSCI, V7, P57, DOI 10.1007/s11910-007-0022-6; Kabuta T, 2008, HUM MOL GENET, V17, P1482, DOI 10.1093/hmg/ddn037; Nagamine S, 2010, NEUROCHEM INT, V57, P102, DOI 10.1016/j.neuint.2010.04.015; Okuyama H, 1975, Rinsho Shinkeigaku, V15, P817; Rajabally YA, 2012, J NEUROL NEUROSUR PS, V83, P711, DOI 10.1136/jnnp-2011-301882; YUKI N, 1993, J EXP MED, V178, P1771, DOI 10.1084/jem.178.5.1771	23	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	JUN	2015	36	6					921	926		10.1007/s10072-015-2137-x		6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CJ7RQ	WOS:000355696700014		
J	Shimo, Y; Nakajima, A; Hattori, N				Shimo, Yasushi; Nakajima, Asuka; Hattori, Nobutaka			Dopamine agonist withdrawal syndrome in a patient with restless legs syndrome without impulse control disorder or drug abuse	NEUROLOGICAL SCIENCES			English	Letter						Restless legs syndrome; Dopamine agonist; Mesocorticolimbic system	RECEPTOR AGONIST; DISEASE		[Shimo, Yasushi; Nakajima, Asuka; Hattori, Nobutaka] Juntendo Univ, Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 113, Japan	Shimo, Y (reprint author), Juntendo Univ, Sch Med, Dept Neurol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 113, Japan.	yshimo@juntendo.ac.jp					Rabinak CA, 2010, ARCH NEUROL-CHICAGO, V67, P58, DOI 10.1001/archneurol.2009.294; Pondal M, 2013, J NEUROL NEUROSUR PS, V84, P130, DOI 10.1136/jnnp-2012-302684; CHEN JF, 1993, NEUROSCIENCE, V54, P669, DOI 10.1016/0306-4522(93)90238-B; Chernoloz O, 2009, NEUROPSYCHOPHARMACOL, V34, P651, DOI 10.1038/npp.2008.114; Millan MJ, 2010, PHARMACOL THERAPEUT, V128, P229, DOI 10.1016/j.pharmthera.2010.06.002; Demartini B, 2014, J NEUROL NEUROSUR PS, V85, P471, DOI 10.1136/jnnp-2013-306043; Dorfman BJ, 2013, PARKINSONISM RELAT D, V19, P269, DOI 10.1016/j.parkreldis.2012.06.006; Koob George F, 2013, Front Psychiatry, V4, P72, DOI 10.3389/fpsyt.2013.00072; Launois C, 2013, SLEEP MED, V14, P696, DOI 10.1016/j.sleep.2013.04.009	9	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	JUN	2015	36	6					1021	1023		10.1007/s10072-014-1996-x		3	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CJ7RQ	WOS:000355696700029		
J	Sakamoto, Y; Mitsumura, H; Nakata, M; Arai, A; Iguchi, Y				Sakamoto, Yuki; Mitsumura, Hidetaka; Nakata, Masahiro; Arai, Ayumi; Iguchi, Yasuyuki			A case of Trousseau's syndrome and pulmonary arteriovenous fistula: a malignant combination for ischemic stroke	NEUROLOGICAL SCIENCES			English	Letter							CANCER		[Sakamoto, Yuki; Mitsumura, Hidetaka; Nakata, Masahiro; Arai, Ayumi; Iguchi, Yasuyuki] Jikei Univ, Sch Med, Dept Neurol, Minato Ku, Tokyo 1058461, Japan	Sakamoto, Y (reprint author), Jikei Univ, Sch Med, Dept Neurol, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	ysakamoto02@gmail.com					Kimura K, 2004, J NEUROL NEUROSUR PS, V75, P311; Schwarzbach CJ, 2012, STROKE, V43, P3029, DOI 10.1161/STROKEAHA.112.658625; Seok JM, 2010, ANN NEUROL, V68, P213, DOI 10.1002/ana.22050; GRAUS F, 1985, MEDICINE, V64, P16; Iguchi Y, 2006, J NEUROL NEUROSUR PS, V77, P1336, DOI 10.1136/jnnp.2006.092940	5	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	JUN	2015	36	6					1035	1036		10.1007/s10072-015-2138-9		2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CJ7RQ	WOS:000355696700034		
J	Johkura, K; Kudo, Y; Amano, Y; Takahashi, K				Johkura, Ken; Kudo, Yosuke; Amano, Yu; Takahashi, Koji			Vestibular examinations in apogeotropic positional nystagmus caused by cerebellar tumor	NEUROLOGICAL SCIENCES			English	Letter							REFLEX; ATAXIA		[Johkura, Ken; Kudo, Yosuke; Amano, Yu] Yokohama Brain & Spine Ctr, Dept Neurol, Isogo Ku, Yokohama, Kanagawa 2350012, Japan; [Takahashi, Koji] Hiratsuka Kyosai Hosp, Div Clin Lab, Hiratsuka, Kanagawa, Japan	Johkura, K (reprint author), Yokohama Brain & Spine Ctr, Dept Neurol, Isogo Ku, Takigashira 1-2-1, Yokohama, Kanagawa 2350012, Japan.	ke00-johkura@city.yokohama.jp					Anastasopoulos D, 1998, BRAIN, V121, P1497, DOI 10.1093/brain/121.8.1497; BARBER HO, 1984, OTOLARYNG HEAD NECK, V92, P649; Funabiki K, 1999, ACTA OTO-LARYNGOL, V119, P413; THURSTON SE, 1987, NEUROLOGY, V37, P53; Wiest G, 2001, BRAIN, V124, P2407, DOI 10.1093/brain/124.12.2407	5	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	JUN	2015	36	6					1051	1052		10.1007/s10072-015-2086-4		2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CJ7RQ	WOS:000355696700040		
J	Nishijima, H; Ueno, T; Suzuki, C; Baba, M; Tomiyama, M				Nishijima, Haruo; Ueno, Tatsuya; Suzuki, Chieko; Baba, Masayuki; Tomiyama, Masahiko			Eyelid ptosis enhanced after steroid pulse therapy in ocular myasthenia gravis: a case report	NEUROLOGICAL SCIENCES			English	Letter									[Nishijima, Haruo; Ueno, Tatsuya; Suzuki, Chieko; Baba, Masayuki; Tomiyama, Masahiko] Aomori Prefectural Cent Hosp, Dept Neurol, Aomori, Aomori 0308553, Japan; [Nishijima, Haruo; Ueno, Tatsuya; Tomiyama, Masahiko] Hirosaki Univ, Grad Sch Med, Inst Brain Sci, Dept Neurophysiol, Hirosaki, Aomori, Japan	Nishijima, H (reprint author), Aomori Prefectural Cent Hosp, Dept Neurol, 2-1-1 Higashi Tsukurimichi, Aomori, Aomori 0308553, Japan.	hnishijima-tky@umin.ac.jp		Nishijima, Haruo/0000-0002-1065-664X			Erb MH, 2004, OPHTHAL PLAST RECONS, V20, P418, DOI 10.1097/01.IOP.0000143714.10858.D4; Jayam A. Trouth, 2012, AUTOIMMUNE DIS, V2012, DOI DOI 10.1155/2012/874680; Komiyama A, 2000, J NEUROL NEUROSUR PS, V68, P214, DOI 10.1136/jnnp.68.2.214; LEPORE FE, 1988, NEUROLOGY, V38, P319; OOSTERHUIS HJGH, 1982, DOC OPHTHALMOL, V52, P363, DOI 10.1007/BF01675867	5	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	JUN	2015	36	6					1055	1056		10.1007/s10072-015-2093-5		2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CJ7RQ	WOS:000355696700042		
J	Wu, JH; Oka, Y				Wu, Jianhui; Oka, Yoshiaki			Subchannel analysis with turbulent mixing rate of supercritical pressure fluid	NUCLEAR ENGINEERING AND DESIGN			English	Article							TEMPERATURE SUPER LWR; PASS CORE DESIGN; LIGHT-WATER; REACTOR; SCWR; FUEL	The subchannel analysis with turbulent mixing rate law of supercritical pressure fluid (SPF) is carried out for supercritical-pressurized light water cooled and moderated reactor (Super LWR). It is different from the turbulent mixing rate law of pressurized water reactor (PWR), which is widely adopted in Super LWR subchannel analysis study, the density difference between adjacent subchannels is taken into account for turbulent mixing rate law of SPF. MCSTs are evaluated on three kinds of fuel assemblies with different pin power distribution patterns, gap spacings and mass flow rates. Compared with that calculated by employing turbulent mixing rate law of PWR, the increase in MCST is smaller even when peaking factor is large and gap spacing is uneven. The sensitivities of MCST on non-uniformity of the subchannel area and power peaking are reduced. (C) 2015 Elsevier B.V. All rights reserved.	[Wu, Jianhui] Waseda Univ, Dept Appl Phys, Tokyo 1698555, Japan; [Oka, Yoshiaki] Univ Tokyo, Tokyo, Japan	Wu, JH (reprint author), Waseda Univ, Dept Appl Phys, Tokyo 1698555, Japan.	wjianhui1985@gmail.com					Oka Y, 2001, J NUCL SCI TECHNOL, V38, P1081; Cao LZ, 2008, J NUCL SCI TECHNOL, V45, P138, DOI 10.3327/jnst.45.138; Cheng X, 2003, NUCL ENG DES, V223, P279, DOI 10.1016/S0029-5493(03)00059-1; Himmel S.R., 2008, P 16 PAC BAS NUCL C; Li CY, 2009, PROG NUCL ENERG, V51, P799, DOI 10.1016/j.pnucene.2009.05.004; Liu XJ, 2010, ANN NUCL ENERGY, V37, P1674, DOI 10.1016/j.anucene.2010.07.014; Liu XJ, 2010, PROG NUCL ENERG, V52, P640, DOI 10.1016/j.pnucene.2010.04.002; Mori H., 2014, J NUCL SCI IN PRESS; Mukohara T, 2000, PROG NUCL ENERG, V37, P197, DOI 10.1016/S0149-1970(00)00046-9; Oka Y., 2014, SUPERCRITICAL PRESSU; Oka Y, 2010, SUPER LIGHT WATER REACTORS AND SUPER FAST REACTORS: SUPERCRITICAL-PRESSURE LIGHT WATER COOLED REACTORS, P1, DOI 10.1007/978-1-4419-6035-1; Oka Y., 2013, ISSCWR 6 SHENZH GUAN; Sadatomi M, 1996, NUCL ENG DES, V162, P245, DOI 10.1016/0029-5493(95)01129-3; Sakurai S., 2011, P ISSCWR5 VANC BRIT; Tanabe T., 2004, P ICAPP04 PITTSB US, P502; Wu J, 2014, NUCL ENG DES, V267, P100, DOI 10.1016/j.nucengdes.2013.12.002; Wu JH, 2013, J NUCL SCI TECHNOL, V50, P1129, DOI 10.1080/00223131.2013.836462; Yoo J, 2007, NUCL ENG DES, V237, P1096, DOI 10.1016/j.nucengdes.2006.11.005	18	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0029-5493			NUCL ENG DES	Nucl. Eng. Des.	JUN	2015	287						119	130		10.1016/j.nucengdes.2015.02.014		12	Nuclear Science & Technology	Nuclear Science & Technology	CK3NP	WOS:000356123100012		
J	Ikeda, Y; Hasegawa, K; Kurosaki, A; Miyara, A; Hanaoka, T; Shintani, D; Imai, Y; Nishikawa, T; Oda, K; Fujiwara, K				Ikeda, Yuji; Hasegawa, Kosei; Kurosaki, Akira; Miyara, Akiko; Hanaoka, Tatsuya; Shintani, Daisuke; Imai, Yuichi; Nishikawa, Tadaaki; Oda, Katsutoshi; Fujiwara, Keiichi			The Risk of Ovarian Malignancy Algorithm (ROMA) as a Predictive Marker of Peritoneal Dissemination in Epithelial Ovarian Cancer Patients	ONCOLOGY RESEARCH AND TREATMENT			English	Article						Epithelial ovarian carcinoma; Peritoneal dissemination; Risk of ovarian malignancy algorithm	PELVIC MASS; CA125; HE-4; WOMEN; PROTEIN; SERUM; CT	Background: This study aimed to determine the efficacy of the risk of ovarian malignancy algorithm (ROMA), calculated using the carbohydrate antigen 125 (CA125) and human epididymis protein 4 (HE4) levels and the menopausal status, as a predictor of peritoneal dissemination in ovarian cancer. Methods: The CA125 and HE4 levels and the ROMA were compared between ovarian cancer patients (n = 122) with or without peritoneal dissemination. The sensitivity, specificity, positive predictive value, and negative predictive value were calculated, and the results were compared with those of computed tomography (CT). Results: The CA125, HE4, and ROMA values differed significantly depending on the presence of peritoneal dissemination (p < 0.0001). The cut-off values were 181 U/ml for CA125, 161 pmol/ml for HE4, 44% for the ROMA (premenopausal), and 86% for the ROMA (postmenopausal). Among these markers, the ROMA (premenopausal) was the strongest predictor of peritoneal dissemination, with a specificity of 85.0% and a positive predictive value of 81.3%. In addition, the detection rates of small disseminations with less than 2 cm in diameter for the ROMA (93%) and HE4 (60%) were superior to that of CT (53%). Conclusions: The ROMA was a significant predictor of peritoneal dissemination and may be superior to CT for the detection of patients with small disseminations.	[Ikeda, Yuji; Hasegawa, Kosei; Kurosaki, Akira; Miyara, Akiko; Hanaoka, Tatsuya; Shintani, Daisuke; Imai, Yuichi; Nishikawa, Tadaaki; Fujiwara, Keiichi] Saitarna Med Univ, Int Med Ctr, Dept Gynecol Oncol, Saitama 3501298, Japan; [Oda, Katsutoshi] Univ Tokyo, Dept Obstet & Gynecol, Tokyo 1138654, Japan	Hasegawa, K (reprint author), Saitarna Med Univ, Int Med Ctr, Dept Gynecol Oncol, 1397-1 Yamane Hidaka, Saitama 3501298, Japan.	koseih@saitama-med.ac					Moore RG, 2009, GYNECOL ONCOL, V112, P40, DOI 10.1016/j.ygyno.2008.08.031; Anastasi E, 2010, TUMOR BIOL, V31, P411, DOI 10.1007/s13277-010-0049-1; Partridge E, 2009, OBSTET GYNECOL, V113, P775, DOI 10.1097/AOG.0b013e31819cda77; Patel CM, 2011, CANCER IMAGING, V11, P123, DOI 10.1102/1470-7330.2011.0016; Karlsen MA, 2012, GYNECOL ONCOL, V127, P379, DOI 10.1016/j.ygyno.2012.07.106; Sandri MT, 2013, GYNECOL ONCOL, V128, P233, DOI 10.1016/j.ygyno.2012.11.026; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Hellstrom I, 2003, CANCER RES, V63, P3695; Sehouli J, 2009, J SURG ONCOL, V99, P424, DOI 10.1002/jso.21288; Coakley FV, 2002, RADIOLOGY, V223, P495, DOI 10.1148/radiol.2232011081; CHECK JH, 1995, HUM REPROD, V10, P674; Davis K R, 1977, Rev Interam Radiol, V2, P15; FEDELE L, 1988, AM J OBSTET GYNECOL, V158, P166; Fotopoulou C, 2010, EJSO-EUR J SURG ONC, V36, P1202, DOI 10.1016/j.ejso.2010.09.008; Fujiwara K, 2013, EXPERT OPIN PHARMACO, V14, P1797, DOI 10.1517/14656566.2013.820705; Gershenson DM, 2012, CLIN OBSTET GYNECOL, V55, P65, DOI 10.1097/GRF.0b013e318248045b; Holcomb K, 2011, AM J OBSTET GYNECOL, V205; Li F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-258; Manegold-Brauer G, 2014, ARCH GYNECOL OBSTET, V289, P491, DOI 10.1007/s00404-013-3081-8; Montagnana M, 2011, CLIN CHEM LAB MED, V49, P521, DOI 10.1515/CCLM.2011.075; Moore R, 2010, TLS-TIMES LIT SUPPL, P6; Panorchan K, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-149; Wimberger P, 2007, GYNECOL ONCOL, V106, P69, DOI 10.1016/j.ygyno.2007.02.026	23	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	2296-5270	2296-5262		ONCOL RES TREAT	Oncol. Res. Treat.	JUN	2015	38	6					276	281		10.1159/000430858		6	Oncology	Oncology	CK1JQ	WOS:000355964000001		
J	Toyokawa, G; Seto, T				Toyokawa, Gouji; Seto, Takashi			Updated Evidence on the Mechanisms of Resistance to ALK Inhibitors and Strategies to Overcome Such Resistance: Clinical and Preclinical Data	ONCOLOGY RESEARCH AND TREATMENT			English	Review						Non-small cell lung cancer; Anaplastic lymphoma kinase; ALK inhibitors; Resistance mechanisms	CELL LUNG-CANCER; ANAPLASTIC LYMPHOMA KINASE; REARRANGED NSCLC PATIENTS; POTENT ANTITUMOR-ACTIVITY; CRIZOTINIB RESISTANCE; ACQUIRED-RESISTANCE; CONFER RESISTANCE; MUTATIONS; ALECTINIB; EML4-ALK	Anaplastic lymphoma kinase (ALK) rearrangement is one of the oncogenes in non-small cell lung cancer (NSCLC) identified in 2007. The PROFILE trials demonstrated that patients with ALK-rearranged NSCLC can be successfully treated with crizotinib, and that crizotinib is superior to chemotherapy in both first- and second-line settings. Furthermore, next-generation ALK inhibitors, such as alectinib and ceritinib, have been shown to harbor excellent efficacy for NSCLC patients with ALK rearrangement. However, it is known that many cases ultimately acquire resistance to ALK inhibitors. Some potential mechanisms of resistance to ALK inhibitors are as follows: ALK dominant resistance, such as secondary mutations and copy number gain in the ALK gene; activation of the bypass tracks, including EGFR, KRAS, KIT, MET, and IGF-1R. Furthermore, treatment strategies to overcome these resistance mechanisms have been proposed, and next-generation ALK inhibitors, agents which inhibit the bypass tracks, and heat shock protein 90 inhibitors are thought to be promising. Thus, clinical and pre-clinical evidence on the resistance mechanisms to ALK inhibitors and treatment strategies to overcome the resistance have been gradually obtained. Herein, we concisely review the current clinical and pre-clinical data regarding the mechanisms of resistance to ALK inhibitors and treatments to overcome such resistance.	[Toyokawa, Gouji; Seto, Takashi] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka 8111395, Japan	Seto, T (reprint author), Kyushu Natl Canc Ctr, Dept Thorac Oncol, Minami Ku, 3-1-1 Notame, Fukuoka 8111395, Japan.	tseto@nk-cc.go.jp			Chugai Pharmaceutical Co., Ltd.; Pfizer Japan Inc.; Novartis Pharma	Dr. Seto received honoraria from Chugai Pharmaceutical Co., Ltd., Pfizer Japan Inc., and Novartis Pharma K.K., as well as research funding from Chugai Pharmaceutical Co., Ltd., Pfizer Japan Inc., and Novartis Pharma K.K.; Dr. Toyokawa received honoraria from Chugai Pharmaceutical Co., Ltd. and Pfizer Japan Inc.	Anai S, 2014, J MED CASES, V5, P631; Sasaki T, 2011, CANCER RES, V71, P6051, DOI 10.1158/0008-5472.CAN-11-1340; Camidge DR, 2012, NAT REV CLIN ONCOL, V9, P268, DOI 10.1038/nrclinonc.2012.43; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Vaishnavi A, 2013, NAT MED, V19, P1469, DOI 10.1038/nm.3352; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; Tanimoto A, 2014, ONCOTARGET, V5, P4920; Gadgeel SM, 2014, LANCET ONCOL, V15, P1119, DOI 10.1016/S1470-2045(14)70362-6; Lovly CM, 2011, CANCER RES, V71, P4920, DOI 10.1158/0008-5472.CAN-10-3879; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Johnson TW, 2014, J MED CHEM, V57, P4720, DOI 10.1021/jm500261q; Ou SHI, 2014, J THORAC ONCOL, V9, P549, DOI 10.1097/JTO.0000000000000094; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Kodama T, 2014, CANCER LETT, V351, P215, DOI 10.1016/j.canlet.2014.05.020; Gainor JF, 2013, CLIN CANCER RES, V19, P4273, DOI 10.1158/1078-0432.CCR-13-0318; Seto T, 2013, LANCET ONCOL, V14, P590, DOI 10.1016/S1470-2045(13)70142-6; Felip E, 2012, ANN ONCOL, V23, P152; Doebele RC, 2012, CLIN CANCER RES, V18, P1472, DOI 10.1158/1078-0432.CCR-11-2906; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Heuckmann JM, 2011, CLIN CANCER RES, V17, P7394, DOI 10.1158/1078-0432.CCR-11-1648; Sasaki T, 2010, CANCER RES, V70, P10038, DOI 10.1158/0008-5472.CAN-10-2956; Friboulet L, 2014, CANCER DISCOV, V4, P662, DOI 10.1158/2159-8290.CD-13-0846; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Sakamoto H, 2011, CANCER CELL, V19, P679, DOI 10.1016/j.ccr.2011.04.004; Ji C, 2014, CANCER BIOL THER, V15, P570, DOI 10.4161/cbt.28162; Katayama R, 2011, P NATL ACAD SCI USA, V108, P7535, DOI 10.1073/pnas.1019559108; Choi YL, 2014, J THORAC ONCOL, V9, P563, DOI 10.1097/JTO.0000000000000093; Kogita A, 2015, INT J ONCOL, V46, P1025, DOI 10.3892/ijo.2014.2797; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Sang J, 2013, CANCER DISCOV, V3, P430, DOI 10.1158/2159-8290.CD-12-0440; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Cui JJ, 2011, J MED CHEM, V54, P6342, DOI 10.1021/jm2007613; Yamada T, 2012, CLIN CANCER RES, V18, P3592, DOI 10.1158/1078-0432.CCR-11-2972; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Hong M, 2014, J THORAC ONCOL, V9, P419, DOI 10.1097/JTO.0000000000000061; Chen Z, 2014, CLIN CANCER RES, V20, P1204, DOI 10.1158/1078-0432.CCR-13-1733; Rossi A, 2014, INT J ONCOL, V45, P499, DOI 10.3892/ijo.2014.2475; Mano H, 2008, CANCER SCI, V99, P2349, DOI 10.1111/j.1349-7006.2008.00972.x; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Giri S, 2014, NEW ENGL J MED, V371, P1655, DOI 10.1056/NEJMc1410799; Gouji T, 2014, J THORAC ONCOL, V9, pE27, DOI 10.1097/JTO.0000000000000113; Katayama R, 2014, CLIN CANCER RES, V20, P5686, DOI 10.1158/1078-0432.CCR-14-1511; Katayama R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003316; Kodama T, 2014, MOL CANCER THER, V13, P2910, DOI 10.1158/1535-7163.MCT-14-0274; Kogita A, 2014, INT J ONCOL, V45, P1430, DOI 10.3892/ijo.2014.2574; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lovly Christine M, 2014, Nat Med, V20, P1027, DOI 10.1038/nm.3667; Mori M, 2012, ANN M P AACR 2012; Ou SHI, 2014, J THORAC ONCOL, V9, P1821, DOI 10.1097/JTO.0000000000000368; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Rachel MS, 2013, ANN M P AACR 2013; Shaw AT, 2014, NEW ENGL J MED, V370, P1189, DOI 10.1056/NEJMoa1311107; Solomon B, 2013, CLIN PHARMACOL THER, V95, P15, DOI DOI 10.1038/CLPT.2013.200; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI 10.1056/NEJMoa1408440; Toyokawa G, 2014, J THORAC ONCOL, V9, pE86, DOI 10.1097/JTO.0000000000000358; Toyokawa G, 2014, CLIN LUNG CANCER, V15, P313, DOI 10.1016/j.cllc.2014.05.001; Toyokawa G, 2015, J THORAC ON IN PRESS	57	2	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	2296-5270	2296-5262		ONCOL RES TREAT	Oncol. Res. Treat.	JUN	2015	38	6					291	298		10.1159/000430852		8	Oncology	Oncology	CK1JQ	WOS:000355964000004		
J	Tamura, T; Kagohashi, K; Satoh, H				Tamura, Tomohiro; Kagohashi, Katsunori; Satoh, Hiroaki			Successful Afatinib Therapy after Resistance to EGFR-TKI in a Patient with Advanced Adenosquamous Cell Lung Cancer	ONCOLOGY RESEARCH AND TREATMENT			English	Letter						Lung cancer; Afatinib; Resistance; EGFR-TKI; Adenosquamous cell lung cancer; Rechallenge	MUTATION		[Tamura, Tomohiro; Kagohashi, Katsunori; Satoh, Hiroaki] Univ Tsukuba, Mito Med Ctr, Div Resp Med, Mito, Ibaraki 3100015, Japan	Satoh, H (reprint author), Univ Tsukuba, Mito Med Ctr, Div Resp Med, 3-2-7 Miya Machi, Mito, Ibaraki 3100015, Japan.	hirosato@md.tsukuba.ac.jp					Kim Y, 2012, MOL CANCER THER, V11, P784, DOI 10.1158/1535-7163.MCT-11-0750; Bordi Paola, 2014, Tumori, V100, pe20, DOI 10.1700/1430.15832; Kuiper JL, 2015, CLIN LUNG CANCER, V16, P60, DOI [10.1016/j.cllc.2014.07.008, 10.1016/j.dlc.2014.07.008]; Schuler M, 2014, ONCOLOGIST, V19, P1100, DOI 10.1634/theoncologist.2014-0103	4	1	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	2296-5270	2296-5262		ONCOL RES TREAT	Oncol. Res. Treat.	JUN	2015	38	6					316	+		10.1159/000431351		2	Oncology	Oncology	CK1JQ	WOS:000355964000008		
J	Kaul-Strehlow, S; Urata, M; Minokawa, T; Stach, T; Wanninger, A				Kaul-Strehlow, Sabrina; Urata, Makoto; Minokawa, Takuya; Stach, Thomas; Wanninger, Andreas			Neurogenesis in directly and indirectly developing enteropneusts: of nets and cords	ORGANISMS DIVERSITY & EVOLUTION			English	Article						Nervous system; Evolution; Enteropneusts; Hemichordates; Deuterostome; Serotonin; Neurogenesis; Plexus; Bipolar receptor cell	NERVOUS-SYSTEM CENTRALIZATION; TORNARIA LARVA; SACCOGLOSSUS-KOWALEVSKII; BRANCHIOSTOMA-FLORIDAE; SEROTONINERGIC NEURONS; PTYCHODERA-FLAVA; APICAL ORGANS; BODY PLAN; EVOLUTION; HEMICHORDATE	Concerning the evolution of deuterostomes, enteropneusts (acorn worms) occupy a pivotal role as they share some characteristics with chordates (e.g., tunicates and vertebrates) but are also closely related to echinoderms (e.g., sea urchin). The nervous system in particular can be a highly informative organ system for evolutionary inferences, and advances in fluorescent microscopy have revealed overwhelming data sets on neurogenesis in various clades. However, immunocytochemical descriptions of neurogenesis of juvenile enteropneusts are particularly scarce, impeding the reconstruction of nervous system evolution in this group. We followed morphogenesis of the nervous system in two enteropneust species, one with direct (Saccoglossus kowalevskii) and the other with indirect development (Balanoglossus misakiensis), using an antibody against serotonin and electron microscopy. We found that all serotonin-like immunoreactive (LIR) neurons in both species are bipolar ciliary neurons that are intercalated between other epidermal cells. Unlike the tornaria larva of B. misakiensis, the embryonic nervous system of S. kowalevskii lacks serotonin-LIR neurons in the apical region as well as an opisthotroch neurite ring. Comparative analysis of both species shows that the projections of the serotonin-LIR somata initially form a basiepidermal plexus throughout the body that disappears within the trunk region soon after settlement before the concentrated dorsal and ventral neurite bundles emerge. Our data reveal a highly conserved mode of neurogenesis in enteropneusts that is independent of the developing mode and is inferred to be a common feature for Enteropneusta. Moreover, all detected serotonin-LIR neurons are presumably receptor cells, and the absence of serotonin-LIR interneurons from the enteropneust nervous system, which are otherwise common in various bilaterian central nervous systems, is interpreted as a loss that might have occurred already in the last common ancestor of Ambulacraria.	[Kaul-Strehlow, Sabrina; Wanninger, Andreas] Univ Vienna, Dept Integrat Zool, A-1090 Vienna, Austria; [Urata, Makoto] Hiroshima Univ, Grad Sch Biosphere Sci, Setouchi Field Sci Ctr, Takehara Marine Sci Stn, Hiroshima 7250024, Japan; [Minokawa, Takuya] Tohoku Univ, Res Ctr Marine Biol, Aomori 0393501, Japan; [Stach, Thomas] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany	Kaul-Strehlow, S (reprint author), Univ Vienna, Dept Integrat Zool, Althanstr 14, A-1090 Vienna, Austria.	sabrina.kaul-strehlow@univie.ac.at			Lise-Meitner grant from the Austrian Science Fund (FWF) [M 1485-B19]; Research Center for Marine Biology, Tohoku University Japan	We thank the staff of the Research Center for Marine Biology Tohoku University in Asamushi, Japan. This study was funded by a Lise-Meitner grant from the Austrian Science Fund (FWF) to SK-S (M 1485-B19). The collection trip of SK-S to Japan was financially supported by a stipend from the Research Center for Marine Biology, Tohoku University Japan. Dr. Elena S. Casey (Georgetown University) is thanked for provision of material of S. kowalevskii. Dr. Alen Kristof (University Vienna) and Dr. Thomas Schwaha (University Vienna) are thanked for technical guidance with the confocal microscope. We thank Julia Bauder (University Vienna) and Barbara Schadl (University Vienna) for additional sectioning of B. misakiensis.	Kuratani S, 1997, J COMP NEUROL, V384, P483; Byrne M, 2007, EVOL DEV, V9, P432; Pani AM, 2012, NATURE, V483, P289, DOI 10.1038/nature10838; Nakajima Y, 2004, ZOOL SCI, V21, P69, DOI 10.2108/0289-0003(2004)21[69:DANOOT]2.0.CO;2; Wanninger A, 2009, BIOL BULL-US, V216, P293; Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0; BULLOCK TH, 1945, Q J MICROSC SCI, V86, P55; Nielsen C, 2007, J MORPHOL, V268, P551, DOI 10.1002/jmor.10533; Wicht H, 2005, CAN J ZOOL, V83, P122, DOI 10.1139/Z04-163; Fritsch M, 2010, J MORPHOL, V271, P1457, DOI 10.1002/jmor.10892; Burke RD, 2006, DEV BIOL, V300, P434, DOI 10.1016/j.ydbio.2006.08.007; Gerhart J, 2005, CURR OPIN GENET DEV, V15, P461, DOI 10.1016/j.gde.2005.06.004; Cameron CB, 2005, CAN J ZOOL, V83, P196, DOI 10.1139/Z04-190; Harzsch S, 2004, J MORPHOL, V259, P198, DOI 10.1002/jmor.10178; Miyamoto N, 2010, EVOL DEV, V12, P416, DOI 10.1111/j.1525-142X.2010.00428.x; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; Nomaksteinsky M, 2009, CURR BIOL, V19, P1264, DOI 10.1016/j.cub.2009.05.063; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; Cannon JT, 2009, MOL PHYLOGENET EVOL, V52, P17, DOI 10.1016/j.ympev.2009.03.027; Lowe CJ, 2004, METHOD CELL BIOL, V74, P171; Kristof A, 2008, CURR BIOL, V18, P1129, DOI 10.1016/j.cub.2008.06.066; FUJII K, 1988, COMP BIOCHEM PHYS C, V89, P233, DOI 10.1016/0742-8413(88)90217-4; Kaul S, 2010, J MORPHOL, V271, P1240, DOI 10.1002/jmor.10868; Arendt D, 2008, PHILOS T R SOC B, V363, P1523, DOI 10.1098/rstb.2007.2242; Benito J, 1997, MICROSCOPICAL ANATOM, V15, P15; Brinkmann N, 2008, EVOL DEV, V10, P606, DOI 10.1111/j.1525-142X.2008.00275.x; Bullock T. H., 1965, STRUCTURE FUNCTION N; Burke RD, 2011, EVOL DEV, V13, P110, DOI 10.1111/j.1525-142X.2010.00460.x; Candiani S, 2001, HISTOCHEM J, V33, P413, DOI 10.1023/A:1013775927978; Caron JB, 2013, NATURE, V495, P503, DOI 10.1038/nature12017; Cavey Michael J., 1994, P345; Chia F. S., 1994, MICROSCOPIC ANATOMY, V14, P169; Cunningham D, 2014, DEV BIOL, V386, P252, DOI 10.1016/j.ydbio.2013.12.001; DAUTOV SS, 1992, BIOL BULL, V183, P463, DOI 10.2307/1542023; De Bernardi F, 2006, CARYOLOGIA, V59, P375; Dilly P.N., 1975, Symposia Zool Soc Lond, VNo. 36, P1; DILLY PN, 1970, Z ZELLFORSCH MIK ANA, V103, P129, DOI 10.1007/BF00335406; EKSTROM P, 1985, DEV BRAIN RES, V17, P209, DOI 10.1016/0165-3806(85)90145-2; Harzsch S, 2009, ZOOMORPHOLOGY, V128, P53, DOI 10.1007/s00435-008-0074-4; Hay-Schmidt, 2000, P ROY SOC LOND B BIO, V267, P1071; Hindinger S, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-31; Holland LZ, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-27; Holland N. D., 2003, NAT REV NEUROSCI, V4, P1, DOI DOI 10.1038/NRN1028.PUBMED:12894237; HOLLAND ND, 1993, ACTA ZOOL-STOCKHOLM, V74, P195; KNIGHTJONES EW, 1952, PHILOS T ROY SOC B, V236, P315, DOI 10.1098/rstb.1952.0004; Lowe CJ, 2006, PLOS BIOL, V4, P1603, DOI 10.1371/journal.pbio.0040291; Marlow H, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-7; Metschnikoff E., 1881, ZOOL ANZ, V4, P139; Miyamoto N, 2007, ZOOL SCI, V24, P1278, DOI 10.2108/zsj.24.1278; Miyamoto N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3713; Nezlin LP, 2004, ZOOMORPHOLOGY, V123, P1, DOI 10.1007/s00435-003-0086-z; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Nieuwenhuys R, 1998, CENTRAL NERVOUS SYST; Nixon M, 2003, BRAINS LIVES CEPHALO; Osborne N.N., 1982, P7; Richter S, 2010, CHLOE, V41, P7; Stach T, 2005, ORG DIVERS EVOL, V5, P15, DOI 10.1016/j.ode.2004.05.004; Stach T, 2013, NATURWISSENSCHAFTEN, V100, P1187, DOI 10.1007/s00114-013-1117-3; Stach T., 2012, A ZOOL, V92, P150; Stach T, 2012, ZOOMORPHOLOGY, V131, P11, DOI 10.1007/s00435-011-0144-x; Strausfeld NJ, 2012, ARTHROPOD BRAINS EVO; Urata M, 2004, ZOOL SCI, V21, P533, DOI 10.2108/zsj.21.533; VANMIER P, 1986, INT J DEV NEUROSCI, V4, P465, DOI 10.1016/0736-5748(86)90028-6; Voronezhskaya EE, 2008, ZOOMORPHOLOGY, V127, P97, DOI 10.1007/s00435-007-0055-z; WALLACE JA, 1985, J COMP NEUROL, V236, P443, DOI 10.1002/cne.902360403; WALLACE JA, 1983, BRAIN RES BULL, V10, P459, DOI 10.1016/0361-9230(83)90144-2; Worsaae K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048529	68	3	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1439-6092	1618-1077		ORG DIVERS EVOL	Org. Divers. Evol.	JUN	2015	15	2					405	422		10.1007/s13127-015-0201-2		18	Evolutionary Biology; Zoology	Evolutionary Biology; Zoology	CJ9PD	WOS:000355833700013		
J	Van Leeuwen, T; Tirry, L; Yamamoto, A; Nauen, R; Dermauw, W				Van Leeuwen, Thomas; Tirry, Luc; Yamamoto, Atsushi; Nauen, Ralf; Dermauw, Wannes			The economic importance of acaricides in the control of phytophagous mites and an update on recent acaricide mode of action research	PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY			English	Article						Acaricide market; Economic damage; Target-site; Cyflumetofen; Cyenopyrafen; Pyflubumide	2-SPOTTED SPIDER-MITE; TETRANYCHUS-URTICAE ACARI; CITRUS RED MITE; IN-FIELD POPULATIONS; CROSS-RESISTANCE; PANONYCHUS-CITRI; KOCH ACARI; TARGET-SITE; INSECTICIDE RESISTANCE; BREVIPALPUS-PHOENICIS	Acaricides are one of the cornerstones of an efficient control program for phytophagous mites. An analysis of the global acaricide market reveals that spider mites such as Tetranychus urticae, Panonychus citri and Panonychus ulmi are by far the most economically important species, representing more than 80% of the market. Other relevant mite groups are false spider mites (mainly Brevipalpus), rust and gall mites and tarsonemid mites. Acaricides are most frequently used in vegetables and fruits (74% of the market), including grape vines and citrus. However, their use is increasing in major crops where spider mites are becoming more important, such as soybean, cotton and corn. As revealed by a detailed case study of the Japanese market, major shifts in acaricide use are partially driven by resistance development and the commercial availability of compounds with novel mode of action. The importance of the latter cannot be underestimated, although some compounds are successfully used for more than 30 years. A review of recent developments in mode of action research is presented, as such knowledge is important for devising resistance management programs. This includes spirocyclic keto-enols as inhibitors of acetylCoA carboxylase, the carbazate bifenazate as a mitochondrial complex III inhibitor, a novel class of complex II inhibitors, and the mite growth inhibitors hexythiazox, clofentezine and etoxazole that interact with chitin synthase I. (C) 2014 Elsevier Inc. All rights reserved.	[Van Leeuwen, Thomas] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1090 GE Amsterdam, Netherlands; [Tirry, Luc; Dermauw, Wannes] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Lab Agrozool, B-9000 Ghent, Belgium; [Yamamoto, Atsushi] Nippon Soda Co Ltd, Div Res & Dev, Chiyoda Ku, Tokyo 1008165, Japan; [Nauen, Ralf] Bayer CropSci AG, Res Pest Control, D-40789 Monheim, Germany	Van Leeuwen, T (reprint author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, POB 9424, NL-1090 GE Amsterdam, Netherlands.	T.B.S.VanLeeuwen@uva.nl	Dermauw, Wannes/H-1583-2015	Dermauw, Wannes/0000-0003-4612-8969	Fund for Scientific Research Flanders (FWO) [3G009312]	The authors want to thank Jan Van Arkel for providing a photograph of T. urticae. This work was supported by a Fund for Scientific Research Flanders (FWO) grant 3G009312 (to LT. and T.V.L.) and W.D. is a postdoctoral fellow of the FWO.	Adamczyk Jr J., 2012, BELTW COTT C ORL FL, V2, P981; Van Leeuwen T, 2011, INSECT MOL BIOL, V20, P135, DOI 10.1111/j.1365-2583.2010.01040.x; MOTOBA K, 1992, PESTIC BIOCHEM PHYS, V43, P37, DOI 10.1016/0048-3575(92)90017-T; Demaeght P, 2014, INSECT BIOCHEM MOLEC, V51, P52, DOI 10.1016/j.ibmb.2014.05.004; Van Leeuwen T, 2012, P NATL ACAD SCI USA, V109, P4407, DOI 10.1073/pnas.1200068109; Van Leeuwen T, 2008, P NATL ACAD SCI USA, V105, P5980, DOI 10.1073/pnas.0802224105; Nauen R, 2001, PEST MANAG SCI, V57, P253, DOI 10.1002/ps.280; Kwon DH, 2014, J ASIA-PAC ENTOMOL, V17, P99, DOI 10.1016/j.aspen.2013.11.001; Dermauw W, 2013, P NATL ACAD SCI USA, V110, pE113, DOI 10.1073/pnas.1213214110; Khalighi M, 2014, PEST MANAG SCI, V70, P365, DOI 10.1002/ps.3641; Dermauw W, 2012, INSECT BIOCHEM MOLEC, V42, P455, DOI 10.1016/j.ibmb.2012.03.002; Van Leeuwen T, 2010, INSECT BIOCHEM MOLEC, V40, P563, DOI 10.1016/j.ibmb.2010.05.008; van Lenteren JC, 2012, BIOCONTROL, V57, P1, DOI 10.1007/s10526-011-9395-1; Van Leeuwen T, 2006, INSECT BIOCHEM MOLEC, V36, P869, DOI 10.1016/j.ibmb.2006.08.005; Bebber DP, 2013, NAT CLIM CHANGE, V3, P985, DOI [10.1038/NCLIMATE1990, 10.1038/nclimate1990]; Van Leeuwen T, 2010, EXP APPL ACAROL, V51, P205, DOI 10.1007/s10493-009-9312-9; Sugimoto N, 2014, PEST MANAG SCI, V70, P1090, DOI 10.1002/ps.3652; Devine GJ, 2001, PEST MANAG SCI, V57, P443, DOI 10.1002/ps.307; Gisi U, 2002, PEST MANAG SCI, V58, P859, DOI 10.1002/ps.565; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; [Anonymous], 2014, EPAHQOPP20120269; Nauen R, 2005, J PESTIC SCI, V30, P272; Hayashi N, 2013, PEST MANAG SCI, V69, P1080, DOI 10.1002/ps.3470; Yu HB, 2012, ARKIVOC, P26; Khajehali J, 2011, PEST MANAG SCI, V67, P1424, DOI 10.1002/ps.2191; Gerson U, 2012, ANNU REV ENTOMOL, V57, P229, DOI 10.1146/annurev-ento-120710-100639; HERRON G, 1993, EXP APPL ACAROL, V17, P433, DOI 10.1007/BF00120501; Flamini G, 2003, STUD NAT PROD CHEM, V28, P381; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Ilias A, 2014, INSECT BIOCHEM MOLEC, V48, P17, DOI 10.1016/j.ibmb.2014.02.006; Goka K, 1998, EXP APPL ACAROL, V22, P699, DOI 10.1023/A:1006062807613; Nakahira K, 2011, J PESTIC SCI, V36, P511, DOI 10.1584/jpestics.W11-34; Kramer T, 2011, PEST MANAG SCI, V67, P1285, DOI 10.1002/ps.2184; Van Leeuwen T, 2005, PEST MANAG SCI, V61, P499, DOI 10.1002/ps.1001; Gerwick BC, 2014, PEST MANAG SCI, V70, P1169, DOI 10.1002/ps.3744; AVEYARD CS, 1986, EXP APPL ACAROL, V2, P223, DOI 10.1007/BF01193954; Bolland HR, 1998, WORLD CATALOGUE SPID; Bretschneider T, 2012, MODERN CROP PROTECTION COMPOUNDS, VOLS 1-3, 2ND EDITION, P1108; Bugeme DM, 2009, MYCOPATHOLOGIA, V167, P221, DOI 10.1007/s11046-008-9164-6; Childers CC, 2003, EXP APPL ACAROL, V30, P5, DOI 10.1023/B:APPA.0000006543.34042.b4; Cranham J.E., 1985, SPIDER MITES THEIR B, V1B, P405; Cullen E., 2009, 2 SPOTTED SPIDER MIT; DEKEYSER MA, 1994, PESTIC SCI, V40, P85, DOI 10.1002/ps.2780400202; Dekeyser MA, 2005, PEST MANAG SCI, V61, P103, DOI 10.1002/ps.994; Dekeyser MA, 1996, BRIGHTON CROP PROTECTION CONFERENCE: PESTS & DISEASES - 1996, VOLS 1-3, P487; Flamini G, 2006, NAT PROD COMMUN, V1, P1151; Fleischer S., 2012, MITE OUTBREAKS HOT W; Furuya T., 2014, 13 IUPAC INT C PEST; Fuzita A. T., 2014, Coffee Science, V9, P102; Fyksen J., 2013, SPIDER MITES DRY WEA; Gore J., 2013, Journal of Cotton Science, V17, P34; Gotoh T, 2011, INT J ACAROL, V37, P93, DOI 10.1080/01647954.2010.497498; Grosscurt A., 2005, P BCPC INT C CROP SC, P49; GROSSCURT AC, 1994, EXP APPL ACAROL, V18, P445, DOI 10.1007/BF00051467; Herron GA, 1998, EXP APPL ACAROL, V22, P633, DOI 10.1023/A:1006058705429; Hiragaki S, 2012, NEUROTOXICOLOGY, V33, P307, DOI 10.1016/j.neuro.2012.01.016; Ishida T, 1994, P BRIGT CROP PROT C, V1, P37; Jeppson L., 1975, MITES INJURIOUS EC P; JPPA, 2012, JPPA HDB PEST; Khajehali J, 2009, EXP APPL ACAROL, V49, P185, DOI 10.1007/s10493-009-9261-3; Kim SS, 2001, APPL ENTOMOL ZOOL, V36, P509, DOI 10.1303/aez.2001.509; Kinoshita S, 1999, J PESTIC SCI, V55, P659, DOI [10.1002/(SICI)1096-9063(199906)55:63.0.CO;2-S, DOI 10.1002/(SICI)1096-9063(199906)55:6<659::AID-PS1>3.0.CO;2-S]; Lindquist E.E., 1996, ERIOPHYOID MITES THE; Lümmen Peter, 2014, Insect Biochem Mol Biol, V55, P1, DOI 10.1016/j.ibmb.2014.09.010; Maniania NK, 2008, EXP APPL ACAROL, V46, P259, DOI 10.1007/s10493-008-9180-8; Marcic D, 2012, J PEST SCI, V85, P395, DOI 10.1007/s10340-012-0442-1; Migeon A., 2014, SPIDER MITES WEB COM; MIZUTANI A, 1988, APPL ENTOMOL ZOOL, V23, P251; Nakano M., 2014, 13 IUPAC INT C PEST; Nauen R, 2012, MODERN CROP PROTECTI, V3, P935; Nauen R., 2008, Bayer CropScience Journal, V61, P245; Nauen R., 2003, Pesticide Outlook, V14, P243, DOI 10.1039/b314855f; Ochiai N, 2007, EXP APPL ACAROL, V43, P181, DOI 10.1007/s10493-007-9115-9; Ostlie K., 2012, DROUGHT HEAT WORSEN; Paik C.-H., 2010, PESTIC SCI, V14, P170; Rodrigues JCV, 2003, EXP APPL ACAROL, V30, P161, DOI 10.1023/B:APPA.0000006547.76802.6e; Sparks T.C., 2014, PESTIC BIOCH PHYSL, DOI [10.1016/j.pestbp.2014.11.014, DOI 10.1016/J.PESTBP.2014.11.014]; Sparks T.C., 2011, MODERN CROP PROTECTI, P1078; Sultan&TRADE; Miticide U.S, 2014, TECHN INF BROCH; Van Nieuwenhuyse P, 2009, PEST MANAG SCI, V65, P404, DOI 10.1002/ps.1705; Van Nieuwenhuyse P, 2012, PESTIC BIOCHEM PHYS, V104, P88, DOI 10.1016/j.pestbp.2012.05.013; Wachendorff U, 2000, PROC BRIGHTON CROP, V1-3, P53; Whalon M.E., 2014, ARTHROPODS RESISTANT; Williams MR, 2012, BELTW COTT C SAN ANT, V2, P546; YAMADA T, 1987, J PESTIC SCI, V12, P327; YAMAMOTO A, 1995, J PESTIC SCI, V20, P493; YAMAMOTO A, 1995, J PESTIC SCI, V20, P307	87	4	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0048-3575	1095-9939		PESTIC BIOCHEM PHYS	Pest. Biochem. Physiol.	JUN	2015	121				SI		12	21		10.1016/j.pestbp.2014.12.009		10	Biochemistry & Molecular Biology; Entomology; Physiology	Biochemistry & Molecular Biology; Entomology; Physiology	CK3IL	WOS:000356109700003		
J	Nakao, T; Banba, S				Nakao, Toshifumi; Banba, Shinichi			Minireview: Mode of action of meta-diamide insecticides	PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY			English	Review						Meta-diamide; Insecticide; RDL GABA receptor; A2 ' mutation	RDL GABA RECEPTOR; GAMMA-AMINOBUTYRIC-ACID; CONVENTIONAL NONCOMPETITIVE ANTAGONISTS; GATED CHLORIDE CHANNELS; SOGATELLA-FURCIFERA; FIPRONIL RESISTANCE; DIELDRIN RESISTANCE; MOLECULAR-CLONING; A2'N MUTATION; A RECEPTORS	Meta-diamides [3-benzamido-N-(4-(perfluoropropan-2-yl)phenyl)benzamides] are a distinct class of RDL GABA receptor noncompetitive antagonists showing high insecticidal activity against Spodoptera litura. The mode of action of the meta-diamides was demonstrated to be distinct from that of conventional noncompetitive antagonists (NCAs) such as fipronil, picrotoxin, lindane, dieldrin, and alpha-endosulfan. It was suggested that meta-diamides act at or near G336 in the M3 region of the Drosophila RDL GABA receptor. Although the site of action of the meta-diamides appears to overlap with that of macrocyclic lactones including avermectins and milbemycins, differential effects of mutations on the actions of the meta-diamides and the macrocyclic lactones were observed. Molecular modeling studies revealed that the meta-diamides may bind to an inter-subunit pocket near G336 in the Drosophila RDL GABA receptor better when in the closed state, which is distinct from the NCA-binding site, which is in a channel formed by M2s. In contrast, the macrocyclic lactones were suggested to bind to an inter-subunit pocket near G336 in the Drosophila RDL GABA receptor when in the open state. Furthermore, mechanisms underlying the high selectivity of meta-diamides are discussed. This minireview highlights the unique features of novel meta-diamide insecticides and demonstrates why meta-diamides are anticipated to become prominent insecticides that are effective against pests resistant to cyclodienes and fipronil. (C) 2014 Elsevier Inc. All rights reserved.	[Nakao, Toshifumi; Banba, Shinichi] Mitsui Chem Agro Inc, Agrochem Res Ctr, Mobara, Chiba 2970017, Japan	Nakao, T (reprint author), Mitsui Chem Agro Inc, Agrochem Res Ctr, Mobara, Chiba 2970017, Japan.	Toshifumi.Nakao@mitsui-chem.co.jp					Nakao T, 2012, J ECON ENTOMOL, V105, P1781, DOI 10.1603/EC12073; Du W, 2005, INSECT MOL BIOL, V14, P179, DOI 10.1111/j.1365-2583.2004.00544.x; FFRENCHCONSTANT RH, 1991, P NATL ACAD SCI USA, V88, P7209, DOI 10.1073/pnas.88.16.7209; Nakao T, 2013, J PESTIC SCI, V38, P157, DOI 10.1584/jpestics.D13-028; Ferry N, 2004, CURR OPIN BIOTECH, V15, P155, DOI 10.1016/j.copbio.2004.01.008; Ozoe Y, 2013, ADV INSECT PHYSIOL, V44, P211, DOI 10.1016/B978-0-12-394389-7.00004-1; Hainzl D, 1998, CHEM RES TOXICOL, V11, P1529, DOI 10.1021/tx980157t; Nakao T, 2013, INSECT BIOCHEM MOLEC, V43, P366, DOI 10.1016/j.ibmb.2013.02.002; Bass C, 2004, PEST MANAG SCI, V60, P1157, DOI 10.1002/ps.937; Zhao XL, 2003, J PHARMACOL EXP THER, V306, P914, DOI 10.1124/jpet.103.051839; Chen LG, 2006, P NATL ACAD SCI USA, V103, P5185, DOI 10.1073/pnas.0600370103; Nakao T, 2013, J PESTIC SCI, V38, P123, DOI 10.1584/jpestics.D13-024; Chiara DC, 2012, BIOCHEMISTRY-US, V51, P836, DOI 10.1021/bi201772m; Thompson SA, 1999, BRIT J PHARMACOL, V127, P1349, DOI 10.1038/sj.bjp.0702687; Hisano Kazutoshi, 2007, Invertebrate Neuroscience, V7, P39, DOI 10.1007/s10158-006-0035-x; MIYAZAKI M, 1995, COMP BIOCHEM PHYS B, V111, P399, DOI 10.1016/0305-0491(95)00007-U; Ozoe Y, 2013, PESTIC BIOCHEM PHYS, V107, P285, DOI 10.1016/j.pestbp.2013.09.005; Sharma HC, 2003, J ECON ENTOMOL, V96, P1886, DOI 10.1603/0022-0493-96.6.1886; Anthony N, 1998, MOL GEN GENET, V260, P165; Nakao T, 2012, J PESTIC SCI, V37, P37, DOI 10.1584/jpestics.D11-018; Gao JR, 2007, PESTIC BIOCHEM PHYS, V88, P66, DOI 10.1016/j.pestbp.2006.09.001; Connolly CN, 2004, BIOCHEM SOC T, V32, P529, DOI 10.1042/BST0320529; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; Nakao T, 2010, PESTIC BIOCHEM PHYS, V97, P262, DOI 10.1016/j.pestbp.2010.03.006; Hope M, 2010, J ECON ENTOMOL, V103, P1355, DOI 10.1603/EC09267; Nakao T, 2011, J ECON ENTOMOL, V104, P646, DOI 10.1603/EC10391; Casida JE, 2008, J PESTIC SCI, V33, P4, DOI 10.1584/jpestics.R07-07; CHARNET P, 1990, NEURON, V4, P87, DOI 10.1016/0896-6273(90)90445-L; Ci S, 2007, J MOL MODEL, V13, P457, DOI 10.1007/s00894-006-0167-2; Nakao T, 2014, J PESTIC SCI, V39, P144, DOI 10.1584/jpestics.D14-043; Nakao T., 2014, PESTIC BIOC IN PRESS, DOI DOI 10.1016/J.PESTBP.2014.09.011	31	4	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0048-3575	1095-9939		PESTIC BIOCHEM PHYS	Pest. Biochem. Physiol.	JUN	2015	121				SI		39	46		10.1016/j.pestbp.2014.09.010		8	Biochemistry & Molecular Biology; Entomology; Physiology	Biochemistry & Molecular Biology; Entomology; Physiology	CK3IL	WOS:000356109700006		
J	Ihara, M; Sattelle, DB; Matsuda, K				Ihara, Makoto; Sattelle, David B.; Matsuda, Kazuhiko			Probing new components (loop G and the alpha-alpha interface) of neonicotinoid binding sites on nicotinic acetylcholine receptors	PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY			English	Review						Nicotinic acetylcholine receptor; Neonicotinoid; alpha-alpha interface; Ligand binding loops (A, B, C, D, E, F and G); Acetylcholine binding protein; Ion channel	XENOPUS-LAEVIS OOCYTES; SUPER AGONIST ACTIONS; COCKROACH NEURONS; DIVERSE ACTIONS; INSECT; NITROMETHYLENE; IDENTIFY; SUBUNIT; PROTEIN; ALPHA-4-BETA-2	Neonicotinoid insecticides interact with the orthosteric site on the extracellular ligand binding domain (LBD) of nicotinic acetylcholine receptors (nAChRs), typically activating the cation permeable ion channels. In nAChRs consisting of two alpha and three non-alpha subunits, LBDs contain six loops (loops A, B and C on the alpha subunit and loops D, E and F on the non-alpha subunit) which make up the orthosteric binding site at the alpha/non-alpha subunit interfaces. Recently, an additional site (loop G) on the beta 1 strand has been identified. Also, when the alpha/non-alpha subunit ratio is 3/2, another binding site is generated at the interface of two adjacent alpha subunits. Roles for loop G and the alpha-alpha interface in the interactions with neonicotinoids are discussed with reference to recent structural and physiological data. (C) 2015 Elsevier Inc. All rights reserved.	[Ihara, Makoto; Matsuda, Kazuhiko] Kinki Univ, Fac Agr, Dept Appl Biol Chem, Nara 6318505, Japan; [Sattelle, David B.] UCL, Dept Med, Wolfson Inst Biomed Res, London WC1E 6BT, England	Matsuda, K (reprint author), Kinki Univ, Fac Agr, Dept Appl Biol Chem, 3327-204 Nakamachi, Nara 6318505, Japan.	kmatsuda@nara.kindai.ac.jp		Ihara, Makoto/0000-0002-6403-0781	Ministry of Agriculture, Forestry, and Fisheries of Japan [PRM-3002]; Department of Medicine, University College, London, UK	Kazuhiko Matsuda was supported by a grant from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement, PRM-3002). David Sattelle acknowledges the support of The Department of Medicine, University College, London, UK.	Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Bass C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-51; Matsuda K, 2005, BIOSCI BIOTECH BIOCH, V69, P1442, DOI 10.1271/bbb.69.1442; Sparks TC, 2013, PESTIC BIOCHEM PHYS, V107, P1, DOI 10.1016/j.pestbp.2013.05.014; Ihara M, 2004, BIOSCI BIOTECH BIOCH, V68, P761, DOI 10.1271/bbb.68.761; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Casida JE, 2013, ANNU REV ENTOMOL, V58, P99, DOI 10.1146/annurev-ento-120811-153645; Spurny R, 2012, P NATL ACAD SCI USA, V109, pE3028, DOI 10.1073/pnas.1208208109; Shimomura M, 2002, BRIT J PHARMACOL, V137, P162, DOI 10.1038/sj.bjp.0704848; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Matsuda K, 2009, MOL PHARMACOL, V76, P1, DOI 10.1124/mol.109.055186; Rucktooa P, 2009, BIOCHEM PHARMACOL, V78, P777, DOI 10.1016/j.bcp.2009.06.098; Matsuda K, 2000, BRIT J PHARMACOL, V130, P981, DOI 10.1038/sj.bjp.0703374; BAI DL, 1991, PESTIC SCI, V33, P197, DOI 10.1002/ps.2780330208; Salgado VL, 2004, J INSECT PHYSIOL, V50, P867, DOI 10.1016/j.jinsphys.2004.07.007; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Talley TT, 2008, P NATL ACAD SCI USA, V105, P7606, DOI 10.1073/pnas.0802197105; Buckingham SD, 1997, J EXP BIOL, V200, P2685; Shimomura M, 2006, MOL PHARMACOL, V70, P1255, DOI 10.1124/mol.106.026815; Sparks TC, 2013, PESTIC BIOCHEM PHYS, V107, P8, DOI 10.1016/j.pestbp.2013.05.012; Matsuda K, 2001, TRENDS PHARMACOL SCI, V22, P573, DOI 10.1016/S0165-6147(00)01820-4; Jeschke P, 2013, ANGEW CHEM INT EDIT, V52, P9464, DOI 10.1002/anie.201302550; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Changeux JP, 2012, J BIOL CHEM, V287, P40207, DOI 10.1074/jbc.R112.407668; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Akdemir A, 2011, BIOORGAN MED CHEM, V19, P6107, DOI 10.1016/j.bmc.2011.08.028; Arias HR, 1997, BRAIN RES REV, V25, P133, DOI 10.1016/S0165-0173(97)00020-9; Brown LA, 2006, J NEUROCHEM, V99, P608, DOI 10.1111/j.1471-4159.2006.04084.x; CHEUNG H, 1992, PESTIC SCI, V34, P187, DOI 10.1002/ps.2780340302; Cordova D., 2014, 13 IUPAC INT C PEST, P215; Grauso M, 2002, GENETICS, V160, P1519; Holyoke C.W., 2014, 13 IUPAC INT C PEST, P117; Ihara M, 2003, NEUROPHARMACOLOGY, V45, P133, DOI 10.1016/S0028-3908(03)00134-5; Ihara M, 2014, MOL PHARMACOL, V86, P736, DOI 10.1124/mol.114.094698; Ihara M., 2008, INVERTEBR NEUROSCI, V8, P71; Ihara M, 2006, J PESTIC SCI, V31, P35, DOI 10.1584/jpestics.31.35; Kagabu S., 1997, REV TOXICOL, V1, P75; Lansdell SJ, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-73; LEECH CA, 1991, FEBS LETT, V290, P90, DOI 10.1016/0014-5793(91)81233-X; Matsuda K, 2001, BIOSCI BIOTECH BIOCH, V65, P1534, DOI 10.1271/bbb.65.1534; Matsuda K, 1998, BRIT J PHARMACOL, V123, P518, DOI 10.1038/sj.bjp.0701618; Salgado V. I., 2005, COMPREHENSIVE MOL IN, V6, P137; SATTELLE DB, 1989, PROC R SOC SER B-BIO, V237, P501, DOI 10.1098/rspb.1989.0062; SCHROEDER ME, 1984, PESTIC BIOCHEM PHYS, V22, P148, DOI 10.1016/0048-3575(84)90084-1; Shimomura M, 2005, NEUROSCI LETT, V385, P168, DOI 10.1016/j.neulet.2005.05.014; Shimomura M, 2004, NEUROSCI LETT, V363, P195, DOI 10.1016/j.neulet.2003.12.115; Soloway S.B., 1979, ADV PESTIC SCI, P206; Toshima K, 2009, NEUROPHARMACOLOGY, V56, P264, DOI 10.1016/j.neuropharm.2008.08.022; Toshima K, 2008, J PESTIC SCI, V33, P146, DOI 10.1584/jpestics.G07-28; Tricoire-Leignel H, 2010, ADV EXP MED BIOL, V683, P45; ZWART R, 1992, EUR J PHARM-ENVIRON, V228, P165, DOI 10.1016/0926-6917(92)90026-9	53	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0048-3575	1095-9939		PESTIC BIOCHEM PHYS	Pest. Biochem. Physiol.	JUN	2015	121				SI		47	52		10.1016/j.pestbp.2015.02.011		6	Biochemistry & Molecular Biology; Entomology; Physiology	Biochemistry & Molecular Biology; Entomology; Physiology	CK3IL	WOS:000356109700007		
J	Shirakata, S				Shirakata, Sho			Photoluminescence characterization of Cu(In,Ga)Se-2 solar-cell processes	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						CIGS solar cell; photoluminescence; photovoltaic effect; solar-cell process	TIME-RESOLVED PHOTOLUMINESCENCE; THIN-FILMS; GAP	Photoluminescence (PL) has been reviewed for the characterization of Cu(In,Ga)Se-2 (CIGS) solar cells with emphasis on PL intensity and lifetime in the photovoltaic heterojunction, characterization of photovoltage by PL mapping, PL in CIGS solar process, and degradation of CIGS surface in air. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	Ehime Univ, Fac Engn, Matsuyama, Ehime 7908577, Japan	Shirakata, S (reprint author), Ehime Univ, Fac Engn, Matsuyama, Ehime 7908577, Japan.	Shirakata.sho.mx@ehime-u.ac.jp			JSPS [26105002]	The authors would like to thank A. Miyata and S. Yudate for technical assistance, Dr. T. Terasako for discussion, and Mr. T. Sakemi for the cooperation. Some of the CIGS solar cell samples were provided by Prof. T. Nakada of Science University of Tokyo. This work was partly supported by JSPS Grant-in-Aid for Scientific Research: Grant Number 26105002.	Metzger WK, 2009, THIN SOLID FILMS, V517, P2360, DOI 10.1016/j.tsf.2008.11.050; Shirakata S, 2007, THIN SOLID FILMS, V515, P6151, DOI 10.1016/j.tsf.2006.12.040; SMESTAD G, 1992, SOL ENERG MAT SOL C, V25, P51, DOI 10.1016/0927-0248(92)90016-I; Shafarman WN, 1996, J APPL PHYS, V79, P7324, DOI 10.1063/1.361431; Metzger WK, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2957983; Metzger WK, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.035301; Herberholz R, 1997, SOL ENERG MAT SOL C, V49, P227, DOI 10.1016/S0927-0248(97)00199-2; Nakada T, 2011, SOL ENERG MAT SOL C, V95, P1463, DOI 10.1016/j.solmat.2010.11.022; Nakamura N., 2014, P 40 IEEE PHOT SPEC; Shirakata S, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FW11; Shirakata S, 2013, PHYS STATUS SOLIDI A, V210, P1322, DOI 10.1002/pssa.201200859; Shirakata S, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.05FC02; Shirakata S., 2007, P MRS SPRING M THIN, P235; Shirakata S, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NC13; Shirakata S, 2009, PHYS STATUS SOLIDI C, V6, P1059, DOI 10.1002/pssc.200881164; Shirakata S, 2011, SOL ENERG MAT SOL C, V95, P219, DOI 10.1016/j.solmat.2010.04.067; Siebentritt S., 2005, WIDE GAP CHALCOPYRIT; Webb H. B., 1972, SEMICONDUCT SEMIMET, V8	18	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	JUN	2015	252	6					1211	1218		10.1002/pssb.201400333		8	Physics, Condensed Matter	Physics	CJ8MO	WOS:000355756200001		
J	Okano, M; Phuong, LQ; Kanemitsu, Y				Okano, Makoto; Le Quang Phuong; Kanemitsu, Yoshihiko			Photocarrier dynamics in CIGS, CZTS, and related materials revealed by ultrafast optical spectroscopy	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						carrier dynamics; multinary semiconductors; optical properties; solar cells	CU(IN,GA)SE-2 THIN-FILMS; TIME-RESOLVED PHOTOLUMINESCENCE; SOLAR-CELLS; CARRIER; SEMICONDUCTOR; EFFICIENCY; CUINSE2; ALGAAS; BANDS; GAAS	We discuss the photocarrier dynamics in emerging thin-film solar-cell materials, Cu(In,Ga)Se-2 (CIGS), Cu2ZnSnS4 (CZTS), and CdTe-based nanocrystals (NCs), using time-resolved photoluminescence and femtosecond pump-probe spectroscopy. In CIGS and CZTS samples, we found long-lived free photocarriers and slow intraband relaxation at room temperature. These distinctive behaviors of the free carriers are considered common features in multinary semiconductors and are related to the complicated near-band edge structure due to potential fluctuations, which might affect solar-cell efficiencies. We revealed the relationship in CdTe-based type-II NCs between hot carrier transfer and intraband relaxation, providing a better understanding of the charge separation mechanism in multinary semiconductors. We also demonstrated the usefulness of ultra-fast optical spectroscopy techniques for clarifying the photocarrier dynamics in various semiconducting bulk and nano-structure materials for solar cells. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Okano, Makoto; Le Quang Phuong; Kanemitsu, Yoshihiko] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan; [Le Quang Phuong; Kanemitsu, Yoshihiko] Kyoto Univ, Japan Sci & Technol Agcy, CREST, Uji, Kyoto 6110011, Japan	Kanemitsu, Y (reprint author), Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan.	kanemitu@scl.kyoto-u.ac.jp	Okano, Makoto/F-9311-2011; Kanemitsu, Yoshihiko/D-2006-2014		KAKENHI [25247052]; Sumitomo Electric Industries Group CSR Foundation; JST-CREST	The authors would like to thank Y. Yamada, K. Akimoto, T. Sakurai, Y. Takabayashi, S. Niki, S. Hajime, K. Yoshino, A. Nagaoka, M. Sakamoto, and T. Teranishi for sample preparation and discussions. Part of this work was supported by KAKENHI (grant no. 25247052), The Sumitomo Electric Industries Group CSR Foundation, and JST-CREST.	Metzger WK, 2009, THIN SOLID FILMS, V517, P2360, DOI 10.1016/j.tsf.2008.11.050; Hafemeister M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.196602; Yamada Y, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.032302; Ohnesorge B, 1998, APPL PHYS LETT, V73, P1224, DOI 10.1063/1.122134; Okano M, 2014, J PHYS CHEM LETT, V5, P2951, DOI 10.1021/jz501564q; Zhang SB, 1998, PHYS REV B, V57, P9642, DOI 10.1103/PhysRevB.57.9642; Shimakawa S, 2006, PHYS STATUS SOLIDI A, V203, P2630, DOI 10.1002/pssa.200669583; Shirakata S, 2007, THIN SOLID FILMS, V515, P6151, DOI 10.1016/j.tsf.2006.12.040; Wei SH, 1998, APPL PHYS LETT, V72, P3199, DOI 10.1063/1.121548; Abou-Ras D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.075502; Chen SC, 2012, OPT EXPRESS, V20, P12675, DOI 10.1364/OE.20.012675; Siebentritt S, 2010, PROG PHOTOVOLTAICS, V18, P390, DOI 10.1002/pip.936; Krustok J, 1999, PHYS SCRIPTA, VT79, P179, DOI 10.1238/Physica.Topical.079a00179; Romero MJ, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.165324; Dirnstorfer I, 1998, PHYS STATUS SOLIDI A, V168, P163, DOI 10.1002/(SICI)1521-396X(199807)168:1<163::AID-PSSA163>3.0.CO;2-T; Siebentritt S, 2012, PROG PHOTOVOLTAICS, V20, P512, DOI 10.1002/pip.2156; Shin B, 2013, PROG PHOTOVOLTAICS, V21, P72, DOI 10.1002/pip.1174; Todorov TK, 2013, ADV ENERGY MATER, V3, P34, DOI 10.1002/aenm.201200348; Metzger WK, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2957983; Tex DM, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.245305; Yamada Y, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4754831; Niki S, 2010, PROG PHOTOVOLTAICS, V18, P453, DOI 10.1002/pip.969; Nagaoka A, 2012, J CRYST GROWTH, V341, P38, DOI 10.1016/j.jcrysgro.2011.12.046; Phuong LQ, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4866666; Saruyama M, 2011, J AM CHEM SOC, V133, P17598, DOI 10.1021/ja2078224; Sakamoto M, 2014, CHEM SCI, V5, P3831, DOI 10.1039/c4sc00635f; Othonos A, 1998, J APPL PHYS, V83, P1789, DOI 10.1063/1.367411; GABOR AM, 1994, APPL PHYS LETT, V65, P198, DOI 10.1063/1.112670; JAFFE JE, 1984, PHYS REV B, V29, P1882, DOI 10.1103/PhysRevB.29.1882; Schmidt SS, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.095506; Okano M, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.195203; Yamada Y, 2014, J AM CHEM SOC, V136, P11610, DOI 10.1021/ja506624n; Tex DM, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.125301; Jackson P, 2011, PROG PHOTOVOLTAICS, V19, P894, DOI 10.1002/pip.1078; Gokmen T, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4820250; Gunawan O, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3522884; KNOX WH, 1988, PHYS REV LETT, V61, P1290, DOI 10.1103/PhysRevLett.61.1290; Levanyuk A. P., 1981, Soviet Physics - Uspekhi, V24, DOI 10.1070/PU1981v024n03ABEH004770; LIN WZ, 1988, IEEE J QUANTUM ELECT, V24, P267, DOI 10.1109/3.123; Monig H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.116802; ITO K, 1988, JPN J APPL PHYS 1, V27, P2094, DOI 10.1143/JJAP.27.2094; Ono M, 2014, CHEM SCI, V5, P2696, DOI 10.1039/c4sc00436a; Persson C, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.266401; Phuong LQ, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4829063; Phuong LQ, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4903802; Sakurai T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.05FC01; SCHOENLEIN RW, 1988, SOLID STATE ELECTRON, V31, P443, DOI 10.1016/0038-1101(88)90314-0; Shirakata S, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NC13; Taguchi S, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.155324; Yamada Y, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.035133; Yan Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.235504	51	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	JUN	2015	252	6					1219	1224		10.1002/pssb.201400260		6	Physics, Condensed Matter	Physics	CJ8MO	WOS:000355756200002		
J	Hosokawa, S; Kamimura, K; Ikemoto, H; Happo, N; Mimura, K; Hayashi, K; Takahashi, K; Wakita, K; Mamedov, N				Hosokawa, Shinya; Kamimura, Kenji; Ikemoto, Hiroyuki; Happo, Naohisa; Mimura, Kojiro; Hayashi, Kouichi; Takahashi, Kohki; Wakita, Kazuki; Mamedov, Nazim			Structural studies on TlInSe2 thermoelectric material by X-ray fluorescence holography, XAFS, and X-ray diffraction	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						intermediate range; local structure; positional fluctuations; thermoelectric material		The local structure around the Tl atoms in TlInSe2 thermoelectric material was investigated by X-ray fluorescence holography (XFH), XAFS, and X-ray diffraction (XD). The temperature dependent XAFS and XD data reveal that no distinct phase change features are found, and the position of the Tl atoms are fluctuated randomly in the Tl chain direction of the crystal, which is consistent with the XFH result at room temperature. Also, an interference between the positions of Tl and In atoms is suggested by all of these experiments. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Hosokawa, Shinya; Kamimura, Kenji] Kumamoto Univ, Grad Sch Sci & Technol, Dept Phys, Kumamoto 8608555, Japan; [Ikemoto, Hiroyuki] Toyama Univ, Dept Phys, Fac Sci, Toyama 9308555, Japan; [Happo, Naohisa] Hiroshima City Univ, Grad Sch Informat Sci, Hiroshima 7313194, Japan; [Mimura, Kojiro] Osaka Prefecture Univ, Grad Sch Engn, Dept Math Sci, Sakai, Osaka 5998531, Japan; [Hayashi, Kouichi; Takahashi, Kohki] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Wakita, Kazuki] Chiba Inst Technol, Fac Engn, Narashino, Chiba 2750016, Japan; [Mamedov, Nazim] Azerbaijan Natl Acad Sci, Inst Phys, Baku 1143, Azerbaijan	Hosokawa, S (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Dept Phys, Kumamoto 8608555, Japan.	hosokawa@sci.kumamoto-u.ac.jp			JSPS [26105006]; Science Development Foundation [EIF-2012-2(6)-39/01/1]	The XD experiments were performed at High Field Laboratory for Superconducting Materials in Institute for Materials Research, Tohoku University. The XAFS experiments were carried out at XAFS beamlines of PF-KEK (Proposal No. 2010G559 and 2012G522). The XFH measurements were performed under the approvals of Taiwan National Synchrotron Research Center at SPring-8 (proposal No. 2009B4139, 2010A4130, and 2011B4125). This work was partially supported by JSPS Grant-in-Aid for Scientific Research on Innovative Areas "3D Active-Site Science" (No. 26105006) and the Science Development Foundation under the President of the Republic of Azerbaijan (No. EIF-2012-2(6)-39/01/1).	Alekperov O. Z., 1998, TURK J PHYS, V22, P1053; Hosokawa S, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.05FC06; Mamedov N, 2006, THIN SOLID FILMS, V499, P275, DOI 10.1016/j.tsf.2005.07.203; Mimura K, 2008, JPN J APPL PHYS, V47, P8188, DOI 10.1143/JJAP.47.8188; Mimura Kojiro, 2011, e-Journal of Surface Science and Nanotechnology, V9, DOI 10.1380/ejssnt.2011.273; MULLER D, 1973, Z ANORG ALLG CHEM, V398, P207, DOI 10.1002/zaac.19733980215	6	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	JUN	2015	252	6					1225	1229		10.1002/pssb.201400247		5	Physics, Condensed Matter	Physics	CJ8MO	WOS:000355756200003		
J	Shigemi, A; Maeda, T; Wada, T				Shigemi, Akio; Maeda, Tsuyoshi; Wada, Takahiro			First-principles calculation of Cu2SnS3 and related compounds	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						band-gap energy; Cu2GeS3; Cu2SiS3; Cu2SnS3; Cu2SnSe3; first-principles calculation	TOTAL-ENERGY CALCULATIONS; AUGMENTED-WAVE METHOD; CRYSTAL-STRUCTURE; GROWTH; DENSITY; FILMS; AG	We evaluate the electronic structures of Cu2SnS3 (CTS) and related compounds, Cu2GeS3 (CGS), Cu2SiS3 (CSS), Cu2SnSe3 (CTSe), Cu2GeSe3 (CGSe), and Cu2SiSe3 (CSSe), using a first-principles calculation. To determine band-gap energy, E-g, without use of the reported crystal structure, we used the Heyd-Scuseria-Ernzerhof (HSE) screened hybrid density functional after geometry optimization by a DFT-D2 approach in consideration of the van der Waals (vdW) forces. The E-g values of the monoclinic CTS and related compounds with a space group of Cc were calculated using the HSE functional with =0.32. The determined E-g values were 0.88eV for CTS, 1.54eV for CGS, 2.87eV for CSS, 0.45eV for CTSe, 0.72eV for CGSe, and 1.72eV for CSSe. Additionally, we discuss the reason for the difference in E-g between CTS and related compounds from density of states (DOS). (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Shigemi, Akio; Maeda, Tsuyoshi; Wada, Takahiro] Ryukoku Univ, Dept Chem Mat, Otsu, Shiga 5202194, Japan	Shigemi, A (reprint author), Ryukoku Univ, Dept Chem Mat, Otsu, Shiga 5202194, Japan.	shigemi@ad.ryukoku.ac.jp			Incorporated Administrative Agency New Energy and Industrial Technology Development Organization (NEDO) under Ministry of Economy, Trade and Industry (METI)	This work was supported by the Incorporated Administrative Agency New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry (METI).	LEHMANN G, 1972, PHYS STATUS SOLIDI B, V54, P469, DOI 10.1002/pssb.2220540211; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Onoda M, 2000, MATER RES BULL, V35, P1563, DOI 10.1016/S0025-5408(00)00347-0; Heyd J, 2003, J CHEM PHYS, V118, P8207, DOI 10.1063/1.1564060; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Tsuji I, 2010, CHEM MATER, V22, P1402, DOI 10.1021/cm9022024; Zhai YT, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075213; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495; PAYNE MC, 1992, REV MOD PHYS, V64, P1045, DOI 10.1103/RevModPhys.64.1045; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; Xi L, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.155201; Berg DM, 2012, THIN SOLID FILMS, V520, P6291, DOI 10.1016/j.tsf.2012.05.085; Marcano G, 2001, J APPL PHYS, V90, P1847, DOI 10.1063/1.1383984; Kim KM, 2013, THIN SOLID FILMS, V536, P111, DOI 10.1016/j.tsf.2013.03.119; Araki H., 2014, GRAND REN EN 2014, V2014; Araki H, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FW10; Aruga A, 2006, JPN J APPL PHYS 1, V45, P4616, DOI 10.1143/JJAP.45.4616; Chandra GH, 2011, J MATER SCI, V46, P6952, DOI 10.1007/s10853-011-5661-y; Delgado GE, 2003, MATER RES BULL, V38, P1949, DOI 10.1016/j.materresbull.2003.09.017; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Morihama M, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FW06; Nomura T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.04CR08; Sarkar BK, 2011, PHYSICA B, V406, P2847, DOI 10.1016/j.physb.2011.04.045; Umehara M, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.045501	25	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	JUN	2015	252	6					1230	1234		10.1002/pssb.201400346		5	Physics, Condensed Matter	Physics	CJ8MO	WOS:000355756200004		
J	Nishimura, T; Kasashima, S; Hirai, Y; Kurokawa, Y; Yamada, A				Nishimura, Takahito; Kasashima, Shunsuke; Hirai, Yoshiaki; Kurokawa, Yasuyoshi; Yamada, Akira			Fabrication of Cu(In,Ga)Se-2 solar cells with a single graded band profile	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						chalcopyrites; CIGS solar cells; Cu(In,Ga)Se-2; graded band profile; interfaces; ordered vacancy	SIMULATION; CUINSE2	It was found that Cu(In,Ga)Se-2 (CIGS) solar cells with single graded (SG) band profile and average bandgap E-g(avg) of 1.15eV has higher efficiency than double graded (DG) band profile with the same E-g(avg), despite no intentional bandgap-widening at a CdS/CIGS interface in SG-CIGS. To explain this contradiction, we focused on the band structure at the CdS/CIGS interface and proposed that the contradiction can be explained by the formation of an ordered vacancy chalcopyrite compound (OVC) layer on the surface of CIGS. Device simulation using wxAMPS revealed that if an OVC layer exists at the interface, conversion efficiency of SG-CIGS solar cells overcomes that of DG-CIGS solar cells due to suppression of surface recombination at the interface, leading to open-circuit voltage (V-OC) improvement. We applied the SG structure to CIGS solar cells with high Ga contents. As a result, the conversion efficiency of 15.1% for the SG-CIGS solar cell with E-g(avg) of 1.4eV was achieved, although in contrast, that of the DG-CIGS solar cells was 12.9%. This efficiency is comparable to the highest efficiency in CIGS solar cells with high Ga contents. Therefore, SG band profile is promising structure and it is expected to achieve high efficiency predicted essentially in CIGS solar cells with high Ga contents. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Nishimura, Takahito; Kasashima, Shunsuke; Hirai, Yoshiaki; Kurokawa, Yasuyoshi; Yamada, Akira] Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528552, Japan; [Yamada, Akira] Tokyo Inst Technol, Photovolta Res Ctr PVREC, Meguro Ku, Tokyo 1528552, Japan	Nishimura, T (reprint author), Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528552, Japan.	nishimura.t.ak@m.titech.ac.jp	Kurokawa, Yasuyoshi/P-1057-2014		New Energy and Industrial Technology Development Organization (NEDO) under Ministry of Economy, Trade and Industry	This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry. Moreover we thank Professor Rockett and Dr. Liu of UIUC, and Professor Fonash of PSU who developed wxAMPS.	Schmid D, 1996, SOL ENERG MAT SOL C, V41-2, P281, DOI 10.1016/0927-0248(95)00107-7; Heath JT, 2002, APPL PHYS LETT, V80, P4540, DOI 10.1063/1.1485301; Zhang SB, 1998, PHYS REV B, V57, P9642, DOI 10.1103/PhysRevB.57.9642; Minemoto T, 2001, SOL ENERG MAT SOL C, V67, P83, DOI 10.1016/S0927-0248(00)00266-X; Contreras MA, 2012, PROG PHOTOVOLTAICS, V20, P843, DOI 10.1002/pip.2244; SCHMID D, 1993, J APPL PHYS, V73, P2902, DOI 10.1063/1.353020; Liu YM, 2012, SOL ENERG MAT SOL C, V98, P124, DOI 10.1016/j.solmat.2011.10.010; Contreras MA, 2005, PROG PHOTOVOLTAICS, V13, P209, DOI 10.1002/pip.626; Hirai Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.014101; Ward JS, 2002, PROG PHOTOVOLTAICS, V10, P41, DOI 10.1002/pip.424; Jackson P, 2011, PROG PHOTOVOLTAICS, V19, P894, DOI 10.1002/pip.1078; Hashimoto Y, 1998, SOL ENERG MAT SOL C, V50, P71, DOI 10.1016/S0927-0248(97)00124-4; Hirai Y, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.012301; Hirai Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NC03; NEGAMI T, 1995, APPL PHYS LETT, V67, P825, DOI 10.1063/1.115456; Repins I, 2008, PROG PHOTOVOLTAICS, V16, P235, DOI 10.1002/pip.822	16	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	JUN	2015	252	6					1235	1238		10.1002/pssb.201400305		4	Physics, Condensed Matter	Physics	CJ8MO	WOS:000355756200005		
J	Kanai, A; Araki, H; Takeuchi, A; Katagiri, H				Kanai, Ayaka; Araki, Hideaki; Takeuchi, Akiko; Katagiri, Hironori			Annealing temperature dependence of photovoltaic properties of solar cells containing Cu2SnS3 thin films produced by co-evaporation	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						co-evaporation; Cu2SnS3; thin film solar cells	OPTICAL-PROPERTIES; EFFICIENCY	The ternary compound Cu2SnS3 (CTS) is composed of elements that are low in cost, non-toxic, and abundant in the Earth's crust. In addition, CTS is a p-type semiconductor with a high reported absorption coefficient of more than 10(4)cm(-1) and a band gap energy of 0.92-1.77eV. It is, therefore, considered to be a suitable candidate for the absorber layer in thin film solar cells. In the present study, CTS thin films were produced by first depositing precursor films by co-evaporation of Cu, Sn, and S, and then annealing them. Solar cells were then fabricated using the CTS films as absorber layers, and the dependence of their photovoltaic properties on the annealing temperature was investigated. The solar cell using the CTS thin film annealed at 570 degrees C exhibited an open-circuit voltage of 248mV, a short-circuit current density of 33.5mA/cm(2), a fill factor of 0.439, and a conversion efficiency of 3.66%. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Kanai, Ayaka; Araki, Hideaki; Takeuchi, Akiko; Katagiri, Hironori] Nagaoka Natl Coll Technol, Nagaoka, Niigata 9408532, Japan; [Araki, Hideaki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Araki, H (reprint author), Nagaoka Natl Coll Technol, 888 Nishikatakai, Nagaoka, Niigata 9408532, Japan.	h-araki@nagaoka-ct.ac.jp			Precursory Research for Embryonic Science and Technology (PRESTO) Japan; NS Promotion Foundation for Science of Perception; Foundation for Applied Research and Technological Uniqueness at NUT	This work was supported in part by the Precursory Research for Embryonic Science and Technology (PRESTO) Japan. A. Kanai would like to thank the NS Promotion Foundation for Science of Perception and The Foundation for Applied Research and Technological Uniqueness at NUT for supporting this research activity.	Green MA, 2014, PROG PHOTOVOLTAICS, V22, P701, DOI 10.1002/pip.2525; Tiwari D, 2013, SOL ENERG MAT SOL C, V113, P165, DOI 10.1016/j.solmat.2013.02.017; Chen QM, 2012, J COLLOID INTERF SCI, V376, P327, DOI 10.1016/j.jcis.2012.03.015; Fiechter S, 2003, J PHYS CHEM SOLIDS, V64, P1859, DOI 10.1016/S0022-3697(03)00172-0; Berg DM, 2012, THIN SOLID FILMS, V520, P6291, DOI 10.1016/j.tsf.2012.05.085; Berg DM, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4712623; Bouaziz M, 2011, VACUUM, V85, P783, DOI 10.1016/j.vacuum.2010.10.001; Fernandes PA, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/21/215403; Aihara N, 2013, PHYS STATUS SOLIDI C, V10, P1086, DOI 10.1002/pssc.201200866; KUKU TA, 1987, SOL ENERG MATER, V16, P199, DOI 10.1016/0165-1633(87)90019-0; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Amlouk A, 2010, VACUUM, V85, P60, DOI 10.1016/j.vacuum.2010.04.002; Toyama T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.075503; Bouaziz M, 2009, THIN SOLID FILMS, V517, P2527, DOI 10.1016/j.tsf.2008.11.039; Chino K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NC35; Koike J, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NC34; Nomura T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FW01; Umehara M, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.045501; Weber A, 2010, J APPL PHYS, V107, DOI 10.1063/1.3273495	19	7	7	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	JUN	2015	252	6					1239	1243		10.1002/pssb.201400297		5	Physics, Condensed Matter	Physics	CJ8MO	WOS:000355756200006		
J	Harasawa, R; Yamamoto, N; Wu, H; Aritake, T; Lu, SL; Ji, L; Tackeuchi, A				Harasawa, Ryo; Yamamoto, Naoki; Wu, Hao; Aritake, Takanori; Lu, Shulong; Ji, Lian; Tackeuchi, Atsushi			Observation of picosecond electron spin relaxation in InGaAsP by time-resolved spin-dependent pump and probe reflection measurement	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						InGaAsP; semiconductors; spin relaxation; spintronics	QUANTUM-WELLS; EPITAXY	We have investigated the electron spin relaxation in undoped InGaAsP grown on an InP substrate. Time-resolved spin-dependent pump and probe reflection measurements revealed a spin relaxation behavior between 10 and 300K. We have observed the electron spin relaxation times of 980ps at 10K and 95ps at room temperature. The observed presence of the carrier density dependence and the weak temperature dependence of spin relaxation time imply that the Bir-Aronov-Pikus (BAP) process is effective at 10-30K. At 100-300K, the observed presence of the temperature dependence and the absence of the carrier density dependence of spin relaxation time indicate that the D'yakonov-Perel' (DP) and Elliott-Yafet (EY) processes are effective. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Harasawa, Ryo; Yamamoto, Naoki; Wu, Hao; Aritake, Takanori; Tackeuchi, Atsushi] Waseda Univ, Dept Appl Phys, Shinjuku Ku, Tokyo 1698555, Japan; [Lu, Shulong; Ji, Lian] Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, Suzhou, Peoples R China	Tackeuchi, A (reprint author), Waseda Univ, Dept Appl Phys, Shinjuku Ku, 3-4-1 Ohkubo, Tokyo 1698555, Japan.	atacke@waseda.jp					YAFET Y, 1963, SOLID STATE PHYS, V14, P1; Uemura M, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4869211; FISHMAN G, 1977, PHYS REV B, V16, P820, DOI 10.1103/PhysRevB.16.820; ELLIOTT RJ, 1954, PHYS REV, V96, P266, DOI 10.1103/PhysRev.96.266; Law DC, 2010, SOL ENERG MAT SOL C, V94, P1314, DOI 10.1016/j.solmat.2008.07.014; Bir G. L., 1975, SOV PHYS JETP, V42, P705; DYAKONOV MI, 1971, SOV PHYS JETP-USSR, V33, P1053; Dharmarasu N, 2001, APPL PHYS LETT, V79, P2399, DOI 10.1063/1.1409270; Ji L, 2014, SOL ENERG MAT SOL C, V127, P1, DOI 10.1016/j.solmat.2014.03.051; Kitatani T, 2004, J CRYST GROWTH, V273, P19, DOI 10.1016/j.jcrysgro.2004.07.094; LAPIERRE RR, 1995, J CRYST GROWTH, V155, P1, DOI 10.1016/0022-0248(95)00123-9; Lee YC, 2001, SOLID STATE COMMUN, V120, P501, DOI 10.1016/S0038-1098(01)00435-5; Marshall D, 2001, OPT QUANT ELECTRON, V33, P1019, DOI 10.1023/A:1017507430891; Sarma S. D., 2001, SOLID STATE COMMUN, V119, P207; TACKEUCHI A, 1990, APPL PHYS LETT, V56, P2213, DOI 10.1063/1.102970; Ushimi T, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4730386	16	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	JUN	2015	252	6					1244	1247		10.1002/pssb.201400321		4	Physics, Condensed Matter	Physics	CJ8MO	WOS:000355756200007		
J	Mamedov, N; Shim, Y; Okada, W; Tashiro, R; Wakita, K				Mamedov, Nazim; Shim, YongGu; Okada, Wataru; Tashiro, Ryo; Wakita, Kazuki			Band gap exciton in ferroelectric TlInS2: Dimensionality and screening	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						band gap exciton; Currie-Weiss law; dielectric function; dielectric screening; spectroscopic ellipsometry	SINGLE-CRYSTALS; TLGASE2; SEMICONDUCTORS; PHASE; TEMPERATURE; TRANSITIONS; POLYTYPES	This work reports two-dimensionality of band-gap exciton in layered ferroelectric TlInS2, accessed by spectroscopic phase modulated ellipsometry in a wide range of temperatures embracing normal, incommensurate, and commensurate phases of this material. A significant decrease in exciton binding energy is observed upon approaching the temperature region of the incommensurate phase on cooling or heating. The effective static rather than optic dielectric screening is shown to be responsible for the observed behavior of exciton binding energy that remains larger than the energy of the longitudinal-optical phonon at all accessed temperatures. The temperature dependence of this screening is remarkable in that it obeys Currie-Weiss law. The values of the exciton's reduced mass and three-dimensional effective Bohr radius are obtained. The former keeps constant to be 0.928 the mass of the free electron while the latter irregularly changes with temperature, remaining within 14-19 angstrom limits. The last values correspond to the doubled thickness of a single layer. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Mamedov, Nazim] Azerbaijan Natl Acad Sci, Inst Phys, Baku 1143, Azerbaijan; [Shim, YongGu; Okada, Wataru; Tashiro, Ryo] Osaka Prefecture Univ, Grad Sch Engn, Dept Phys & Elect, Sakai, Osaka 5998531, Japan; [Wakita, Kazuki] Chiba Inst Technol, Dept Elect Elect & Comp Engn, Narashino, Chiba 2750016, Japan	Mamedov, N (reprint author), Azerbaijan Natl Acad Sci, Inst Phys, Baku 1143, Azerbaijan.	n.mamedov@physics.ab.az			Science Development Foundation under President of the Republic of Azerbaijan-grant [EIF-2012-2(6)-39/01/1]	This work was partly supported by the Science Development Foundation under the President of the Republic of Azerbaijan-grant no. EIF-2012-2(6)-39/01/1.	Abay B, 1998, J APPL PHYS, V84, P3872, DOI 10.1063/1.368566; Adachi S., 1994, GAAS RELATED MAT BUL, P356; ADACHI S, 1988, PHYS REV B, V38, P12966, DOI 10.1103/PhysRevB.38.12966; Alekperov O, 2009, INORG MATER+, V45, P7, DOI 10.1134/S0020168509010026; Alekperov OZ, 2009, PHYS STATUS SOLIDI C, V6, P977, DOI 10.1002/pssc.200881193; Aliev R. A., 1984, Soviet Physics - Solid State, V26; HENKEL W, 1982, PHYS REV B, V26, P3211, DOI 10.1103/PhysRevB.26.3211; Johnsen S, 2011, CHEM MATER, V23, P3120, DOI 10.1021/cm200946y; Kashida S, 1999, J PHYS-CONDENS MAT, V11, P1027, DOI 10.1088/0953-8984/11/4/010; Mustafaeva SN, 1998, PHYS SOLID STATE+, V40, P561, DOI 10.1134/1.1130352; Arai T., 2001, JAPANESE RES REV PIO, P24; BELENKII GL, 1989, NUOVO CIMENTO D, V11, P1571, DOI 10.1007/BF02451012; Gasanly NM, 2010, J KOREAN PHYS SOC, V57, P164, DOI 10.3938/jkps.57.164; GASANLY NM, 1983, PHYS STATUS SOLIDI B, V116, P427, DOI 10.1002/pssb.2221160204; Grivickas V, 2014, PHYS STATUS SOLIDI-R, V8, P639, DOI 10.1002/pssr.201409148; Grivickas V., 2006, Materials Science, V12; Guseinov G.D., 1970, PHYS LETT A, V33, P412; HANIAS MP, 1992, MATER RES BULL, V27, P25, DOI 10.1016/0025-5408(92)90039-3; KALOMIROS JA, 1994, PHYS REV B, V50, P7488, DOI 10.1103/PhysRevB.50.7488; Karpovich A., 1972, B ACAD SCI USSR INOR, V8, P58; Karpovich A., 1972, IAN SSSR NEORG MATER, V8, P70; Mamedov N., 2001, P 25 INT C SEM PHYS, P123; Mamedov N, 2002, JPN J APPL PHYS 1, V41, P7254, DOI 10.1143/JJAP.41.7254; Mamedov N, 2008, THIN SOLID FILMS, V517, P1434, DOI 10.1016/j.tsf.2008.09.012; Mamedov N, 2006, PHYS STATUS SOLIDI A, V203, P2873, DOI 10.1002/pssa.200669656; MCMORROW DF, 1990, J PHYS-CONDENS MAT, V2, P3699, DOI 10.1088/0953-8984/2/16/001; Orudzhev G, 2008, JPN J APPL PHYS, V47, P8182, DOI 10.1143/JJAP.47.8182; Panich M., 2008, J PHYS, V20; POLLMANN J, 1977, PHYS REV B, V16, P4480, DOI 10.1103/PhysRevB.16.4480; POLLMANN J, 1975, SOLID STATE COMMUN, V17, P1171, DOI 10.1016/0038-1098(75)90279-3; Seyidov MY, 2012, PHYS LETT A, V376, P643, DOI 10.1016/j.physleta.2011.11.024; Shim YG, 2007, J APPL PHYS, V102, DOI 10.1063/1.2800827; Vakhrushev S. B., 1984, JETP LETT, V39, P21; VOLKOV AA, 1983, JETP LETT+, V37, P615	34	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	JUN	2015	252	6					1248	1253		10.1002/pssb.201400334		6	Physics, Condensed Matter	Physics	CJ8MO	WOS:000355756200008		
J	Shim, Y; Kawabata, T; Wakita, K; Mamedov, N				Shim, YongGu; Kawabata, Toshiyuki; Wakita, Kazuki; Mamedov, Nazim			Temperature behavior of dielectric function spectra and optical transitions in TlGaS2	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						dielectric function; optical transitions; structural phase transitions; thallium compounds	PHASE; CRYSTALS	The dielectric function spectra of TlGaS2 crystal with quasi-two-dimensional layered structure have been studied by means of spectroscopic elipsometry over the photon range 1.5-6.0eV in the temperature range 100-400K. The absolute values of the dielectric function show a sudden temperature-induced change around 180 and 280K. The energy of the inter-band optical transitions retrieved from the dielectric function spectra display an abrupt temperature change around the same temperatures. Structural phase transitions are behind the observed change of electronic band structure of TlGaS2. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Shim, YongGu; Kawabata, Toshiyuki] Osaka Prefecture Univ, Grad Sch Engn, Naka Ku, Sakai, Osaka 5998531, Japan; [Wakita, Kazuki] Chiba Inst Technol, Narashino, Chiba 2750016, Japan; [Mamedov, Nazim] Azerbaijan Natl Acad Sci, Inst Phys, AZ-1143 Baku, Azerbaijan	Shim, Y (reprint author), Osaka Prefecture Univ, Grad Sch Engn, Naka Ku, Gakuen Cho 1-1, Sakai, Osaka 5998531, Japan.	shim@pe.osakafu-u.ac.jp			JSPS KAKENHI [24560381]	This work was supported by JSPS KAKENHI (Grant number 24560381).	VARSHNI YP, 1967, PHYSICA, V34, P149, DOI 10.1016/0031-8914(67)90062-6; Kashida S, 1999, J PHYS-CONDENS MAT, V11, P1027, DOI 10.1088/0953-8984/11/4/010; Panich AM, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/29/293202; Ates A., 2002, Turkish Journal of Physics, V26; AYDINLI A, 1993, SOLID STATE COMMUN, V88, P387, DOI 10.1016/0038-1098(93)90230-K; Grivickas V., 2006, MAT SCI, V12, P280; Kato A, 2003, J PHYS CHEM SOLIDS, V64, P1713, DOI 10.1016/S0022-3697(03)00065-9; Kawabata S., 2014, THIN SOLID FILMS, V571, P589; Mamedov N, 2008, THIN SOLID FILMS, V517, P1434, DOI 10.1016/j.tsf.2008.09.012; Mamedov N., 2006, THIN SOLID FILMS, V499, P159; Shim YG, 2007, J APPL PHYS, V102, DOI 10.1063/1.2800827; SOKOLOFF JB, 1982, PHYS REV B, V25, P5901, DOI 10.1103/PhysRevB.25.5901	12	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	JUN	2015	252	6					1254	1257		10.1002/pssb.201400342		4	Physics, Condensed Matter	Physics	CJ8MO	WOS:000355756200009		
J	Yaakob, Y; Kuwataka, Y; Yusop, MZM; Tanaka, S; Rosmi, MS; Kalita, G; Tanemura, M				Yaakob, Yazid; Kuwataka, Yu; Yusop, Mohd Zamri Mohd; Tanaka, Shihomi; Rosmi, Mohamad Saufi; Kalita, Golap; Tanemura, Masaki			Room-temperature growth of ion-induced Si- and Ge-incorporated carbon nanofibers	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						carbon nanofibers; composite nanomaterials; germanium; ion irradiation; silicon	BATTERY ANODES; SILICON; NANOWIRES; NANOTUBES; EMISSION; CORE	We have demonstrated the fabrication of Si- and Ge-incorporated carbon nanofibers (CNFs) at room temperature. Graphite foil surfaces were irradiated by Ar+ and Ne+ ions with simultaneous Si and Ge supply, and the dependences of the ion-induced composite CNFs surface morphology on the ion species and type of incorporated materials were investigated. The sample surfaces were characterized by various kinds of densely distributed nanostructures, such as conical protrusions, nanoneedles, nanocones, and CNF-tipped cones, depending on the Si and Ge supply rates during ion irradiation. In addition, Ne+ irradiation yielded longer CNFs compared to Ar+-irradiated CNFs. Thus, the nanostructures growth was controllable by adjusting the ion and material species. Surface morphology of ion-induced Ge-incorporated CNFs. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Yaakob, Yazid; Kuwataka, Yu; Yusop, Mohd Zamri Mohd; Tanaka, Shihomi; Rosmi, Mohamad Saufi; Kalita, Golap; Tanemura, Masaki] Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan; [Yaakob, Yazid] Univ Putra Malaysia, Dept Phys, Fac Sci, Upm Serdang 43400, Selangor, Malaysia; [Yusop, Mohd Zamri Mohd] Univ Teknol Malaysia, Dept Mat, Fac Mech Engn, Skudai 81310, Johor, Malaysia; [Rosmi, Mohamad Saufi] Univ Pendidikan Sultan Idris, Fac Sci & Math, Dept Chem, Tanjong Malim 35900, Perak, Malaysia	Yusop, MZM (reprint author), Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	zamriyusop@fkm.utm.my	Mohd Yusop, Mohd Zamri/K-6600-2012; Rosmi, Mohamad Saufi/B-4371-2015	Mohd Yusop, Mohd Zamri/0000-0003-0897-2712; Rosmi, Mohamad Saufi/0000-0003-0639-8876	Japan Society for the Promotion of Science (JSPS) [23360020]	The first two authors contributed equally to the work. This work was partially supported by a grant from the Japan Society for the Promotion of Science (JSPS; Grant-in-Aid for Scientific Research B, Grant No. 23360020).	Fan Y, 2013, NANOSCALE, V5, P1503, DOI 10.1039/c3nr33683b; Peng MF, 2011, CHEM MATER, V23, P3296, DOI 10.1021/cm200186v; Paradise M, 2007, MATER DESIGN, V28, P1477, DOI 10.1016/j.matdes.2006.03.008; Wang Y, 2003, SYNTHETIC MET, V138, P423, DOI 10.1016/S0379-6779(02)00472-1; Pan ZW, 1998, NATURE, V394, P631, DOI 10.1038/29206; Zhong ZH, 2003, SCIENCE, V302, P1377, DOI 10.1126/science.1090899; Choi WB, 1999, APPL PHYS LETT, V75, P3129, DOI 10.1063/1.125253; Zhong C, 2013, J MATER CHEM A, V1, P10798, DOI 10.1039/c3ta11796k; Cui Y, 2003, NANO LETT, V3, P149, DOI 10.1021/nl025875l; Garnett EC, 2008, J AM CHEM SOC, V130, P9224, DOI 10.1021/ja8032907; Fan Y, 2013, CARBON, V59, P264, DOI 10.1016/j.carbon.2013.03.017; LAEGREID N, 1961, J APPL PHYS, V32, P365, DOI 10.1063/1.1736012; Badi N, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-360; FLORO JA, 1983, J VAC SCI TECHNOL A, V1, P1398, DOI 10.1116/1.572029; FUJIMOTO Y, 1995, J APPL PHYS, V77, P2725, DOI 10.1063/1.359569; Tanemura M, 2006, SURF SCI, V600, P3663, DOI 10.1016/j.susc.2006.02.059; Tanemura M, 2004, APPL PHYS LETT, V84, P3831, DOI 10.1063/1.1745109; Tanemura M, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1884749; WEHNER GK, 1985, J VAC SCI TECHNOL A, V3, P1821, DOI 10.1116/1.573386; Yaakob Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.11NL01; Yamaguchi K, 2008, DIAM RELAT MATER, V17, P525, DOI 10.1016/j.diamond.2008.01.043	21	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	JUN	2015	252	6					1345	1349		10.1002/pssb.201451660		5	Physics, Condensed Matter	Physics	CJ8MO	WOS:000355756200022		
J	Xiao, SF; Yin, FX; Hu, WY				Xiao, Shifang; Yin, Fuxing; Hu, Wangyu			The anisotropic character of Snoek relaxation in FeC system: A kinetic Monte Carlo and molecular dynamics simulation	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						FeC alloy; kinetic Monte Carlo; molecular dynamics; Snoek relaxation	ALLOYS; CARBON; METALS; IRON	Kinetic Monte Carlo and molecular dynamics simulations, with interatomic interaction described by an embedded atom method, have been performed to study the Snoek relaxation behavior in FeC alloy. The reorientation of elastic dipole under uniaxial cycle stress is modeled with kinetic Monte Carlo and the corresponding anelastic stain resulted by the reorientation is calculated from molecular dynamics. Internal friction is obtained directly in terms of energy definition. The results indicate the calculated Snoek relaxation profiles are in good agreement with those of experiments and linear point defect theory with characteristic temperature corresponding to Snoek peak being 320 +/- 5K at the stress frequency of 1Hz. The fitted shape factors of elastic dipole from the concentration-dependent and orientation-dependent Snoek profiles are consistent, with the value of about 0.72. This method can realize microstructural evolution and kinetic process, which is promising for investigating the Snoek relaxation in concentrated interstitial alloys and complex alloy system with substitutional elements. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Xiao, Shifang; Hu, Wangyu] Hunan Univ, Sch Phys & Elect, Changsha 410082, Hunan, Peoples R China; [Xiao, Shifang; Yin, Fuxing] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Yin, Fuxing] Hebei Univ Technol, Res Inst Energy Equipment Mat, Tianjin 300132, Peoples R China	Xiao, SF (reprint author), Hunan Univ, Sch Phys & Elect, Changsha 410082, Hunan, Peoples R China.	shifangxiao@hnu.edu.cn	Hu, Wangyu/B-5762-2009		JSPS; National Natural Science Foundation of China [50801024]	S. Xiao acknowledges the financial support under a JSPS fellowship and the National Natural Science Foundation of China (grants no. 50801024). The discussions from Dr. S. Garruchet and Prof. C. S. Becquart are appreciated.	Ackland G. J., 2004, J PHYS-CONDENS MAT, V16, P1; Magalas LB, 1996, J PHYS IV, V6, P151, DOI 10.1051/jp4:1996831; Domain C, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.144112; Henkelman G, 2000, J CHEM PHYS, V113, P9978, DOI 10.1063/1.1323224; POWERS RW, 1959, J APPL PHYS, V30, P514, DOI 10.1063/1.1702398; Becquart CS, 2007, COMP MATER SCI, V40, P119, DOI 10.1016/j.commatsci.2006.11.005; NUMAKURA H, 1995, ACTA METALL MATER, V43, P705, DOI 10.1016/0956-7151(94)00262-G; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Veiga RGA, 2014, COMP MATER SCI, V82, P118, DOI 10.1016/j.commatsci.2013.09.048; Snoek JL, 1941, PHYSICA, V8, P711, DOI 10.1016/S0031-8914(41)90517-7; Weller M, 2001, MATER SCI FORUM, V366-3, P95; Yin FX, 2006, ADV MATER, V18, P1541, DOI 10.1002/adma.200600128; Jiang DE, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.214103; Dmitriev VV, 2012, J PHYS CHEM SOLIDS, V73, P182, DOI 10.1016/j.jpcs.2011.11.008; Garruchet S, 2008, COMP MATER SCI, V43, P286, DOI 10.1016/j.commatsci.2007.11.004; Golovin IS, 1997, PHYS STATUS SOLIDI A, V160, P49, DOI 10.1002/1521-396X(199703)160:1<49::AID-PSSA49>3.0.CO;2-P; Haneczok G, 1998, PHILOS MAG A, V78, P845; Kushnareva N. P., 1995, ACTA METALL MATER, V43, P4303; Nose S., 1990, J PHYS-CONDENS MAT, V2, P115; Nowick A. S., 1972, ANELASTIC RELAXATION; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Schaller R, 2001, MATER SCI FORUM, V366-3, P621; Weller M., 2001, MATER SCI FORUM, V366-368, P35; Yu LM, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.174105	24	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	JUN	2015	252	6					1382	1387		10.1002/pssb.201451642		6	Physics, Condensed Matter	Physics	CJ8MO	WOS:000355756200027		
J	Yagi, H; Fukuzawa, N; Tasaka, Y; Matsuo, K; Zhang, Y; Yamaguchi, T; Kondo, S; Nakazawa, S; Hashii, N; Kawasaki, N; Matsumura, T; Kato, K				Yagi, Hirokazu; Fukuzawa, Noriho; Tasaka, Yasushi; Matsuo, Kouki; Zhang, Ying; Yamaguchi, Takumi; Kondo, Sachiko; Nakazawa, Shiori; Hashii, Noritaka; Kawasaki, Nana; Matsumura, Takeshi; Kato, Koichi			NMR-based structural validation of therapeutic antibody produced in Nicotiana benthamiana	PLANT CELL REPORTS			English	Article						Fc; Immunoglobulin G; Isotope labeling; NMR spectroscopy; Therapeutic antibody; Transgenic tobacco	HUMAN-IMMUNOGLOBULIN G1; N-GLYCANS; MONOCLONAL-ANTIBODY; FC; PLANTS; GLYCOSYLATION; FUCOSE; SPECTROSCOPY; EXPRESSION; BINDING	Key message We successfully developed a method for metabolic isotope labeling of recombinant proteins produced in transgenic tobacco. This enabled assessment of structural integrity of plant-derived therapeutic antibodies by NMR analysis. Abstract A variety of expression vehicles have been developed for the production of promising biologics, including plants, fungi, bacteria, insects, and mammals. Glycoprotein biologics often experience altered folding and post-translational modifications that are typified by variant glycosylation patterns. These differences can dramatically affect their efficacy, as exemplified by therapeutic antibodies. However, it is generally difficult to validate the structural integrity of biologics produced using different expression vehicles. To address this issue, we have developed and applied a stable-isotope-assisted nuclear magnetic resonance (NMR) spectroscopy method for the conformational characterization of recombinant antibodies produced in plants. Nicotiana benthamiana used as a vehicle for the production of recombinant immunoglobulin G (IgG) was grown in a N-15-enriched plant growth medium. The Fc fragment derived from the N-15-labeled antibody thus prepared was subjected to heteronuclear two-dimensional (2D) NMR measurements. This approach enabled assessment of the structural integrity of the plant-derived therapeutic antibodies by comparing their NMR spectral properties with those of an authentic IgG-Fc derived from mammalian cells.	[Yagi, Hirokazu; Zhang, Ying; Yamaguchi, Takumi; Kondo, Sachiko; Kato, Koichi] Nagoya City Univ, Fac & Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Fukuzawa, Noriho; Tasaka, Yasushi; Matsuo, Kouki; Matsumura, Takeshi] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Toyohira Ku, Sapporo, Hokkaido 0628517, Japan; [Zhang, Ying; Yamaguchi, Takumi; Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan; [Zhang, Ying; Yamaguchi, Takumi; Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Kondo, Sachiko; Kato, Koichi] Med & Biol Labs Co Ltd, Chikusa Ku, Nagoya, Aichi 4640858, Japan; [Nakazawa, Shiori; Hashii, Noritaka; Kawasaki, Nana] Natl Inst Hlth Sci, Div Biol Chem & Biol, Setagaya Ku, Tokyo 1588501, Japan; [Kato, Koichi] Ochanomizu Univ, Glycosci Inst, Bunkyo Ku, Tokyo 1128610, Japan	Kato, K (reprint author), Nagoya City Univ, Fac & Grad Sch Pharmaceut Sci, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	matsumura-t@aist.go.jp; kkato@phar.nagoya-cu.ac.jp			Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); Ministry of Education, Culture, Sports, Science and Technology (MEXT) [24249002, 25102008, 25860053]; Nanotechnology Platform Program (Molecule and Material Synthesis) of MEXT	This work was supported, in part, by the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), and by Grants-in-Aid for Scientific Research (24249002, 25102008, and 25860053) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). This work was partly supported by the Nanotechnology Platform Program (Molecule and Material Synthesis) of MEXT. We gratefully acknowledge Drs. Minoru Tada and Akiko Ishii-Watabe (National Institute of Health Sciences) for providing ADM expression vector for mammalian cells. We also thank Ms. Kiyomi Senda and Ms. Kumiko Hattori (Nagoya City University) for their help in purification of IgG.	Bakker H, 2001, P NATL ACAD SCI USA, V98, P2899, DOI 10.1073/pnas.031419998; Jefferis R, 1998, IMMUNOL REV, V163, P59, DOI 10.1111/j.1600-065X.1998.tb01188.x; YAMAGUCHI Y, 1995, J IMMUNOL METHODS, V181, P259, DOI 10.1016/0022-1759(95)00010-8; BURTON DR, 1992, ADV IMMUNOL, V51, P1, DOI 10.1016/S0065-2776(08)60486-1; Takahashi N, 2003, TRENDS GLYCOSCI GLYC, V15, P235; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Matsumiya S, 2007, J MOL BIOL, V368, P767, DOI 10.1016/j.jmb.2007.02.034; HORSCH RB, 1986, P NATL ACAD SCI USA, V83, P2571, DOI 10.1073/pnas.83.8.2571; Loos A, 2012, ARCH BIOCHEM BIOPHYS, V526, P167, DOI 10.1016/j.abb.2012.05.011; Yagi H, 2012, J BIOL CHEM, V287, P24356, DOI 10.1074/jbc.M112.365643; Yamaguchi Y, 2006, BBA-GEN SUBJECTS, V1760, P693, DOI 10.1016/j.bbagen.2005.10.002; Schahs M, 2007, PLANT BIOTECHNOL J, V5, P657, DOI 10.1111/j.1467-7652.2007.00273.x; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Houde D, 2010, MOL CELL PROTEOMICS, V9, P1716, DOI 10.1074/mcp.M900540-MCP200; Idusogie EE, 2000, J IMMUNOL, V164, P4178; Mizushima T, 2011, GENES CELLS, V16, P1071, DOI 10.1111/j.1365-2443.2011.01552.x; Zeitlin L, 2011, P NATL ACAD SCI USA, V108, P20690, DOI 10.1073/pnas.1108360108; Strasser R, 2004, FEBS LETT, V561, P132, DOI 10.1016/S0014-5793(04)00150-4; Cegelski L, 2006, J MAGN RESON, V178, P1, DOI 10.1016/j.jmr.2005.10.010; Cox KM, 2006, NAT BIOTECHNOL, V24, P1591, DOI 10.1038/nbt1260; Cabanes-Macheteau M, 1999, GLYCOBIOLOGY, V9, P365, DOI 10.1093/glycob/9.4.365; Chen Q, 2014, BIOMED RES INT, DOI 10.1155/2014/418064; DeLano W. L., 2002, PYMOL MOL GRAPHICS S; Dubel S, 2007, APPL MICROBIOL BIOT, V74, P723, DOI 10.1007/s00253-006-0810-y; He JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093541; Ippel JH, 2004, PROTEOMICS, V4, P226, DOI 10.1002/pmic.200300506; Kaulfurst-Soboll H, 2011, J BIOL CHEM, V286, P22955, DOI 10.1074/jbc.M110.196097; Kneller D, 1993, SPARKY 3; Matsuo K, 2014, J BIOSCI BIOENG, V118, P448, DOI 10.1016/j.jbiosc.2014.04.005; Mylne JS, 2008, BIOPOLYMERS, V90, P575, DOI 10.1002/bip.21012; Rau R., 2002, Annals of the Rheumatic Diseases, V61, pii70; Yagi H, 2010, CARBOHYD RES, V345, P442, DOI 10.1016/j.carres.2009.12.002; Yagi H, 2014, BIOMOL NMR ASSIGN, DOI [10.1007/s12104-014-9586-7, DOI 10.1007/S12104-014-9586-7]; Yamaguchi Y, 2007, COMPREHENSIVE GLYCOS, V3, P745	34	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-7714	1432-203X		PLANT CELL REP	Plant Cell Reports	JUN	2015	34	6					959	968		10.1007/s00299-015-1757-1		10	Plant Sciences	Plant Sciences	CK2OS	WOS:000356050900006		
J	Takatsuka, H; Umeda-Hara, C; Umeda, M				Takatsuka, Hirotomo; Umeda-Hara, Chikage; Umeda, Masaaki			Cyclin-dependent kinase-activating kinases CDKD;1 and CDKD;3 are essential for preserving mitotic activity in Arabidopsis thaliana	PLANT JOURNAL			English	Article						Arabidopsis thaliana; CDK-activating kinase; cell cycle; cyclin-dependent kinase; gametogenesis	MALE GAMETOPHYTE DEVELOPMENT; GATEWAY BINARY VECTORS; EMBRYO SAC DEVELOPMENT; RNA-POLYMERASE-II; CELL-CYCLE; PROTEIN-KINASES; FEMALE GAMETOPHYTE; MALE GAMETOGENESIS; TERMINAL DOMAIN; WILD-TYPE	For the full activation of cyclin-dependent kinases (CDKs), not only cyclin binding but also CDK phosphorylation is required. This activating phosphorylation is mediated by CDK-activating kinases (CAKs). Arabidopsis has four genes showing similarity to vertebrate-type CAKs, three CDKDs (CDKD;1-CDKD;3) and one CDKF (CDKF;1). We previously found that the cdkf;1 mutant is defective in post-embryonic development, even though the kinase activities of core CDKs remain unchanged relative to the wild type. This raised a question about the involvement of CDKDs in CDK activation in planta. Here we report that the cdkd;1cdkd;3 double mutant showed gametophytic lethality. Most cdkd;1-1cdkd;3-1 pollen grains were defective in pollen mitosis I and II, producing one-cell or two-cell pollen grains that lacked fertilization ability. We also found that the double knock-out of CDKD;1 and CDKD;3 caused arrest and/or delay in the progression of female gametogenesis at multiple steps. Our genetic analyses revealed that the functions of CDKF;1 and CDKD;1 or CDKD;3 do not overlap, either during gametophyte and embryo development or in post-embryonic development. Consistent with these analyses, CDKF;1 expression in the cdkd;1-1cdkd;3-1 mutant could not rescue the gametophytic lethality. These results suggest that, in Arabidopsis, CDKD;1 and CDKD;3 function as CAKs controlling mitosis, whereas CDKF;1 plays a distinct role, mainly in post-embryonic development. We propose that CDKD;1 and CDKD;3 phosphorylate and activate all core CDKs, CDKA, CDKB1 and CDKB2, thereby governing cell cycle progression throughout plant development. Significance Statement We found that CDKD;1 and CDKD;3 are essential CDK-activating kinases (CAKs) of Arabidopsis that phosphorylate and activate the core CDKs in vivo, thus overturning the view in cell cycle research that two types of CAK (i.e., CDKD and CDKF) are involved in CDK activation in plants.	[Takatsuka, Hirotomo; Umeda-Hara, Chikage; Umeda, Masaaki] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Umeda, Masaaki] JST, CREST, Nara 6300192, Japan	Umeda, M (reprint author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300192, Japan.	mumeda@bs.naist.jp			MEXT KAKENHI [21027026, 22119009]; JSPS KAKENHI [26291061]; JST, CREST	This work was supported by MEXT KAKENHI (grant numbers 21027026 and 22119009), JSPS KAKENHI (grant number 26291061) and JST, CREST.	ALEXANDE.MP, 1969, STAIN TECHNOL, V44, P117; Umeda M, 2005, PLANT CELL PHYSIOL, V46, P1437, DOI 10.1093/pcp/pci170; Park SK, 1998, DEVELOPMENT, V125, P3789; KONCZ C, 1990, EMBO J, V9, P1337; Day RC, 2008, PLANT PHYSIOL, V148, P1964, DOI 10.1104/pp.108.128108; Nakagawa T, 2008, BIOSCI BIOTECH BIOCH, V72, P624, DOI 10.1271/bbb.706781; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Chaudhury AM, 1997, P NATL ACAD SCI USA, V94, P4223, DOI 10.1073/pnas.94.8.4223; Yu HJ, 2005, PLANT PHYSIOL, V139, P1853, DOI 10.1104/pp.105.067314; Nakagami H, 2002, PLANT CELL, V14, P1847, DOI 10.1105/tpc.002550; Brownfield L, 2009, PLANT CELL, V21, P1940, DOI 10.1105/tpc.109.066373; Nowack MK, 2006, NAT GENET, V38, P63, DOI 10.1038/ng1694; Christensen CA, 2002, PLANT CELL, V14, P2215, DOI 10.1105/tpc.002170; Liu JJ, 2008, PLANT CELL, V20, P1538, DOI 10.1105/tpc.108.059741; Iwakawa H, 2006, PLANT J, V45, P819, DOI 10.1111/j.1365-313X.2005.02643.x; Shimotohno A, 2004, PLANT CELL, V16, P2954, DOI 10.1105/tpc.104.025601; Dumas C, 2008, CR BIOL, V331, P715, DOI 10.1016/j.crvi.2008.07.013; Joubes J, 2000, PLANT MOL BIOL, V43, P607, DOI 10.1023/A:1006470301554; Onodera Y, 2008, GENETICS, V180, P207, DOI 10.1534/genetics.108.090621; Vandepoele K, 2002, PLANT CELL, V14, P903, DOI 10.1105/tpc.010445; Boudolf V, 2009, PLANT PHYSIOL, V150, P1482, DOI 10.1104/pp.109.140269; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; Nowack MK, 2012, DEV CELL, V22, P1030, DOI 10.1016/j.devcel.2012.02.015; Christensen CA, 1997, SEX PLANT REPROD, V10, P49, DOI 10.1007/s004970050067; SCHNEITZ K, 1995, PLANT J, V7, P731, DOI 10.1046/j.1365-313X.1995.07050731.x; Yamaguchi M, 1998, PLANT J, V16, P613, DOI 10.1046/j.1365-313x.1998.00338.x; Dissmeyer N, 2007, PLANT CELL, V19, P972, DOI 10.1105/tpc.050401; Vandepoele K, 2005, PLANT PHYSIOL, V139, P316, DOI 10.1104/pp.105.066290; Ravi M, 2008, NATURE, V451, P1121, DOI 10.1038/nature06557; Menges M, 2005, PLANT J, V41, P546, DOI 10.1111/j.1365-313X.2004.02319.x; McCormick S, 2004, PLANT CELL, V16, pS142, DOI 10.1105/tpc.016659; Shimotohno A, 2006, PLANT J, V47, P701, DOI 10.1111/j.1365-313X.2006.02820.x; WEBB MC, 1990, SEX PLANT REPROD, V3, P244; Fisher RP, 2005, J CELL SCI, V118, P5171, DOI 10.1242/jcs.02718; Irish VF, 2010, PLANT J, V61, P1014, DOI 10.1111/j.1365-313X.2009.04065.x; Bemer M, 2008, PLANT CELL, V20, P2088, DOI 10.1105/tpc.108.058958; Berger F, 1999, CURR OPIN PLANT BIOL, V2, P28, DOI 10.1016/S1369-5266(99)80006-5; Bockstaele L, 2009, MOL CELL BIOL, V29, P4188, DOI 10.1128/MCB.01823-08; Bowman J, 1994, ARABIDOPSIS ATLAS MO; Brownfield L., 2009, PLOS GENET, V5; Chao WS, 2007, PLANT MOL BIOL, V63, P365, DOI 10.1007/s11103-006-9094-y; Chen Z, 2008, DEVELOPMENT, V135, P65, DOI 10.1242/dev.010108; Drews GN, 2002, ANNU REV GENET, V36, P99, DOI 10.1146/annurev.genet.36.040102.131941; Hajheidari M, 2012, PLANT CELL, V24, P1626, DOI 10.1105/tpc.112.096834; Harashima H, 2007, PLANT J, V52, P435, DOI 10.1111/j.1365-313X.2007.03247.x; Hirano H, 2008, PLANT MOL BIOL, V66, P259, DOI 10.1007/s11103-007-9268-2; Lalanne E, 2002, PLANT PHYSIOL, V129, P865, DOI 10.1104/pp.003301; Larochelle S, 1998, GENE DEV, V12, P370, DOI 10.1101/gad.12.3.370; Liu JJ, 2008, MOL PLANT, V1, P564, DOI 10.1093/mp/ssn033; Liu Y, 2004, J BIOL CHEM, V279, P4507, DOI 10.1074/jbc.M309995200; MANSFIELD SG, 1991, CAN J BOT, V69, P447; MCCORMICK S, 1993, PLANT CELL, V5, P1265, DOI 10.1105/tpc.5.10.1265; MISRA R. C., 1962, AGRA UNIV JOUR RES SCI, V11, P191; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; MURGIA M, 1993, AM J BOT, V80, P824, DOI 10.2307/2445602; Poliakova T. F., 1964, ISSLEDOV GENET USSR, V2, P125; Shimotohno A, 2003, FEBS LETT, V534, P69, DOI 10.1016/S0014-5793(02)03780-8; Steffen JG, 2008, PLANT PHYSIOL, V148, P259, DOI 10.1104/pp.108.119404; Takahashi N., 2014, CELL BIOL, P1; Takatsuka H, 2009, PLANT J, V59, P475, DOI 10.1111/j.1365-313X.2009.03884.x; Umeda M, 1998, P NATL ACAD SCI USA, V95, P5021, DOI 10.1073/pnas.95.9.5021; WEBB MC, 1994, SEX PLANT REPROD, V7, P153; Yang WC, 2000, CURR OPIN PLANT BIOL, V3, P53, DOI 10.1016/S1369-5266(99)00037-0	63	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	JUN	2015	82	6					1004	1017		10.1111/tpj.12872		14	Plant Sciences	Plant Sciences	CK3BH	WOS:000356089900009		
J	Hasegawa, U; Moriyama, M; Uyama, H; van der Vlies, AJ				Hasegawa, Urara; Moriyama, Masaki; Uyama, Hiroshi; van der Vlies, Andre J.			Catechol-bearing block copolymer micelles: Structural characterization and antioxidant activity	POLYMER			English	Article						Polymeric micelles; Catechol; Reactive oxygen species	POLY(ETHYLENE GLYCOL) HYDROGELS; ANGIOGENESIS; POLYPHENOLS; MECHANISMS; CELLS; PH	Oxidative stress caused by uncontrolled production of reactive oxygen species (ROS) has been linked to the initiation and progression of some diseases. Therefore, the use of antioxidants capable of scavenging ROS has attracted growing interest. We recently reported antioxidant micelles having catechol moieties, a structural motif found among natural antioxidants. These micelles showed a strong inhibitory effect in ROS-mediated angiogenesis as compared to the small catecholic compound dopamine. Here, we aim to explain this interesting function of the micelles by correlating the effects of self-assembled structures on the auto-oxidation stability and anti-angiogenic activity. The micelles were prepared from a hydrophilic poly(N-acryloyl morpholine) and a hydrophobic catechol-bearing block with different catechol content. The micelles with higher catechol content formed stable spherical micelles and showed increased stability against auto-oxidation, while micellization did not affect the redox potential of catechol moieties. Furthermore, the micelles with higher catechol content showed a stronger anti-angiogenic activity. (C) 2015 Elsevier Ltd. All rights reserved.	[Hasegawa, Urara] Osaka Univ, Grad Sch Engn, Frontier Res Base Young Researchers, Suita, Osaka 565, Japan; [Hasegawa, Urara; Moriyama, Masaki; Uyama, Hiroshi; van der Vlies, Andre J.] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 565, Japan; [van der Vlies, Andre J.] Osaka Univ, Grad Sch Engn, Frontier Res Ctr, Suita, Osaka 565, Japan	Hasegawa, U (reprint author), 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	urara.hasegawa@chem.eng.osaka-u.ac.jp			Japan Society for the Promotion of Science [26560241]	We would like to thank Prof. Kazunari Akiyoshi (Kyoto University, Japan) for TEM and Dr. Madoka Hasegawa (Swiss Federal Laboratories for Materials Science and Technology, Switzerland) for her advice for the electrochemical experiments. This work was supported by Grant-in-Aid for Challenging Exploratory Research, No. 26560241, from the Japan Society for the Promotion of Science.	Medintz IL, 2010, NAT MATER, V9, P676, DOI [10.1038/nmat2811, 10.1038/NMAT2811]; Chiefari J, 1998, MACROMOLECULES, V31, P5559, DOI 10.1021/ma9804951; Yang J, 2014, CHEM SOC REV, V43, P8271, DOI 10.1039/c4cs00185k; Schweigert N, 2001, ENVIRON MICROBIOL, V3, P81, DOI 10.1046/j.1462-2920.2001.00176.x; Lee BP, 2002, BIOMACROMOLECULES, V3, P1038, DOI 10.1021/bm025546n; Moriyama M, 2015, ADV HEALTHC MATER, V4, P569, DOI 10.1002/adhm.201400249; Liu YL, 2014, CHEM REV, V114, P5057, DOI 10.1021/cr400407a; Cencer M, 2014, BIOMACROMOLECULES, V15, P2861, DOI 10.1021/bm500701u; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; Garvin S, 2006, CANCER LETT, V231, P113, DOI 10.1016/j.canlet.2005.01.031; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/nchembio.607, 10.1038/NCHEMBIO.607]; Hasegawa U, 2010, J AM CHEM SOC, V132, P18273, DOI 10.1021/ja1075025; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Hasegawa U, 2015, DATA IN BRIEF UNPUB; Meiser J, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-34; Munoz P, 2012, PARKINSONS DIS, V2012, P13; RODRIGUEZLOPEZ JN, 1993, INT J BIOCHEM, V25, P1175, DOI 10.1016/0020-711X(93)90596-7; Scalbert A, 2005, AM J CLIN NUTR, V81, p215S; Vita JA, 2005, AM J CLIN NUTR, V81, p292S	20	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0032-3861	1873-2291		POLYMER	Polymer	JUN 1	2015	66						1	7		10.1016/j.polymer.2015.03.080		7	Polymer Science	Polymer Science	CK0GQ	WOS:000355884100003		
J	Wei, QS; Sugihara, Y; Tanabe, T; Mukaida, M; Kirihara, K; Naitoh, Y; Ishida, T				Wei, Qingshuo; Sugihara, Yoshinori; Tanabe, Taro; Mukaida, Masakazu; Kirihara, Kazuhiro; Naitoh, Yasuhisa; Ishida, Takao			Synthesis and thermopower of poly(3-methoxythiophene-2,5-diyl-co-3,4-ethylenedioxythiophene-2,5-diyl)/tosylate	POLYMER			English	Article						Conducting polymers; Seebeck coefficient; Ionization potential	THERMOELECTRIC PROPERTIES; ORGANIC SEMICONDUCTORS; PEDOTPSS; ELECTRONICS; POLYMERS; FILMS	A novel conducting polymer, Poly(3-methoxythiophene-2,5-diyl-co-3,4-ethylenedioxythiophene-2,5-diyl]/tosylate (P1/tos), was synthesized by oxidative in situ polymerization using Fe(tos)(3) as an oxidant. Compared with poly(3,4-ethylenedioxythiophene) (PEDOT), P1 has a deeper HOMO level and a wider energy gap as observed by ultraviolet-visible spectroscopy and photoelectron yield spectroscopy. P1/tos showed electrical conductivity of 10 S/cm and a carrier mobility of about 0.6 cm(2)/(V s), which was extracted by using ion-gel thin film transistors. The calculated carrier concentration was on the order of 10(20) cm(-3), which is lower than that of PEDOT/tos. The Seebeck coefficient of P1/tos was higher than that of PEDOT/tos. (C) 2015 Elsevier Ltd. All rights reserved.	[Wei, Qingshuo; Mukaida, Masakazu; Kirihara, Kazuhiro; Naitoh, Yasuhisa; Ishida, Takao] Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, Tsukuba, Ibaraki 3058564, Japan; [Sugihara, Yoshinori; Tanabe, Taro] Tokyo Chem Ind Co Ltd, Toda R&D Ctr, Toda, Saitama 3350033, Japan	Wei, QS (reprint author), Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, 1-2-1 Namiki, Tsukuba, Ibaraki 3058564, Japan.	qingshuo.wei@aist.go.jp; mskz.mukaida@aist.go.jp	Wei, Qingshuo/A-1916-2010		MEXT, Japan [25888025]	This work was supported by a Grant-in-Aid for Research Activity Start-up 25888025 from MEXT, Japan. The authors thank Dr. Zhiping Wang, Dr. Miyadera Tetsuhiko and Dr. Yoshida Yuji (AIST) for assisting with the PYS measurements. The authors thank Mr. Yamazaki Ryuuji and Mrs. Akima Chika (TCI Chemicals) for helpful discussion.	Park T, 2013, ENERG ENVIRON SCI, V6, P788, DOI 10.1039/c3ee23729j; Bubnova O, 2011, NAT MATER, V10, P429, DOI [10.1038/nmat3012, 10.1038/NMAT3012]; Wei QS, 2013, ADV MATER, V25, P2831, DOI 10.1002/adma.201205158; Kim GH, 2013, NAT MATER, V12, P719, DOI [10.1038/nmat3635, 10.1038/NMAT3635]; Bubnova O, 2014, NAT MATER, V13, P190, DOI [10.1038/nmat3824, 10.1038/NMAT3824]; Lussem B, 2013, PHYS STATUS SOLIDI A, V210, P9, DOI 10.1002/pssa.201228310; Bubnova O, 2012, J AM CHEM SOC, V134, P16456, DOI 10.1021/ja305188r; Bubnova O, 2012, ENERG ENVIRON SCI, V5, P9345, DOI 10.1039/c2ee22777k; Park H, 2014, J MATER CHEM A, V2, P6532, DOI 10.1039/c3ta14960a; Shi CJ, 2006, J AM CHEM SOC, V128, P8980, DOI 10.1021/ja061664x; Massonnet N, 2014, J MATER CHEM C, V2, P1278, DOI 10.1039/c3tc31674b; Wei QS, 2014, RSC ADV, V4, P28802, DOI 10.1039/c4ra04946b; Lee SH, 2014, J MATER CHEM A, V2, P13380, DOI 10.1039/c4ta01839g; Forrest SR, 2007, CHEM REV, V107, P923, DOI 10.1021/cr0501590; Elschner A., 2010, PEDOT PRINCIPLES APP; Glaudell AM, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201401072; Groenendaal L. B., 2000, ADV MATER, V12, P481, DOI DOI 10.1002/(SICI)1521-4095(200004)12:7<LESS; Hokazono M, 2014, J ELECTRON MATER, V43, P2196, DOI 10.1007/s11664-014-3003-y; Poehler TO, 2012, ENERG ENVIRON SCI, V5, P8110, DOI 10.1039/c2ee22124a; Wei Q, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.031601; Wei QS, 2014, SYNTHETIC MET, V196, P139, DOI 10.1016/j.synthmet.2014.07.028; Wei QS, 2014, ACS MACRO LETT, V3, P948, DOI 10.1021/mz500446z	22	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0032-3861	1873-2291		POLYMER	Polymer	JUN 1	2015	66						38	42		10.1016/j.polymer.2015.04.001		5	Polymer Science	Polymer Science	CK0GQ	WOS:000355884100007		
J	Xin, YR; Sakamoto, J; van der Vlies, AJ; Hasegawa, U; Uyama, H				Xin, Yuanrong; Sakamoto, Junji; van der Vlies, Andre J.; Hasegawa, Urara; Uyama, Hiroshi			Phase separation approach to a reactive polycarbonate monolith for "click" modifications	POLYMER			English	Article						Polycarbonate monolith; Porous material; Thiol-ene click reaction	POROUS POLYMER MONOLITHS; ION-EXCHANGE CHROMATOGRAPHY; EPOXY-BASED MONOLITHS; SURFACE-CHEMISTRY; STATIONARY PHASES; HYBRID MONOLITH; CAPILLARY ELECTROCHROMATOGRAPHY; PHOTOINITIATED POLYMERIZATION; MACROPOROUS MONOLITHS; LIQUID-CHROMATOGRAPHY	A new polycarbonate monolith carrying allyl groups has been introduced. The monolith was fabricated via the phase separation induced by adding cyclohexane to a solution of the polymer in chloroform. Cross-sectional analysis of the monolith was performed by scanning electron microscopy that unveiled a three-dimensionally networked porous structure inside the monolith. As a result of nitrogen adsorption/desorption experiments, the specific surface area of the monolith was calculated to be 145 m(2)/g with the Brunauer Emmett Teller equation. The allyl groups of the monolith were subjected to a thiol-ene click reaction with 2-mercaptoethanol and an olefin metathesis with a Grubbs catalyst. With the porous structure largely maintained, the click reaction attained high conversions and the metathesis internally crosslinked the monolith to the degree that confers solvent resistance. These results qualify the present monolith as a versatile platform for chemical transformations into a wide range of functional monoliths. (C) 2015 Elsevier Ltd. All rights reserved.	[Xin, Yuanrong; Sakamoto, Junji; van der Vlies, Andre J.; Hasegawa, Urara; Uyama, Hiroshi] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan; [van der Vlies, Andre J.] Osaka Univ, Grad Sch Engn, Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Hasegawa, Urara] Osaka Univ, Grad Sch Engn, Frontier Res Base Young Researchers, Suita, Osaka 5650871, Japan	Uyama, H (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan.	uyama@chem.eng.osaka-u.ac.jp			Japan Society for the Promotion of Science [25288090]; Project for Creating Start-ups from Advanced Research and Technology, MEXT	This study was financially supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 25288090) and a Project for Creating Start-ups from Advanced Research and Technology, MEXT.	Abele S, 2008, ANALYST, V133, P864, DOI 10.1039/b802693a; Peters EC, 1999, MACROMOLECULES, V32, P6377, DOI 10.1021/ma990538t; Nischang I, 2010, ANAL BIOANAL CHEM, V397, P953, DOI 10.1007/s00216-010-3550-x; Nguyen AM, 2006, CHEM MATER, V18, P6308, DOI 10.1021/cm060645j; Meyer U, 2000, MACROMOLECULES, V33, P7769, DOI 10.1021/ma000797e; Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.3.CO;2-6; Anderson EB, 2012, CHEMCATCHEM, V4, P30, DOI 10.1002/cctc.201100086; Lv YQ, 2012, ANALYST, V137, P4114, DOI 10.1039/c2an35706b; Josic D, 2001, J CHROMATOGR B, V752, P191, DOI 10.1016/S0378-4347(00)00499-0; Hilder EF, 2004, J CHROMATOGR A, V1044, P3, DOI 10.1016/j.chroma.2004.04.057; Buchmeiser MR, 2007, POLYMER, V48, P2187, DOI 10.1016/j.polymer.2007.02.045; Zhang YJ, 2014, POLYM CHEM-UK, V5, P105, DOI 10.1039/c3py00727h; Xin YR, 2012, POLYMER, V53, P2847, DOI 10.1016/j.polymer.2012.04.029; Yoneda S, 2014, POLYMER, V55, P3212, DOI 10.1016/j.polymer.2014.05.031; Svec F, 2006, ANAL CHEM, V78, P2100, DOI 10.1021/ac069383v; Xie SF, 1998, CHEM MATER, V10, P4072, DOI 10.1021/cm9804867; Nordborg A, 2009, ANAL BIOANAL CHEM, V394, P71, DOI 10.1007/s00216-009-2636-9; Wang GW, 2015, RSC ADV, V5, P25777, DOI 10.1039/c5ra03585f; Tijunelyte I, 2012, POLYMER, V53, P29, DOI 10.1016/j.polymer.2011.11.014; Courtois J, 2006, POLYMER, V47, P2603, DOI 10.1016/j.polymer.2006.01.096; Kanamori K, 2006, ADV MATER, V18, P2407, DOI 10.1002/adma.200601026; Liu ZS, 2014, J CHROMATOGR A, V1342, P70, DOI 10.1016/j.chroma.2014.03.058; Namera A, 2011, J SEP SCI, V34, P901, DOI 10.1002/jssc.201000795; Okuyama K, 2003, MACROMOLECULES, V36, P6953, DOI 10.1021/ma034442h; Svec F, 2009, J SEP SCI, V32, P3, DOI 10.1002/jssc.200800530; Kim J, 2008, POLYMER, V49, P394, DOI 10.1016/j.polymer.2007.11.046; Wang KY, 2012, TALANTA, V91, P52, DOI 10.1016/j.talanta.2012.01.009; Okada K, 2011, CHEM COMMUN, V47, P7422, DOI 10.1039/c1cc12402a; Ghanem A, 2011, J SEP SCI, V34, P1945, DOI 10.1002/jssc.201100086; Chen YZ, 2011, J CHROMATOGR A, V1218, P7982, DOI 10.1016/j.chroma.2011.09.002; Laaniste A, 2014, J CHROMATOGR A, V1355, P296, DOI 10.1016/j.chroma.2014.06.031; Tucker-Schwartz AK, 2011, J AM CHEM SOC, V133, P11026, DOI 10.1021/ja202292q; Peterson DS, 2002, ANAL CHEM, V74, P4081, DOI 10.1021/ac020180q; Campos MAC, 2010, CHEM COMMUN, V46, P5512, DOI 10.1039/c0cc01264e; Viklund C, 1996, CHEM MATER, V8, P744, DOI 10.1021/cm950437j; Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062; Chambers SD, 2011, J CHROMATOGR A, V1218, P2546, DOI 10.1016/j.chroma.2011.02.055; Berthold A, 2011, MACROMOL RAPID COMM, V32, P1259, DOI 10.1002/marc.201100243; Svec F, 2004, J SEP SCI, V27, P747, DOI 10.1002/jssc.200401721; Nandi M, 2012, CHEM COMMUN, V48, P10283, DOI 10.1039/c2cc35334b; Haba O, 1999, J POLYM SCI POL CHEM, V37, P2087, DOI 10.1002/(SICI)1099-0518(19990701)37:13<2087::AID-POLA23>3.3.CO;2-X; Kundu D, 2014, REACT FUNCT POLYM, V79, P8, DOI 10.1016/j.reactfunctpolym.2014.03.002; SVEC F, 1992, ANAL CHEM, V64, P820, DOI 10.1021/ac00031a022; Tingaut P, 2011, J MATER CHEM, V21, P16066, DOI 10.1039/c1jm11620g; Guerrouache M, 2014, SURF INTERFACE ANAL, V46, P1009, DOI 10.1002/sia.5493; Bandari R, 2007, MACROMOL RAPID COMM, V28, P2090, DOI 10.1002/marc.200700441; Beria L, 2014, BIOMATER SCI-UK, V2, P67, DOI 10.1039/c3bm60171d; Cai T, 2011, POLYM CHEM-UK, V2, P1849, DOI 10.1039/c1py00106j; Carrasco-Correa EJ, 2014, J CHROMATOGR A, V1367, P123, DOI 10.1016/j.chroma.2014.09.066; Cheng LW, 2013, TALANTA, V115, P823, DOI 10.1016/j.talanta.2013.06.060; Dinh NP, 2009, J SEP SCI, V32, P2556, DOI 10.1002/jssc.200900243; Eeltink S, 2007, ELECTROPHORESIS, V28, P137, DOI 10.1002/elps.200600573; Elhaj A, 2014, ACS APPL MATER INTER, V6, P15653, DOI 10.1021/am502977z; Gilbert EC, 1974, ACS SYM SER, V4, P49; Han WJ, 2014, POLYM DEGRAD STABIL, V109, P362, DOI 10.1016/j.polymdegradstab.2014.05.032; Hemstrom P, 2006, J SEP SCI, V29, P25, DOI 10.1002/jssc.200500239; IKEDA K, 1973, IND ENG CHEM PROD RD, V12, P202, DOI 10.1021/i360047a010; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5; Korn MR, 2005, ACS SYM SER, V898, P39, DOI 10.1021/bk-2005-0898.ch004; Krenkova J, 2009, J CHROMATOGR A, V1216, P6824, DOI 10.1016/j.chroma.2009.08.031; Mai NA, 2008, CHEM MATER, V20, P6244, DOI 10.1021/cm800088a; Mallik R, 2006, J SEP SCI, V29, P1686, DOI 10.1002/jssc.200600152; Martin EH, 2002, POLYM BULL, V47, P517, DOI 10.1007/s002890200016; Nguyen AM, 2009, J SEP SCI, V32, P2619, DOI 10.1002/jssc.200900241; Park SB, 2014, POLYM DEGRAD STABIL, V99, P99, DOI 10.1016/j.polymdegradstab.2013.11.019; Park SB, 2013, POLYMER, V54, P6114, DOI 10.1016/j.polymer.2013.09.014; Patra AK, 2014, MICROPOR MESOPOR MAT, V193, P122, DOI 10.1016/j.micromeso.2014.03.024; Peters EC, 1997, CHEM MATER, V9, P1898, DOI 10.1021/cm970204n; Safrany A, 2005, POLYMER, V46, P2862, DOI 10.1016/j.polymer.2005.02.024; STEFAN D, 1974, J APPL POLYM SCI, V18, P1279, DOI 10.1002/app.1974.070180502; Sun X., 2013, NANOSCALE RES LETT, V8, P1; Sun XX, 2013, POLYM J, V45, P1101, DOI 10.1038/pj.2013.18; Svec F, 1999, IND ENG CHEM RES, V38, P34, DOI 10.1021/ie970598s; Urman YG, 1983, POLYM SCI USSR, V25, P2687, DOI 10.1016/0032-3950(83)90345-3; Viklund C, 1997, CHEM MATER, V9, P463, DOI 10.1021/cm9603011; Walsh Z, 2008, CHEM COMMUN, P6504, DOI 10.1039/b816958f; Xin Y, 2012, J POLYM RES, V19, P1; Xin YR, 2012, CHEM LETT, V41, P1509, DOI 10.1246/cl.2012.1509; Yoshimizu H, 2012, POLYM J, V44, P827, DOI 10.1038/pj.2012.128	79	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0032-3861	1873-2291		POLYMER	Polymer	JUN 1	2015	66						52	57		10.1016/j.polymer.2015.04.008		6	Polymer Science	Polymer Science	CK0GQ	WOS:000355884100009		
J	Miyauchi, S; Sugioka, T; Sumida, Y; Kaneko, Y				Miyauchi, Shunya; Sugioka, Takuo; Sumida, Yasutaka; Kaneko, Yoshiro			Preparation of soluble polysilsesquioxane containing phthalimido side-chain groups and its optical and thermal properties	POLYMER			English	Article						Phthalimido group; Polysilsesquioxane; Thermal stability	SOL-GEL REACTION; HEXAGONALLY STACKED STRUCTURE; ROD-LIKE POLYSILSESQUIOXANE; CROSS-LINKING AGENT; LADDER POLYSILSESQUIOXANE; CUBIC SILSESQUIOXANES; RODLIKE POLYSILOXANE; PENDENT GROUP; POSS; CHEMISTRY	In this study, polysilsesquioxane (PSQ) containing phthalimido side-chain groups (PSQ-PI) with solubility and high thermal stability was prepared by the two-step reaction of an ammonium-group-containing soluble ladder-like PSQ (PSQ-NH3Cl) with phthalic anhydride. First, the reaction of PSQ-NH3Cl with phthalic anhydride was performed in the presence of triethylamine in a DMSO/water mixed solvent to obtain PSQ containing phthalamic acid side-chain groups (PSQ-PA). Next, PSQ-PI was prepared by refluxing a solution of PSQ-PA in DMF with stirring. PSQ-PI was soluble in organic solvents such as chloroform, DMF, and DMSO. The film of PSQ-PI could be prepared by drying its solution in DMF. The UV-Vis spectrum of PSQ-PI cast film showed high transmittance in the visible wavelength region. The pyrolysis temperatures of PSQ-PI under nitrogen flow were relatively high (T-d5 = 394 degrees C and T-d10 = 438 degrees C) because PSQ-PI has both a thermally stable Si-O-Si main-chain and phthalimido side-chains. (C) 2015 Elsevier Ltd. All rights reserved.	[Miyauchi, Shunya; Kaneko, Yoshiro] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 8900065, Japan; [Sugioka, Takuo; Sumida, Yasutaka] Nippon Shokubai, Suita, Osaka 5648512, Japan	Kaneko, Y (reprint author), Kagoshima Univ, Grad Sch Sci & Engn, 1-21-40 Korimoto, Kagoshima 8900065, Japan.	ykaneko@eng.kagoshima-u.ac.jp					Abade MJM, 1991, POLYIMIDES OTHER HIG; Toyodome H, 2012, POLYMER, V53, P6021, DOI 10.1016/j.polymer.2012.10.052; Ren ZJ, 2012, CHEM-EUR J, V18, P4115, DOI 10.1002/chem.201103684; Toiserkani H, 2010, EUR POLYM J, V46, P185, DOI 10.1016/j.eurpolymj.2009.11.006; Alves F, 2013, CHEM-EUR J, V19, P17310, DOI 10.1002/chem.201303759; Furgal JC, 2013, J AM CHEM SOC, V135, P12259, DOI 10.1021/ja4043092; Choi J, 2001, J AM CHEM SOC, V123, P11420, DOI 10.1021/ja0107201; Kaneko Y, 2004, CHEM MATER, V16, P3417, DOI 10.1021/cm0495212; Perez-Ojeda ME, 2013, CHEM-EUR J, V19, P6630, DOI 10.1002/chem.201300339; BROWN JF, 1960, J AM CHEM SOC, V82, P6194, DOI 10.1021/ja01508a054; Laine RM, 2011, MACROMOLECULES, V44, P1073, DOI 10.1021/ma102360t; Tokunaga T, 2014, J MATER CHEM C, V2, P2496, DOI 10.1039/c3tc32292k; Ervithayasuporn V, 2013, INORG CHEM, V52, P13108, DOI 10.1021/ic401994m; Sun JS, 2013, CHEM-EUR J, V19, P12613, DOI 10.1002/chem.201301875; Kaneko Y, 2005, POLYMER, V46, P1828, DOI 10.1016/j.polymer.2004.12.038; Wang FK, 2011, J MATER CHEM, V21, P2775, DOI 10.1039/c0jm02785e; Tanaka K, 2012, J MATER CHEM, V22, P1733, DOI 10.1039/c1jm14231c; BROWN JF, 1964, J AM CHEM SOC, V86, P1120, DOI 10.1021/ja01060a033; Kaneko Y, 2014, CHEM-EUR J, V20, P9394, DOI 10.1002/chem.201402011; Kaneko Y, 2012, J MATER CHEM, V22, P14475, DOI 10.1039/c2jm32355a; Unno M, 2005, B CHEM SOC JPN, V78, P1105, DOI 10.1246/bcsj.78.1105; Cordes DB, 2010, CHEM REV, V110, P2081, DOI 10.1021/cr900201r; Seki H, 2010, J ORGANOMET CHEM, V695, P1363, DOI 10.1016/j.jorganchem.2010.02.008; Kuo SW, 2011, PROG POLYM SCI, V36, P1649, DOI 10.1016/j.progpolymsci.2011.05.002; Loy DA, 2000, CHEM MATER, V12, P3624, DOI 10.1021/cm000451i; Yu XF, 2010, J AM CHEM SOC, V132, P16741, DOI 10.1021/ja1078305; Arake T, 2013, POLYMER, V54, P5643, DOI 10.1016/j.polymer.2013.08.035; BANEY RH, 1995, CHEM REV, V95, P1409, DOI 10.1021/cr00037a012; Behniafar H, 2006, EUR POLYM J, V42, P3236, DOI 10.1016/j.eurpolymj.2006.09.004; Behniafar H, 2005, POLYMER, V46, P4627, DOI 10.1016/j.polymer.2005.03.067; Chimjarn S, 2015, DALTON T, V44, P916, DOI 10.1039/c4dt02941k; Jaroentomeechai T, 2012, INORG CHEM, V51, P12266, DOI 10.1021/ic3015145; Kaneko Y, 2009, J MATER CHEM, V19, P7106, DOI 10.1039/b910345g; Kaneko Y, 2007, Z KRISTALLOGR, V222, P656, DOI 10.1524/zkri.2007.222.11.656; Kaneko Y, 2012, INT J POLYM SCI, DOI 10.1155/2012/684278; Kaneko Y, 2014, KOBUNSHI RONBUNSHU, V71, P443; Kaneko Y, 2011, J MATER CHEM, V21, P16638, DOI 10.1039/c1jm13414k; Kaneko Y, 2005, J MATER CHEM, V15, P1572, DOI 10.1039/b418579j; Kaneko Y, 2006, J MATER CHEM, V16, P1746, DOI 10.1039/b602847k; Kaneko Y, 2010, KOBUNSHI RONBUNSHU, V67, P280; Kaneko Y, 2007, POLYM J, V39, P1078, DOI 10.1295/polymj.PJ2007028; Kim KM, 2003, J MATER CHEM, V13, P1384, DOI 10.1039/b211030j; Liaw DJ, 2001, J POLYM SCI POL CHEM, V39, P1557, DOI 10.1002/pola.1131; Liaw JD, 1999, J MOL CATAL A-CHEM, V147, P23; Mallakpour S, 2007, EUR POLYM J, V43, P3344, DOI 10.1016/j.eurpolymj.2007.06.006; Mallakpour S, 2008, REACT FUNCT POLYM, V68, P91, DOI 10.1016/j.reactfunctpolym.2007.10.007; Mittal K. L., 1984, POLYIMIDES SYNTHESIS; Zhang XJ, 2006, ANGEW CHEM INT EDIT, V45, P3112, DOI 10.1002/anie.200504474	48	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0032-3861	1873-2291		POLYMER	Polymer	JUN 1	2015	66						122	126		10.1016/j.polymer.2015.04.035		5	Polymer Science	Polymer Science	CK0GQ	WOS:000355884100017		
J	Nakajima, M; Nakajima, H; Fujiwara, T; Kimura, Y; Sasaki, S				Nakajima, Maho; Nakajima, Hajime; Fujiwara, Tomoko; Kimura, Yoshiharu; Sasaki, Sono			Nano-structured micelle particles of polylactide-poly(oxyethylene) block copolymers with different block sequences: Specific influence of stereocomplex formation of the polylactide blocks	POLYMER			English	Article						Polylactide-poly(oxyethylene) block copolymers; Micelle formation; Stereocomplex	DRUG-DELIVERY SYSTEMS; POLY(ETHYLENE GLYCOL); TRIBLOCK COPOLYMERS; RELEASE BEHAVIOR; PEG; PLA; POLY(L-LACTIDE); POLYMERS; DIBLOCK; MICELLIZATION	Triblock copolymers consisting of poly(oxyethylene) (PEG), poly(D-lactide) (PDLA), and poly(L-lactide) (PLLA) were successfully prepared by the two-step ring-opening polymerization of D- and L-lactides via PEG-PDLA diblock copolymers. These triblock copolymers as well as the diblock copolymer PEG-PDLA and a mixture of enantiomeric diblock copolymers PEG-PDLA/PEG-PLLA were emulsified to make their aqueous micelle solutions. It was found out that the triblock copolymers and the diblock copolymer mixture can form sc crystals in the core to highly stabilize the core shell particles. In particular, the micelle of a triblock copolymer having a short middle PDLA block gave the smallest particles covered with thin layer of PEG coronas, because the sc crystals had formed around the core shell interface. These results suggested that the micelle particle morphology can be tuned by changing the core structure even at constant hydrophilic/hydrophobic balance of the block chains. (C) 2015 Elsevier Ltd. All rights reserved.	[Nakajima, Maho; Nakajima, Hajime; Kimura, Yoshiharu; Sasaki, Sono] Kyoto Inst Technol, Dept Biobased Mat Sci, Sakyo Ku, Kyoto 6068585, Japan; [Fujiwara, Tomoko] Univ Memphis, Dept Chem, Memphis, TN 38152 USA	Kimura, Y (reprint author), Kyoto Inst Technol, Dept Biobased Mat Sci, Sakyo Ku, Kyoto 6068585, Japan.	ykimura@kit.ac.jp					Hagan SA, 1996, LANGMUIR, V12, P2153, DOI 10.1021/la950649v; FISCHER EW, 1973, KOLLOID Z Z POLYM, V251, P980, DOI 10.1007/BF01498927; Hsu YI, 2013, MACROMOL CHEM PHYS, V214, P1559, DOI 10.1002/macp.201300230; Tobio M, 1998, PHARMACEUT RES, V15, P270, DOI 10.1023/A:1011922819926; ASTAFIEVA I, 1993, MACROMOLECULES, V26, P7339, DOI 10.1021/ma00078a034; Garofalo C, 2014, BIOMACROMOLECULES, V15, P403, DOI 10.1021/bm401812r; Tsuji H, 2006, BIOMACROMOLECULES, V7, P3316, DOI 10.1021/bm060786e; Dai ZL, 2004, COLLOID POLYM SCI, V282, P343, DOI 10.1007/s00396-003-0937-7; Fukushima K, 2006, POLYM INT, V55, P626, DOI 10.1002/pi.2010; Riley T, 2001, LANGMUIR, V17, P3168, DOI 10.1021/la001226i; Jeong B, 1999, J CONTROL RELEASE, V62, P109, DOI 10.1016/S0168-3659(99)00061-9; Jeong B, 2000, J BIOMED MATER RES, V50, P171, DOI 10.1002/(SICI)1097-4636(200005)50:2<171::AID-JBM11>3.0.CO;2-F; Tsuji H, 2010, POLYMER, V51, P4937, DOI 10.1016/j.polymer.2010.08.010; Mukose T, 2004, MACROMOL BIOSCI, V4, P361, DOI 10.1002/mabi.200300112; Ma CL, 2015, LANGMUIR, V31, P1527, DOI 10.1021/la503869d; GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245; Kang N, 2005, NANO LETT, V5, P315, DOI 10.1021/nl048037v; HALPERIN A, 1987, MACROMOLECULES, V20, P2943, DOI 10.1021/ma00177a051; Fukushima K, 2007, MACROMOLECULES, V40, P3049, DOI 10.1021/ma070156k; Chen L, 2007, J NANOPART RES, V9, P777, DOI 10.1007/s11051-006-9103-8; Abebe DG, 2012, BIOMACROMOLECULES, V13, P1828, DOI 10.1021/bm300325v; Jeong B, 1997, NATURE, V388, P860; Fujiwara T, 2001, MACROMOLECULES, V34, P4043, DOI 10.1021/ma010056t; Fujiwara T, 2002, MACROMOL BIOSCI, V2, P11, DOI 10.1002/1616-5195(20020101)2:1<11::AID-MABI11>3.3.CO;2-H; Lee CW, 1996, B CHEM SOC JPN, V69, P1787, DOI 10.1246/bcsj.69.1787; Lee CW, 2012, MACROMOL CHEM PHYS, V213, P2174, DOI 10.1002/macp.201200375; Loomis G.L., 1990, POLYM PREPR AM CHEM, V31, P55; Sun L, 2010, J POLYM SCI POL CHEM, V48, P4583, DOI 10.1002/pola.24255; Tsuji H, 2015, POLYM INT, V64, P54, DOI 10.1002/pi.4806; Wang J, 2012, J POLYM SCI POL CHEM, V50, P2553, DOI 10.1002/pola.26040; Wang JX, 2015, MATERIALS, V8, P216, DOI 10.3390/ma8010216; Watanabe J, 2002, BIOMACROMOLECULES, V3, P1109, DOI 10.1021/bm025586r; Zhao Y, 2001, J PHYS CHEM B, V105, P848, DOI 10.1021/jp003001m	33	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0032-3861	1873-2291		POLYMER	Polymer	JUN 1	2015	66						160	166		10.1016/j.polymer.2015.04.036		7	Polymer Science	Polymer Science	CK0GQ	WOS:000355884100021		
J	Akutagawa, K; Hamatani, S; Nashi, T				Akutagawa, Keizo; Hamatani, Satoshi; Nashi, Takayuki			The new interpretation for the heat build-up phenomena of rubbery materials during deformation	POLYMER			English	Article						Rubber; Heat build-up; Non-equilibrium thermodynamics	ELASTICITY	The first and second laws of thermodynamics can describe the heat build-up phenomena of rubbery materials during deformation. When the force is applied on rubber specimen, the rubber starts to deform and the work is stored as heat inside rubber. The temperature increase due to deformation can be scaled by the heat capacity as a function of the work. This can be well explained by the entropic process. It can be noted that the entropic process is the reversible heat process, but the most of rubber applications are based on the behaviours such as viscoelastic process, which are not reversible heat process. In this paper we measured the phenomenological behaviours of temperature changes on stretching and un-stretching rubber. As a result it was reduced to two processes, which are the reversible process and irreversible process. The non-equilibrium thermodynamics equation was newly derived in order to describe these processes. The reversible process can be associated with the configurational entropic process of rubber elasticity, but in the irreversible process it was suggested that the work is leaked as heat to the external system. Some of work is transferred into the fluctuation of the molecular motion inside rubber. The fluctuation is never recovered as the mechanical force and is mechanically observed as the stress relaxation. This gives us the new interpretation why rubbery materials can produce heat during deformation. (C) 2015 Elsevier Ltd. All rights reserved.	[Akutagawa, Keizo; Hamatani, Satoshi; Nashi, Takayuki] Bridgestone Corp, Kodaira, Tokyo 1878531, Japan	Akutagawa, K (reprint author), Bridgestone Corp, 3-1-1 Ogawahigashi Cho, Kodaira, Tokyo 1878531, Japan.	keizo.akutagawa@bridgestone.com					Akutagwa K, 2008, RUBBER CHEM TECHNOL, V81, P182, DOI 10.5254/1.3548203; ALLEN G, 1971, T FARADAY SOC, V67, P1278, DOI 10.1039/tf9716701278; Lehn JM, 2002, POLYM INT, V51, P825, DOI 10.1002/pi.852; Morita H, 2006, MACROMOLECULES, V39, P6233, DOI 10.1021/ma052632h; Li Y, 2012, POLYMER, V53, P5935, DOI 10.1016/j.polymer.2012.09.055; Flory P. J., 1953, PRINCIPLES POLYM CHE; Garden JL, 2012, J CHEM PHYS, V137; Hayakawa Y, 2006, HIHEIKOUKEI NO DAINA; Ivan S, 2013, VITREOUS STATE THERM; Joule J.P., 1859, PHILOS T R SOC LONDO, V149, P91, DOI 10.1098/rstl.1859.0005; Kubo R, 1996, GOMU DANSEI; Kubo R, 1998, STAT PHYS, Vsecond; Mouri H, 2000, RUBBER CHEM TECHNOL, V73, P960; Price C, 1975, J CHEM SOC F1, V71, P548; Raos G, 2006, MACROMOLECULES, V39, P6744, DOI 10.1021/ma061008h; Sakata A, 2013, J THERM ANAL CALORIM, V113, P1555, DOI 10.1007/s10973-013-3066-7; THOMAS AG, 1955, T FARADAY SOC, V51, P569, DOI 10.1039/tf9555100569; Treloar LRG, 1975, PHYSICS RUBBER ELAST, V3rd; Wickstrom U, 2007, INTERFLAM 2007, P943; Wolynes PG, 1997, J RES NATL INST STAN, V102, P187; Yasar D, 2010, NONEQUILIBRIUM THERM	21	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0032-3861	1873-2291		POLYMER	Polymer	JUN 1	2015	66						201	209		10.1016/j.polymer.2015.04.040		9	Polymer Science	Polymer Science	CK0GQ	WOS:000355884100026		
J	Kihara, M; Sakakiyama, Y; Yamazaki, S; Kimura, K				Kihara, Masahiro; Sakakiyama, Yuma; Yamazaki, Shinichi; Kimura, Kunio			Preparation of aromatic polyesters by direct polymerization in the presence of boronic anhydride under non-stoichiometric condition	POLYMER			English	Article						Stoichiometry; Polyesters; Direct polymerization	REACTION-INDUCED CRYSTALLIZATION; DIRECT POLYCONDENSATION; SINGLE-CRYSTALS; DIPHENYL CHLOROPHOSPHATE; HYDROXYBENZOIC ACIDS; POLY(4-HYDROXYBENZOATE); N,N-DIMETHYLFORMAMIDE; TRIPHENYLPHOSPHINE; TSCL/DMF/PY; MORPHOLOGY	Direct polymerizations of p-hydroxybenzoic acid (HBA) and 2-hydroxy-6-naphthoic acid (HNA) in the presence of boronic anhydride were examined by using crystallization under non-stoichiometric condition. The polymerizations were carried out with the addition of monofunctional compounds such as an aromatic carboxylic acid and a phenol. High molecular weight poly(p-oxybenzoyl) (PUB) and poly(2-oxy-6-naphthoyl) (PUN) were obtained in the form of precipitates, and their molecular weights were much higher than those calculated according to the stoichiometric imbalance. Oligomers were formed by the direct polymerization with eliminating water in the solution, and then they were precipitated to form the crystals at the initial stage of the polymerization. Oligomers end-capped by monofunctional compounds were also formed in the solution, but the polymerization continued with the elimination of monofunctional compounds by the ester exchange reaction. The end-capped oligomers were precipitated in the middle of the polymerization, and the polymerization proceeded efficiently even in the precipitated crystals by not only the direct polymerization but also the ester exchange polymerization, resulting in the increase in molecular weight. (C) 2015 Elsevier Ltd. All rights reserved.	[Kihara, Masahiro; Sakakiyama, Yuma; Yamazaki, Shinichi; Kimura, Kunio] Okayama Univ, Grad Sch Environm & Life Sci, Kita Ku, Okayama 7008530, Japan	Kimura, K (reprint author), Okayama Univ, Grad Sch Environm & Life Sci, Kita Ku, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	polykim@cc.okayama-u.ac.jp					Kimura K, 2006, POLYM J, V38, P1005, DOI 10.1295/polymj.PJ2006083; SNYDER HR, 1958, J AM CHEM SOC, V80, P3611, DOI 10.1021/ja01547a033; Cowie JMG, 2001, POLYM ADVAN TECHNOL, V12, P506, DOI 10.1002/pat111; Economy J, 1977, MACROMOL MONOGR, V3, P45; ECONOMY J, 1976, J POLYM SCI POL CHEM, V14, P2207, DOI 10.1002/pol.1976.170140911; ECONOMY J, 1984, MOL CRYST LIQ CRYST, V105, P289, DOI 10.1080/00268948408071659; Flory P. J., 1953, PRINCIPLE POLYM CHEM; GILMAN H, 1957, J AM CHEM SOC, V79, P3077, DOI 10.1021/ja01569a024; HIGASHI F, 1985, J POLYM SCI POL CHEM, V23, P69, DOI 10.1002/pol.1985.170230108; Higashi F, 2001, MACROMOL RAPID COMM, V22, P109, DOI 10.1002/1521-3927(200102)22:2<109::AID-MARC109>3.0.CO;2-T; HIGASHI F, 1980, J POLYM SCI POL CHEM, V18, P2879, DOI 10.1002/pol.1980.170180912; HIGASHI F, 1984, J POLYM SCI POL CHEM, V22, P1653, DOI 10.1002/pol.1984.170220712; Higashi F, 1999, J POLYM SCI POL CHEM, V37, P3625, DOI 10.1002/(SICI)1099-0518(19990915)37:18<3625::AID-POLA10>3.0.CO;2-V; HIGASHI F, 1984, J POLYM SCI POL CHEM, V22, P2181, DOI 10.1002/pol.1984.170220919; Islam TMB, 2002, ANAL SCI, V18, P363, DOI 10.2116/analsci.18.363; Kihara M, 2011, POLYM CHEM-UK, V2, P1195, DOI 10.1039/c0py00420k; Kihara M, 2011, J POLYM SCI POL CHEM, V49, P1088, DOI 10.1002/pola.24521; Kihara N, 1999, MACROMOLECULES, V32, P4776, DOI 10.1021/ma981835l; Kimura K, 2003, MACROMOLECULES, V36, P5043, DOI 10.1021/ma0258307; Kimura K, 2002, MACROMOLECULES, V35, P7545, DOI 10.1021/ma0205919; KITAYAMA S, 1984, J POLYM SCI POL CHEM, V22, P2705, DOI 10.1002/pol.1984.170221034; Kohama S, 2005, POLYM INT, V54, P471, DOI 10.1002/pi.1728; Kohama SI, 2005, J POLYM SCI POL CHEM, V43, P1757, DOI 10.1002/pola.20651; KRICHELDORF HR, 1991, MAKROMOL CHEM, V192, P2371; KRICHELDORF HR, 1991, MACROMOLECULES, V24, P3485, DOI 10.1021/ma00012a004; Lenz RW, 1967, ORGANIC CHEM SYNTHET; LIESER G, 1983, J POLYM SCI POL PHYS, V21, P1599, DOI 10.1002/pol.1983.180210902; LIESER G, 1983, J POLYM SCI POL PHYS, V21, P1611, DOI 10.1002/pol.1983.180210903; limori H, 2003, MACROMOL S, V199, P23; Liu J, 1997, POLYMER, V38, P6031, DOI 10.1016/S0032-3861(97)00161-4; Nomura N, 1999, J AM CHEM SOC, V121, P7268, DOI 10.1021/ja991211a; OGATA N, 1981, POLYM J, V13, P989, DOI 10.1295/polymj.13.989; SCHWARZ G, 1988, MAKROMOL CHEM-RAPID, V9, P717; Zhao DH, 2003, J AM CHEM SOC, V125, P16294, DOI 10.1021/ja038252y	34	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0032-3861	1873-2291		POLYMER	Polymer	JUN 1	2015	66						222	229		10.1016/j.polymer.2015.04.019		8	Polymer Science	Polymer Science	CK0GQ	WOS:000355884100028		
J	Jiang, N; Abe, H				Jiang, Ni; Abe, Hideki			Morphological changes in poly(L-lactide)/poly(3-hydroxybutyrate-co-3-hydroxyvalerate) blends induced by different miscibility	POLYMER			English	Article						Crystalline/crystalline polymer blend; Miscibility; Interpenetrating spherulite	SUCCINATE)/POLY(ETHYLENE OXIDE) BLENDS; CRYSTALLINE/CRYSTALLINE POLYMER BLENDS; END-CAPPED POLY(L-LACTIDE); SPHERULITIC GROWTH; CARBONATE)/POLY(L-LACTIC ACID); POLY(VINYLIDENE FLUORIDE); POLY(BUTYLENE SUCCINATE); MISCIBLE BLENDS; BINARY BLENDS; CRYSTALLIZATION	The poly(L-lactide) (PLLA)/poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) crystalline/crystalline blends with different miscibility were prepared by varying the molecular weight of the PLLA component. The relationship between miscibility and spherulitic morphology were studied by differential scanning calorimetry (DSC), polarized optical microscopy (POM) and atomic force microscopy (AFM) in this work. Penetration of PHBV spherulites into the pre-existing PLLA spherulites was found at intermediate and higher temperature in both the miscible PLLA25/PHBV blend and the partially miscible PLLA150/PHBV blend. However, the penetration of PLLA crystals into the spherulites of PHBV was only found in PLLA25/PHBV blend during the cold crystallization and simultaneous isothermal crystallization, because there were not enough uncrystallized PLLA150 inside the lamellae of PHBV for the PLLA150/PHBV blend. The formation of interpenetrating spherulites was analyzed on the basis of birefringence. In the case of immiscible PLLA1800/PHBV blend, the morphology results under any crystallization condition imply that the spherulites of one component have no influence on the crystallization of the other one. It is concluded that the miscibility of the two components plays an important role in determining the morphologies of polymer blends. (C) 2015 Elsevier Ltd. All rights reserved.	[Jiang, Ni; Abe, Hideki] RIKEN, Ctr Sustainable Resource Sci, Biomass Engn Program Cooperat Div, Bioplast Res Team, Wako, Saitama 3510198, Japan	Abe, H (reprint author), RIKEN, Ctr Sustainable Resource Sci, Biomass Engn Program Cooperat Div, Bioplast Res Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	habe@riken.jp					Yang F, 2009, POLYMER, V50, P2328, DOI 10.1016/j.polymer.2009.03.029; Koyama N, 1997, POLYMER, V38, P1589, DOI 10.1016/S0032-3861(96)00685-4; Jiang N, 2015, POLYMER, V60, P260, DOI 10.1016/j.polymer.2015.01.060; Qiu JS, 2013, MACROMOLECULES, V46, P5806, DOI 10.1021/ma401084y; Qiu ZB, 2007, J PHYS CHEM B, V111, P2783, DOI 10.1021/jp067606f; Ikehara T, 2005, MACROMOLECULES, V38, P5104, DOI 10.1021/ma0502809; Hirano S, 2002, POLYM J, V34, P85, DOI 10.1295/polymj.34.85; Qiu ZB, 2002, MACROMOLECULES, V35, P8251, DOI 10.1021/ma025599x; Wang TC, 2011, J PHYS CHEM B, V115, P7814, DOI 10.1021/jp203680e; Ikehara T, 2009, J POLYM SCI POL PHYS, V47, P539, DOI 10.1002/polb.21661; Ikehara T, 2003, POLYMER, V44, P6657, DOI 10.1016/S0032-3861(03)00685-2; Ju DD, 2015, RSC ADV, V5, P5474, DOI 10.1039/c4ra12313a; Ikehara T, 2007, MACROMOLECULES, V40, P8726, DOI 10.1021/ma070973k; Li QH, 2013, COLLOID POLYM SCI, V291, P2007, DOI 10.1007/s00396-013-2929-6; Sombatmankhong K, 2007, POLYMER, V48, P1419, DOI 10.1016/j.polymer.2007.01.014; Kobori Y, 2004, BIOMACROMOLECULES, V5, P530, DOI 10.1021/bm034382n; Furukawa T, 2005, MACROMOLECULES, V38, P6445, DOI 10.1021/ma0504668; Kurokawa K, 2008, BIOMACROMOLECULES, V9, P1071, DOI 10.1021/bm701259r; Wang HJ, 2015, CHINESE J POLYM SCI, V33, P349, DOI 10.1007/s10118-015-1585-3; Wang TC, 2011, POLYM CHEM-UK, V2, P1688, DOI 10.1039/c1py00134e; Yoshie N, 2004, MACROMOLECULES, V37, P3770, DOI 10.1021/ma049858p; Zeng LX, 2012, POLYM CHEM-UK, V3, P2537, DOI 10.1039/c2py20331f	22	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0032-3861	1873-2291		POLYMER	Polymer	JUN 1	2015	66						259	267		10.1016/j.polymer.2015.04.051		9	Polymer Science	Polymer Science	CK0GQ	WOS:000355884100032		
J	Sasaki, T; Shabana, AA				Sasaki, Takeshi; Shabana, Ahmed A.			Prediction of dynamic stresses using flexible multibody system algorithms: Application to tracked vehicle upper structure	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART K-JOURNAL OF MULTI-BODY DYNAMICS			English	Article						Tracked vehicle; bulldozers; floating frame of reference formulation; flexible multibody system dynamics; dynamic stress analysis	SPATIAL DYNAMICS; PART II; SIMULATION; EQUATIONS; CONTACT; MOTION; MODEL	The objective of this investigation is to develop a general procedure for predicting the dynamic stresses when the nonlinear floating frame of reference formulation is used to model flexible components in multibody system applications. The procedure utilizes the concept of the floating frame of reference intermediate finite element coordinate system and the general continuum mechanics approach to develop accurate definitions of the floating frame of reference kinematic equations that enter into the formulations of the strains. These general equations are used to design a computational algorithm for the calculation of the dynamic stresses. In order to demonstrate the use of the procedure developed in this investigation for the stress prediction, a tracked vehicle system is used as the study model. Taking into consideration the actual endurance test, a model for a bulldozer upper structure is developed using computer aided engineering solution framework which includes flexible multibody system algorithms. In order to obtain the dynamic stresses, the flexible structure of the tracked vehicle is modeled using Mindlin shell finite elements. The equations of motion are developed using the finite element/floating frame of reference formulation that allows for effectively reducing the number of degrees of freedom by neglecting high-frequency modes of vibration using component mode synthesis techniques. The stresses are obtained using a procedure that takes into consideration the dynamic coupling between the rigid body motion and the elastic deformations. The use of the general continuum mechanics theory to formulate the strain and stress equations allows for applying the procedure developed in this paper to other element types. Kinematic relationships are used to formulate several components and elements of the undercarriage including the idler cushion system and the maximum reverse angle. Numerical results are presented in order to demonstrate the use of the general floating frame of reference procedure in the stress analysis of the tracked vehicle undercarriage system.	[Sasaki, Takeshi] Komatsu Ltd, Small Size Machine Dev Grp, Construct Equipment Tech Ctr, Dev Div, Komatsu City, Ishikawa, Japan; [Shabana, Ahmed A.] Univ Illinois, Dept Mech & Ind Engn, Chicago, IL 60607 USA	Shabana, AA (reprint author), Univ Illinois, Dept Mech & Ind Engn, 842 West Taylor St, Chicago, IL 60607 USA.	shabana@uic.edu					Abe M, 2007, J SYST DES DYN, V1, P27, DOI 10.1299/jsdd.1.27; AGRAWAL OP, 1985, COMPUT STRUCT, V21, P1303, DOI 10.1016/0045-7949(85)90184-1; [Anonymous], 2007, ANSYS US MAN, V11th; Campanelli M., 1998, Multibody System Dynamics, V2, DOI 10.1023/A:1009758701296; Chen B, 2011, ADV MATER RES-SWITZ, V199-200, P1358, DOI 10.4028/www.scientific.net/AMR.199-200.1358; Choi JH, 1998, VEHICLE SYST DYN, V29, P27, DOI 10.1080/00423119808969365; DHIR A, 1994, J TERRAMECHANICS, V31, P107, DOI 10.1016/0022-4898(94)90010-8; Dvorkin EN, 1984, ENG COMPUT, V1, P77, DOI DOI 10.1108/EB023562; Hamed AM, 2014, ASME J COMP IN PRESS; Lee HC, 1998, VEHICLE SYST DYN, V29, P113, DOI 10.1080/00423119808969369; Ma ZD, 2006, MULTIBODY SYST DYN, V15, P351, DOI 10.1007/s11044-005-9001-3; NAKANISHI T, 1994, NONLINEAR DYNAM, V6, P391; Nakanishi T, 1996, J DYN SYST-T ASME, V118, P499, DOI 10.1115/1.2801173; Ozaki T, 2003, INT J MULTISCALE COM, V1, P253, DOI 10.1615/IntJMultCompEng.v1.i23.90; Ryu HS, 2000, INT J NUMER METH ENG, V48, P1481, DOI 10.1002/1097-0207(20000810)48:10<1481::AID-NME959>3.0.CO;2-P; Ryu HS, 2003, JSME INT J C-MECH SY, V46, P540, DOI 10.1299/jsmec.46.540; Sarwar MK, 1995, J VIB CONTROL, V1, P201, DOI 10.1177/107754639500100205; Shabana AA, 2013, DYNAMICS OF MULTIBODY SYSTEMS, 4TH EDITION, P1; Shabana A.A., 2010, COMPUTATIONAL DYNAMI; SHABANA AA, 1985, J VIB ACOUST, V107, P431; Shabana A.A., 1997, VIBRATION DISCRETE C; Shabana AA, 2012, COMPUTATIONAL CONTIN; Spencer A.J. M., 1980, CONTINUUM MECH; Wallin M, 2013, NONLINEAR DYNAM, V74, P783, DOI 10.1007/s11071-013-1005-6; Wang L, 2014, ASME J COMP IN PRESS; Yamakawa J, 2004, J TERRAMECHANICS, V41, P113, DOI 10.1016/j.jterra.2004.02.007; Zhou CK, 2014, ADV MATER RES-SWITZ, V842, P351, DOI 10.4028/www.scientific.net/AMR.842.351; Zienkiewicz OC, 2005, FINITE ELEMENT METHOD FOR FLUID DYNAMICS, 6TH EDITION, P1; Zienkiewicz OC, 1979, FINITE ELEMENT METHO, V3rd	29	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1464-4193	2041-3068		P I MECH ENG K-J MUL	Proc. Inst. Mech Eng Pt K-J Multi-Body Dyn.	JUN	2015	229	2					177	192		10.1177/1464419314557300		16	Engineering, Mechanical; Mechanics	Engineering; Mechanics	CK1YX	WOS:000356007000006		
J	Kasai, M; Meguro, K; Akanuma, K; Yamaguchi, S				Kasai, Mari; Meguro, Kenichi; Akanuma, Kyoko; Yamaguchi, Satoshi			Alzheimer's disease patients institutionalized in group homes run by long-term care insurance exhibit fewer symptoms of behavioural problems as evaluated by the Behavioural Pathology in Alzheimer's Disease Rating Scale	PSYCHOGERIATRICS			English	Article						Alzheimer's disease; BEHAVE-AD; behavioural and psychological symptoms of dementia; group home	BEHAVE-AD-FW; PSYCHOLOGICAL SYMPTOMS; CAREGIVER BURDEN; DEMENTIA; RESIDENTS; SERVICES; SYSTEM	BackgroundThe behavioural and psychological symptoms of dementia (BPSD) caused by Alzheimer's disease (AD) can burden caregivers. Group homes (GH), small nursing homes, for the elderly with dementia are institutions commonly run by the public long-term care insurance system in Japan. The purpose of this study was to compare the prevalence of BPSD of AD, as evaluated by the Behavioural Pathology in Alzheimer's Disease Rating Scale, between GH patients and community residents. MethodsA total of 74 patients with AD were enrolled: 37 were patients institutionalized in GH (Hachinski score < 5) and 37 were demographic-matched community residents undergoing treatment at the Osaki-Tajiri SKIP Center. There were no significant differences in mean age (81.4 vs 81.1 years, P = 0.816), mean educational level (7.7 vs 8.0 years, P = 0.497), sex (women/men: 30/7 vs 30/7, P = 1.000) and mean Mini-Mental State Examination scores (14.1 vs 14.1, P = 0.950) between the two groups. Care level (range: 0.5-5.0, slight to bedridden), activities of daily living care level (range: 1-7, almost normal to severe), and the presence or absence BPSD based on the domains of the Behavioural Pathology in Alzheimer's Disease Rating Scale were compared. ResultsGH patients had a significantly higher care level (P < 0.05) and activities of daily living care level (P < 0.05) but had fewer symptoms of BPSD (P < 0.05) than community residents. When the activities of daily living care level was controlled, GH patients had significantly fewer symptoms than community residents in Aggressiveness (21% vs 50%; (2) = 4.5, P = 0.035), Affective disturbances (13% vs 42%; (2) = 5.1, P = 0.023), and Anxieties and phobias (4% vs 46%; (2) = 11.1, P = 0.001). ConclusionsGH run by the long-term care insurance system appear to be effective in improving environmental factors for moderate AD patients and reducing Aggressiveness, Affective disturbances, and Anxieties and phobias.	[Kasai, Mari; Meguro, Kenichi; Akanuma, Kyoko] Tohoku Univ, CYRIC, Div Geriatr Behav Neurol, Sendai, Miyagi 9808575, Japan; [Meguro, Kenichi; Akanuma, Kyoko; Yamaguchi, Satoshi] Osaki Tajiri SKIP Ctr, Osaki, Japan	Meguro, K (reprint author), Tohoku Univ, CYRIC, Div Geriatr Behav Neurol, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	k-meg@umin.ac.jp			France Bed Medical Home Care Research Subsidy Public Interest Incorporated Foundation (Tokyo, Japan)	France Bed Medical Home Care Research Subsidy Public Interest Incorporated Foundation (Tokyo, Japan) provided funding for this study.	Yoshioka E, 2013, AGING MENT HEALTH, V17, P966, DOI 10.1080/13607863.2013.790927; Ito T, 2007, J CLIN NEUROSCI, V14, P850, DOI 10.1016/j.jocn.2006.06.010; REISBERG B, 1987, J CLIN PSYCHIAT, V48, P9; Matsumoto N, 2007, DEMENT GERIATR COGN, V23, P219, DOI 10.1159/000099472; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632; Tanaka Y, 2003, ANN NUCL MED, V17, P567; Arai Y, 2003, INT J GERIATR PSYCH, V18, P346, DOI 10.1002/gps.836; Cheng TW, 2009, INT PSYCHOGERIATR, V21, P1134, DOI 10.1017/S1041610209990767; Femia EE, 2007, GERONTOLOGIST, V47, P775; Finkel S I, 1996, Int Psychogeriatr, V8 Suppl 3, P497; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ishizaki J, 1998, J GERONTOL B-PSYCHOL, V53 B, P359; Ishizaki J, 2000, INT J GERIATR PSYCH, V15, P532, DOI 10.1002/1099-1166(200006)15:6<532::AID-GPS144>3.0.CO;2-9; MCKHANN G, 1984, NEUROLOGY, V34, P939; Meguro K, 2014, INT PSYCHOGERIATR, V26, P871, DOI 10.1017/S1041610213002305; Ministry of Health Labour and Welfare, 2002, LONG TERM CAR INS JA; Monteiro IM, 2001, EUR PSYCHIAT, V16, p5S; Muraki I, 2008, CEREBROVASC DIS, V25, P234, DOI 10.1159/000113861	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1346-3500	1479-8301		PSYCHOGERIATRICS	Psychogeriatrics	JUN	2015	15	2					102	108		10.1111/psyg.12079		7	Geriatrics & Gerontology; Psychiatry	Geriatrics & Gerontology; Psychiatry	CK3AH	WOS:000356086800003		
J	Ukai, K; Fujishiro, H; Iritani, S; Ozaki, N				Ukai, Katsuyuki; Fujishiro, Hiroshige; Iritani, Shuji; Ozaki, Norio			Long-term efficacy of donepezil for relapse of visual hallucinations in patients with dementia with Lewy bodies	PSYCHOGERIATRICS			English	Article						appropriate dose; cholinesterase inhibitor; dementia with Lewy bodies (DLB); donepezil; pharmacotherapy; visual hallucinations	BODY DEMENTIA; OPEN-LABEL; SYMPTOMS; DISEASE; CONSORTIUM; PSYCHOSIS; DIAGNOSIS; SAFETY	BackgroundThe use of cholinesterase inhibitors is recommended for the treatment of dementia with Lewy bodies (DLB) in the guidelines of the DLB Consortium. However, no consensus regarding therapeutic approaches for DLB-related visual hallucinations has been reached. To the best of our knowledge, an appropriate dose of donepezil for the treatment of DLB at each stage has not been discussed. MethodsEight patients suffering from DLB with visual hallucinations were treated with donepezil. We summarize the effects of donepezil on these visual hallucinations chronologically in all cases and discuss its efficacy and characteristics. ResultsDonepezil contributed to the complete disappearance of visual hallucinations in all cases, and its effects were maintained for more than 6 months. However, relapses of visual hallucinations also occurred in all cases. Against these relapses, an increased dose of donepezil was very effective in resolving them again in almost all cases in this study. ConclusionsDonepezil was highly effective against visual hallucinations in DLB patients, but there were some issues regarding pharmacotherapy for DLB.	[Ukai, Katsuyuki] Kamiiida Daiichi Gen Hosp, Dept Psychogeriatr, Nagoya, Aichi 4620802, Japan; [Ukai, Katsuyuki; Fujishiro, Hiroshige; Iritani, Shuji; Ozaki, Norio] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4648601, Japan	Ukai, K (reprint author), Kamiiida Daiichi Gen Hosp, Dept Psychogeriatr, Kita Ku, 2-70 Kamiiida Kitamachi, Nagoya, Aichi 4620802, Japan.	ukai777@kamiiida-hp.jp	Ozaki, Norio/M-8908-2014	Ozaki, Norio/0000-0002-7360-4898			ALLEN RL, 1995, LANCET, V346, P185, DOI 10.1016/S0140-6736(95)91245-2; McKeith IG, 1996, NEUROLOGY, V47, P1113; Lanctot KL, 2000, INT J GERIATR PSYCH, V15, P338, DOI 10.1002/(SICI)1099-1166(200004)15:4<338::AID-GPS119>3.0.CO;2-U; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McKeith I, 2000, LANCET, V356, P2031, DOI 10.1016/S0140-6736(00)03399-7; PERRY EK, 1994, NEUROREPORT, V5, P747, DOI 10.1097/00001756-199403000-00002; KOSAKA K, 1984, CLIN NEUROPATHOL, V3, P185; Emre M, 2010, LANCET NEUROL, V9, P969, DOI [10.1016/S1474-4422(10)70194-0, 10.1016/S1474-4422(10)20194-0]; Mori E, 2012, ANN NEUROL, V72, P41, DOI 10.1002/ana.23557; Ikeda M, 2013, DEMENT GERIATR COGN, V36, P229, DOI 10.1159/000351672; Cummings JL, 2002, DEMENT GERIATR COGN, V13, P67, DOI 10.1159/000048636; Fergusson E, 2000, INT J GERIATR PSYCH, V15, P280, DOI 10.1002/(SICI)1099-1166(200003)15:3<280::AID-GPS108>3.3.CO;2-E; Iwasaki K, 2012, PSYCHOGERIATRICS, V12, P235, DOI 10.1111/j.1479-8301.2012.00413.x; KOSAKA K, 1976, ACTA NEUROPATHOL, V36, P221; KOSAKA K, 1979, ARCH PSYCHIAT NERVEN, V226, P241, DOI 10.1007/BF00342237; Kosaka K, 2008, PSYCHOGERIATRICS, V8, P134, DOI 10.1111/j.1479-8301.2008.00248.x; Manabe Y, 2009, CLIN PSYCHIATR, V51, P1165; Mori S, 2006, PSYCHIAT CLIN NEUROS, V60, P190, DOI 10.1111/j.1440-1819.2006.01485.x; Rajas-fernandez CH, 2001, ANN PHARMACOTHER, V35, P202; Ukai K, 2010, PSYCHOGERIATRICS, V10, P201, DOI 10.1111/j.1479-8301.2010.00336.x; Ukai K, 2011, CLIN NEUROPHARMACOL, V2, P56	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1346-3500	1479-8301		PSYCHOGERIATRICS	Psychogeriatrics	JUN	2015	15	2					133	137		10.1111/psyg.12089		5	Geriatrics & Gerontology; Psychiatry	Geriatrics & Gerontology; Psychiatry	CK3AH	WOS:000356086800007		
J	Otaki, M; Moriguchi, K; Lebowitz, A; Asada, T				Otaki, Masayo; Moriguchi, Kyoko; Lebowitz, Adam; Asada, Takashi			Memories of falling in elderly patients with dementia: response concordance rate and reproducibility	PSYCHOGERIATRICS			English	Article						concordance in memories of falling; dementia; fear of falling; memories of falling; reproducibility of fear of falling	COMMUNITY; PEOPLE; FEAR; BALANCE; SCALE	BackgroundAlthough demented elderly patients have impaired memory, memories of falling are not uncommon. We aim to clarify reliability of memories of falling in such patients. MethodsSubjects included 62 patients (18 men, 44 women) diagnosed with dementia who resided in long-term care facilities. Mean age was 82.9 7.8 years, mean Mini-Mental State Examination score was 16.4 4.7 points, and mean Functional Independence Measure score was 67.9 +/- 18.4 points. Subjects were asked a closed question about whether they were aware of having fallen (i.e. memories of falling) over the past year. Fear of falling was quantified using the visual analogue scale and FACES Pain Rating Scale. Scores were re-measured during retest approximately 10 days later to examine reproducibility of memories and fear of falling. Subjects whom staff had witnessed suffering a fall between baseline and retest session were excluded. ResultsFall memory concordance rate was 0.84, visual analogue scale reproducibility (correlation coefficient) was 0.98, and FACES Pain Rating Scale was 0.86. No differences in Mini-Mental State Examination scores were noted between groups for whom memories of falling were or were not reproducible. No correlation was observed among Mini-Mental State Examination, Functional Independence Measure scores, and intensity of fear of falling. ConclusionsThere was a high concordance rate for patients' memories of falling, which suggests that falls were retained as memories. No relationship was observed between memories of falling and degree of cognitive impairment, and severe dementia did not necessarily imply memories of falling were unreliable. The reproducibility of fear of falling suggested the intensity of fear of falling was not easily altered. It was possible memories of falling and fear of falling mutually interacted to reinforce and fixate with each other, leading to the observed phenomenon. Therefore, it appeared memories of falling were retained by patients; this fact can be used in fall prevention and vital function maintenance.	[Otaki, Masayo; Moriguchi, Kyoko] Hlth Sci Univ, Dept Occupat Therapy, Fac Hlth Sci, Fujikawaguchiko, Japan; [Otaki, Masayo; Lebowitz, Adam; Asada, Takashi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan	Otaki, M (reprint author), Hlth Sci Univ, Dept Occupat Therapy, 7187 kodachi, Minamitsuru, Yamanashi 4010380, Japan.	masayo@otaki.jp					Ageing WHO, 2008, WHO GLOB REP FALLS P; AITKEN RCB, 1969, P ROY SOC MED, V62, P989; Ikeda M, 1998, BRIT J PSYCHIAT, V172, P425, DOI 10.1192/bjp.172.5.425; Friedman SM, 2002, J AM GERIATR SOC, V50, P1329, DOI 10.1046/j.1532-5415.2002.50352.x; Collins SL, 1997, PAIN, V72, P95, DOI 10.1016/S0304-3959(97)00005-5; LORISH CD, 1986, ARTHRITIS RHEUM, V29, P906, DOI 10.1002/art.1780290714; Asada T, 1996, AGE AGEING, V25, P22, DOI 10.1093/ageing/25.1.22; MURPHY J, 1982, GERONTOLOGY, V28, P265; Lin MR, 2006, PHYS THER, V86, P1189, DOI 10.2522/ptj.20040408; Ozcan A, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-90; Data Management Service of the Uniform Data System for Medical Rehabilitation and the Center for Functional Assessment Research, 1990, GUID US UN DAT SET M; Edagawa Y, 2006, J HUM ENV ENG, V8, P188; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; vansDoorn C, 2003, J AM GERIATR SOC, V51, P1213; WALKER JE, 1991, AM J OCCUP THER, V45, P119; Wolf B, 2001, CLIN REHABIL, V15, P624, DOI 10.1191/0269215501cr456oa; Wong D L, 1988, Pediatr Nurs, V14, P9	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1346-3500	1479-8301		PSYCHOGERIATRICS	Psychogeriatrics	JUN	2015	15	2					138	143		10.1111/psyg.12102		6	Geriatrics & Gerontology; Psychiatry	Geriatrics & Gerontology; Psychiatry	CK3AH	WOS:000356086800008		
J	Takaki, M; Honda, H; Terada, S; Uchitomi, Y				Takaki, Manabu; Honda, Hajime; Terada, Seishi; Uchitomi, Yosuke			Effect and tolerability of blonanserin in severe delusion with various types of dementia	PSYCHOGERIATRICS			English	Article						blonanserin; D-3 receptor; delusion; dementia; hallucination	SCHIZOPHRENIA; MANAGEMENT; EFFICACY	Low-dose blonanserin was effective for treating severe delusions in six patients with various types of dementia, and it was also well tolerated. Delusion and hallucination scores, as measured by the Neuropsychiatric Inventory, improved, and extrapyramidal symptom scores, as measured by the Drug-Induced Extrapyramidal Symptoms Scale, were unchanged. Blonanserin has strong dopamine D-2 receptor-, 5-hydroxytryptamine 2A receptor-, and dopamine D-3 receptor-blocking activities and weak 5-hydroxytryptamine-2C, (1)-, histamine H-1-, and muscarinic M-1-blocking activities. Its unique characteristics may make it suitable for treating severe delusions and hallucination in patients with dementia.	[Takaki, Manabu; Honda, Hajime; Terada, Seishi; Uchitomi, Yosuke] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neuropsychiat, Okayama 7008558, Japan	Takaki, M (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neuropsychiat, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	manabuta@cc.okayama-u.ac.jp			Zikei Institute of Psychiatry (Okayama, Japan)	This study was partly supported by a grant from the Zikei Institute of Psychiatry (Okayama, Japan).	Gill SS, 2007, ANN INTERN MED, V146, P775; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Joyce JN, 2005, DRUG DISCOV TODAY, V10, P917, DOI 10.1016/S1359-6446(05)03491-4; Yang J, 2010, CLIN NEUROPHARMACOL, V33, P169, DOI 10.1097/WNF.0b013e3181dcda50; Schneeweiss S, 2007, CAN MED ASSOC J, V176, P627, DOI 10.1503/cmaj.061250; Deeks ED, 2010, CNS DRUGS, V24, P65, DOI 10.2165/11202620-000000000-00000; Hamuro A, 2010, PSYCHOGERIATRICS, V10, P198, DOI 10.1111/j.1479-8301.2010.00338.x; Takaki M, 2012, ACTA NEUROPSYCHIATR, V24, P380, DOI 10.1111/j.1601-5215.2012.00663.x	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1346-3500	1479-8301		PSYCHOGERIATRICS	Psychogeriatrics	JUN	2015	15	2					144	146		10.1111/psyg.12090		3	Geriatrics & Gerontology; Psychiatry	Geriatrics & Gerontology; Psychiatry	CK3AH	WOS:000356086800009		
J	Arasaki, T; Ikeda, Y; Shinnaka, Y; Itose, C; Nakamichi, A; Kawakita, H				Arasaki, Takayuki; Ikeda, Yuji; Shinnaka, Yoshiharu; Itose, Chisato; Nakamichi, Akika; Kawakita, Hideyo			The Very precise Echelle SpectroPolarimeter on the Araki telescope (VESPolA)	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						instrumentation: polarimeters; instrumentation: spectrographs; techniques: polarimetric; techniques: spectroscopic	H-ALPHA; LINEAR-POLARIZATION; STARS; POLARIMETER; ATLAS; SPECTROGRAPH; NORTHERN; ESPADONS; BETA	We report on the construction of a high-resolution spectropolarimeter, the Very precise Echelle SpectroPolarimeter on the Araki telescope (VESPolA). The instrument operates in the visible spectral range, i.e., 400-850 nm, and is mounted on the 1.3 m Araki telescope at the Koyama Astronomical Observatory of Kyoto Sangyo University (Kyoto, Japan). It employs an echelle-type spectrograph and a non-ripple super-achromatic half-wave plate, resulting in high polarimetric accuracy of delta P < 0.1% for linear polarization with a spectral resolution of R = 8000 at the central wavelengths and a wide wavelength coverage of delta lambda = 150-250 nm in a single exposure. VESPolA is designed for 1-2 m telescopes that have a Cassegrain focus. This configuration provides a dozen polarization line profiles of various nuclear species from the target spectra simultaneously, and we can therefore obtain complementary information on both the geometry and the velocity field of the nebular emission lines from the circumstellar envelopes. We evaluated the performance of our system by observing a spectroscopic standard star and several polarization standard stars during 2012-2013. VESPolA achieved a spectral resolution 7750 < R < 8250, with a polarimetric accuracy of delta P < 0.1% for linear polarization and a limiting magnitude of m(v) = 7.8 mag with delta P < 0.1% and an integration time of 4 hr. We show preliminary results of variable stars P Cyg, beta Lyr, and VY CMa. We observed polarization profiles across the H alpha and He lines, as well as the TiO absorption bands, which indicate a complex spatial distribution and velocity field of the surrounding gaseous nebulae.	[Arasaki, Takayuki; Ikeda, Yuji; Shinnaka, Yoshiharu; Itose, Chisato; Kawakita, Hideyo] Kyoto Sangyo Univ, Fac Sci, Kita Ku, Kyoto, Kyoto 6038555, Japan; [Ikeda, Yuji] Photocoding, Sakyo Ku, Kyoto, Kyoto 6060025, Japan; [Nakamichi, Akika] Kyoto Sangyo Univ, Koyama Astron Observ, Kita Ku, Kyoto 6038555, Japan	Arasaki, T (reprint author), Kyoto Sangyo Univ, Fac Sci, Kita Ku, Kyoto, Kyoto 6038555, Japan.	ara.arasaki@gmail.com			JSPS KAKENHI [26400234]; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) program for the Strategic Research Foundation at Private Universities [S0801061]	We would like to thank S. Kondo and N. Fujishiro for their support throughout this program. We would also like to acknowledge the developers of LIPS, especially R. Hirata, M. Seki, K. S. Kawabata, and H. Akitaya, for providing an opportunity to build VESPolA and for providing technical comments on the spectropolarimeter. A. Hori took part in the initial phase of building VESPolA. K. Nakamura supported the estimation of the limiting magnitude of the field viewer system. We are grateful to all of the staff of Koyama Astronomical Observatory. This study was supported financially by JSPS KAKENHI Grant Number 26400234, the Japan Society for the Promotion of Science, and the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) program for the Strategic Research Foundation at Private Universities, 2008-2012, S0801061.	Akitaya H, 2009, ASTRON ASTROPHYS, V499, P163, DOI 10.1051/0004-6361/200811275; Silvester J, 2012, MON NOT R ASTRON SOC, V426, P1003, DOI 10.1111/j.1365-2966.2012.21587.x; TURNSHEK DA, 1990, ASTRON J, V99, P1243, DOI 10.1086/115413; SCHMIDT GD, 1992, ASTRON J, V104, P1563, DOI 10.1086/116341; Donati JF, 2006, ASTR SOC P, V358, P362; Lasker BM, 2008, ASTRON J, V136, P735, DOI 10.1088/0004-6256/136/2/735; WHITTET DCB, 1992, ASTROPHYS J, V386, P562, DOI 10.1086/171039; Kashikawa N, 2002, PUBL ASTRON SOC JPN, V54, P819; STENFLO JO, 1982, SOL PHYS, V80, P209, DOI 10.1007/BF00147969; HSU JC, 1982, ASTROPHYS J, V262, P732, DOI 10.1086/160467; Kawabata KS, 1999, PUBL ASTRON SOC PAC, V111, P898, DOI 10.1086/316387; Arasaki T, 2014, PROC SPIE, V9147, DOI 10.1117/12.2055700; ASPIN C, 1985, ASTRON ASTROPHYS, V151, P169; Catanzaro G, 2013, ASTRON ASTROPHYS, V550, DOI 10.1051/0004-6361/201220357; de Diego J. A., 1994, BAAS, V184, P1707; DHILLON VS, 1995, MON NOT R ASTRON SOC, V274, P27; Donati JF, 1999, ASTRON ASTROPHYS SUP, V134, P149, DOI 10.1051/aas:1999130; Donati JF, 1997, ASTRON ASTROPHYS, V326, P1135; Ebizuka N., 2011, PASJ, V63, P613; Hoffman JL, 1998, ASTRON J, V115, P1576, DOI 10.1086/300274; Ikeda Y, 2003, P SOC PHOTO-OPT INS, V4843, P437, DOI 10.1117/12.458833; Ikeda Y, 2004, ASTROPHYS J, V604, P357, DOI 10.1086/381877; Ilyin I, 2011, ASTRON NACHR, V332, P753, DOI 10.1002/asna.201111600; Lamers H. J. G. L. M., 1985, ASTRON ASTROPHYS, V139, P29; Nakamichi A, 2012, MON NOT R ASTRON SOC, V423, P2977, DOI 10.1111/j.1365-2966.2012.20862.x; Pontefract M, 2000, MON NOT R ASTRON SOC, V319, pL19, DOI 10.1046/j.1365-8711.2000.04118.x; RASILLA JL, 1993, ASTR SOC P, V37, P203; Schroeder D. J., 2000, ASTRONOMICAL OPTICS; Seifert W, 2000, P SOC PHOTO-OPT INS, V4008, P96, DOI 10.1117/12.395405; Serkowski K., 1974, METHODS EXPT PHYS A, V12; Snik F, 2011, ASTR SOC P, V437, P237; STAHL O, 1993, ASTRON ASTROPHYS SUP, V99, P167; Wolff M. J., 1996, AAS, V28, P914; WOOD K, 1993, ASTRON ASTROPHYS, V271, P492; Yoshikawa T, 2012, PROC SPIE, V8444, DOI 10.1117/12.925428	35	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	JUN	2015	67	3							35	10.1093/pasj/psv004		19	Astronomy & Astrophysics	Astronomy & Astrophysics	CK4GQ	WOS:000356182500006		
J	Doi, Y; Takita, S; Ootsubo, T; Arimatsu, K; Tanaka, M; Kitamura, Y; Kawada, M; Matsuura, S; Nakagawa, T; Morishima, T; Hattori, M; Komugi, S; White, GJ; Ikeda, N; Kato, D; Chinone, Y; Etxaluze, M; Cypriano, EF				Doi, Yasuo; Takita, Satoshi; Ootsubo, Takafumi; Arimatsu, Ko; Tanaka, Masahiro; Kitamura, Yoshimi; Kawada, Mitsunobu; Matsuura, Shuji; Nakagawa, Takao; Morishima, Takahiro; Hattori, Makoto; Komugi, Shinya; White, Glenn J.; Ikeda, Norio; Kato, Daisuke; Chinone, Yuji; Etxaluze, Mireya; Cypriano, Elysandra F.			The AKARI far-infrared all-sky survey maps	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						atlases; Galaxy: general; infrared: galaxies; ISM: general; surveys	T TAURI STARS; INTERSTELLAR DUST; GALACTIC CIRRUS; MOLECULAR CLOUDS; CONFUSION NOISE; AURIGA REGION; POWER SPECTRA; COLD DUST; EMISSION; HERSCHEL	We present a far-infrared all-sky atlas from a sensitive all-sky survey using the Japanese AKARI satellite. The survey covers >99% of the sky in four photometric bands centred at 65 mu m, 90 mu m, 140 mu m, and 160 mu m, with spatial resolutions ranging from 1' to 1 ''.5. These data provide crucial information on the investigation and characterisation of the properties of dusty material in the interstellar medium (ISM), since a significant portion of its energy is emitted between similar to 50 and 200 mu m. The large-scale distribution of interstellar clouds, their thermal dust temperatures, and their column densities can be investigated with the improved spatial resolution compared to earlier all-sky survey observations. In addition to the point source distribution, the large-scale distribution of ISM cirrus emission, and its filamentary structure, are well traced. We have made the first public release of the full-sky data to provide a legacy data set for use in the astronomical community.	[Doi, Yasuo; Ootsubo, Takafumi] Univ Tokyo, Dept Earth Sci & Astron, Meguro Ku, Tokyo, Japan; [Takita, Satoshi; Arimatsu, Ko; Kitamura, Yoshimi; Kawada, Mitsunobu; Matsuura, Shuji; Nakagawa, Takao; Komugi, Shinya; Ikeda, Norio; Kato, Daisuke] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Tanaka, Masahiro] Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki 3058577, Japan; [Morishima, Takahiro; Hattori, Makoto; Chinone, Yuji] Tohoku Univ, Astron Inst, Aoba Ku, Sendai, Miyagi 9808578, Japan; [White, Glenn J.; Etxaluze, Mireya; Cypriano, Elysandra F.] Open Univ, Dept Phys & Astron, Milton Keynes MK7 6BJ, Bucks, England; [White, Glenn J.; Etxaluze, Mireya] Rutherford Appleton Lab, Space Sci & Technol Dept, Didcot OX11 0QX, Oxon, England; [Cypriano, Elysandra F.] Univ Sao Paulo, Dept Astron, IAG, BR-05508090 Sao Paulo, SP, Brazil	Doi, Y (reprint author), Univ Tokyo, Dept Earth Sci & Astron, Meguro Ku, 3-8-1 Komaba, Tokyo, Japan.	doi@ea.c.u-tokyo.ac.jp			JSPS KAKENHI [19204020, 21111005, 25247016, 25400220]	The authors are grateful to the anonymous referee for the useful discussions and suggestions. This research is based on observations with AKARI, a JAXA project with the participation of ESA. This work has been supported by JSPS KAKENHI Grant Numbers 19204020, 21111005, 25247016, and 25400220. The authors are grateful to Dr. Sunao Hasegawa for the evaluation of the planets' and asteroids' positions.	Abergel A, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201323195; Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321529; Andre P., 2015, HIGHLIGHTS ASTRONOMY, V16, P31; Andre P., 2014, PROTOSTARS PLANETS, VVI, P27; Andre P, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014666; Wichmann R, 1996, ASTRON ASTROPHYS, V312, P439; LOW FJ, 1984, ASTROPHYS J, V278, pL19, DOI 10.1086/184213; Lagache G, 1998, ASTRON ASTROPHYS, V333, P709; BOGGESS NW, 1992, ASTROPHYS J, V397, P420, DOI 10.1086/171797; Kenyon SJ, 2008, MONOGR ASTRON SOC PA, V4, P405; Kawada M, 2007, PUBL ASTRON SOC JPN, V59, pS389; Kiss C, 2001, ASTRON ASTROPHYS, V379, P1161, DOI 10.1051/0004-6361:20011394; Roy A, 2010, ASTROPHYS J, V708, P1611, DOI 10.1088/0004-637X/708/2/1611; Boulanger F, 1996, ASTRON ASTROPHYS, V312, P256; BOULANGER F, 1988, ASTROPHYS J, V330, P964, DOI 10.1086/166526; Bernard JP, 1999, ASTRON ASTROPHYS, V347, P640; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; MATHIS JS, 1983, ASTRON ASTROPHYS, V128, P212; Rebull LM, 2010, ASTROPHYS J SUPPL S, V186, P259, DOI 10.1088/0067-0049/186/2/259; STROM KM, 1989, ASTRON J, V97, P1451, DOI 10.1086/115085; DESERT FX, 1990, ASTRON ASTROPHYS, V237, P215; Gudel M, 2007, ASTRON ASTROPHYS, V468, P353, DOI 10.1051/0004-6361:20065724; Onaka T, 2007, PUBL ASTRON SOC JPN, V59, pS401; Draine BT, 2007, ASTROPHYS J, V657, P810, DOI 10.1086/511055; Gorjian V, 2000, ASTROPHYS J, V536, P550, DOI 10.1086/308974; BECKWITH SVW, 1990, ASTRON J, V99, P924, DOI 10.1086/115385; Kelsall T, 1998, ASTROPHYS J, V508, P44, DOI 10.1086/306380; Murakami H, 2007, PUBL ASTRON SOC JPN, V59, pS369; Lagache G, 2000, ASTRON ASTROPHYS, V354, P247; Torres RM, 2007, ASTROPHYS J, V671, P1813, DOI 10.1086/522924; Compiegne M, 2010, ASTROPHYS J LETT, V724, pL44, DOI 10.1088/2041-8205/724/1/L44; Arzoumanian D, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201116596; Arzoumanian D, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201220822; Beichman C. A., 1988, INFRARED ASTRONOMICA, V1; Bernard JP, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014540; Berriman GB, 2008, ASTR SOC P, V394, P83; Compiegne M, 2011, ASTRON ASTROPHYS, V525, DOI 10.1051/0004-6361/201015292; Doi Y., 2014, PUBL KOREAN AS UNPUB; Doi Y, 2009, ASTR SOC P, V418, P387; Doi Y., 2012, PKAS, V27, P111; Draine BT, 2003, ANNU REV ASTRON ASTR, V41, P241, DOI 10.1146/annurev.astro.41.011802.094840; GAUTIER TN, 1992, ASTRON J, V103, P1313, DOI 10.1086/116144; Hauser M.G., 1988, COBE DIFFUSE INFRARE; Jeong WS, 2005, MON NOT R ASTRON SOC, V357, P535, DOI 10.1111/j.1365-2966.2005.08627.x; JONCAS G, 1992, ASTROPHYS J, V397, P165, DOI 10.1086/171776; Kaneda H, 2009, PUBL ASTRON SOC PAC, V121, P549; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Kiss C, 2003, ASTRON ASTROPHYS, V399, P177, DOI 10.1051/0004-6361:20021787; Konyves V, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014689; Li JZ, 1998, ASTRON ASTROPHYS SUP, V132, P173, DOI 10.1051/aas:1998288; Magazzu A, 1997, ASTRON ASTROPHYS SUP, V124, P449, DOI 10.1051/aas:1997202; Martin P.G., 2010, ASTRON ASTROPHYS, V518, P105; MATHIS JS, 1990, ANNU REV ASTRON ASTR, V28, P37; Meisner AM, 2015, ASTROPHYS J, V798, DOI 10.1088/0004-637X/798/2/88; Miville-Deschenes MA, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014678; Miville-Deschenes MA, 2002, ASTRON ASTROPHYS, V393, P749, DOI 10.1051/0004-6361:20020929; Miville-Deschenes MA, 2005, ASTROPHYS J SUPPL S, V157, P302, DOI 10.1086/427938; Miville-Deschenes MA, 2007, ASTRON ASTROPHYS, V469, P595, DOI 10.1051/0004-6361:20066962; Nagata H, 2004, IEEE T ELECTRON DEV, V51, P270, DOI 10.1109/TED.2003.821764; Nakagawa T, 2007, PUBL ASTRON SOC JPN, V59, pS377; Neugebauer G., 1984, AP J, V278, pL1; Pilbratt GL, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014759; Planck Collaboration, 2014, ARXIV14092495; Planck Commentoration, 2011, ASTRON ASTROPHYS, V536, pA19; Poglitsch A, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014535; Pyo J, 2010, ASTRON ASTROPHYS, V523, DOI 10.1051/0004-6361/201014196; Shirahata M, 2009, PUBL ASTRON SOC JPN, V61, P737; Sousbie T, 2013, 1302015 ASTR SOURC C; Suzuki T, 2008, PUBL ASTRON SOC PAC, V120, P895, DOI 10.1086/591291; Takita S., 2015, PASJ, V67, P49; Takita S, 2010, ASTRON ASTROPHYS, V519, DOI 10.1051/0004-6361/200913475; Toth LV, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/pst017; Ward-Thompson D, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014618; Wheelock S. L., 1994, 9522539 NASA STIRECO; Wright EL, 1998, ASTROPHYS J, V496, P1, DOI 10.1086/305345; Yamamura I, 2009, ASTR SOC P, V418, P3	76	4	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	JUN	2015	67	3							50	10.1093/pasj/psv022		22	Astronomy & Astrophysics	Astronomy & Astrophysics	CK4GQ	WOS:000356182500021		
J	Fujisawa, K; Eriguchi, Y				Fujisawa, Kotaro; Eriguchi, Yoshiharu			Appearance of the prolate and the toroidal magnetic field dominated stars: Analytic approach	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						stars: magnetars; stars: magnetic fields; stars: rotation	NEUTRON-STARS; BAROTROPIC STARS; EQUILIBRIUM-CONFIGURATIONS; HYDROMAGNETIC EQUILIBRIUM; ADIABATIC STABILITY; RELATIVISTIC STARS; MERIDIONAL FLOWS; FOSSIL FIELDS; WHITE-DWARFS; APPROXIMATION	We have analyzed magnetized equilibrium states and shown a condition for the appearance of the prolate and the toroidal magnetic field-dominated stars using analytic approaches. Both observations and numerical stability analysis support that the magnetized star would have prolate and large internal toroidal magnetic fields. In this context, many investigations concerning magnetized equilibrium states have been tried to obtain the prolate and the toroidal dominant solutions, but many of them have failed to obtain such configurations. Since the Lorentz force is a cross-product of current density and magnetic field, the prolate-shaped configurations and the large toroidal magnetic fields in stars require a special relation between current density and the Lorentz force. We have analyzed simple analytical solutions and found that the prolate and the toroidal-dominant configuration require non-force-free toroidal current density that flows in the opposite direction with respect to the bulk current within the star. Such current density results in the Lorentz force which makes the stellar shape prolate. Satisfying this special relation between the current density and the Lorentz force is a key to the appearance of the prolate and the toroidal magnetic field-dominated magnetized star.	[Fujisawa, Kotaro] Waseda Univ, Adv Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Eriguchi, Yoshiharu] Univ Tokyo, Grad Sch Arts & Sci, Dept Earth Sci & Astron, Meguro Ku, Tokyo 1538902, Japan	Fujisawa, K (reprint author), Waseda Univ, Adv Res Inst Sci & Engn, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.	fujisawa@heap.phys.waseda.ac.jp			 [24103006]	KF would like to thank the anonymous reviewer for useful comments and suggestions that helped us to improve this paper. This works was supported by a Grant-in-Aid for Scientific Research on Innovative Areas, No. 24103006.	Haskell B, 2008, MON NOT R ASTRON SOC, V385, P531, DOI 10.1111/j.1365-2966.2008.12861.x; Lander SK, 2012, MON NOT R ASTRON SOC, V419, P732, DOI 10.1111/j.1365-2966.2011.19720.x; DUNCAN RC, 1992, ASTROPHYS J, V392, pL9, DOI 10.1086/186413; Lander SK, 2012, MON NOT R ASTRON SOC, V424, P482, DOI 10.1111/j.1365-2966.2012.21213.x; Bucciantini N, 2015, MON NOT R ASTRON SOC, V447, P3278, DOI 10.1093/mnras/stu2689; Braithwaite J, 2004, NATURE, V431, P819, DOI 10.1038/nature02934; Makishima K, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.171102; THOMPSON C, 1995, MON NOT R ASTRON SOC, V275, P255; Mastrano A, 2012, MON NOT R ASTRON SOC, V421, P760, DOI 10.1111/j.1365-2966.2011.20350.x; Akgun T, 2013, MON NOT R ASTRON SOC, V433, P2445, DOI 10.1093/mnras/stt913; Braithwaite J, 2006, ASTRON ASTROPHYS, V453, P687, DOI 10.1051/0004-6361:20041282; Rea N, 2010, SCIENCE, V330, P944, DOI 10.1126/science.1196088; Duez V, 2010, ASTROPHYS J LETT, V724, pL34, DOI 10.1088/2041-8205/724/1/L34; PRENDERGAST KH, 1956, ASTROPHYS J, V123, P498, DOI 10.1086/146186; Mitchell JP, 2015, MON NOT R ASTRON SOC, V447, P1213, DOI 10.1093/mnras/stu2514; Lander SK, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.071101; Ciolfi R, 2013, MON NOT R ASTRON SOC, V435, pL43, DOI 10.1093/mnrasl/slt092; Mastrano A, 2011, MON NOT R ASTRON SOC, V417, P2288, DOI 10.1111/j.1365-2966.2011.19410.x; Bera P, 2014, MON NOT R ASTRON SOC, V445, P3951, DOI 10.1093/mnras/stu2014; Fujisawa K, 2014, MON NOT R ASTRON SOC, V445, P2777, DOI 10.1093/mnras/stu1911; Ciolfi R, 2009, MON NOT R ASTRON SOC, V397, P913, DOI 10.1111/j.1365-2966.2009.14990.x; OSTRIKER JP, 1969, ASTROPHYS J, V157, P1395, DOI 10.1086/150160; Pili AG, 2014, MON NOT R ASTRON SOC, V439, P3541, DOI 10.1093/mnras/stu215; Braithwaite J, 2007, ASTRON ASTROPHYS, V469, P275, DOI 10.1051/0004-6361:20065903; Uryu K, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.101501; Kiuchi K, 2008, MON NOT R ASTRON SOC, V385, P1327, DOI 10.1111/j.1365-2966.2007.12791.x; TAYLER RJ, 1973, MON NOT R ASTRON SOC, V161, P365; MARKEY P, 1973, MON NOT R ASTRON SOC, V163, P77; Glampedakis K, 2012, MON NOT R ASTRON SOC, V420, P1263, DOI 10.1111/j.1365-2966.2011.20112.x; Broderick AE, 2008, MON NOT R ASTRON SOC, V383, P943, DOI 10.1111/j.1365-2966.2007.12634.x; Armaza C, 2015, ASTROPHYS J, V802, DOI 10.1088/0004-637X/802/2/121; Braithwaite J, 2008, MON NOT R ASTRON SOC, V386, P1947, DOI 10.1111/j.1365-2966.2008.13218.x; Braithwaite J, 2009, MON NOT R ASTRON SOC, V397, P763, DOI 10.1111/j.1365-2966.2008.14034.x; CHANDRASEKHAR S, 1956, P NATL ACAD SCI USA, V42, P5, DOI 10.1073/pnas.42.1.5; Ciolfi R, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/1; Ciolfi R, 2010, MON NOT R ASTRON SOC, V406, P2540, DOI 10.1111/j.1365-2966.2010.16847.x; Ciolfi R, 2011, ASTROPHYS J LETT, V736, DOI 10.1088/2041-8205/736/1/L6; Duez V, 2010, ASTRON ASTROPHYS, V517, DOI 10.1051/0004-6361/200913496; Fujisawa K, 2014, MON NOT R ASTRON SOC, V438, pL61, DOI 10.1093/mnrasl/slt159; Fujisawa K, 2012, MON NOT R ASTRON SOC, V422, P434, DOI 10.1111/j.1365-2966.2012.20614.x; Fujisawa K, 2013, MON NOT R ASTRON SOC, V431, P1453, DOI 10.1093/mnras/stt275; Fujisawa K, 2013, MON NOT R ASTRON SOC, V432, P1245, DOI 10.1093/mnras/stt541; Ioka K, 2004, ASTROPHYS J, V600, P296, DOI 10.1086/379650; Kiuchi K, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201016242; Kiuchi K, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.044045; Lander SK, 2009, MON NOT R ASTRON SOC, V395, P2162, DOI 10.1111/j.1365-2966.2009.14667.x; Lasky PD, 2011, ASTROPHYS J LETT, V735, DOI 10.1088/2041-8205/735/1/L20; MESTEL L, 1972, MON NOT R ASTRON SOC, V156, P419; MESTEL L, 1961, MON NOT R ASTRON SOC, V122, P473; Rea N, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/27; ROXBURGH IW, 1966, MON NOT R ASTRON SOC, V132, P347; Spruit H.C., 2009, IAU S, V259, P61; TAYLER RJ, 1980, MON NOT R ASTRON SOC, V191, P151; Tomimura Y, 2005, MON NOT R ASTRON SOC, V359, P1117, DOI 10.1111/j.1365-2966.2005.08967.x; WENTZEL DG, 1961, ASTROPHYS J, V133, P170, DOI 10.1086/147014; Wentzel D. G, 1960, APJS, V5, P187, DOI 10.1086/190055; WOLTJER L, 1959, ASTROPHYS J, V130, P405, DOI 10.1086/146732; WOLTJER L, 1960, ASTROPHYS J, V131, P227, DOI 10.1086/146823; WOLTJER L, 1959, ASTROPHYS J, V130, P400, DOI 10.1086/146731; Yoshida S, 2006, ASTROPHYS J SUPPL S, V164, P156, DOI 10.1086/501050; Yoshida S, 2006, ASTROPHYS J, V651, P462, DOI 10.1086/507513; Yoshida S, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.044012; Yoshida S, 2013, MON NOT R ASTRON SOC, V435, P893, DOI 10.1093/mnras/stt1362	63	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	JUN	2015	67	3							53	10.1093/pasj/psv024		14	Astronomy & Astrophysics	Astronomy & Astrophysics	CK4GQ	WOS:000356182500024		
J	Fukue, J				Fukue, Jun			Relativistic radiative transfer in a moving stratus irradiated by a luminous flat source	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						accretion; accretion disks; galaxies: active; radiative transfer; relativistic processes; stars: winds, outflows	ACTIVE GALACTIC NUCLEI; PLANE-PARALLEL FLOWS; VARIABLE EDDINGTON FACTOR; CLOUDY ACCRETION DISKS; DENSE CLOUDS; PRESSURE	Relativistic radiative transfer in a geometrically thin stratus (sheet-like gaseous cloud with finite optical depth), which is moving at a relativistic speed around a luminous flat source, such as accretion disks, and is irradiated by the source, is examined under the special relativistic treatment. Incident radiation is aberrated and Doppler-shifted when it is received by the stratus, and emitted radiation is also aberrated and Doppler-shifted when it leaves the stratus. Considering these relativistic effects, we analytically obtain the emergent intensity as well as other radiative quantities in the purely scattering case for both infinite and finite strati. We mainly consider the frequency-integrated case, but also briefly show the frequency-dependent one. We also solve the relativistic radiative transfer equation numerically, and compare the results with the analytical solutions. In the infinite stratus, the mean intensity in the comoving and inertial frames decreases and becomes constant, as the stratus speed increases. The flux in the comoving frame decreases exponentially with the optical depth. The emergent intensity decreases as the speed increases, since the incident photons are redshifted at the bottom-side of the stratus. In the finite stratus, the mean intensity in the comoving and inertial frames quickly increases in the top-side region due to the aberrated photons. The flux in the comoving frame is positive in the range of 0 < beta <= 0.4, while it becomes negative for beta greater than or similar to 0.5. The behavior of the emergent intensity is similar to that of the infinite case, although there is an irradiation effect caused by the aberrated photons.	Osaka Kyoiku Univ, Astron Inst, Osaka 5828582, Japan	Fukue, J (reprint author), Osaka Kyoiku Univ, Astron Inst, Osaka 5828582, Japan.	fukue@cc.osaka-kyoiku.ac.jp					Alonso-Herrero A, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/2/82; Krause M, 2011, MON NOT R ASTRON SOC, V411, P550, DOI 10.1111/j.1365-2966.2010.17698.x; Karas V, 2000, MON NOT R ASTRON SOC, V318, P547; GUILBERT PW, 1988, MON NOT R ASTRON SOC, V233, P475; Arav N, 2001, ASTROPHYS J, V561, P118, DOI 10.1086/323369; LIGHTMAN AP, 1988, ASTROPHYS J, V335, P57, DOI 10.1086/166905; Chelouche D, 2001, MON NOT R ASTRON SOC, V326, P916, DOI 10.1046/j.1365-8711.2001.04586.x; Castor J., 2004, RAD HYDRODYNAMICS; Chandrasekhar S., 1960, RAD TRANSFER; Czerny B, 2012, J PHYS CONF SER, V372, DOI 10.1088/1742-6596/372/1/012013; Elvis M, 2000, ASTROPHYS J, V545, P63, DOI 10.1086/317778; Elvis M, 2012, ASTR SOC P, V460, P186; Fukue J, 2006, PUBL ASTRON SOC JPN, V58, P461; Fukue J, 2013, MON NOT R ASTRON SOC, V436, P2550, DOI 10.1093/mnras/stt1751; Fukue J, 2005, PUBL ASTRON SOC JPN, V57, P1023; Fukue J, 2012, PUBL ASTRON SOC JPN, V64; Fukue J, 2013, MON NOT R ASTRON SOC, V436, P2560, DOI 10.1093/mnras/stt1752; Fukue J, 2012, PROG THEOR PHYS, V126, P135; Fukue J, 2008, PUBL ASTRON SOC JPN, V60, P627; Fukue J, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/pst013; Fukue J, 2011, PROG THEOR PHYS, V126, P135, DOI 10.1143/PTP.126.135; Fukue J, 1996, PUBL ASTRON SOC JPN, V48, P89; Fukue J, 2000, PUBL ASTRON SOC JPN, V52, P613; Fukue J, 2009, PUBL ASTRON SOC JPN, V61, P367; Fukue J, 2012, PUBL ASTRON SOC JPN, V64; Hartnoll SA, 2001, MON NOT R ASTRON SOC, V324, P257, DOI 10.1046/j.1365-8711.2001.04333.x; ICKE V, 1989, ASTRON ASTROPHYS, V216, P294; Kato S., 2008, BLACK HOLE ACCRETION; King AL, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/1/2; Kitabatake E, 2003, PUBL ASTRON SOC JPN, V55, P267; Kitabatake E, 2003, PUBL ASTRON SOC JPN, V55, P1115; Mihalas D., 1970, STELLAR ATMOSPHERES; Mihalas D, 2001, J QUANT SPECTROSC RA, V71, P61, DOI 10.1016/S0022-4073(01)00013-9; NANDRA K, 1994, MON NOT R ASTRON SOC, V267, P974; Peraiah A., 2001, INTRO RADIATIVE TRAN; Plewa P. M., 2013, MNRAS, V431, P1127; Rees M.J., 1987, MNRAS, V228; Rybicki G. B., 1979, RAD PROCESSES ASTROP; SIVRON R, 1993, ASTROPHYS J, V402, P420, DOI 10.1086/172146	39	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	JUN	2015	67	3							44	10.1093/pasj/psv015		14	Astronomy & Astrophysics	Astronomy & Astrophysics	CK4GQ	WOS:000356182500015		
J	Fukue, J				Fukue, Jun			Eddington limit for a gaseous stratus with finite optical depth	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						accretion: accretion disks; quasars: supermassive black holes; radiative transfer; stars: winds, outflows	ACCRETION DISKS; RADIATIVE-TRANSFER	The Eddington luminosity of a spherical source is usually defined for a uniformly extending normal plasma. We usually suppose that the gas can accrete to the central object at the sub-Eddington luminosity, while it would be blown off from the central luminous source in the super-Eddington case. We reconsider this central dogma of the Eddington limit under the radiative transfer effect for the purely scattering case, using analytical and numerical methods. For the translucent isolated gas cloud (stratus) with finite optical depth, the concept of the Eddington luminosity is drastically changed. In an heuristic way, we find that the critical condition is approximately expressed as Gamma = (1 + mu(*) + tau(c))/2, where Gamma (= L/L-E) is the central luminosity L normalized by the Eddington luminosity L-E, tau(c) is the optical depth of the stratus, and mu(*) (=root 1 - R-*(2)/R-2) is the direction cosine of the central object, R-* being the radius of the central object, and R the distance from the central object. When the optical depth of the stratus is around unity, the classical Eddington limit roughly holds for the stratus; Gamma similar to 1. However, when the optical depth is greater than unity, the critical condition becomes roughly Gamma similar to tau(c)/2, and the stratus would infall on to the central source even at the highly super-Eddington luminosity. When the optical depth is less than unity, on the other hand, the critical condition reduces to Gamma greater than or similar to (1 + mu(*))/2, and the stratus could be blown off in some limited ranges, depending on mu(*). This new concept of the Eddington limit for the isolated stratus could drastically change the accretion and outflow physics of highly inhomegeneous plasmas, with relevance for astrophysical jets and winds and supermassive black hole formation.	Osaka Kyoiku Univ, Astron Inst, Osaka 5828582, Japan	Fukue, J (reprint author), Osaka Kyoiku Univ, Astron Inst, Osaka 5828582, Japan.	fukue@cc.osaka-kyoiku.ac.jp					Heinzeller D, 2007, MON NOT R ASTRON SOC, V374, P1146, DOI 10.1111/j.1365-2966.2006.11233.x; Owocki SP, 2004, ASTROPHYS J, V616, P525, DOI 10.1086/424910; BELL KR, 1994, ASTROPHYS J, V427, P987, DOI 10.1086/174206; Begelman MC, 2006, ASTROPHYS J, V643, P1065, DOI 10.1086/503093; BEGELMAN MC, 1978, MON NOT R ASTRON SOC, V184, P53; Eddington A. S., 1926, INTERNAL CONSITITUTI; Frank J., 2002, ACCRETION POWER ASTR; Fukue J, 2013, MON NOT R ASTRON SOC, V436, P2550, DOI 10.1093/mnras/stt1751; Fukue J, 2000, PUBL ASTRON SOC JPN, V52, P829; Fukue J, 2004, PUBL ASTRON SOC JPN, V56, P569; Fukue J, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/pst013; Fukue J, 2015, PUBL ASTRON SOC JPN, V67, DOI 10.1093/pasj/psv015; Fukue J, 2011, PUBL ASTRON SOC JPN, V63, P1273; Kato S., 2008, BLACK HOLE ACCRETION; Ruszkowski M., 2004, APJ, V586, P384; Shaviv NJ, 2000, ASTROPHYS J, V532, pL137, DOI 10.1086/312585; Shaviv NJ, 1998, ASTROPHYS J, V494, pL193, DOI 10.1086/311182	17	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	JUN	2015	67	3							57	10.1093/pasj/psv036		9	Astronomy & Astrophysics	Astronomy & Astrophysics	CK4GQ	WOS:000356182500028		
J	Hamana, T; Sakurai, J; Koike, M; Miller, L				Hamana, Takashi; Sakurai, Junya; Koike, Michitaro; Miller, Lance			Cosmological constraints from Subaru weak lensing cluster counts	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						cosmological parameters; cosmology: observations; dark matter; large-scale structure of universe	DARK-MATTER HALOS; GALAXY SHAPE MEASUREMENT; POINT-SPREAD FUNCTION; DIGITAL SKY SURVEY; COSMIC SHEAR; SUPRIME-CAM; PEAK STATISTICS; HIGH-REDSHIFT; CFHTLS-WIDE; DEEP	We present results of weak lensing cluster counts obtained from 11-degree(2) Subaru/SuprimeCam data. Although the area is much smaller than previous work dealing with weak lensing peak statistics, the number density of galaxies usable for weak lensing analysis is about twice as large. The higher galaxy number density reduces the noise in the weak lensing mass maps, and thus increases the signal-to-noise ratio (S/N) of peaks of the lensing signal due to massive clusters. This enables us to construct a weak lensing selected cluster sample by adopting a high threshold S/N, such that the contamination rate due to false signals is small. We find six peaks with S/N > 5. For all the peaks, previously identified clusters of galaxies are matched within a separation of 1, demonstrating good correspondence between the peaks and clusters of galaxies. We evaluate the statistical error in the weak lensing cluster counts using mock weak lensing data generated from full-sky ray-tracing simulations, and find N-peak = 6 +/- 3.1 in an effective area of 9.0 degree(2). We compare the measured weak lensing cluster counts with the theoretical model prediction based on halo models and place the constraint on the Omega(m)-sigma(8) plane which is found to be consistent with currently standard Lambda CDM models. It is demonstrated that the weak lensing cluster counts can place a unique constraint on the sigma(8)-c(0) plane, where c(0) is the normalization of the dark matter halo mass-concentration relationship. Finally we discuss prospects for ongoing/future wide field optical galaxy surveys.	[Hamana, Takashi; Sakurai, Junya; Koike, Michitaro] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Miller, Lance] Univ Oxford, Dept Phys, Oxford OX1 3RH, England	Hamana, T (reprint author), Natl Astron Observ Japan, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan.	hamana.tk@nao.ac.jp			JSPS Promotion of Science [23540324]	We thank Y. Okura, M. Takada, M. Oguri and S. Miyazaki for useful discussions/comments. We are grateful to R. Takahashi and M. Shirasaki for assistance with running the N-body simulations for the full-sky gravitational lensing simulation. We would like to thank Matthew R. Becker for making the source codes of CALCLENS publicly available, and HEALPix team for making the HEALPix software publicly available. This paper makes use of software developed for the Large Synoptic Survey Telescope. We thank the LSST Project for making their code available as free software. 5 We would like to thank HSC Data Analysis Software Team for their effort to develop the hscPipe software suite. TH and LM thank the Aspen Center for Physics for their warm hospitality, where this work was partly done. Numerical computations in this paper were in part carried out Cray XC30 at Center for Computational Astrophysics, National Astronomical Observatory of Japan. This work is based in part on data collected at Subaru Telescope and obtained from the SMOKA, which is operated by the Astronomy Data Center, National Astronomical Observatory of Japan. This work is supported in part by Grant-in-Aid for Scientific Research from the JSPS Promotion of Science (23540324).	Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Duffy AR, 2008, MON NOT R ASTRON SOC, V390, pL64, DOI 10.1111/j.1745-3933.2008.00537.x; Borgani S, 2001, ASTROPHYS J, V561, P13, DOI 10.1086/323214; Bertin E, 2002, ASTR SOC P, V281, P228; Liu XK, 2015, MON NOT R ASTRON SOC, V450, P2888, DOI 10.1093/mnras/stv784; Warren MS, 2006, ASTROPHYS J, V646, P881, DOI 10.1086/504962; Axelrod T, 2010, PROC SPIE, V7740, DOI 10.1117/12.857297; Mantz A, 2010, MON NOT R ASTRON SOC, V406, P1759, DOI 10.1111/j.1365-2966.2010.16992.x; Hennawi JF, 2005, ASTROPHYS J, V624, P59, DOI 10.1086/428749; Hamana T, 2012, MON NOT R ASTRON SOC, V425, P2287, DOI 10.1111/j.1365-2966.2012.21582.x; Gorski KM, 2005, ASTROPHYS J, V622, P759, DOI 10.1086/427976; Ettori S, 2013, SPACE SCI REV, V177, P119, DOI 10.1007/s11214-013-9976-7; Bellagamba F, 2011, MON NOT R ASTRON SOC, V413, P1145, DOI 10.1111/j.1365-2966.2011.18202.x; Bullock JS, 2001, MON NOT R ASTRON SOC, V321, P559, DOI 10.1046/j.1365-8711.2001.04068.x; Gal RR, 2003, ASTRON J, V125, P2064, DOI 10.1086/368240; Rhodes JD, 2007, ASTROPHYS J SUPPL S, V172, P203, DOI 10.1086/516592; Marian L, 2010, ASTROPHYS J, V709, P286, DOI 10.1088/0004-637X/709/1/286; Fan ZH, 2010, ASTROPHYS J, V719, P1408, DOI 10.1088/0004-637X/719/2/1408; Scoville N, 2007, ASTROPHYS J SUPPL S, V172, P150, DOI 10.1086/516751; Ilbert O, 2009, ASTROPHYS J, V690, P1236, DOI 10.1088/0004-637X/690/2/1236; Schirmer M, 2007, ASTRON ASTROPHYS, V462, P875, DOI 10.1051/0004-6361:20065955; King LJ, 2011, MON NOT R ASTRON SOC, V416, P2539, DOI 10.1111/j.1365-2966.2011.19009.x; Wittman D, 2006, ASTROPHYS J, V643, P128, DOI 10.1086/502621; Heymans C, 2012, MON NOT R ASTRON SOC, V427, P146, DOI 10.1111/j.1365-2966.2012.21952.x; Miyazaki S, 2007, ASTROPHYS J, V669, P714, DOI 10.1086/521621; Shupe DL, 2005, ASTR SOC P, V347, P491; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Miyazaki S, 2002, PUBL ASTRON SOC JPN, V54, P833; Ludlow AD, 2014, MON NOT R ASTRON SOC, V441, P378, DOI 10.1093/mnras/stu483; Miller L, 2007, MON NOT R ASTRON SOC, V382, P315, DOI 10.1111/j.1365-2966.2007.12363.x; Dietrich JP, 2012, NATURE, V487, P202, DOI 10.1038/nature11224; Maturi M, 2005, ASTRON ASTROPHYS, V442, P851, DOI 10.1051/0004-6361:20042600; Bartelmann M, 2001, ASTRON ASTROPHYS, V378, P361, DOI 10.1051/0004-6361:20011199; Wen ZL, 2009, ASTROPHYS J SUPPL S, V183, P197, DOI 10.1088/0067-0049/183/2/197; Hamana T, 2004, MON NOT R ASTRON SOC, V350, P893, DOI 10.1111/j.1365-2966.2004.07691.x; Hamana T, 2013, PUBL ASTRON SOC JPN, V65; Baba H, 2002, ASTR SOC P, V281, P298; Schneider P, 2002, ASTRON ASTROPHYS, V389, P729, DOI 10.1051/0004-6361:20020626; Zhao DH, 2009, ASTROPHYS J, V707, P354, DOI 10.1088/0004-637X/707/1/354; Taniguchi Y, 2007, ASTROPHYS J SUPPL S, V172, P9, DOI 10.1086/516596; Prada F, 2012, MON NOT R ASTRON SOC, V423, P3018, DOI 10.1111/j.1365-2966.2012.21007.x; Hilbert S, 2009, ASTRON ASTROPHYS, V499, P31, DOI 10.1051/0004-6361/200811054; Navarro JF, 1997, ASTROPHYS J, V490, P493, DOI 10.1086/304888; Kitching TD, 2008, MON NOT R ASTRON SOC, V390, P149, DOI 10.1111/j.1365-2966.2008.13628.x; Gavazzi R, 2007, ASTRON ASTROPHYS, V462, P459, DOI 10.1051/0004-6361:20065677; Baltz EA, 2009, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2009/01/015; Becker MR, 2013, MON NOT R ASTRON SOC, V435, P115, DOI 10.1093/mnras/stt1352; Bertin E., 2006, ASP C SER, V351, P112; Bohringer H, 2014, ASTRON ASTROPHYS, V570, DOI 10.1051/0004-6361/201323155; Cardone VF, 2015, ASTRON ASTROPHYS, V574, DOI 10.1051/0004-6361/201424699; Diemer B, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/1/108; Finoguenov A, 2007, ASTROPHYS J SUPPL S, V172, P182, DOI 10.1086/516577; Fu L, 2008, ASTRON ASTROPHYS, V479, P9, DOI 10.1051/0004-6361:20078522; Hamana T, 2008, PUBL ASTRON SOC JPN, V60, P1363; Hao JG, 2010, ASTROPHYS J SUPPL S, V191, P254, DOI 10.1088/0067-0049/191/2/254; Henry JP, 2004, ASTROPHYS J, V609, P603, DOI 10.1086/421336; Hinshaw G, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/19; Ivezic Z., 2008, ARXIV08052366; Klypin AA, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/2/102; Koester BP, 2007, ASTROPHYS J, V660, P239, DOI 10.1086/509599; Kubo JM, 2009, ASTROPHYS J, V702, P980, DOI 10.1088/0004-637X/702/2/980; Kwan J, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/123; Liu J, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.063507; Maccio AV, 2008, MON NOT R ASTRON SOC, V391, P1940, DOI 10.1111/j.1365-2966.2008.14029.x; Mainini R, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/08/063; Maturi M, 2010, ASTRON ASTROPHYS, V519, DOI 10.1051/0004-6361/200912866; Miller L, 2013, MON NOT R ASTRON SOC, V429, P2858, DOI 10.1093/mnras/sts454; Miyazaki S, 2002, ASTROPHYS J, V580, pL97, DOI 10.1086/345613; Miyazaki S., 2012, SPIE C P, V8446; Rozo E, 2010, ASTROPHYS J, V708, P645, DOI 10.1088/0004-637X/708/1/645; Schneider P, 1996, MON NOT R ASTRON SOC, V283, P837; Shan HY, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/1/56; Shirasaki M., 2015, MNRAS UNPUB; Springel V, 2005, MON NOT R ASTRON SOC, V364, P1105, DOI 10.1111/j.1365-2966.2005.09655.x; Takey A, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201117498; Teyssier R, 2009, ASTRON ASTROPHYS, V497, P335, DOI 10.1051/0004-6361/200810657; Vikhlinin A, 2009, ASTROPHYS J, V692, P1060, DOI 10.1088/0004-637X/692/2/1060; Wen ZL, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/1/68; Zwicky F., 1961, CATALOGUE GALAXIES C, VI	79	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	JUN	2015	67	3							34	10.1093/pasj/psv034		16	Astronomy & Astrophysics	Astronomy & Astrophysics	CK4GQ	WOS:000356182500005		
J	Inoue, Y; Nakashima, S; Tahara, M; Kataoka, J; Totani, T; Fujita, Y; Sofue, Y				Inoue, Yoshiyuki; Nakashima, Shinya; Tahara, Masaya; Kataoka, Jun; Totani, Tomonori; Fujita, Yutaka; Sofue, Yoshiaki			Metal enrichment in the Fermi bubbles as a probe of their origin	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						Galaxy: abundances; Galaxy: center; Galaxy: halo; X-rays: ISM	GALACTIC CHEMICAL EVOLUTION; X-RAY EMISSION; GAMMA-RAY; HOT GAS; SUPERNOVA RATE; MILKY-WAY; IA SUPERNOVAE; COSMIC-RAYS; JETS; MASS	The Fermi bubbles are gigantic gamma-ray structures in our Galaxy. The physical origin of the bubbles is still under debate. The leading scenarios can be divided into two categories. One is nuclear star-forming activity similar to extragalactic starburst galaxies and the other is past active galactic nucleus (AGN)-like activity of the Galactic center supermassive black hole. In this letter, we propose that metal abundance measurements will provide an important clue to probe their origin. Based on a simple spherically symmetric bubble model, we find that the generated metallicity and abundance patterns of the bubbles' gas strongly depend on assumed star formation or AGN activities. Star formation scenarios predict higher metallicities and abundance ratios of [O/Fe] and [Ne/Fe] than AGN scenarios do because of supernovae ejecta. Furthermore, the resultant abundance depends on the gamma-ray emission process because different mass injection histories are required for the different gamma-ray emission processes due to the acceleration and cooling time scales of non-thermal particles. Future X-ray missions such as ASTRO-H and Athena will give a clue to probe the origin of the bubbles through abundance measurements with their high energy resolution instruments.	[Inoue, Yoshiyuki; Nakashima, Shinya] Inst Space & Astronaut Sci JAXA, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Tahara, Masaya; Kataoka, Jun] Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Totani, Tomonori] Univ Tokyo, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Fujita, Yutaka] Osaka Univ, Grad Sch Sci, Dept Earth & Space Sci, Toyonaka, Osaka 5600043, Japan; [Sofue, Yoshiaki] Univ Tokyo, Inst Astron, Mitaka, Tokyo 1810015, Japan	Inoue, Y (reprint author), Inst Space & Astronaut Sci JAXA, Chuo Ku, 3-1-1 Yoshinodai, Sagamihara, Kanagawa 2525210, Japan.	yinoue@astro.isas.jaxa.jp			JAXA international top young fellowship	We thank the anonymous referee for useful comments and suggestions. We also thank Noriko Yamasaki and Dmitry Malyshev for useful comments and discussions. Y.I. acknowledges support by the JAXA international top young fellowship.	Ackermann M, 2014, ASTROPHYS J, V793, DOI 10.1088/0004-637X/793/1/64; Ade P.A.R., 2013, ASTRON ASTROPHYS, V554, P139; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; Tominaga N, 2007, ASTROPHYS J, V660, P516, DOI 10.1086/513063; Nomoto K, 2006, NUCL PHYS A, V777, P424, DOI 10.1016/j.nuclphysa.2006.05.008; Iwamoto K, 1999, ASTROPHYS J SUPPL S, V125, P439, DOI 10.1086/313278; Kawasaki MT, 2002, ASTROPHYS J, V572, P897, DOI 10.1086/340383; Su M, 2010, ASTROPHYS J, V724, P1044, DOI 10.1088/0004-637X/724/2/1044; Hooper D, 2013, PHYS DARK UNIVERSE, V2, P118, DOI 10.1016/j.dark.2013.06.003; Mertsch P, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.091101; Crocker RM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.101102; Totani T, 2008, PUBL ASTRON SOC JPN, V60, P1327; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Strickland DK, 2002, ASTROPHYS J, V568, P689, DOI 10.1086/338889; Hirschi R, 2005, ASTRON ASTROPHYS, V433, P1013, DOI 10.1051/0004-6361:20041554; Yates RM, 2013, MON NOT R ASTRON SOC, V435, P3500, DOI 10.1093/mnras/stt1542; Snowden SL, 1997, ASTROPHYS J, V485, P125, DOI 10.1086/304399; Matsunaga N, 2011, NATURE, V477, P188, DOI 10.1038/nature10359; Nomoto K, 2013, ANNU REV ASTRON ASTR, V51, P457, DOI 10.1146/annurev-astro-082812-140956; Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Yang HYK, 2013, MON NOT R ASTRON SOC, V436, P2734, DOI 10.1093/mnras/stt1772; Horiuchi S, 2010, ASTROPHYS J, V723, P329, DOI 10.1088/0004-637X/723/1/329; Dobler G, 2010, ASTROPHYS J, V717, P825, DOI 10.1088/0004-637X/717/2/825; Zubovas K, 2011, MON NOT R ASTRON SOC, V415, pL21, DOI 10.1111/j.1745-3933.2011.01070.x; Mannucci F, 2005, ASTRON ASTROPHYS, V433, P807, DOI 10.1051/0004-6361:20041411; OSTRIKER JP, 1988, REV MOD PHYS, V60, P1, DOI 10.1103/RevModPhys.60.1; Kobayashi C, 2006, ASTROPHYS J, V653, P1145, DOI 10.1086/508914; Dobler G, 2008, ASTROPHYS J, V680, P1222, DOI 10.1086/587862; Carretti E, 2013, NATURE, V493, P66, DOI 10.1038/nature11734; Migliari S, 2002, SCIENCE, V297, P1673, DOI 10.1126/science.1073660; Strickland DK, 2009, ASTROPHYS J, V697, P2030, DOI 10.1088/0004-637X/697/2/2030; Bland-Hawthorn J, 2003, ASTROPHYS J, V582, P246; Celotti A, 2008, MON NOT R ASTRON SOC, V385, P283, DOI 10.1111/j.1365-2966.2007.12758.x; Cheng KS, 2011, ASTROPHYS J LETT, V731, DOI 10.1088/2041-8205/731/1/L17; Crocker RM, 2014, ASTROPHYS J LETT, V791, DOI 10.1088/2041-8205/791/2/L20; Crocker RM, 2012, MON NOT R ASTRON SOC, V423, P3512, DOI 10.1111/j.1365-2966.2012.21149.x; Fang TT, 2014, ASTROPHYS J LETT, V785, DOI 10.1088/2041-8205/785/2/L24; Finkbeiner DP, 2004, ASTROPHYS J, V614, P186, DOI 10.1086/423482; Fox A. J., 2014, ARXIV14121480; Fujita Y, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/1/67; Fujita Y, 2013, ASTROPHYS J LETT, V775, DOI 10.1088/2041-8205/775/1/L20; Guo FL, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/181; Guo FL, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/182; Horiuchi S, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/154; Kataoka J., 2015, UNPUB; Kataoka J, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/57; Kroupa P, 2001, MON NOT R ASTRON SOC, V322, P231, DOI 10.1046/j.1365-8711.2001.04022.x; Lacki BC, 2014, MON NOT R ASTRON SOC, V444, pL39, DOI 10.1093/mnrasl/slu107; Mihalas D., 1984, FDN RAD HYDRODYNAMIC; Miller M. J., 2014, ARXIV E PRINTS; Miller MJ, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/2/118; Mou GB, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/2/109; Nakashima S, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/20; Nandra K., 2013, ARXIV13062307; Portinari L, 1998, ASTRON ASTROPHYS, V334, P505; Sakai K, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/psu058; Schanne S, 2007, ESA SP PUBL, V622, P117; Sikora M, 2005, ASTROPHYS J, V625, P72, DOI 10.1086/429314; Sikora M, 2000, ASTROPHYS J, V534, P109, DOI 10.1086/308756; Su M, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/61; Tahara M., 2015, ARXIV150104405; Takahashi T., 2012, SPIE P, V8443; Thoudam S, 2013, ASTROPHYS J LETT, V778, DOI 10.1088/2041-8205/778/1/L20; Totani T, 2006, PUBL ASTRON SOC JPN, V58, P965; Uchiyama H, 2013, PUBL ASTRON SOC JPN, V65; Yao Y, 2009, ASTROPHYS J, V690, P143, DOI 10.1088/0004-637X/690/1/143	66	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	JUN	2015	67	3							56	10.1093/pasj/psv032		8	Astronomy & Astrophysics	Astronomy & Astrophysics	CK4GQ	WOS:000356182500027		
J	Itoh, R; Fukazawa, Y; Tanaka, YT; Kawabata, KS; Takaki, K; Hayashi, K; Uemura, M; Ui, T; Sasada, M; Yamanaka, M; Yoshida, M				Itoh, Ryosuke; Fukazawa, Yasushi; Tanaka, Yasuyuki T.; Kawabata, Koji S.; Takaki, Katsutoshi; Hayashi, Kazuma; Uemura, Makoto; Ui, Takahiro; Sasada, Mahito; Yamanaka, Masayuki; Yoshida, Michitoshi			An emergence of a new polarized emission region in blazar Mrk 421 associated with an X-ray flare	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						BL Lacertae objects: individual (Mrk 421, Polarization); Galaxies: jets	BL LACERTAE OBJECTS; ACTIVE GALACTIC NUCLEI; LARGE-AREA TELESCOPE; SPECTRAL ENERGY-DISTRIBUTION; OPTICAL POLARIZATION; ELECTRON ACCELERATION; OUTBURST; JET; MARKARIAN-421; VARIABILITY	We report on long-term multi-wavelength monitoring of blazar Mrk 421 from 2010 to 2011. The source exhibited extreme X-ray flares in 2010. Our research group performed optical photopolarimetric follow-up observations using the Kanata telescope. In 2010, the variability in the X-ray band was significant, while the optical and ultraviolet (UV) flux decreased gradually. Polarization properties also exhibited unique variability in 2010, suggesting the presence of a systematic component of polarization and magnetic field alignment for the emergence of a new polarized emission region. In contrast, in 2011 the variability in the X-ray band was smaller, and the variability in the optical and UV bands was larger, than in 2010. To explore the reasons for these differences, spectral fitting analysis was performed via simple synchrotron self-Compton modeling; the results revealed different behaviors in terms of spectral evolution between these periods, suggesting different variabilitymechanisms between 2010 and 2011. In 2010, the radiation was likely the result of energy injection into the emitting regions with an aligned magnetic field. In contrast, in 2011 the superposition of different emission regions may have contributed to the low degree of observed polarization. It also implies that high-energy electrons which were not accelerated to ultra-relativistic velocities were injected in 2011.	[Itoh, Ryosuke; Fukazawa, Yasushi; Takaki, Katsutoshi; Hayashi, Kazuma; Ui, Takahiro] Hiroshima Univ, Dept Phys Sci, Hiroshima 7398526, Japan; [Tanaka, Yasuyuki T.; Kawabata, Koji S.; Uemura, Makoto; Yoshida, Michitoshi] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Hiroshima 7398526, Japan; [Sasada, Mahito] Kyoto Univ, Kwasan Observ, Yamashina Ku, Kyoto, Kyoto 6078471, Japan; [Yamanaka, Masayuki] Konan Univ, Fac Sci & Engn, Dept Phys, Kobe, Hyogo 6588501, Japan	Itoh, R (reprint author), Hiroshima Univ, Dept Phys Sci, Hiroshima 7398526, Japan.	itoh@hep01.hepl.hiroshima-u.ac.jp			Japan Society for the Promotion of Science (JSPS)	This work was supported by the Japan Society for the Promotion of Science (JSPS).	Abdo AA, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/2/131; Abdo AA, 2010, ASTROPHYS J, V716, P30, DOI 10.1088/0004-637X/716/1/30; Ackermann M, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/171; Burrows DN, 2005, SPACE SCI REV, V120, P165, DOI 10.1007/s11214-005-5097-2; Tramacere A, 2009, ASTRON ASTROPHYS, V501, P879, DOI 10.1051/0004-6361/200810865; Urry CM, 2000, ASTROPHYS J, V532, P816, DOI 10.1086/308616; URRY CM, 1995, PUBL ASTRON SOC PAC, V107, P803, DOI 10.1086/133630; Poole TS, 2008, MON NOT R ASTRON SOC, V383, P627, DOI 10.1111/j.1365-2966.2007.12563.x; PUNCH M, 1992, NATURE, V358, P477, DOI 10.1038/358477a0; Hagen-Thorn VA, 2008, ASTROPHYS J, V672, P40, DOI 10.1086/523841; Marscher AP, 2008, NATURE, V452, P966, DOI 10.1038/nature06895; Ikejiri Y, 2011, PUBL ASTRON SOC JPN, V63, P639; SCHULZ A, 1983, ASTRON ASTROPHYS, V121, P158; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Massaro E, 2004, ASTRON ASTROPHYS, V413, P489, DOI 10.1051/0004-6361:20031558; Marscher AP, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/87; Tramacere A, 2007, ASTRON ASTROPHYS, V466, P521, DOI 10.1051/0004-6361:20066723; MEAD ARG, 1990, ASTRON ASTROPHYS SUP, V83, P183; Abdo AA, 2010, NATURE, V463, P919, DOI 10.1038/nature08841; Villata M, 1998, ASTRON ASTROPHYS SUP, V130, P305, DOI 10.1051/aas:1998415; Ushio M, 2010, ASTROPHYS J, V724, P1509, DOI 10.1088/0004-637X/724/2/1509; Finke JD, 2008, ASTROPHYS J, V686, P181, DOI 10.1086/590900; BAND DL, 1985, ASTROPHYS J, V298, P128, DOI 10.1086/163593; Isobe N, 2010, PUBL ASTRON SOC JPN, V62, pL55; Itoh R, 2013, ASTROPHYS J LETT, V775, DOI 10.1088/2041-8205/775/1/L26; Kawabata KS, 2008, P SOC PHOTO-OPT INS, V7014, pL144, DOI 10.1117/12.788569; Lico R, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201424341; LOCKMAN FJ, 1995, ASTROPHYS J SUPPL S, V97, P1, DOI 10.1086/192133; MOORE RL, 1982, ASTROPHYS J, V260, P415, DOI 10.1086/160266; Morozova DA, 2014, ASTRON J, V148, DOI 10.1088/0004-6256/148/3/42; Nolan PL, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/2/31; Piner BG, 2005, ASTROPHYS J, V622, P168, DOI 10.1086/428039; Spada M, 2001, MON NOT R ASTRON SOC, V325, P1559, DOI 10.1046/j.1365-8711.2001.04557.x; Uemura M, 2010, PUBL ASTRON SOC JPN, V62, P69; Visvanathan N, 1998, ASTRON J, V116, P2119, DOI 10.1086/300610; Wright EL, 2006, PUBL ASTRON SOC PAC, V118, P1711, DOI 10.1086/510102; Zhang YH, 2002, ASTROPHYS J, V572, P762, DOI 10.1086/340349	37	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	JUN	2015	67	3							45	10.1093/pasj/psv016		9	Astronomy & Astrophysics	Astronomy & Astrophysics	CK4GQ	WOS:000356182500016		
J	Izawa, M; Dotani, T; Fujinaga, T; Bamba, A; Ozaki, M; Hiraga, JS				Izawa, Masaharu; Dotani, Tadayasu; Fujinaga, Takahisa; Bamba, Aya; Ozaki, Masanobu; Hiraga, Junko S.			Suzaku observations of the old pulsar wind nebula candidate HESS J1356-645	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						ISM: individual objects (HESS J1356-645, PSR J1357-6429); X-rays: ISM	X-RAY-DETECTOR; BOARD SUZAKU; SUPERNOVA-REMNANTS; EVOLUTION; EMISSION; YOUNG; J1357-6429; DISCOVERY; VIEW; XIS	A largely extended X-ray emission was discovered around the pulsar PSR J1357-6429 with the Suzaku deep observations. The pulsar, whose characteristic age is 7.3 kyr, is located within the TeV gamma-ray source HESS J1356-645. The extended emission is found to have a 1 sigma X-ray size of similar to 4', or similar to 3 pc at 2.4 kpc, with a small offset from the pulsar. Its X-ray spectrum is well reproduced by a simple power-law model with a photon index of 1.70(-0.06)(+0.07). No significant spatial variation was found for the X-ray photon index as a function of distance from the pulsar. We conclude that the extended emission is associated to the pulsar wind nebula (PWN) of PSR J1357-6429. This is a new sample of largely extended nebulae around middle-aged pulsars. We discuss the evolution of this PWN according to the relic PWN scenario.	[Izawa, Masaharu; Dotani, Tadayasu] Tokyo Inst Technol, Dept Phys, Meguro Ku, Tokyo 1528550, Japan; [Dotani, Tadayasu; Ozaki, Masanobu] Inst Space & Astron Sci JAXA, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Dotani, Tadayasu] SOKENDAI, Sch Phys Sci, Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Fujinaga, Takahisa] Tsudakoma Corp, Kanazawa, Ishikawa 9218650, Japan; [Bamba, Aya] Aoyama Gakuin Univ, Dept Phys & Math, Chuo Ku, Sagamihara, Kanagawa 2525258, Japan; [Hiraga, Junko S.] Univ Tokyo, Bunkyo Ku, Tokyo 1130033, Japan	Izawa, M (reprint author), Tokyo Inst Technol, Dept Phys, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528550, Japan.	izawa@astro.isas.jaxa.jp; bamba@phys.aoyama.ac.jp	XRAY, SUZAKU/A-1808-2009		Japanese Ministry of Education, Culture, Sports, Science and Technology [22684012]	We thank the anonymous referee for fruitful comments. MI and AB thank Makoto Sawada for his help on the Suzaku data analysis. We also thank Koji Mori for the useful comments on the NXB spectra. This work was supported in part by Grant-in-Aid for Scientific Research of the Japanese Ministry of Education, Culture, Sports, Science and Technology, No. 22684012 (AB).	Abramowski A, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117445; Anada T, 2010, PUBL ASTRON SOC JPN, V62, P179; Blondin JM, 2001, ASTROPHYS J, V563, P806, DOI 10.1086/324042; Kalberla PMW, 2005, ASTRON ASTROPHYS, V440, P775, DOI 10.1051/0004-6361:20041864; Gaensler BM, 2006, ANNU REV ASTRON ASTR, V44, P17, DOI 10.1146/annurev.astro.44.051905.092528; Bamba A, 2010, ASTROPHYS J LETT, V719, pL116, DOI 10.1088/2041-8205/719/2/L116; Rho J, 1998, ASTROPHYS J, V503, pL167, DOI 10.1086/311538; Smith RK, 2001, ASTROPHYS J, V556, pL91, DOI 10.1086/322992; Aharonian F, 2006, ASTROPHYS J, V636, P777, DOI 10.1086/498013; Gelfand JD, 2009, ASTROPHYS J, V703, P2051, DOI 10.1088/0004-637X/703/2/2051; Bamba A, 2010, ASTROPHYS J, V709, P507, DOI 10.1088/0004-637X/709/1/507; Ryu SG, 2009, PUBL ASTRON SOC JPN, V61, P751; Camilo F, 2004, ASTROPHYS J, V611, DOI 10.1086/423620; Cappelluti N, 2012, MON NOT R ASTRON SOC, V427, P651, DOI 10.1111/j.1365-2966.2012.21867.x; Chang CH, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/81; Chaves R. C. G., 2009, P 31 INT COSM RAY C, P1336; Cordes J. M., 2002, ARXIVASTROPH0207156; Danilenko A, 2012, ASTRON ASTROPHYS, V540, DOI 10.1051/0004-6361/201118591; Duncan AR, 1997, MON NOT R ASTRON SOC, V287, P722; DUNCAN AR, 1995, MON NOT R ASTRON SOC, V277, P36; Esposito P, 2007, ASTRON ASTROPHYS, V467, pL45, DOI 10.1051/0004-6361:20077480; Fujinaga T, 2013, PUBL ASTRON SOC JPN, V65; Ishida M, 2009, PUBL ASTRON SOC JPN, V61, pS77; Ishisaki Y, 2007, PUBL ASTRON SOC JPN, V59, pS113; Kargaltsev O., 2008, MAGNETARS MORE, V983, P171, DOI DOI 10.1063/1.2900138; Kargaltsev O, 2007, ASTROPHYS J, V670, P655, DOI 10.1086/521814; Kokubun M., 2007, PASJ, V59, pS53; Koyama K, 2007, PUBL ASTRON SOC JPN, V59, pS23; Mattana F, 2009, ASTROPHYS J, V694, P12, DOI 10.1088/0004-637X/694/1/12; Mitsuda K, 2007, PUBL ASTRON SOC JPN, V59, pS1; Nakajima H, 2008, PUBL ASTRON SOC JPN, V60, pS1; Serlemitsos PJ, 2007, PUBL ASTRON SOC JPN, V59, pS9; Takahashi T, 2007, PUBL ASTRON SOC JPN, V59, pS35; Tawa N, 2008, PUBL ASTRON SOC JPN, V60, pS11; Terada Y, 2008, PUBL ASTRON SOC JPN, V60, pS25; Uchiyama H, 2009, PUBL ASTRON SOC JPN, V61, pS189; Uchiyama Y., 2008, PASJ, V60, P35; Ueda Y, 1999, ASTROPHYS J, V518, P656, DOI 10.1086/307291; Yoshino T, 2009, PUBL ASTRON SOC JPN, V61, P805; Zavlin V., 2007, NEUTRON STAR CRUST S	40	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	JUN	2015	67	3							43	10.1093/pasj/psv013		8	Astronomy & Astrophysics	Astronomy & Astrophysics	CK4GQ	WOS:000356182500014		
J	Koyama, S; Yamada, S; Kubota, A; Tashiro, MS; Terada, Y; Makishima, K				Koyama, Shu; Yamada, Shin'ya; Kubota, Aya; Tashiro, Makoto S.; Terada, Yukikatsu; Makishima, Kazuo			Suzaku observation of X-ray variability in soft state LMCX-1	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						accretion, accretion disks; black hole physics; X-rays: individual (LMC X-1)	BLACK-HOLE; GAMMA-RAY; LOW/HARD STATE; BOARD SUZAKU; X-1; SPECTRA; DISK; LINE; IRON; DIAGNOSTICS	This paper reports the results of Suzaku observation of the spectral variation of the black hole binary LMCX-1 in the soft state. The observation was carried out in 2009 from July 21 to 24. the obtained net count rate was similar to 30 counts s(-1) in the 0.5-50 keV band with similar to 10% peak-to-peak flux variation. The time-averaged X-ray spectrum cannot be described by a multi-color disk and single Compton component with its reflection, but requires additional Comptonized emissions. This double Compton component model allows a slightly larger inner radius of the multi-color disk, implying a lower spin parameter. Significant spectral evolution was observed above 8 keV along with a flux decrease on a timescale of similar to 10(4)-10(5) s. By spectral fitting, we show that this behavior is well explained by changes in the hard Comptonized emission component in contrast to the maintained disk and soft Comptonized emission.	[Koyama, Shu; Tashiro, Makoto S.; Terada, Yukikatsu] Saitama Univ, Dept Phys, Sakura Ku, Saitama, Saitama 3388570, Japan; [Yamada, Shin'ya] Tokyo Metropolitan Univ, Dept Phys, Hachioji, Tokyo 1920397, Japan; [Kubota, Aya] Shibaura Inst Technol, Dept Elect Informat Syst, Minuma Ku, Saitama 3378570, Japan; [Makishima, Kazuo] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Koyama, S (reprint author), Saitama Univ, Dept Phys, Sakura Ku, Shimo Okubo 255, Saitama, Saitama 3388570, Japan.	koyama@heal.phy.saitama-u.ac.jp	XRAY, SUZAKU/A-1808-2009		Ministry of Education, Culture, Sports, Science and Technology of Japan [13J08352, 23340055, 22340039]	This work is supported by a Grant-in-Aid for JSPS Fellows (No. 13J08352, S.K.) and Grants-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 23340055, Y.T.; No. 22340039, M.S.T.).	MIYAMOTO S, 1991, ASTROPHYS J, V383, P784, DOI 10.1086/170837; Kubota A, 2004, MON NOT R ASTRON SOC, V353, P980, DOI 10.1111/j.1365-2966.2004.08134.x; SHIMURA T, 1995, ASTROPHYS J, V445, P780, DOI 10.1086/175740; ZDZIARSKI AA, 1993, ASTROPHYS J, V414, pL93, DOI 10.1086/187004; MAKISHIMA K, 1986, ASTROPHYS J, V308, P635, DOI 10.1086/164534; Steiner JF, 2010, ASTROPHYS J LETT, V718, pL117, DOI 10.1088/2041-8205/718/2/L117; Gou LJ, 2009, ASTROPHYS J, V701, P1076, DOI 10.1088/0004-637X/701/2/1076; Orosz JA, 2009, ASTROPHYS J, V697, P573, DOI 10.1088/0004-637X/697/1/573; MITSUDA K, 1984, PUBL ASTRON SOC JPN, V36, P741; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Bird AJ, 2010, ASTROPHYS J SUPPL S, V186, P1, DOI 10.1088/0067-0049/186/1/1; BOLDT E, 1987, PHYS REP, V146, P215, DOI 10.1016/0370-1573(87)90108-6; Wilms J, 2000, ASTROPHYS J, V542, P914, DOI 10.1086/317016; Kubota A, 2004, ASTROPHYS J, V601, P428, DOI 10.1086/380433; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; Campana R, 2008, MON NOT R ASTRON SOC, V389, P691, DOI 10.1111/j.1365-2966.2008.13619.x; Ross RR, 2005, MON NOT R ASTRON SOC, V358, P211, DOI 10.1111/j.1365-2966.2005.08797.x; Kolehmainen M, 2011, MON NOT R ASTRON SOC, V416, P311, DOI 10.1111/j.1365-2966.2011.19040.x; Steiner JF, 2009, PUBL ASTRON SOC PAC, V121, P1279; Davis SW, 2005, ASTROPHYS J, V621, P372, DOI 10.1086/427278; Done C, 2006, MON NOT R ASTRON SOC, V371, P1216, DOI 10.1111/j.1365-2966.2006.10737.x; EBISAWA K, 1993, ASTROPHYS J, V403, P684, DOI 10.1086/172239; Frontera F, 2001, ASTROPHYS J, V561, P1006, DOI 10.1086/323258; Fukazawa Y, 2009, PUBL ASTRON SOC JPN, V61, pS17; Gierlinski M, 1999, MON NOT R ASTRON SOC, V309, P496, DOI 10.1046/j.1365-8711.1999.02875.x; Gierlinski M, 1997, MON NOT R ASTRON SOC, V288, P958; Hanke M, 2010, ASTRON ASTROPHYS, V509, DOI 10.1051/0004-6361/200913583; Hori T, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/1/20; Ishida M, 2011, PUBL ASTRON SOC JPN, V63, pS657; Ishisaki Y, 2007, PUBL ASTRON SOC JPN, V59, pS113; Kobayashi Y, 2003, PUBL ASTRON SOC JPN, V55, P273; Kokubun M, 2007, PUBL ASTRON SOC JPN, V59, pS53; Koyama K, 2007, PUBL ASTRON SOC JPN, V59, pS245; Kubota A, 2007, PUBL ASTRON SOC JPN, V59, pS185; LAOR A, 1991, ASTROPHYS J, V376, P90, DOI 10.1086/170257; Makishima K, 2008, PUBL ASTRON SOC JPN, V60, P585; Makishima K, 2000, ASTROPHYS J, V535, P632, DOI 10.1086/308868; Mitsuda K, 2007, PUBL ASTRON SOC JPN, V59, pS1; Ruhlen L, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/75; Serlemitsos PJ, 2007, PUBL ASTRON SOC JPN, V59, pS9; Steiner JF, 2012, MON NOT R ASTRON SOC, V427, P2552, DOI 10.1111/j.1365-2966.2012.22128.x; Takahashi H, 2008, PUBL ASTRON SOC JPN, V60, pS69; Takahashi T, 2007, PUBL ASTRON SOC JPN, V59, pS35; Tamura M, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/65; Yamada S, 2012, PUBL ASTRON SOC JPN, V64; Zdziarski AA, 2004, PROG THEOR PHYS SUPP, P99; Zdziarski AA, 1996, MON NOT R ASTRON SOC, V283, P193	47	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	JUN	2015	67	3							46	10.1093/pasj/psv017		9	Astronomy & Astrophysics	Astronomy & Astrophysics	CK4GQ	WOS:000356182500017		
J	Kutsuna, M; Shigeyama, T				Kutsuna, Masamichi; Shigeyama, Toshikazu			Revealing progenitors of type Ia supernovae from their light curves and spectra	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						hydrodynamics; line: profiles; radiative transfer; supernovae: general	BINARY-SYSTEMS; COMPANION STAR; SN 2014J; EMISSION; IMPACT; HOLE; M82	In the single degenerate (SD) scenario of type Ia supernovae (SNe Ia), the collision of the ejecta with its companion results in stripping hydrogen-rich matter from the companion star. This hydrogen-rich matter might leave its trace in the light curves and/or spectra. In this paper, we perform radiation hydrodynamical simulations of this collision for three binary systems. As a result, we find that the emission from the shock-heated region is not as strong as in previous studies. This weak emission, however, may be a result of our underestimation of the coupling between the gas and radiation in the shock interaction. Therefore, though our results suggest that the observed early light curves of SNeIa cannot rule out a binary system with a short separation as the progenitor system, more elaborate numerical studies will be needed to reach a fair conclusion. Alternatively, our results indicate that the feature observed in the early phase of a recent type Ia SN2014J might result from interaction of the ejecta with a red giant companion star. We also discuss the dependence of spectral features of H alpha and Si II absorption lines on viewing angles and investigate whether they can constrain the event rate of the SD progenitor.	[Kutsuna, Masamichi; Shigeyama, Toshikazu] Univ Tokyo, Grad Sch Sci, Res Ctr Early Universe, Bunkyo Ku, Tokyo 1130033, Japan; [Kutsuna, Masamichi] Univ Tokyo, Grad Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan	Kutsuna, M (reprint author), Yasuda Gakuen Senior High Sch, Sumida Ku, Tokyo 1308615, Japan.	shigeyama@resceu.s.u-tokyo.ac.jp			JSPS KAKENHI [23224004]	This work was supported by JSPS KAKENHI Grant Number 23224004.	WHELAN J, 1973, ASTROPHYS J, V186, P1007, DOI 10.1086/152565; Katz B, 2010, ASTROPHYS J, V716, P781, DOI 10.1088/0004-637X/716/1/781; WHEELER JC, 1975, ASTROPHYS J, V200, P145, DOI 10.1086/153771; IBEN I, 1984, ASTROPHYS J SUPPL S, V54, P335, DOI 10.1086/190932; Krause O, 2008, NATURE, V456, P617, DOI 10.1038/nature07608; VANLEER B, 1979, J COMPUT PHYS, V32, P101, DOI 10.1016/0021-9991(79)90145-1; RYBICKI GB, 1978, ASTROPHYS J, V219, P654, DOI 10.1086/155826; Marietta E, 2000, ASTROPHYS J SUPPL S, V128, P615, DOI 10.1086/313392; NOMOTO K, 1984, ASTROPHYS J, V286, P644, DOI 10.1086/162639; Pakmor R, 2008, ASTRON ASTROPHYS, V489, P943, DOI 10.1051/0004-6361:200810456; Ohsuga K, 2009, PUBL ASTRON SOC JPN, V61, pL7; Arnett D., 1996, SUPERNOVAE NUCLEOSYN; Folatelli G, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/74; FRANSSON C, 1989, ASTROPHYS J, V343, P323, DOI 10.1086/167707; Goobar A, 2014, ASTROPHYS J LETT, V784, DOI 10.1088/2041-8205/784/1/L12; Goobar A, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/1/106; Hayden BT, 2010, ASTROPHYS J, V722, P1691, DOI 10.1088/0004-637X/722/2/1691; Kasen D, 2010, ASTROPHYS J, V708, P1025, DOI 10.1088/0004-637X/708/2/1025; Kasen D, 2004, ASTROPHYS J, V610, P876, DOI 10.1086/421699; Leonard DC, 2007, ASTROPHYS J, V670, P1275, DOI 10.1086/522367; Maeda K, 2014, ASTROPHYS J, V794, DOI 10.1088/0004-637X/794/1/37; PACZYNSK.B, 1971, ANNU REV ASTRON ASTR, V9, P183, DOI 10.1146/annurev.aa.09.090171.001151; Richmond Michael W., 2012, Journal of the American Association of Variable Star Observers, V40; Toro E. F., 1994, Shock Waves, V4, DOI 10.1007/BF01414629; WEAVER TA, 1976, ASTROPHYS J SUPPL S, V32, P233, DOI 10.1086/190398; Webbink R. F., 1984, APJ, V277, P355; Zheng WK, 2014, ASTROPHYS J LETT, V783, DOI 10.1088/2041-8205/783/1/L24	27	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	JUN	2015	67	3							54	10.1093/pasj/psv028		14	Astronomy & Astrophysics	Astronomy & Astrophysics	CK4GQ	WOS:000356182500025		
J	Masuda, T; Fukue, J				Masuda, Takao; Fukue, Jun			Photosphere, thermalization surface and spectra of black hole accretion flows under electron scattering	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						black hole physics; radiative transfer; relativistic processes	OPTICALLY THICK ACCRETION; STATIONARY SPHERICAL ACCRETION; OBSERVATIONAL APPEARANCE; SUPERCRITICAL ACCRETION; WINDS; DISKS	We examine the expected spectra of black hole accretion flows, which are assumed to be steady and spherically symmetric, considering the separation of the apparent photosphere and thermalization surface under electron scattering. Although the flow itself is spherical, the apparent shape of the photosphere is not spherical, since the density distribution gradually decreases with radius. Furthermore, due to electron scattering, the thermalization surface decouples with the photosphere, and is located deep inside the photosphere for scattering-dominated flows. Since the shape of the thermalization surface is also aspherical, the temperature there is not uniform, which causes a strong limb-darkening effect, and we may observe a non-blackbody spectrum with multi-color-type.	[Masuda, Takao; Fukue, Jun] Osaka Kyoiku Univ, Astron Inst, Osaka 5828582, Japan	Masuda, T (reprint author), Osaka Kyoiku Univ, Astron Inst, Osaka 5828582, Japan.	j149338@ex.osaka-kyoiku.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [22540251]	This work has been supported in part by the Grant-in-Aid for Scientific Research (C) of the Ministry of Education, Culture, Sports, Science, and Technology (22540251 JF).	Fukue J, 2009, PUBL ASTRON SOC JPN, V61, P615; BONDI H, 1952, MON NOT R ASTRON SOC, V112, P195; Sumitomo N, 2007, PUBL ASTRON SOC JPN, V59, P1043; ABRAMOWICZ MA, 1991, ASTROPHYS J, V369, P175, DOI 10.1086/169748; Fukue J, 2010, PUBL ASTRON SOC JPN, V62, P1399; BEGELMAN MC, 1978, MON NOT R ASTRON SOC, V184, P53; BEGELMAN MC, 1982, ASTROPHYS J, V253, P873, DOI 10.1086/159688; BLONDIN JM, 1986, ASTROPHYS J, V308, P755, DOI 10.1086/164548; BURGER HL, 1980, ASTROPHYS J, V236, P921, DOI 10.1086/157819; FLAMMANG RA, 1984, MON NOT R ASTRON SOC, V206, P589; FLAMMANG RA, 1982, MON NOT R ASTRON SOC, V199, P833; Fukue J, 2011, PUBL ASTRON SOC JPN, V63, P803; Fukue J, 2009, PUBL ASTRON SOC JPN, V61, P1305; Kato S., 2008, BLACK HOLE ACCRETION; KATZ JI, 1977, ASTROPHYS J, V215, P265, DOI 10.1086/155355; Kobayashi H, 2013, PUBL ASTRON SOC JPN, V65; Niedzwiecki A, 2006, MON NOT R ASTRON SOC, V365, P606, DOI 10.1111/j.1365-2966.2005.09752.x; NOBILI L, 1991, ASTROPHYS J, V383, P250, DOI 10.1086/170781; Ogura K, 2013, PUBL ASTRON SOC JPN, V65; TAMAZAWA S, 1975, ASTROPHYS SPACE SCI, V32, P403, DOI 10.1007/BF00643153; Tomida M., 2015, PASJ UNPUB	21	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	JUN	2015	67	3							38	10.1093/pasj/psv007		8	Astronomy & Astrophysics	Astronomy & Astrophysics	CK4GQ	WOS:000356182500009		
J	Morokuma-Matsui, K; Baba, J; Sorai, K; Kuno, N				Morokuma-Matsui, Kana; Baba, Junichi; Sorai, Kazuo; Kuno, Nario			CO emissions from optically selected galaxies at z similar to 0.1-0.2: Tight anti-correlation between molecular gas fraction and 4000 angstrom break strength	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						galaxies: evolution; galaxies: ISM; ISM: molecules; Radio lines: ISM	DIGITAL SKY SURVEY; STAR-FORMING GALAXIES; ULTRALUMINOUS INFRARED GALAXIES; 1ST SPECTROSCOPIC DATA; INITIAL MASS FUNCTION; IRAM LEGACY SURVEY; NEARBY GALAXIES; METALLICITY RELATION; FORMATION HISTORIES; SPIRAL GALAXIES	We performed (CO)-C-12(J = 1-0) (hereafter, CO) observations toward 12 normal star-forming galaxies with stellar masses of M-star = 10(10.6)-10(11.3) M-circle dot at z = 0.1-0.2 with the 45 m telescope at the Nobeyama Radio Observatory. The samples were selected with D-n(4000), that is, the strength of the 4000 angstrom break, instead of the commonly used far-infrared (FIR) flux. We successfully detected the CO emissions from eight galaxies with signal-to-noise ratio larger than three, demonstrating the effectiveness of the D-n(4000)-based sample selection. For the first time, we find a tight anti-correlation between D-n(4000) and molecular gas fraction (f(mol)) using literature data of nearby galaxies in which the galaxies with more fuel for star formation have younger stellar populations. We find that our CO-detected galaxies at z similar to 0.1-0.2 also follow the same relation as nearby galaxies. This implies that the galaxies evolve along this D-n(4000)-f(mol) relation, and that D-n(4000) seems to be able to be used as a proxy for fmol, which requires many time-consuming observations. Based on the comparison with the model calculation with a population synthesis code, we find that star formation from metal enriched gas and its quenching in the early time are necessary to reproduce galaxies with large D-n(4000) and non-zero gas fraction.	[Morokuma-Matsui, Kana] Nobeyama Radio Observ, Minamimaki, Nagano 3841305, Japan; [Baba, Junichi] Tokyo Inst Technol, Earth Life Sci Inst, Meguro Ku, Tokyo 1528550, Japan; [Sorai, Kazuo] Hokkaido Univ, Dept Phys, Dept Cosmosci, Sapporo, Hokkaido 0600810, Japan; [Kuno, Nario] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3508577, Japan	Morokuma-Matsui, K (reprint author), Nobeyama Radio Observ, 462-2 Nobeyama, Minamimaki, Nagano 3841305, Japan.	kana.matsui@nao.ac.jp; babajn@elsi.jp; sorai@astro1.sci.hokudai.ac.jp; kuno.nario.gt@u.tsukuba.ac.jp			JSPS [26800099]; Alfred P. Sloan Foundation; National Science Foundation; U.S. Department of Energy Office of Science; University of Arizona; Brazilian Participation Group; Brookhaven National Laboratory; Carnegie Mellon University; University of Florida; French Participation Group; German Participation Group; Harvard University; Instituto de Astrofisica de Canarias; Michigan State/Notre Dame/JINA Participation Group; Johns Hopkins University; Lawrence Berkeley National Laboratory; Max Planck Institute for Astrophysics; Max Planck Institute for Extraterrestrial Physics; New Mexico State University; New York University; Ohio State University; Pennsylvania State University; University of Portsmouth; Princeton University; Spanish Participation Group; University of Tokyo; University of Utah; Vanderbilt University; University of Virginia; University of Washington; Yale University	PEGASE calculations were carried out on computers at the Center for Computational Astrophysics, National Astronomical Observatory of Japan. JB was supported by JSPS Grant-in-Aid for Young Scientists (B) Grand Number 26800099.; Funding for SDSS-III has been provided by the Alfred P. Sloan Foundation, the Participating Institutions, the National Science Foundation, and the U.S. Department of Energy Office of Science. The SDSS-III web site is < http://www.sdss3.org/>. SDSS-III is managed by the Astrophysical Research Consortium for the Participating Institutions of the SDSS-III Collaboration including the University of Arizona, the Brazilian Participation Group, Brookhaven National Laboratory, Carnegie Mellon University, University of Florida, the French Participation Group, the German Participation Group, Harvard University, the Instituto de Astrofisica de Canarias, the Michigan State/Notre Dame/JINA Participation Group, Johns Hopkins University, Lawrence Berkeley National Laboratory, Max Planck Institute for Astrophysics, Max Planck Institute for Extraterrestrial Physics, New Mexico State University, New York University, Ohio State University, Pennsylvania State University, University of Portsmouth, Princeton University, the Spanish Participation Group, University of Tokyo, University of Utah, Vanderbilt University, University of Virginia, University of Washington, and Yale University.	Ahn CP, 2014, ASTROPHYS J SUPPL S, V211, DOI 10.1088/0067-0049/211/2/17; Ahn CP, 2012, ASTROPHYS J SUPPL S, V203, DOI 10.1088/0067-0049/203/2/21; ANDERSEN J, 1991, ASTRON ASTROPHYS REV, V3, P91, DOI 10.1007/BF00873538; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; SANDERS DB, 1988, ASTROPHYS J, V325, P74, DOI 10.1086/165983; Poggianti BM, 1997, ASTRON ASTROPHYS, V325, P1025; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Duffy AR, 2012, MON NOT R ASTRON SOC, V420, P2799, DOI 10.1111/j.1365-2966.2011.19894.x; Alatalo K, 2013, MON NOT R ASTRON SOC, V432, P1796, DOI 10.1093/mnras/sts299; Shimasaku K, 2001, ASTRON J, V122, P1238, DOI 10.1086/322094; Solomon PM, 1997, ASTROPHYS J, V478, P144, DOI 10.1086/303765; Saintonge A, 2011, MON NOT R ASTRON SOC, V415, P32, DOI 10.1111/j.1365-2966.2011.18677.x; Wong T, 2002, ASTROPHYS J, V569, P157, DOI 10.1086/339287; HENRY TJ, 1993, ASTRON J, V106, P773, DOI 10.1086/116685; Tremonti CA, 2004, ASTROPHYS J, V613, P898, DOI 10.1086/423264; Balogh ML, 1999, ASTROPHYS J, V527, P54, DOI 10.1086/308056; Martig M, 2009, ASTROPHYS J, V707, P250, DOI 10.1088/0004-637X/707/1/250; Bigiel F, 2008, ASTRON J, V136, P2846, DOI 10.1088/0004-6256/136/6/2846; Oppenheimer BD, 2010, MON NOT R ASTRON SOC, V406, P2325, DOI 10.1111/j.1365-2966.2010.16872.x; Brinchmann J, 2004, MON NOT R ASTRON SOC, V351, P1151, DOI 10.1111/j.1365-2966.2004.07881.x; Nakajima T, 2013, PUBL ASTRON SOC PAC, V125, P252, DOI 10.1086/670124; BALDWIN JA, 1981, PUBL ASTRON SOC PAC, V93, P5, DOI 10.1086/130766; Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Chung A, 2009, ASTRON J, V138, P858, DOI 10.1088/0004-6256/138/3/858; Oppenheimer BD, 2008, MON NOT R ASTRON SOC, V387, P577, DOI 10.1111/j.1365-2966.2008.13280.x; Kauffmann G, 2003, MON NOT R ASTRON SOC, V341, P33, DOI 10.1046/j.1365-8711.2003.06291.x; Sanders DB, 1996, ANNU REV ASTRON ASTR, V34, P749, DOI 10.1146/annurev.astro.34.1.749; Bolatto AD, 2013, ANNU REV ASTRON ASTR, V51, P207, DOI 10.1146/annurev-astro-082812-140944; Kennicutt RC, 2012, ANNU REV ASTRON ASTR, V50, P531, DOI 10.1146/annurev-astro-081811-125610; Bauermeister A, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/132; Cantinella B, 2010, MNRAS, V403, P683; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Chang RX, 2010, ASTROPHYS J, V722, P380, DOI 10.1088/0004-637X/722/1/380; Combes F., 2013, ASTRON ASTROPHYS, V550, P41; Conselice CJ, 2006, MON NOT R ASTRON SOC, V373, P1389, DOI 10.1111/j.1365-2966.2006.11114.x; Davis T. A., 2013, MNRAS, V429, P555; Fioc M, 1997, ASTRON ASTROPHYS, V326, P950; Fioc M, 1999, ASTRON ASTROPHYS, V351, P869; Geach J. E., 2011, APJ, V730, P19; Kauffmann G, 2012, MON NOT R ASTRON SOC, V422, P997, DOI 10.1111/j.1365-2966.2012.20672.x; Kriek M., 2011, APJ, V742, P168; Le Borgne D, 2002, ASTRON ASTROPHYS, V386, P446, DOI 10.1051/0004-6361:20020259; Leitner SN, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/149; Lilly SJ, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/119; Matsui K, 2012, PUBL ASTRON SOC JPN, V64; Petrosian V., 1976, APJ, V209, P1; POPPER DM, 1980, ANNU REV ASTRON ASTR, V18, P115, DOI 10.1146/annurev.aa.18.090180.000555; RANA NC, 1992, ASTRON ASTROPHYS, V265, P499; Sanchez S. F., 2014, ASTRON ASTROPHYS, V563, P49; Shen SJ, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/50; Strateva I, 2001, ASTRON J, V122, P1861, DOI 10.1086/323301; Tacconi LJ, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/74; TOOMRE A, 1964, ASTROPHYS J, V139, P1217, DOI 10.1086/147861; Tsalmantza P, 2007, ASTRON ASTROPHYS, V470, P761, DOI 10.1051/0004-6361:20077300; van Dokkum P. G., 2013, APJ, V771, P35; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237	56	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	JUN	2015	67	3							36	10.1093/pasj/psv005		13	Astronomy & Astrophysics	Astronomy & Astrophysics	CK4GQ	WOS:000356182500007		
J	Notsu, Y; Honda, S; Maehara, H; Notsu, S; Shibayama, T; Nogami, D; Shibata, K				Notsu, Yuta; Honda, Satoshi; Maehara, Hiroyuki; Notsu, Shota; Shibayama, Takuya; Nogami, Daisaku; Shibata, Kazunari			High dispersion spectroscopy of solar-type superflare stars. I. Temperature, surface gravity, metallicity, and vsin i	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						stars: abundances; stars: activity; stars: flare; stars: rotation; stars: solar-type	KEPLER INPUT CATALOG; DIFFERENTIAL ROTATION; MAIN-SEQUENCE; ATMOSPHERIC PARAMETERS; STELLAR INCLINATIONS; SUBARU TELESCOPE; EMISSION MEASURE; LI ABUNDANCES; ANALOG STARS; LIGHT CURVES	We conducted high-dispersion spectroscopic observations of 50 superflare stars with Subaru High Dispersion Spectrograph (HDS), and measured the stellar parameters of them. These 50 targets were selected from the solar-type (G-type main sequence) superflare stars that we had discovered from the Kepler photometric data. As a result of these spectroscopic observations, we found that more than half (34) of our 50 targets have no evidence of binary systems. We then estimated the effective temperature (T-eff), surface gravity (log g), metallicity ([Fe/H]), and projected rotational velocity (vsin i) of these 34 superflare stars on the basis of our spectroscopic data. The accuracy of our estimations is higher than that of the Kepler Input Catalog (KIC) values, and the differences between our values and KIC values [(Delta T-eff)(rms) similar to 219 K, (Delta log g)(rms) similar to 0.37 dex, and (Delta[Fe/H])(rms) similar to 0.46 dex] are comparable to the large uncertainties and systematic differences of KIC values reported by the previous researchers. We confirmed that the estimated Teff and log g values of the 34 superflare stars are roughly in the range of solar-type stars. In particular, these parameters and the brightness variation period (P-0) of nine of the stars are in the range of "Sun-like" stars (5600 <= T-eff <= 6000 K, log g >= 4.0, and P-0 > 10 d). Five of the 34 target stars are fast rotators (vsin i >= 10 km s(-1)), while 22 stars have relatively low vsin i values (vsin i < 5 km s(-1)). These results suggest that stars that have spectroscopic properties similar to the Sun can have superflares, and this supports the hypothesis that the Sun might cause a superflare.	[Notsu, Yuta; Notsu, Shota; Nogami, Daisaku] Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto, Kyoto 6068502, Japan; [Honda, Satoshi] Univ Hyogo, Ctr Astron, Sayo, Hyogo 6795313, Japan; [Maehara, Hiroyuki] Univ Tokyo, Sch Sci, Inst Astron, Kiso Observ, Kiso, Nagano 3970101, Japan; [Maehara, Hiroyuki] Natl Astron Observ Japan, Okayama Astrophys Observ, Kamogatacho, Okayama 7190232, Japan; [Shibayama, Takuya] Nagoya Univ, Solar Terr Environm Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Nogami, Daisaku; Shibata, Kazunari] Kyoto Univ, Kwasan & Hida Observ, Yamashina Ku, Kyoto, Kyoto 6078471, Japan	Notsu, Y (reprint author), Kyoto Univ, Dept Astron, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto, Kyoto 6068502, Japan.	ynotsu@kwasan.kyoto-u.ac.jp			NASA Science Mission Directorate; Ministry of Education, Culture, Sports, Science and Technology of Japan [25287039, 26400231, 26800096]	The authors sincerely thank the anonymous referee for their very useful and constructive comments. This study is based on observational data collected with the Subaru Telescope, which is operated by the National Astronomical Observatory of Japan. We are grateful to Dr. Akito Tajitsu and other staff at the Subaru Telescope for making large contributions towards carrying out our observations. We would also thank Dr. Yoichi Takeda for his many pieces of useful advice on the analysis of our Subaru/HDS data, and for opening the TGVIT and SPTOOL programs for public use. Kepler was selected as the tenth Discovery mission. Funding for this mission is provided by the NASA Science Mission Directorate. The Kepler data presented in this paper were obtained from the Multimission Archive at STScI. This work was supported by the Grant-in-Aids from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Nos. 25287039, 26400231, and 26800096).	Ammler-von Eiff M, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201118724; Segura A, 2010, ASTROBIOLOGY, V10, P751, DOI 10.1089/ast.2009.0376; Schaefer BE, 2000, ASTROPHYS J, V529, P1026, DOI 10.1086/308325; Notsu S, 2013, PUBL ASTRON SOC JPN, V65; SODERBLOM DR, 1991, ASTROPHYS J, V375, P722, DOI 10.1086/170238; Takeda Y, 2008, PUBL ASTRON SOC JPN, V60, P781; Stumpe MC, 2012, PUBL ASTRON SOC PAC, V124, P985, DOI 10.1086/667698; Shibata K, 2002, ASTROPHYS J, V577, P422, DOI 10.1086/342141; WALTER FM, 1981, ASTROPHYS J, V245, P671, DOI 10.1086/158842; Takeda Y, 2002, PUBL ASTRON SOC JPN, V54, P451; SODERBLOM DR, 1993, ASTRON J, V106, P1059, DOI 10.1086/116704; Koch DG, 2010, ASTROPHYS J LETT, V713, pL79, DOI 10.1088/2041-8205/713/2/L79; Bruntt H, 2012, MON NOT R ASTRON SOC, V423, P122, DOI 10.1111/j.1365-2966.2012.20686.x; Molenda-Zakowicz J, 2010, ASTRON NACHR, V331, P981, DOI 10.1002/asna.201011440; Lanza AF, 2003, ASTRON ASTROPHYS, V403, P1135, DOI 10.1051/0004-6361:20030401; Noguchi K, 2002, PUBL ASTRON SOC JPN, V54, P855; Anderson RI, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/201014769; Valenti JA, 2005, ASTROPHYS J SUPPL S, V159, P141, DOI 10.1086/430500; Bressan A, 2012, MON NOT R ASTRON SOC, V427, P127, DOI 10.1111/j.1365-2966.2012.21948.x; Thygesen AO, 2012, ASTRON ASTROPHYS, V543, DOI 10.1051/0004-6361/201219237; Vaughan S, 2005, ASTRON ASTROPHYS, V431, P391, DOI 10.1051/0004-6361:20041453; Maehara H, 2012, NATURE, V485, P478, DOI 10.1038/nature11063; Takeda Y, 2007, ASTRON ASTROPHYS, V468, P663, DOI 10.1051/0004-6361:20077220; Datson J, 2012, MON NOT R ASTRON SOC, V426, P484, DOI 10.1111/j.1365-2966.2012.21730.x; Doyle AP, 2014, MON NOT R ASTRON SOC, V444, P3592, DOI 10.1093/mnras/stu1692; Voges W, 1999, ASTRON ASTROPHYS, V349, P389; King JR, 2005, ASTRON J, V130, P2318, DOI 10.1086/452640; Takeda Y, 2009, PUBL ASTRON SOC JPN, V61, P471; Aulanier G, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201220406; Balona LA, 2012, MON NOT R ASTRON SOC, V423, P3420, DOI 10.1111/j.1365-2966.2012.21135.x; Brown TM, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/4/112; Candelaresi S, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/67; Emslie AG, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/71; Frasca A, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201116980; Garcia RA, 2011, MON NOT R ASTRON SOC, V414, pL6, DOI 10.1111/j.1745-3933.2011.01042.x; Gershberg R. E., 2005, SOLAR TYPE ACTIVITY; Gray D. F., 2005, OBSERVATION ANAL STE; Hirano T, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/1/9; Hirano T, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/1/66; KURUCZ RL, 1993, KURUCZ CD ROM 13 ATL; McQuillan A, 2014, ASTROPHYS J SUPPL S, V211, DOI 10.1088/0067-0049/211/2/24; Nielsen MB, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201321912; Nogami D, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/psu012; Notsu Y, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/2/127; Notsu Y, 2015, PUBL ASTRON SOC JPN, V67, DOI 10.1093/pasj/psv002; Pinsonneault MH, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/2/30; Press W. H., 1978, Comments on Astrophysics. Comments on Modern Physics: Part C, V7; Priest E. R., 1981, SOLAR FLARE MAGNETOH; Reinhold T, 2013, ASTRON ASTROPHYS, V560, DOI 10.1051/0004-6361/201321970; Sestito P, 2005, ASTRON ASTROPHYS, V442, P615, DOI 10.1051/0004-6361:20053482; Shibata K, 2013, PUBL ASTRON SOC JPN, V65; Shibata K, 1999, ASTROPHYS J, V526, pL49, DOI 10.1086/312354; Shibata K, 2011, LIVING REV SOL PHYS, V8; Shibayama T, 2013, ASTROPHYS J SUPPL S, V209, DOI 10.1088/0067-0049/209/1/5; Tajitsu A, 2012, PUBL ASTRON SOC JPN, V64; Takeda Y, 2010, ASTRON ASTROPHYS, V515, DOI 10.1051/0004-6361/200913897; Takeda Y, 2005, PUBL ASTRON SOC JPN, V57, P415; TAKEDA Y, 1995, PUBL ASTRON SOC JPN, V47, P337; TAKEDA Y, 1995, PUBL ASTRON SOC JPN, V47, P287; Van Cleve J. E., 2009, KEPLER INSTRUMENT HD, VKSCI-19033-001; Voges W., 2000, IAU CIRC, V7432, P3; Walkowicz LM, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/2/50; Wichmann R, 2014, ASTRON ASTROPHYS, V567, DOI 10.1051/0004-6361/201423717	63	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	JUN	2015	67	3							32	10.1093/pasj/psv001		24	Astronomy & Astrophysics	Astronomy & Astrophysics	CK4GQ	WOS:000356182500003		
J	Notsu, Y; Honda, S; Maehara, H; Notsu, S; Shibayama, T; Nogami, D; Shibata, K				Notsu, Yuta; Honda, Satoshi; Maehara, Hiroyuki; Notsu, Shota; Shibayama, Takuya; Nogami, Daisaku; Shibata, Kazunari			High dispersion spectroscopy of solar-type superflare stars. II. Stellar rotation, starspots, and chromospheric activities	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						stars: activity; stars: flare; stars: rotation; stars: solar-type; starspots	DYNAMICS-OBSERVATORY SDO; LOWER MAIN-SEQUENCE; MAGNETIC ACTIVITY; PHOTOMETRIC VARIABILITY; DIFFERENTIAL ROTATION; G-DWARFS; SUN; EMISSION; ABUNDANCES; EVOLUTION	We conducted high dispersion spectroscopic observations of 50 superflare stars with Subaru/HDS. These 50 stars were selected from the solar-type superflare stars that we had discovered from the Kepler data. More than half (34 stars) of these 50 target superflare stars show no evidence of binarity, and we estimated stellar parameters of these 34 stars in our previous study (Notsu et al. 2015, PASJ, 67, 32). According to our previous studies using Kepler data, superflare stars show quasi-periodic brightness variations whose amplitude (0.1%-10%) is much larger than that of the solar brightness variations (0.01%-0.1%) caused by the existence of sunspots on the rotating solar surface. In this study, we investigated whether these quasi-periodic brightness variations of superflare stars are explained by the rotation of a star with fairly large starspots, by using stellar parameters derived in Paper I. First, we confirmed that the value of the projected rotational velocity, v sin i, is consistent with the rotational velocity estimated from the period of the brightness variation. Next, we measured the intensity of Ca II infrared triplet lines and H alpha line, good indicators of the stellar chromospheric activity, and compared them with other stellar properties. The intensity of Ca II infrared triplet lines indicates that the mean magnetic field strength (< fB >) of the target superflare stars can be higher than that of the Sun. A correlation between the amplitude of the brightness variation and the intensity of Ca II triplet line was found. All the targets expected to have large starspots because of their large amplitude of the brightness variation show high chromospheric activities compared to the Sun. These results support the idea that the brightness variation of superflare stars is due to the rotation with large starspots.	[Notsu, Yuta; Notsu, Shota; Nogami, Daisaku] Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto, Kyoto 6068502, Japan; [Honda, Satoshi] Univ Hyogo, Ctr Astron, Sayo, Hyogo 6795313, Japan; [Maehara, Hiroyuki] Univ Tokyo, Sch Sci, Inst Astron, Kiso Observ, Kiso, Nagano 3970101, Japan; [Maehara, Hiroyuki] Natl Astron Observ Japan, Okayama Astrophys Observ, Okayama 7190232, Japan; [Shibayama, Takuya] Nagoya Univ, Solar Terr Environm Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Nogami, Daisaku; Shibata, Kazunari] Kyoto Univ, Kwasan & Hida Observ, Yamashina Ku, Kyoto, Kyoto 6078471, Japan	Notsu, Y (reprint author), Kyoto Univ, Dept Astron, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto, Kyoto 6068502, Japan.	ynotsu@kwasan.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25287039, 26400231, 26800096]	This study is based on observational data collected with Subaru Telescope, which is operated by the National Astronomical Observatory of Japan. We are grateful to Dr. Akito Tajitsu and other staff of the Subaru Telescope for making large contributions in carrying out our observations. We would also like to thank Dr. Yoichi Takeda for his many useful contributions on the analysis of our Subaru/HDS data, and for his opening the TGVIT and SPTOOL programs for the public. When we conducted our solar observation at Hida Observatory (mentioned in subsection 3.2) we received important advice and kind support from Dr. Satoru Ueno, Dr. Tetsu Anan, Dr. Reizaburo Kitai, Dr. Ayumi Asai, and other members of Kwasan and Hida Observatories, Kyoto University. Kepler was selected as the tenth Discovery mission. Funding for this mission is provided by the NASA Science Mission Directorate. The Kepler data presented in this paper were obtained from the Multimission Archive at STScI. This work was supported by the Grant-in-Aids from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Nos. 25287039, 26400231, and 26800096).	Schaefer BE, 2000, ASTROPHYS J, V529, P1026, DOI 10.1086/308325; Notsu S, 2013, PUBL ASTRON SOC JPN, V65; Livingston W, 2007, ASTROPHYS J, V657, P1137, DOI 10.1086/511127; SODERBLOM DR, 1991, ASTROPHYS J, V375, P722, DOI 10.1086/170238; SODERBLOM DR, 1993, ASTRON J, V106, P1059, DOI 10.1086/116704; SCHRIJVER CJ, 1989, ASTROPHYS J, V337, P964, DOI 10.1086/167168; Koch DG, 2010, ASTROPHYS J LETT, V713, pL79, DOI 10.1088/2041-8205/713/2/L79; Scherrer PH, 2012, SOL PHYS, V275, P207, DOI 10.1007/s11207-011-9834-2; Lanza AF, 2003, ASTRON ASTROPHYS, V403, P1135, DOI 10.1051/0004-6361:20030401; Alonso A, 1996, ASTRON ASTROPHYS, V313, P873; Noguchi K, 2002, PUBL ASTRON SOC JPN, V54, P855; Anderson RI, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/201014769; Martinez-Arnaiz R, 2011, MON NOT R ASTRON SOC, V414, P2629, DOI 10.1111/j.1365-2966.2011.18584.x; Maehara H, 2012, NATURE, V485, P478, DOI 10.1038/nature11063; Pesnell WD, 2012, SOL PHYS, V275, P3, DOI 10.1007/s11207-011-9841-3; NOYES RW, 1984, ASTROPHYS J, V279, P763, DOI 10.1086/161945; Schou J, 2012, SOL PHYS, V275, P229, DOI 10.1007/s11207-011-9842-2; Basri G, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/1/20; Brown TM, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/4/112; Emslie AG, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/71; FRASCA A, 1994, ASTRON ASTROPHYS, V284, P883; Frasca A, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201116980; Hall JC, 1996, PUBL ASTRON SOC PAC, V108, P313, DOI 10.1086/133724; Hirano T, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/1/66; Nakai Y., 1985, KYOTO U FACULTY SCI, V36, P385; Nogami D, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/psu012; Notsu Y, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/2/127; Notsu Y, 2015, PUBL ASTRON SOC JPN, V67, DOI [10.1093/pasj/psv002, 10.1093/pasj/psv001]; Priest E. R., 1981, SOLAR FLARE MAGNETOH; Reinhold T, 2013, ASTRON ASTROPHYS, V560, DOI 10.1051/0004-6361/201321970; Sestito P, 2005, ASTRON ASTROPHYS, V442, P615, DOI 10.1051/0004-6361:20053482; Shibata K, 2013, PUBL ASTRON SOC JPN, V65; Shibata K, 2011, LIVING REV SOL PHYS, V8; Shibayama T, 2013, ASTROPHYS J SUPPL S, V209, DOI 10.1088/0067-0049/209/1/5; SODERBLOM DR, 1993, ASTROPHYS J SUPPL S, V85, P315, DOI 10.1086/191767; Takeda Y, 2010, ASTRON ASTROPHYS, V515, DOI 10.1051/0004-6361/200913897; Thompson S. E., 2013, KSCI19063001 NASA AM	37	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	JUN	2015	67	3							33	10.1093/pasj/psv002		14	Astronomy & Astrophysics	Astronomy & Astrophysics	CK4GQ	WOS:000356182500004		
J	Onozato, H; Ita, Y; Ono, K; Fukagawa, M; Yanagisawa, K; Izumiura, H; Nakada, Y; Matsunaga, N				Onozato, Hiroki; Ita, Yoshifusa; Ono, Kenji; Fukagawa, Misato; Yanagisawa, Kenshi; Izumiura, Hideyuki; Nakada, Yoshikazu; Matsunaga, Noriyuki			A study on the mid-infrared sources that dramatically brightened	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						circumstellar matter; infrared: stars; stars: late-type; stars: pre-main sequence	ALL-SKY SURVEY; LARGE-MAGELLANIC-CLOUD; INFRARED-SPECTROSCOPY; NORTHERN SKY; VARIABILITY SURVEY; STARS; OBJECTS; VARIABLES; PROTOSTAR; CATALOGS	We present results of near-infrared (NIR) photometric and spectroscopic observations of mid-infrared (MIR) sources that brightened dramatically. Using Infrared Astronomical Satellite (IRAS), AKARI, and Wide-field Infrared Survey Explorer (WISE) point source catalogs, we found that four sources (IRAS 19574+4941, V2494 Cyg, IRAS 22343+7501, and V583 Cas) significantly brightened at MIR wavelengths over a period of 20-30 yr, depending on an interval between two different observation epoch. Little is known about these sources except V2494 Cyg, which is considered as an FU Orionis star. Our observation clearly resolves IRAS 22343+7501 into four stars (2MASS J22352345+7517076, 2MASS J22352442+7517037, [RD95] C, and 2MASS J22352497+7517113) and the first JHKs photometric data for all four sources are obtained. Two of these stars (2MASS J22352442+7517037 and 2MASS J22352497+7517113) are known as T Tau stars. Our spectroscopic observation reveals that IRAS 19574+4941 is an M-type evolved star and V583 Cas a carbon star. 2MASS J22352345+7517076 is probably a young stellar object, judging from our observation showing that it has a featureless NIR spectrum and also showed dramatic brightening in NIR (about 4 mag in the K-s band). Likely reasons for dramatic brightening in MIR are discussed in this paper.	[Onozato, Hiroki; Ita, Yoshifusa] Tohoku Univ, Grad Sch Sci, Astron Inst, Aoba Ku, Sendai, Miyagi 9800857, Japan; [Ono, Kenji] Univ Tokyo, Inst Cosm Ray Res, Kashiwa, Chiba 2778582, Japan; [Fukagawa, Misato] Osaka Univ, Grad Sch Sci, Dept Earth & Space Sci, Toyonaka, Osaka 5600043, Japan; [Yanagisawa, Kenshi; Izumiura, Hideyuki] Natl Astron Observ Japan, Okayama Astrophys Observ, Okayama 7190232, Japan; [Nakada, Yoshikazu] Univ Tokyo, Sch Sci, Inst Astron, Kiso Observ, Kiso, Nagano 3970101, Japan; [Matsunaga, Noriyuki] Univ Tokyo, Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan	Onozato, H (reprint author), Tohoku Univ, Grad Sch Sci, Astron Inst, Aoba Ku, 6-3 Aramaki Aoba, Sendai, Miyagi 9800857, Japan.	h.onozato@astr.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26287028]; National Aeronautics and Space Administration (NASA); NASA; National Science Foundation; Ballistic Missile Defense Organization; NASA Office of Space Science	We thank the anonymous referee for his/her very kind and valuable comments that greatly helped to improve this paper. This research is based on data taken at Okayama Astrophysical Observatory (OAO), which is operated by National Astronomical Observatory of Japan. We are grateful to all staff members of OAO for their support during the observations. This research is also based on data taken at Nishi-Harima Astronomical Observatory. We thank Dr. Akira Arai for his help on the operation of the Nayuta Telescope. This work is supported by the Grant-in-Aid for Scientific Research (B) No. 26287028 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.; This work makes use of the data obtained in IRAS survey data. This research is based on observations with AKARI, a JAXA project with the participation of ESA. This publication makes use of data products from the Wide-field Infrared Survey Explorer, which is a joint project of the University of California, Los Angeles, and the Jet Propulsion Laboratory/California Institute of Technology, funded by the National Aeronautics and Space Administration (NASA). This publication makes use of data products from the Two Micron All Sky Survey, which is a joint project of the University of Massachusetts and the Infrared Processing and Analysis Center/California Institute of Technology, funded by the NASA and the National Science Foundation. This research made use of data products from the Mid-course Space Experiment. Processing of the data was funded by the Ballistic Missile Defense Organization with additional support from NASA Office of Space Science. This research has also made use of the NASA/IPAC Infrared Science Archive, which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under contract with the NASA. This work is based in part on data taken with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology under a contract with NASA. This research has made use of the SIMBAD database and the VizieR catalogue access tool, CDS, Strasbourg, France. The original description of the VizieR service was published in A&AS 143, 23.	Alksnis A., 2001, BALT ASTRON, V10, P1; Meixner M, 2006, ASTRON J, V132, P2268, DOI 10.1086/508185; Monet DG, 2003, ASTRON J, V125, P984, DOI 10.1086/345888; Wozniak PR, 2004, ASTRON J, V128, P2965, DOI 10.1086/425526; Smith BJ, 2002, ASTRON J, V123, P948, DOI 10.1086/338647; Droege TF, 2006, PUBL ASTRON SOC PAC, V118, P1666, DOI 10.1086/510197; Muzerolle J, 2013, NATURE, V493, P378, DOI 10.1038/nature11746; Price SD, 2001, ASTRON J, V121, P2819, DOI 10.1086/320404; Wozniak PR, 2004, ASTRON J, V127, P2436, DOI 10.1086/382719; Melis C, 2012, NATURE, V487, P74, DOI 10.1038/nature11210; Di Francesco J, 2008, ASTROPHYS J SUPPL S, V175, P277, DOI 10.1086/523645; Kun M, 2009, ASTROPHYS J SUPPL S, V185, P451, DOI 10.1088/0067-0049/185/2/451; Wright EL, 2010, ASTRON J, V140, P1868, DOI 10.1088/0004-6256/140/6/1868; Aringer B, 2009, ASTRON ASTROPHYS, V503, P913, DOI 10.1051/0004-6361/200911703; HARTMANN L, 1985, ASTROPHYS J, V299, P462, DOI 10.1086/163713; Roeser S, 2010, ASTRON J, V139, P2440, DOI 10.1088/0004-6256/139/6/2440; Rayner JT, 2009, ASTROPHYS J SUPPL S, V185, P289, DOI 10.1088/0067-0049/185/2/289; Duerbeck HW, 1996, ASTROPHYS J, V468, pL111, DOI 10.1086/310241; Egan M. P., 2003, AFRLVSTR20031589; Fischer WJ, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/1/99; Flaherty KM, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/1/71; Gandhi D., 2012, APJ, V751, pL1; Greene TP, 2008, ASTRON J, V135, P1421, DOI 10.1088/0004-6256/135/4/1421; Helou G., 1988, INFRARED ASTRONOMICA; Hoard DW, 2009, ASTR SOC P, V404, P234; Ishihara D, 2010, ASTRON ASTROPHYS, V514, DOI 10.1051/0004-6361/200913811; Ita Y, 2010, ASTRON ASTROPHYS, V514, DOI 10.1051/0004-6361/200913695; Joyce RR, 1998, ASTRON J, V115, P2059, DOI 10.1086/300318; Kessler M.F., 1996, ASTRON ASTROPHYS, V315, P27; Knapp GR, 1999, ASTRON ASTROPHYS, V351, P97; Kurtanidze O. M., 1989, Astrophysics, V31, DOI 10.1007/BF01012730; Magakian TY, 2013, MON NOT R ASTRON SOC, V432, P2685, DOI 10.1093/mnras/stt626; Morales-Calderon C., 2011, APJ, V733, P50; Neugebauer G., 1984, AP J, V278, pL1; Pickles AJ, 1998, PUBL ASTRON SOC PAC, V110, P863, DOI 10.1086/316197; Rebull L. M., 2011, ASP C SER, V448; Reipurth B, 1997, ASTRON J, V114, P2700, DOI 10.1086/118680; Rosino L., 1976, Astronomy and Astrophysics Supplement Series, V24; ROSVICK JM, 1995, PUBL ASTRON SOC PAC, V107, P49, DOI 10.1086/133514; Skiff B. A., 1997, IBVS, V4441, P1; Skrutskie M. F., 2006, AJ, V131, P11636; Tokunaga A. T., 2000, ALLENS ASTROPHYSICAL, P151; Vijh UP, 2009, ASTRON J, V137, P3139, DOI 10.1088/0004-6256/137/2/3139; Yanagisawa K., 2006, P SOC PHOTO-OPT INS, V6269, P62693; Yanagisawa K, 2008, P SOC PHOTO-OPT INS, V7014, P1437, DOI 10.1117/12.788905	45	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	JUN	2015	67	3							39	10.1093/pasj/psv008		26	Astronomy & Astrophysics	Astronomy & Astrophysics	CK4GQ	WOS:000356182500010		
J	Shibata, S; Tominaga, N				Shibata, Sanshiro; Tominaga, Nozomu			Nuclear composition of magnetized gamma-ray burst jets	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						gamma-ray burst: general; magnetohydrodynamics (MHD); nuclear reactions, nucleosynthesis, abundances	ENERGY COSMIC-RAYS; METAL-POOR STARS; RELATIVISTIC JETS; SUPERNOVA EXPLOSIONS; QUASI-EQUILIBRIUM; GRB OUTFLOWS; BLACK-HOLES; NUCLEOSYNTHESIS; MODEL; ACCELERATION	We investigate the fraction of metal nuclei in the relativistic jets of gamma-ray bursts associated with core-collapse supernovae. We simulate the fallback in jet-induced explosions with two-dimensional relativistic hydrodynamics calculations and the jet acceleration with steady, radial, relativistic magnetohydrodynamics calculations, and derive the detailed nuclear composition of the jet by post-processing calculation. We found that if the temperature at the jet launch site is above 4.7 x 10(9) K, quasi-statistical equilibrium is established and heavy nuclei are dissociated into light particles such as He-4 during the acceleration of the jets. The criterion for the survival of metal nuclei is written in terms of the isotropic jet luminosity as L-j(iso) less than or similar to 3.9 x 10(50)(R-i/10(7) cm)(2)(1 + sigma(i)) erg s(-1), where R-i and sigma(i) are the initial radius of the jets and the initial magnetization parameter, respectively. If the jet is initially dominated by radiation field (i.e., sigma(i) << 1) and the isotropic luminosity is relatively high (L-j(iso) greater than or similar to 4 x 10(52) erg s(-1)), the metal nuclei cannot survive in the jet. On the other hand, if the jet is mainly accelerated by magnetic field (i.e., sigma(i) >> 1), metal nuclei initially contained in the jet can survive without serious dissociation even in the case of a high-luminosity jet. If the jet contains metal nuclei, the dominant nuclei are Si-28, O-16, and S-32 and the mean mass number can be < A > similar to 25.	[Shibata, Sanshiro; Tominaga, Nozomu] Konan Univ, Dept Phys, Nada Ku, Kobe, Hyogo 6588501, Japan; [Shibata, Sanshiro; Tominaga, Nozomu] Univ Tokyo, Kavli Inst Phys & Math Universe, Kashiwa, Chiba 2778583, Japan	Shibata, S (reprint author), Konan Univ, Dept Phys, Nada Ku, 8-9-1 Okamoto, Kobe, Hyogo 6588501, Japan.	d1221001@center.konan-u.ac.jp			World Premier International Research Center Initiative, MEXT, Japan; JSPS [23740157, 25.2912]	We thank Hajime Susa for his helpful comments. This research has been supported in part by World Premier International Research Center Initiative, MEXT, Japan, and by the Grant-in-Aid for Scientific Research of the JSPS (23740157, 25.2912). Data analyses were in part carried out on the general-purpose PC farm at the Center for Computational Astrophysics, CfCA, of National Astronomical Observatory of Japan.	VIETRI M, 1995, ASTROPHYS J, V453, P883, DOI 10.1086/176448; McKinney JC, 2006, MON NOT R ASTRON SOC, V368, P1561, DOI 10.1111/j.1365-2966.2006.10256.x; Abbasi RU, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.161101; MacFadyen AI, 1999, ASTROPHYS J, V524, P262, DOI 10.1086/307790; Qian YZ, 1996, ASTROPHYS J, V471, P331, DOI 10.1086/177973; Iwamoto K, 1998, NATURE, V395, P672; Umeda H, 2005, ASTROPHYS J, V619, P427, DOI 10.1086/426097; Freiburghaus C, 1999, ASTROPHYS J, V516, P381, DOI 10.1086/307072; Murase K, 2006, ASTROPHYS J, V651, pL5, DOI 10.1086/509323; Murase K, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.023005; WAXMAN E, 1995, PHYS REV LETT, V75, P386, DOI 10.1103/PhysRevLett.75.386; Liang EW, 2007, ASTROPHYS J, V662, P1111, DOI 10.1086/517959; SAIO H, 1988, ASTROPHYS J, V331, P388, DOI 10.1086/166565; Metzger BD, 2011, MON NOT R ASTRON SOC, V413, P2031, DOI 10.1111/j.1365-2966.2011.18280.x; WOOSLEY SE, 1973, ASTROPHYS J SUPPL S, V26, P231, DOI 10.1086/190282; Zhang WQ, 2003, ASTROPHYS J, V586, P356, DOI 10.1086/367609; Morsony BJ, 2010, ASTROPHYS J, V723, P267, DOI 10.1088/0004-637X/723/1/267; Pruet J, 2002, ASTROPHYS J, V580, P368, DOI 10.1086/342838; Tominaga N, 2007, ASTROPHYS J, V657, pL77, DOI 10.1086/513193; Morsony BJ, 2007, ASTROPHYS J, V665, P569, DOI 10.1086/519483; Meszaros P, 2006, REP PROG PHYS, V69, P2259, DOI 10.1088/0034-4885/69/8/R01; Mizuta A, 2009, ASTROPHYS J, V699, P1261, DOI 10.1088/0004-637X/699/2/1261; Abraham J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.091101; Gupta N, 2007, ASTROPART PHYS, V27, P386, DOI 10.1016/j.astropartphys.2007.01.004; Drenkhahn G, 2002, ASTRON ASTROPHYS, V391, P1141, DOI 10.1051/0004-6361:20020839; Hix WR, 1996, ASTROPHYS J, V460, P869, DOI 10.1086/177016; Fujimoto SI, 2008, ASTROPHYS J, V680, P1350, DOI 10.1086/529416; Beloborodov AM, 2003, ASTROPHYS J, V588, P931, DOI 10.1086/374217; Bisnovatyi-Kogan G. S, 2002, STELLAR PHYS, V2; BLANDFORD RD, 1977, MON NOT R ASTRON SOC, V179, P433; Bromberg O, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/2/100; Brown GE, 2000, NEW ASTRON, V5, P191, DOI 10.1016/S1384-1076(00)00026-9; Drenkhahn G, 2002, ASTRON ASTROPHYS, V387, P714, DOI 10.1051/0004-6361:20020390; Ghirlanda G., 2010, ASTRON ASTROPHYS, V511, P43; GOODMAN J, 1986, ASTROPHYS J, V308, pL47, DOI 10.1086/184741; Guiriec S, 2011, ASTROPHYS J LETT, V727, DOI 10.1088/2041-8205/727/2/L33; Hix WR, 1999, ASTROPHYS J, V511, P862, DOI 10.1086/306692; Hooper D, 2010, ASTROPART PHYS, V33, P151, DOI 10.1016/j.astropartphys.2010.01.003; Horiuchi S, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/69; Lemoine M, 2002, ASTRON ASTROPHYS, V390, pL31, DOI 10.1051/0004-6361:20020939; Lyutikov M., 2003, ASTROPH0312347; Maeda K, 2003, ASTROPHYS J, V598, P1163, DOI 10.1086/378948; Maeda K, 2009, MON NOT R ASTRON SOC, V394, P1317, DOI 10.1111/j.1365-2966.2009.14460.x; Metzger BD, 2011, MON NOT R ASTRON SOC, V415, P2495, DOI 10.1111/j.1365-2966.2011.18873.x; PACZYNSKI B, 1986, ASTROPHYS J, V308, pL43, DOI 10.1086/184740; Zhang B, 2009, ASTROPHYS J LETT, V700, pL65, DOI 10.1088/0004-637X/700/2/L65; Piran T, 2004, REV MOD PHYS, V76, P1143, DOI 10.1103/RevModPhys.76.1143; Tominaga N, 2009, ASTROPHYS J, V690, P526, DOI 10.1088/0004-637X/690/1/526; Uzdensky DA, 2007, ASTROPHYS J, V669, P546, DOI 10.1086/521322; Wang XY, 2008, ASTROPHYS J, V677, P432, DOI 10.1086/529018; WOOSLEY SE, 1993, ASTROPHYS J, V405, P273, DOI 10.1086/172359; Zhang B, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/2/90	52	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	JUN	2015	67	3							49	10.1093/pasj/psv020		10	Astronomy & Astrophysics	Astronomy & Astrophysics	CK4GQ	WOS:000356182500020		
J	Takita, S; Doi, Y; Ootsubo, T; Arimatsu, K; Ikeda, N; Kawada, M; Kitamura, Y; Matsuura, S; Nakagawa, T; Hattori, M; Morishima, T; Tanaka, M; Komugi, S				Takita, Satoshi; Doi, Yasuo; Ootsubo, Takafumi; Arimatsu, Ko; Ikeda, Norio; Kawada, Mitsunobu; Kitamura, Yoshimi; Matsuura, Shuji; Nakagawa, Takao; Hattori, Makoto; Morishima, Takahiro; Tanaka, Masahiro; Komugi, Shinya			Calibration of the AKARI far-infrared all-sky survey maps	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						infrared: general; space vehicles; surveys	PERFORMANCE; MISSION	We present an initial analysis of the properties of an all-sky image obtained by the Far-Infrared Surveyor (FIS) onboard the AKARI satellite, at 65 mu m (N60), 90 mu m (WIDE-S), 140 mu m (WIDE-L), and 160 mu m (N160). An absolute flux calibration was determined by comparing the data with COBE/DIRBE data sets; the intensity range was as wide as from a few M Jy sr(-1) to > 1GJy sr(-1). The uncertainties are considered to be the standard deviations with respect to the DIRBE data, and are less than 10% for intensities above 10, 3, 25, and 26M Jy sr(-1) at the N60, WIDE-S, WIDE-L, and N160 bands, respectively. The characteristics of point sources in the image were also determined by stacking maps centred on photometric standard stars. The full width at half maxima of the point spread functions (PSFs) were 63 '', 78 '', and 88 '' at the N60, WIDE-S, and WIDE-L bands, respectively. The PSF at the N160 band was not obtained due to the sensitivity, but it is thought to be the same as that of the WIDE-L one.	[Takita, Satoshi; Arimatsu, Ko; Ikeda, Norio; Kawada, Mitsunobu; Kitamura, Yoshimi; Matsuura, Shuji; Nakagawa, Takao] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Doi, Yasuo; Ootsubo, Takafumi] Univ Tokyo, Grad Sch Arts & Sci, Dept Earth Sci & Astron, Meguro Ku, Tokyo 1538902, Japan; [Arimatsu, Ko] Univ Tokyo, Grad Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Hattori, Makoto; Morishima, Takahiro] Tohoku Univ, Grad Sch Sci, Astron Inst, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Tanaka, Masahiro] Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki 3058577, Japan; [Komugi, Shinya] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan	Takita, S (reprint author), Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, 3-1-1 Yoshinodai, Sagamihara, Kanagawa 2525210, Japan.	takita@ir.isas.jaxa.jp			JSPS KAKENHI [19204020, 21111005, 25247016, 25400220]	This research is based on observations with AKARI, a JAXA project with the participation of ESA. This work has been supported by JSPS KAKENHI Grant Numbers 19204020, 21111005, 25247016, and 25400220.	Arimatsu K, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/psu010; BOGGESS NW, 1992, ASTROPHYS J, V397, P420, DOI 10.1086/171797; Cohen M, 1999, ASTRON J, V117, P1864, DOI 10.1086/300813; Hauser MG, 1998, ASTROPHYS J, V508, P25, DOI 10.1086/306379; Gorjian V, 2000, ASTROPHYS J, V536, P550, DOI 10.1086/308974; Murakami H, 2007, PUBL ASTRON SOC JPN, V59, pS369; Doi Y., 2009, ASP C SER, V418, P387; Doi Y, 2015, PUBL ASTRON SOC JPN, V67, DOI 10.1093/pasj/psv022; Ikeda N, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/48; Kawada M., 2007, PASJ, V59, P389; Landsman W. B, 1993, P ASP C, V52, P246; Matsuura S, 2007, PUBL ASTRON SOC JPN, V59, pS503; Miville-Deschenes MA, 2005, ASTROPHYS J SUPPL S, V157, P302, DOI 10.1086/427938; Nakagawa T, 2007, PUBL ASTRON SOC JPN, V59, pS377; Neugebauer G., 1984, AP J, V278, pL1; Shirahata M, 2009, PUBL ASTRON SOC JPN, V61, P737	16	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	JUN	2015	67	3							51	10.1093/pasj/psv033		8	Astronomy & Astrophysics	Astronomy & Astrophysics	CK4GQ	WOS:000356182500022		
J	Tonegawa, M; Totani, T; Iwamuro, F; Akiyama, M; Dalton, G; Glazebrook, K; Ohta, K; Okada, H; Yabe, K				Tonegawa, Motonari; Totani, Tomonori; Iwamuro, Fumihide; Akiyama, Masayuki; Dalton, Gavin; Glazebrook, Karl; Ohta, Kouji; Okada, Hiroyuki; Yabe, Kiyoto			FIELD: Automated emission line detection software for Subaru/FMOS near-infrared spectroscopy	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						cosmology: observations; instrumentation: spectrographs; methods: data analysis	GALAXY REDSHIFT SURVEY; GROWTH-RATE; H-ALPHA; TELESCOPE; DENSITY; FMOS	We describe the development of automated emission line detection software for the Fiber Multi-Object Spectrograph (FMOS), which is a near-infrared spectrograph fed by 400 fibers from the 0.2 deg(2) prime focus field of view of the Subaru Telescope. The software, FIELD (FMOS software for Image-based Emission Line Detection), is developed and tested mainly for the FastSound survey, which is targeting Ha emitting galaxies at z similar to 1.3 to measure the redshift space distortion as a test of general relativity beyond z similar to 1. The basic algorithm is to calculate the line signal-to-noise ratio (S/N) along the wavelength direction, given by a 2D convolution of the spectral image and a detection kernel representing a typical emission line profile. A unique feature of FMOS is its use of OH airglow suppression masks, requiring the use of flat-field images to suppress noise around the mask regions. Bad pixels on the detectors and pixels affected by cosmic rays are efficiently removed using the information obtained from the FMOS analysis pipeline. We limit the range of acceptable line-shape parameters for the detected candidates to further improve the reliability of line detection. The final performance of line detection is tested using a subset of the FastSound data; the false detection rate of spurious objects is examined by using inverted frames obtained by exchanging object and sky frames. The false detection rate is < 1% at S/N > 5, allowing an efficient and objective emission line search for FMOS data at the line flux level of greater than or similar to 1.0 x 10(-16) erg cm(-2) s(-1).	[Tonegawa, Motonari; Totani, Tomonori; Okada, Hiroyuki] Univ Tokyo, Fac Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Iwamuro, Fumihide; Ohta, Kouji] Kyoto Univ, Fac Sci, Dept Astron, Sakyo Ku, Kyoto, Kyoto 6068502, Japan; [Akiyama, Masayuki] Tohoku Univ, Fac Sci, Astron Inst, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Dalton, Gavin] Univ Oxford, Dept Phys, Oxford OX1 3RH, England; [Dalton, Gavin] STFC RALSpace, Oxford OX11 0QX, England; [Glazebrook, Karl] Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia; [Yabe, Kiyoto] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan	Tonegawa, M (reprint author), Univ Tokyo, Fac Sci, Dept Astron, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	tonegawa@astron.s.u-tokyo.ac.jp	Glazebrook, Karl/N-3488-2015	Glazebrook, Karl/0000-0002-3254-9044	JSPS KAKENHI [23684007]	This work was supported in part by JSPS KAKENHI Grant Number 23684007.	Hawkins E, 2003, MON NOT R ASTRON SOC, V346, P78, DOI 10.1046/j.1365-2966.2003.07063.x; Guzzo L, 2008, NATURE, V451, P541, DOI 10.1038/nature06555; Beutler F, 2012, MON NOT R ASTRON SOC, V423, P3430, DOI 10.1111/j.1365-2966.2012.21136.x; Iwamuro F, 2001, PUBL ASTRON SOC JPN, V53, P355; Reid BA, 2012, MON NOT R ASTRON SOC, V426, P2719, DOI 10.1111/j.1365-2966.2012.21779.x; Gilbank DG, 2010, MON NOT R ASTRON SOC, V405, P2594, DOI 10.1111/j.1365-2966.2010.16640.x; Blake C, 2011, MON NOT R ASTRON SOC, V415, P2876, DOI 10.1111/j.1365-2966.2011.18903.x; de la Torre S, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201321463; Gwyn S. D. J., 2012, ASTRON ASTROPHYS, V143, pA38; Iwamuro F, 2012, PUBL ASTRON SOC JPN, V64; Kimura M, 2010, PUBL ASTRON SOC JPN, V62, P1135; Samushia L., 2013, MNRAS, V420, P2102; Tonegawa M, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/psu022	13	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	JUN	2015	67	3							31	10.1093/pasj/psu127		9	Astronomy & Astrophysics	Astronomy & Astrophysics	CK4GQ	WOS:000356182500002		
J	Tsujimoto, T; Ishigaki, MN; Shigeyama, T; Aoki, W				Tsujimoto, Takuji; Ishigaki, Miho N.; Shigeyama, Toshikazu; Aoki, Wako			Chemical feature of Eu abundance in the Draco dwarf spheroidal galaxy	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						early universe; nuclear reactions, nucleosynthesis, abundances; galaxies: dwarf; galaxies: individual (Draco); stars: abundances	NEUTRON-CAPTURE ELEMENTS; METAL-POOR STARS; R-PROCESS ELEMENTS; MERGERS; NUCLEOSYNTHESIS; SUPERNOVAE; SCULPTOR; INSIGHTS; SEXTANS; GIANTS	The chemical abundance of r-process elements in nearby dwarf spheroidal (dSph) galaxies is a powerful tool to probe the site of r-process since their small-mass scale can assess the potential rarity of events associated with the r-process production. A merger of binary neutron stars is a promising candidate for such a site. In faint, or less-massive, dSph galaxies such as the Draco, a few binary neutron star mergers are expected to have occurred at most over the whole past. We have measured the chemical abundance, including Eu and Ba, of three red giants in the Draco dSph by Subaru High-Dispersion Spectrograph observation. The Eu detection for one star with [Fe/H] = -1.45 confirms a broadly constant [Eu/H] of similar to -1.3 for stars with [Fe/H] greater than or similar to -2. This feature is shared by other dSphs with similar masses, i.e., the Sculptor and the Carina, and suggests that a neutron star merger is the origin of r-process elements in terms of the rarity of this event. In addition, two very metal-poor stars with [Fe/H] = -2.12 and -2.51 are found to exhibit very low Eu abundances, such as [Eu/H] < -2, with the suggestion of a sudden increase of Eu abundance by more than 0.7 dex at [Fe/H] approximate to -2.2 in the Draco dSph. The detection of Ba abundances for these stars suggests that the r-process enrichment began no later than the time when only a few percent of stars in the present-day Draco dSph were formed. Though identifying the origin of an early Eu production inside the Draco dSph should be left until more abundant data of stars with [Fe/H] less than or similar to -2 in Draco, as well as other faint dSphs, become available, the implied early emergence of an Eu production event might be reconciled with the presence of extremely metal-poor stars enriched by r-process elements in the Galactic halo.	[Tsujimoto, Takuji; Aoki, Wako] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Ishigaki, Miho N.] Univ Tokyo, Kavli Inst Phys & Math Universe WPI, Kashiwa, Chiba 2778583, Japan; [Shigeyama, Toshikazu] Univ Tokyo, Grad Sch Sci, Res Ctr Early Universe, Bunkyo Ku, Tokyo 1130033, Japan	Tsujimoto, T (reprint author), Natl Astron Observ Japan, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan.	taku.tsujimoto@nao.ac.jp					Martin NF, 2008, ASTROPHYS J, V684, P1075, DOI 10.1086/590336; Burris DL, 2000, ASTROPHYS J, V544, P302, DOI 10.1086/317172; KROUPA P, 1993, MON NOT R ASTRON SOC, V262, P545; Argast D, 2004, ASTRON ASTROPHYS, V416, P997, DOI 10.1051/0004-6361:20034265; Shetrone M, 2003, ASTRON J, V125, P684, DOI 10.1086/345966; Cohen JG, 2009, ASTROPHYS J, V701, P1053, DOI 10.1088/0004-637X/701/2/1053; Fulbright JP, 2004, ASTROPHYS J, V612, P447, DOI 10.1086/421712; Lawler JE, 2001, ASTROPHYS J, V563, P1075, DOI 10.1086/323407; Shetrone MD, 2001, ASTROPHYS J, V548, P592, DOI 10.1086/319022; Korobkin O, 2012, MON NOT R ASTRON SOC, V426, P1940, DOI 10.1111/j.1365-2966.2012.21859.x; Orban C, 2008, ASTROPHYS J, V686, P1030, DOI 10.1086/591496; Thompson TA, 2001, ASTROPHYS J, V562, P887, DOI 10.1086/323861; Noguchi K, 2002, PUBL ASTRON SOC JPN, V54, P855; Demarque P, 2004, ASTROPHYS J SUPPL S, V155, P667, DOI 10.1086/424966; Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Geisler D, 2005, ASTRON J, V129, P1428, DOI 10.1086/427540; Aoki W, 2009, ASTROPHYS J, V698, P1803, DOI 10.1088/0004-637X/698/2/1803; MATHEWS GJ, 1990, NATURE, V345, P491, DOI 10.1038/345491a0; Tanvir NR, 2013, NATURE, V500, P547, DOI 10.1038/nature12505; Barnes J, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/18; Bauswein A, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/78; Berger E., 2013, APJ, V773, P78; Castelli F., 2003, IAU S, V210, P20; Hotokezaka K, 2013, ASTROPHYS J LETT, V778, DOI 10.1088/2041-8205/778/1/L16; Ishigaki MN, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/1/67; Ishigaki MN, 2014, ASTRON ASTROPHYS, V562, DOI 10.1051/0004-6361/201322796; Kirby EN, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/2/78; Kirby EN, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/6/168; Lemasle B, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201118132; Ramirez I, 2005, ASTROPHYS J, V626, P465, DOI 10.1086/430102; Roederer IU, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/1/26; Simon JD, 2015, ASTROPHYS J, V802, DOI 10.1088/0004-637X/802/2/93; Tafelmeyer M, 2010, ASTRON ASTROPHYS, V524, DOI 10.1051/0004-6361/201014733; Tsujimoto T, 2014, ASTRON ASTROPHYS, V565, DOI 10.1051/0004-6361/201423751; Venn KA, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/2/102; Wanajo S, 2014, ASTROPHYS J LETT, V789, DOI 10.1088/2041-8205/789/2/L39; Wanajo S, 2013, ASTROPHYS J LETT, V770, DOI 10.1088/2041-8205/770/2/L22; Wehmeyer B., 2015, MNRAS UNPUB; Winteler C, 2012, ASTROPHYS J LETT, V750, DOI 10.1088/2041-8205/750/1/L22	39	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	JUN	2015	67	3							L3	10.1093/pasj/psv035		6	Astronomy & Astrophysics	Astronomy & Astrophysics	CK4GQ	WOS:000356182500001		
J	Uemura, M; Kawabata, KS; Ikeda, S; Maeda, K				Uemura, Makoto; Kawabata, Koji S.; Ikeda, Shiro; Maeda, Keiichi			Variable selection for modeling the absolute magnitude at maximum of Type Ia supernovae	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						distance scale; methods: statistical; supernovae: general	GALAXIES; LUMINOSITIES; BRIGHTNESS; DIVERSITY; DISTANCES; IMPROVE; DUST	We discuss what is an appropriate set of explanatory variables in order to predict the absolute magnitude at the maximum of Type Ia supernovae. In order to have a good prediction, the error for future data, which is called the "generalization error," should be small. We use cross-validation in order to control the generalization error and a LASSO-type estimator in order to choose the set of variables. This approach can be used even in the case that the number of samples is smaller than the number of candidate variables. We studied the Berkeley supernova database with our approach. Candidates for the explanatory variables include normalized spectral data, variables about lines, and previously proposed flux ratios, as well as the color and light-curve widths. As a result, we confirmed the past understanding about Type Ia supernovae: (i) The absolute magnitude at maximum depends on the color and light-curve width. (ii) The light-curve width depends on the strength of Si II. Recent studies have suggested adding more variables in order to explain the absolute magnitude. However, our analysis does not support adding any other variables in order to have a better generalization error.	[Uemura, Makoto; Kawabata, Koji S.] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Hiroshima 7398526, Japan; [Uemura, Makoto; Kawabata, Koji S.] Hiroshima Univ, Core Res Energet Universe, Hiroshima 7398526, Japan; [Ikeda, Shiro] Inst Stat Math, Tokyo 1908562, Japan; [Ikeda, Shiro] JST, CREST, Tokyo 1908562, Japan; [Maeda, Keiichi] Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan; [Maeda, Keiichi] Univ Tokyo, Kavli Inst Phys & Math Universe WPI, Kashiwa, Chiba 2778583, Japan	Uemura, M (reprint author), Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Kagamiyama 1-3-1, Hiroshima 7398526, Japan.	uemuram@hiroshima-u.ac.jp			JSPS KAKENHI [25120007, 25120008, 26800100]; WPI Initiative, MEXT, Japan	We would like to thank Drs J. M. Silverman and A. V. Filippenko for providing the Berkeley supernova database. We also appreciate the comments and suggestions from the anonymous referee. This work was supported by JSPS KAKENHI Grant Number 25120007, 25120008, and 26800100. The work by K.M. is partly supported by the WPI Initiative, MEXT, Japan.	Aldering G., 2002, SPIE, V4836, P61; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Guy J, 2007, ASTRON ASTROPHYS, V466, P11, DOI 10.1051/0004-6361:20066930; Hachinger S, 2006, MON NOT R ASTRON SOC, V370, P299, DOI [10.1111/j.1365-2966.2006.10468.x, 10.1111/j.136-2966.2006.10468.x]; Sullivan M, 2010, MON NOT R ASTRON SOC, V406, P782, DOI 10.1111/j.1365-2966.2010.16731.x; Pan YC, 2015, MON NOT R ASTRON SOC, V446, P354, DOI 10.1093/mnras/stu2121; Bailey S, 2009, ASTRON ASTROPHYS, V500, pL17, DOI 10.1051/0004-6361/200911973; Peek JEG, 2010, ASTROPHYS J, V719, P415, DOI 10.1088/0004-637X/719/1/415; Conley A, 2007, ASTROPHYS J, V664, pL13, DOI 10.1086/520625; Arsenijevic V, 2008, ASTRON ASTROPHYS, V492, P535, DOI 10.1051/0004-6361:200810675; Blondin S, 2011, ASTRON ASTROPHYS, V526, DOI 10.1051/0004-6361/201015792; Foley RJ, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/55; Foley RJ, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/57; Mazzali PA, 2001, ASTROPHYS J, V547, P988, DOI 10.1086/318428; PHILLIPS MM, 1993, ASTROPHYS J, V413, pL105, DOI 10.1086/186970; Silverman JM, 2012, MON NOT R ASTRON SOC, V425, P1889, DOI 10.1111/j.1365-2966.2012.21526.x	17	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	JUN	2015	67	3							55	10.1093/pasj/psv031		9	Astronomy & Astrophysics	Astronomy & Astrophysics	CK4GQ	WOS:000356182500026		
J	Yamamoto, S; Saitoh, TR; Makino, J				Yamamoto, Satoko; Saitoh, Takayuki R.; Makino, Junichiro			Smoothed particle hydrodynamics with smoothed pseudo-density	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						hydrodynamics; methods: numerical; planets and satellites: surface	KELVIN-HELMHOLTZ INSTABILITIES; SIMULATIONS; SPH; EQUATION	In this paper, we present a new formulation of smoothed particle hydrodynamics (SPH), which, unlike the standard SPH (SSPH), is well behaved at the contact discontinuity. The SSPH scheme cannot handle discontinuities in density (e.g., the contact discontinuity and the free surface), because it requires that the density of fluid is positive and continuous everywhere. Thus there is inconsistency in the formulation of the SSPH scheme at discontinuities of the fluid density. To solve this problem, we introduce a new quantity associated with particles and the "density" of that quantity. This "density" evolves through the usual continuity equation with an additional artificial diffusion term, in order to guarantee the continuity of the "density." We use this "density," or pseudo-density, instead of the mass density, to formulate our SPH scheme. We call our new method SPH with smoothed pseudo-density, and we show that it is physically consistent and can handle discontinuities quite well.	[Yamamoto, Satoko] Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; [Saitoh, Takayuki R.; Makino, Junichiro] Tokyo Inst Technol, Earth Life Sci Inst, Meguro Ku, Tokyo 1528550, Japan; [Makino, Junichiro] RIKEN Adv Inst Computat Sci, Chuo Ku, Kobe, Hyogo 6500047, Japan	Yamamoto, S (reprint author), Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan.	yamamoto.s.an@geo.titech.ac.jp	Saitoh, Takayuki/A-2740-2014		MEXT SPIRE; JICFuS; JSPS [26707007]	We thank the anonymous referee for her/his insightful comments and suggestions. This work is supported by MEXT SPIRE and JICFuS and JSPS Grants-in-Aid for Scientific Research (26707007).	Hosono N, 2013, PUBL ASTRON SOC JPN, V65; Read JI, 2010, MON NOT R ASTRON SOC, V405, P1513, DOI 10.1111/j.1365-2966.2010.16577.x; Price DJ, 2008, J COMPUT PHYS, V227, P10040, DOI 10.1016/j.jcp.2008.08.011; Agertz O, 2007, MON NOT R ASTRON SOC, V380, P963, DOI 10.1111/j.1365-2966.2007.12183.x; Monaghan JJ, 1997, J COMPUT PHYS, V136, P298, DOI 10.1006/jcph.1997.5732; SOD GA, 1978, J COMPUT PHYS, V27, P1, DOI 10.1016/0021-9991(78)90023-2; LUCY LB, 1977, ASTRON J, V82, P1013, DOI 10.1086/112164; Springel V, 2010, ANNU REV ASTRON ASTR, V48, P391, DOI 10.1146/annurev-astro-081309-130914; Okamoto T, 2003, MON NOT R ASTRON SOC, V345, P429, DOI 10.1046/j.1365-8711.2003.06948.x; Dehnen W, 2012, MON NOT R ASTRON SOC, V425, P1068, DOI 10.1111/j.1365-2966.2012.21439.x; Ritchie BW, 2001, MON NOT R ASTRON SOC, V323, P743, DOI 10.1046/j.1365-8711.2001.04268.x; GINGOLD RA, 1977, MON NOT R ASTRON SOC, V181, P375; Springel V, 2002, MON NOT R ASTRON SOC, V333, P649, DOI 10.1046/j.1365-8711.2002.05445.x; Rosswog S, 2009, NEW ASTRON REV, V53, P78, DOI 10.1016/j.newar.2009.08.007; BALSARA DS, 1995, J COMPUT PHYS, V121, P357, DOI 10.1016/S0021-9991(95)90221-X; BROOKSHAW L, 1985, P ASTRON SOC AUST, V6, P207; Cha SH, 2010, MON NOT R ASTRON SOC, V403, P1165, DOI 10.1111/j.1365-2966.2010.16200.x; Garcia-Senz D, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201117939; Hopkins PF, 2013, MON NOT R ASTRON SOC, V428, P2840, DOI 10.1093/mnras/sts210; Inutsuka S, 2002, J COMPUT PHYS, V179, P238, DOI 10.1006/jcph.2002.7053; Murante G, 2011, MON NOT R ASTRON SOC, V417, P136, DOI 10.1111/j.1365-2966.2011.19021.x; Ott F., 2003, ARXIVPHYSICS0303112; Rosswog S., 2014, ARXIV14056034; Saitoh TR, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/44; Toro E.F., 2009, RIEMANN SOLVERS NUME	25	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	JUN	2015	67	3							37	10.1093/pasj/psv006		18	Astronomy & Astrophysics	Astronomy & Astrophysics	CK4GQ	WOS:000356182500008		
J	Yasuda, T; Iwakiri, WB; Tashiro, MS; Terada, Y; Kouzu, T; Enoto, T; Nakagawa, YE; Bamba, A; Urata, Y; Yamaoka, K; Ohno, M; Shibata, S; Makishima, K				Yasuda, Tetsuya; Iwakiri, Wataru B.; Tashiro, Makoto S.; Terada, Yukikatsu; Kouzu, Tomomi; Enoto, Teruaki; Nakagawa, Yujin E.; Bamba, Aya; Urata, Yuji; Yamaoka, Kazutaka; Ohno, Masanori; Shibata, Shinpei; Makishima, Kazuo			Sub-MeV band observation of a hard burst from AXP 1E 1547.0-5408 with the Suzaku Wide-band All-sky Monitor	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						stars: magnetars; X-rays: bursts; X-rays: individual (AXP 1E 1547.0-5408, SGR J1550-5418, PSR J1550-5418)	GAMMA-RAY BURSTS; MAGNETIZED NEUTRON-STARS; SGR J1550-5418 BURSTS; IN-ORBIT PERFORMANCE; 1998 AUGUST 27; GIANT FLARE; RADIATIVE MECHANISM; DETECTOR HXD; BOARD SUZAKU; SGR-1806-20	The 2.1-s anomalous X-ray pulsar 1E 1547.0-5408 exhibited an X-ray outburst on 2009 January 22, emitting a large number of short bursts. The wide-band all-sky monitor (WAM) on-board Suzaku detected at least 254 bursts in the 160 keV-6.2MeV band over the period of January 22 00: 57-17: 02 UT from the direction of 1E 1547.0-5408. One of these bursts, which occurred at 06: 45: 13, produced the brightest fluence in the 0.5-6.2 MeV range, with an averaged 0.16-6.2 MeV flux and extrapolated 25 keV-2 MeV fluence of about 1x10(-5) erg cm(-2) s(-1) and about 3x10(-4) erg cm(-2), respectively. After pile-up corrections, the time-resolved WAM spectra of this burst were well-fitted in the 0.16-6.2 MeV range by two-component models; specifically, a blackbody plus an optically thin thermal bremsstrahlung or a combination of a blackbody and a power-law component with an exponential cut-off. These results are compared with previous works reporting the persistent emission and weaker short bursts followed by the same outburst.	[Yasuda, Tetsuya; Tashiro, Makoto S.; Terada, Yukikatsu; Kouzu, Tomomi] Saitama Univ, Grad Sch Sci & Engn, Saitama, Saitama 3388570, Japan; [Iwakiri, Wataru B.; Enoto, Teruaki] RIKEN Nishina Ctr, Wako, Saitama 3510198, Japan; [Enoto, Teruaki] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Nakagawa, Yujin E.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Bamba, Aya] Aoyama Gakuin Univ, Dept Phys & Math, Chuo Ku, Sagamihara, Kanagawa 2525258, Japan; [Urata, Yuji] Natl Cent Univ, Inst Astron, Chungli 32054, Taiwan; [Yamaoka, Kazutaka] Nagoya Univ, Solar Terr Environm Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Yamaoka, Kazutaka] Nagoya Univ, Grad Sch Sci, Div Particle & Astrophys Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Ohno, Masanori] Hiroshima Univ, Dept Phys Sci, Hiroshima 7398526, Japan; [Shibata, Shinpei] Yamagata Univ, Dept Phys, Yamagata 9908560, Japan; [Makishima, Kazuo] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Yasuda, T (reprint author), Saitama Univ, Grad Sch Sci & Engn, 255 Shimo Okubo, Saitama, Saitama 3388570, Japan.	yasuda@heal.phy.saitama-u.ac.jp	XRAY, SUZAKU/A-1808-2009		Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [24-10233, 23340055, 22340039]; MEXT [22684012]; JSPS [24540309]	This work was supported in part by Grant-in-Aid for the Japan Society for the Promotion of Science (JSPS) Fellows (No. 24-10233, T.Y.), Grants-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (No. 23340055, Y.T.; No. 22340039, M.S.T.), a Grant-in-Aid for Young Scientists (A) from MEXT (No. 22684012, A. B.), and JSPS KAKENHI (No. 24540309, Y.E.N.).	DUNCAN RC, 1992, ASTROPHYS J, V392, pL9, DOI 10.1086/186413; Enoto T, 2010, PUBL ASTRON SOC JPN, V62, P475; Frederiks DD, 2007, ASTRON LETT+, V33, P1, DOI 10.1134/S106377370701001X; Olive JF, 2004, ASTROPHYS J, V616, P1148, DOI 10.1086/424957; Hurley K, 1999, NATURE, V397, P41, DOI 10.1038/16199; THOMPSON C, 1995, MON NOT R ASTRON SOC, V275, P255; Palmer DM, 2005, NATURE, V434, P1107, DOI 10.1038/nature03525; Boggs SE, 2007, ASTROPHYS J, V661, P458, DOI 10.1086/516732; Enoto T, 2012, MON NOT R ASTRON SOC, V427, P2824, DOI 10.1111/j.1365-2966.2012.22086.x; Mereghetti S, 2009, ASTROPHYS J LETT, V696, pL74, DOI 10.1088/0004-637X/696/1/L74; Gelfand JD, 2007, ASTROPHYS J, V667, P1111, DOI 10.1086/520526; Thompson C, 2001, ASTROPHYS J, V561, P980, DOI 10.1086/323256; Endo A, 2010, PUBL ASTRON SOC JPN, V62, P1341; Feroci M, 2001, ASTROPHYS J, V549, P1021, DOI 10.1086/319441; Feroci M, 2004, ASTROPHYS J, V612, P408, DOI 10.1086/422405; Yamaoka K, 2009, PUBL ASTRON SOC JPN, V61, pS35; Mereghetti S, 2005, ASTROPHYS J, V624, pL105, DOI 10.1086/430669; Hurley K, 2005, NATURE, V434, P1098, DOI 10.1038/nature03519; Esposito P, 2007, ASTRON ASTROPHYS, V476, P321, DOI 10.1051/0004-6361:20078562; Bellm E., 2009, 8857 GCN, V8857; Connaughton V., 2009, 8835 GCN, V8835; Deller AT, 2012, ASTROPHYS J LETT, V748, DOI 10.1088/2041-8205/748/1/L1; Dib R, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/1/3; Golenetskii S., 2009, GCN CIRC, V8858; Golenetskii S., 2009, 8878 GCN, V8878; Golenetskii S., 2009, 8863 GCN, V8863; Gronwall C., 2009, GCN, P8833; Kaspi VM, 2007, ASTROPHYS SPACE SCI, V308, P1, DOI 10.1007/s10509-007-9309-y; Kokubun M, 2007, PUBL ASTRON SOC JPN, V59, pS53; Lin L, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/1/54; Mereghetti S., 2009, GCN, P8841; Mereghetti S, 2008, ASTRON ASTROPHYS REV, V15, P225, DOI 10.1007/s00159-008-0011-Z; Mitsuda K, 2007, PUBL ASTRON SOC JPN, V59, pS1; Nakagawa YE, 2007, PUBL ASTRON SOC JPN, V59, P653; Nakagawa YE, 2011, PUBL ASTRON SOC JPN, V63, pS813; Ohno M, 2005, IEEE T NUCL SCI, V52, P2758, DOI 10.1109/TNS.2005.860172; Ozaki M., 2005, IEEE T NUCL SCI, V53, P1310; Sakamoto T, 2011, PUBL ASTRON SOC JPN, V63, P215; Savchenko V., 2009, GCN, P8837; Savchenko V, 2010, ASTRON ASTROPHYS, V510, DOI 10.1051/0004-6361/200911988; Takahashi T, 2007, PUBL ASTRON SOC JPN, V59, pS35; Tashiro MS, 2012, PUBL ASTRON SOC JPN, V64, DOI 10.1093/pasj/64.2.26; Terada Y., 2008, PASJ, V60, P25; Terada Y, 2005, IEEE T NUCL SCI, V52, P902, DOI 10.1109/TNS.2005.852681; Terada Y., 2009, GCN CIRC, P8845; Tiengo A, 2010, ASTROPHYS J, V710, P227, DOI 10.1088/0004-637X/710/1/227; Urata Y, 2012, ASTROPHYS J LETT, V748, DOI 10.1088/2041-8205/748/1/L4; Urata Y, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/2/146; van der Horst AJ, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/2/122; Woods P. M., 2006, COMPACT STELLAR XRAY, V39, P547; Younes G, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/1/52	51	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	JUN	2015	67	3							41	10.1093/pasj/psv011		12	Astronomy & Astrophysics	Astronomy & Astrophysics	CK4GQ	WOS:000356182500012		
J	Ogihara, S; Tarnow, DP				Ogihara, Shigeki; Tarnow, Dennis P.			Efficacy of forced eruption/enamel matrix derivative with freeze-dried bone allograft or with demineralized freeze-dried bone allograft in infrabony defects: A randomized trial	QUINTESSENCE INTERNATIONAL			English	Article						bone; clinical trial; enamel matrix protein; forced eruption; randomized; tissue regeneration	ORTHODONTIC TOOTH MOVEMENT; PERIODONTAL REGENERATION; STATISTICAL SIGNIFICANCE; INTRABONY DEFECTS; OSSEOUS DEFECTS; CLINICAL-TRIAL; MINOCYCLINE; THERAPY; SURGERY; GRAFT	Objective: To determine the efficacy of enamel matrix derivative (EMD) and forced eruption alone or in combination with freeze-dried bone allograft (FDBA) or demineralized FDBA (DFDBA) when managing infrabony defects. Method and Materials: Seventy-four patients with an inadequate biologic width due to subgingival caries were randomly assigned to one of three intervention groups: Ortho/EMD/FDBA (OEF) (n = 25), Ortho/EMD/DFDBA (OED) (n = 24), and Ortho/EMD alone without graft material as a control (OE) (n = 25). Each patient donated an infrabony defect. The primary outcomes were absolute change in probing depth (PD) reduction and clinical attachment level (CAL) gain from baseline to 1- and 3-year follow-up. Infrabony defects were surgically treated with EMD/FDBA, EMD/DFDBA, or EMD alone 4 weeks before orthodontic extrusive force was applied to reestablish a biologic width of 2 mm. Results: Seventy-four patients (OEF, n = 25; OED, n = 24; OE, n = 25) were analyzed. All groups demonstrated significant improvement in PD reduction and CAL gain from baseline. The changes at 1 year for PD were: OEF (mm, 95% CI), 4.3, 3.7 to 4.7; OED, 4.2, 3.6 to 4.9; and OE, 3.4, 3.1 to 3.7; for CAL, changes were: OEF, 4.3, 3.9 to 4.7; OED, 3.9, 3.5 to 4.4; and OE, 3.3, 3.1 to 3.5. Longer follow-ups showed similar findings. Conclusion: This study showed that both forced eruption/EMD/FDBA and forced eruption/EMD/DFDBA combination therapies result in greater soft tissue improvements at 1- and 3-year follow-up in addition to greater hard tissue improvements at 6-month re-entry compared with forced eruption/EMD alone.	[Tarnow, Dennis P.] Columbia Univ, Coll Dent Med, Dept Periodontol, New York, NY USA	Ogihara, S (reprint author), 23-5 Adachi 4 Chome,Adachi Ku, Tokyo 1200015, Japan.	oshigeki@spn1.speednet.ne.jp					Zhang M, 1997, J PERIODONTOL, V68, P1085; KATONA TR, 1995, J BIOMECH, V28, P27, DOI 10.1016/0021-9290(94)E0041-Z; Reichert C, 2011, J OROFAC ORTHOP, V72, P165, DOI 10.1007/s00056-011-0023-6; Melsen B, 2001, EUR J ORTHODONT, V23, P671, DOI 10.1093/ejo/23.6.671; Tonetti MS, 2002, J CLIN PERIODONTOL, V29, P317, DOI 10.1034/j.1600-051X.2002.290407.x; Reichert C, 2009, J OROFAC ORTHOP, V70, P6, DOI 10.1007/s00056-009-0814-1; RUMMELHART JM, 1989, J PERIODONTOL, V60, P655; Tsitoura E, 2004, J CLIN PERIODONTOL, V31, P643, DOI 10.1111/j.1600-051X.2004.00555.x; Schwartz Z, 1996, J PERIODONTOL, V67, P918; Melsen B, 1999, ANGLE ORTHOD, V69, P151; Gkantidis N, 2010, J ORAL REHABIL, V37, P377, DOI 10.1111/j.1365-2842.2010.02068.x; Moher D, 2012, INT J SURG, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Jung DY, 2012, J CLIN PERIODONTOL, V39, P753, DOI 10.1111/j.1600-051X.2012.01908.x; INGBER JS, 1976, J PERIODONTOL, V47, P203; Bach Normand, 2004, J Can Dent Assoc, V70, P775; Corn H., 1989, ATLAS ADULT ORTHODON, P60; Cortellini P, 2011, J CLIN PERIODONTOL, V38, P915, DOI 10.1111/j.1600-051X.2011.01768.x; Esposito M, 2009, COCHRANE DB SYST REV, V7, DOI DOI 10.1002/14651858.CD003875.PUB3; Giannobile William V, 2003, Ann Periodontol, V8, P193, DOI 10.1902/annals.2003.8.1.193; Greenstein G, 2003, J AM DENT ASSOC, V134, P583; INGBER JS, 1974, J PERIODONTOL, V45, P199; Ingber JS, 1989, ATLAS ADULT ORTHODON, P413; Juzanx I, 2006, PERIO, V4, P7; Man-Son-Hing Malcolm, 2002, Journal of General Internal Medicine, V17, P469, DOI 10.1046/j.1525-1497.2002.11111.x; Ogihara S, 2010, J PERIODONTOL, V81, P1734, DOI 10.1902/jop.2010.100127; Ogihara S, 2014, J PERIODONTOL, V85, P1351, DOI 10.1902/jop.2014.130520; Park JB, 2011, J CRANIOFAC SURG, V22, P1839, DOI 10.1097/SCS.0b013e31822e8216; Reichert C, 2010, QUINTESSENCE INT, V41, P665; Rethman MP, 1999, J PERIODONTOL, V70, P700, DOI 10.1902/jop.1999.70.6.700; Rosen PS, 2002, J PERIODONTOL, V73, P942, DOI 10.1902/jop.2002.73.8.942; Sculean S, 2011, CLIN ADV PERIODONTIC, V1, P101; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; Trombelli L, 2002, J CLIN PERIODONTOL, V29, P117, DOI 10.1034/j.1600-051X.29.s3.7.x; Verna C, 2003, Orthod Craniofac Res, V6, P155, DOI 10.1034/j.1600-0544.2003.03262.x	34	0	0	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0033-6572	1936-7163		QUINTESSENCE INT	Quintessence Int.	JUN	2015	46	6					481	490		10.3290/j.qi.a33936		10	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CK1SE	WOS:000355986800005		
J	Kitao, A; Matsui, O; Yoneda, N; Kozaka, K; Kobayashi, S; Sanada, J; Koda, W; Minami, T; Inoue, D; Yoshida, K; Yamashita, T; Yamashita, T; Kaneko, S; Takamura, H; Ohta, T; Ikeda, H; Nakanuma, Y; Kita, R; Gabata, T				Kitao, Azusa; Matsui, Osamu; Yoneda, Norihide; Kozaka, Kazuto; Kobayashi, Satoshi; Sanada, Junichiro; Koda, Wataru; Minami, Tetsuya; Inoue, Dai; Yoshida, Kotaro; Yamashita, Taro; Yamashita, Tatsuya; Kaneko, Shuichi; Takamura, Hiroyuki; Ohta, Tetsuo; Ikeda, Hiroko; Nakanuma, Yasuni; Kita, Ryuichi; Gabata, Toshifumi			Hepatocellular Carcinoma with beta-Catenin Mutation: Imaging and Pathologic Characteristics	RADIOLOGY			English	Article							SIGNAL INTENSITY; SHOWING HYPERINTENSITY; HEPATOBILIARY-PHASE; EXPRESSION; CANCER; LIVER; GENE; OVEREXPRESSION; CHOLESTASIS; PROGNOSIS	Purpose: To identify the imaging features of hepatocellular carcinoma (HCC) associated with beta-catenin mutation and their relationship to pathologic findings. Materials and Methods: Institutional ethics committee approval and informed consent were obtained. One hundred thirty-eight surgically resected HCCs were analyzed in this study. Immunohistochemical expression of beta-catenin and its transcriptional product, glutamine synthetase (GS), were graded and classified into three groups: the beta-catenin positive and GS positive group (HCC with beta-catenin mutation), the beta-catenin negative and GS positive group (intermediate HCC), and the beta-catenin negative and GS negative group (HCC without beta-catenin mutation). Clinical, pathologic, and imaging findings from dynamic computed tomography (CT) and gadoxetic acid-enhanced magnetic resonance (MR) imaging (T1-weighted, T2-weighted, diffusion-weighted, and hepatobiliary phase imaging) were evaluated. Correlations among immunohistochemical expression of beta-catenin, GS, and organic anion transporting polypeptide 1B3 (uptake transporter of gadoxetic acid) were evaluated. The x(2), Kruskal-Wallis, and Spearman correlation tests were used. Results: HCCs with beta-catenin mutation (n = 27) showed a lower median contrast-to-noise ratio at diffusion-weighted imaging than did intermediate HCCs (n = 23) and HCCs without beta-catenin mutation (n = 84) (13.2, 24.4, and 27.0, respectively; P = .02), higher apparent diffusion coefficient (1.33, 1.13, and 1.12, respectively; P < .0001), higher contrast-to-noise ratio (0.58, -28.7, and -45.0, respectively; P < .0001) and higher enhancement ratio during the hepatobiliary phase (0.90, 0.50, and 0.42, respectively; P < .0001). At pathologic examination, HCCs with beta-catenin mutation showed pseudoglandular proliferation and bile production with a higher grade of differentiation (P = .04, .001, and .005, respectively). There were significant positive correlations among expression of beta-catenin, GS, and organic anion transporting polypeptide 1B3 (P < .0001). Conclusion: HCCs with beta-catenin mutation showed a higher grade of differentiation with frequent pseudoglandular patterns and bile production, and characteristic imaging findings included a high enhancement ratio at gadoxetic acid-enhanced MR imaging and a high apparent diffusion coefficient at diffusion-weighted imaging. (C)RSNA, 2015	[Kitao, Azusa; Matsui, Osamu; Yoneda, Norihide; Kozaka, Kazuto; Kobayashi, Satoshi; Sanada, Junichiro; Koda, Wataru; Minami, Tetsuya; Inoue, Dai; Yoshida, Kotaro; Gabata, Toshifumi] Kanazawa Univ, Grad Sch Med Sci, Dept Radiol, Kanazawa, Ishikawa 9208640, Japan; [Yamashita, Taro; Yamashita, Tatsuya; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med Sci, Dept Gastroenterol, Kanazawa, Ishikawa 9208640, Japan; [Takamura, Hiroyuki; Ohta, Tetsuo] Kanazawa Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kanazawa, Ishikawa 9208640, Japan; [Ikeda, Hiroko; Nakanuma, Yasuni] Kanazawa Univ, Grad Sch Med Sci, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan; [Kita, Ryuichi] Osaka Red Cross Hosp, Dept Gastroenterol, Osaka, Japan	Kitao, A (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Radiol, 13-1 Takaramachi, Kanazawa, Ishikawa 9208640, Japan.	kitaoa@staff.kanazawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [26860989]	Supported in part by a Grant-in-Aid for Scientific Research (26860989) from the Ministry of Education, Culture, Sports, Science and Technology.	Colletti M, 2009, GASTROENTEROLOGY, V137, P660, DOI 10.1053/j.gastro.2009.05.038; Zender L, 2010, J HEPATOL, V52, P921, DOI 10.1016/j.jhep.2009.12.034; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Mao TL, 2001, J PATHOL, V193, P95, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH720>3.0.CO;2-3; Kitao A, 2012, RADIOLOGY, V265, P780, DOI 10.1148/radiol.12120226; Cadoret A, 2002, ONCOGENE, V21, P8293, DOI 10.1038/sj.onc.1206118; Audard V, 2007, J PATHOL, V212, P345, DOI 10.1002/path.2169; Caldwell S, 2009, J GASTROENTEROL, V44, P96, DOI 10.1007/s00535-008-2258-6; Muhi A, 2009, J MAGN RESON IMAGING, V30, P1005, DOI 10.1002/jmri.21931; Loeppen S, 2002, CANCER RES, V62, P5685; Nasu K, 2009, AM J ROENTGENOL, V193, P438, DOI 10.2214/AJR.08.1424; Narita M, 2009, J GASTROENTEROL, V44, P793, DOI 10.1007/s00535-009-0056-4; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Yoneda N, 2013, JPN J RADIOL, V31, P480, DOI 10.1007/s11604-013-0224-6; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Yoneda N, 2012, JPN J RADIOL, V30, P777, DOI 10.1007/s11604-012-0115-2; Bioulac-Sage P, 2009, HEPATOLOGY, V50, P481, DOI 10.1002/hep.22995; Sekine S, 2011, CANCER SCI, V102, P1742, DOI 10.1111/j.1349-7006.2011.01990.x; Miyoshi Y, 1998, CANCER RES, V58, P2524; Kitao A, 2010, RADIOLOGY, V256, P817, DOI 10.1148/radiol.10092214; Austinat M, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-21; Hirohashi S, 2000, PATHOLOGY GENETICS T, P157; Kojiro M, 2009, HEPATOLOGY, V49, P658, DOI 10.1002/hep.22709; Liver Cancer Study Group of Japan, 2010, GEN RUL CLIN PATH ST; Nhieu J T, 1999, Am J Pathol, V155, P703, DOI 10.1016/S0002-9440(10)65168-1; Soejima Y, 2012, KANZO, V53, P779; Yamashita T, 2014, HEPATOLOGY, V60, P1674, DOI 10.1002/hep.27093	28	0	0	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	JUN	2015	275	3					708	717		10.1148/radiol.14141315		10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CK1SZ	WOS:000355988900011		
J	Kanda, T; Osawa, M; Oba, H; Toyoda, K; Kotoku, J; Haruyama, T; Takeshita, K; Furui, S				Kanda, Tomonori; Osawa, Marie; Oba, Hiroshi; Toyoda, Keiko; Kotoku, Jun'ichi; Haruyama, Takahiro; Takeshita, Koji; Furui, Shigeru			High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration	RADIOLOGY			English	Article							NEPHROGENIC SYSTEMIC FIBROSIS; SMOOTHING PARAMETER-ESTIMATION; HUMAN BONE TISSUE; CONTRAST AGENTS; SPECTROSCOPY; RETENTION; STABILITY; OMNISCAN; LESIONS; MODELS	Purpose: To assess whether an association exists between hyper-intensity in the dentate nucleus (DN) on unenhanced T1-weighted magnetic resonance (MR) images and previous administration of gadolinium-based contrast agents (GBCAs) that contain different types of gadolinium chelates. Materials and Methods: The institutional review board approved this study. Written informed consent was waived because this was a retrospective study. Evaluated were 127 cases among 360 consecutive patients who underwent contrast agent-enhanced brain MR imaging. Two radiologists conducted visual evaluation and quantitative analysis on unenhanced T1-weighted MR images by using regions of interest. DN-to-cerebellum (DN/cerebellum) signal intensity ratios were calculated and the relationship between DN/cerebellum and several factors was evaluated, including the number of previous linear chelate and/or macrocyclic GBCA administrations by using a generalized additive model. The Akaike information criterion was used in model selection. Interobserver correlation was evaluated with paired t tests and the Lin concordance correlation coefficient. Results: The images of nine patients (7.1%) showed hyperintensity in the DN. Twenty-three patients (18.1%) received linear GBCAs (median, two patients; maximum, 11 patients), 36 patients (28.3%) received macrocyclic GBCAs (median, two patients; maximum, 15 patients), 14 patients (11.0%) received both types of GBCA (linear [median, two patients; maximum, five patients] and macrocyclic [median, three patients; maximum, eight patients]), and 54 patients (42.5%) had no history of administration of gadolinium chelate. Interobserver correlation was almost perfect (0.992 [95% confidence interval: 0.990, 0.994]). The DN/cerebellum ratio was associated with linear GBCA (P < .001), but not with macrocyclic GBCA exposure (P = .875). According to the Akaike information criterion, only linear GBCA was selected for the final model, and the DN/cerebellum ratio had strong association only with linear GBCA. Conclusion: Hyperintensity in the DN on unenhanced T1-weighted MR images is associated with previous administration of linear GBCA, while the previous administration of macrocyclic GBCAs showed no such association. (C) RSNA, 2015	[Kanda, Tomonori; Osawa, Marie; Oba, Hiroshi; Toyoda, Keiko; Haruyama, Takahiro; Takeshita, Koji; Furui, Shigeru] Teikyo Univ, Sch Med, Dept Radiol, Itabashi Ku, Tokyo 1738605, Japan; [Kotoku, Jun'ichi] Teikyo Univ, Sch Med, Fac Med Technol, Dept Radiol Technol,Itabashi Ku, Tokyo 1738605, Japan	Kanda, T (reprint author), Teikyo Univ, Sch Med, Dept Radiol, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	k_a@hotmail.co.jp			Bayer Healthcare	TK. disclosed no relevant relationships. M.O. disclosed no relevant relationships. H.O. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: author disclosed a grant from Bayer Healthcare. Other relationships: disclosed no relevant relationships. K. Toyoda disclosed no relevant relationships. J.K. disclosed no relevant relationships. T.H. disclosed no relevant relationships. K. Takeshita Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: author disclosed a grant from Bayer Healthcare. Other relationships: disclosed no relevant relationships. S.F. disclosed no relevant relationships.	Kasahara S, 2011, RADIOLOGY, V258, P222, DOI 10.1148/radiol.10100508; Frenzel T, 2008, INVEST RADIOL, V43, P817, DOI 10.1097/RLI.0b013e3181852171; Idee JM, 2009, J MAGN RESON IMAGING, V30, P1249, DOI 10.1002/jmri.21967; Roccatagliata L, 2009, RADIOLOGY, V251, P503, DOI 10.1148/radiol.2511081269; Kanda T, 2014, RADIOLOGY, V270, P834, DOI 10.1148/radiol.13131669; Aime S, 2009, J MAGN RESON IMAGING, V30, P1259, DOI 10.1002/jmri.21969; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Hao DP, 2012, J MAGN RESON IMAGING, V36, P1060, DOI 10.1002/jmri.23725; Gibby WA, 2004, INVEST RADIOL, V39, P138, DOI 10.1097/01.rli.0000112789.57341.01; Ginat DT, 2012, RADIOGRAPHICS, V32, P499, DOI 10.1148/rg.322105761; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374; Wertman R, 2008, RADIOLOGY, V248, P799, DOI 10.1148/radiol.2483072093; Wang YB, 2011, RADIOLOGY, V260, P105, DOI 10.1148/radiol.11102340; Sieber MA, 2008, EUR RADIOL, V18, P2164, DOI 10.1007/s00330-008-0977-y; Hastie T, 1995, Stat Methods Med Res, V4, P187, DOI 10.1177/096228029500400302; Kaewlai R, 2012, AM J ROENTGENOL, V199, pW17, DOI 10.2214/AJR.11.8144; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Martin-Duverneuil N, 2006, EUR RADIOL, V16, P2074, DOI 10.1007/s00330-006-0200-y; Runge V M, 2000, J Magn Reson Imaging, V12, P205, DOI 10.1002/1522-2586(200008)12:2<205::AID-JMRI1>3.0.CO;2-P; Tweedle MF, 1992, INVEST RADIOL, V27, P2; White GW, 2006, INVEST RADIOL, V41, P272, DOI 10.1097/01.rli.0000186569.32408.95; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Wood SN, 2000, J ROY STAT SOC B, V62, P413, DOI 10.1111/1467-9868.00240	23	8	8	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	JUN	2015	275	3					803	809		10.1148/radiol.14140364		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CK1SZ	WOS:000355988900021		
J	Kanematsu, M; Goshima, S; Kawai, N; Kondo, H; Miyoshi, T; Watanabe, H; Noda, Y; Tanahashi, Y; Bae, KT				Kanematsu, Masayuki; Goshima, Satoshi; Kawai, Nobuyuki; Kondo, Hiroshi; Miyoshi, Toshiharu; Watanabe, Haruo; Noda, Yoshifumi; Tanahashi, Yukichi; Bae, Kyongtae T.			Low-Iodine-Load and Low-Tube-Voltage CT Angiographic Imaging of the Kidney by Using Bolus Tracking with Saline Flushing	RADIOLOGY			English	Article							ITERATIVE RECONSTRUCTION ALGORITHM; INITIAL CLINICAL-EXPERIENCE; RENAL-CELL CARCINOMA; 256-DETECTOR ROW CT; 80 KVP; MULTIDETECTOR CT; CONTRAST AGENT; ABDOMINAL CT; DYNAMIC CT; QUALITY	Purpose: To prospectively determine the feasibility of low-iodineload and low-tube-voltage computed tomographic (CT) angiographic imaging of the kidney and to evaluate the opacification and image quality compared with moderate-iodine-load and high-iodine-load techniques. Materials and Methods: Institutional review board approval and written informed consent was obtained. One hundred thirteen consecutive patients randomly underwent three protocols for dual-phase renal CT angiographic imaging: high-iodine-load (600 mg iodine per kilogram of body weight at 120 kVp); moderate-iodine-load (400 mg iodine per kilogram of body weight at 80 kVp); and low-iodine-load (contrast agent injection initially prepared at 400 mg iodine per kilogram of body weight but stopped immediately after bolus-tracking trigger at 80 kVp) scanning. CT numbers of vessels and kidneys were measured. CT numbers and signal-to-noise ratio (SNR) were compared with one-way analysis of variance and posthoc Tukey-Kramer test and depiction of vessels and image noise, with Kruskal-Wallis test and pairwise Mann-Whitney test with Bonferroni correction. Results: Mean iodine weight administered was significantly reduced in order of low- (16.4 g), moderate- (23.5 g), and high-iodine-load (33.7 g) protocols (P < .001). Mean CT numbers of abdominal aorta, renal artery, and renal cortex in first phase were significantly lower with high-iodine-load protocol (308, 274, and 132 HU, respectively) than with moderate- (347, 334, and 156 HU, respectively; P = .001-.006) or low- iodine-load ( 362, 316, and 161 HU, respectively; P = .001-.003) protocol. Mean CT number of renal vein in second phase was significantly lower with low-iodine-load protocol (223 HU) than with moderate- (299 HU; P < .001) or high-iodine-load (258 HU; P = .020). Mean SNR of renal medulla in second phase was significantly lower (P = .019) with moderate- iodine-load protocol (mean SNR, 7.2) than with high-iodine-load protocol (mean SNR, 10.0). No significant difference in image quality grades was found between high-iodine-load (mean grade, 2.6-2.9), moderate-iodineload (mean grade, 2.6-3.0), and low-iodine-load (mean grade, 2.6-2.9) protocols (P = .018-.31). Conclusion: Combined application of low-iodine-load, bolus tracking with saline flushing, and low- tube-voltage scanning is feasible and resulted in substantial reduction of iodine dose for renal CT angiographic imaging without compromising image quality. (C) RSNA, 2014.	[Kanematsu, Masayuki; Goshima, Satoshi; Kawai, Nobuyuki; Kondo, Hiroshi; Watanabe, Haruo; Noda, Yoshifumi; Tanahashi, Yukichi] Gifu Univ Hosp, Dept Radiol, Gifu 5011194, Japan; [Kanematsu, Masayuki; Miyoshi, Toshiharu] Gifu Univ Hosp, Dept Radiol Serv, Gifu 5011194, Japan; [Bae, Kyongtae T.] Univ Pittsburgh, Dept Radiol, Med Ctr, Pittsburgh, PA 15260 USA	Kanematsu, M (reprint author), Gifu Univ Hosp, Dept Radiol, 1-1 Yanagido, Gifu 5011194, Japan.	masa_gif@yahoo.co.jp					Alonso RC, 2009, RADIOGRAPHICS, V29, P2033, DOI 10.1148/rg.297095071; Kalra MK, 2004, RADIOLOGY, V233, P649, DOI 10.1148/radiol.2333031150; Nguyen SA, 2008, RADIOLOGY, V248, P97, DOI 10.1148/radiol.2481071484; Zhang YY, 2013, CLIN RADIOL, V68, P365, DOI 10.1016/j.crad.2012.08.028; Wintermark M, 2000, AM J NEURORADIOL, V21, P1881; Marin D, 2010, RADIOLOGY, V256, P450, DOI 10.1148/radiol.10091819; Marin D, 2009, RADIOLOGY, V251, P771, DOI 10.1148/radiol.2513081330; Marin D, 2010, RADIOLOGY, V254, P145, DOI 10.1148/radiol.09090094; Nakayama Y, 2005, RADIOLOGY, V237, P945, DOI 10.1148/radiol.2373041655; Grimm LJ, 2013, J COMPUT ASSIST TOMO, V37, P415, DOI 10.1097/RCT.0b013e3182873235; Kanematsu M, 2014, AM J ROENTGENOL, V202, pW106, DOI 10.2214/AJR.13.10720; Nakaura T, 2012, RADIOLOGY, V264, P445, DOI 10.1148/radiol.12111082; Bahner ML, 2005, INVEST RADIOL, V40, P229, DOI 10.1097/01.rli.0000155281.32319.52; Cocheteux B, 2001, EUR RADIOL, V11, P779, DOI 10.1007/s003300000675; Davarpanah AH, 2013, AM J ROENTGENOL, V201, pW753, DOI 10.2214/AJR.12.10439; Gupta S, 2000, ACTA RADIOL, V41, P280, DOI 10.1080/028418500127345253; Karlo CA, 2013, AM J ROENTGENOL, V201, pW821, DOI 10.2214/AJR.13.10785; Nakaura T, 2011, RADIOLOGY, V261, P467, DOI 10.1148/radiol.11110021; Sigal-Cinqualbre AB, 2004, RADIOLOGY, V231, P169, DOI 10.1148/radiol.2311030191	19	1	1	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	JUN	2015	275	3					832	840		10.1148/radiol.14141457		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CK1SZ	WOS:000355988900024		
J	Yamada, I; Miyasaka, N; Hikishima, K; Kato, K; Kojima, K; Kawano, T; Ito, E; Kobayashi, D; Eishi, Y; Okano, H				Yamada, Ichiro; Miyasaka, Naoyuki; Hikishima, Keigo; Kato, Keiji; Kojima, Kazuyuki; Kawano, Tatsuyuki; Ito, Eisaku; Kobayashi, Daisuke; Eishi, Yoshinobu; Okano, Hideyuki			Gastric Carcinoma: Ex Vivo MR Imaging at 7.0 T-Correlation with Histopathologic Findings	RADIOLOGY			English	Article							ENDOSCOPIC ULTRASOUND; IN-VITRO; NEOADJUVANT CHEMOTHERAPY; COMPUTED-TOMOGRAPHY; PREOPERATIVE T; CANCER; ULTRASONOGRAPHY; MDCT; CT	Purpose: To determine the imaging detail and diagnostic information that can be obtained at 7.0-T magnetic resonance (MR) imaging with a voxel volume of 9.5-14.0 nL as a means of evaluating the depth of mural invasion by gastric carcinomas ex vivo. Materials and Methods: This study was approved by the institutional review board, and written informed consent was obtained from each patient. Twenty gastric specimens containing 20 carcinomas were studied with a 7.0-T MR imaging system equipped with a four-channel surface coil. MR images were obtained with a 50-60 x 25-30 mm field of view, a 512 x 256 matrix, and a 1.0-mm section thickness, resulting in a voxel volume of 0.0095-0.0140 mm(3) (9.5-14.0 nL). The signal intensity of the gastric wall layers, tumor tissue, and fibrosis was described as low, intermediate, or high by comparing it with the signal intensity of the muscularis propria. Depth of invasion initially was assessed by two reviewers independently and then by the two reviewers in consensus. MR images were compared with histopathologic findings. Results: The 7.0-T T2-weighted MR images clearly depicted the normal gastric wall in all 20 specimens (100%) as consisting of seven layers, which clearly corresponded to the tissue layers of the gastric wall. These MR images enabled clear differentiation between tumor tissue and fibrosis. Reviewers disagreed on the depth of invasion at the initial reading in three (15%) of 20 specimens (between mucosa and submucosa in two specimens and between muscularis propria and subserosa and serosa in one specimen); however, in all 20 gastric carcinomas, the depth of invasion could be accurately determined on T2-weighted images after consensus interpretation. Conclusion: Ex vivo 7.0-T MR imaging enables clear delineation of the gastric wall layers and clear differentiation of tumor tissue from fibrosis and allows one to assess the depth of mural invasion by gastric carcinomas. (C) RSNA, 2015	[Yamada, Ichiro] Tokyo Med & Dent Univ, Grad Sch, Dept Diagnost Radiol & Oncol, Bunkyo Ku, Tokyo 1138519, Japan; [Miyasaka, Naoyuki] Tokyo Med & Dent Univ, Grad Sch, Dept Pediat Perinatal & Maternal Med, Bunkyo Ku, Tokyo 1138519, Japan; [Kato, Keiji; Kojima, Kazuyuki] Tokyo Med & Dent Univ, Grad Sch, Dept Gastr Surg, Bunkyo Ku, Tokyo 1138519, Japan; [Kawano, Tatsuyuki] Tokyo Med & Dent Univ, Grad Sch, Dept Esophageal Surg, Bunkyo Ku, Tokyo 1138519, Japan; [Ito, Eisaku; Kobayashi, Daisuke; Eishi, Yoshinobu] Tokyo Med & Dent Univ, Grad Sch, Dept Pathol, Bunkyo Ku, Tokyo 1138519, Japan; [Hikishima, Keigo; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan; [Hikishima, Keigo] Cent Inst Expt Anim, Kawasaki, Kanagawa, Japan	Yamada, I (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Diagnost Radiol & Oncol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	yamada.crad@tmd.ac.jp	Okano, Hideyuki/J-5973-2013		MEXT, Japan [23591753]	I.Y. supported by the Grant-in-Aid for Scientific Research of MEXT, Japan (grant 23591753).	Akashi K, 2006, Int J Gastrointest Cancer, V37, P133; Liu S, 2014, J COMPUT ASSIST TOMO, V38, P544, DOI 10.1097/RCT.0000000000000090; Ahn HS, 2010, CANCER-AM CANCER SOC, V116, P5592, DOI 10.1002/cncr.25550; Hizawa K, 2002, ENDOSCOPY, V34, P973, DOI 10.1055/s-2002-35851; van der Kolk AG, 2013, EUR J RADIOL, V82, P708, DOI 10.1016/j.ejrad.2011.07.007; Choi JI, 2014, WORLD J GASTROENTERO, V20, P4546, DOI 10.3748/wjg.v20.i16.4546; Kwee RM, 2007, J CLIN ONCOL, V25, P2107, DOI 10.1200/JCO.2006.09.5224; Anzidei M, 2009, RADIOL MED, V114, P1065, DOI 10.1007/s11547-009-0455-x; AUH YH, 1994, RADIOLOGY, V191, P129; Bucher O, 1980, CYTOLOGIE HIST MIKRO, V10th, P287; Cho Jin Woong, 2013, Clin Endosc, V46, P239, DOI 10.5946/ce.2013.46.3.239; Edge S, 2010, AJCC CANC STAGING MA, P117; Feng XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078846; Guo T, 2014, ASIA-PAC J CLIN ONCO, V10, pE28, DOI 10.1111/ajco.12045; Hallinan JTPD, 2013, CANCER IMAGING, V13, P212, DOI 10.1102/1470-7330.2013.0023; Heye T, 2009, EUR J RADIOL, V70, P336, DOI 10.1016/j.ejrad.2008.01.037; Heye T, 2006, EUR RADIOL, V16, P2401, DOI 10.1007/s00330-006-0318-y; IMAI Y, 1990, RADIOLOGY, V177, P695; Kida M, 1998, Endoscopy, V30 Suppl 1, pA64, DOI 10.1055/s-2007-1001474; Kumano S, 2012, EUR J RADIOL, V81, P2953, DOI 10.1016/j.ejrad.2011.12.039; Kutup A, 2012, ENDOSCOPY, V44, P572, DOI 10.1055/s-0032-1308950; Lei C, 2013, MOL CLIN ONCOL, V1, P699; Maccioni F, 2010, CLIN TER, V161, pE57; Park SR, 2008, CANCER, V112, P2368, DOI 10.1002/cncr.23483; Park Young Soo, 2008, Korean J Gastroenterol, V52, P86; Satoh T, 1993, REGIONAL ANATOMY GAS, P163; Schlick T, 1999, SURG ENDOSC-ULTRAS, V13, P894, DOI 10.1007/s004649901128; Stollfuss JC, 2006, RADIOLOGY, V241, P132, DOI 10.1148/radiol.2411050942; Wakelin SJ, 2002, EUR J RADIOL, V41, P161, DOI 10.1016/S0720-048X(01)00418-1; Yamada I, 2009, CLIN IMAG, V33, P354, DOI 10.1016/j.clinimag.2009.01.011; Yamada I, 2001, RADIOLOGY, V220, P115; Yoshinaga Shigetaka, 2012, World J Gastrointest Endosc, V4, P218, DOI 10.4253/wjge.v4.i6.218; Zeineh MM, 2014, INVEST RADIOL, V49, P278, DOI 10.1097/RLI.0000000000000015	33	1	1	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	JUN	2015	275	3					841	848		10.1148/radiol.14141878		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CK1SZ	WOS:000355988900025		
J	Ohno, Y; Koyama, H; Yoshikawa, T; Takenaka, D; Seki, S; Yui, M; Yamagata, H; Aoyagi, K; Matsumoto, S; Sugimura, K				Ohno, Yoshiharu; Koyama, Hisanobu; Yoshikawa, Takeshi; Takenaka, Daisuke; Seki, Shinichiro; Yui, Masao; Yamagata, Hitoshi; Aoyagi, Kota; Matsumoto, Sumiaki; Sugimura, Kazuro			Three-way Comparison of Whole-Body MR, Coregistered Whole-Body FDG PET/MR, and Integrated Whole-Body FDG PET/CT Imaging: TNM and Stage Assessment Capability for Non-Small Cell Lung Cancer Patients	RADIOLOGY			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CONTRAST-ENHANCED CT; QUALITATIVE ASSESSMENT; PULMONARY NODULES; COMPUTED-TOMOGRAPHY; METASTASES; GUIDELINES; DIAGNOSIS; EFFICACY; THERAPY	Purpose: To prospectively compare the capabilities for TNM classification and assessment of clinical stage and operability among whole-body magnetic resonance (MR) imaging, coregistered positron emission tomographic (PET)/MR imaging with and without MR signal intensity (SI) assessment, and integrated fluorine 18 fluorodeoxyglucose (FDG) PET/computed tomography (CT) in non-small cell lung cancer (NSCLC) patients. Materials and Methods: The institutional review board approved this study, and written informed consent was obtained from each patient. One hundred forty consecutive NSCLC patients (75 men, 65 women; mean age, 72 years) prospectively underwent whole-body MR imaging, FDG PET/CT, conventional radiologic examinations, and surgical, pathologic, and/or follow-up examinations. All factors and clinical stage and operability were then visually assessed. All PET/MR examinations were assessed with and without SI assessment. One examination used anatomic, metabolic, and relaxation-time information, and the other used only anatomic and metabolic information. kappa statistics were used for assessment of all factors and clinical stages with final diagnoses. McNemar test was used to compare the capability of all methods to assess operability. Results: Agreements of assessment of every factor (kappa = 0.63-0.97) and clinical stage (kappa = 0.65-0.90) were substantial or almost perfect. Regarding capability to assess operability, accuracy of whole-body MR imaging and PET/MR imaging with SI assessment (97.1% [136 of 140]) was significantly higher than that of MR/PET without SI assessment and integrated FDG PET/CT (85.0% [119 of 140]; P, < .001). Conclusion: Accuracies of whole-body MR imaging and PET/MR imaging with SI assessment are superior to PET/MR without SI assessment and PET/CT for identification of TNM factor, clinical stage, and operability evaluation of NSCLC patients. (C) RSNA, 2015	[Ohno, Yoshiharu; Yoshikawa, Takeshi; Matsumoto, Sumiaki] Kobe Univ, Grad Sch Med, Adv Biomed Imaging Res Ctr, Chuo Ku, Akashi, Hyogo 6500017, Japan; [Ohno, Yoshiharu; Yoshikawa, Takeshi; Matsumoto, Sumiaki] Kobe Univ, Grad Sch Med, Div Funct & Diagnost Imaging Res, Dept Radiol,Chuo Ku, Akashi, Hyogo 6500017, Japan; [Koyama, Hisanobu; Takenaka, Daisuke; Seki, Shinichiro; Sugimura, Kazuro] Kobe Univ, Grad Sch Med, Div Radiol, Dept Radiol,Chuo Ku, Akashi, Hyogo 6500017, Japan; [Takenaka, Daisuke] Hyogo Canc Ctr, Dept Radiol, Kobe, Hyogo, Japan; [Yui, Masao; Yamagata, Hitoshi; Aoyagi, Kota] Toshiba Med Syst Corp, Otawara, Japan	Ohno, Y (reprint author), Kobe Univ, Grad Sch Med, Adv Biomed Imaging Res Ctr, Chuo Ku, 7-5-2 Kusunoki Cho, Akashi, Hyogo 6500017, Japan.	yosirad@kobe-u.ac.jp			Toshiba Medical Systems Co; Eizai Co Ltd; Bayer Pharma	Supported in part by Toshiba Medical Systems Co, Eizai Co Ltd, and Bayer Pharma.	DEVITA VT, 1975, CANCER, V35, P98, DOI 10.1002/1097-0142(197501)35:1<98::AID-CNCR2820350115>3.0.CO;2-B; Ohno Y, 2004, RADIOLOGY, V231, P872, DOI 10.1148/radiol.2313030103; Takenaka D, 2009, J MAGN RESON IMAGING, V30, P298, DOI 10.1002/jmri.21858; Ohno Y, 2011, RADIOLOGY, V261, P605, DOI 10.1148/radiol.11110281; Schmidt H, 2013, INVEST RADIOL, V48, P247, DOI 10.1097/RLI.0b013e31828d56a1; Sommer G, 2014, EUR J RADIOL, V83, P600, DOI 10.1016/j.ejrad.2013.11.012; Yi CA, 2013, CANCER-AM CANCER SOC, V119, P1784, DOI 10.1002/cncr.28000; Kim YN, 2012, EUR RADIOL, V22, P1537, DOI 10.1007/s00330-012-2388-3; Ohno Y, 2008, RADIOLOGY, V248, P643, DOI 10.1148/radiol.2482072039; Rappeport ED, 2007, ACTA RADIOL, V48, P369, DOI 10.1080/02841850701294560; SVANHOLM H, 1989, APMIS, V97, P689; Koyama H, 2010, EUR RADIOL, V20, P790, DOI 10.1007/s00330-009-1615-z; Yi CA, 2008, RADIOLOGY, V248, P632, DOI 10.1148/radiol.2482071822; Sommer G, 2012, EUR RADIOL, V22, P2859, DOI 10.1007/s00330-012-2542-y; Schwenzer NF, 2012, RADIOLOGY, V264, P551, DOI 10.1148/radiol.12111942; Ohno Y, 2007, J MAGN RESON IMAGING, V26, P498, DOI 10.1002/jmri.21031; Brodowicz T, 2012, ANN ONCOL, V23, P1223, DOI 10.1093/annonc/mdr381; Gunluoglu MZ, 2011, EUR J CARDIO-THORAC, V40, P287, DOI 10.1016/j.ejcts.2010.11.030; Kersjes W, 1997, EUR RADIOL, V7, P1190, DOI 10.1007/s003300050272; Kitajima K, 2010, EUR J NUCL MED MOL I, V37, P1490, DOI 10.1007/s00259-010-1440-2; Koyama H, 2008, EUR RADIOL, V18, P2120, DOI 10.1007/s00330-008-1001-2; Nanni C, 2013, BIOMED PHARMACOTHER, V67, P172, DOI 10.1016/j.biopha.2012.12.003; Ohno Y, 2013, EUR J RADIOL, V82, P2018, DOI 10.1016/j.ejrad.2013.07.016; Pfannenberg AC, 2007, EUR J NUCL MED MOL I, V34, P36, DOI 10.1007/s00259-006-0186-3; RAK JW, 1995, ANTI-CANCER DRUG, V6, P3, DOI 10.1097/00001813-199502000-00001; Ravenel JG, 2010, J THORAC IMAG, V25, pW107, DOI 10.1097/RTI.0b013e3181f51e7f; Regier M, 2007, EUR RADIOL, V17, P1341, DOI 10.1007/s00330-006-0422-z; Schroeder T, 2005, AM J ROENTGENOL, V185, P979, DOI 10.2214/AJR.04.0814; Silvestri GA, 2007, CHEST, V132, p178S, DOI 10.1378/chest.07-1360; Silvestri GA, 2013, CHEST S, V143; Silvestri GA, 2003, CHEST, V123, p147S, DOI 10.1378/chest.123.1_suppl.147S; Sobin LH, 2010, TNM CLASSIFICATION M	32	4	4	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	JUN	2015	275	3					849	861		10.1148/radiol.14140936		13	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CK1SZ	WOS:000355988900026		
J	Soyer, P; Taouli, B; Guiu, B; Koh, DM; Luciani, A; Manfredi, R; Vilgrain, V; Hoeffel, C; Kanematsu, M; Vicaut, E				Soyer, Philippe; Taouli, Bachir; Guiu, Boris; Koh, Doh-Mu; Luciani, Alain; Manfredi, Riccardo; Vilgrain, Valerie; Hoeffel, Christine; Kanematsu, Masayuki; Vicaut, Eric			Intravenous Contrast Material and Acute Kidney Injury: A Need for Caution Response	RADIOLOGY			English	Letter							METAANALYSIS		[Soyer, Philippe] Hop Lariboisiere, AP HP, Dept Body & Intervent Imaging, F-75475 Paris 10, France; [Soyer, Philippe] Univ Paris Diderot, Paris, France; [Taouli, Bachir] Mt Sinai Med Ctr, Body MR Imaging & Translat & Mol Imaging Inst, Dept Radiol, New York, NY 10029 USA; [Guiu, Boris] Hop Univ St Eloi, Dept Med Imaging, Montpellier, France; [Koh, Doh-Mu] Royal Marsden NHS Fdn Trust, Royal Marsden Hosp, Dept Radiol, Sutton, Surrey, England; [Luciani, Alain] Hop Henri Mondor, AP HP, Dept Radiol, F-94010 Creteil, France; [Manfredi, Riccardo] Univ Verona, Dept Radiol, I-37100 Verona, Italy; Hop Beaujon, AP HP, Dept Radiol, Clichy, France; [Hoeffel, Christine] Hop Robert Debre, Dept Radiol, Reims, France; [Kanematsu, Masayuki] Gifu Univ Hosp, Dept Radiol, Gifu, Japan; [Vicaut, Eric] Hop Lariboisiere, AP HP, Dept Clin Res, F-75475 Paris 10, France	Soyer, P (reprint author), Hop Lariboisiere, AP HP, Dept Body & Intervent Imaging, 2 Rue Ambroise Pare, F-75475 Paris 10, France.	philippe.soyer@lrb.aphp.fr					Barral M, 2015, RADIOLOGY, V274, P45, DOI 10.1148/radiol.14130778; Barral M, 2013, Diagn Interv Imaging, V94, P418, DOI 10.1016/j.diii.2012.12.007; Barral M, 2013, Diagn Interv Imaging, V94, P619, DOI 10.1016/j.diii.2013.02.011; Lin PL, 2014, EUR RADIOL, V24, P2729, DOI 10.1007/s00330-014-3320-9; Soyer P, 2013, Diagn Interv Imaging, V94, P571, DOI 10.1016/j.diii.2013.05.003; Soyer P, 2013, EUR RADIOL, V23, P388, DOI 10.1007/s00330-012-2595-y; Spick C, 2014, RADIOLOGY, V273, P401, DOI 10.1148/radiol.14140474	7	0	0	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	JUN	2015	275	3					933	934				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CK1SZ	WOS:000355988900042		
J	Takenaka, S; Ventura, W; Sterrantino, AF; Kawashima, A; Koide, K; Hori, K; Farina, A; Sekizawa, A				Takenaka, Shin; Ventura, Walter; Sterrantino, Anna Freni; Kawashima, Akihiro; Koide, Keiko; Hori, Kyoko; Farina, Antonio; Sekizawa, Akihiko			Prediction of Fetal Growth Restriction by Analyzing the Messenger RNAs of Angiogenic Factor in the Plasma of Pregnant Women	REPRODUCTIVE SCIENCES			English	Article						messenger RNA; fetal growth restriction; vascular endothelial growth factor receptor 1; small for gestational age	UTERINE ARTERY DOPPLER; FOR-GESTATIONAL-AGE; MATERNAL PLASMA; TYROSINE KINASE-1; FACTOR RECEPTOR-1; SOLUBLE ENDOGLIN; PREECLAMPSIA; RISK; SERUM; 1ST-TRIMESTER	Objective: To predict the occurrence of fetal growth restriction (FGR) by analyzing messenger RNA (mRNA) expression levels of vascular endothelial growth factor receptor 1 (fms-like tyrosine kinase 1 [Flt-1]) in maternal blood. Study Design: Eleven women with FGR were matched with 88 controls. Plasma samples were obtained during each trimester. The Flt-1 mRNA expression levels were compared between groups. Predicted probabilities were calculated, and sensitivity-specificity (receiver-operating characteristic [ROC]) curves were assessed based on regression models for each trimester measurement and possible combinations of measurements. Results: The mRNA levels of the FGR group during all trimesters were significantly higher than those of the control group. The ROC curve of combined first and second trimester data yielded a detection rate of 60% at a 10% false-positive rate, with an area under curve of 0.79. Conclusion: The Flt-1 mRNA expression in maternal blood can be used as a marker to predict the development of FGR, long before a clinical diagnosis is made.	[Takenaka, Shin; Ventura, Walter; Kawashima, Akihiro; Koide, Keiko; Hori, Kyoko; Sekizawa, Akihiko] Showa Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 1428666, Japan; [Ventura, Walter] Inst Nacl Materno Perinatal, Fetal Med Unit, Lima, Peru; [Sterrantino, Anna Freni] Univ Bologna, Dept Stat Sci, Bologna, Italy; [Farina, Antonio] Univ Bologna, Dept Med & Surg DIMEC, Div Prenatal Med, Bologna, Italy	Takenaka, S (reprint author), Showa Univ, Sch Med, Dept Obstet & Gynecol, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428666, Japan.	shin-take@med.showa-u.ac.jp			Ministry of Education, Science, Sport, and Culture of Japan [23592417, 26462501]; Smoking Research Foundation; Ogyaa Foundation	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported in part by a Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sport, and Culture of Japan (Nos. 23592417 and 26462501) and Smoking Research Foundation and Ogyaa Foundation.	Ng EKO, 2003, P NATL ACAD SCI USA, V100, P4748, DOI 10.1073/pnas.0637450100; Savvidou MD, 2006, AM J OBSTET GYNECOL, V195, P1668, DOI 10.1016/j.ajog.2006.03.065; Nevo O, 2008, J CLIN ENDOCR METAB, V93, P285, DOI 10.1210/jc.2007-1042; Sekizawa A, 2010, BJOG-INT J OBSTET GY, V117, P557, DOI 10.1111/j.1471-0528.2010.02491.x; Wathen KA, 2006, J CLIN ENDOCR METAB, V91, P180, DOI 10.1210/jc.2005-1076; Valsamakis G, 2006, ANN NY ACAD SCI, V1092, P138, DOI 10.1196/annals.1365.012; Erez O, 2008, J MATERN-FETAL NEO M, V21, P279, DOI 10.1080/14767050802034545; Wallner W, 2007, CLIN SCI, V112, P51, DOI 10.1042/CS20060161; Thadhani R, 2004, J CLIN ENDOCR METAB, V89, P770, DOI 10.1210/jc.2003-031244; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Smith GCS, 2007, OBSTET GYNECOL, V109, P1316, DOI 10.1097/01.AOG.0000265804.09161.0d; Crispi F, 2006, AM J OBSTET GYNECOL, V195, P201, DOI 10.1016/j.ajog.2006.01.014; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Pilalis A, 2007, ULTRASOUND OBST GYN, V29, P135, DOI 10.1002/uog.3881; Pang WWI, 2009, PRENATAL DIAG, V29, P495, DOI 10.1002/pd.2230; Poon LLM, 2000, CLIN CHEM, V46, P1832; Mutter WP, 2008, MICROVASC RES, V75, P1, DOI 10.1016/j.mvr.2007.04.009; Wibowo N, 2012, J OBSTET GYNAECOL RE, V38, P1152, DOI 10.1111/j.1447-0756.2012.01855.x; Farina A, 2010, AM J OBSTET GYNECOL, V203; Neerhof MG, 2008, SEMIN PERINATOL, V32, P201, DOI 10.1053/j.semperi.2007.11.002; NORTH RA, 1994, OBSTET GYNECOL, V83, P378; Okazaki S, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.040634; Purwosunu Y, 2009, AM J OBSTET GYNECOL, V200; Shibata E, 2005, J CLIN ENDOCR METAB, V90, P4895, DOI 10.1210/jc.2004-1955; Stepan H, 2007, J CLIN ENDOCR METAB, V92, P2831, DOI 10.1210/jc.2006-2774; Whitehead CL, 2013, AM J OBSTET GYNECOL, V209	27	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1933-7191	1933-7205		REPROD SCI	Reprod. Sci.	JUN	2015	22	6					743	749		10.1177/1933719114557895		7	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CK2AR	WOS:000356012200014		
J	Hatayama, H; Tahara, K				Hatayama, Hiroki; Tahara, Kiyotaka			Evaluating the sufficiency of Japan's mineral resource entitlements for supply risk mitigation	RESOURCES POLICY			English	Article						Resource security; Mineral interests; Resource entitlements; Supply risk; Criticality; Japan	CRITICALITY; METALS; SCARCITY	The Japanese government and industries have been attempting to secure the future availability of mineral resources, because Japan imports most of its metals. To mitigate supply risk, the acquisition of mineral interests in foreign mining projects has been declared a pillar of the government's resource strategies. The sufficiency of the mineral interests held by Japanese companies, however, has not been evaluated quantitatively from a long-term perspective. By focusing on resource entitlements that accompany mineral interests, we developed an indicator named "reserve entitlements to demand ratio" that can be used to compare the sufficiency of mineral interests held between different metals. We then calculated the indicator for 17 metals and found that Japan held relatively high levels of entitlements for niobium, tungsten and lead in 2012, whereas it was quite low for palladium, platinum, and tin. The results revealed the possible overrating of supply risk for those highly-entitled metals and vice versa in the past assessments because they failed to consider the mineral interest as a criticality component. The developed methodology supports the choice of measures for securing mineral resources in Japan's resource strategy. (C) 2015 Elsevier Ltd. All rights reserved.	[Hatayama, Hiroki; Tahara, Kiyotaka] Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil, Tsukuba, Ibaraki 3058569, Japan	Hatayama, H (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil, 16-1 Onogawa, Tsukuba, Ibaraki 3058569, Japan.	h-hatayama@aist.go.jp; k.tahara@aist.go.jp					Kuriki S, 2010, J JPN I MET, V74, P801, DOI 10.2320/jinstmet.74.801; Achzet B, 2013, RESOUR POLICY, V38, P435, DOI 10.1016/j.resourpol.2013.06.003; Daigo I, 2010, RESOUR CONSERV RECY, V54, P851, DOI 10.1016/j.resconrec.2010.01.004; Graedel TE, 2012, ENVIRON SCI TECHNOL, V46, P1063, DOI 10.1021/es203534z; Gleich B, 2013, RESOUR POLICY, V38, P350, DOI 10.1016/j.resourpol.2013.03.011; Seo Y, 2014, RESOUR POLICY, V39, P15, DOI 10.1016/j.resourpol.2013.10.007; Yaksic A, 2009, RESOUR POLICY, V34, P185, DOI 10.1016/j.resourpol.2009.05.002; Erdmann L, 2011, ENVIRON SCI TECHNOL, V45, P7620, DOI 10.1021/es200563g; Tabayashi H, 2009, ISIJ INT, V49, P1265; Liu G, 2013, ENVIRON SCI TECHNOL, V47, P4882, DOI 10.1021/es305108p; Wellmer FW, 2008, Z DTSCH GES GEOWISS, V159, P575, DOI 10.1127/1860-1804/2008/0159-0575; Buijs B., 2012, P ICE WASTE RESOUR M, V165, P201; Canadian Institute of Mining, 2014, CIM DEF STAND MIN RE; Chihara H., 2011, REPORT DOMESTIC ENTI; Editorial Committee of Natural Resource & Energy, 2012, ED COMM NAT RES EN, P738; European Commission, 2010, CRIT RAW MAT EU; Japan Mining Industry Association, 2011, CHANG CIRC MIN RES D; Japan Oil Gas and Metals National Corporation UOGMEC), 2011, JFE STEEL NIPP STEEL; JX Holdings. Inc, 2012, CONS FIN RES FISC YE; Ministry of Economy Trade and Industry (METI), 2010, STRAT EN PLAN JAP; Ministry of Finance, 2014, TRAD STAT JAP; Mitsubishi Corporation, 2012, MITS CORP ENT AGR DE; Nakajima K, 2013, ENVIRON SCI TECHNOL, V47, P4653, DOI 10.1021/es3043559; National Research Council, 2008, MIN CRIT MIN US EC; New Energy and Industrial Technology Development Organization (NEDO), 2009, TTREND REP DEV MAT S; Prime Minister of Japan and His Cabinet, 2012, RES SEC STRAT; Schneider L, 2014, INT J LIFE CYCLE ASS, V19, P601, DOI 10.1007/s11367-013-0666-1; Hatayama H, 2015, MATER TRANS, V56, P229, DOI 10.2320/matertrans.M2014380; United Nations Environmental Programme International Panel on Sustainable Resource Management, 2011, EST LONG RUN GEOL ST; U.S. Geological Survey, 2013, MIN COMM SUMM	30	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0301-4207	1873-7641		RESOUR POLICY	Resour. Policy	JUN	2015	44						72	80		10.1016/j.resourpol.2015.02.004		9	Environmental Studies	Environmental Sciences & Ecology	CJ7UW	WOS:000355706800009		
J	Maeda, T; Kamikura, T; Tanaka, Y; Yamashita, A; Kubo, M; Takei, Y; Inaba, H				Maeda, Tetsuo; Kamikura, Takahisa; Tanaka, Yoshio; Yamashita, Akira; Kubo, Minoru; Takei, Yutaka; Inaba, Hideo			Impact of bystander-performed ventilation on functional outcomes after cardiac arrest and factors associated with ventilation-only cardiopulmonary resuscitation: A large observational study	RESUSCITATION			English	Article						Out-of-hospital cardiac arrest; Bystander cardiopulmonary resuscitation; Ventilation	AMERICAN-HEART-ASSOCIATION; BASIC LIFE-SUPPORT; CHEST-COMPRESSION; GUIDELINES; CARE; METAANALYSIS; LAYPERSONS; PHYSICIANS; NATIONWIDE; PERSONNEL	Aim: To determine the effectiveness of ventilations in bystander cardiopulmonary resuscitation (BCPR) and to identify the factors associated with ventilation-only BCPR. Methods: From out-of-hospital cardiac arrest (OHCA) data prospectively collected from 2005 to 2011 in Japan, we extracted data for 210,134 bystander-witnessed OHCAs with complete datasets but no prehospital involvement of physician [no BCPR, 115,733; ventilation-only, 2093; compression-only, 61,075; and conventional (compressions+ventilations) BCPR, 31,233] and determined the factors associated with 1-month neurologically favourable survival using simple and multivariable logistic regression analyses. In 91,885 patients with known BCPR durations, we determined the factors associated with ventilation-only BCPR. Results: The rate of survival in the no BCPR, ventilation-only, compression-only and conventional group was 2.8%, 3.9%, 4.5% and 5.0%, respectively. After adjustment for other factors associated with outcomes, the survival rate in the ventilation-only group was higher than that in the no BCPR group (adjusted OR; 95% CI, 1.29; 1.01-1.63), but lower than that in the compression-only (0.76; 0.59-0.96) or conventional groups (0.70; 0.55-0.89). Conventional CPR had the highest OR for survival in almost all OHCA subgroups. The adjusted OR (95% CI) for survival after dividing BCPR into ventilation and compression components was 1.19 (1.11-1.27) and 1.60 (1.51-1.69), respectively. Older guidelines, female sex, younger patient age, bystander-initiated CPR without instruction, early BCPR and short BCPR duration were associated with ventilation-only BCPR. Conclusions: Ventilation is a significant component of BCPR, but alone is less effective than compression in improving neurologically favourable survival after OHCAs. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Maeda, Tetsuo; Kamikura, Takahisa; Tanaka, Yoshio; Takei, Yutaka; Inaba, Hideo] Kanazawa Univ, Grad Sch Med, Dept Emergency Med Sci, Kanazawa, Ishikawa 9208641, Japan; [Yamashita, Akira] Noto Gen Hosp, Dept Cardiol, Nanao, Ishikawa 9260816, Japan; [Kubo, Minoru] Ishikawa Prefectural Cent Hosp, Dept Pediat, Kanazawa, Ishikawa 9208201, Japan; [Takei, Yutaka] Hiroshima Int Univ, Dept Med Sci & Technol, Hiroshima 7392695, Japan	Inaba, H (reprint author), Kanazawa Univ, Grad Sch Med, Dept Emergency Med Sci, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	tetsumae@med.kanazawa-u.ac.jp; kamitaka911@gmail.com; ytanaka.md@gmail.com; yamashita@noto-hospital.jp; min-kubo3e@ipch.jp; y-takei@hs.hirokoku-u.ac.jp; hidinaba@med.kanazawa-u.ac.jp					American Heart Association, 2005, CIRCULATION, V112, P1; Willerson JT, 2000, CIRCULATION, V102, P1; Bobrow BJ, 2010, JAMA-J AM MED ASSOC, V304, P1447, DOI 10.1001/jama.2010.1392; Hallstrom A, 2000, NEW ENGL J MED, V342, P1546, DOI 10.1056/NEJM200005253422101; Kuisma M, 1997, EUR HEART J, V18, P1122; Tibballs J, 2009, RESUSCITATION, V80, P61, DOI 10.1016/j.resuscitation.2008.10.002; Bahr J, 1997, RESUSCITATION, V35, P23, DOI 10.1016/S0300-9572(96)01092-1; Berg RA, 2000, CIRCULATION, V101, P1743; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Kitamura T, 2010, LANCET, V375, P1347, DOI 10.1016/S0140-6736(10)60064-5; Hupfl M, 2010, LANCET, V376, P1552, DOI 10.1016/S0140-6736(10)61454-7; Berg MD, 2010, CIRCULATION, V122, pS862, DOI 10.1161/CIRCULATIONAHA.110.971085; Handley AJ, 2005, RESUSCITATION, V67, pS7, DOI 10.1016/j.resuscitation.2005.10.007; Ruppert M, 1999, ANN EMERG MED, V34, P720, DOI 10.1016/S0196-0644(99)70097-1; Arrich J, 2009, RESUSCITATION, V80, P876, DOI 10.1016/j.resuscitation.2009.04.045; CHAMBERLAIN D, 1991, RESUSCITATION, V22, P1, DOI 10.1016/0300-9572(91)90061-3; Gabrini L, 2010, HSR P INTENSIVE CARE, V2, P279; International Liaison Committee on Resuscitation America Heart Association European Resuscitation Council, 2005, CIRCULATION, V112, pIII; Isaacs E, 2000, ANN EMERG MED, V35, P147, DOI 10.1016/S0196-0644(00)70134-X; Ogawa T, 2011, BMJ-BRIT MED J, V342, P7106; Ohta K, 2012, RESUSCITATION, V83, P1098, DOI 10.1016/j.resuscitation.2011.09.036; Preacher KJ, 2015, CALCULATION CHI SQUA; Safar P., 1981, BRAIN FAILURE RESUSC, P155; Nagao K, 2007, LANCET, V369, P920; WIK L, 1994, RESUSCITATION, V28, P195, DOI 10.1016/0300-9572(94)90064-7; Yao L, 2014, AM J EMERG MED, V32, P517, DOI 10.1016/j.ajem.2014.01.055; Yasunaga H, 2010, CRIT CARE, V14, DOI 10.1186/cc9319	27	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	JUN	2015	91						122	130		10.1016/j.resuscitation.2015.02.033		9	Critical Care Medicine; Emergency Medicine	General & Internal Medicine; Emergency Medicine	CK0ZV	WOS:000355935500029		
J	Ide, J; Somura, H; Nakamura, T; Mori, Y; Takeda, I; Nishida, K				Ide, J.; Somura, H.; Nakamura, T.; Mori, Y.; Takeda, I.; Nishida, K.			Hydrological Effects on Relationships Between N-15 of River Nitrate and Land Use in a Rural River Basin, Western Japan	RIVER RESEARCH AND APPLICATIONS			English	Article						anthropogenic and natural sources; diffuse pollution; hilly and mountainous area; nitrogen; stable isotope	WATER-QUALITY; NUTRIENT CONCENTRATIONS; ISOTOPIC ANALYSIS; FRESH-WATER; NITROGEN; IMPACT; ECOSYSTEMS; DEPOSITION; POLLUTION; SEAWATER	This study aimed to examine how the relationship between N-15 of nitrate (N-15(NO3)) in rivers and land use within a river basin changes with varying hydrological conditions. This information would aid in identifying the dominant source contributing to increased nitrate concentrations in rural rivers. For this, N-15(NO3) in river water was investigated monthly in the five subbasins of the Hii River basin (area: 911km(2)), western Japan, for 1year and 3months. There were significant correlations (p<0.05) between N-15(NO3) and the land-use ratio (i.e. ratios of forested, agricultural and residential areas in a subbasin) for the majority of the observation days, indicating that N-15(NO3) reflected land use within the basin. N-15(NO3) ranged from +1.4 parts per thousand to +8.5 parts per thousand and was lower in a subbasin with a higher forested area ratio. We found that the absolute value of the regression slope of the relationship between N-15(NO3) and the land-use ratio decreased with increasing river discharge. This finding demonstrates that differences in N-15(NO3) among subbasins with different land-use compositions became smaller under higher flow conditions. Because N-15(NO3) decreased with increasing river discharge, the small absolute value of the regression slope under high flow conditions indicates that forested areas could be the dominant source of river nitrate during high flows in all subbasins investigated regardless of land-use composition. The results suggest that forested areas make a large contribution to the increase in nitrate concentration in downstream rivers during high flows, because the nitrate concentration increased with increasing river discharge. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Ide, J.] Finnish Forest Res Inst, Joensuu Res Unit, Joensuu, Finland; [Ide, J.] Univ Hyogo, Sch Human Sci & Environm, Himeji, Hyogo 6700092, Japan; [Somura, H.; Takeda, I.] Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane, Japan; [Nakamura, T.; Nishida, K.] Univ Yamanashi, Int Res Ctr River Basin Environm, Kofu, Yamanashi, Japan; [Mori, Y.] Okayama Univ, Grad Sch Environm & Life Sci, Okayama, Japan	Ide, J (reprint author), Univ Hyogo, Sch Human Sci & Environm, 1-1-12 Shinzaike Honcho, Himeji, Hyogo 6700092, Japan.	ide.junichiro@gmail.com			Shimane University Priority Research Project; Espec Foundation for Global Environment Research and Technology; Sasagawa Scientific Research Grant from the Japan Science Society; River Fund in charge of the Foundation of River and Watershed Environment Management, Japan; Founding Program for Next Generation World-Leading Researchers (NEXT programme) from the Japan Society for the Promotion of Science	This work was supported in part by the Shimane University Priority Research Project, the Espec Foundation for Global Environment Research and Technology, a Sasagawa Scientific Research Grant from the Japan Science Society, the River Fund in charge of the Foundation of River and Watershed Environment Management, Japan, and the Founding Program for Next Generation World-Leading Researchers (NEXT programme) from the Japan Society for the Promotion of Science. We also thank Mr Atsushi Fujihara, Mr Yuichi Sugitani and Dr Taihei Morisawa for supporting field surveys in the Hii River basin and Dr Kuniaki Sato for providing information on fertilizer and compost.	Casciotti KL, 2002, ANAL CHEM, V74, P4905, DOI 10.1021/ac020113w; McClelland JW, 1998, LIMNOL OCEANOGR, V43, P577; Tufford DL, 2003, J AM WATER RESOUR AS, V39, P301, DOI 10.1111/j.1752-1688.2003.tb04385.x; Gundersen P, 1998, FOREST ECOL MANAG, V101, P37, DOI 10.1016/S0378-1127(97)00124-2; Ohte N, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020908; Ocampo CJ, 2006, J HYDROL, V331, P643, DOI 10.1016/j.jhydrol.2006.06.010; Kaushal SS, 2011, ENVIRON SCI TECHNOL, V45, P8225, DOI 10.1021/es200779e; Johnson LB, 1997, FRESHWATER BIOL, V37, P193, DOI 10.1046/j.1365-2427.1997.d01-539.x; Brett MT, 2005, ENVIRON MANAGE, V35, P330, DOI 10.1007/s00267-003-0311-z; Sigman DM, 2001, ANAL CHEM, V73, P4145, DOI 10.1021/ac010088e; Ahearn DS, 2005, J HYDROL, V313, P234, DOI 10.1016/j.jhydrol.2005.02.038; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; RICHARDS RP, 1987, WATER RESOUR RES, V23, P1939, DOI 10.1029/WR023i010p01939; Jordan TE, 1997, WATER RESOUR RES, V33, P2579, DOI 10.1029/97WR02005; Mayer B, 2002, BIOGEOCHEMISTRY, V57, P171, DOI 10.1023/A:1015744002496; Wakida FT, 2005, WATER RES, V39, P3, DOI 10.1016/j.watres.2004.07.026; Kendall C, 2007, ECOL METHOD CONCEPT, P375, DOI 10.1002/9780470691854.ch12; Fujibe F, 2006, J METEOROL SOC JPN, V84, P1033, DOI 10.2151/jmsj.84.1033; VALIELA I, 1992, ESTUARIES, V15, P443, DOI 10.2307/1352389; Walter MT, 2000, J SOIL WATER CONSERV, V55, P277; Harrington RR, 1998, CHEM GEOL, V147, P281, DOI 10.1016/S0009-2541(98)00018-7; Arnold JG, 1998, J AM WATER RESOUR AS, V34, P73, DOI 10.1111/j.1752-1688.1998.tb05961.x; Burns DA, 2009, J ENVIRON QUAL, V38, P1149, DOI 10.2134/jeq2008.0371; Ileva NY, 2009, SUSTAIN SCI, V4, P189, DOI 10.1007/s11625-009-0081-5; Barnes RT, 2010, ECOL APPL, V20, P1961, DOI 10.1890/08-1328.1; Bedard-Haughn A, 2003, J HYDROL, V272, P175, DOI 10.1016/S0022-1694(02)00263-9; Chiwa M, 2012, ECOSYSTEMS, V15, P230, DOI 10.1007/s10021-011-9505-z; Fujita SI, 2003, TELLUS B, V55, P23, DOI 10.1034/j.1600-0889.2003.00001.x; Fujihara M, 2003, ATMOS ENVIRON, V37, P2725, DOI 10.1016/S1352-2310(03)00232-2; Ide J, 2012, ENVIRON MONIT ASSESS, V184, P4747, DOI [10.1007/s10661-011-2299-9, DOI 10.1007/S10661-011-2299-9]; Nakamura T, 2010, P JAPANESE ASS HYDRO, V25, P19; Nakamura T, 2011, J JPN ASS HYDROL SCI, V41, P79, DOI 10.4145/jahs.41.79; Nishio M., 2001, Japanese Journal of Soil Science and Plant Nutrition, V72, P513; Noguchi I, 2010, GLOBAL ENV RES, V15, P111; Ohrui K, 1997, ECOL APPL, V7, P391; Ohte N, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR007871; Osaka K, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG000977; R Development Core Team, 2011, R LANG ENV STAT COMP; Rock L, 2004, WATER AIR SOIL POLL, V4, P545, DOI [10.1007/978-94-007-0952-2_37, DOI 10.1023/B:WAFO.0000028377.94365.09]; Sebestyen SD, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR006983; Shimane Prefecture, 2000, STAT INF SHIM; Somura H, 2009, HYDROL PROCESS, V23, P1887, DOI 10.1002/hyp.7321; Somura H, 2012, J HYDROL, V450, P25, DOI 10.1016/j.jhydrol.2012.05.032; Takeda Ikuo, 2009, Journal of Water and Environmental Technology, V7, DOI 10.2965/jwet.2009.293; YONEYAMA T, 1990, SOIL SCI PLANT NUTR, V36, P667; Zenkanken (Japan Environmental Laboratories Association), 2010, J ENV LAB ASS, V35, P179	46	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1535-1459	1535-1467		RIVER RES APPL	River Res. Appl.	JUN	2015	31	5					639	649		10.1002/rra.2756		11	Environmental Sciences; Water Resources	Environmental Sciences & Ecology; Water Resources	CK1WL	WOS:000355999100011		
J	Sugiura, S; Masuya, H				Sugiura, Shinji; Masuya, Hayato			Keratin subsidies promote feather decomposition via an increase in keratin-consuming arthropods and microorganisms in bird breeding colonies	SCIENCE OF NATURE			English	Article						Allochthonous input; Egret and heron feathers; Keratinophilic fungi; Resource subsidies; Scavenging arthropods	FOOD WEBS; ALLOCHTHONOUS INPUT; ECOSYSTEM; DYNAMICS; ISLANDS; CORMORANTS; LANDSCAPE; DIGESTION; INSECTS; MARINE	Resource subsidies are well known to increase population densities of consumers. The decomposition process of these subsidised resources can be influenced by increasing consumer abundance. However, few studies have assessed whether resource subsidies can promote resource decomposition via a population increase in consumers. Here, we examined the effects of keratin subsidies on feather decomposition in egret and heron breeding colonies. Egrets and herons (Ardeidae) frequently breed in inland forests and provide large amounts of keratin materials to the forest floor in the form of feathers of chicks (that die). We compared the decrease in the weights of egret and heron feathers (experimentally placed on the forest floor) over a 12-month period among egret/heron breeding colonies (five sites) and areas outside of colonies (five sites) in central Japan. Of the feathers placed experimentally on forest floors, 92-97 % and 99-100 % in colonies and 47-50 % and 71-90 % in non-colony areas were decomposed after 4 and 12 months, respectively. Then, decomposition rates of feathers were faster in colonies than in areas outside of colonies, suggesting that keratin subsidies can promote feather decomposition in colonies. Field observations and laboratory experiments indicated that keratin-feeding arthropods and keratinophilic fungi played important roles in feather decomposition. Therefore, scavenging arthropods and keratinophilic fungi, which dramatically increased in egret and heron breeding colonies, could accelerate the decomposition of feathers supplied to the forest floor of colonies.	[Sugiura, Shinji] Kobe Univ, Grad Sch Agr Sci, Nada Ku, Kobe, Hyogo 6578501, Japan; [Masuya, Hayato] Forestry & Forest Prod Res Inst, Tohoku Branch, Morioka, Iwate 0200123, Japan	Sugiura, S (reprint author), Kobe Univ, Grad Sch Agr Sci, Nada Ku, Kobe, Hyogo 6578501, Japan.	sugiura.shinji@gmail.com					Goldstein G, 2004, AUK, V121, P656, DOI 10.1642/0004-8038(2004)121[0656:BDOBAW]2.0.CO;2; Tank JL, 2010, J N AM BENTHOL SOC, V29, P118, DOI 10.1899/08-170.1; Spiller DA, 2010, ECOLOGY, V91, P1424, DOI 10.1890/09-0715.1; Yu MK, 2004, INT J DEV BIOL, V48, P181, DOI 10.1387/ijdb.15272383; Mashiko M, 2013, FORKTAIL, P71; Zhang FC, 2010, NATURE, V463, P1075, DOI 10.1038/nature08740; WATERHOUSE DF, 1957, ANNU REV ENTOMOL, V2, P1, DOI 10.1146/annurev.en.02.010157.000245; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; BENFIELD EF, 1985, FRESHWATER BIOL, V15, P113, DOI 10.1111/j.1365-2427.1985.tb00701.x; Lin SJ, 2013, DEV GROWTH DIFFER, V55, P139, DOI 10.1111/dgd.12024; Carter DO, 2007, NATURWISSENSCHAFTEN, V94, P12, DOI 10.1007/s00114-006-0159-1; Blyskal B, 2009, INT BIODETER BIODEGR, V63, P631, DOI 10.1016/j.ibiod.2009.02.006; PUGH GJF, 1970, T BRIT MYCOL SOC, V54, P233; DAVIS PG, 1995, GEOLOGY, V23, P783, DOI 10.1130/0091-7613(1995)023<0783:FOF>2.3.CO;2; Kolb GS, 2012, ECOGRAPHY, V35, P726, DOI 10.1111/j.1600-0587.2011.06808.x; Klemmer AJ, 2012, J ANIM ECOL, V81, P770, DOI 10.1111/j.1365-2656.2012.01966.x; Sanchez-Pinero F, 2000, ECOLOGY, V81, P3117, DOI 10.2307/177405; Hughes J, 2006, INSECT BIOCHEM MOLEC, V36, P584, DOI 10.1016/j.ibmb.2006.04.007; Parmenter RR, 2009, ECOL MONOGR, V79, P637, DOI 10.1890/08-0972.1; Aoki J, 1999, PICTORIAL KEYS SOIL; Bates Douglas, 2011, LME4 LINEAR MIXED EF; Crawley MJ., 2005, STAT INTRO USING R; Ishiwata S, 2005, INSECT LARVAE JAPAN; Japanese Ant Database Group, 2008, JAP ANT IM DAT; Kawai S, 2005, ATLAS JAPANESE SCARA, V1; Kolb GS, 2010, ECOSYSTEMS, V13, P353, DOI 10.1007/s10021-010-9323-8; Lauber CL, 2014, APPL ENVIRON MICROB, V80, P4920, DOI 10.1128/AEM.00957-14; McIntosh AR, 2005, FRESHWATER BIOL, V50, P1206, DOI 10.1111/j.1365-2427.2005.01394.x; Mondor EB, 2012, NAT ED KNOWLEDGE, V3, P21; Pechal JL, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00022.1; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; PUGH GJF, 1970, T BRIT MYCOL SOC, V54, P241; R Development Core Team, 2012, R LANG ENV STAT COMP; RUSHTON SP, 1983, OECOLOGIA, V57, P415, DOI 10.1007/BF00377189; Sharma RS, 2003, RESONANCE, V8, P28, DOI [10.1007/BF02837919, DOI 10.1007/BF02837919]; Sugiura S, 2013, NATURWISSENSCHAFTEN, V100, P749, DOI 10.1007/s00114-013-1071-0; Sugiura S, 2013, BIOL CONSERV, V159, P206, DOI 10.1016/j.biocon.2012.11.003; Sugiura S, 2014, NATURWISSENSCHAFTEN, V101, P187, DOI 10.1007/s00114-013-1137-z; Takemoto S, 2014, FUNGAL ECOL, V7, P1, DOI 10.1016/j.funeco.2013.10.004; TRIVEDI JP, 1991, INT BIODETERIOR, V27, P327, DOI 10.1016/0265-3036(91)90061-U; Ueno S, 1985, COLEOPTERA JAPAN COL, VII; Ueno Yusuke, 2006, Ornithological Science, V5, P199, DOI 10.2326/osj.5.199; WATERHOUSE DF, 1952, AUST J SCI RES SER B, V5, P444; WILLIAMS CM, 1990, APPL ENVIRON MICROB, V56, P1509	44	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0028-1042	1432-1904		SCI NAT-HEIDELBERG	Sci. Nat.	JUN	2015	102	5-6								10.1007/s00114-015-1275-6		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CK1CI	WOS:000355942600005		
J	Rodriguez Plasencia, G				Rodriguez Plasencia, Girardo			Joining Soka Gakkai in Cuba: Affiliation patterns and factors influencing conversion careers	SOCIAL COMPASS			English	Article						Buddhism; conversion careers; Cuba; new spiritualities; Soka Gakkai	BUDDHISM	Why do Cubans convert to Soka Gakkai (SGI)? What factors influence their religious choice? Based on fieldwork conducted in Havana, three main affiliation patterns are identified: the pursuit of practical benefits, spiritual quests and the irreligious paths. At the micro level, these are explained by the converts' perceived congruence between their own (non-)religious worldview and SGI. Next, at the meso level, it is shown that a major institutional factor is SGI's capacity to supply simultaneously a utilitarian religious perspective, an alternative spirituality and a non-theistic humanistic message. Finally, individual and institutional factors are linked to the socio-cultural context.	Seinan Gakuin Univ, Sch Intercultural Studies, Sawara Ku, Fukuoka 8148511, Japan	Rodriguez Plasencia, G (reprint author), Seinan Gakuin Univ, Sch Intercultural Studies, Sawara Ku, 6-2-92 Nishijin, Fukuoka 8148511, Japan.	girardorp@gmail.com			Japanese government (MEXT); RCAPS (APU)	This work is part of the author's doctoral research, which benefits from a scholarship from the Japanese government (MEXT: 2011-2014). RCAPS (APU) provided funds to cover the travel expenses incurred in presenting an earlier version of this article at the ISSR 2013 conference.	LOFLAND J, 1981, J SCI STUD RELIG, V20, P373, DOI 10.2307/1386185; LOFLAND J, 1965, AM SOCIOL REV, V30, P862, DOI 10.2307/2090965; Zuckerman P, 2007, CAMBR COMPANION PHIL, P47, DOI 10.1017/CCOL0521842700.004; Campbell Colin, 2007, EASTERNIZATION W THE; Cornejo M, 2013, GENDER POWER CONT SP, P62; Delgado de la Guardia J, 2002, SGI Q            APR; Diaz AM, 1994, SOC COMPASS, V41, P225; Fabelo L, 2009, 2 S INT CIPS 2009 CI; Gooren H, 2007, J SCI STUD RELIG, V46, P337, DOI 10.1111/j.1468-5906.2007.00362.x; Gooren H, 2010, RELIGIOUS CONVERSION AND DISAFFILIATION: TRACING PATTERNS OF CHANGE IN FAITH PRACTICES, P1, DOI 10.1057/9780230113039; GREIL AL, 1977, SOCIOL ANAL, V38, P115, DOI 10.2307/3710172; Hammond PE, 1999, SOKA GAKKAI AM ACCOM; Heelas Paul, 1996, NEW AGE MOVEMENT CEL; Inoue D, 2006, ALTERIDADES, V16, P43; Jimenez S, 2005, ALGUNAS TENDEN UNPUB; Jimenez S, 2006, NEW AGE NUEVA OPCION; Mathe T, 2005, BOUDDHISME FRANCAIS; Mathe T, 2010, SOC COMPASS, V57, P521, DOI 10.1177/0037768610383373; Metraux DA, 2001, INT EXPANSION MODERN; RAMBO Lewis R., 1993, UNDERSTANDING RELIG; Ramirez Calzadilla J, 2004, RELIGIOSIDAD POPULAR, P25; Ramirez Calzadilla J, 2009, ARCH SCI SOCIALES RE, V54, P157; Reader Ian, 1991, RELIG CONT JAPAN; Reader Ian, 1998, PRACTICALLY RELIG WO; Richardson JT, 1978, CONVERSION CAREERS O; Rodriguez Plasencia G, 2014, J RELIG JAPAN, V3, P198; Shoji R, 2002, REV ESTUDOS RELIGIAO, V2, P85; SNOW DA, 1980, SOC PROBL, V27, P430, DOI 10.1525/sp.1980.27.4.03a00070; Soka Gakkai International, 2007, SGI CUB 1 BUDDH ASS; SOLOMON TJ, 1980, JPN J RELIG STUD, V7, P34; Stark Rodney, 2000, ACTS FAITH EXPLAININ; Stone GP, 1970, SOCIAL PSYCHOL SYMBO, P594; STRAUS RA, 1979, SOCIOL ANAL, V40, P158, DOI 10.2307/3709786; Wilson Bryan, 1994, TIME CHANT SOKA GAKK	34	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0037-7686	1461-7404		SOC COMPASS	Soc. Compass	JUN	2015	62	2					159	171		10.1177/0037768615571687		13	Sociology; Religion	Sociology; Religion	CJ7RR	WOS:000355696800004		
J	Yu, Y; Bathurst, RJ; Miyata, Y				Yu, Yan; Bathurst, Richard J.; Miyata, Yoshihisa			Numerical analysis of a mechanically stabilized earth wall reinforced with steel strips	SOILS AND FOUNDATIONS			English	Article						Numerical analysis; MSE walls; Steel strips; Concrete panel facing; FLAC	SOIL SEGMENTAL WALLS; PREDICTED LOADS; RETAINING WALL; JAPAN; PERFORMANCE; INTERFACE; MODELS	A mechanically stabilized earth wall with steel strip soil reinforcement was built and instrumented by the Public Works Research Institute of Japan. Measured reinforcement loads and Vertical toe loads are compared to values predicted using the finite difference program FLAC. Backfill and foundation soil properties were not reported in the original case study. A novel relative error technique was used to select the best estimates of the single-value elastic modulus for both soils. The relative errors were computed from the calculated and measured values of the tensile load in the steel strips and the vertical toe load at the end of the wall construction. Minimum relative errors were visually detectable in the contour plots of the weighted relative errors, and these minima were used to select the elastic moduli of the baseline backfill soil and the foundation soil. The baseline values were shown to yield predicted tensile and vertical toe loads that are judged to be in good agreement with the measured data Parametric analyses were carried out to examine the quantitative influence on the computed reinforcement loads and the vertical toe load of the various soil modulus, interface shear stiffness and interface friction angles around the baseline Values. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Yu, Yan; Bathurst, Richard J.] Royal Mil Coll Canada, Dept Civil Engn, GeoEngn Ctr Queens RMC, Kingston, ON K7K 7B4, Canada; [Miyata, Yoshihisa] Natl Def Acad, Dept Civil & Environm Engn, Yokosuka, Kanagawa 2398686, Japan	Miyata, Y (reprint author), Natl Def Acad, Dept Civil & Environm Engn, 1-10-20 Hashirimizu, Yokosuka, Kanagawa 2398686, Japan.	yan.yu@queensu.ca; bathurst-r@rmc.ca; miyamiya@nda.ac.jp			Natural Sciences and Engineering Research Council of Canada (NSERC) [194344-2013, 446148-2013]	The work reported in this paper was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) (Grant nos. 194344-2013 & 446148-2013) held by the second author.	Abdelouhab A, 2011, GEOTEXT GEOMEMBRANES, V29, P116, DOI 10.1016/j.geotexmem.2010.10.011; Allen T.M., 2013, ASCE GEOTECHNICAL SP, V230, P500; KISHIDA H, 1987, GEOTECHNIQUE, V37, P45; [Anonymous], AASHTO LRFD BRIDG DE; Hatami K, 2006, J GEOTECH GEOENVIRON, V132, P673, DOI 10.1061/(ASCE)1090-0241(2006)132:6(673); Huang BQ, 2009, J GEOTECH GEOENVIRON, V135, P1486, DOI 10.1061/(ASCE)GT.1943-5606.0000092; [Anonymous], 2010, BS8006; Rowe RK, 2001, GEOTEXT GEOMEMBRANES, V19, P387; Miyata Y, 2009, SOILS FOUND, V49, P1, DOI 10.3208/sandf.49.1; Miyata Y, 2012, SOILS FOUND, V52, P1, DOI 10.1016/j.sandf.2012.01.009; Huang BQ, 2010, CAN GEOTECH J, V47, P885, DOI 10.1139/T10-002; Arai Y., 2007, P 42 JAP GEOT SOC AN, P593; Bathurst R.J., 2011, GEORISK, V5, P218; Bathurst R.J., 2015, SOILS FOUND, V52, P437; Bourgeois E, 2013, SOILS FOUND, V53, P259, DOI 10.1016/j.sandf.2013.02.006; Chida S., 1979, P INT C SOIL REINF, VII, P533; Chida S., 1980, MONTHLY MAGAZINE JAP, V24, P18; Damians IP, 2013, ASCE J GEOTECH GEOEN, V139, P1419; Damians I.P., 2015, ASCE INT J GEOMECH, V15; Damians I. P., 2014, International Journal of Geotechnical Engineering, V8, DOI 10.1179/1939787913Y.0000000039; Findlay T.W., 1978, GROUND ENG, V11, P42; Hatami K, 2005, CAN GEOTECH J, V42, P1066, DOI 10.1139/T05-040; Hirai T., 2003, P INT S EARTH REINF, P1009; Itasca, 2011, FLAC FAST LAGR AN CO; KARPURAPU R, 1995, COMPUT GEOTECH, V17, P279, DOI 10.1016/0266-352X(95)99214-C; Kawai Y., 1999, P 34 JAP GEOT SOC AN, P1823; Lindquist D.D., 2008, SEISMIC MODELING 135, P1; Miyata Y, 2012, SOILS FOUND, V52, P481, DOI 10.1016/j.sandf.2012.05.007; Mori K., 2001, P 36 JAP GEOT SOC AN, P2073; Ochiai H, 2007, P INT S EARTH REINF, P1; Public Works Research Center (PWRC), 2003, DES METH CONSTR MAN, Vthird; Runser DJ, 2001, GEOSYNTH INT, V8, P367; Stuedlein AW, 2010, J GEOTECH GEOENVIRON, V136, P786, DOI 10.1061/(ASCE)GT.1943-5606.0000294; Yorita M., 1995, P 50 JAP SOC CIV ENG, P1604; Yu Y, 2015, J GEOTECH GEOENVIRON, V141, DOI 10.1061/(ASCE)GT.1943-5606.0001281; Yu Y, 2015, COMPUT GEOTECH, V65, P164, DOI 10.1016/j.compgeo.2014.12.009	36	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	JUN	2015	55	3					536	547		10.1016/j.sandf.2015.04.006		12	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CK0ZJ	WOS:000355934100006		
J	De Silva, LIN; Koseki, J; Chiaro, G; Sato, T				De Silva, Laddu Indika Nalin; Koseki, Junichi; Chiaro, Gabriele; Sato, Takeshi			A stress-strain description of saturated sand under undrained cyclic torsional shear loading	SOILS AND FOUNDATIONS			English	Article						Liquefaction behavior; Stess-dilatancy relationship; Over-consolidation; Sand; Constitutive model	INITIAL STATIC SHEAR; TOYOURA SAND; DEFORMATION PROPERTIES; NUMERICAL-MODEL; LIQUEFACTION; TESTS; BEHAVIOR	A constitutive model to describe the cyclic undrained behavior of saturated sand is presented. The increments in volumetric strain during undrained loading, which are equal to zero, are assumed to consist of increments due to dilatancy and increments due to consolidation/swelling. This assumption enables the proposed model to evaluate increments in volumetric strain due to dilataricy as mirror images of increments in volumetric strain due to consolidation/swelling, thus simulating the generation of excess pore water pressure (i.e., reduction in mean effective principal stress) during undrained cyclic shear loading. Based on the results of drained tests, the increments in volumetric strain due to consolidation/swelling are evaluated by assuming that the quasi-elastic bulk modulus can be expressed as a unique function of the mean effective principal stress. On the other hand, in evaluating the increments in volumetric strain due to dilatancy, a normalized stress plastic shear strain relationship is employed in combination with a novel empirical stress dilatancy relationship derived for torsional shear loading. The proposed stress dilatancy relationship accounts for the effects of over-consolidation during cyclic loading. Numerical simulations show that the proposed model can satisfactorily simulate the generation of excess pore water pressure and the stress strain relationship of saturated Toyoura sand specimens subjected to unchained cyclic torsional shear loading. It is found that the liquefaction resistance of loose Toyoura sand specimens can be accurately predicted by the model, while the liquefaction resistance of dense Toyoura sand specimens may be slightly underestitnated. (i.e., the liquefaction potential is higher). Yet, the model predictions are conservative. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[De Silva, Laddu Indika Nalin] Univ Moratuwa, Dept Civil Engn, Moratuwa, Sri Lanka; [De Silva, Laddu Indika Nalin] Univ Tokyo, Dept Civil Engn, Tokyo 1138654, Japan; [Koseki, Junichi; Chiaro, Gabriele] Univ Tokyo, Inst Ind Sci, Tokyo 1138654, Japan; [Sato, Takeshi] Integrated Geotechnol Inst Ltd, Tokyo, Japan	De Silva, LIN (reprint author), Univ Moratuwa, Dept Civil Engn, Moratuwa, Sri Lanka.	nalinds@uom.lk; koseki@iis.u-tokyo.ac.jp; chiaroga@iis.u-tokyo.ac.jp; tsato@iis.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [21360221]	Our special appreciation goes to Prof. R. Uzuoka of the University of Tokushima, Japan, for his valuable suggestions in developing the cyclic elasto-plastic model. In addition, the authors sincerely acknowledge the Ministry of Education, Culture, Sports, Science, and Technology (Grants-in-Aid for Scientific Research #21360221), Japan for providing the financial assistance for the current research.	Oka F, 1999, GEOTECHNIQUE, V49, P661; MROZ Z, 1978, INT J NUMER ANAL MET, V2, P203; Ling HI, 2006, J ENG MECH-ASCE, V132, P1380, DOI 10.1061/(ASCE)0733-9399(2006)132:12(1380); JEFFERIES MG, 1993, GEOTECHNIQUE, V43, P91; Balakrishnaiyer K., 2000, IMPLICATIONS RECENT, V2, P105; Chiaro G, 2012, SOILS FOUND, V52, P498, DOI 10.1016/j.sandf.2012.05.008; Chiaro G, 2013, SOILS FOUND, V53, P23, DOI 10.1016/j.sandf.2012.07.016; De Silva L.I.N., 2005, P 2 JAP US WORKSH TE, V156; De Silva L.I.N., 2012, ADV TRANSPORTATION G, VII, P686; De Silva LIN, 2014, SOILS FOUND, V54, P845, DOI 10.1016/j.sandf.2014.06.015; De Silva LIN, 2006, PROC MONOGR ENG WATE, P29; HongNam N., 2008, P 4 INT S DEF CHAR G, V2, P801; HongNam N, 2005, SOILS FOUND, V45, P19; Iai S., 1992, SOILS FOUND, V32, P1; Ishihara K., 1972, SOILS FOUND, V12, P19; Ishihara K., 1975, SOILS FOUND, V15, P29; Kiyota T, 2008, SOILS FOUND, V48, P727, DOI 10.3208/sandf.48.727; Koseki J, 2005, SOILS FOUND, V45, P103; Koseki J., 1998, GEOTECHNICAL ENG SOI, V75; LIOU CP, 1977, J GEOTECHNICAL ENG D, V103, P589; Liyanapathirana DS, 2002, SOIL DYN EARTHQ ENG, V22, P1007, DOI 10.1016/S0267-7261(02)00125-2; Masuda T., 1999, SOILS FOUND, V39, P31; Namikawa T., 2011, P 5 INT C EARTHQ GEO, P1; Nishimura S., 2002, THESIS U TOKYO JAPAN; Nishimura S, 2004, SOILS FOUND, V44, P103; OKA F, 1992, PROCEEDINGS OF THE TENTH WORLD CONFERENCE ON EARTHQUAKE ENGINEERING, VOLS 1-10, P2529; Seed H.B., 1966, P ASCE SM6, P105; Tatsuoka F., 1997, THEME LECT PLENARY S, V4, P2129; Tatsuoka F, 2003, J GEOTECH GEOENVIRON, V129, P450, DOI 10.1061/(ASCE)1090-0241(2003)129:6(450); Tatsuoka F., 1991, J IIS, V43, P435; Towhata I, 1985, SOILS FOUND, V25, P135, DOI DOI 10.3208/SANDF1972.25.2_135; Towhata I, 1985, SOILS FOUND, V25, P73, DOI DOI 10.3208/SANDF1972.25.3_; VAID YP, 1995, J GEOTECH ENG-ASCE, V121, P163, DOI 10.1061/(ASCE)0733-9410(1995)121:2(163)	33	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	JUN	2015	55	3					559	574		10.1016/j.sandf.2015.04.008		16	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CK0ZJ	WOS:000355934100008		
J	Suzuki, M; Shimura, N; Fukumura, T; Yoneda, O; Tasaka, Y				Suzuki, Motoyuki; Shimura, Naoki; Fukumura, Takuto; Yoneda, Osamu; Tasaka, Yukio			Seismic performance of reinforced soil wall with untreated and cement-treated soils as backfill using a 1-g shaking table	SOILS AND FOUNDATIONS			English	Article						Reinforced soil wall; Steel strip; Retaining wall; Seismic performance; Shaking table; Stabilisation; Pullout resistance	RETAINING WALLS	Reinforced soil walls were only slightly damaged in the recent earthquake disasters in Japan. However, because sandy soils are generally used as backfill in steel-strip reinforced soil walls, these walls may deform during or immediately after an earthquake. Therefore, it is important to clarify the resistance of this type of wall to seismic shocks and to improve the waifs seismic performance for stabilisation through such methods as cement treatment. For this purpose, we developed a reinforced soil wall model to simulate the stress and deformation around an embedded reinforcement. The reinforcement used here was a steel strip with ribs. First, a series of conventional pullout tests was performed to examine the pullout resistance of the strip with its ribs embedded in the soil layer. Next, shaking table tests were performed using a reinforced soil wall model with different initial pullout loads applied to the strip. The conditions of the horizontal shaking table tests briefly consisted of a maximum acceleration of 1000 Gal and a frequency of 3 Hz. The initial pullout load before the shaking tests was set at 75% of the maximum load obtained from the pullout tests. Sand, clay, and cement-treated sand and clay were used for the soil samples. The clay had a line fraction content of over 25%. This paper discusses the seismic behaviour of a reinforced soil wall composed of sand, clay, and cement-treated clay based on the results of pullout and shaking table tests. The primary conclusions can be summarised as follows: 1) When no overburden pressure was applied, shaking caused the strip in the untreated sand layer to slip within a couple of seconds. Conversely, when the overburden pressure was above 50 kPa, the strip did not slip at all during 3 min of shaking. When the initial pullout load was decreased by 5%, the facing wall moved forward by only 0.2% of its height. Therefore, no large deformations affecting the instability of the wall were recognised during the shaking tests. 2) Furthermore, in the case of untreated clay with or without overburden pressure, the resistance between the strip and the soil was negligible, and the strip was simultaneously made to slip from the shaking table tests to the same extent as the untreated sand without overburden pressure. 3) After the cement treatment was applied to the clay, the strip did not slip during 3 min of shaking, the initial pullout load did not decrease, and the facing wall did not move during the shaking period. 4) When the strip was connected to the facing wall, the strip slipped more slowly than when it was not connected. 5) The stability and seismic performance of the reinforced soil wall were not affected by the ratio of the initial pullout load to the maximum pullout load within the tested range. 6) Conversely, when the acceleration was set to 1500 Gal, the initial pullout load decreased by only a maximum of 5%. Therefore, the use of cement-treated soil can crucially improve the stability of a reinforced soil wall, even if a large acceleration occurs during an earthquake. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Suzuki, Motoyuki] Yamaguchi Univ, Yamaguchi, Japan; [Shimura, Naoki] Hirose Co Ltd, Osaka, Japan; [Fukumura, Takuto] Fukken Co Ltd, Tokyo, Japan; [Yoneda, Osamu; Tasaka, Yukio] Ube Ind Ltd, Tokyo, Japan	Suzuki, M (reprint author), Yamaguchi Univ, Yamaguchi, Japan.	msuzuki@yamaguchi-u.ac.jp; n-shimura@hirose-net.co.jp					Miyata Y, 2012, SOILS FOUND, V52, P1, DOI 10.1016/j.sandf.2012.01.009; Futaki M., 1996, P 11 WORLD C EARTHQ; Hyodo M., 1994, SOILS FOUND, V34, P1; Koseki J., 2007, P 13 AS REG C SOIL M, P222; Koseki J., 2006, P 8 INT C GEOS YOK, V1, P51; Ling HI, 1997, GEOTECHNIQUE, V47, P933; Matsuo O, 1998, GEOSYNTH INT, V5, P97; Miyata T., 2001, P INT S EARTH REINF, V2, P1107; Public Works Research Center (PWRC), 2003, DES METH CONSTR MAN, Vthird; RICHARDSON GN, 1977, J GEOTECH ENG-ASCE, V103, P1; Richardson G.N., 1975, J GEOTECHNICAL ENG D, V101, P167; Sahara K, 2012, P INT JOINT S URB GE, P74; Sato M., 2006, P 41 JAP NAT C GEOT, P1847; Suzuki M., 2007, P 5 INT S EARTH REIN, P693; Tasaka Y., 2010, J JSCE GEOTECH ENG C, V66, P516; The Japanese Geotechnical Society, 2006, NEW APPL EARTH REINF; Uezawa H., 1974, 889 JAP NAT RAILW RA, P1; Watanabe K, 2003, SOILS FOUND, V43, P13; YOGENDRAKUMAR M, 1992, J GEOTECH ENG-ASCE, V118, P1158, DOI 10.1061/(ASCE)0733-9410(1992)118:8(1158)	19	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	JUN	2015	55	3					626	636		10.1016/j.sandf.2015.04.013		11	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CK0ZJ	WOS:000355934100013		
J	Morita, T; Yamada, T; Watanabe, T; Nagahori, E				Morita, T.; Yamada, T.; Watanabe, T.; Nagahori, E.			Lifestyle risk factors for pressure ulcers in community-based patients with spinal cord injuries in Japan	SPINAL CORD			English	Article							WHEELCHAIR USERS; INDIVIDUALS; THERAPISTS; VETERANS	Study design: Case-control study. Objectives: To identify daily living-related risk factors for pressure ulcer (PU) occurrence in community-living patients with spinal cord injury (SCI). To determine whether seat pressure influences PU occurrence, and how often patients with SCI perform pressure relief activities while living in the community. Setting: Kanagawa Rehabilitation Hospital, Kanagawa, Japan. Methods: Thirty-one patients admitted to this hospital for PU treatment were included in the case (PU) group. Thirty outpatients who did not have PUs at the time of the study, and had lived without PUs for at least a year, were included in the control (No PU) group. Patients were interviewed about lifestyle-related PU risk factors and a pressure-mapping system was used to measure interface pressure (IP) on their wheelchair seat. The No PU group patients recorded their daily activities and pressure relief maneuvers for 1 week. Results: Eight lifestyle factors and one risk assessment scale significantly differed between groups. Three factors showed significant odds ratios by logistic regression. IP did not significantly differ between groups. The self-counted number of pressure relief maneuvers (median (25th-75th percentile)) performed per hour in the No PU group was 2.5 (0.7-4.3) and including transfer and urination was 3.5 (2.0-5.3). Conclusion: We identified potential PU risk factors related to lifestyle. The scores of one risk assessment scale were also associated with PU risk. Our results did not suggest an IP damage threshold. Patients in the No PU group performed pressure relief maneuvers, including related activities, approximately once every 17min.	[Morita, T.] Kanagawa Rehabil Hosp, Dept Phys Therapy, Atsugi, Kanagawa 2430121, Japan; [Morita, T.; Yamada, T.] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Phys Therapy, Arakawa, Japan; [Watanabe, T.] Kanagawa Rehabil Hosp, Dept Orthoped, Atsugi, Kanagawa 2430121, Japan; [Nagahori, E.] Kanagawa Rehabil Hosp, Dept Nursing, Atsugi, Kanagawa 2430121, Japan	Morita, T (reprint author), Kanagawa Rehabil Hosp, Dept Phys Therapy, 516 Nanasawa, Atsugi, Kanagawa 2430121, Japan.	moritatomoyuki170@gmail.com					Brienza DM, 2001, ARCH PHYS MED REHAB, V82, P529, DOI 10.1053/apmr.2001.21854; van Loo MA, 2010, SPINAL CORD, V48, P423, DOI 10.1038/sc.2009.142; Crawford SA, 2005, CLIN REHABIL, V19, P224, DOI 10.1191/0269215505cr826oa; Sumiya T, 1997, SPINAL CORD, V35, P595, DOI 10.1038/sj.sc.3100467; Garber SL, 2003, J REHABIL RES DEV, V40, P433; Krause JS, 2004, ARCH PHYS MED REHAB, V85, P1257, DOI 10.1016/j.apmr.2003.08.108; Oomens CWJ, 2010, J TISSUE VIABILITY, V19, P35, DOI 10.1016/j.jtv.2009.11.002; Biglari B, 2014, SPINAL CORD, V52, P80, DOI 10.1038/sc.2013.130; Consortium for Spinal Cord Medicine Clinical Practice Guideline, 2002, PROT AR ARCT CONS FU, P15; European Pressure Ulcer Advisory Panel and National Pressure Ulcer Advisory Panel, 2009, TE SAT 2009 EU TERRO, P19; Gelis A, 2009, SPINAL CORD, V47, P651, DOI 10.1038/sc.2009.32; Guihan M, 2009, J SPINAL CORD MED, V32, P560; Guihan M, 2008, J SPINAL CORD MED, V31, P551; Mathew A, 2013, SPINAL CORD, V51, P150, DOI 10.1038/sc.2012.112; Mortenson WB, 2008, SPINAL CORD, V46, P168, DOI 10.1038/sj.sc.3102129; Royal College of Nursing, 2007, CLIN PRACT GUID PRES, P18; The Japanese Society of Pressure Ulcers Guideline Revision Committee, 2014, JPN J PU, V16, P12; Urasaki Masaya, 2011, Disabil Rehabil Assist Technol, V6, P38, DOI 10.3109/17483107.2010.512968; Yang YS, 2009, SPINAL CORD, V47, P67, DOI 10.1038/sc.2008.72	19	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	JUN	2015	53	6					476	481		10.1038/sc.2015.18		6	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CK1DP	WOS:000355946300012		
J	Matsumoto, A; Szidarovszky, F				Matsumoto, Akio; Szidarovszky, Ferenc			Nonlinear multiplier-accelerator model with investment and consumption delays	STRUCTURAL CHANGE AND ECONOMIC DYNAMICS			English	Article						Nonlinear multiplier accelerator model; Business cycle; Investment delay; Consumption delay; Stability switch	BUSINESS CYCLES; CAPITAL STOCK; TRADE CYCLE; FLOOR	This paper shows how cyclic dynamics of national income can emerge in the multiplier accelerator model with continuous time scale when delays in investment and consumption are present. An S-shaped functional form of investment and a linear consumption function are adopted to illustrate the phenomenon and to compute the stability-switching curves on which a stability gain or loss occurs. Assuming that the equilibrium national income is locally stable if there are no delays, it is demonstrated that one delay is harmless and with two delays, the system can produce limit cycles and the stability switch repeatedly occurs when one of the delays increases and the other is kept to be positive constant. (C) 2015 Elsevier B.V. All rights reserved.	[Matsumoto, Akio] Chuo Univ, Dept Econ, Int Ctr Further Dev Dynam Econ Res, Hachioji, Tokyo 1920393, Japan; [Szidarovszky, Ferenc] Univ Pecs, Dept Appl Math, H-7624 Pecs, Hungary	Matsumoto, A (reprint author), Chuo Univ, Dept Econ, Int Ctr Further Dev Dynam Econ Res, 742-1 Higashi Nakano, Hachioji, Tokyo 1920393, Japan.	akiom@tamacc.chuo-u.ac.jp; szidarka@gmail.com			MEXT-Supported Program for the Strategic Research Foundation at Private Universities; Japan Society for the Promotion of Science [24530202, 25380238, 26380316]	The authors are grateful to constructive suggestions and comments by two reviewers. They highly appreciate the financial supports from the MEXT-Supported Program for the Strategic Research Foundation at Private Universities 2013-207, the Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research (C) 24530202, 25380238 and 26380316).	Kalecki M, 1935, ECONOMETRICA, V3, P327, DOI 10.2307/1905325; Goodwin RM, 1951, ECONOMETRICA, V19, P1, DOI 10.2307/1907905; Gu KQ, 2005, J MATH ANAL APPL, V311, P231, DOI 10.1016/j.jmaa.2005.02.034; Phillips AW, 1954, ECON J, V64, P290, DOI 10.2307/2226835; Kaldor N, 1940, ECON J, V50, P78, DOI 10.2307/2225740; Gandolfo G, 2009, ECONOMIC DYNAMICS, FOURTH EDITION, P1, DOI 10.1007/978-3-642-03871-6; Hicks J., 1950, CONTRIBUTION THEORY; Hommes C.H., 1995, STRUCTURAL CHANGE EC, V6, P435, DOI 10.1016/0954-349X(95)00032-I; Lines M., 2006, BUSINESS CYCLE DYNAM, P255, DOI 10.1007/3-540-32168-3_10; Matsumoto A, 2009, J ECON DYN CONTROL, V33, P832, DOI 10.1016/j.jedc.2008.08.013; Matsumoto A., 2014, 220 IERCU DP; Matsumoto A, 2010, J ECON BEHAV ORGAN, V75, P95, DOI 10.1016/j.jebo.2010.03.010; Matsumoto A., MATH PANNON IN PRESS; Puu T., 2000, ATTRACTORS BIFURCATI; Puu T, 2007, J ECON DYN CONTROL, V31, P575, DOI 10.1016/j.jedc.2005.12.004; Puu T, 2005, J ECON BEHAV ORGAN, V56, P331, DOI 10.1016/j.jebo.2003.10.008; Samuelson PA, 1939, REV ECON STATISTICS, V21, P75, DOI 10.2307/1927758; Sushko I, 2010, J ECON BEHAV ORGAN, V75, P77, DOI 10.1016/j.jebo.2010.01.007; Westerhoff FH, 2006, APPL ECON LETT, V13, P89, DOI 10.1080/13504850500390663	19	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0954-349X			STRUCT CHANGE ECON D	Struct. Change and Econ. Dyn.	JUN	2015	33						1	9		10.1016/j.strueco.2015.01.003		9	Economics	Business & Economics	CK0HP	WOS:000355886600001		
J	Osaki, T; Sugiyama, D; Magari, Y; Souri, M; Ichinose, A				Osaki, Tsukasa; Sugiyama, Daisuke; Magari, Yasuo; Souri, Masayoshi; Ichinose, Akitada			Rapid immunochromatographic test for detection of anti-factor XIII A subunit antibodies can diagnose 90 % of cases with autoimmune haemorrhaphilia XIII/13	THROMBOSIS AND HAEMOSTASIS			English	Article						Acquired coagulation disorders; autoantibodies; autoimmune diseases; factor XIII / transglutaminases; diagnosis management	DEEP-VEIN THROMBOSIS; PLASMA FACTOR-XIII; SIMPLIFY D-DIMER; B-SUBUNIT; DEFICIENCY; HEMORRHAPHILIA; CLASSIFICATION; DISSOCIATION; ASSAY	Autoimmune haemorrhaphilia XIII/13 (AH13) is an acquired life-threatening bleeding disorder due to anti-factor XIII (FXIII) autoantibodies (auto-Abs). AH13 patients may die of haemorrhage without correct diagnosis and proper treatment because of lack of awareness and the absence of rapid easy-to-use tests specific for this disease. Currently, the definitive diagnosis is established by cumbersome and time-consuming laboratory tests such as dot-blot assays and enzyme-linked immunosorbent assays (ELISA), and therefore these tests are generally not carried out. To save AH13 patients' lives, there is an urgent necessity for developing a rapid test for FXIII auto-Abs. We first generated and characterised mouse monoclonal antibodies (mAb) against human FXIII A subunit (FXIII-A), and then developed a rapid immunochromatographic test (ICT) for detection of anti-FXIII-A auto, Abs using one mAb with a dissociation constant of 9.3 x 10(-11) M. The auto-Ab-FXIII-A complex was captured by the mAb on a nitrocellulose membrane and visualised by Au-conjugated anti-human IgG Ab. Mixing with healthy control plasma improved the detection of auto-Abs in patients having extremely low levels of FXIII-A. The specificity and sensitivity of the ICT were 87% and 94%, respectively. We also detected auto-Abs against activated FXIII (FXIIIa) in three patients by pre-converting FXIII to FXIIIa by thrombin treatment. ICT values were significantly inversely correlated with FXIII activity levels, indicating an association between the quantity of anti-FXIII autoantibodies and AH13. This reliable rapid ICT assay can be applied to a point-of-care test to detect anti-FXIII-A auto-Abs, and will contribute to early diagnosis and treatment of AH13.	[Osaki, Tsukasa; Souri, Masayoshi; Ichinose, Akitada] Yamagata Univ, Fac Med, Dept Mol Pathobiochem & Pathobiol, Yamagata 9909585, Japan; [Sugiyama, Daisuke; Magari, Yasuo] Qmay Lab Corp, Oita, Japan	Ichinose, A (reprint author), Yamagata Univ, Sch Med, Dept Mol Pathobiochem & Pathobiol, 2-2-2 Iida Nishi, Yamagata 9909585, Japan.	aichinos@med.id.yamagata-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology; Japanese Ministry of Health, Labor, and Welfare	We would like to thank all members of Japanese Collaborative Research Group on AH13 for their cooperation in conducting a nationwide survey on AH13 from the Japanese business year 2009 through 2013, Ms. Keiko Ninomiya for her assistance in experiments, Dr. Arijit Biswas for his valuable advice, and Ms. Yuriko Shibue for her help in preparation of this manuscript. This study was supported in part by research grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, and the Japanese Ministry of Health, Labor, and Welfare, and was presented in part at the 35th Annual Meeting of The Japanese Society on Thrombosis and Hemostasis in Yamagata, in June 2013.	Komaromi I, 2011, J THROMB HAEMOST, V9, P9, DOI 10.1111/j.1538-7836.2010.04070.x; Handali S, 2010, CLIN VACCINE IMMUNOL, V17, P631, DOI 10.1128/CVI.00511-09; Ichinose A, 2012, INT J HEMATOL, V95, P362, DOI 10.1007/s12185-012-1064-3; Schroeder V, 2013, SEMIN THROMB HEMOST, V39, P632, DOI 10.1055/s-0033-1353392; Ichinose A, 2011, THROMB HAEMOSTASIS, V105, P925, DOI 10.1160/TH10-11-0724; Wada H, 2013, THROMB HAEMOSTASIS, V109, P661, DOI 10.1160/TH12-12-0936; Sugiyama H, 2013, BLOOD COAGUL FIBRIN, V24, P85, DOI 10.1097/MBC.0b013e328358e8e7; Warrener L, 2010, J MED VIROL, V82, P485, DOI 10.1002/jmv.21693; Ajzner E, 2009, BLOOD, V113, P723, DOI 10.1182/blood-2008-09-179333; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Ichinose A, 2012, INT J HEMATOL, V95, P47, DOI 10.1007/s12185-011-0992-7; Kohler HP, 2011, J THROMB HAEMOST, V9, P1404, DOI 10.1111/j.1538-7836.2011.04315.x; Ichinose A, 2011, SEMIN THROMB HEMOST, V37, P382, DOI 10.1055/s-0031-1276587; Cini M, 2003, J THROMB HAEMOST, V1, P2681, DOI 10.1111/j.1538-7836.2003.0543d.x; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Egbring Rudolf, 1996, Seminars in Thrombosis and Hemostasis, V22, P419, DOI 10.1055/s-2007-999041; Green D, 1994, ANTICOAGULANTS PHYSL, P169; HOYLAERTS MF, 1990, J IMMUNOL METHODS, V126, P253, DOI 10.1016/0022-1759(90)90158-R; Lorand L, 1980, Prog Hemost Thromb, V5, P245; Lorand L., 1977, HAEMOSTASIS BIOCH PH, P405; Lorand L, 1999, BLOOD, V93, P909; LUKACOVA D, 1991, BIOCHEMISTRY-US, V30, P10164, DOI 10.1021/bi00106a013; Nagaraj N, 2012, MOL CELL PROTEOMICS, V11, P1; Neale D, 2004, EMERG MED J, V21, P663, DOI 10.1136/emj.2003.011049; Souri M, 2008, BIOCHEMISTRY-US, V47, P8656, DOI 10.1021/bi8006143; Souri M, 2014, HAEMOPHILIA, V20, P255, DOI 10.1111/hae.12298; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615	27	0	0	SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN	STUTTGART	HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY	0340-6245			THROMB HAEMOSTASIS	Thromb. Haemost.	JUN	2015	113	6					1347	1356		10.1160/TH14-09-0745		10	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CJ8TM	WOS:000355776400024		
J	Uchinaka, A; Hamada, Y; Mori, S; Miyagawa, S; Saito, A; Sawa, Y; Matsuura, N; Kawaguchi, N				Uchinaka, Ayako; Hamada, Yoshinosuke; Mori, Seiji; Miyagawa, Shigeru; Saito, Atsuhiro; Sawa, Yoshiki; Matsuura, Nariaki; Kawaguchi, Naomasa			Cardioprotective Effects on Ischemic Myocardium Induced by SVVYGLR Peptide via Its Angiogenic-Promoting Activity	TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						Peptides; Myocardial ischemia; Angiogenesis; Remodeling; Osteopontin	HEPATOCYTE GROWTH-FACTOR; MICE LACKING OSTEOPONTIN; CARDIAC-FUNCTION; CELL-SURVIVAL; GENE-TRANSFER; III REPEAT; IN-VIVO; G-CSF; INFARCTION; INTEGRINS	In ischemic heart disease, cardiomyocyte death results from both necrosis and apoptosis, and the area of infarction gradually increases. The induction of therapeutic angiogenesis is a promising therapy for this condition. In the present study, we investigated the actions of SV peptide-a 7-amino-acid sequence with angiogenic properties derived from osteopontin in the extracellular matrix-in a rat model of myocardial ischemia. We examined the angiogenesis activity of SV ex vivo using ring assay and dorsal air sac assay and in ischemic myocardium. We also conducted histological evaluations of left-ventricle remodeling and evaluated left ventricular (LV) function by echocardiography. The SV peptide had strong angiogenic effects both ex vivo and in vivo. In the experimental rats, this peptide stimulated the formation of new blood vessels in ischemic myocardium. Histological evaluation of the left ventricle in the SV-treated group showed a significant decrease in the size of the infarction, rate of myocardial fibrosis, and cardiomyocyte hypertrophy. Moreover, administration of the SV peptide significantly improved LV function. These results indicate that SV peptide induced angiogenesis in ischemic myocardium and improved cardiac function. Thus, it could serve as a potentially useful new therapy for ischemic heart disease.	[Uchinaka, Ayako; Kawaguchi, Naomasa] Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Cardiovasc Pathol, Suita, Osaka 5650871, Japan; [Uchinaka, Ayako; Hamada, Yoshinosuke; Mori, Seiji; Matsuura, Nariaki] Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Mol Pathol, Suita, Osaka 5650871, Japan; [Hamada, Yoshinosuke] Osaka Dent Univ, Dept Pediat Dent, Hirakata, Osaka, Japan; [Miyagawa, Shigeru; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 5650871, Japan; [Saito, Atsuhiro] Osaka Univ, Grad Sch Med, Osaka Univ Hosp, Med Ctr Translat Res, Suita, Osaka 5650871, Japan	Kawaguchi, N (reprint author), Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Cardiovasc Pathol, 1-7 Yamada Oka, Suita, Osaka 5650871, Japan.	kawaguch@sahs.med.osaka-u.ac.jp					Iwanaga K, 2004, BIOCHEM BIOPH RES CO, V325, P1353, DOI 10.1016/j.bbrc.2004.10.149; Haider HK, 2008, CIRC RES, V103, P1300, DOI 10.1161/CIRCRESAHA.108.186742; Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Uchinaka A, 2013, CARDIOVASC RES, V99, P102, DOI 10.1093/cvr/cvt088; Ueda H, 2001, CARDIOVASC RES, V51, P41, DOI 10.1016/S0008-6363(01)00272-3; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Ross RS, 2002, J CARD FAIL, V8, pS326, DOI 10.1054/jcaf.2002.129263; Ross RS, 2001, CIRC RES, V88, P1112, DOI 10.1161/hh1101.091862; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Hamada Y, 2004, DENT MATER J, V23, P650; Krishnamurthy P, 2009, MOL CELL BIOCHEM, V322, P53, DOI 10.1007/s11010-008-9939-6; Trueblood NA, 2001, CIRC RES, V88, P1080, DOI 10.1161/hh1001.090842; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kim JH, 2011, BIOMATERIALS, V32, P6080, DOI 10.1016/j.biomaterials.2011.05.003; Hamada Y, 2003, BIOCHEM BIOPH RES CO, V310, P153, DOI 10.1016/j.bbrc.2003.09.001; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061; Aoki M, 2000, GENE THER, V7, P417, DOI 10.1038/sj.gt.3301104; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Chen XH, 2007, J CARD FAIL, V13, P874, DOI 10.1016/j.cardfail.2007.07.004; Denhardt DT, 1998, J CELL BIOCHEM, P92; Ghostine S, 2002, CIRCULATION S1, V106, pI131; Jayasankar Vasant, 2003, Circulation, V108 Suppl 1, pII230, DOI 10.1161/01.cir.0000087444.53354.66; Kunugiza Y, 2006, GENE THER, V13, P1143, DOI 10.1038/sj.gt.3302767; Li YW, 2003, CIRCULATION, V107, P2499, DOI 10.1161/01.CIR.0000065579.19126.B8; Mehrabi MR, 2003, PATHOL RES PRACT, V199, P129, DOI 10.1078/0344-0338-00365; Miyagawa S, 2006, TRANSPLANTATION, V81, P902, DOI 10.1097/01.tp.0000202843.86864.10; Mori S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057927; Takano H, 2006, J MOL MED-JMM, V84, P185, DOI 10.1007/s00109-005-0035-z; TANIYAMA Y, 2002, PERTENSION, V40, P47; Tomita S, 1999, Circulation, V100, pII247; Wai PY, 2004, J SURG RES, V121, P228, DOI 10.1016/j.jss.2004.03.028; Yokosaki Y, 2005, MATRIX BIOL, V24, P418, DOI 10.1016/j.matbio.2005.05.005; YOKOSAKI Y, 1994, J BIOL CHEM, V269, P26691; Yokosaki Y, 1998, J BIOL CHEM, V273, P11423, DOI 10.1074/jbc.273.19.11423; Yoo KJ, 2000, ANN THORAC SURG, V70, P859, DOI 10.1016/S0003-4975(00)01630-1	39	0	0	KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC	JONGRO-GU	199-1, DONGSUNG-DONG,, JONGRO-GU, SEOUL 110-810, SOUTH KOREA	1738-2696			TISSUE ENG REGEN MED	Tissue Eng. Regen. Med.	JUN	2015	12	3					162	171		10.1007/s13770-015-0087-2		10	Cell & Tissue Engineering; Engineering, Biomedical	Cell Biology; Engineering	CK6KA	WOS:000356335800003		
J	Sun, XH; Yamamoto, T; Morikawa, T				Sun, Xiao-Hui; Yamamoto, Toshiyuki; Morikawa, Takayuki			Charge timing choice behavior of battery electric vehicle users	TRANSPORTATION RESEARCH PART D-TRANSPORT AND ENVIRONMENT			English	Article						Battery electric vehicle; Charge timing; Choice behavior; Normal charging; Mixed logit model; Unobserved heterogeneity	LOGIT; COST	This paper aims to examine choice behavior in respect of the time at which battery electric vehicle users charge their vehicles. The focus is on normal charging after the last trip of the day, and the alternatives presented are no charging, charging immediately after arrival, nighttime charging, and charging at other times. A mixed logit model with unobserved heterogeneity is applied to panel data extracted from a two-year field trial on battery electric vehicle usage in Japan. Estimation results, obtained using separate models for commercial and private vehicles, suggest that state of charge, interval in days before the next travel day, and vehicle-kilometers to be traveled on the next travel day are the main predictors for whether a user charges the vehicle or not, that the experience of fast charging negatively affects normal charging, and that users tend to charge during the nighttime in the latter half of the trial. On the other hand, the probability of normal charging after the last trip of a working day is increased for commercial vehicles, while is decreased for private vehicles. Commercial vehicles tend not to be charged when they arrival during the nighttime, while private vehicles tend to be charged immediately. Further, the correlations of nighttime charging with charging immediately and charging at other times reveal that it may be possible to encourage charging during off-peak hours to lessen the load on the electricity grid. This finding is supported by the high variance for the alternative of nighttime charging. (C) 2015 Elsevier Ltd. All rights reserved.	[Sun, Xiao-Hui] Nagoya Univ, Dept Civil Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Yamamoto, Toshiyuki] Nagoya Univ, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Morikawa, Takayuki] Nagoya Univ, Inst Innovat Future Soc, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Sun, XH (reprint author), Nagoya Univ, Dept Civil Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	xhsun347@gmail.com; yamamoto@civil.nagoya-u.ac.jp; morikawa@nagoya-u.jp	Yamamoto, Toshiyuki/F-3814-2012	Yamamoto, Toshiyuki/0000-0002-7540-5040	Ministry of Economy, Trade and Industry (METI); Ministry of Education, Culture, Sports, Science and Technology, Japan [25289164]; Japan Society for the Promotion of Science	This is a part of the results obtained by the Project of Consigning Technology Development for Rational Use of Energy (Promotion of aggregation and sharing of probe information) supported by the Ministry of Economy, Trade and Industry (METI). Additional thanks are due to Japan Automobile Research Institute (JARI) for providing the dataset used in this study. This study was also supported by Grant-in-Aid for Scientific Research (No. 25289164) from the Ministry of Education, Culture, Sports, Science and Technology, Japan and the Japan Society for the Promotion of Science. The authors also would like to thank the anonymous reviewers for their valuable comments and suggestions to improve the quality of this paper.	Acha S., 2010, TRANSM DISTR C EXP 2, P1; [Anonymous], 2010, J1772 SAE; Eaves S, 2004, J POWER SOURCES, V130, P208, DOI 10.1016/j.jpowsour.2003.12.016; Campanari S, 2009, J POWER SOURCES, V186, P464, DOI 10.1016/j.jpowsour.2008.09.115; Revelt D, 1998, REV ECON STAT, V80, P647, DOI 10.1162/003465398557735; Delucchi MA, 2001, TRANSPORT RES D-TR E, V6, P371, DOI 10.1016/S1361-9209(00)00031-6; Funk K, 1999, TRANSPORT RES D-TR E, V4, P397, DOI 10.1016/S1361-9209(99)00018-8; van Vliet O, 2011, J POWER SOURCES, V196, P2298, DOI 10.1016/j.jpowsour.2010.09.119; Axsen J, 2010, TRANSPORT RES D-TR E, V15, P212, DOI 10.1016/j.trd.2010.02.004; Ben-Akiva M. E., 1996, WORKING PAPER; Bhat CR, 2001, TRANSPORT RES B-METH, V35, P677, DOI 10.1016/S0191-2615(00)00014-X; Clement K., 2009, IEEE PES POW SYST C, P1; Dingemans D., 1986, TRANSPORT RES REC, V1096, P1; Elgowainy A, 2012, TRANSPORT RES REC, P9, DOI 10.3141/2287-02; Geweke J., 1995, 192 FED RES BANK MIN; Green li RC, 2011, RENEW SUST ENERG REV, V15, P544; Hadley S. W., 2006, ORNLTM2006554; Halton J. H., 1960, NUMER MATH, V2, P84, DOI DOI 10.1007/BF01386213; Jabeen F., 2013, AUSTR TRANSP RES FOR; Revelt D., 2000, CUSTOMER SPECIFIC TA; Shao S., 2009, P IEEE POW EN SOC GE, P1; Sun XH, 2015, TRANSPORT RES D-TR E, V34, P83, DOI 10.1016/j.trd.2014.10.006; Train K., 2000, HALTON SEQUENCES MIX; Train K., 2003, DISCRETE CHOICE METH; Venayagamoorthy G. K., 2009, IEEE ECCE JUN, V226, P3937; Zoepf S, 2013, TRANSPORT RES REC, P1, DOI 10.3141/2385-01	26	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1361-9209			TRANSPORT RES D-TR E	Transport. Res. Part D-Transport. Environ.	JUN	2015	37						97	107		10.1016/j.trd.2015.04.007		11	Environmental Studies; Transportation; Transportation Science & Technology	Environmental Sciences & Ecology; Transportation	CK4NO	WOS:000356200700008		
J	Kitamura, K; Matsui, T; Kobayashi, M; Saitou, H; Namikawa, K; Tsuda, Y				Kitamura, Keiko; Matsui, Tetsuya; Kobayashi, Makoto; Saitou, Hitoshi; Namikawa, Kanji; Tsuda, Yoshiaki			Decline in gene diversity and strong genetic drift in the northward-expanding marginal populations of Fagus crenata	TREE GENETICS & GENOMES			English	Article						Northward expansion; Fagaceae; STRUCTURE analysis; Marginal process; Colonization history; Population genetics	MULTILOCUS GENOTYPE DATA; ALLELE FREQUENCY DATA; MICROSATELLITE MARKERS; CHLOROPLAST DNA; EUROPEAN BEECH; NORTHERN JAPAN; CLIMATE-CHANGE; F-STATISTICS; POSTGLACIAL COLONIZATION; INTRASPECIFIC VARIATION	The species distribution of Fagus crenata, or Japanese beech, in the Japanese archipelago shifted northward during phytogeographical changes that occurred during the Pleistocene and Holocene epochs. Presently, the continuous natural distribution of beech reaches north to the Kuromatsunai-Depression of Hokkaido Island, Japan. In addition, dozens of marginal patches and isolated individuals north of the continuous distribution have been observed. F. crenata grows remarkably well among these small-scattered northern marginal populations, which must have originated from seeds dispersed beyond the northern limit of the continuous beech forest. It is conceivable that the distribution of F. crenata is still in the process of expanding northward. We investigated the genetic structure of 33 beech populations to evaluate the population gene diversity at the leading northern edge of the range expansion. We analyzed 12 nuclear microsatellite loci in each of the 1,693 individuals. Genetic diversity parameters such as expected heterozygosity and allelic richness were clearly lower in the northernmost populations. We found genetic differentiation in the northernmost distribution range (F-ST=0.045, G(ST)'=0.242). STRU CTURE analysis revealed that the southwestern continuous populations consisted of homogeneous ancestral clusters. However, northeastern marginal populations consisted of mixtures of highly differentiated clusters with higher levels of genetic drift than found in the continuous populations.	[Kitamura, Keiko; Matsui, Tetsuya] Hokkaido Res Ctr, Forestry & Forest Prod Res Inst, Toyohira Ku, Sapporo, Hokkaido 0628516, Japan; [Kobayashi, Makoto] Echigo Matsunoyama Museum Nat Sci, Tokamachi, Niigata 9421411, Japan; [Saitou, Hitoshi] Kuromatsunai Beech Tree Museum, Kuromatsunai, Hokkaido 0480101, Japan; [Namikawa, Kanji] Hokkaido Univ, Biol Lab, Kita Ku, Sapporo, Hokkaido 0028502, Japan; [Tsuda, Yoshiaki] Uppsala Univ, Dept Plant Ecol & Evolut, Evolutionary Biol Ctr, Uppsala, Sweden; [Matsui, Tetsuya] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan	Kitamura, K (reprint author), Hokkaido Res Ctr, Forestry & Forest Prod Res Inst, Toyohira Ku, 7 Hitsujigaoka, Sapporo, Hokkaido 0628516, Japan.	kitamq@ffpri.affrc.go.jp			Japan Society for the Promotion of Science [21580189, 23370006]; Sumitomo Foundation [083216]; Kuromatsunai Municipality [14]; Global Environmental Research of Japan from the Ministry of the Environment [S-8]	This study was supported by Grants-in-Aid for Scientific Research (21580189, 23370006) from the Japan Society for the Promotion of Science, a Grant for Environmental Research Projects from the Sumitomo Foundation (083216), a Grant for Natural Science Research from the Kuromatsunai Municipality (No. 14, 2010), and Global Environmental Research of Japan (S-8) from the Ministry of the Environment. The authors declare that they have no conflict of interest.	Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; Cornuet JM, 1996, GENETICS, V144, P2001; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; McLachlan JS, 2005, ECOLOGY, V86, P2088, DOI 10.1890/04-1036; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Liepelt S, 2009, REV PALAEOBOT PALYNO, V153, P139, DOI 10.1016/j.revpalbo.2008.07.007; Pritchard JK, 2000, GENETICS, V155, P945; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Tomaru N, 1997, HEREDITY, V78, P241; Cheddadi R, 2006, GLOBAL ECOL BIOGEOGR, V15, P271, DOI [10.1111/j.1466-822x.2006.00226.x, 10.1111/j.1466-822X.2006.00226.x]; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; KONNERT M, 1995, PLANT SYST EVOL, V196, P19, DOI 10.1007/BF00985333; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Tanaka K, 1999, THEOR APPL GENET, V99, P11, DOI 10.1007/s001220051203; CWYNAR LC, 1987, AM NAT, V129, P463, DOI 10.1086/284651; HUSBAND BC, 1992, EVOLUTION, V46, P1875, DOI 10.2307/2410037; Pastorelli R, 2003, MOL ECOL NOTES, V3, P76, DOI 10.1046/j.1471-8286.2003.00355.x; Petit RJ, 2004, FOREST ECOL MANAG, V197, P117, DOI 10.1016/j.foreco.2004.05.009; Newton AC, 1999, TRENDS ECOL EVOL, V14, P140, DOI 10.1016/S0169-5347(98)01555-9; Magri D, 2008, J BIOGEOGR, V35, P450, DOI 10.1111/j.1365-2699.2007.01803.x; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Petit RJ, 2002, FOREST ECOL MANAG, V156, P49, DOI 10.1016/S0378-1127(01)00634-X; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Rousset F, 1997, GENETICS, V145, P1219; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hiraoka K, 2009, J PLANT RES, V122, P269, DOI 10.1007/s10265-009-0217-9; Fujii N, 2002, PLANT SYST EVOL, V232, P21, DOI 10.1007/s006060200024; Matsui T, 2004, J VEG SCI, V15, P605, DOI 10.1658/1100-9233(2004)015[0605:PDVASI]2.0.CO;2; Comps B, 2001, GENETICS, V157, P389; Okaura T, 2002, HEREDITY, V88, P322, DOI 10.1038/sj/hdy/6800048; Falush D, 2003, GENETICS, V164, P1567; Asuka Y, 2004, MOL ECOL NOTES, V4, P101, DOI 10.1046/j.1471-8286.2003.00583.x; Barrett S. C. H., 1990, Plant population genetics, breeding, and genetic resources., P254; Barrett SCH, 2008, TRENDS ECOL EVOL, V23, P38; Furuhata Y, 1932, HOKKAIDO RINGYO KAIH, V358, P17; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hagiwara S, 1988, MEM NATL SCI MUS, V21, P99; Hara M, 1996, BUNARIN NO SHIZENSHI; Honda S, 1900, DAI NIPPON SANRIN KA, V205, P4; Honda S, 1900, DAI NIPPON SANRIN KA, V207, P1; Honda S, 1900, DAI NIPPON SANRIN KA, V206, P7; Igarashi Y, 1994, TREE BREED HOKKAIDO, V37, P1; Kaji M, 1999, T MEET HOKKAIDO BR J, V47, P54; Kawano Shoichi, 1997, Plant Species Biology, V12, P157, DOI 10.1111/j.1442-1984.1997.tb00164.x; Kira T, 1977, VEGETATION SCI ENV P, P21; Kitabatake T, 2001, J FOR RES, V6, P111, DOI 10.1007/BF02762496; Kitamura K, 2001, J PLANT RES, V114, P353, DOI 10.1007/PL00013997; Kitamura K, 2007, J FOREST RES-JPN, V12, P467, DOI 10.1007/s10310-007-0026-8; Kito N, 2012, QUATERN INT, V254, P118, DOI 10.1016/j.quaint.2011.06.050; Kobayashi M, 2003, B GEOENVIRO SCI, V5, P1; Kobayashi M, 2009, THESIS HOKKAIDO U; Kobayashi Makoto, 2009, Bulletin of the Forestry and Forest Products Research Institute, V8, P143; Kobayashi M, 2013, SILVAE GENET, V62, P1; Koike T, 1998, BOT ACTA, V111, P87; Langella O, 2007, POPULATIONS 1 2 3 0; McLachlan JS, 2004, FOR ECOL MANAG, V197, P39; Miguchi Hideo, 1996, Japanese Journal of Ecology (Sendai), V46, P185; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Miyawaki A, 1967, NIHON NO SHOKUSEI; Mizunaga H, 2005, J FOR RES-JPN, V10, P481, DOI 10.1007/s10310-005-0165-8; Mousadik EA, 1996, THEOR APPL GENET, V92, P832; Namikawa K, 2010, PLANT ECOL, V207, P161, DOI 10.1007/s11258-009-9662-8; Nanbu K, 1927, HOKKAIDO RINGYO KAIH, V292, P232; Nei M., 1987, MOL EVOLUTIONARY GEN; OHMORI H, 1988, Quaternary Research (Tokyo), V27, P81; Ohwi J, 1965, NIHON SHOKUBUTSUSHI; Peakall R, 2006, MOL ECOL NOTES, V6, P288; Peters R, 1997, BEECH FORESTS; Sakaguchi Y, 1989, B DEP GEOGRAPHY U TO, V21, P1; SASAKI Y, 1970, Vegetatio, V20, P214, DOI 10.1007/BF01965535; Suzuki T, 1966, JPN J FOR ENV, V8, P1; Suzuki W, 2005, FOREST ECOL MANAG, V205, P105, DOI 10.1016/j.foreco.2004.10.050; TAKAHASHI M, 1994, CAN J FOREST RES, V24, P1071, DOI 10.1139/x94-141; Takahashi M, 2002, SILVAE GENET, V51, P219; Tanaka J, 1900, SANRIN, V209, P11; Tatewaki M, 1948, ECOL REV, V11, P46; Terazawa K, 1995, J JPN FOREST SOC, V77, P137; Tomaru N, 1998, AM J BOT, V85, P629, DOI 10.2307/2446531; TSUKADA M, 1982, Japanese Journal of Ecology, V32, P113; TSUKADA M, 1982, BOT MAG TOKYO, V95, P203, DOI 10.1007/BF02488586; Watanabe S, 1988, MEM NATL SCI MUS, V21, P87; Watanabe S, 1987, HOKUGEN NO BUNARIN; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.2307/2408641; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; Yagihashi T, 2007, PLANT SPEC BIOL, V22, P217, DOI 10.1111/j.1442-1984.2007.00196.x; Yagihashi Tsutomu, 2003, Japanese Journal of Ecology (Otsu), V53, P85; Yasuda Y, 1998, NIHONRETTO SHOKUSEIS	93	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1614-2942	1614-2950		TREE GENET GENOMES	Tree Genet. Genomes	JUN	2015	11	3							36	10.1007/s11295-015-0857-y		12	Forestry; Genetics & Heredity; Horticulture	Forestry; Genetics & Heredity; Agriculture	CJ7UH	WOS:000355704700004		
J	Moriya, S; Iwanami, H; Haji, T; Okada, K; Yamada, M; Yamamoto, T; Abe, K				Moriya, Shigeki; Iwanami, Hiroshi; Haji, Takashi; Okada, Kazuma; Yamada, Masahiko; Yamamoto, Toshiya; Abe, Kazuyuki			Identification and genetic characterization of a quantitative trait locus for adventitious rooting from apple hardwood cuttings	TREE GENETICS & GENOMES			English	Article						Broad-sense heritability; Candidate gene; JM rootstock; Malus; QTL analysis	X-DOMESTICA BORKH.; VEGETATIVE PROPAGATION; GENOME; AUXIN; ROOTSTOCKS; MARKERS; ARABIDOPSIS; RESISTANCE; ACID; IBR5	Vegetative propagation enables the multiplication of plants that are genetically identical to the original. Hardwood cuttings have a low cost advantage and are used widely for the propagation of JM series apple rootstocks, which root well from hardwood cuttings. To breed new apple rootstocks with similarly high rooting capabilities, the development of a marker-assisted selection method is desirable. Therefore, it is important to understand the genetic mechanisms behind the rooting capabilities of hardwood cuttings. We identified quantitative trait loci (QTLs) for the rooting capability of 'JM7' using a QTL analysis with phenotypic data obtained under two environmental conditions. The QTLs for rooting rate and root quantity co-located. The QTL for rooting rate explained 66 % of the genetic variance and 57 % of the phenotypic variance. Graphical genotyping and database searching revealed candidate genes, including three related to auxin response, one related to ethylene response, and a gene encoding a WRKY transcription factor.	[Moriya, Shigeki; Iwanami, Hiroshi; Haji, Takashi; Okada, Kazuma; Abe, Kazuyuki] NARO Inst Fruit Tree Sci, Apple Res Stn, Morioka, Iwate 0200123, Japan; [Yamada, Masahiko; Yamamoto, Toshiya] NARO Inst Fruit Tree Sci, Tsukuba, Ibaraki 3058605, Japan	Moriya, S (reprint author), NARO Inst Fruit Tree Sci, Apple Res Stn, Morioka, Iwate 0200123, Japan.	moriyas@affrc.go.jp			National Agriculture and Food Research Organization [211]	This work was supported by the National Agriculture and Food Research Organization Research Project No. 211, "Establishment of an Integrated Basis for Development and Application of Advanced Tools for DNA Marker-Assisted Selection in Horticultural Crops."	Li TY, 2012, PLANT MOL BIOL REP, V30, P1408, DOI 10.1007/s11105-012-0457-z; Licausi F, 2013, NEW PHYTOL, V199, P639, DOI 10.1111/nph.12291; Celton JM, 2009, TREE GENET GENOMES, V5, P93, DOI 10.1007/s11295-008-0171-z; Monroe-Augustus M, 2003, PLANT CELL, V15, P2979, DOI 10.1105/tpc.017046; Moriya S, 2012, PLANT BREEDING, V131, P641, DOI 10.1111/j.1439-0523.2012.01985.x; Legue V, 2014, PHYSIOL PLANTARUM, V151, P192, DOI 10.1111/ppl.12197; Bus VGM, 2008, TREE GENET GENOMES, V4, P223, DOI 10.1007/s11295-007-0103-3; Liebhard R, 2002, MOL BREEDING, V10, P217, DOI 10.1023/A:1020525906332; Pacurar DI, 2014, PHYSIOL PLANTARUM, V151, P83, DOI 10.1111/ppl.12171; Lee JS, 2009, PLANT J, V57, P975, DOI 10.1111/j.1365-313X.2008.03741.x; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; van Dyk MM, 2010, TREE GENET GENOMES, V6, P489, DOI 10.1007/s11295-009-0266-1; Antanaviciute L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-203; Arakawa O, 2006, HORTICULTURE JAPAN 2, P34; Butler ED, 1999, J EXP BOT, V50, P551, DOI 10.1093/jexbot/50.333.551; Foster TM, 2015, HORTIC RES-ENGLAND, V2, DOI 10.1038/hortres.2015.1; Fukuda H, 1988, B FRUIT TREE RES S C, V15, P29; GRATTAPAGLIA D, 1995, THEOR APPL GENET, V90, P933, DOI 10.1007/BF00222906; HOWARD BH, 1968, J HORTIC SCI BIOTECH, V43, P23; Marques CM, 1999, THEOR APPL GENET, V99, P936, DOI 10.1007/s001220051400; Moriya S, 2012, TREE GENET GENOMES, V8, P709, DOI 10.1007/s11295-011-0458-3; Moriya S, 2010, TREE GENET GENOMES, V6, P195, DOI 10.1007/s11295-009-0240-y; Moriya S, 2008, J JPN SOC HORTIC SCI, V77, P236, DOI 10.2503/jjshs1.77.236; Nekoduka S, 2001, ANN REP SOC PLANT PR, V52, P105; Pilcher RLR, 2008, J AM SOC HORTIC SCI, V133, P100; Shepherd M, 2006, MOL BREEDING, V18, P11, DOI 10.1007/s11032-006-9006-5; Shepherd M, 2007, CAN J FOREST RES, V37, P2563, DOI 10.1139/X07-111; Shepherd M, 2008, TREE GENET GENOMES, V4, P715, DOI 10.1007/s11295-008-0145-1; Silfverberg-Dilworth E, 2006, TREE GENET GENOMES, V2, P202, DOI 10.1007/s11295-006-0045-1; Siviero A., 2003, Crop Breeding and Applied Biotechnology, V3, P83; Smolka A, 2009, PLANT SCI, V177, P710, DOI 10.1016/j.plantsci.2009.09.009; Soejima J, 2004, J JPN SOC HORTIC S2, V73, P114; Soejima J, 2002, J JPN SOC HORTIC S1, V71, P201; Soejima J, 2013, B NATL I FRUIT TREE, V16, P19; Soejima Junichi, 2010, Bulletin of the National Institute of Fruit Tree Science, P1; Thumma BR, 2010, TREE GENET GENOMES, V6, P877, DOI 10.1007/s11295-010-0298-6; Van Ooijen J. W., 2009, MAPQTL 6 SOFTWARE MA; Webster AD, 1995, NEW ZEAL J CROP HORT, V23, P355; Wertheim S. J., 2003, P125, DOI 10.1079/9780851995922.0125	40	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1614-2942	1614-2950		TREE GENET GENOMES	Tree Genet. Genomes	JUN	2015	11	3							59	10.1007/s11295-015-0883-9		11	Forestry; Genetics & Heredity; Horticulture	Forestry; Genetics & Heredity; Agriculture	CJ7UH	WOS:000355704700027		
J	Nakanishi, A; Yoshimaru, H; Tomaru, N; Miura, M; Manabe, T; Yamamoto, S				Nakanishi, Atsushi; Yoshimaru, Hiroshi; Tomaru, Nobuhiro; Miura, Masahiro; Manabe, Tohru; Yamamoto, Shin-ichi			Inbreeding depression at the sapling stage and its genetic consequences in a population of the outcrossing dominant tree species, Castanopsis sieboldii	TREE GENETICS & GENOMES			English	Article						Gene dispersal; Inbreeding coefficient; Microsatellite; Pollen dispersal; Pollination; Spatial genetic structure	BROAD-LEAVED FOREST; OLD-GROWTH; POLLEN DISPERSAL; QUERCUS-SALICINA; PATTERNS; EVERGREEN; PLANTS; FLOW; DIFFERENTIATION; SEED	Highly frequent pollination at short distances combined with spatial genetic structure (SGS) among reproductive individuals, as observed in populations of many forest tree species, may lead to highly frequent pollinations between genetically related individuals located close to each other. This could increase frequencies of biparental inbreeding and strengthen the degree of SGS across generations. However, the degree of SGS observed in forest tree populations is not usually strong, suggesting that such processes are restricted by other factors, which may include inbreeding depression. To test this hypothesis, we examined inbreeding depression in Castanopsis sieboldii saplings in a population known to have significant SGS and high frequencies of short-distance pollination. We determined genotypes at eight microsatellite loci of 125 adult trees and 899 saplings in a 4-ha plot. The neighborhood model approach, assuming an exponential power function, showed highly frequent pollination at short distance among parents of saplings. SGS was significantly stronger among saplings than among adults. The average value of Fis (individual inbreeding coefficient based on kinship coefficients between genes within individuals) was also significantly higher among saplings than among adults. Furthermore, average values for saplings were relatively high (0.036-0.052) in 30-50 to 90-110 cm height classes and rapidly decreased to 0.006 for the >= 110-cm class. Analysis of covariance, taking into account the canopy state, showed that inbreeding depression had a significant negative effect on the saplings' height. Thus, the level of inbreeding in saplings decreased with size classes increasing, probably due to pronounced inbreeding depression resulting in mortality or reduced growth of inbred saplings, and hence, the inbreeding depression may prevent increasing of the level of inbreeding and the degree of SGS in subsequent generations.	[Nakanishi, Atsushi] Aichi Prefectural Forestry Res Inst, Shinshiro, Aichi 4411622, Japan; [Yoshimaru, Hiroshi] Forestry & Forest Prod Res Inst, Tama Forest Sci Garden, Hachioji, Tokyo 1930843, Japan; [Tomaru, Nobuhiro] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Miura, Masahiro] Forestry & Forest Prod Res Inst, Forest Tree Breeding Ctr, Kansai Reg Breeding Off, Katsuta, Okayama 7094335, Japan; [Manabe, Tohru] Kitakyushu Museum Nat Hist & Human Hist, Kitakyushu, Fukuoka 8050071, Japan; [Yamamoto, Shin-ichi] Okayama Univ, Okayama 7008530, Japan	Nakanishi, A (reprint author), Aichi Prefectural Forestry Res Inst, Shinshiro, Aichi 4411622, Japan.	atsunakanishi@yahoo.co.jp			Japan Society for the Promotion of Science [11460069, 14206017]	Field and laboratory assistance was provided by members of the Laboratory of Forest Ecology and Physiology of Nagoya University, whose help is gratefully acknowledged. We thank the Tsushima District Forest Office for allowing us to undertake this study, which was supported by Grants-in-Aid for Scientific Research (Nos. 11460069 and 14206017) from the Japan Society for the Promotion of Science.	WRIGHT S, 1946, GENETICS, V31, P39; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; RUNKLE JR, 1981, ECOLOGY, V62, P1041, DOI 10.2307/1937003; Oddou-Muratorio S, 2010, FOREST ECOL MANAG, V259, P2151, DOI 10.1016/j.foreco.2010.03.001; ITOW S, 1991, J VEG SCI, V2, P477, DOI 10.2307/3236029; Isagi Y, 2007, J ECOL, V95, P983, DOI 10.1111/j.1365-2745.2007.01272.x; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Nakanishi A, 2009, HEREDITY, V102, P182, DOI 10.1038/hdy.2008.101; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; CANHAM CD, 1989, ECOLOGY, V70, P548, DOI 10.2307/1940200; Husband BC, 1996, EVOLUTION, V50, P54, DOI 10.2307/2410780; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.ecolsys.18.1.237; Austerlitz F, 2004, MOL ECOL, V13, P937, DOI 10.1111/j.1365-294X.2004.02100.x; Hardy OJ, 2006, MOL ECOL, V15, P559, DOI 10.1111/j.1365-294X.2005.02785.x; Manabe T, 2000, PLANT ECOL, V151, P181, DOI 10.1023/A:1026512404110; Clark JS, 1998, AM NAT, V152, P204, DOI 10.1086/286162; Wright S, 1943, GENETICS, V28, P114; Bittencourt JVM, 2007, HEREDITY, V99, P580, DOI 10.1038/sj.hdy.6801019; Burczyk J, 2006, GENETICS, V173, P363, DOI 10.1534/genetics.105.046805; Chybicki IJ, 2010, MOL ECOL RESOUR, V10, P1071, DOI 10.1111/j.1755-0998.2010.02849.x; Doerksen TK, 2014, TREE GENET GENOMES, V10, P203, DOI 10.1007/s11295-013-0676-y; Inanaga M, 2014, BOTANY, V92, P1; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; LUMARET R, 1991, BIOCHEMICAL MARKERS IN THE POPULATION GENETICS OF FOREST TREES, P149; Miura M, 2003, FOREST ECOL MANAG, V183, P387, DOI 10.1016/S0378-1127(03)00140-3; Miura M, 2003, ECOL RES, V18, P115, DOI 10.1046/j.1440-1703.2003.00540.x; Nakanishi A, 2004, SILVAE GENET, V53, P258; Nakanishi A, 2012, J HERED, V103, P547, DOI 10.1093/jhered/ess026; R Development Core Team, 2012, R LANG ENV STAT COMP; RAYMOND M, 1995, J HERED, V86, P248; Ritland K, 1996, GENOME, V39, P1, DOI 10.1139/g96-001; Setsuko S, 2007, AM J BOT, V94, P128, DOI 10.3732/ajb.94.1.128; Ubukata M., 1999, Journal of the Japanese Forestry Society, V81, P280	34	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1614-2942	1614-2950		TREE GENET GENOMES	Tree Genet. Genomes	JUN	2015	11	3							62	10.1007/s11295-015-0890-x		10	Forestry; Genetics & Heredity; Horticulture	Forestry; Genetics & Heredity; Agriculture	CJ7UH	WOS:000355704700030		
J	Nashima, K; Terakami, S; Nishitani, C; Kunihisa, M; Shoda, M; Takeuchi, M; Urasaki, N; Tarora, K; Yamamoto, T; Katayama, H				Nashima, K.; Terakami, S.; Nishitani, C.; Kunihisa, M.; Shoda, M.; Takeuchi, M.; Urasaki, N.; Tarora, K.; Yamamoto, T.; Katayama, H.			Complete chloroplast genome sequence of pineapple (Ananas comosus)	TREE GENETICS & GENOMES			English	Article						Ananas comosus; Chloroplast DNA; Complete sequences; Phylogeny	PHYLOGENETIC-RELATIONSHIPS; DNA; ORGANIZATION; ANGIOSPERMS; DIVERSITY; EVOLUTION; GRASSES; MARKERS; PLANTS; GENES	Since chloroplasts are maternally inherited and have unique features in evolution, their genome sequences have been broadly used in phylogenetic studies of plants. Here, we assembled the chloroplast genome sequence of cultivated pineapple (Ananas comosus (L.) Merr.) that is the most economically significant plant in the Bromeliaceae using next-generation sequencers. The genome length was 159,636 bp and included a pair of inverted repeats of 26,774 bp separated by a small single-copy region of 18,622 bp and a large single-copy region of 87,466 bp. The genome contained 113 unique genes (79 protein-coding, 4 rRNA, and 30 tRNA genes), 19 of which were duplicated in the inverted repeats, giving a total of 132 genes. We identified a total of 65 simple sequence repeats of >10 bp in length. Phylogenetic tree identified Ananas as a basal member of the Poales, closer to Musa (Musaceae, Zingiberales) than to species of the Poaceae. The genes, indels, and simple sequence repeats identified in this study will provide tools for use in evolutionary studies at both intra-and interspecific levels.	[Nashima, K.; Terakami, S.; Nishitani, C.; Kunihisa, M.; Yamamoto, T.] NARO Inst Fruit Tree Sci, Tsukuba, Ibaraki 3058605, Japan; [Shoda, M.; Takeuchi, M.; Urasaki, N.; Tarora, K.] Okinawa Prefectural Agr Res Ctr, Itoman, Okinawa 9010336, Japan; [Katayama, H.] Kobe Univ, Food Resources Educ & Res Ctr, Kasai, Hyogo 6752103, Japan	Katayama, H (reprint author), Kobe Univ, Food Resources Educ & Res Ctr, 1348 Uzurano, Kasai, Hyogo 6752103, Japan.	hkata@kobe-u.ac.jp			Okinawa special promotion grant	This study was partially supported by an Okinawa special promotion grant.	Leebens-Mack J, 2005, MOL BIOL EVOL, V22, P1948, DOI 10.1093/molbev/msi191; Goremykin VV, 2005, MOL BIOL EVOL, V22, P1813, DOI 10.1093/molbev/msi173; Duval MF, 2003, GENOME, V46, P990, DOI 10.1139/G03-074; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Kim JS, 2006, PLANT CELL REP, V25, P334, DOI 10.1007/s00299-005-0097-y; Naito K, 2013, BREEDING SCI, V63, P176, DOI 10.1270/jsbbs.63.176; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Ishii T, 2001, GENOME, V44, P658, DOI 10.1139/gen-44-4-658; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Guisinger MM, 2010, J MOL EVOL, V70, P149, DOI 10.1007/s00239-009-9317-3; POWELL W, 1995, P NATL ACAD SCI USA, V92, P7759, DOI 10.1073/pnas.92.17.7759; Bremer K, 2000, P NATL ACAD SCI USA, V97, P4707, DOI 10.1073/pnas.080421597; Paz EY, 2005, J AM SOC HORTIC SCI, V130, P575; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; Asano T, 2004, DNA RES, V11, P93, DOI 10.1093/dnares/11.2.93; Bausher MG, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-21; D'Eeckenbrugge G. C., 1997, Horticultural Reviews, V21, P133; Coppens d'Eeckenbrugge G, 2002, PINEAPPLE BOT PRODUC, P13; Duval MF, 2001, THEOR APPL GENET, V102, P83, DOI 10.1007/s001220051621; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Hamdan N, 2013, J TEKNOLGI, V64, P29; Hepton A, 2002, PINEAPPLE BOT PRODUC, P109; Jansen RK, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-32; Katayama H, 1996, CURR GENET, V29, P572; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Malezieux E, 2002, PINEAPPLE BOT PRODUC, P69; Martin G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067350; Ogihara Y, 2000, PLANT MOL BIOL REP, V18, P243, DOI 10.1007/BF02823995; Paz EY, 2012, CROP BREED APPL BIOT, V12, P104, DOI 10.1590/S1984-70332012000200002; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Ravi V, 2006, TREE GENET GENOMES, V3, P49, DOI DOI 10.1007/S11295-006-0051-3; Rohrbach KG, 2002, PINEAPPLE BOT PRODUC, P1; Ruhlman T, 2006, BMC GENOMICS, V7, P224; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025; Terakami S, 2012, TREE GENET GENOMES, V8, P841, DOI 10.1007/s11295-012-0469-8; West-Eberhard MJ, 2011, SCIENCE, V332, P311, DOI 10.1126/science.1205336	40	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1614-2942	1614-2950		TREE GENET GENOMES	Tree Genet. Genomes	JUN	2015	11	3							60	10.1007/s11295-015-0892-8		11	Forestry; Genetics & Heredity; Horticulture	Forestry; Genetics & Heredity; Agriculture	CJ7UH	WOS:000355704700028		
J	Tamura, M; Hisataka, Y; Moritsuka, E; Watanabe, A; Uchiyama, K; Futamura, N; Shinohara, K; Tsumura, Y; Tachida, H				Tamura, Miho; Hisataka, Yosuke; Moritsuka, Etsuko; Watanabe, Atsushi; Uchiyama, Kentaro; Futamura, Norihiro; Shinohara, Kenji; Tsumura, Yoshihiko; Tachida, Hidenori			Analyses of random BAC clone sequences of Japanese cedar, Cryptomeria japonica	TREE GENETICS & GENOMES			English	Article						BAC clone; Cupressaceae; Repeat elements; Intron length	DNA METHYLATION; GENOME SEQUENCE; LTR RETROTRANSPOSONS; REPETITIVE ELEMENTS; CONIFER GENOME; DRAFT SEQUENCE; REPBASE UPDATE; EVOLUTION; GENE; IDENTIFICATION	Conifers have larger genomes than most angiosperms, long generation times, and undergone relatively few chromosome duplications during their evolution. Thus, conifers are interesting targets for molecular evolutionary studies. Despite this, there have been few studies regarding their genome structure, and these studies are mostly limited to the Pinaceae. Our target species, Cryptomeria japonica, belongs to the Cupressaceae family, which is phylogenetically separated from the Pinaceae family by a few hundred million years, and is the most important timber tree in Japan, making investigation of its genome structure both interesting and worthwhile. We analyzed the sequences of eight random bacterial artificial chromosome (BAC) clones from C. japonica and compared them with sequences of comparable size from eight other model plants, including Arabidopsis thaliana and Pinus taeda. From this analysis, we identified several features of the C. japonica genome. First, the genome of C. japonica has many divergent repetitive sequences, similar to those of Physcomitrella patens and P. taeda. Additionally, some C. japonica transposable elements (TEs) seem to have been active until recently, and some might be unidentified novel TEs. We also found a putative protein-coding gene with a very long intron (approximately 70 kb). The three Pinaceae species whose genome sequences have been determined share these features, despite the few hundred million years of independent evolution separating the Pinaceae species from C. japonica.	[Tamura, Miho; Hisataka, Yosuke] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka, Fukuoka 8128581, Japan; [Moritsuka, Etsuko; Tachida, Hidenori] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka, Fukuoka 8128581, Japan; [Watanabe, Atsushi] Kyushu Univ, Fac Agr, Dept Forest Environm Sci, Fukuoka, Fukuoka 8128581, Japan; [Uchiyama, Kentaro; Tsumura, Yoshihiko] Forestry & Forest Prod Res Inst, Dept Forest Genet, Tsukuba, Ibaraki 3058687, Japan; [Futamura, Norihiro; Shinohara, Kenji] Forestry & Forest Prod Res Inst, Dept Mol & Cell Biol, Tsukuba, Ibaraki 3058687, Japan; [Tsumura, Yoshihiko] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Tachida, H (reprint author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka, Fukuoka 8128581, Japan.	htachida@kyudai.jp			Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Japan Society for the Promotion of Science [22370083, 26291082]	We would like to thank Alfred E. Szmidt, Junko Kusumi, and two anonymous referees for constructive comments on earlier drafts of the manuscript. This study was partially supported by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry and by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (nos. 22370083 and 26291082).	Ahuja MR, 2005, SILVAE GENET, V54, P126; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Hizume M, 2002, THEOR APPL GENET, V105, P491, DOI 10.1007/s00122-002-0975-4; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; OHRI D, 1986, PLANT SYST EVOL, V153, P119, DOI 10.1007/BF00989421; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tsumura Y, 2012, HEREDITY, V109, P349, DOI 10.1038/hdy.2012.50; Moritsuka E, 2012, GENETICS, V190, P1145, DOI 10.1534/genetics.111.136697; Kusumi J, 2000, AM J BOT, V87, P1480, DOI 10.2307/2656874; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; CHANDLER VL, 1986, P NATL ACAD SCI USA, V83, P1767, DOI 10.1073/pnas.83.6.1767; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; GRUENBAUM Y, 1981, NATURE, V292, P860, DOI 10.1038/292860a0; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Wegrzyn JL, 2014, GENETICS, V196, P891, DOI 10.1534/genetics.113.159996; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Keeling CI, 2010, PLANT PHYSIOL, V152, P1197, DOI 10.1104/pp.109.151456; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Birol I, 2013, BIOINFORMATICS, V29, P1492, DOI 10.1093/bioinformatics/btt178; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Havecker ER, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-225; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; FLAVELL RB, 1994, P NATL ACAD SCI USA, V91, P3490, DOI 10.1073/pnas.91.9.3490; Futamura N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-383; Gadek PA, 2000, AM J BOT, V87, P1480; Gao CH, 2012, GENOMICS, V100, P222, DOI 10.1016/j.ygeno.2012.07.004; Hamberger B, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-106; Jurka J, 1998, CURR OPIN STRUC BIOL, V8, P333, DOI 10.1016/S0959-440X(98)80067-5; Kado T, 2003, GENETICS, V164, P1547; Kaul S, 2000, NATURE, V408, P796; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kovach A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-420; Lee Ed, 2009, Bioinformatics, V25, P1836, DOI 10.1093/bioinformatics/btp314; Leslie AB, 2012, P NATL ACAD SCI USA, V109, P1217; Liu WX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-553; Martienssen R, 1998, TRENDS GENET, V14, P263, DOI 10.1016/S0168-9525(98)01518-2; McLysaght A, 2000, YEAST, V17, P22, DOI 10.1002/(SICI)1097-0061(200004)17:1<22::AID-YEA5>3.3.CO;2-J; Misksche JP, 1973, CHROMOSOMA, V41, P29; Moriguchi Y, 2012, BMC GENOMICS, V19, P95; Neale DB, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r59; Ohtsubo Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-376; Perlman PS, 2004, SCIENCE, V303, P182, DOI 10.1126/science.1093514; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sakharkar Meena Kishore, 2004, In Silico Biology, V4, P387; Vinogradov AE, 1999, J MOL EVOL, V49, P376, DOI 10.1007/PL00006561; Willyard Ann, 2007, Mol Biol Evol, V24, P90	57	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1614-2942	1614-2950		TREE GENET GENOMES	Tree Genet. Genomes	JUN	2015	11	3							50	10.1007/s11295-015-0859-9		13	Forestry; Genetics & Heredity; Horticulture	Forestry; Genetics & Heredity; Agriculture	CJ7UH	WOS:000355704700018		
J	AboEllail, MAM; Kanenishi, K; Tenkumo, C; Kawanishi, K; Kaji, T; Hata, T				AboEllail, M. A. M.; Kanenishi, K.; Tenkumo, C.; Kawanishi, K.; Kaji, T.; Hata, T.			Diagnosis of truncus arteriosus in first trimester of pregnancy using transvaginal four-dimensional color Doppler ultrasound	ULTRASOUND IN OBSTETRICS & GYNECOLOGY			English	Article									[AboEllail, M. A. M.; Kanenishi, K.; Tenkumo, C.; Hata, T.] Kagawa Univ, Grad Sch Med, Dept Perinatol & Gynecol, Miki, Kagawa 7610739, Japan; [Kawanishi, K.] Yashima Gen Hosp, Dept Obstet & Gynecol, Takamatsu, Kagawa, Japan; [Kaji, T.] Univ Tokushima, Sch Med, Dept Obstet & Gynecol, Inst Hlth Biosci, Tokushima 770, Japan	Hata, T (reprint author), Kagawa Univ, Grad Sch Med, Dept Perinatol & Gynecol, 1750-1 Ikenobe, Miki, Kagawa 7610739, Japan.	toshi28@med.kagawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [24119004, 25462561]	This work was supported by a Grant-in-Aid for scientific Research on Innovative Areas 'Constructive Developmental Science' (No. 24119004), and a research grant (No. 25462561) from The Ministry of Education, Culture, Sports, Science and Technology, Japan.	Hidaka N, 2009, J CLIN ULTRASOUND, V37, P295, DOI 10.1002/jcu.20545; Gotsch F, 2010, J MATERN-FETAL NEO M, V23, P297, DOI 10.3109/14767050903108206; Hata T, 2014, AM J CARDIOL, V114, P1603, DOI [10.1016/j.amjcard.2014.08.025, 10.1016/j.amjpard.2014.08.025]; Sharland G., 2002, PROG PEDIATR CARDIOL, V15, P33, DOI 10.1016/S1058-9813(02)00006-1; Tometzki AJP, 1999, J AM COLL CARDIOL, V33, P1696, DOI 10.1016/S0735-1097(99)00049-2	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7692	1469-0705		ULTRASOUND OBST GYN	Ultrasound Obstet. Gynecol.	JUN	2015	45	6					759	760		10.1002/uog.14868		2	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	CJ7KU	WOS:000355674700026		
J	Nishimura, N; Simms, CK; Wood, DP				Nishimura, Naoya; Simms, Ciaran K.; Wood, Denis P.			Impact characteristics of a vehicle population in low speed front to rear collisions	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Rear end collision; Accident reconstruction; Regression analysis; Impact modeling	WHIPLASH; INJURY	Rear impact collisions are mostly low severity, but carry a very high societal cost due to reported symptoms of whiplash and related soft tissue injuries. Given the difficulty in physiological measurement of damage in whiplash patients, there is a significant need to assess rear impact severity on the basis of vehicle damage. This paper presents fundamental impact equations on the basis of an equivalent single vehicle to rigid barrier collision in order to predict relationships between impact speed, maximum dynamic crush, mean and peak acceleration, time to common velocity and vehicle stiffness. These are then applied in regression analysis of published staged low speed rear impact tests. The equivalent mean and peak accelerations are linear functions of the collision closing speed, while the time to common velocity is independent of the collision closing speed. Furthermore, the time to common velocity can be used as a surrogate measure of the normalized vehicle stiffness, which provides opportunity for future accident reconstruction. (C) 2015 Elsevier Ltd. All rights reserved.	[Nishimura, Naoya; Simms, Ciaran K.] Univ Dublin Trinity Coll, Ctr Bioengn, Sch Engn, Dublin 2, Ireland; [Nishimura, Naoya] Meijo Univ, Dept Vehicle & Mech Engn, Nagoya, Aichi, Japan; [Wood, Denis P.] Denis Wood Associates, Dublin, Ireland	Simms, CK (reprint author), Univ Dublin Trinity Coll, FTCD, Parsons Bldg, Dublin 2, Ireland.	csimms@tcd.ie		Simms, Ciaran/0000-0001-5564-1620			AGU, 2014, CRASH TEST DAT; Bailey M., 1995, SOC AUT ENG WORLD C, P139; Bonugli E., 2014, 2014011994 SAE INT; Brach R., 2003, 2003010491 SAE INT; Cipriani A. L., 2002, 2002010540 SAE INT; Elliott JM, 2014, PAIN MED, V15, P1938, DOI 10.1111/pme.12518; Funk J., 2014, SAE INT J PASSENGER, V7; Happer A., 2003, 2003010492 SAE INT; Moser A., 2011, IRCOBI C P INT RES C; Ojalvo I., 1997, 970779 SAE INT; Ojalvo I., 1998, 980365 SAE INT; Scott W.R., 2010, SAE INT J PASSENG CA, V3, P21; Scott W.R., 2012, SAE INT J PASSENGER, V5, P592; Thomson R., 1993, P CAN MULT ROAD SAF; Viano DC, 2001, J TRAUMA, V51, P959, DOI 10.1097/00005373-200111000-00022; Viano D.C., 2002, ROLE SEAT REAR CRASH; Worsfold C, 2014, J FORENSIC LEG MED, V25, P96, DOI 10.1016/j.jflm.2014.04.013; Yoganandan N, 2013, SEMIN SPINE SURG, p[25, 67]	18	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	JUN	2015	79						1	12		10.1016/j.aap.2015.02.001		12	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	CJ2ZF	WOS:000355352500001		
J	Nuss, J; Muhle, C; Hayama, K; Abdolazimi, V; Takagi, H				Nuss, Juergen; Muehle, Claus; Hayama, Kyouhei; Abdolazimi, Vahideh; Takagi, Hidenori			Tilting structures in inverse perovskites, M(3)TtO (M = Ca, Sr, Ba, Eu; Tt = Si, Ge, Sn, Pb)	ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS			English	Article						inverse perovskites; tetrelide oxides; phase transitions; multiple twinning; reticular merohedry; pseudo-symmetry	EFFECTIVE IONIC-RADII; X-RAY-DIFFRACTION; CRYSTAL-STRUCTURES; ZINTL PHASES; FACE FORMS; SUPERCONDUCTIVITY; EIGENSYMMETRIES; TRANSITION; MEROHEDRY; SYMMETRY	Single-crystal X-ray diffraction experiments were performed for a series of inverse perovskites, M3TtO (M = Ca, Sr, Ba, Eu; Tt = tetrel element: Si, Ge, Sn, Pb) in the temperature range 500-50 K. For Tt = Sn, Pb, they crystallize as an 'ideal' perovskite-type structure (Pm (3) over barm, cP5); however, all of them show distinct anisotropies of the displacement ellipsoids of the M atoms at room temperature. This behavior vanishes on cooling for M = Ca, Sr, Eu, and the structures can be regarded as 'ideal' cubic perovskites at 50 K. The anisotropies of the displacement ellipsoids are much more enhanced in the case of the Ba compounds. Finally, their structures undergo a phase transition at similar to 150 K. They change from cubic to orthorhombic (Ibmm, oI20) upon cooling, with slightly tilted OBa6 octahedra, and bonding angles O-Ba-O similar or equal to 174 degrees (100 K). For the larger Ba2+ cations, the structural changes are in agreement with smaller tolerance factors (t) as defined by Goldschmidt. Similar structural behavior is observed for Ca(3)TtO. Smaller Tt(4-) anions (Si, Ge) introduce reduced tolerance factors. Both compounds Ca3SiO and Ca3GeO with cubic structures at 500 K, change into orthorhombic (Ibmm) at room temperature. Whereby, Ca3SiO is the only representative within the M(3)TtO family where three polymorphs can be found within the temperature range 500-50 K: Pm (3) over barm-Ibmm-Pbnm. They show tiny differences in the tilting of the OCa6 octahedra, expressed by O-Ca-O bond angles of 180 degrees (500 K), similar to 174 degrees (295 K) and 170 degrees (100 K). For larger M (Sr, Eu, Ba), together with smaller Tt (Si, Ge) atoms, pronounced tilting of the OM6 octahedra, and bonding angles of O-M-O similar or equal to 160 degrees (295 K) are observed. They crystallize in the anti-GdFeO3 type of structure (Pbnm, oP20), and no phase transitions occur between 500 and 50 K. The observed phase transitions are all accompanied by multiple twinning, in terms of pseudo-merohedry or reticular pseudo-merohedry.	[Nuss, Juergen; Muehle, Claus; Abdolazimi, Vahideh; Takagi, Hidenori] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany; [Hayama, Kyouhei; Takagi, Hidenori] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Takagi, Hidenori] Univ Stuttgart, Inst Funct Matter & Quantum Technol, D-70569 Stuttgart, Germany	Nuss, J (reprint author), Max Planck Inst Solid State Res, Heisenbergstr 1, D-70569 Stuttgart, Germany.	j.nuss@fkf.mpg.de	Takagi, Hidenori/B-2935-2010; Nuss, Juergen/G-2711-2010	Nuss, Juergen/0000-0002-0679-0184			Lee YF, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4820770; Bock O, 2002, ACTA CRYSTALLOGR B, V58, P594, DOI 10.1107/S0108768102001490; Iikubo S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.205901; Nespolo M, 2015, CRYST RES TECHNOL, V50, P362, DOI 10.1002/crat.201400422; Nesper R, 2014, Z ANORG ALLG CHEM, V640, P2639, DOI 10.1002/zaac.201400403; BERTAUT EF, 1968, SOLID STATE COMMUN, V6, P251, DOI 10.1016/0038-1098(68)90098-7; He T, 2001, NATURE, V411, P54, DOI 10.1038/35075014; Kariyado T, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.083704; Bhalla AS, 2000, MATER RES INNOV, V4, P3, DOI 10.1007/s100190000062; Woodward PM, 1997, ACTA CRYSTALLOGR B, V53, P32, DOI 10.1107/S0108768196010713; Chi EO, 2001, SOLID STATE COMMUN, V120, P307, DOI 10.1016/S0038-1098(01)00395-7; Sun Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.216406; Cakmak G, 2009, Z ANORG ALLG CHEM, V635, P631, DOI 10.1002/zaac.200900056; Takenaka K, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2147726; Asano K, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2917472; Goldschmidt VM, 1926, NATURWISSENSCHAFTEN, V14, P477; GLAZER AM, 1975, ACTA CRYSTALLOGR A, V31, P756, DOI 10.1107/S0567739475001635; Barnighausen H., 1980, COMMUN MATH CHEM, V9, P139; Bruker AXS, 2013, BRUK SUIT VERS 2013; BRUZZONE G, 1978, J LESS-COMMON MET, V57, P201, DOI 10.1016/0022-5088(78)90239-4; ECKERLIN P, 1961, Z ANORG ALLG CHEM, V307, P145, DOI 10.1002/zaac.19613070306; EISENMAN.B, 1972, Z ANORG ALLG CHEM, V391, P241, DOI 10.1002/zaac.19723910305; Friedel G., 1926, LECONS CRISTALLOGRAP; FRUCHART D, 1971, J PHYS PARIS, V0032; GLAZER AM, 1972, ACTA CRYSTALLOGR B, VB 28, P3384, DOI 10.1107/S0567740872007976; Goldschmidt V. M., 1926, SKRIFTER NORSKE VIDE, V2, P8; GOMONAJ EV, 1992, PHASE TRANSIT, V40, P225, DOI 10.1080/01411599208207749; Hahn Th., 2003, INT TABLES CRYSTALLO, VD, P393; HELLEIS O, 1963, Z ANORG ALLG CHEM, V320, P86, DOI 10.1002/zaac.19633200113; Henke H, 2003, Z KRISTALLOGR, V218, P617, DOI 10.1524/zkri.218.9.617.20674; Huang BQ, 1998, Z ANORG ALLG CHEM, V624, P1787, DOI 10.1002/(SICI)1521-3749(1998110)624:11<1787::AID-ZAAC1787>3.0.CO;2-P; Janaovec V., 2003, INT TABLES CHRYSTALL, VD, P449; Kamishima K., 2001, Physical Review B (Condensed Matter), V63, DOI 10.1103/PhysRevB.63.024426; Kariyado T, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.064701; Kirchner M, 2006, Z ANORG ALLG CHEM, V632, P559, DOI 10.1002/zaac.200500399; Klapper H, 2010, ACTA CRYSTALLOGR A, V66, P327, DOI 10.1107/S0108767310001091; Klapper H, 2012, ACTA CRYSTALLOGR A, V68, P82, DOI 10.1107/S0108767311032454; KLEMM W, 1958, P CHEM SOC LONDON, P329; Muller U., 2006, INORGANIC STRUCTURAL; Muller U., 2013, SYMMETRY RELATIONSHI; Nespolo M, 2004, Z KRISTALLOGR, V219, P57, DOI 10.1524/zkri.219.2.57.26317; Niewa R, 2013, Z ANORG ALLG CHEM, V639, P1699, DOI 10.1002/zaac.201300063; Nuss J, 2007, ACTA CRYSTALLOGR B, V63, P719, DOI 10.1107/S0108768107037147; Nuss J, 2007, ACTA CRYSTALLOGR B, V63, P843, DOI 10.1107/S0108768107051282; Petricek V., 2006, JANA2006; ROHR C, 1995, Z KRISTALLOGR, V210, P781, DOI 10.1524/zkri.1995.210.10.781; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; SHANNON RD, 1969, ACTA CRYSTALL B-STRU, VB 25, P925, DOI 10.1107/S0567740869003220; Sheldrick G. M., 2012, TWINABS VERSION 2012; Sheldrick G. M., 2012, SADABS VERSION 2012; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; TURBAN K, 1973, Z NATURFORSCH B, VB 28, P220; Turck R., 1994, THESIS U STUTTGART G; Velden A, 2004, Z ANORG ALLG CHEM, V630, P234, DOI 10.1002/zaac.200300313; Wang BS, 2010, PHYSICA B, V405, P2427, DOI 10.1016/j.physb.2010.03.001; Wang C, 2013, ADV COND MATTER PHYS, DOI 10.1155/2013/214120; WIDERA A, 1980, MATER RES BULL, V15, P1805, DOI 10.1016/0025-5408(80)90200-7; WIDERA A, 1981, J LESS-COMMON MET, V77, P29, DOI 10.1016/0022-5088(81)90005-9; Wondraschek H., 2008, INT TABLES CRYSTAL A, VA1; ZHAO JT, 1995, J ALLOY COMPD, V230, P1, DOI 10.1016/0925-8388(95)01909-X; Zintl E, 1939, ANGEW CHEM-GER EDIT, V52, P1, DOI 10.1002/ange.19390520102	61	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0108-7681	1600-5740		ACTA CRYSTALLOGR B	Acta Crystallogr. Sect. B-Struct. Sci.Cryst. Eng. Mat.	JUN	2015	71		3				300	312		10.1107/S2052520615006150		13	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	CJ5VJ	WOS:000355560000008		
J	Imai, K				Imai, Kazuhiro			Analysis of Vertebral Bone Strength, Fracture Pattern, and Fracture Location: A Validation Study Using a Computed Tomography-Based Nonlinear Finite Element Analysis	AGING AND DISEASE			English	Article						vertebral fracture; bone strength; finite element analysis; osteoporosis	TRABECULAR BONE; LUMBAR VERTEBRAE; YIELD STRAIN; MODEL; PREDICTION; THICKNESS; STIFFNESS; BEHAVIOR; MODULUS; DENSITY	Finite element analysis (FEA) is an advanced computer technique of structural stress analysis developed in engineering mechanics. Because the compressive behavior of vertebral bone shows nonlinear behavior, a nonlinear FEA should be utilized to analyze the clinical vertebral fracture. In this article, a computed tomography-based nonlinear FEA (CT/FEA) to analyze the vertebral bone strength, fracture pattern, and fracture location is introduced. The accuracy of the CT/FEA was validated by performing experimental mechanical testing with human cadaveric specimens. Vertebral bone strength and the minimum principal strain at the vertebral surface were accurately analyzed using the CT/FEA. The experimental fracture pattern and fracture location were also accurately simulated. Optimization of the element size was performed by assessing the accuracy of the CT/FEA, and the optimum element size was assumed to be 2 mm. It is expected that the CT/FEA will be valuable in analyzing vertebral fracture risk and assessing therapeutic effects on osteoporosis.	[Imai, Kazuhiro] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan	Imai, K (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan.	imaik-ort@umin.ac.jp					Imai K, 2011, J BONE MINER METAB, V29, P645, DOI 10.1007/s00774-011-0281-9; Imai K, 2006, SPINE, V31, P1789, DOI 10.1097/01.brs.0000225993.57349.df; Hou FJ, 1998, J BIOMECH, V31, P1009, DOI 10.1016/S0021-9290(98)00110-9; Silva MJ, 1998, J ORTHOPAED RES, V16, P300, DOI 10.1002/jor.1100160305; ROCKOFF SD, 1969, CALC TISS RES, V3, P163, DOI 10.1007/BF02058659; Martin H, 1998, BIOMED TECH, V43, P82, DOI 10.1515/bmte.1998.43.4.82; Morgan EF, 2001, J BIOMECH, V34, P569, DOI 10.1016/S0021-9290(01)00011-2; Dougherty G, 1999, MED PHYS, V26, P1341, DOI 10.1118/1.598629; JENSEN KS, 1990, BONE, V11, P417, DOI 10.1016/8756-3282(90)90137-N; KEAVENY TM, 1994, J BIOMECH, V27, P1137, DOI 10.1016/0021-9290(94)90054-X; Rho JY, 1997, BIOMATERIALS, V18, P1325, DOI 10.1016/S0142-9612(97)00073-2; Kopperdahl DL, 1998, J BIOMECH, V31, P601, DOI 10.1016/S0021-9290(98)00057-8; Prevrhal S, 1999, PHYS MED BIOL, V44, P751, DOI 10.1088/0031-9155/44/3/017; Crawford RP, 2003, BONE, V33, P744, DOI 10.1016/S8756-3282(03)00210-2; HUISKES R, 1983, J BIOMECH, V16, P385, DOI 10.1016/0021-9290(83)90072-6; FAULKNER KG, 1991, RADIOLOGY, V179, P669; Matsumoto T, 2009, SPINE, V34, P1464, DOI 10.1097/BRS.0b013e3181a55636; BREKELMA.WA, 1972, ACTA ORTHOP SCAND, V43, P301, DOI 10.3109/17453677208998949; Imai K, 2008, SPINE, V33, P27, DOI 10.1097/BRS.0b013e31815e3993; Imai K, 2009, OSTEOPOROSIS INT, V20, P801, DOI 10.1007/s00198-008-0750-8; Ito M, 2005, J BONE MINER METAB, V23, pS115; Keyak JH, 1998, J BIOMECH, V31, P125; Ladd AJC, 1998, J ORTHOP RES, V16, P622, DOI 10.1002/jor.1100160516; Liebschner MAK, 2003, SPINE, V28, P559, DOI 10.1097/00007632-200303150-00009; Mosekilde L., 1993, CALCIFIED TISSUE INT, V53, P121; Overaker DW, 1999, J BIOMECH ENG-T ASME, V121, P542, DOI 10.1115/1.2835085; SILVA MJ, 1994, BONE, V15, P409, DOI 10.1016/8756-3282(94)90817-6; VESTERBY A, 1991, BONE, V12, P219, DOI 10.1016/8756-3282(91)90044-J	28	0	0	INT SOC AGING & DISEASE	FORT WORTH	EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA	2152-5250			AGING DIS	Aging Dis.	JUN	2015	6	3					180	187				8	Geriatrics & Gerontology	Geriatrics & Gerontology	CJ5TB	WOS:000355551200003		
J	Kawai, T; Yamada, T; Tamaki, S; Morita, T; Furukawa, Y; Iwasaki, Y; Kawasaki, M; Kikuchi, A; Kondo, T; Takahashi, S; Ishimi, M; Hakui, H; Ozaki, T; Sato, Y; Seo, M; Sakata, Y; Fukunami, M				Kawai, Tsutomu; Yamada, Takahisa; Tamaki, Shunsuke; Morita, Takashi; Furukawa, Yoshio; Iwasaki, Yusuke; Kawasaki, Masato; Kikuchi, Atsushi; Kondo, Takumi; Takahashi, Satoshi; Ishimi, Masashi; Hakui, Hideyuki; Ozaki, Tatsuhisa; Sato, Yoshihiro; Seo, Masahiro; Sakata, Yasushi; Fukunami, Masatake			Usefulness of Cardiac Meta-Iodobenzylguanidine Imaging to Identify Patients With Chronic Heart Failure and Left Ventricular Ejection Fraction < 35% at Low Risk for Sudden Cardiac Death	AMERICAN JOURNAL OF CARDIOLOGY			English	Article							IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; IDIOPATHIC DILATED CARDIOMYOPATHY; PROGNOSTIC VALUE; RATE-VARIABILITY; SYMPATHETIC INNERVATION; PREDICTION; MORTALITY; PLASMA; NEED	Patients with chronic heart failure (CHF) at risk of sudden cardiac death (SCD) are often treated with implantable cardiac defibrillators (ICDs). However, current criteria for device use that is based largely on left ventricular ejection fraction (LVEF) lead to many patients receiving ICDs that never deliver therapy. It is of clinical significance to identify patients who do not require ICDs. Although cardiac 1-123 meta-iodobenzylguanidine (MIBG) imaging provides prognostic information about CHF, whether it can identify patients with CHF who do not require an ICD remains unclear. We studied 81 patients with CHF and LVEF <35%, assessed by cardiac MIBG imaging at enrollment. The heart-to-mediastinal ratio (HIM) in delayed images, and washout rates were divided into 6 grades from 0 to 5, according to the degree of deviation from control values, The study patients were classified into 3 groups: low (1 to 4), intermediate (5 to 7), and high (8 to 10), according to the MIBG scores defined as the sum of the HIM and washout rate scores. Sixteen patients died of SCD during a follow-up period. Patients with low MIBG score had a significantly lower risk of SCD than those with intermediate and high scores (low [n = 19], 0%; intermediate [n = 37], 19%; high [n = 25], 36%; p = 0.001). The positive predictive value of low MIBG score for identifying patients without SCD was 100%. In conclusion, the MIBG score can identify patients with CHF and LVEF <35% who have low risk of developing SCD. (C) 2015 Elsevier Inc. All rights reserved.	[Kawai, Tsutomu; Yamada, Takahisa; Tamaki, Shunsuke; Morita, Takashi; Furukawa, Yoshio; Iwasaki, Yusuke; Kawasaki, Masato; Kikuchi, Atsushi; Kondo, Takumi; Takahashi, Satoshi; Ishimi, Masashi; Hakui, Hideyuki; Ozaki, Tatsuhisa; Sato, Yoshihiro; Seo, Masahiro; Fukunami, Masatake] Osaka Gen Med Ctr, Div Cardiol, Osaka, Japan; [Sakata, Yasushi] Osaka Univ, Grad Sch Med, Div Cardiovasc Med, Osaka, Japan	Yamada, T (reprint author), Osaka Gen Med Ctr, Div Cardiol, Osaka, Japan.	takaymda@nike.eonet.ne.jp					Anastasiou-Nana MI, 2005, AM J CARDIOL, V96, P427, DOI 10.1016/j.amjcard.2005.03.093; Ogita H, 2001, HEART, V86, P656, DOI 10.1136/heart.86.6.656; Jacobson AF, 2010, J AM COLL CARDIOL, V55, P2212, DOI 10.1016/j.jacc.2010.01.014; Nagahara D, 2008, J NUCL MED, V49, P225, DOI 10.2967/jnumed.107.042564; Moss AJ, 2004, CIRCULATION, V110, P3760, DOI 10.1161/01.CIR.0000150390.04704.B7; Arora R, 2003, J NUCL CARDIOL, V10, P121, DOI 10.1067/mnc.2003.2; Boogers MJ, 2010, J AM COLL CARDIOL, V55, P2769, DOI 10.1016/j.jacc.2009.12.066; Nakata T, 2013, JACC-CARDIOVASC IMAG, V6, P772, DOI 10.1016/j.jcmg.2013.02.007; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; FOTI A, 1987, CLIN CHEM, V33, P2209; Epstein AE, 2013, CIRCULATION, V127, pE283, DOI 10.1161/CIR.0b013e318276ce9b; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; MERLET P, 1992, J NUCL MED, V33, P471; Nishisato K, 2010, J NUCL MED, V51, P1241, DOI 10.2967/jnumed.110.074971; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kioka H, 2007, HEART, V93, P1213, DOI 10.1136/hrt.2006.094524; Koutelou M, 2009, ANN NUCL MED, V23, P677, DOI 10.1007/s12149-009-0289-6; Kuramoto Y, 2011, AM J CARDIOL, V107, P1185, DOI 10.1016/j.amjcard.2010.12.019; Nakajima K, 2014, EUR J NUCL MED MOL I, V41, P1673, DOI 10.1007/s00259-014-2759-x; YUSUF S, 1991, NEW ENGL J MED, V325, P293; Yamada T, 2003, J AM COLL CARDIOL, V41, P231, DOI 10.1016/S0735-1097(02)02700-6; Zecchin M, 2012, AM J CARDIOL, V109, P729, DOI 10.1016/j.amjcard.2011.10.033	23	0	0	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9149	1879-1913		AM J CARDIOL	Am. J. Cardiol.	JUN 1	2015	115	11					1549	1554		10.1016/j.amjcard.2015.02.058		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CJ6ZL	WOS:000355643600013		
J	Kaufmann, P; Okubo, K; Bruderer, S; Mant, T; Yamada, T; Dingemanse, J; Mukai, H				Kaufmann, Priska; Okubo, Kaori; Bruderer, Shirin; Mant, Tim; Yamada, Tetsuhiro; Dingemanse, Jasper; Mukai, Hideya			Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag	AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS			English	Article							PULMONARY-ARTERIAL-HYPERTENSION; PROSTANOID THERAPY; TREPROSTINIL; SURVIVAL; INFUSION	Purpose Targeting the prostacyclin pathway is an effective treatment option for pulmonary arterial hypertension (PAH). Patients with PAH have a deficiency of prostacyclin and prostacyclin synthase. Selexipag is an orally available and selective prostacyclin receptor (IP receptor) agonist. Selexipag is hydrolyzed to its active metabolite ACT-333679, also a selective and potent agonist at the IP receptor. Methods In this phase I study the pharmacokinetics (PK) and tolerability of single and multiple ascending doses of selexipag were investigated in a double-blind, placebo-controlled manner in 64 healthy male subjects. An additional group of 12 subjects received an open-label dose of selexipag 400 mu g in the fasted condition and after a meal. Results Maximum plasma concentrations of selexipag and ACT-333679 were reached within 2.5 and 4 h, respectively, with mean half-lives of 0.7-2.3 and 9.4-14.22 h. In the presence of food, exposure to ACT-333679 was decreased by 27 %. The most frequent adverse event was headache. Selexipag was well tolerated up to a single dose of 400 mu g and multiple doses of 600 mu g following an up-titration step. No relevant treatment-related effects on vital signs, clinical laboratory, and electrocardiogram (ECG) parameters were detected. Conclusion Selexipag exhibits a good tolerability profile and PK properties that warrant further investigation.	[Kaufmann, Priska; Bruderer, Shirin; Dingemanse, Jasper] Actel Pharmaceut Ltd, Dept Clin Pharmacol, CH-4123 Allschwil, Switzerland; [Okubo, Kaori; Yamada, Tetsuhiro; Mukai, Hideya] Nippon Shinyaku Co Ltd, Kyoto 601, Japan; [Mant, Tim] Guys Hosp, Quintiles Drug Res Unit, London SE1 9RT, England	Kaufmann, P (reprint author), Actel Pharmaceut Ltd, Dept Clin Pharmacol, Gewerbestr 16, CH-4123 Allschwil, Switzerland.	priska.kaufmann@actelion.com			Nippon Shinyaku Co. Ltd.	The authors thank apothecom scopemedical Ltd for editorial assistance and Shin Nippon Biomedical Laboratories Ltd for bioanalytical services. This study was sponsored by Nippon Shinyaku Co. Ltd.	McLaughlin VV, 2013, CLIN CHEST MED, V34, P825, DOI 10.1016/j.ccm.2013.09.003; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; Simonneau G, 2002, AM J RESP CRIT CARE, V165, P800, DOI 10.1164/rccm.2106079; CHRISTMAN BW, 1992, NEW ENGL J MED, V327, P70, DOI 10.1056/NEJM199207093270202; McLaughlin VV, 2002, CIRCULATION, V106, P1477, DOI 10.1161/01.CIR.0000029100.82385.58; Kuwano K, 2007, J PHARMACOL EXP THER, V322, P1181, DOI 10.1124/jpet.107.124248; Hassoun PM, 2009, J AM COLL CARDIOL, V54, pS10, DOI 10.1016/j.jacc.2009.04.006; Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; EISEN SA, 1990, ARCH INTERN MED, V150, P1881, DOI 10.1001/archinte.150.9.1881; Morrison K, 2012, J PHARMACOL EXP THER, V343, P547, DOI 10.1124/jpet.112.197152; Schermuly RT, 2011, NAT REV CARDIOL, V8, P443, DOI 10.1038/nrcardio.2011.87; Mubarak KK, 2010, RESP MED, V104, P9, DOI 10.1016/j.rmed.2009.07.015; Badesch DB, 2004, J AM COLL CARDIOL, V43, p56S, DOI 10.1016/j.jacc.2004.02.036; Delcroix M, 2009, Eur Respir Rev, V18, P253, DOI 10.1183/09059180.00003109; Galiè N, 2009, Eur Respir Rev, V18, P148, DOI 10.1183/09059180.00003809; Galiè Nazzareno, 2003, Am J Respir Med, V2, P123; Gough K, 1995, DRUG INF J, V29, P1039; Humbert M, 2001, CLIN CHEST MED, V22, P459, DOI 10.1016/S0272-5231(05)70284-7; Jin Jing, 2008, Ther Clin Risk Manag, V4, P269; Kelloway JS, 2000, ANN ALLERG ASTHMA IM, V84, P324, DOI 10.1016/S1081-1206(10)62781-0; Naeije R, 2007, EXPERT OPIN PHARMACO, V8, P2247, DOI 10.1517/14656566.8.14.2247; O'Callaghan Dermot S, 2012, Eur Respir Rev, V21, P218, DOI 10.1183/09059180.00003512; Pulido T, 2013, NEW ENGL J MED, V369, P809, DOI 10.1056/NEJMoa1213917; Sitbon Olivier, 2012, Eur Respir Rev, V21, P321, DOI 10.1183/09059180.00004812; Skoro-Sajer Nika, 2008, Vasc Health Risk Manag, V4, P507; Skoro-Sajer N, 2012, DRUGS, V72, P2351, DOI 10.2165/11638260-000000000-00000; US Department of Health and Human Services, 2002, GUID IND FOOD EFF BI	27	2	2	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1175-3277	1179-187X		AM J CARDIOVASC DRUG	Am. J. Cardiovasc. Drugs	JUN	2015	15	3					195	203		10.1007/s40256-015-0117-4		9	Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy	Cardiovascular System & Cardiology; Pharmacology & Pharmacy	CJ6SW	WOS:000355624900005		
J	Miyoshi, T; Nakamura, K; Doi, M; Ito, H				Miyoshi, Toru; Nakamura, Keigo; Doi, Masayuki; Ito, Hiroshi			Impact of Ezetimibe Alone or in Addition to a Statin on Plasma PCSK9 Concentrations in Patients with Type 2 Diabetes and Hypercholesterolemia: A Pilot Study	AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS			English	Article							CORONARY-ARTERY-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; LDL-CHOLESTEROL; HEART-DISEASE; GENE-EXPRESSION; ATORVASTATIN; TRIAL; THERAPY; RISK; SIMVASTATIN	Background and Aim The increase in proprotein convertase subtilisin/kexin type 9 (PCSK9) leads to low-density lipoprotein (LDL) receptor degradation. Statins significantly reduce LDL-cholesterol levels, but upregulate PCSK9. This study evaluated the effect of ezetimibe monotherapy or ezetimibe in combination with a statin on serum levels of PCSK9 in patients with type 2 diabetes and hypercholesterolemia. Methods Ezetimibe treatment was given to ten patients with diabetes without statin therapy and ten patients with statin therapy. Plasma levels of PCSK9 were examined at baseline and 24 weeks after treatment. Results At baseline, PCSK9 concentrations in patients with statin therapy were significantly higher than those in patients without statin use and in control subjects [median (25th-75th percentile) 411 (272-467) and 382 (356-453) ng/mL, respectively, p<0.01]. After ezetimibe treatment for 24 weeks, LDL-cholesterol, triglyceride and remnant-like lipoprotein cholesterol were significantly decreased in both groups. However, PCSK9 concentration did not change compared with baseline measurements in both groups. The percentage change in LDL-cholesterol after ezetimibe therapy for 24 weeks was not correlated with the percentage change in PCSK9 concentration. Conclusion Ezetimibe may reduce LDL-cholesterol levels without affecting PCSK9 in patients with type 2 diabetes and hypercholesterolemia.	[Miyoshi, Toru; Ito, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama 7008558, Japan; [Nakamura, Keigo] Kagawa Prefectural Cent Hosp, Dept Diabetol, Takamatsu, Kagawa, Japan; [Doi, Masayuki] Kagawa Prefectural Cent Hosp, Dept Cardiol, Takamatsu, Kagawa, Japan	Miyoshi, T (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	miyoshit@cc.okayama-u.ac.jp			 [24591053]	This work was supported by a Grant-in-Aid for Scientific Research (C), Grant Number 24591053. HI has received honoraria from Merck & Co. in the past. None of the other authors have any potential conflicts of interest that might be relevant to this work.	Alagona Peter Jr, 2009, Am J Manag Care, V15, pS65; Janis MT, 2013, ATHEROSCLEROSIS, V228, P380, DOI 10.1016/j.atherosclerosis.2013.03.029; Lakoski SG, 2010, J CLIN ENDOCR METAB, V95, P800, DOI 10.1210/jc.2009-1952; Nozue T, 2013, AM J CARDIOL, V111, P1415, DOI 10.1016/j.amjcard.2013.01.289; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Awan Z, 2012, CLIN CHEM, V58, P183, DOI 10.1373/clinchem.2011.172932; Sabatine MS, 2015, NEW ENGL J MED, V372, P1500, DOI 10.1056/NEJMoa1500858; Kathiresan S, 2008, NEW ENGL J MED, V358, P2299, DOI 10.1056/NEJMc0707445; Stein EA, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0310-3; Yunoki K, 2011, AM J CARDIOL, V108, P333, DOI 10.1016/j.amjcard.2011.03.049; Welder G, 2010, J LIPID RES, V51, P2714, DOI 10.1194/jlr.M008144; Sanderson LM, 2010, PHYSIOL GENOMICS, V41, P42, DOI 10.1152/physiolgenomics.00127.2009; Careskey HE, 2008, J LIPID RES, V49, P394, DOI 10.1194/jlr.M700437-JLR200; Robinson JG, 2014, JAMA-J AM MED ASSOC, V311, P1870, DOI 10.1001/jama.2014.4030; Tibolla G, 2011, NUTR METAB CARDIOVAS, V21, P835, DOI 10.1016/j.numecd.2011.06.002; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; AUSTIN MA, 1990, CIRCULATION, V82, P495; Morris PB, 2014, J AM COLL CARDIOL, V64, P196, DOI 10.1016/j.jacc.2014.05.015; Berneis K, 2010, EUR HEART J, V31, P1633, DOI 10.1093/eurheartj/ehq181; Berthold HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060095; Christopher P, 2014, CIRCULATION, V130, P2105, DOI 10.1161/01.cir.0000457464.79076.2c; Dadu RT, 2014, NAT REV CARDIOL, V11, P563, DOI 10.1038/nrcardio.2014.84; FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499; Han L, 2012, PHARMACOLOGY, V89, P74, DOI 10.1159/000335783; Hentze H, 2013, ATHEROSCLEROSIS, V231, P84, DOI 10.1016/j.atherosclerosis.2013.08.028; Huijgen R, 2012, J AM COLL CARDIOL, V59, P1778, DOI 10.1016/j.jacc.2011.12.043; Kubo M, 2014, AM J CARDIOVASC DRUG, V14, P387, DOI 10.1007/s40256-014-0082-3; Lan H, 2010, J CELL PHYSIOL, V224, P273, DOI 10.1002/jcp.22130; Li S, 2015, J ATHEROSCLER THROMB, V22, P221, DOI 10.5551/jat.27615; Nakamura T, 2011, ATHEROSCLEROSIS, V218, P163, DOI 10.1016/j.atherosclerosis.2011.04.040; Nakamura T, 2012, J CARDIOL, V60, P12, DOI 10.1016/j.jjcc.2012.02.005; Schectman G, 1996, CLIN CHEM, V42, P732; Teramoto T, 2012, J ATHEROSCLER THROMB, V20, P517; Uemura Y, 2012, J CARDIOL, V59, P50, DOI 10.1016/j.jjcc.2011.09.001; Zhang Y, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-35	36	0	0	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1175-3277	1179-187X		AM J CARDIOVASC DRUG	Am. J. Cardiovasc. Drugs	JUN	2015	15	3					213	219		10.1007/s40256-015-0119-2		7	Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy	Cardiovascular System & Cardiology; Pharmacology & Pharmacy	CJ6SW	WOS:000355624900007		
J	Kawaguchi, M; Kanemaru, A; Sawaguchi, A; Yamamoto, K; Baba, T; Lin, CY; Johnson, MD; Fukushima, T; Kataoka, H				Kawaguchi, Makiko; Kanemaru, Ai; Sawaguchi, Akira; Yamamoto, Koji; Baba, Takashi; Lin, Chen-Yong; Johnson, Michael D.; Fukushima, Tsuyoshi; Kataoka, Hiroaki			Hepatocyte Growth Factor Activator Inhibitor Type 1 Maintains the Assembly of Keratin into Desmosomes in Keratinocytes by Regulating Protease-Activated Receptor 2-Dependent p38 Signaling	AMERICAN JOURNAL OF PATHOLOGY			English	Article							TRANSMEMBRANE SERINE-PROTEASE; EPIDERMAL BARRIER FUNCTION; TRYPSIN-LIKE PROTEASE; EPITHELIAL-CELLS; KAPPA-B; MATRIPTASE ACTIVATION; PROTEOLYTIC CASCADE; CANCER CELLS; EXPRESSION; SKIN	Hepatocyte growth factor activator inhibitor type 1 (HAI-1; official symbol SPINT1) is a membrane-associated serine proteinase inhibitor abundantly expressed in epithelial tissues. Genetically engineered mouse models demonstrated that HAI-1 is critical for epidermal function, possibly through direct and indirect regulation of cell surface proteases, such as matriptase and prostasin. To obtain a better understanding of the role of HAI-1 in maintaining epidermal integrity, we performed ultrastructural analysis of Spint1-deleted mouse epidermis and organotypic culture of an HAI-1 knockdown (KD) human keratinocyte cell Line, HaCaT. We found that the aggregation of tonofilaments to desmosomes was significantly reduced in HAI-1 deficient mouse epidermis with decreased desmosome number. Similar findings were observed in HAI-1 KD HaCaT organotypic cultures. Immunoblot and immunohistochemical analyses revealed that p38 mitogen-activated protein kinase was activated in response to HAI-1 insufficiency. Treatment of HAI-1 KD HaCaT cells with a p38 inhibitor abrogated the above-observed ultrastructural abnormalities. The activation of p38 induced by the loss of HAI-1 Likely resulted from enhanced signaling of protease-activated receptor-2 (PAR-2), because its silencing abrogated the enhanced activation of p38. Consequently, treatment of HAI-1 KD HaCaT cells with a serine protease inhibitor, aprotinin, or PAR-2 antagonist alleviated the abnormal ultrastructural phenotype in organotypic culture. These results suggest that HAT-1 may have a critical role in maintaining normal keratinocyte morphology through regulation of PAR-2 dependent p38 mitogen-activated protein kinase signaling.	[Kawaguchi, Makiko; Kanemaru, Ai; Yamamoto, Koji; Fukushima, Tsuyoshi; Kataoka, Hiroaki] Miyazaki Univ, Sect Oncopathol & Regenerat Biol, Dept Pathol, Fac Med, Kiyotake, Miyazaki 8891692, Japan; [Sawaguchi, Akira] Miyazaki Univ, Sect Ultrastruct Cell Biol, Dept Anat, Fac Med, Kiyotake, Miyazaki 8891692, Japan; [Yamamoto, Koji; Baba, Takashi] Miyazaki Univ, Fac Med, Dept Oral & Maxillofacial Surg, Kiyotake, Miyazaki 8891692, Japan; [Lin, Chen-Yong; Johnson, Michael D.] Georgetown Univ, Sch Med, Dept Oncol, Lambardi Comprehens Canc Ctr, Washington, DC USA	Kataoka, H (reprint author), Miyazaki Univ, Sect Oncopathol & Regenerat Biol, Dept Pathol, Fac Med, 5200 Kihara, Kiyotake, Miyazaki 8891692, Japan.	mejina@med.miyazaki-u.ac.jp			Ministry of Education, Science, Sports and Culture, Japan [24390099, 25860166]	Supported by Ministry of Education, Science, Sports and Culture, Japan, grants-in-aid for scientific research 24390099 (H.K.) and 25860166 (M.K.).	Kataoka H, 2003, CANCER METAST REV, V22, P223, DOI 10.1023/A:1023051500010; Antalis TM, 2010, BIOCHEM J, V428, P325, DOI 10.1042/BJ20100046; Kitajima Y, 2013, KAOHSIUNG J MED SCI, V29, P1, DOI 10.1016/j.kjms.2012.08.001; Kawaguchi M, 2011, AM J PATHOL, V179, P1815, DOI 10.1016/j.ajpath.2011.06.038; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Sales KU, 2010, NAT GENET, V42, P676, DOI 10.1038/ng.629; Chokki M, 2004, AM J RESP CELL MOL, V30, P470, DOI 10.1165/rcmb.2003-0199OC; Wang S, 2009, J DERMATOL, V36, P534, DOI 10.1111/j.1346-8138.2009.00696.x; Wallace L, 2012, J CELL SCI, V125, P1750, DOI 10.1242/jcs.097139; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Kroger C, 2013, J CELL BIOL, V201, P681, DOI 10.1083/jcb.201208162; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; Madison KC, 2003, J INVEST DERMATOL, V121, P231, DOI 10.1046/j.1523-1747.2003.12359.x; Moniaga CS, 2013, AM J PATHOL, V182, P841, DOI 10.1016/j.ajpath.2012.11.039; Hovnanian A, 2013, CELL TISSUE RES, V351, P289, DOI 10.1007/s00441-013-1558-1; Jiang R, 2011, J BIOL CHEM, V286, P9127, DOI 10.1074/jbc.M110.191361; Kanke T, 2001, J BIOL CHEM, V276, P31657, DOI 10.1074/jbc.M100377200; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Chamcheu JC, 2011, J INVEST DERMATOL, V131, P1684, DOI 10.1038/jid.2011.93; Wilson S, 2005, BIOCHEM J, V388, P967, DOI 10.1042/BJ20041066; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj/onc/1205502; Buzza MS, 2013, J BIOL CHEM, V288, P10328, DOI 10.1074/jbc.M112.443432; Berkowitz P, 2005, J BIOL CHEM, V280, P23778, DOI 10.1074/jbc.M501365200; Basel-Vanagaite L, 2007, AM J HUM GENET, V80, P467, DOI 10.1086/512487; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Baba T, 2012, J PATHOL, V228, P181, DOI 10.1002/path.3993; Carvalho RFD, 2010, EXP DERMATOL, V19, P117, DOI 10.1111/j.1600-0625.2009.00998.x; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Derian CK, 1997, CELL GROWTH DIFFER, V8, P743; Frateschi S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1162; Friis S, 2014, J BIOL CHEM, V289, P22319, DOI 10.1074/jbc.M114.574400; Hashimoto T, 2010, FEBS J, V277, P4888, DOI 10.1111/j.1742-4658.2010.07894.x; Julovi SM, 2011, AM J PATHOL, V179, P2233, DOI 10.1016/j.ajpath.2011.07.024; Kataoka H, 2000, HISTOCHEM CELL BIOL, V114, P469; Kataoka H, 1999, J HISTOCHEM CYTOCHEM, V47, P673; Kataoka H, 2000, CANCER RES, V60, P6148; Kataoka H, 2010, FEBS J, V277, P2230, DOI 10.1111/j.1742-4658.2010.07640.x; Kato M, 2012, J BIOCHEM, V151, P179, DOI 10.1093/jb/mvr131; Kohama K, 2012, HUM CELL, V25, P100, DOI 10.1007/s13577-012-0055-2; Mao XM, 2011, J BIOL CHEM, V286, P1283, DOI 10.1074/jbc.M110.172874; Mavropoulos A, 2013, AUTOIMMUNE DIS, V2013; McMillan JR, 2003, J INVEST DERMATOL, V121, P96, DOI 10.1046/j.1523-1747.2003.12324.x; Mukai S, 2008, FEBS J, V275, P1003, DOI 10.1111/j.1742-4658.2008.06265.x; Nagaike K, 2008, AM J PATHOL, V173, P1464, DOI 10.2353/ajpath.2008.071142; Rattenholl A, 2008, DRUG NEWS PERSPECT, V21, P369, DOI 10.1358/dnp.2008.21.7.1255294; Roelandt T, 2011, J DERMATOL SCI, V61, P101, DOI 10.1016/j.jdermsci.2010.11.016; Sales KU, 2015, ONCOGENE, V34, P288, DOI 10.1038/onc.2013.563; Shi K, 2013, J THROMB HAEMOST, V11, P1892, DOI 10.1111/jth.12361; Szabo R, 2009, AM J PATHOL, V174, P2015, DOI 10.2353/ajpath.2009.090053; Tanaka H, 2005, MOL CELL BIOL, V25, P5687, DOI 10.1128/MCB.25.13.5687-8698.2005; Wadhawan V, 2012, BIOCHEM J, V447, P61, DOI 10.1042/BJ20111432; Wan H, 2004, BRIT J DERMATOL, V150, P878, DOI 10.1111/j.1365-2133.2004.05996.x; Wesselborg S, 1997, J BIOL CHEM, V272, P12422, DOI 10.1074/jbc.272.19.12422	53	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	JUN	2015	185	6					1610	1623		10.1016/j.ajpath.2015.02.009		14	Pathology	Pathology	CJ2YL	WOS:000355350500012		
J	Furuta, A; Kikuchi, H; Fujita, H; Yamada, D; Fujiwara, Y; Kabuta, T; Nishino, I; Wada, K; Uchiyama, Y				Furuta, Akiko; Kikuchi, Hisae; Fujita, Hiromi; Yamada, Daisuke; Fujiwara, Yuuki; Kabuta, Tomohiro; Nishino, Ichizo; Wada, Keiji; Uchiyama, Yasuo			Property of Lysosomai Storage Disease Associated with Midbrain Pathology in the Central Nervous System of Lamp-2-Deficient Mice	AMERICAN JOURNAL OF PATHOLOGY			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; MEMBRANE-PROTEIN LAMP-2; ALPHA-SYNUCLEIN; DANON-DISEASE; PARKINSONS-DISEASE; OXIDATIVE STRESS; DEGRADATION; CELLS; NEURODEGENERATION; CARDIOMYOPATHY	Lysosome-associated membrane protein-2 (LAMP-2) is the gene responsible for Danon disease, which is characterized by cardiomyopathy, autophagic vacuolar myopathy, and variable mental retardation. To elucidate the function of LAMP-2 in the central nervous system, we investigated the neuropathological changes in Lamp-2-deficient mice. Immunohistochemical observations revealed that Lamp-1 and cathepsin D-positive lysosomal structures increased in the large neurons of the mouse brain. Ubiquitin-immunoreactive aggregates and concanavalin A positive materials were detected in these neurons. By means of ultrastructural studies, we found various-shaped accumulations, including Lipofuscin, glycolipid-like materials, and membranous structures, in the neurons and glial cells of Lamp-2-deficient brains. In deficient mice, glycogen granules accumulated in hepatocyte lysosomes but were not observed in neurons. These pathological features indicate lysosomal storage disease; however, the findings are unlikely a consequence of deficiency of a single lysosomal enzyme. Although previous study results have shown a Large amount of autophagic vacuoles in parenchymal cells of the visceral organs, these findings were rarely detected in the brain tissue except for some axons in the substantia nigra, in which abundant activated microglial cells with increased lipid peroxidation were observed. Thus, LAMP-2 in the central nervous system has a possible role in the degradation of the various macromolecules in lysosomes and an additional function concerning protection from oxidative stress, especially in the substantia nigra.	[Furuta, Akiko; Uchiyama, Yasuo] Juntendo Univ, Grad Sch Med, Dept Cellular & Mol Neuropathol, Tokyo 1138421, Japan; [Kikuchi, Hisae; Fujita, Hiromi; Yamada, Daisuke; Fujiwara, Yuuki; Kabuta, Tomohiro; Wada, Keiji] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Kodaira, Tokyo 187, Japan; [Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Kodaira, Tokyo 187, Japan; [Fujiwara, Yuuki] Waseda Univ, Dept Elect Engn & Biosci, Grad Sch Adv Sci & Engn, Shinjuku Ku, Tokyo, Japan	Furuta, A (reprint author), Juntendo Univ, Grad Sch Med, Dept Cellular & Mol Neuropathol, Bunkyo Ku, Hongo 2-1-1, Tokyo 1138421, Japan.	afuruta@juntendo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [23590244]; Japan Society for the Promotion of Science [25290027, 16GS0315, 23111004, 23110517]; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Japan [05-32]; Ministry of Education, Culture, Sports, Science and Technology, Japan	Supported in part by Grant-in-Aid for Scientific Research (C) 23590244 from the Ministry of Education, Culture, Sports, Science and Technology (A.F.), Grant-in-Aid for Scientific Research 25290027 from the Japan Society for the Promotion of Science (K.W.), Grants-in-Aid for Scientific Research 05-32 from the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Japan (K.W.), Grant-in-Aid for Creative Scientific Research 16GS0315 and Grants-in-Aid for Scientific Research on Innovative Areas 23111004 and 23110517 from the Japan Society for the Promotion of Science (Y.U.), and the Ministry of Education, Culture, Sports, Science and Technology, Japan-supported Program for the Strategic Research Foundation at Private Universities (Y.U.).	Xilouri M, 2013, MOL NEUROBIOL, V47, P537, DOI 10.1007/s12035-012-8341-2; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; DANON MJ, 1981, NEUROLOGY, V31, P51; Bellettato CM, 2010, J INHERIT METAB DIS, V33, P347, DOI 10.1007/s10545-010-9075-9; Schneede A, 2011, J CELL MOL MED, V15, P280, DOI 10.1111/j.1582-4934.2009.00973.x; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Tanaka Y, 2000, NATURE, V406, P902; Koga H, 2011, NEUROBIOL DIS, V43, P29, DOI 10.1016/j.nbd.2010.07.006; Sugie K, 2005, J NEUROPATH EXP NEUR, V64, P513; Eskelinen EL, 2004, MOL BIOL CELL, V15, P3132, DOI 10.1091/mbc.E04-02-0103; Fujiwara Y, 2013, AUTOPHAGY, V9, P403, DOI 10.4161/auto.23002; Di Malta C, 2012, P NATL ACAD SCI USA, V109, pE2334, DOI 10.1073/pnas.1209577109; Fortunato F, 2009, GASTROENTEROLOGY, V137, P350, DOI 10.1053/j.gastro.2009.04.003; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Subramaniam SR, 2013, PROG NEUROBIOL, V106, P17, DOI 10.1016/j.pneurobio.2013.04.004; Fujiwara Y, 2013, AUTOPHAGY, V9, P1167, DOI 10.4161/auto.24880; Andrejewski N, 1999, J BIOL CHEM, V274, P12692, DOI 10.1074/jbc.274.18.12692; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Eskelinen EL, 2002, MOL BIOL CELL, V13, P3355, DOI 10.1091/mbc.E02-02-0114; Peschel A, 2014, J AM SOC NEPHROL, V25, P455, DOI 10.1681/ASN.2013030320; Dehay B, 2013, MOVEMENT DISORD, V28, P725, DOI 10.1002/mds.25462; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Furuta A, 2013, ACTA NEUROPATHOL, V125, P459, DOI 10.1007/s00401-012-1075-4; Crotzer VL, 2010, IMMUNOLOGY, V131, P318, DOI 10.1111/j.1365-2567.2010.03309.x; Eskelinen EL, 2005, TRAFFIC, V6, P1058, DOI 10.1111/j.1600-0854.2005.00337.x; FUKUDA M, 1988, J BIOL CHEM, V263, P18920; Furuta K, 2001, AM J PATHOL, V159, P449, DOI 10.1016/S0002-9440(10)61716-6; MANONI M, 1991, GENOMICS, V9, P551, DOI 10.1016/0888-7543(91)90424-D; Nishino Ichizo, 2003, Curr Neurol Neurosci Rep, V3, P64, DOI 10.1007/s11910-003-0040-y; Roy E, 2012, HUM MOL GENET, V21, P1481, DOI 10.1093/hmg/ddr584; Tsuchiya Y, 2007, FREE RADICAL BIO MED, V43, P1604, DOI 10.1016/j.freeradbiomed.2007.08.024; VIRTANEN I, 1980, PEDIATR RES, V14, P1199, DOI 10.1203/00006450-198011000-00010	35	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	JUN	2015	185	6					1713	1723		10.1016/j.ajpath.2015.02.015		11	Pathology	Pathology	CJ2YL	WOS:000355350500020		
J	Toriyama, Y; Iesato, Y; Imai, A; Sakurai, T; Kamiyoshi, A; Ichikawa-Shindo, Y; Kawate, H; Yamauchi, A; Igarashi, K; Tanaka, M; Liu, T; Xian, X; Zhai, LY; Owa, S; Murata, T; Shindo, T				Toriyama, Yuichi; Iesato, Yasuhiro; Imai, Akira; Sakurai, Takayuki; Kamiyoshi, Akiko; Ichikawa-Shindo, Yuka; Kawate, Hisaka; Yamauchi, Akihiro; Igarashi, Kyoko; Tanaka, Megumu; Liu, Tian; Xian, Xian; Zhai, Liuyu; Owa, Shinji; Murata, Toshinori; Shindo, Takayuki			Pathophysiological Function of Endogenous Calcitonin Gene-Related Peptide in Ocular Vascular Diseases	AMERICAN JOURNAL OF PATHOLOGY			English	Article							OXYGEN-INDUCED RETINOPATHY; CHOROIDAL NEOVASCULARIZATION; MACULAR DEGENERATION; ADRENOMEDULLIN-RAMP2 SYSTEM; TUMOR-GROWTH; IN-VIVO; ANGIOGENESIS; MICE; INFLAMMATION; INTEGRITY	Calcitonin gene-related peptide (CGRP; official name CALCA) has a variety of functions and exhibits both angiogenic and anti-inflammatory properties. We previously reported the angiogenic effects of the CGRP family peptide adrenomedullin in oxygen-induced retinopathy; however, the effects of CGRP on ocular angiogenesis remain unknown. Herein, we used CGRP knockout (CGRP(-/-)) mice to investigate the roles of CGRP in ocular vascular disease. Observation of pathological retinal angiogenesis in the oxygen-induced retinopathy model revealed no difference between CGRP(-/-) and wild-type mice. However, much higher Levels of the CGRP receptor were present in the choroid than the retina. Laser-induced choroidal neovascularization (CNV), a model of exudative age-related macular degeneration, revealed more severe CNV Lesions in CGRP(-/-) than wild-type mice, and fluorescein angiography showed greater leakage from CNV in CGRP(-/-). In addition, macrophage infiltration and tumor necrosis factor (TNF)-alpha production were enhanced within the CNV lesions in CGRP(-/-) mice, and the TNF-alpha, in turn, suppressed the barrier formation of retinal pigment epithelial cells. In vivo, CGRP administration suppressed CNV formation, and CGRP also dose dependently suppressed TNF-alpha production by isolated macrophages. From these data, we conclude that CGRP suppresses the development of leaky CNV through negative regulation of inflammation. CGRP may thus be a promising therapeutic agent for the treatment of ocular vascular diseases associated with inflammation.	[Toriyama, Yuichi; Iesato, Yasuhiro; Imai, Akira; Sakurai, Takayuki; Kamiyoshi, Akiko; Ichikawa-Shindo, Yuka; Kawate, Hisaka; Yamauchi, Akihiro; Igarashi, Kyoko; Tanaka, Megumu; Liu, Tian; Xian, Xian; Zhai, Liuyu; Owa, Shinji; Shindo, Takayuki] Shinshu Univ, Grad Sch Med, Dept Cardiovasc Dis, Matsumoto, Nagano 3908621, Japan; [Toriyama, Yuichi; Iesato, Yasuhiro; Imai, Akira; Murata, Toshinori] Shinshu Univ, Sch Med, Dept Ophthalmol, Matsumoto, Nagano 3908621, Japan	Shindo, T (reprint author), Shinshu Univ, Grad Sch Med, Dept Cardiovasc Dis, Asahi 3-1-1, Matsumoto, Nagano 3908621, Japan.	tshindo@shinshu-u.ac.jp			Cabinet Office, Government of Japan; Funding Program for Next Generation World-Leading Researchers (NEXT Program); (KAKENHI), the Japan Science and Technology Agency CREST; National Cardiovascular Center research grant for cardiovascular diseases; Novartis Foundation for Gerontological Research; Ichiro Kanehara Foundation; Cosmetology Research Foundation; SENSHIN Medical Research Foundation; Nagao Memorial Fund research grant; Kanzawa Medical Research Foundation; Ono Medical Research Foundation; Nakatomi Foundation; Japan Heart Foundation; Astellas/Pfizer; Research Foundation for Opto-Science and Technology; Japan Vascular Disease Research Foundation; Takeda Science Foundation	Supported by the Cabinet Office, Government of Japan, Funding Program for Next Generation World-Leading Researchers (NEXT Program), a Grant-in-Aid for Scientific Research (KAKENHI), the Japan Science and Technology Agency CREST, a National Cardiovascular Center research grant for cardiovascular diseases, and the Novartis Foundation for Gerontological Research research grant, the Ichiro Kanehara Foundation research grant, the Cosmetology Research Foundation research grant, SENSHIN Medical Research Foundation research grant, Nagao Memorial Fund research grant, Kanzawa Medical Research Foundation research grant, Ono Medical Research Foundation research grant, the Nakatomi Foundation research grant, the Japan Heart Foundation and Astellas/Pfizer grant for research on atherosclerosis update, the Research Foundation for Opto-Science and Technology research grant, the Japan Vascular Disease Research Foundation research grant, and Takeda Science Foundation research grant.	Iimuro S, 2004, CIRC RES, V95, P415, DOI 10.1161/01.RES.0000138018.61065.d1; Ashizuka S, 2009, MICROBIOL IMMUNOL, V53, P573, DOI 10.1111/j.1348-0421.2009.00159.x; Mor F, 2004, J IMMUNOL, V172, P4618; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; McLatchie LM, 1998, NATURE, V393, P333; Niu P, 2004, CIRCULATION, V109, P1789, DOI 10.1161/01.CIR.0000118466.47982.CC; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; LOPEZ PF, 1991, AM J OPHTHALMOL, V112, P647; Yu HG, 2008, INVEST OPHTH VIS SCI, V49, P2599, DOI 10.1167/iovs.07-1508; Shindo T, 2001, CIRCULATION, V104, P1964, DOI 10.1161/hc4101.097111; Zheng SA, 2010, AM J PHYSIOL-CELL PH, V299, pC1485, DOI 10.1152/ajpcell.00173.2010; Mapp PI, 2012, BRIT J PHARMACOL, V166, P1261, DOI 10.1111/j.1476-5381.2012.01848.x; Khandhadia S, 2012, IMMUNOBIOLOGY, V217, P127, DOI 10.1016/j.imbio.2011.07.019; Oh-hashi Y, 2001, CIRC RES, V89, P983, DOI 10.1161/hh2301.100812; Ichikawa-Shindo Y, 2008, J CLIN INVEST, V118, P29, DOI 10.1172/JCI33022; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; ROSENFELD MG, 1983, NATURE, V304, P129, DOI 10.1038/304129a0; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Izumi-Nagai K, 2007, AM J PATHOL, V170, P2149, DOI 10.2353/ajpath.2007.061018; Mishima T, 2011, AM J PHYSIOL-HEART C, V300, pH431, DOI 10.1152/ajpheart.00466.2010; Koyama T, 2013, CIRCULATION, V127, P842, DOI 10.1161/CIRCULATIONAHA.112.000756; Yasuda M, 2009, OPHTHALMOLOGY, V116, P2135, DOI 10.1016/j.ophtha.2009.04.017; Kamiyoshi A, 2009, LIVER INT, V29, P642, DOI 10.1111/j.1478-3231.2008.01841.x; Toda M, 2008, P NATL ACAD SCI USA, V105, P13550, DOI 10.1073/pnas.0800767105; Yuda K, 2012, AM J PATHOL, V181, P1464, DOI 10.1016/j.ajpath.2012.06.028; Toda M, 2008, BIOMED PHARMACOTHER, V62, P352, DOI 10.1016/j.biopha.2008.02.003; Kawasaki R, 2010, OPHTHALMOLOGY, V117, P921, DOI 10.1016/j.ophtha.2009.10.007; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; Hoerster R, 2012, GRAEF ARCH CLIN EXP, V250, P1579, DOI 10.1007/s00417-012-1990-z; de Hoz R, 2008, HISTOL HISTOPATHOL, V23, P1249; Holzmann B, 2013, CURR PROTEIN PEPT SC, V14, P268; Iesato Y, 2013, AM J PATHOL, V182, P2380, DOI 10.1016/j.ajpath.2013.02.015; Kamiyoshi Akiko, 2006, Biochem Biophys Res Commun, V343, P152, DOI 10.1016/j.bbrc.2006.02.132; Malchiodi-Albedi F, 2008, PPAR RES, DOI 10.1155/2008/295784; Matsuda R, 2012, INVEST OPHTH VIS SCI, V53, P5475, DOI 10.1167/iovs.12-9935; Ohno T, 2008, GASTROENTEROLOGY, V134, P215, DOI 10.1053/j.gastro.2007.10.001; Rozewski DM, 2012, AAPS J, V14, P872, DOI 10.1208/s12248-012-9401-2	38	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	JUN	2015	185	6					1783	1794		10.1016/j.ajpath.2015.02.017		12	Pathology	Pathology	CJ2YL	WOS:000355350500025		
J	Nakagawa, S; Ozaki, R; Take, Y; Mae, T; Hayashida, K				Nakagawa, Shigeto; Ozaki, Ritsuro; Take, Yasuhiro; Mae, Tatsuo; Hayashida, Kenji			Bone Fragment Union and Remodeling After Arthroscopic Bony Bankart Repair for Traumatic Anterior Shoulder Instability With a Glenoid Defect: Influence on Postoperative Recurrence of Instability	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						traumatic anterior shoulder instability; glenoid defect; arthroscopic bony Bankart repair; bone union; bone fragment remodeling; postoperative recurrence	GLENOHUMERAL INSTABILITY; LESIONS; DISLOCATION; STABILITY	Background: Although good clinical outcomes have been reported after arthroscopic bony Bankart repair, the extent of bone union is still unclear. Purpose: To investigate bone union after arthroscopic bony Bankart repair and its influence on postoperative recurrence of instability. Study Design: Cohort study; Level of evidence, 3. Methods: Among 113 consecutive shoulders that underwent arthroscopic bony Bankart repair, postoperative evaluation of bone union by computed tomography (CT) was performed at various times in 81 shoulders. Bone union was investigated during 3 periods: 3 to 6 months postoperatively (first period), 7 to 12 months postoperatively (second period), and 13 months or more postoperatively (third period). The influence of the size of the preoperative glenoid defect and the size of the bone fragment on bone union was investigated, as well as the influence of bone union on postoperative recurrence of instability. In shoulders with bone union, bone fragment remodeling and changes in the glenoid defect size were also investigated. Results: The bone union rate was 30.5% in the first period, 55.3% in the second period, and 84.6% in the third period. Among 53 shoulders with CT evaluation in the second period or later and follow-up for a minimum of 1 year, there was complete union in 33 shoulders (62.3%), partial union in 3 (5.7%), nonunion in 8 (15.1%), and no fragment on CT in 9 (17.0%). The complete union rate was 50% for 22 shoulders with small bone fragments (<5% of the glenoid diameter), 56.3% for 16 shoulders with medium fragments (5%-10%), and 86.7% for 15 shoulders with large fragments (>10%). The recurrence rate for postoperative instability was only 6.1% for shoulders with complete union, while it was 50% for shoulders with partial union, nonunion, no fragment, and no fragment on CT. The recurrence rate was significantly higher (36.4%) in shoulders with small fragments, but it was significantly lower in shoulders with bone union. In shoulders with bone union, the bone fragment frequently became larger over time, while the size of the glenoid defect decreased significantly from 18.6% preoperatively to 4.7% postoperatively. Conclusion: Bone union was not always achieved after arthroscopic bony Bankart repair, and union was often delayed. Recurrence of instability was significantly more frequent when bone union failed. The size of the glenoid defect decreased significantly in shoulders with bone union.	[Nakagawa, Shigeto; Ozaki, Ritsuro; Take, Yasuhiro; Mae, Tatsuo; Hayashida, Kenji] Yukioka Hosp, Dept Orthopaed Sports Med, Osaka, Osaka 5300021, Japan	Nakagawa, S (reprint author), Yukioka Hosp, Dept Orthopaed Sports Med, Kita Ku, 2-2-3 Ukita, Osaka, Osaka 5300021, Japan.	nakagawa@yukioka.or.jp					Sugaya H, 2003, J BONE JOINT SURG AM, V85A, P878; Kim YK, 2014, AM J SPORT MED, V42, P86, DOI 10.1177/0363546513509062; Boileau P, 2007, ARTHROSCOPY, V23, P593, DOI 10.1016/j.arthro.2007.03.096; Griffith JF, 2008, AM J ROENTGENOL, V190, P1247, DOI 10.2214/AJR.07.3009; Burkhart SS, 2000, ARTHROSCOPY, V16, P677, DOI 10.1053/jars.2000.17715; Jiang CY, 2013, AM J SPORT MED, V41, P2617, DOI 10.1177/0363546513499304; Sugaya H, 2005, J BONE JOINT SURG AM, V87A, P1752, DOI 10.2106/JBJS.D.02204; Porcellini G, 2007, AM J SPORT MED, V35, P2067, DOI 10.1177/0363546507305011; Milano G, 2011, AM J SPORT MED, V39, P1870, DOI 10.1177/0363546511411699; Nakagawa S, 2013, AM J SPORT MED, V41, P1380, DOI 10.1177/0363546513483087; Itoi E, 2000, J BONE JOINT SURG AM, V82A, P35; Yamamoto N, 2009, AM J SPORT MED, V37, P949, DOI 10.1177/0363546508330139; Park JY, 2012, ARTHROSCOPY, V28, P465, DOI 10.1016/j.arthro.2011.09.008; Saito H, 2005, AM J SPORT MED, V33, P889, DOI 10.1177/0363546504271521; Lo IKY, 2004, ARTHROSCOPY, V20, P169, DOI 10.1016/j.arthro.2003.11.036; Fujii Y, 2006, J SHOULDER ELB SURG, V15, P218, DOI 10.1016/j.jse.2005.06.006; Kitayama S, 2013, ARTHROSCOPY, V29, pe150; Lafosse L, 2007, ARTHROSCOPY, V23, p[1242, e1241], DOI DOI 10.1016/J.ARTHR0.2007.06.008; Nakagawa S, ORTHOP J SPORTS MED, DOI [10. 1177/2325967114529920, DOI 10.1177/2325967114529920]; Taverna E, 2008, KNEE SURG SPORT TR A, V16, P872, DOI 10.1007/s00167-008-0541-y	20	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JUN	2015	43	6					1438	1447		10.1177/0363546515571555		10	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	CJ3JM	WOS:000355379200020		
J	Taniguchi, D; Mizoguchi, Y				Taniguchi, Daiki; Mizoguchi, Yasushi			Retinoic acids change gene expression profiles of bovine intramuscular adipocyte differentiation, based on microarray analysis	ANIMAL SCIENCE JOURNAL			English	Article						beef marbling; bovine intramuscular preadipocyte; intramuscular adipogenesis; retinoic acids receptors; vitamin A	ADIPOSE-TISSUE; VITAMIN-A; INHIBITS DIFFERENTIATION; ADIPOGENESIS; PREADIPOCYTES; PROTEIN; HOMEOSTASIS; METABOLISM; INDUCTION; COLLAGEN	Beef marbling is caused by intramuscular deposition and it is an economically important trait in the beef industry. Vitamin A (VA) is an important feed supplement for cattle, but it can hinder marbling if provided in excess. In cattle, VA forms various derivatives such as all-trans retinoic acid (ATRA) and 9-cis retinoic acid (9cRA). Therefore, we investigated the genes involved in bovine intramuscular adipogenesis after VA treatment with ATRA and 9cRA. Differential gene expression levels were validated by microarray analysis in a clonal bovine intramuscular preadipocyte (BIP) cell line derived from the intramuscular adipose tissue of Japanese Black cattle. BIP cells were harvested 6 days after adipogenic stimulation with either 1mol/L ATRA, 1mol/L 9cRA or non-retinoic acid control. The ATRA- and 9cRA-treated cells exhibited reduced transcription of genes involved in the circulatory system and muscle development compared with the no retinoic acid (RA) treatment. In addition, the ATRA- and 9cRA-treated cells exhibited increased transcription of genes involved in the immune system, protein kinase B signaling and responses to various stimuli. These results demonstrate the lower expression of muscle development in ATRA- and 9cRA-treated BIP cells during adipogenesis.	[Taniguchi, Daiki; Mizoguchi, Yasushi] Meiji Univ, Grad Sch Agr, Kawasaki, Kanagawa 2148571, Japan; [Mizoguchi, Yasushi] Meiji Univ, Sch Agr, Kawasaki, Kanagawa 2148571, Japan	Mizoguchi, Y (reprint author), Meiji Univ, Sch Agr, Kawasaki, Kanagawa 2148571, Japan.	yasum@isc.meiji.ac.jp			Meiji University	We would like to thank Dr. Hisashi Aso of the Tohoku University for providing BIP cells. We also thank Dr. I. McTaggart for his critical review of this manuscript. This work was supported by Research Project Grants from the Meiji University.	Adachi K, 1999, J VET MED SCI, V61, P961, DOI 10.1292/jvms.61.961; Ziouzenkova O, 2008, FEBS LETT, V582, P32, DOI 10.1016/j.febslet.2007.11.081; Burgos C, 2012, MEAT SCI, V90, P309, DOI 10.1016/j.meatsci.2011.07.016; Puchau B, 2009, EUR J CLIN NUTR, V63, P858, DOI 10.1038/ejcn.2008.48; Xue JC, 1996, MOL CELL BIOL, V16, P1567; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Li JP, 2003, P NATL ACAD SCI USA, V100, P9476, DOI 10.1073/pnas.1133426100; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Oka A, 1998, MEAT SCI, V48, P159, DOI 10.1016/S0309-1740(97)00086-7; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Ohyama M, 1998, J ANIM SCI, V76, P61; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; Desruisseaux MS, 2007, INFECT IMMUN, V75, P1066, DOI 10.1128/IAI.01455-06; Hirai S, 2007, DOMEST ANIM ENDOCRIN, V32, P1, DOI 10.1016/j.domaniend.2005.12.001; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; ASO H, 1995, BIOCHEM BIOPH RES CO, V213, P369, DOI 10.1006/bbrc.1995.2141; Chae S. H., 2003, Journal of Animal Science and Technology, V45, P585; Fontanesi L, 2010, J ANIM SCI, V88, P2235, DOI 10.2527/jas.2009-2560; Garcia-Rojas P, 2010, J ANIM SCI, V88, P1801, DOI 10.2527/jas.2009-2579; Gauvreau D, 2012, MOL IMMUNOL, V51, P73, DOI 10.1016/j.molimm.2012.02.110; Inafuku M, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-124; Inoue-Murayama M, 2000, DIFFERENTIATION, V65, P281, DOI 10.1046/j.1432-0436.2000.6550281.x; Kato Y, 2011, J ANIM SCI, V89, P951, DOI 10.2527/jas.2010-2872; Mizoguchi Y, 2010, ANIM GENET, V41, P436, DOI 10.1111/j.1365-2052.2010.02022.x; Mizoguchi Y, 2014, ANIM SCI J, V85, P101, DOI 10.1111/asj.12101; Muthuraman P, 2014, APPL BIOCHEM BIOTECH, V173, P571, DOI 10.1007/s12010-014-0866-6; Nade T, 2003, ASIAN AUSTRAL J ANIM, V16, P353; Tahara K, 2004, DIFFERENTIATION, V72, P113, DOI 10.1111/j.1432-0436.2004.07204006.x; VOLPE JJ, 1973, ANNU REV BIOCHEM, V42, P21, DOI 10.1146/annurev.bi.42.070173.000321; Yamasaki Tadashi, 2005, Animal Science Journal, V76, P479, DOI 10.1111/j.1740-0929.2005.00294.x; Yamasaki T, 2006, CELL TISSUE RES, V326, P139, DOI 10.1007/s00441-006-0194-4	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	JUN	2015	86	6					579	587		10.1111/asj.12338		9	Agriculture, Dairy & Animal Science	Agriculture	CJ7SF	WOS:000355698700002		
J	Zhang, J; Guo, G; Chen, L; Li, JF; Yuan, XJ; Yu, CQ; Shimojo, M; Shao, T				Zhang, Jie; Guo, Gang; Chen, Lei; Li, Junfeng; Yuan, Xianjun; Yu, Chengqun; Shimojo, Masataka; Shao, Tao			Effect of applying lactic acid bacteria and propionic acid on fermentation quality and aerobic stability of oats-common vetch mixed silage on the Tibetan plateau	ANIMAL SCIENCE JOURNAL			English	Article						aerobic stability; fermentation quality; lactic acid bacteria; oat-common vetch mixture; propionic acid	CORN-SILAGE; FORMIC-ACID; LACTOBACILLUS-BUCHNERI; VOLUNTARY INTAKE; CROP SILAGES; ADDITIVES; WHEAT; MOLASSES; DIGESTIBILITY; INOCULANT	The objective of this study was to evaluate effects of lactic acid bacteria and propionic acid on the fermentation quality and aerobic stability of oats-common vetch mixed silage by using a small-scale fermentation system on the Tibetan plateau. (i) An inoculant (Lactobacillus plantarum) (L) or (ii) propionic acid (P) or (iii) inoculant+propionic acid (PL) were used as additives. After fermenting for 60 days, silos were opened and the aerobic stability was tested for the following 15 days. The results showed that all silages were well preserved with low pH and NH3-N, and high lactic acid content and V-scores. L and PL silages showed higher (P<0.05) lactic acid and crude protein content than the control silage. P silage inhibited lactic acid production. Under aerobic conditions, L silage had similar yeast counts as the control silage (>10(5)cfu/g fresh matter (FM)); however, it numerically reduced aerobic stability for 6h. P and PL silages showed fewer yeasts (<10(5)cfu/g FM) (P<0.05) and markedly improved the aerobic stability (>360h). The result suggested that PL is the best additive as it could not only improved fermentation quality, but also aerobic stability of oats-common vetch mixed silage on the Tibetan plateau.	[Zhang, Jie; Guo, Gang; Chen, Lei; Li, Junfeng; Yuan, Xianjun; Shao, Tao] Nanjing Agr Univ, Inst Ensiling & Proc Grass, Coll Anim Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China; [Yu, Chengqun] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Shimojo, Masataka] Kyushu Univ, Fac Agr, Dept Anim & Marine Bioresource Sci, Fukuoka 812, Japan	Shao, T (reprint author), Nanjing Agr Univ, Inst Ensiling & Proc Grass, Coll Anim Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China.	taoshaolan@163.com			grant for key techniques research in straw-grass mixed silage from Tibet [XZ20093ZD]; National '12th Five-Year' Plan for Science and Technology: Comprehensive treatment key technology and demonstration project of the Degraded grassland in north Tibetan Plateau [2011BAC09B03]; Tibet innovation platform construction by Chinese Academy of Sciences 'construction and demonstration of agriculture and animal husbandry combination technology to promote the income of farmers and herdsmen in Tibet'	This work was supported by the grant for key techniques research in straw-grass mixed silage from Tibet (XZ20093ZD), National '12th Five-Year' Plan for Science and Technology: Comprehensive treatment key technology and demonstration project of the Degraded grassland in north Tibetan Plateau (2011BAC09B03) and Tibet innovation platform construction by Chinese Academy of Sciences 'construction and demonstration of agriculture and animal husbandry combination technology to promote the income of farmers and herdsmen in Tibet'.	Adesogan AT, 2002, GRASS FORAGE SCI, V57, P25, DOI 10.1046/j.1365-2494.2002.00298.x; Adesogan AT, 2004, J SCI FOOD AGR, V84, P983, DOI 10.1002/jsfa.1745; BRODERICK GA, 1980, J DAIRY SCI, V63, P64; MOON NJ, 1983, J APPL BACTERIOL, V55, P453, DOI 10.1111/j.1365-2672.1983.tb01685.x; Weissbach F, 1996, LANDBAUFORSCH VOLK, V46, P10; WOOLFORD MK, 1975, J SCI FOOD AGR, V26, P219, DOI 10.1002/jsfa.2740260213; Baytok E, 2005, TURK J VET ANIM SCI, V29, P469; Assefa G, 2001, ANIM FEED SCI TECH, V92, P95, DOI 10.1016/S0377-8401(01)00242-5; Barker SB, 1941, J BIOL CHEM, V138, P535; Ranjit NK, 2000, J DAIRY SCI, V83, P526; THOMAS TA, 1977, J SCI FOOD AGR, V28, P639; Mandebvu P, 1999, ANIM FEED SCI TECH, V77, P317, DOI 10.1016/S0377-8401(98)00247-8; PLAYNE MJ, 1966, J SCI FOOD AGR, V17, P264, DOI 10.1002/jsfa.2740170609; Lauriault LM, 2004, AGRON J, V96, P352; Basso FC, 2012, REV BRAS ZOOTECN, V41, P1789, DOI 10.1590/S1516-35982012000700032; Bilal MQ, 2009, PAK VET J, V29, P19; Britt DG, 1977, J DAIRY SCI, V58, P532; Cao J, 2011, GRASS FORAGE SCI, V66, P333, DOI 10.1111/j.1365-2494.2011.00793.x; Fraser MD, 2000, GRASS FORAGE SCI, V55, P271, DOI 10.1046/j.1365-2494.2000.00225.x; GARCIA AD, 1989, J DAIRY SCI, V72, P93; Horii S, 1971, ANIMAL NUTR TESTING, V1st, P280; Huber JT, 1977, J DAIRY SCI, V59, P2063; Huisden CM, 2009, J DAIRY SCI, V92, P690, DOI 10.3168/jds.2008-1546; Kaiser A. G., 1987, Temperate pastures: their production, use and management., P397; Kennelly JJ, 2003, SILAGE SCI TECHNOLOG, P749; KRISHNAMOORTHY U, 1982, J DAIRY SCI, V65, P217; LUNNAN T, 1989, Norwegian Journal of Agricultural Sciences, V3, P57; McDonald P, 1991, BIOCH SILAGE, P81; McDonald P., 2002, ANIMAL NUTR; Muck RE, 1997, P SIL FIELD FEEDB N, P187; Pursiainen P, 2008, GRASS FORAGE SCI, V63, P60, DOI 10.1111/j.1365-2494.2007.00614.x; Shao T, 2005, ASIAN AUSTRAL J ANIM, V18, P1582; Takahashi Toshiyoshi, 2005, Animal Science Journal, V76, P353, DOI 10.1111/j.1740-0929.2005.00275.x; Titterton M, 1997, ANIM FEED SCI TECH, V69, P263, DOI 10.1016/S0377-8401(97)81640-9; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583; WEINBERG ZG, 1993, GRASS FORAGE SCI, V48, P70, DOI 10.1111/j.1365-2494.1993.tb01838.x; Weinberg ZG, 2008, CURRENT DEV SOLID ST, P443, DOI 10.1007/978-0-387-75213-6_19; Wilkinson J.M., 2005, ANAL CLIN ASSESSMENT, P198; Woolford MK, 1984, SILAGE MANAGEMENT, P42	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	JUN	2015	86	6					595	602		10.1111/asj.12340		8	Agriculture, Dairy & Animal Science	Agriculture	CJ7SF	WOS:000355698700004		
J	Jin, J; Hashizume, T				Jin, Jin; Hashizume, Tsutomu			Effects of hypothalamic dopamine on growth hormone-releasing hormone-induced growth hormone secretion and thyrotropin-releasing hormone-induced prolactin secretion in goats	ANIMAL SCIENCE JOURNAL			English	Article						dopamine; GH; GHRH; goat; PRL	OVINE PITUITARY-CELLS; FEMALE GOATS; TYROSINE-HYDROXYLASE; SOMATOSTATIN NEURONS; BETA-HYDROXYLASE; GENE-EXPRESSION; GH SECRETION; IN-VITRO; STIMULATION; PHOTOPERIOD	The aim of the present study was to clarify the effects of hypothalamic dopamine (DA) on the secretion of growth hormone (GH) in goats. The GH-releasing response to an intravenous (i.v.) injection of GH-releasing hormone (GHRH, 0.25g/kg body weight (BW)) was examined after treatments to augment central DA using carbidopa (carbi, 1mg/kg BW) and L-dopa (1mg/kg BW) in male and female goats under a 16-h photoperiod (16h light, 8h dark) condition. GHRH significantly and rapidly stimulated the release of GH after its i.v. administration to goats (P<0.05). The carbi and L-dopa treatments completely suppressed GH-releasing responses to GHRH in both male and female goats (P<0.05). The prolactin (PRL)-releasing response to an i.v. injection of thyrotropin-releasing hormone (TRH, 1g/kg BW) was additionally examined in male goats in this study to confirm modifications to central DA concentrations. The treatments with carbi and L-dopa significantly reduced TRH-induced PRL release in goats (P<0.05). These results demonstrated that hypothalamic DA was involved in the regulatory mechanisms of GH, as well as PRL secretion in goats.	[Jin, Jin; Hashizume, Tsutomu] Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan	Hashizume, T (reprint author), Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan.	hashi@iwate-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [24380149]	The authors wish to thank Dr. T. Johke, National Institute of Animal Industry, Tsukuba, Japan, for providing monkey anti-bGH, and the USDA Animal Hormone Program, Beltsville, MD, USA, for providing USDAbGH-B-1. They also wish to thank Dr. A. F. Parlow, National Hormone and Peptide Program, Harbor-UCLA Medical Center, Torrance, CA, USA for providing oPRL (NIDDK oPRL-1-3) and oPRL antiserum (AFP-C358106). This research was supported in part by a Grant-in-Aid for Scientific Research (No. 24380149) provided by the Japan Society for the Promotion of Science (JSPS).	Toth BE, 2002, NEUROTOXICOL TERATOL, V24, P655, DOI 10.1016/S0892-0362(02)00216-7; Veldhuis JD, 1996, J PEDIATR ENDOCR MET, V9, P237; TANNENBAUM GS, 1976, ENDOCRINOLOGY, V98, P562; Mogi K, 2002, ENDOCR J, V49, P145, DOI 10.1507/endocrj.49.145; Hashizume T, 2005, REGUL PEPTIDES, V126, P61, DOI 10.1016/j.regpep.2004.08.010; JANSSON JO, 1985, ENDOCR REV, V6, P128; Missale C, 1998, PHYSIOL REV, V78, P189; ROBERTSON DRC, 1989, BRIT J CLIN PHARMACO, V28, P61; Freeman ME, 2000, PHYSIOL REV, V80, P1523; LESHIN LS, 1995, J CHEM NEUROANAT, V9, P175, DOI 10.1016/0891-0618(95)00080-1; BANSAL S, 1981, J CLIN ENDOCR METAB, V53, P301; CAMANNI F, 1978, J CLIN ENDOCR METAB, V47, P647; CARLSON HE, 1986, J CLIN ENDOCR METAB, V63, P249; CURLEWIS JD, 1992, REPROD FERT DEVELOP, V4, P1, DOI 10.1071/RD9920001; Greg JL, 1984, FEBS LETT, V166, P189; Gruszka A, 2012, MOL CELL ENDOCRINOL, V362, P104, DOI 10.1016/j.mce.2012.05.020; HANEW K, 1986, TOHOKU J EXP MED, V148, P151, DOI 10.1620/tjem.148.151; Hanew K, 1996, J CLIN ENDOCR METAB, V81, P1952, DOI 10.1210/jc.81.5.1952; Hashizume T, 2000, DOMEST ANIM ENDOCRIN, V18, P253, DOI 10.1016/S0739-7240(99)00082-X; Hashizume Tsutomu, 1999, Journal of Reproduction and Development, V45, P273, DOI 10.1262/jrd.45.273; Hashizume T, 2012, ANIM SCI J, V83, P63, DOI 10.1111/j.1740-0929.2011.00914.x; Hashizume T, 2009, DOMEST ANIM ENDOCRIN, V36, P99, DOI 10.1016/j.domaniend.2008.11.001; Hashizume T, 1997, ENDOCR J, V44, P811, DOI 10.1507/endocrj.44.811; HASHIZUME T, 1994, DOMEST ANIM ENDOCRIN, V11, P331, DOI 10.1016/0739-7240(94)90004-3; Jaffe CA, 1996, J CLIN INVEST, V97, P934, DOI 10.1172/JCI118516; Jin J, 2012, ANIM SCI J, V83, P610, DOI 10.1111/j.1740-0929.2011.00998.x; Jin J, 2013, ANIM SCI J, V84, P130, DOI 10.1111/j.1740-0929.2012.01050.x; Jin J, 2013, ANIM SCI J, V84, P790, DOI 10.1111/asj.12073; Jin J, 2014, ANIM SCI J, V85, P461, DOI 10.1111/asj.12157; Kasuya E, 2013, ANIM SCI J, V84, P562, DOI 10.1111/asj.12037; LAW GJ, 1984, FEBS LETT, V166, P189, DOI 10.1016/0014-5793(84)80070-8; LESHIN LS, 1994, NEUROENDOCRINOLOGY, V59, P251, DOI 10.1159/000126666; MARS H, 1973, CLIN PHARMACOL THER, V14, P390; McMahon CD, 2001, DOMEST ANIM ENDOCRIN, V20, P65, DOI 10.1016/S0739-7240(01)00084-4; McMahon CD, 1998, DOMEST ANIM ENDOCRIN, V15, P257, DOI 10.1016/S0739-7240(98)00011-3; Neill Jimmy D., 1994, P1833; PINDER RM, 1976, DRUGS, V11, P329, DOI 10.2165/00003495-197611050-00001; Pletscher A, 1973, ADV NEUROL, V3, P49; SOYOOLA EO, 1994, P SOC EXP BIOL MED, V207, P26; STOLAR MW, 1986, METABOLISM, V35, P883, DOI 10.1016/0026-0495(86)90233-7; THIERY JC, 1991, J NEUROENDOCRINOL, V3, P407, DOI 10.1111/j.1365-2826.1991.tb00295.x; TILLET Y, 1989, J COMP NEUROL, V290, P69, DOI 10.1002/cne.902900106; Tillet Y, 1995, J Reprod Fertil Suppl, V49, P199; Veldhuis JD, 1998, GROWTH HORM IGF RES, V8, P49, DOI 10.1016/S1096-6374(98)80024-5; WAKABAYASHI I, 1977, ENDOCRINOL JAPON, V24, P601; West CR, 1997, DOMEST ANIM ENDOCRIN, V14, P349, DOI 10.1016/S0739-7240(97)00031-3; Yaegashi T, 2012, ANIM SCI J, V83, P418, DOI 10.1111/j.1740-0929.2011.00965.x; Yen SSC, 1991, REPROD ENDOCRINOLOGY, P357; Yonezawa T, 2005, ENDOCRINOLOGY, V146, P2736, DOI 10.1210/en.2004-1434	49	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	JUN	2015	86	6					634	640		10.1111/asj.12333		7	Agriculture, Dairy & Animal Science	Agriculture	CJ7SF	WOS:000355698700009		
J	Tsumura, K; Maeda, Y; Watanabe, H				Tsumura, Kyosuke; Maeda, Yoshitaka; Watanabe, Hiroyuki			Rare transition event with self-consistent theory of large-amplitude collective motion	ANNALS OF PHYSICS			English	Article						Rare transition event; Collective path	MINIMUM ENERGY PATHS; COORDINATE METHOD; ELEMENTARY THEORY; SADDLE-POINTS; DYNAMICS; PARTICLES; PROTEINS	A numerical simulation method, based on Dang et al.'s selfconsistent theory of large-amplitude collective motion, for rare transition events is presented. The method provides a one-dimensional pathway without knowledge of the final configuration, which includes a dynamical effect caused by not only a potential but also kinetic term. Although it is difficult to apply the molecular dynamics simulation to a narrow-gate potential, the method presented is applicable to the case. A toy model with a high-energy barrier and/or the narrow gate shows that while the Dang et al. treatment is unstable for a changing of model parameters, our method stable for it. (C) 2015 Elsevier Inc. All rights reserved.	[Tsumura, Kyosuke; Maeda, Yoshitaka; Watanabe, Hiroyuki] Fujifilm Corp, Anal Technol Ctr, Res & Dev Management Headquarters, Kanagawa 2500193, Japan	Tsumura, K (reprint author), Fujifilm Corp, Anal Technol Ctr, Res & Dev Management Headquarters, Kanagawa 2500193, Japan.	kyosuke.tsumura@fujifilm.com					Nakajima N, 1997, J PHYS CHEM B, V101, P817, DOI 10.1021/jp962142e; RUNGE E, 1984, PHYS REV LETT, V52, P997, DOI 10.1103/PhysRevLett.52.997; Henkelman G, 2000, J CHEM PHYS, V113, P9978, DOI 10.1063/1.1323224; Miyashita O, 2003, P NATL ACAD SCI USA, V100, P12570, DOI 10.1073/pnas.2135471100; Fukunishi Y, 2003, J PHYS CHEM B, V107, P13201, DOI 10.1021/jp035478e; MULLER K, 1979, THEOR CHIM ACTA, V53, P75, DOI 10.1007/BF00547608; FUKUI K, 1975, J AM CHEM SOC, V97, P1, DOI 10.1021/ja00834a001; MCCAMMON JA, 1984, REP PROG PHYS, V47, P1, DOI 10.1088/0034-4885/47/1/001; Matsuo M, 2000, PROG THEOR PHYS, V103, P959, DOI 10.1143/PTP.103.959; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; TOMONAGA S, 1955, PROG THEOR PHYS, V13, P467, DOI 10.1143/PTP.13.467; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; AOYAMA H, 1992, NUCL PHYS B, V369, P219, DOI 10.1016/0550-3213(92)90384-N; CHOU KC, 1984, BIOPHYS CHEM, V20, P61, DOI 10.1016/0301-4622(84)80005-8; Dang G. D., 2000, Physics Reports, V335, DOI 10.1016/S0370-1573(99)00119-2; DEBRUNNER PG, 1982, ANNU REV PHYS CHEM, V33, P283, DOI 10.1146/annurev.pc.33.100182.001435; DODANG G, 1987, PHYS REV C, V36, P2661, DOI 10.1103/PhysRevC.36.2661; KLEIN A, 1991, ANN PHYS-NEW YORK, V208, P90, DOI 10.1016/0003-4916(91)90343-7; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; MARUMORI T, 1980, PROG THEOR PHYS, V64, P1294, DOI 10.1143/PTP.64.1294; MATSUO M, 1986, PROG THEOR PHYS, V76, P372, DOI 10.1143/PTP.76.372; MATSUO M, 1985, PROG THEOR PHYS, V74, P288, DOI 10.1143/PTP.74.288; TOMONAGA S, 1955, PROG THEOR PHYS, V13, P482, DOI 10.1143/PTP.13.482; Tsumura K., UNPUB; WALET NR, 1989, J CHEM PHYS, V91, P2848, DOI 10.1063/1.456954; Wang J., 2004, J COMPUT CHEM, V25	26	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-4916	1096-035X		ANN PHYS-NEW YORK	Ann. Phys.	JUN	2015	357						79	94		10.1016/j.aop.2015.04.001		16	Physics, Multidisciplinary	Physics	CK0JY	WOS:000355892700006		
J	Koch-Dandolo, CL; Filtenborg, T; Fukunaga, K; Skou-Hansen, J; Jepsen, PU				Koch-Dandolo, Corinna L.; Filtenborg, Troels; Fukunaga, Kaori; Skou-Hansen, Jacob; Jepsen, Peter Uhd			Reflection terahertz time-domain imaging for analysis of an 18th century neoclassical easel painting	APPLIED OPTICS			English	Article								Terahertz time-domain imaging (THz-TDI) has been applied for imaging a hidden portrait and other subsurface composition layers of an 18th century (18C) easel painting by Nicolai Abildgaard, the most important 18C Danish neoclassical painter of historical and mythological subjects. For the first time, a real hidden portrait on an easel painting has been imaged by THz-TDI, with an unexpected richness of detail. THz C-and B-scans have been compared with images obtained by x-ray radiography and invasive cross-sectional imaging, leading to a deeper understanding of the strengths and limitations of this technique for art diagnostic purposes and defining its role among complementary tools for the investigation of art objects. We present a fast and effective method to separate single THz pulse reflections of interest from the entire signal across the image, adapted for uneven surfaces typically encountered in practical applications of the technique. Interfaces between layers of the painting have been successfully imaged, contributing substantially to the understanding of the structure of the painting. (C) 2015 Optical Society of America	[Koch-Dandolo, Corinna L.; Jepsen, Peter Uhd] Tech Univ Denmark, Dept Photon Engn, DK-2800 Lyngby, Denmark; [Filtenborg, Troels; Skou-Hansen, Jacob] Statens Museum Kunst, DK-1307 Copenhagen K, Denmark; [Fukunaga, Kaori] Natl Inst Informat & Commun Technol, Tokyo, Japan	Koch-Dandolo, CL (reprint author), Tech Univ Denmark, Dept Photon Engn, DK-2800 Lyngby, Denmark.	clkd@fotonik.dtu.dk					Janssens K, 2010, ACCOUNTS CHEM RES, V43, P814, DOI 10.1021/ar900248e; Abraham E, 2010, APPL PHYS A-MATER, V100, P585, DOI 10.1007/s00339-010-5642-z; Buron JD, 2012, NANO LETT, V12, P5074, DOI 10.1021/nl301551a; Seco-Martorell C, 2013, OPT EXPRESS, V21, P17800, DOI 10.1364/OE.21.017800; Alfeld M, 2013, SPECTROCHIM ACTA B, V88, P211, DOI 10.1016/j.sab.2013.07.009; Adam AJL, 2009, OPT EXPRESS, V17, P3407, DOI 10.1364/OE.17.003407; Filippidis G, 2012, APPL PHYS A-MATER, V106, P257, DOI 10.1007/s00339-011-6691-7; Filtenborg T., 2014, FORMULA FREESTYLE NI; Fukunaga K., 2010, ICECOM C P 20 23 SEP; Jackson JB, 2008, OPT COMMUN, V281, P527, DOI 10.1016/j.optcom.2007.10.049; Radpour R, 2014, PROC SPIE, V9199, DOI 10.1117/12.2062228	11	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	JUN 1	2015	54	16					5123	5129		10.1364/AO.54.005123		7	Optics	Optics	CJ5UF	WOS:000355555700025		
J	Takabayashi, M; Okamoto, A; Eto, T; Okamoto, T				Takabayashi, Masanori; Okamoto, Atsushi; Eto, Taisuke; Okamoto, Takashi			Recording procedures for high-quality signal readout in self-referential holographic data storage	APPLIED OPTICS			English	Article							EFFICIENCY; DESIGN	Two methods are proposed to improve the readout quality of signals in self-referential holographic data storage (SR-HDS), in which no reference beam is required to record and read digital data holographically: the off-the-focus (OtF) method and the oversampling additional pattern (OsAP) method. The focal point is located outside of the recording medium in the OtF method, and the signal pattern is recorded with an additional pattern that possesses a higher spatial frequency than the signal pattern in the OsAP method. Experimental results show that both methods are effective for drastically improving the signal-to-noise ratio (SNR). In addition, through numerical simulation, it can be observed that the readout quality is improved by the achievement of homogeneous hologram distribution. (C) 2015 Optical Society of America	[Takabayashi, Masanori; Eto, Taisuke; Okamoto, Takashi] Kyushu Inst Technol, Dept Syst Design & Informat, Iizuka, Fukuoka 8208502, Japan; [Okamoto, Atsushi] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido 0600814, Japan	Takabayashi, M (reprint author), Kyushu Inst Technol, Dept Syst Design & Informat, 680-4 Kawazu, Iizuka, Fukuoka 8208502, Japan.	takabayashi@ces.kyutech.ac.jp	Okamoto, Takashi/B-1351-2008	Okamoto, Takashi/0000-0001-6351-236X			Psaltis D, 1998, COMPUTER, V31, P52, DOI 10.1109/2.652917; Duran V, 2006, OPT EXPRESS, V14, P5607, DOI 10.1364/OE.14.005607; Tanaka K, 2007, OPT EXPRESS, V15, P16196, DOI 10.1364/OE.15.016196; Horimai H, 2005, APPL OPTICS, V44, P2575, DOI 10.1364/AO.44.002575; Barada D, 2012, OPT LETT, V37, P4528, DOI 10.1364/OL.37.004528; Okamoto A, 2011, OPT EXPRESS, V19, P13436, DOI 10.1364/OE.19.013436; VANHEERDEN PJ, 1963, APPL OPTICS, V2, P393; Nobukawa T, 2014, APPL OPTICS, V53, P3773, DOI 10.1364/AO.53.003773; Takabayashi M, 2013, OPT EXPRESS, V21, P3669, DOI 10.1364/OE.21.003669; Orlov SS, 2004, APPL OPTICS, V43, P4902, DOI 10.1364/AO.43.004902; Burckhardt C. B., APPL OPT, V9, P695; Curtis K., 2010, HOLOGRAPIC DATA STOR; Hosaka M, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09LD01; Katahira C, 2010, J POLYM SCI POL CHEM, V48, P4445, DOI 10.1002/pola.24234; Koppa P., APPL OPT, V46, P3561; Psaltis D., SCI AM, V273, P70; Saita Y, 2014, APPL OPTICS, V53, P4136, DOI 10.1364/AO.53.004136; Sun C. C., 2013, INT WORKSH HOL REL T; Takabayashi M, 2014, APPL OPTICS, V53, P4375, DOI 10.1364/AO.53.004375; Tanaka J, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.03A028	20	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	JUN 1	2015	54	16					5167	5174		10.1364/AO.54.005167		8	Optics	Optics	CJ5UF	WOS:000355555700031		
J	Ikeda, Y; Kobayashi, N; Sarugaku, Y; Sukegawa, T; Sugiyama, S; Kaji, S; Nakanishi, K; Kondo, S; Yasui, C; Kataza, H; Nakagawa, T; Kawakita, H				Ikeda, Yuji; Kobayashi, Naoto; Sarugaku, Yuki; Sukegawa, Takashi; Sugiyama, Shigeru; Kaji, Sayumi; Nakanishi, Kenshi; Kondo, Sohei; Yasui, Chikako; Kataza, Hirokazu; Nakagawa, Takao; Kawakita, Hideyo			Machined immersion grating with theoretically predicted diffraction efficiency	APPLIED OPTICS			English	Article							INFRARED ASTRONOMY; SUBARU TELESCOPE; SPECTROGRAPH; SPECTROSCOPY	An immersion grating composed of a transmissive material with a high refractive index (n > 2) is a powerful device for high-resolution spectroscopy in the infrared region. Although the original idea is attributed to Fraunhofer about 200 years ago, an immersion grating with high diffraction efficiency has never been realized due to the difficulty in processing infrared crystals that are mostly brittle. While anisotropic etching is one successful method for fabricating a fine groove pattern on Si crystal, machining is necessary for realizing the ideal groove shape on any kind of infrared crystal. In this paper, we report the realization of the first, to the best of our knowledge, machined immersion grating made of single-crystal CdZnTe with a high diffraction efficiency that is almost identical to that theoretically predicted by rigorous coupled-wave analysis. (C) 2015 Optical Society of America	[Ikeda, Yuji] Photocoding, Sakyo Ku, Kyoto 6060025, Japan; [Ikeda, Yuji; Kobayashi, Naoto; Nakanishi, Kenshi; Kondo, Sohei; Kawakita, Hideyo] Kyoto Sangyo Univ, Koyama Astron Observ, Lab Infrared High Resolut Spect LIH, Kita Ku, Kyoto 6038555, Japan; [Kobayashi, Naoto] Univ Tokyo, Inst Astron, Mitaka, Tokyo 1810015, Japan; [Kataza, Hirokazu; Nakagawa, Takao] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Sukegawa, Takashi] Canon Inc, Corp R&D Headquarters, Utsunomiya, Tochigi 3213298, Japan; [Sugiyama, Shigeru] Canon Inc, Prod Engn Headquarters, Saiwai Ku, Kawasaki, Kanagawa 2128602, Japan; [Kaji, Sayumi; Kawakita, Hideyo] Kyoto Sangyo Univ, Fac Sci, Kita Ku, Kyoto 6038555, Japan; [Yasui, Chikako] Univ Tokyo, Grad Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Sarugaku, Yuki] Univ Tokyo, Inst Astron, Kiso Observ, Kiso, Nagano 3970101, Japan	Ikeda, Y (reprint author), Photocoding, Sakyo Ku, 460-102 Iwakura Naka Machi, Kyoto 6060025, Japan.	ikeda@photocoding.com			Japan Society for the Promotion of Science [16684001, 20340042, 21840052, 26247030]; Ministry of Education, Culture, Sports, Science, and Technology [S0801061, S1411028]	Japan Society for the Promotion of Science (16684001, 20340042, 21840052, 26247030); Ministry of Education, Culture, Sports, Science, and Technology (S0801061, S1411028).	van Amerongen AH, 2012, PROC SPIE, V8450, DOI 10.1117/12.925612; COMBES LS, 1951, J OPT SOC AM, V41, P215, DOI 10.1364/JOSA.41.000215; Kobayashi N, 2000, PROC SPIE, V4008, P1056, DOI 10.1117/12.395423; Bernstein R., 2014, P SOC PHOTO-OPT INS, V9145, P9145; Deen CP, 2008, P SOC PHOTO-OPT INS, V7014, pC142, DOI 10.1117/12.788565; Ebizuka N, 2003, P SOC PHOTO-OPT INS, V4842, P293, DOI 10.1117/12.457402; Feigelson R. S., 2004, 50 YEARS PROGR CRYST; Ge J, 2001, P SOC PHOTO-OPT INS, V4485, P393; Ge J, 2012, PROC SPIE, V8450, DOI 10.1117/12.925803; Gully-Santiago M, 2012, PROC SPIE, V8450, DOI 10.1117/12.926434; Ikeda Y, 2010, PROC SPIE, V7739, DOI 10.1117/12.856631; Ikeda Y, 2006, PROC SPIE, V6269, DOI 10.1117/12.672665; Ikeda Y, 2008, P SOC PHOTO-OPT INS, V7014, P1469, DOI 10.1117/12.788126; Ikeda Y, 2009, OPT ENG, V48, DOI 10.1117/1.3206734; Ikeda Y, 2014, PROC SPIE, V9151, DOI 10.1117/12.2055378; Jacoby G., 2014, P SOC PHOTO-OPT INS, V9147, P9147; Kaji S., 2014, P SOC PHOTO-OPT INS, V9147; Kataza H., 2015, J ASTRON INSTRUM, V4; Keller Luke D., 2002, Proceedings of the SPIE - The International Society for Optical Engineering, V4485, DOI 10.1117/12.454274; Kobayashi N, 2008, P SOC PHOTO-OPT INS, V7010, P1032, DOI 10.1117/12.799423; Kuzmenko PJ, 2006, P SOC PHOTO-OPT INS, V6273, pT2733, DOI 10.1117/12.670565; KUZMENKO PJ, 1994, P SOC PHOTO-OPT INS, V2266, P566, DOI 10.1117/12.187593; Loewen E., 1997, OPTICAL SCI ENG SERI; Marsh JP, 2006, P SOC PHOTO-OPT INS, V6269, pJ2694, DOI 10.1117/12.672198; Marsh JP, 2007, APPL OPTICS, V46, P3400, DOI 10.1364/AO.46.003400; Moon B, 2012, PROC SPIE, V8450, DOI 10.1117/12.925702; OHMORI H, 1992, INT J JPN S PREC ENG, V26, P273; Park C, 2014, PROC SPIE, V9147, DOI 10.1117/12.2056431; Rayner J, 2012, PROC SPIE, V8446, DOI 10.1117/12.925511; Rayner JT, 1998, P SOC PHOTO-OPT INS, V3354, P289, DOI 10.1117/12.317311; Sarugaku Y, 2012, PROC SPIE, V8442, DOI 10.1117/12.926742; Sukegawa T., 2014, U.S. patent, Patent No. [8,774,247, 8774247]; Sukegawa T, 2012, PROC SPIE, V8450, DOI 10.1117/12.924956; WIEDEMANN G, 1993, P SOC PHOTO-OPT INS, V1946, P622, DOI 10.1117/12.158716; Yasui C, 2008, P SOC PHOTO-OPT INS, V7014, P1433, DOI 10.1117/12.788371; Yuk IS, 2010, PROC SPIE, V7735, DOI 10.1117/12.856864	36	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	JUN 1	2015	54	16					5193	5202		10.1364/AO.54.005193		10	Optics	Optics	CJ5UF	WOS:000355555700034		
J	Nishii, T; Morita, S; Genkawa, T; Watari, M; Ishikawa, D; Ozaki, Y				Nishii, Takashi; Morita, Shigeaki; Genkawa, Takuma; Watari, Masahiro; Ishikawa, Daitaro; Ozaki, Yukihiro			Moving-Window Two-Dimensional Heterospectral (MW2DHetero) Correlation Analysis and Its Application for the Process Monitoring of Alcoholic Fermentation	APPLIED SPECTROSCOPY			English	Article						Moving-window; Two-dimensional correlation spectroscopy; Heterospectral correlation; Near-infrared spectroscopy; Infrared spectroscopy; Ethanol fermentation; Process analysis	NEAR-INFRARED SPECTROSCOPY; DUAL-REGION SPECTROMETER; TEMPERATURE-DEPENDENT CHANGES; FOURIER-TRANSFORM-RAMAN; CELLULOSE I-BETA; HYDROGEN-BONDS; ETHANOL; BLENDS; WATER	The technique of moving-window two-dimensional heterospectral (MW2DHetero) correlation spectroscopy is proposed. This computational method is based on the ideas of perturbation-correlation moving-window two-dimensional (PCMW2D) correlation spectroscopy and two-dimensional heterospectral correlation analysis. Not only small spectral variations, but also detailed bands assignments were captured using the analysis. This method was applied to near-infrared (NIR) spectra in the 10 000-4000 cm(-1) region and mid-infrared (mid-IR) spectra in the 5000-1200 cm(-1) region, which were simultaneously detected using a dual-region spectrometer. Near-infrared and mid-IR spectra collected during an alcoholic fermentation process using a solution containing glucose and fructose were reported. Slight time differences for the consumption of sugars compared with the production of ethanol were found between 50 and 150 min. It was concluded that these slight time differences are evidence for different consumption times between glucose and fructose during the fermentation process. The result proved a possibility of the selective monitoring of the simultaneous reaction processes between productive and consumptive components.	[Nishii, Takashi; Ozaki, Yukihiro] Kwansei Gakuin Univ, Sch Sci & Technol, Sanda 6691337, Japan; [Morita, Shigeaki] Osaka Electrocommun Univ, Dept Engn Sci, Neyagawa, Osaka 5728530, Japan; [Genkawa, Takuma] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Watari, Masahiro] ST Japan Inc, Dept Engn, Chuo Ku, Tokyo 1030014, Japan; [Ishikawa, Daitaro] Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan	Morita, S (reprint author), Osaka Electrocommun Univ, Dept Engn Sci, 18-8 Hatsucho, Neyagawa, Osaka 5728530, Japan.	smorita@isc.osakac.ac.jp			"Innovation Promotion Program" by the New Energy and Industrial Technology Development Organization (NEDO), Ministry of Economy, Trade, and Industry, Japan	This work was supported by the "Innovation Promotion Program" by the New Energy and Industrial Technology Development Organization (NEDO), Ministry of Economy, Trade, and Industry, Japan. We would like to thank Prof. Hidetoshi Yamada (Kwansei Gakuin University) whose technical support contributed to our work.	Watanabe A, 2007, BIOMACROMOLECULES, V8, P2969, DOI 10.1021/bm700678u; Nishii T, 2012, ANAL SCI, V28, P1165; Genkawa T, 2012, APPL SPECTROSC, V66, P773, DOI 10.1366/11-06499; Morita S, 2006, APPL SPECTROSC, V60, P398, DOI 10.1366/000370206776593690; Burikov S, 2010, MOL PHYS, V108, P2427, DOI 10.1080/00268976.2010.516277; Genkawa T, 2013, APPL SPECTROSC, V67, P724, DOI 10.1366/12-06871; Thomas M, 2000, VIB SPECTROSC, V24, P137, DOI 10.1016/S0924-2031(00)00086-2; Watanabe A, 2006, BIOMACROMOLECULES, V7, P3164, DOI 10.1021/bm0603591; Liu YL, 2004, J AGR FOOD CHEM, V52, P505, DOI 10.1021/jf0303464; Watanabe A, 2006, APPL SPECTROSC, V60, P611, DOI 10.1366/000370206777670549; Berthels NJ, 2004, FEMS YEAST RES, V4, P683, DOI 10.1016/j.femsyr.2004.02.005; BARTON FE, 1992, APPL SPECTROSC, V46, P420, DOI 10.1366/0003702924125375; CAVINATO AG, 1990, ANAL CHEM, V62, P1977, DOI 10.1021/ac00217a015; Garrido-Vidal D, 2004, J NEAR INFRARED SPEC, V12, P15; Jung YM, 2000, J PHYS CHEM B, V104, P7812, DOI 10.1021/jp0008041; Matsushita A, 2000, VIB SPECTROSC, V24, P171, DOI 10.1016/S0924-2031(00)00062-X; Mazarevica G, 2004, APPL SPECTROSC, V58, P804, DOI 10.1366/0003702041389229; Noda I, 2000, APPL SPECTROSC, V54, p236A; Noda I., 2004, 2 DIMENSIONAL CORREL; NODA I, 1993, APPL SPECTROSC, V47, P1329, DOI 10.1366/0003702934067694; Ren Y, 2000, VIB SPECTROSC, V23, P207, DOI 10.1016/S0924-2031(00)00063-1; Watari M, 2010, OPT REV, V17, P317, DOI 10.1007/s10043-010-0057-9; Yamasaki H, 2012, APPL SPECTROSC, V66, P926, DOI 10.1366/11-06437; Zhang HW, 2004, J PROCESS CONTR, V14, P41, DOI 10.1016/S0959-1524(03)00044-1	24	0	0	SOC APPLIED SPECTROSCOPY	FREDERICK	5320 SPECTRUM DRIVE SUITE C, FREDERICK, MD 21703 USA	0003-7028	1943-3530		APPL SPECTROSC	Appl. Spectrosc.	JUN	2015	69	6					665	670		10.1366/14-07771		6	Instruments & Instrumentation; Spectroscopy	Instruments & Instrumentation; Spectroscopy	CJ8UO	WOS:000355779200002		
J	Nagase, H; Kutsumura, N				Nagase, Hiroshi; Kutsumura, Noriki			Synthesis of Novel Triplets with a 1,3,5-Trioxazatriquinane Skeleton and Their Pharmacologies for Opioid Receptors	ARCHIV DER PHARMAZIE			English	Review						Receptor; Capped trimer; Compound libraries; Opioid; Triplet	PROTEIN-COUPLED RECEPTORS; FUNALTREXAMINE BETA-FNA; BIVALENT LIGANDS; SALVINORIN-A; KAPPA; AGONIST; POTENT; MU; DERIVATIVES; DESIGN	We designed and synthesized novel triplet molecules with 1,3,5-trioxazatriquinane skeletons. One class comprises double-capped triplets with a morphinan skeleton; the other class comprises simple phenol derivatives with phenethylamine moieties. One compound with m-phenolic hydroxyl group, called SYK-146, is a highly selective, potent agonist for the receptor, with activity nearly equivalent to that of U-50488H. The o-phenolic isomer of SYK-146, called SYK-524, showed potent but non-selective agonistic activity for the opioid receptors. We also added several simple phenol derivatives to a library of compounds that target opioid receptors, and they showed high hit rates for the receptor. This library might also be expected to show high hit rates for other receptors.	[Nagase, Hiroshi; Kutsumura, Noriki] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki 3058577, Japan	Nagase, H (reprint author), Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	nagase.hiroshi.gt@u.tsukuba.ac.jp					ACETO MD, 1986, EUR J PHARMACOL, V123, P387, DOI 10.1016/0014-2999(86)90713-2; Fujii H, 2011, TOP CURR CHEM, V299, P239, DOI 10.1007/128_2010_76; Portoghese PS, 2001, J MED CHEM, V44, P2259, DOI 10.1021/jm010158+; Zheng Y, 2009, J MED CHEM, V52, P247, DOI 10.1021/jm800174p; Yamaotsu N, 2011, TOP CURR CHEM, V299, P277, DOI 10.1007/128_2010_84; TAKEMORI AE, 1981, EUR J PHARMACOL, V70, P445, DOI 10.1016/0014-2999(81)90355-1; Nagase H, 2011, TOP CURR CHEM, V299, P187, DOI 10.1007/128_2010_75; Ida Y, 2012, BIOORGAN MED CHEM, V20, P949, DOI 10.1016/j.bmc.2011.11.047; Roth BL, 2002, P NATL ACAD SCI USA, V99, P11934, DOI 10.1073/pnas.182234399; Spetea M, 2012, J MED CHEM, V55, P10302, DOI 10.1021/jm301258w; Yekkirala AS, 2011, P NATL ACAD SCI USA, V108, P5098, DOI 10.1073/pnas.1016277108; Devi LA, 2001, TRENDS PHARMACOL SCI, V22, P532, DOI 10.1016/S0165-6147(00)01799-5; ENDOH T, 1992, ARCH INT PHARMACOD T, V316, P30; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Kawai K, 2008, BIOORGAN MED CHEM, V16, P9188, DOI 10.1016/j.bmc.2008.09.011; Nemoto T, 2008, BIOORG MED CHEM LETT, V18, P6398, DOI 10.1016/j.bmcl.2008.10.081; SZMUSZKOVICZ J, 1982, J MED CHEM, V25, P1125, DOI 10.1021/jm00352a005; [Anonymous], 2014, VERS 2 7 012 SMALL M; Yamaotsu N, 2010, BIOORGAN MED CHEM, V18, P4446, DOI 10.1016/j.bmc.2010.04.069; [Anonymous], 2012, ADMET PRED VERS 6 1; Suzuki S, 2002, EXP CELL RES, V280, P192, DOI 10.1006/excr.2002.5638; Nagase H, 1998, CHEM PHARM BULL, V46, P366; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Harding WW, 2005, J MED CHEM, V48, P4765, DOI 10.1021/jm048963m; Beans Marvin, 2014, MARV BEANS VERS 6 2; Contreras JM, 2008, PRACTICE OF MEDICINAL CHEMISTRY, 3RD EDITION, P380, DOI 10.1016/B978-0-12-374194-3.00018-4; HAYES AG, 1985, J PHARM PHARMACOL, V37, P841; Hirayama S, 2014, BIOORG MED CHEM LETT, V24, P4895, DOI 10.1016/j.bmcl.2014.08.012; Hirayama S, 2014, ACS MED CHEM LETT, V5, P868, DOI 10.1021/ml5000542; Le Naour M., 2011, J MED CHEM, V55, P670; Nagase H, 2011, BIOORG MED CHEM LETT, V21, P6198, DOI 10.1016/j.bmcl.2011.07.065; Nagase H, 2012, HETEROCYCLES, V85, P1821, DOI 10.3987/REV-12-738; Nagase H, 2009, ORG LETT, V11, P539, DOI 10.1021/ol8024988; Nagase H, 2011, BIOORG MED CHEM LETT, V21, P4023, DOI 10.1016/j.bmcl.2011.04.134; Nemoto T, 2013, BIOORG MED CHEM LETT, V23, P268, DOI 10.1016/j.bmcl.2012.10.100; Nemoto T, 2008, BIOORGAN MED CHEM, V16, P4304, DOI 10.1016/j.bmc.2008.02.082; OLDENZIE.OH, 1974, TETRAHEDRON LETT, P163; Tidgewell K, 2006, J NAT PROD, V69, P914, DOI 10.1021/np060094b; Toll L, 1998, NIDA Res Monogr, V178, P440; Wada N, 2012, BIOORG MED CHEM LETT, V22, P7551, DOI 10.1016/j.bmcl.2012.10.023; WARD SJ, 1982, EUR J PHARMACOL, V80, P377, DOI 10.1016/0014-2999(82)90083-8	41	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0365-6233	1521-4184		ARCH PHARM	Arch. Pharm.	JUN	2015	348	6					375	389		10.1002/ardp.201500031		18	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CJ6SZ	WOS:000355625200001		
J	Ganzorig, K; Kuroda, S; Maeda, Y; Mansjur, K; Sato, M; Nagata, K; Tanaka, E				Ganzorig, Khaliunaa; Kuroda, Shingo; Maeda, Yuichi; Mansjur, Karima; Sato, Minami; Nagata, Kumiko; Tanaka, Eiji			Low-intensity pulsed ultrasound enhances bone formation around miniscrew implants	ARCHIVES OF ORAL BIOLOGY			English	Article						Low-intensity pulsed ultrasound; Miniscrew implant; Bone formation; Stainless steel; Titanium	AGGRECAN GENE-EXPRESSION; ORTHODONTIC ANCHORAGE; STAINLESS-STEEL; FRACTURE MODEL; TITANIUM; SCREW; COMPLICATIONS; METAANALYSIS; STABILITY; STRENGTH	Miniscrew implants (MSIs) are currently used to provide absolute anchorage in orthodontics; however, their initial stability is an issue of concern. Application of low-intensity pulsed ultrasound (LIPUS) can promote bone healing. Therefore, LIPUS application may stimulate bone formation around MSIs and enhance their initial stability. Aim: To investigate the effect of LIPUS exposure on bone formation after implantation of titanium (Ti) and stainless steel (SS) MSIs. Methods: MSIs made of Ti-6Al-4V and 316L SS were placed on rat tibiae and treated with LIPUS. The bone morphology around MSIs was evaluated by scanning electron microscopy and three-dimensional micro-computed tomography. MC3T3-E1 cells cultured on Ti and SS discs were treated with LIPUS, and the temporary expression of alkaline phosphatase (ALP) was examined. Results: Bone-implant contact increased gradually from day 3 to day 14 after MSI insertion. LIPUS application increased the cortical bone density, cortical bone thickness, and cortical bone rate after implantation of Ti and SS MSIs (P < 0.05). LIPUS exposure induced ALP upregulation in MC3T3-E1 cells at day 3 (P < 0.05). Conclusion: LIPUS enhanced bone formation around Ti and SS MSIs, enhancing the initial stability of MSIs. (C) 2015 Elsevier Ltd. All rights reserved.	[Ganzorig, Khaliunaa; Maeda, Yuichi; Mansjur, Karima; Sato, Minami] Univ Tokushima, Grad Sch Oral Sci, Dept Orthodont & Dentofacial Orthoped, Tokushima 7708504, Japan; [Kuroda, Shingo; Nagata, Kumiko; Tanaka, Eiji] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Orthodont & Dentofacial Orthoped, Tokushima 7708504, Japan	Tanaka, E (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Orthodont & Dentofacial Orthoped, 3-18-15 Kuramoto Cho, Tokushima 7708504, Japan.	etanaka@tokushima-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25463185]	This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (No. 25463185).	Deguchi T, 2003, J DENT RES, V82, P377; Kim JW, 2005, AM J ORTHOD DENTOFAC, V128, P190, DOI 10.1016/j.ajodo.2004.01.030; Nagata K, 2013, ANN BIOMED ENG, V41, P1095, DOI 10.1007/s10439-013-0757-y; Kravitz ND, 2007, AM J ORTHOD DENTOFAC, V131, pS43, DOI 10.1016/j.ajodo.2006.04.027; Parvizi J, 1999, J ORTHOPAED RES, V17, P488, DOI 10.1002/jor.1100170405; Cornelis MA, 2007, AM J ORTHOD DENTOFAC, V131, pS52, DOI 10.1016/j.ajodo.2006.05.033; Yang KH, 1996, J ORTHOP RES, V14, P802, DOI 10.1002/jor.1100140518; Kuroda S, 2007, AM J ORTHOD DENTOFAC, V131, P9, DOI 10.1016/j.ajodo.2005.02.032; Singh S, 2012, AM J ORTHOD DENTOFAC, V141, P327, DOI 10.1016/j.ajodo.2011.07.022; Pounder NM, 2008, ULTRASONICS, V48, P330, DOI 10.1016/j.ultras.2008.02.005; Inubushi T, 2013, BONE, V53, P497, DOI 10.1016/j.bone.2013.01.021; Busse JW, 2002, CAN MED ASSOC J, V166, P437; Wijdicks CA, 2009, ULTRASOUND MED BIOL, V35, P1629, DOI 10.1016/j.ultrasmedbio.2009.04.017; Umemori M, 1999, AM J ORTHOD DENTOFAC, V115, P166, DOI 10.1016/S0889-5406(99)70345-8; Papageorgiou SN, 2012, AM J ORTHOD DENTOFAC, V142, P577, DOI 10.1016/j.ajodo.2012.05.016; Reher P, 2002, BONE, V31, P236, DOI 10.1016/S8756-3282(02)00789-5; Angle SR, 2011, ULTRASONICS, V51, P281, DOI 10.1016/j.ultras.2010.09.004; Liu Q, 2012, BRIT J ORAL MAX SURG, V50, P244, DOI 10.1016/j.bjoms.2011.03.001; Brown RN, 2014, AM J ORTHOD DENTOFAC, V145, P496, DOI 10.1016/j.ajodo.2013.12.022; Kuroda S, 2004, ANGLE ORTHOD, V74, P558; Azuma Y, 2001, J BONE MINER RES, V16, P671, DOI 10.1359/jbmr.2001.16.4.671; Unsworth J, 2007, ULTRASOUND MED BIOL, V33, P1468, DOI 10.1016/j.ultrasmedbio.2006.12.003; Takikawa S, 2001, J ULTRAS MED, V20, P197; ROBERTS WE, 1989, ANGLE ORTHOD, V59, P247; Bachoura A, 2012, ISRN ORTHOP, V2012, P1; Basha AG, 2010, IMPLANT DENT, V19, P128, DOI 10.1097/ID.0b013e3181cc4aa5; Blaya MG, 2011, J DENT SCI, V26, P209; Chen PQ, 2003, SPINE, V28, P881, DOI 10.1097/00007632-200305010-00008; Creekmore T D, 1983, J Clin Orthod, V17, P266; Katiyar Amit, 2014, J Ther Ultrasound, V2, P1, DOI 10.1186/2050-5736-2-1; Kyung Hee-Moon, 2003, J Clin Orthod, V37, P321; Lim K, 2013, BIOMED RES INT, P1; Lim YW, 2011, CLIN ORTHOP RELAT R, V469, P330, DOI 10.1007/s11999-010-1613-0; Pan CY, 2012, KAOHSIUNG J MED SCI, V28, P673, DOI 10.1016/j.kjms.2012.04.037; Park H S, 2001, J Clin Orthod, V35, P417; Pipi E, 2010, ULTRASOUND MED BIOL, V36, P2057; Shakouri K, 2010, J ORTHOP SCI, V15, P240, DOI 10.1007/s00776-009-1436-6; Ustun Yakup, 2008, Eur J Dent, V2, P254; Waden SJ, 2000, CALCIFIED TISSUE INT, V66, P157; Wall EJ, 2008, J BONE JOINT SURG AM, V90A, P1305, DOI 10.2106/JBJS.G.00328	40	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0003-9969	1879-1506		ARCH ORAL BIOL	Arch. Oral Biol.	JUN	2015	60	6					902	910		10.1016/j.archoralbio.2015.02.014		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CJ3AH	WOS:000355355300013		
J	Tokutomi, F; Wada-Takahashi, S; Sugiyama, S; Toyama, T; Sato, T; Hamada, N; Tsukinoki, K; Takahashi, SS; Lee, MCI				Tokutomi, Fumiaki; Wada-Takahashi, Satoko; Sugiyama, Shuta; Toyama, Toshizo; Sato, Takenori; Hamada, Nobushiro; Tsukinoki, Keiichi; Takahashi, Shun-suke; Lee, Masaichi Chang-il			Porphyromonas gingivalis-induced alveolar bone loss is accelerated in the stroke-prone spontaneously hypertensive rat	ARCHIVES OF ORAL BIOLOGY			English	Article						Inflammation and innate immunity; Periodontitis; Periodontal medicine; Bone biology; Oxidative stress; Reactive oxygen species (ROS)	SPIN-RESONANCE SPECTROSCOPY; NF-KAPPA-B; PERIODONTAL-DISEASE; IN-VIVO; NADPH OXIDASE; NITRIC-OXIDE; SUPEROXIDE GENERATION; OXIDATIVE STRESS; GENE-EXPRESSION; CORONARY HEART	Porphyromonas gingivalis (P. gingivalis) is one of the prominent periodontal pathogens and is the most important bacteria involved in the onset and exacerbation of periodontitis. P. gingivalis is an anaerobic, Gram-negative coccobacillus that plays a role in the progression of periodontal disease by promoting alveolar bone resorption. The aim of the present study was to examine P. gingivalis-induced osteoclastic bone resorption in the stroke-prone spontaneously hypertensive rat (SHRSP), in which oxidative stress induced by reactive oxygen species (ROS) is increased. In the present study, we used animals orally challenged with P. gingivalis as a chronic inflammation model. Horizontal bone loss around the maxillary molars was assessed morphometrically. Animals were divided into four groups: (1) P. gingivalis-non-infected Wister Kyoto Rat (WKY), (2) orally challenged with P. gingivalis WKY (WKY + Pg), (3) P. gingivalis-noninfected SHRSP, and (4) orally challenged with P. gingivalis SHRSP (SHRSP + Pg). Alveolar bone resorption was significantly increased in the orally challenged with P. gingivalis groups, and was accelerated in the SHRSP group. Histological analysis revealed that the infiltration of inflammatory cells was absent in all groups. However, the infiltration of osteoclasts was observed in the SHRSP + Pg and SHRSP groups. We examined P. gingivalis-induced alveolar bone loss in both the SHRSP and WKY. The results obtained demonstrated that P. gingivalis-induced alveolar bone loss would be involved in hypertension and stroke animal model, such as SHRSP and/or periodontal disease. (C) 2015 Elsevier Ltd. All rights reserved.	[Tokutomi, Fumiaki; Wada-Takahashi, Satoko; Sugiyama, Shuta; Tsukinoki, Keiichi; Takahashi, Shun-suke] Kanagawa Dent Univ, Grad Sch Dent, Dept Oral Sci, Yokosuka, Kanagawa 2388580, Japan; [Toyama, Toshizo; Sato, Takenori; Hamada, Nobushiro] Kanagawa Dent Univ, Grad Sch Dent, Dept Infect Control, Div Microbiol, Yokosuka, Kanagawa 2388580, Japan; [Lee, Masaichi Chang-il] Kanagawa Dent Univ, Grad Sch Dent, Yokosuka Shonan Disaster Hlth Emergency Res Ctr, Yokosuka, Kanagawa 2388580, Japan; [Lee, Masaichi Chang-il] Kanagawa Dent Univ, Grad Sch Dent, ESR Labs, Yokosuka, Kanagawa 2388580, Japan	Takahashi, SS (reprint author), Kanagawa Dent Univ, Grad Sch Dent, Dept Oral Sci, Dent Circulat Control Div, 82 Inaoka Cho, Yokosuka, Kanagawa 2388580, Japan.	takahashi.shunsuke@kdu.ac.jp; lee@kdu.ac.jp			High-Tech Research Center Project of Kanagawa Dental College, Yokosuka, Kanagawa, Japan; Japanese Ministry of Education, Science, and Culture [23593073]	Supported by grants from the High-Tech Research Center Project of Kanagawa Dental College, Yokosuka, Kanagawa, Japan, and Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Science, and Culture (23593073).	Lee CI, 2000, J BIOL CHEM, V275, P9369, DOI 10.1074/jbc.275.13.9369; Sugiyama S, 2012, J CLIN BIOCHEM NUTR, V51, P108, DOI 10.3164/jcbn.11-103; Sculley DV, 2002, P NUTR SOC, V61, P137, DOI 10.1079/PNS2001141; Higashi Y, 2008, HYPERTENSION, V51, P446, DOI 10.1161/HYPERTENSIONAHA.107.101535; Itoh K, 2003, J IMMUNOL, V170, P3688; Qin LY, 2004, J BIOL CHEM, V279, P1415, DOI 10.1074/jbc.M307657200; LYNN WA, 1992, IMMUNOL TODAY, V13, P271, DOI 10.1016/0167-5699(92)90009-V; Umemoto T, 2003, J PERIODONTOL, V74, P119, DOI 10.1902/jop.2003.74.1.119; Cheng WC, 2010, J PERIODONTAL RES, V45, P788, DOI 10.1111/j.1600-0765.2010.01301.x; Toyama T, 2012, ARCH ORAL BIOL, V57, P1529, DOI 10.1016/j.archoralbio.2012.05.011; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244; Morrison HI, 1999, J CARDIOVASC RISK, V6, P7; Waddington RJ, 2000, ORAL DIS, V6, P138; Kono H, 2000, J CLIN INVEST, V106, P867, DOI 10.1172/JCI9020; Williams RC, 2008, J PERIODONTOL, V79, P1552, DOI 10.1902/jop.2008.080182; Govindaraj J, 2010, INDIAN J EXP BIOL, V48, P133; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Cai X, 2008, J PERIODONTAL RES, V43, P14, DOI 10.1111/j.1600-0765.2007.00989.x; Hla T, 2001, SCIENCE, V294, P1875, DOI 10.1126/science.1065323; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; MATTILA KJ, 1989, BRIT MED J, V298, P779; Kim DY, 2007, ARCH PHARM RES, V30, P1283, DOI 10.1007/BF02980269; Ezzo PJ, 2003, PERIODONTOL 2000, V32, P24, DOI 10.1046/j.0906-6713.2003.03203.x; Mochizuki A, 2006, J IMMUNOL, V177, P4360; Graves DT, 2011, J DENT RES, V90, P143, DOI 10.1177/0022034510385236; Kasuyama K, 2011, J CLIN PERIODONTOL, V38, P1085, DOI 10.1111/j.1600-051X.2011.01801.x; DESTEFANO F, 1993, BRIT MED J, V306, P688; Di Paola R, 2005, J CLIN PERIODONTOL, V32, P1062, DOI 10.1111/j.1600-051X.2005.00818.x; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; Hamada N, 2007, J PERIODONTOL, V78, P933, DOI 10.1902/jop.2007.060245; Hanaoka Y, 2013, HYPERTENS RES, V36, P829, DOI 10.1038/hr.2013.46; Holt SC, 1999, PERIODONTOLOGY, V2000, P168; Katsuragi Hiroaki, 2003, Odontology, V91, P13, DOI 10.1007/s10266-003-0022-1; Lee C, 2000, J BIOL CHEM, V275, P38965, DOI 10.1074/jbc.M006341200; Lee MC, 2004, HYPERTENS RES, V27, P485, DOI 10.1291/hypres.27.485; Kobayashi K, 2008, ANESTHESIOLOGY, V109, P426, DOI 10.1097/ALN.0b013e318182a903; Lee Masaichi-Chang-Il, 2003, Magn Reson Med Sci, V2, P79, DOI 10.2463/mrms.2.79; Lee MCI, 2002, REDOX REP, V7, P271, DOI 10.1179/135100002125000776; Maekawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020240; Miyazaki H, 2002, REDOX REP, V7, P260, DOI 10.1179/135100002125000758; Wang PL, 2000, BIOCHEM BIOPH RES CO, V273, P1161, DOI 10.1006/bbrc.2000.3060; Zhang WJ, 2009, FREE RADICAL BIO MED, V46, P791, DOI 10.1016/j.freeradbiomed.2008.12.003	42	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0003-9969	1879-1506		ARCH ORAL BIOL	Arch. Oral Biol.	JUN	2015	60	6					911	918		10.1016/j.archoralbio.2015.02.012		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CJ3AH	WOS:000355355300014		
J	Yamasaki, S; Hashimoto, Y; Terai, S; Takigami, J; Takahashi, S; Nakamura, H				Yamasaki, Shinya; Hashimoto, Yusuke; Terai, Shozaburo; Takigami, Junsei; Takahashi, Shinji; Nakamura, Hiroaki			Proposed Referential Index to Resect Femoroacetabular Cam-Type Impingement During Arthroscopy Using a Cadaveric Hip Model	ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY			English	Article							HEAD-NECK JUNCTION; FEMORAL-HEAD; SURGICAL DISLOCATION; ACETABULAR CARTILAGE; EARLY OSTEOARTHRITIS; FINITE-ELEMENT; ALPHA; ABNORMALITIES; MANAGEMENT; MORPHOLOGY	Purpose: To establish a reference index for the simple identification of the optimum resection point for cam-type impingement on arthroscopy. Methods: Twelve cadaveric left hips with a 20 degrees to 40 degrees center-edge angle, without osteoarthritis, were examined (mean age, 85 +/- 10.1 years). The pelvis was fixed such that the anterior pelvic plane and femur were parallel to the table. The resection line for impingement was first defined on the femoral head surface 5 mm distal to the acetabular labrum, from the 9-o'clock (anterior) to 12-o'clock (superior) position. Next, we measured the hip flexion angle necessary for the head-neck junction to reach the resection line. After positioning the wire on the femoral head surface along the resection line from the 9- to 12-o'clock area of the femoral head, we measured the target alpha angle on radiographs at 0 degrees, 15 degrees, 30 degrees, 45 degrees, and 60 degrees of hip flexion using the frog-leg 45/45/30 view (45 degrees of flexion, 45 degrees of abduction, and 30 degrees of external rotation) and Dunn 45 view (45 degrees of flexion, 20 degrees of abduction, and neutral rotation). Results: The mean hip flexion angle at which the head-neck junction reached the resection line was 31 degrees +/- 4.6 degrees. For 0 degrees, 15 degrees, 30 degrees, 45 degrees, and 60 degrees of hip flexion, the mean target alpha angle was 75.5 degrees +/- 5.5 degrees, 65.3 degrees +/- 5.6 degrees, 56.3 degrees +/- 5.8 degrees, 49.0 degrees +/- 6.6 degrees, and 42.6 degrees +/- 5.8 degrees, respectively, using the frog-leg 45/45/30 view and 75.0 degrees +/- 6.0 degrees, 65.8 degrees +/- 6.2 degrees, 57.2 degrees +/- 7.3 degrees, 50.7 degrees +/- 6.9 degrees, and 44.2 degrees +/- 5.8 degrees, respectively, using the Dunn 45 view. There were no significant differences between the 2 radiographic techniques (P = .82, P = .84, P = .76, P = .57, and P = .52, respectively). Conclusions: A description of the degree of hip flexion during cam resection can affect the final alpha angle when using the labrum as a reference for resection.	[Yamasaki, Shinya; Hashimoto, Yusuke; Terai, Shozaburo; Takigami, Junsei; Takahashi, Shinji; Nakamura, Hiroaki] Osaka City Univ, Grad Sch Med, Dept Orthopaed Surg, Abeno Ku, Osaka 5458585, Japan	Hashimoto, Y (reprint author), Osaka City Univ, Grad Sch Med, Dept Orthopaed Surg, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	hussy@med.osaka-cu.ac.jp					Alonso-Rasgado T, 2012, J ORTHOP RES, V30, P1999, DOI 10.1002/jor.22164; Ganz R, 2001, J BONE JOINT SURG BR, V83B, P1119, DOI 10.1302/0301-620X.83B8.11964; Beaule PE, 2005, J ORTHOP RES, V23, P1286, DOI 10.1016/j.orthres.2005.03.011; Ganz R, 2008, CLIN ORTHOP RELAT R, V466, P264, DOI 10.1007/s11999-007-0060-z; Beaule PE, 2012, CLIN ORTHOP RELAT R, V470, P3361, DOI 10.1007/s11999-012-2601-3; Ilizaliturri VM, 2009, CLIN ORTHOP RELAT R, V467, P760, DOI 10.1007/s11999-008-0618-4; Meyer DC, 2006, CLIN ORTHOP RELAT R, P181, DOI 10.1097/01.blo.0000201168.72388.24; Beck M, 2005, J BONE JOINT SURG BR, V87B, P1012, DOI 10.1302/0301-620X.87B7.15203; Mardones RA, 2005, J BONE JOINT SURG AM, V87A, P273, DOI 10.2106/JBJS.D.01793; Siebenrock KA, 2004, CLIN ORTHOP RELAT R, P54; Rothenfluh E, 2012, AM J SPORT MED, V40, P2002, DOI 10.1177/0363546512456011; Notzli HP, 2002, J BONE JOINT SURG BR, V84B, P556, DOI 10.1302/0301-620X.84B4.12014; Philippon MJ, 2007, AM J SPORT MED, V35, P1571, DOI 10.1177/0363546507300258; Clohisy JC, 2007, CLIN ORTHOP RELAT R, P115, DOI 10.1097/BLO.0b013e3180f60b53; [Anonymous], 2004, CLIN ORHTOP RELAT RE, DOI 10.1097/01.blo.0000150119.49983.ef; Nepple JJ, 2011, AM J SPORT MED, V39, P296, DOI 10.1177/0363546510384787; MURPHY SB, 1987, J BONE JOINT SURG AM, V69A, P1169; Hack K, 2010, J BONE JOINT SURG AM, V92A, P2436, DOI 10.2106/JBJS.J.01280; Pfirrmann CWA, 2006, RADIOLOGY, V240, P778, DOI 10.1148/radiol.2403050767; Johnston TL, 2008, ARTHROSCOPY, V24, P669, DOI 10.1016/j.arthro.2008.01.010; Rakhra KS, 2009, CLIN ORTHOP RELAT R, V467, P660, DOI 10.1007/s11999-008-0627-3; Agricola R, 2013, ANN RHEUM DIS, V72, P918, DOI 10.1136/annrheumdis-2012-201643; Botser IB, 2011, ARTHROSCOPY, V27, P270, DOI 10.1016/j.arthro.2010.11.008; Mardones R, 2009, ARTHROSCOPY, V25, P175, DOI 10.1016/j.arthro.2008.09.011; Nepple JJ, 2012, CLIN ORTHOP RELAT R, V470, P3313, DOI 10.1007/s11999-012-2510-5; Cavaignac E, 2012, INT ORTHOP, V36, P1783, DOI 10.1007/s00264-012-1550-5; Domayer SE, 2011, EUR J RADIOL, V80, P805, DOI 10.1016/j.ejrad.2010.10.016; Domb BG, 2013, ARTHROSCOPY, V29, P1506, DOI 10.1016/j.arthro.2013.06.010; Ejnisman L, 2011, CLIN SPORT MED, V30, P369, DOI 10.1016/j.csm.2010.12.007; MacFarlane RJ, 2014, ANN ROY COLL SURG, V96, P331, DOI 10.1308/003588414X13946184900723; Myers CA, 2011, AM J SPORT MED, V39, p85S, DOI 10.1177/0363546511412161; Philippon MJ, 2010, ARTHROSCOPY, V26, P757, DOI 10.1016/j.arthro.2009.11.003; Smyth PA, 2014, SCANNING, V36, P368, DOI 10.1002/sca.21128; Vaughn ZD, 2010, SPORTS MED ARTHROSC, V18, P90, DOI 10.1097/JSA.0b013e3181dfce63	34	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-8063	1526-3231		ARTHROSCOPY	Arthroscopy	JUN	2015	31	6					1069	1076		10.1016/j.arthro.2014.12.024		8	Orthopedics; Surgery	Orthopedics; Surgery	CJ6WS	WOS:000355636500011		
J	Ando, M; Kimura, F				Ando, Mitsuyo; Kimura, Fukunari			Globalization and Domestic Operations: Applying the JC/JD Method to Japanese Manufacturing Firms	ASIAN ECONOMIC PAPERS			English	Article							PERFORMANCE; MARKETS; FDI	Does outward foreign direct investment accelerate de-industrialization at home or generate domestic jobs and operations? This paper applies the job creation (JC)/destruction (JD) method to micro data of Japanese manufacturing firms and provides a bird's eye view of the dynamism of globalizing firms in terms of domestic employment, domestic establishments, domestic affiliates, exports, and imports. It examines gross and net changes in domestic operations by multinational enterprises (MNEs) that expand operations abroad (expanding MNEs), compared with non-expanding MNEs and local firms, for the periods of 1998-2002, 2002-06, 2006-08, and 2008-10. It also conducts the Kolmogorov-Smirnov test to investigate whether the changes in domestic operations and trade by expanding MNEs are larger than those by other firm types. Major findings are the following: (1) gross changes in domestic employment and domestic operations are much larger than net changes, showing restructuring dynamism and firm heterogeneity; (2) de-industrialization or the shrinkage of the manufacturing sector is not relevant except for the period 1998-2002, though a slight declining trend in manufacturing activities is observed in recent years; (3) expanding multinational small- and medium-sized enterprises (SMEs) tends to enlarge domestic employment and domestic operations, compared with other types of SMEs; (4) expanding MNEs intensify headquarters activities; and (5) expanding multinational SMEs are likely to expand exports and imports more than other types of SMEs.	[Ando, Mitsuyo] Keio Univ, Fac Business & Commerce, Minato Ku, Tokyo 1088345, Japan; [Kimura, Fukunari] Keio Univ, Fac Econ, Minato Ku, Tokyo 1088345, Japan	Ando, M (reprint author), Keio Univ, Fac Business & Commerce, Minato Ku, 2-15-45 Mita, Tokyo 1088345, Japan.	m-ando@fbc.keio.ac.jp; fkimura@econ.keio.ac.jp					Ando Mitsuyo, 2005, NBER E ASIA SEMINAR, V14, P177; Ando Mitsuyo, 2012, ASIAN ECON J, V26, P259; Hijzen A, 2011, REV WORLD ECON, V147, P457, DOI 10.1007/s10290-011-0094-x; Delgado MA, 2002, J INT ECON, V57, P397, DOI 10.1016/S0022-1996(01)00154-4; Harrison A, 2011, REV ECON STAT, V93, P857, DOI 10.1162/REST_a_00085; Wagner J, 2011, REV WORLD ECON, V147, P217, DOI 10.1007/s10290-010-0078-2; Arnold JM, 2010, REV INT ECON, V18, P595, DOI 10.1111/j.1467-9396.2010.00888.x; Baldwin Richard, 2011, 56 CEPR; Davis Steven J., 1996, JOB CREATION DESTRUC; Edamura Kazuma, 2011, RIETI DISCUSSION PAP, V11-E-069; Faggio Giulia, 2003, EC SYSTEMS, V27, P129, DOI DOI 10.1016/S0939-3625(03)00036-0; Fuchs Michaela, 2010, EMPIRICA, V27, P425; Hayakawa K, 2013, JPN WORLD ECON, V27, P25, DOI 10.1016/j.japwor.2013.03.006; Hijzen A, 2010, OXFORD B ECON STAT, V72, P621, DOI 10.1111/j.1468-0084.2010.00584.x; Hijzen Alexander, 2007, RIETI DISCUSSION PAP, V07-E-006; Ito Keiko, 2014, RIETI DISCUSSION PAP, V14-E-011; Kambayashi Ryo, 2014, RIETI DISCUSSION PAP, V14-E-051; Matsuura Toshiyuki, 2013, RIETI DISCUSSION PAP, V13-E-036; Tanaka A., 2012, RIETI DISCUSSION PAP; Tanaka A, 2012, ECON LETT, V117, P1, DOI 10.1016/j.econlet.2012.04.079; Yamashita N, 2010, JPN WORLD ECON, V22, P88, DOI 10.1016/j.japwor.2009.10.001	21	1	1	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	1535-3516	1536-0083		ASIAN ECON PAP	Asian Econ. Pap.	SUM	2015	14	2					1	35		10.1162/ASEP_a_00342		35	Economics	Business & Economics	CK1RO	WOS:000355985100001		
J	Kodama, N; Inui, T				Kodama, Naomi; Inui, Tomohiko			The Impact of Globalization on Establishment-Level Employment Dynamics in Japan	ASIAN ECONOMIC PAPERS			English	Article							JOB CREATION; FIRMS	This study applies Davis, Haltiwanger, and Schuh's method (1996) to measure job creation/destruction rates of establishments in manufacturing firms using Japanese Economic Census data in 2006 and 2009. Results show that the decrease in net domestic employment arises mainly from firms without subsidiary companies, and non-expanding multinational enterprises. Domestic employment increases when the number of overseas subsidiaries increases. Both job creation/destruction rates of multinational enterprises are high, and the globalization of Japanese firms accelerates de-industrialization in Japan. The job creation and the net employment growth rates of establishments belonging to small-sized firms are lower than those in large-sized firms.	[Kodama, Naomi] Hitotsubashi Univ, Inst Econ Res, RIETI, Kunitachi, Tokyo 1868603, Japan; [Inui, Tomohiko] Gakushuin Univ, Fac Int Studies, Preparatory Off, RIETI,Toshima Ku, Tokyo 1718588, Japan	Kodama, N (reprint author), Hitotsubashi Univ, Inst Econ Res, RIETI, 2-1 Naka, Kunitachi, Tokyo 1868603, Japan.	kodaman@ier.hit-u.ac.jp; tomohiko.inui@gakushuin.ac			RIETI; Japan Society for the Promotion of Science (JSPS) [26380359]	We are grateful to the participants of the Asian Economic Panel Meeting and the seminar at the Research Institute of Economy, Trade and Industry (RIETI) for their helpful discussions regarding this paper, especially Michael Ward, Vu Quoc Huy, Fukunari Kimura, Toshihiro Okubo, Masahisa Fujita, Kyoji Fukao, and Masayuki Morikawa. This study was conducted as a part of a project sponsored by RIETI. We also gratefully acknowledge the support from a Grant-in-Aid for Scientific Research (Grant no. 26380359) from the Japan Society for the Promotion of Science (JSPS). All remaining errors are our own and the views expressed in this paper are solely those of the authors and are not necessarily those of the organizations to which we belong.	Ando Mitsuyo, 2014, GLOBALIZATION DOMEST; Ando Mitsuyo, 2011, RIETI DISCUSSION PAP, V11-E-034; Desai MA, 2009, AM ECON J-ECON POLIC, V1, P181, DOI 10.1257/pol.1.1.181; Moscarini G, 2012, AM ECON REV, V102, P2509, DOI 10.1257/aer.102.6.2509; Hijzen A, 2011, REV WORLD ECON, V147, P457, DOI 10.1007/s10290-011-0094-x; Harrison A, 2011, REV ECON STAT, V93, P857, DOI 10.1162/REST_a_00085; Brainard S. Lael, 1997, NBER WORKING PAPER S, V5958; Davis Steven J., 1996, JOB CREATION DESTRUC; Edamura Kazuma, 2011, RIETI DISCUSSION PAP, V11-E-069; Genda Yuji, 2004, JOB CREATION; Hayakawa K, 2013, JPN WORLD ECON, V27, P25, DOI 10.1016/j.japwor.2013.03.006; Hijzen A, 2010, OXFORD B ECON STAT, V72, P621, DOI 10.1111/j.1468-0084.2010.00584.x; Hijzen Alexander, 2007, RIETI DISCUSSION PAP, V07-E-006; Kneller R, 2012, REV WORLD ECON, V148, P647, DOI 10.1007/s10290-012-0135-0; Ministry of Economy Trade and Industry (METI), 2012, PROC JAP JAP MAN FOR, P1; Navaretti B., 2010, OXFORD ECON PAP, V62, P234; Riker David A., 1997, NBER WORKING PAPER S, V5959; Yamashita N, 2010, JPN WORLD ECON, V22, P88, DOI 10.1016/j.japwor.2009.10.001	18	0	0	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	1535-3516	1536-0083		ASIAN ECON PAP	Asian Econ. Pap.	SUM	2015	14	2					41	65		10.1162/ASEP_a_00345		25	Economics	Business & Economics	CK1RO	WOS:000355985100004		
J	Gao, H; Lu, M; Sato, H				Gao, Hong; Lu, Ming; Sato, Hiroshi			Inclusive Urban Employment: How Does City Scale Affect Job Opportunities for Different People?	ASIAN ECONOMIC PAPERS			English	Article							TECHNOLOGICAL-CHANGE; LABOR-MARKET; PRODUCTIVITY; CITIES; EDUCATION; WORKERS; CHINA	This paper investigates the influence of city scale on employment using data from China. Probit models of employment determination are estimated. The historical population growth during China's planned economy, when migration was directed by the government and voluntary location choice was prohibited, is used as the instrumental variable of current population size. Instrumental variables estimates show that it is more likely for individuals to gain employment in big cities. A 1 percent increase in city scale increases one's employment probability by between 0.044 and 0.050 percentage points. Moreover, the scale advantage of big cities is heterogeneous among individuals with different levels of human capital, with the least-skilled workers benefiting the most.	[Gao, Hong] Fudan Univ, Dept Econ, Shanghai 200433, Peoples R China; [Lu, Ming] Shanghai Jiao Tong Univ, Dept Econ, Shanghai 200052, Peoples R China; [Lu, Ming] Fudan Univ, Dept Econ, Shanghai 200052, Peoples R China; [Sato, Hiroshi] Hitotsubashi Univ, Dept Econ, Tokyo 1868601, Japan	Lu, M (reprint author), Shanghai Jiao Tong Univ, Dept Econ, 535 Fahuazhen Rd, Shanghai 200052, Peoples R China.	gaohongfd@gmail.com; luming1973@sjtu.edu.cn; satohrs@econ.hit-u.ac.jp			National Natural Science Funds [71273055, 71133004]; National Social Science Funds [13ZD015]; Ford Foundation; National Foundation of Social Sciences of China; SIDA; AusAid; University of Western Ontario; Beijing Normal University; Hitotsubashi University; Ontario Research Foundation; JSPS (Global COE program); Fudan Lab for China Development Studies; JSPS [24330083, 15H03340]	The authors gratefully acknowledge funding by the National Natural Science Funds (71273055 and 71133004) and the National Social Science Funds (13&ZD015). Financial support for the 2002 and 2007 CHIP surveys by the Ford Foundation, the National Foundation of Social Sciences of China, SIDA, AusAid, the University of Western Ontario, Beijing Normal University, Hitotsubashi University, the Ontario Research Foundation, and the JSPS (Global COE program) is also gratefully acknowledged. This research is also supported by the Fudan Lab for China Development Studies, and the JSPS Grants-in-Aid for Scientific Research Nos. 24330083 and 15H03340. We thank Shihe Fu, Cheryl Xiaoning Long, Guanghua Wan, Wing Thye Woo, Lixin Colin Xu, and participants at the 2013 Asian Economic Panel Meeting, the 2010 International Symposium on Contemporary Labor Economics, the 2010 Shanghai Workshop of the Ronald Coase Institute, the Sixth Biennial Conference of the Hong Kong Economic Association, the 2012 Conference on Urbanization and Urban Economics Studies in China and the 2012 International Workshop on Regional, Urban and Spatial Economics in China for helpful discussions and comments. All remaining errors are our own.	Moretti E, 2004, AM ECON REV, V94, P656, DOI 10.1257/0002828041464623; Moretti E, 2010, AM ECON REV, V100, P373, DOI 10.1257/aer.100.2.373; Moretti E, 2004, J ECONOMETRICS, V121, P175, DOI 10.1016/j.jeconom.2003.10.015; Mazzolari F, 2013, REV ECON STAT, V95, P74; Au CC, 2006, REV ECON STUD, V73, P549, DOI 10.1111/j.1467-937X.2006.00387.x; Meng X, 2012, J ECON PERSPECT, V26, P75, DOI 10.1257/jep.26.4.75; Manning A, 2004, SCOT J POLIT ECON, V51, P581, DOI 10.1111/j.0036-9292.2004.00322.x; Autor DH, 2003, Q J ECON, V118, P1279, DOI 10.1162/003355303322552801; Cai F, 2008, MIGRATION DEV BORDER, P245; Duranton G., 2004, HDB REGIONAL URBAN E, V4, P2063; Fujita M., 2001, SPATIAL EC CITIES RE; Gao Hong, 2014, J WORLD EC, V10, P145; Ge Jianxiong, 2010, TANSUO ZHENGMING EXP, V2, P71; Gill I, 2007, EAST ASIAN RENAISSANCE: IDEAS FOR ECONOMIC GROWTH, P1, DOI 10.1596/978-0-8213-6747-6; Glaeser E. L., 2009, 15103 NBER; Gustafsson BA, 2008, INEQUALITY AND PUBLIC POLICY IN CHINA, P1, DOI 10.1017/CBO9780511510922; Jacobs J, 1969, EC CITIES; Knight J, 2008, ECON TRANSIT, V16, P389, DOI 10.1111/j.1468-0351.2008.00329.x; Krugman, 1991, J POLITICAL EC, V99, P483; Li S, 2009, CESIFO ECON STUD, V55, P624, DOI 10.1093/cesifo/ifp016; Shi L, 2013, RISING INEQUALITY IN CHINA: CHALLENGES TO A HARMONIOUS SOCIETY, P1; Liu Hongkang, 1988, CHINESE POPULATION S; Lu Ming, 2011, J WORLD EC, V12, P3; Lu Ming, 2011, J WORLD EC, V6, P3; Marshall A., 1890, PRINCIPLES EC; Moretti E., 2004, HDB REGIONAL URBAN E, V4, P2243; National Bureau of Statistics of China, 1997, CHIN CIT STAT YB; RAUCH JE, 1993, J URBAN ECON, V34, P380, DOI 10.1006/juec.1993.1042; Redding Stephen J., 2009, 7126 CEPR; Rosenthal Stuart S., 2004, EVIDENCE NATURE SOUR, P2119; SVEIKAUSKAS L, 1975, Q J ECON, V89, P393, DOI 10.2307/1885259; World Bank, 2009, WHAT IS INCL GROWTH; Zhao Z., 2004, CHINA EC Q, V3, P517	33	0	0	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	1535-3516	1536-0083		ASIAN ECON PAP	Asian Econ. Pap.	SUM	2015	14	2					98	128		10.1162/ASEP_a_00352		31	Economics	Business & Economics	CK1RO	WOS:000355985100011		
J	Shintani, R				Shintani, Ryo			Recent Advances in the Transition-Metal-Catalyzed Enantioselective Synthesis of Silicon-Stereogenic Organosilanes	ASIAN JOURNAL OF ORGANIC CHEMISTRY			English	Review						asymmetric catalysis; desymmetrization; hydrosilylation; organosilanes; silicon stereocenters	ASYMMETRIC-SYNTHESIS; KINETIC RESOLUTION; RHODIUM COMPLEXES; SILANES; HYDROSILYLATION; DESYMMETRIZATION; DERIVATIVES; SILACYCLOBUTANES; DIBENZOSILOLES; ALCOHOLYSIS	Asymmetric catalysis is one of the most attractive and efficient ways of synthesizing chiral enantioenriched compounds from achiral precursors. Compared with the well-investigated enantioselective preparation of carbon-stereogenic compounds, the corresponding preparation of silicon-stereogenic compounds is much less established. In particular, the available methods typically rely on the use of stoichiometric amounts of chiral reagents, and little progress has been made on catalytic enantioselective synthesis using prochiral organosilanes until recently. This Focus Review highlights recent advances in the catalytic enantioselective preparation of silicon-stereogenic organosilanes under transition-metal catalysis through desymmetrization of prochiral organosilanes including diorganodihydrosilanes and tetraorganosilanes.	Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan	Shintani, R (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	shintani@chembio.t.u-tokyo.ac.jp					Kurihara Y, 2012, CHEM COMMUN, V48, P11564, DOI 10.1039/c2cc36238d; Kuninobu Y, 2013, ANGEW CHEM INT EDIT, V52, P1520, DOI 10.1002/anie.201207723; Igawa K, 2010, ANGEW CHEM INT EDIT, V49, P728, DOI 10.1002/anie.200904922; Shintani R, 2012, J AM CHEM SOC, V134, P7305, DOI 10.1021/ja302278s; Onoe M, 2012, J AM CHEM SOC, V134, P19477, DOI 10.1021/ja3096174; Rendler S, 2006, ADV SYNTH CATAL, V348, P1171, DOI 10.1002/adsc.200606071; Rendler S, 2005, ANGEW CHEM INT EDIT, V44, P7620, DOI 10.1002/ANIE.200502631; Yasutomi Y, 2010, J AM CHEM SOC, V132, P4510, DOI 10.1021/ja100833h; Tamao K, 1996, J AM CHEM SOC, V118, P12469, DOI 10.1021/ja962754c; Xu LW, 2011, CHEM SOC REV, V40, P1777, DOI 10.1039/c0cs00037j; CORRIU RJP, 1973, TETRAHEDRON LETT, P4469; CORRIU RJP, 1976, J ORGANOMET CHEM, V120, P337, DOI 10.1016/S0022-328X(00)98043-4; CORRIU RJP, 1974, J ORGANOMET CHEM, V64, pC51; HAYASHI T, 1974, TETRAHEDRON LETT, P331; Igawa K., 2012, ANGEW CHEM, V124, P12917; Igawa K., 2010, ANGEW CHEM, V122, P740; Igawa K, 2012, ANGEW CHEM INT EDIT, V51, P12745, DOI 10.1002/anie.201207361; Igawa K, 2008, J AM CHEM SOC, V130, P16132, DOI 10.1021/ja805848z; Kuninobu Y., 2013, ANGEW CHEM, V125, P1560; Oestreich M, 2007, SYNLETT, P1629, DOI 10.1055/s-2007-980385; OHTA T, 1994, J CHEM SOC CHEM COMM, P2525, DOI 10.1039/c39940002525; Rendler S, 2007, J AM CHEM SOC, V129, P502, DOI 10.1021/ja067780h; Rendler S., 2005, ANGEW CHEM, V117, P7793, DOI 10.1002/ange.200502631; Schmidt DR, 2003, J AM CHEM SOC, V125, P1190, DOI 10.1021/ja0283201; Shintani R, 2012, J AM CHEM SOC, V134, P16955, DOI 10.1021/ja3076555; Shintani R, 2011, J AM CHEM SOC, V133, P16440, DOI 10.1021/ja208621x; Shintani R., 2015, ANGEW CHEM, V127, P1636; Shintani R, 2015, ANGEW CHEM INT EDIT, V54, P1616, DOI 10.1002/anie.201409733; Shintani R, 2012, ORG LETT, V14, P2902, DOI 10.1021/ol301191u; Sommer L. H., 1965, STEREOCHEMISTRY MECH; Strohmann C, 2002, CHEM COMMUN, P766, DOI 10.1039/b111687h; Trzoss M, 2004, TETRAHEDRON-ASYMMETR, V15, P1501, DOI 10.1016/j.tetasy.2004.03.014; Weickgenannt A, 2010, ORG BIOMOL CHEM, V8, P1497, DOI 10.1039/b925722e; Xu L. W., 2012, ANGEW CHEM, V124, P13106; Xu LW, 2012, ANGEW CHEM INT EDIT, V51, P12932, DOI 10.1002/anie.201207932	35	3	3	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2193-5807	2193-5815		ASIAN J ORG CHEM	Asian J. Org. Chem.	JUN	2015	4	6					510	514		10.1002/ajoc.201500066		15	Chemistry, Organic	Chemistry	CJ7CG	WOS:000355651000001		
J	Huang, ZY; Yang, YD; Tokunaga, E; Shibata, N				Huang, Zhongyan; Yang, Yu-Dong; Tokunaga, Etsuko; Shibata, Norio			Synthesis of Billard-Langlois Reagents and their Derivatives by Copper-Catalyzed N-Trifluoromethylthiolation of Arylamines with a Trifluoromethanesulfonyl Hypervalent Iodonium Ylide	ASIAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						arylamines; copper; hypervalent iodine; trifluoromethanesulfenamides; trifluoromethylthiolation	ELECTROPHILIC TRIFLUOROMETHYLTHIOLATION; CARBONYL-COMPOUNDS; ARYL SULFIDES; ACIDS; CHLORIDE; TRIFLUOROMETHYLSULFENYLATION; ALKYNES; ESTERS; BONDS; MILD	A one-step synthesis of Billard-Langlois reagents and their derivatives, trifluoromethanesulfenamides, is reported. A series of primary and secondly arylamines were directly N-H trifluoromethylthiolated by a trifluoromethanesulfonyl hypervalent iodonium ylide under mild, copper-catalyzed reaction conditions in high yields. Heteroaromatic amines were also successfully trifluoromethylthiolated under the same reaction conditions. An arylamine with an NH-pyrrole moiety was chemoselectively N-trifluoromethylthiolated.	[Huang, Zhongyan; Yang, Yu-Dong; Tokunaga, Etsuko; Shibata, Norio] Nagoya Inst Technol, Dept Nanopharmaceut Sci, Showa Ku, Nagoya, Aichi 4668555, Japan	Shibata, N (reprint author), Nagoya Inst Technol, Dept Nanopharmaceut Sci, Showa Ku, Nagoya, Aichi 4668555, Japan.	nozshiba@nitech.ac.jp			MEXT Japan; Japan Science and Technology (JST) Agency; JSPS [25288045, 25670055]; Hoansha Foundation; Kobayashi International Scholarship Foundation	This research was financially supported in part by the Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT Japan, the Advanced Catalytic Transformation (ACT-C) from the Japan Science and Technology (JST) Agency, a JSPS Grand-in-Aid Scientific Research (B) (25288045), a JSPS Grand-in-Aid for Exploratory Research (25670055), the Hoansha Foundation, and the Kobayashi International Scholarship Foundation.	Adams DJ, 2000, CHEM COMMUN, P987, DOI 10.1039/b002560g; Alazet S., 2013, ANGEW CHEM, V125, P11014, DOI DOI 10.1002/ANGE.201305179; Yang YD, 2013, J AM CHEM SOC, V135, P8782, DOI [10.1021/ja402455f, 10.1021/ja402055f]; Xu CF, 2014, ORG LETT, V16, P2046, DOI 10.1021/ol5006533; Baert F, 2012, ANGEW CHEM INT EDIT, V51, P10382, DOI 10.1002/anie.201205156; Ferry A, 2009, ANGEW CHEM INT EDIT, V48, P8551, DOI 10.1002/anie.200903387; Zhu W, 2014, J FLUORINE CHEM, V167, P37, DOI 10.1016/j.jfluchem.2014.06.026; O'Hagan D, 2008, CHEM SOC REV, V37, P308, DOI 10.1039/b711844a; Rueping M, 2013, CHEM-EUR J, V19, P14043, DOI 10.1002/chem.201302692; Teverovskiy G, 2011, ANGEW CHEM INT EDIT, V50, P7312, DOI 10.1002/anie.201102543; Xiao Q, 2013, CHEM COMMUN, V49, P8647, DOI 10.1039/c3cc44263b; Sheng J, 2014, CHEM COMMUN, V50, P578, DOI 10.1039/c3cc45958f; Liang T, 2013, ANGEW CHEM INT EDIT, V52, P8214, DOI 10.1002/anie.201206566; Munavalli S, 2000, SYNTHETIC COMMUN, V30, P2847, DOI 10.1080/00397910008087435; Liu JB, 2013, ORG LETT, V15, P894, DOI 10.1021/ol400032g; Toulgoat F, 2014, EUR J ORG CHEM, V2014, P2415, DOI 10.1002/ejoc.201301857; Alazet S, 2013, ANGEW CHEM INT EDIT, V52, P10814, DOI 10.1002/anie.201305179; Wang J, 2014, CHEM REV, V114, P2432, DOI 10.1021/cr4002879; Alazet S, 2014, CHEM-EUR J, V20, P8589, DOI 10.1002/chem.201403409; NODIFF EA, 1960, J ORG CHEM, V25, P60, DOI 10.1021/jo01071a018; Boiko VN, 2010, BEILSTEIN J ORG CHEM, V6, P880, DOI 10.3762/bjoc.6.88; Ferry A, 2012, J FLUORINE CHEM, V134, P160, DOI 10.1016/j.jfluchem.2011.02.005; Landelle G, 2013, BEILSTEIN J ORG CHEM, V9, P2476, DOI 10.3762/bjoc.9.287; Weng ZQ, 2013, ANGEW CHEM INT EDIT, V52, P1548, DOI 10.1002/anie.201208432; Zhang CP, 2012, J AM CHEM SOC, V134, P183, DOI 10.1021/ja210364r; Tlili A, 2013, ANGEW CHEM INT EDIT, V52, P6818, DOI 10.1002/anie.201301438; Alazet S, 2013, BEILSTEIN J ORG CHEM, V9, P2354, DOI 10.3762/bjoc.9.270; Xu CF, 2014, ANGEW CHEM INT EDIT, V53, P9316, DOI 10.1002/anie.201403983; Adams DJ, 2000, J ORG CHEM, V65, P1456, DOI 10.1021/jo9915933; Shao XX, 2013, ANGEW CHEM INT EDIT, V52, P3457, DOI 10.1002/anie.201209817; Pluta R, 2014, ANGEW CHEM INT EDIT, V53, P1650, DOI 10.1002/anie.201307484; Ferry A, 2008, J ORG CHEM, V73, P9362, DOI 10.1021/jo8018544; Hu F, 2014, ANGEW CHEM INT EDIT, V53, P6105, DOI 10.1002/anie.201402573; Bootwicha T, 2013, ANGEW CHEM INT EDIT, V52, P12856, DOI 10.1002/anie.201304957; ANDREADES S, 1964, J ORG CHEM, V29, P898, DOI 10.1021/jo01027a034; Wang XQ, 2013, ANGEW CHEM INT EDIT, V52, P12860, DOI 10.1002/anie.201305075; Arimori A., 2015, ORG LETT, V17, P1063; Baert F., 2012, ANGEW CHEM, V124, P10528, DOI DOI 10.1002/ANGE.201205156; Banks R. E., 1994, ORGANOFLUORINE CHEM; Bootwicha T., 2013, ANGEW CHEM, V125, P13093; Ferry A., 2007, THESIS U LYON LYON F; Ferry A., 2009, ANGEW CHEM, V121, P8703, DOI DOI 10.1002/ANGE.200903387; HANACK M, 1981, TETRAHEDRON LETT, V22, P3047, DOI 10.1016/S0040-4039(01)81823-2; Hiyama T., 2000, ORGANOFLUORINE COMPO; Hu F., 2014, ANGEW CHEM, V126, P6219; Huang ZY, 2015, ORG LETT, V17, P1094, DOI 10.1021/ol503616y; Kang K, 2014, ORG CHEM FRONT, V1, P294, DOI 10.1039/c3qo00068k; Kirsch P., 2004, MODERN FLUOROORGANIC; KOLASA A, 1987, J FLUORINE CHEM, V36, P29, DOI 10.1016/S0022-1139(00)82051-5; Kremsner JA, 2009, TETRAHEDRON LETT, V50, P3665, DOI 10.1016/j.tetlet.2009.03.103; Liang T., 2013, ANGEW CHEM, V125, P8372, DOI DOI 10.1002/ANGE.201206566; MAN EH, 1959, J AM CHEM SOC, V81, P3575, DOI 10.1021/ja01523a023; Pluta R., 2014, ANGEW CHEM, V126, P1676; POPOV VI, 1990, J FLUORINE CHEM, V47, P131, DOI 10.1016/S0022-1139(00)80455-8; Scherer O., 1939, ANGEW CHEM, V52, P457; Shao X., 2013, ANGEW CHEM, V125, P3541; SOLOSHONOK V, 1992, SYNLETT, P657; Teverovskiy G., 2011, ANGEW CHEM, V123, P7450; Tlili A., 2013, ANGEW CHEM, V125, P6952, DOI DOI 10.1002/ANGE.201301438; Uneyama K., 2006, ORGANOFLUORINE CHEM; WAKSELMAN C, 1984, J CHEM SOC CHEM COMM, P793, DOI 10.1039/c39840000793; Wang X., 2013, ANGEW CHEM, V125, P13098; Weng Z., 2013, ANGEW CHEM, V125, P1588; Xu C., 2014, ANGEW CHEM, V126, P9470; Xu XH, 2015, CHEM REV, V115, P731, DOI 10.1021/cr500193b	65	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2193-5807	2193-5815		ASIAN J ORG CHEM	Asian J. Org. Chem.	JUN	2015	4	6					525	527		10.1002/ajoc.201500067		3	Chemistry, Organic	Chemistry	CJ7CG	WOS:000355651000004		
J	Ono, S; Kagawa, H; Takahasi, M; Seki, Y; Okanoya, K				Ono, Satoko; Kagawa, Hiroko; Takahasi, Miki; Seki, Yoshimasa; Okanoya, Kazuo			Limitations of a habituation task to demonstrate discrimination of natural signals in songbirds	BEHAVIOURAL PROCESSES			English	Article						Animal cognition; Bengalese finch; Discrimination task; Habituation; Songbird	ZEBRA FINCHES; SONG; INFANTS; RECOGNITION	The habituation-dishabituation (HDH) paradigm is a common method used to examine animal cognition. Recent studies reported that spontaneous vocalizations could be used as an index of song familiarity and novelty in songbirds. However, these studies assigned only a few stimulus sets for all subjects, which might cause pseudoreplication. Therefore, we examined universality and general applicability of this method in Bengalese finches using a variety of stimulus sets. Seven unfamiliar conspecific songs were collected as a stimulus pool and a habituation song was randomly chosen for each subject. The subject was exposed to the habituation song repeatedly over 2 h. During the test phase, the habituation song and a novel song randomly chosen from the stimulus pool were presented. We compared the degree of increase in call production during playback of those two songs. Although the degree was greater for the novel song compared with the habituation song in some birds, the trend was not consistent across all stimulus sets tested in these birds. Our results show that the HDH paradigm is not suitable to test song discrimination in songbirds unless precautions are taken to increase external validity by utilizing a variety of stimulus sets for each subject. (C) 2015 Elsevier B.V. All rights reserved.	[Ono, Satoko; Kagawa, Hiroko; Takahasi, Miki; Okanoya, Kazuo] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; [Seki, Yoshimasa; Okanoya, Kazuo] Japan Sci & Technol Agcy, Okanoya Emot Informat Project, ERATO, Wako, Saitama 3510198, Japan	Okanoya, K (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	cokanoya@mail.ecc.u-tokyo.ac.jp			JSPS KAKENHI [23240033, 26240019]	This work was supported by JSPS KAKENHI to Kazuo Okanoya (Grant Numbers 23240033 and 26240019). We thank Dr. Ryosuke Tachibana for suggestions on song analysis.	SEARCY WA, 1981, SCIENCE, V213, P926, DOI 10.1126/science.213.4510.926; STODDARD PK, 1991, BEHAV ECOL SOCIOBIOL, V29, P211, DOI 10.1007/BF00166403; SCHARFF C, 1991, J NEUROSCI, V11, P2896; ten Cate C, 2012, PHILOS T R SOC B, V367, P1984, DOI 10.1098/rstb.2012.0055; KROODSMA DE, 1989, ANIM BEHAV, V37, P600, DOI 10.1016/0003-3472(89)90039-0; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Oakes LM, 2010, J COGN DEV, V11, P255, DOI 10.1080/15248371003699977; Saffran J, 2008, COGNITION, V107, P479, DOI 10.1016/j.cognition.2007.10.010; Abe K, 2011, NAT NEUROSCI, V14, P1067, DOI 10.1038/nn.2869; Turati C, 2006, CHILD DEV, V77, P297, DOI 10.1111/j.1467-8624.2006.00871.x; Berwick RC, 2011, TRENDS COGN SCI, V15, P113, DOI 10.1016/j.tics.2011.01.002; KAPLAN PS, 1995, DEV PSYCHOBIOL, V28, P45, DOI 10.1002/dev.420280105; Stripling R, 2003, NEUROBIOL LEARN MEM, V79, P41, DOI 10.1016/S1074-7427(02)00005-9; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Chaudhury D, 2010, BEHAV NEUROSCI, V124, P490, DOI 10.1037/a0020293; Clayton D., 1989, ANIM BEHAV, V38, P352; Dong S, 2008, GENES BRAIN BEHAV, V7, P802, DOI 10.1111/j.1601-183X.2008.00423.x; Douglas A. N., 1990, COMP PERCEPTION COMP, V2, P443; Dunning JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089438; MCGREGOR PK, 1992, NATO ADV SCI I A-LIF, V228, P1; Peeke H., 1984, HABITUATION SENSITIZ, P1; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; WANG DL, 1992, J COMP PHYSIOL A, V170, P317; WEARY DM, 1992, NATO ADV SCI I A-LIF, V228, P201; ZUCCHI H, 1975, EXPERIENTIA, V31, P817, DOI 10.1007/BF01938482	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0376-6357	1872-8308		BEHAV PROCESS	Behav. Processes	JUN	2015	115						100	108		10.1016/j.beproc.2015.03.004		9	Psychology, Biological; Behavioral Sciences; Zoology	Psychology; Behavioral Sciences; Zoology	CJ4ZV	WOS:000355498100014		
J	Hu, RQ; Li, F; Lv, JQ; He, Y; Lu, DT; Yamada, T; Ono, N				Hu, Ruiqing; Li, Fen; Lv, Jiaqi; He, Ying; Lu, Detang; Yamada, Takashi; Ono, Naoki			Microfluidic analysis of pressure drop and flow behavior in hypertensive micro vessels	BIOMEDICAL MICRODEVICES			English	Article						Microfluidic device; Pressure drop; Hematocrit; RBC velocity; Fahreaus effect	MICROCHANNELS; CAPILLARIES	The retinal arterial network is the only source of the highly nutrient-consumptive retina, thus any insult on the arteries can impair the retinal oxygen and nutrient supply and affect its normal function. The aim of this work is to study the influences of vascular structure variation on the flow and pressure characteristics via microfluidic devices. Two sets of micro-channel were designed to mimic the stenosed microvessels and dichotomous branching structure in the retinal arteries. Three working fluids including red blood cell (RBC) suspension were employed to investigate the pressure drop in the stenosed channel. The flow behaviors of RBC suspensions inside the micro channels were observed using high speed camera system. Pressure drop of different working fluids and RBC velocity profiles in the stenosed channel were obtained. Moreover, hematocrit levels of RBC suspensions inside the bifurcated channels were analyzed from the sequential images of RBC flow. The results of the flow in the stenosed channel show that RBCs drift from the center of the channels, and RBC velocity is influenced not only by the inlet flow rate but also the interaction between RBCs. The measured pressure drops in the stenosed channel increase notably with the increase of fluid viscosity. Furthermore, the dimensionless pressure drop due to the stenosis decreases with Reynolds number. On the other hand, the results of flow through the bifurcated channels show that as the ratio of the daughter-branch width to the mother-channel width increases, the ratio of hematocrit in two connected branches (Ht/Hd) decreases, which is in favorable agreement with the available analysis results.	[Hu, Ruiqing; Li, Fen; Lv, Jiaqi; Lu, Detang] Univ Sci & Technol China, Dept Modern Mech, Hefei 230027, Anhui, Peoples R China; [He, Ying] Dalian Univ Technol, Sch Energy & Power Engn, Dalian, Peoples R China; [Yamada, Takashi; Ono, Naoki] Shibaura Inst Technol, Coll Engn, Tokyo 1358548, Japan	He, Y (reprint author), Dalian Univ Technol, Sch Energy & Power Engn, 2 Linggong Rd, Dalian, Peoples R China.	heying@dlut.edu.cn; dtlu@ustc.edu.cn			Fundamental Research Funds for the Central Universities of Dalian University of Technology [2342013DUT13RC(3)104]	The work was partially supported by The Fundamental Research Funds for the Central Universities of Dalian University of Technology (No. 2342013DUT13RC(3)104)	Fujiwara H, 2009, J BIOMECH, V42, P838, DOI 10.1016/j.jbiomech.2009.01.026; Wang GJ, 2007, BIOMED MICRODEVICES, V9, P657, DOI 10.1007/s10544-007-9067-1; Choi KD, 2006, J NEUROL SCI, V246, P169, DOI 10.1016/j.jns.2006.02.014; Zhou JW, 2010, ELECTROPHORESIS, V31, P2, DOI 10.1002/elps.200900475; Song Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.134501; Bahrami M, 2006, J FLUID ENG-T ASME, V128, P1036, DOI 10.1115/1.2234786; Wada Y, 2009, GASTROINTEST ENDOSC, V70, P522, DOI 10.1016/j.gie.2009.01.040; Song Y, 2011, MED ENG PHYS, V33, P849, DOI 10.1016/j.medengphy.2010.10.001; Au WY, 2014, ANN HEMATOL, V93, P881, DOI 10.1007/s00277-013-1902-2; Byung H.J., 2000, J MICROELECTROMECH S, V9, P76; Dhawdal A., 1997, J APPL PHYSIOL, V83, P1711; Fen L., 2014, CHIN J THEOR APPL ME, V46, P1; Huang YQ, 2001, J APPL PHYSIOL, V90, P545; Hyakutake T, 2015, MICROVASC RES, V97, P115, DOI 10.1016/j.mvr.2014.10.001; Ismi O., 2014, J CRANIOFAC SURG; Ji J.C., 2014, THESIS U SCI TECHNOL; Le G., 2014, APPL MATH MODEL, P1; Leble V, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3672689; Liu D, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005529; MicroChem, PERM EP NEG PHOT PRO; Oba S, 2010, SCAND J GASTROENTERO, V45, P1084, DOI 10.3109/00365521003734166; Obrist B.D., 2010, PHIL T R SOC A, V368, P2897; Pozrikidis C, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1830484; Shen ZY, 2012, CHINESE PHYS LETT, V29, DOI 10.1088/0256-307X/29/2/024703; Xiong WJ, 2012, BIOMECH MODEL MECHAN, V11, P575, DOI 10.1007/s10237-011-0334-y	25	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1387-2176	1572-8781		BIOMED MICRODEVICES	Biomed. Microdevices	JUN	2015	17	3							60	10.1007/s10544-015-9959-4		9	Engineering, Biomedical; Nanoscience & Nanotechnology	Engineering; Science & Technology - Other Topics	CJ8SY	WOS:000355775000013		
J	Konishi, S; Teramachi, Y; Shimomura, S; Tonomura, W; Tajima, S; Tabata, Y				Konishi, Satoshi; Teramachi, Yumi; Shimomura, Shuhei; Tonomura, Wataru; Tajima, Shuhei; Tabata, Yasuhiko			Cellular aggregate capture by fluidic manipulation device highly compatible with micro-well-plates	BIOMEDICAL MICRODEVICES			English	Article						Cellular aggregate; uTAS; Capture; Fluidic manipulation; Micro-well-plate	MESENCHYMAL STEM-CELLS; SCAFFOLD; CARTILAGE; BONE	This paper proposes a capture device to manipulate and transport a cellular aggregate in a micro-well. A cellular aggregate (a few hundreds mu m in diameter) is currently manipulated by a pipette. The manual manipulation by a pipette has problems; low reliability, low throughput, and difficulty in confirmation of task completion. We took into account of compatibility with existing methods such as a micro-wellplate and designed for the capture device of a cellular aggregate in a micro-well. A newly developed capture device flows and carries a cellular aggregate from a bottom of a well to a trap of the capture device. We designed a curved surface at the bottom of the capture device to form a space to act as a channel between the inner wall of the micro-well. This paper presents concept, design, fabrication, and of the proposed cellular aggregate capture, followed by successful experimental results.	[Konishi, Satoshi; Tonomura, Wataru] Ritsumeikan Univ, Dept Mech Engn, Kusatsu, Shiga 5258577, Japan; [Teramachi, Yumi; Shimomura, Shuhei] Ritsumeikan Univ, Grad Sch Sci & Engn, Kusatsu, Shiga 5258577, Japan; [Tajima, Shuhei; Tabata, Yasuhiko] Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan	Konishi, S (reprint author), Ritsumeikan Univ, Dept Mech Engn, 1-1-1 Noji Higashi, Kusatsu, Shiga 5258577, Japan.	konishi@se.ritsumei.ac.jp			JSPS [24240075]	This work was partially supported by Grant-in-Aid for Scientific Research (A) : JSPS KAKENHI Grant Number 24240075.	Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X; Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005; Vigolo D, 2010, SOFT MATTER, V6, P3489, DOI 10.1039/c002057e; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209; Moon HS, 2011, LAB CHIP, V11, P1118, DOI 10.1039/c0lc00345j; Sakai S, 2009, BIOMATERIALS, V30, P5937, DOI 10.1016/j.biomaterials.2009.07.031; Kurosawa H, 2007, J BIOSCI BIOENG, V103, P389, DOI 10.1263/jbb.103.389; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; Augustsson P, 2009, LAB CHIP, V9, P810, DOI 10.1039/b811027a; Vepari CP, 2006, BIOTECHNOL BIOENG, V93, P1130, DOI 10.1002/bit.20833; Huang SB, 2013, LAB CHIP, V13, P1371, DOI 10.1039/c3lc41256c; Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b; Hosseinkhani H, 2006, BIOMATERIALS, V27, P4269, DOI 10.1016/j.biomaterials.2006.02.033; Nishijima T., 2012, P IEEE MEMS 2012 JAN, P92; Zengerle R., 2012, P MICROTAS, P239	16	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1387-2176	1572-8781		BIOMED MICRODEVICES	Biomed. Microdevices	JUN	2015	17	3							48	10.1007/s10544-015-9953-x		6	Engineering, Biomedical; Nanoscience & Nanotechnology	Engineering; Science & Technology - Other Topics	CJ8SY	WOS:000355775000001		
J	Kato, S; Pewsey, A				Kato, Shogo; Pewsey, Arthur			A Mobius transformation-induced distribution on the torus	BIOMETRIKA			English	Article						Bioinformatics; Bivariate circular distribution; Circular correlation; Goodness-of-fit; Markov process; Wrapped Cauchy distribution	VON MISES DISTRIBUTIONS; DIRECTIONAL-DATA; CORRELATION-COEFFICIENT; FUNCTION MINIMIZATION; CIRCULAR REGRESSION; UNIT VECTORS; MODELS; STATISTICS; TESTS	We propose a five-parameter bivariate wrapped Cauchy distribution as a unimodal model for toroidal data. It is highly tractable, displays numerous desirable properties, including marginal and conditional distributions that are all wrapped Cauchy, and arises as an appealing submodel of a six-parameter distribution obtained by applying Mobius transformation to a pre-existing bivariate circular model. Method of moments and maximum likelihood estimation of its parameters are fast, and tests for independence and goodness-of-fit are available. An analysis involving dihedral angles of the proteinogenic amino acid Tyrosine illustrates the distribution's application. A Markov process for circular data is also explored.	[Kato, Shogo] Inst Stat Math, Tachikawa, Tokyo 1908562, Japan; [Pewsey, Arthur] Univ Extremadura, Dept Math, Escuela Politecn, Caceres 10003, Spain	Kato, S (reprint author), Inst Stat Math, 10-3 Midori Cho, Tachikawa, Tokyo 1908562, Japan.	skato@ism.ac.jp; apewsey@unex.es	Pewsey, Arthur/L-5760-2014	Pewsey, Arthur/0000-0003-3093-2469	Japan Society for the Promotion of Science; Spanish Ministry of Science and Education	We are grateful to the editor, an associate editor and two referees for their valuable comments, Professor Charles Taylor for supplying us with the proteinogenic amino acid data, and to Professor Shinto Eguchi for helpful advice on maximum entropy characterizations. This work was partially supported by the Japan Society for the Promotion of Science and the Spanish Ministry of Science and Education.	WEHRLY TE, 1980, BIOMETRIKA, V67, P255; JUPP PE, 1980, BIOMETRIKA, V67, P163; SHANNO DF, 1970, MATH COMPUT, V24, P647, DOI 10.2307/2004840; Shieh GS, 2011, BIOINFORMATICS, V27, P912, DOI 10.1093/bioinformatics/btr049; NELDER JA, 1965, COMPUT J, V7, P308; GOLDFARB D, 1970, MATH COMPUT, V24, P23, DOI 10.2307/2004873; FLETCHER R, 1970, COMPUT J, V13, P317, DOI 10.1093/comjnl/13.3.317; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95; Kato S, 2008, STAT SINICA, V18, P633; Singh H, 2002, BIOMETRIKA, V89, P719, DOI 10.1093/biomet/89.3.719; FISHER NI, 1983, BIOMETRIKA, V70, P327, DOI 10.1093/biomet/70.2.327; Mardia KV, 2007, BIOMETRICS, V63, P505, DOI 10.1111/j.1541-0420.2006.00682.x; Di Marzio M, 2011, J STAT PLAN INFER, V141, P2156, DOI 10.1016/j.jspi.2011.01.002; Shieh GS, 2005, ANN I STAT MATH, V57, P789, DOI 10.1007/BF02915439; Broyden C., 1970, J I MATH ITS APPL, V6, P76, DOI DOI 10.1093/IMAMAT/6.1.76; Downs TD, 2002, BIOMETRIKA, V89, P683, DOI 10.1093/biomet/89.3.683; Fernandez-Duran JJ, 2007, BIOMETRICS, V63, P579, DOI 10.1111/j.1541-0420.2006.00716.x; JOHNSON RA, 1977, J ROY STAT SOC B MET, V39, P222; JUPP PE, 1989, INT STAT REV, V57, P261, DOI 10.2307/1403799; Kato S, 2009, BERNOULLI, V15, P898, DOI 10.3150/08-BEJ178; Kent J. T., 1988, J APPL STAT, V15, P247, DOI 10.1080/02664768800000029; Kent J. T., 2008, P LEEDS A STAT RES W, P70; Liu DL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-87; LOCKHART RA, 1985, BIOMETRIKA, V72, P647, DOI 10.1093/biomet/72.3.647; MARDIA KV, 1975, J ROY STAT SOC B MET, V37, P349; Mardia KV, 2010, J APPL STAT, V37, P515, DOI 10.1080/02664760903551267; McCullagh P, 1996, ANN STAT, V24, P787; Pertsemlidis A, 2005, STAT APPL GENET MO B, V4; R Development Core Team, 2015, R LANG ENV STAT COMP; RIVEST LP, 1988, COMMUN STAT THEORY, V17, P461, DOI 10.1080/03610928808829634; SenGupta A., 2004, B CALCUTTA MATH SOC, V96, P139; WELLNER JA, 1979, ANN STAT, V7, P929, DOI 10.1214/aos/1176344779	32	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-3444	1464-3510		BIOMETRIKA	Biometrika	JUN	2015	102	2					359	370		10.1093/biomet/asv003		12	Biology; Mathematical & Computational Biology; Statistics & Probability	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology; Mathematics	CJ7LT	WOS:000355677500008		
J	Li, Z; Mitsuoka, M; Inoue, E; Okayasu, T; Hirai, Y				Li, Zhen; Mitsuoka, Muneshi; Inoue, Eiji; Okayasu, Takashi; Hirai, Yasumaru			Development of stability indicators for dynamic Phase I overturn of conventional farm tractors with front axle pivot	BIOSYSTEMS ENGINEERING			English	Article						Conventional farm tractor; Front axle pivot; 3D mathematical model; Dynamic Phase I overturn; Tractor stability indicator; Critical speed	MATHEMATICAL-MODEL; IMPACT BEHAVIOR; SIDE-SLOPES; ROLLOVER; PREDICTION; MOTION	Tractor overturns are serious potential hazards for operators. While rollover protective structures (ROPS) protect operators passively, greater protection can be achieved through theoretical prediction of a potential overturn. Given effective warning, an operator can act to correct a tractor's motion when a tyre is about to lose contact with the ground. Such a loss of contact is associated with the initiation of a Phase I tractor overturn. However, it remains unclear how the initiation of tractor overturn is influenced by certain factors. Furthermore, the current mathematical models for tractors should be further extended for general utilisation. This study was conducted to develop stability indicators based on a more general model for dynamic Phase I tractor overturn. We considered practical tractor configurations and motion characteristics in a three-dimensional (3D) reference frame in formulating the mathematical model. Tractor stability indicators for overturn and sideslip were derived from force calculations. A parametric study was conducted using an example tractor. The tractor speed and slope angle were found to affect the overturning stability significantly. The coefficient of maximum static friction was found to be the main factor contributing to tractor sideslip. Critical tractor speeds for various ground conditions were identified by considering the zero values of the tractor stability indicators. The critical tractor speed was determined as a function of the maximum static friction and the slope angle. By providing a display device based on ergonomics principles, the results of this study can be further implemented in the form of guidance to operators. (c) 2015 IAgrE. Published by Elsevier Ltd. All rights reserved.	[Li, Zhen] Kyushu Univ, Grad Sch Biores & Bioenvironm Sci, Higashi Ku, Fukuoka 8128581, Japan; [Mitsuoka, Muneshi; Inoue, Eiji; Okayasu, Takashi; Hirai, Yasumaru] Kyushu Univ, Fac Agr, Higashi Ku, Fukuoka 8128581, Japan	Mitsuoka, M (reprint author), Kyushu Univ, Fac Agr, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	lizhensail@gmail.com; mitsuoka@bpes.kyushu-u.ac.jp			China Scholarship Council	The authors acknowledge the scholarship support received from the China Scholarship Council and valuable English revisions by anonymous reviewers.	Abubakar M. S., 2010, PERTANIKA J SCI TECH, V18, P377; Ahmadi I, 2011, J TERRAMECHANICS, V48, P339, DOI 10.1016/j.jterra.2011.07.001; Ahmadi I, 2013, TURK J AGRIC FOR, V37, P203, DOI 10.3906/tar-1103-19; Mashadi B, 2009, J TERRAMECHANICS, V46, P299, DOI 10.1016/j.jterra.2009.08.006; [Anonymous], 2013, REP FAT FARM ACC HAP; SPENCER HB, 1985, J AGR ENG RES, V31, P81, DOI 10.1016/0021-8634(85)90126-X; [Anonymous], 2012, REP FAT FARM ACC HAP; [Anonymous], 2011, REP FAT FARM ACC HAP; BAKER CJ, 1986, J WIND ENG IND AEROD, V22, P69, DOI 10.1016/0167-6105(86)90012-7; Baker V, 2013, BIOSYST ENG, V116, P179, DOI 10.1016/j.biosystemseng.2013.07.016; CHISHOLM CJ, 1979, J AGR ENG RES, V24, P441, DOI 10.1016/0021-8634(79)90082-9; CHISHOLM CJ, 1979, J AGR ENG RES, V24, P417, DOI 10.1016/0021-8634(79)90081-7; CHISHOLM CJ, 1979, J AGR ENG RES, V24, P375, DOI 10.1016/0021-8634(79)90079-9; CHISHOLM CJ, 1979, J AGR ENG RES, V24, P395, DOI 10.1016/0021-8634(79)90080-5; DAVIS DC, 1974, T ASAE, V17, P477; DAVIS DC, 1974, T ASAE, V17, P484; Franceschetti B, 2014, BIOSYST ENG, V127, P79, DOI 10.1016/j.biosystemseng.2014.08.010; Guzzomi A, 2013, J Agric Saf Health, V19, P237; Guzzmi AL, 2009, BIOSYST ENG, V104, P318, DOI 10.1016/j.biosystemseng.2009.07.005; Guzzomi AL, 2012, BIOSYST ENG, V113, P65, DOI 10.1016/j.biosystemseng.2012.06.007; Kamide J., 1975, J JAPANESE SOC AGR M, V36, P513; Kayacan E, 2014, COMPUT ELECTRON AGR, V106, P1, DOI 10.1016/j.compag.2014.05.002; KIM KU, 1987, T ASAE, V30, P615; LARSON DL, 1976, T ASAE, V19, P195; Li Z, 2014, J FAC AGR KYUSHU U, V59, P345; Li Z, 2014, J FAC AGR KYUSHU U, V59, P339; Liljedahl J. B., 1979, TRACTORS THEIR POWER, V3rd; Liu B, 2013, COMPUT ELECTRON AGR, V98, P117, DOI 10.1016/j.compag.2013.08.002; Malviya V, 2014, APPL MATH MODEL, V38, P4756, DOI 10.1016/j.apm.2014.03.029; MURPHY DJ, 1985, APPL ERGON, V16, P187, DOI 10.1016/0003-6870(85)90007-9; Nichol C I, 2005, J Agric Saf Health, V11, P99; Pershing R. L., 1969, T ASAE, V12, P715; Previati G, 2014, INT J VEHICLE DES, V64, P280, DOI 10.1504/IJVD.2014.058486; Rabbani MA, 2011, BIOSYST ENG, V110, P178, DOI 10.1016/j.biosystemseng.2011.07.013; Raney J. P., 1961, T ASAE, V4, P215; Schwanghart H., 1973, GRUNDL LANDTECHN, V23, P170; Takeda J., 2010, Journal of the Japanese Society of Agricultural Machinery, V72, P464; Takeda J., 2010, Journal of the Japanese Society of Agricultural Machinery, V72, P457; Takeuchi M., 1971, J JAPANESE SOC AGR M, V33, P230; Tyre Design Principle Guiding Committee, 1999, OFF ROAD TYR ENG FUN, P197; Vidoni R, 2015, BIOSYST ENG, V129, P197, DOI 10.1016/j.biosystemseng.2014.10.003; WOLKEN LP, 1974, T ASAE, V17, P468; Yang J. H., 1991, Journal of the Japanese Forestry Society, V73, P1; Yisa MG, 1998, J TERRAMECHANICS, V35, P1, DOI 10.1016/S0022-4898(98)00008-1	44	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1537-5110	1537-5129		BIOSYST ENG	Biosyst. Eng.	JUN	2015	134						55	67		10.1016/j.biosystemseng.2015.03.016		13	Agricultural Engineering; Agriculture, Multidisciplinary	Agriculture	CJ7VG	WOS:000355707800006		
J	Kimura, K; Nakano, K; Ohashi, S; Takizawa, K; Nakano, T				Kimura, Kohei; Nakano, Kazuhiro; Ohashi, Shintaroh; Takizawa, Kenichi; Nakano, Takayuki			LED measurement for development of a non-destructive detector of unsuitable chicken eggs in influenza vaccine production	BIOSYSTEMS ENGINEERING			English	Article						Fertilised chicken egg; Influenza vaccine; Non-destructive detection; VNIR spectroscopy; Linear discriminant analysis	NEAR-INFRARED SPECTROSCOPY; NIR; APPLE	In Japan, fertilised chicken eggs are used to produce influenza vaccines; however, some eggs die and then contaminate the vaccine stock solution, which causes large economic losses and raises health concerns. Therefore, a non-destructive test that allows distinction of normal and unsuitable chicken eggs was developed, first using visible and near-infrared (VNIR) spectroscopy and subsequently a light-emitting diode (LED) light source. Eggs were sampled from an egg farm, and each of the eggs categorised as either normal or unsuitable using candling. Linear discriminant analysis was applied using wavelength absorbance data to distinguish between normal and unsuitable eggs. All of the optical absorbance values of the normal eggs were found to be higher than those of unsuitable eggs. To reduce the production cost, LED lights and photodiodes were used as the light source and light receptors, respectively. A discrimination rate of 92.9% was obtained when LED was used as the light source. (c) 2015 IAgrE. Published by Elsevier Ltd. All rights reserved.	[Kimura, Kohei; Nakano, Kazuhiro; Ohashi, Shintaroh; Takizawa, Kenichi] Niigata Univ, Grad Sch Sci & Technol, Nishi Ku, Niigata 9502181, Japan; [Nakano, Takayuki] Kagoshima Immaculate Heart Univ, Kagoshima 8950011, Japan	Nakano, K (reprint author), Niigata Univ, Grad Sch Sci & Technol, Nishi Ku, 8050 Ikarashi 2-No Cho, Niigata 9502181, Japan.	knakano@agr.niigata-u.ac.jp			JSPS [23380148]	This work was supported by JSPS Grant-in-Aid for Scientific Research (B) Grant Number (23380148).	[Anonymous], 2009, H1N1 VACCINE IS MADE; Teerachaichayut S, 2007, POSTHARVEST BIOL TEC, V43, P202, DOI 10.1016/j.postharvbio.2006.09.007; Cozzolino D, 2008, J AGR FOOD CHEM, V56, P7631, DOI 10.1021/jf801563z; Hsiao SC, 2010, COMPUT ELECTRON AGR, V72, P127, DOI 10.1016/j.compag.2010.03.005; Ventura M, 1998, POSTHARVEST BIOL TEC, V14, P21, DOI 10.1016/S0925-5214(98)00030-1; Zhao HJ, 2002, PHYS MED BIOL, V47, P2075, DOI 10.1088/0031-9155/47/12/306; Clark CJ, 2003, POSTHARVEST BIOL TEC, V28, P87, DOI 10.1016/S0925-5214(02)00122-9; Armstrong PR, 2006, APPL ENG AGRIC, V22, P767; Dawood S. F., 2012, LANCET INFECT DIS, V12, P687; Dover S. J., 1999, J DERMATOLOGIC SURG, V25, P328; Ito H., 2007, J B NATL I VEGETABLE, V6, P83; Kemps BJ, 2010, BIOTECHNOL PROGR, V26, P512, DOI 10.1002/btpr.321; Komiyama Seiichi, 2010, Horticultural Research (Japan), V9, P229; Ohtake K, 2010, NITRIC OXIDE-BIOL CH, V23, P65, DOI 10.1016/j.niox.2010.04.004; Schaare N. P., 2000, POSTHARVEST BIOL TEC, V20, P175; Shimizu H., 2011, C 18 IFAC WORLD C MI, V18, P605; Takizawa K., 2012, Bulletin of the Faculty of Agriculture, Niigata University, V64, P179; Tanaka S., 2008, J BIOMECH SCI ENG, V3, P332, DOI 10.1299/jbse.3.332; Usui Y., 2003, P EUR FED INF TECHN, P625; Xu ChunCheng, 2006, Japanese Journal of Grassland Science, V51, P374	20	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1537-5110	1537-5129		BIOSYST ENG	Biosyst. Eng.	JUN	2015	134						68	73		10.1016/j.biosystemseng.2015.03.011		6	Agricultural Engineering; Agriculture, Multidisciplinary	Agriculture	CJ7VG	WOS:000355707800007		
J	Yen, HW; Ho, SH; Chen, CY; Chang, JS				Yen, Hong-Wei; Ho, Shih-Hsin; Chen, Chun-Yen; Chang, Jo-Shu			CO2, NOx and SOx removal from flue gas via microalgae cultivation: A critical review	BIOTECHNOLOGY JOURNAL			English	Review						CO2 fixation; Flue gas; Microalgae; NOx; SOx	FIRED POWER-PLANT; CARBON-DIOXIDE; CHLORELLA SP; NITRIC-OXIDE; BIODIESEL PRODUCTION; BIOMASS PRODUCTION; CULTURE; CAPTURE; GROWTH; PHOTOBIOREACTOR	Flue gas refers to the gas emitting from the combustion processes, and it contains CO2, NOx, SOx and other potentially hazardous compounds. Due to the increasing concerns of CO2 emissions and environmental pollution, the cleaning process of flue gas has attracted much attention. Using microalgae to clean up flue gas via photosynthesis is considered a promising CO2 mitigation process for flue gas. However, the impurities in the flue gas may inhibit microalgal growth, leading to a lower microalgae-based CO2 fixation rate. The inhibition effects of SOx that contribute to the low pH could be alleviated by maintaining a stable pH level, while NOx can be utilized as a nitrogen source to promote microalgae growth when it dissolves and is oxidized in the culture medium. The yielded microalgal biomass from fixing flue gas CO2 and utilizing NOx and SOx as nutrients would become suitable feedstock to produce biofuels and bio-based chemicals. In addition to the removal of SOx, NOx and CO2, using microalgae to remove heavy metals from flue gas is also quite attractive. In conclusion, the use of microalgae for simultaneous removal of CO2, SOx and NOx from flue gas is an environmentally benign process and represents an ideal platform for CO2 reutilization.	[Yen, Hong-Wei] Dept Chem & Mat Engn, Taichung, Taiwan; [Ho, Shih-Hsin] Kobe Univ, Org Adv Sci & Technol, Kobe, Hyogo 657, Japan; [Chen, Chun-Yen; Chang, Jo-Shu] Natl Cheng Kung Univ, Ctr Biosci & Biotechnol, Tainan 701, Taiwan; [Chang, Jo-Shu] Natl Cheng Kung Univ, Res Ctr Energy Technol & Strategy, Tainan 701, Taiwan; [Chang, Jo-Shu] Natl Cheng Kung Univ, Dept Chem Engn, Tainan 701, Taiwan	Chang, JS (reprint author), Natl Cheng Kung Univ, Dept Chem Engn, Tainan 701, Taiwan.	changjs@mail.ncku.edu.tw			Ministry of Science and Technology, Taiwan [MOST-104-3113-E-006-003, MOST-103-2221-E-006-190-MY3]; Top University Project of National Cheng Kung University; Ministry of Education, Taiwan	This work was financially supported by the Ministry of Science and Technology, Taiwan, in the framework of the project MOST-104-3113-E-006-003 and MOST-103-2221-E-006-190-MY3. This work is also partially supported by the Top University Project of National Cheng Kung University granted by Ministry of Education, Taiwan.	Adaikpoh EO, 2005, J APPL SCI ENV MANAG, V9, P5; Chen CY, 2011, BIORESOURCE TECHNOL, V102, P71, DOI 10.1016/j.biortech.2010.06.159; Chen JC, 1999, SCI TOTAL ENVIRON, V228, P67, DOI 10.1016/S0048-9697(99)00030-3; MAEDA K, 1995, ENERG CONVERS MANAGE, V36, P717, DOI 10.1016/0196-8904(95)00105-M; Chiu SY, 2011, BIORESOURCE TECHNOL, V102, P9135, DOI 10.1016/j.biortech.2011.06.091; Borkenstein CG, 2011, J APPL PHYCOL, V23, P131, DOI 10.1007/s10811-010-9551-5; Pawlowski A, 2014, BIORESOURCE TECHNOL, V170, P1, DOI 10.1016/j.biortech.2014.07.088; Kanniche M, 2010, APPL THERM ENG, V30, P53, DOI 10.1016/j.applthermaleng.2009.05.005; Grobbelaar JU, 2012, J APPL PHYCOL, V24, P315, DOI 10.1007/s10811-011-9728-6; Rio S, 2007, J HAZARD MATER, V148, P521, DOI 10.1016/j.jhazmat.2007.03.009; Nagase H, 2001, BIOCHEM ENG J, V7, P241, DOI 10.1016/S1369-703X(00)00122-4; Doucha J, 2005, J APPL PHYCOL, V17, P403, DOI 10.1007/s10811-005-8701-7; Farrelly DJ, 2013, RENEW SUST ENERG REV, V21, P712, DOI 10.1016/j.rser.2012.12.038; Sillman S, 1999, ATMOS ENVIRON, V33, P1821, DOI 10.1016/S1352-2310(98)00345-8; Praveenkumar R, 2014, BIORESOURCE TECHNOL, V171, P500, DOI 10.1016/j.biortech.2014.08.112; Van den Hende S, 2012, BIOTECHNOL ADV, V30, P1405, DOI 10.1016/j.biotechadv.2012.02.015; Jiang YL, 2013, BIORESOURCE TECHNOL, V128, P359, DOI 10.1016/j.biortech.2012.10.119; Aksu Z, 2006, PROCESS BIOCHEM, V41, P860, DOI 10.1016/j.procbio.2005.10.025; Pires JCM, 2012, RENEW SUST ENERG REV, V16, P3043, DOI 10.1016/j.rser.2012.02.055; CALVIN M, 1989, PHOTOSYNTH RES, V21, P3, DOI 10.1007/BF00047170; Li FF, 2011, IND ENG CHEM RES, V50, P6496, DOI 10.1021/ie200040q; Saarnio K, 2014, J AEROSOL SCI, V73, P14, DOI 10.1016/j.jaerosci.2014.03.004; Kumar K, 2011, BIORESOURCE TECHNOL, V102, P4945, DOI 10.1016/j.biortech.2011.01.054; de Godos I, 2014, BIORESOURCE TECHNOL, V153, P307, DOI 10.1016/j.biortech.2013.11.087; Douskova I, 2009, APPL MICROBIOL BIOT, V82, P179, DOI 10.1007/s00253-008-1811-9; ZEILER KG, 1995, ENERG CONVERS MANAGE, V36, P707, DOI 10.1016/0196-8904(95)00103-K; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Yen HW, 2013, BIORESOURCE TECHNOL, V135, P166, DOI 10.1016/j.biortech.2012.10.099; Evans J, 2000, PROCESS SAF ENVIRON, V78, P40, DOI 10.1205/095758200530439; Mussgnug JH, 2007, PLANT BIOTECHNOL J, V5, P802, DOI 10.1111/j.1467-7652.2007.00285.x; Cheah WY, 2015, BIORESOURCE TECHNOL, V184, P190, DOI 10.1016/j.biortech.2014.11.026; Jin YM, 2005, J CHEM TECHNOL BIOT, V80, P483, DOI 10.1002/jctb.1260; Kao CY, 2014, BIORESOURCE TECHNOL, V166, P485, DOI 10.1016/j.biortech.2014.05.094; Nagase H, 1998, J FERMENT BIOENG, V86, P421, DOI 10.1016/S0922-338X(99)89018-7; Spolaore P, 2006, J BIOSCI BIOENG, V101, P87, DOI 10.1263/jbb.101.87; Packer M, 2009, ENERG POLICY, V37, P3428, DOI 10.1016/j.enpol.2008.12.025; Zhang X, 2014, ENVIRON SCI TECHNOL, V48, P10497, DOI 10.1021/es5013824; Chronopoulos T, 2014, MICROPOR MESOPOR MAT, V197, P288, DOI 10.1016/j.micromeso.2014.06.032; Chiu SY, 2008, BIORESOURCE TECHNOL, V99, P3389, DOI 10.1016/j.biortech.2007.08.013; Ho SH, 2011, BIOTECHNOL ADV, V29, P189, DOI 10.1016/j.biotechadv.2010.11.001; Costa JAV, 2000, WORLD J MICROB BIOT, V16, P15, DOI 10.1023/A:1008992826344; Ho SH, 2013, BIORESOURCE TECHNOL, V143, P163, DOI 10.1016/j.biortech.2013.05.043; Ho SH, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-97; International Energy Agency, 2014, IMP GLOB COAL SUPPL; Kizililsoley M., 2008, MAXIMIZING AREAL PRO; Lee JS, 2003, BIOTECHNOL BIOPROC E, V8, P354, DOI 10.1007/BF02949279; Lee JS, 2002, BIORESOURCE TECHNOL, V82, P1, DOI 10.1016/S0960-8524(01)00158-4; Lin Q, 2012, BIORESOURCE TECHNOL, V111, P353, DOI 10.1016/j.biortech.2012.02.008; Matsumoto H., J CHEM ENG; Monteiro C. M., 2009, CHEM LETT, V9, P169; Nagase H, 1997, J FERMENT BIOENG, V83, P461, DOI 10.1016/S0922-338X(97)83001-2; NEGORO M, 1991, APPL BIOCHEM BIOTECH, V28-9, P877, DOI 10.1007/BF02922657; Niessen W. R., 2002, COMBUSTION INCINERAT; Ronda SR, 2014, BIORESOURCE TECHNOL, V152, P283, DOI 10.1016/j.biortech.2013.10.091; Santiago DEO, 2010, PROCESS BIOCHEM, V45, P1949, DOI 10.1016/j.procbio.2010.04.003; Simoneit B., 2000, CHEMOSPHERE GLOBAL C, V2, P107, DOI DOI 10.1016/S1465-9972(99)00048-3; Singh R, 2014, RENEW SUST ENERG REV, V29, P854, DOI 10.1016/j.rser.2013.09.005; Travieso L, 1999, B ENVIRON CONTAM TOX, V62, P144; U.S. Department of Energy Office of Energy Efficiency and Renewable Energy Biomass Program, 2010, NAT ALG BIOF TECHN R; Yoo C, 2010, BIORESOURCE TECHNOL, V101, pS71, DOI 10.1016/j.biortech.2009.03.030; Yoshihara KI, 1996, J FERMENT BIOENG, V82, P351, DOI 10.1016/0922-338X(96)89149-5; Zhu BH, 2014, BIORESOURCE TECHNOL, V174, P53, DOI 10.1016/j.biortech.2014.09.116	62	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1860-6768	1860-7314		BIOTECHNOL J	Biotechnol. J.	JUN	2015	10	6			SI		829	839		10.1002/biot.201400707		11	Biochemical Research Methods; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	CJ9TH	WOS:000355845400002		
J	Aikawa, S; Ho, SH; Nakanishi, A; Chang, JS; Hasunuma, T; Kondo, A				Aikawa, Shimpei; Ho, Shih-Hsin; Nakanishi, Akihito; Chang, Jo-Shu; Hasunuma, Tomohisa; Kondo, Akihiko			Improving polyglucan production in cyanobacteria and microalgae via cultivation design and metabolic engineering	BIOTECHNOLOGY JOURNAL			English	Review						Bioethanol; Cyanobacteria; Metabolic engineering; Microalgae; Polyglucan	SYNECHOCYSTIS-SP PCC-6803; SP PCC 6803; OBLIQUUS CNW-N; ADP-GLUCOSE PYROPHOSPHORYLASE; SIGMA-FACTOR SIGE; CHLAMYDOMONAS-REINHARDTII; RESPONSE-REGULATOR; NITROGEN STARVATION; LIGHT-INTENSITY; GENE-EXPRESSION	Photosynthetic microorganisms, such as cyanobacteria and microalgae, are currently being investigated as alternative biomass resources for bioethanol production, owing to their benefits, including high-photosynthetic activity and whole-year cultivation without utilization of arable land. Polyglucans comprise the major carbohydrate content of these organisms. Polyglucans can be utilized as a carbon source for microbial fermentation. Although polyglucan production has so far been promoted by nutrient limitation, it must be further enhanced to accommodate market demand. This review focuses on the recent progress in the production of -polyglucans such asglycogen and starch in cyanobacteria and green microalgae via cultivation design, including modifying the nutrient supply and replacing the growth medium. The control and manipulation of polyglucan metabolism necessitates the elucidation of the polyglucan production mechanism. We reviewed gene expression and metabolite accumulation profiles of cyanobacteria and green microalgae during nutrient limitation-stimulated -polyglucan accumulation. We also focus on the enhancement in cyanobacterial glycogen production via the genetic engineering of glycolysis, CO2 concentration mechanism, and photosynthetic light-harvesting protein based on the polyglucan accumulation mechanism. The combined strategies of cultivation design and genetic engineering should be considered for further enhancement of polyglucan productivity for bioethanol production.	[Aikawa, Shimpei; Kondo, Akihiko] Kobe Univ, Dept Chem Sci & Engn, Kobe, Hyogo 6578501, Japan; [Aikawa, Shimpei; Hasunuma, Tomohisa; Kondo, Akihiko] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kobe, Hyogo, Japan; [Ho, Shih-Hsin; Nakanishi, Akihito; Hasunuma, Tomohisa] Kobe Univ, Org Adv Sci & Technol, Kobe, Hyogo 6578501, Japan; [Chang, Jo-Shu] Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan; [Chang, Jo-Shu] Natl Cheng Kung Univ, Res Ctr Energy Technol & Strategy, Tainan 70101, Taiwan; [Chang, Jo-Shu] Natl Cheng Kung Univ, Ctr Biosci & Biotechnol, Tainan 70101, Taiwan; [Kondo, Akihiko] RIKEN, Biomass Engn Program, Kobe, Hyogo, Japan	Kondo, A (reprint author), Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	akondo@kobe-u.ac.jp	Hasunuma, Tomohisa/A-1949-2015; NAKANISHI, Akihito/A-2096-2015; Aikawa, Shimpei/A-6512-2014	Hasunuma, Tomohisa/0000-0002-8382-2362; NAKANISHI, Akihito/0000-0002-4596-5805; 	Core Research for Evolutional Science and Technology (CREST) of Promoting Globalization on Strategic Basic Research Programs of the Japan Science and Technology Agency	This review was supported by Core Research for Evolutional Science and Technology (CREST) of Promoting Globalization on Strategic Basic Research Programs of the Japan Science and Technology Agency.	AIBA H, 1994, MOL MICROBIOL, V13, P25, DOI 10.1111/j.1365-2958.1994.tb00399.x; Aikawa S, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-88; AJLANI G, 1995, BBA-BIOENERGETICS, V1231, P189, DOI 10.1016/0005-2728(95)00086-X; Shimonaga T, 2007, MAR BIOTECHNOL, V9, P192, DOI 10.1007/s10126-006-6104-7; Osanai T, 2014, ENVIRON MICROBIOL, V16, P512, DOI 10.1111/1462-2920.12170; van Zyl WH, 2012, APPL MICROBIOL BIOT, V95, P1377, DOI 10.1007/s00253-012-4248-0; Mollers KB, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-64; John RP, 2011, BIORESOURCE TECHNOL, V102, P186, DOI 10.1016/j.biortech.2010.06.139; NEUHAUS HE, 1990, PLANTA, V182, P445; Wang ZT, 2009, EUKARYOT CELL, V8, P1856, DOI 10.1128/EC.00272-09; Hasunuma T, 2013, J EXP BOT, V64, P2943, DOI 10.1093/jxb/ert134; Dismukes GC, 2008, CURR OPIN BIOTECH, V19, P235, DOI 10.1016/j.copbio.2008.05.007; Lin Y, 2006, APPL MICROBIOL BIOT, V69, P627, DOI 10.1007/s00253-005-0229-x; Ho SH, 2013, BIORESOURCE TECHNOL, V145, P142, DOI 10.1016/j.biortech.2013.02.119; Azuma M, 2011, PLANT CELL PHYSIOL, V52, P404, DOI 10.1093/pcp/pcq204; Li KX, 2014, INT J ENERG RES, V38, P965, DOI 10.1002/er.3164; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Schwarz R, 2005, MICROBIOL-SGM, V151, P2503, DOI 10.1099/mic.0.27883-0; Grundel M, 2012, MICROBIOL-SGM, V158, P3032, DOI 10.1099/mic.0.062950-0; Bolling C, 2005, PLANT PHYSIOL, V139, P1995, DOI 10.1104/pp.105.071589; Markou G, 2012, APPL MICROBIOL BIOT, V96, P631, DOI 10.1007/s00253-012-4398-0; BOUSSIBA S, 1980, ARCH MICROBIOL, V125, P143, DOI 10.1007/BF00403211; D'Hulst C, 2010, NEW PHYTOL, V188, P13, DOI 10.1111/j.1469-8137.2010.03361.x; Zhang ZD, 2004, EUKARYOT CELL, V3, P1331, DOI 10.1128/EC.3.5.1331-1348.2004; Prochazkova G, 2014, J APPL PHYCOL, V26, P1359, DOI 10.1007/s10811-013-0154-9; Li YT, 2010, METAB ENG, V12, P387, DOI 10.1016/j.ymben.2010.02.002; Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3; Ducat DC, 2011, TRENDS BIOTECHNOL, V29, P95, DOI 10.1016/j.tibtech.2010.12.003; Melis A, 2009, PLANT SCI, V177, P272, DOI 10.1016/j.plantsci.2009.06.005; Xu Y, 2013, METAB ENG, V16, P56, DOI 10.1016/j.ymben.2012.12.002; Kaniya Y, 2013, PLANT PHYSIOL, V162, P1153, DOI 10.1104/pp.113.218784; Osanai T, 2005, J BIOL CHEM, V280, P30653, DOI 10.1074/jbc.M505043200; Nobles DR, 2001, PLANT PHYSIOL, V127, P529, DOI 10.1104/pp.127.2.529; Miao XL, 2003, FEMS MICROBIOL LETT, V218, P71, DOI 10.1016/S0378-1097(02)01145-X; Tetu SG, 2009, ISME J, V3, P835, DOI 10.1038/ismej.2009.31; Kawano Y, 2011, PLANT CELL PHYSIOL, V52, P957, DOI 10.1093/pcp/pcr047; Joseph A, 2014, FEBS LETT, V588, P466, DOI 10.1016/j.febslet.2013.12.008; Yao CH, 2013, APPL MICROBIOL BIOT, V97, P6099, DOI 10.1007/s00253-013-4983-x; Harun R, 2014, BIOTECHNOL J, V9, P73, DOI 10.1002/biot.201200353; Carrieri D, 2010, APPL ENVIRON MICROB, V76, P6455, DOI 10.1128/AEM.00975-10; Irihimovitch V, 2008, FEMS MICROBIOL LETT, V283, P1, DOI 10.1111/j.1574-6968.2008.01154.x; Miller R, 2010, PLANT PHYSIOL, V154, P1737, DOI 10.1104/pp.110.165159; Monfils AK, 2011, PHYCOLOGIA, V50, P156, DOI 10.2216/09-112.1; Okuda K, 2002, J PLANT RES, V115, P283, DOI 10.1007/s10265-002-0034-x; Rioux LE, 2010, PHYTOCHEMISTRY, V71, P1586, DOI 10.1016/j.phytochem.2010.05.021; Branyikova I, 2011, BIOTECHNOL BIOENG, V108, P766, DOI 10.1002/bit.23016; Ramazanov A, 2006, PHYCOL RES, V54, P255, DOI 10.1111/j.1440-1835.2006.00416.x; Hirani TA, 2001, PLANT MOL BIOL, V45, P133, DOI 10.1023/A:1006425214168; Moseley JL, 2006, EUKARYOT CELL, V5, P26, DOI 10.1128/EC.5.1.26-44.2006; Kocar G, 2013, RENEW SUST ENERG REV, V28, P900, DOI 10.1016/j.rser.2013.08.022; Aikawa S, 2013, ENERG ENVIRON SCI, V6, P1844, DOI 10.1039/c3ee40305j; Chellamuthu VR, 2013, PLANTA, V237, P451, DOI 10.1007/s00425-012-1801-0; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; Chen CY, 2013, BIOCHEM ENG J, V78, P1, DOI 10.1016/j.bej.2013.03.006; Alderkamp AC, 2007, FEMS MICROBIOL ECOL, V59, P108, DOI 10.1111/j.1574-6941.2006.00219.x; Popper ZA, 2010, PLANT PHYSIOL, V153, P373, DOI 10.1104/pp.110.158055; MELENDEZHEVIA E, 1993, BIOCHEM J, V295, P477; Dragone G, 2011, APPL ENERG, V88, P3331, DOI 10.1016/j.apenergy.2011.03.012; Tsekos I, 1999, J PHYCOL, V35, P635, DOI 10.1046/j.1529-8817.1999.3540635.x; Wang X, 2011, J INTEGR PLANT BIOL, V53, P246, DOI 10.1111/j.1744-7909.2010.01024.x; Aikawa S, 2012, BIORESOURCE TECHNOL, V108, P211, DOI 10.1016/j.biortech.2012.01.004; Markou G, 2012, WORLD J MICROB BIOT, V28, P2661, DOI 10.1007/s11274-012-1076-4; Harun R, 2011, CHEM ENG J, V168, P1079, DOI 10.1016/j.cej.2011.01.088; Storseth TR, 2006, CARBOHYD RES, V341, P2108, DOI 10.1016/j.carres.2006.05.005; Wijffels RH, 2013, CURR OPIN BIOTECH, V24, P405, DOI 10.1016/j.copbio.2013.04.004; Nakamura Y, 2005, PLANT CELL PHYSIOL, V46, P539, DOI 10.1093/pcp/pci045; Guerra LT, 2013, J BIOTECHNOL, V166, P65, DOI 10.1016/j.jbiotec.2013.04.005; Ballicora MA, 2003, MICROBIOL MOL BIOL R, V67, P213, DOI 10.1128/MMBR.67.2.213-225.2003; Melis A, 2007, PLANTA, V226, P1075, DOI 10.1007/s00425-007-0609-9; Ho SH, 2012, BIORESOURCE TECHNOL, V113, P244, DOI 10.1016/j.biortech.2011.11.133; Liew WH, 2014, J CLEAN PROD, V71, P11, DOI 10.1016/j.jclepro.2014.01.006; Ball S., 2011, J EXP BOT, V6, P1775; Busi M.V, 2013, STARCH, V66, P28; Chow T. J., 2014, BIORESOURCE TECHNOL, DOI [10.1016/j.biortech.2014.10.065, DOI 10.1016/J.BI0RTECH.2014.10.065]; Ehira S, 2011, J BIOL CHEM, V286, P38109, DOI 10.1074/jbc.M111.289124; Ehira S, 2006, MOL MICROBIOL, V59, P1692, DOI 10.1111/j.1365-2958.2006.05049.x; Falkowski P. G., 2007, AQUATIC PHOTOSYNTHES; Fu J, 2006, FEMS MICROBIOL LETT, V260, P201, DOI 10.1111/j.1574-6968.2006.00312.x; Fuzard M. A., 2013, AQUAT BIOSYST, V9, P5; Gonzalez-Fernandez C, 2012, BIOTECHNOL ADV, V30, P1655, DOI 10.1016/j.biotechadv.2012.07.003; Harvey W. B., 2012, CURR OPIN BIOTECH, V23, P390; Hirokawa Y, 2008, PLANTA, V227, P589, DOI 10.1007/s00425-007-0641-9; Ho SH, 2013, BIORESOURCE TECHNOL, V143, P163, DOI 10.1016/j.biortech.2013.05.043; Joseph A, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0017-z; Kumaraswamy G. K., 2013, ENERG ENVIRON SCI, V6, P1844; MARCHESSAULT RH, 1979, CARBOHYD RES, V75, P231, DOI 10.1016/S0008-6215(00)84642-X; McFadden G. I., 1997, Phycological Research, V45, P145, DOI 10.1111/j.1440-1835.1997.tb00087.x; Menshova RV, 2014, CARBOHYD POLYM, V99, P101, DOI 10.1016/j.carbpol.2013.08.037; Ogawa Y, 2014, INT J BIOL MACROMOL, V64, P415, DOI 10.1016/j.ijbiomac.2013.12.027; Osanai T, 2006, DNA RES, V13, P185, DOI 10.1093/dnares/ds1010; Osanai T, 2007, PHOTOCH PHOTOBIO SCI, V6, P508, DOI 10.1039/b616219n; Santelia D, 2011, CURR OPIN BIOTECH, V22, P271, DOI 10.1016/j.copbio.2010.11.014; SHEN GZ, 1993, PLANT CELL, V5, P1853; Siaut M, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-7; Simmons TJ, 2013, PHYTOCHEMISTRY, V95, P322, DOI 10.1016/j.phytochem.2013.08.003; Sorek N., BIOSCIENCE, DOI [10.1093/biosci/bit037, DOI 10.1093/BI0SCI/BIT037]; Suzuki E, 2010, APPL ENVIRON MICROB, V76, P3153, DOI 10.1128/AEM.00397-08; Suzuki E, 2007, BBA-GEN SUBJECTS, V1770, P763, DOI 10.1016/j.bbagen.2007.01.006; Suzuki E., 2013, J APPL GLYCOSCI, V60, P21; Tolonen AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100087; Van den Hoek C., 1995, INTRO PHYCOLOGY; Zhu L. D., 2014, BIORESOURCE TECHNOL, V144, P14	102	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1860-6768	1860-7314		BIOTECHNOL J	Biotechnol. J.	JUN	2015	10	6			SI		886	898		10.1002/biot.201400344		13	Biochemical Research Methods; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	CJ9TH	WOS:000355845400006		
J	Yang, LM; Fujimoto, J				Yang, Limin; Fujimoto, Junichiro			Childhood cancer mortality in Japan, 1980-2013	BMC CANCER			English	Article						Cancer; Children; Mortality; Trend	SURVIVAL RATES; TRENDS; OSAKA	Background: This study aimed to provide an updated analysis of childhood cancer mortality rates and long-term trends to 2013 to describe the current level of deaths and identify changes in recent decades. Methods: Data on number of deaths from cancer in children aged under 15 years were derived from Vital Statistics in Japan and the World Health Organization (WHO) mortality database for comparison countries. Trends in mortality were examined by fitting a joinpoint regression model. Results: For all cancers combined, the mortality rate during 2010-2013 was 19.9 per 1,000,000 population for boys and 17.5 for girls in Japan. Mortality from all cancers combined decreased significantly from 1980 to 2003 for boys and from 1980 to 2001 for girls. Afterwards, the rates remained stable for both sexes. Mortality from leukemia declined over the entire study period by 4.6 % per year (p < 0.05) in boys and 4.3 % per year (p < 0.05) in girls. For central nervous system (CNS) tumors, a slight increase in mortality was observed for both sexes, with a statistically significant annual percent change (APC) of 0.5 % (p < 0.05) for boys and 0.6 % (p < 0.05) for girls. Conclusions: We provided updated information on recent trends of childhood cancer death. The establishment of a nationwide, childhood cancer registry is required in Japan. Moreover, trends in cancer mortality should be monitored continuously.	[Yang, Limin] Natl Ctr Child Hlth & Dev, Med Support Ctr Japan Environm & Childrens Study, Dept Med Subspecialties, Div Allergy,Setagaya Ku, Tokyo 1578535, Japan; [Yang, Limin; Fujimoto, Junichiro] Natl Ctr Child Hlth & Dev, Epidemiol & Clin Res Ctr Childrens Canc, Setagaya Ku, Tokyo 1578535, Japan	Yang, LM (reprint author), Natl Ctr Child Hlth & Dev, Med Support Ctr Japan Environm & Childrens Study, Dept Med Subspecialties, Div Allergy,Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	yo-r@ncchd.go.jp					Ajiki W, 2004, JPN J CLIN ONCOL, V34, P50, DOI 10.1093/jjco/hyh003; Linet MS, 1999, J NATL CANCER I, V91, P1051, DOI 10.1093/jnci/91.12.1051; Bosetti C, 2010, EUR J CANCER, V46, P384, DOI 10.1016/j.ejca.2009.09.011; Chatenoud L, 2010, CANCER-AM CANCER SOC, V116, P5063, DOI 10.1002/cncr.25406; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Matsuda A, 2014, JPN J CLIN ONCOL, V44, P388, DOI 10.1093/jjco/hyu003; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.3.CO;2-Q; Horibe K, 2013, INT J HEMATOL, V98, P74, DOI 10.1007/s12185-013-1364-2; PERCY C, 1981, AM J PUBLIC HEALTH, V71, P242, DOI 10.2105/AJPH.71.3.242; Yang L, 2009, ANN ONCOL, V20, P166, DOI 10.1093/annonc/mdn562; Youlden DR, 2012, CANCER EPIDEMIOL, V36, P476, DOI 10.1016/j.canep.2012.06.001; Baba S, 2010, CANCER SCI, V101, P787, DOI 10.1111/j.1349-7006.2009.01443.x; Centers for Disease C Prevention, 2007, MMWR-MORBID MORTAL W, V56, P1257; Ikeda A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-73; Marugame T, 2007, JPN J CLIN ONCOL, V37, P319, DOI 10.1093/jjco/hym020; Miller RW, 1980, JAMA-J AM MED ASSOC, V251, P1567; Nishi M., 2014, J TUMOR, V2, P261; R Core Team, 2013, R LANG ENV STAT COMP; Statistical Research and Applications Branch National Cancer Institute, 2012, JOINP REGR PROGR VER; Sugiyama H, 2009, ASIAN PAC J CANCER P, V10, P675; World health organization statistical information system, WHO MORT DAT	21	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2407			BMC CANCER	BMC Cancer	JUN 1	2015	15								446	10.1186/s12885-015-1472-x		8	Oncology	Oncology	CJ3RZ	WOS:000355402900001		
J	Mohty, M; Malard, F; Abecassis, M; Aerts, E; Alaskar, AS; Aljurf, M; Arat, M; Bader, P; Baron, F; Bazarbachi, A; Blaise, D; Ciceri, F; Corbacioglu, S; Dalle, JH; Duarte, RF; Fukuda, T; Huynh, A; Masszi, T; Michallet, M; Nagler, A; NiChonghaile, M; Pagluica, T; Peters, C; Petersen, FB; Richardson, PG; Ruutu, T; Savani, BN; Wallhult, E; Yakoub-Agha, I; Carreras, E				Mohty, M.; Malard, F.; Abecassis, M.; Aerts, E.; Alaskar, A. S.; Aljurf, M.; Arat, M.; Bader, P.; Baron, F.; Bazarbachi, A.; Blaise, D.; Ciceri, F.; Corbacioglu, S.; Dalle, J-H; Duarte, R. F.; Fukuda, T.; Huynh, A.; Masszi, T.; Michallet, M.; Nagler, A.; NiChonghaile, M.; Pagluica, T.; Peters, C.; Petersen, F. B.; Richardson, P. G.; Ruutu, T.; Savani, B. N.; Wallhult, E.; Yakoub-Agha, I.; Carreras, E.			Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT)	BONE MARROW TRANSPLANTATION			English	Article							STEM-CELL TRANSPLANTATION; HEPATIC VENOOCCLUSIVE-DISEASE; ALLOGENEIC HEMATOPOIETIC SCT; ACUTE MYELOID-LEUKEMIA; HIGH-RISK POPULATION; URSODEOXYCHOLIC ACID; INTRAVENOUS BUSULFAN; CONDITIONING REGIMEN; ENDOTHELIAL-CELLS; RANDOMIZED-TRIAL	Sinusoidal obstruction syndrome or veno-occlusive disease (SOS/VOD) is a potentially life-threatening complication of hematopoietic SCT (HSCT). This review aims to highlight, on behalf of the European Society for Blood and Marrow Transplantation, the current knowledge on SOS/VOD pathophysiology, risk factors, diagnosis and treatments. Our perspectives on SOS/VOD are (i) to accurately identify its risk factors; (ii) to define new criteria for its diagnosis; (iii) to search for SOS/VOD biomarkers and (iv) to propose prospective studies evaluating SOS/ VOD prevention and treatment in adults and children.	[Mohty, M.; Malard, F.] Hop St Antoine, Dept Hematol, F-75571 Paris 12, France; [Mohty, M.; Malard, F.] Univ Paris 06, Paris, France; [Abecassis, M.] Inst Portugues Oncol Francisco Gentil, Lisbon, Portugal; [Aerts, E.] Univ Zurich Hosp, Dept Haematol, CH-8091 Zurich, Switzerland; [Alaskar, A. S.] King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Dept Oncol, King Abdulaziz Med City,Minist Natl Guard Hlth Af, Riyadh, Saudi Arabia; [Aljurf, M.] King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia; [Arat, M.] Sisli Florence Nightingale Hosp, HSCT Unit, Istanbul, Turkey; [Bader, P.] Goethe Univ Frankfurt, Univ Hosp, Dept Children & Adolescents, Div Stem Cell Transplantat & Immunol, D-60054 Frankfurt, Germany; [Baron, F.] Univ Liege, Dept Hematol, Liege, Belgium; [Bazarbachi, A.] Amer Univ Beirut, Dept Internal Med, Beirut, Lebanon; [Blaise, D.] Inst J Paoli I Calmettes, Dept Hematol, Blood & Marrow Transplantat Program, F-13009 Marseille, France; [Ciceri, F.] IRCCS, San Raffaele Sci Inst, Hematol & Bone Marrow Transplantat Unit, Milan, Italy; [Corbacioglu, S.] Univ Regensburg, Dept Hematol Oncol & Stem Cell Transplant, D-93053 Regensburg, Germany; [Dalle, J-H] Univ Paris 07, Hosp Robert Debre, Dept Hematol & Immunol, Paris, France; [Duarte, R. F.] Hosp Duran & Reynals, Inst Catala Oncol, Dept Haematol, Barcelona, Spain; [Fukuda, T.] Natl Canc Ctr, HSCT Div, Tokyo, Japan; [Huynh, A.] Inst Univ Canc Toulouse Oncopole, Dept Hematol, Toulouse, France; [Masszi, T.] Semmelweis Univ, Dept Hematol & Stem Cell Transplantat, St Istvan & St Laszlo Hosp, Budapest Dept Internal Med 3, H-1085 Budapest, Hungary; [Michallet, M.] Univ Lyon 1, EST, Hosp Civils Lyon, Hematol Dept,Grp Hosp Sud, Pierre Benite, France; [Nagler, A.] Chaim Sheba Med Ctr, Hematol & Bone Marrow Transplantat, IL-52621 Tel Hashomer, Israel; [NiChonghaile, M.] Univ Dublin Trinity Coll, Natl Stem Cell Transplant Unit Adults, Dept Haematol, St Jamess Hosp, Dublin 2, Ireland; [NiChonghaile, M.] Univ Dublin Trinity Coll, Acad Dept Haematol, Dublin 2, Ireland; [Pagluica, T.] Kings Coll Hosp London, Dept Haematol, London, England; [Peters, C.] St Anna Childrens Hosp, Dept Pediat, Vienna, Austria; [Petersen, F. B.] LDS Hosp, Salt Lake City, UT USA; [Richardson, P. G.] Dana Farber Canc Inst, Dept Med Oncol, Div Hematol Malignancy, Boston, MA 02115 USA; [Ruutu, T.] Univ Helsinki, Cent Hosp, Ctr Comprehens Canc, Helsinki, Finland; [Savani, B. N.] Vanderbilt Univ, Dept Med, Hematol & Stem Cell Transplantat Sect, Div Hematol Oncol, Nashville, TN USA; [Savani, B. N.] Vet Affairs Med Ctr, Nashville, TN 37212 USA; [Wallhult, E.] Sahlgrens Univ Hosp, Dept Internal Med, Sect Haematol & Coagulat, Gothenburg, Sweden; [Yakoub-Agha, I.] CHU Lille, Bone Marrow Transplantat Unit, F-59037 Lille, France; [Carreras, E.] Josep Carreras Leukaemia Res Inst, Barcelona, Spain; [Carreras, E.] Hosp Clin Barcelona, Dept Haematol, Barcelona, Spain; [Carreras, E.] Josep Carreras Fdn, Spanish Bone Marrow Donor Program, Barcelona, Spain	Mohty, M (reprint author), Hop St Antoine, Dept Hematol, 184 Rue Faubourg St Antoine, F-75571 Paris 12, France.	mohamad.mohty@inserm.fr			'Association for Training, Education and Research in Hematology, Immunology and Transplantation' (ATERHIT, Nantes, France)	MM thanks Professor JV Melo (Adelaide, Australia) for critical reading of the manuscript. FM was supported by educational grants from the 'Association for Training, Education and Research in Hematology, Immunology and Transplantation' (ATERHIT, Nantes, France).	CARRERAS E, 1993, ANN HEMATOL, V66, P77, DOI 10.1007/BF01695888; de Lima M, 2004, BLOOD, V104, P857, DOI 10.1182/blood-2004-02-0414; DeLeve LD, 1996, HEPATOLOGY, V24, P830, DOI 10.1002/hep.510240414; Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383; Azoulay D, 2000, BONE MARROW TRANSPL, V25, P987, DOI 10.1038/sj.bmt.1702386; Richardson PG, 2002, BLOOD, V100, P4337, DOI 10.1182/blood-2002-04-1216; MCDONALD GB, 1984, HEPATOLOGY, V4, P116, DOI 10.1002/hep.1840040121; Malard F, 2014, BIOL BLOOD MARROW TR, V20, P1217, DOI 10.1016/j.bbmt.2014.04.021; Dignan FL, 2013, BRIT J HAEMATOL, V163, P444, DOI 10.1111/bjh.12558; Carreras E, 2011, BONE MARROW TRANSPL, V46, P1495, DOI 10.1038/bmt.2011.65; BEARMAN SI, 1993, J CLIN ONCOL, V11, P1729; Tay J, 2007, BIOL BLOOD MARROW TR, V13, P206, DOI 10.1016/j.bbmt.2006.09.012; Carmona A, 2013, BIOL BLOOD MARROW TR, V19, P1439, DOI 10.1016/j.bbmt.2013.07.001; Richardson PG, 2010, BIOL BLOOD MARROW TR, V16, P1005, DOI 10.1016/j.bbmt.2010.02.009; Schmid C, 2005, J CLIN ONCOL, V23, P5675, DOI 10.1200/JCO.2005.07.061; Wadleigh M, 2003, BLOOD, V102, P1578, DOI 10.1182/blood-2003-01-0255; Nagler A, 2013, J CLIN ONCOL, V31, P3549, DOI 10.1200/JCO.2013.48.8114; Coppell JA, 2010, BIOL BLOOD MARROW TR, V16, P157, DOI 10.1016/j.bbmt.2009.08.024; Carreras E, 1998, BLOOD, V92, P3599; Luznik L, 2008, BIOL BLOOD MARROW TR, V14, P641, DOI 10.1016/j.bbmt.2008.03.005; JONES RJ, 1987, TRANSPLANTATION, V44, P778, DOI 10.1097/00007890-198712000-00011; Srivastava A, 2004, BLOOD, V104, P1574, DOI 10.1182/blood-2003-11-3778; Richardson PG, 1998, BLOOD, V92, P737; Cesaro S, 2005, HAEMATOL-HEMATOL J, V90, P1396; MCDONALD GB, 1993, ANN INTERN MED, V118, P255; Palomo M, 2010, BIOL BLOOD MARROW TR, V16, P985, DOI 10.1016/j.bbmt.2010.02.008; Almog S, 2011, BIOL BLOOD MARROW TR, V17, P117, DOI 10.1016/j.bbmt.2010.06.017; Cutler C, 2008, BLOOD, V112, P4425, DOI 10.1182/blood-2008-07-169342; Kim ID, 2002, AM J TRANSPLANT, V2, P796, DOI 10.1034/j.1600-6143.2002.20815.x; Carreras E, 2011, BIOL BLOOD MARROW TR, V17, P1713, DOI 10.1016/j.bbmt.2011.06.006; Richardson PG, 2013, EXPERT OPIN DRUG SAF, V12, P123, DOI 10.1517/14740338.2012.749855; Corbacioglu S, 2012, LANCET, V379, P1301, DOI 10.1016/S0140-6736(11)61938-7; Biedermann BC, 2008, BEST PRACT RES CL HA, V21, P129, DOI 10.1016/j.beha.2008.02.003; Imran H, 2006, BONE MARROW TRANSPL, V37, P677, DOI 10.1038/sj.bmt.1705297; DeLeve LD, 2002, SEMIN LIVER DIS, V22, P27, DOI 10.1055/s-2002-23204; Hogan WJ, 2004, BLOOD, V103, P78, DOI 10.1182/blood-2003-04-1311; ATTAL M, 1992, BLOOD, V79, P2834; BEARMAN SI, 1992, BLOOD, V80, P2458; Cantoni N, 2011, BONE MARROW TRANSPL, V46, P344, DOI 10.1038/bmt.2010.137; Carreras E, 2000, EUR J HAEMATOL, V64, P281, DOI 10.1034/j.1600-0609.2000.9r200.x; Carreras E., 2014, BRIT J HAEMATOL, V168, P481; Cheuk DKL, 2007, BONE MARROW TRANSPL, V40, P935, DOI 10.1038/sj.bmt.1705835; Cooke KR, 2008, BIOL BLOOD MARROW TR, V14, P23, DOI 10.1016/j.bbmt.2007.10.008; Corbacioglu S, 2006, BONE MARROW TRANSPL, V38, P547, DOI 10.1038/sj.bmt.1705485; Dirou S, 2014, BONE MARROW TRANSPL, V49, P622, DOI 10.1038/bmt.2014.15; Eissner G, 1998, BONE MARROW TRANSPL, V21, P1286, DOI 10.1038/sj.bmt.1701264; Essell JH, 1998, ANN INTERN MED, V128, P975; Fuste B, 2004, HAEMATOLOGICA, V89, P578; Hagglund H, 1998, BLOOD, V92, P4568; Lee JH, 1998, BONE MARROW TRANSPL, V22, P883, DOI 10.1038/sj.bmt.1701445; Majhail NS, 2008, BONE MARROW TRANSPL, V41, P997, DOI 10.1038/bmt.2008.99; MARSAVILA L, 1991, EUR J HAEMATOL, V47, P346; Mercanoglu F, 2004, TRANSPLANT P, V36, P1357, DOI 10.1016/j.transproceed.2004.05.073; Mohty M, 2014, CANCER, V121, P562; Mohty M, 2014, BLOOD, V124, P1228; Moscardo F, 2003, EXP HEMATOL, V31, P545, DOI 10.1016/S0301-472X(03)00070-5; Nagler A, 2014, BONE MARROW TRANSPL, V49, P628, DOI 10.1038/bmt.2014.7; Ohashi K, 2000, AM J HEMATOL, V64, P32, DOI 10.1002/(SICI)1096-8652(200005)64:1<32::AID-AJH6>3.3.CO;2-E; Or R, 1996, TRANSPLANTATION, V61, P1067, DOI 10.1097/00007890-199604150-00014; Palomo M, 2009, BIOL BLOOD MARROW TR, V15, P537, DOI 10.1016/j.bbmt.2009.01.013; Park SH, 2002, BONE MARROW TRANSPL, V29, P137, DOI 10.1038/sj.bmt.1703342; Richardson P, 2009, ASH ANN M, V114, P654; Richardson PG, 2013, BIOL BLOOD MARROW TR, V19, pS88, DOI 10.1016/j.bbmt.2012.10.023; Richardson PG, 2013, ASH ANN M, V122, P700; Ruutu T, 2002, BLOOD, V100, P1977, DOI 10.1182/blood-2001-12-0159; Seifert C, J CANC RES CLIN ONCO; SOIFFER RJ, 1991, TRANSPLANTATION, V52, P1014, DOI 10.1097/00007890-199112000-00015; Trottier BJ, 2013, BLOOD, V122, P1678, DOI 10.1182/blood-2013-04-499772	68	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	JUN	2015	50	6					781	789		10.1038/bmt.2015.52		9	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CJ6HO	WOS:000355594900005		
J	Kurita, N; Frassoni, F; Chiba, S; Podesta, M				Kurita, N.; Frassoni, F.; Chiba, S.; Podesta, M.			Impact of length of cryopreservation and origin of cord blood units on hematologic recovery following cord blood transplantation	BONE MARROW TRANSPLANTATION			English	Article							BONE-MARROW; ACUTE-LEUKEMIA; HEMATOPOIETIC PROGENITOR; UNRELATED DONORS; STEM-CELLS; OUTCOMES; ADULTS; ENGRAFTMENT; QUALITY; ISSUES	As the history of the cord blood banking system has lengthened, the number of cord blood units (CBUs) cryopreserved for years has increased. The global expansion of cord blood banking resulted in active international exchange of CBUs. To determine whether long-term cryopreservation and international shipment of CBUs affect the quality of the units and outcome after transplantation, we retrospectively analyzed the quality of 95 CBUs and the hematologic recovery of 127 patients with hematological malignancy following single-unit cord blood transplantation. Of the 127 CBUs used to transplant, 42 units were cryopreserved for long periods (5-11.8 years), and 44 units were shipped from distant countries. We found that length of cryopreservation and origin of CBUs did not affect the ratio of viable total-nucleated cells after thawing. Also, neutrophil engraftment was not affected by long-term cryopreservation (4 5 years) or origin (from distant countries), (hazard ratio, 0.91 and 1.2; P = 0.65 and 0.41; respectively). The number of CD34(+) cells before freezing (>1.4 cells/kg recipient) was the only factor that enhanced neutrophil engraftment (hazard ratio, 1.8; P<0.01). This suggests that length of cryopreservation and origin need not be prioritized over the CD34(+) cell dose when selecting CBUs.	[Kurita, N.; Chiba, S.] Univ Tsukuba, Fac Med, Dept Hematol, Tsukuba, Ibaraki 3058575, Japan; [Frassoni, F.; Podesta, M.] Ist Giannina Gaslini, Stem Cell & Cell Therapy Lab, I-16148 Genoa, Italy	Kurita, N (reprint author), Univ Tsukuba, Fac Med, Dept Hematol, Tennodai 1-1-1, Tsukuba, Ibaraki 3058575, Japan.	kuripon@mvb.biglobe.ne.jp			European Hematology Association-Japanese Society of Hematology Fellowship Exchange Award	This study was supported by a grant from the European Hematology Association-Japanese Society of Hematology Fellowship Exchange Award in 2011. We thank Dr M Gosho (CREIL Center, University of Tsukuba) for statistical advice, and Brian K. Purdue (Medical English Communications Center, University of Tsukuba) for grammatical review and advice. This study was supported by a grant from the European Hematology Association-Japanese Society of Hematology Fellowship Exchange Award in 2011.	Eapen M, 2007, LANCET, V369, P1947, DOI 10.1016/S0140-6736(07)60915-5; Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; Kudo Y, 2011, INT J HEMATOL, V93, P645, DOI 10.1007/s12185-011-0830-y; Scaradavou A, 2010, BIOL BLOOD MARROW TR, V16, P500, DOI 10.1016/j.bbmt.2009.11.013; Rodrigues CA, 2009, J CLIN ONCOL, V27, P256, DOI 10.1200/JCO.2007.15.8865; Wagner JE, 2002, BLOOD, V100, P1611, DOI 10.1182/blood-2002-01-0294; RUBINSTEIN P, 1995, P NATL ACAD SCI USA, V92, P10119, DOI 10.1073/pnas.92.22.10119; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; Querol S, 2010, BONE MARROW TRANSPL, V45, P970, DOI 10.1038/bmt.2010.7; Welte K, 2010, BONE MARROW TRANSPL, V45, P825, DOI 10.1038/bmt.2010.11; Broxmeyer HE, 2011, BLOOD, V117, P4773, DOI 10.1182/blood-2011-01-330514; Broxmeyer HE, 2003, P NATL ACAD SCI USA, V100, P645, DOI 10.1073/pnas.0237086100; Barker JN, 2011, BLOOD, V117, P2332, DOI 10.1182/blood-2010-04-280966; Foundation for the Accreditation of Cellular Therapy (FACT) International Netcord Foundation, 2013, NETCORD FACT INT STA, V5th; Frassoni F, 2008, LANCET ONCOL, V9, P831, DOI 10.1016/S1470-2045(08)70180-3; Goodwin HS, 2003, CYTOTHERAPY, V5, P80, DOI 10.1080/14653240310000100; Jubert C, 2008, TRANSFUSION, V48, P2028, DOI 10.1111/j.1537-2995.2008.01848.x; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Lin DY, 1997, STAT MED, V16, P901, DOI 10.1002/(SICI)1097-0258(19970430)16:8<901::AID-SIM543>3.0.CO;2-M; McCullough J, 2005, TRANSFUSION, V45, P832, DOI 10.1111/j.1537-2995.2005.04265.x; Mugishima H, 1999, BONE MARROW TRANSPL, V23, P395, DOI 10.1038/sj.bmt.1701580; Sutherland D R, 1996, J Hematother, V5, P213, DOI 10.1089/scd.1.1996.5.213; Wall DA, 2010, BEST PRACT RES CL HA, V23, P171, DOI 10.1016/j.beha.2010.05.006	23	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	JUN	2015	50	6					818	821		10.1038/bmt.2015.56		4	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CJ6HO	WOS:000355594900011		
J	Kawano, H; Tanaka, H; Yamashita, T; Hirata, K; Ishii, S; Suzuki, T; Wakahashi, K; Kawano, Y; Sada, A; Minagawa, K; Kawakami, F; Itoh, T; Baba, A; Matsui, T; Katayama, Y				Kawano, H.; Tanaka, H.; Yamashita, T.; Hirata, K-i; Ishii, S.; Suzuki, T.; Wakahashi, K.; Kawano, Y.; Sada, A.; Minagawa, K.; Kawakami, F.; Itoh, T.; Baba, A.; Matsui, T.; Katayama, Y.			Very late-onset reversible cardiomyopathy in patients with chronic GvHD	BONE MARROW TRANSPLANTATION			English	Letter							VERSUS-HOST-DISEASE; DILATED CARDIOMYOPATHY; CARDIAC DYSFUNCTION; AUTOANTIBODIES		[Kawano, H.; Ishii, S.; Suzuki, T.; Wakahashi, K.; Kawano, Y.; Sada, A.; Minagawa, K.; Katayama, Y.] Kobe Univ, Grad Sch Med, Dept Med, Div Hematol, Kobe, Hyogo 657, Japan; [Tanaka, H.; Yamashita, T.; Hirata, K-i] Kobe Univ, Grad Sch Med, Dept Med, Div Cardiol, Kobe, Hyogo 657, Japan; [Kawakami, F.; Itoh, T.] Kobe Univ Hosp, Diagnost Pathol, Kobe, Hyogo, Japan; [Baba, A.] Kitasato Univ, Sch Med, Kitasato Inst Hosp, Dept Cardiol, Tokyo, Japan; [Matsui, T.] Nishiwaki Municipal Hosp, Dept Hematol, Nishiwaki, Japan	Kawano, H (reprint author), Kobe Univ, Grad Sch Med, Dept Med, Div Hematol, Kobe, Hyogo 657, Japan.	hkawano@med.kobe-u.ac.jp					Jahns R, 2004, J CLIN INVEST, V113, P1419, DOI 10.1172/JCI200420149; Blazar BR, 2012, NAT REV IMMUNOL, V12, P443, DOI 10.1038/nri3212; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Ewer MS, 2005, J CLIN ONCOL, V23, P2900, DOI 10.1200/JCO.2005.05.827; Staudt A, 2002, CIRCULATION, V106, P2448, DOI 10.1161/01.CIR.0000036746.49449.64; Murdych T, 2001, BONE MARROW TRANSPL, V28, P283, DOI 10.1038/sj.bmt.1703133; Baker KS, 2012, BONE MARROW TRANSPL, V47, P619, DOI 10.1038/bmt.2011.118; Prabhu SD, 2004, CIRC RES, V95, P1140, DOI 10.1161/01.RES.0000150734.79804.92; Baba A, 2008, THER APHER DIAL, V12, P109, DOI 10.1111/j.1744-9987.2008.00555.x; Baba A, 2010, CIRC J, V74, P1372, DOI 10.1253/circj.CJ-09-0748; Dhakal B, 2015, BONE MARROW TRANSPL, V50, P449, DOI 10.1038/bmt.2014.261; Rackley C, 2005, BIOL BLOOD MARROW TR, V11, P773, DOI 10.1016/j.bbmt.2005.07.002	12	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	JUN	2015	50	6					870	872		10.1038/bmt.2015.40		3	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CJ6HO	WOS:000355594900021		
J	Kudo, H; Kudo, K; Uemura, M; Kawai, S				Kudo, Hiroaki; Kudo, Kazuaki; Uemura, Matsuo; Kawai, Shigenao			Magnesium inhibits cadmium translocation from roots to shoots, rather than the uptake from roots, in barley	BOTANY			English	Article						alleviate; cadmium; competition; magnesium; plasma membrane vesicles; translocation	ZEA-MAYS L.; PLASMA-MEMBRANE; PLANTS; TRANSPORT; TOXICITY; PHYTOSIDEROPHORES; SEEDLINGS; EXPOSURE; STRESS	We examined the effect of magnesium (Mg) on cadmium (Cd) toxicity symptoms, uptake, and sorption to the plasma membrane in barley (Hordeum vulgare L. 'Minorimugi'). Plants were grown in a constant concentration of Cd with variable Mg concentrations. Plants supplied with Cd only had necrotic first leaves, undeveloped emerging leaves, and outgrown lateral buds. The latter may account for greater dry mass accumulation in plants treated with Cd only than plants supplied with Mg. The symptoms of Cd stress were at least partly alleviated by the addition of Mg to the medium. Mg reduced accumulation of Cd in both shoots and roots, although there was a clear dose response in shoots only. We conclude that Mg inhibited Cd accumulation either by competing with Cd for uptake by the root or by inhibiting Cd translocation to the shoot. Cd sorption to plasma membrane vesicles from roots was unaffected by a concentration of Mg similar to that of Cd, but was reduced by high concentrations of Mg. This evidence of only weak competition between the two minerals suggests that the primary effect of Mg on reducing Cd accumulation is not through competition at the root surface but that Mg inhibits Cd translocation to shoots.	[Kudo, Hiroaki; Kudo, Kazuaki] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 0208550, Japan; [Uemura, Matsuo] Iwate Univ, Fac Agr, Cryobiofrontier Res Ctr, Morioka, Iwate 0208550, Japan; [Kawai, Shigenao] Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan	Kudo, K (reprint author), NARO Tohoku Agr Res Ctr, 4 Akahira, Morioka, Iwate 0200198, Japan.	ku7thkaz@affrc.go.jp			Sasakawa Scientific Research Grant from the Japan Science Society [18-152]	This work was supported by the Sasakawa Scientific Research Grant from the Japan Science Society (18-152).	Hermans C, 2011, NEW PHYTOL, V192, P428, DOI 10.1111/j.1469-8137.2011.03814.x; Kramer U, 2007, FEBS LETT, V581, P2263, DOI 10.1016/j.febslet.2007.04.010; Kashem MA, 2007, SOIL SCI PLANT NUTR, V53, P246, DOI 10.1111/j.1747-0765.2007.00129.x; NORAHO N, 1995, BIOMETALS, V8, P95; Su Y, 2014, ENVIRON EXP BOT, V97, P40, DOI 10.1016/j.envexpbot.2013.10.001; Lagriffoul A, 1998, PLANT SOIL, V200, P241, DOI 10.1023/A:1004346905592; di Toppi LS, 1999, ENVIRON EXP BOT, V41, P105, DOI 10.1016/S0098-8472(98)00058-6; SALT DE, 1995, PLANT PHYSIOL, V107, P1293; Shaul O, 2002, BIOMETALS, V15, P309; Das P, 1997, ENVIRON POLLUT, V98, P29, DOI 10.1016/S0269-7491(97)00110-3; Chou TS, 2011, J PLANT PHYSIOL, V168, P1021, DOI 10.1016/j.jplph.2010.12.004; Tran TA, 2013, TURK J BOT, V37, P1, DOI 10.3906/bot-1112-16; Hall JL, 2003, J EXP BOT, V54, P2601, DOI 10.1093/jxb/erg303; Sarwar N, 2010, J SCI FOOD AGR, V90, P925, DOI 10.1002/jsfa.3916; Astolfi S, 2014, PHYSIOL PLANTARUM, V152, P646, DOI 10.1111/ppl.12207; Burzynski M, 2005, PLANT SCI, V168, P1609, DOI 10.1016/j.plantsci.2005.02.014; Kudo H, 2011, PLANT SCI, V180, P300, DOI 10.1016/j.plantsci.2010.09.008; Kudo K, 2013, BOTANY, V91, P568, DOI 10.1139/cjb-2013-0035; Kudo K, 2007, SOIL SCI PLANT NUTR, V53, P259, DOI 10.1111/j.1747-0765.2007.00131.x; Rahat Nazar, 2012, American Journal of Plant Sciences, V3, P1476; OLBE M, 1991, PHYSIOL PLANTARUM, V83, P535; Perriguey J, 2008, ENVIRON EXP BOT, V63, P333, DOI 10.1016/j.envexpbot.2007.12.014; SAS INSTITUTE, 2011, SAS STAT 9 3 US GUID; UEMURA M, 1983, PLANT PHYSIOL, V73, P586, DOI 10.1104/pp.73.3.586	24	0	0	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	1916-2790	1916-2804		BOTANY	Botany	JUN	2015	93	6					345	351		10.1139/cjb-2015-0002		7	Plant Sciences	Plant Sciences	CJ6JK	WOS:000355599900004		
J	Hitsuma, G; Morisawa, T; Yagihashi, T				Hitsuma, Gaku; Morisawa, Takeshi; Yagihashi, Tsutomu			Orthotropic lateral branches contribute to shade tolerance and survival of Thujopsis dolabrata var. hondai saplings by altering crown architecture and promoting layering	BOTANY			English	Article						apical control; epicormic shoot; light intensity; longevity in shade; orthotropic end of a branch; vegetative reproduction	RAIN-FOREST TREE; CANOPY ARCHITECTURE; THUJA-OCCIDENTALIS; BIOMASS ALLOCATION; LIGHT AVAILABILITY; BOREAL FORESTS; DOUGLAS-FIR; GROWTH; UNDERSTORY; SEEDLINGS	We describe observed long-term adaptive responses to light conditions in the morphology of saplings of Thujopsis dolabrata var. hondai Makino, a shade-tolerant conifer species. Under stably bright conditions, the crown shape was slender and conical. In contrast, in stably dark conditions, the crowns had a highly distinctive broad, shallow, bowl-like shape, due to the formation of characteristic orthotropic lateral branches with higher apices than the stem. Leaf display by these branches may reduce self-shading and stem elongation requirements for leaf arrangement in dark conditions, thereby minimizing increases in maintenance costs associated with increasing tree size. Epicormic terminal leaders were frequently present on long branches in the lower part of the crowns. These branches did not show vigorous growth or contribute to crown expansion. However, the low-hanging branches in the lowest quarter of the crown may frequently touch the ground, particularly under snow pressure, and produce adventitious roots under these leaders, thereby increasing numbers of ramets. The snow pressure may also cause stem layering and restrain saplings from increasing their height to more than 1m. These morphological and reproductive traits of lateral branches may contribute to shade tolerance and improve survival of the saplings.	[Hitsuma, Gaku; Morisawa, Takeshi] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; [Yagihashi, Tsutomu] Forestry & Forest Prod Res Inst, Tohoku Res Ctr, Morioka, Iwate 0200123, Japan	Hitsuma, G (reprint author), Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan.	hitsuma@affrc.go.jp	Yagihashi, Tsutomu/B-4567-2008	Yagihashi, Tsutomu/0000-0001-8325-4062	Japan Society for the Promotion of Science KAKENHI [26450213]; Forestry and Forest Product Research Institute [200608]	The authors thank H. Sugita for critical comments on early versions of the manuscript. Discussions on this study with M. Shibata, T. Yagi, T. Saito, and M. Noguchi were very valuable. We also thank the staff of the Northern Sanriku District and Shimokita Forest Office for their help in establishing the study sites. This study was supported in part by Japan Society for the Promotion of Science KAKENHI Grant No. 26450213 and Research Grant No. 200608 of the Forestry and Forest Product Research Institute.	Beaudet M, 1998, CAN J FOREST RES, V28, P1007, DOI 10.1139/cjfr-28-7-1007; Poorter L, 2001, FUNCT ECOL, V15, P113, DOI 10.1046/j.1365-2435.2001.00503.x; Montgomery RA, 2001, ECOLOGY, V82, P2707; OCONNELL BM, 1994, TREE PHYSIOL, V14, P89; Chen HYH, 1996, CAN J FOREST RES, V26, P1149, DOI 10.1139/x26-128; WARING RH, 1987, BIOSCIENCE, V37, P569, DOI 10.2307/1310667; TUCKER GF, 1987, FOREST ECOL MANAG, V21, P249, DOI 10.1016/0378-1127(87)90047-8; Kneeshaw DD, 2006, J ECOL, V94, P471, DOI 10.1111/j.1365-2745.2005.01070.x; Wang GG, 2006, FOREST ECOL MANAG, V226, P173, DOI 10.1016/j.foreco.2005.12.063; GIVNISH TJ, 1988, AUST J PLANT PHYSIOL, V15, P63; Messier C, 1999, CAN J FOREST RES, V29, P812, DOI 10.1139/cjfr-29-6-812; Delagrange S, 2004, TREE PHYSIOL, V24, P775; CANHAM CD, 1988, ECOLOGY, V69, P786, DOI 10.2307/1941027; Connell JH, 2000, ECOLOGY, V81, P568, DOI 10.1890/0012-9658(2000)081[0568:SDOTTY]2.0.CO;2; Williams H, 1999, CAN J FOREST RES, V29, P222, DOI 10.1139/cjfr-29-2-222; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; GRIME JP, 1965, J ECOL, V53, P621, DOI 10.2307/2257624; Osada N, 2011, FUNCT ECOL, V25, P777, DOI 10.1111/j.1365-2435.2011.01833.x; Wilson BF, 2000, AM J BOT, V87, P601, DOI 10.2307/2656846; KOBE RK, 1995, ECOL APPL, V5, P517, DOI 10.2307/1942040; Dun EA, 2006, PLANT PHYSIOL, V142, P812, DOI 10.1104/pp.106.086868; Messier C, 1998, J VEG SCI, V9, P511, DOI 10.2307/3237266; Walters MB, 1996, ECOLOGY, V77, P841, DOI 10.2307/2265505; Brooks JR, 1996, OECOLOGIA, V107, P21, DOI 10.1007/BF00582231; Barthelemy D, 2007, ANN BOT-LONDON, V99, P375, DOI 10.1093/aob/mcl260; Begin C, 1999, CAN J BOT, V77, P664, DOI 10.1139/cjb-77-5-664; BRIAND CH, 1991, BOT GAZ, V152, P494, DOI 10.1086/337911; EDELIN C, 1991, TREES, P127; Forest Soil Division, 1976, B GOV FOR EXP STN, V280, P1; GERRISH G, 1990, ECOLOGY, V71, P1176, DOI 10.2307/1937385; Grassi G, 2005, ANN FOREST SCI, V62, P269, DOI 10.1051/forest:2005019; HARA M, 1987, VEGETATIO, V71, P67; Hashimoto R., 1998, Journal of the Japanese Forestry Society, V80, P189; Hashimoto R., 1999, Journal of the Japanese Forestry Society, V81, P169; Hayakawa T, 2004, ECOL RES, V19, P411, DOI 10.1111/j.1440-1703.2004.00652.x; Hitsuma G, 2006, J FOREST RES-JPN, V11, P387, DOI 10.1007/s10310-006-0206-y; Holmes SA, 2010, CAN J FOREST RES, V40, P1627, DOI 10.1139/X10-105; Horn H.S., 1971, ADAPTIVE GEOMETRY TR, P104; Ishii H, 2001, CAN J BOT, V79, P251, DOI 10.1139/cjb-79-3-251; Itoya Y., 1991, J TOHOKU BRANCH JPN, V43, P44; Kohyama T, 1987, FUNCT ECOL, V1, P399, DOI 10.2307/2389797; KOOP H, 1987, VEGETATIO, V72, P103; LARSON DW, 1993, INT J PLANT SCI, V154, P496, DOI 10.1086/297133; Millet J, 2012, ARCHITECTURE ARBRES; Millet J, 1999, ECOSCIENCE, V6, P187; Osada N, 2005, CAN J BOT, V83, P1590, DOI 10.1139/b05-133; Ota T., 1993, J TOHOKU BRANCH JPN, V45, P129; Soil Survey Staff, 2010, KEYS SOIL TAX; Tanabe H., 1994, J JPN FOREST SOC, V76; Utsumi Y., 1996, Journal of the Japanese Forestry Society, V78, P457; Welander NT, 1998, FOREST ECOL MANAG, V107, P117, DOI 10.1016/S0378-1127(97)00326-5; Woods KD, 2008, CAN J FOREST RES, V38, P480, DOI 10.1139/X07-136; Yamanouchi S., 1936, J JPN FOREST SOC, V18, P81; Young JA, 1992, SEEDS WOODY PLANTS N; ywiec M., 2012, FOREST ECOL MANAG, V284, P205, DOI [10.1016/j.foreco.2012.08.007, DOI 10.1016/J.FORECO.2012.08.007]	55	1	1	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	1916-2790	1916-2804		BOTANY	Botany	JUN	2015	93	6					353	360		10.1139/cjb-2014-0237		8	Plant Sciences	Plant Sciences	CJ6JK	WOS:000355599900005		
J	Sumida, K; Sato, N; Ota, M; Sakai, K; Nippashi, Y; Sone, D; Yokoyama, K; Ito, K; Maikusa, N; Imabayashi, E; Matsuda, H; Yamada, K; Murata, M; Kunimatsu, A; Ohtomo, K				Sumida, Kaoru; Sato, Noriko; Ota, Miho; Sakai, Koji; Nippashi, Yasumasa; Sone, Daichi; Yokoyama, Kota; Ito, Kimiteru; Maikusa, Norihide; Imabayashi, Etsuko; Matsuda, Hiroshi; Yamada, Kei; Murata, Miho; Kunimatsu, Akira; Ohtomo, Kuni			Intraventricular cerebrospinal fluid temperature analysis using MR diffusion-weighted imaging thermometry in Parkinson's disease patients, multiple system atrophy patients, and healthy subjects	BRAIN AND BEHAVIOR			English	Article						Cerebrospinal fluid; diffusion-weighted imaging thermometry; multiple system atrophy; Parkinson's disease; temperature	MAGNETIC-RESONANCE-SPECTROSCOPY; CORE BODY-TEMPERATURE; CEREBRAL-BLOOD-FLOW; BRAIN TEMPERATURE; MITOCHONDRIAL DYSFUNCTION; AUTONOMIC DYSFUNCTION; POSTMENOPAUSAL WOMEN; DIAGNOSIS; SCINTIGRAPHY; PROGRESSION	Purpose: We examined the temperature of the intraventricular cerebrospinal fluid (T-v) in patients with Parkinson's disease (PD) and those with multiple system atrophy (MSA) in comparison with healthy subjects, and we examined normal changes in this temperature with aging. Methods: T-v was estimated by magnetic resonance (MR) diffusion-weighted imaging (DWI) thermometry in 36 PD patients (19 males, 17 females), 34 MSA patients (17 males, 17 females), 64 age-matched controls (27 men, 37 women), and 114 all-age adult controls (47 men, 67 women; 28-89years old). The volume of lateral ventricles was also estimated using FreeSurfer in all subjects. T-v and ventricular volume data were compared among the PD and MSA patients and age-matched controls. We also evaluated the relationship between T-v and age in the 114 all-age controls, controlling for ventricular volume. Men and women were analyzed separately. Results: The male PD and MSA patients had significantly higher T-v values compared to the male controls, with no significant difference in ventricular volume among them. There was no significant difference in T-v between the female patients and controls. In the all-age male controls, there was a significant negative correlation between T-v and age controlling for ventricular volume, and this was not observed in the women. Conclusion: DWI thermometry is a useful and easy method for demonstrating an altered intracranial environment in male patients and healthy controls, but not in females. DWI thermometry can thus be used to help to explore the pathophysiology of Parkinsonian syndromes and to differentiate individuals affected by neurodegenerative disease with autonomic dysfunction from those without it.	[Sumida, Kaoru; Sato, Noriko; Nippashi, Yasumasa; Yokoyama, Kota] Natl Ctr Hosp Neurol & Psychiat, Dept Radiol, Kodaira, Tokyo 1878502, Japan; [Sumida, Kaoru; Nippashi, Yasumasa; Kunimatsu, Akira; Ohtomo, Kuni] Univ Tokyo, Grad Sch Med, Dept Radiol, Bunkyo Ku, Tokyo 1138655, Japan; [Sumida, Kaoru; Nippashi, Yasumasa; Kunimatsu, Akira; Ohtomo, Kuni] Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1138655, Japan; [Ota, Miho] Natl Inst Mental Hlth, Dept Mental Disorder Res, Tokyo 1878502, Japan; [Nippashi, Yasumasa] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Sakyo Ku, Kyoto 6068507, Japan; [Sone, Daichi] Natl Ctr Hosp Neurol & Psychiat, Dept Psychiat, Kodaira, Tokyo 1878502, Japan; [Ito, Kimiteru] Tokyo Metropolitan Geriatr Hosp, Dept Radiol, Itabashi Ku, Tokyo 1730015, Japan; [Imabayashi, Etsuko; Matsuda, Hiroshi] Natl Ctr Neurol & Psychiat, Integrat Brain Imaging Ctr, Kodaira, Tokyo 1878551, Japan; [Yamada, Kei] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Radiol, Kamigyo Ku, Kyoto 6028566, Japan; [Murata, Miho] Natl Ctr Hosp Neurol & Psychiat, Dept Neurol, Kodaira, Tokyo 1878502, Japan	Sato, N (reprint author), Natl Ctr Hosp Neurol & Psychiat, Dept Radiol, 4-1-1 Ogawahigashi Cho, Kodaira, Tokyo 1878551, Japan.	snoriko@ncnp.go.jp					Powers WJ, 2008, J CEREBR BLOOD F MET, V28, P1754, DOI 10.1038/jcbfm.2008.63; COHEN J, 1987, ANN NEUROL, V22, P692, DOI 10.1002/ana.410220604; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; HOEHN MM, 1967, NEUROLOGY, V17, P427; Sakakibara R, 2014, PARKINSONISM RELAT D, V20, P267, DOI 10.1016/j.parkreldis.2013.11.001; Geser F, 2006, MOVEMENT DISORD, V21, P179, DOI 10.1002/mds.20678; Kozak LR, 2010, ACTA PAEDIATR, V99, P237, DOI 10.1111/j.1651-2227.2009.01528.x; Sakai K, 2011, NMR BIOMED, V24, P1063, DOI 10.1002/nbm.1656; Hattingen E, 2009, BRAIN, V132, P3285, DOI 10.1093/brain/awp293; Iodice V, 2011, J NEUROL SCI, V310, P133, DOI 10.1016/j.jns.2011.07.014; Murphy PJ, 2007, SLEEP, V30, P1788; SCHAPIRA AHV, 1994, MOVEMENT DISORD, V9, P125, DOI 10.1002/mds.870090202; Aarsland D, 2001, NEUROLOGY, V56, P730; Karaszewski B, 2006, ANN NEUROL, V60, P438, DOI 10.1002/ana.20957; Wenning GK, 1997, MOVEMENT DISORD, V12, P133, DOI 10.1002/mds.870120203; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Yamada K, 2010, NEUROREPORT, V21, P851, DOI 10.1097/WNR.0b013e32833d6b7a; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Brennan KA, 2010, BMJ-BRIT MED J, V341, P990; Brooks EM, 1997, J APPL PHYSIOL, V83, P477; BUXTON CL, 1948, J CLIN ENDOCRINOL, V8, P585; Childs C, 2007, MAGN RESON MED, V57, P59, DOI 10.1002/mrm.21100; Dougherty P, 1999, NEUROSCIENCE; Gu M, 1997, MOVEMENT DISORD, V12, P418, DOI 10.1002/mds.870120323; Guatteo E, 2005, J NEUROPHYSIOL, V94, P3069, DOI 10.1152/jn.00066.2005; Gunes UY, 2008, J CLIN NURS, V17, P2284, DOI 10.1111/j.1365-2702.2007.02272.x; Henchcliffe C, 2008, ANN NY ACAD SCI, V1147, P206, DOI 10.1196/annals.1427.037; HOWELL T H, 1948, Lancet, V1, P517; KONAGAYA M, 1994, J NEUROL NEUROSUR PS, V57, P1528, DOI 10.1136/jnnp.57.12.1528; LEENDERS KL, 1985, BRAIN, V108, P171, DOI 10.1093/brain/108.1.171; MAGALHAES M, 1995, ACTA NEUROL SCAND, V91, P98; MARION GS, 1991, GERONTOLOGY, V37, P225; MILLS R, 1973, J PHYS CHEM-US, V77, P685, DOI 10.1021/j100624a025; Miyoshi F, 2013, AM J NEURORADIOL, V34, P2113, DOI 10.3174/ajnr.A3567; Nagy Z., 2009, P INT SOC MAG RESON, V17, P2700; Ota M, 2014, J CEREBR BLOOD F MET, V34, P1868, DOI 10.1038/jcbfm.2014.151; Pierangeli G, 2001, MOVEMENT DISORD, V16, P226, DOI 10.1002/mds.1039; Quinn N, 1986, J NEUROL NEUROSUR PS, V52, P78; Rango M, 2014, J CEREBR BLOOD F MET, V34, P915, DOI 10.1038/jcbfm.2014.38; Rango M, 2012, NEUROREPORT, V23, P129, DOI 10.1097/WNR.0b013e32834e8fac; Roghmann MC, 2001, AM J MED SCI, V322, P68, DOI 10.1097/00000441-200108000-00003; Sai A, 2014, J MAGN RESON IMAGING, V40, P649, DOI 10.1002/jmri.24396; Sakai K, 2012, NMR BIOMED, V25, P340, DOI 10.1002/nbm.1755; Sakai K., 2013, 35 ANN INT C IEEE, V2957; SAVOIARDO M, 1990, RADIOLOGY, V174, P693; Siesjo B. K., 1978, BRAIN ENERGY METABOL; Tazoe J, 2014, NEURORADIOLOGY, V56, P809, DOI 10.1007/s00234-014-1384-5; WOLLMUTH LP, 1989, J COMP PHYSIOL B, V159, P83, DOI 10.1007/BF00692686	48	0	0	JOHN WILEY & SONS INC	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	JUN	2015	5	6							e00340	10.1002/brb3.340		9	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CJ8ED	WOS:000355731700005		
J	Joosten, A; Huynh, T; Suehiro, K; Canales, C; Cannesson, M; Rinehart, J				Joosten, A.; Huynh, T.; Suehiro, K.; Canales, C.; Cannesson, M.; Rinehart, J.			Goal-Directed fluid therapy with closed-loop assistance during moderate risk surgery using noninvasive cardiac output monitoring: A pilot study	BRITISH JOURNAL OF ANAESTHESIA			English	Article						cardiac output; monitoring; noninvasive; safety	PERIOPERATIVE SURGICAL HOME; VOLUME OPTIMIZATION; ARTERIAL-PRESSURE; BLOOD-FLOW; RESPONSIVENESS; MANAGEMENT; CARE; RESUSCITATION; ACCURACY; OUTCOMES	Background. Goal directed fluid therapy (GDFT) has been shown to improve outcomes in moderate to high-risk surgery. However, most of the present GDFT protocols based on cardiac output optimization use invasive devices and the protocols may require significant practitioner attention and intervention to apply them accurately. The aim of this prospective pilot study was to evaluate the clinical feasibility of GDFT using a closed-loop fluid administration system with a non-invasive cardiac output monitoring device (Nexfin(TM), BMEYE, Amsterdam, Netherlands). Methods. Patients scheduled for elective moderate risk surgery under general anaesthesia were enrolled. The primary anaesthesia team managing the case selected GDFT targets using the controller interface and all patients received a baseline 3 ml kg(-1) h(-1) crystalloid infusion. Colloid solutions were delivered by the closed-loop system for intravascular volume expansion using data from the NexfinTM monitor. Compliance with GDFT management was defined as acceptable when a patient spent more than 85% of the surgery time in a preload independent state (defined as pulse pressure variation <13%) or when average cardiac index during surgery was >2.5 litre min(-1) m(-2). Results. A total of 13 patients were included in the study group. All patients met the established criteria for delivery of GDFT for greater than 85% of case time. The median length of stay in the hospital was 5 [3-6] days. Conclusion. In this pilot study, GDFT management using the closed-loop fluid administration system with a non-invasive CO monitoring device was feasible and maintained a high rate of protocol compliance.	[Joosten, A.; Huynh, T.; Suehiro, K.; Canales, C.; Cannesson, M.; Rinehart, J.] Univ Calif Irvine, Dept Anesthesiol & Perioperat Care, Orange, CA 92868 USA; [Joosten, A.] Free Univ Brussels, Dept Anesthesiol & Crit Care, Erasme Univ Hosp, Brussels, Belgium; [Suehiro, K.] Osaka City Univ, Dept Anesthesiol, Grad Sch Med, Osaka 558, Japan	Rinehart, J (reprint author), Univ Calif Irvine, Dept Anesthesiol & Perioperat Care, Sch Med, 101 S City Dr, Orange, CA 92868 USA.	jrinehar@uci.edu					Spanjersberg WR, 2009, EMERG MED J, V26, P23, DOI 10.1136/emj.2008.058073; Rinehart J, 2012, J CARDIOTHOR VASC AN, V26, P933, DOI 10.1053/j.jvca.2012.05.015; Gill F, 2012, J SPEC PEDIATR NURS, V17, P136, DOI 10.1111/j.1744-6155.2012.00331.x; Kim SH, 2014, ANESTHESIOLOGY, V120, P1080, DOI 10.1097/ALN.0000000000000226; Rinehart J, 2013, ANESTH ANALG, V117, P1119, DOI 10.1213/ANE.0b013e3182937d61; Truijen J, 2012, J CLIN MONIT COMPUT, V26, P267, DOI 10.1007/s10877-012-9375-8; Lipton JA, 2011, DIABETES TECHNOL THE, V13, P343, DOI 10.1089/dia.2010.0100; Peyton PJ, 2010, ANESTHESIOLOGY, V113, P1220, DOI 10.1097/ALN.0b013e3181ee3130; Angus DC, 2006, CRIT CARE MED, V34, P1016, DOI 10.1097/01.CCM.0000206105.05626.15; Muller L, 2011, ANESTHESIOLOGY, V115, P541, DOI 10.1097/ALN.0b013e318229a500; Cannesson M, 2011, ANESTHESIOLOGY, V115, P231, DOI 10.1097/ALN.0b013e318225b80a; Gustafsson UO, 2013, WORLD J SURG, V37, P259, DOI 10.1007/s00268-012-1772-0; Sinclair S, 1997, BRIT MED J, V315, P909; Pearse RM, 2014, JAMA-J AM MED ASSOC, V311, P2181, DOI 10.1001/jama.2014.5305; Grocott MPW, 2013, BRIT J ANAESTH, V111, P535, DOI 10.1093/bja/aet155; Rinehart J, 2013, ANESTH ANALG, V117, P1110, DOI 10.1213/ANE.0b013e3182930050; Hamilton MA, 2011, ANESTH ANALG, V112, P1392, DOI 10.1213/ANE.0b013e3181eeaae5; Kain ZN, 2014, ANESTH ANALG, V118, P1126, DOI 10.1213/ANE.0000000000000190; Julious SA, 2005, PHARM STAT, V4, P287, DOI 10.1002/pst.185; Cannesson M, 2011, CRIT CARE, V15, DOI 10.1186/cc10364; Garson L, 2014, ANESTH ANALG, V118, P1081, DOI 10.1213/ANE.0000000000000191; Lobo SM, 2013, CRIT CARE, V17, DOI 10.1186/cc11861; Monnet X, 2007, CURR OPIN CRIT CARE, V13, P549, DOI 10.1097/MCC.0b013e3282ec68b2; National Institute for Health and Clinical Excellence, 2011, MED TECHN GUID MTG3; Pytte M, 2006, ACTA ANAESTH SCAND, V50, P718, DOI 10.1111/j.1399-6576.2006.01045.x; Rinehart J, 2014, Ann Fr Anesth Reanim, V33, pe35, DOI 10.1016/j.annfar.2013.11.016; Rinehart J, 2011, CRIT CARE, V15, DOI 10.1186/cc10562; Scheer Bernd, 2002, Crit Care, V6, P199, DOI 10.1186/cc1489; Vallet B, 2013, Ann Fr Anesth Reanim, V32, pe151, DOI 10.1016/j.annfar.2013.09.010	29	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0007-0912	1471-6771		BRIT J ANAESTH	Br. J. Anaesth.	JUN	2015	114	6					886	892		10.1093/bja/aev002		7	Anesthesiology	Anesthesiology	CJ8SB	WOS:000355772700008		
J	Hirokawa, M; Sawada, K; Fujishima, N; Teramura, M; Bessho, M; Dan, K; Tsurumi, H; Nakao, S; Urabe, A; Fujisawa, S; Yonemura, Y; Kawano, F; Oshimi, K; Sugimoto, K; Matsuda, A; Karasawa, M; Arai, A; Komatsu, N; Harigae, H; Omine, M; Ozawa, K; Kurokawa, M				Hirokawa, Makoto; Sawada, Kenichi; Fujishima, Naohito; Teramura, Masanao; Bessho, Masami; Dan, Kazuo; Tsurumi, Hisashi; Nakao, Shinji; Urabe, Akio; Fujisawa, Shin; Yonemura, Yuji; Kawano, Fumio; Oshimi, Kazuo; Sugimoto, Koichi; Matsuda, Akira; Karasawa, Masamitsu; Arai, Ayako; Komatsu, Norio; Harigae, Hideo; Omine, Mitsuhiro; Ozawa, Keiya; Kurokawa, Mineo		PRCA Collaborative Study Grp	Long-term outcome of patients with acquired chronic pure red cell aplasia (PRCA) following immunosuppressive therapy: a final report of the nationwide cohort study in 2004/2006 by the Japan PRCA collaborative study group	BRITISH JOURNAL OF HAEMATOLOGY			English	Article						pure red cell aplasia; idiopathic; thymoma; large granular lymphocyte leukaemia; immunosuppressive therapy	GRANULAR LYMPHOCYTE LEUKEMIA; IRON CHELATION-THERAPY; MYELODYSPLASTIC SYNDROME; STAT3 MUTATIONS; ANEMIA; HEMATOPOIESIS; DEFERASIROX; ASSOCIATION; IMPROVEMENT; EXPANSION	Immunosuppressive therapy has been employed as the initial treatment for acquired chronic pure red cell aplasia (PRCA), such as idiopathic, thymoma-associated, or large granular lymphocyte (LGL) leukaemia-associated PRCA, which is thought to be immune-mediated. To explore the overall long-term outcome following immunosuppression and to identify the risk factors for death in these disorders, we conducted nationwide surveys in Japan 2004 and 2006, and identified a total of 185 patients with acquired chronic PRCA, including 72 idiopathic, 41 thymoma-associated and 14 LGL leukaemia-associated cases of PRCA for whom data was available. The present study evaluated 127 patients with these three subsets of PRCA. The median overall survival has not yet been reached in idiopathic PRCA. The estimated median overall survival times in patients with thymoma-associated and LGL leukaemia-associated PRCA were 1421 and 1478months, respectively. Twenty-two deaths were reported, and the response to induction therapy and relapse of anaemia were found to be associated with death. The major causes of death were infection in seven patients and organ failure in another seven patients. The results suggest that maintenance therapy and the management of infectious complications are crucial for improving the prognosis of chronic PRCA.	[Hirokawa, Makoto] Akita Univ Grad Sch Med, Dept Gen Internal Med & Clin Lab Med, Akita, Japan; [Sawada, Kenichi; Fujishima, Naohito] Akita Univ Grad Sch Med, Dept Haematol Nephrol & Rheumatol, Akita, Japan; [Teramura, Masanao] Tokyo Womens Med Univ, Dept Haematol, Tokyo, Japan; [Bessho, Masami] Saitama Med Univ, Div Haematol, Dept Internal Med, Saitama, Japan; [Dan, Kazuo] Nippon Med Sch, Dept Haematol, Tokyo 113, Japan; [Tsurumi, Hisashi] Gifu Univ Sch Med, Dept Internal Med 1, Gifu, Japan; [Nakao, Shinji] Kanazawa Univ Grad Sch Med, Dept Cellular Transplantat Biol, Kanazawa, Ishikawa, Japan; [Urabe, Akio] NTT Med Ctr, Div Haematol, Tokyo, Japan; [Fujisawa, Shin] Yokohama City Univ Med Ctr, Dept Haematol, Yokohama, Kanagawa, Japan; [Yonemura, Yuji] Kumamoto Univ Sch Med, Dept Transfus Med & Cell Therapy Blood Transfus S, Kumamoto, Japan; [Kawano, Fumio] Natl Hosp Org Kumamoto Natl Hosp Med Ctr, Kumamoto, Japan; [Oshimi, Kazuo; Sugimoto, Koichi; Komatsu, Norio] Juntendo Univ Sch Med, Div Haematol, Tokyo, Japan; [Matsuda, Akira] Saitama Med Univ, Saitama Int Med Ctr, Saitama, Japan; [Karasawa, Masamitsu] Gunma Univ Hosp, Blood Transfus Serv, Maebashi, Gunma, Japan; [Arai, Ayako] Tokyo Med & Dent Univ, Dept Haematol, Tokyo, Japan; [Harigae, Hideo] Tohoku Univ Grad Sch Med, Dept Haematol & Immunol, Sendai, Miyagi, Japan; [Omine, Mitsuhiro] Showa Univ Fujigaoka Hosp, Div Haematol, Internal Med, Yokohama, Kanagawa, Japan; [Ozawa, Keiya] Jichi Med Sch, Div Haematol, Dept Med, Shimotsuke, Tochigi, Japan; [Kurokawa, Mineo] Univ Tokyo, Dept Haematol & Oncol, Grad Sch Med, Tokyo, Japan	Hirokawa, M (reprint author), Akita Univ Grad Sch Med, Dept Gen Internal Med & Clin Lab Med, 1-1-1 Hondo, Akita 0108543, Japan.	mhirokawa@hos.akita-u.ac.jp			Idiopathic Disorders of Haematopoietic Organs Research Committee of the Ministry of Health, Labour and Welfare of Japan	This study was supported by a research grant from the Idiopathic Disorders of Haematopoietic Organs Research Committee of the Ministry of Health, Labour and Welfare of Japan.	Oliva EN, 2010, TRANSFUSION, V50, P1568, DOI 10.1111/j.1537-2995.2010.02617.x; Takatoku M, 2007, EUR J HAEMATOL, V78, P487, DOI 10.1111/j.1600-0609.2007.00842.x; Sawada K, 2008, BRIT J HAEMATOL, V142, P505, DOI 10.1111/j.1365-2141.2008.07216.x; CLARK DA, 1984, BLOOD, V63, P277; Go RS, 2001, BLOOD, V98, P483, DOI 10.1182/blood.V98.2.483; ANDERSON JR, 1983, J CLIN ONCOL, V1, P710; Suzuki T, 2008, INT J HEMATOL, V88, P30, DOI 10.1007/s12185-008-0119-y; Jerez A, 2013, BLOOD, V122, P2453, DOI 10.1182/blood-2013-04-494930; Sawada KI, 2007, HAEMATOL-HEMATOL J, V92, P1021, DOI 10.3324/haematol.11192; Fujishima N, 2008, HAEMATOL-HEMATOL J, V93, P1555, DOI 10.3324/haematol.12871; Fasan A, 2013, LEUKEMIA, V27, P1598, DOI 10.1038/leu.2012.350; Hirokawa M, 2008, HAEMATOL-HEMATOL J, V93, P27, DOI 10.3324/haematol.11655; Dessypris E., 2004, WINTROBES CLIN HEMAT, P1421; Fujishima Naohito, 2006, Haematologica, V91, pECR47; Garcia-Suarez J, 1998, AM J HEMATOL, V58, P319, DOI 10.1002/(SICI)1096-8652(199808)58:4<319::AID-AJH12>3.0.CO;2-2; Handgretinger R, 1999, NEW ENGL J MED, V340, P278, DOI 10.1056/NEJM199901283400405; Inui Y, 2012, INTERNAL MED, V51, P1579, DOI 10.2169/internalmedicine.51.7298; Ishida F, 2014, CANCER SCI, V105, P342, DOI 10.1111/cas.12341; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kojima M, 2013, INT J HEMATOL, V98, P719, DOI 10.1007/s12185-013-1455-0; KRANTZ SB, 1973, J CLIN INVEST, V52, P324, DOI 10.1172/JCI107188; Lacy MQ, 1996, BLOOD, V87, P3000; Lee SE, 2013, ACTA HAEMATOL-BASEL, V129, P72, DOI 10.1159/000342772; Masuda M, 1997, AM J HEMATOL, V54, P324, DOI 10.1002/(SICI)1096-8652(199704)54:4<324::AID-AJH12>3.0.CO;2-B; Masuda M, 1999, AM J HEMATOL, V62, P193, DOI 10.1002/(SICI)1096-8652(199911)62:3<193::AID-AJH10>3.0.CO;2-D; Mi XJ, 2013, J CLIN EPIDEMIOL, V66, pS138, DOI 10.1016/j.jclinepi.2013.01.014; SOCIE G, 1993, NEW ENGL J MED, V329, P1152, DOI 10.1056/NEJM199310143291603; Wang SA, 2007, BRIT J HAEMATOL, V138, P271, DOI 10.1111/j.1365-2141.2007.06648.x	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	JUN	2015	169	6					879	886		10.1111/bjh.13376		8	Hematology	Hematology	CJ7EN	WOS:000355657300016		
J	Ok, J; Pisith, S; Watanabe, H; Thuyet, DQ; Boulange, J; Takagi, K				Ok, Junghun; Pisith, Sok; Watanabe, Hirozumi; Dang Quoc Thuyet; Boulange, Julien; Takagi, Kazuhiro			Effect of Rice Husk Gasification Residue Application on Herbicide Behavior in Micro Paddy Lysimeter	BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY			English	Article						Rice husk gasification residue; Butachlor; Pyrazosulfuron-ethyl; Micro paddy lysimeter	MANAGEMENT PRACTICE; WATER; PESTICIDES; BUTACHLOR; RUNOFF; SOILS; FATE	Effects of rice husk gasification residues (RHGR) application on the fate of herbicides, butachlor and pyrazosulfuron-ethyl, in paddy water were investigated using micro paddy lysimeters (MPLs). The dissipation of both herbicides in paddy water was faster in the RHGR treated MPL than in the control MPL. The average concentrations of butachlor and pyrazosulfuron-ethyl in paddy water in the lysimeter treated with RHGR during 21 days were significantly reduced by 51 % and 48 %, respectively, as compared to those in the lysimeter without RHGR application. The half-lives (DT50) of butachlor in paddy water for control and treatment were 3.1 and 2.3 days respectively, and these values of pyrazosulfuron-ethyl were 3.0 and 2.2 days, respectively. Based on this study, RHGR application in rice paddy environment is an alternative method to reduce the concentration of herbicide in paddy field water and consequently to reduce potential pollution to aquatic environment.	[Ok, Junghun] Natl Acad Agr Sci, Organ Agr Div, Wanju Gun 565851, Jeollabuk Do, South Korea; [Pisith, Sok; Watanabe, Hirozumi; Boulange, Julien] Tokyo Univ Agr & Technol, Fuchu, Tokyo 1838509, Japan; [Dang Quoc Thuyet] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Takagi, Kazuhiro] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 3058604, Japan	Watanabe, H (reprint author), Tokyo Univ Agr & Technol, 3-5-8 Saiwaicho, Fuchu, Tokyo 1838509, Japan.	pochi@cc.tuat.ac.jp	Dang, Thuyet/G-3792-2011	Dang, Thuyet/0000-0001-6654-2855	Research program for Agricultural Science & Technology Development, National Academy of Agricultural Science, Rural Development Administration, Republic of Korea [PJ01086501]	This research was partially supported by "Research program for Agricultural Science & Technology Development (Project No. PJ01086501)", National Academy of Agricultural Science, Rural Development Administration, Republic of Korea.	Si YB, 2011, J CONTAM HYDROL, V123, P75, DOI 10.1016/j.jconhyd.2010.12.008; Spokas KA, 2009, CHEMOSPHERE, V77, P574, DOI 10.1016/j.chemosphere.2009.06.053; Kookana RS, 2010, AUST J SOIL RES, V48, P627, DOI 10.1071/SR10007; Inao K, 1999, PESTIC SCI, V55, P38, DOI 10.1002/ps.2780550108; Pal OR, 2001, SEP PURIF TECHNOL, V24, P167, DOI 10.1016/S1383-5866(00)00226-4; Watanabe H, 2007, AGR WATER MANAGE, V88, P132, DOI 10.1016/j.agwat.2006.10.009; Ok J, 2012, B ENVIRON CONTAM TOX, V89, P306, DOI 10.1007/s00128-012-0700-1; Wang HL, 2010, J SOIL SEDIMENT, V10, P283, DOI 10.1007/s11368-009-0111-z; Boulange J, 2014, J HYDROL, V517, P146, DOI 10.1016/j.jhydrol.2014.05.013; Chen YL, 1979, J PESTIC SCI, V4, P432; Iwafune T, 2010, J PESTIC SCI, V35, P114, DOI 10.1584/jpestics.G09-49; Kondo K, 2012, J PESTIC SCI, V37, P312, DOI 10.1584/jpestics.D11-058; Mesa A.C., 2011, HERBICIDES ENV, P315; Nhung DTT, 2009, CHEMOSPHERE, V77, P1393, DOI 10.1016/j.chemosphere.2009.09.014; Phong TK, 2011, PEST MANAG SCI, V67, P70, DOI 10.1002/ps.2033; Takagi K, 2003, P 3 INT C CONT SOIL; Thuyet DQ, 2012, J PESTIC SCI, V37, P20, DOI 10.1584/jpestics.G11-19; Thuyet D. Q., 2010, Paddy and Water Environment, V8, P235; Tian C, 2010, AGR SCI CHINA, V9, P257, DOI 10.1016/S1671-2927(09)60091-2; Vu HS, 2006, PEST MANAG SCI, V62, P1193; Watanabe H, 2008, PESTICIDE RISK ASSES, P167; Xu J, 2008, CHEMOSPHERE, V74, P682; Ying GG, 2000, ENVIRON POLLUT, V107, P399, DOI 10.1016/S0269-7491(99)00178-5	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0007-4861	1432-0800		B ENVIRON CONTAM TOX	Bull. Environ. Contam. Toxicol.	JUN	2015	94	6					791	795		10.1007/s00128-015-1515-7		5	Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	CJ8KQ	WOS:000355749500019		
J	Yokoyama, S; Ito, M; Nagasawa, S; Morohashi, M; Ohno, M; Todate, Y; Kose, T; Kawata, K				Yokoyama, Sayako; Ito, Masataka; Nagasawa, Shunsuke; Morohashi, Masayuki; Ohno, Masaki; Todate, Yukitaka; Kose, Tomohiro; Kawata, Kuniaki			Runoff and Degradation of Aerially Applied Dinotefuran in Paddy Fields and River	BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY			English	Article						Neonicotinoid; Water; Soil; Half-life	NEONICOTINOIDS	Variation, run-off and degradation characteristics of the insecticide dinotefuran, (EZ)-(RS)-1-methyl-2-nitro- 3-(tetrahydro-3-furyl-methyl) guanidine, in water and soil from two paddy fields after aerial application was investigated as well as in river water. Maximum concentrations of dinotefuran were 290 and 720 mu g/L in the two paddy waters, 25 and 28 mu g/kg dry in the two paddy soils, and 10 mu g/L in the river water. Runoff ratios of dinotefuran from the paddy fields were calculated as 14 %-41 %. Mean half-lives of dinotefuran were 5.4 days in the paddy water and 12 days in the paddy soil. Results obtained in this study are important for the evaluation of the actual behavior of dinotefuran in paddy fields and rivers.	[Yokoyama, Sayako; Ito, Masataka; Nagasawa, Shunsuke; Todate, Yukitaka; Kose, Tomohiro; Kawata, Kuniaki] Niigata Univ Pharm & Appl Life Sci, Fac Appl Life Sci, Akiha Ku, Niigata, Niigata 9568603, Japan; [Morohashi, Masayuki] Japan Environm Sanitat Ctr, Asia Ctr Air Pollut Res, Nishi Ku, Niigata, Niigata 9502144, Japan; [Ohno, Masaki] Hiroshima Univ, Environm Res & Management Ctr, Higashihiroshima, Hiroshima 7398513, Japan	Kawata, K (reprint author), Niigata Univ Pharm & Appl Life Sci, Fac Appl Life Sci, Akiha Ku, 265-1 Higashijima, Niigata, Niigata 9568603, Japan.	kawata@nupals.ac.jp					Yamamoto A, 2012, J ENVIRON MONITOR, V14, P2189, DOI 10.1039/c2em30296a; van der Sluijs JP, 2013, CURR OPIN ENV SUST, V5, P293, DOI 10.1016/j.cosust.2013.05.007; Food Safety Commission, 2005, DIN EV REP; Japan Plant Protection Association, 2011, REP NY 2010 SURV RES; Japan Plant Protection Association, 2010, REP FY 2009 SURV RES; Japan Plant Protection Association, 2008, REP INV EV MAN METH; Morohashi M, 2012, B ENVIRON CONTAM TOX, V88, P521, DOI 10.1007/s00128-012-0531-0; Wakita T, 2005, J PESTIC SCI, V30, P122, DOI 10.1584/jpestics.30.122; Yamada T, 2012, JPN J CLIN ECOL, V21, P10	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0007-4861	1432-0800		B ENVIRON CONTAM TOX	Bull. Environ. Contam. Toxicol.	JUN	2015	94	6					796	800		10.1007/s00128-015-1554-0		5	Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	CJ8KQ	WOS:000355749500020		
J	Tsukatani, H; Tobiishi, K				Tsukatani, Hiroko; Tobiishi, Kazuhiro			Determination of N,N-Dimethyldodecylamine and N,N-Dimethyloctadecylamine in River and Sea Water Using Liquid Chromatography Tandem Mass Spectrometry	BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY			English	Article						N,N-Dimethyldodecylamine; N,N-Dimethyloctadecylamine; River; Sea; Solid phase extraction (SPE); Liquid chromatography/tandem mass spectrometry (LC/MS/MS)	NONIONIC SURFACTANTS; SEDIMENTS; EXTRACTION	We developed a selective method for determining N, N-dimethyldodecylamine (DMDA) and N, N-dimethyloctadecylamine (DMOA) concentrations in river and sea water samples using liquid chromatography/tandem mass spectrometry (LC/MS/MS). DMDA and DMOA are suspected to be toxic, and DMDA is categorized as a "Class I Designated Chemical Substance'' under the "Act on Confirmation, etc. of Release Amounts of Specific Chemical Substances in the Environment and Promotion of Improvements to the Management Thereof'' in Japan. The analytes are extracted from a water sample using solid phase extraction and the extract is evaporated and dissolved in 1 mL methanol for LC/MS/MS analysis. We analyzed DMDA and DMOA in real water samples and found that the analyte peaks were resolved effectively. The method detection limits for DMDA and DMOA were 4.7 and 0.80 ng/L, respectively.	[Tsukatani, Hiroko; Tobiishi, Kazuhiro] Fukuoka Inst Hlth & Environm Sci, Dazaifu, Fukuoka 8180135, Japan	Tsukatani, H (reprint author), Fukuoka Inst Hlth & Environm Sci, 39 Mukaizano, Dazaifu, Fukuoka 8180135, Japan.	tsukatani@fihes.pref.fukuoka.jp			Ministry of the Environment of Japan	This work was supported in part by a Grant-in-Aid from the Ministry of the Environment of Japan.	Lara-Martin PA, 2006, J CHROMATOGR A, V1114, P205, DOI 10.1016/j.chroma.2006.03.014; [Anonymous], 2013, RESULTS ECOTOXICITY; [Anonymous], 2002, MANUAL INVESTIGATION; Petrovic M, 2002, ENVIRON TOXICOL CHEM, V21, P37, DOI 10.1897/1551-5028(2002)021<0037:OADONS>2.0.CO;2; Cantero M, 2005, J CHROMATOGR A, V1067, P161, DOI 10.1016/j.chroma.2004.11.017; Dyer SD, 2006, ENVIRON MONIT ASSESS, V120, P45, DOI 10.1007/s10661-005-9048-x; Kobuke Y, 2004, WATER SCI TECHNOL, V50, P355; Takino M, 2000, J CHROMATOGR A, V904, P65, DOI 10.1016/S0021-9673(00)00918-3; Wegner C, 2002, ENVIRON SCI TECHNOL, V36, P3250, DOI 10.1021/es025532p; Wererniuk AM, 2006, J SEP SCI, V29, P2251, DOI 10.1002/jssc.200600041	10	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0007-4861	1432-0800		B ENVIRON CONTAM TOX	Bull. Environ. Contam. Toxicol.	JUN	2015	94	6					801	806		10.1007/s00128-015-1464-1		6	Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	CJ8KQ	WOS:000355749500021		
J	Chaves, LF; Kawashima, E; Futami, K; Minakawa, N; Rodriguez, RM				Fernando Chaves, Luis; Kawashima, Emiko; Futami, Kyoko; Minakawa, Noboru; Marin Rodriguez, Rodrigo			Lack of kdr mutations in a population of Asian tiger mosquitoes from Costa Rica	BULLETIN OF INSECTOLOGY			English	Article						insecticide resistance; invasive species; Aedes albopicius; dengue; chikungunya	AEDES-ALBOPICTUS; RESISTANCE	Use of insecticides has led to the fixation of alleles for single amino acid changes in the voltage gated sodium channel (VGSC) associated with knockdown resistance (kdr) in insects of agricultural or medical importance. In this short note, we study allele frequencies of 5 kdr loci, S989, 11011, L1014, V1016 and F1534 in a population of the Asian tiger mosquito, Aedes albopicius (Skuse) (Diptera Culicidae), collected in the only identified location with persistent infestations in Costa Rica. We found no mutant alleles associated with kdr resistance, and a synonymous point mutation was observed at loci V1016. Our results likely reflect the recent invasion of the Asian tiger mosquito in Costa Rica, and also provide a baseline for future studies looking at the global distribution of kdr mutations in this important vector of dengue and chikungunya viruses.	[Fernando Chaves, Luis; Kawashima, Emiko; Futami, Kyoko; Minakawa, Noboru] Nagasaki Univ, Inst Trop Med NEKKEN, Nagasaki 8528523, Japan; [Fernando Chaves, Luis] Univ Nacl, Escuela Med Vet, Programa Invest Enfermedades Trop, Heredia, Costa Rica; [Marin Rodriguez, Rodrigo] Minist Salud, Dept Control Vectores, San Jose, Costa Rica	Chaves, LF (reprint author), Nagasaki Univ, Inst Trop Med NEKKEN, Sakamoto 1-12-4, Nagasaki 8528523, Japan.	lchaves@nagasaki-u.ac.jp	Chaves, Luis Fernando/F-3448-2010	Chaves, Luis Fernando/0000-0002-5301-2764	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); MEXT, Japan; Nagasaki University	Junko Sakemoto (NEKKEN, Japan) offered valuable administrative support. Yukiko Higa, and Hitoshi Kawada (NEKKEN, Japan) and the reviewers provided insightful comments on the analysis methods and ms contents. Kogomi Minagawa (NEKKEN, Japan) helped with laboratory procedures and data processing and Mario Baldi (UNA, Costa Rica) helped with the mosquito sampling. This study was funded by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), MEXT, Japan and Nagasaki University (Program for Nurturing Global Leaders in Tropical and Emerging Communicable Diseases).	[Anonymous], 2002, ANN REV ENTOMOLOGY, V47, P233; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Kliot A, 2012, PEST MANAG SCI, V68, P1431, DOI 10.1002/ps.3395; Rueda LM, 2004, ZOOTAXA, P1; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; CALDERON ARGUEDAS O., 2012, REV COSTARRIC SALUD, V21, P76; Donnelly MJ, 2009, TRENDS PARASITOL, V25, P213, DOI 10.1016/j.pt.2009.02.007; Futami K, 2015, J ECON ENTOMOL, V108, P761, DOI 10.1093/jee/tou028; Kasai S, 2011, JPN J INFECT DIS, V64, P217; Kawada H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003032; LEWONTIN R. C., 1965, GENETICS COLONIZING, P79; Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992; MARIN R., 2009, REV BIOMED, V20, P15	14	0	0	ALMA MATER STUDIORUM, UNIV BOLOGNA	BOLOGNA	DEPT AGROENVIRONMENTAL SCIENCES & TECHNOLOGY, VIALE G FANIN, 42, BOLOGNA, 40127, ITALY	1721-8861			B INSECTOL	Bull. Insectology	JUN	2015	68	1					61	63				3	Entomology	Entomology	CK1JN	WOS:000355963700010		
J	Usuba, K				Usuba, Kunihiro			Partial regularity of minimizers of p(x)-growth functionals with 1 < p(x) < 2	BULLETIN OF THE LONDON MATHEMATICAL SOCIETY			English	Article							QUADRATIC FUNCTIONALS; BOUNDARY-REGULARITY; NONQUADRATIC GROWTH; HOLDER CONTINUITY; MINIMA	We prove partial regularity of minimizers u for p(x)-energy functionals of the following type: epsilon(u) = integral(Omega) (A(ij)(alpha beta) (x, u) D(alpha)u(i) D(beta)u(j))(p(x)/2) dx, assuming that A(ij)(alpha beta)(x, u) and p(x) are sufficiently smooth and that p(x) is subquadratic. We prove that u is an element of C-0,C-alpha (Omega(0)) for some alpha is an element of (0,1) and an open set Omega(0) subset of Omega with Hm-gamma 1(Omega -Omega(0)) = 0, where H-s denotes the s-dimensional Hausdorff measure and gamma(1) = inf(Omega) p(x).	Tokyo Univ Sci, Fac Sci & Technol, Dept Math, Noda, Chiba 2788510, Japan	Usuba, K (reprint author), Tokyo Univ Sci, Fac Sci & Technol, Dept Math, Noda, Chiba 2788510, Japan.	usuba_kunihiro@ma.noda.tus.ac.jp					ACERBI E, 1989, J MATH ANAL APPL, V140, P115, DOI 10.1016/0022-247X(89)90098-X; Acerbi E., 2001, ANN SC NORM SUPER S, V30, P311; Coscia A, 1999, CR ACAD SCI I-MATH, V328, P363, DOI 10.1016/S0764-4442(99)80226-2; Eleuteri M, 2004, B UNIONE MAT ITAL, V7B, P129; JOST J, 1983, MATH ANN, V262, P549, DOI 10.1007/BF01456068; Acerbi E, 2001, ARCH RATION MECH AN, V156, P121, DOI 10.1007/s002050100117; Zhikov VV, 1997, RUSS J MATH PHYS, V5, P105; GIAQUINTA M, 1983, INVENT MATH, V72, P285, DOI 10.1007/BF01389324; Coscia A, 2002, ESAIM CONTR OPTIM CA, V7, P495, DOI 10.1051/cocv:2002065; Duzaar F, 2004, J CONVEX ANAL, V11, P437; FUSCO N, 1989, ANN MAT PUR APPL, V155, P1, DOI 10.1007/BF01765932; GIAQUINTA M, 1986, MANUSCRIPTA MATH, V57, P55, DOI 10.1007/BF01172492; Giaquinta M., 1984, ANN SCUOLA NORM SU 4, V11, P45; Ragusa MA, 2013, T AM MATH SOC, V365, P3329; UHLENBECK K, 1977, ACTA MATH-DJURSHOLM, V138, P219, DOI 10.1007/BF02392316	15	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0024-6093	1469-2120		B LOND MATH SOC	Bull. London Math. Soc.	JUN	2015	47		3				455	472		10.1112/blms/bdv013		18	Mathematics	Mathematics	CJ7HC	WOS:000355664300008		
J	Kumai, T; Nagato, T; Kobayashi, H; Komabayashi, Y; Ueda, S; Kishibe, K; Ohkuri, T; Takahara, M; Celis, E; Harabuchi, Y				Kumai, Takumi; Nagato, Toshihiro; Kobayashi, Hiroya; Komabayashi, Yuki; Ueda, Seigo; Kishibe, Kan; Ohkuri, Takayuki; Takahara, Miki; Celis, Esteban; Harabuchi, Yasuaki			CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma	CANCER IMMUNOLOGY IMMUNOTHERAPY			English	Article						CCR4; CCL17; CCL22; Nasal NK/T-cell lymphoma; Chemokine	EPSTEIN-BARR-VIRUS; REGULATORY T-CELLS; HODGKIN LYMPHOMA; MOLECULAR TARGET; LINES; EXPRESSION; CHEMOKINES; RECEPTOR; LEUKEMIA; CCR4	Nasal natural killer/T-cell lymphoma (NNKTL) is associated with Epstein-Barr virus and has a poor prognosis because of local invasion and/or multiple dissemination. Various chemokines play a role in tumor proliferation and invasion, and chemokine receptors including the C-C chemokine receptor 4 (CCR4) are recognized as potential targets for treating hematologic malignancies. The aim of the present study was to determine whether specific chemokines are produced by NNKTL. We compared chemokine expression patterns in culture supernatants of NNKTL cell lines with those of other lymphoma or leukemia cell lines using chemokine protein array and ELISA. Chemokine (C-C motif) ligand (CCL) 17 and CCL22 were highly produced by NNKTL cell lines as compared to the other cell lines. In addition, CCL17 and CCL22 were readily observed in the sera of NNKTL patients. The levels of these chemokines were significantly higher in patients than in healthy controls. Furthermore, we detected the expression of CCR4 (the receptor for CCL17 and CCL22) on the surface of NNKTL cell lines and in tissues of NNKTL patients. Anti-CCR4 monoclonal antibody (mAb) efficiently induced antibody-dependent cellular cytotoxicity mediated by natural killer cells against NNKTL cell lines. Our results suggest that CCL17 and CCL22 may be important factors in the development of NNKTL and open up the possibility of immunotherapy of this lymphoma using anti-CCR4 mAb.	[Kumai, Takumi; Nagato, Toshihiro; Komabayashi, Yuki; Ueda, Seigo; Kishibe, Kan; Takahara, Miki; Harabuchi, Yasuaki] Asahikawa Med Univ, Dept Otolaryngol Head & Neck Surg, Asahikawa, Hokkaido 0788510, Japan; [Kumai, Takumi; Kobayashi, Hiroya; Ohkuri, Takayuki] Asahikawa Med Univ, Dept Pathol, Asahikawa, Hokkaido 0788510, Japan; [Celis, Esteban] Georgia Regents Univ Canc Ctr, Canc Immunol Inflammat & Tolerance Program, Augusta, GA USA	Nagato, T (reprint author), Asahikawa Med Univ, Dept Otolaryngol Head & Neck Surg, Midorigaoka Higashi 2-1-1-1, Asahikawa, Hokkaido 0788510, Japan.	rijun@asahikawa-med.ac.jp; hiroya@asahikawa-med.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [24791735, 23791869, 25460430, 24390385]; National Institutes of Health (NIH) [R01CA136828, R01CA157303]	The authors thank Dr. Shimizu N (Tokyo Medical and Dental University) and Prof. Klein E (Karolinska Institute) for generously providing cell lines. This study was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI [Grant Numbers 24791735 (Kumai T), 23791869 (Nagato T), 25460430 (Kobayashi H), and 24390385 (Harabuchi Y)] and by National Institutes of Health (NIH) Grants [Grant Numbers R01CA136828 and R01CA157303 (Celis E)].	Yoshino K, 2013, BRIT J HAEMATOL, V160, P331, DOI 10.1111/bjh.12136; Harabuchi Y, 1996, CANCER, V77, P2137, DOI 10.1002/(SICI)1097-0142(19960515)77:10<2137::AID-CNCR27>3.3.CO;2-N; Emile JF, 1996, BLOOD, V87, P1466; Ishida T, 2006, CANCER RES, V66, P5716, DOI 10.1158/0008-5472.CAN-06-0261; Marshall NA, 2004, BLOOD, V103, P1755, DOI 10.1182/blood-2003-07-2594; Buglio D, 2008, BLOOD, V112, P1424, DOI 10.1182/blood-2008-01-133769; Nomiyama H, 1998, CYTOGENET CELL GENET, V81, P10, DOI 10.1159/000015000; MINAROVITS J, 1994, J GEN VIROL, V75, P77, DOI 10.1099/0022-1317-75-1-77; Sarvaiya PJ, 2013, ONCOTARGET, V4, P2171; Di Stasi A, 2009, BLOOD, V113, P6392, DOI 10.1182/blood-2009-03-209650; Takegawa S, 2008, CANCER SCI, V99, P296, DOI 10.1111/j.1349-7006.2007.00687.x; Ishii T, 2010, CLIN CANCER RES, V16, P1520, DOI 10.1158/1078-0432.CCR-09-2697; Yagita M, 2000, LEUKEMIA, V14, P922, DOI 10.1038/sj.leu.2401769; RAVID Z, 1980, INT J CANCER, V25, P705, DOI 10.1002/ijc.2910250604; Ishida T, 2006, CANCER SCI, V97, P1139, DOI 10.1111/j.1349-7006.200.00307; Wang JM, 1998, J IMMUNOL METHODS, V220, P1, DOI 10.1016/S0022-1759(98)00128-8; Nakayama T, 2004, J VIROL, V78, P1665, DOI 10.1128/JVI.78.4.1665-1674.2004; Niens M, 2008, BRIT J HAEMATOL, V140, P527, DOI 10.1111/j.1365-2141.2007.06964.x; Takahara M, 2006, INT J CANCER, V119, P2775, DOI 10.1002/ijc.22139; Middeldorp JM, 2008, SEMIN CANCER BIOL, V18, P388, DOI 10.1016/j.semcancer.2008.10.004; Imai T, 1997, J BIOL CHEM, V272, P15036, DOI 10.1074/jbc.272.23.15036; Alvaro T, 2005, CLIN CANCER RES, V11, P1467, DOI 10.1158/1078-0432.CCR-04-1869; Ito A, 2009, J IMMUNOL, V183, P4782, DOI 10.4049/jimmunol.0900699; Yoshie O, 2002, BLOOD, V99, P1505, DOI 10.1182/blood.V99.5.1505; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; HARABUCHI Y, 1990, LANCET, V335, P128, DOI 10.1016/0140-6736(90)90002-M; Yamamoto K, 2010, J CLIN ONCOL, V28, P1591, DOI 10.1200/JCO.2009.25.3575; DREXLER HG, 1986, LEUKEMIA RES, V10, P487, DOI 10.1016/0145-2126(86)90084-6; Harabuchi Y, 2009, INT J CLIN ONCOL, V14, P181, DOI 10.1007/s10147-009-0882-7; Harris N L, 2000, Hematol J, V1, P53, DOI 10.1038/sj.thj.6200013; Hashimoto S, 2006, J DERMATOL SCI, V44, P93, DOI 10.1016/j.jdermsci.2006.08.004; Ishida T, 2006, LEUKEMIA, V20, P2162, DOI 10.1038/sj.leu.2404415; Ishii H, 2012, INT J CANCER, V130, P48, DOI 10.1002/ijc.25969; Kanazawa T, 2014, CLIN CANCER RES, V20, P5075, DOI 10.1158/1078-0432.CCR-14-0580; Komabayashi Y, 2014, AM J HEMATOL, V89, P25, DOI 10.1002/ajh.23570; Laurence ADJ, 2006, BRIT J HAEMATOL, V132, P255, DOI 10.1111/j.1365-2141.2005.05841.x; Maggio E, 2002, ANN ONCOL, V13, P52, DOI 10.1093/annonc/mdf610; MINOWADA J, 1972, J NATL CANCER I, V49, P891; Moriai S, 2009, CLIN CANCER RES, V15, P6771, DOI 10.1158/1078-0432.CCR-09-1052; Nagata H, 2001, BLOOD, V97, P708, DOI 10.1182/blood.V97.3.708; Nagata H, 2001, PATHOL INT, V51, P778, DOI 10.1046/j.1440-1827.2001.01276.x; Nagato T, 2005, CLIN CANCER RES, V11, P8250, DOI 10.1158/1078-0432.CCR-05-1426; Nieto JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031297; Takahara M, 2013, EXP HEMATOL, V41, P711, DOI 10.1016/j.exphem.2013.03.009; YODOI J, 1985, J IMMUNOL, V134, P1623	45	1	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-7004	1432-0851		CANCER IMMUNOL IMMUN	Cancer Immunol. Immunother.	JUN	2015	64	6					697	705		10.1007/s00262-015-1675-7		9	Oncology; Immunology	Oncology; Immunology	CJ8TD	WOS:000355775500005		
J	Hashimoto, N; Tsuboi, A; Kagawa, N; Chiba, Y; Izumoto, S; Kinoshita, M; Kijima, N; Oka, Y; Morimoto, S; Nakajima, H; Morita, S; Sakamoto, J; Nishida, S; Hosen, N; Oji, Y; Arita, N; Yoshimine, T; Sugiyama, H				Hashimoto, Naoya; Tsuboi, Akihiro; Kagawa, Naoki; Chiba, Yasuyoshi; Izumoto, Shuichi; Kinoshita, Manabu; Kijima, Noriyuki; Oka, Yoshihiro; Morimoto, Soyoko; Nakajima, Hiroko; Morita, Satoshi; Sakamoto, Junichi; Nishida, Sumiyuki; Hosen, Naoki; Oji, Yusuke; Arita, Norio; Yoshimine, Toshiki; Sugiyama, Haruo			Wilms tumor 1 peptide vaccination combined with temozolomide against newly diagnosed glioblastoma: safety and impact on immunological response	CANCER IMMUNOLOGY IMMUNOTHERAPY			English	Article						WT1 peptide vaccination; Temozolomide; Newly diagnosed glioblastoma; Safe combination; Immunological response	PHASE-II TRIAL; DENDRITIC CELL VACCINATION; RECURRENT MALIGNANT GLIOMA; CYTOTOXIC T-LYMPHOCYTES; LOW-DOSE TEMOZOLOMIDE; ADJUVANT TEMOZOLOMIDE; GENE WT1; ANTITUMOR IMMUNITY; CANCER REGRESSION; CLINICAL-TRIAL	To investigate the safety of combined Wilms tumor 1 peptide vaccination and temozolomide treatment of glioblastoma, a phase I clinical trial was designed. Seven patients with histological diagnosis of glioblastoma underwent concurrent radiotherapy and temozolomide therapy. Patients first received Wilms tumor 1 peptide vaccination 1 week after the end of combined concurrent radio/temozolomide therapy, and administration was continued once per week for 7 weeks. Temozolomide maintenance was started and performed for up to 24 cycles, and the observation period for safety encompassed 6 weeks from the first administration of maintenance temozolomide. All patients showed good tolerability during the observation period. Skin disorders, such as grade 1/2 injection-site reactions, were observed in all seven patients. Although grade 3 lymphocytopenia potentially due to concurrent radio/temozolomide therapy was observed in five patients (71.4 %), no other grade 3/4 hematological or neurological toxicities were observed. No autoimmune reactions were observed. All patients are still alive, and six are on Wilms tumor 1 peptide vaccination without progression, yielding a progression-free survival from histological diagnosis of 5.2-49.1 months. Wilms tumor 1 peptide vaccination was stopped in one patient after 12 injections by the patient's request. The safety profile of the combined Wilms tumor 1 peptide vaccination and temozolomide therapy approach for treating glioblastoma was confirmed.	[Hashimoto, Naoya; Kagawa, Naoki; Chiba, Yasuyoshi; Kinoshita, Manabu; Kijima, Noriyuki; Yoshimine, Toshiki] Osaka Univ, Dept Neurosurg, Grad Sch Med, Suita, Osaka 5650871, Japan; [Tsuboi, Akihiro] Osaka Univ, Dept Canc Immunotherapy, Grad Sch Med, Suita, Osaka 5650871, Japan; [Oka, Yoshihiro; Morimoto, Soyoko; Nakajima, Hiroko] Osaka Univ, Dept Canc Immunol, Grad Sch Med, Suita, Osaka 5650871, Japan; [Oka, Yoshihiro; Nishida, Sumiyuki] Osaka Univ, Dept Resp Med Allergy & Rheumat Dis, Grad Sch Med, Suita, Osaka 5650871, Japan; [Sugiyama, Haruo] Osaka Univ, Dept Funct Diagnost Sci, Grad Sch Med, Suita, Osaka 5650871, Japan; [Hosen, Naoki; Oji, Yusuke] Osaka Univ, Dept Canc Stem Cell Biol, Grad Sch Med, Suita, Osaka 5650871, Japan; [Oka, Yoshihiro] Osaka Univ, Dept Immunopathol, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Izumoto, Shuichi; Arita, Norio] Hyogo Coll Med, Dept Neurosurg, Nishinomiya, Hyogo 6638501, Japan; [Morita, Satoshi] Kyoto Univ, Dept Biomed Stat & Bioinformat, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan; [Sakamoto, Junichi] Tokai Cent Hosp, Gifu 5048601, Japan	Hashimoto, N (reprint author), Osaka Univ, Dept Neurosurg, Grad Sch Med, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	hashimotonaoya@me.com			Ministry of Education, Culture, Sports, Science, and Technology, Japan [23592123, 22591609]	The authors would like to thank Ms. Tomoe Umeda, Department of Cancer Immunotherapy, for her technical assistance. They would also thank Ms. Mariko Kakinoki and Ms. Yuko Komiyama, Department of Neurosurgery, for their secretarial assistance. This work was supported in part by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (No. 23592123 to Naoya Hashimoto and No. 22591609 to Akihiro Tsuboi).	Abacioglu U, 2011, J NEURO-ONCOL, V103, P585, DOI 10.1007/s11060-010-0423-2; Brandes AA, 2006, BRIT J CANCER, V95, P1155, DOI 10.1038/sj.bjc.6603376; Stupp R, 2002, J CLIN ONCOL, V20, P1375, DOI 10.1200/JCO.20.5.1375; Perry JR, 2010, J CLIN ONCOL, V28, P2051, DOI 10.1200/JCO.2009.26.5520; Kong DS, 2010, NEURO-ONCOLOGY, V12, P289, DOI 10.1093/neuonc/nop030; Gorlia T, 2008, LANCET ONCOL, V9, P29, DOI 10.1016/S1470-2045(07)70384-4; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Sampson JH, 2010, J CLIN ONCOL, V28, P4722, DOI 10.1200/JCO.2010.28.6963; Chiba Y, 2010, JPN J CLIN ONCOL, V40, P395, DOI 10.1093/jjco/hyp196; Oji Y, 2004, CANCER SCI, V95, P822, DOI 10.1111/j.1349-7006.2004.tb02188.x; Sampson JH, 2011, NEURO-ONCOLOGY, V13, P324, DOI 10.1093/neuonc/noq157; Yamanaka R, 2005, CLIN CANCER RES, V11, P4160, DOI 10.1158/1078-0432.CCR-05-0120; Li J, 2011, INT J RADIAT ONCOL, V81, P623, DOI 10.1016/j.ijrobp.2010.06.012; Tsuboi A, 2002, CANCER IMMUNOL IMMUN, V51, P614, DOI 10.1007/s00262-002-0328-9; Kim CH, 2007, IMMUNOLOGY, V122, P615, DOI 10.1111/j.1365-2567.2007.02680.x; Wick A, 2007, J CLIN ONCOL, V25, P3357, DOI 10.1200/JCO.2007.10.7722; Oka Y, 2004, P NATL ACAD SCI USA, V101, P13885, DOI 10.1073/pnas.0405884101; Tsuboi A, 1999, LEUKEMIA RES, V23, P499, DOI 10.1016/S0145-2126(99)00037-5; Yu JS, 2004, CANCER RES, V64, P4973, DOI 10.1158/0008-5472.CAN-03-3505; NORTH RJ, 1982, J EXP MED, V155, P1063, DOI 10.1084/jem.155.4.1063; Banissi C, 2009, CANCER IMMUNOL IMMUN, V58, P1627, DOI 10.1007/s00262-009-0671-1; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Izumoto S, 2008, J NEUROSURG, V108, P963, DOI 10.3171/JNS/2008/108/5/0963; Su YB, 2004, J CLIN ONCOL, V22, P610, DOI 10.1200/JCO.2004.07.060; Heimberger AB, 2008, NEURO-ONCOLOGY, V10, P98, DOI 10.1215/15228517-2007-046; Omuro A, 2013, NEURO-ONCOLOGY, V15, P242, DOI 10.1093/neuonc/nos295; Khan RB, 2002, NEURO-ONCOLOGY, V4, P39, DOI 10.1215/15228517-4-1-39; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Capper D, 2009, ACTA NEUROPATHOL, V118, P599, DOI 10.1007/s00401-009-0595-z; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Fadul CE, 2011, NEURO-ONCOLOGY, V13, P393, DOI 10.1093/neuonc/noq204; Appay V, 2007, J IMMUNOTHER, V30, P240, DOI 10.1097/01.cji.0000211332.68643.98; Fujimoto Y, 2012, INT J CLIN ONCOL, V17, P290, DOI 10.1007/s10147-011-0294-3; Jordan JT, 2008, CANCER IMMUNOL IMMUN, V57, P123, DOI 10.1007/s00262-007-0336-x; Momota S, 2013, NEURO-ONCOLOGY, V15, P1445; Oka Y, 2000, J IMMUNOL, V164, P1873; Park SD, 2007, VACCINE, V25, P3485, DOI 10.1016/j.vaccine.2006.12.060; Sanchez-Perez LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059082; Terasaki M, 2010, J CLIN ONCOL, V29, P337	40	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-7004	1432-0851		CANCER IMMUNOL IMMUN	Cancer Immunol. Immunother.	JUN	2015	64	6					707	716		10.1007/s00262-015-1674-8		10	Oncology; Immunology	Oncology; Immunology	CJ8TD	WOS:000355775500006		
J	Chen, NN; Nishio, N; Ito, S; Tanaka, Y; Sun, Y; Isobe, K				Chen, Nana; Nishio, Naomi; Ito, Sachiko; Tanaka, Yuriko; Sun, Yang; Isobe, Ken-ichi			Growth arrest and DNA damage-inducible protein (GADD34) enhanced liver inflammation and tumorigenesis in a diethylnitrosamine (DEN)-treated murine model	CANCER IMMUNOLOGY IMMUNOTHERAPY			English	Article						DEN; GADD34; Inflammation; Hepatocellular carcinoma	CANCER-RELATED INFLAMMATION; NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA; MACROPHAGE BIOLOGY; APOPTOSIS; CELLS; CARCINOGENESIS; STRESS; INJURY; DEATH	Growth arrest and DNA damage-inducible protein (GADD34/Ppp1r15a) is induced by various stimuli including DNA damage and ER stress. DNA damage and oncogene activation, accompanied by tumor-specific DNA repair defects and a failure to stall the cell cycle, are early markers of hepatocellular carcinoma (HCC). However, whether GADD34 accounts for regulating HCC tumorigenesis remains elusive. Here, we demonstrated that GADD34 expression was upregulated in the liver of mice after exposure to a carcinogen, diethylnitrosamine (DEN). In both acute and chronic DEN treatment models, GADD34 deficiency not only decreased oncogene expression, but also reduced hepatic damage. Moreover, loss of GADD34 attenuated immune cell infiltration, pro-inflammatory cytokine expression and hepatic compensatory proliferation. Finally, GADD34-deficient mice showed impaired hepatocarcinogenesis. Thus, the process of DEN-induced HCC proceeded as follows. First, DEN treatment induced DNA damage in hepatocytes, resulting in elevated expression of GADD34 in the liver. The increased expression of GADD34 augmented hepatic necrosis followed by elevated expression of interleukin (IL)-1 beta and monocyte chemoattractant protein 1. This process promoted immune cell infiltration and Kupffer cell/macrophage activation followed by production of reactive oxygen species and pro-tumorigenic cytokines such as IL-6 and tumor necrosis factor-alpha. The pro-tumorigenic cytokines stimulated compensatory proliferation of surviving and mutant hepatocytes. Together with oncogene c-Myc expression, these processes led to HCC. Our results suggest therapeutic opportunities for HCC by targeting GADD34-related pathways.	[Chen, Nana; Nishio, Naomi; Ito, Sachiko; Tanaka, Yuriko; Sun, Yang; Isobe, Ken-ichi] Nagoya Univ, Dept Immunol, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan	Isobe, K (reprint author), Nagoya Univ, Dept Immunol, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	kisobe@med.nagoya-u.ac.jp			Ministry of Education, Science, Technology, Sports and Culture, Japan; China Scholarship Council, China [201408050020]	We thank Mr. Tanaka for technical assistance with flow cytometry experiments and Mrs. Mizuguchi for confocal microscopic analysis (Laboratory of Division for Medical Research Engineering, Nagoya University Graduate School of Medicine) as well as N. Oiwa for administrative assistance. This research was supported by the Ministry of Education, Science, Technology, Sports and Culture, Japan, and China Scholarship Council, China (Project Number: 201408050020).	Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Min LH, 2012, NAT CELL BIOL, V14, P1203, DOI 10.1038/ncb2590; Wogan GN, 2004, SEMIN CANCER BIOL, V14, P473, DOI 10.1016/j.semcancer.2004.06.010; Kuraishy A, 2011, IMMUNITY, V35, P467, DOI 10.1016/j.immuni.2011.09.006; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022; Ramachandran IR, 2013, J IMMUNOL, V190, P3815, DOI 10.4049/jimmunol.1203373; Fan Y, 2008, TRENDS CELL BIOL, V18, P467, DOI 10.1016/j.tcb.2008.08.001; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Yagi A, 2003, J CELL BIOCHEM, V90, P1242, DOI 10.1002/jcb.10711; Schetter AJ, 2010, CARCINOGENESIS, V31, P37, DOI 10.1093/carcin/bgp272; Bonecchi R, 2011, CANCER CELL, V19, P434, DOI 10.1016/j.ccr.2011.03.017; Pello OM, 2012, BLOOD, V119, P411, DOI 10.1182/blood-2011-02-339911; FORNACE AJ, 1988, P NATL ACAD SCI USA, V85, P8800, DOI 10.1073/pnas.85.23.8800; Galdiero MR, 2013, J CELL PHYSIOL, V228, P1404, DOI 10.1002/jcp.24260; Adler HT, 1999, MOL CELL BIOL, V19, P7050; Balkwill FR, 2012, SEMIN CANCER BIOL, V22, P33, DOI 10.1016/j.semcancer.2011.12.005; Rose ML, 1999, CARCINOGENESIS, V20, P27, DOI 10.1093/carcin/20.1.27; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Center MM, 2011, CANCER EPIDEM BIOMAR, V20, P2362, DOI 10.1158/1055-9965.EPI-11-0643; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Hollander MC, 2003, ONCOGENE, V22, P3827, DOI 10.1038/sj.onc.1206567; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Hollander MC, 1997, J BIOL CHEM, V272, P13731, DOI 10.1074/jbc.272.21.13731; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Nakagawa H, 2012, WORLD J GASTROENTERO, V18, P4071, DOI 10.3748/wjg.v18.i31.4071; Poirier MC, 2004, NAT REV CANCER, V4, P630, DOI 10.1038/nrc1410; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Kojima E, 2003, FASEB J, V17, P1573, DOI 10.1096/fj.02-1184fje; Farook JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.280; Kumar M, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-5; Lanaya H, 2014, NAT CELL BIOL, V16, P972, DOI 10.1038/ncb3031; Leong Trishe Y-M, 2005, HPB (Oxford), V7, P5, DOI 10.1080/13651820410024021; Nishio N, 2014, IMMUNOL CELL BIOL, V92, P170, DOI 10.1038/icb.2013.78; Ryoo HD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008797; Scaiewicz V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081065	44	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-7004	1432-0851		CANCER IMMUNOL IMMUN	Cancer Immunol. Immunother.	JUN	2015	64	6					777	789		10.1007/s00262-015-1690-8		13	Oncology; Immunology	Oncology; Immunology	CJ8TD	WOS:000355775500014		
J	Ishida-Yamamoto, A; Igawa, S				Ishida-Yamamoto, Akemi; Igawa, Satomi			The biology and regulation of corneodesmosomes	CELL AND TISSUE RESEARCH			English	Review						Corneodesmosin; Corneodesmosome; Desquamation; Kallikrein-related peptidases; Lympho-epithelial Kazal-type inhibitor (LEKTI)	KALLIKREIN-RELATED-PEPTIDASES; SERINE-PROTEASE INHIBITOR; HUMAN STRATUM-CORNEUM; EPIDERMAL DESQUAMATION; LAMELLAR GRANULES; CYSTATIN-M/E; HUMAN SKIN; DEGRADATION; ACTIVATION; DESMOSOMES	The stratum corneum of the epidermis is composed of stacked dead corneocytes embedded in lipid layers and is the main protective shield of the skin. The thickness of the stratum corneum is maintained fairly constantly through the balance between new cell creation and old cell removal. Corneodesmosomes are the main intercellular adhesive structures in the stratum corneum. They are transformed from desmosomes at the most superficial layer of the stratum granulosum of the epidermis. The major compositional distinction from desmosomes is the presence of corneodesmosin in the extracellular portion. Furthermore, corneodesmosomes are structurally different from desmosomes in that (1) they do not have a tri-lamellar desmoglea but rather one that is homogeneously electron-dense and (2) attachment plaques are integrated into a part of the cornified cell envelopes. When the extracellular regions of corneodesmosomes are fully degraded, desquamation occurs. The degradation process of corneodesmosomes is carefully controlled by a number of proteases and their inhibitors. The most important proteases involved in this process are the kallikrein-related peptidases. Their main inhibitor is the lympho-epithelial Kazal-type related inhibitor. Other regulators of this process include matriptase, meprin and mesotrypsin.	[Ishida-Yamamoto, Akemi] Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido, Japan; [Igawa, Satomi] Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan	Ishida-Yamamoto, A (reprint author), Asahikawa Med Univ, Dept Dermatol, Midorigaoka Higashi 2-1-1-1, Asahikawa, Hokkaido, Japan.	akemi@asahikawa-med.ac.jp					Ishida-Yamamoto A, 2005, J INVEST DERMATOL, V124, P360, DOI 10.1111/j.0022-202X.2004.23583.x; Beaufort N, 2010, BIOL CHEM, V391, P581, DOI 10.1515/BC.2010.055; Sotiropoulou G, 2009, J BIOL CHEM, V284, P32989, DOI 10.1074/jbc.R109.027946; Sales KU, 2010, NAT GENET, V42, P676, DOI 10.1038/ng.629; Haftek M, 2011, EXP DERMATOL, V20, P617, DOI 10.1111/j.1600-0625.2011.01315.x; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Kantyka T, 2011, PEPTIDES, V32, P1187, DOI 10.1016/j.peptides.2011.03.009; Naoe Y, 2010, J DERMATOL SCI, V57, P192, DOI 10.1016/j.jdermsci.2009.12.014; Rawlings AV, 2013, CELL TISSUE RES, V351, P217, DOI 10.1007/s00441-012-1501-x; Borgono CA, 2007, J BIOL CHEM, V282, P3640, DOI 10.1074/jbc.M607567200; Zeeuwen PLJM, 2009, J INVEST DERMATOL, V129, P1327, DOI 10.1038/jid.2009.40; Franzke CW, 1996, J BIOL CHEM, V271, P21886; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj/onc/1205502; Igawa S, 2011, EXP DERMATOL, V20, P53, DOI 10.1111/j.1600-0625.2010.01170.x; Nakane H, 2002, J INVEST DERMATOL, V119, P50, DOI 10.1046/j.1523-1747.2002.01803.x; Deraison C, 2007, MOL BIOL CELL, V18, P3607, DOI 10.1091/mbc.E07-02-0124; Ishida-Yamamoto A, 2014, J DERMATOL SCI, V74, P99, DOI 10.1016/j.jdermsci.2014.02.005; CHAPMAN SJ, 1990, ARCH DERMATOL RES, V282, P304, DOI 10.1007/BF00375724; Bernard D, 2003, J INVEST DERMATOL, V120, P592, DOI 10.1046/j.1523-1747.2003.12086.x; Brattsand M, 2009, J INVEST DERMATOL, V129, P1656, DOI 10.1038/jid.2008.448; Debela M, 2007, J MOL BIOL, V373, P1017, DOI 10.1016/j.jmb.2007.08.042; Debela M, 2007, P NATL ACAD SCI USA, V104, P16086, DOI 10.1073/pnas.0707811104; Elias PM, 2004, J INVEST DERMATOL, V122, P314, DOI 10.1046/j.1523-1747.2003.22258.x; Fischer J, 2013, J INVEST DERMATOL, V133, P1170, DOI 10.1038/jid.2012.482; Galliano MF, 2006, J BIOL CHEM, V281, P5780, DOI 10.1074/jbc.M508017200; Heiker JT, 2013, CELL MOL LIFE SCI, V70, P2569, DOI 10.1007/s00018-013-1258-8; Horikoshi I, 1999, BRIT J DERMATOL, V141, P453; Igarashi S, 2004, BRIT J DERMATOL, V151, P355, DOI 10.1111/j.1365-2133.2004.06061.x; IshidaYamamoto A, 1996, J HISTOCHEM CYTOCHEM, V44, P167; Ishida-Yamamoto A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031641; Ishida-Yamamoto A, 2011, J DERMATOL, V38, P645, DOI 10.1111/j.1346-8138.2011.01227.x; Jonca N, 2011, EUR J DERMATOL, V21, P35, DOI 10.1684/ejd.2011.1264; Meyer-Hoffert U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004372; Meyer-Hoffert U, 2010, J BIOL CHEM, V285, P32174, DOI 10.1074/jbc.M109.091850; Miyai M, 2014, J INVEST DERMATOL, V134, P1665, DOI 10.1038/jid.2014.3; Ohler A, 2010, BIOL CHEM, V391, P455, DOI 10.1515/BC.2010.023; RAKNERUD N, 1975, J ULTRA MOL STRUCT R, V52, P32, DOI 10.1016/S0022-5320(75)80020-7; Scott FL, 2007, J BIOCHEM, V142, P435, DOI 10.1093/jb/mvm156; Ya-Xian Zhen, 1999, Archives of Dermatological Research, V291, P555, DOI 10.1007/s004030050453; Zeeuwen PLJM, 2007, J INVEST DERMATOL, V127, P120, DOI 10.1038/sj.jid.5700480	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	JUN	2015	360	3					477	482		10.1007/s00441-014-2037-z		6	Cell Biology	Cell Biology	CJ5XW	WOS:000355568200004		
J	Yamada, S				Yamada, Shuhei			CATABOLISM OF CHONDROITIN SULFATE	CELLULAR & MOLECULAR BIOLOGY LETTERS			English	Review						Chondroitin sulfate; Hyaluronan; Glycosaminoglycan; Catabolism; Hydrolase; Hyaluronidase; Proteoglycan; Mucopolysaccharidosis	HYALURONIC-ACID; CAENORHABDITIS-ELEGANS; SUBSTRATE-SPECIFICITY; BETA-HEXOSAMINIDASE; CELL-DIVISION; GLYCOSAMINOGLYCANS; IDENTIFICATION; PROTEOGLYCANS; EXPRESSION; HYDROLASE	Chondroitin sulfate (CS) is a ubiquitous component of the cell surface and extracellular matrix of animal tissues. CS chains are covalently bound to a core protein to form a proteoglycan, which is involved in various biological events including cell proliferation, migration, and invasion. Their functions are executed by regulating the activity of bioactive proteins, such as growth factors, morphogens, and cytokines. This review article focuses on the catabolism of CS. This catabolism predominantly occurs in lysosomes to control the activity of CS-proteoglycans. CS chains are fragmented by endo-type glycosidase(s), and the resulting oligosaccharides are then cleaved into monosaccharide moieties from the nonreducing end by exoglycosidases and sulfatases. However, the endo-type glycosidase responsible for the systemic catabolism of CS has not yet been identified. Based on recent advances in studies on hyaluronidases, which were previously considered to be hyaluronan-degrading enzymes, it appears that they recognize CS as their original substrate rather than hyaluronan and acquired hyaluronan-hydrolyzing activity at a relatively late stage of evolution.	Meijo Univ, Fac Pharm, Dept Pathobiochem, Tempaku Ku, Nagoya, Aichi 4688503, Japan	Yamada, S (reprint author), Meijo Univ, Fac Pharm, Dept Pathobiochem, Tempaku Ku, 150 Yagotoyama, Nagoya, Aichi 4688503, Japan.	shuheiy@meijo-u.ac.jp					Mikami T, 2009, J BIOL CHEM, V284, P4494, DOI 10.1074/jbc.M809227200; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Harris EN, 2007, J BIOL CHEM, V282, P2785, DOI 10.1074/jbc.M607787200; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; Li ZQ, 2008, J MOL BIOL, V383, P78, DOI 10.1016/j.jmb.2008.07.038; Volpi N, 2003, BIOCHIMIE, V85, P619, DOI 10.1016/S0300-9084(03)00083-X; Miyata S, 2012, NAT NEUROSCI, V15, P414, DOI 10.1038/nn.3023; Raspanti M, 2008, J STRUCT BIOL, V164, P134, DOI 10.1016/j.jsb.2008.07.001; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Jedrzejas MJ, 2005, PROTEINS, V61, P227, DOI 10.1002/prot.20592; Fisher D, 2011, J NEUROSCI, V31, P14051, DOI 10.1523/JNEUROSCI.1737-11.2011; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Stern R, 2008, SEMIN CANCER BIOL, V18, P275, DOI 10.1016/j.semcancer.2008.03.017; Kaneiwa T, 2012, J BIOL CHEM, V287, P42119, DOI 10.1074/jbc.M112.360693; Kaneiwa T, 2010, GLYCOBIOLOGY, V20, P300, DOI 10.1093/glycob/cwp174; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; Sugahara KN, 2008, CANCER RES, V68, P7191, DOI 10.1158/0008-5472.CAN-07-6198; Zhang L, 2009, J BIOL CHEM, V284, P9433, DOI 10.1074/jbc.M900210200; Baba D, 2002, J BIOL CHEM, V277, P30310, DOI 10.1074/jbc.M204596200; Mikami T, 2012, J BIOL CHEM, V287, P38531, DOI 10.1074/jbc.M111.336925; Cherr GN, 2001, MATRIX BIOL, V20, P515, DOI 10.1016/S0945-053X(01)00171-8; Csoka AB, 2013, GLYCOBIOLOGY, V23, P398, DOI 10.1093/glycob/cws218; Prabhakar V, 2006, ADV PHARMACOL, V53, P69, DOI 10.1016/S1054-3589(06)53005-9; Kaneiwa T, 2008, J BIOL CHEM, V283, P14971, DOI 10.1074/jbc.M709236200; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Asada M, 2009, BBA-GEN SUBJECTS, V1790, P40, DOI 10.1016/j.bbagen.2008.09.001; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; Izumikawa T, 2010, J BIOL CHEM, V285, P12190, DOI 10.1074/jbc.M110.100941; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Atmuri V, 2008, MATRIX BIOL, V27, P653, DOI 10.1016/j.matbio.2008.07.006; SUGAHARA K, 1994, CARBOHYD RES, V255, P165, DOI 10.1016/S0008-6215(00)90977-7; Csoka AB, 1999, GENOMICS, V60, P356, DOI 10.1006/geno.1999.5876; Gushulak L, 2012, J BIOL CHEM, V287, P16689, DOI 10.1074/jbc.M112.350447; Lokeshwar VB, 2001, J BIOL CHEM, V276, P11922, DOI 10.1074/jbc.M008432200; Yoshida H, 2013, P NATL ACAD SCI USA, V110, P5612, DOI 10.1073/pnas.1215432110; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267; Singh K, 2008, NAT STRUCT MOL BIOL, V15, P932, DOI 10.1038/nsmb.1479; Chao KL, 2007, BIOCHEMISTRY-US, V46, P6911, DOI 10.1021/bi700382g; Chow G, 2006, OSTEOARTHR CARTILAGE, V14, P1312, DOI 10.1016/j.joca.2006.08.005; DeAngelis PL, 2002, ANAT REC, V268, P317, DOI 10.1002/ar.10163; Fransson L.-A., 1985, POLYSACCHARIDES, V3, P337; Hamad OA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012889; Hashiguchi T, 2011, BBA-GEN SUBJECTS, V1810, P406, DOI 10.1016/j.bbagen.2011.01.001; Hashiguchi T, 2010, GLYCOCONJUGATE J, V27, P49, DOI 10.1007/s10719-009-9253-x; Honda Tomoko, 2012, Biomolecules, V2, P549, DOI 10.3390/biom2040549; Keyhani NO, 1996, J BIOL CHEM, V271, P33425; Neufeld EF, 2001, METABOLIC MOL BASES, VIII, P3421; Pennybacker M, 1996, J BIOL CHEM, V271, P17377; Shetty AK, 2009, CARBOHYD RES, V344, P1526, DOI 10.1016/j.carres.2009.02.029; Troeberg L, 2014, CHEM BIOL, V21, P1300, DOI 10.1016/j.chembiol.2014.07.014; Yamada Shuhei, 2008, Curr Drug Discov Technol, V5, P289, DOI 10.2174/157016308786733564; Yamada Shuhei, 2011, Commun Integr Biol, V4, P150, DOI 10.4161/cib.4.2.14547; Yamada S, 2009, GLYCOBIOLOGY, V19, P488, DOI 10.1093/glycob/cwp005; Zhang FM, 2012, BIOCHIMIE, V94, P242, DOI 10.1016/j.biochi.2011.10.015	56	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1425-8153	1689-1392		CELL MOL BIOL LETT	Cell. Mol. Biol. Lett.	JUN	2015	20	2					196	212		10.1515/cmble-2015-0011		17	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CJ6DE	WOS:000355582800002		
J	Sun, J; Xu, HY; Liu, GG; Zhu, PF; Fan, RG; Yoneyama, Y; Tsubaki, N				Sun, Jian; Xu, Hengyong; Liu, Guoguo; Zhu, Pengfei; Fan, Ronggang; Yoneyama, Yoshiharu; Tsubaki, Noritatsu			Green Synthesis of Rice Bran Microsphere Catalysts Containing Natural Biopromoters	CHEMCATCHEM			English	Article						biomass; carbon; hydrocarbons; iron; rice	FISCHER-TROPSCH SYNTHESIS; IRON-BASED CATALYSTS; AQUEOUS-SOLUTIONS; CONFINEMENT; SORPTION; SPHERES; IONS	The application of rice-bran catalysts containing biopromoters, from rice bran, in the production of synthetic oil was investigated. Trace minerals such as K, Mg, and Mn from rice bran were successfully incorporated into Fe@C microspherical cores and played a cooperative promotional role on the iron species. The yield of the hydrocarbons was strikingly higher than that obtained with the unpromoted catalyst. Further, rice bran is a natural carbon source, not a chemical carbon source, that can be used to fabricate the carbon microsphere support. This concept opens a new avenue for recycling and boosts the value of abundant waste biomass in nature.	[Sun, Jian; Liu, Guoguo; Zhu, Pengfei; Yoneyama, Yoshiharu; Tsubaki, Noritatsu] Toyama Univ, Sch Engn, Dept Appl Chem, Toyama 930, Japan; [Sun, Jian; Xu, Hengyong] Chinese Acad Sci, Dalian Inst Chem Phys, Dalian Natl Lab Clean Energy DNL, Dalian 116023, Peoples R China; [Fan, Ronggang] Shinka Co Ltd, Toyama, Japan	Tsubaki, N (reprint author), Toyama Univ, Sch Engn, Dept Appl Chem, Gofuku 3190, Toyama 930, Japan.	tsubaki@eng.u-toyama.ac.jp					Lakkakula NR, 2004, BIORESOURCE TECHNOL, V92, P157, DOI 10.1016/j.biortech.2003.08.010; Davis BH, 2003, CATAL TODAY, V84, P83, DOI 10.1016/S0920-5861(03)00304-3; Yang Y, 2004, APPL CATAL A-GEN, V266, P181, DOI 10.1016/j.apcata.2004.02.018; Chen W, 2008, J AM CHEM SOC, V130, P9414, DOI 10.1021/ja8008192; Werner S, 2014, CHEMCATCHEM, V6, P2881, DOI 10.1002/cctc.201402260; Oliveira EA, 2005, PROCESS BIOCHEM, V40, P3485, DOI 10.1016/j.procbio.2005.02.026; Pendyala VRR, 2014, CHEMCATCHEM, V6, P1952, DOI 10.1002/cctc.201402073; Titirici MM, 2006, CHEM MATER, V18, P3808, DOI 10.1021/cm052768u; Sun GX, 2008, ENVIRON SCI TECHNOL, V42, P7542, DOI 10.1021/es801238p; Yu GB, 2010, J AM CHEM SOC, V132, P935, DOI 10.1021/ja906370b; Yamashita T, 2008, APPL SURF SCI, V254, P2441, DOI 10.1016/j.apsusc.2007.09.063; Bonnet F, 2002, SURF INTERFACE ANAL, V34, P418, DOI 10.1002/sia.1330; Montanher SF, 2005, J HAZARD MATER, V117, P207, DOI 10.1016/j.jhazmat.2004.09.015; Bae JW, 2009, CATAL COMMUN, V10, P1358, DOI 10.1016/j.catcom.2009.02.023; Toda M, 2005, NATURE, V438, P178, DOI 10.1038/438178a; Li SZ, 2002, J CATAL, V206, P202, DOI 10.1006/jcat.2001.3506; Butt J. B., 1990, CATAL LETT, V7, P61; Sun J, 2013, J MATER CHEM A, V1, P5670, DOI 10.1039/c3ta10627f	18	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1867-3880	1867-3899		CHEMCATCHEM	ChemCatChem	JUN 1	2015	7	11					1642	1645		10.1002/cctc.201500375		4	Chemistry, Physical	Chemistry	CJ8EV	WOS:000355733800004		
J	Hayashi, Y; Watanabe, S; Yasui, Y; Umemiya, S				Hayashi, Yujiro; Watanabe, Shoya; Yasui, Yusuke; Umemiya, Shigenobu			Asymmetric Aldol Reaction of Chloral Catalyzed by Diarylprolinol	CHEMCATCHEM			English	Article						aldehydes; aldol reaction; asymmetric synthesis; chloral; organocatalysis	ALPHA-AMINO-ACIDS; ENANTIOSELECTIVE SYNTHESIS; CARBOXYLIC-ACIDS; ALDEHYDES; ACETALDEHYDE; ORGANOCATALYSTS; ETHERS	The asymmetric cross-aldol reaction of chloral hydrate with aldehyde pronucleophiles catalyzed by a trifluoromethyl-substituted diarylprolinol was accomplished to afford -trichloro--hydroxy aldehydes in good yields with excellent enantioselectivities. The resulting aldehyde products were converted into chiral -azido, -(4-methyl)phenoxy, and -fluoro esters without a loss in the diastereo- or enantioselectivities.	[Hayashi, Yujiro; Watanabe, Shoya; Yasui, Yusuke; Umemiya, Shigenobu] Tohoku Univ, Grad Sch Sci, Dept Chem, Aoba Ku, Sendai, Miyagi 9808578, Japan	Hayashi, Y (reprint author), Tohoku Univ, Grad Sch Sci, Dept Chem, Aoba Ku, 6-3 Aramaki Aza Aoba, Sendai, Miyagi 9808578, Japan.	yhayashi@m.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Advanced Molecular Transformations by Organocatalysts" from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Mielgo A, 2008, CHEM-ASIAN J, V3, P922, DOI 10.1002/asia.200700417; COREY EJ, 1992, TETRAHEDRON LETT, V33, P3431, DOI 10.1016/S0040-4039(00)92655-8; COREY EJ, 1992, J AM CHEM SOC, V114, P1906, DOI 10.1021/ja00031a069; Jensen KL, 2012, ACCOUNTS CHEM RES, V45, P248, DOI 10.1021/ar200149w; Tennyson RL, 2002, ORG LETT, V4, P533, DOI 10.1021/ol017120b; Hayashi Y, 2005, ANGEW CHEM INT EDIT, V44, P4212, DOI 10.1002/anie.200500599; Hayashi Y, 2008, ANGEW CHEM INT EDIT, V47, P2082, DOI 10.1002/anie.200704870; Khrimian AP, 1996, TETRAHEDRON-ASYMMETR, V7, P37, DOI 10.1016/0957-4166(95)00415-7; Itoh T, 2009, ORG LETT, V11, P3854, DOI 10.1021/ol901432a; Hayashi Y, 2011, ANGEW CHEM INT EDIT, V50, P2804, DOI 10.1002/anie.201005577; Marigo M, 2005, ANGEW CHEM INT EDIT, V44, P794, DOI 10.1002/anie.200462101; Torii H, 2004, ANGEW CHEM INT EDIT, V43, P1983, DOI 10.1002/anie.200352724; Xu LW, 2010, ADV SYNTH CATAL, V352, P243, DOI 10.1002/adsc.200900797; Mukherjee S, 2007, CHEM REV, V107, P5471, DOI 10.1021/cr0684016; Dalko PI, 2013, COMPREHENSIVE ENANTIOSELECTIVE ORGANOCATALYSIS: CATALYSTS, REACTIONS, AND APPLICATIONS, VOLS 1-3, P1, DOI 10.1002/9783527658862; Gotoh H., 2013, SUSTAINABLE CATALYSI, P287; Hayashi Y, 2013, CHEMCATCHEM, V5, P2887, DOI 10.1002/cctc.201300390; Hayashi Y, 2013, CHEMCATCHEM, V5, P2883, DOI 10.1002/cctc.201300247; Hayashi Y, 2008, ORG LETT, V10, P5581, DOI 10.1021/ol802438u; Hayashi Y, 2013, CHEM LETT, V42, P1294, DOI 10.1246/cl.130544; Hayashi Y., 2008, ANGEW CHEM, V120, P2112, DOI 10.1002/ange.200704870; Hayashi Y., 2005, ANGEW CHEM, V117, P4284, DOI 10.1002/ange.200500599; Hayashi Y, 2012, CHEM COMMUN, V48, P4570, DOI 10.1039/c2cc31230a; Hayashi Y, 2011, SYNLETT, P485, DOI 10.1055/s-0030-1259543; Jiang H, 2013, COMPREHENSIVE ENANTIOSELECTIVE ORGANOCATALYSIS: CATALYSTS, REACTIONS, AND APPLICATIONS, VOLS 1-3, P33; List B., 2012, ASYMMETRIC ORGANOCAT, V1; Mahrwald R., 2004, MODERN ALDOL REACTIO, V1; Mahrwald R., 2004, MODERN ALDOL REACTIO, V2; Marigo M., 2005, ANGEW CHEM, V117, P804, DOI 10.1002/ange.200462101; OLIVER JE, 1994, SYNTHESIS-STUTTGART, P273; Torii H., 2004, ANGEW CHEM, V116, P2017, DOI 10.1002/ange.200352724; Urushima T, 2010, ORG LETT, V12, P2966, DOI 10.1021/ol1009812; Yasui Y, 2014, CHEM LETT, V43, P556, DOI 10.1246/cl.131199; Zhang FL, 2006, SYNLETT, P1703, DOI 10.1055/s-2006-948164	34	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1867-3880	1867-3899		CHEMCATCHEM	ChemCatChem	JUN 1	2015	7	11					1646	1649		10.1002/cctc.201500282		4	Chemistry, Physical	Chemistry	CJ8EV	WOS:000355733800005		
J	Oonishi, Y				Oonishi, Yoshihiro			Development of Novel Cyclizations via Rhodacycle Intermediate and Its Application to Synthetic Organic Chemistry	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Review						rhodium; cyclization; ionic liquid; hydroacylation; cycloisomerization	MEDIATED ENE CARBOCYCLIZATIONS; CATALYTIC INTRAMOLECULAR HYDROACYLATION; 4+2 CYCLOISOMERIZATION REACTIONS; IONIC LIQUIDS; ASYMMETRIC CYCLIZATION; HYDROACYLATION/CYCLOISOMERIZATION CASCADE; RHODIUM(I)-CATALYZED CYCLOISOMERIZATION; NATURAL (+)-AROMADENDRENE; HOMOGENEOUS CATALYSIS; CHIRAL LIGANDS	Novel Rh(I)-catalyzed cyclizations through a different type of rhodacycle intermediate which is formed by hydroacylation of 4,6-dienal or oxidative addition of diene and alkene are described. Hydroacylation of 4,6-dienal afforded various 7-membered rings in good to high yields, while cycloisomerization of diene and alkene provided 5- or 6-membered rings in good yields. On the basis of these studies, we have also succeeded in developing the sequential reaction of hydroacylation followed by cycloisomerization to produce bicyclic compounds in a stereoselective manner and thus this reaction was expanded to the synthesis of epiglobulol. Furthermore, both Rh(I)-catalyzed hydroacylation and cycloisomerization using ionic liquid (IL) as a solvent were investigated and it was found that the IL recovered after the reaction, which contains the Rh(I) catalyst, could be recycled several times without loss of catalytic activity.	Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan	Oonishi, Y (reprint author), Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan.	oonishi@pharm.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Akiyama Foundation	All of the research in this review was conducted at the Faculty of Pharmaceutical Sciences, Hokkaido University. The author is grateful to Professor Yoshihiro Sato for his continued support and helpful discussions. The author would like to express his sincere appreciation to all of the students whose names are acknowledged in our publications cited in this review. These studies were supported in part by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science, and Research Grant from the Akiyama Foundation.	Aissa C, 2013, ORG LETT, V15, P1322, DOI 10.1021/ol400266g; Imai M, 2001, TETRAHEDRON, V57, P1205, DOI 10.1016/S0040-4020(00)01107-8; Willis MC, 2010, CHEM REV, V110, P725, DOI 10.1021/cr900096x; Sato Y, 2002, ANGEW CHEM INT EDIT, V41, P1218, DOI 10.1002/1521-3773(20020402)41:7<1218::AID-ANIE1218>3.0.CO;2-D; TAURA Y, 1989, TETRAHEDRON LETT, V30, P6349, DOI 10.1016/S0040-4039(01)93891-2; Crepin D, 2011, CHEM COMMUN, V47, P10957, DOI 10.1039/c1cc14626b; Barnhart RW, 1997, INORG CHIM ACTA, V263, P1, DOI 10.1016/S0020-1693(97)05564-3; Singh MP, 2000, J ANTIBIOT, V53, P256; Wilkes JS, 2002, GREEN CHEM, V4, P73, DOI 10.1039/b110838g; FAIRLIE DP, 1988, ORGANOMETALLICS, V7, P946, DOI 10.1021/om00094a026; BARNHART RW, 1994, J AM CHEM SOC, V116, P1821, DOI 10.1021/ja00084a025; Kundu K, 2005, J AM CHEM SOC, V127, P16042, DOI 10.1021/ja0564416; Aissa C, 2007, J AM CHEM SOC, V129, P14836, DOI 10.1021/ja0746316; Tanaka M, 2000, J ORG CHEM, V65, P5806, DOI 10.1021/jo000781m; FAIRLIE DP, 1988, ORGANOMETALLICS, V7, P936, DOI 10.1021/om00094a025; JAMES BR, 1985, J ORGANOMET CHEM, V285, P321, DOI 10.1016/0022-328X(85)87377-0; Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t; Wasserscheid P, 2000, ANGEW CHEM INT EDIT, V39, P3772, DOI 10.1002/1521-3773(20001103)39:21<3772::AID-ANIE3772>3.0.CO;2-5; Takeishi K, 2004, CHEM-EUR J, V10, P5681, DOI 10.1002/chem.200400679; BARTON DHR, 1985, TETRAHEDRON, V41, P3901, DOI 10.1016/S0040-4020(01)97173-X; GABLE KP, 1991, TETRAHEDRON LETT, V32, P3473, DOI 10.1016/0040-4039(91)80809-K; Aloise AD, 2000, J AM CHEM SOC, V122, P12610, DOI 10.1021/ja0055920; TAKACS JM, 1987, J AM CHEM SOC, V109, P2200, DOI 10.1021/ja00241a059; Crepin D, 2010, ANGEW CHEM INT EDIT, V49, P620, DOI 10.1002/anie.200904527; Barnhart W., 1997, CHEM COMMUN, P589; BUCHI G, 1959, TETRAHEDRON LETT, P14; Ducray P, 1999, J ORG CHEM, V64, P3800, DOI 10.1021/jo990507w; Dupont J., 2002, CHEM REV, V102, P3667; Dyson P. J., 2005, METAL CATALYSED REAC; Fujio M, 1998, CHEM LETT, P881, DOI 10.1246/cl.1998.881; GIJSEN HJM, 1992, TETRAHEDRON, V48, P2465, DOI 10.1016/S0040-4020(01)88765-2; GIJSEN HJM, 1990, TETRAHEDRON, V46, P7237, DOI 10.1016/S0040-4020(01)87904-7; Gilbertson SR, 1998, J ORG CHEM, V63, P10077, DOI 10.1021/jo981870q; Gilbertson SR, 1998, TETRAHEDRON LETT, V39, P2075, DOI 10.1016/S0040-4039(98)00265-2; Heath H, 2001, SYNTHESIS-STUTTGART, P2341; Hiersemann M., 2006, NACHR CHEM, V54, P29; Hiersemann M, 2005, TOP CURR CHEM, V243, P73, DOI 10.1007/b96882; JOLLY RS, 1990, J AM CHEM SOC, V112, P4965, DOI 10.1021/ja00168a055; Maifeld SV, 2006, SYNLETT, P1623, DOI 10.1055/s-2006-944213; Marce P, 2008, ORG LETT, V10, P4735, DOI 10.1021/ol801791g; MCKINSTRY L, 1994, TETRAHEDRON, V50, P6145, DOI 10.1016/S0040-4020(01)80636-0; Mischne M, 2005, CURR ORG SYNTH, V2, P261, DOI 10.2174/1570179053545350; O'Mahony DJR, 1998, SYNLETT, P443; O'Mahony DJR, 2003, ORG BIOMOL CHEM, V1, P2038, DOI 10.1039/b302426c; Oonishi Y, 2010, SYNTHESIS-STUTTGART, P2884, DOI 10.1055/s-0030-1258184; Oonishi Y, 2007, SYNTHESIS-STUTTGART, P2323, DOI 10.1055/s-2007-983774; Oonishi Y, 2007, TETRAHEDRON LETT, V48, P7505, DOI 10.1016/j.tetlet.2007.08.061; Oonishi Y, 2006, TETRAHEDRON LETT, V47, P5617, DOI 10.1016/j.tetlet.2006.06.036; Oonishi Y, 2009, SYNTHESIS-STUTTGART, P969, DOI 10.1055/s-0028-1087973; Oonishi Y, 2009, GREEN CHEM, V11, P330, DOI 10.1039/b818725h; SAKAI K, 1984, TETRAHEDRON LETT, V25, P961, DOI 10.1016/S0040-4039(01)80074-5; SAKAI K, 1972, TETRAHEDRON LETT, P1287; Sato Y, 2003, ORGANOMETALLICS, V22, P30, DOI 10.1021/om0206958; Sheldon R, 2001, CHEM COMMUN, P2399, DOI 10.1039/b107270f; TAKACS BE, 1990, TETRAHEDRON LETT, V31, P2865; TAKACS JM, 1987, TETRAHEDRON LETT, V28, P5627, DOI 10.1016/S0040-4039(00)96797-2; TAKACS JM, 1992, TETRAHEDRON LETT, V33, P317, DOI 10.1016/S0040-4039(00)74120-7; TAKACS JM, 1990, TETRAHEDRON, V46, P5507, DOI 10.1016/S0040-4020(01)87749-8; TAURA Y, 1991, TETRAHEDRON, V47, P4879, DOI 10.1016/S0040-4020(01)80954-6; Wang B, 2000, TETRAHEDRON LETT, V41, P8041, DOI 10.1016/S0040-4039(00)01432-5; Wasserscheid P., 2003, IONIC LIQUIDS SYNTHE; Welton T, 2004, COORDIN CHEM REV, V248, P2459, DOI 10.1016/j.ccr.2004.04.015; JAMES BR, 1983, J CHEM SOC CHEM COMM, P1215, DOI 10.1039/c39830001215	63	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	JUN	2015	63	6					397	407				11	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CJ3LP	WOS:000355385700001		
J	Takeguchi, K; Hirakura, Y; Yamazaki, K; Shimada, I; Ieda, S; Okada, M; Takiyama, H				Takeguchi, Kazuhiro; Hirakura, Yutaka; Yamazaki, Kouji; Shimada, Itsuro; Ieda, Shigeru; Okada, Minoru; Takiyama, Hiroshi			Characterization and Thermodynamic Stability of Polymorphs of Di(arylamino) Aryl Compound ASP3026	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						polymorph characterization; transition temperature; solution calorimetry	MOLECULAR-CRYSTALS; PHARMACEUTICALS; RULES	(N-{2-methoxy-444-(4-methylpiperazin-l-yl)piperidin-l-yl]pheny1}-N'[2-(propane-2-sulfonyl)phenyl]-1,3,5-triazine-2,4-diamine) was developed in Astellas Pharma Inc. as a novel and selective inhibitor of the fusion protein EML4-ALK. We investigated the thermodynamic stability of five polymorphs of ASP3026 (A01, A02, A03, A04, and A05) in detail. To determine the most stable form at ambient temperature, powder X-ray diffraction, differential scanning calorimetry, and solubility measurements were conducted. Of the five polymorphs, A04 was the most stable and A05 was the least stable. The relationship between A04 and A03 and A04 and A01 were mutually monotropic, while that between A01 and A02 was enantiotropic. The transition temperature from A02 to A01 was estimated as 325K. A02 was more thermodynamically stable at ambient temperature than A01. Furthermore, the method to estimate polymorphic transition temperatures using solution calorimetry was found to be effective. The systematic characterization of ASP3026 polymorphs presented in this study enables the selective crystallization of the most stable form and design of solid formulations.	[Takeguchi, Kazuhiro; Okada, Minoru] Astellas Pharma Inc, Technol Proc Chem Labs, Takahagi, Ibaraki 3180001, Japan; [Hirakura, Yutaka] Astellas Pharma Inc, Technol Analyt Res Labs, Takahagi, Ibaraki 3180001, Japan; [Yamazaki, Kouji] Astellas Pharma Inc, Drug Discovery Res Anal Lab, Tsukuba, Ibaraki 3058585, Japan; [Yamazaki, Kouji] Astellas Pharma Inc, Pharmacokinet Res Lab, Tsukuba, Ibaraki 3058585, Japan; [Shimada, Itsuro] Astellas Pharma Inc, Drug Discovery Res Med Chem Res Labs, Tsukuba, Ibaraki 3058585, Japan; [Ieda, Shigeru] Astellas Pharma Tech Co Ltd, Takahagi, Ibaraki 3180001, Japan; [Takeguchi, Kazuhiro; Takiyama, Hiroshi] Tokyo Univ Agr & Technol, Dept Chem Engn, Koganei, Tokyo 1848588, Japan	Takeguchi, K (reprint author), Astellas Pharma Inc, Technol Proc Chem Labs, 160-2 Akahama, Takahagi, Ibaraki 3180001, Japan.	kazuhiro.takeguchi@astellas.com	Takiyama, Hiroshi/C-9769-2013				Urakami K, 2002, CHEM PHARM BULL, V50, P263, DOI 10.1248/cpb.50.263; Singhal D, 2004, ADV DRUG DELIVER REV, V56, P335, DOI 10.1016/j.addr.2003.10.008; Chemburkar SR, 2000, ORG PROCESS RES DEV, V4, P413, DOI 10.1021/op000023y; BORKA L, 1990, ACTA PHARM JUGOSL, V40, P71; Datta S, 2004, NAT REV DRUG DISCOV, V3, P42, DOI 10.1038/nrd1280; BURGER A, 1979, MIKROCHIM ACTA, V2, P273; BURGER A, 1979, MIKROCHIM ACTA, V2, P259; HALEBLIA.J, 1969, J PHARM SCI, V58, P911, DOI 10.1002/jps.2600580802; Kimura N, 2001, CHEM PHARM BULL, V49, P1321, DOI 10.1248/cpb.49.1321; Kondoh Y., 2009, PCT Int. Appl., Patent No. [WO 2009008371 Al, 2009008371, WO2009008371 A1]; Minamisono T, 2011, J CHEM ENG JPN, V44, P197, DOI 10.1252/jcej.10we280; Prashad M, 2010, ORG PROCESS RES DEV, V14, P878, DOI 10.1021/op100115u; Shimada I., 2011, PCT Int. Appl., Patent No. [WO2011145548 Al, 2011145548, WO2011145548 A1]	13	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	JUN	2015	63	6					418	422				5	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CJ3LP	WOS:000355385700003		
J	Onuki, Y; Machida, Y; Yokawa, T; Seike, C; Sakurai, S; Takayama, K				Onuki, Yoshinori; Machida, Yoshiaki; Yokawa, Takashi; Seike, Chieko; Sakurai, Shotaro; Takayama, Kozo			Magnetic Resonance Imaging Study on the Physical Stability of Menthol and Diphenhydramine Cream for the Treatment of Chronic Kidney Disease-Associated Pruritus	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						magnetic resonance imaging; T-2 map; chemical shift selective image; apparent diffusion coefficient map; magnetic resonance (MR) spectroscopy	EMULSION STABILITY; WATER; MICROEMULSIONS; SCATTERING; PHASE	A cream that contains menthol and diphenhydramine is widely prepared in hospital pharmacies and prescribed to patients for the treatment of pruritus associated with chronic kidney disease. However, there is a serious concern regarding its physical stability; therefore, we investigated this issue using magnetic resonance imaging (MRI). For a sample preparation, a menthol-containing ethanol solution was mixed with a commercial diphenhydramine cream. After storage for 7d at 40 degrees C, substantial phase separation into two distinct layers (upper and lower layers) was observed in the sample. This study further examined the components of the phase-separated layers using magnetic resonance (MR) spectroscopy and chemical shift selective images, and it was verified that the upper layer consisted of packed oil droplet layers, whereas the lower was an aqueous phase. Subsequently, the time-dependent phase separation of the sample at different temperatures was investigated. From the MR images, including a T, relaxation time map and apparent diffusion coefficient maps, it was obvious that the phase separation developed further with increasing temperature; the most substantial phase separation was observed from the sample stored at 40 degrees C, while no phase separation was detected at 25 degrees C. In the final phase of this study, we conducted a formulation study and succeeded in improving the cream's physical stability by adding a hydrophilic surfactant to the preparation.	[Onuki, Yoshinori; Takayama, Kozo] Hoshi Univ, Dept Pharmaceut, Shinagawa Ku, Tokyo 1428501, Japan; [Machida, Yoshiaki; Sakurai, Shotaro] Hoshi Univ, Div Appl Pharmaceut Educ & Res, Shinagawa Ku, Tokyo 1428501, Japan; [Yokawa, Takashi] Bio View Corp, Chiyoda Ku, Tokyo 1010032, Japan; [Seike, Chieko] Odawara Circulatory Organ Hosp, Dept Pharmaceut, Odawara, Kanagawa 2500873, Japan	Onuki, Y (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Pharmaceut Technol, 2630 Sugitani, Toyama 9300194, Japan.	onuki@pha.u-toyama.ac.jp			Japan Society for the Promotion of Science [25460045]	This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (#25460045). We thank Mr. Koji Ito at Nikko Chemicals for a generous gift of PEG-60-hydrogenated castor oil (Nikkol HCO-60) and Ms. Kana Endo at Hoshi University for technical assistance.	McClements DJ, 2007, CRIT REV FOOD SCI, V47, P611, DOI 10.1080/10408390701289292; Onuki Y, 2014, DRUG DEV IND PHARM, V40, P937, DOI 10.3109/03639045.2013.790903; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Nishikawa M, 2011, CHEM PHARM BULL, V59, P332, DOI 10.1248/cpb.59.332; Hessien M, 2011, LANGMUIR, V27, P2299, DOI 10.1021/la104728r; Song MG, 2000, J COLLOID INTERF SCI, V230, P213, DOI 10.1006/jcis.2000.7090; Feramisco JD, 2010, DERMATOL CLIN, V28, P467, DOI 10.1016/j.det.2010.03.004; Aramwit P, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-119; Hashemi R. H., 2010, MRI BASICS; Kowalczuk J, 2011, EUR J PHARM SCI, V42, P354, DOI 10.1016/j.ejps.2010.12.009; Kristl J, 1992, STP PHARMA SCI, V2, P265; Mettang M, 2010, Skin Therapy Lett, V15, P1; Onuki Y, 2015, CHEM PHARM BULL, V63, P377, DOI 10.1248/cpb.c15-00088; Patel TS, 2007, AM J KIDNEY DIS, V50, P11, DOI 10.1053/j.ajkd.2007.03.010; Shukla A, 2002, PHARMACEUT RES, V19, P881, DOI 10.1023/A:1016173303738; Shukla A, 2003, J PHARM PHARMACOL, V55, P741, DOI 10.1211/0022357021017	16	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	JUN	2015	63	6					457	462				6	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CJ3LP	WOS:000355385700009		
J	Abe, H; Sakashita, C; Kawada, M; Nomoto, A; Watanabe, T; Shibasaki, M				Abe, Hikaru; Sakashita, Chiharu; Kawada, Manabu; Nomoto, Akio; Watanabe, Takumi; Shibasaki, Masakatsu			Synthesis and Structure-Activity Relationship Study of NBRI16716B, an Antitumor Natural Product	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						antitumor agent; natural product; diketopiperazine; tumor-stroma interaction; structure-activity relationship	STROMAL CELL-INTERACTIONS; HUMAN PROSTATE-CANCER; GROWTH-FACTOR-I; REACTIVE STROMA; INTERVENOLIN; PROGRESSION; COMPOUND	The total synthesis of NBRI16716B (2), a naturally occurring modulator of tumor stroma interactions, was successfully achieved. Using this synthetic route, a dehydroxy analogue (21) and a derivative lacking the 5-hydroxy-3-methylpentenoyl side chain (22) became accessible. A preliminary structure activity relationship study to unveil the structural requirements for selective inhibition of tumor cells cocultured with stromal cells revealed that both of the hydroxamate structures of 2 are indispensable, whereas the 5-hydroxy-3-methylpentenoyl side chain is not essential.	[Abe, Hikaru; Sakashita, Chiharu; Nomoto, Akio; Watanabe, Takumi; Shibasaki, Masakatsu] Inst Microbial Chem BIKAKEN, Shinagawa Ku, Tokyo 1410021, Japan; [Kawada, Manabu] Inst Microbial Chem BIKAKEN, Shizuoka 4100301, Japan	Watanabe, T (reprint author), Inst Microbial Chem BIKAKEN, Shinagawa Ku, 3-14-23 Kamiosaki, Tokyo 1410021, Japan.	twatanabe@bikaken.or.jp; mshibasa@bikaken.or.jp					CAMPS JL, 1990, P NATL ACAD SCI USA, V87, P75, DOI 10.1073/pnas.87.1.75; Kawada M, 2010, INT J CANCER, V126, P810, DOI 10.1002/ijc.24915; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Abe H, 2013, ORG LETT, V15, P2124, DOI 10.1021/ol400587a; El-Faham A, 2009, CHEM-EUR J, V15, P9404, DOI 10.1002/chem.200900615; Grossfeld GD, 1998, ENDOCR-RELAT CANCER, V5, P253, DOI 10.1677/erc.0.0050253; Kawada M, 2006, CANCER RES, V66, P4419, DOI 10.1158/0008-5472.CAN-05-4239; FREDERICK CB, 1982, BIOCHEM BIOPH RES CO, V105, P133, DOI 10.1016/S0006-291X(82)80021-1; ISOWA Y, 1972, B CHEM SOC JPN, V45, P1467, DOI 10.1246/bcsj.45.1467; Kawada M, 2004, ANTICANCER RES, V24, P1561; Kawada M, 2008, ANTICANCER RES, V28, P721; Kawada M, 2013, J ANTIBIOT, V66, P543, DOI 10.1038/ja.2013.42; Kawada M, 2009, J ANTIBIOT, V62, P243, DOI 10.1038/ja.2009.20; Kawada M, 2009, CANCER SCI, V100, P150, DOI 10.1111/j.1349-7006.2008.00996.x; Kawada M, 2010, J ANTIBIOT, V63, P319, DOI 10.1038/ja.2010.42; Kawada M., 2013, FOR IMMUNOPATHOL DIS, V4, P53; Nakatsu N, 2007, MOL PHARMACOL, V72, P1171, DOI 10.1124/mol.107.038836; PICARD O, 1986, CANCER RES, V46, P3290; Tuxhorn JA, 2001, J UROLOGY, V166, P2472, DOI 10.1016/S0022-5347(05)65620-0; Wernert N, 1997, VIRCHOWS ARCH, V430, P433, DOI 10.1007/s004280050053; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431	22	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	JUN	2015	63	6					463	468				6	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CJ3LP	WOS:000355385700010		
J	Gabriel, AF; Li, Z; Kusuda, R; Tanaka, C; Miyamoto, T				Gabriel, Adeyemi Francis; Li, Zhen; Kusuda, Ryouhei; Tanaka, Chiaki; Miyamoto, Tomofumi			Six New Polyacetylenic Alcohols from the Marine Sponges Petrosia sp and Halichondria sp.	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						polyacetylenic alcohol; marine sponge; Petrosia sp.; Halichondria sp.; strongylotriol; pellynol	METABOLITES	Six new polyacetylenic alcohols, termed strongylotriols A and B; pellynols J, K, and L; and isopellynol A, together with three known polyacetylenic alcohols, pellynols A, B, and C were isolated from the marine sponges Petrosia sp., and Halichondria sp. collected in Okinawa, Japan. Their planer structures were determined based on 2D-NMR and mass spectrometric analysis of the degraded products by RuCl3 oxidation. The absolute stereochemistry of isolates was examined by their Mosher's esters. The strongylotriols were found to be optically pure compounds, whereas the pellynols are diastereomeric mixtures at the C-6 position. Proliferation experiments using the HeLa and K562 cell lines suggested that the essential structural units for activity are the "hexa-2,4-diyn-1,6-diol" and "pent-1-en-4-yn-3-ol" on the termini.	[Gabriel, Adeyemi Francis; Li, Zhen; Kusuda, Ryouhei; Tanaka, Chiaki; Miyamoto, Tomofumi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Nat Prod Chem, Higashi Ku, Fukuoka 8128582, Japan	Miyamoto, T (reprint author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Nat Prod Chem, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	miyamoto@phar.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; JSPS KAKENHI [24590139]	We wish to thank the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan for the financial support to Mr. Gabriel Adeyemi Francis. This work was supported by JSPS KAKENHI Grant Number 24590139.	ALLEN EH, 1971, PHYTOCHEMISTRY, V10, P1579, DOI 10.1016/0031-9422(71)85027-6; Perry NB, 2001, TETRAHEDRON LETT, V42, P4325, DOI 10.1016/S0040-4039(01)00720-1; OHTANI I, 1991, J AM CHEM SOC, V113, P4092, DOI 10.1021/ja00011a006; Bohlmann F., 1973, NATURALLY OCCURING A; Bohlmann F., 1998, CHEM BIOL NATURALLY; BRAEKMAN JC, 1978, B SOC CHIM BELG, V87, P917; De Weerdt W. H., 2002, FAMILY CHALINIDAE GA; Fu X, 1997, TETRAHEDRON, V53, P799, DOI 10.1016/S0040-4020(96)01037-X; FUSETANI N, 1989, TETRAHEDRON LETT, V30, P6891, DOI 10.1016/S0040-4039(01)93381-7; Jung H. J., 2006, BIOMATERIALS AQUATIC; Shirouzu T, 2013, J NAT PROD, V76, P1337, DOI 10.1021/np400297p; Zhou G.-X., 2003, MAR DRUGS, V1, P46, DOI 10.3390/md101046	12	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	JUN	2015	63	6					469	475				7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CJ3LP	WOS:000355385700011		
J	Asamoto, H; Nobushi, Y; Oi, T; Uchikura, K				Asamoto, Hiromichi; Nobushi, Yasuhito; Oi, Takahiko; Uchikura, Kazuo			Determination of Miglitol by Column-Switching Ion-Pair HPLC with Tris(2,2 '-bipyridine)ruthenium(II)-Electrogenerated Chemiluminescence Detection	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						miglitol; tris(2,2 '-bipyridine)ruthenium(II); column-switching ion-pair HPLC	PERFORMANCE LIQUID-CHROMATOGRAPHY; ALPHA-GLUCOSIDASE INHIBITOR; MASS-SPECTROMETRY; HUMAN PLASMA; SPARTEINE; OXIDATION; AMINES; URINE	We have developed a highly sensitive, simple method for the quantitative determination of miglitol in standard serum samples using column-switching ion-pair HPLC with tris(2,2'-bipyridine)ruthenium(H)-electrogenerated chemiluminescence detection. The serum samples were directly injected into a column-switching HPLC system with a Shim-pack MAYI-SCX precolumn to remove the serum matrix. Chromatographic separation of miglitol was achieved on a TSKgel ODS 100-V column using a mobile phase containing sodium 1-octanesulfonate as an ion-pair reagent. The detection and quantification limits of miglitol were 3 and 10 ng/mL, respectively. The calibration curve for miglitol in the serum samples showed good linearity (r(2)=0.9997) in the range of 10-2500 ng/mL. The recovery rate of miglitol from the serum samples was more than 94% as calculated from blank serum samples spiked with miglitol 50, 100, 500, 1000, and 2000 ng/mL. Therefore, this method can be applied to routine therapeutic monitoring of miglitol in serum samples.	[Asamoto, Hiromichi] Nihon Univ, Coll Ind Technol, Narashino, Chiba 2758576, Japan; [Nobushi, Yasuhito; Oi, Takahiko; Uchikura, Kazuo] Nihon Univ, Coll Pharm, Funabashi, Chiba 2748555, Japan	Asamoto, H (reprint author), Nihon Univ, Coll Ind Technol, 2-11-1 Shinei, Narashino, Chiba 2758576, Japan.	asamoto.hiromichi@nihon-u.ac.jp					Amioka K, 2007, YAKUGAKU ZASSHI, V127, P2051, DOI 10.1248/yakushi.127.2051; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; van de Laar FA, 2005, DIABETES CARE, V28, P154, DOI 10.2337/diacare.28.1.154; Ahr HJ, 1997, ARZNEIMITTEL-FORSCH, V47, P734; Nirogi RVS, 2006, ARZNEIMITTEL-FORSCH, V56, P328; Enami T., 2001, CHROMATOGRAPHY, V22, P33; Fujita Y, 2012, INTERNAL MED, V51, P2581, DOI 10.2169/internalmedicine.51.8171; Ikehara T, 2005, ANAL CHIM ACTA, V536, P129, DOI 10.1016/j.aca.2004.12.060; International Diabetes Federation, DIAB FACTS FIG; ISHIZAKI T, 1987, BRIT J CLIN PHARMACO, V23, P482; Kim H. B., 2003, BIOMED CHROMATOGR, V17, P373; Kuboyama Noboru, 2006, Folia Pharmacologica Japonica, V127, P223, DOI 10.1254/fpj.127.223; Li X, 2007, RAPID COMMUN MASS SP, V21, P247, DOI 10.1002/rcm.2822; Ramanathan K., 2010, J PROTEOM BIOINFORM, V3, P310; Saito K, 1999, ANAL CHIM ACTA, V378, P43, DOI 10.1016/S0003-2670(98)00611-4; Shibano Y, 2011, CHEM PHARM BULL, V59, P249, DOI 10.1248/cpb.59.249; SKOTTY DR, 1995, J CHROMATOGR B, V665, P27, DOI 10.1016/0378-4347(94)00519-B; Tsukamoto K., 2001, JPN PHARMACOL THER, V29, P623; UCHIKURA K, 1991, ANAL SCI, V7, P971, DOI 10.2116/analsci.7.971; Uchikura K, 2003, BUNSEKI KAGAKU, V52, P641, DOI 10.2116/bunsekikagaku.52.641; UCHIKURA K, 1991, ANAL SCI, V7, P803, DOI 10.2116/analsci.7.803; UCHIKURA K, 1993, ANAL SCI, V9, P121, DOI 10.2116/analsci.9.121; Uchikura K, 2003, CHEM PHARM BULL, V51, P1092; Um SY, 2006, J PHARMACEUT BIOMED, V41, P1458, DOI 10.1016/j.jpba.2006.03.021; Yamamoto E, 2004, J CHROMATOGR B, V807, P327, DOI 10.1016/j.jchromb.2004.04.028	25	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	JUN	2015	63	6					476	480				5	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CJ3LP	WOS:000355385700012		
J	Hirano-Iwata, A; Ishinari, Y; Yamamoto, H; Niwano, M				Hirano-Iwata, Ayumi; Ishinari, Yutaka; Yamamoto, Hideaki; Niwano, Michio			Micro- and Nano-Technologies for Lipid Bilayer-Based Ion-Channel Functional Assays	CHEMISTRY-AN ASIAN JOURNAL			English	Review						bilayer lipid membrane; channel current; channel integration; ion channel; microfabricaiton	MEMBRANE-PROTEINS; MICROFLUIDIC DEVICE; SOLUTION EXCHANGE; DROPLET BILAYERS; PLANAR BILAYERS; SILICON CHIPS; RECORDINGS; RECONSTITUTION; APERTURES; PLATFORM	Ion channel proteins provide gated pores that allow ions to passively flow across cell membranes. Owing to their crucial roles in regulating transmembrane ion flow, ion channel proteins have attracted the attention of pharmaceutical investigators as drug targets for use in the studies of both therapeutics and side effects. In this review, we discuss the current technologies that are used in the formation of ion channel-integrated bilayer lipid membranes (BLMs) in microfabricated devices as a potential platform for next-generation drug screening systems. Advances in BLM fabrication methodology have allowed the preparation of BLMs in sophisticated formats, such as microfluidic, automated, and/or array systems, which can be combined with channel current recordings. A much more critical step is the integration of the target channels into BLMs. Current technologies for the functional reconstitution of ion channel proteins are presented and discussed. Finally, the remaining issues of the BLM-based methods for recording ion channel activities and their potential applications as drug screening systems are discussed.	[Hirano-Iwata, Ayumi; Ishinari, Yutaka] CREST Japan Sci & Technol Agcy JST, Kawaguchi, Saitama 3320012, Japan; [Hirano-Iwata, Ayumi; Ishinari, Yutaka; Yamamoto, Hideaki; Niwano, Michio] Tohoku Univ, Grad Sch Biomed Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Yamamoto, Hideaki] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Niwano, Michio] Tohoku Univ, Elect Commun Res Inst, Lab Nanoelect & Spintron, Aoba Ku, Sendai, Miyagi 9808579, Japan	Hirano-Iwata, A (reprint author), CREST Japan Sci & Technol Agcy JST, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan.				Japan Society for the Promotion of Science [24350032, 26620111]	The authors wish to acknowledge the financial support by Grant-in-Aids from the Japan Society for the Promotion of Science (Grant number: 24350032 and 26620111).	Acharya SA, 2013, SCI REP-UK, V3, DOI 10.1038/srep03139; ERAY M, 1994, BIOSENS BIOELECTRON, V9, P343, DOI 10.1016/0956-5663(94)80034-0; Thapliyal T, 2011, BIOSENS BIOELECTRON, V26, P2651, DOI 10.1016/j.bios.2010.01.017; Holden MA, 2006, NAT CHEM BIOL, V2, P314, DOI 10.1038/nchembio793; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Hirano-Iwata A, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4736263; El-Arabi AM, 2012, LAB CHIP, V12, P2409, DOI [10.1039/c2lc40087a, 10.1039/c21c40087a]; Schmitt EK, 2006, BIOPHYS J, V91, P2163, DOI 10.1529/biophysj.106.083592; Kresak S, 2009, SOFT MATTER, V5, P4021, DOI 10.1039/b907661a; Zagnoni M, 2007, LAB CHIP, V7, P1176, DOI 10.1039/b703818f; Liu BW, 2009, BIOSENS BIOELECTRON, V24, P1843, DOI 10.1016/j.bios.2008.09.019; Heron AJ, 2007, J AM CHEM SOC, V129, P16042, DOI 10.1021/ja075715h; Poulos JL, 2009, BIOSENS BIOELECTRON, V24, P1806, DOI 10.1016/j.bios.2008.08.041; Hirano-Iwata A, 2008, TRAC-TREND ANAL CHEM, V27, P512, DOI 10.1016/j.trac.2008.04.006; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; White RJ, 2007, J AM CHEM SOC, V129, P11766, DOI 10.1021/ja073174q; Kreir M, 2008, LAB CHIP, V8, P587, DOI 10.1039/b713982a; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Romer W, 2004, BIOPHYS J, V86, P955; MUELLER P, 1962, NATURE, V194, P979, DOI 10.1038/194979a0; Mayer M, 2003, BIOPHYS J, V85, P2684, DOI 10.1016/S0006-3495(03)74691-8; Hirano-Iwata A, 2012, ANAL SCI, V28, P1049; Demarche S, 2011, ANALYST, V136, P1077, DOI 10.1039/c0an00828a; Leptihn S, 2011, J AM CHEM SOC, V133, P9370, DOI 10.1021/ja200128n; Bowie JU, 2001, CURR OPIN STRUC BIOL, V11, P397, DOI 10.1016/S0959-440X(00)00223-2; Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; Schmitt EK, 2009, SOFT MATTER, V5, P3347, DOI 10.1039/b901683j; Shim JW, 2007, ANAL CHEM, V79, P2207, DOI 10.1021/ac0614285; Hirano-Iwata A, 2010, LANGMUIR, V26, P1949, DOI 10.1021/la902522j; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Zagnoni M, 2012, LAB CHIP, V12, P1026, DOI 10.1039/c2lc20991h; Han XJ, 2007, ADV MATER, V19, P4466, DOI 10.1002/adma.200700468; Holden MA, 2007, J AM CHEM SOC, V129, P8650, DOI 10.1021/ja072292a; Schmidt C, 2000, ANGEW CHEM INT EDIT, V39, P3137, DOI 10.1002/1521-3773(20000901)39:17<3137::AID-ANIE3137>3.0.CO;2-D; Sumitomo K, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.107001; Dorr JM, 2014, P NATL ACAD SCI USA, V111, P18607, DOI 10.1073/pnas.1416205112; Funakoshi K, 2006, ANAL CHEM, V78, P8169, DOI 10.1021/ac0613479; Dunlop J, 2008, NAT REV DRUG DISCOV, V7, P358, DOI 10.1038/nrd2552; Batishchev OV, 2008, BIOELECTROCHEMISTRY, V74, P22, DOI 10.1016/j.bioelechem.2008.02.002; Bright LK, 2013, ACS APPL MATER INTER, V5, P11918, DOI 10.1021/am403605h; COHEN FS, 1984, J CELL BIOL, V98, P1054, DOI 10.1083/jcb.98.3.1054; CORONADO R, 1983, BIOPHYS J, V43, P231; Costello RF, 1998, ADV MATER OPT ELECTR, V8, P47, DOI 10.1002/(SICI)1099-0712(199803/04)8:2<47::AID-AMO325>3.0.CO;2-5; ERAY M, 1995, BIOSYSTEMS, V35, P183, DOI 10.1016/0303-2647(94)01511-5; Friddin MS, 2013, ANALYST, V138, P7294, DOI 10.1039/c3an01540h; Guo Liang, 2005, Journal of Pharmacological and Toxicological Methods, V52, P123, DOI 10.1016/j.vascn.2005.04.002; Hirano A, 2000, BIOSENS BIOELECTRON, V15, P173, DOI 10.1016/S0956-5663(00)00058-0; Hirano A, 2000, ANAL BIOCHEM, V283, P258, DOI 10.1006/abio.2000.4650; Hirano M, 2009, ANAL CHEM, V81, P3151, DOI 10.1021/ac900286z; Hirano-Iwata A, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3441298; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Hutter I, 2013, MICROFLUID NANOFLUID, V14, P421, DOI 10.1007/s10404-012-1061-0; Ide T, 2005, BIOSENS BIOELECTRON, V21, P672, DOI 10.1016/j.bios.2004.12.018; Ide T, 2008, ANAL CHEM, V80, P7792, DOI 10.1021/ac801224a; Kalsi S, 2014, BIOPHYS J, V106, P1650, DOI 10.1016/j.bpj.2014.02.033; Kaufeld T, 2015, J PHYS D APPL PHYS, V48, DOI 10.1088/0022-3727/48/2/025401; Kawano R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01995; Kongsuphol P, 2013, SENSOR ACTUAT B-CHEM, V185, P530, DOI 10.1016/j.snb.2013.04.119; Le Pioufle B, 2008, ANAL CHEM, V80, P328, DOI 10.1021/ac7016635; Maurer JA, 2007, BIOSENS BIOELECTRON, V22, P2577, DOI 10.1016/j.bios.2006.10.017; Meadows KE, 2014, SOFT MATTER, V10, P8433, DOI 10.1039/c3sm51406d; Miller C., 1986, ION CHANNEL RECONSTI; Oshima A, 2013, ANAL CHEM, V85, P4363, DOI 10.1021/ac303484k; Portonovo SA, 2012, BIOMED MICRODEVICES, V14, P187, DOI 10.1007/s10544-011-9596-5; Sandison ME, 2007, LANGMUIR, V23, P8277, DOI 10.1021/la7007528; Schmidt C., 2000, ANGEW CHEM, V112, P3267, DOI 10.1002/1521-3757(20000901)112:17<3267::AID-ANGE3267>3.0.CO;2-1; Shinozaki Y, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.107001; Sondermann M, 2006, BBA-BIOMEMBRANES, V1758, P545, DOI 10.1016/j.bbamem.2006.03.023; Studer A, 2011, BIOSENS BIOELECTRON, V26, P1924, DOI 10.1016/j.bios.2010.06.008; Suzuki H, 2009, BIOMED MICRODEVICES, V11, P17, DOI 10.1007/s10544-008-9205-4; Syeda R, 2008, J AM CHEM SOC, V130, P15543, DOI 10.1021/ja804968g; TAKAGI M, 1965, Annual Report of Biological Works Faculty of Science Osaka University, V13, P107; Tiefenauer L, 2012, MATERIALS, V5, P2205, DOI 10.3390/ma5112205; WOODBURY DJ, 1990, BIOPHYS J, V58, P833; Zagnoni M, 2009, BIOSENS BIOELECTRON, V24, P1235, DOI 10.1016/j.bios.2008.07.022; Zanetti M, 2014, ELECTROANAL, V26, P1653, DOI 10.1002/elan.201400152	76	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	JUN	2015	10	6					1266	1274		10.1002/asia.201403391		9	Chemistry, Multidisciplinary	Chemistry	CJ2UC	WOS:000355339100001		
J	Murata, R; Hirano, K; Uchiyama, M				Murata, Ryo; Hirano, Keiichi; Uchiyama, Masanobu			Highly Chemoselective and Versatile Method for Direct Conversion of Carboxylic Acids to Ketones Utilizing Zinc Ate Complexes	CHEMISTRY-AN ASIAN JOURNAL			English	Article						carboxylic acids; chemoselective; density functional calculations; ketones; organozincates	DIANION-TYPE ZINCATE; ZN-ATE; ALPHA,BETA-UNSATURATED KETONES; ORGANOLITHIUM COMPOUNDS; GRIGNARD-REAGENTS; MILD CONDITIONS; ATOM ECONOMY; METAL; CHLORIDES; PATH	Various carboxylic acids were directly transformed into the corresponding ketones by utilizing organozinc ate complexes, which provide high chemoselectivity without any overreaction to the undesired tertiary carbinol, owing to formation of a stable tetrahedral zincioketal intermediate. This method offers good overall atom/step/pot economy and operational simplicity.	[Murata, Ryo; Hirano, Keiichi; Uchiyama, Masanobu] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Hirano, Keiichi; Uchiyama, Masanobu] RIKEN, Ctr Sustainable Resource Sci, Adv Elements Chem Res Team, Wako, Saitama 3510198, Japan; [Hirano, Keiichi; Uchiyama, Masanobu] Elements Chem Lab, Wako, Saitama 3510198, Japan	Hirano, K (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	k1hirano@mol.f.u-tokyo.ac.jp; uchiyama@mol.f.u-tokyo.ac.jp	Uchiyama, Masanobu/B-7181-2015		JSPS KAKENHI [24229011]; Takeda Science Foundation; Asahi Glass Foundation; Daiichi-Sankyo Foundation of Life Sciences; Mochida Memorial Foundation; Tokyo Biochemical Research Foundation; Foundation NAGASE Science Technology Development; Sumitomo Foundation; JSPS [24850005, 26860010]	This work was supported by JSPS KAKENHI (S) (No. 24229011), Takeda Science Foundation, The Asahi Glass Foundation, Daiichi-Sankyo Foundation of Life Sciences, Mochida Memorial Foundation, Tokyo Biochemical Research Foundation, Foundation NAGASE Science Technology Development, and Sumitomo Foundation (to M. U.), JSPS Grant-in-Aid for Young Scientists (Start-up) (No. 24850005) and JSPS Grant-in-Aid for Young Scientists (B) (No. 26860010) (to K. H.) (No. 24850005). The calculations were performed on the Riken Integrated Cluster of Clusters (RICC). We gratefully acknowledge Advanced Center for Computing and Communication (RIKEN) for providing computational resources.	Alonso F, 1996, J ORG CHEM, V61, P6058, DOI 10.1021/jo9605962; Uchiyama M, 1998, J AM CHEM SOC, V120, P4934, DOI 10.1021/ja973855t; KNOCHEL P, 1988, J ORG CHEM, V53, P2390, DOI 10.1021/jo00245a057; GONZALEZ C, 1989, J CHEM PHYS, V90, P2154, DOI 10.1063/1.456010; ISHIDA K, 1977, J CHEM PHYS, V66, P2153, DOI 10.1063/1.434152; Wang C, 2012, CHEM-EUR J, V18, P3482, DOI 10.1002/chem.201103784; Uchiyama M, 2006, J AM CHEM SOC, V128, P8404, DOI 10.1021/ja058246x; Wender PA, 2009, NATURE, V460, P197, DOI 10.1038/460197a; Wender PA, 2006, TETRAHEDRON, V62, P7505, DOI 10.1016/j.tet.2006.02.085; Wang XJ, 2005, ORG LETT, V7, P5593, DOI 10.1021/ol052150q; Nakamura S, 2005, J AM CHEM SOC, V127, P13116, DOI 10.1021/ja0541074; NAHM S, 1981, TETRAHEDRON LETT, V22, P3815, DOI 10.1016/S0040-4039(01)91316-4; TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206; [Anonymous], 2007, ANGEW CHEM, V119, P944; RUBOTTOM GM, 1983, J ORG CHEM, V48, P1550, DOI 10.1021/jo00157a038; Wilkinson MC, 2011, ORG LETT, V13, P2232, DOI 10.1021/ol200482s; Nakamura S, 2004, J AM CHEM SOC, V126, P11146, DOI 10.1021/ja047144o; Nagashima Y, 2013, J AM CHEM SOC, V135, P18730, DOI 10.1021/ja409748m; Uchiyama M, 1996, J AM CHEM SOC, V118, P8733, DOI 10.1021/ja961320e; LEVINE R, 1975, J ORG CHEM, V40, P1770, DOI 10.1021/jo00900a020; [Anonymous], 1995, ANGEW CHEM, V107, P285; Bare T. M., 1973, ORG SYNTH, V5, P775; BURDON J, 1979, J CHEM SOC CHEM COMM, P1147, DOI 10.1039/c39790001147; Despotopoulou C, 2008, CHEM-EUR J, V14, P2499, DOI 10.1002/chem.200701431; FUKUI K, 1981, ACCOUNTS CHEM RES, V14, P363, DOI 10.1021/ar00072a001; Genna DT, 2011, ORG LETT, V13, P5358, DOI 10.1021/ol202237j; Gilman H, 1933, J AM CHEM SOC, V55, P1258, DOI 10.1021/ja01330a070; GONZALEZ C, 1990, J PHYS CHEM-US, V94, P5523, DOI 10.1021/j100377a021; ISOBE M, 1977, CHEM LETT, P679, DOI 10.1246/cl.1977.679; Jorgenson M. J., 1970, ORG REACTIONS, V18, P1; LUBELL WD, 1988, J AM CHEM SOC, V110, P7447, DOI 10.1021/ja00230a027; Ohki M, 2009, CHEM LETT, V38, P856, DOI 10.1246/cl.2009.856; Posner G. H., 1972, J AM CHEM SOC, V94, P5106; TAKAI K, 1981, B CHEM SOC JPN, V54, P1281, DOI 10.1246/bcsj.54.1281; TROST BM, 1995, ANGEW CHEM INT EDIT, V34, P259, DOI 10.1002/anie.199502591; TUCKMANTEL W, 1986, CHEM BER-RECL, V119, P1581, DOI 10.1002/cber.19861190513; Uchiyama M, 2007, ANGEW CHEM INT EDIT, V46, P926, DOI 10.1002/anie.200602664; Uchiyama M, 2008, J AM CHEM SOC, V130, P472, DOI 10.1021/ja071268u; Uchiyama M, 1997, J AM CHEM SOC, V119, P11425, DOI 10.1021/ja9718477; WEHMEYER RM, 1988, TETRAHEDRON LETT, V29, P4513, DOI 10.1016/S0040-4039(00)80534-1	40	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	JUN	2015	10	6					1286	1290		10.1002/asia.201500308		5	Chemistry, Multidisciplinary	Chemistry	CJ2UC	WOS:000355339100004		
J	Yamanaka, M; Yanai, K; Zama, Y; Tsuchiyagaito, J; Yoshida, M; Ishii, A; Hasegawa, M				Yamanaka, Masamichi; Yanai, Kazushige; Zama, Yusuke; Tsuchiyagaito, Junko; Yoshida, Masaru; Ishii, Ayumi; Hasegawa, Miki			Cation-Tuned Stimuli-Responsive and Optical Properties of Supramolecular Hydrogels	CHEMISTRY-AN ASIAN JOURNAL			English	Article						energy transfer; gels; lanthanides; self-assembly; supramolecular polymers; ureas	SELF-ORGANIZATION; TRIS-UREA; LIGAND; GEL; LUMINESCENCE; NANOFIBERS; COMPLEXES; GELATION; DESIGN	Hierarchical self-assembly of an amphiphilic tris-urea in aqueous media is shown. A mixture of the amphiphilic tris-urea and an alkaline solution gave a viscous solution composed of fibrous aggregates. This viscous solution transformed into supramolecular hydrogels, which are capable of hierarchically organizing into higher-order aggregates in response to several cationic triggers. The resulting supramolecular hydrogels were relatively stiff and their storage moduli attained over 10(3)Pa. The stimuli-responsive and optical properties of the resulting hydrogels were influenced by the cationic trigger. Proton and calcium ion triggers gave pH- and chemical stimuli-responsive hydrogels, respectively. A terbium ion trigger also provided a highly luminescent hydrogel through energy transfer from the tris-urea to terbium.	[Yamanaka, Masamichi; Yanai, Kazushige] Shizuoka Univ, Grad Sch Sci, Dept Chem, Suruga Ku, Shizuoka 4228529, Japan; [Zama, Yusuke; Tsuchiyagaito, Junko; Ishii, Ayumi; Hasegawa, Miki] Aoyama Gakuin Univ, Coll Sci & Engn, Chuo Ku, Sagamihara, Kanagawa 2525258, Japan; [Yoshida, Masaru] Natl Inst Adv Ind Sci & Technol, Res Inst Sustainable Chem, Hiroshima 7390046, Japan	Yamanaka, M (reprint author), Shizuoka Univ, Grad Sch Sci, Dept Chem, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.	yamanaka.masamichi@shizuoka.ac.jp; hasemiki@chem.aoyama.ac.jp			Supported Program for the Strategic Research Foundation at Private Universities;  [2206];  [25107713];  [25107730];  [24310089]	This work was supported by Grant-in-aid for the Scientific Research on the Innovative Areas: "Fusion Materials" (Area No. 2206, No. 25107713 for MY, No. 25107730 for MH), Grant-in-aid for the Scientific Research (B) (No. 24310089 for MY), and the Supported Program for the Strategic Research Foundation at Private Universities (2013-2017 for MH).	Muraoka T, 2008, J AM CHEM SOC, V130, P2946, DOI 10.1021/ja711213s; Yu GC, 2013, CHEM SOC REV, V42, P6697, DOI 10.1039/c3cs60080g; Shi JF, 2011, LANGMUIR, V27, P14425, DOI 10.1021/la2033862; Kuang Y, 2011, CHEM COMMUN, V47, P12625, DOI 10.1039/c1cc15577f; Boekhoven J, 2010, ANGEW CHEM INT EDIT, V49, P4825, DOI 10.1002/anie.201001511; Qiao Y, 2011, CHEM-EUR J, V17, P5180, DOI 10.1002/chem.201003255; Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962; Bowerman CJ, 2010, J AM CHEM SOC, V132, P9526, DOI 10.1021/ja1025535; Estroff LA, 2004, CHEM REV, V104, P1201, DOI 10.1021/cr0302049; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Higashi D, 2013, CHEM-ASIAN J, V8, P2584, DOI 10.1002/asia.201300779; Kotova O, 2012, ANGEW CHEM INT EDIT, V51, P7208, DOI 10.1002/anie.201201506; Komatsu H, 2009, J AM CHEM SOC, V131, P5580, DOI 10.1021/ja8098239; LEHN JM, 1975, J AM CHEM SOC, V97, P6700, DOI 10.1021/ja00856a018; Vemula PK, 2006, J AM CHEM SOC, V128, P8932, DOI 10.1021/ja062650u; Zhang Y, 2003, J AM CHEM SOC, V125, P13680, DOI 10.1021/ja036817k; Yagai S, 2012, J AM CHEM SOC, V134, P18205, DOI 10.1021/ja308519b; Muraoka T, 2009, ANGEW CHEM INT EDIT, V48, P5946, DOI 10.1002/anie.200901524; De Greef TFA, 2009, CHEM REV, V109, P5687, DOI 10.1021/cr900181u; Lehn JM, 2002, SCIENCE, V295, P2400, DOI 10.1126/science.1071063; Mahesh S, 2012, J AM CHEM SOC, V134, P7227, DOI 10.1021/ja301002g; Li XM, 2011, ANGEW CHEM INT EDIT, V50, P9365, DOI 10.1002/anie.201103641; Wood DM, 2012, CHEM-EUR J, V18, P2692, DOI 10.1002/chem.201102137; [Anonymous], ANGEW CHEM; Hasegawa M, 2014, NEW J CHEM, V38, P1225, DOI 10.1039/c3nj00910f; DIEKE GH, 1963, APPL OPTICS, V2, P675, DOI 10.1364/AO.2.000675; Micklitsch CM, 2011, ANGEW CHEM INT EDIT, V50, P1577, DOI 10.1002/anie.201006652; Boekhoven J, 2013, NAT CHEM, V5, P433, DOI 10.1038/nchem.1617; Banerjee S, 2011, SOFT MATTER, V7, P8207, DOI 10.1039/c1sm05672g; Boekhoven J., 2010, ANGEW CHEM, V122, P4935; de Loos M, 2005, EUR J ORG CHEM, P3615, DOI 10.1002/ejoc.200400723; Jinno Y, 2012, CHEM-ASIAN J, V7, P1768, DOI 10.1002/asia.201200152; Jung SH, 2014, CHEM COMMUN, V50, P13107, DOI 10.1039/c4cc06074a; Kotova O., 2012, ANGEW CHEM, V124, P7320; Kuang Y, 2011, CHEM COMMUN, V47, P8772, DOI 10.1039/c1cc13115j; Qiu ZJ, 2009, CHEM COMMUN, P3342, DOI 10.1039/b822840j; Tanabe K, 2012, J AM CHEM SOC, V134, P5652, DOI 10.1021/ja3001979; Wang H, 2010, DALTON T, V39, P7294, DOI 10.1039/c001842b; Yamanaka M, 2013, J INCL PHENOM MACRO, V77, P33, DOI 10.1007/s10847-013-0299-9; Yamanaka M, 2011, CHEM-ASIAN J, V6, P1022, DOI 10.1002/asia.201000791; Yamanaka M, 2008, TETRAHEDRON, V64, P11558, DOI 10.1016/j.tet.2008.10.036	41	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	JUN	2015	10	6					1299	1303		10.1002/asia.201500274		5	Chemistry, Multidisciplinary	Chemistry	CJ2UC	WOS:000355339100007		
J	Ji, QM; Ishihara, S; Terentyeva, TG; Deguchi, K; Ohki, S; Tansho, MS; Shimizu, T; Hill, JP; Ariga, K				Ji, Qingmin; Ishihara, Shinsuke; Terentyeva, Tatyana G.; Deguchi, Kenzo; Ohki, Shinobu; Tansho, Ma-sataka; Shimizu, Tadashi; Hill, Jonathan P.; Ariga, Katsuhiko			Manipulation of Shell Morphology of Silicate Spheres from Structural Evolution in a Purely Inorganic System	CHEMISTRY-AN ASIAN JOURNAL			English	Article						complex shell; hollow sphere; inorganic system; silica; template free	MESOPOROUS SILICA; BORATE GLASSES; VITREOUS SILICA; DRUG-DELIVERY; METAL-OXIDE; NANOSTRUCTURES; SOL; ARCHITECTURES; SPECTROSCOPY; GENERATION	We have investigated the structural transformation of solid silica spheres into various more complex spherical structures including flower-like, thick or thin nanosheet-shelled and porous shelled spheres. In the absence of organic additives, sodium salts contained in this inorganic reaction system apparently direct the silica dissolution and regrowth of dissolved silicate at the nanometer-scale, leading to the formation of a nanosheet network rather than solid aggregates. Subsequent removal of the salts by simple water washing results in voids in the siloxane network and a significant availability of surface silanol groups so that the resulting nanosheets and spheres composed of them possess large surface areas, pore volumes, and morphological flexibility, which can be varied by an applied stimulus. The results represent a rare example of the transformation of a simple silicate structure into a much more complex spherical structure involving a purely inorganic reaction system.	[Ji, Qingmin; Terentyeva, Tatyana G.; Hill, Jonathan P.; Ariga, Katsuhiko] Natl Inst Mat Sci, WPI Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan; [Ishihara, Shinsuke] Natl Inst Mat Sci, Funct Geomat Grp, Tsukuba, Ibaraki 3050044, Japan; [Deguchi, Kenzo; Ohki, Shinobu; Tansho, Ma-sataka; Shimizu, Tadashi] Natl Inst Mat Sci, High Field NMR Grp, Tsukuba, Ibaraki 3050003, Japan	Ji, QM (reprint author), Natl Inst Mat Sci, WPI Ctr Mat Nanoarchitecton, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	JI.Qingmin@nims.go.jp; ARIGA.Katsuhiko@nims.go.jp	ARIGA, Katsuhiko/H-2695-2011; ISHIHARA, Shinsuke/O-4549-2014		World Premier International Research Center Initiative (WPI Initiative) on Materials Nanoarchitectonics, from MEXT, Japan; CREST program of Japan Science and Technology Agency (JST), Japan	This research was supported World Premier International Research Center Initiative (WPI Initiative) on Materials Nanoarchitectonics, from MEXT, Japan and CREST program of Japan Science and Technology Agency (JST), Japan. The authors thank Dr. S. Takenouchi for ICP-AES measurements.	Ahmed A, 2012, ADV MATER, V24, P6042, DOI 10.1002/adma.201202810; Andersen MD, 2004, CEMENT CONCRETE RES, V34, P857, DOI 10.1016/j.cemconres.2003.10.009; Hanrahan JP, 2007, J MATER CHEM, V17, P3881, DOI 10.1039/b705023b; Kojima Y, 2002, INT J HYDROGEN ENERG, V27, P1029, DOI 10.1016/S0360-3199(02)00014-9; Acharya S, 2013, NANO LETT, V13, P409, DOI 10.1021/nl303568d; Chen Y, 2014, ACCOUNTS CHEM RES, V47, P125, DOI 10.1021/ar400091e; Concha BM, 2010, PHYS CHEM CHEM PHYS, V12, P11507, DOI 10.1039/c003652h; Chiang CL, 2002, EUR POLYM J, V38, P2219, DOI 10.1016/S0014-3057(02)00123-4; Li C, 2005, J AM CHEM SOC, V127, P4548, DOI 10.1021/ja050168q; Nardecchia S, 2013, CHEM SOC REV, V42, P794, DOI 10.1039/c2cs35353a; Raula M, 2010, LANGMUIR, V26, P8769, DOI 10.1021/la904507q; Lin YY, 2010, CHEM MATER, V22, P6711, DOI 10.1021/cm102181e; Ji QM, 2013, J MATER CHEM A, V1, P3600, DOI 10.1039/c3ta01572f; Mann S, 2009, NAT MATER, V8, P781, DOI [10.1038/nmat2496, 10.1038/NMAT2496]; Peak D, 2003, GEOCHIM COSMOCHIM AC, V67, P2551, DOI 10.1016/S0016-7037(03)00096-6; Du LS, 2004, J NON-CRYST SOLIDS, V337, P196, DOI 10.1016/j.jnoncrysol.2004.03.115; Gadt T, 2009, NAT MATER, V8, P144, DOI [10.1038/nmat2356, 10.1038/NMAT2356]; Zhang TR, 2008, ANGEW CHEM INT EDIT, V47, P5806, DOI 10.1002/anie.200800927; Tan LF, 2013, RSC ADV, V3, P5649, DOI 10.1039/c3ra40733k; Yan CL, 2014, NEW J CHEM, V38, P1883, DOI 10.1039/c3nj00888f; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Ji QM, 2012, SMALL, V8, P2345, DOI 10.1002/smll.201200317; Zhang AQ, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/13/135608; Wang C, 2013, CHEM SOC REV, V42, P2592, DOI 10.1039/c2cs35325c; Mai YY, 2012, CHEM SOC REV, V41, P5969, DOI 10.1039/c2cs35115c; Shimizu T, 2002, MACROMOL RAPID COMM, V23, P311, DOI 10.1002/1521-3927(20020401)23:5/6<311::AID-MARC311>3.0.CO;2-U; Zhang Q, 2009, NANO TODAY, V4, P494, DOI 10.1016/j.nantod.2009.10.008; Wang ZY, 2012, ADV MATER, V24, P1903, DOI 10.1002/adma.201200469; Chen Y, 2010, ACS NANO, V4, P529, DOI 10.1021/nn901398j; Furukawa S, 2013, CHEM LETT, V42, P570, DOI 10.1246/cl.130357; Niu DC, 2010, J AM CHEM SOC, V132, P15144, DOI 10.1021/ja1070653; Busseron E, 2013, NANOSCALE, V5, P7098, DOI 10.1039/c3nr02176a; Ji QM, 2012, CHEM COMMUN, V48, P8496, DOI 10.1039/c2cc34289h; RAM S, 1995, PHYS REV B, V51, P6280, DOI 10.1103/PhysRevB.51.6280; Qiu HB, 2011, CHEM SOC REV, V40, P1259, DOI 10.1039/c0cs00002g; van Bommel KJC, 2003, ANGEW CHEM INT EDIT, V42, P980, DOI 10.1002/anie.200390284; SCHRAMLMARTH M, 1992, J NON-CRYST SOLIDS, V143, P93, DOI 10.1016/S0022-3093(05)80557-5; Zhou LP, 2011, SOFT MATTER, V7, P9624, DOI 10.1039/c1sm05593c; Wang T, 2013, CHEM SOC REV, V42, P2804, DOI 10.1039/c2cs35318k; Schmidt BC, 1998, J NON-CRYST SOLIDS, V240, P91, DOI 10.1016/S0022-3093(98)00698-X; Kamitsos EI, 2003, PHYS CHEM GLASSES, V44, P79; Li N, 2011, CHEM MATER, V23, P4241, DOI 10.1021/cm2017856; Ma MG, 2012, INT J NANOMED, V7, P1781, DOI 10.2147/IJN.S29884; Tsukuda T, 2012, B CHEM SOC JPN, V85, P151, DOI 10.1246/bcsj.20110227; Antonietti M, 2003, ADV MATER, V15, P1323, DOI 10.1002/adma.200300010; Doweidar H, 2009, J NON-CRYST SOLIDS, V355, P348, DOI 10.1016/j.jnoncrysol.2008.12.008; Terentyeva TG, 2013, J MATER CHEM B, V1, P3248, DOI 10.1039/c3tb20461h; Ariga K, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/1/014109; Coleman JN, 2013, ACCOUNTS CHEM RES, V46, P14, DOI 10.1021/ar300009f; Fang, 2011, NANOSCALE, V3, P1632; Fang AP, 2011, CHEM MATER, V23, P4660, DOI 10.1021/cm202145s; HARTWIG CM, 1978, PHYS REV B, V18, P3006, DOI 10.1103/PhysRevB.18.3006; Kaehr B, 2012, P NATL ACAD SCI USA, V109, P17336, DOI 10.1073/pnas.1205816109; Kellermeier M, 2012, EUR J INORG CHEM, P5123, DOI 10.1002/ejic.201201029; Kim SS, 2004, CERAM INT, V30, P171, DOI 10.1016/S0272-8842(03)00085-3; Kiyonaka S, 2003, CHEM-EUR J, V9, P976, DOI 10.1002/chem.200390120; Li H, 2014, CHEM-EUR J, V20, P499, DOI 10.1002/chem.201302660; Li YY, 2009, CHEM COMMUN, P1085, DOI 10.1039/b818553k; Lin HP, 2001, MICROPOR MESOPOR MAT, V48, P135, DOI 10.1016/S1387-1811(01)00336-5; Nistico R, 2014, Z ANORG ALLG CHEM, V640, P582, DOI 10.1002/zaac.201300526; Ono Y, 2001, J MATER CHEM, V11, P2412, DOI 10.1039/b102550n; Pan A., 2013, ANGEW CHEM INT EDIT, V125, P2282, DOI DOI 10.1002/ANGE.201209535; Richards GJ, 2011, PHYS CHEM CHEM PHYS, V13, P4868, DOI 10.1039/c0cp02025g; Sedlmaier SJ, 2012, J MATER CHEM, V22, P15511, DOI 10.1039/c2jm32100a; Shi CX, 2013, J MATER CHEM A, V1, P14555, DOI 10.1039/c3ta13025h; Shrestha LK, 2013, J AM CHEM SOC, V135, P586, DOI 10.1021/ja3108752; SMITH J, 1973, J MOL SPECTROSC, V45, P327, DOI 10.1016/0022-2852(73)90205-1; Stuart B., 2004, INFRARED SPECTROSCOP; van Bommel K. J. C., 2003, ANGEW CHEM, V115, P1010, DOI 10.1002/ange.200390229; Viart N, 1997, J SOL-GEL SCI TECHN, V8, P183, DOI 10.1023/A:1026425304873; Yuan JJ, 2011, LANGMUIR, V27, P9588, DOI 10.1021/la201645b; Zha CJ, 1998, J SOL-GEL SCI TECHN, V13, P103, DOI 10.1023/A:1008663624419; Zhang HA, 2011, CHEM COMMUN, V47, P7791, DOI 10.1039/c1cc11787d; Zhang T, 2008, ANGEW CHEM, V120, P5890, DOI 10.1002/ange.200800927	74	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	JUN	2015	10	6					1379	1386		10.1002/asia.201500098		8	Chemistry, Multidisciplinary	Chemistry	CJ2UC	WOS:000355339100017		
J	Chen, HX; Imai, S; Toki, H; Geng, LS				Chen Hua-Xing; Imai, Shotaro; Toki, Hiroshi; Geng Li-Sheng			Study of hadrons using the Gaussian functional method in the O(4) linear sigma model	CHINESE PHYSICS C			English	Article						linear sigma model; sigma and pion; Gaussian functional method; Bethe-Salpeter equation; Nambu-Goldstone theorem; finite temperature	QUANTUM-FIELD-THEORY; FINITE-TEMPERATURE; GOLDSTONE THEOREM; SYMMETRY-BREAKING; APPROXIMATION; SUPERCONDUCTIVITY; RENORMALIZATION; STATES	We study properties of hadrons in the O(4) linear a model, where we take into account fluctuations of mesons around their mean field values using the Gaussian functional (GF) method. In the GF method we calculate dressed sigma and pi masses, where we include the effect of fluctuations of mesons to find a better ground state wave function than the mean field approximation. Then we solve the Bethe-Salpeter equations and calculate physical sigma and pi masses. We recover the Nambu-Goldstone :theorem for the physical pion mass to be zero in the chiral limit. The sigma meson is a strongly correlated meson-meson state, and seems to have a two meson composite structure. We calculate sigma and pi masses as functions of temperature for both the chiral limit and explicit chiral symmetry breaking case. We get similar behaviors for the physical sigma and pi masses as the case of the mean field approximation, but the coupling constants are much larger than the values of the case of the mean field approximation.	[Chen Hua-Xing; Geng Li-Sheng] Beihang Univ, Sch Phys & Nucl Energy Engn, Beijing 100191, Peoples R China; [Chen Hua-Xing; Geng Li-Sheng] Beihang Univ, Int Res Ctr Nuclei & Particles Cosmos, Beijing 100191, Peoples R China; [Imai, Shotaro] Kyoto Univ, Dept Phys, Sakyo Ku, Kyoto 6068502, Japan; [Imai, Shotaro] Hokkaido Univ, Meme Media Lab, Sapporo, Hokkaido 0608628, Japan; [Toki, Hiroshi] Osaka Univ, Nucl Phys Res Ctr, Osaka 5670047, Japan	Chen, HX (reprint author), Beihang Univ, Sch Phys & Nucl Energy Engn, Beijing 100191, Peoples R China.	hxchen@buaa.edu.cn; imai@nucl.sci.hokudai.ac.jp; toki@rcnp.osaka-u.ac.jp; lisheng.geng@buaa.edu.cn			National Natural Science Foundation of China [11205011, 11475015, 11005007]; Fundamental Research Funds for the Central Universities; Grant for Scientific Research from MEXT of Japan [E01:21105006, 23540306]; JSPS Research [21540267]	Supported by National Natural Science Foundation of China (11205011, 11475015, 11005007), Fundamental Research Funds for the Central Universities, the Grant for Scientific Research from MEXT of Japan [Priority Areas "New Hadrons" (E01:21105006), (C) No. 23540306], and the JSPS Research (21540267)	STEVENSON PM, 1985, PHYS REV D, V32, P1389, DOI 10.1103/PhysRevD.32.1389; Nemoto Y, 2000, EUR PHYS J A, V9, P245, DOI 10.1007/s100500070042; STEVENSON PM, 1987, PHYS REV D, V35, P2407, DOI 10.1103/PhysRevD.35.2407; Lenaghan JT, 2000, PHYS REV D, V62, DOI 10.1103/PhysRevD.62.085008; Pilaftsis A, 2013, NUCL PHYS B, V874, P594, DOI 10.1016/j.nuclphysb.2013.06.004; Kondo KI, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.061702; Petropoulos N, 1999, J PHYS G NUCL PARTIC, V25, P2225, DOI 10.1088/0954-3899/25/11/305; Roh HS, 1998, EUR PHYS J A, V1, P205, DOI 10.1007/s100500050050; Mao H, 2014, NUCL PHYS A, V925, P185, DOI 10.1016/j.nuclphysa.2014.02.011; CORNWALL JM, 1974, PHYS REV D, V10, P2428, DOI 10.1103/PhysRevD.10.2428; BARNES T, 1980, PHYS REV D, V22, P924, DOI 10.1103/PhysRevD.22.924; Beringer J, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.010001; BRIHAYE Y, 1985, PHYS LETT B, V157, P48, DOI 10.1016/0370-2693(85)91209-2; Chen HX, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.114034; Chen HX, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.034011; Chiku S, 1998, PHYS REV D, V57, P6; Dmitrasinovic V, 2003, J MATH PHYS, V44, P2839, DOI 10.1063/1.1576907; DMITRASINOVIC V, 1995, ANN PHYS-NEW YORK, V238, P332, DOI 10.1006/aphy.1995.1024; Dmitrasinovic V, 1996, Z PHYS C PART FIELDS, V69, P359, DOI 10.1007/s002880050036; EGUCHI T, 1976, PHYS REV D, V14, P2755, DOI 10.1103/PhysRevD.14.2755; Imai S, 2013, NUCL PHYS A, V913, P71, DOI 10.1016/j.nuclphysa.2013.06.001; Kerman AK, 1998, ANN PHYS-NEW YORK, V269, P55, DOI 10.1006/aphy.1998.5838; Marko G, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.105001; Nakamura I, 2001, PROG THEOR PHYS, V106, P1195, DOI 10.1143/PTP.106.1195; Nakamura I, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.056004; NAMBU Y, 1961, PHYS REV, V122, P345, DOI 10.1103/PhysRev.122.345; Ogure K, 1999, PROG THEOR PHYS, V102, P209, DOI 10.1143/PTP.102.209; Okopinska A, 1996, PHYS LETT B, V375, P213, DOI 10.1016/0370-2693(96)00198-0; OKOPINSKA A, 1993, ANN PHYS-NEW YORK, V228, P19, DOI 10.1006/aphy.1993.1086; ROSEN G, 1968, PHYS REV, V173, P1680, DOI 10.1103/PhysRev.173.1680; SCHIFF LI, 1963, PHYS REV, V130, P458, DOI 10.1103/PhysRev.130.458; STEVENSON PM, 1987, Z PHYS C PART FIELDS, V35, P467, DOI 10.1007/BF01596898; SYMANZIK K, 1981, NUCL PHYS B, V190, P1, DOI 10.1016/0550-3213(81)90482-X; Tsue Y, 2008, PROG THEOR PHYS, V121, P577; Tsue Y, 1999, PROG THEOR PHYS, V102, P313, DOI 10.1143/PTP.102.313	35	0	0	CHINESE PHYSICAL SOC	BEIJING	P O BOX 603, BEIJING 100080, PEOPLES R CHINA	1674-1137			CHINESE PHYS C	Chin. Phys. C	JUN	2015	39	6							064103	10.1088/1674-1137/39/6/664103		12	Physics, Nuclear; Physics, Particles & Fields	Physics	CJ5ZB	WOS:000355571700009		
J	Ohara, M; Tomoda, F; Koike, T; Liu, HX; Uno, K; Nitta, A; Inoue, H				Ohara, Maiko; Tomoda, Fumihiro; Koike, Tsutomu; Liu, Hexing; Uno, Kyosuke; Nitta, Atsumi; Inoue, Hiroshi			Pubertal administration of antiserum against nerve growth factor regresses renal vascular remodeling in spontaneously hypertensive rats	CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY			English	Article						immunosympathectomy; nerve growth factor; renal vascular remodeling; spontaneously hypertensive rat; vasodilated perfused kidney	FACTOR MESSENGER-RNA; BLOOD-PRESSURE; SYMPATHETIC INNERVATION; STRUCTURAL-PROPERTIES; RESISTANCE; IMMUNOSYMPATHECTOMY; NEUROTROPHINS; HYPERTROPHY; MECHANISMS; KIDNEYS	To investigate the role of nerve growth factor (NGF) in the development of hypertensive renal vascular remodeling, antiserum against NGF (anti-NGF) or vehicle was injected at 3weeks of age in spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats (n=9 for each treatment in each strain). Flow-pressure (F-P) and pressure-glomerular filtration rate (P-GFR) relationships at vasodilated perfused kidneys were determined at 10weeks of age. In the vehicle rats, blood pressure, renal noradrenaline content, the gradient of F-P (minimal vascular resistance at pre- and post-glomerular vasculature) and the X-intercept of P-GFR (preglomerular:postglomerular vascular resistance ratio) were greater in SHR than in WKY rats, although the gradient of P-GFR (glomerular filtration capacity) did not differ significantly between the strains. Blood pressure and renal noradrenaline content were lower in SHR receiving anti-NGF than in SHR receiving vehicle, although such difference was not observed in WKY rats. The gradient of F-P was less but the gradient of P-GFR was greater in SHR receiving anti-NGF compared with SHR receiving vehicle, although the similar differences did not occur in WKY rats. Blood pressure and renal noradrenaline content remained greater in SHR treated with anti-NGF compared with WKY rats treated with vehicle; however, the gradient of F-P did not differ significantly between them. Contrary, anti-NGF did not affect the X-intercept of P-GFR in either strain. In conclusion, NGF could contribute to the genesis of renal vascular remodeling, at least in part, through modification of renal sympathetic activity and blood pressure in SHR.	[Ohara, Maiko; Tomoda, Fumihiro; Koike, Tsutomu; Liu, Hexing; Inoue, Hiroshi] Toyama Univ, Dept Internal Med 2, Toyama 9300194, Japan; [Uno, Kyosuke; Nitta, Atsumi] Toyama Univ, Dept Pharmaceut Therapy & Neuropharmacol, Toyama 9300194, Japan	Tomoda, F (reprint author), Toyama Univ, Dept Internal Med 2, 2630 Sugitani, Toyama 9300194, Japan.	tomoda@med.u-toyama.ac.jp					Aloe L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-239; Anderson WP, 1995, BLOOD PRESSURE S2, V4, P74; Mulvany MJ, 2012, BASIC CLIN PHARMACOL, V110, P49, DOI 10.1111/j.1742-7843.2011.00758.x; Tomoda F, 1997, J HYPERTENS, V15, P1187, DOI 10.1097/00004872-199715100-00018; SKOV K, 1992, HYPERTENSION, V20, P821; Branchi I, 2004, BEHAV PHARMACOL, V15, P353, DOI 10.1097/00008877-200409000-00006; LEE RMKW, 1991, CIRC RES, V69, P714; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; Lee TM, 2012, CLIN SCI, V123, P445, DOI 10.1042/CS20120080; Zhou SM, 2004, CIRC RES, V95, P76, DOI 10.1161/01.RES.0000133678.22968.e3; Mulvany MJ, 1999, CARDIOVASC RES, V41, P9, DOI 10.1016/S0008-6363(98)00289-2; Caporali A, 2009, PHYSIOL REV, V89, P279, DOI 10.1152/physrev.00007.2008; LEVIMONTALCINI R, 1995, J NEUROL SCI, V130, P119, DOI 10.1016/0022-510X(95)00007-O; Esler M, 2003, ACTA PHYSIOL SCAND, V177, P275, DOI 10.1046/j.1365-201X.2003.01089.x; Clark CG, 2011, J NEUROSCI, V31, P12318, DOI 10.1523/JNEUROSCI.0746-11.2011; BARAJAS L, 1990, AM J PHYSIOL, V259, pF503; Bobik A, 1998, J HYPERTENS, V16, pS51; Bonofiglio R, 2007, J NEPHROL, V20, P186; Brock JA, 1996, J AUTONOM NERV SYST, V61, P97, DOI 10.1016/S0165-1838(96)00063-X; Charchar FJ, 1998, HYPERTENSION, V32, P705; CUTILLETTA AF, 1980, HYPERTENSION, V2, P304; DIBONA GF, 1995, HYPERTENSION, V25, P531; FALCKH PH, 1992, CLIN EXP PHARMACOL P, V19, P541, DOI 10.1111/j.1440-1681.1992.tb00502.x; FOLKOW B, 1972, ACTA PHYSIOL SCAND, V84, P512, DOI 10.1111/j.1748-1716.1972.tb05202.x; HEAD RJ, 1989, BLOOD VESSELS, V26, P1; Hristova MG, 2013, MED HYPOTHESES, V81, P627, DOI 10.1016/j.mehy.2013.07.018; KETT MM, 1995, HYPERTENSION, V25, P335; Kinuno H, 2005, CLIN EXP PHARMACOL P, V32, P173, DOI 10.1111/j.1440-1681.2005.04167.x; KORNER P, 1993, HYPERTENSION, V22, P243; LABORDA J, 1991, NUCLEIC ACIDS RES, V19, P3998, DOI 10.1093/nar/19.14.3998; Lohmeier TE, 2005, AM J PHYSIOL-REG I, V288, pR828, DOI 10.1152/ajpregu.00591.2004; NORRELUND H, 1994, HYPERTENSION, V24, P301; Rush RA, 1997, CLIN EXP PHARMACOL P, V24, P549, DOI 10.1111/j.1440-1681.1997.tb02089.x; Tomoda F, 2000, HYPERTENSION, V36, P68; UEYAMA T, 1992, J HYPERTENS, V10, P215, DOI 10.1097/00004872-199203000-00003; Uno K, 2011, J CELL PHYSIOL, V226, P2953, DOI 10.1002/jcp.22642; Wright CE, 2002, J HYPERTENS, V20, P1023, DOI 10.1097/00004872-200205000-00039; Yu SM, 1996, CIRCULATION, V94, P547; ZETTLER C, 1991, BRAIN RES, V538, P251, DOI 10.1016/0006-8993(91)90437-Z; ZETTLER C, 1993, BRAIN RES, V614, P15, DOI 10.1016/0006-8993(93)91012-H	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1440-1681			CLIN EXP PHARMACOL P	Clin. Exp. Pharmacol. Physiol.	JUN	2015	42	6					687	694		10.1111/1440-1681.12411		8	Pharmacology & Pharmacy; Physiology	Pharmacology & Pharmacy; Physiology	CK0EO	WOS:000355878500018		
J	Asahina, M; Poudel, A; Hirano, S				Asahina, Masato; Poudel, Anupama; Hirano, Shigeki			Sweating on the palm and sole: physiological and clinical relevance	CLINICAL AUTONOMIC RESEARCH			English	Review						Emotional sweating; Eccrine gland; Apocrine gland; Glabrous skin; Electrodermal activity; Sympathetic nervous system	SYMPATHETIC SKIN-RESPONSE; ELECTRODERMAL ACTIVITY; ELECTRICAL-STIMULATION; PARKINSONS-DISEASE; SUDOMOTOR; BRAIN; NEURONS; RAPHE; NEUROPATHY; VASOMOTOR	In mammals, sweating is a multifunctional response that aids in locomotion, thermal regulation, self-protection, and communication of psychological state. Humans possess three types of sweat glands (apocrine, eccrine, and apoeccrine) that are differentially distributed on the body surface and make unique contributions to these distinct functions of the sweating response. In humans, eccrine glands, which are widely distributed on hairy skin, play an important role in thermoregulation. They are also found on the glabrous skin of the palm and sole, where they are not usually activated by heat, but rather by deep respiration, mental stress, and local tactile stimulation. Sweating on the palm and sole, so-called "emotional sweating", acts to prevent slippage while grasping or performing a delicate task using the fingertips. Although the central pathways of emotional sweating are not yet elucidated in detail, it is thought that the amygdala, cingulate cortex, and medulla participate via efferent fibers that descend through the spinal cord and connect to preganglionic sympathetic neurons in the nucleus intermediolateralis. The limbic system, including the amygdala and cingulate cortex, is critical for emotional processing and many cognitive functions. Thus, measurement of sweat output on the palm or sole is useful for evaluating sympathetic function and limbic activity in autonomic and psychiatric disorders.	[Asahina, Masato; Poudel, Anupama; Hirano, Shigeki] Chiba Univ, Sch Med, Dept Neurol, Chuo Ku, Chiba 2608670, Japan	Asahina, M (reprint author), Chiba Univ, Sch Med, Dept Neurol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	asahina@faculty.chiba-u.jp					Salzman CD, 2010, ANNU REV NEUROSCI, V33, P173, DOI 10.1146/annurev.neuro.051508.135256; Mangina CA, 1996, INT J PSYCHOPHYSIOL, V22, P1, DOI 10.1016/0167-8760(96)00022-0; JOHNSON LC, 1966, PSYCHOPHYSIOLOGY, V3, P8, DOI 10.1111/j.1469-8986.1966.tb02673.x; Asahina M, 2003, INT J PSYCHOPHYSIOL, V47, P87, DOI 10.1016/S0167-8760(02)00123-X; Vetrugno R, 2003, CLIN AUTON RES, V13, P256, DOI 10.1007/s10286-003-0107-5; Asahina M, 2003, CLIN AUTON RES, V13, P91, DOI 10.1007/s10286-003-0072-z; Nagai Y, 2011, CURR NEUROL NEUROSCI, V11, P443, DOI 10.1007/s11910-011-0201-3; Mason P, 2001, ANNU REV NEUROSCI, V24, P737, DOI 10.1146/annurev.neuro.24.1.737; Morrison SF, 2011, FRONT BIOSCI-LANDMRK, V16, P74, DOI 10.2741/3677; Morrison SE, 2010, CURR OPIN NEUROBIOL, V20, P221, DOI 10.1016/j.conb.2010.02.007; Cariga P, 2002, J NEUROL NEUROSUR PS, V72, P356, DOI 10.1136/jnnp.72.3.356; Shibasaki M, 2006, J APPL PHYSIOL, V100, P1692, DOI 10.1152/japplphysiol.01124.2005; Medford N, 2010, BRAIN STRUCT FUNCT, V214, P535, DOI 10.1007/s00429-010-0265-x; Asahina M, 2011, J NEUROL SCI, V306, P16, DOI 10.1016/j.jns.2011.04.007; Akaogi Y, 2009, NEUROLOGY, V73, P59, DOI 10.1212/WNL.0b013e3181aae83c; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Macefield VG, 2013, INT J PSYCHOPHYSIOL, V89, P451, DOI 10.1016/j.ijpsycho.2013.06.002; Asahina M, 2006, JP J PERSPIRATION RE, V13, P6; Asahina M, 2007, NEUROSCI LETT, V415, P283, DOI 10.1016/j.neulet.2007.01.033; Asahina M, 2008, J DIABETES COMPLICAT, V22, P278, DOI 10.1016/j.jdiacomp.2007.03.009; Blessing WW, 1999, NEUROSCI LETT, V270, P33, DOI 10.1016/S0304-3940(99)00459-0; Boucsein W., 1992, ELECTRODERMAL ACTIVI; Cohn BA, 1998, INT J DERMATOL, V37, P821, DOI 10.1046/j.1365-4362.1998.00575.x; DRORY VE, 1993, NEUROLOGY, V43, P1818; Forester O, 1936, HDB NEUROLOGIE, P32; Groscurth P, 2002, CURR PROBL DERMATOL, V30, P1; HASHIMOT.K, 1965, J INVEST DERMATOL, V45, P139, DOI 10.1038/jid.1965.110; Hilz MJ, 1999, NEUROLOGY, V52, P1652; Hurst P, 2012, ENDOCRINOLOGY, V153, P1908, DOI 10.1210/en.2011-1827; Kikkawa Y, 2003, PARKINSONISM RELAT D, V10, P101, DOI 10.1016/S1353-8020(03)00109-3; Lim CL, 2003, CLIN NEUROPHYSIOL, V114, P2172, DOI 10.1016/S1388-2457(03)00204-9; Magnifico F, 1998, CLIN AUTON RES, V8, P133, DOI 10.1007/BF02281117; Marchello L, 1996, FUNCT NEUROL, V11, P283; Mathias CJ, 2002, AUTONOMIC FAILURE TX, P169; MCALLEN RM, 1986, NEUROSCIENCE, V18, P51, DOI 10.1016/0306-4522(86)90178-8; Mesulam MM, 2000, PRINCIPLES BEHAV COG, P4; Morrison SF, 1999, AM J PHYSIOL-REG I, V276, pR962; Nakazato Y, 2004, NEUROLOGY, V63, P1476; NATHAN PW, 1987, J NEUROL NEUROSUR PS, V50, P1253, DOI 10.1136/jnnp.50.10.1253; NAVARRO X, 1993, MUSCLE NERVE, V16, P404, DOI 10.1002/mus.880160410; Noel F, 2012, INT J DERMATOL, V51, P647, DOI 10.1111/j.1365-4632.2011.05307.x; Pierard GE, 2003, SKIN PHARMACOL APPL, V16, P324, DOI 10.1159/000072072; Saga K, 2002, PROG HISTOCHEM CYTO, V37, P323, DOI 10.1016/S0079-6336(02)80005-5; SATO M, 1979, BRAIN RES BULL, V4, P184, DOI 10.1016/0361-9230(79)90088-1; Shafton AD, 2013, AM J PHYSIOL-REG I, V304, pR804, DOI 10.1152/ajpregu.00040.2013; Shivji ZM, 1999, MUSCLE NERVE, V22, P1283, DOI 10.1002/(SICI)1097-4598(199909)22:9<1283::AID-MUS19>3.0.CO;2-#; SOLIVEN B, 1987, MUSCLE NERVE, V10, P711, DOI 10.1002/mus.880100806; Wakabayashi K, 1997, EUR NEUROL, V38, P2, DOI 10.1159/000113469; WANG SJ, 1994, MUSCLE NERVE, V17, P411, DOI 10.1002/mus.880170408; Watanabe H, 2003, GERONTOLOGY, V49, P366, DOI 10.1159/000073764; YOKOTA T, 1991, BRAIN, V114, P1381, DOI 10.1093/brain/114.3.1381; Zahn TP, 1999, NEUROPSYCHOLOGIA, V37, P1227, DOI 10.1016/S0028-3932(99)00020-2	52	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0959-9851	1619-1560		CLIN AUTON RES	Clin. Auton. Res.	JUN	2015	25	3					153	159		10.1007/s10286-015-0282-1		7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CK1CF	WOS:000355942300003		
J	Sato, H; Higashi, S; Miyazaki, K				Sato, Hiroki; Higashi, Shouichi; Miyazaki, Kaoru			Amino-terminal fragments of laminin gamma 2 chain stimulate migration of metastatic breast cancer cells by interacting with CD44	CLINICAL & EXPERIMENTAL METASTASIS			English	Article						Laminin gamma 2 chain; CD44; Cell migration; Tumor invasion; Cancer stem cells	STEM-CELLS; TGF-BETA; COLORECTAL-CANCER; GROWTH-FACTOR; SHORT ARM; BIOLOGICAL-ACTIVITY; CARCINOMA-CELLS; TUMOR INVASION; EXPRESSION; VARIANT	Laminin gamma 2 (Lm gamma 2) chain, a subunit of the basement membrane protein laminin-332, is regarded as a typical cancer invasion marker. The overexpression of Lm gamma 2 chain by invasive cancer cells correlates with poor prognosis of cancer patients, and its forced expression in human cancer cells promotes their invasive growth in a nude mouse model. However, its actual roles in cancer progression, as well as the mechanism of its proinvasive effect, remain unclear. CD44 is known to be an important cancer stem cell marker and support cancer progression and stem cell functions. Here we demonstrate that amino-terminal fragments of Lm gamma 2 interact with CD44 on the membrane of breast cancer cells. Lm gamma 2 highly bound to the metastatic cell line MDA-MB-231 but poorly to the benign cell line MCF-7. The membrane receptor for Lm gamma 2 on MDA-MB-231 cells was identified to be the standard form of CD44 (CD44s) by co-immunoprecipitation, affinity chromatography and direct protein interaction assay. Lm gamma 2 interacted with CD44s through EGF-like repeat 2/3 in the Lm gamma 2 amino-terminus. Amino-terminal fragments of Lm gamma 2 induced the phosphorylation of CD44 cytoplasmic domain and stimulated migration of the cancer cells in a CD44-dependent manner. This migration was blocked by inhibitors of TGF-beta receptor I (TGF-beta RI) kinase. These results suggest that two important tumor markers, Lm gamma 2 and CD44, cooperate for cancer progression and possibly for cancer stem cell functions. TGF-beta RI may be involved in the Lm gamma 2/CD44 interaction.	[Sato, Hiroki; Higashi, Shouichi; Miyazaki, Kaoru] Yokohama City Univ, Dept Genome Sci, Grad Sch Nanobiosci, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan; [Sato, Hiroki; Higashi, Shouichi; Miyazaki, Kaoru] Yokohama City Univ, Div Cell Biol, Kihara Inst Biol Res, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan; [Miyazaki, Kaoru] Kanagawa Canc Ctr, Res Inst, Asahi Ku, Yokohama, Kanagawa 2418515, Japan	Miyazaki, K (reprint author), Kanagawa Canc Ctr, Res Inst, Asahi Ku, 2-3-2 Nakao, Yokohama, Kanagawa 2418515, Japan.	miyazaki@yokohama-cu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23112517, 23300351]	This work was supported by Grants-in-Aid (23112517 and 23300351) for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We thank Ms Naoko Watanabe and Atsuko Sugino for technical assistance. We are grateful to Drs. Eriko Komiya and Jun Oyanagi for technical support and helpful discussion.	Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Katayama M, 2004, J MOL HISTOL, V35, P277; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Koshikawa N, 1999, CANCER RES, V59, P5596; Bourguignon LYW, 1997, J BIOL CHEM, V272, P27913, DOI 10.1074/jbc.272.44.27913; Mima K, 2012, CANCER RES, V72, P3414, DOI 10.1158/0008-5472.CAN-12-0299; Wang SJ, 2009, LARYNGOSCOPE, V119, P1518, DOI 10.1002/lary.20506; Ogawa T, 2007, MOL BIOL CELL, V18, P1621, DOI 10.1091/mbc.E06-09-0806; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Bourguignon LYW, 2012, J BIOL CHEM, V287, P32800, DOI 10.1074/jbc.M111.308528; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Sherman L, 1998, GENE DEV, V12, P1058, DOI 10.1101/gad.12.7.1058; WIELENGA VJM, 1993, CANCER RES, V53, P4754; Sato H, 2014, CANCER SCI, V105, P168, DOI 10.1111/cas.12323; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702; Miyazaki K, 2006, CANCER SCI, V97, P91, DOI 10.1111/j.1349-7006.00150.x; Ban S, 2005, J RADIAT RES, V46, P43, DOI 10.1269/jrr.46.43; BENNETT KL, 1995, J CELL BIOL, V128, P687, DOI 10.1083/jcb.128.4.687; DALL P, 1994, CANCER RES, V54, P3337; Gagnoux-Palacios L, 2001, J CELL BIOL, V153, P835, DOI 10.1083/jcb.153.4.835; Hamasaki H, 2011, BRIT J CANCER, V105, P824, DOI 10.1038/bjc.2011.283; Kariya Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035546; Katayama M, 2005, CANCER LETT, V225, P167, DOI 10.1016/j.canlet.2004.11.052; KAUFMANN M, 1995, LANCET, V345, P615, DOI 10.1016/S0140-6736(95)90521-9; Koshikawa N, 2005, J BIOL CHEM, V280, P88, DOI 10.1074/jbc.M411824200; Ogawa T, 2004, J CELL BIOCHEM, V92, P701, DOI 10.1002/jcb.20112; Olsson E, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-418; Oyanagi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053209; PYKE C, 1994, AM J PATHOL, V145, P782; Sasaki T, 2001, J MOL BIOL, V314, P751, DOI 10.1006/jmbi.2001.5176; Shen XM, 2007, CLIN EXP METASTAS, V24, P541, DOI 10.1007/s10585-007-9091-9; Tsubota Y, 2010, INT J CANCER, V127, P2031, DOI 10.1002/ijc.25231; Veitch DP, 2003, J BIOL CHEM, V278, P15661, DOI 10.1074/jbc.M210588200; Wielenga VJM, 2000, AM J PATHOL, V157, P1563, DOI 10.1016/S0002-9440(10)64793-1	43	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0262-0898	1573-7276		CLIN EXP METASTAS	Clin. Exp. Metastasis	JUN	2015	32	5					405	415		10.1007/s10585-015-9705-6		11	Oncology	Oncology	CK0WR	WOS:000355926700001		
J	Yan, X; Zhang, XW; Gao, J; Matsushita, Y; Koyano, K; Jiang, X; Ai, HJ				Yan, Xu; Zhang, Xinwen; Gao, Jie; Matsushita, Yasuyuki; Koyano, Kiyoshi; Jiang, Xi; Ai, Hongjun			Maxillary Sinus Augmentation without Grafting Material with Simultaneous Implant Installation: A Three-Dimensional Finite Element Analysis	CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH			English	Article						dental implants; finite element analysis; maxillary sinus augmentation without grafting material; stress distribution	FLOOR ELEVATION; DENTAL IMPLANTS; MEMBRANE ELEVATION; HISTOLOGIC-CHANGES; SURVIVAL RATES; ORAL IMPLANTS; BONE-GRAFTS; PLACEMENT; STRESS; REGION	PurposeThe study aims to provide a theoretical guidance of postmaxillary implant in the augmented sinus without grafting materials by establishing a three-dimensional model of this new implant restorative technique, evaluating failure risk of sinus augmentation without grafting materials of different alveolar ridge heights, and analyzing stress distribution of different healing stage. Materials and MethodsSeventeen three-dimensional finite element models of a posterior maxillary region with sinus mucosa and different elevation heights were constructed according to anatomical data of sinus area, and the standard implant model based on Nobel Biocare implant system were created via computer-aided design software. All materials were assumed to be isotropic and linearly elastic. Axial force of 150N was applied. The von Mises stress, stress distribution, and implant displacement were calculated with software. ResultsWith the height of the alveolar ridge reducing, the maximum von Mises stress of tissues and the displacement of the implant are on the rise, especially when the height of the bone is less than 7mm. When the height decreased to 4mm, the data may be doubled. After the stiff callus stage, the stress and displacement were close to the control model. ConclusionFor maxillary sinus augmentation without grafting material implant technique, the stress of different tissues and the displacement of the implant were not increased much when the height of alveolar ridge is more than 7mm. But if the alveolar bone height is less than 4mm, this implant technique is not suggested. Immediately loading is not suggested and the loading opportunity should be after the stiff callus stage at least to improve the success rate.	[Zhang, Xinwen] China Med Univ, Sch Stomatol, Ctr Implant Dent, Shenyang 110001, Peoples R China; [Gao, Jie; Matsushita, Yasuyuki; Koyano, Kiyoshi] Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Sect Removable Prosthodont, Fukuoka 812, Japan; [Jiang, Xi] Peking Univ, Sch & Hosp Stomatol, Dept Oral Implantol, Beijing 100871, Peoples R China; [Yan, Xu; Ai, Hongjun] China Med Univ, Sch Stomatol, Dept Prosthodont, Shenyang 110001, Peoples R China	Yan, X (reprint author), China Med Univ, Sch Stomatol, Dept Prosthodont, 117 Nanjing North St, Shenyang 110001, Peoples R China.	xuyan5119@yeah.net			School of Stomatology, China Medical University, Shenyang, China [K101593-12-34]; Regenerative Dentistry and Implant Center; Section of Removable Prosthodontics, Division of Oral Rehabilitation, the Faculty of Dental Science, Kyushu University, Fukuoka, Japan	This research was supported by School of Stomatology, China Medical University, Shenyang, China (grantsK101593-12-34). The authors would like to thank the Regenerative Dentistry and Implant Center, and Section of Removable Prosthodontics, Division of Oral Rehabilitation, the Faculty of Dental Science, Kyushu University, Fukuoka, Japan, for their support and allowing us to use of their facilities.	Akca K, 2006, MED BIOL ENG COMPUT, V44, P527, DOI 10.1007/s11517-006-0072-y; Lacroix D, 2002, MED BIOL ENG COMPUT, V40, P14, DOI 10.1007/BF02347690; Zijderveld SA, 2005, INT J ORAL MAX IMPL, V20, P432; Viceconti M, 2001, CLIN BIOMECH, V16, P765, DOI 10.1016/S0268-0033(01)00052-3; Ding X, 2009, J PROSTHODONT, V18, P393, DOI 10.1111/j.1532-849X.2009.00453.x; Palma VC, 2006, CLIN IMPLANT DENT R, V8, P11, DOI 10.2310/6480.2005.00026; Timmenga NM, 2003, EUR J ORAL SCI, V111, P189, DOI 10.1034/j.1600-0722.2003.00012.x; Inglam S, 2010, MED BIOL ENG COMPUT, V48, P681, DOI 10.1007/s11517-010-0584-3; Van Staden R. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P257, DOI 10.1080/10255840600837074; WETZEL AC, 1995, CLIN ORAL IMPLAN RES, V6, P155, DOI 10.1034/j.1600-0501.1995.060304.x; Mellal A, 2004, CLIN ORAL IMPLAN RES, V15, P239, DOI 10.1111/j.1600-0501.2004.01000.x; ULM CW, 1995, INT J ORAL MAX SURG, V24, P279, DOI 10.1016/S0901-5027(95)80029-8; Claes LE, 1999, J BIOMECH, V32, P255, DOI 10.1016/S0021-9290(98)00153-5; Del Fabbro M, 2008, EUR J ORAL SCI, V116, P497, DOI 10.1111/j.1600-0722.2008.00571.x; Del Fabbro M, 2004, INT J PERIODONT REST, V24, P565; Thor A, 2007, J ORAL MAXIL SURG, V65, P64, DOI 10.1016/j.joms.2006.10.047; Winter AA, 2002, INT J ORAL MAX IMPL, V17, P687; Gosau M, 2009, ANAT REC, V292, P352, DOI 10.1002/ar.20859; Koca OL, 2005, J PROSTHET DENT, V93, P38, DOI 10.1016/j.prosdent.2004.10.001; Ferrigno N, 2006, CLIN ORAL IMPLAN RES, V17, P194, DOI 10.1111/j.1600-0501.2005.01192.x; Ariji Y, 1996, DENTOMAXILLOFAC RAD, V25, P19; Bergh J, 2000, CLIN ORAL IMPLAN RES, V11, P256; Block MS, 1995, ENDOSSEOUS IMPLANTS, P696; Bravetti P, 1998, J ORAL MAXIL SURG, V56, P1170, DOI 10.1016/S0278-2391(98)90765-0; Cattaneo PM, 2003, AM J ORTHOD DENTOFAC, V123, P367, DOI 10.1067/mod.2003.73; Doi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049051; Esposito M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003878.pub5; Fanuscu Mete I, 2004, J Oral Implantol, V30, P59, DOI 10.1563/0.674.1; Gabbert O, 2009, J CLIN PERIODONTOL, V36, P177, DOI 10.1111/j.1600-051X.2008.01357.x; Huang HL, 2008, INT J ORAL MAXILLOF, V24, P455; Hurzeler MB, 1997, CLIN ORAL IMPLAN RES, V8, P476, DOI 10.1034/j.1600-0501.1997.080606.x; Li T, 2012, OR SURG OR MED OR PA, V114, pE1, DOI 10.1016/j.oooo.2011.08.010; [刘晓芳 Liu Xiaofang], 2011, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V15, P9742; Lundgren Stefan, 2004, Clin Implant Dent Relat Res, V6, P165, DOI 10.1111/j.1708-8208.2004.tb00224.x; Lundgren Stefan, 2003, Clin Implant Dent Relat Res, V5, P78, DOI 10.1111/j.1708-8208.2003.tb00187.x; Mertens C, 2014, CLIN IMPLANT DENT R, V16, P365, DOI 10.1111/j.1708-8208.2012.00484.x; Nedir R, 2006, CLIN ORAL IMPLAN RES, V17, P679, DOI 10.1111/j.1600-0501.2006.01264.x; Okumura Nobuaki, 2010, J Prosthodont Res, V54, P133, DOI 10.1016/j.jpor.2009.12.004; Okumura Nobuaki, 2011, J Prosthodont Res, V55, P24, DOI 10.1016/j.jpor.2010.07.002; Pommer B, 2009, CLIN ORAL IMPLAN RES, V20, P633, DOI 10.1111/j.1600-0501.2008.01686.x; Rues S, 2004, P APPL MATH MECH, V4, P368, DOI 10.1002/pamm.200410165; Schuller-Gotzburg P, 2012, INT J ORAL MAX IMPL, V27, P359; Sul SH, 2008, ORAL SURG ORAL MED O, V105, pE1, DOI 10.1016/j.tripleo.2007.11.019; Underwood AS, 1910, J ANAT PHYSIOL, V44, P354; Winter AA, 2003, INT J PERIODONT REST, V23, P557	45	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1523-0899	1708-8208		CLIN IMPLANT DENT R	Clin. Implant Dent. Relat. Res.	JUN	2015	17	3					515	524		10.1111/cid.12254		10	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CJ7DX	WOS:000355655500012		
J	Okubo, T; Tsuchida, A; Kokufuta, E				Okubo, Tsuneo; Tsuchida, Akira; Kokufuta, Etsuo			Drying dissipative structures of gelatin solution	COLLOID AND POLYMER SCIENCE			English	Article						Gelation; Gelatin; Drying pattern; Dissipative structure; Broad ring; Sharpness parameter	DEIONIZED AQUEOUS SUSPENSION; THERMOSENSITIVE GEL SPHERES; POLY(RIBOADENYLIC ACID); POLY(ETHYLENE GLYCOL); POTASSIUM-SALTS; SODIUM-SALTS; COVER GLASS; CRYSTALLIZATION; PATTERNS; POLY(N-ISOPROPYLACRYLAMIDE)	Macroscopic and microscopic drying patterns formed from aqueous gelatin solutions on a cover glass were studied as a function of gelatin concentration and temperature. Specific drying patterns were observed within the circular dried film resulting from a droplet of the solution (0.1 ml) placed on the cover glass surface when the droplet evaporated. Two broad rings formed at the outside edge of the dried film and the inner area. d (f) /d (i) values of the inner broad rings decreased sharply with increasing gel concentration, where d (f) is the final size of the broad ring in the dried film and d (i) is the size of initial liquid in diameter. Thickness profiles of the dried film changed sharply from the broad ring to the round hill at the center as gelatin concentration increased. The sharpness parameter S (or S') were evaluated from the ratio of the film size (diameter) against the full widths at half maximum (or the full widths at the bottom layer) in the thickness profiles of the broad ring and/or the round hill. The S (or S') values changed transitionally at the critical concentration and temperature of gelation. The gelation of gelatin collagen was resulted in the disturbed convectional diffusion of solutes during dryness. The round hill-like thickness profile at the high polymer concentration and at low temperature also supports the gelation. These observations support that gelation process of collagen molecules is followed from decrease in S (or S') values in the macroscopic patterns. Dendritic, hedrite, and/or spherulite microscopic drying patterns were observed especially in the central area and at low temperatures.	[Okubo, Tsuneo] Inst Colloidal Org, Uji, Kyoto 6110012, Japan; [Tsuchida, Akira] Gifu Univ, Dept Appl Chem, Gifu 5011193, Japan; [Kokufuta, Etsuo] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Kokufuta, Etsuo] Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3058572, Japan	Okubo, T (reprint author), Inst Colloidal Org, Hatoyama 3-1-112, Uji, Kyoto 6110012, Japan.	okubotsu@ybb.ne.jp					RAMACHANDRAN GN, 1954, NATURE, V174, P269, DOI 10.1038/174269c0; Okubo T, 2014, COLLOID POLYM SCI, V292, P1419, DOI 10.1007/s00396-014-3200-5; Yamaguchi T, 2005, COLLOID POLYM SCI, V283, P1123, DOI 10.1007/s00396-004-1258-1; Okubo T, 2009, COLLOID POLYM SCI, V287, P1435, DOI 10.1007/s00396-009-2110-4; Okubo T, 2011, COLLOID SURFACE B, V87, P11, DOI 10.1016/j.colsurfb.2011.03.022; Okubo T, 2012, COLLOID POLYM SCI, V290, P1901, DOI 10.1007/s00396-012-2727-6; HULMES DJS, 1979, NATURE, V282, P878, DOI 10.1038/282878a0; Fujii S, 2014, COLLOID POLYM SCI, V292, P2621, DOI 10.1007/s00396-014-3315-8; Fujii S, 2014, COLLOID POLYM SCI, V292, P2303, DOI 10.1007/s00396-014-3277-x; HALL CE, 1958, J AM CHEM SOC, V80, P1269, DOI 10.1021/ja01539a001; Ida T, 2008, J APPL CRYSTALLOGR, V41, P393, DOI 10.1107/S0021889807067659; Morawetz H., 1965, MACROMOLECULES SOLUT; Nagai T., 2012, Food and Nutrition Sciences, V3, P72; Okubo T, 2006, MOL COLLOIDAL ELECTR, P573; Okubo T, 2013, COLLOID POLYM SCI, V291, P1019, DOI 10.1007/s00396-012-2825-5; Okubo T, 2011, COLLOID POLYM SCI, V289, P1729, DOI 10.1007/s00396-011-2495-8; Okubo T, 2014, COLLOID POLYM SCI, V292, P133, DOI 10.1007/s00396-013-3053-3; Okubo T, 2014, COLLOID POLYM SCI, V292, P3187, DOI 10.1007/s00396-014-3370-1; Okubo T, 2011, COLLOID SURFACE B, V87, P439, DOI 10.1016/j.colsurfb.2011.06.006; Okubo T, 2010, COLLOID POLYM SCI, V288, P245, DOI 10.1007/s00396-009-2177-y; Okubo T, 2008, NANOPARTICLES SYNTHE, P256; Okubo T, 2011, COLLOID POLYM SCI, V289, P1205, DOI 10.1007/s00396-011-2444-6; Okubo T, 2010, COLLOID POLYM SCI, V288, P189, DOI 10.1007/s00396-009-2152-7; Okubo T, 2013, COLLOID POLYM SCI, V291, P2447, DOI 10.1007/s00396-013-2972-3; Okubo T, 2012, COLLOID POLYM SCI, V290, P867, DOI 10.1007/s00396-012-2602-5; Okubo T, 2004, COLLOID POLYM SCI, V282, P230, DOI 10.1007/s00396-003-0899-9; Okubo T, 2011, COLLOID POLYM SCI, V289, P807, DOI 10.1007/s00396-011-2402-3; Okubo T, 2009, COLLOID POLYM SCI, V287, P1155, DOI 10.1007/s00396-009-2075-3; Okubo T, COLLOID POLYM SCI, V291, P2805; Okubo T, 2012, COLLOID POLYM SCI, V290, P411, DOI 10.1007/s00396-011-2561-2; Okubo T, 2006, COLLOID POLYM SCI, V285, P339, DOI 10.1007/S00396-006-1577-5; Okubo T, 2007, COLLOID POLYM SCI, V285, P999, DOI 10.1007/s00396-007-1645-5; Okubo T, 2010, COLLOID POLYM SCI, V288, P981, DOI 10.1007/s00396-010-2218-6; Okubo T, 2010, COLLOID POLYM SCI, V288, P1551, DOI 10.1007/s00396-010-2239-4; Okubo T, 2011, COLLOID POLYM SCI, V289, P159, DOI 10.1007/s00396-010-2324-5; Okubo T, 2010, COLLOID POLYM SCI, V288, P1435, DOI 10.1007/s00396-010-2281-z; Okubo T, 2005, LANGMUIR, V21, P9889, DOI 10.1021/la050692a; Okubo T, 2010, MACROMOL SYMP, V288, P67, DOI 10.1002/masy.201050209; Okubo T, 2014, COLLOID POLYM SCI, V292, P381, DOI 10.1007/s00396-013-3082-y; Okubo T, 2013, COLLOID POLYM SCI, V291, P1887, DOI 10.1007/s00396-013-2930-0; Okubo T, 2009, COLLOID POLYM SCI, V287, P933, DOI 10.1007/s00396-009-2049-5; Von Hippel P. H., 1969, STRUCTURE STABILITY, P417; Ward A. G., 1977, SCI TECHNOLOGY GELAT	43	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	JUN	2015	293	6					1583	1591		10.1007/s00396-015-3558-z		9	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CJ2SK	WOS:000355334600001		
J	Kuwahara, RY; Oi, T; Hashimoto, K; Tamesue, S; Yamauchi, T; Tsubokawa, N				Kuwahara, Rie Yamazaki; Oi, Takuya; Hashimoto, Kumi; Tamesue, Shingo; Yamauchi, Takeshi; Tsubokawa, Norio			Easy preparation of graphene-based conducting polymer composite via organogel	COLLOID AND POLYMER SCIENCE			English	Article						Reduced graphene oxide; Conducting polymer; Organogel; Composite material; Electrical conductivity; Organogelator	IN-SITU POLYMERIZATION; ORGANIC ELECTRONICS; OXIDE; POLYANILINE; FABRICATION; DISPERSION	A highly electrically conducting graphene (reduced graphene oxide, rGO)-based polymer composite was successfully prepared via organogels using an organically dispersible polyaniline (PANI) and a low molecular-weight organogelator consisting of cholesterol derivatives. The plain gel was prepared by heat treatment of a mixture of toluene and the organogelator. PANI-rGO organogel was prepared by adding PANI and rGO to the plain gel and mixing them. Microscopic studies established that organogelators formed three-dimensional networks and that the PANI aggregates and rGO particles were dispersed within the organogels. Viscoelastic measurements demonstrated that the PANI-rGO organogel showed rapid and repeatedly thixotropic behavior. "Dried" PANI-rGO composites showed high electrical conductivity. A ballpoint pen was filled with the PANI-rGO organogel and used to produce lines similar to the ones produced by commercially available ballpoint pen. The line showed electrical conductivity. The novel PANI-rGO composite shows high electrical conductivity through easy preparation, one which is just like mixing.	[Kuwahara, Rie Yamazaki; Oi, Takuya; Tamesue, Shingo; Yamauchi, Takeshi] Niigata Univ, Grad Sch Sci & Technol, Nishi Ku, Niigata 9502181, Japan; [Hashimoto, Kumi; Tamesue, Shingo; Yamauchi, Takeshi; Tsubokawa, Norio] Niigata Univ, Fac Engn, Dept Sci & Technol, Nishi Ku, Niigata 9502181, Japan	Yamauchi, T (reprint author), Niigata Univ, Fac Engn, Dept Sci & Technol, Nishi Ku, Ikarashi 2 No Cho, Niigata 9502181, Japan.	yamauchi@gs.niigata-u.ac.jp	Tamesue, Shingo/D-9009-2013				Das TK, 2013, POLYM-PLAST TECHNOL, V52, P319, DOI 10.1080/03602559.2012.751410; Hirst AR, 2008, ANGEW CHEM INT EDIT, V47, P8002, DOI 10.1002/anie.200800022; Lingappan N, 2013, MOL CRYST LIQ CRYST, V585, P60, DOI 10.1080/15421406.2013.849510; Kuilla T, 2010, PROG POLYM SCI, V35, P1350, DOI 10.1016/j.progpolymsci.2010.07.005; Zhang W, 2014, ACS APPL MATER INTER, V6, P2248, DOI 10.1021/am4057562; Wang HL, 2010, ACS APPL MATER INTER, V2, P821, DOI 10.1021/am900815k; Karim MR, 2005, SYNTHETIC MET, V151, P131, DOI 10.1016/j.synthmet.2005.03.012; Yan J, 2010, CARBON, V48, P487, DOI 10.1016/j.carbon.2009.09.066; Potts JR, 2011, POLYMER, V52, P5, DOI 10.1016/j.polymer.2010.11.042; Loh KP, 2010, NAT CHEM, V2, P1015, DOI [10.1038/nchem.907, 10.1038/NCHEM.907]; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; Buerkle LE, 2012, CHEM SOC REV, V41, P6089, DOI 10.1039/c2cs35106d; Loh KP, 2010, J MATER CHEM, V20, P2277, DOI 10.1039/b920539j; Wang DW, 2009, ACS NANO, V3, P1745, DOI 10.1021/nn900297m; Kumar NA, 2012, ACS NANO, V6, P1715, DOI 10.1021/nn204688c; Pang SP, 2011, ADV MATER, V23, P2779, DOI 10.1002/adma.201100304; Du JH, 2012, MACROMOL CHEM PHYS, V213, P1060, DOI 10.1002/macp.201200029; Zelikman E, 2008, POLYM ENG SCI, V48, P1872, DOI 10.1002/pen.21208; Singh V, 2011, PROG MATER SCI, V56, P1178, DOI 10.1016/j.pmatsci.2011.03.003; Kim J, 2012, ACCOUNTS CHEM RES, V45, P1356, DOI 10.1021/ar300047s; Ramasamy MS, 2014, J MATER CHEM A, V2, P4788, DOI 10.1039/c3ta14734g; Babu SS, 2012, ANGEW CHEM INT EDIT, V51, P1766, DOI 10.1002/anie.201106767; Kostarelos K, 2014, SCIENCE, V344, P261, DOI 10.1126/science.1246736; Dawn A, 2011, CHEM-ASIAN J, V6, P266, DOI 10.1002/asia.201000217; Zhang JT, 2012, J PHYS CHEM C, V116, P5420, DOI 10.1021/jp211474e; Mishra SK, 2014, SENSOR ACTUAT B-CHEM, V199, P190, DOI 10.1016/j.snb.2014.03.109; Baibarac M, 2003, CHEM MATER, V15, P4149, DOI 10.1021/cm021287x; Arzac A, 2014, PART PART SYST CHAR, V31, P143, DOI 10.1002/ppsc.201300286; Bhadra S, 2009, PROG POLYM SCI, V34, P783, DOI 10.1016/j.progpolymsci.2009.04.003; Ghatak S, 2011, J APPL POLYM SCI, V119, P1016, DOI 10.1002/app.31962; HANABUSA K, 1993, J CHEM SOC CHEM COMM, P1382, DOI 10.1039/c39930001382; Jaber-Ansari L, 2012, MRS BULL, V37, P1167, DOI 10.1557/mrs.2012.182; Kuramoto N, 2008, Japan Patent Kokai, Patent No. [2008-169255, 2008169255]; Kuwahara RY, 2015, POLYMER, V61, P99, DOI 10.1016/j.polymer.2014.12.059; Maheshkumar KV, 2014, POLYM COMPOSITE, V35, P2297, DOI 10.1002/pc.22899; Park OK, 2009, SCRIPTA MATER, V60, P551, DOI 10.1016/j.scriptamat.2008.12.005; Saha A, 2010, NANOSCALE, V2, P2777, DOI 10.1039/c0nr00376j; Weiss R. G., 2006, MOL GELS MAT SELF AS; Yamazaki R, 1999, B NAGAOKA U TECH, V21, P97; Yang JH, 2010, J PHYS CHEM SOLIDS, V71, P448, DOI 10.1016/j.jpcs.2009.12.008; Yu YJ, 2005, SYNTHETIC MET, V150, P271, DOI 10.1016/j.synthmet.2005.02.011	43	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	JUN	2015	293	6					1635	1645		10.1007/s00396-015-3539-2		11	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CJ2SK	WOS:000355334600006		
J	Biswas, CS; Mitra, K; Singh, S; Ramesh, K; Misra, N; Maiti, B; Panda, AK; Maiti, P; Kamigaito, M; Okamoto, Y; Ray, B				Biswas, Chandra Sekhar; Mitra, Kheyanath; Singh, Shikha; Ramesh, Kalyan; Misra, Nira; Maiti, Biswajit; Panda, Amiya Kumar; Maiti, Pralay; Kamigaito, Masami; Okamoto, Yoshio; Ray, Biswajit			Study of the effect of isotacticity on some physical properties of poly(N-isopropylacrylamide)	COLLOID AND POLYMER SCIENCE			English	Article						Isotactic PNIPAM; Solubility; Thermogravimetry; Powder XRD; Cloud point; Surface tension; Viscosity	Y(OTF)(3) LEWIS-ACID; N-ISOPROPYLACRYLAMIDE; AQUEOUS-SOLUTIONS; PHASE-SEPARATION; STEREOCONTROLLED POLY(N-ISOPROPYLACRYLAMIDE); RADICAL POLYMERIZATION; MOLECULAR-WEIGHT; SYNDIOTACTIC-SPECIFICITY; ANIONIC-POLYMERIZATION; RHEOLOGICAL BEHAVIOR	Some physical properties of high molecular weight linear poly(N-isopropylacrylamide)s (PNIPAM) having different isotacticities (m, meso dyad = 47, 62, 68, 81, and 88 %) have been studied. The solubility of these polymers in different solvents varied with their isotacticity. Thermal degradation of higher isotactic polymer started slightly earlier. Cloud point of these polymers in water gradually decreased with increase in m up to 68 %. Surface tension of these polymers in N,N-dimethylformamide (DMF) was slightly lower than DMF and almost independent of their isotacticity in the temperature range of 20-60 A degrees C. But it decreased linearly with the increase in temperature. Moreover, for all polymers, it decreased very slightly with the increase in their concentrations in the range of 0.001-0.01 % (w/v). Viscosity of these polymers in DMF increased with (i) the increase in the concentration range of 1-5 % (w/v), (ii) the increase in their m values, and (iii) the decrease in the temperature in the range of 20-60 C-o.	[Biswas, Chandra Sekhar; Mitra, Kheyanath; Singh, Shikha; Maiti, Biswajit; Ray, Biswajit] Banaras Hindu Univ, Fac Sci, Dept Chem, Varanasi 221005, Uttar Pradesh, India; [Ramesh, Kalyan; Misra, Nira] Banaras Hindu Univ, Sch Biomed Engn, Indian Inst Technol, Varanasi 221005, Uttar Pradesh, India; [Panda, Amiya Kumar] Univ N Bengal, Dept Chem, Darjeeling 734013, India; [Maiti, Pralay] Banaras Hindu Univ, Sch Mat Sci & Technol, Indian Inst Technol, Varanasi 221005, Uttar Pradesh, India; [Kamigaito, Masami] Nagoya Univ, Grad Sch Engn, Dept Appl Chem, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Okamoto, Yoshio] Nagoya Univ, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Ray, B (reprint author), Banaras Hindu Univ, Fac Sci, Dept Chem, Varanasi 221005, Uttar Pradesh, India.	biswajitray2003@yahoo.co.in			Council of Scientific and Industrial Research (CSIR), Government of India [02(0002)/11/EMR-II]	The CSB and BR gratefully acknowledge the financial support from the Council of Scientific and Industrial Research (CSIR), Government of India, through research grant no. 02(0002)/11/EMR-II.	Kujawa P, 2005, EUR PHYS J E, V17, P129, DOI 10.1140/epje/i2004-10134-9; Ray B, 2003, MACROMOLECULES, V36, P543, DOI 10.1021/ma0257595; OSADA Y, 1992, NATURE, V355, P242, DOI 10.1038/355242a0; Pelton R, 2010, J COLLOID INTERF SCI, V348, P673, DOI 10.1016/j.jcis.2010.05.034; Yamato M, 2002, BIOMATERIALS, V23, P561, DOI 10.1016/S0142-9612(01)00138-7; Tan BH, 2010, POLYMER, V51, P3238, DOI 10.1016/j.polymer.2010.04.059; Biswas CS, 2010, LANGMUIR, V26, P6775, DOI 10.1021/la9041259; Satarkar NS, 2008, J CONTROL RELEASE, V130, P246, DOI 10.1016/j.jconrel.2008.06.008; Zhang XZ, 2005, BIOMATERIALS, V26, P3299, DOI 10.1016/j.biomaterials.2004.08.024; Tong Z, 1999, MACROMOLECULES, V32, P4488, DOI 10.1021/ma990062d; Huang G, 2004, J CONTROL RELEASE, V94, P303, DOI 10.1016/j.jconrel.2003.10.007; HIROKAWA Y, 1984, J CHEM PHYS, V81, P6379, DOI 10.1063/1.447548; Ito M, 2006, J POLYM SCI POL CHEM, V44, P4832, DOI 10.1002/pola.21583; Milewska A, 2003, J POLYM SCI POL PHYS, V41, P1219, DOI 10.1002/polb.10469; Hirano T, 2006, J POLYM SCI POL CHEM, V44, P4450, DOI 10.1002/pola.21546; FUJISHIGE S, 1989, J PHYS CHEM-US, V93, P3311, DOI 10.1021/j100345a085; WINNIK FM, 1990, MACROMOLECULES, V23, P2415, DOI 10.1021/ma00210a048; Kobayashi M, 2000, J POLYM SCI POL CHEM, V38, P4677; SCHILD HG, 1991, MACROMOLECULES, V24, P948, DOI 10.1021/ma00004a022; Koyama M, 2008, J PHYS CHEM B, V112, P10854, DOI 10.1021/jp800759w; Ray B, 2005, POLYM J, V37, P234, DOI 10.1295/polymj.37.234; Anya JH, 2011, J COLLOID INTERF SCI, V357, P300; Badiger MV, 2003, MACROMOL CHEM PHYSIC, V204, P600, DOI 10.1002/macp.200390026; Biswas CS, 2012, LANGMUIR, V28, P7014, DOI 10.1021/la3003806; Biswas CS, 2011, MACROMOLECULES, V44, P5822, DOI 10.1021/ma200735k; Chen JP, 2009, POLYMER, V50, P107, DOI 10.1016/j.polymer.2008.10.045; de Azevedo RG, 2001, FLUID PHASE EQUILIBR, V185, P189; Durand A, 2000, J PHYS CHEM B, V104, P9371, DOI 10.1021/jp993769a; Durand A, 1999, POLYMER, V40, P4941, DOI 10.1016/S0032-3861(98)00698-3; Frisch M J, 2010, GAUSSIAN 09 REVISION; Hamamoto H, 2006, ORG LETT, V8, P4015, DOI 10.1021/ol061562b; Haraguchi K, 2011, MACROMOL S, V306-307, P33; Heskins M, 1968, MACROMOL SCI CHEM A, VA2, P1441, DOI DOI 10.1080/10601326808051910; Hietala H, 2008, MACROMOLECULES, V41, P2627; Hirano T, 2008, J POLYM SCI POL CHEM, V46, P4575, DOI 10.1002/pola.22797; Hirano T, 2005, POLYMER, V46, P5501, DOI 10.1016/j.polymer.2005.05.043; Hofmann CH, 2013, MACROMOLECULES, V46, P523, DOI 10.1021/ma302384v; Isobe Y, 2001, J AM CHEM SOC, V123, P7180, DOI 10.1021/ja015888l; Katsumoto Y, 2008, MACROMOLECULES, V41, P5955, DOI 10.1021/ma800881r; Kawaguchi M, 1996, LANGMUIR, V12, P3523, DOI 10.1021/la950944f; Kelarakis A, 2008, J COLLOID INTERF SCI, V320, P70, DOI 10.1016/j.jcis.2007.12.030; Kenji K, 1990, POLYM J, V22, P15; Lin HH, 2001, MACROMOLECULES, V34, P3710, DOI 10.1021/ma001852m; Monteux C, 2006, MACROMOLECULES, V39, P3408, DOI 10.1021/ma052552d; Monteux C, 2010, LANGMUIR, V26, P13839, DOI 10.1021/la1019982; Nakano S, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3637943; NANDI AK, 1983, EUR POLYM J, V19, P283, DOI 10.1016/0014-3057(83)90161-1; Niskanen J, 2012, LANGMUIR, V28, P14792, DOI 10.1021/la302468j; Noskov BA, 2004, LANGMUIR, V20, P9669, DOI 10.1021/la048836t; Nuopponen M, 2008, J POLYM SCI POL CHEM, V46, P38, DOI 10.1002/pola.22355; Nuopponen M, 2008, MACROMOLECULES, V41, P4881, DOI 10.1021/ma800083t; Oscar C, 1979, MAKROMOL CHEM, V180, P969; Ray B, 2004, MACROMOLECULES, V37, P1702, DOI 10.1021/ma035119h; Stieger M, 2003, MACROMOLECULES, V36, P8811, DOI 10.1021/ma034788s; Yang H, 2000, J POLYM SCI POL PHYS, V38, P1188; Zeng F, 1998, POLYMER, V39, P1249, DOI 10.1016/S0032-3861(97)00471-0; Zhang J, 1999, J POLYM SCI POL CHEM, V37, P2137, DOI 10.1002/(SICI)1099-0518(19990701)37:13<2137::AID-POLA29>3.0.CO;2-Q; Zhang J, 1996, LANGMUIR, V12, P2611, DOI 10.1021/la950548x	58	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	JUN	2015	293	6					1749	1757		10.1007/s00396-015-3562-3		9	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CJ2SK	WOS:000355334600017		
J	Yoshida, E				Yoshida, Eri			Morphological changes in polymer giant vesicles by intercalation of a segment copolymer as a sterol model in plasma membrane	COLLOID AND POLYMER SCIENCE			English	Article						Poly(methacrylic acid)-block-poly(methyl methacrylate-random-methacrylic acid); Photopolymerization-induced self-assembly; A segment copolymer; Morphological changes; Spherical vesicles; Planar bilayer; Intercalation; A sterol model	RANDOM BLOCK-COPOLYMERS; RANDOM-MATHACRYLIC ACID); RADICAL POLYMERIZATION; HUMAN-FIBROBLASTS; CHOLESTEROL; METHACRYLATE; PHOSPHATIDYLCHOLINE; SPHINGOMYELIN; TRANSPORT	The morphological changes in polymer giant vesicles comprised of amphiphilic poly(methacrylic acid)-block-poly(methyl methacrylate-random-methacrylic acid), PMAA-b-P(MMA-r-MAA), were explored in the presence of a P(MMA-r-MAA) segment copolymer as the model for sterols in plasma membranes for the purpose of inventing a new biomembrane model using the polymer vesicles. PMAA-b-P(MMA-r-MAA) produced spherical vesicles with a 2.5-mu m diameter by the photopolymerization-induced self-assembly in the absence of the segment copolymer in an aqueous methanol solution. The block copolymer formed a planar bilayer in the presence of the segment copolymer that had the MMA/MAA ratio and length identical to those of the hydrophobic block composing the amphiphilic random block copolymer. The thermal analysis demonstrated that the segment copolymer was completely intercalated between the hydrophobic block chains forming the vesicle cores. This intercalation disordered the vesicle surface of the hydrophilic PMAA blocks and decreased the crystallinity of the hydrophilic block chains.	Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi, Aichi 4418580, Japan	Yoshida, E (reprint author), Toyohashi Univ Technol, Dept Environm & Life Sci, 1-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.	eyoshida@ens.tut.ac.jp			JSPS [25390003]	The author is thankful for a JSPS Grant-in-Aid for Scientific Research (Grant Number 25390003).	Anitschkow N, 1913, ZENTRALBL ALLG PATHO, V24, P1; ANDERSON RGW, 1977, CELL, V10, P351, DOI 10.1016/0092-8674(77)90022-8; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Yoshida E, 2015, COLLOID POLYM SCI, V293, P249, DOI 10.1007/s00396-014-3403-9; NEZIL FA, 1992, BIOPHYS J, V61, P1176; LEVINE YK, 1971, NATURE-NEW BIOL, V230, P69; ELGSAETER A, 1986, SCIENCE, V234, P1217, DOI 10.1126/science.3775380; KOBAYASHI S, 1990, POLYM J, V22, P759, DOI 10.1295/polymj.22.759; LANGE Y, 1989, J BIOL CHEM, V264, P3786; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; Yoshida E, 2014, COLLOID POLYM SCI, V292, P763, DOI 10.1007/s00396-013-3154-z; Zhang WJ, 2014, MACROMOLECULES, V47, P1664, DOI 10.1021/ma402497y; Baumann NA, 2005, BIOCHEMISTRY-US, V44, P5816, DOI 10.1021/bi048296z; Maulik PR, 1996, BIOPHYS J, V70, P2256; Yoshida E, 2014, COLLOID POLYM SCI, V292, P1463, DOI 10.1007/s00396-014-3216-x; Yoshida E, 2013, COLLOID POLYM SCI, V291, P2733, DOI 10.1007/s00396-013-3056-0; BROCKERH.H, 1974, LIPIDS, V9, P645, DOI 10.1007/BF02532169; HABERLAN.ME, 1973, P NATL ACAD SCI USA, V70, P2313, DOI 10.1073/pnas.70.8.2313; MIYAZAWA T, 1985, J ORG CHEM, V50, P1332, DOI 10.1021/jo00208a047; NEWMAN GC, 1975, BIOCHEMISTRY-US, V14, P3363, DOI 10.1021/bi00686a012; Sadava DE, 1993, CELL BIOL ORGANELLE, P130; Wolozin B, 2004, CURR OPIN LIPIDOL, V15, P667, DOI 10.1097/00041433-200412000-00007; Yoshida E, 2009, COLLOID POLYM SCI, V287, P767, DOI 10.1007/s00396-009-2023-2; Yoshida E, 2015, COLLOID POLYM SCI, V293, P1275, DOI 10.1007/s00396-015-3519-6; Yoshida E, 2014, COLLOID POLYM SCI, V292, P2555, DOI 10.1007/s00396-014-3297-6; Yoshida E, 2015, SUPRAMOL CHEM, V27, P274, DOI 10.1080/10610278.2014.959014; Yoshida E, 2015, COLLOID POLYM SCI, V293, P649, DOI 10.1007/s00396-014-3482-7	27	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	JUN	2015	293	6					1835	1840		10.1007/s00396-015-3577-9		6	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CJ2SK	WOS:000355334600026		
J	Yoshida, E				Yoshida, Eri			Fabrication of microvillus-like structure by photopolymerization-induced self-assembly of an amphiphilic random block copolymer	COLLOID AND POLYMER SCIENCE			English	Article						Microvillus-like structure; Amphiphilic random block copolymer; Poly(methacrylic acid)-block-poly(methyl methacrylate-random-methacrylic acid); Photopolymerization-induced self-assembly; Film-like precipitates; An inverted cone-like critical packing shape; Worm-like vesicles	RANDOM-MATHACRYLIC ACID); GIANT VESICLES; RADICAL POLYMERIZATION; MORPHOLOGY CONTROL; INFLUENZA-VIRUS; CELL MEMBRANE; METHACRYLATE; PHOSPHOLIPIDS; ASYMMETRY	A microvillus-like structure observed in digestive systems and glands was fabricated by the photopolymerization-induced self-assembly using an amphiphilic random block copolymer consisting of hydrophilic poly(methacrylic acid), PMAA, and hydrophobic poly(methyl methacrylate-random-methacrylic acid), P(MMA-r-MAA). The random block copolymerization of methyl methacrylate and methacrylic acid using a PMAA end-capped with 4-methoxy-2,2,6,6-tetramethylpiperidine-1-oxyl for the photopolymerization-induced self-assembly produced spherical vesicles and micelles during the early stage of the polymerization. These spherical particles transformed into worm-like vesicles, accompanied by the precipitation of a film-like product as the hydrophobic block chain grew according to the polymerization progress. Further extension of the hydrophobic block length produced the microvillus-like structure on the surface of the precipitating film. The finger-like structure in the microvilli had an ca. 8.5-mu m height. An inverted cone-like critical packing shape of the copolymer with the hydrophobic block longer than the hydrophilic block contributed to the formation of the microvillus-like structure.	Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi, Aichi 4418580, Japan	Yoshida, E (reprint author), Toyohashi Univ Technol, Dept Environm & Life Sci, 1-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.	eyoshida@ens.tut.ac.jp			JSPS [25390003]	The author is thankful for a JSPS Grant-in-Aid for Scientific Research (Grant Number 25390003).	ANDERSON RGW, 1977, CELL, V10, P351, DOI 10.1016/0092-8674(77)90022-8; Yoshida E, 2015, COLLOID POLYM SCI, V293, P249, DOI 10.1007/s00396-014-3403-9; Norris V, 2002, J MOL BIOL, V318, P455, DOI 10.1016/S0022-2836(02)00098-0; KOBAYASHI S, 1990, POLYM J, V22, P759, DOI 10.1295/polymj.22.759; KAWAI K, 1974, BIOCHIM BIOPHYS ACTA, V369, P222; Papanikolaou A, 2005, J BIOL CHEM, V280, P26406, DOI 10.1074/jbc.M413927200; Yoshida E, 2014, COLLOID POLYM SCI, V292, P763, DOI 10.1007/s00396-013-3154-z; VERKLEIJ AJ, 1973, BIOCHIM BIOPHYS ACTA, V323, P178, DOI 10.1016/0005-2736(73)90143-0; Yoshida E, 2014, COLLOID POLYM SCI, V292, P1463, DOI 10.1007/s00396-014-3216-x; Yoshida E, 2013, COLLOID POLYM SCI, V291, P2733, DOI 10.1007/s00396-013-3056-0; GETZ GS, 1968, BIOCHIM BIOPHYS ACTA, V152, P325, DOI 10.1016/0005-2760(68)90040-4; Israelachvili JN, 2011, INTERMOLECULAR SURFA, V3rd, P559; Kessel RG, 1979, TISSUES ORGANS TEXT, P199; ROTHMAN JE, 1976, BIOCHEMISTRY-US, V15, P2361, DOI 10.1021/bi00656a018; TSAI KH, 1975, NATURE, V253, P554, DOI 10.1038/253554a0; Yoshida E, 2009, COLLOID POLYM SCI, V287, P767, DOI 10.1007/s00396-009-2023-2; Yoshida E, 2015, COLLOID POLYM SCI, V293, P1275, DOI 10.1007/s00396-015-3519-6; Yoshida E, 2014, COLLOID POLYM SCI, V292, P2555, DOI 10.1007/s00396-014-3297-6; Yoshida E, 2012, ISPN POLYM SCI, DOI 10.5402/2012/102186; Yoshida E, 2015, SUPRAMOL CHEM, V27, P274, DOI 10.1080/10610278.2014.959014; Yoshida E, 2015, COLLOID POLYM SCI, V293, P649, DOI 10.1007/s00396-014-3482-7	21	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	JUN	2015	293	6					1841	1845		10.1007/s00396-015-3600-1		5	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CJ2SK	WOS:000355334600027		
J	Jaumouille, E; Almeida, PM; Stahli, P; Koch, R; Nagoshi, E				Jaumouille, Edouard; Almeida, Pedro Machado; Staehli, Patrick; Koch, Rafael; Nagoshi, Emi			Transcriptional Regulation via Nuclear Receptor Crosstalk Required for the Drosophila Circadian Clock	CURRENT BIOLOGY			English	Article							REV-ERB-ALPHA; GENE-EXPRESSION; PACEMAKER NEURONS; OSCILLATORS; BEHAVIOR; RHYTHMS; CYCLES; HEME; BETA	Circadian clocks in large part rely on transcriptional feedback loops. At the core of the clock machinery, the transcriptional activators CLOCK/BMAL1 (in mammals) and CLOCK/CYCLE (CLK/CYC) (in Drosophila) drive the expression of the period (per) family genes. The PER-containing complexes inhibit the activity of CLOCK/BMAL1 or CLK/CYC, thereby forming a negative feedback loop [1]. In mammals, the ROR and REV-ERB family nuclear receptors add positive and negative transcriptional regulation to this core negative feedback loop to ensure the generation of robust circadian molecular oscillation [2]. Despite the overall similarities between mammalian and Drosophila clocks, whether comparable mechanisms via nuclear receptors are required for the Drosophila clock remains unknown. We show here that the nuclear receptor E75, the fly homolog of REV-ERB a and REV-ERB beta, and the NR2E3 subfamily nuclear receptor UNF are components of the molecular clocks in the Drosophila pacemaker neurons. In vivo assays in conjunction with the in vitro experiments demonstrate that E75 and UNF bind to per regulatory sequences and act together to enhance the CLK/CYC-mediated transcription of the per gene, thereby completing the core transcriptional feedback loop necessary for the free-running clockwork. Our results identify a missing link in the Drosophila clock and highlight the significance of the transcriptional regulation via nuclear receptors in metazoan circadian clocks.	[Jaumouille, Edouard; Staehli, Patrick] Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland; [Jaumouille, Edouard; Almeida, Pedro Machado; Koch, Rafael; Nagoshi, Emi] Univ Geneva, Dept Genet & Evolut, Sci 3, CH-1211 Geneva 4, Switzerland; [Nagoshi, Emi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Nagoshi, E (reprint author), Univ Geneva, Dept Genet & Evolut, Sci 3, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	emi.nagoshi@unige.ch			JST PRESTO program; Swiss National Science Foundation [31003A_149893]; European Research Council [ERC-StG-311194]; University of Bern; University of Geneva	We thank T. Lee, H. Krause, Bloomington Drosophila Stock Center (NIH P40OD018537), and the Vienna Drosophila Resource Center (VDRC) for fly stocks. We thank S. Robinow for a plasmid and Drosophila Genomics Resource Center for an EST clone. We also thank D. Beuchle and K. Sugino for technical assistance and U. Schibler for discussions. This work was supported by the JST PRESTO program, the Swiss National Science Foundation (31003A_149893), the European Research Council (ERC-StG-311194), the University of Bern, and the University of Geneva.	Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Bialecki M, 2002, DEV CELL, V3, P209, DOI 10.1016/S1534-5807(02)00204-6; Nagoshi E, 2010, NAT NEUROSCI, V13, P60, DOI 10.1038/nn.2451; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Murad A, 2007, NEURON, V53, P689, DOI 10.1016/j.neuron.2007.01.034; Kula-Eversole E, 2010, P NATL ACAD SCI USA, V107, P13497, DOI 10.1073/pnas.1002081107; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Abruzzi KC, 2011, GENE DEV, V25, P2374, DOI [10.1101/gad.174110.111, 10.1101/gad.178079.111]; Aranda A, 2001, PHYSIOL REV, V81, P1269; Stoleru D, 2007, CELL, V129, P207, DOI 10.1016/j.cell.2007.02.038; Zhang Y, 2010, CURR BIOL, V20, P600, DOI 10.1016/j.cub.2010.02.044; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Aicart-Ramos C, 2012, BIOCHEMISTRY-US, V51, P7403, DOI 10.1021/bi300848x; Jetten AM, 2001, PROG NUCLEIC ACID RE, V69, P205, DOI 10.1016/S0079-6603(01)69048-2; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Zhao X, 2014, EMBO REP, V15, P518, DOI 10.1002/embr.201338271; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; Zhang LY, 2010, CURR BIOL, V20, P591, DOI 10.1016/j.cub.2010.02.056; Beuchle D, 2012, CURR BIOL, V22, P1221, DOI 10.1016/j.cub.2012.04.052; Caiceres L., 2011, GENE DEV, V25, P1476; Haley B, 2008, DEV BIOL, V321, P482, DOI 10.1016/j.ydbio.2008.06.015; Kadener S, 2007, GENE DEV, V21, P1675, DOI 10.1101/gad.1552607; Kumar S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6697; Lin SW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008392; SEGRAVES WA, 1990, GENE DEV, V4, P204, DOI 10.1101/gad.4.2.204; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Taylor P, 2008, MOL CELL BIOL, V28, P4642, DOI 10.1128/MCB.01612-07; Yu WJ, 2006, J CELL SCI, V119, P4793, DOI 10.1242/jcs.03174	32	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0960-9822	1879-0445		CURR BIOL	Curr. Biol.	JUN 1	2015	25	11					1502	1508		10.1016/j.cub.2015.04.017		7	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CJ5UM	WOS:000355556600026		
J	Mashiko, T; Abo, Y; Kuno, S; Yoshimura, K				Mashiko, Takanobu; Abo, Yoshihisa; Kuno, Shinichiro; Yoshimura, Kotaro			A Novel Facial Rejuvenation Treatment Using Pneumatic Injection of Non-Cross-Linked Hyaluronic Acid and Hypertonic Glucose Solution	DERMATOLOGIC SURGERY			English	Letter							SUBDERMAL MINIMAL SURGERY; TECHNOLOGY; SCARS		[Mashiko, Takanobu; Kuno, Shinichiro; Yoshimura, Kotaro] Univ Tokyo, Sch Med, Dept Plast Surg, Tokyo 113, Japan; [Abo, Yoshihisa] North Aoyama D Clin, Dept Surg, Tokyo, Japan	Mashiko, T (reprint author), Univ Tokyo, Sch Med, Dept Plast Surg, Tokyo 113, Japan.						Rabago D, 2009, BRIT J SPORT MED, V43, P471, DOI 10.1136/bjsm.2008.052761; Han TY, 2011, DERMATOL SURG, V37, P1291, DOI 10.1111/j.1524-4725.2011.02057.x; Kim BJ, 2009, DERMATOL SURG, V35, P1439, DOI 10.1111/j.1524-4725.2009.01255.x; Kim HK, 2012, INT J DERMATOL, V51, P1502, DOI 10.1111/j.1365-4632.2012.05607.x; Lee JW, 2010, DERMATOL SURG, V36, P1281, DOI 10.1111/j.1524-4725.2010.01623.x	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1076-0512	1524-4725		DERMATOL SURG	Dermatol. Surg.	JUN	2015	41	6					755	758		10.1097/DSS.0000000000000359		4	Dermatology; Surgery	Dermatology; Surgery	CJ7DY	WOS:000355655600018		
J	Wang, K; Omotezako, T; Kishi, K; Nishida, H; Onuma, TA				Wang, Kai; Omotezako, Tatsuya; Kishi, Kanae; Nishida, Hiroki; Onuma, Takeshi A.			Maternal and zygotic transcriptomes in the appendicularian, Oikopleura dioica: novel protein-encoding genes, intra-species sequence variations, and trans-spliced RNA leader	DEVELOPMENT GENES AND EVOLUTION			English	Article						Transcriptome; Appendicularian; Intra-species variation; Trans-splicing	CIONA-INTESTINALIS; REFERENCE GENOME; CELL LINEAGES; SEQ DATA; CD-HIT; CHORDATE; UROCHORDATE; GENERATION; SPECIATION; TUNICATES	RNA sequencing analysis was carried out to characterize egg and larval transcriptomes in the appendicularian, Oikopleura dioica, a planktonic chordate, which is characterized by rapid development and short life cycle of 5 days, using a Japanese population of the organism. De novo transcriptome assembly matched with 16,423 proteins corresponding to 95.4 % of the protein-encoding genes deposited in the OikoBase, the genome database of the Norwegian population. Nucleotide and amino acid sequence identities between the Japanese and Norwegian O. dioica were estimated to be around 91.0 and 94.8 %, respectively. We discovered 175 novel protein-encoding genes: 144 unigenes were common to both the Japanese and Norwegian populations, whereas 31 unigenes were not found in the OikoBase genome reference. Among the total 12,311 unigenes, approximately 63 % were detected in egg-stage RNAs, whereas 99 % were detected in larval stage RNAs; 3772 genes were up-regulated, and 1336 genes were down-regulated more than four-fold in the larvae. Gene ontology analyses characterized gene activities in these two developmental stages. We found a messenger RNA (mRNA) 5' trans-spliced leader, which was observed in 40.8 % of the total unique transcripts. It showed preferential linkage to adenine at the 5' ends of the downstream exons. Trans-splicing was observed more frequently in egg mRNAs compared with larva-specific mRNAs.	[Wang, Kai; Omotezako, Tatsuya; Kishi, Kanae; Nishida, Hiroki; Onuma, Takeshi A.] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 5600043, Japan	Wang, K (reprint author), Osaka Univ, Grad Sch Sci, Dept Biol Sci, 1-1 Machikaneyama Cho, Toyonaka, Osaka 5600043, Japan.	wangk@bio.sci.osaka-u.ac.jp; otamazako@bio.sci.osaka-u.ac.jp; kkishi@bio.sci.osaka-u.ac.jp; hnishida@bio.sci.osaka-u.ac.jp; takeo@bio.sci.osaka-u.ac.jp			JSPS [22370078, 26650079, 22870019, 26840079]; MEXT [125058]; Mitsubishi Corporation [MITSU1451]; Osaka University	This work was supported by Grants-in-Aid for Scientific Research from the JSPS to H.N. (22370078, 26650079) and T.A.O. (22870019, 26840079). K.W. is supported by a MEXT Scholarship (125058), a Mitsubishi Corporation International Scholarship (MITSU1451), and an Osaka University Scholarship and Research Assistant Fellowship.	Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Nydam ML, 2010, MOL PHYLOGENET EVOL, V56, P718, DOI 10.1016/j.ympev.2010.03.042; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Denoeud F, 2010, SCIENCE, V330, P1381, DOI 10.1126/science.1194167; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Seo HC, 2001, SCIENCE, V294, P2506, DOI 10.1126/science.294.5551.2506; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Boutet Emmanuel, 2007, V406, P89; Vandenberghe AE, 2001, GENE DEV, V15, P294, DOI 10.1101/gad.865401; Griggio F, 2014, GENOME BIOL EVOL, V6, P591, DOI 10.1093/gbe/evu041; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Stach T, 2008, P NATL ACAD SCI USA, V105, P7229, DOI 10.1073/pnas.0710196105; Suzuki MM, 2005, J MOL EVOL, V61, P627, DOI 10.1007/s00239-005-0009-3; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Nishida H, 2008, DEV GROWTH DIFFER, V50, pS239, DOI 10.1111/j.1440-169X.2008.01035.x; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Adiconis X, 2013, NAT METHODS, V10, P623, DOI 10.1038/nmeth.2483; Caputi L, 2007, P NATL ACAD SCI USA, V104, P9364, DOI 10.1073/pnas.0610158104; Bouquet JM, 2009, J PLANKTON RES, V31, P359, DOI 10.1093/plankt/fbn132; Xie YL, 2014, BIOINFORMATICS, V30, P1660, DOI 10.1093/bioinformatics/btu077; Bassham S, 2000, DEV BIOL, V220, P322, DOI 10.1006/dbio.2000.9647; Danks G, 2013, NUCLEIC ACIDS RES, V41, pD845, DOI 10.1093/nar/gks1159; Danks GB, 2015, MOL BIOL EVOL, V32, P585, DOI 10.1093/molbev/msu336; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fujii S, 2008, DEV GENES EVOL, V218, P69, DOI 10.1007/s00427-008-0205-4; Ganot P, 2004, MOL CELL BIOL, V24, P7795, DOI 10.1128/MCB.24.17.7795-7805.2004; Gasparini F, 2011, DEV GENES EVOL, V220, P329, DOI 10.1007/s00427-011-0351-y; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kishi K, 2014, DEV BIOL, V395, P299, DOI 10.1016/j.ydbio.2014.09.006; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Matsumoto J, 2010, GENOME RES, V20, P636, DOI 10.1101/gr.100271.109; Nishida H, 2014, ZOOL SCI, V31, P645, DOI 10.2108/zs140117; Omotezako T, 2013, DEV GENES EVOL, V223, P261, DOI 10.1007/s00427-013-0438-8; Satou Y, 2006, NUCLEIC ACIDS RES, V34, P3378, DOI 10.1093/nar/gkl418; Shirae-Kurabayashi M, 2006, DEVELOPMENT, V133, P2683, DOI 10.1242/dev.02446; Wu B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-15	42	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0949-944X	1432-041X		DEV GENES EVOL	Dev. Genes Evol.	JUN	2015	225	3					149	159		10.1007/s00427-015-0502-7		11	Cell Biology; Evolutionary Biology; Developmental Biology	Cell Biology; Evolutionary Biology; Developmental Biology	CK0BW	WOS:000355870000003		
J	Suzuki, MG; Tochigi, M; Sakaguchi, H; Aoki, F; Miyamoto, N				Suzuki, Masataka G.; Tochigi, Mayuko; Sakaguchi, Honami; Aoki, Fugaku; Miyamoto, Norio			Identification of a transformer homolog in the acorn worm, Saccoglossus kowalevskii, and analysis of its activity in insect cells	DEVELOPMENT GENES AND EVOLUTION			English	Article						Transformer; Saccoglossus kowalevskii; TRA-CAM domain; Doublesex; Sex determination	PRE-MESSENGER-RNA; SEX DETERMINATION; GENE; EXPRESSION; EVOLUTION; INSIGHTS	The transformer (tra) gene is an intermediate component of the sex determination hierarchy in many insect species. The homolog of tra is also found in two branchiopod crustacean species but is not known outside arthropods. We have isolated a tra homolog in the acorn worm, Saccoglossus kowalevskii, which is a hemichordate belonging to the deuterostome superphylum. The full-length complementary DNA (cDNA) of the S. kowalevskii tra homolog (Sktra) has a 3786-bp open reading frame that encodes a 1261-amino acid sequence including a TRA-CAM domain and an arginine/serine (RS)-rich domain, both of which are characteristic of TRA orthologs. Reverse transcription PCR (RT-PCR) analyses demonstrated that Sktra showed no differences in expression patterns between testes and ovaries, but its expression level was approximately 7.5-fold higher in the testes than in the ovaries. TRA, together with the protein product of the transformer-2 (tra-2) gene, assembles on doublesex (dsx) pre-messenger RNA (mRNA) via the cis-regulatory element, enhancing female-specific splicing of dsx in Drosophila. To understand functional conservation of the SkTRA protein as a dsx-splicing activator, we investigated whether SkTRA is capable of inducing female-specific splicing of the Drosophila dsx. Ectopic expression of Sktra cDNA in insect cultured cells did not induce the female-specific splicing of dsx. On the other hand, forced expression of Sktra-2 (a tra-2 homolog of S. kowalevskii) was able to induce the female-specific dsx splicing. These results demonstrate that the function as a dsx-splicing activator is not conserved in SkTRA even though SkTRA-2 is capable of functionally replacing the Drosophila TRA-2. We have also found a tra homolog in an echinoderm genome. This study provides the first evidence that that tra is conserved not only in arthropods but also in basal species of deuterostoms.	[Suzuki, Masataka G.; Tochigi, Mayuko; Sakaguchi, Honami; Aoki, Fugaku] Univ Tokyo, Grad Sch Frontier Sci, Div Biol Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan; [Miyamoto, Norio] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan	Suzuki, MG (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Div Biol Sci, Dept Integrated Biosci, 302 Biosci Bldg,5-1-5 Kashiwanoha, Kashiwa, Chiba 2778562, Japan.	gakyo@k.u-tokyo.ac.jp			 [26292172]	We gratefully acknowledge Prof. Christopher Lowe for providing the EST clone and the adult gonads of S. kowalevskii. This work was supported financially by a Grant-in-Aid for Scientific Research (B), 26292172, 2014.	Kato Y, 2010, GENOMICS, V95, P160, DOI 10.1016/j.ygeno.2009.12.005; Kopp A, 2012, TRENDS GENET, V28, P175, DOI 10.1016/j.tig.2012.02.002; Chen P, 2014, ANIM REPROD SCI, V146, P227, DOI 10.1016/j.anireprosci.2014.03.010; El-Mogharbel N, 2007, GENOMICS, V89, P10, DOI 10.1016/j.ygeno.2006.07.017; Geuverink E, 2014, SEX DEV, V8, P38, DOI 10.1159/000357056; Budd GE, 2009, NATURE, V457, P812, DOI 10.1038/nature07890; Matson CK, 2012, NAT REV GENET, V13, P163, DOI 10.1038/nrg3161; Brown FD, 2008, GENESIS, V46, P605, DOI 10.1002/dvg.20471; Ogiso S, 2005, ZOOL SCI, V22, P579, DOI 10.2108/zsj.22.579; Bopp D, 2014, SEX DEV, V8, P20, DOI 10.1159/000356458; Sanchez L, 2008, INT J DEV BIOL, V52, P837, DOI [10.1387/ijdb.072396ls, 10.1387/ijdb.0723961s]; Graveley BR, 1998, EMBO J, V17, P6747, DOI 10.1093/emboj/17.22.6747; Suzuki MG, 2012, INT J DEV BIOL, V56, P693, DOI 10.1387/ijdb.120049ms; Toyota K, 2011, BMC GENOMICS, V14, P239; Xu S, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105130	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0949-944X	1432-041X		DEV GENES EVOL	Dev. Genes Evol.	JUN	2015	225	3					161	169		10.1007/s00427-015-0498-z		9	Cell Biology; Evolutionary Biology; Developmental Biology	Cell Biology; Evolutionary Biology; Developmental Biology	CK0BW	WOS:000355870000004		
J	Watanabe, A; Mochiki, E; Kimura, A; Kogure, N; Yanai, M; Ogawa, A; Toyomasu, Y; Ogata, K; Ohno, T; Suzuki, H; Kuwano, H				Watanabe, Akira; Mochiki, Erito; Kimura, Akiharu; Kogure, Norimichi; Yanai, Mitsuhiro; Ogawa, Atsushi; Toyomasu, Yoshitaka; Ogata, Kyoichi; Ohno, Tetsuro; Suzuki, Hideki; Kuwano, Hiroyuki			Nesfatin-1 Suppresses Gastric Contractions and Inhibits Interdigestive Migrating Contractions in Conscious Dogs	DIGESTIVE DISEASES AND SCIENCES			English	Article						Nesfatin-1; Ghrelin; Motilin; Gastrointestinal motility; Interdigestive migrating contractions	BLOOD-BRAIN-BARRIER; FOOD-INTAKE; GASTROINTESTINAL MOTILITY; GHRELIN; NUCLEUS; RATS; NEURONS; GUT	Background Nesfatin-1 is a novel 82-amino acid anorectic peptide. Acute injection of nesfatin-1 into the third brain ventricle reduces food consumption during the dark phase in rats. Nesfatin-1 is also expressed in gastric X/A-like cells in the peripheral tissues. Nesfatin-1 has been reported to reduce gastric and duodenal motility and to delay gastric emptying. Aim In the present study, we investigated the effects of nesfatin-1 on gastrointestinal motility in conscious dogs. Methods Force transducers were implanted onto the serosal surfaces of the gastric bodies, gastric antra, duodena, and jejuna of healthy beagle dogs, and gastrointestinal motility was monitored. We evaluated the effects of nesfatin-1 on gastrointestinal motility and on the circulating levels of nesfatin-1 in the fasted and fed states. Results The intravenous administration of nesfatin-1 reduced gastric contractions and inhibited cyclical interdigestive migrating contractions in the fasted state. In the fasted state, circulating levels of nesfatin-1 tended to increase during late phase I. In addition, the kinetics of the circulating levels of nesfatin-1 were opposite to those of ghrelin during the fasted state. Conclusions Nesfatin-1 regulates gastrointestinal motility, and, in particular, it inhibits gastric contractions in the fasted state. Interdigestive migrating contractions may be regulated by interactions between nesfatin-1, ghrelin, and motilin.	[Watanabe, Akira; Kimura, Akiharu; Kogure, Norimichi; Yanai, Mitsuhiro; Ogawa, Atsushi; Toyomasu, Yoshitaka; Ogata, Kyoichi; Ohno, Tetsuro; Suzuki, Hideki; Kuwano, Hiroyuki] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gunma 3718511, Japan; [Watanabe, Akira] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci Surg 1, Maebashi, Gunma 3718511, Japan; [Mochiki, Erito] Saitama Med Univ, Saitama Med Ctr, Dept Digest Tract & Gen Surg, Kawagoe, Saitama 3508550, Japan	Watanabe, A (reprint author), Gunma Univ, Grad Sch Med, Dept Gen Surg Sci Surg 1, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	akira_watanabe@gunma-u.ac.jp					Shimizu H, 2009, ENDOCRINOLOGY, V150, P662, DOI 10.1210/en.2008-0598; Stengel A, 2009, ENDOCRINOLOGY, V150, P232, DOI 10.1210/en.2008-0747; Stengel A, 2012, PEPTIDES, V35, P143, DOI 10.1016/j.peptides.2012.03.015; Stengel A, 2010, REGUL PEPTIDES, V163, P18, DOI 10.1016/j.regpep.2010.05.002; Xia ZF, 2012, AM J PHYSIOL-GASTR L, V303, pG570, DOI 10.1152/ajpgi.00178.2012; Price TO, 2007, PEPTIDES, V28, P2372, DOI 10.1016/j.peptides.2007.10.008; Merali Z, 2008, PSYCHOPHARMACOLOGY, V201, P115, DOI 10.1007/s00213-008-1252-2; Kerbel B, 2012, J NEUROENDOCRINOL, V24, P366, DOI 10.1111/j.1365-2826.2011.02246.x; Li ZL, 2013, EUR J NEUROSCI, V38, P3636, DOI 10.1111/ejn.12366; Pan WH, 2007, PEPTIDES, V28, P2223, DOI 10.1016/j.peptides.2007.09.005; Bonnet MS, 2013, REGUL PEPTIDES, V187, P17, DOI 10.1016/j.regpep.2013.10.001; BORMANS V, 1987, SCAND J GASTROENTERO, V22, P781, DOI 10.3109/00365528708991914; Zhang WZ, 2013, EXP PHYSIOL, V98, P1696, DOI 10.1113/expphysiol.2013.074930; Atsuchi K, 2010, NEUROREPORT, V21, P1008, DOI 10.1097/WNR.0b013e32833f7b96; Cuomo R, 2011, MINERVA ENDOCRINOL, V36, P281; Stengel A, 2009, ENDOCRINOLOGY, V150, P4911, DOI 10.1210/en.2009-0578; Cuomo R, 2004, NUTR METAB CARDIOVAS, V14, P173, DOI 10.1016/S0939-4753(04)80001-2; ITOH Z, 1978, AM J DIG DIS, V23, P929, DOI 10.1007/BF01072469; Kamiyama Y, 2007, NEUROGASTROENT MOTIL, V19, P233, DOI 10.1111/j.1365-2982.2006.00881.x; Ogawa A, 2012, AM J PHYSIOL-REG I, V302, pR233, DOI 10.1152/ajpregu.00078.2011; Oh IS, 2006, NATURE, V443, P709, DOI DOI 10.1038/NATURE05162; Ohno T, 2006, NEUROGASTROENT MOTIL, V18, P129, DOI 10.1111/j.1365-2982.2005.00747.x; Stengel A, 2011, OBES REV, V12, P261, DOI 10.1111/j.1467-789X.2010.00770.x	23	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	JUN	2015	60	6					1595	1602		10.1007/s10620-014-3505-8		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CJ6CM	WOS:000355580800014		
J	Araki, T; Kawamura, M; Tanaka, K; Okita, Y; Fujikawa, H; Uchida, K; Toiyama, Y; Inoue, Y; Mohri, Y; Kusunoki, M				Araki, Toshimitsu; Kawamura, Mikio; Tanaka, Koji; Okita, Yoshiki; Fujikawa, Hiroyuki; Uchida, Keiichi; Toiyama, Yuji; Inoue, Yasuhiro; Mohri, Yasuhiko; Kusunoki, Masato			FK506-Binding Protein 5 mRNA Levels in Ileal Mucosa Are Associated with Pouchitis in Patients with Ulcerative Colitis	DIGESTIVE DISEASES AND SCIENCES			English	Article						Pouchitis; Steroid; FKBP5 gene; Pouch-anal anastomosis; Ulcerative colitis	INFLAMMATORY-BOWEL-DISEASE; PEPTIDYL-PROLYL ISOMERASE; ANAL ANASTOMOSIS; DOUBLE-BLIND; EXTRAINTESTINAL MANIFESTATIONS; MEMBRANE TRANSLOCATION; MULTIVARIATE-ANALYSIS; IMMUNOPHILIN FKBP51; CONTROLLED TRIAL; RISK-FACTORS	Background Although the pathogenesis of pouchitis is incompletely understood, steroid and FK506 therapy are significantly associated with pouchitis. These medical treatments are regulated by the FK506-binding protein (FKBP) 4 and FKBP5 genes. Aim This study aimed to evaluate the relationship between pouchitis and FKBP4 and FKBP5 mRNA expression in ileal mucosa at the time of colectomy. Methods Ileal mucosa specimens were collected from 71 patients who underwent ileal pouch-anal anastomosis for ulcerative colitis. FKBP4 and FKBP5 mRNA expression was evaluated. The relationship between mRNA expression and clinicopathological factors, including developed pouchitis, was investigated. Results Of these 71 patients, 25 (35.2 %) patients developed pouchitis in a mean duration of 20.2 months (range 0-68 months). FKBP4 mRNA levels in patients who received an immunomodulator were significantly higher than those in untreated patients (0.167 +/- 0.060 vs 0.131 +/- 0.065, p = 0.009). However, FKBP5 mRNA levels in patients who received a three-stage operation were significantly lower than those in the other patients (1.97 +/- 1.15 vs 2.70 +/- 1.12, p = 0.02). A total dose of prednisolone >9.4 g (HR 2.84, p = 0.02) before colectomy and FKBP5 mRNA level higher than the median (HR 4.49, p = 0.01) were identified as factors related to pouchitis. Conclusions FKBP5 mRNA levels in ileal mucosa at the time of colectomy are significantly associated with pouchitis and may be a predictive factor for developing pouchitis.	[Araki, Toshimitsu; Kawamura, Mikio; Tanaka, Koji; Okita, Yoshiki; Fujikawa, Hiroyuki; Uchida, Keiichi; Toiyama, Yuji; Inoue, Yasuhiro; Mohri, Yasuhiko; Kusunoki, Masato] Mie Univ, Grad Sch Med, Inst Life Sci, Div Reparat Med,Dept Gastrointestinal & Pediat Su, Tsu, Mie 5148507, Japan	Araki, T (reprint author), Mie Univ, Grad Sch Med, Inst Life Sci, Div Reparat Med,Dept Gastrointestinal & Pediat Su, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	taraki@clin.medic.mie-u.ac.jp					BAUGHMAN G, 1995, MOL CELL BIOL, V15, P4395; Shen B, 2001, INFLAMM BOWEL DIS, V7, P301, DOI 10.1097/00054725-200111000-00004; Shen B, 2012, J CROHNS COLITIS, V6, P198, DOI 10.1016/j.crohns.2011.08.006; Hoda KM, 2008, DIS COLON RECTUM, V51, P554, DOI 10.1007/s10350-008-9194-7; Gionchetti P, 2003, GASTROENTEROLOGY, V124, P1202, DOI 10.1016/S0016-5085(03)00171-9; Sambuelli A, 2002, ALIMENT PHARM THERAP, V16, P27, DOI 10.1046/j.1365-2036.2002.01139.x; Mostaghel EA, 2007, CANCER RES, V67, P5033, DOI 10.1158/0008-5472.CAN-06-3332; Marz AM, 2013, MOL CELL BIOL, V33, P1357, DOI 10.1128/MCB.00678-12; Shen B, 2005, AM J GASTROENTEROL, V100, P93, DOI 10.1111/j.1572-0241.2005.40778.x; Kalkan IH, 2012, CLIN RES HEPATOL GAS, V36, P622, DOI 10.1016/j.clinre.2012.04.012; Hawkins GA, 2009, J ALLERGY CLIN IMMUN, V123, P1376, DOI 10.1016/j.jaci.2009.01.049; Mimura T, 2002, ALIMENT PHARM THERAP, V16, P909, DOI 10.1046/j.1365-2036.2002.01203.x; Galigniana NM, 2012, J NEUROCHEM, V122, P4, DOI 10.1111/j.1471-4159.2012.07775.x; Lipman JM, 2011, DIS COLON RECTUM, V54, P311, DOI 10.1007/DCR.0b013e3181fded4d; Hashavia E, 2012, COLORECTAL DIS, V14, P1365, DOI 10.1111/j.1463-1318.2012.02993.x; Achkar JP, 2005, CLIN GASTROENTEROL H, V3, P60, DOI 10.1053/S1542-3565(04)00604-4; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Denny WB, 2000, ENDOCRINOLOGY, V141, P4107, DOI 10.1210/en.141.11.4107; MADDEN MV, 1994, DIGEST DIS SCI, V39, P1193, DOI 10.1007/BF02093783; Lang AE, 2014, CELL MICROBIOL, V16, P490, DOI 10.1111/cmi.12228; Riggs DL, 2007, MOL CELL BIOL, V27, P8658, DOI 10.1128/MCB.00985-07; Shen B, 2003, DIS COLON RECTUM, V46, P748, DOI 10.1097/01.DCR.0000070528.00563.D9; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; Penna C, 1996, GUT, V38, P234, DOI 10.1136/gut.38.2.234; LOHMULLER JL, 1990, ANN SURG, V211, P622; Fleshner P, 2007, CLIN GASTROENTEROL H, V5, P952, DOI 10.1016/j.cgh.2007.03.020; Lee RS, 2010, ENDOCRINOLOGY, V151, P4332, DOI 10.1210/en.2010-0225; Jaaskelainen T, 2011, CURR OPIN PHARMACOL, V11, P326, DOI 10.1016/j.coph.2011.04.006; Riggs DL, 2003, EMBO J, V22, P1158, DOI 10.1093/emboj/cdg108; Gosselink MP, 2004, DIS COLON RECTUM, V47, P876, DOI 10.1007/s10350-004-0525-z; Banasiewicz T, 2011, MED SCI MONITOR, V17, pCR91; Baumgart DC, 2006, AM J GASTROENTEROL, V101, P1048, DOI 10.1111/j.1542-0241.2006.00524.x; Baumgart DC, 2003, ALIMENT PHARM THERAP, V17, P1273, DOI 10.1046/j.0269-2813.2003.01534.x; Binder Elisabeth B, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS186, DOI 10.1016/j.psyneuen.2009.05.021; Coffey JC, 2009, AM J GASTROENTEROL, V104, P1013, DOI 10.1038/ajg.2008.127; Hata K, 2003, SCAND J GASTROENTERO, V38, P1055, DOI 10.1080/00365520310005938; Kaiser E, 2012, CELL MICROBIOL, V14, P1193, DOI 10.1111/j.1462-5822.2012.01788.x; Matsushita R, 2010, CLIN EXP RHEUMATOL, V28, P87; Ng SC, 2007, INFLAMM BOWEL DIS, V13, P129, DOI 10.1002/ibd.20052; O'Donnell Sarah, 2010, Ther Adv Chronic Dis, V1, P177, DOI 10.1177/2040622310379293; Okita Y, 2013, DIGESTION, V88, P101, DOI 10.1159/000353151; Schouten WR, 1998, MEDIAT INFLAMM, V7, P175, DOI 10.1080/09629359891117; Schulke JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011717; Toiyama Y, 2005, WORLD J GASTROENTERO, V11, P6888; Wasmuth HH, 2010, J GASTROINTEST SURG, V14, P1099, DOI 10.1007/s11605-010-1223-x	46	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	JUN	2015	60	6					1617	1623		10.1007/s10620-015-3528-9		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CJ6CM	WOS:000355580800016		
J	Arioka, Y; Ito, H; Ando, T; Ogiso, H; Hirata, A; Hara, A; Seishima, M				Arioka, Yuko; Ito, Hiroyasu; Ando, Tatsuya; Ogiso, Hideyuki; Hirata, Akihiro; Hara, Akira; Seishima, Mitsuru			Pre-stimulated Mice with Carbon Tetrachloride Accelerate Early Liver Regeneration After Partial Hepatectomy	DIGESTIVE DISEASES AND SCIENCES			English	Article						Liver regeneration; Partial hepatectomy; Matrix metalloproteinase 9; Cell proliferation	RENIN-ANGIOTENSIN SYSTEM; MATRIX METALLOPROTEASE 9; REPERFUSION INJURY; RAT-LIVER; EXPRESSION; ISCHEMIA; CELLS	Background and Aim The liver has a high capacity of its regeneration. Most hepatic cells are quiescent unless otherwise stimulated such as their injury or ablation. A previous study suggest that pre-activated hepatic cells have a positive effect on their regeneration. In this study, we examined whether the pre-activated hepatic cells for regeneration accelerate the subsequent liver regeneration. Methods We administered a single injection of carbon tetrachloride (CCl4) to mice 7 days before partial hepatectomy (PHx). Liver weight/body weight ratio and several parameters for cell proliferation such as mitotic index and the number of Ki67 positive cells in the liver were examined after PHx as indexes of liver regeneration. Results Compared to control mice, those pre-stimulated with CCl4 showed earlier liver regeneration 48 h after PHx. Regardless of their accelerated regeneration, pre-stimulated mice showed less cell proliferation than did control mice during liver regeneration. Hepatic fibrosis was not observed in both control and CCl4-pretreated mice after PHx. Mice pre-treated with CCl4 showed the higher matrix metalloproteinase 9 (MMP9) expression than those pre-treated with olive oil. When matrix metalloproteinase 9 (MMP9) activity was inhibited, the pre-stimulated mice did not demonstrate accelerated liver regeneration and they returned to the original state for cell proliferations after PHx. Conclusions Pre-activated liver by CCl4 promoted its subsequent regeneration after PHx. This was not a cause of fibrosis and partly dependent on MMP9 pre-activity rather than cell proliferation in liver. Our findings would not only provide a novel strategy for liver regeneration without cell proliferation as much as possible and also propose a new method for liver transplantation.	[Arioka, Yuko; Ito, Hiroyasu; Ando, Tatsuya; Ogiso, Hideyuki; Seishima, Mitsuru] Gifu Univ, Grad Sch Med, Dept Informat Clin Med, Gifu 5011194, Japan; [Hirata, Akihiro] Gifu Univ, Life Sci Res Ctr, Div Anim Expt, Gifu 5011194, Japan; [Hara, Akira] Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu 5011194, Japan	Arioka, Y (reprint author), Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668560, Japan.	ariokay@gifu-u.ac.jp			Ministry for Education, Culture, Sports, Science and Technology of Japan [25893084]	This work was supported by Grant-in-Aid for Research Activity start-up (25893084) from the Ministry for Education, Culture, Sports, Science and Technology of Japan. We are grateful to Kyoko Takahashi for technical assistance.	Kato H, 2014, J HEPATOL, V60, P1032, DOI 10.1016/j.jhep.2013.12.022; Feng M, 2013, J SURG RES, V180, P156, DOI 10.1016/j.jss.2012.09.042; Csanaky IL, 2009, AM J PHYSIOL-GASTR L, V297, pG419, DOI 10.1152/ajpgi.90728.2008; Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Palmes D, 2004, BIOMATERIALS, V25, P1601, DOI 10.1016/S0142-9612(03)00508-8; Moore C, 2007, AM J PATHOL, V170, P567, DOI 10.2353/ajpath.2007.060456; Haruyama T, 2000, BIOCHEM BIOPH RES CO, V272, P681, DOI 10.1006/bbrc.2000.2837; Ji J, 2013, J SURG RES, V185, P545, DOI 10.1016/j.jss.2012.12.028; Michalopoulos GK, 2005, ADV BIOCHEM ENG BIOT, V93, P101, DOI 10.1007/b99968; Koh SL, 2013, J SURG RES, V179, P66, DOI 10.1016/j.jss.2012.09.007; Fausto N, 2012, J HEPATOL, V57, P692, DOI 10.1016/j.jhep.2012.04.016; Hu JH, 2014, SCIENCE, V343, P416, DOI 10.1126/science.1244880; Miyaoka Y, 2012, CURR BIOL, V22, P1166, DOI 10.1016/j.cub.2012.05.016; Koh SL, 2010, LIVER INT, V30, P1414, DOI 10.1111/j.1478-3231.2010.02306.x; Olle EW, 2006, HEPATOLOGY, V44, P540, DOI 10.1002/hep.21314; Mehendale HM, 2005, TOXICOL PATHOL, V33, P41, DOI 10.1080/01926230590881808; Ito H, 2003, HEPATOLOGY, V38, P1116, DOI 10.1053/jhep.2003.50471; Gazit V, 2012, HEPATOLOGY, V56, P1489, DOI 10.1002/hep.25880; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Darzynkiewicz Z, 1996, CYTOMETRY, V25, P1; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Iwasaki H, 2010, BLOOD, V116, P544, DOI 10.1182/blood-2009-08-240903; DELAHUNT.TJ, 1970, J LIPID RES, V11, P536; Hamada T, 2008, HEPATOLOGY, V47, P186, DOI 10.1002/hep.21922; Jacob S, 2003, INDIAN J BIOCHEM BIO, V40, P324; Jiao Jingjing, 2012, Hepatology, V55, P244, DOI 10.1002/hep.24621; Menjo M, 1998, J GASTROEN HEPATOL, V13, pS100; Nejak-Bowen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059836; Quondamatteo F, 1999, HISTOCHEM CELL BIOL, V112, P277, DOI 10.1007/s004180050448; Shi JH, 2014, SCAND J GASTROENTERO, V49, P99, DOI 10.3109/00365521.2013.854406; Wang CG, 2003, MOL CELL BIOL, V23, P6159, DOI 10.1128/MCB.23.17.6159-6173.2003; Wu Q, 2009, DIGEST DIS SCI, V54, P1918, DOI 10.1007/s10620-008-0650-y	32	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	JUN	2015	60	6					1699	1706		10.1007/s10620-015-3536-9		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CJ6CM	WOS:000355580800025		
J	Xiao, Y; Faucherre, A; Pola-Morell, L; Heddleston, JM; Liu, TL; Chew, TL; Sato, F; Sehara-Fujisawa, A; Kawakami, K; Lopez-Schier, H				Xiao, Yan; Faucherre, Adele; Pola-Morell, Laura; Heddleston, John M.; Liu, Tsung-Li; Chew, Teng-Leong; Sato, Fuminori; Sehara-Fujisawa, Atsuko; Kawakami, Koichi; Lopez-Schier, Hernan			High-resolution live imaging reveals axon-glia interactions during peripheral nerve injury and repair in zebrafish	DISEASE MODELS & MECHANISMS			English	Article						High-resolution imaging; Neurotrauma; Regeneration; Schwann cells; Haptotaxis	SCHWANN-CELL DENERVATION; TARGETED GENE-EXPRESSION; BEAM PLANE ILLUMINATION; LATERAL-LINE; MYELINATED AXONS; EXPERIMENTAL STRATEGIES; FUNCTIONAL RECOVERY; REGENERATION; GROWTH; ADULT	Neural damage is a devastating outcome of physical trauma. The glia are one of the main effectors of neuronal repair in the nervous system, but the dynamic interactions between peripheral neurons and Schwann cells during injury and regeneration remain incompletely characterized. Here, we combine laser microsurgery, genetic analysis, high-resolution intravital imaging and lattice light-sheet microscopy to study the interaction between Schwann cells and sensory neurons in a zebrafish model of neurotrauma. We found that chronic denervation by neuronal ablation leads to Schwann-cell death, whereas acute denervation by axonal severing does not affect the overall complexity and architecture of the glia. Neuronal-circuit regeneration begins when Schwann cells extend bridging processes to close the injury gap. Regenerating axons grow faster and directionally after the physiological clearing of distal debris by the Schwann cells. This might facilitate circuit repair by ensuring that axons are guided through unoccupied spaces within bands of Bungner towards their original peripheral target. Accordingly, in the absence of Schwann cells, regenerating axons are misrouted, impairing the re-innervation of sensory organs. Our results indicate that regenerating axons use haptotaxis as a directional cue during the reconstitution of a neural circuit. These findings have implications for therapies aimed at neurorepair, which will benefit from preserving the architecture of the peripheral glia during periods of denervation.	[Xiao, Yan; Lopez-Schier, Hernan] Helmholtz Zentrum Munchen, Res Unit Sensory Biol Organogenesis, D-85764 Munich, Germany; [Faucherre, Adele; Pola-Morell, Laura; Lopez-Schier, Hernan] Ctr Genom Regulat, Cell & Dev Biol, Barcelona 08003, Spain; [Heddleston, John M.; Liu, Tsung-Li; Chew, Teng-Leong] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Sato, Fuminori; Sehara-Fujisawa, Atsuko] Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan; [Kawakami, Koichi] Grad Univ Adv Studies Sokendai, Natl Inst Genet, Div Mol & Dev Biol, Mishima, Shizuoka 4118540, Japan; [Kawakami, Koichi] Grad Univ Adv Studies Sokendai, Dept Genet, Mishima, Shizuoka 4118540, Japan	Lopez-Schier, H (reprint author), Helmholtz Zentrum Munchen, Res Unit Sensory Biol Organogenesis, D-85764 Munich, Germany.	hernan.lopez-schier@helmholtz-muenchen.de	Liu, Tsung-li/M-4473-2015		HDC Diabetes Portfolio of the Helmholtz Gemeinschaft; Program Grant of the Human Frontier Science Program [RGP0033/2014]; National BioResource Project (NBRP); Ministry of Education, Science, Sports and Technology (MEXT) of Japan [23241063]; Gordon and Betty Moore Foundation; Howard Hughes Medical Institute	This work was funded by the HDC Diabetes Portfolio of the Helmholtz Gemeinschaft, and by a Program Grant of the Human Frontier Science Program (RGP0033/2014) to H.L.-S.; and by the National BioResource Project (NBRP) and Grants-in-Aid for Scientific Research (23241063 to K.K. and 2212207 to A.F.-S.) from the Ministry of Education, Science, Sports and Technology (MEXT) of Japan. The AIC at Janelia is sponsored by the Gordon and Betty Moore Foundation and by the Howard Hughes Medical Institute.	SMITH SJ, 1988, SCIENCE, V242, P708, DOI 10.1126/science.3055292; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; Kang H, 2014, J NEUROSCI, V34, P6323, DOI 10.1523/JNEUROSCI.4673-13.2014; Allodi I, 2012, PROG NEUROBIOL, V98, P16, DOI 10.1016/j.pneurobio.2012.05.005; Painter MW, 2014, NEURON, V83, P331, DOI 10.1016/j.neuron.2014.06.016; Gordon T, 2003, J PERIPHER NERV SYST, V8, P236, DOI 10.1111/j.1085-9489.2003.03029.x; Brosamle C, 2002, GLIA, V39, P47, DOI 10.1002/glia.10088; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Gilmour DT, 2002, NEURON, V34, P577, DOI 10.1016/S0896-6273(02)00683-9; Meier C, 1999, J NEUROSCI, V19, P3847; David G, 1997, J PHYSIOL-LONDON, V498, P295; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Martin SM, 2010, DEVELOPMENT, V137, P3985, DOI 10.1242/dev.053611; Court FA, 2004, NATURE, V431, P191, DOI 10.1038/nature02841; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Asakawa K, 2008, DEV GROWTH DIFFER, V50, P391, DOI [10.1111/j.1440-169X.2008.01044.x, 10.1111/j.1440-169x.2008.01044.x]; Sharghi-Namini S, 2006, J NEUROSCI, V26, P6364, DOI 10.1523/JNEUROSCI.0157-06.2006; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; Kidd GJ, 2013, HAND CLINIC, V115, P55, DOI 10.1016/B978-0-444-52902-2.00005-9; Stankovic K, 2004, J NEUROSCI, V24, P8651, DOI 10.1523/JNEUROSCI.0733-04.2004; Toyama BH, 2013, CELL, V154, P971, DOI 10.1016/j.cell.2013.07.037; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Misgeld T, 2007, NAT PROTOC, V2, P263, DOI 10.1038/nprot.2007.24; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Raphael AR, 2011, CURR TOP DEV BIOL, V97, P1, DOI 10.1016/B978-0-12-385975-4.00007-3; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Graciarena M, 2014, P NATL ACAD SCI USA, V111, P1610, DOI 10.1073/pnas.1319405111; Pogoda HM, 2006, DEV BIOL, V298, P118, DOI 10.1016/j.ydbio.2006.06.021; Dedkov EI, 2002, ACTA NEUROPATHOL, V103, P565, DOI 10.1007/s00401-001-0504-6; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Perlin JR, 2011, DEVELOPMENT, V138, P4639, DOI 10.1242/dev.068072; Gao L, 2014, NAT PROTOC, V9, P1083, DOI 10.1038/nprot.2014.087; Scherer SS, 2008, GLIA, V56, P1578, DOI 10.1002/glia.20751; Munzel EJ, 2012, GLIA, V60, P253, DOI 10.1002/glia.21260; Rodrigues F, 2011, CELL MOL LIFE SCI, V68, P55, DOI 10.1007/s00018-010-0512-6; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Halpern ME, 2008, ZEBRAFISH, V5, P97, DOI 10.1089/zeb.2008.0530; Goedhart J, 2010, NAT METHODS, V7, P137, DOI [10.1038/nmeth.1415, 10.1038/NMETH.1415]; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/nmeth.1586, 10.1038/NMETH.1586]; BASTMEYER M, 1994, GLIA, V11, P300, DOI 10.1002/glia.440110403; Beirowski Bogdan, 2013, Front Cell Neurosci, V7, P256, DOI 10.3389/fncel.2013.00256; BUETTNER HM, 1994, DEV BIOL, V163, P407, DOI 10.1006/dbio.1994.1158; Cashman C. R., 2015, NEUROSCI LETT; Chada S, 1997, J CELL SCI, V110, P1179; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Czopka T, 2011, METHOD CELL BIOL, V105, P25, DOI 10.1016/B978-0-12-381320-6.00002-3; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Faber C. G., 2015, NEUROSCI LETT; Faucherre A, 2014, METHODS MOL BIOL, V1082, P187, DOI 10.1007/978-1-62703-655-9_13; Faucherre A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004477; Faucherre A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016587; FENELEY MR, 1991, EXP NEUROL, V114, P275, DOI 10.1016/0014-4886(91)90153-4; Goessling W, 2014, DIS MODEL MECH, V7, P769, DOI 10.1242/dmm.016352; Grant KA, 2005, NEURON, V45, P69, DOI 10.1016/j.neuron.2004.12.020; Hall SM, 1999, ANN NY ACAD SCI, V883, P215, DOI 10.1111/j.1749-6632.1999.tb08584.x; Jung SH, 2010, DEV DYNAM, V239, P592, DOI 10.1002/dvdy.22166; Kang H, 2013, J NEUROSCI, V33, P19480, DOI 10.1523/JNEUROSCI.4067-13.2013; Kawakami K, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-105; LAFONT F, 1994, PERSPECT DEV NEUROBI, V2, P259; Lewis G. M., 2013, JOVE; Lombardo FL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086405; Lopez-Schier H, 2005, P NATL ACAD SCI USA, V102, P1496, DOI 10.1073/pnas.0409361102; Lush ME, 2014, ELIFE, V3, DOI 10.7554/eLife.01832; Monk KR, 2013, DIS MODEL MECH, V6, P135, DOI 10.1242/dmm.009217; Patton EE, 2014, DIS MODEL MECH, V7, P731, DOI 10.1242/dmm.017004; Pujol-Marti J, 2012, J NEUROSCI, V32, P2976, DOI 10.1523/JNEUROSCI.5157-11.2012; Ruohonen S, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-26; Scherer SS, 1997, CURR OPIN NEUROL, V10, P386, DOI 10.1097/00019052-199710000-00006; SHEPPARD CJR, 1981, J MICROSC-OXFORD, V124, P107; Shy ME, 2009, ADV EXP MED BIOL, V652, P171, DOI 10.1007/978-90-481-2813-6_11; Soares L, 2014, SCI REP-UK, V4, DOI 10.1038/srep06199; SPIRA ME, 1993, J NEUROBIOL, V24, P300, DOI 10.1002/neu.480240304; Sulaiman OAR, 2009, NEUROSURGERY, V65, pA105, DOI 10.1227/01.NEU.0000358537.30354.63; Sulaiman OAR, 2002, EXP NEUROL, V176, P342, DOI 10.1006/exnr.2002.7928; Villegas R, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-19; WEINBERG HJ, 1978, J NEUROCYTOL, V7, P555, DOI 10.1007/BF01260889; Wuhr M, 2011, METHOD CELL BIOL, V101, P1, DOI 10.1016/B978-0-12-387036-0.00001-3	81	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	1754-8403	1754-8411		DIS MODEL MECH	Dis. Model. Mech.	JUN	2015	8	6					553	564		10.1242/dmm.018184		12	Cell Biology; Pathology	Cell Biology; Pathology	CJ5VD	WOS:000355559100004		
J	Kihara, H; Nakamura, T				Kihara, Hideki; Nakamura, Tomohiko			Early standard development assessment characteristics in very low birth weight infants later classified with autism spectrum disorder	EARLY HUMAN DEVELOPMENT			English	Article						Screening; ASD; VLBWI	PRETERM INFANTS; RISK-FACTORS; BIOLOGICAL MOTION; BORN; OUTCOMES; CHILDREN; JAPAN; AGE; GESTATION; MORTALITY	Background: The prevalence of autism spectrum disorder (ASD) symptoms is high among very low birth weight infants (VLBWIs). Early diagnosis of ASD is crucial, because early intervention for ASD is effective. Objective: To evaluate early standard development assessment characteristics in VLBWIs later classified with ASD. Methods: Thirty-five VLBWIs later diagnosed with ASD were compared with 169 children with typical development who were admitted to the neonatal intensive care unit at Nagano Children's Hospital between 2001 and 2005. We retrospectively evaluated developmental quotient (DQ) using the Kyoto Scale of Psychological Development (KSPD) at 6 and 18 months post-term age (PTA) and 3 year chronological age. Results: KSPD DQ was significantly lower in ASD infants than in typical development infants at all ages. Posturalmotor DQs of ASD infants at 18 months PTA and 3 year chronological age showed some increase compared to that at 6 months PTA. Conclusion: Early recognition of ASD using standardized development assessment tools in VLBWIs might be possible. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Kihara, Hideki] Nagano Childrens Hosp, Dept Rehabil, Nagano 3998288, Japan; [Nakamura, Tomohiko] Nagano Childrens Hosp, Div Neonatol, Nagano 3998288, Japan	Nakamura, T (reprint author), Nagano Childrens Hosp, Div Neonatol, 3100 Toyoshina, Nagano 3998288, Japan.	tnakamura@naganoch.gr.jp			Ministry of Health, Labour and Welfare, Japan	This study was funded by a grant for scientific research from Ministry of Health, Labour and Welfare, Japan.	Aamoudse-Moens CSH, 2009, PEDIATRICS, V124, P717; Kono Y, 2011, PEDIATR INT, V53, P930, DOI 10.1111/j.1442-200X.2011.03424.x; Karmel BZ, 2010, PEDIATRICS, V126, P457, DOI 10.1542/peds.2009-2680; Kono Y, 2011, PEDIATR INT, V53, P1051, DOI 10.1111/j.1442-200X.2011.03480.x; Iwata S, 2012, PEDIATRICS, V129, pE1138, DOI 10.1542/peds.2011-1735; Kanemaru N, 2013, DEV MED CHILD NEUROL, V55, P713, DOI 10.1111/dmcn.12156; Barre N, 2011, J PEDIATR-US, V158, P766, DOI 10.1016/j.jpeds.2010.10.032; Mori R, 2011, J PEDIATR-US, V159, P110, DOI 10.1016/j.jpeds.2010.12.039; Isayama T, 2012, PEDIATRICS, V130, pE957, DOI 10.1542/peds.2012-0336; Kusuda S, 2012, PEDIATR RES, V72, P531, DOI 10.1038/pr.2012.114; Limperopoulos C, 2008, PEDIATRICS, V121, P758, DOI 10.1542/peds.2007-2158; Kolevzon A, 2007, ARCH PEDIAT ADOL MED, V161, P326, DOI 10.1001/archpedi.161.4.326; Klin A, 2008, DEVELOPMENTAL SCI, V11, P40, DOI 10.1111/j.1467-7687.2007.00608.x; Ishii N, 2013, PEDIATRICS, V132, P62, DOI 10.1542/peds.2012-2857; Schendel D, 2008, PEDIATRICS, V121, P1155, DOI 10.1542/peds.2007-1049; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; Itabashi K, 2009, PEDIATRICS, V123, P445, DOI 10.1542/peds.2008-0763; Klin A, 2009, NATURE, V459, P257, DOI 10.1038/nature07868; Kuban KCK, 2009, J PEDIATR-US, V154, P535, DOI 10.1016/j.jpeds.2008.10.011; Bryson SE, 2007, J AUTISM DEV DISORD, V37, P12, DOI 10.1007/s10803-006-0328-2; Johnson S, 2010, J PEDIATR-US, V156, P525, DOI 10.1016/j.jpeds.2009.10.041; Limperopoulos C, 2007, PEDIATRICS, V120, P584, DOI 10.1542/peds.2007-1041; Johnson S, 2011, ARCH DIS CHILD, V96, P73, DOI 10.1136/adc.2010.194795; Tamaru S, 2011, EARLY HUM DEV, V87, P55, DOI 10.1016/j.earlhumdev.2010.10.004; van Noort-van der Spek IL, 2012, PEDIATRICS, V129, P745, DOI 10.1542/peds.2011-1728	25	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-3782	1872-6232		EARLY HUM DEV	Early Hum. Dev.	JUN	2015	91	6					357	359		10.1016/j.earlhumdev.2015.03.012		3	Obstetrics & Gynecology; Pediatrics	Obstetrics & Gynecology; Pediatrics	CJ7WG	WOS:000355710500003		
J	Utsunomiya, H; Hidaka, T; Masada, K; Shimonaga, T; Higaki, T; Iwasaki, T; Mitsuba, N; Ishibashi, K; Kurisu, S; Kihara, Y				Utsunomiya, Hiroto; Hidaka, Takayuki; Masada, Kenji; Shimonaga, Takashi; Higaki, Tadanao; Iwasaki, Toshitaka; Mitsuba, Naoya; Ishibashi, Ken; Kurisu, Satoshi; Kihara, Yasuki			Value of Resting Echocardiographic Findings and Dobutamine Stress Echocardiography for Diagnosing Myocardial Ischemia in Patients with Suspected Angina Pectoris	ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES			English	Article						coronary flow imaging; diagnostic imaging tool; dobutamine stress echocardiography; myocardial ischemia; transthoracic echocardiography; tissue Doppler imaging	CORONARY-ARTERY-DISEASE; AORTIC-VALVE SCLEROSIS; TISSUE DOPPLER; CARDIOVASCULAR MORTALITY; ASYMPTOMATIC PATIENTS; COMPUTED-TOMOGRAPHY; SYSTOLIC FUNCTION; FLOW RESERVE; ALL-CAUSE; CALCIFICATION	BackgroundWe evaluated the diagnostic value of resting echocardiographic findings including total heart calcification (THC) score in combination with dobutamine stress echocardiography (DSE) for detection of myocardial ischemia. MethodsAltogether, 110 patients with suspected angina pectoris underwent resting echocardiography and DSE. On the basis of resting echocardiography, we determined the THC score, left anterior descending artery diastole-to-systole velocity ratio (LAD-DSVR), and positive myocardial velocity during isovolumic relaxation phase (V-IVR) detected by color-coded tissue Doppler imaging. Myocardial ischemia was diagnosed by a 25% or greater reduction in the internal diameter of major coronary vessels with impaired fractional flow reserve (FFR 0.80). ResultsDSE had excellent specificity (89%) but modest sensitivity (52%) for wall-motion abnormality (WMA) analysis. Multivariate analysis showed that THC score 2 (odds ratio and 95% confidence interval: 4.49 [2.29-10.6]; P=0.018), LAD-DSVR 1.5 (6.43 [1.39-20.3], P=0.019), and duration of positive V-IVR 71msec (7.93 [3.72-12.1]; P<0.001) were independent predictors of ischemia. The combination of inducible WMA and THC score yielded significantly higher sensitivity for ischemia detection than the inducible WMA alone (80% vs. 52%, P=0.0008). Using receiver operating characteristics analyses, adding all three resting echocardiographic findings to clinical variables plus inducible WMA further improved prediction of ischemia (P=0.028). ConclusionsIntegration of DSE and resting echocardiographic findings describing degree of heart calcification, impaired LAD flow, and extent of delayed ejection motion of the myocardium improves detection of coronary angiogram-based FFR-guided ischemia.	[Utsunomiya, Hiroto] Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA; [Utsunomiya, Hiroto; Hidaka, Takayuki; Masada, Kenji; Shimonaga, Takashi; Higaki, Tadanao; Iwasaki, Toshitaka; Mitsuba, Naoya; Ishibashi, Ken; Kurisu, Satoshi; Kihara, Yasuki] Hiroshima Univ Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Med, Hiroshima, Japan	Utsunomiya, H (reprint author), Cedars Sinai Heart Inst, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.	Hiroto.Utsunomiya@cshs.org					Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Budoff MJ, 2011, ATHEROSCLEROSIS, V215, P196, DOI 10.1016/j.atherosclerosis.2010.11.017; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Jeon DS, 2001, J AM COLL CARDIOL, V38, P1988, DOI 10.1016/S0735-1097(01)01678-3; Edvardsen T, 2002, CIRCULATION, V105, P2071, DOI 10.1161/01.CIR.0000014614.63980.BA; Utsunomiya H, 2010, ATHEROSCLEROSIS, V213, P166, DOI 10.1016/j.atherosclerosis.2010.08.070; Volzke H, 2010, ATHEROSCLEROSIS, V209, P606, DOI 10.1016/j.atherosclerosis.2009.10.030; Utsunomiya H, 2011, INT J CARDIOL, V147, P88, DOI 10.1016/j.ijcard.2009.08.009; Geleijnse ML, 2009, J AM SOC ECHOCARDIOG, V22, P1199, DOI 10.1016/j.echo.2009.07.006; Cramariuc D, 2009, JACC-CARDIOVASC IMAG, V2, P390, DOI 10.1016/j.jcmg.2008.12.021; Voigt JV, 2003, J AM SOC ECHOCARDIOG, V16, P415, DOI 10.1016/S0894-7317(03)00111-1; Ng ACT, 2009, AM HEART J, V158, P836, DOI 10.1016/j.ahj.2009.09.010; Elhendy A, 1997, AM J CARDIOL, V80, P1414, DOI 10.1016/S0002-9149(97)00707-8; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Madler CF, 2003, EUR HEART J, V24, P1584, DOI 10.1016/S0195-668X(03)00099-X; Rossi A, 2012, DIABETES CARE, V35, P1781, DOI 10.2337/dc12-0134; Chandraratna PAN, 2012, ECHOCARDIOGR-J CARD, V29, P695, DOI 10.1111/j.1540-8175.2012.01687.x; Choi MJ, 2013, ATHEROSCLEROSIS, V229, P369, DOI 10.1016/j.atherosclerosis.2013.05.026; Daimon M, 2005, J AM SOC ECHOCARDIOG, V18, P949, DOI 10.1016/j.echo.2005.01.006; DesSimone G, 1995, J AM COLL CARDIOL, V25, P1056; Ferreiro DE, 2013, ECHOCARDIOGR-J CARD, V30, P1156, DOI 10.1111/echo.12242; Lacalzada J, 2012, ECHOCARDIOGR-J CARD, V29, P1120, DOI 10.1111/j.1540-8175.2012.01755.x; Mainigi SK, 2012, ECHOCARDIOGR-J CARD, V29, P1017, DOI 10.1111/j.1540-8175.2012.01752.x; MARWICK T, 1993, CIRCULATION, V87, P345; McCulloch M, 2006, J AM SOC ECHOCARDIOG, V19, P744, DOI 10.1016/j.echo.2006.01.020; Onishi T, 2007, J AM SOC ECHOCARDIOG, V20, P158, DOI 10.1016/j.echo.2006.08.007; Otto CM, 1999, NEW ENGL J MED, V341, P142, DOI 10.1056/NEJM199907153410302; Parker KM, 2015, ECHOCARDIOGR-J CARD, V32, P349, DOI 10.1111/echo.12636; Smart SC, 2000, CIRCULATION, V101, P258; Yamazato R, 2012, J NUCL MED, V53, P1216, DOI 10.2967/jnumed.111.099275; Yoon SJ, 2011, ECHOCARDIOGR-J CARD, V28, P1119, DOI 10.1111/j.1540-8175.2011.01493.x; Yuda S, 2004, J AM SOC ECHOCARDIOG, V17, P448, DOI 10.1016/j.echo.2004.01.001	32	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-2822	1540-8175		ECHOCARDIOGR-J CARD	Echocardiography-J. Cardiovasc. Ultrasound Allied Tech.	JUN	2015	32	6					993	1002		10.1111/echo.12800		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CJ8IN	WOS:000355743600014		
J	Kubota, Y; Shiono, T; Kusumoto, B				Kubota, Yasuhiro; Shiono, Takayuki; Kusumoto, Buntarou			Role of climate and geohistorical factors in driving plant richness patterns and endemicity on the east Asian continental islands	ECOGRAPHY			English	Article							LATITUDINAL DIVERSITY GRADIENT; SPECIES RICHNESS; GLOBAL PATTERNS; SPATIAL AUTOCORRELATION; BIODIVERSITY HOTSPOTS; GEOGRAPHICAL ECOLOGY; TEMPERATE PLANTS; BETA DIVERSITY; JAPAN SEA; SCALE	We investigated the roles of climate, geography, and geology in plant diversity and endemicity on the east Asian continental islands, by testing predictions from contrasting hypotheses considering current climate, habitat stability, and isolation as major drivers of plant richness and endemicity. We created a fine-resolution map of vascular plant richness (5614 species) with 10 x 10 km grid cells. Using this large dataset and regression models, we explored correlations between species richness/number of endemics and temperature, precipitation, Quaternary temperature/precipitation changes, Quaternary alluvial development and volcanic disturbances (presence of alluvial plains and of pyroclastic flows), distance from the continent, and elevation. We applied these analyses to the vascular plant assemblage as a whole and separately to trees, herbs, and ferns. Temperature and precipitation were associated with the richness of vascular plants overall and of their endemics. Quaternary temperature change was negatively associated with the richness of vascular plants overall and of their endemics. The presence of pyroclastic flows and of lowland alluvial plains was negatively associated with those. Distance from the continent and elevation were positively associated with endemic species richness, especially those of trees and herbs. While current climate was an important predictor of species richness (especially of ferns), geographical isolation and habitat stability were the main predictors of the endemic species richness of trees and herbs. The relative importance of current climate and historical factors may be related to the dispersal ability of functional groups. Our results illustrate that the diverse geographical conditions reflecting the characteristics of the island led to the various historical effects on biodiversity patterns. The highly endemic flora on the east Asian islands resulted from species accumulation and in situ diversification, suggesting that the climate and historical hypotheses are not mutually exclusive, but can be reconciled as the interplay between recent ecological and evolutionary processes.	[Kubota, Yasuhiro; Shiono, Takayuki; Kusumoto, Buntarou] Univ Ryukyus, Fac Sci, Nishihara, Okinawa 9030213, Japan	Kubota, Y (reprint author), Univ Ryukyus, Fac Sci, 1 Senbaru, Nishihara, Okinawa 9030213, Japan.	kubota.yasuhiro@gmail.com			Japan Society for the Promotion of Science [21310025, 21247006, 22657008, 22405006, 24651037]	We thank Kana Kubota, Shin-jiro Fujii, and Ryo Maeshiro for assistance with compiling flora data, Toshihide Hirao, and Werner Ulrich for their comments on an earlier draft. We also thank Andres Baselga for his thoughtful comments and suggestions. We are particularly grateful to local botanists, vegetation researchers, and naturalists. The information on plant distribution compiled in this study has been accumulated through the fieldwork of numerous people including citizen scientists, over past decades. This study is part of the Project of Mapping Biodiversity in Japan led by YK. Financial support was provided by the Japan Society for the Promotion of Science (nos. 21310025, 21247006, 22657008, 22405006, 24651037).	Francis AP, 2003, AM NAT, V161, P523, DOI 10.1086/368223; Jetz W, 2004, ECOL LETT, V7, P1180, DOI 10.1111/j.1461-0248.2004.00678.x; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Svenning JC, 2003, ECOL LETT, V6, P646, DOI 10.1046/j.1461-0248.2003.00477.x; Hawkins BA, 2012, J BIOGEOGR, V39, P1, DOI 10.1111/j.1365-2699.2011.02637.x; Dubuis A, 2011, DIVERS DISTRIB, V17, P1122, DOI 10.1111/j.1472-4642.2011.00792.x; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; [Anonymous], 2008, GLOBAL ECOL BIOGEOGR, DOI DOI 10.1111/J.1466-8238.2007.00334.X; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P129, DOI 10.1111/j.1466-8238.2006.00279.x; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; TADA R, 1994, PALAEOGEOGR PALAEOCL, V108, P487, DOI 10.1016/0031-0182(94)90248-8; Millien-Parra V, 1999, J BIOGEOGR, V26, P959, DOI 10.1046/j.1365-2699.1999.00346.x; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; [Anonymous], 2002, JMA MESH CLIM DAT 20; Svenning JC, 2007, GLOBAL ECOL BIOGEOGR, V16, P234, DOI 10.1111/j.1466-822x.2006.00280.x; Kissling WD, 2012, GLOBAL ECOL BIOGEOGR, V21, P909, DOI 10.1111/j.1466-8238.2011.00728.x; Vetaas OR, 2002, GLOBAL ECOL BIOGEOGR, V11, P291, DOI 10.1046/j.1466-822X.2002.00297.x; Lopez-Pujol J, 2011, J BIOGEOGR, V38, P1267, DOI 10.1111/j.1365-2699.2011.02504.x; Schmidt-Lebuhn AN, 2012, J BIOGEOGR, V39, P2072, DOI 10.1111/j.1365-2699.2012.02756.x; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Bini LM, 2009, ECOGRAPHY, V32, P193, DOI 10.1111/j.1600-0587.2009.05717.x; Hortal J, 2011, ECOL LETT, V14, P741, DOI 10.1111/j.1461-0248.2011.01634.x; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; Oba T, 1991, PALEOCEANOGRAPHY, V6, P499, DOI 10.1029/91PA00560; Harrison SP, 2001, NATURE, V413, P129, DOI 10.1038/35093166; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Willis KJ, 2004, PHILOS T R SOC B, V359, P159, DOI 10.1098/rstb.2003.1387; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Milne RI, 2002, ADV BOT RES, V38, P281, DOI 10.1016/S0065-2296(02)38033-9; Araujo MB, 2008, ECOGRAPHY, V31, P8, DOI 10.1111/j.2007.0906-7590.05318.x; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Montoya D, 2007, ECOGRAPHY, V30, P173, DOI 10.1111/j.2006.0906-7590.04873.x; Flojgaard C, 2011, GLOBAL ECOL BIOGEOGR, V20, P218, DOI 10.1111/j.1466-8238.2010.00604.x; Lomolino MV, 2000, GLOBAL ECOL BIOGEOGR, V9, P1, DOI 10.1046/j.1365-2699.2000.00185.x; Crisp MD, 2001, J BIOGEOGR, V28, P183, DOI 10.1046/j.1365-2699.2001.00524.x; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; Bivand R., 2006, SPDEP SPATIAL DEPEND; CZEREPANOV S. K., 1995, VASCULAR PLANTS RUSS; Ferrer-Castan D, 2005, GLOBAL ECOL BIOGEOGR, V14, P155, DOI 10.1111/j.1466-822X.2004.00140.x; Flora of Korea Editorial Committee, 2007, GEN VASC PLANTS KOR; Flora of Taiwan Editorial Committee, 1975, FLORA TAIWAN; Fox J., 2014, CAR COMPANION APPL R; Freeman E., 2014, PRESENCEABSENCE PRES; Gotanda K, 2008, QUATERN INT, V184, P84, DOI 10.1016/j.quaint.2007.09.029; Hawkins BA, 2003, GLOBAL ECOL BIOGEOGR, V12, P475, DOI 10.1046/j.1466-822X.2003.00060.x; IIJIMA A, 1990, Journal of the Faculty of Science University of Tokyo Section II Geology Mineralogy Geography Geophysics, V22, P121; Kaizuka S., 1980, GEOJOURNAL, V4, P101, DOI 10.1007/BF00705517; Kreft H, 2008, ECOL LETT, V11, P116, DOI 10.1111/j.1461-0248.2007.01129.x; Kubota Y, 2014, J BIOGEOGR, V41, P1267, DOI 10.1111/jbi.12290; Kubota Y, 2011, J BIOGEOGR, V38, P1006, DOI 10.1111/j.1365-2699.2011.02491.x; Latham Roger Earl, 1993, P294; Maeno F, 2007, J VOLCANOL GEOTH RES, V167, P212, DOI 10.1016/j.jvolgeores.2007.05.003; Mateo RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032586; Mittermeier R. A., 2005, HOTSPOTS REVISITED E; Oksanen J., 2012, VEGAN COMMUNITY ECOL; OOI N, 1990, Ecological Research, V5, P81; Ota Y., 1987, I BRIT GEOGRAPHERS S, V20, P182; Satake Y., 1989, WILD FLOWERS JAPAN W, V1; Takahara H, 2000, J BIOGEOGR, V27, P665, DOI 10.1046/j.1365-2699.2000.00432.x; Weigelt P, 2013, ECOGRAPHY, V36, P417, DOI 10.1111/j.1600-0587.2012.07669.x; Yonekura K., 2003, BG PLANTS INDEX JAPA; Yoshikawa T., 1981, LANDFORMS JAPAN	75	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-7590	1600-0587		ECOGRAPHY	Ecography	JUN	2015	38	6					639	648		10.1111/ecog.00981		10	Biodiversity Conservation; Ecology	Biodiversity & Conservation; Environmental Sciences & Ecology	CJ7OA	WOS:000355684500010		
J	Cato, S				Cato, Susumu			Weak independent decisiveness and the existence of a unique vetoer	ECONOMICS LETTERS			English	Article						Social choice; Vetoer; Weak decisiveness; Weak independent decisiveness	SOCIAL CHOICE; ARROWS THEOREM; DICTATORS	This paper is concerned with an aggregation of individual preferences. We introduce the concept of weak independent decisiveness, which is a weakening of Sen's independent decisiveness. We show that a Paretian social welfare function satisfies weak independent decisiveness if and only if the family of weakly decisive sets forms an ultrafilter. (C) 2015 Elsevier B.V. All rights reserved.	Univ Tokyo, Inst Social Sci, Bunkyo Ku, Tokyo 1130033, Japan	Cato, S (reprint author), Univ Tokyo, Inst Social Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	susumu.cato@gmail.com			JSPS KAKENHI [26870477]	I thank an anonymous referee for constructive comments and suggestions. This work was supported by JSPS KAKENHI Grant Number 26870477.	Aliprantis C.D., 2006, INFINITE DIMENSIONAL; Campbell DE, 2000, ECON LETT, V66, P183, DOI 10.1016/S0165-1765(99)00209-8; BAIGENT N, 1987, J ECON, V47, P407, DOI 10.1007/BF01229471; ARROW KENNETH J., 1963, SOCIAL CHOICE INDIVI; Cato S, 2013, SOC CHOICE WELFARE, V41, P169, DOI 10.1007/s00355-012-0677-z; Cato S, 2013, THEOR DECIS, V75, P563, DOI 10.1007/s11238-013-9352-9; Coban C., 2014, SOC CHOICE IN PRESS; Deb R, 2011, HBK ECON, V2, P335, DOI 10.1016/S0169-7218(10)00019-5; Denicolo V, 1998, SOC CHOICE WELFARE, V15, P563, DOI 10.1007/s003550050124; Gibbard AF, 2014, ECON PHILOS, V30, P269, DOI 10.1017/S026626711400025X; HANSSON B, 1976, PUBLIC CHOICE, V28, P89, DOI 10.1007/BF01718460; Iritani J, 2013, SOC CHOICE WELFARE, V40, P155, DOI 10.1007/s00355-011-0591-9; KIRMAN AP, 1972, J ECON THEORY, V5, P267, DOI 10.1016/0022-0531(72)90106-8; Quesada A, 2002, SOC CHOICE WELFARE, V19, P449, DOI 10.1007/s003550100121; SEN A, 1993, ECONOMETRICA, V61, P495, DOI 10.2307/2951715	15	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0165-1765	1873-7374		ECON LETT	Econ. Lett.	JUN	2015	131						59	61		10.1016/j.econlet.2015.03.015		3	Economics	Business & Economics	CJ3EW	WOS:000355367200015		
J	Morimura, N; Takahashi, K; Doi, T; Ohnuki, T; Sakamoto, T; Uchida, Y; Takahashi, H; Fujita, T; Ikeda, H				Morimura, Naoto; Takahashi, Kohei; Doi, Tomoki; Ohnuki, Takahiro; Sakamoto, Tetsuya; Uchida, Yasuyuki; Takahashi, Hiroki; Fujita, Takashi; Ikeda, Hiroto			A pilot study of quantitative capillary refill time to identify high blood lactate levels in critically ill patients	EMERGENCY MEDICINE JOURNAL			English	Article							BASE DEFICIT; SHOCK; TEMPERATURE; PREDICTOR; CHILDREN; INJURY; ADULTS; GAP; PH	Introduction We developed a new device to quantify capillary refill time (CRT) by applying the pulse oximeter principle, and evaluated the correlation between quantitative CRT (Q-CRT) and hypoperfusion status, as represented by blood lactate levels, in critically ill patients. Methods A pilot study was undertaken in the intensive care unit (ICU) in a tertiary emergency medical centre. While the pulse oxygen saturation sensor was placed on the finger of the patients, transmitted light intensity (TLI) was measured with a pulse oximeter (OLV-3100; Nihon Kohden, Tokyo, Japan) before and during compression of the finger. Q-CRT was defined as the interval from the release of compression to the time when TLI reached 90% of baseline. Results Q-CRT was analysed in a total of 57 waveforms among 23 patients and statistically correlated with lactate levels (Spearman's rank correlation coefficient, 0.681; p<0.001). The cut-off value of Q-CRT for predicting a lactate level of >= 2.0 mmol/L was 6.81 s (area under the curve (AUC) (95% CI 1.000 (1.000 to 1.000), p<0.001), and the value for predicting a lactate level of >= 4.0 mmol/L was 7.27 s (AUC=0.989 (95% CI 0.954 to 1.000), p<0.001). Conclusions Q-CRT correlated with blood lactate levels in this pilot study. The most useful threshold for Q-CRT was similar to 6-8 s. Further study is needed to investigate the potential role of this modality as a non-invasive predictor of hypoperfusion in the emergency department, ICU and operating room settings.	[Morimura, Naoto; Takahashi, Kohei; Doi, Tomoki] Yokohama City Univ, Grad Sch Med, Dept Emergency Med, Yokohama, Kanagawa 2320034, Japan; [Ohnuki, Takahiro; Sakamoto, Tetsuya; Uchida, Yasuyuki; Takahashi, Hiroki; Fujita, Takashi; Ikeda, Hiroto] Teikyo Univ, Sch Med, Dept Emergency Med, Tokyo 173, Japan	Morimura, N (reprint author), Yokohama City Univ, Grad Sch Med, Dept Emergency Med, Minami Ku, 4-57 Urafunecho, Yokohama, Kanagawa 2320034, Japan.	molimula@yokohama-cu.ac.jp					Anderson B, 2008, HONG KONG J EMERG ME, V15, P71; Holcomb JB, 2005, MIL MED, V170, P7; GORELICK MH, 1993, PEDIATRICS, V92, P699; Martin MJ, 2006, AM J SURG, V191, P625, DOI 10.1016/j.amjsurg.2006.02.014; Shavit I, 2006, PEDIATRICS, V118, P2402, DOI 10.1542/peds.2006-1108; Tibby SM, 1999, ARCH DIS CHILD, V80, P163; Wodey E, 1998, CRIT CARE MED, V26, P1437, DOI 10.1097/00003246-199808000-00034; Shapiro NI, 2005, ANN EMERG MED, V45, P524, DOI 10.1016/j.annemergmed.2004.12.006; Steiner MJ, 2004, JAMA-J AM MED ASSOC, V291, P2746, DOI 10.1001/jama.291.22.2746; BRODER G, 1964, SCIENCE, V143, P1457, DOI 10.1126/science.143.3613.1457; SCHRIGER DL, 1991, ANN EMERG MED, V20, P601, DOI 10.1016/S0196-0644(05)82375-3; Garner A, 2001, ANN EMERG MED, V38, P541, DOI 10.1067/mem.2001.119053; McEwen MP, 2009, PHYSIOL MEAS, V30, P869, DOI 10.1088/0967-3334/30/9/001; Davis JW, 1998, J TRAUMA, V44, P114, DOI 10.1097/00005373-199801000-00014; Lima A, 2005, INTENS CARE MED, V31, P1316, DOI 10.1007/s00134-005-2790-2; Raju NV, 1999, CLIN PEDIATR, V38, P139, DOI 10.1177/000992289903800303; Kaplan LJ, 2004, CRIT CARE MED, V32, P1120, DOI 10.1097/01.CCM.0000125517.74; SCHRIGER DL, 1988, ANN EMERG MED, V17, P932, DOI 10.1016/S0196-0644(88)80675-9; Aoyagi Takuo, 2003, J Anesth, V17, P259, DOI 10.1007/s00540-003-0192-6; Asimos AW, 1997, J TRAUMA, V42, P571, DOI 10.1097/00005373-199703000-00036; BEECHER HK, 1947, SURGERY, V22, P672; Benson M, 1996, Prehosp Disaster Med, V11, P117; CHAMPION HR, 1995, J TRAUMA, V38, P94, DOI 10.1097/00005373-199501000-00024; Eastridge BJ, 2007, J TRAUMA, V63, P291, DOI 10.1097/TA.0b013e31809ed924; Evans JA, 2006, J PEDIATR-US, V149, P676, DOI 10.1016/j.peds.2006.07.040; Klupp N, 2007, FOOT, V17, P15, DOI 10.1016/j.foot.2006.08.006; LeFlore Judy L, 2005, Adv Neonatal Care, V5, P147, DOI 10.1016/j.adnc.2005.02.008; Leonard PA, 2004, EUR J EMERG MED, V11, P158, DOI 10.1097/01.mej.0000127643.38834.86; Lewin J, 2008, EMERG MED J, V25, P325, DOI 10.1136/emj.2007.055244; Otieno H, 2004, ARCH DIS CHILD, V89, P977, DOI 10.1136/adc.2003.043901; PERETZ DI, 1964, CAN MED ASSOC J, V90, P673; Pickard A, 2011, ANESTH ANALG, V113, P120, DOI 10.1213/ANE.0b013e31821569f9	32	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	JUN	2015	32	6					444	448		10.1136/emermed-2013-203180		5	Emergency Medicine	Emergency Medicine	CJ1TU	WOS:000355268200008		
J	Deguchi, T; Yasuda, M; Horie, K; Seike, K; Kikuchi, M; Mizutani, K; Tsuchiya, T; Yokoi, S; Nakano, M; Hoshina, S				Deguchi, Takashi; Yasuda, Mitsuru; Horie, Kengo; Seike, Kensaku; Kikuchi, Mina; Mizutani, Kohsuke; Tsuchiya, Tomohiro; Yokoi, Shigeaki; Nakano, Masahiro; Hoshina, Shinji			Drug Resistance-Associated Mutations in Mycoplasma genitalium in Female Sex Workers, Japan	EMERGING INFECTIOUS DISEASES			English	Article							NONGONOCOCCAL URETHRITIS; MACROLIDE RESISTANCE; INFECTION; FLUOROQUINOLONE; PREVALENCE; REGIMENS; FAILURE; UGANDA	Mycoplasma genitalium was detected in 21(14.1%) of 149 vaginal swab samples and in 1 (0.7%) of 149 throat washing samples from female sex workers during 2013-2014 in Japan. Prevalences of M. genitalium with macrolide resistance associated 23S rRNA mutations and fluoroquinolone resistance associated parC alterations were 47.1% and 36.8%, respectively.	[Deguchi, Takashi; Yasuda, Mitsuru; Horie, Kengo; Seike, Kensaku; Kikuchi, Mina; Mizutani, Kohsuke; Tsuchiya, Tomohiro; Yokoi, Shigeaki; Nakano, Masahiro] Gifu Univ, Gifu, Gifu 5011194, Japan; [Hoshina, Shinji] Hoshina Clin, Kyoto, Japan	Deguchi, T (reprint author), Gifu Univ, Dept Urol, Grad Sch Med, 1-1 Yanagido, Gifu, Gifu 5011194, Japan.	deguchit@gifu-u.ac.jp			Japan Society for the Promotion of Science, Tokyo, Japan [25462509]	This work was supported in part by the Japan Society for the Promotion of Science, Tokyo, Japan (Grant-in-Aid for Scientific Research [C] 25462509).	Bissessor M, 2015, CLIN INFECT DIS, V60, P1228, DOI 10.1093/cid/ciu1162; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Deguchi T, 2012, EXPERT REV ANTI-INFE, V10, P791, DOI [10.1586/eri.12.38, 10.1586/ERI.12.38]; Tagg KA, 2013, J CLIN MICROBIOL, V51, P2245, DOI 10.1128/JCM.00495-13; Manhart LE, 2013, CLIN INFECT DIS, V56, P934, DOI 10.1093/cid/cis1022; Vandepitte J, 2012, J INFECT DIS, V205, P289, DOI 10.1093/infdis/jir733; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Deguchi T, 2009, J INFECT CHEMOTHER, V15, P410, DOI 10.1007/s10156-009-0726-4; Kikuchi M, 2014, J ANTIMICROB CHEMOTH, V69, P2376, DOI 10.1093/jac/dku164; Mawu FO, 2011, SEX HEALTH, V8, P52, DOI 10.1071/SH10023; McGowin CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001324; Pond MJ, 2014, CLIN INFECT DIS, V58, P631, DOI 10.1093/cid/cit752; Takanashi M, 2015, INFECT CHEMOTHER; Vandepitte J, 2014, SEX TRANSM INFECT, V90, P545, DOI 10.1136/sextrans-2013-051467; Xiang Z, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-414	15	1	1	CENTERS  DISEASE CONTROL	ATLANTA	1600 CLIFTON RD, ATLANTA, GA 30333 USA	1080-6040	1080-6059		EMERG INFECT DIS	Emerg. Infect. Dis	JUN	2015	21	6					1062	1064		10.3201/eid2106.142013		3	Immunology; Infectious Diseases	Immunology; Infectious Diseases	CJ3MA	WOS:000355386900024		
J	Sawada, N; Hatta, T; Kishigami, H; Shimizu, M; Yoda, T; Goda, H				Sawada, N.; Hatta, T.; Kishigami, H.; Shimizu, M.; Yoda, T.; Goda, H.			The effect of a newly developed wheelchair with thoracic and pelvic support on cervical movement and muscle activity in healthy elderly women	EUROPEAN GERIATRIC MEDICINE			English	Article						Wheelchair; Aged; Forward head posture; Head-neck alignment; Cervical muscle; Electromyography	HEAD POSTURE; NECK PAIN; CONTROL PATTERN; COMPUTER USERS; OLDER-ADULTS; WORK; ACTIVATION; DISABILITY; YOUNG; AGE	Background: As the population ages, the number of elderly individuals using a wheelchair is increasing. A standard wheelchair with a vertical backrest (S-WC) pushes on a kyphotic spine and exacerbates forward head posture. Forward head posture limits cervical movement. We used a new wheelchair (N-WC) that does not exacerbate thoracic kyphosis. The N-WC does not have a flat backrest, but has a support belt for the thorax and pelvis. The purpose of this study was to compare head-neck angle, cervical range of motion, and cervical muscle activity in the N-WC and the S-WC in healthy elderly women. Methods: We measured head-neck alignment, trunk tilt angle, cervical muscle activity, and pressure distribution on the backrest. Data from 17 subjects were analyzed. Results: Head-neck angle was close to neutral in the N-WC. The trunk was tilted further back and the area over which pressure was distributed on the backrest was expanded in the N-WC. Cervical range of motion and cervical muscle activity during neck extension were significantly greater in the N-WC than in the S-WC, but during neck flexion, there was no significant difference between the wheelchairs. Conclusion: In the N-WC, head-neck alignment was close to the neutral posture because the wheelchair support belt accommodated kyphosis and did not push the spine forward, so cervical muscle activity may be reduced when at rest. These results suggest that the N-WC prevented forward head posture and improved cervical movement and muscle activity. (C) 2014 Elsevier Masson SAS and European Union Geriatric Medicine Society. All rights reserved.	[Sawada, N.; Shimizu, M.; Yoda, T.; Goda, H.] Hokkaido Univ, Grad Sch Hlth Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Hatta, T.; Kishigami, H.] Hokkaido Univ, Fac Hlth Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Hatta, T (reprint author), Hokkaido Univ, Fac Hlth Sci, Kita Ku, Kita 12,Nishi 5, Sapporo, Hokkaido 0600812, Japan.	thatta@hs.hokudai.ac.jp					Lau KT, 2010, MANUAL THER, V15, P457, DOI 10.1016/j.math.2010.03.009; Quek J, 2013, MANUAL THER, V18, P65, DOI 10.1016/j.math.2012.07.005; Yip CHT, 2008, MANUAL THER, V13, P148, DOI 10.1016/j.math.2006.11.002; Burgess-Limerick R, 1998, CLIN BIOMECH, V13, P584, DOI 10.1016/S0268-0033(98)00021-7; Morl F, 2013, J ELECTROMYOGR KINES, V23, P362, DOI 10.1016/j.jelekin.2012.10.002; Carcone SM, 2007, APPL ERGON, V38, P755, DOI 10.1016/j.apergo.2006.11.001; Szeto GPY, 2005, MANUAL THER, V10, P270, DOI 10.1016/j.math.2005.01.004; Soderberg GL, 2000, PHYS THER, V80, P485; Straker LM, 2008, J ELECTROMYOGR KINES, V18, P336, DOI 10.1016/j.jelekin.2006.10.007; Walmsley RP, 1996, SPINE, V21, P2435, DOI 10.1097/00007632-199611010-00005; Caneiro JP, 2010, MANUAL THER, V15, P54, DOI 10.1016/j.math.2009.06.002; Chiu TT, 2005, ARCH PHYS MED REHAB, V86, P534, DOI 10.1016/j.apmr.2004.02.030; Kuo YL, 2009, J MANIP PHYSIOL THER, V32, P210, DOI 10.1016/j.jmpt.2009.02.002; McLean L, 2005, J ELECTROMYOGR KINES, V15, P527, DOI 10.1016/j.jelekin.2005.06.003; Nam SH, 2013, J PHYS THER SCI, V25, P737, DOI 10.1589/jpts.25.737; Boyle JJW, 2002, CLIN BIOMECH, V17, P361, DOI 10.1016/S0268-0033(02)00030-X; Friebert IM, 1999, J BACK MUSCULOSKELET, V12, P165; Gomes MM, 2013, INT J GERONTOL, V7, P106, DOI 10.1016/j.ijge.2012.11.013; Grimmer-Somers Karen, 2008, J Manipulative Physiol Ther, V31, P509, DOI 10.1016/j.jmpt.2008.08.005; Hinman Martha R, 2004, Spine J, V4, P413, DOI 10.1016/j.spinee.2004.01.002; Horton SJ, 2009, SPINE, V35, pE542; Hsiao LP, 2012, APPL ERGON, V43, P926, DOI 10.1016/j.apergo.2011.12.014; Laughton A, 2003, GAIT POSTURE, V18, P101; Laursen B, 2001, EURO J APPL PHYSL, V84, P527; Lin F, 2006, ARCH PHYS MED REHAB, V87, P504, DOI 10.1016/j.apmr.2005.11.031; Nemmers TM, 2009, J GERIATR PHYS THER, V32, P10; Shigeo N, 2013, HOKKAIDO J OCCUP THE, V30, P21; Stezo GP, 2002, APPL ERGON, V33, P75; Yang JF, 2012, APPL ERGON, V43, P785, DOI 10.1016/j.apergo.2011.11.013	29	1	1	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	1878-7649	1878-7657		EUR GERIATR MED	Eur. Geriatr. Med.	JUN	2015	6	3					286	290		10.1016/j.eurger.2014.11.001		5	Geriatrics & Gerontology	Geriatrics & Gerontology	CJ5VC	WOS:000355558900021		
J	Hanif, EAM; Kennedy, R; Mullan, P				Hanif, Ezanee Azlina Mohamad; Kennedy, Richard; Mullan, Paul			MiR205 is a p53/p63-dependent marker lost in poor outcome Triple Negative Breast Cancers	EUROPEAN JOURNAL OF CANCER CARE			English	Meeting Abstract									[Hanif, Ezanee Azlina Mohamad; Kennedy, Richard; Mullan, Paul] Queens Univ Belfast, Ctr Canc Res & Cell Biol CCRCB, Belfast BT7 1NN, Antrim, North Ireland; [Hanif, Ezanee Azlina Mohamad] UKM Med Mol Biol Inst UMBI, Chiba, Japan; [Hanif, Ezanee Azlina Mohamad] Natl Univ Malaysia UKM, Kuala Lumpur, Malaysia								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-5423	1365-2354		EUR J CANCER CARE	Eur. J. Cancer Care	JUN	2015	24			1	SI	P-17	29	30				2	Oncology; Health Care Sciences & Services; Nursing; Rehabilitation	Oncology; Health Care Sciences & Services; Nursing; Rehabilitation	CJ8FW	WOS:000355736600077		
J	Kuwabara, A; Tsugawa, N; Tanaka, K; Uejima, Y; Ogawa, J; Otao, N; Yamada, N; Masaki, T; Nishigori, C; Moriwaki, S; Okano, T				Kuwabara, A.; Tsugawa, N.; Tanaka, K.; Uejima, Y.; Ogawa, J.; Otao, N.; Yamada, N.; Masaki, T.; Nishigori, C.; Moriwaki, S.; Okano, T.			High prevalence of vitamin D deficiency in patients with xeroderma pigmetosum-A under strict sun protection	EUROPEAN JOURNAL OF CLINICAL NUTRITION			English	Article							SERUM 25-HYDROXYVITAMIN D; SKIN COLOR; D INSUFFICIENCY; PIGMENTOSUM; ASSOCIATION; CANCER; PREVENTION; EXPOSURE; HEALTH; DNA	BACKGROUND/OBJECTIVES: Xeroderma pigmentosum (XP) is a rare autosomal recessive disease characterized by defective repair of ultraviolet (UV) irradiation-induced DNA damage and high risk of skin cancer. Thus, these patients require strict photoprotection. Considering the importance of UV-mediated cutaneous vitamin D production, such rigorous photoprotection would cause vitamin D deficiency. Then, we have studied the vitamin D status in patients with XP-A, a group requiring the most strict photoprotection. SUBJECTS/METHODS: Twenty-one patients with XP-A (aged 6-25) were evaluated for their vitamin D intake, serum levels of 25-hydroxy-vitamin D (25OHD) and parathyroid hormone (PTH). Vitamin D intake was assessed by a 2-day food weighing method. RESULTS: Median dietary intake of vitamin D was 4.1 mu g/day, and the median concentrations of serum 25OHD and PTH were 7.7 and 49.9 pg/ml, respectively. In 76% of the patients, serum 25OHD level was lower than 10 ng/ml, indicating vitamin D deficiency. Vitamin D intake and serum 25OHD level were significantly lower in patients under enteral nutrition (EN) than those with oral intake (OI). Multivariate analyses revealed that EN was a significant predictor of decreased serum 25OHD level (beta coefficient = -0.59, P=0.03). CONCLUSIONS: Vitamin D deficiency is highly prevalent in XP-A patients, and supplementation should be considered to avoid unfavorable skeletal consequences in these patients. In addition, determination of dietary vitamin D requirement has been a difficult work issue in the decision of dietary reference intakes (DRIs) because of its cutaneous production. Data from XP patients would yield useful information for the determination of DRIs for vitamin D.	[Kuwabara, A.; Uejima, Y.; Ogawa, J.; Otao, N.; Yamada, N.] Osaka Shoin Womens Univ, Dept Hlth & Nutr, Higashiosaka, Osaka 5778550, Japan; [Tsugawa, N.; Okano, T.] Kobe Pharmaceut Univ, Dept Hyg Sci, Kobe, Hyogo 658, Japan; [Tanaka, K.] Kyoto Womens Univ, Dept Food & Nutr, Kyoto, Japan; [Masaki, T.; Nishigori, C.] Kobe Univ, Grad Sch Med, Dept Dermatol, Clin Mol Med, Kobe, Hyogo 657, Japan; [Moriwaki, S.] Osaka Med Coll, Dept Dermatol, Osaka, Japan	Kuwabara, A (reprint author), Osaka Shoin Womens Univ, Dept Hlth & Nutr, 4-2-26 Hishiyanishi, Higashiosaka, Osaka 5778550, Japan.	kuwabara.akiko@osaka-shoin.ac.jp			JSPS KAKENHI Grant [25750061, 25350157]	This work was supported by JSPS KAKENHI Grant Number 25750061 and 25350157.	CLEAVER JE, 1968, NATURE, V218, P652, DOI 10.1038/218652a0; Rockell JEP, 2008, OSTEOPOROSIS INT, V19, P1639, DOI 10.1007/s00198-008-0620-4; Libon F, 2013, DERMATOLOGY, V227, P250, DOI 10.1159/000354750; Yoshimura N, 2013, OSTEOPOROSIS INT, V24, P2775, DOI 10.1007/s00198-013-2372-z; Bradford PT, 2011, J MED GENET, V48, P168, DOI 10.1136/jmg.2010.083022; KRAEMER KH, 1987, ARCH DERMATOL, V123, P241, DOI 10.1001/archderm.123.2.241; Valcour A, 2012, J CLIN ENDOCR METAB, V97, P3989, DOI 10.1210/jc.2012-2276; Kraemer KH, 2007, NEUROSCIENCE, V145, P1388, DOI 10.1016/j.neuroscience.2006.12.020; Garland CF, 2011, ANTICANCER RES, V31, P607; Hossein-nezhad A, 2013, MAYO CLIN PROC, V88, P720, DOI 10.1016/j.mayocp.2013.05.011; Nessvi S, 2011, PHOTOCHEM PHOTOBIOL, V87, P1173, DOI 10.1111/j.1751-1097.2011.00956.x; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Holick MF, 2003, RECENT RES CANCER, V164, P3; Armas LAG, 2007, J AM ACAD DERMATOL, V57, P588, DOI 10.1016/j.jaad.2007.03.004; Pludowski P, 2013, AUTOIMMUN REV, V12, P976, DOI 10.1016/j.autrev.2013.02.004; Hall LM, 2010, J NUTR, V140, P542, DOI 10.3945/jn.109.115253; Hirai Y, 2006, MUTAT RES-FUND MOL M, V601, P171, DOI 10.1016/j.mrfmmm.2006.06.010; DeLong LK, 2010, SEMIN CUTAN MED SURG, V29, P185, DOI 10.1016/j.sder.2010.06.001; Godar Dianne E, 2011, Dermatoendocrinol, V3, P243, DOI 10.4161/derm.3.4.15292; Hoesl M, 2010, EUR J DERMATOL, V20, P457, DOI 10.1684/ejd.2010.0968; Institute of Medicine, 2011, DIETARY REFERENCE IN; Kaneko F, 2005, INT J COSMETIC SCI, V27, P66; Ministry of Education Culture Sports Science and Technology; the Government of Japan, 2010, STAND TABL FOOD COMP; Ministry of Health, 2015, DIET REF INT JAP; Sahota O, 2006, OSTEOPOROSIS INT, V17, P1013, DOI 10.1007/s00198-006-0084-3; Sollitto RB, 1997, J AM ACAD DERMATOL, V37, P942, DOI 10.1016/S0190-9622(97)70069-0; Tang JY, 2012, J AM ACAD DERMATOL, V67, pe1	27	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0954-3007	1476-5640		EUR J CLIN NUTR	Eur. J. Clin. Nutr.	JUN	2015	69	6					693	696		10.1038/ejcn.2015.1		4	Nutrition & Dietetics	Nutrition & Dietetics	CJ6MG	WOS:000355607300008		
J	Kita, S; Matsubara, H; Kasai, Y; Tamaoki, T; Okabe, Y; Fukuhara, H; Kamishikiryo, J; Krayukhina, E; Uchiyama, S; Ose, T; Kuroki, K; Maenaka, K				Kita, Shunsuke; Matsubara, Haruki; Kasai, Yoshiyuki; Tamaoki, Takaharu; Okabe, Yuki; Fukuhara, Hideo; Kamishikiryo, Jun; Krayukhina, Elena; Uchiyama, Susumu; Ose, Toyoyuki; Kuroki, Kimiko; Maenaka, Katsumi			Crystal structure of extracellular domain of human lectin-like transcript 1 (LLT1), the ligand for natural killer receptor-P1A	EUROPEAN JOURNAL OF IMMUNOLOGY			English	Article						Cell surface receptor; Crystal structure; C-type lectin-like receptor; Natural killer cell; Protein-protein interactions	GENE-COMPLEX; IMMUNE-RESPONSES; HUMAN NKR-P1A; REVEALS BASIS; MISSING SELF; CUTTING EDGE; NK CELL; RECOGNITION; PROTEIN; EXPRESSION	Emerging evidence has revealed the pivotal roles of C-type lectin-like receptors (CTLRs) in the regulation of a wide range of immune responses. Human natural killer cell receptor-P1A (NKRP1A) is one of the CTLRs and recognizes another CTLR, lectin-like transcript 1 (LLT1) on target cells to control NK, NKT and Th17 cells. The structural basis for the NKRP1A-LLT1 interaction was limitedly understood. Here, we report the crystal structure of the ectodomain of LLT1. The plausible receptor-binding face of the C-type lectin-like domain is flat, and forms an extended -sheet. The residues of this face are relatively conserved with another CTLR, keratinocyte-associated C-type lectin, which binds to the CTLR member, NKp65. A LLT1-NKRP1A complex model, prepared using the crystal structures of LLT1 and the keratinocyte-associated C-type lectin-NKp65 complex, reasonably satisfies the charge consistency and the conformational complementarity to explain a previous mutagenesis study. Furthermore, crystal packing and analytical ultracentrifugation revealed dimer formation, which supports a complex model. Our results provide structural insights for understanding the binding modes and signal transduction mechanisms, which are likely to be conserved in the CTLR family, and for further rational drug design towards regulating the LLT1 function.	[Kita, Shunsuke; Matsubara, Haruki; Kasai, Yoshiyuki; Tamaoki, Takaharu; Okabe, Yuki; Fukuhara, Hideo; Ose, Toyoyuki; Kuroki, Kimiko; Maenaka, Katsumi] Hokkaido Univ, Fac Pharmaceut Sci, Lab Biomol Sci, Sapporo, Hokkaido 0600812, Japan; [Kamishikiryo, Jun] Fukuyama Univ, Fac Pharm & Pharmaceut Sci, Fukuyama, Hiroshima, Japan; [Krayukhina, Elena; Uchiyama, Susumu] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Osaka, Japan; [Krayukhina, Elena] U Med Corp, Osaka, Japan; [Matsubara, Haruki] Grad Univ Adv Studies, High Energy Accelerator Res Org KEK, Inst Mat Struct Sci,Photon Factory, Dept Mat Struct Sci,Struct Biol Res Ctr, Tsukuba, Ibaraki 305, Japan; [Okabe, Yuki] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Chiba, Japan	Maenaka, K (reprint author), Hokkaido Univ, Pharmaceut Sci, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan.	maenaka@pharm.hokudai.ac.jp			Platform for Drug Discovery, Informatics, and Structural Life Science; Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labor and Welfare of Japan	We thank the beamline staff of the Photon Factory and SPring-8 for their assistance with X-ray diffraction data collection. We also thank Dr. T. Tadokoro for helpful discussion. This work was supported in part by Platform for Drug Discovery, Informatics, and Structural Life Science and other grants from the Ministry of Education, Culture, Sports, Science and Technology, and the Ministry of Health, Labor and Welfare of Japan.	Welte S, 2006, NAT IMMUNOL, V7, P1334, DOI 10.1038/ni1402; Barrow AD, 2008, IMMUNOL REV, V224, P98, DOI 10.1111/j.1600-065X.2008.00653.x; Kelley J, 2005, PLOS GENET, V1, P129, DOI 10.1371/journal.pgen.0010027; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bryceson YT, 2011, J INNATE IMMUN, V3, P216, DOI 10.1159/000325265; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Rosen DB, 2005, J IMMUNOL, V175, P7796; Kaiser BK, 2008, P NATL ACAD SCI USA, V105, P6696, DOI 10.1073/pnas.0802736105; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Borrego F, 2006, IMMUNOL RES, V35, P263, DOI 10.1385/IR:35:3:263; Spreu J, 2010, P NATL ACAD SCI USA, V107, P5100, DOI 10.1073/pnas.0913108107; Germain C, 2011, J BIOL CHEM, V286, P37964, DOI 10.1074/jbc.M111.285312; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Aldemir H, 2005, J IMMUNOL, V175, P7791; Li YL, 2009, IMMUNITY, V31, P35, DOI 10.1016/j.immuni.2009.04.019; Mesci A, 2006, IMMUNOL RES, V35, P13, DOI 10.1385/IR:35:1:13; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Rosen DB, 2008, J IMMUNOL, V180, P6508; Satkunanathan S, 2014, J VIROL, V88, P2366, DOI 10.1128/JVI.02789-13; Schuck P, 2000, BIOPHYS J, V78, P1606; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Kolenko P, 2011, J STRUCT BIOL, V175, P434, DOI 10.1016/j.jsb.2011.05.001; Cooper MA, 2004, TRENDS IMMUNOL, V25, P47, DOI 10.1016/j.it.2003.10.012; Di Santo JP, 2008, NAT IMMUNOL, V9, P473, DOI 10.1038/ni.f.201; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Sovova Z, 2011, J MOL MODEL, V17, P1353, DOI 10.1007/s00894-010-0837-y; Bartel Y, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00362; Fukuda K, 2000, BIOCHEMISTRY-US, V39, P1915, DOI 10.1021/bi992134z; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kamishikiryo J, 2011, J BIOL CHEM, V286, P23823, DOI 10.1074/jbc.M110.214254; Kaplan N. O., 1997, METHODS ENZYMOLOGY A, V276; Kirkham CL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00214; Kolenko P, 2011, ACTA CRYSTALLOGR F, V67, P1519, DOI 10.1107/S1744309111046203; Kolenko P, 2009, ACTA CRYSTALLOGR F, V65, P1258, DOI 10.1107/S1744309109043152; Kuroki K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00429; Li YL, 2013, P NATL ACAD SCI USA, V110, P11505, DOI 10.1073/pnas.1303300110; Mathew PA, 2004, MOL IMMUNOL, V40, P1157, DOI 10.1016/j.molimm.2003.11.024; Petrie EJ, 2008, J EXP MED, V205, P725, DOI 10.1084/jem.20072525; Rahim MMA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00145; Skalova T., 2013, MOUSE CLR G LIGAND N, DOI [10.4049/jimmunol.1200880, DOI 10.4049/JIMMUNOL.1200880]; Vogler I, 2011, J INNATE IMMUN, V3, P227, DOI 10.1159/000324112	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2980	1521-4141		EUR J IMMUNOL	Eur. J. Immunol.	JUN	2015	45	6					1605	1613		10.1002/eji.201545509		9	Immunology	Immunology	CJ9QE	WOS:000355836500005		
J	Shibuya, M; Fujio, K; Shoda, H; Okamura, T; Okamoto, A; Sumitomo, S; Yamamoto, K				Shibuya, Mihoko; Fujio, Keishi; Shoda, Hirofumi; Okamura, Tomohisa; Okamoto, Akiko; Sumitomo, Shuji; Yamamoto, Kazuhiko			A new T-cell activation mode for suboptimal doses of antigen under the full activation of Tcells with different specificity	EUROPEAN JOURNAL OF IMMUNOLOGY			English	Article						Antigen specificity; Autoimmunity; Autoreactive Tcells; Bystander activation; Epitope spreading	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; COLLAGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; BYSTANDER ACTIVATION; MULTIPLE-SCLEROSIS; CD40 LIGAND; MICE; INDUCTION; EPITOPES	Loss of tolerance for autoantigens is a common feature in autoimmune diseases. Bystander T-cell activation is the activation of Tcells to produce functional changes through TCR-independent stimulation. Although bystander activation may be related to tolerance loss to multiple autoantigens, the activation mechanism of Tcells directed to an autoantigen with limited amount is not clear. We investigated an activation mode of Tcells (designated as associator Tcells) directed to a suboptimal dose of cognate antigen X in the presence of fully activated Tcells (designated as responder Tcells) directed to an optimal dose of antigen Y. In in vitro coculture, the activation of associator Tcells was dependent on the presentation of antigen X, and soluble factors from activated responder Tcells were not sufficient. Therefore, we conclude this activation mode is different from bystander activation and named it extended antigen priming (EAP). Tcells with EAP showed a different phenotype compared to conventionally primed cells, suggesting the unique nature of EAP. Intriguingly, EAP was dependent on the CD40-CD40L signaling pathway. Thus, the EAP model is a T-cell activation mode for suboptimal dose of antigen and presumably related to the immune response to autoantigens in autoimmune status.	[Shibuya, Mihoko; Fujio, Keishi; Shoda, Hirofumi; Okamura, Tomohisa; Okamoto, Akiko; Sumitomo, Shuji; Yamamoto, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; [Shibuya, Mihoko; Fujio, Keishi; Shoda, Hirofumi; Okamura, Tomohisa; Okamoto, Akiko; Sumitomo, Shuji; Yamamoto, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo 1138655, Japan	Fujio, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kfujio-tky@umin.ac.jp		Sumitomo, Shuji/0000-0003-4980-2664	Japan Society for the Promotion of Science, KAKENHI [23791103]	This work was supported by grants from the Japan Society for the Promotion of Science, KAKENHI grant number 23791103. We are grateful to Kanako Sakashita, Kazuko Inoue, and Kayako Watada for their excellent technical assistance.	GREWAL IS, 1995, NATURE, V378, P617, DOI 10.1038/378617a0; STUART JM, 1983, J EXP MED, V158, P378, DOI 10.1084/jem.158.2.378; HOLMDAHL R, 1994, J AUTOIMMUN, V7, P739, DOI 10.1006/jaut.1994.1058; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Roth EB, 2006, CLIN EXP RHEUMATOL, V24, P12; BENNUN A, 1981, EUR J IMMUNOL, V11, P195, DOI 10.1002/eji.1830110307; Kivity S, 2009, TRENDS IMMUNOL, V30, P409, DOI 10.1016/j.it.2009.05.005; Sherer Y, 2004, SEMIN ARTHRITIS RHEU, V34, P501, DOI 10.1016/j.semarthrit.2004.07.002; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; ZAMVIL S, 1985, NATURE, V317, P355, DOI 10.1038/317355a0; Bischof F, 2004, J IMMUNOL, V172, P2878; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Vanderlugt CL, 2002, NAT REV IMMUNOL, V2, P85, DOI 10.1038/nri724; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Lodolce JP, 2001, J EXP MED, V194, P1187, DOI 10.1084/jem.194.8.1187; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Tuohy VK, 1998, IMMUNOL REV, V164, P93, DOI 10.1111/j.1600-065X.1998.tb01211.x; Deshpande S, 2001, J IMMUNOL, V167, P2902; Wucherpfennig KW, 2001, J CLIN INVEST, V108, P1097, DOI 10.1172/JCI14235; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Brooks-Worrell B, 2001, J IMMUNOL, V166, P5265; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; LEHMANN PV, 1992, NATURE, V358, P155, DOI 10.1038/358155a0; Sattler A, 2009, BLOOD, V113, P1948, DOI 10.1182/blood-2008-02-139147; Balasa B, 1997, J IMMUNOL, V159, P4620; Bangs SC, 2006, TRENDS IMMUNOL, V27, P518, DOI 10.1016/j.it.2006.09.006; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Bonifacio E, 2000, DIABETES, V49, P202, DOI 10.2337/diabetes.49.2.202; Baker RL, 2012, EUR J IMMUNOL, V42, P672, DOI 10.1002/eji.201142071; Bennett Sean R, 2003, Curr Rheumatol Rep, V5, P255, DOI 10.1007/s11926-003-0003-y; BERNARD CCA, 1976, EUR J IMMUNOL, V6, P655, DOI 10.1002/eji.1830060912; Boyman O, 2010, EUR J IMMUNOL, V40, P936, DOI 10.1002/eji.201040466; CAYABYAB M, 1994, J IMMUNOL, V152, P1523; Di Genova G, 2010, EUR J IMMUNOL, V40, P976, DOI 10.1002/eji.200940017; Evans TI, 1995, ARTHRITIS RHEUM, V38, P1754, DOI 10.1002/art.1780381208; Freed JH, 2000, J IMMUNOL, V164, P4697; GAY S, 1993, ANN RHEUM DIS, V52, pS39, DOI 10.1136/ard.52.Suppl_1.S39; Gobel K, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-41; Grewal IS, 1996, SCIENCE, V273, P1864, DOI 10.1126/science.273.5283.1864; Lehmann PV, 1998, IMMUNOL REV, V164, P53, DOI 10.1111/j.1600-065X.1998.tb01207.x; Luckey D, 2014, EUR J IMMUNOL, V44, P3429, DOI 10.1002/eji.201344424; Malek Thomas R, 2008, Annu Rev Immunol, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Mangalam AK, 2004, EUR J IMMUNOL, V34, P280, DOI 10.1002/eji.200324597; Monneaux F, 2002, ARTHRITIS RHEUM, V46, P1430, DOI 10.1002/art.10263; Reynolds J, 2004, KIDNEY INT, V66, P1444, DOI 10.1111/j.1523-1755.2004.00907.x; Svendsen P, 2004, J IMMUNOL, V173, P7037; Vanderlugt CJ, 1996, CURR OPIN IMMUNOL, V8, P831, DOI 10.1016/S0952-7915(96)80012-4; vansBoxel J. A., 1975, NEW ENGL J MED, V293, P517; Whitmire JK, 1999, J IMMUNOL, V163, P3194	49	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2980	1521-4141		EUR J IMMUNOL	Eur. J. Immunol.	JUN	2015	45	6					1643	1653		10.1002/eji.201444965		11	Immunology	Immunology	CJ9QE	WOS:000355836500009		
J	Yoshikawa, S; Kida, H; Sato, K				Yoshikawa, Shinichi; Kida, Haruyasu; Sato, Kiyotaka			Fat crystallization with talc particles is influenced by particle size, concentration, and cooling rate	EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY			English	Article						Talc; Heterogeneous nucleation; Trilauroylglycerol; Tripalmitoylglycerol; 1; 3-dipalmitoyl-2-oleoyl glycerol	X-RAY-DIFFRACTION; IN-OIL EMULSIONS; INTERFACIAL CRYSTALLIZATION; POLYMORPHIC TRANSFORMATION; PALM OIL; POP; ADDITIVES; GLYCEROL; CRYSTALS; SURFACES	We recently found that new types of additives including talc promoted the crystallization of monoacid saturated triacylglycerols (TAGs) in stable polymorphs. This study reports the effects of size and concentration of talc particles and cooling rate on the crystallization of trilauroylglycerol (LLL), tripalmitoylglycerol (PPP), and 1,3-dipalmitoyl-2-oleoyl glycerol (POP). Talc particles were mixed with molten TAGs, and the mixtures were then cooled at designated cooling rates. Polymorphic crystallization was observed by simultaneous use of X-ray diffractometry and differential scanning calorimetry and by polarized optical microscopy. The following results were obtained: (i) talc promoted the crystallization of LLL in stable polymorphs with decreasing particle size and increasing concentration; (ii) the promotional effects were influenced by the cooling rate; (iii) the same behavior was observed for PPP and POP; and (iv) hydrophobic modification of talc surfaces did not affect the promotional effects. These results indicate that talc particles having median sizes of less than 2.5m and concentrations exceeding 0.1wt.% effectively promote fat crystallization, and that the promotional effects can be maximized by choosing proper cooling rates according to the target fats. Furthermore, we propose a model of the heterogeneous nucleation of TAG crystals taking account of the molecular adsorption on cleavage surfaces of talc. Practical applicationsTalc is widely approved as a food-grade ingredient, and the additive effects on various triacylglycerols widen its applicability to fat-based food and cosmetic materials. With grinding, talc particles exhibit anisotropic surfaces: cleavage surfaces are hydrophobic, and edge (lateral) surfaces are hydrophilic. Hydrophobic modification of the edge surfaces does not affect the additive effects of talc particles on fat crystallization, indicating adsorption of fat molecules on the cleavage surfaces.	[Yoshikawa, Shinichi; Kida, Haruyasu] Fuji Oil Co Ltd, Inst Basic Res, R&D, Tsukubamirai, Ibaraki 3002497, Japan; [Sato, Kiyotaka] Hiroshima Univ, Higashihiroshima 724, Japan	Yoshikawa, S (reprint author), Fuji Oil Co Ltd, Inst Basic Res, R&D, 4-3 Kinunodai, Tsukubamirai, Ibaraki 3002497, Japan.	yoshikawa.shinichi@so.fujioil.co.jp					Acevedo NC, 2012, STRUCTURE FUNCTION A, P5; Masuchi MH, 2014, J AM OIL CHEM SOC, V91, P1111, DOI 10.1007/s11746-014-2469-3; Shimamura K, 2013, CRYST GROWTH DES, V13, P4746, DOI 10.1021/cg400910g; Verstringe S, 2014, CRYST GROWTH DES, V14, P5219, DOI 10.1021/cg5010209; Nalaskowski J, 2007, CAN METALL QUART, V46, P227; Smith KW, 2011, J AM OIL CHEM SOC, V88, P1085, DOI 10.1007/s11746-011-1819-7; Marangoni AG, 2012, SOFT MATTER, V8, P1275, DOI 10.1039/c1sm06234d; Bayes-Garcia L, 2011, CRYSTENGCOMM, V13, P3592, DOI 10.1039/c1ce05024a; Wassell P, 2012, LANGMUIR, V28, P5539, DOI 10.1021/la204501t; Sato K, 2013, EUR J LIPID SCI TECH, V115, P1224, DOI 10.1002/ejlt.201300049; Sposito G, 1999, P NATL ACAD SCI USA, V96, P3358, DOI 10.1073/pnas.96.7.3358; Ghosh S, 2012, CRYST GROWTH DES, V12, P4944, DOI 10.1021/cg300872m; Bayes-Garcia L, 2013, CRYSTENGCOMM, V15, P302, DOI 10.1039/c2ce26522b; Acevedo NC, 2012, LANGMUIR, V28, P16207, DOI 10.1021/la303365d; Bayes-Garcia L, 2013, J PHYS CHEM B, V117, P9170, DOI 10.1021/jp403872a; SATO K, 1989, J AM OIL CHEM SOC, V66, P664, DOI 10.1007/BF02669949; Verstringe S, 2013, FOOD RES INT, V51, P344, DOI 10.1016/j.foodres.2012.12.034; Boistelle R., 1988, CRYSTALLIZATION POLY, P189; Gribble CM, 2010, J COLLOID INTERF SCI, V352, P483, DOI 10.1016/j.jcis.2010.07.062; Gunstone F. D., 2006, LIPID TECHNOLOGIES A, P19; Hagemann J. W., 1988, CRYSTALLIZATION POLY, P9; Larsson K., 2006, LIPIDS STRUCTURE PHY; PERDIKATSIS B, 1981, Z KRISTALLOGR, V156, P177, DOI 10.1524/zkri.1981.156.3-4.177; Perkins D., 2010, MINERALOGY, V3rd; Takeuchi M, 2003, CRYST GROWTH DES, V3, P369, DOI 10.1021/cg025594r; Ueno S, 2008, CRYST GROWTH DES, V8, P751, DOI 10.1021/cg0706159; Walsta P., 2001, CRYSTALLIZATION PROC, P289; WATANABE A, 1992, J AM OIL CHEM SOC, V69, P1077, DOI 10.1007/BF02541040; YANO J, 1993, J PHYS CHEM-US, V97, P12967, DOI 10.1021/j100151a053; Yoshikawa S, 2014, J OLEO SCI, V63, P333, DOI 10.5650/jos.ess13155	30	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1438-7697	1438-9312		EUR J LIPID SCI TECH	Eur. J. Lipid Sci. Technol.	JUN	2015	117	6					858	868		10.1002/ejlt.201400420		121	Food Science & Technology; Nutrition & Dietetics	Food Science & Technology; Nutrition & Dietetics	CJ8IW	WOS:000355744500002		
J	Sasaki-Hamada, S; Hojo, Y; Koyama, H; Otsuka, H; Oka, JI				Sasaki-Hamada, Sachie; Hojo, Yuki; Koyama, Hajime; Otsuka, Hayuma; Oka, Jun-Ichiro			Changes in hippocampal synaptic functions and protein expression in monosodium glutamate-treated obese mice during development of glucose intolerance	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						diabetes; glutamate receptor; hippocampal synaptic plasticity; obesity; VGluT	LONG-TERM POTENTIATION; CA1 PYRAMIDAL CELLS; LASTING POTENTIATION; PHOSPHATE TRANSPORTER; COGNITIVE DYSFUNCTION; POSSIBLE INVOLVEMENT; MOLECULAR-CLONING; RAT HIPPOCAMPUS; AMPA RECEPTORS; SPATIAL MEMORY	Glucose is the sole neural fuel for the brain and is essential for cognitive function. Abnormalities in glucose tolerance may be associated with impairments in cognitive function. Experimental obese model mice can be generated by an intraperitoneal injection of monosodium glutamate (MSG; 2mg/g) once a day for 5days from 1day after birth. MSG-treated mice have been shown to develop glucose intolerance and exhibit chronic neuroendocrine dysfunction associated with marked cognitive malfunctions at 28-29 weeks old. Although hippocampal synaptic plasticity is impaired in MSG-treated mice, changes in synaptic transmission remain unknown. Here, we investigated whether glucose intolerance influenced cognitive function, synaptic properties and protein expression in the hippocampus. We demonstrated that MSG-treated mice developed glucose intolerance due to an impairment in the effectiveness of insulin actions, and showed cognitive impairments in the Y-maze test. Moreover, long-term potentiation (LTP) at Schaffer collateral-CA1 pyramidal synapses in hippocampal slices was impaired, and the relationship between the slope of extracellular field excitatory postsynaptic potential and stimulus intensity of synaptic transmission was weaker in MSG-treated mice. The protein levels of vesicular glutamate transporter 1 and GluA1 glutamate receptor subunits decreased in the CA1 region of MSG-treated mice. These results suggest that deficits in glutamatergic presynapses as well as postsynapses lead to impaired synaptic plasticity in MSG-treated mice during the development of glucose intolerance, though it remains unknown whether impaired LTP is due to altered inhibitory transmission. It may be important to examine changes in glucose tolerance in order to prevent cognitive malfunctions associated with diabetes.	[Sasaki-Hamada, Sachie; Hojo, Yuki; Koyama, Hajime; Otsuka, Hayuma; Oka, Jun-Ichiro] Tokyo Univ Sci, Fac Pharmaceut Sci, Pharmacol Lab, Noda, Chiba 2788510, Japan	Oka, JI (reprint author), Tokyo Univ Sci, Fac Pharmaceut Sci, Pharmacol Lab, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	okaji@rs.noda.tus.ac.jp					ABRAHAM WC, 1987, J PHYSIOL-LONDON, V394, P367; Allen KV, 2004, EUR J PHARMACOL, V490, P169, DOI 10.1016/j.ejphar.2004.02.054; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Paulsen O, 1998, TRENDS NEUROSCI, V21, P273, DOI 10.1016/S0166-2236(97)01205-8; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; WIGSTROM H, 1985, ACTA PHYSIOL SCAND, V125, P159, DOI 10.1111/j.1748-1716.1985.tb07703.x; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451; Stranahan AM, 2008, NAT NEUROSCI, V11, P309, DOI 10.1038/nn2055; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Nagata M, 2006, EXP ANIM TOKYO, V55, P109, DOI 10.1538/expanim.55.109; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2; Stewart R, 1999, DIABETIC MED, V16, P93, DOI 10.1046/j.1464-5491.1999.00027.x; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Seidenman KJ, 2003, J NEUROSCI, V23, P9220; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Herzog E, 2001, J NEUROSCI, V21, part. no.; KUBO T, 1993, BRAIN RES, V616, P311, DOI 10.1016/0006-8993(93)90223-A; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; Belanger A, 2004, PHYSIOL BEHAV, V83, P483, DOI 10.1016/j.physbeh.2004.08.031; Strachan MWJ, 1997, DIABETES CARE, V20, P438, DOI 10.2337/diacare.20.3.438; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Takamori S, 2000, NATURE, V407, P189; Varoqui H, 2002, J NEUROSCI, V22, P142; Li XL, 2002, NEUROSCIENCE, V113, P607, DOI 10.1016/S0306-4522(02)00162-8; Chapman CA, 1998, HIPPOCAMPUS, V8, P289, DOI 10.1002/(SICI)1098-1063(1998)8:3<289::AID-HIPO10>3.0.CO;2-X; Gerges NZ, 2003, NEUROSCIENCE, V120, P535, DOI 10.1016/S0306-4522(03)00297-5; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Schafer MKH, 2002, J BIOL CHEM, V277, P50734, DOI 10.1074/jbc.M206738200; Takamori S, 2001, J NEUROSCI, V21; Tordera RM, 2007, EUR J NEUROSCI, V25, P281, DOI 10.1111/j.1460-9568.2006.05259.x; Sasaki Y, 2009, LIFE SCI, V85, P490, DOI 10.1016/j.lfs.2009.07.017; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; Bai LQ, 2001, J BIOL CHEM, V276, P36764, DOI 10.1074/jbc.M104578200; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Cukierman T, 2005, DIABETOLOGIA, V48, P2460, DOI 10.1007/s00125-005-0023-4; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Hirata AE, 1997, BRAZ J MED BIOL RES, V30, P671; WIGSTROM H, 1983, NATURE, V301, P603, DOI 10.1038/301603a0; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Matyskova R, 2008, PHYSIOL RES, V57, P727; ANWYL R, 1989, BRAIN RES, V503, P148, DOI 10.1016/0006-8993(89)91716-2; ARAUJO PE, 1973, AM J PHYSIOL, V225, P764; Awad N, 2002, BEHAV NEUROSCI, V116, P691, DOI 10.1037//0735-7044.116.4.691; Beas-Zarate C, 2001, NEUROCHEM INT, V39, P1, DOI 10.1016/S0197-0186(01)00008-0; Beas-Zarate C, 2002, BRAIN RES, V952, P275, DOI 10.1016/S0006-8993(02)03252-3; BERRY HK, 1974, DEV PSYCHOBIOL, V7, P165, DOI 10.1002/dev.420070210; Biessels GJ, 2002, EUR J PHARMACOL, V441, P1, DOI 10.1016/S0014-2999(02)01486-3; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; desCarvalho P., 2002, LIFE SCI, V71, P1917; desMello M. A., 2001, PHYSL CHEM PHYS M, V33, P63; IWATA S, 1979, TOXICOL LETT, V4, P345, DOI 10.1016/0378-4274(79)90045-6; Kamal A, 2012, BRAIN RES, V1435, P99, DOI 10.1016/j.brainres.2011.11.057; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kaneko T., 2004, SCIENCE, V304, P1815; Lauri SE, 2003, MOL CELL NEUROSCI, V22, P107, DOI 10.1016/S1044-7431(02)00012-X; MCNAUGHTON BL, 1982, J PHYSIOL-LONDON, V324, P249; Meredith RM, 2003, J NEUROSCI, V23, P11142; MULLER D, 1989, BRAIN RES, V479, P290, DOI 10.1016/0006-8993(89)91631-4; NEMEROFF CB, 1977, PSYCHONEUROENDOCRINO, V2, P179, DOI 10.1016/0306-4530(77)90023-3; NIKOLETSEAS MM, 1977, PHYSIOL BEHAV, V19, P767, DOI 10.1016/0031-9384(77)90313-4; PIZZI WJ, 1976, PHARMACOL BIOCHEM BE, V5, P551, DOI 10.1016/0091-3057(76)90268-9; Sanabria ERG, 2002, BRAIN RES BULL, V59, P47, DOI 10.1016/S0361-9230(02)00837-7; Santaguida PL, 2005, EVID REP TECHNOL ASS, V128, P1; Sasaki-Hamada S, 2014, J PHARMACOL SCI, V124, P192, DOI 10.1254/jphs.13179FP; Takamori S, 2002, EMBO REP, V3, P798, DOI 10.1093/embo-reports/kvf159; TERRY LC, 1981, BRAIN RES, V217, P129; Vesikansa A, 2007, J PHYSIOL-LONDON, V583, P145, DOI 10.1113/jphysiol.2007.133975; Wong PTH, 1997, PHARMACOL BIOCHEM BE, V57, P383, DOI 10.1016/S0091-3057(96)00338-3; World Health Organization (WHO), 2015, DIABETES	73	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	JUN	2015	41	11					1393	1401		10.1111/ejn.12891		9	Neurosciences	Neurosciences & Neurology	CK0FX	WOS:000355882000001		
J	Nakata, H; Sakamoto, K; Honda, Y; Kakigi, R				Nakata, Hiroki; Sakamoto, Kiwako; Honda, Yukiko; Kakigi, Ryusuke			Temporal dynamics of neural activity in motor execution and inhibition processing	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						electroencephalography; event-related potentials; inhibition; magnetoencephalography; No-go	EVENT-RELATED POTENTIALS; TRIGGERING VOLUNTARY MOVEMENT; SOMATOSENSORY GO/NOGO TASKS; EVOKED MAGNETIC-FIELDS; RESPONSE-INHIBITION; STIMULUS PROBABILITY; FUNCTIONAL MRI; INTERSTIMULUS-INTERVAL; SELECTIVE ATTENTION; CORTEX	Although many neuroimaging studies using functional magnetic resonance imaging have shown the neuronal networks for motor execution and inhibition processing, the precise activation timing of each brain region is not yet well understood. In the present study, we investigated the temporal dynamics of neural activities in multiple brain regions using magnetoencephalography (MEG) and electroencephalography (EEG) simultaneously during somatosensory Go/No-go paradigms. The results of MEG showed that neural activities in the bilateral premotor area at approximately 150ms and in the primary motor cortex at approximately 250ms were only detected in Go trials, while brain responses in the bilateral prefrontal cortex at approximately 170ms were only observed in No-go trials. In addition, the amplitudes of the N140 and P300 components in EEG was significantly larger in No-go trials than in Go trials, and the latencies of N140 and P300 were significantly later in No-go trials than in Go trials. Our results indicated the time courses of neural processing in response execution and inhibition processing, and revealed differences in their underlying neural mechanisms.	[Nakata, Hiroki; Sakamoto, Kiwako; Honda, Yukiko; Kakigi, Ryusuke] Natl Inst Physiol Sci, Dept Integrat Physiol, Okazaki, Aichi 444, Japan; [Nakata, Hiroki] Nara Womens Univ, Fac Human Life & Environm, Dept Hlth Sci, Nara 6308506, Japan	Nakata, H (reprint author), Natl Inst Physiol Sci, Dept Integrat Physiol, Okazaki, Aichi 444, Japan.	hiroki-nakata@cc.nara-wu.ac.jp					Akatsuka K, 2007, EXP BRAIN RES, V181, P607, DOI 10.1007/s00221-007-0958-4; Nakata H, 2006, NEUROSCI LETT, V397, P318, DOI 10.1016/j.neulet.2005.12.041; Nakata H, 2006, CLIN NEUROPHYSIOL, V117, P1669, DOI 10.1016/j.clinph.2006.03.032; Nakata H, 2010, NEUROSCI LETT, V478, P124, DOI 10.1016/j.neulet.2010.05.002; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Roche RAP, 2005, EXP BRAIN RES, V160, P60, DOI 10.1007/s00221-004-1985-z; Bokura H, 2001, CLIN NEUROPHYSIOL, V112, P2224, DOI 10.1016/S1388-2457(01)00691-5; Kekoni J, 1996, EVOKED POTENTIAL, V100, P115, DOI 10.1016/0013-4694(95)00231-6; Kopp B, 1996, ELECTROEN CLIN NEURO, V99, P19, DOI 10.1016/0921-884X(96)95617-9; Nakata H, 2004, CLIN NEUROPHYSIOL, V115, P361, DOI 10.1016/j.clinph.2003.09.013; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; KOK A, 1986, BIOL PSYCHOL, V23, P21, DOI 10.1016/0301-0511(86)90087-6; Nakata H, 2005, EUR J NEUROSCI, V22, P1784, DOI 10.1111/j.1460-9568.2005.04368.x; Nakata H, 2008, NEUROIMAGE, V39, P1858, DOI 10.1016/j.neuroimage.2007.10.041; Watanabe J, 2002, NEUROIMAGE, V17, P1207, DOI 10.1006/nimg.2002.1198; Hatem SM, 2007, CLIN NEUROPHYSIOL, V118, P1503, DOI 10.1016/j.clinph.2007.03.021; Kida T, 2004, COGNITIVE BRAIN RES, V19, P33, DOI 10.1016/j.cogbrainres.2003.10.016; Akatsuka K, 2007, CLIN NEUROPHYSIOL, V118, P403, DOI 10.1016/j.clinph.2006.09.030; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Hari R, 2000, TRENDS COGN SCI, V4, P455, DOI 10.1016/S1364-6613(00)01549-7; Kida T, 2006, NEUROIMAGE, V32, P1355, DOI 10.1016/j.neuroimage.2006.05.015; Kamijo K, 2004, EUR J APPL PHYSIOL, V92, P305, DOI 10.1007/s00421-004-1097-2; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Nakata H, 2008, BRAIN RES BULL, V77, P197, DOI 10.1016/j.brainresbull.2008.07.008; Nakata H, 2012, EUR J APPL PHYSIOL, V112, P207, DOI 10.1007/s00421-011-1973-5; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; EIMER M, 1993, BIOL PSYCHOL, V35, P123, DOI 10.1016/0301-0511(93)90009-W; Mima T, 1998, J NEUROPHYSIOL, V80, P2215; Tabu H, 2012, NEUROIMAGE, V59, P3373, DOI 10.1016/j.neuroimage.2011.10.092; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; Nakata H, 2005, EXP BRAIN RES, V162, P293, DOI 10.1007/s00221-004-2195-4; Nakata H, 2010, NEUROREPORT, V21, P1040, DOI 10.1097/WNR.0b013e32833f7bb5; Salisbury DF, 2004, CLIN NEUROPHYSIOL, V115, P1550, DOI 10.1016/j.clinph.2004.01.028; Bonte M, 2006, CEREB CORTEX, V16, P115, DOI 10.1093/cercor/bhi091; Chikazoe J, 2009, CEREB CORTEX, V19, P146, DOI 10.1093/cercor/bhn065; Fujiwara N, 2002, COGNITIVE BRAIN RES, V14, P389, DOI 10.1016/S0926-6410(02)00141-6; Hoshiyama M, 1997, EXP BRAIN RES, V115, P6, DOI 10.1007/PL00005685; Jasper H. H., 1958, ELECTROENCEPHALOGRAP, V10, P371, DOI DOI 10.1016/0013-4694(58)90053-1; Kakigi R, 2000, PROG NEUROBIOL, V61, P495, DOI 10.1016/S0301-0082(99)00063-5; Kida T, 2007, J NEUROPHYSIOL, V97, P3585, DOI 10.1152/jn.00007.2007; Maguire RP, 2003, NEUROIMAGE, V20, P1339, DOI 10.1016/S1053-8119(03)00402-6; Nakata H, 2008, NEUROIMAGE, V42, P858, DOI 10.1016/j.neuroimage.2008.05.017; Nakata H, 2009, NEUROIMAGE, V45, P129, DOI 10.1016/j.neuroimage.2008.11.026; Nishitani N, 1999, J NEUROSCI, V19, P2647; Ploner M, 2000, J NEUROPHYSIOL, V83, P1770; ROBERTS LE, 1994, ELECTROEN CLIN NEURO, V92, P44, DOI 10.1016/0168-5597(94)90006-X; Suzuki M, 2013, BRAIN BEHAV, V3, P747, DOI 10.1002/brb3.186; Talairach J., 1988, COPLANAR STEREOTAXIC; Tarkiainen A, 2003, NEUROIMAGE, V19, P1194, DOI 10.1016/S1053-8119(03)00161-7	51	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	JUN	2015	41	11					1448	1458		10.1111/ejn.12889		11	Neurosciences	Neurosciences & Neurology	CK0FX	WOS:000355882000006		
J	Ooyama, Y; Uenaka, K; Ohshita, J				Ooyama, Yousuke; Uenaka, Koji; Ohshita, Joji			Development of D-pi-A Fluorescent Dyes with a 3-Pyridyl Group as Electron-Withdrawing Anchoring Group for Dye-Sensitized Solar Cells	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Dyes/Pigments; Solar cells; Fluorescence; Adsorption; Sensitizers; Nitrogen heterocycles	12 PERCENT EFFICIENCY; 2 PYRIDYL GROUPS; ORGANIC-DYES; LIGHT-ABSORPTION; ZINC PORPHYRINS; TIO2 FILMS; RING; COST	D-pi-A and (D-pi-)(2)A fluorescent dyes (OUY-1 and OUY-2) with a 3-pyridyl group as an electron-withdrawing anchoring group have been newly developed as photosensitizers for dye-sensitized solar cells (DSSCs). We found that both dyes OUY-1 and OUY-2 were adsorbed onto a TiO2 electrode through the formation of pyridinium ions and/or hydrogen bonding of the pyridyl group with the Bronsted-acidic sites on the TiO2 surface. However, D-pi-A dye NI-6, with a 4-pyridyl group, was predominantly adsorbed onto the TiO2 surface through coordinate bonding between the pyridyl group and the Lewis-acidic sites on the TiO2 surface. The photovoltaic performance of DSSC based on dye OUY-1 is comparable to that of the dye NI-6. On the other hand, the photovoltaic performance of DSSC based on dye OUY-2 is much lower than that of the dye OUY-1. This work revealed that the binding mode of D-pi-A dyes with pyridyl groups on the TiO2 surface can be changed by control of the basicity and electron density of pyridyl groups.	[Ooyama, Yousuke; Uenaka, Koji; Ohshita, Joji] Hiroshima Univ, Grad Sch Engn, Dept Appl Chem, Higashihiroshima 7398527, Japan	Ooyama, Y (reprint author), Hiroshima Univ, Grad Sch Engn, Dept Appl Chem, Higashihiroshima 7398527, Japan.	yooyama@hiroshima-u.ac.jp	Ohshita, Joji/C-7576-2011		Japan Society for the Promotion of Science (JSPS) KAKENHI [24550225]; Iwatani Naoji Foundation	This work was supported by Grants-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (JSPS) KAKENHI (grant number 24550225) and a grant from The Iwatani Naoji Foundation.	Ooyama Y, 2014, J MATER CHEM A, V2, P3293, DOI 10.1039/c3ta15067d; Harima Y, 2013, J PHYS CHEM C, V117, P16364, DOI 10.1021/jp405835y; Massin J, 2014, J PHYS CHEM C, V118, P10677, DOI 10.1021/jp502488g; Hagfeldt A, 2010, CHEM REV, V110, P6595, DOI 10.1021/cr900356p; Mao JY, 2014, ASIAN J ORG CHEM, V3, P153; Li LL, 2013, CHEM SOC REV, V42, P291, DOI 10.1039/c2cs35257e; Daphnomili D, 2012, RSC ADV, V2, P12899, DOI 10.1039/c2ra22129b; Agosta R, 2014, CHEM COMMUN, V50, P9451, DOI 10.1039/c4cc01801j; Amacher A, 2014, CHEM COMMUN, V50, P6540, DOI 10.1039/c4cc02696a; Mishra A, 2009, ANGEW CHEM INT EDIT, V48, P2474, DOI 10.1002/anie.200804709; Ambre RB, 2014, CHEM COMMUN, V50, P725, DOI 10.1039/c3cc47985d; Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688; Kakiage K, 2014, CHEM COMMUN, V50, P6379, DOI 10.1039/c4cc02192d; Ning ZJ, 2010, ENERG ENVIRON SCI, V3, P1170, DOI 10.1039/c003841e; Ooyama Y, 2014, RSC ADV, V4, P30225, DOI 10.1039/c4ra03999h; Daphnomili D, 2013, J PHOTOCH PHOTOBIO A, V253, P88, DOI 10.1016/j.jphotochem.2012.12.013; Ooyama Y, 2013, CHEM COMMUN, V49, P2548, DOI 10.1039/c3cc40498f; Ooyama Y, 2011, ANGEW CHEM INT EDIT, V50, P7429, DOI 10.1002/anie.201102552; Ladomenou K, 2014, RSC ADV, V4, P21379, DOI 10.1039/c4ra00985a; Sakurada T, 2014, RSC ADV, V4, P13201, DOI 10.1039/c3ra41317a; Li SG, 2014, CHEM COMMUN, V50, P4309, DOI 10.1039/c4cc00783b; Ooyama Y, 2013, NEW J CHEM, V37, P2479, DOI 10.1039/c3nj00456b; Dessi A, 2014, CHEM COMMUN, V50, P13952, DOI 10.1039/c4cc06160h; Mathew S, 2014, NAT CHEM, V6, P242, DOI [10.1038/nchem.1861, 10.1038/NCHEM.1861]; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Panda DK, 2014, CHEM COMMUN, V50, P5358, DOI 10.1039/c3cc47498d; Lu JF, 2013, CHEM-ASIAN J, V8, P956, DOI 10.1002/asia.201201136; Wang XZ, 2014, CHEM COMMUN, V50, P3965, DOI 10.1039/c4cc00577e; Bessho T, 2010, ANGEW CHEM INT EDIT, V49, P6646, DOI 10.1002/anie.201002118; Shibayama N, 2014, CHEM COMMUN, V50, P6398, DOI 10.1039/c3cc49461f; Ooyama Y, 2011, CHEM-EUR J, V17, P14837, DOI 10.1002/chem.201101923; Ooyama Y, 2009, EUR J ORG CHEM, P2903, DOI 10.1002/ejoc.200900236; Ooyama Y, 2015, RSC ADV, V5, P2531, DOI 10.1039/c4ra14190c; Stangel C, 2014, INORG CHEM, V53, P11871, DOI 10.1021/ic502283d; Ooyama Y, 2012, CHEMPHYSCHEM, V13, P4032, DOI 10.1002/cphc.201200218; Zhang MD, 2013, PHYS CHEM CHEM PHYS, V15, P634, DOI 10.1039/c2cp42993d; Zhang L, 2015, ACS APPL MATER INTER, V7, P3427, DOI 10.1021/am507334m; Bessho T., 2010, ANGEW CHEM, V122, P6796, DOI 10.1002/ange.201002118; Ikeuchi T, 2014, CHEM COMMUN, V50, P1941, DOI 10.1039/c3cc47714b; Manfredi N, 2014, EUR J ORG CHEM, P7069, DOI 10.1002/ejoc.201402422; Mishra A, 2009, ANGEW CHEM, V121, P2510, DOI DOI 10.1002/ANGE.200804709; Ning ZJ, 2009, CHEM COMMUN, P5483, DOI 10.1039/b908802d; Ooyama Y., 2011, ANGEW CHEM, V123, P7567; Ooyama Y, 2010, EUR J ORG CHEM, P92, DOI 10.1002/ejoc.200900983; Sun X, 2014, CHEM COMMUN, V50, P15609, DOI 10.1039/c4cc07963a; Wang L, 2013, RSC ADV, V3, P13677, DOI 10.1039/c3ra41182f; Yella A., 2014, ANGEW CHEM, V126, P3017; Yella A, 2014, ANGEW CHEM INT EDIT, V53, P2973, DOI 10.1002/anie.201309343; Zhang L, 2014, ACS APPL MATER INTER, V6, P7535, DOI 10.1021/am502186k	49	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	JUN	2015		17					3713	3720		10.1002/ejoc.201500341		8	Chemistry, Organic	Chemistry	CJ5NM	WOS:000355534600010		
J	Neya, S; Suzuki, M; Mochizuki, T; Hoshino, T; Kawaguchi, AT				Neya, Saburo; Suzuki, Masaaki; Mochizuki, Tomomi; Hoshino, Tyuji; Kawaguchi, Akira T.			Porphyrinoid Aromaticity Induced by the Interaction between Oxidized and Reduced Pyridine Subunits	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Aromaticity; Crystallography; Porphyrinoids; Pyridinoids; Synthetic methods	SODIUM BOROHYDRIDE; MACROCYCLES; HYBRID; OXYPYRIPORPHYRIN; REDUCTION; COMPLEXES; MECHANISM; IONS	The coupling of 3-hydroxypyridine-2,6-dicarbaldehyde with a tripyrrane-like precursor bearing a central pyridine ring afforded a new porphyrinoid with two pyridine-related sub-units. The sharp Soret-like band at 421 nm in the electronic spectrum and the pyrrole NH signal at delta = -2.98 ppm in the NMR spectrum indicated that the product is aromatic with an 18 pi-electron circuit. The proton and carbon NMR spectra further suggested that the electron circuit is produced not only by the keto-enol isomerization of the 3-hydroxypyridine unit but also by the local hydrogenative dearomatization in the other pyridine unit at the diagonal site. Single-crystal Xray structure analysis revealed that the carbon atom in the latter pyridine unit is indeed dearomatized to exhibit sp(3) character. These observations, taken together, provide a rare example showing that aromaticity of porphyrinoids is accomplished by the cooperative interaction between oxidized and reduced pyridine rings.	[Neya, Saburo; Suzuki, Masaaki; Mochizuki, Tomomi; Hoshino, Tyuji] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Phys Chem, Chiba 2608675, Japan; [Kawaguchi, Akira T.] Tokai Univ, Sch Med, Isehara, Kanagawa 2591193, Japan	Neya, S (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Dept Phys Chem, Chiba 2608675, Japan.	sneya@faculty.chiba-u.jp; akira@is.icc.u-tokai.ac.jp			Ministry of Education, Culture, Japan [26460031, 20249072]	This work was supported by the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Japan [Nos. 26460031 (C) and 20249072 (A)].	ANDERSON PS, 1964, TETRAHEDRON LETT, P153; ANDERSON PS, 1965, TETRAHEDRON LETT, P4011; Lash TD, 1996, CHEM-EUR J, V2, P944, DOI 10.1002/chem.19960020808; Zhang Z, 2012, J AM CHEM SOC, V134, P4076, DOI 10.1021/ja211985k; Vogel E, 1996, J HETEROCYCLIC CHEM, V33, P1461; Setsune J, 2012, CHEM COMMUN, V48, P4447, DOI 10.1039/c2cc30981e; Ho IT, 2014, J AM CHEM SOC, V136, P4281, DOI 10.1021/ja412520g; Berlin K., 1994, ANGEW CHEM, V106, P229, DOI 10.1002/ange.19941060226; BERLIN K, 1994, ANGEW CHEM INT EDIT, V33, P219, DOI 10.1002/anie.199402191; Bonnet R., 1997, J CHEM SOC P1, V1, P1769; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gordon A. J., 1972, CHEM COMPANION, p[54, 107]; Katagiri D, 2008, J COMPUT CHEM, V29, P1930, DOI 10.1002/jcc.20963; Mysliborski R, 2006, EUR J ORG CHEM, P3064; Nakamura M, 2006, COORDIN CHEM REV, V250, P2271, DOI 10.1016/j.ccr.2006.03.001; Neya S, 2012, INORG CHEM, V51, P3891, DOI 10.1021/ic3001043; Neya S, 2008, INORG CHEM, V47, P10771, DOI 10.1021/ic801406x; PAINE JB, 1985, J ORG CHEM, V50, P5598, DOI 10.1021/jo00350a033; Scheer H., 1978, PORPHYRINS, V2, P45; Schonemeier T, 1997, SYNTHESIS-STUTTGART, P273; Setsune J, 2012, J PORPHYR PHTHALOCYA, V16, P508, DOI 10.1142/S1088424612500502; Sheldrick G. M., 1997, SHELXS 97 PROGRAM CR; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Smith K. M., 2000, PORPHYRIN HDB, V2, P1; Sobarzo-Sanchez E, 2007, SYNTHETIC COMMUN, V37, P1331, DOI 10.1080/00397910701227168	25	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	JUN	2015		17					3824	3829		10.1002/ejoc.201500260		6	Chemistry, Organic	Chemistry	CJ5NM	WOS:000355534600023		
J	Kuroyanagi, G; Otsuka, T; Yamamoto, N; Matsushima-Nishiwaki, R; Kozawa, O; Tokuda, H				Kuroyanagi, Gen; Otsuka, Takanobu; Yamamoto, Naohiro; Matsushima-Nishiwaki, Rie; Kozawa, Osamu; Tokuda, Haruhiko			Resveratrol suppresses TGF-beta-induced VEGF synthesis in osteoblasts: Inhibition of the p44/p42 MAPK and SAPK/JNK pathways	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						resveratrol; transforming growth factor-beta; vascular endothelial growth factor; osteoblast	SMALL-MOLECULE ACTIVATORS; OSTEOPROTEGERIN SYNTHESIS; CYCLIC-AMP; CROSS-TALK; BONE; CELLS; KINASE; WINE	Resveratrol, which is found in grape and berry skins and red wine, is generally known to be beneficial for human health due to its anti-inflammation and antioxidant effects. We have recently reported that transforming growth factor-beta (TGF-beta) stimulates vascular endothelial growth factor (VEGF) synthesis through Smad-independent pathways, such as the p38 mitogen-activated protein (MAP) kinase, p44/p42 MAP kinase and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) pathways, in osteoblast-like MC3T3-E1 cells. The aim of the present study was to investigate the effect of resveratrol on the TGF-beta-induced VEGF synthesis and the mechanism in osteoblast-like MC3T3-E1 cells. Resveratrol significantly suppressed the TGF-beta-stimulated release of VEGF and the VEGF mRNA expression levels. SRT1720, a synthetic sirtuin 1 (SIRT1) activator, also reduced the VEGF release and the mRNA levels. With regard to the intracellular signaling in the TGF-beta-stimulated VEGF synthesis, resveratrol and SRT1720 significantly attenuated the phosphorylation of p44/p42 MAP kinase and SAPK/JNK stimulated by TGF-beta; however, the TGF-beta-induced phosphorylation of Smad2 and p38 MAP kinase was hardly affected by resveratrol or SRT1720. These results strongly suggest that the TGF-beta-stimulated VEGF synthesis is suppressed by resveratrol through the inhibition of p44/p42 MAP kinase and SAPK/JNK in osteoblasts, and that the suppressive effect is mediated, at least in part, via SIRT1 activation.	[Kuroyanagi, Gen; Otsuka, Takanobu; Yamamoto, Naohiro] Nagoya City Univ Grad Sch Med Sci, Dept Orthoped Surg, Nagoya, Chubu 4678601, Japan; [Kuroyanagi, Gen; Yamamoto, Naohiro; Matsushima-Nishiwaki, Rie; Kozawa, Osamu; Tokuda, Haruhiko] Gifu Univ Grad Sch Med, Dept Pharmacol, Gifu 5011194, Japan; [Tokuda, Haruhiko] Natl Ctr Geriatr & Gerontol, Dept Clin Lab, Obu, Aichi 4748511, Japan	Tokuda, H (reprint author), Natl Ctr Geriatr & Gerontol, Dept Clin Lab, 35 Gengo, Obu, Aichi 4748511, Japan.	tokuda@ncgg.go.jp			Ministry of Education, Science, Sports and Culture of Japan [19591042]; National Center for Geriatrics and Gerontology, Japan [23-9, 25-4]	This investigation was supported in part by the Grant-in-Aid for Scientific Research (no. 19591042) from the Ministry of Education, Science, Sports and Culture of Japan and Research Funding for Longevity Sciences (no. 23-9, 25-4) from the National Center for Geriatrics and Gerontology, Japan. The authors would like to thank Yumiko Kurokawa for her skillful technical assistance.	Clarkin CE, 2013, CELL BIOCHEM FUNCT, V31, P1, DOI 10.1002/cbf.2911; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Kuroyanagi G, 2014, PROSTAG LEUKOTR ESS, V91, P73, DOI 10.1016/j.plefa.2014.04.003; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Simpson D, 2000, MOL VIS, V6, P178; Chim SM, 2013, CYTOKINE GROWTH F R, V24, P297, DOI 10.1016/j.cytogfr.2013.03.008; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Parfitt AM, 2002, BONE, V30, P5, DOI 10.1016/S8756-3282(01)00642-1; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Zhen GH, 2014, TRENDS PHARMACOL SCI, V35, P227, DOI 10.1016/j.tips.2014.03.005; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Kular J, 2012, CLIN BIOCHEM, V45, P863, DOI 10.1016/j.clinbiochem.2012.03.021; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Kato K, 1996, J NEUROCHEM, V66, P946; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; KOZAWA O, 1992, EXP CELL RES, V198, P130, DOI 10.1016/0014-4827(92)90158-5; Kanno Y, 2005, HORM METAB RES, V37, P140, DOI 10.1055/s-2005-861291; Kondo A, 2014, INT J MOL MED, V33, P1013, DOI 10.3892/ijmm.2014.1626; Koo SH, 2006, CELL, V127, P1091, DOI 10.1016/j.cell.2006.11.034; Kubo JT, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-36; Kuroyanagi G, 2014, ARCH BIOCHEM BIOPHYS, V542, P39, DOI 10.1016/j.abb.2013.12.002; Tokuda H, 2003, ARCH BIOCHEM BIOPHYS, V415, P117, DOI 10.1016/S0003-9861(03)00225-X	27	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	JUN	2015	9	6					2303	2310		10.3892/etm.2015.2389		8	Medicine, Research & Experimental	Research & Experimental Medicine	CJ4ZI	WOS:000355496800044		
J	Kobayashi, T; Shiraishi, A; Hara, Y; Kadota, Y; Yang, LJ; Inoue, T; Shirakata, Y; Ohashi, Y				Kobayashi, Takeshi; Shiraishi, Atsushi; Hara, Yuko; Kadota, Yuko; Yang, Lujun; Inoue, Tomoyuki; Shirakata, Yuji; Ohashi, Yuichi			Stromal-epithelial interaction study: The effect of corneal epithelial cells on growth factor expression in stromal cells using organotypic culture model	EXPERIMENTAL EYE RESEARCH			English	Article						Cornea; Stromal-epithelial interaction; Organotypic culture; Growth factor; Stromal cell	MUSCLE ACTIN EXPRESSION; ALPHA MESSENGER-RNA; AMNIOTIC MEMBRANE; STEM-CELLS; IN-VITRO; TGF-ALPHA; OCULAR SURFACE; HUMAN LIMBAL; TRANSFORMING GROWTH-FACTOR-BETA-1; EGF FAMILY	Interactions between stromal and epithelial cells play important roles in the development, homeostasis, and pathological conditions of the cornea. Soluble cytokines are critical factors in stromal epithelial interactions, and growth factors secreted from corneal stromal cells contribute to the regulation of proliferation and differentiation of corneal epithelial cells (CECs). However, the manner in which the expression of growth factors is regulated in stromal cells has not been completely determined. To study stromal epithelial cell interactions, we used an organotypic culture model. Human or rabbit CECs (HCECs or RCECs) were cultured on amniotic membranes placed on human corneal fibroblasts (HCFs) embedded in a collagen gel. The properties of the organotypic culture were examined by hematoxylin -eosin staining and immunofluorescence. In the organotypic culture, HCECs or RCECs were stratified into two-three layers after five days and five-seven layers after nine days. However, stratification was not observed when the HCECs were seeded on a collagen gel without fibroblasts. K3/K12 were expressed on day 9. The HCF-embedded collagen gels were collected on days 3, 5, or 9 after seeding the RCECs, and mRNA expression of growth factors FGF7, HGF, NGF, EGF, TGF-alpha, SCF, TGF-beta 1, TGF-beta 2, and TGF-beta 3 were quantified by real-time PCR. mRNA expression of the growth factors in HCFs cultured with RCECs were compared with those cultured without RCECs, as well as in monolayer cultures. mRNA expression of TGF-alpha was markedly increased in HCFs cultured with RCECs. However, mRNA expression of the TGF-beta family was suppressed in HCFs cultured with RCECs. Principal component analysis revealed that mRNA expression of the growth factors in HCFs were generally similar when they were cultured with RCECs. In organotypic cultures, the morphological changes in the CECs and the expression patterns of the growth factors in the stromal cells clearly demonstrated stromal-epithelial cell interactions, and the results suggest that stromal cells and epithelial cells may act in concert in the cornea. (C) 2015 Elsevier Ltd. All rights reserved.	[Kobayashi, Takeshi] Ehime Univ, Grad Sch Med, Dept Ophthalmol & Regenerat Med, Toon, Ehime 7910295, Japan; [Shiraishi, Atsushi; Hara, Yuko; Kadota, Yuko; Inoue, Tomoyuki; Ohashi, Yuichi] Ehime Univ, Grad Sch Med, Dept Ophthalmol, Toon, Ehime 7910295, Japan; [Kobayashi, Takeshi; Shiraishi, Atsushi] Ehime Univ, Grad Sch Med, Dept Stem Cell Biol, Toon, Ehime 7910295, Japan; [Yang, Lujun; Shirakata, Yuji] Ehime Univ, Grad Sch Med, Dept Dermatol, Toon, Ehime 7910295, Japan; [Ohashi, Yuichi] Ehime Univ, Grad Sch Med, Dept Infect Dis, Toon, Ehime 7910295, Japan	Shiraishi, A (reprint author), Ehime Univ, Grad Sch Med, Dept Ophthalmol, Toon, Ehime 7910295, Japan.	shiraia@m.ehime-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [20592079, 23592607]	Supported by a grant from Grant-in-Aid for Scientific Research (C) 20592079 and 23592607 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Alaminos M, 2006, INVEST OPHTH VIS SCI, V47, P3311, DOI 10.1167/iovs.05-1647; Thompson RE, 2013, TISSUE ENG PT A, V19, P1564, DOI [10.1089/ten.TEA.2012.0084, 10.1089/ten.tea.2012.0084]; CHEN WYW, 1994, CURR EYE RES, V13, P765, DOI 10.3109/02713689409047012; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Meller D, 2002, BRIT J OPHTHALMOL, V86, P463, DOI 10.1136/bjo.86.4.463; Yuan Y, 2013, INVEST OPHTH VIS SCI, V54, P1829, DOI 10.1167/iovs.12-11477; Koizumi N, 2000, CORNEA, V19, P65, DOI 10.1097/00003226-200001000-00013; Koizumi N, 2000, INVEST OPHTH VIS SCI, V41, P2506; Grueterich M, 2003, SURV OPHTHALMOL, V48, P631, DOI 10.1016/j.survophthal.2003.08.003; Nishimura T, 1998, EXP EYE RES, V66, P105, DOI 10.1006/exer.1997.0419; Maltseva O, 2001, INVEST OPHTH VIS SCI, V42, P2490; LI DQ, 1995, J CELL PHYSIOL, V163, P61, DOI 10.1002/jcp.1041630108; Fini ME, 1999, PROG RETIN EYE RES, V18, P529, DOI 10.1016/S1350-9462(98)00033-0; Yu FSX, 2010, BRAIN RES BULL, V81, P229, DOI 10.1016/j.brainresbull.2009.08.024; Terai K, 2011, INVEST OPHTH VIS SCI, V52, P8208, DOI 10.1167/iovs.11-8017; Picht G, 2001, GRAEF ARCH CLIN EXP, V239, P199, DOI 10.1007/s004170000252; Xu KP, 2007, INVEST OPHTH VIS SCI, V48, P636, DOI 10.1167/iovs.06-0203; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; WILSON SE, 1992, INVEST OPHTH VIS SCI, V33, P1756; Figueira EC, 2007, INVEST OPHTH VIS SCI, V48, P144, DOI 10.1167/iovs.06-0346; SOTOZONO C, 1994, EXP EYE RES, V59, P385, DOI 10.1006/exer.1994.1122; Morita S, 2007, MOL VIS, V13, P2119; Kim A, 2010, INVEST OPHTH VIS SCI, V51, P864, DOI 10.1167/iovs.09-4200; [Anonymous], 1992, ACTA OPHTHALMOL    S; Honma Y, 1997, EXP EYE RES, V65, P391, DOI 10.1006/exer.1997.0338; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; WILSON SE, 1994, EXP EYE RES, V59, P665, DOI 10.1006/exer.1994.1152; Li DQ, 1996, INVEST OPHTH VIS SCI, V37, P2068; Espana EM, 2003, INVEST OPHTH VIS SCI, V44, P5136, DOI 10.1167/iovs.03-0484; Jester JV, 1996, CORNEA, V15, P505; Kakazu A, 2004, INVEST OPHTH VIS SCI, V45, P3485, DOI 10.1167/iovs.04-0372; McClintock JL, 2010, INVEST OPHTH VIS SCI, V51, P3455, DOI 10.1167/iovs.09-4386; MINAMI Y, 1993, INVEST OPHTH VIS SCI, V34, P2316; Cheng CC, 2009, J CELL SCI, V122, P4473, DOI 10.1242/jcs.054791; West-Mays JA, 2006, INT J BIOCHEM CELL B, V38, P1625, DOI 10.1016/j.biocel.2006.03.010; MISHIMA H, 1992, CURR EYE RES, V11, P691, DOI 10.3109/02713689209000742; Wilson SE, 2012, EXP EYE RES, V99, P78, DOI 10.1016/j.exer.2012.03.018; SUN TT, 1977, NATURE, V269, P489, DOI 10.1038/269489a0; Ban Y, 2003, EXP EYE RES, V76, P663, DOI 10.1016/S0014-4835(03)00054-X; Stramer BM, 2003, INVEST OPHTH VIS SCI, V44, P4237, DOI 10.1167/iovs.02-1188; Shiraishi A, 1998, INVEST OPHTH VIS SCI, V39, P2554; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Jester JV, 1999, PROG RETIN EYE RES, V18, P311, DOI 10.1016/S1350-9462(98)00021-4; WILSON SE, 1993, INVEST OPHTH VIS SCI, V34, P2544; Wilson SE, 1999, PROG RETIN EYE RES, V18, P293, DOI 10.1016/S1350-9462(98)00017-2; Yoshioka R, 2010, INVEST OPHTH VIS SCI, V51, P5630, DOI 10.1167/iovs.10-5158; Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219; Kawakita T, 2005, J BIOL CHEM, V280, P27085, DOI 10.1074/jbc.M409567200; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P100, DOI 10.1167/iovs.03-0700; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Miyamoto K, 2012, MOL VIS, V18, P1505; Builles N, 2007, CELL BIOL TOXICOL, V23, P279, DOI 10.1007/s10565-006-0191-0; CHEN WYW, 1995, EXP EYE RES, V61, P521, DOI 10.1016/S0014-4835(05)80046-6; Chen Z, 2006, MOL VIS, V12, P983; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Foreman DM, 1996, EXP EYE RES, V62, P555, DOI 10.1006/exer.1996.0065; Gipson I K, 1995, Curr Opin Ophthalmol, V6, P3; Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169; JESTER JV, 1987, AM J PATHOL, V127, P140; Joyce NC, 1997, INVEST OPHTH VIS SCI, V38, P1922; KHAW PT, 1992, INVEST OPHTH VIS SCI, V33, P3302; Kobayashi T, 2009, MOL VIS, V15, P1589; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; LUTTRULL JK, 1985, INVEST OPHTH VIS SCI, V26, P1449; Matsuda A, 1996, CURR EYE RES, V15, P1033, DOI 10.3109/02713689609017652; OHJI M, 1994, INVEST OPHTH VIS SCI, V35, P479; Qi H, 2008, EXP EYE RES, V86, P34, DOI 10.1016/j.exer.2007.09.003; Qi H, 2007, MOL VIS, V13, P1934; Reichl S, 2003, INT J PHARM, V250, P191, DOI 10.1016/S0378-5173(02)00541-0; Schlotzer-Schrehardt U, 2005, EXP EYE RES, V81, P247, DOI 10.1016/j.exer.2005.02.016; Schneider AI, 1999, IN VITRO CELL DEV-AN, V35, P515; Shirakata Y, 2004, J DERMATOL SCI, V36, P41, DOI 10.1016/j.jdermsci.2004.07.002; Shirakata Y, 2003, J DERMATOL SCI, V32, P209, DOI 10.1016/S0923-1811(03)00103-8; Taliana L, 2001, INVEST OPHTH VIS SCI, V42, P81; TRINKAUSRANDALL V, 1988, INVEST OPHTH VIS SCI, V29, P1800; Tuli SS, 2006, CURR EYE RES, V31, P709, DOI 10.1080/02713680600837390; WILSON SE, 1993, INVEST OPHTH VIS SCI, V34, P1977; Wilson SL, 2014, TISSUE ENG PT A, V20, P225, DOI [10.1089/ten.TEA.2013.0167, 10.1089/ten.tea.2013.0167]; Yang L, 2006, CELL TISSUE RES, V326, P69, DOI 10.1007/s00441-006-0208-2; Zagon IS, 1998, BRAIN RES, V792, P72, DOI 10.1016/S0006-8993(98)00123-1; Zieske JD, 2004, J TOXICOL-CUTAN OCUL, V23, P19, DOI 10.1081/CUS-120027484	82	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0014-4835	1096-0007		EXP EYE RES	Exp. Eye Res.	JUN	2015	135						109	117		10.1016/j.exer.2015.02.009		9	Ophthalmology	Ophthalmology	CJ8RC	WOS:000355770200012		
J	Nakahara, T; Hoshino, M; Hoshino, S; Mori, A; Sakamoto, K; Ishii, K				Nakahara, Tsutomu; Hoshino, Maya; Hoshino, Shin-ichiro; Mori, Asami; Sakamoto, Kenji; Ishii, Kunio			Structural and functional changes in retinal vasculature induced by retinal ischemia-reperfusion in rats	EXPERIMENTAL EYE RESEARCH			English	Article						Endothelial cells; Pericytes; Vascular endothelial growth factor; Vascular damage; Retinal neuron damage	ENDOTHELIAL GROWTH-FACTOR; NITRIC-OXIDE SYNTHASE; IN-VIVO; CAPILLARY DEGENERATION; PROTECTIVE ROLE; PERICYTE LOSS; INJURY; INHIBITION; RETINOPATHY; GLAUCOMA	Recent studies have shown retinal blood vessel damage in experimental models of retinal degeneration. The present study aimed to provide a detailed description of the structural and functional changes in retinal vasculature induced by retinal ischemia-reperfusion (I/R) in rats. Retinal ischemia was induced for 60 min by raising the intraocular pressure to 130 mmHg. Morphological changes in vascular components (endothelial cells, pericytes, and basement membranes), the patency and perfusion of blood vessels, and expression of vascular endothelial growth factor (VEGF) were assessed in the retinas at 2, 7, and 14 days after I/R. Significant reductions in vascular densities were observed at 7 and 14 days after I/R. Pericyte loss occurred after the appearance of endothelial cell degeneration, whereas the vascular basement membranes remained unchanged. Some vessels showed no perfusion in damaged retina. A decrease in the immunoreactivity of VEGF in the region extending from the ganglion cell layer to the outer plexiform layer was evident 2 days after I/R. In retinal I/R model, retinal ganglion cells are rapidly (<2 day) damaged following reperfusion, therefore, the current results suggest that neuronal cell damage precedes capillary degeneration, and neuronal cells may play an important role in maintaining vascular structure and function through the production and release of endothelial cell survival factors, including VEGF. Neuronal cell damage could be an additional cause of progression of ischemic retinal damage by reducing blood supply to the retinal neurons due to the destruction of the blood vessel network. (C) 2015 Elsevier Ltd. All rights reserved.	[Nakahara, Tsutomu; Hoshino, Maya; Hoshino, Shin-ichiro; Mori, Asami; Sakamoto, Kenji; Ishii, Kunio] Kitasato Univ, Sch Pharmaceut Sci, Dept Mol Pharmacol, Minato Ku, Tokyo 1088641, Japan	Nakahara, T (reprint author), Kitasato Univ, Sch Pharmaceut Sci, Dept Mol Pharmacol, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	nakaharat@pharm.kitasato-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23122517, 25122712, 20590090, 23590112]; Suzuken Memorial Foundation; Kitasato University Research Grant for Young Researchers	This study was supported by Grants-in-Aid for Scientific Research on Innovative Areas (Nos. 23122517, 25122712, T.N.) and Grants-in-Aid for Scientific Research (C) (Nos. 20590090, 23590112, T.N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Suzuken Memorial Foundation (T.N.) and by Kitasato University Research Grant for Young Researchers (T.N.).	Al-Gayyar MMH, 2011, BRIT J PHARMACOL, V164, P170, DOI 10.1111/j.1476-5381.2011.01336.x; Al-Gayyar MMH, 2010, AM J PATHOL, V177, P1187, DOI 10.2353/ajpath.2010.091289; Ozaki H, 2000, AM J PATHOL, V156, P697, DOI 10.1016/S0002-9440(10)64773-6; Lam TT, 1999, INVEST OPHTH VIS SCI, V40, P2391; Inai T, 2004, AM J PATHOL, V165, P35, DOI 10.1016/S0002-9440(10)63273-7; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Li CZ, 2012, INVEST OPHTH VIS SCI, V53, P3241, DOI 10.1167/iovs.11-8406; Sakamoto K, 2009, EXP EYE RES, V88, P974, DOI 10.1016/j.exer.2008.12.011; Vorwerk CK, 1997, INVEST OPHTH VIS SCI, V38, P2038; SZABO ME, 1991, INVEST OPHTH VIS SCI, V32, P1471; Kilic U, 2006, J NEUROSCI, V26, P12439, DOI 10.1523/JNEUROSCI.0434-06.2006; Mozaffarieh M, 2013, CURR OPIN PHARMACOL, V13, P43, DOI 10.1016/j.coph.2012.10.001; Ueda K, 2013, EUR J PHARMACOL, V699, P188, DOI 10.1016/j.ejphar.2012.11.054; Nakazawa T, 2007, J NEUROCHEM, V100, P1018, DOI 10.1111/j.1471-4159.2006.04274.x; Clermont AC, 2007, MICROCIRCULATION, V14, P49, DOI 10.1080/10739680601072164; STONE J, 1995, J NEUROSCI, V15, P4738; Ejaz S, 2008, DIABETES OBES METAB, V10, P53, DOI 10.1111/j.1463-1326.2007.00795.x; Hangai M, 1996, EXP EYE RES, V63, P501, DOI 10.1006/exer.1996.0140; Morizane C, 1997, EUR J PHARMACOL, V328, P45, DOI 10.1016/S0014-2999(97)83026-9; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Tsujikawa A, 1999, INVEST OPHTH VIS SCI, V40, P1183; AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Foxton RH, 2013, AM J PATHOL, V182, P1379, DOI 10.1016/j.ajpath.2012.12.032; Zhang C, 2005, EXP EYE RES, V81, P700, DOI 10.1016/j.exer.2005.04.008; Dilsiz N, 2006, GRAEF ARCH CLIN EXP, V244, P627, DOI 10.1007/s00417-005-0084-6; Wilkinson-Berka JL, 2004, AM J PATHOL, V164, P1263, DOI 10.1016/S0002-9440(10)63214-2; Venkataraman ST, 2010, MICROCIRCULATION, V17, P568, DOI 10.1111/j.1549-8719.2010.00045.x; Wei YH, 2011, FREE RADICAL BIO MED, V51, P216, DOI 10.1016/j.freeradbiomed.2011.04.026; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510; Lam TT, 1997, J OCUL PHARMACOL TH, V13, P129, DOI 10.1089/jop.1997.13.129; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH547, DOI 10.1152/ajpheart.00616.2005; Bek T, 2009, ACTA OPHTHALMOL, V87, P362, DOI 10.1111/j.1755-3768.2008.01429.x; Chen BH, 2009, INVEST OPHTH VIS SCI, V50, P5587, DOI 10.1167/iovs.09-3633; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Lagreze WA, 1998, INVEST OPHTH VIS SCI, V39, P1063; Manabe S, 2003, INVEST OPHTH VIS SCI, V44, P385, DOI 10.1167/iovs.02-0187; Matsumoto H, 2008, J CEREBR BLOOD F MET, V28, P149, DOI 10.1038/sj.jcbfm.9600519; Matsuzaki H, 2001, FASEB J, V15, P1218; Mori A., 2008, J PHARM SCI S1, V106; Motiejunaite R, 2008, EXP EYE RES, V86, P171, DOI 10.1016/j.exer.2007.10.013; Ogata N, 1998, CURR EYE RES, V17, P1087, DOI 10.1076/ceyr.17.11.1087.5234; Sakamoto K, 2010, J PHARMACOL SCI, V112, P327, DOI 10.1254/jphs.09302FP; Smirkin A, 2010, J CEREBR BLOOD F MET, V30, P603, DOI 10.1038/jcbfm.2009.233; Thurston G, 1996, AM J PHYSIOL-HEART C, V271, pH2547; Ueda K, 2010, NEUROSCI LETT, V485, P55, DOI 10.1016/j.neulet.2010.08.061; Wada Y, 2010, J PHARMACOL SCI, V112, P290; Wang LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023194	51	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0014-4835	1096-0007		EXP EYE RES	Exp. Eye Res.	JUN	2015	135						134	145		10.1016/j.exer.2015.02.020		12	Ophthalmology	Ophthalmology	CJ8RC	WOS:000355770200015		
J	Nezu, A; Morita, T; Tojyo, Y; Nagai, T; Tanimura, A				Nezu, Akihiro; Morita, Takao; Tojyo, Yosuke; Nagai, Takeharu; Tanimura, Akihiko			Partial agonistic effects of pilocarpine on Ca2+ responses and salivary secretion in the submandibular glands of live animals	EXPERIMENTAL PHYSIOLOGY			English	Article							PAROTID ACINAR-CELLS; INOSITOL 1,4,5-TRISPHOSPHATE; ELECTROLYTE SECRETION; PROTEIN SECRETION; RAT; FLUID; RECEPTORS; VASODILATATION; XEROSTOMIA; STIM1-MKO1	New Findings What is the central question of this study? Pilocarpine stimulates salivary secretion via muscarinic ACh receptors (mAChRs), although the Ca2+-mobilizing effect of pilocarpine in salivary gland cells is extremely small. Therefore, we examined the effect of pilocarpine on Ca2+ responses in submandibular gland cells and on secretion in vitro and in vivo. What is the main finding and its importance? Pilocarpine induces small Ca2+ responses and reduces the effects of other mAChR agonists on Ca2+ responses via its partial agonistic effects. These effects of pilocarpine on Ca2+ responses in the submandibular gland were further established in vivo with a novel Ca2+ imaging system and a genetically encoded Ca2+ indicator. Pilocarpine stimulates salivary secretion via muscarinic ACh receptors (mAChRs), although the effect of pilocarpine on Ca2+ responses in dispersed salivary gland cells is extremely small. Here, we demonstrate the effect of pilocarpine on Ca2+ responses and salivary secretion in the rat submandibular gland (SMG). In fura-2-loaded SMG cells, the maximal effect of pilocarpine on [Ca2+](i) elevation was 16% of that of carbachol, and pilocarpine attenuated carbachol- and bethanechol (Bet)-induced [Ca2+](i) increases, indicating that pilocarpine acts as a partial agonist for mAChR-mediated Ca2+ responses. The partial agonistic effect of pilocarpine on Ca2+ dynamics in the SMG was also confirmed in live animals using the genetically encoded Ca2+ indicator, YC-Nano50. Administration of pilocarpine (3mgkg(-1), i.p.) elicited a small increase in [Ca2+](i) in the SMG. Quantitative analyses demonstrated that resting [Ca2+](i) was approximate to 37nm, which was increased by pilocarpine (3mgkg(-1)) and Bet (10mgkg(-1)) to 44 and 69nm, respectively. The inhibitory effects of pilocarpine on Bet-induced Ca2+ responses were also elucidated in vivo. We further examined real-time changes in pilocarpine-induced SMG salivary secretion and showed that pilocarpine induced an extremely weak secretory response and reduced Bet-induced secretion. Unlike Ca2+ responses, pilocarpine failed to reduce the effect of Bet on SMG blood flow. Our results demonstrate that pilocarpine acts as a partial agonist of mAChRs to induce weak salivary secretion that is correlated with small increases in [Ca2+](i). Furthermore, pilocarpine exhibits an antagonistic effect on mAChR-induced Ca2+ responses and salivary secretion.	[Nezu, Akihiro; Morita, Takao; Tojyo, Yosuke; Tanimura, Akihiko] Hlth Sci Univ Hokkaido, Sch Dent, Dept Pharmacol, Ishikari, Hokkaido 0610293, Japan; [Nagai, Takeharu] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan	Nezu, A (reprint author), Hlth Sci Univ Hokkaido, Sch Dent, Dept Pharmacol, Ishikari, Hokkaido 0610293, Japan.	a-nezu@hoku-iryo-u.ac.jp			HAITEKU from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Research Institute of Personalized Health Sciences, Health Sciences University of Hokkaido;  [23592745]	This study was supported in part by a Grant-in-Aid for Scientific Research (no. 23592745; to A.N.), by HAITEKU (2011) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by a Grant-in-Aid for the 2012-2013 Research Project of the Research Institute of Personalized Health Sciences, Health Sciences University of Hokkaido.	Jakubik J, 1997, MOL PHARMACOL, V52, P172; Turner RJ, 2002, ORAL DIS, V8, P3, DOI 10.1034/j.1601-0825.2002.10815.x; Niioka T, 2009, ARCH ORAL BIOL, V54, P1022, DOI 10.1016/j.archoralbio.2009.08.006; Forrester KR, 2004, IEEE T BIO-MED ENG, V51, P2074, DOI 10.1109/TBME.2004.834259; FOX PC, 1991, ARCH INTERN MED, V151, P1149, DOI 10.1001/archinte.151.6.1149; IZUMI H, 1994, AM J PHYSIOL, V267, pR747; Unno T, 2003, BRIT J PHARMACOL, V139, P337, DOI 10.1038/sj.bjp.0705267; Bruce JIE, 2002, J BIOL CHEM, V277, P1340, DOI 10.1074/jbc.M106609200; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; Mizuta K, 2000, AM J PHYSIOL-REG I, V279, pR677; JOHNSON JT, 1993, NEW ENGL J MED, V329, P390, DOI 10.1056/NEJM199308053290603; BABA A, 1994, ARCH ORAL BIOL, V39, P979, DOI 10.1016/0003-9969(94)90082-5; BAUM BJ, 1993, ANN NY ACAD SCI, V694, P17; Cecanho R, 1999, J AUTONOM NERV SYST, V76, P9, DOI 10.1016/S0165-1838(99)00002-8; COMPTON J, 1981, ARCH ORAL BIOL, V26, P555, DOI 10.1016/0003-9969(81)90017-0; Demaurex N, 2005, CELL CALCIUM, V38, P213, DOI 10.1016/j.ceca.2005.06.026; Grynkiewicz G, 1985, J BIOL CHEM, V260, P3400; Horikawa K, 2010, NAT METHODS, V7, P729, DOI 10.1038/nmeth.1488; Inagaki T, 2010, AUTON NEUROSCI-BASIC, V154, P102, DOI 10.1016/j.autneu.2009.12.005; Kim M, 2004, AUTON NEUROSCI-BASIC, V111, P27, DOI 10.1016/j.autneu.2004.01.006; Kondo Y, 2011, J PHARMACOL EXP THER, V337, P267, DOI 10.1124/jpet.110.174946; Li JC, 2006, LIFE SCI, V79, P2441, DOI 10.1016/j.lfs.2006.08.006; MARTINEZ JR, 1987, J DENT RES, V66, P638; Morita T, 2013, BIOCHEM BIOPH RES CO, V439, P433, DOI 10.1016/j.bbrc.2013.08.080; Morita T, 2011, ARCH ORAL BIOL, V56, P1356, DOI 10.1016/j.archoralbio.2011.06.001; Nezu A, 2005, ARCH ORAL BIOL, V50, P585, DOI 10.1016/j.archoralbio.2004.07.014; Nezu A, 2000, JPN J PHARMACOL, V84, P25, DOI 10.1254/jjp.84.25; Takakura ACT, 2003, J DENT RES, V82, P993; Tanimura A, 1998, BIOCHEM J, V332, P769; YULE DI, 1993, AM J PHYSIOL, V264, pG786	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0958-0670	1469-445X		EXP PHYSIOL	Exp. Physiol.	JUN 1	2015	100	6					640	651		10.1113/EP085110		12	Physiology	Physiology	CK1XD	WOS:000356001600006		
J	Narita, K; Sasamoto, S; Koizumi, S; Okazaki, S; Nakamura, H; Inoue, T; Takeda, S				Narita, Keishi; Sasamoto, Shohei; Koizumi, Schuichi; Okazaki, Shizuka; Nakamura, Hideki; Inoue, Takafumi; Takeda, Sen			TRPV4 regulates the integrity of the blood-cerebrospinal fluid barrier and modulates transepithelial protein transport	FASEB JOURNAL			English	Article						subcellular localization; calcium imaging; actin	RECEPTOR POTENTIAL VANILLOID-4; CHOROID-PLEXUS EPITHELIUM; CATION CHANNEL TRPV4; BRAIN-BARRIER; CELLS; EXPRESSION; RECRUITMENT; ACTIVATION; RELEASE; ENTRY	The diffusion of materials from systemic circulation to the central nervous system (CNS) is restricted by the blood-brain barrier (BBB) and the blood-cerebrospinal fluid barrier (BCSFB). Choroid plexus epithelial cells (CPECs) of the brain ventricles constitute the BCSFB and regulate the infiltration of plasma proteins as well as immune cells into the interstitium of the CNS. The barrier function is altered in pathologic conditions. However, the regulatory mechanism of BCSFB is not fully understood. Here, we investigated the function of transient receptor potential vanilloid 4 (TRPV4), a polymodally gated divalent cation channel that is highly expressed in CPECs. TRPV4 was localized broadly on the apical membrane in swine CPECs, in contrast with an intense ciliary localization found on other cell types. Treatment with the TRPV4-specific agonist, GSK1016790A (GSK; EC50 34 nM), induced a robust calcium influx and an immediate serine/threonine protein phosphorylation. The agonist treatment induced a marked decrease in the amount of filamentous actin and disintegrated the cell junctions in 10-20 minutes. In contrast, inhibition of the basal TRPV4 activity with the TRPV4-specific antagonist, HC067047 (HC; IC50 74 nM), reduced the basolateral-to-apical transport of alpha-2-macroglobulin (A2M). Overall, this study demonstrated a novel physiologic function of TRPV4 in the regulation of BCSFB permeability.	[Narita, Keishi; Sasamoto, Shohei; Takeda, Sen] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Anat & Cell Biol, Chuo Ku, Yamanashi 4093898, Japan; [Koizumi, Schuichi] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Neuropharmacol, Chuo Ku, Yamanashi 4093898, Japan; [Okazaki, Shizuka; Nakamura, Hideki; Inoue, Takafumi] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo, Japan	Takeda, S (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Anat & Cell Biol, Chuo Ku, Yamanashi 4093898, Japan.	stakeda@yamanashi.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [19590188]; Yamada Science Foundation; MEXT [22770190, 26440094]	The authors acknowledge contributions from the following colleagues: Prof. Ryohei Kato and Mikiko Yoda for preparation of tissue sections; Drs. Youichi Shinozaki, Keisuke Shibata, and Eiji Shigetomi for helping with Ca<SUP>2+</SUP> imaging; Dr. Ryohei Komatsu for helping with the ATP assay; Prof. Masao Saito for TEER measurement; the staff of Yamanashi Meat Logistics Center and Yamanashi Meat Hygiene Inspection Office for isolation of swine choroid plexus tissue; Mamiko Otagiri for performing routine laboratory works; and Kazuko Sawanobori for secretarial assistance. This research was supported by the Grant-in-Aid for Scientific Research (C) from Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT; 19590188), and the Yamada Science Foundation to S.T., and Grants-in-Aid for Young Scientists (B) (22770190) and Scientific Research (C) (26440094) from MEXT to K.N.	Knowland D, 2014, NEURON, V82, P603, DOI 10.1016/j.neuron.2014.03.003; Imura Y, 2013, GLIA, V61, P1320, DOI 10.1002/glia.22517; Shigetomi E, 2008, J NEUROSCI, V28, P6659, DOI 10.1523/JNEUROSCI.1717-08.2008; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Filosa JA, 2013, J CARDIOVASC PHARM, V61, P113, DOI 10.1097/FJC.0b013e318279ba42; Gradilone SA, 2007, P NATL ACAD SCI USA, V104, P19138, DOI 10.1073/pnas.0705964104; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Redzic ZB, 2005, CURR TOP DEV BIOL, V71, P1, DOI 10.1016/S0070-2153(05)71001-2; Reiter B, 2006, FASEB J, V20, P1802, DOI 10.1096/fj.06-5772com; Lechner SG, 2011, NEURON, V69, P332, DOI 10.1016/j.neuron.2010.12.028; Strotmann R, 2000, NAT CELL BIOL, V2, P695; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Imura A, 2007, SCIENCE, V316, P1615, DOI 10.1126/science.1135901; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; BORTH W, 1992, FASEB J, V6, P3345; Takayama Y, 2014, FASEB J, V28, P2238, DOI 10.1096/fj.13-243436; Nonami Y, 2013, CYTOSKELETON, V70, P797, DOI 10.1002/cm.21132; Kohler R, 2006, ARTERIOSCL THROM VAS, V26, P1495, DOI 10.1161/01.ATV.0000225698.36212.6a; Schwartz M, 2014, EMBO J, V33, P7, DOI 10.1002/embj.201386609; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Ottervald J, 2010, J PROTEOMICS, V73, P1117, DOI 10.1016/j.jprot.2010.01.004; Fernandez J, 1998, ELECTROPHORESIS, V19, P1036, DOI 10.1002/elps.1150190619; Honda A, 2010, J BIOL CHEM, V285, P31362, DOI 10.1074/jbc.M110.150540; Willette RN, 2008, J PHARMACOL EXP THER, V326, P443, DOI 10.1124/jpet.107.134551; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Shibasaki K, 2007, J NEUROSCI, V27, P1566, DOI 10.1523/JNEUROSCI.4284-06.2007; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Wang FS, 2013, J NEUROSCI, V33, P17404, DOI 10.1523/JNEUROSCI.2178-13.2013; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; URADE Y, 1993, P NATL ACAD SCI USA, V90, P9070, DOI 10.1073/pnas.90.19.9070; Everaerts W, 2010, P NATL ACAD SCI USA, V107, P19084, DOI 10.1073/pnas.1005333107; Zlokovic BV, 2000, ENDOCRINOLOGY, V141, P1434, DOI 10.1210/en.141.4.1434; Brightman M W, 1968, Prog Brain Res, V29, P19; Brown RC, 2008, MICROCIRCULATION, V15, P359, DOI 10.1080/10739680701762656; Kanoh Y, 1997, BIOCHEM MOL BIOL INT, V43, P269; KLUGE H, 1986, J NEUROL, V233, P195, DOI 10.1007/BF00314017; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Kottgen M, 2005, PFLUG ARCH EUR J PHY, V451, P286, DOI 10.1007/s00424-005-1417-3; Lorenzo IM, 2008, P NATL ACAD SCI USA, V105, P12611, DOI 10.1073/pnas.0803970105; Narita K, 2010, TRAFFIC, V11, P287, DOI 10.1111/j.1600-0854.2009.01016.x; Narita K, 2012, BIOL OPEN, V1, P815, DOI 10.1242/bio.20121081; Redzic Zoran, 2011, Fluids Barriers CNS, V8, P3, DOI 10.1186/2045-8118-8-3; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Stockinger W, 1998, J BIOL CHEM, V273, P32213, DOI 10.1074/jbc.273.48.32213; Tian W, 2004, AM J PHYSIOL-RENAL, V287, pF17, DOI 10.1152/ajprenal.00397.2003; VANDEURS B, 1979, J CELL BIOL, V80, P662, DOI 10.1083/jcb.80.3.662; Xu XP, 2009, CHANNELS, V3, P156	50	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2247	2259		10.1096/fj.14-261396		13	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	WOS:000355209500004		
J	Takai, S; Yasumatsu, K; Inoue, M; Iwata, S; Yoshida, R; Shigemura, N; Yanagawa, Y; Drucker, DJ; Margolskee, RF; Ninomiya, Y				Takai, Shingo; Yasumatsu, Keiko; Inoue, Mayuko; Iwata, Shusuke; Yoshida, Ryusuke; Shigemura, Noriatsu; Yanagawa, Yuchio; Drucker, Daniel J.; Margolskee, Robert F.; Ninomiya, Yuzo			Glucagon-like peptide-1 is specifically involved in sweet taste transmission	FASEB JOURNAL			English	Article						gustation; transmitter; incretin	VASOACTIVE-INTESTINAL-PEPTIDE; RECEPTOR-CELLS; MAMMALIAN TASTE; COEXPRESSION PATTERNS; CHORDA TYMPANI; ATP RELEASE; BUDS; EXPRESSION; MICE; MOUSE	Five fundamental taste qualities (sweet, bitter, salty, sour, umami) are sensed by dedicated taste cells (TCs) that relay quality information to gustatory nerve fibers. In peripheral taste signaling pathways, ATP has been identified as a functional neurotransmitter, but it remains to be determined how specificity of different taste qualities is maintained across synapses. Recent studies demonstrated that some gut peptides are released from taste buds by prolonged application of particular taste stimuli, suggesting their potential involvement in taste information coding. In this study, we focused on the function of glucagon-like peptide-1 (GLP-1) in initial responses to taste stimulation. GLP-1 receptor (GLP-1R) null mice had reduced neural and behavioral responses specifically to sweet compounds compared to wild-type (WT) mice. Some sweet responsive TCs expressed GLP-1 and its receptors were expressed in gustatory neurons. GLP-1 was released immediately from taste bud cells in response to sweet compounds but not to other taste stimuli. Intravenous administration of GLP-1 elicited transient responses in a subset of sweet-sensitive gustatory nerve fibers but did not affect other types of fibers, and this response was suppressed by pre-administration of the GLP-1R antagonist Exendin-4(3-39). Thus GLP-1 may be involved in normal sweet taste signal transmission in mice.	[Takai, Shingo; Inoue, Mayuko; Iwata, Shusuke; Yoshida, Ryusuke; Shigemura, Noriatsu; Ninomiya, Yuzo] Kyushu Univ, Grad Sch Dent Sci, Sect Oral Neurosci, Fukuoka 8128582, Japan; [Yasumatsu, Keiko; Ninomiya, Yuzo] Kyushu Univ, Res & Dev Ctr Taste & Odor Sensing, Div Sensory Physiol, Fukuoka 8128582, Japan; [Yanagawa, Yuchio] Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gumma 371, Japan; [Yanagawa, Yuchio] JST, CREST, Maebashi, Gumma, Japan; [Drucker, Daniel J.] Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Margolskee, Robert F.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Ninomiya, Y (reprint author), Kyushu Univ, Grad Sch Dent Sci, Sect Oral Neurosci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ninomoiya.yuzo.285@m.kyushu-u.ac.jp			KAKENHI from Japan Society for the promotion of science [18077004, 18109013, 23249081, 20689034, 23689076]	The authors thank Dr. Charles Pyke (Novo Nordisk A/S) for providing the GLP-1R antibody. This work was supported by KAKENHI 18077004, 18109013, 23249081 (Y.N.), 20689034 (N.S.), 23689076 (R.Y.) for Scientific Research from Japan Society for the promotion of science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no competing financial interests.	Yoshida R, 2010, P NATL ACAD SCI USA, V107, P935, DOI 10.1073/pnas.0912048107; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Kataoka S, 2008, CHEM SENSES, V33, P243, DOI 10.1093/chemse/bjm083; Shigemura N, 2013, J NEUROSCI, V33, P6267, DOI 10.1523/JNEUROSCI.5599-12.2013; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Nakabayashi H, 1996, AM J PHYSIOL-ENDOC M, V271, pE808; Herness S, 2002, J NEUROSCI, V22, P10018; Yoshida R, 2006, J NEUROPHYSIOL, V96, P3088, DOI 10.1152/jn.00409.2006; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Ishida Y, 2009, J COMP NEUROL, V514, P131, DOI 10.1002/cne.22000; Tomchik SM, 2007, J NEUROSCI, V27, P10840, DOI 10.1523/JNEUROSCI.1863-07.2007; Roper SD, 2013, SEMIN CELL DEV BIOL, V24, P71, DOI 10.1016/j.semcdb.2012.12.002; Hansen L, 1999, ENDOCRINOLOGY, V140, P5356, DOI 10.1210/en.140.11.5356; Vandenbeuch A, 2010, J NEUROSCI, V30, P14695, DOI 10.1523/JNEUROSCI.1570-10.2010; Martin B, 2009, ANN NY ACAD SCI, V1170, P98, DOI 10.1111/j.1749-6632.2009.03920.x; Vandenbeuch A, 2013, P NATL ACAD SCI USA, V110, P14789, DOI 10.1073/pnas.1309468110; Clapp TR, 2004, J COMP NEUROL, V468, P311, DOI 10.1002/cne.10963; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Yoshida R, 2009, J PHYSIOL-LONDON, V587, P4425, DOI 10.1113/jphysiol.2009.175075; Shin YK, 2008, J NEUROCHEM, V106, P455, DOI 10.1111/j.1471-4159.2008.05397.x; Fujita Y, 2009, AM J PHYSIOL-ENDOC M, V296, pE473, DOI 10.1152/ajpendo.90636.2008; NAGAHAMA S, 1985, J GEN PHYSIOL, V85, P431, DOI 10.1085/jgp.85.3.431; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Steinert RE, 2011, CLIN NUTR, V30, P524, DOI 10.1016/j.clnu.2011.01.007; Yasumatsu K, 2012, J PHYSIOL-LONDON, V590, P1155, DOI 10.1113/jphysiol.2011.211920; Dotson CD, 2013, SEMIN CELL DEV BIOL, V24, P232, DOI 10.1016/j.semcdb.2013.01.004; Shen T, 2005, NEUROSCIENCE, V130, P229, DOI 10.1016/j.neuroscience.2004.09.017; Hansotia T, 2005, REGUL PEPTIDES, V128, P125, DOI 10.1016/j.regpep.2004.07.019; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Bo XN, 1999, NEUROREPORT, V10, P1107, DOI 10.1097/00001756-199904060-00037; Wong GT, 1999, J NEUROSCI, V19, P5802; Murata Y, 2010, J NEUROPHYSIOL, V104, P896, DOI 10.1152/jn.00414.2010; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; Geraedts MCP, 2013, J NEUROSCI, V33, P7559, DOI 10.1523/JNEUROSCI.0372-13.2013; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Taruno A, 2013, NATURE, V495, P223, DOI 10.1038/nature11906; Damak S, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-96; Elson AET, 2010, FASEB J, V24, P3960, DOI 10.1096/fj.10-158105; Feng XH, 2008, ACTA HISTOCHEM, V110, P151, DOI 10.1016/j.acthis.2007.10.005; HERNESS MS, 1989, NEUROSCIENCE, V33, P411, DOI 10.1016/0306-4522(89)90220-0; KELLING ST, 1983, SCIENCE, V219, P412, DOI 10.1126/science.6849142; Lu SG, 2003, NEUROSCI LETT, V351, P157, DOI 10.1016/S0304-3940(03)00973-X; MontroseRafizadeh C, 1997, J BIOL CHEM, V272, P21201, DOI 10.1074/jbc.272.34.21201; NINOMIYA Y, 1995, AM J PHYSIOL-REG I, V268, pR1019; Ninomiya Y, 1999, J NEUROPHYSIOL, V81, P3087; Ohara-Imaizumi M, 2009, BIOCHEM BIOPH RES CO, V390, P16, DOI 10.1016/j.bbrc.2009.09.043; Shin YK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012729; Yoshida R, 2010, INT REV CEL MOL BIO, V279, P101, DOI 10.1016/S1937-6448(10)79004-3; Zhao FL, 2005, P NATL ACAD SCI USA, V102, P11100, DOI 10.1073/pnas.0501988102	52	1	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2268	2280		10.1096/fj.14-265355		13	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	WOS:000355209500006		
J	Hifumi, E; Arakawa, M; Matsumoto, S; Yamamoto, T; Katayama, Y; Uda, T				Hifumi, Emi; Arakawa, Mitsue; Matsumoto, Shingo; Yamamoto, Tatsuhiro; Katayama, Yoshiki; Uda, Taizo			Biochemical features and antiviral activity of a monomeric catalytic antibody light-chain 23D4 against influenza A virus	FASEB JOURNAL			English	Article						suppression; infection; hydrolysis; AFM image	FACTOR-VIII; PROTEOLYTIC ANTIBODIES; DNA; HYDROLYSIS; HEMOPHILIA; PEPTIDE; ABILITY; GP120; HIV-1; GP41	Catalytic antibodies have exhibited interesting functions against some infectious viruses such as HIV, rabies virus, and influenza virus in vitro as well as in vivo. In some cases, a catalytic antibody light chain takes on several structures from the standpoint of molecular size (monomer, dimer, etc.) and/or isoelectronic point. In this study, we prepared a monomeric 23D4 light chain by mutating the C-terminal Cys to Ala of the wild-type. The mutated 23D4 molecule took a simple monomeric form, which could hydrolyze synthetic 4-methyl-coumaryl-7-amide substrates and a plasmid DNA. Because the monomeric 23D4 light chain suppressed the infection of influenza virus A/Hiroshima/37/2001 in an in vitro assay, the corresponding experiments were conducted in vivo, after the virus strain (which was taken from a human patient) was successfully adapted into BALB/cN Sea mice. In the experiments, a mixture of the monomeric 23D4 and the virus was nasally administered 1) with preincubation and 2) without preincubation. As a result, the monomeric 23D4 clearly exhibited the ability to suppress the influenza virus infection in both cases, indicating a potential drug for preventing infection of the influenza A virus.	[Hifumi, Emi] Oita Univ, Res Promot Inst, Oita, Oita 8701192, Japan; [Hifumi, Emi; Arakawa, Mitsue; Matsumoto, Shingo; Yamamoto, Tatsuhiro; Uda, Taizo] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan; [Arakawa, Mitsue] Oita Univ, Fac Med, Yufu City, Oita, Japan; [Matsumoto, Shingo; Uda, Taizo] Oita Univ, Dept Appl Chem, Oita, Oita 8701192, Japan; [Matsumoto, Shingo; Katayama, Yoshiki] Kyushu Univ, Grad Sch Syst Life Sci, Nishi Ku, Fukuoka 812, Japan; [Yamamoto, Tatsuhiro; Uda, Taizo] Inst Syst Informat Technol & Nanotechnol, Nanotechnol Lab, Fukuoka, Japan	Hifumi, E (reprint author), Oita Univ, Res Promot Inst, 700 Dan Noharu, Oita, Oita 8701192, Japan.	e-hifumi@oita-u.ac.jp			Japan Science and Technology Agency (Core Research for Evolutional Science and Technology/"Establishment of Innovative Manufacturing Technology Based on Nanoscience"); Ministry of Education, Culture, Sports, Science and Technology of Japan [24350085]	The authors thank AVSS Company Limited (Drs. T. Haruyama and N. Kobayashi), Oxford Instruments KK (Dr. H. Sugasawa), and Ms. N. Fujimoto and Ms. E. Saito for their assistance with this study. This study was supported by the Japan Science and Technology Agency (Core Research for Evolutional Science and Technology/"Establishment of Innovative Manufacturing Technology Based on Nanoscience") and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (24350085).	Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Parkhomenko TA, 2010, BIOCHIMIE, V92, P545, DOI 10.1016/j.biochi.2010.01.022; Kolesnikov AV, 2000, P NATL ACAD SCI USA, V97, P13526, DOI 10.1073/pnas.200360497; Odintsova ES, 2011, J MOL RECOGNIT, V24, P45, DOI 10.1002/jmr.1022; Paul S, 2003, J BIOL CHEM, V278, P20429, DOI 10.1074/jbc.M300870200; Nishiyama Y, 2014, J BIOTECHNOL, V180, P17, DOI 10.1016/j.jbiotec.2014.03.026; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Sharma V, 2009, J BIOL CHEM, V284, P33079, DOI 10.1074/jbc.M109.036087; Hifumi E, 2012, FASEB J, V26, P1607, DOI 10.1096/fj.11-195339; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Paul S, 2004, J BIOL CHEM, V279, P39611, DOI 10.1074/jbc.M406719200; Hifumi E, 2008, J BIOL CHEM, V283, P899, DOI 10.1074/jbc.M705674200; Durova OM, 2009, MOL IMMUNOL, V47, P87, DOI 10.1016/j.molimm.2008.12.020; GAO QS, 1994, J BIOL CHEM, V269, P32389; Hifumi E, 2010, J BIOSCI BIOENG, V109, P598, DOI 10.1016/j.jbiosc.2009.11.020; Hifumi E, 2013, J BIOL CHEM, V288, P19558, DOI 10.1074/jbc.M113.454579; Hifumi E, 2000, APPL BIOCHEM BIOTECH, V83, P209, DOI 10.1385/ABAB:83:1-3:209; Hifumi E, 2011, J AM CHEM SOC, V133, P15015, DOI 10.1021/ja203922r; Hifumi E, 2002, J IMMUNOL METHODS, V269, P283, DOI 10.1016/S0022-1759(02)00242-9; Kotsovilis S, 2014, METHODS MOL BIOL, V1060, P37, DOI 10.1007/978-1-62703-586-6_3; Kou J., 2014, MOL NEUROBIOL, V51, P43; Kozyr A. V., 2012, AUTOIMMUNE DIS, V2012; Krasnorutskii MA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1065, DOI 10.1134/S0006297911090124; Krasnorutskii MA, 2008, INT IMMUNOL, V20, P1031, DOI 10.1093/intimm/dxn061; Lacroix-Desmazes S, 1999, NAT MED, V5, P1044, DOI 10.1038/12483; Le Minoux D, 2012, MOL IMMUNOL, V50, P160, DOI 10.1016/j.molimm.2012.01.004; MEI S, 1991, J BIOL CHEM, V266, P15571; Nevinsky GA, 2002, J IMMUNOL METHODS, V269, P235, DOI 10.1016/S0022-1759(02)00234-X; Ohara K, 2004, BIOCHEM BIOPH RES CO, V315, P612, DOI 10.1016/j.bbrc.2004.01.094; Ponomarenko NA, 2007, BIOCHEMISTRY-US, V46, P14598, DOI 10.1021/bi7013954; Ramsland PA, 2006, BIOCHEM J, V395, P473, DOI 10.1042/BJ20051739; Rodkey LS, 2000, APPL BIOCHEM BIOTECH, V83, P95, DOI 10.1385/ABAB:83:1-3:95; Schmidt N. J., 1989, DIAGNOSTIC PROCEDURE, V6th, P51; SHUSTER AM, 1992, SCIENCE, V256, P665, DOI 10.1126/science.1585181; Smirnov I, 2011, P NATL ACAD SCI USA, V108, P15954, DOI 10.1073/pnas.1108460108; Stanley WM, 1944, J EXP MED, V79, P267, DOI 10.1084/jem.79.3.267; Uda T, 2004, J BIOSCI BIOENG, V97, P143, DOI 10.1016/S1389-1723(04)70183-8; Wootla B, 2009, FEBS LETT, V583, P2565, DOI 10.1016/j.febslet.2009.07.009; Wootla B, 2009, CLIN REV ALLERG IMMU, V37, P97, DOI 10.1007/s12016-009-8116-3	39	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2347	2358		10.1096/fj.14-264275		12	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	WOS:000355209500013		
J	Yasuda, D; Imura, Y; Ishii, S; Shimizu, T; Nakamura, M				Yasuda, Daisuke; Imura, Yuki; Ishii, Satoshi; Shimizu, Takao; Nakamura, Motonao			The atypical N-glycosylation motif, Asn-Cys-Cys, in human GPR109A is required for normal cell surface expression and intracellular signaling	FASEB JOURNAL			English	Article						Nicotinic acid receptor; N-linked glycosylation; Asn-X-Cys motif; STT3B; receptor activation	SITE-DIRECTED MUTAGENESIS; NICOTINIC-ACID RECEPTOR; MUSCARINIC ACETYLCHOLINE-RECEPTOR; LINKED GLYCOSYLATION; QUALITY-CONTROL; MOLECULAR-IDENTIFICATION; ENDOPLASMIC-RETICULUM; PROTEIN-STRUCTURE; PUMA-G; SEQUENCE	Asparagine-linked glycosylation (N-glycosylation) is necessary for the proper folding of secreted and membrane proteins, including GPCRs. Thus, many GPCRs possess the N-glycosylation motif Asn-X-Ser/Thr at their N-termini and/or extracellular loops. We found that human GPR109A (hGPR109A) has an N-glycosylation site at Asn(17) in the N-terminal atypical motif, Asn(17)-Cys(18)-Cys(19). Why does hGPR109A require the atypical motif, rather than the typical sequence? Here we show that Asn(17)-Cys(18)-Cys(19) sequence of hGPR109A possesses 2 biologic roles. First, Asn(17)-X-Cys(19) contributed to hGPR109A N-glycosylation by acting as an atypical motif. This modification is required for the normal surface expression of hGPR109A, as evidenced by the reduced surface expression of the nonglycosylated mutants, hGPR109A/N17A, and the finding that hGPR109A/C19S and hGPR109A/C19T, which are N-glycosylated at Asn(17), exhibited expression similar to the wild-type receptor. Second, the X-Cys(18)-Cys(19) dicysteine is indispensable for hGPR109A function. Substitution of Cys(18) or Cys(19) residue to Ala impaired G(i)-mediated signaling via hGPR109A. We propose the disulfide bond formations of these residues with other Cys existed in the extracellular loops for the proper folding. Together, these results suggest that the atypical motif Asn(17)-Cys(18)-Cys(19) is crucial for the normal surface trafficking and function of hGPR109A.	[Yasuda, Daisuke; Imura, Yuki; Shimizu, Takao; Nakamura, Motonao] Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Tokyo 113, Japan; [Yasuda, Daisuke; Ishii, Satoshi] Akita Univ, Fac Med, Dept Immunol, Akita 010, Japan; [Shimizu, Takao] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Tokyo, Japan; [Shimizu, Takao] Okayama Univ Sci, Fac Sci, Dept Life Sci, Okayama, Okayama 7000005, Japan	Nakamura, M (reprint author), Okayama Univ Sci, Fac Sci, Dept Life Sci, Kita Ku, 1-1 Ridai Cho, Okayama, Okayama 7000005, Japan.	moto-nakamura@dls.ous.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science (Global COE program); Center for NanoBio Integration at the University of Tokyo	The authors are grateful to Dr. Y. Kita (University of Tokyo), Dr. H. Shindou (National Center for Global Health and Medicine), and Drs. N. Akahoshi and T. Ohto (Akita University), and to all members of their laboratory for technical advice and useful discussions. The authors also thank Mrs. C. Kanokoda and Mrs. Y. Sugimoto-Aruga for their technical support. This work was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to D.Y., M.N., and T.S.), and grants from the Japan Society for the Promotion of Science (Global COE program) and the Center for NanoBio Integration at the University of Tokyo.	Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Ray K, 1998, J BIOL CHEM, V273, P34558, DOI 10.1074/jbc.273.51.34558; Offermanns S, 2006, TRENDS PHARMACOL SCI, V27, P384, DOI 10.1016/j.tips.2006.05.008; Digby JE, 2012, ARTERIOSCL THROM VAS, V32, P582, DOI 10.1161/ATVBAHA.111.236315; Ruddock LW, 2006, J CELL SCI, V119, P4373, DOI 10.1242/jcs.03225; Tunaru S, 2005, MOL PHARMACOL, V68, P1271, DOI 10.1124/mol.105.015750; RANDS E, 1990, J BIOL CHEM, V265, P10759; Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5; Matsui T, 2011, GLYCOBIOLOGY, V21, P994, DOI 10.1093/glycob/cwq198; Araki T, 1998, ARCH BIOCHEM BIOPHYS, V351, P250, DOI 10.1006/abbi.1997.0564; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012; TITANI K, 1986, BIOCHEMISTRY-US, V25, P3171, DOI 10.1021/bi00359a015; Vance BA, 1997, J BIOL CHEM, V272, P23117, DOI 10.1074/jbc.272.37.23117; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Markkanen PMH, 2008, J BIOL CHEM, V283, P29086, DOI 10.1074/jbc.M801880200; JENSEN CH, 1994, EUR J BIOCHEM, V225, P83, DOI 10.1111/j.1432-1033.1994.00083.x; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Gil GC, 2009, PROTEOMICS, V9, P2555, DOI 10.1002/pmic.200800775; NODA K, 1994, J BIOL CHEM, V269, P6743; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Michineau S, 2004, BIOL CHEM, V385, P49, DOI 10.1515/BC.2004.007; BAUSE E, 1979, FEBS LETT, V108, P341, DOI 10.1016/0014-5793(79)80559-1; Bisello A, 1996, BIOCHEMISTRY-US, V35, P15890, DOI 10.1021/bi962111+; Chen QA, 2010, AM J PHYSIOL-ENDOC M, V299, pE62, DOI 10.1152/ajpendo.00067.2010; Couvineau A, 1996, BIOCHEMISTRY-US, V35, P1745, DOI 10.1021/bi952022h; DAVIS D, 1995, MOL ENDOCRINOL, V9, P159, DOI 10.1210/me.9.2.159; FUKUSHIMA Y, 1995, BIOCHEM J, V310, P553; Giuffrida MG, 1997, J PROTEIN CHEM, V16, P747, DOI 10.1023/A:1026359715821; Hirota N, 2010, J BIOL CHEM, V285, P5931, DOI 10.1074/jbc.M109.066282; Innamorati G, 1996, MOL PHARMACOL, V50, P467; Kohno T, 2002, FASEB J, V16, P983, DOI 10.1096/fj.01-0809com; Krogh TN, 1997, EUR J BIOCHEM, V244, P334, DOI 10.1111/j.1432-1033.1997.00334.x; Kuei C, 2011, MOL PHARMACOL, V80, P848, DOI 10.1124/mol.111.074500; Marshall R. D., 1974, BIOCHEM SOC S, V40, P17; Rutz C, 2006, J BIOL CHEM, V281, P24910, DOI 10.1074/jbc.M601554200; Sato C, 2000, J BIOCHEM-TOKYO, V127, P65; SAVARESE TM, 1992, J BIOL CHEM, V267, P11439; SAWUTZ DG, 1987, MOL PHARMACOL, V32, P565; Shukla AK, 2006, BIOCHEM BIOPH RES CO, V349, P6, DOI 10.1016/j.bbrc.2006.07.210; Siffroi-Fernandez S, 2002, EUR J BIOCHEM, V269, P4930, DOI 10.1046/j.1432-1033.2002.03192.x; STENFLO J, 1982, J BIOL CHEM, V257, P2180; Tan CM, 2003, J BIOL CHEM, V278, P35678, DOI 10.1074/jbc.M301888200; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Valliere-Douglass JF, 2010, J BIOL CHEM, V285, P16012, DOI 10.1074/jbc.M109.096412; VANKOPPEN CJ, 1990, J BIOL CHEM, V265, P20887; Wanders D, 2011, DIABETES OBES METAB, V13, P685, DOI 10.1111/j.1463-1326.2011.01400.x; Whitaker GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032675; Xiao YP, 2011, J BIOL CHEM, V286, P22991, DOI 10.1074/jbc.M110.204271; Yasuda D, 2009, FASEB J, V23, P1470, DOI 10.1096/fj.08-125385	51	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2412	2422		10.1096/fj.14-267096		11	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	WOS:000355209500018		
J	Cheng, Y; Feng, Y; Jansson, L; Sato, Y; Deguchi, M; Kawamura, K; Hsueh, AJ				Cheng, Yuan; Feng, Yi; Jansson, Lina; Sato, Yorino; Deguchi, Masashi; Kawamura, Kazuhiro; Hsueh, Aaron J.			Actin polymerization-enhancing drugs promote ovarian follicle growth mediated by the Hippo signaling effector YAP	FASEB JOURNAL			English	Article						Jasplakinolide; sphingosine-1-phosphate; connective tissue growth factor	SPHINGOSINE 1-PHOSPHATE; F-ACTIN; CELL-MIGRATION; ORGAN SIZE; PROTEIN; PATHWAY; SPHINGOSINE-1-PHOSPHATE; DISRUPTION; CYTOSKELETON; INDUCTION	Hippo signaling pathway consists of conserved serine/threonine kinases to maintain optimal organ sizes. Studies have demonstrated that fragmentation of murine ovaries increases actin polymerization and disrupts Hippo signaling, leading to nuclear translocation of Hippo signaling effector Yes-associated protein (YAP) in ovarian follicles and follicle growth. For patients with polycystic ovarian syndrome showing follicle arrest, ovarian wedge resection and laser drilling promote follicle growth. Because these damaging procedures likely involve actin polymerization, we tested whether actin polymerization-promoting drugs could promote YAP translocation and stimulate follicle growth. Treatment of murine ovaries with mu M Jasplakinolide (JASP), an actin polymerization-promoting cyclic peptide, or sphingosine-1-phosphate (S1P), a follicular fluid constituent known to promote actin polymerization, increased the conversion of globular actin to the filamentous form, followed by increased nuclear YAP and expression of downstream connective tissue growth factor (CCN2). After short-term treatments with JASP or S1P, in vitro cultured and in vivo grafted ovaries showed follicle growth. Furthermore, induction of constitutively active YAP in ovarian grafts of transgenic mice enhanced follicle development, whereas treatment of human ovarian cortices with JASP or S1P increased CCN2 expression. Thus, JASP and S1P stimulate follicle growth and are potential therapeutic agents for treating polycystic ovarian syndrome and other ovarian disorders.	[Cheng, Yuan; Feng, Yi; Deguchi, Masashi; Hsueh, Aaron J.] Stanford Univ, Dept Obstet & Gynecol, Sch Med, Stanford, CA 94305 USA; [Jansson, Lina] Stanford Univ, Dept Otolaryngol, Sch Med, Stanford, CA 94305 USA; [Sato, Yorino; Kawamura, Kazuhiro] St Mariana Univ, Dept Obstet & Gynecol, Kawasaki, Kanagawa, Japan; [Kawamura, Kazuhiro] Akita Univ, Grad Sch Med, Dept Obstet & Gynecol, Akita 010, Japan	Hsueh, AJ (reprint author), 300 Pasteur Dr,Room A344, Stanford, CA 94305 USA.	aaron.hsueh@stanford.edu			U.S. National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (Specialized Cooperative Centers Program in Reproduction and Infertility Research) [U54-HD068158]; Smoking Research Foundation; Takeda Science Foundation; Coordination, Support and Training Program for Translational Research, Seeds B;  [24390376];  [24659722];  [26114510]	This work was supported by the U.S. National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (Grant U54-HD068158 to A.H., as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research); Grant-in-Aid for Scientific Research (Research B [24390376], Challenging Exploratory Research [24659722], and Innovative Areas, Mechanisms Regulating Gamete Formation in Animals [26114510]); and by research funds from the Smoking Research Foundation, the Takeda Science Foundation, and the Coordination, Support and Training Program for Translational Research, Seeds B (to K.K.).	Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Morita Y, 2000, NAT MED, V6, P1109; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Kawamura K, 2013, P NATL ACAD SCI USA, V110, P17474, DOI 10.1073/pnas.1312830110; Boggiano JC, 2012, DEV CELL, V22, P695, DOI 10.1016/j.devcel.2012.03.013; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Visser-Grieve S, 2011, CELL RES, V21, P1513, DOI 10.1038/cr.2011.122; Stein IF, 1935, AM J OBSTET GYNECOL, V29, P181; Hergovich A, 2012, BIOCHEM SOC T, V40, P124, DOI 10.1042/BST20110619; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Li J, 2010, P NATL ACAD SCI USA, V107, P10280, DOI 10.1073/pnas.1001198107; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Yatomi Y, 2006, CURR PHARM DESIGN, V12, P575, DOI 10.2174/138161206775474404; Becker S, 2011, BIOL REPROD, V84, P604, DOI 10.1095/biolreprod.110.084152; Cheng Y, 2013, FASEB J, V27, P2175, DOI 10.1096/fj.12-223412; Farquhar C., 2012, COCHRANE DB SYST REV, V6; Fukui H, 2014, DEV CELL, V31, P128, DOI 10.1016/j.devcel.2014.08.014; Hendriks ML, 2007, HUM REPROD UPDATE, V13, P249, DOI 10.1093/humupd/dm1058; Hsueh AJW, 2015, ENDOCR REV, V36, P1, DOI 10.1210/er.2014-1020; Jansson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032013; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; SENDEROWICZ AMJ, 1995, J NATL CANCER I, V87, P46, DOI 10.1093/jnci/87.1.46; Soleimani R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019475; Zelinski M. B., 2011, FERTIL STERIL, V95	33	1	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2423	2430		10.1096/fj.14-267856		8	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	WOS:000355209500019		
J	Koeberle, A; Pergola, C; Shindou, H; Koeberle, SC; Shimizu, T; Laufer, SA; Werz, O				Koeberle, Andreas; Pergola, Carlo; Shindou, Hideo; Koeberle, Solveigh C.; Shimizu, Takao; Laufer, Stefan A.; Werz, Oliver			Role of p38 mitogen-activated protein kinase in linking stearoyl-CoA desaturase-1 activity with endoplasmic reticulum homeostasis	FASEB JOURNAL			English	Article						bioactive lipid; fatty acid; lipidomics; phospholipid; unfolded protein response	POLYUNSATURATED FATTY-ACIDS; INSULIN-RESISTANCE; ACYLTRANSFERASE 3; CELL-CYCLE; STRESS; MEMBRANE; MUSCLE; PHOSPHOLIPIDS; PROGRESSION; SENSITIVITY	Endoplasmic reticulum (ER) homeostasis is regulated by a network of signaling pathways to which stearoyl-CoA desaturase (SCD)-1, p38 mitogen-activated protein kinase (MAPK) and the unfolded protein response (UPR) belong. Because all these pathways are located at the interface of cell cycle control and cell stress, we hypothesized a cross-regulation. Interference with SCD-1, either by small interfering (si) RNA or the specific SCD-1 inhibitor CAY10566 (EC50 1 mu M; >= 24 h), specifically induced phosphorylation and thus activation of p38 MAPK in NIH-3T3 mouse fibroblasts (1.5- to 2-fold; 48 hours). During lipotoxic and cell cycle stress, prolonged activation of p38 MAPK due to SCD-1 inhibition induced ER stress, the UPR, and ER/Golgi remodeling as shown by Western blot and immunofluorescence microscopy (1.2- to 3.5-fold). Specific inhibition of p38 MAPK by Skepinone-L [half maximal inhibitory concentration (IC50) 25-50 nM] reversed these effects (at 1 mu M; 48 hours). The specificity by which SCD-1 modulates the phospholipid composition and inhibits p38 MAPK signaling (among survival/stress pathways), thereby preventing ER stress (but not other SCD-1-dependent responses), suggests selective protein-lipid interactions. Palmitoleoyl/oleoyl-phosphatidylinositol (PI) was accordingly identified as potential lipid mediator using chromatography-coupled ESI tandem mass spectrometry. We conclude that the negative regulation of p38 MAPK mediates the protective effects of SCD-1 on ER homeostasis under distinct stress conditions.	[Koeberle, Andreas; Pergola, Carlo; Werz, Oliver] Univ Jena, Inst Pharm, D-07743 Jena, Germany; [Shindou, Hideo; Shimizu, Takao] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Res Inst, Tokyo, Japan; [Koeberle, Solveigh C.] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Shimizu, Takao] Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Tokyo 113, Japan; [Laufer, Stefan A.] Univ Tubingen, Dept Pharmaceut Chem, Inst Pharmaceut, Tubingen, Germany	Koeberle, A (reprint author), Univ Jena, Inst Pharm, Chair Pharmaceut Med Chem, Philosophenweg 14, D-07743 Jena, Germany.	andreas.koeberle@uni-jena.de			Deutsche Forschungsgemeinschaft [KO 4589/4-1]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Cell Science Research Foundation; Takeda Science Foundation	The authors thank Kevin Schomburg and Christoph Seidel for expert technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft (KO 4589/4-1 to A.K.); Grant-in-Aid for Scientific Research (S) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to T.S.); Grant-in-Aid for Young Scientists (B) from the MEXT of Japan (to H.S.); the Cell Science Research Foundation (to H.S.); and Takeda Science Foundation (to A.K.).	Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Dobrzyn A, 2005, J BIOL CHEM, V280, P23356, DOI 10.1074/jbc.M502436200; Koeberle A, 2012, J BIOL CHEM, V287, P27244, DOI 10.1074/jbc.M111.274829; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Guijas C, 2012, J LIPID RES, V53, P2343, DOI 10.1194/jlr.M028423; Liu Zhenqi, 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P38; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Hodson L, 2013, PROG LIPID RES, V52, P15, DOI 10.1016/j.plipres.2012.08.002; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Brewer JW, 1999, P NATL ACAD SCI USA, V96, P8505, DOI 10.1073/pnas.96.15.8505; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; Peter A, 2009, DIABETES, V58, P1757, DOI 10.2337/db09-0188; Ariyama H, 2010, J BIOL CHEM, V285, P22027, DOI 10.1074/jbc.M110.126870; Liu G, 2007, J MED CHEM, V50, P3086, DOI 10.1021/jm070219p; Doria ML, 2013, J CELL PHYSIOL, V228, P457, DOI 10.1002/jcp.24152; Rahman SM, 2003, P NATL ACAD SCI USA, V100, P11110, DOI 10.1073/pnas.1934571100; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Koeberle A, 2009, BRIT J PHARMACOL, V156, P952, DOI 10.1111/j.1476-5381.2009.00070.x; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; Koeberle SC, 2012, NAT CHEM BIOL, V8, P141, DOI 10.1038/nchembio.761; Pinnamaneni SK, 2006, DIABETOLOGIA, V49, P3027, DOI 10.1007/s00125-006-0427-9; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; Koeberle A, 2012, FASEB J, V26, P169, DOI 10.1096/fj.11-184879; Koeberle A, 2013, P NATL ACAD SCI USA, V110, P2546, DOI 10.1073/pnas.1216182110; Fritz V, 2010, MOL CANCER THER, V9, P1740, DOI 10.1158/1535-7163.MCT-09-1064; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Bolognesi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055537; BROTHERUS J, 1977, BIOCHIM BIOPHYS ACTA, V486, P243, DOI 10.1016/0005-2760(77)90020-0; Ide Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061204; Koeberle A, 2010, FASEB J, V24, P4929, DOI 10.1096/fj.10-162818; Ralston JC, 2014, INT J OBESITY, V38, P1449, DOI 10.1038/ijo.2014.35; Takenaka K, 1998, SCIENCE, V280, P599, DOI 10.1126/science.280.5363.599; Vessby B, 2012, NUTR METAB CARDIOVAS, V22, P176, DOI 10.1016/j.numecd.2010.07.011; Wang YQ, 2009, J NUTR BIOCHEM, V20, P982, DOI 10.1016/j.jnutbio.2008.09.002	38	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2439	2449		10.1096/fj.14-268474		11	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	WOS:000355209500021		
J	Liu, NA; Sun, JY; Kono, K; Horikoshi, Y; Ikura, T; Tong, X; Haraguchi, T; Tashiro, S				Liu, Ning-Ang; Sun, Jiying; Kono, Kazuteru; Horikoshi, Yasunori; Ikura, Tsuyoshi; Tong, Xing; Haraguchi, Tokuko; Tashiro, Satoshi			Regulation of homologous recombinational repair by lamin B1 in radiation-induced DNA damage	FASEB JOURNAL			English	Article						B-type lamins; nuclear envelope; progeria syndrome; RAD51; recombinational DNA repair	STRAND BREAK REPAIR; GILFORD-PROGERIA-SYNDROME; A-TYPE LAMINS; RAD51 GENE; CELL-CYCLE; DEFECTIVE MATURATION; NUCLEAR ARCHITECTURE; IONIZING-RADIATION; MAMMALIAN-CELLS; STEM-CELLS	DNA double-strand breaks (DSBs) are the major lethal lesion induced by ionizing radiation (IR). RAD51-dependent homologous recombination (HR) is one of the most important pathways in DSB repair and genome integrity maintenance. However, the mechanism of HR regulation by RAD51 remains unclear. To understand the mechanism of RAD51-dependent HR, we searched for interacting partners of RAD51 by a proteomics analysis and identified lamin B1 in human cells. Lamins are nuclear lamina proteins that play important roles in the structural organization of the nucleus and the regulation of chromosome functions. Immunoblotting analyses revealed that siRNA-mediated lamin B1 depletion repressed the DNA damage-dependent increase of RAD51 after IR. The repression was abolished by the proteasome inhibitor MG132, suggesting that lamin B1 stabilizes RAD51 by preventing proteasome-mediated degradation in cells with IR-induced DNA damage. We also showed that lamin B1 depletion repressed RAD51 focus formation and decreased the survival rates after IR. On the basis of these results, we propose that lamin B1 promotes DSB repair and cell survival by maintaining the RAD51 protein levels for HR upon DSB induction after IR.	[Liu, Ning-Ang; Sun, Jiying; Kono, Kazuteru; Horikoshi, Yasunori; Tashiro, Satoshi] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Cellular Biol, Hiroshima, Hiroshima 7348553, Japan; [Horikoshi, Yasunori; Tashiro, Satoshi] Hiroshima Univ, Res Ctr Math Chromatin Live Dynam RcMcD, Hiroshima, Hiroshima 7348553, Japan; [Ikura, Tsuyoshi] Kyoto Univ, Ctr Radiat Biol, Dept Mutagenesis, Lab Chromatin Dynam, Kyoto, Japan; [Tong, Xing] Soochow Univ, Coll Med, Lab Ctr, Suzhou, Peoples R China; [Haraguchi, Tokuko] Natl Inst Informat & Commun Technol, Adv ICT Res Inst Kobe, Kobe, Hyogo, Japan	Tashiro, S (reprint author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Cellular Biol, Minami Ku, Kasumi 1-2-3, Hiroshima, Hiroshima 7348553, Japan.	ktashiro@hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	The authors thank M. Jasin, J. Kobayashi, and K. Komatsu for providing the U2OS-DRGFP cells and are grateful to K. Fujioka for technical assistance with the SCE assay. This work was supported by Grants-in-Aid and the Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Taimen P, 2009, P NATL ACAD SCI USA, V106, P20788, DOI 10.1073/pnas.0911895106; Shimi T, 2011, GENE DEV, V25, P2579, DOI 10.1101/gad.179515.111; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; Raderschall E, 2002, CANCER RES, V62, P219; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Liu Y, 2008, FASEB J, V22, P603, DOI 10.1096/fj.07-8598com; Richardson C, 2004, ONCOGENE, V23, P546, DOI 10.1038/sj.onc.1207098; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Huang S, 2008, EXP CELL RES, V314, P82, DOI 10.1016/j.yexcr.2007.08.004; Daboussi F, 2002, CELL SIGNAL, V14, P969, DOI 10.1016/S0898-6568(02)00052-9; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Dreesen O, 2013, J CELL BIOL, V200, P605, DOI 10.1083/jcb.201206121; Collis SJ, 2001, NUCLEIC ACIDS RES, V29, P1534, DOI 10.1093/nar/29.7.1534; Vispe S, 1998, NUCLEIC ACIDS RES, V26, P2859, DOI 10.1093/nar/26.12.2859; Tashiro S, 2000, J CELL BIOL, V150, P283, DOI 10.1083/jcb.150.2.283; Malhas AN, 2009, J CELL BIOL, V184, P45, DOI 10.1083/jcb.200804155; Arias-Lopez C, 2006, EMBO REP, V7, P219, DOI 10.1038/sj.embor.7400587; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Barascu A, 2012, EMBO J, V31, P1080, DOI 10.1038/emboj.2011.492; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Kousholt AN, 2012, J CELL BIOL, V197, P869, DOI 10.1083/jcb.201111065; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Kim Y, 2011, SCIENCE, V334, P1706, DOI 10.1126/science.1211222; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; ROBER RA, 1989, DEVELOPMENT, V105, P365; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Tang CW, 2008, J CELL SCI, V121, P1014, DOI 10.1242/jcs.020982; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Tian L, 2010, ONCOGENE, V29, P6125, DOI 10.1038/onc.2010.345; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Vergnes L, 2004, P NATL ACAD SCI USA, V101, P10428, DOI 10.1073/pnas.0401424101; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Taddei A, 2004, ANNU REV GENET, V38, P305, DOI 10.1146/annurev.genet.37.110801.142705; Coffinier C, 2011, MOL BIOL CELL, V22, P4683, DOI 10.1091/mbc.E11-06-0504; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Huang YY, 1999, MOL CELL BIOL, V19, P2986; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Atwell S, 2012, NUCLEIC ACIDS RES, V40, P11769, DOI 10.1093/nar/gks1131; Butin-Israeli V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069169; Butin-Israeli V., 2014, MOL CELL BIOL; Constantinescu D, 2010, EXP CELL RES, V316, P2747, DOI 10.1016/j.yexcr.2010.05.015; Dechat T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000547; De Vos WH, 2010, BBA-GEN SUBJECTS, V1800, P448, DOI 10.1016/j.bbagen.2010.01.002; Dreesen O, 2013, NUCLEUS-AUSTIN, V4, P283, DOI 10.4161/nucl.25808; Du LQ, 2011, MED ONCOL, V28, P1481, DOI 10.1007/s12032-010-9605-1; Flygare J, 1996, BBA-MOL CELL RES, V1312, P231, DOI 10.1016/0167-4889(96)00040-7; Fojo T, 2001, J NATL CANCER I, V93, P1434, DOI 10.1093/jnci/93.19.1434; Gonzalez-Suarez I, 2009, EMBO J, V28, P2414, DOI 10.1038/emboj.2009.196; Gonzalo S, 2014, ADV EXP MED BIOL, V773, P377, DOI 10.1007/978-1-4899-8032-8_17; Hosoya N, 2012, EMBO REP, V13, P44, DOI 10.1038/embor.2011.221; Kobayashi J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-34; Krejci L, 2001, MOL CELL BIOL, V21, P966, DOI 10.1128/MCB.21.3.966-976.2001; Liu YY, 2006, J CELL SCI, V119, P4644, DOI 10.1242/jcs.03263; Nishibuchi I, 2014, INT J RADIAT ONCOL, V89, P736, DOI 10.1016/j.ijrobp.2014.03.031; Pierce Andrew J, 2005, Methods Mol Biol, V291, P373; Redwood AB, 2011, CELL CYCLE, V10, P2549, DOI 10.4161/cc.10.15.16531; Redwood AB, 2011, CELL CYCLE, V10, P3652, DOI 10.4161/cc.10.21.18201; Russell JS, 2003, CANCER RES, V63, P7377; Sakogawa K, 2013, CANCER SCI, V104, P1593, DOI 10.1111/cas.12281; Shi L, 2012, RADIAT RES, V177, P533, DOI 10.1667/RR2849.1; Shima H, 2013, J CELL SCI, V126, P5284, DOI 10.1242/jcs.133744; Sigurdsson S, 2002, J BIOL CHEM, V277, P42790, DOI 10.1074/jbc.M208004200; STEWART C, 1987, CELL, V51, P383; Yamamoto A, 1996, MOL GEN GENET, V251, P1	69	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2514	2525		10.1096/fj.14-265546		12	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	WOS:000355209500028		
J	Ishida, R; Yamamoto, A; Nakayama, K; Sohda, M; Misumi, Y; Yasunaga, T; Nakamura, N				Ishida, Ryuichi; Yamamoto, Akitsugu; Nakayama, Kazuhisa; Sohda, Miwa; Misumi, Yoshio; Yasunaga, Takuo; Nakamura, Nobuhiro			GM130 is a parallel tetramer with a flexible rod-like structure and N-terminally open (Y-shaped) and closed (I-shaped) conformations	FEBS JOURNAL			English	Article						coiled coil; Golgi matrix; golgins; GRASP65; p115	GOLGI MATRIX PROTEIN; APPARATUS; MEMBRANE; P115; ER; PHOSPHORYLATION; CISTERNAE; STACKING; GRASP65; RIBBON	GM130 is a cytoplasmic peripheral membrane protein localized on the cis side of the Golgi apparatus. GM130 is proposed to function as a membrane skeleton, maintaining the structure of the Golgi apparatus, and as a vesicle tether that facilitates vesicle fusion to the Golgi membrane. More than 60% of the GM130 molecule is believed to exist as coiled-coil structures with a probability above 90%, based on its primary amino acid sequence. The predicted coiled-coil region was similar to that of yeast Uso1p and its mammalian homolog, p115, both of which form coiled-coil homodimers. Therefore, GM130 has long been thought to form a homodimer with a rod-like shape. However, our biochemical and electron microscopical analyses revealed that GM130 is a parallel homotetramer with a flexible rod-like structure with I- and Y-shaped conformations. The structure of the N-terminal region may interchange between an open conformation (branched or Y-shaped) and a closed conformation (non-branched or I-shaped), possibly with the help of interacting molecules. This conformational change may alter the oligomeric state of the GM130 molecules and the function of GM130 in the vesicle tethering and the maintenance of the Golgi structure.	[Ishida, Ryuichi; Nakamura, Nobuhiro] Kyoto Sangyo Univ, Fac Life Sci, Kyoto 6068555, Japan; [Yamamoto, Akitsugu] Nagahama Inst Biosci & Technol, Nagahama, Shiga, Japan; [Nakayama, Kazuhisa] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Sohda, Miwa] Niigata Univ, Grad Sch Med & Dent Sci, Div Oral Biochem, Niigata 95021, Japan; [Misumi, Yoshio] Fukuoka Univ, Sch Med, Cell Biol, Fukuoka, Japan; [Yasunaga, Takuo] Kyushu Inst Technol, Dept Biosci & Bioinformat, Fukuoka, Japan	Nakamura, N (reprint author), Kyoto Sangyo Univ, Fac Life Sci, Kita Ku, Kyoto 6068555, Japan.	osaru3@cc.kyoto-su.ac.jp	Nakamura, Nobuhiro/F-7811-2011	Nakamura, Nobuhiro/0000-0002-8836-6714	Japan Society for the Promotion of Science [18570173, 25440092]; Ministry of Education, Culture, Sports, Science and Technology (Japan) [24112525]; Kyoto Sangyo University; Japan Society for the Promotion of Science	Parts of this work were performed by Tomoaki Sakaguchi and Satoshi Kumamoto (Graduate School of Natural Science and Technology, Kanazawa University, Japan) under the supervision of N.N. and presented in the theses for their Master's degrees (T.S. in Feb. 2007, S.K. in Feb. 2009, Kanazawa University). We thank Yuko Yano and Takakazu Mori (Kyoto Sangyo University, Japan) for verifying the mathematical model, Testurou Nomura and Akira Kawabe for helpful comments, Keiko Okamoto-Furuta and Haruyasu Kohda (Division of Electron Microscopic Study, Center for Anatomical Studies, Graduate School of Medicine, Kyoto University, Japan) for their support with the electron microscopy experiments, and all past and present members of Nakamura Laboratory for their support and discussions. This work was supported by research grants to N.N. from the Japan Society for the Promotion of Science (18570173 and 25440092), the Ministry of Education, Culture, Sports, Science and Technology (Japan) (24112525) and Kyoto Sangyo University, and a Sasakawa Scientific Research Grant from the Japan Society for the Promotion of Science to R.I.	Vincent TL, 2013, BIOINFORMATICS, V29, P69, DOI 10.1093/bioinformatics/bts648; SAPPERSTEIN SK, 1995, P NATL ACAD SCI USA, V92, P522, DOI 10.1073/pnas.92.2.522; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Yamakawa H, 1996, J STRUCT BIOL, V116, P356, DOI 10.1006/jsbi.1996.0053; Kodani A, 2008, MOL BIOL CELL, V19, P745, DOI 10.1091/mbc.E07-08-0847; Wei JH, 2010, TRAFFIC, V11, P1391, DOI 10.1111/j.1600-0854.2010.01114.x; Marra P, 2007, MOL BIOL CELL, V18, P1595, DOI 10.1091/mbc.E06-10-0886; Klumperman J, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005181; Diao A, 2008, J BIOL CHEM, V283, P6957, DOI 10.1074/jbc.M708401200; Nakamura N, 2012, CURR OPIN CELL BIOL, V24, P467, DOI 10.1016/j.ceb.2012.05.009; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Ramirez IBR, 2009, SEMIN CELL DEV BIOL, V20, P770, DOI 10.1016/j.semcdb.2009.03.011; Bachert C, 2010, J BIOL CHEM, V285, P16294, DOI 10.1074/jbc.M110.116129; Truschel ST, 2012, J BIOL CHEM, V287, P19870, DOI 10.1074/jbc.M111.326256; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nakamura N, 2010, J PHARMACOL SCI, V112, P255, DOI 10.1254/jphs.09R03CR; Klute MJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007849; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Glick BS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005215; Moyer BD, 2001, TRAFFIC, V2, P268, DOI 10.1034/j.1600-0854.2001.1o007.x; Sohda M, 1998, J BIOL CHEM, V273, P5385, DOI 10.1074/jbc.273.9.5385; Valsdottir R, 2001, FEBS LETT, V508, P201, DOI 10.1016/S0014-5793(01)02993-3; Weide T, 2001, EMBO REP, V2, P336, DOI 10.1093/embo-reports/kve065; Yoshida Y, 2008, EXP CELL RES, V314, P3427, DOI 10.1016/j.yexcr.2008.07.023; Yoshimura S, 2001, J CELL SCI, V114, P4105	29	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	JUN	2015	282	11					2232	2244		10.1111/febs.13271		13	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CJ7GZ	WOS:000355664000013		
J	Scarbrough, SL; Jackson, CR; Marchman, S; Allen, G; Louch, J; Miwa, M				Scarbrough, S. Lynsey; Jackson, C. Rhett; Marchman, Samantha; Allen, Ginny; Louch, Jeff; Miwa, Masato			Herbicide Concentrations in First-Order Streams after Routine Application for Competition Control in Establishing Pine Plantations	FOREST SCIENCE			English	Article						best management practices (BMPs); silviculture; herbicides; water quality; hydrology	FORESTED FILTER STRIPS; BUFFER STRIPS; MANAGEMENT ZONES; UNITED-STATES; RUNOFF; HEXAZINONE; PIEDMONT; WATER; RETENTION; TRANSPORT	Herbicides are an important tool for managing competitive vegetation in pine silviculture, and forestry best management practices (BMPs) were designed partly to minimize the movement of overland flow and dissolved herbicides into adjacent streams. We measured herbicide concentrations in streams before and after application when all modern forestry BMPs were applied to silvicultural operations. Imazapyr, hexazinone, and sulfometuron methyl were applied operationally to pine plantations covering 45 and 54% of the watershed area of two first-order streams in the Upper Coastal Plain of Georgia, USA. Herbicides in stream water were sampled and analyzed before and for several months after application. All three herbicides were detected during stormflows after application, but the highest observed concentration was 7.7 parts per billion (ppb), just a few ppb above the level of quantification. The highest concentrations occurred in the first or second stormflow event after application, and peak concentrations diminished rapidly in subsequent events. Quantifiable concentrations occurred as pulses lasting 1/2-1 day after the hydrograph peak. Herbicide concentrations were below or near the level of quantification for all baseflow samples. Our results suggest that transport of these operational silvicultural herbicides to streams is low with proper application and use of modern forestry BMPs, and these results are in concurrence with other recent studies of herbicide movement from modern forestry operations.	[Scarbrough, S. Lynsey] Univ Georgia, Athens, GA 30602 USA; [Jackson, C. Rhett] Univ Georgia, Warnell Sch Forest Resources, Athens, GA 30602 USA; [Miwa, Masato] Fukuoka Univ, Fukuoka, Japan	Scarbrough, SL (reprint author), Univ Georgia, Athens, GA 30602 USA.	lynsey@uga.edu; rjackson@warnell.uga.edu; smarchman1@gmail.com; gallen@ncasi.org; jlouch@ncasi.org; mmiwa@ura.kyushu-u.ac.jp			NCASI, Inc.; International Paper Company; J.W. Jones Ecological Research Center; Georgia Forestry Commission	This research was funded in part by the NCASI, Inc., International Paper Company, the J.W. Jones Ecological Research Center, and the Georgia Forestry Commission. Scott Terrell, David Jones, William Summer, Michael Bell, Andrew Morrison, and Andrew Mishler conducted the field data collection and assisted with data analysis. Steve Golladay provided valuable advice on sampling and analysis.	FAWCETT RS, 1994, J SOIL WATER CONSERV, V49, P126; Rivenbark BL, 2004, J AM WATER RESOUR AS, V40, P1043, DOI 10.1111/j.1752-1688.2004.tb01065.x; Patty L, 1997, PESTIC SCI, V49, P243; Ward JM, 2004, J AM WATER RESOUR AS, V40, P1421, DOI 10.1111/j.1752-1688.2004.tb01596.x; Arora K, 2003, T ASAE, V46, P635; Arora K, 1996, T ASAE, V39, P2155; ASMUSSEN LE, 1977, J ENVIRON QUAL, V6, P159; Environmental Protection Agency (EPA), 2006, 738R06007 EPA; Ganapathy C, 1996, ENV FATE HEXAZINONE; Georgia Forestry Commission, 1999, GEORG BEST MAN PRACT; Jackson CR, 2014, J FOREST, V112, P47; LAVY TL, 1989, J ENVIRON QUAL, V18, P507; Lowrance R, 1997, T ASAE, V40, P1047; Marchman SC, 2015, HYDROL PROCESS, V29, P13, DOI 10.1002/hyp.10121; McBroom W.M., 2013, FOREST SCI, V59, P197; Mersie W, 1999, J ENVIRON QUAL, V28, P816; Michael JL, 2003, J ENVIRON QUAL, V32, P456; Michael JL, 1999, CAN J FOREST RES, V29, P1170, DOI 10.1139/cjfr-29-7-1170; MICHAEL J.L., 2004, WATER AIR SOIL POLL, V4, P95, DOI 10.1023/B:WAFO.0000012823.14182.84; Michael JL, 2006, CAN J FOREST RES, V36, P2497, DOI 10.1139/X06-109; MICHAEL JL, 1993, ENVIRON TOXICOL CHEM, V12, P405, DOI 10.1897/1552-8618(1993)12[405:HDSISF]2.0.CO;2; Michael J.L., 1991, P 6 BIENN SO SILV RE, V2, P641; National Council for Air and Steam Improvement Inc, 2013, 1301 NCASI RES TRIAN; National Council for Air and Steam Improvement Inc, 2007, 0701 NCASI RES TRIAN; NEARY DG, 1983, WEED SCI, V31, P543; NEARY DG, 1986, FOREST ECOL MANAG, V14, P23, DOI 10.1016/0378-1127(86)90050-2; Pinho AP, 2008, J AM WATER RESOUR AS, V44, P1564, DOI 10.1111/j.1752-1688.2008.00260.x; Seybold C, 2001, COMMUN SOIL SCI PLAN, V32, P723, DOI 10.1081/CSS-100103904; Shepard JP, 2004, WILDLIFE SOC B, V32, P1020, DOI 10.2193/0091-7648(2004)032[1020:FHITUS]2.0.CO;2; Tatum VL, 2004, WILDLIFE SOC B, V32, P1042, DOI 10.2193/0091-7648(2004)032[1042:TTAFOF]2.0.CO;2; Terrell S.B., 2012, T ASABE, V54, P2117; White WJ, 2007, J SOIL WATER CONSERV, V62, P453	32	0	0	SOC AMER FORESTERS	BETHESDA	5400 GROSVENOR LANE, BETHESDA, MD 20814 USA	0015-749X	1938-3738		FOREST SCI	For. Sci.	JUN	2015	61	3					604	612		10.5849/forsci.14-051		9	Forestry	Forestry	CJ7ZA	WOS:000355717700022		
J	Zhu, K; Kakehi, T; Matsumoto, M; Iwata, K; Ibi, M; Ohshima, Y; Zhang, J; Liu, JJ; Wen, XP; Taye, A; Fan, CY; Katsuyama, M; Sharma, K; Yabe-Nishimura, C				Zhu, Kai; Kakehi, Tomoko; Matsumoto, Misaki; Iwata, Kazumi; Ibi, Masakazu; Ohshima, Yoichi; Zhang, Jia; Liu, Junjie; Wen, Xiaopeng; Taye, Ashraf; Fan, Chunyuan; Katsuyama, Masato; Sharma, Kumar; Yabe-Nishimura, Chihiro			NADPH oxidase NOX1 is involved in activation of protein kinase C and premature senescence in early stage diabetic kidney	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Diabetic nephropathy; NADPH oxidase; NOX1; Protein kinase C; Senescence; Free radicals	NOX1/NADPH OXIDASE; CELL-CYCLE; NEPHROPATHY; EXPRESSION; COMPLICATIONS; INHIBITION; P27(KIP1); MICE; PHOSPHORYLATION; HYPERTENSION	Increased oxidative stress and activation of protein kinase C (PKC) under hyperglycemia have been implicated in the development of diabetic nephropathy. Because reactive oxygen species derived from nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, NOX1 accelerate the translocation of PKC isoforms, NOX1 is postulated to play a causative role in the development of diabetic nephropathy. Hyperglycemia was induced in wild-type and Nox1-deficient mice (KO) by two doses of streptozotocin injection. At 3 weeks after the induction of hyperglycemia, glomeruli and cortical tubules were isolated from kidneys. The mRNA level of Nox1 was significantly upregulated in the renal cortex at 3 weeks of hyperglycemia. Urinary albumin and expression of inflammatory or fibrotic mediators were similarly elevated in diabetic wild-type and KO; however, increases in glomerular volume and mesangial matrix area were attenuated in diabetic KO. Nox1 deficiency significantly reduced the levels of renal thiobarbituric acid-reacting substances and 8-hydroxydeoxyguanosine, membranous translocation of PKC alpha/beta, activity of PKC, and phosphorylation of p38 mitogen-activated protein kinase in the diabetic kidney. Furthermore, increased staining of senescence-associated beta galactosidase in glomeruli and cortical tubules of diabetic mice was significantly suppressed in KO. Whereas the levels of cyclin-dependent kinase inhibitors, p16(INK4A) and p21(Cip1), were equivalent between the genotypes, increased levels of p27(Kip1) and gamma-H2AX, a biomarker for DNA double-strand breaks, were significantly attenuated in isolated glomeruli and cortical tubules of diabetic KO. Taken together, NOX1 modulates the p38/p27(Kip1) signaling pathway by activating PKC and promotes premature senescence in early stage diabetic nephropathy. (C) 2015 Elsevier Inc. All rights reserved.	[Zhu, Kai; Kakehi, Tomoko; Matsumoto, Misaki; Iwata, Kazumi; Ibi, Masakazu; Ohshima, Yoichi; Zhang, Jia; Liu, Junjie; Wen, Xiaopeng; Taye, Ashraf; Yabe-Nishimura, Chihiro] Kyoto Prefectural Univ Med, Dept Pharmacol, Kyoto 6028566, Japan; [Katsuyama, Masato] Kyoto Prefectural Univ Med, Radioisotope Ctr, Kyoto 6028566, Japan; [Sharma, Kumar] Univ Calif San Diego, Dept Med, Div Nephrol Hypertens, Ctr Renal Translat Med, La Jolla, CA 92093 USA; [Sharma, Kumar] VA San Diego Healthcare Syst, La Jolla, CA 92093 USA; [Fan, Chunyuan] Dujiangyan City Med Ctr, Dujiangyan Chengdu 611830, Sichuan, Peoples R China	Yabe-Nishimura, C (reprint author), Kyoto Prefectural Univ Med, Dept Pharmacol, Kyoto 6028566, Japan.	nchihiro@koto.kpu-m.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [20390071, 24390063]; VA Merit Grant [5101BX000277-02]; NIH [1DP3DK094352]	This work was supported by Grants-in-Aid for Scientific Research (B: 20390071 and 24390063 to C.Y.-N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. K.S. was supported by a VA Merit Grant (5101BX000277-02) and funding from the NIH (1DP3DK094352). We thank Dr. Naoaki Saito at the Biosignal Research Center, Kobe University, for insightful discussions. C.Y.-N. is a cofounder of a startup company developing NOX inhibitors.	ANDERSON S, 1993, AM J PHYSIOL, V265, pF477; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Verzola D, 2008, AM J PHYSIOL-RENAL, V295, pF1563, DOI 10.1152/ajprenal.90302.2008; De Keulenaer GW, 1998, CIRC RES, V82, P1094; Ibi M, 2011, J NEUROSCI, V31, P18094, DOI 10.1523/JNEUROSCI.4136-11.2011; Kakehi T, 2008, SEMIN IMMUNOPATHOL, V30, P301, DOI 10.1007/s00281-008-0122-7; Matsuno K, 2005, CIRCULATION, V112, P2677, DOI 10.1161/CIRCULATIONAHA.105.573709; Thallas-Bonke V, 2008, DIABETES, V57, P460, DOI 10.2337/db07-1119; Holterman CE, 2014, J AM SOC NEPHROL, V25, P784, DOI 10.1681/ASN.2013040371; Mima A, 2012, FASEB J, V26, P2963, DOI 10.1096/fj.11-202994; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Matsumoto M, 2014, FREE RADICAL BIO MED, V68, P196, DOI 10.1016/j.freeradbiomed.2013.12.013; De Vita F, 2012, CELL CYCLE, V11, P1583, DOI 10.4161/cc.20003; Yogi A, 2008, HYPERTENSION, V51, P500, DOI 10.1161/HYPERTENSIONAHA.107.103192; Kodama R, 2013, GENES CELLS, V18, P32, DOI 10.1111/gtc.12015; Jha JC, 2014, J AM SOC NEPHROL, V25, P1237, DOI 10.1681/ASN.2013070810; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Craven PA, 2001, DIABETES, V50, P2114, DOI 10.2337/diabetes.50.9.2114; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; You YH, 2013, AM J PHYSIOL-RENAL, V304, pF840, DOI 10.1152/ajprenal.00511.2012; Babelova A, 2012, FREE RADICAL BIO MED, V53, P842, DOI 10.1016/j.freeradbiomed.2012.06.027; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Adhikary L, 2004, DIABETOLOGIA, V47, P1210, DOI 10.1007/s00125-004-1437-0; Li JM, 2003, J AM SOC NEPHROL, V14, pS221, DOI 10.1097/01.ASN.0000077406.67663.E7; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Ibi M, 2008, J NEUROSCI, V28, P9486, DOI 10.1523/JNEUROSCI.1857-08.2008; Cakir Y, 2005, ANTIOXID REDOX SIGN, V7, P726, DOI 10.1089/ars.2005.7.726; Chen GJ, 2007, AM J KIDNEY DIS, V49, P394, DOI 10.1053/j.ajkd.2006.12.011; Lassegue B, 2003, AM J PHYSIOL-REG I, V285, pR277, DOI 10.1152/ajpregu.00758.2002; Cui WH, 2009, J PHARMACOL SCI, V111, P260, DOI 10.1254/jphs.09148FP; Howard AB, 1997, AM J PHYSIOL-CELL PH, V272, pC421; Ito J, 2010, AM J PHYSIOL-GASTR L, V298, pG916, DOI 10.1152/ajpgi.00429.2009; Pillai MS, 2011, INT J BIOCHEM CELL B, V43, P919, DOI 10.1016/j.biocel.2011.03.007; Satriano J, 2010, AM J PHYSIOL-CELL PH, V299, pC374, DOI 10.1152/ajpcell.00096.2010; Swat A, 2009, MOL CELL BIOL, V29, P3332, DOI 10.1128/MCB.01955-08; Wolf G, 1999, DIABETOLOGIA, V42, P1425, DOI 10.1007/s001250051314; Wolf G, 1997, AM J PHYSIOL-RENAL, V273, pF348; Wolf G, 1998, KIDNEY INT, V53, P869, DOI 10.1046/j.1523-1755.1998.00829.x; Yang J, 2009, AM J PHYSIOL-RENAL, V297, pF1220, DOI 10.1152/ajprenal.00314.2009; Zimmerman MC, 2011, HYPERTENSION, V58, P446, DOI 10.1161/HYPERTENSIONAHA.111.177006; Zimpelmann J, 2000, KIDNEY INT, V58, P2320, DOI 10.1046/j.1523-1755.2000.00416.x	42	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	JUN	2015	83						21	30		10.1016/j.freeradbiomed.2015.02.009		10	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CJ6BI	WOS:000355577600003		
J	Okumura, M; Kadokura, H; Inaba, K				Okumura, Masaki; Kadokura, Hiroshi; Inaba, Kenji			Structures and functions of protein disulfide isomerase family members involved in proteostasis in the endoplasmic reticulum	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						ER quality control; Oxidative protein folding; ER-associated degradation; Disulfide bond; PDI family	QUIESCIN-SULFHYDRYL OXIDASES; BOND FORMATION; PDI FAMILY; CRYSTAL-STRUCTURE; QUALITY-CONTROL; SECRETORY PATHWAY; ER STRESS; MISFOLDED PROTEINS; THIOREDOXIN FAMILY; RESIDENT PROTEIN	The endoplasmic reticulum (ER) is an essential cellular compartment in which an enormous number of secretory and cell surface membrane proteins are synthesized and subjected to cotranslational or posttranslational modifications, such as glycosylation and disulfide bond formation. Proper maintenance of ER protein homeostasis (sometimes termed proteostasis) is essential to avoid cellular stresses and diseases caused by abnormal proteins. Accumulating knowledge of cysteine-based redox reactions catalyzed by members of the protein disulfide isomerase (PDI) family has revealed that these enzymes play pivotal roles in productive protein folding accompanied by disulfide formation, as well as efficient ER-associated degradation accompanied by disulfide reduction. Each of PDI family members forms a protein-protein interaction with a preferential partner to fulfill a distinct function. Multiple redox pathways that utilize PDIs appear to function synergistically to attain the highest quality and productivity of the ER, even under various stress conditions. This review describes the structures, physiological functions, and cooperative actions of several essential PDIs, and provides important insights into the elaborate proteostatic mechanisms that have evolved in the extremely active and stress-sensitive ER. (C) 2015 Elsevier Inc. All rights reserved.	[Okumura, Masaki; Kadokura, Hiroshi; Inaba, Kenji] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Inaba, K (reprint author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan.	kinaba@tagen.tohoku.ac.jp			Next Generation World-Leading Researchers program (MEXT); Takeda Science Foundation	This work was supported by funding from the Next Generation World-Leading Researchers program (MEXT) and the Takeda Science Foundation (to K. Inaba), a Grant-in-Aid for Scientific Research (C) (to H. Kadokura), a Grant-in-Aid for Scientific Research on Innovative Areas (to K. Inaba and H. Kadokura), and a Grant-in-Aid for JSPS Fellows (to M. Okumura). The authors declare that there are no conflicts of interest related to this work.	Alanen HI, 2006, J BIOL CHEM, V281, P33727, DOI 10.1074/jbc.M604314200; Amin NT, 2013, BIOCHEM J, V450, P321, DOI 10.1042/BJ20121635; Anelli T, 2003, EMBO J, V22, P5015, DOI 10.1093/emboj/cdg491; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Koritzinsky M, 2013, J CELL BIOL, V203, P615, DOI 10.1083/jcb.201307185; Cunnea PM, 2003, J BIOL CHEM, V278, P1059, DOI 10.1074/jbc.M206995200; Bulleid NJ, 2011, TRENDS BIOCHEM SCI, V36, P485, DOI 10.1016/j.tibs.2011.05.004; Serve O, 2010, J MOL BIOL, V396, P361, DOI 10.1016/j.jmb.2009.11.049; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Higa A, 2014, MOL CELL BIOL, V34, P1839, DOI 10.1128/MCB.01484-13; Oka OBV, 2013, MOL CELL, V50, P793, DOI 10.1016/j.molcel.2013.05.014; Nguyen VD, 2011, J MOL BIOL, V406, P503, DOI 10.1016/j.jmb.2010.12.039; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010; Ilani T, 2013, SCIENCE, V341, P74, DOI 10.1126/science.1238279; Hagiwara M, 2011, MOL CELL, V41, P432, DOI 10.1016/j.molcel.2011.01.021; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Anelli T, 2002, EMBO J, V21, P835, DOI 10.1093/emboj/21.4.835; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086; Kojer K, 2014, BBA-PROTEINS PROTEOM, V1844, P1383, DOI 10.1016/j.bbapap.2014.02.004; Tavender TJ, 2010, ANTIOXID REDOX SIGN, V13, P1177, DOI 10.1089/ars.2010.3230; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Araki K, 2013, J CELL BIOL, V202, P861, DOI 10.1083/jcb.201303027; Chakravarthi S, 2004, J BIOL CHEM, V279, P39872, DOI 10.1074/jbc.M406912200; Kakihana T, 2013, J BIOL CHEM, V288, P29586, DOI 10.1074/jbc.M113.467845; Kojima R, 2014, STRUCTURE, V22, P431, DOI 10.1016/j.str.2013.12.013; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; Nadanaka S, 2007, MOL CELL BIOL, V27, P1027, DOI 10.1128/MCB.00408-06; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI 10.1089/ARS.2009.2466; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; Wang L, 2014, ANTIOXID REDOX SIGN, V20, P545, DOI 10.1089/ars.2013.5236; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06; Kadokura H, 2010, ANTIOXID REDOX SIGN, V13, P1231, DOI 10.1089/ars.2010.3187; Sato Y, 2012, FEBS J, V279, P2262, DOI 10.1111/j.1742-4658.2012.08593.x; Ushioda R, 2013, MOL BIOL CELL, V24, P3155, DOI 10.1091/mbc.E13-03-0138; Anelli T, 2007, EMBO J, V26, P4177, DOI 10.1038/sj.emboj.7601844; Knoblach B, 2003, MOL CELL PROTEOMICS, V2, P1104, DOI 10.1074/mcp.M300053-MCP200; Sullivan DC, 2003, J BIOL CHEM, V278, P47079, DOI 10.1074/jbc.M308124200; Schulman S, 2010, P NATL ACAD SCI USA, V107, P15027, DOI 10.1073/pnas.1009972107; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Eletto D, 2014, MOL CELL, V53, P562, DOI 10.1016/j.molcel.2014.01.004; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Araki K, 2012, ANTIOXID REDOX SIGN, V16, P790, DOI 10.1089/ars.2011.4418; Berg J. M., 2012, METABOLISM BASIC CON, V7th; Cao ZB, 2011, J BIOL CHEM, V286, P42257, DOI 10.1074/jbc.M111.298810; Charlton HK, 2010, BIOCHEM BIOPH RES CO, V392, P234, DOI 10.1016/j.bbrc.2010.01.029; Chen DL, 2012, BIOCHEM BIOPH RES CO, V426, P324, DOI 10.1016/j.bbrc.2012.08.072; Cuozzo JW, 1999, NAT CELL BIOL, V1, P130; Fraldi A, 2008, HUM MOL GENET, V17, P2610, DOI 10.1093/hmg/ddn161; GOLDBERGER RF, 1964, J BIOL CHEM, V239, P1406; Grek C., 2014, ENDOPLASMIC RETICULU, V1, P4; Groenendyk J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004983; Heckler EJ, 2008, BBA-MOL CELL RES, V1783, P567, DOI 10.1016/j.bbamcr.2007.10.002; Hosoda A, 2003, J BIOL CHEM, V278, P2669, DOI 10.1074/jbc.M208346200; Inaba K, 2010, EMBO J, V29, P3330, DOI 10.1038/emboj.2010.222; Irvine AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082511; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Kadokura H, 2013, BIOCHEM BIOPH RES CO, V440, P245, DOI 10.1016/j.bbrc.2013.09.063; Kober FX, 2013, J BIOL CHEM, V288, P2029, DOI 10.1074/jbc.M112.410522; Kojima R., 2013, ELS, DOI [10.1002/9780470015902.a0024169., DOI 10.1002/9780470015902.A0024169]; Lash AE, 2000, GENOME RES, V10, P1051, DOI 10.1101/gr.10.7.1051; Marcus N, 1996, BBA-GENE STRUCT EXPR, V1309, P253, DOI 10.1016/S0167-4781(96)00133-9; Masui S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.231357; Montero D, 2013, REDOX BIOL, V1, P508, DOI 10.1016/j.redox.2013.10.005; Okumura M, 2014, J BIOL CHEM, V289, P27004, DOI 10.1074/jbc.M114.564104; Otsu M, 2006, ANTIOXID REDOX SIGN, V8, P274, DOI 10.1089/ars.2006.8.274; Ramming T, 2014, FREE RADICAL BIO MED, V70, P106, DOI 10.1016/j.freeradbiomed.2014.01.018; Rutkevich LA, 2012, MOL BIOL CELL, V23, P2017, DOI 10.1091/mbc.E12-02-0102; Sannino S, 2014, J CELL SCI, V127, P4260, DOI 10.1242/jcs.153239; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02456; Sevier CS, 2012, ANTIOXID REDOX SIGN, V16, P800, DOI 10.1089/ars.2011.4450; Shepherd C, 2014, BIOCHEM J, V461, P107, DOI 10.1042/BJ20140234; Tsunoda S, 2014, ELIFE, V3, DOI 10.7554/eLife.03421; van den Berg Bert, 1999, EMBO (European Molecular Biology Organization) Journal, V18, P4794, DOI 10.1093/emboj/18.17.4794; Vavassori S, 2013, MOL CELL, V50, P783, DOI 10.1016/j.molcel.2013.04.016; Wajih N, 2007, J BIOL CHEM, V282, P2626, DOI 10.1074/jbc.M608954200; Wang C, 2013, ANTIOXID REDOX SIGN, V19, P44, DOI 10.1089/ars.2012.4630; Wang LK, 2008, EMBO REP, V9, P642, DOI 10.1038/embor.2008.88; Wang X, 2012, BIOCHEM J, V441, P113, DOI 10.1042/BJ20110380; WEISSMAN JS, 1993, NATURE, V365, P185, DOI 10.1038/365185a0	86	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	JUN	2015	83						314	322		10.1016/j.freeradbiomed.2015.02.010		9	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CJ6BI	WOS:000355577600032		
J	Ramming, T; Okumura, M; Kanemura, S; Baday, S; Birk, J; Moes, S; Spiess, M; Jeno, P; Berneche, S; Inaba, K; Appenzeller-Herzog, C				Ramming, Thomas; Okumura, Masaki; Kanemura, Shingo; Baday, Sefer; Birk, Julia; Moes, Suzette; Spiess, Martin; Jenoe, Paul; Berneche, Simon; Inaba, Kenji; Appenzeller-Herzog, Christian			A PDI-catalyzed thiol-disulfide switch regulates the production of hydrogen peroxide by human Ero1	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Endoplasmic reticulum; Hydrogen peroxide; Oxidative folding; Disulfide bond formation; Ero1; Peroxidase: Free radicals	RETICULUM OXIDOREDUCTIN-1-ALPHA ERO1-ALPHA; ENDOPLASMIC-RETICULUM; BOND FORMATION; OXIDATIVE ACTIVITY; ISOMERASE PDI; ACTIVE-SITES; PROTEIN; PATHWAY; STRESS; FAMILY	Oxidative folding in the endoplasmic reticulum (ER) involves ER oxidoreductin 1 (Ero1)-mediated disulfide formation in protein disulfide isomerase (PDI). In this process, Ero1 consumes oxygen (O-2) and releases hydrogen peroxide (H2O2), but none of the published Ero1 crystal structures reveal any potential pathway for entry and exit of these reactants. We report that additional mutation of the Cys(208)-Cys(241) disulfide in hyperactive Ero1 alpha (Ero1 alpha-C104A/C131A) potentiates H2O2 production, ER oxidation, and cell toxicity. This disulfide clamps two helices that seal the Flavin cofactor where O-2 is reduced to H2O2. Through its carboxyterminal active site, PDI unlocks this seal by forming a Cys(208)/cy-(241) - dependent mixed-disulfide complex with Ero1 alpha. The H2O2-detoxifying glutathione peroxidase 8 also binds to the Cys(208)/Cys(241) loop region. Supported by O-2 diffusion simulations, these data describe the first enzymatically controlled O-2 access into a flavoprotein active site, provide molecular-level understanding of En:Act regulation and H2O2 production/detoxification, and establish the deleterious consequences of constitutive Ero1 activity. (C) 2015 Elsevier Inc. All rights reserved.	[Ramming, Thomas; Birk, Julia; Appenzeller-Herzog, Christian] Univ Basel, Dept Pharmaceut Sci, Div Mol & Syst Toxicol, CH-4056 Basel, Switzerland; [Okumura, Masaki; Kanemura, Shingo; Inaba, Kenji] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan; [Baday, Sefer; Berneche, Simon] Univ Basel, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland; [Baday, Sefer; Moes, Suzette; Spiess, Martin; Jenoe, Paul; Berneche, Simon] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	Appenzeller-Herzog, C (reprint author), Univ Basel, Dept Pharmaceut Sci, Div Mol & Syst Toxicol, CH-4056 Basel, Switzerland.	Christian.Appenzeller@sbl.ch			Boehringer Ingelheim Fonds; JSPS; MEXT; Swiss National Science Foundation (Ambizione); University of Basel; Freiwillige Akademische Gesellschaft	This paper is dedicated to Emil, who was born during the finalization of the manuscript. We are grateful to Alex Odermatt for generous support. We also thank Adam Lister for editing of the manuscript; Lloyd Ruddock, Neil Bulleid, Jan Riemer, Miklos Geiszt, Roberto Sitia, Hans-Peter Hauri, and An Helenius for sharing reagents; and PRACE for awarding us access to resource Lindgren based in Sweden at the PDC Center for High Performance Computing. This work was supported by a Ph.D. fellowship from the Boehringer Ingelheim Fonds (to T.R.), a Grant-in-Aid for JSPS Fellows (to M.O.), a grant for Next Generation World-Leading Researchers from MEXT (to K.I.), and the Swiss National Science Foundation (Ambizione), the University of Basel, and the Freiwillige Akademische Gesellschaft (all to C.A.H.). The synchrotron radiation experiment was performed at BL45XU in SPring-8 with the approval of RIKEN (Proposal No. 2014A1345).	Vitu E, 2010, J BIOL CHEM, V285, P18155, DOI 10.1074/jbc.M109.064931; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Araki K, 2011, J BIOL CHEM, V286, P32705, DOI 10.1074/jbc.M111.227181; Fass D, 2008, BBA-MOL CELL RES, V1783, P557, DOI 10.1016/j.bbamcr.2007.11.009; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3155, DOI 10.1021/ci3003649; Gess B, 2003, EUR J BIOCHEM, V270, P2228, DOI 10.1046/j.1432-1033.2003.03590.x; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; Denoncin K, 2013, ANTIOXID REDOX SIGN, V19, P63, DOI 10.1089/ars.2012.4864; Nguyen VD, 2011, J MOL BIOL, V406, P503, DOI 10.1016/j.jmb.2010.12.039; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; Tavender TJ, 2010, ANTIOXID REDOX SIGN, V13, P1177, DOI 10.1089/ars.2010.3230; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Araki K, 2013, J CELL BIOL, V202, P861, DOI 10.1083/jcb.201303027; Kakihana T, 2013, J BIOL CHEM, V288, P29586, DOI 10.1074/jbc.M113.467845; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Baron R, 2009, P NATL ACAD SCI USA, V106, P10603, DOI 10.1073/pnas.0903809106; May D, 2005, ONCOGENE, V24, P1011, DOI 10.1038/sj.onc.1208325; Ramming T, 2012, ANTIOXID REDOX SIGN, V16, P1109, DOI 10.1089/ars.2011.4475; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; Alon A, 2010, FEBS LETT, V584, P1521, DOI 10.1016/j.febslet.2010.03.001; Wang L, 2014, ANTIOXID REDOX SIGN, V20, P545, DOI 10.1089/ars.2013.5236; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct3004000x; Enyedi B, 2010, ANTIOXID REDOX SIGN, V13, P721, DOI 10.1089/ars.2009.2880; Sato Y, 2012, FEBS J, V279, P2262, DOI 10.1111/j.1742-4658.2012.08593.x; Garg AD, 2014, PHOTOCH PHOTOBIO SCI, V13, P474, DOI 10.1039/c3pp50333j; Oka OBV, 2013, BBA-MOL CELL RES, V1833, P2425, DOI 10.1016/j.bbamcr.2013.02.007; Sevier CS, 2006, MOL BIOL CELL, V17, P2256, DOI 10.1091/mbc.E05-05-0417; Appenzeller-Herzog C, 2008, ANTIOXID REDOX SIGN, V10, P55, DOI 10.1089/ars.2007.1837; Appenzeller-Herzog C, 2010, EMBO J, V29, P3318, DOI 10.1038/emboj.2010.203; Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Araki K, 2012, ANTIOXID REDOX SIGN, V16, P790, DOI 10.1089/ars.2011.4418; Bertoli G, 2004, J BIOL CHEM, V279, P30047, DOI 10.1074/jbc.M403192200; Birk J, 2013, J CELL SCI, V126, P1604, DOI 10.1242/jcs.117218; Birk Julia, 2013, Frontiers in Genetics, V4, P108, DOI 10.3389/fgene.2013.00108; Chin KT, 2011, FASEB J, V25, P2583, DOI 10.1096/fj.11-184622; Eletto D, 2014, J CELL SCI, V127, P3649, DOI 10.1242/jcs.153643; Fischer M., 2013, INT J CELL BIOL, V2013; Frand AR, 2000, MOL BIOL CELL, V11, P2833; Hansen HG, 2014, BIOSCIENCE REP, V34, P155, DOI 10.1042/BSR20130124; Hansen HG, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405050; Inaba K, 2010, EMBO J, V29, P3330, DOI 10.1038/emboj.2010.222; Karala AR, 2009, ANTIOXID REDOX SIGN, V11, P963, DOI 10.1089/ARS.2008.2326; Kerppola Tom K, 2013, Cold Spring Harb Protoc, V2013, P727, DOI 10.1101/pdb.prot076497; Kutomi G, 2013, CANCER SCI, V104, P1091, DOI 10.1111/cas.12177; Masui S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.231357; Ramming T, 2014, FREE RADICAL BIO MED, V70, P106, DOI 10.1016/j.freeradbiomed.2014.01.018; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02456; Shepherd C, 2014, BIOCHEM J, V461, P107, DOI 10.1042/BJ20140234; Villegas JM, 2014, BBA-PROTEINS PROTEOM, V1844, P576, DOI 10.1016/j.bbapap.2013.12.021; Wright J, 2013, J BIOL CHEM, V288, P31010, DOI 10.1074/jbc.M113.510065; Zhang LH, 2014, J BIOL CHEM, V289, P31188, DOI 10.1074/jbc.M114.602961	57	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	JUN	2015	83						361	372		10.1016/j.freeradbiomed.2015.02.011		12	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CJ6BI	WOS:000355577600037		
J	Fujii, J; Ikeda, Y; Kurahashi, T; Homma, T				Fujii, Junichi; Ikeda, Yoshitaka; Kurahashi, Toshihiro; Homma, Takujiro			Physiological and pathological views of peroxiredoxin 4	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Peroxiredoxin; Hydrogen peroxide signal; Oxidative protein folding; Sulfoxidase	PROTEIN-DISULFIDE-ISOMERASE; CYSTEINE-SULFINIC ACID; NF-KAPPA-B; ENDOPLASMIC-RETICULUM; OXIDATIVE STRESS; SACCHAROMYCES-CEREVISIAE; SIGNAL-TRANSDUCTION; SITE CYSTEINE; PDI FAMILY; IV	Peroxiredoxins (PRDXs) form an enzyme family that exhibits peroxidase activity using electrons from thioredoxin and other donor molecules. As the signaling roles of hydrogen peroxide in response to extracellular stimuli have emerged, the involvement of PRDX in the hydrogen peroxide-mediated signaling has become evident. Among six PRDX members in mammalian cells, PRDX4 uniquely possesses a hydrophobic signal peptide at the amino terminus, and, hence, it undergoes either secretion or retention by the endoplasmic reticulum (ER) lumen. The role of PRDX4 as a sulfoxidase in ER is now attracting much attention regarding the oxidative protein folding of nascent proteins. Contrary to this role in the ER, the functional significance of PRDX4 in the extracellular milieu is virtually unknown despite its implications as a biomarker under pathological conditions in some diseases. Other than its systemically expressed form, a variant form of PRDX4 is transcribed from the upstream promoter/exon 1 of the systemic promoter/exon 1 and is uniquely expressed in sexually matured testes. Circumstantial evidence, together with deduced functions from the systemic form, suggests that there are potential roles for testicular PRDX4 in the reproductive processes such as the regulation of hormonal signals and the oxidative packaging of sperm chromatin. Elucidation of these PRDX4 functions under in vivo situations is expected to show the whole picture of how PRDX4 has evolved in multicellular organisms. (C) 2015 Elsevier Inc. All rights reserved.	[Fujii, Junichi; Kurahashi, Toshihiro; Homma, Takujiro] Yamagata Univ, Grad Sch Med Sci, Dept Biochem & Mol Biol, Yamagata 9909585, Japan; [Ikeda, Yoshitaka] Saga Univ, Fac Med, Dept Biomol Sci, Mol Cell Biol Div, Saga 8498501, Japan	Fujii, J (reprint author), Yamagata Univ, Grad Sch Med Sci, Dept Biochem & Mol Biol, 2-2-2 Iidanishi, Yamagata 9909585, Japan.	jfujii@med.id.yamagata-u.ac.jp			Japan Society for the Promotion of Sciences	This work was supported, in part, by the Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation from the Japan Society for the Promotion of Sciences.	Abbasi A, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002956; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Jonsson TJ, 2008, NATURE, V451, P98, DOI 10.1038/nature06415; Cao ZB, 2014, J BIOL CHEM, V289, P5490, DOI 10.1074/jbc.M113.529305; Iuchi Y, 2009, BIOCHEM J, V419, P149, DOI 10.1042/BJ20081526; Mehmeti I, 2014, J BIOL CHEM, V289, P26904, DOI 10.1074/jbc.M114.568329; KIM KW, 1988, J BIOL CHEM, V263, P4704; Bulleid NJ, 2011, TRENDS BIOCHEM SCI, V36, P485, DOI 10.1016/j.tibs.2011.05.004; Wei QO, 2011, P NATL ACAD SCI USA, V108, P7004, DOI 10.1073/pnas.1013012108; Abbasi A, 2014, DIABETOLOGIA, V57, P1842, DOI 10.1007/s00125-014-3278-9; Wang L, 2013, BLOOD, V122, P3642, DOI 10.1182/blood-2013-06-506691; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Palande K, 2011, J CELL SCI, V124, P3695, DOI 10.1242/jcs.089656; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wong CM, 2000, ANTIOXID REDOX SIGN, V2, P507, DOI 10.1089/15230860050192288; Vance JE, 2014, BBA-MOL CELL BIOL L, V1841, P595, DOI 10.1016/j.bbalip.2013.11.014; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Laurindo FRM, 2012, FREE RADICAL BIO MED, V52, P1954, DOI 10.1016/j.freeradbiomed.2012.02.037; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Lim JC, 2008, J BIOL CHEM, V283, P28873, DOI 10.1074/jbc.M804087200; Swiatkowska M, 2010, J BIOL CHEM, V285, P29874, DOI 10.1074/jbc.M109.092486; Zito E, 2012, MOL CELL, V48, P39, DOI 10.1016/j.molcel.2012.08.010; Schneider M, 2009, FASEB J, V23, P3233, DOI 10.1096/fj.09-132795; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Kakihana T, 2013, J BIOL CHEM, V288, P29586, DOI 10.1074/jbc.M113.467845; Imai H, 2009, J BIOL CHEM, V284, P32522, DOI 10.1074/jbc.M109.016139; Fujii J, 2002, REDOX REP, V7, P123, DOI 10.1179/135100002125000352; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; Tavender TJ, 2010, J CELL SCI, V123, P2672, DOI 10.1242/jcs.067843; Basu A, 2011, PROSTATE, V71, P755, DOI 10.1002/pros.21292; O'Flaherty C, 2011, BIOL REPROD, V84, P238, DOI 10.1095/biolreprod.110.085712; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Matsumoto A, 1999, FEBS LETT, V443, P246, DOI 10.1016/S0014-5793(98)01736-0; Okado-Matsumoto A, 2000, J BIOCHEM-TOKYO, V127, P493; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Kim SH, 2014, J NEUROSCI RES, V92, P1419, DOI 10.1002/jnr.23431; Tokuhiro K, 2012, P NATL ACAD SCI USA, V109, P3850, DOI 10.1073/pnas.1117963109; Sasagawa I, 2001, EUR J BIOCHEM, V268, P3053, DOI 10.1046/j.1432-1327.2001.02200.x; Laurindo FRM, 2014, ANTIOXID REDOX SIGN, V20, P2755, DOI 10.1089/ars.2013.5605; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Enyedi B, 2010, ANTIOXID REDOX SIGN, V13, P721, DOI 10.1089/ars.2009.2880; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Fisher AB, 2011, ANTIOXID REDOX SIGN, V15, P831, DOI 10.1089/ars.2010.3412; CHAE HZ, 1993, J BIOL CHEM, V268, P16815; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Kim K, 2013, BLOOD, V122, P1052, DOI 10.1182/blood-2013-03-492504; Schulte J, 2010, CLIN CHIM ACTA, V411, P1258, DOI 10.1016/j.cca.2010.05.016; Bertolotti M, 2010, ANTIOXID REDOX SIGN, V13, P1133, DOI 10.1089/ars.2009.3079; Cao ZB, 2011, J BIOL CHEM, V286, P42257, DOI 10.1074/jbc.M111.298810; Demasi APD, 2013, VIRCHOWS ARCH, V463, P47, DOI 10.1007/s00428-013-1433-1; Ding Y, 2010, ANTIOXID REDOX SIGN, V13, P1477, DOI 10.1089/ars.2010.3137; Flohe Leopold, 2007, V44, P1; Fujii J., 2014, SPERMATOGENESIS, V4; Gerr HD, 2007, CANCER GENET CYTOGEN, V176, P131, DOI 10.1016/j.cancergencyto.2007.03.010; Gerrits EG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089719; Giguere P, 2007, FEBS LETT, V581, P3863, DOI 10.1016/j.febslet.2007.07.011; Guo X, 2012, ANTIOXID REDOX SIGN, V17, P1362, DOI 10.1089/ars.2012.4549; Haridas V, 1998, J IMMUNOL, V161, P1; Hendriks WJAJ, 2008, FEBS J, V275, P816, DOI 10.1111/j.1742-4658.2008.06249.x; Ikeda Y, 2010, PROTEIN EXPRES PURIF, V72, P1, DOI 10.1016/j.pep.2010.02.001; Ikeda Y, 2011, J BIOCHEM, V149, P443, DOI 10.1093/jb/mvq156; Ito R, 2012, MOL MED REP, V6, P379, DOI 10.3892/mmr.2012.935; Kim HG, 2014, DIGEST ENDOSC, V16, P1; Kim TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042818; Nabeshima A, 2013, ANTIOXID REDOX SIGN, V19, P1983, DOI 10.1089/ars.2012.4946; Okumura M., 2015, FREE RADIC IN PRESS; Palande KK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016340; Ramming T., 2013, INT J CELL BIOL, V2013; Ryser HJP, 2005, DRUG DISCOV TODAY, V10, P1085, DOI 10.1016/S1359-6446(05)03550-6; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02456; Schulte Janin, 2011, BMC Med, V9, P137, DOI 10.1186/1741-7015-9-137; Schulte J, 2011, SHOCK, V35, P460, DOI 10.1097/SHK.0b013e3182115f40; Tavender TJ, 2008, BIOCHEM J, V411, P191, DOI 10.1042/BJ20071428; Wang X, 2012, BIOCHEM J, V441, P113, DOI 10.1042/BJ20110380; Yi N., 2014, MOL CLIN ONCOL, V2, P767; Yim SH, 2011, J BIOL CHEM, V286, P39002, DOI 10.1074/jbc.M111.257220; Zhang YM, 2004, GENE CHROMOSOME CANC, V40, P365, DOI 10.1002/gcc.20050; Zito E., 2015, FREE RADIC IN PRESS	87	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	JUN	2015	83						373	379		10.1016/j.freeradbiomed.2015.01.025		7	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CJ6BI	WOS:000355577600038		
J	Azam, S; Yoshii, Y; Yousofzadeh, M				Azam, Saeid; Yoshii, Yoji; Yousofzadeh, Malihe			j Jordan tori for a torsion free abelian group	FRONTIERS OF MATHEMATICS IN CHINA			English	Article						Jordan tori; extended affine Lie algebra; invariant affine reflection algebra	LIE-ALGEBRAS; SYSTEMS	We classify Jordan G-tori, where G is any torsion-free abelian group. Using the Zelmanov prime structure theorem, such a class divides into three types, the Hermitian type, the Clifford type, and the Albert type. We concretely describe Jordan G-tori of each type.	[Azam, Saeid; Yousofzadeh, Malihe] Univ Isfahan, Dept Math, Esfahan, Iran; [Azam, Saeid; Yousofzadeh, Malihe] Inst Res Fundamental Sci IPM, Sch Math, Tehran, Iran; [Yoshii, Yoji] Iwate Univ, Dept Math Educ, Morioka, Iwate 0208550, Japan	Azam, S (reprint author), Univ Isfahan, Dept Math, POB 81745-163, Esfahan, Iran.	azam@sci.ui.ac.ir			IPM [91130217, 91170415]	The first author's research was in part supported by a research grant from IPM (No. 91130217) and partially carried out in IPM-Isfahan branch. He also would like to thank the Center of Excellence for Mathematics, University of Isfahan. The third author's research was in part supported by a grant from IPM (No. 91170415) and partially carried out in IPM-Isfahan branch.	Allison B., 1997, MEM AM MATH SOC, V126, P603; Azam S, 2012, J ALGEBRA, V371, P63, DOI 10.1016/j.jalgebra.2012.08.004; Yoshii Y, 2004, J LIE THEORY, V14, P371; OSBORN JM, 1995, J ALGEBRA, V176, P417, DOI 10.1006/jabr.1995.1252; LOOS O, 1967, MATH Z, V99, P141, DOI 10.1007/BF01123745; Jacobson N., 1981, U ARKANSAS LECT NOTE, V5; Jacobson N., 1968, AM MATH SOC C PUBL, V39; Lam T Y., 1991, GRADUATE TEXTS MATH, V131; McCrimmon K., 2004, TASTE JORDAN ALGEBRA; McCrimmon K, 1988, ADV MATH, V69, P132; Passman D., 1977, ALGEBRAIC STRUCTURE; Yoshii Y, 2000, J ALGEBRA, V234, P128, DOI 10.1006/jabr.2000.8450; Zhevlakov K. A., 1982, RINGS ARE NEARLY ASS	13	0	0	HIGHER EDUCATION PRESS	BEIJING	SHATANHOU ST 55, BEIJING 100009, PEOPLES R CHINA	1673-3452	1673-3576		FRONT MATH CHINA	Front. Math. China	JUN	2015	10	3					477	509		10.1007/s11464-014-0414-2		33	Mathematics	Mathematics	CJ6RY	WOS:000355622500001		
J	Satproedprai, N; Wichukchinda, N; Suphankong, S; Inunchot, W; Kuntima, T; Kumpeerasart, S; Wattanapokayakit, S; Nedsuwan, S; Yanai, H; Higuchi, K; Harada, N; Mahasirimongkol, S				Satproedprai, N.; Wichukchinda, N.; Suphankong, S.; Inunchot, W.; Kuntima, T.; Kumpeerasart, S.; Wattanapokayakit, S.; Nedsuwan, S.; Yanai, H.; Higuchi, K.; Harada, N.; Mahasirimongkol, S.			Diagnostic value of blood gene expression signatures in active tuberculosis in Thais: a pilot study	GENES AND IMMUNITY			English	Article							GAMMA-RECEPTOR-I; IMMUNE-RESPONSE; CELL-DEATH; IGG; SUSCEPTIBILITY; ASSOCIATION; BIOMARKERS; INFECTION; DISEASE; APOL1	Tuberculosis (TB) is a major global health problem. Routine laboratory tests or newly developed molecular detection are limited to the quality of sputum sample. Here we selected genes specific to TB by a minimum redundancy-maximum relevancy package using publicly available microarray data and determine level of selected genes in blood collected from a Thai TB cohort of 40 active TB patients, 38 healthy controls and 18 previous TB patients using quantitative real-time PCR. FCGR1A, FCGR1B variant 1, FCGR1B variant 2, APOL1, GBP5, PSTPIP2, STAT1, KCNJ15, MAFB and KAZN had significantly higher expression level in active TB individuals as compared with healthy controls and previous TB cases (P < 0.01). A mathematical method was applied to calculate TB predictive score, which contains the level of expression of seven genes and this score can identify active TB cases with 82.5% sensitivity and 100% specificity as compared with conventional culture confirmation. In addition, TB predictive scores in active TB patients were reduced to normal after completion of standard short-course therapy, which was mostly in concordant with the disease outcome. These finding suggested that blood gene expression measurement and TB Sick Score could have potential value in terms of diagnosis of TB and anti-TB treatment monitoring.	[Satproedprai, N.; Wichukchinda, N.; Suphankong, S.; Inunchot, W.; Kumpeerasart, S.; Wattanapokayakit, S.; Mahasirimongkol, S.] Minist Publ Hlth, Med Life Sci Inst, Ctr Med Genet, Dept Med Sci, Nonthaburi, Thailand; [Kuntima, T.] TB HIV Res Fdn, Chiangrai, Thailand; [Nedsuwan, S.] Chiangrai Hosp, Dept Med Serv, Chiangrai, Thailand; [Yanai, H.] Fukujuji Hosp, Dept Clin Lab, Tokyo, Japan; [Higuchi, K.; Harada, N.] Japan Anti TB Assoc, Res Inst TB, Tokyo, Japan; [Higuchi, K.; Harada, N.] Res Inst Immune Diag, Tokyo, Japan	Mahasirimongkol, S (reprint author), Minist Publ Hlth, Med Life Sci Inst, Ctr Med Genet, Dept Med Sci, 88-7 Tiwanon Rd, Muang 11000, Nontaburi, Thailand.	surakameth@hotmail.com			Department of Medical Sciences; Ministry of Public Health, Thailand; National Research Council of Thailand; Japan Society for the Promotion of Sciences	We thank all participants in this study. In addition, the authors are really appreciated all assistance in subject recruitment and all administrative works from the TB-HIV research foundation. This work was financially supported by the Department of Medical Sciences, the Ministry of Public Health, Thailand, the National Research Council of Thailand and the Japan Society for the Promotion of Sciences. The method for gene expression measurement described in this work is in the process of patenting in the Kingdom of Thailand (No. 1401004750).	Siberil S, 2006, IMMUNOL LETT, V106, P111, DOI 10.1016/j.imlet.2006.05.009; Xie T, 2012, J IMMUNOL, V188, P2437, DOI 10.4049/jimmunol.1101070; Cliff JM, 2013, J INFECT DIS, V207, P18, DOI 10.1093/infdis/jis499; Jacobsen M, 2007, J MOL MED-JMM, V85, P613, DOI 10.1007/s00109-007-0157-6; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Zhaorigetu S, 2008, AUTOPHAGY, V4, P1079; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Fjaertoft G, 1999, PEDIATR RES, V45, P871, DOI 10.1203/00006450-199906000-00016; Smith EE, 2009, GENOME RES, V19, P850, DOI 10.1101/gr.085647.108; van der Poel CE, 2011, J IMMUNOL, V186, P2699, DOI 10.4049/jimmunol.1003526; Mahasirimongkol S, 2012, J HUM GENET, V57, P363, DOI 10.1038/jhg.2012.35; Streimish I, 2012, PEDIATR INFECT DIS J, V31, P777, DOI 10.1097/INF.0b013e318256fb07; Sutherland JS, 2014, CLIN MICROBIOL INFEC, V20, pO230, DOI 10.1111/1469-0691.12383; Anderson ST, 2014, NEW ENGL J MED, V370, P1712, DOI 10.1056/NEJMoa1303657; Kim H, 2010, NAT IMMUNOL, V11, P743, DOI 10.1038/ni.1897; Friedman J, 2010, J STAT SOFTW, V33, P1; Sarrazin S, 2009, CELL, V138, P300, DOI 10.1016/j.cell.2009.04.057; Bloom CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046191; Bloom CI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070630; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; Hartman SE, 2005, GENE DEV, V19, P2953, DOI 10.1101/gad.1371305; Jacobsen M, 2008, BIOL CHEM, V389, P487, DOI 10.1515/BC.2008.053; Kaforou M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001538; Li S, 2012, INT J INFECT DIS, V17, pe12; Maertzdorf J., 2011, PLoS ONE, pe26938, DOI 10.1371/journal.pone.0026938; Mahasirimongkol S, 2009, GENES IMMUN, V10, P77, DOI 10.1038/gene.2008.81; Monajemi H, 2002, GENOMICS, V79, P539, DOI 10.1006/geno.2002.6729; Parida SK, 2010, DRUG DISCOV TODAY, V15, P148, DOI 10.1016/j.drudis.2009.10.005; Pays E, 2009, CURR OPIN IMMUNOL, V21, P493, DOI 10.1016/j.coi.2009.05.024; Ridruechai C, 2010, GENES IMMUN, V11, P416, DOI 10.1038/gene.2010.26; Roussel M, 2012, AM J RESP CRIT CARE, V186, P1058; Serezani CH, 2009, BLOOD, V114, P3316, DOI 10.1182/blood-2009-01-199919; Wasser WG, 2012, J NEPHROL, V25, P603, DOI 10.5301/jn.5000179; Weyer K, 2011, J INFECT DIS, V204, pS1196, DOI 10.1093/infdis/jir452	35	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-4879	1476-5470		GENES IMMUN	Genes Immun.	JUN	2015	16	4					253	260		10.1038/gene.2015.4		8	Genetics & Heredity; Immunology	Genetics & Heredity; Immunology	CJ8OU	WOS:000355763400003		
J	Washio, K; Kotani, T; Saito, Y; Respatika, D; Murata, Y; Kaneko, Y; Okazawa, H; Ohnishi, H; Fukunaga, A; Nishigori, C; Matozaki, T				Washio, Ken; Kotani, Takenori; Saito, Yasuyuki; Respatika, Datu; Murata, Yoji; Kaneko, Yoriaki; Okazawa, Hideki; Ohnishi, Hiroshi; Fukunaga, Atsushi; Nishigori, Chikako; Matozaki, Takashi			Dendritic cell SIRP regulates homeostasis of dendritic cells in lymphoid organs	GENES TO CELLS			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; SIGNALING CONTROLS; LANGERHANS CELLS; STEADY-STATE; IN-VIVO; MACROPHAGES; ALPHA; IMMUNITY; SUBSETS; SPLEEN	Signal regulatory protein (SIRP), an immunoglobulin superfamily protein that is expressed predominantly in myeloid lineage cells such as dendritic cells (DCs) or macrophages, mediates cell-cell signaling. In the immune system, SIRP is thought to be important for homeostasis of DCs, but it remains unclear whether SIRP intrinsic to DCs is indeed indispensable for such functional role. Thus, we here generated the mice, in which SIRP was specifically ablated in CD11c(+) DCs (Sirpa(DC)). Sirpa(DC) mice manifested a marked reduction of CD4(+) CD8(-) conventional DCs (cDCs) in the secondary lymphoid organs, as well as of Langerhans cells in the epidermis. Such reduction of cDCs in Sirpa(DC) mice was comparable to that apparent with the mice, in which SIRP was systemically ablated. Expression of SIRP in DCs was well correlated with that of either endothelial cell-selective adhesion molecule (ESAM) or Epstein-Barr virus-induced molecule 2 (EBI2), both of which were also implicated in the regulation of DC homeostasis. Indeed, ESAM(+) or EBI2(+) cDCs were markedly reduced in the spleen of Sirpa(DC) mice. Thus, our results suggest that SIRP intrinsic to CD11c(+) DCs is essential for homeostasis of cDCs in the secondary lymphoid organs and skin.	[Washio, Ken; Kotani, Takenori; Saito, Yasuyuki; Respatika, Datu; Murata, Yoji; Okazawa, Hideki; Matozaki, Takashi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Signaling, Kobe, Hyogo 6500017, Japan; [Washio, Ken; Fukunaga, Atsushi; Nishigori, Chikako] Kobe Univ, Div Dermatol, Dept Internal Related, Grad Sch Med, Kobe, Hyogo 6500017, Japan; [Kaneko, Yoriaki] Gunma Univ, Grad Sch Med, Dept Med & Clin Sci, Maebashi, Gunma 3718511, Japan; [Ohnishi, Hiroshi] Gunma Univ, Grad Sch Hlth Sci, Dept Lab Sci, Maebashi, Gunma 3718514, Japan	Saito, Y (reprint author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Signaling, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	ysaito@med.kobe-u.ac.jp; matozaki@med.kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Naito Foundation; Takeda Science Foundation	We thank D. Tanaka for technical assistance. This work was supported in part by a grant-in-aid for Scientific Research (B) and (C), a grant-in-aid for Young Scientists (B), and a grant to the Global Center of Excellence Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. This work was also supported in part by the Naito Foundation and Takeda Science Foundation.	Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Kaneko T, 2012, J IMMUNOL, V188, P5397, DOI 10.4049/jimmunol.1103210; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Gatto D, 2013, NAT IMMUNOL, V14, P446, DOI 10.1038/ni.2555; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Yi TS, 2012, IMMUNITY, V37, P535, DOI 10.1016/j.immuni.2012.06.015; Lahoud MH, 2006, J IMMUNOL, V177, P372; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Saito Y, 2010, BLOOD, V116, P3517, DOI 10.1182/blood-2010-03-277244; Bajenoff M, 2008, J IMMUNOL, V181, P3947; Hochrein H, 2001, J IMMUNOL, V166, P5448; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Pooley JL, 2001, J IMMUNOL, V166, P5327; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Okazawa H, 2005, J IMMUNOL, V174, P2004; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Saito Y, 2013, EUR J IMMUNOL, V43, P1651, DOI 10.1002/eji.201243163; Radtke F, 2013, NAT REV IMMUNOL, V13, P427, DOI 10.1038/nri3445; Inagaki K, 2000, EMBO J, V19, P6721, DOI 10.1093/emboj/19.24.6721; Ishikawa-Sekigami T, 2006, BLOOD, V107, P341, DOI 10.1182/blood-2005-05-1896; Iwamura H, 2011, IMMUNOL LETT, V135, P100, DOI 10.1016/j.imlet.2010.10.004; Leenen PJM, 1998, J IMMUNOL, V160, P2166; Murata Y, 2014, METHODS, V65, P254, DOI 10.1016/j.ymeth.2013.09.016; Murata Y, 2014, J BIOCHEM, V155, P335, DOI 10.1093/jb/mvu017; Sadakata H, 2009, GENES CELLS, V14, P295, DOI 10.1111/j.1365-2443.2008.01270.x; Sparber F, 2014, BLOOD, V123, P217, DOI 10.1182/blood-2013-08-518555; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Tomizawa T, 2007, J IMMUNOL, V179, P869; Yi TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00757	38	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	JUN	2015	20	6					451	463		10.1111/gtc.12238		13	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CJ7RT	WOS:000355697000001		
J	Goto, M; Kitamura, H; Alam, MM; Ota, N; Haseba, T; Akimoto, T; Shimizu, A; Takano-Yamamoto, T; Yamamoto, M; Motohashi, H				Goto, Maki; Kitamura, Hiroshi; Alam, Md Morshedul; Ota, Nao; Haseba, Takeshi; Akimoto, Toshio; Shimizu, Akio; Takano-Yamamoto, Teruko; Yamamoto, Masayuki; Motohashi, Hozumi			Alcohol dehydrogenase 3 contributes to the protection of liver from nonalcoholic steatohepatitis	GENES TO CELLS			English	Article							S-NITROSOGLUTATHIONE REDUCTASE; ANTIOXIDANT RESPONSE ELEMENTS; FATTY LIVER; METABOLIC SYNDROME; GENETIC-VARIATION; NRF2; MICE; PHOSPHATIDYLCHOLINE; INHIBITION; PATHWAY	Nutritional steatohepatitis is closely associated with dysregulation of lipid metabolism and oxidative stress control. ADH3 is a highly conserved bifunctional enzyme involved in formaldehyde detoxification and termination of nitric oxide signaling. Formaldehyde and nitric oxide are nonenzymatically conjugated with glutathione, which is regenerated after ADH3 metabolizes the conjugates. To clarify roles of ADH3 in nutritional liver diseases, we placed Adh3-null mice on a methionine- and choline-deficient (MCD) diet. The Adh3-null mice developed steatohepatitis more rapidly than wild-type mice, indicating that ADH3 protects liver from nutritional steatohepatitis. NRF2, which is a key regulator of cytoprotective genes against oxidative stress, was activated in the Adh3-null mice with liver damage. In the absence of NRF2, the Adh3 disruption caused severe steatohepatitis by the MCD diet feeding accompanied by significant decrease in glutathione, suggesting cooperative function between ADH3 and NRF2 in the maintenance of cellular glutathione level for cytoprotection. Conversely, with enhanced NRF2 activity, the Adh3 disruption did not cause steatohepatitis but induced steatosis, suggesting that perturbation of lipid metabolism in ADH3-deficiency is not compensated by NRF2. Thus, ADH3 protects liver from steatosis by supporting normal lipid metabolism and prevents progression of steatosis into steatohepatitis by maintaining the cellular glutathione level.	[Goto, Maki; Kitamura, Hiroshi; Alam, Md Morshedul; Ota, Nao; Motohashi, Hozumi] Tohoku Univ, Inst Dev Aging & Canc, Dept Gene Express Regulat, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Goto, Maki; Takano-Yamamoto, Teruko] Tohoku Univ, Grad Sch Dent, Dept Orthodont & Dentofacial Orthoped, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Haseba, Takeshi] Nippon Med Sch, Dept Legal Med, Bunkyo Ku, Tokyo 1130022, Japan; [Akimoto, Toshio] Nippon Med Sch, Div Lab Anim Sci, Bunkyo Ku, Tokyo 1130022, Japan; [Shimizu, Akio] Soka Univ, Dept Environm Engn Symbiosis, Fac Engn, Hachioji, Tokyo 1928577, Japan; [Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, Sendai, Miyagi 9808575, Japan	Motohashi, H (reprint author), Tohoku Univ, Inst Dev Aging & Canc, Dept Gene Express Regulat, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	hozumim@idac.tohoku.ac.jp			JSPS KAKENHI [24249015, 24390075]; MEXT KAKENHI [23116002]; Takeda Scientific Foundation; Core Research for Evolutional Science and Technology from JST	This work was supported by JSPS KAKENHI Grant Numbers 24249015 (MY) and 24390075 (HM), MEXT KAKENHI Grant Number 23116002 (HM), the Takeda Scientific Foundation (HM and MY) and the Core Research for Evolutional Science and Technology from the JST (HM and MY).	Poortmans JR, 2005, MED SCI SPORT EXER, V37, P1717, DOI 10.1294/01.mss.0000176398.64189.e6; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; McMahon M, 2010, P NATL ACAD SCI USA, V107, P18838, DOI 10.1073/pnas.1007387107; Motohashi H, 2006, MOL CELL BIOL, V26, P4652, DOI 10.1128/MCB.02196-05; Sawa T, 2007, NAT CHEM BIOL, V3, P727, DOI 10.1038/nchembio.2007.33; Uruno A, 2011, NITRIC OXIDE-BIOL CH, V25, P153, DOI 10.1016/j.niox.2011.02.007; Kohlmeier M, 2005, P NATL ACAD SCI USA, V102, P16025, DOI 10.1073/pnas.0504285102; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Zhang YKJ, 2010, TOXICOL APPL PHARM, V245, P326, DOI 10.1016/j.taap.2010.03.016; Goodloe AH, 2014, EUR J HEART FAIL, V16, P942, DOI 10.1002/ejhf.145; Suzuki T, 2013, MOL CELL BIOL, V33, P2402, DOI 10.1128/MCB.00065-13; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Marzec JM, 2007, FASEB J, V21, P2237, DOI 10.1096/fj.06-7759com; Deltour L, 1999, J BIOL CHEM, V274, P16796, DOI 10.1074/jbc.274.24.16796; Green LS, 2012, BIOCHEMISTRY-US, V51, P2157, DOI 10.1021/bi201785u; Sips PY, 2013, AM J PHYSIOL-HEART C, V304, pH1134, DOI 10.1152/ajpheart.00887.2012; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Okawa H, 2006, BIOCHEM BIOPH RES CO, V339, P79, DOI 10.1016/j.bbrc.2005.10.185; Cox AG, 2014, CELL REP, V6, P56, DOI 10.1016/j.celrep.2013.12.007; Vance DE, 2008, CURR OPIN LIPIDOL, V19, P229, DOI 10.1097/MOL.0b013e3282fee935; Obeid R, 2009, FEBS LETT, V583, P1215, DOI 10.1016/j.febslet.2009.03.038; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Pagano G, 2002, HEPATOLOGY, V35, P367, DOI 10.1053/jhep.2002.30690; Motohashi H, 2011, MOL CELL BIOL, V31, P151, DOI 10.1128/MCB.00798-10; Beigi F, 2012, P NATL ACAD SCI USA, V109, P4314, DOI 10.1073/pnas.1113319109; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Motohashi H, 2004, P NATL ACAD SCI USA, V101, P6379, DOI 10.1073/pnas.0305902101; Foster MW, 2012, J PROTEOME RES, V11, P2480, DOI 10.1021/pr201180m; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Carter-Kent C, 2008, AM J GASTROENTEROL, V103, P1036, DOI 10.1111/j.1572-0241.2007.01709.x; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; Maruyama A, 2008, ARCH BIOCHEM BIOPHYS, V477, P139, DOI 10.1016/j.abb.2008.06.004; Chowdhry S, 2010, FREE RADICAL BIO MED, V48, P357, DOI 10.1016/j.freeradbiomed.2009.11.007; Yi HS, 2014, HEPATOLOGY, V60, P1044, DOI 10.1002/hep.27137; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Taguchi K, 2010, MOL CELL BIOL, V30, P3016, DOI 10.1128/MCB.01591-09; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; YAO ZM, 1988, J BIOL CHEM, V263, P2998; Rosado IV, 2011, NAT STRUCT MOL BIOL, V18, P1432, DOI 10.1038/nsmb.2173; dasSilva R. P., 2014, BIOFACTORS, V40, P277; Sugimoto H., 2010, AM J PHYSIOL-GASTR L, V298, P283; Sugimoto M, 2010, ELECTROPHORESIS, V31, P2311, DOI 10.1002/elps.200900584; Tang CH, 2013, BIOCHEM BIOPH RES CO, V442, P122, DOI 10.1016/j.bbrc.2013.11.028; Tang CH, 2013, CANCER RES, V73, P2897, DOI 10.1158/0008-5472.CAN-12-3980; Wei W, 2011, CARCINOGENESIS, V32, P973, DOI 10.1093/carcin/bgr041; Wei W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000328	47	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	JUN	2015	20	6					464	480		10.1111/gtc.12237		17	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CJ7RT	WOS:000355697000002		
J	Nakazawa, N; Sajiki, K; Xu, XY; Villar-Briones, A; Arakawa, O; Yanagida, M				Nakazawa, Norihiko; Sajiki, Kenichi; Xu, Xingya; Villar-Briones, Alejandro; Arakawa, Orie; Yanagida, Mitsuhiro			RNA pol II transcript abundance controls condensin accumulation at mitotically up-regulated and heat-shock-inducible genes in fission yeast	GENES TO CELLS			English	Article							UBIQUITOUS PROTEIN FAMILY; NON-SMC SUBUNITS; CHROMOSOME CONDENSATION; SCHIZOSACCHAROMYCES-POMBE; CELL-CYCLE; DNA; MITOSIS; COHESIN; GENOME; ROLES	Condensin plays fundamental roles in chromosome dynamics. In this study, we determined the binding sites of condensin on fission yeast (Schizosaccharomyces pombe) chromosomes at the level of nucleotide sequences using chromatin immunoprecipitation (ChIP) and ChIP sequencing (ChIP-seq). We found that condensin binds to RNA polymerase I-, II- and III-transcribed genes during both mitosis and interphase, and we focused on pol II constitutive and inducible genes. Accumulation sites for condensin are distinct from those of cohesin and DNA topoisomerase II. Using cell cycle stage and heat-shock-inducible genes, we show that pol II-mediated transcripts cause condensin accumulation. First, condensin's enrichment on mitotically activated genes was abolished by deleting the sep1(+) gene that encodes an M-phase-specific forkhead transcription factor. Second, by raising the temperature, condensin accumulation was rapidly induced at heat-shock protein genes in interphase and even during mid-mitosis. In interphase, condensin accumulates preferentially during the postreplicative phase. Pol II-mediated transcription was neither repressed nor activated by condensin, as levels of transcripts per se did not change when mutant condensin failed to associate with chromosomal DNA. However, massive chromosome missegregation occurred, suggesting that abundant pol II transcription may require active condensin before proper chromosome segregation.	[Nakazawa, Norihiko; Sajiki, Kenichi; Xu, Xingya; Villar-Briones, Alejandro; Arakawa, Orie; Yanagida, Mitsuhiro] Okinawa Inst Sci & Technol Grad Univ, G0 Cell Unit, Onna son, Okinawa 9040495, Japan; [Nakazawa, Norihiko; Sajiki, Kenichi; Xu, Xingya; Villar-Briones, Alejandro; Arakawa, Orie; Yanagida, Mitsuhiro] Grad Univ, Okinawa Inst Sci & Technol, Cell Unit G0, Onna Son, Okinawa 9040495, Japan	Nakazawa, N (reprint author), Grad Univ, Okinawa Inst Sci & Technol, Cell Unit G0, Onna Son, Okinawa 9040495, Japan.	nakazawa@oist.jp			CREST Research Fund from Japan Science and Technology Corporation; Kyoto University; Japan Society for the Promotion of Science (JSPS) [25840013]; JSPS; OIST Graduate University	We are indebted to Drs Christopher. J. McInerny and Takashi Toda for the S. pombe strains. We thank Dr Takashi Sutani and Professor Katsuhiko Shirahige for generously sharing unpublished results with us, and Dr Steven D. Aird for editing the manuscript. This study was partly supported by the CREST Research Fund from the Japan Science and Technology Corporation when M.Y. was affiliated with Kyoto University. N.N. was supported by a Grant-in-Aid for Young Scientists (B) 25840013 from the Japan Society for the Promotion of Science (JSPS). X.X. was supported by a Grant-in-Aid for JSPS Fellows from JSPS. We are also grateful for the generous support of OIST Graduate University.	Adachi Y, 2008, CELL CYCLE, V7, P765; ADOLPH KW, 1977, P NATL ACAD SCI USA, V74, P4937, DOI 10.1073/pnas.74.11.4937; Akai Y, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110023; D'Ambrosio C, 2008, GENE DEV, V22, P2215, DOI 10.1101/gad.1675708; Sutani T, 1999, GENE DEV, V13, P2271, DOI 10.1101/gad.13.17.2271; Ribar B, 1999, BIOCHEM BIOPH RES CO, V263, P465, DOI 10.1006/bbrc.1999.1333; Choi ES, 2011, J BIOL CHEM, V286, P23600, DOI 10.1074/jbc.M111.228510; SHIOZAKI K, 1992, J CELL BIOL, V119, P1023, DOI 10.1083/jcb.119.5.1023; Takeda T, 1995, EMBO J, V14, P6193; Koshland D, 1996, ANNU REV CELL DEV BI, V12, P305, DOI 10.1146/annurev.cellbio.12.1.305; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Buck V, 2004, J CELL SCI, V117, P5623, DOI 10.1242/jcs.01473; Tada K, 2011, NATURE, V474, P477, DOI 10.1038/nature10179; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Tanaka A, 2012, MOL CELL, V48, P532, DOI 10.1016/j.molcel.2012.09.011; Dowen JM, 2013, STEM CELL REP, V1, P371, DOI 10.1016/j.stemcr.2013.09.002; Yoshimura SH, 2002, CURR BIOL, V12, P508, DOI 10.1016/S0960-9822(02)00719-4; St-Pierre J, 2009, MOL CELL, V34, P416, DOI 10.1016/j.molcel.2009.04.013; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Sutani T, 1997, NATURE, V388, P798; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Durand-Dubief M, 2010, EMBO J, V29, P2126, DOI 10.1038/emboj.2010.109; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Yanagida M, 2009, NAT REV MOL CELL BIO, V10, P489, DOI 10.1038/nrm2712; Castel SE, 2014, CELL, V159, P572, DOI 10.1016/j.cell.2014.09.031; Cuylen S, 2011, TRENDS CELL BIOL, V21, P552, DOI 10.1016/j.tcb.2011.06.003; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Sakai A, 2003, EMBO J, V22, P2764, DOI 10.1093/emboj/cdg247; Wood AJ, 2010, NAT REV GENET, V11, P391, DOI 10.1038/nrg2794; Nakazawa N, 2008, J CELL BIOL, V180, P1115, DOI 10.1083/jcb.200708170; Hirano T, 2012, GENE DEV, V26, P1659, DOI 10.1101/gad.194746.112; SAITOH N, 1994, J CELL BIOL, V127, P303, DOI 10.1083/jcb.127.2.303; SAKA Y, 1994, EMBO J, V13, P4938; Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Nakazawa N, 2011, J CELL SCI, V124, P1795, DOI 10.1242/jcs.078733; Aono N, 2002, NATURE, V417, P197, DOI 10.1038/417197a; Iwasaki O, 2010, MOL BIOL CELL, V21, P254, DOI 10.1091/mbc.E09-09-0790; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; BIRKENBIHL RP, 1995, J BIOL CHEM, V270, P7703; Carlsten JO, 2012, MOL CELL BIOL, V32, P4035, DOI 10.1128/MCB.00374-12; Clemente-Blanco A, 2009, NATURE, V458, P219, DOI 10.1038/nature07652; HIRAOKA Y, 1984, CELL, V39, P349, DOI 10.1016/0092-8674(84)90013-8; Hudson DF, 2009, CHROMOSOME RES, V17, P131, DOI 10.1007/s10577-008-9009-7; Kim JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3537; Kranz AL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r112; Lopez-Serra L, 2014, NAT GENET, V46, P1147, DOI 10.1038/ng.3080; Matsusaka T, 1998, CURR BIOL, V8, P1031, DOI 10.1016/S0960-9822(07)00425-3; Norman-Axelsson U, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003371; Sajiki K, 2009, J CELL SCI, V122, P1418, DOI 10.1242/jcs.046466; SCHAAK J, 1982, NUCLEIC ACIDS RES, V10, P2851, DOI 10.1093/nar/10.9.2851; Schmidt CK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r52; STRUNNIKOV AV, 1993, J CELL BIOL, V123, P1635, DOI 10.1083/jcb.123.6.1635; STRUNNIKOV AV, 1995, GENE DEV, V9, P587, DOI 10.1101/gad.9.5.587; TAYLOR JH, 1960, ANN NY ACAD SCI, V90, P409, DOI 10.1111/j.1749-6632.1960.tb23259.x; TODA T, 1984, CURR GENET, V8, P93, DOI 10.1007/BF00420224; Wang BD, 2005, MOL CELL BIOL, V25, P7216, DOI 10.1128/MCB.25.16.7216-7225.2005	58	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	JUN	2015	20	6					481	499		10.1111/gtc.12239		19	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CJ7RT	WOS:000355697000003		
J	Nakano, Y; Negishi, N; Gocho, S; Mine, T; Sakurai, Y; Yazawa, M; Abe, K; Yagita, H; Habu, S; Kageyama, R; Kawaguchi, Y; Hozumi, K				Nakano, Yasuhiro; Negishi, Naoko; Gocho, Seiho; Mine, Tetsuya; Sakurai, Yuri; Yazawa, Masaki; Abe, Koichiro; Yagita, Hideo; Habu, Sonoko; Kageyama, Ryoichiro; Kawaguchi, Yoshiya; Hozumi, Katsuto			Disappearance of centroacinar cells in the Notch ligand-deficient pancreas	GENES TO CELLS			English	Article							DUCTAL PROGENITOR CELLS; DIFFERENTIATION; EXPRESSION; ENDOCRINE; ORGANOGENESIS; PLASTICITY; REVEALS; CD133; GLAND; SOX9	Notch signaling has been shown to contribute to murine pancreatic development at various stages. Delta-like 1 (Dll1) or Jagged1 (Jag1) are the Notch ligands that solely function to trigger this signaling during the pancreatic bud stage (similar to e9.5) or after birth, respectively. However, it has not been elucidated whether these Notch ligands are required at the later stage (e10.5-18.5) when the particular pancreas structures form. Here, we detected the dual expression of Dll1 and Jag1 in the epithelium after e10.5, which was restricted to the ductal cell lineage, including centroacinar cells expressing Sox9, CD133 and Hes1 but not the ductal cell markers Hnf1 and DBA, at e18.5. To evaluate the significance of the Notch ligands during this period, we established double-floxed mice of Dll1 and Jag1 genes with Ptf1a-Cre knock-in allele and examined the effects on development. The abrogation of both ligands but not a single one led to the loss of centroacinar cells, which was due to the decrease in cell proliferation and the increase in cell death, as well as to the reduction of Sox9. These results suggested that Dll1 and Jag1 function redundantly and are necessary to maintain the centroacinar cells as an environmental niche in the developing pancreas.	[Nakano, Yasuhiro; Negishi, Naoko; Sakurai, Yuri; Yazawa, Masaki; Hozumi, Katsuto] Tokai Univ, Sch Med, Dept Immunol, Isehara, Kanagawa 2591193, Japan; [Nakano, Yasuhiro; Negishi, Naoko; Sakurai, Yuri; Yazawa, Masaki; Hozumi, Katsuto] Tokai Univ, Sch Med, Res Ctr Regenerat Med, Isehara, Kanagawa 2591193, Japan; [Nakano, Yasuhiro; Kawaguchi, Yoshiya] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Clin Applicat, Sakyo Ku, Kyoto 6068507, Japan; [Negishi, Naoko; Yagita, Hideo; Habu, Sonoko] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan; [Gocho, Seiho; Mine, Tetsuya] Tokai Univ, Sch Med, Dept Internal Med, Isehara, Kanagawa 2591193, Japan; [Abe, Koichiro] Tokai Univ, Sch Med, Div Basic Med Sci & Mol Med, Isehara, Kanagawa 2591193, Japan; [Kageyama, Ryoichiro] Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan	Kawaguchi, Y (reprint author), Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Clin Applicat, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	yoshiyak@cira.kyoto-u.ac.jp; hozumi@is.icc.u-tokai.ac.jp					Ahnfelt-Ronne J, 2012, DEVELOPMENT, V139, P33, DOI 10.1242/dev.071761; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Kopinke D, 2012, DEV BIOL, V362, P57, DOI 10.1016/j.ydbio.2011.11.010; Hosokawa S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08518; Horn S, 2012, P NATL ACAD SCI USA, V109, P7356, DOI 10.1073/pnas.1203605109; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Fukuda A, 2006, J CLIN INVEST, V116, P1484, DOI 10.1172/JC127704; Shih HP, 2012, DEVELOPMENT, V139, P2488, DOI 10.1242/dev.078634; ARAKI K, 1995, P NATL ACAD SCI USA, V92, P160, DOI 10.1073/pnas.92.1.160; Immervoll H, 2011, J HISTOCHEM CYTOCHEM, V59, P441, DOI 10.1369/0022155411398275; Afelik S, 2012, DEVELOPMENT, V139, P1744, DOI 10.1242/dev.075804; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Reichert M, 2011, J CLIN INVEST, V121, P4572, DOI 10.1172/JCI57131; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ashizawa N, 2005, PANCREAS, V31, P401, DOI 10.1097/01.mpa.0000181488.27399.dd; Fujikura J, 2007, DEV DYNAM, V236, P2779, DOI 10.1002/dvdy.21310; Golson ML, 2009, MECH DEVELOP, V126, P687, DOI 10.1016/j.mod.2009.05.005; Oshima Y, 2007, GASTROENTEROLOGY, V132, P720, DOI 10.1053/j.gastro.2006.11.027; Yoshida T, 2003, DIFFERENTIATION, V71, P486, DOI 10.1046/j.1432-0436.2003.7108006.x	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	JUN	2015	20	6					500	511		10.1111/gtc.12243		12	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CJ7RT	WOS:000355697000004		
J	Yamamoto-Hino, M; Yoshida, H; Ichimiya, T; Sakamura, S; Maeda, M; Kimura, Y; Sasaki, N; Aoki-Kinoshita, KF; Kinoshita-Toyoda, A; Toyoda, H; Ueda, R; Nishihara, S; Goto, S				Yamamoto-Hino, Miki; Yoshida, Hideki; Ichimiya, Tomomi; Sakamura, Sho; Maeda, Megumi; Kimura, Yoshinobu; Sasaki, Norihiko; Aoki-Kinoshita, Kiyoko F.; Kinoshita-Toyoda, Akiko; Toyoda, Hidenao; Ueda, Ryu; Nishihara, Shoko; Goto, Satoshi			Phenotype-based clustering of glycosylation-related genes by RNAi-mediated gene silencing	GENES TO CELLS			English	Article							UDP-N-ACETYLGALACTOSAMINE; GDP-FUCOSE TRANSPORTER; DROSOPHILA-MELANOGASTER; HEPARAN-SULFATE; 5'-PHOSPHOSULFATE TRANSPORTER; FUNCTIONAL-CHARACTERIZATION; T-ANTIGEN; CHONDROITIN SULFATE; MOLECULAR-CLONING; CHAIN INITIATION	Glycan structures are synthesized by a series of reactions conducted by glycosylation-related (GR) proteins such as glycosyltransferases, glycan-modifying enzymes, and nucleotide-sugar transporters. For example, the common core region of glycosaminoglycans (GAGs) is sequentially synthesized by peptide-O-xylosyltransferase, 1,4-galactosyltransferase I, 1,3-galactosyltransferase II, and 1,3-glucuronyltransferase. This raises the possibility that functional impairment of GR proteins involved in synthesis of the same glycan might result in the same phenotypic abnormality. To examine this possibility, comprehensive silencing of genes encoding GR and proteoglycan core proteins was conducted in Drosophila. Drosophila GR candidate genes (125) were classified into five functional groups for synthesis of GAGs, N-linked, O-linked, Notch-related, and unknown glycans. Spatiotemporally regulated silencing caused a range of malformed phenotypes that fell into three types: extra veins, thick veins, and depigmentation. The clustered phenotypes reflected the biosynthetic pathways of GAGs, Fringe-dependent glycan on Notch, and glycans placed at or near nonreducing ends (herein termed terminal domains of glycans). Based on the phenotypic clustering, CG33145 was predicted to be involved in formation of terminal domains. Our further analysis showed that CG33145 exhibited galactosyltransferase activity in synthesis of terminal N-linked glycans. Phenotypic clustering, therefore, has potential for the functional prediction of novel GR genes.	[Yamamoto-Hino, Miki; Goto, Satoshi] Rikkyo Univ, Dept Life Sci, Toshima Ku, Tokyo 171, Japan; [Yamamoto-Hino, Miki; Yoshida, Hideki; Kinoshita-Toyoda, Akiko; Toyoda, Hidenao; Ueda, Ryu; Nishihara, Shoko; Goto, Satoshi] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol CREST, Kawaguchi, Saitama, Japan; [Yoshida, Hideki; Ichimiya, Tomomi; Sasaki, Norihiko; Aoki-Kinoshita, Kiyoko F.; Nishihara, Shoko] Soka Univ, Dept Bioinformat, Fac Engn, Hachioji, Tokyo, Japan; [Yoshida, Hideki] Kyoto Inst Technol, Insect Biomed Res Ctr, Dept Appl Biol, Sakyo Ku, Kyoto 606, Japan; [Sakamura, Sho; Maeda, Megumi; Kimura, Yoshinobu] Okayama Univ, Grad Sch Environm & Life Sci, Dept Biofunct Chem, Okayama, Japan; [Sasaki, Norihiko] Tokyo Metropolitan Inst Gerontol, Res Team Geriatr Med Vasc Med, Itabashi Ku, Tokyo, Japan; [Kinoshita-Toyoda, Akiko; Toyoda, Hidenao] Ritsumeikan Univ, Coll Pharmaceut Sci, Kusatsu, Shiga, Japan; [Ueda, Ryu] Natl Inst Genet, Invertebrate Genet Lab, Mishima, Shizuoka 411, Japan	Goto, S (reprint author), Rikkyo Univ, Dept Life Sci, Toshima Ku, Tokyo 171, Japan.	shoko@soka.ac.jp; stgoto@rikkyo.ac.jp			Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST); MEXT/JSPS KAKENHI	We thank H. Hamamoto, Y. Omae, K. Ohtsu, and W. Awano for technical assistance. This work was supported by the Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST), and MEXT/JSPS KAKENHI.	Akasaka-Manya K, 2004, BIOCHEM BIOPH RES CO, V325, P75, DOI 10.1016/j.bbrc.2004.10.001; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Yoshida H, 2008, GLYCOBIOLOGY, V18, P1094, DOI 10.1093/glycob/cwn094; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; SPEICHER SA, 1994, DEVELOPMENT, V120, P535; BRAND AH, 1993, DEVELOPMENT, V118, P401; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Ichimiya T, 2004, J BIOL CHEM, V279, P42638, DOI 10.1074/jbc.M404900200; Shakhmantsir I, 2014, DEV DYNAM, V243, P393, DOI 10.1002/dvdy.24080; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Sun X, 1997, DEVELOPMENT, V124, P3439; Panin VM, 1997, NATURE, V387, P908; Koles K, 2004, J BIOL CHEM, V279, P4346, DOI 10.1074/jbc.M309912200; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Muller R, 2005, FEBS J, V272, P4295, DOI 10.1111/j.1742-4658.2005.04838.x; Leonard R, 2006, J BIOL CHEM, V281, P4867, DOI 10.1074/jbc.M511023200; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Haines N, 2005, GLYCOBIOLOGY, V15, P335, DOI 10.1093/glycob/cwi017; Aoki K, 2010, METHOD ENZYMOL, V480, P297, DOI 10.1016/S0076-6879(10)80014-X; Kalidas S, 2002, NEURON, V33, P177, DOI 10.1016/S0896-6273(02)00560-3; Paschinger K, 2005, GLYCOBIOLOGY, V15, P463, DOI 10.1093/glycob/cwi028; Sarkar M, 2001, BIOL CHEM, V382, P209, DOI 10.1515/BC.2001.028; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochems.73.011303.074043; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; MartinBlanco E, 1996, P NATL ACAD SCI USA, V93, P6048, DOI 10.1073/pnas.93.12.6048; CAPDEVILA J, 1994, EMBO J, V13, P4459; Heitzler P, 1996, GENETICS, V143, P1271; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Milan M, 1997, P NATL ACAD SCI USA, V94, P5691, DOI 10.1073/pnas.94.11.5691; Kamiyama S, 2003, J BIOL CHEM, V278, P25958, DOI 10.1074/jbc.M302439200; Cao JG, 2011, EMBO J, V30, P3701, DOI 10.1038/emboj.2011.254; Carlow DA, 2009, IMMUNOL REV, V230, P75, DOI 10.1111/j.1600-065X.2009.00797.x; Chen YW, 2007, DEV BIOL, V306, P736, DOI 10.1016/j.ydbio.2007.04.013; Fabini G, 2001, J BIOL CHEM, V276, P28058, DOI 10.1074/jbc.M100573200; Geisler C, 2012, J BIOL CHEM, V287, P29599, DOI 10.1074/jbc.M112.379313; Goda E, 2006, J BIOL CHEM, V281, P28508, DOI 10.1074/jbc.M605045200; Goto S, 2001, NAT CELL BIOL, V3, P816, DOI 10.1038/ncb0901-816; Isaji T, 2010, METHOD ENZYMOL, V480, P445, DOI 10.1016/S0076-6879(10)80019-9; Ishikawa HO, 2010, J BIOL CHEM, V285, P4122, DOI 10.1074/jbc.M109.016964; Ishikawa HO, 2005, P NATL ACAD SCI USA, V102, P18532, DOI 10.1073/pnas.0504115102; Johnson RL, 1995, DEVELOPMENT, V121, P4161; Kamimura K, 2004, J CELL BIOL, V166, P1069, DOI 10.1083/jcb.200403077; Kamimura K, 2001, J BIOL CHEM, V276, P17014, DOI 10.1074/jbc.M011354200; Kim BT, 2002, J BIOL CHEM, V277, P13659, DOI 10.1074/jbc.M111630200; Kim BT, 2003, J BIOL CHEM, V278, P9116, DOI 10.1074/jbc.M209344200; Kimura Y, 2007, BIOSCI BIOTECH BIOCH, V71, P1111, DOI 10.1271/bbb.70081; Kimura Y, 2006, BIOSCI BIOTECH BIOCH, V70, P2583, DOI 10.1271/bbb.60331; Kohyama-Koganeya A, 2004, J BIOL CHEM, V279, P35995, DOI 10.1074/jbc.M400444200; Luders F, 2003, EMBO J, V22, P3635, DOI 10.1093/emboj/cdg345; Luhn K, 2004, EXP CELL RES, V301, P242, DOI 10.1016/j.yexcr.2004.08.043; Mucha J, 2004, BIOCHEM J, V382, P67; Muller R, 2002, J BIOL CHEM, V277, P32417, DOI 10.1074/jbc.C200381200; Nakamura Y, 2002, J BIOL CHEM, V277, P46280, DOI 10.1074/jbc.M203873200; Nakayama S, 1997, MOL GEN GENET, V254, P449; Nishihara S, 2010, METHOD ENZYMOL, V480, P323, DOI 10.1016/S0076-6879(10)80015-1; Nishihara S., 2007, COMPREHENSIVE GLYCOS, P49; Nybakken K, 2002, BBA-GEN SUBJECTS, V1573, P280, DOI 10.1016/S0304-4165(02)00395-1; PARKER CG, 1995, EMBO J, V14, P1294; Sasaki N, 2007, BIOCHEM BIOPH RES CO, V354, P522, DOI 10.1016/j.bbrc.2007.01.015; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Segawa H, 2002, EUR J BIOCHEM, V269, P128, DOI 10.1046/j.0014-2956.2001.02632.x; Selva EM, 2001, NAT CELL BIOL, V3, P809, DOI 10.1038/ncb0901-809; Spradling A. C., 1986, DROSOPHILA PRACTICAL, P175; STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585; Takemae H, 2003, J BIOL CHEM, V278, P15571, DOI 10.1074/jbc.M301123200; Ten Hagen KG, 2003, J BIOL CHEM, V278, P35039, DOI 10.1074/jbc.M303836200; Toyoda H, 2000, J BIOL CHEM, V275, P21856, DOI 10.1074/jbc.M003540200; Ueyama M, 2008, J BIOL CHEM, V283, P6076, DOI 10.1074/jbc.M709189200; Ueyama M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011557; Vadaie N, 2002, GLYCOBIOLOGY, V12, P589, DOI 10.1093/glycob/cwf074; vansReeuwijk J., 2005, J MED GENET, V42, P907; Wandall HH, 2003, J BIOL CHEM, V278, P1411, DOI 10.1074/jbc.C200619200; Wilson IBH, 2002, J BIOL CHEM, V277, P21207, DOI 10.1074/jbc.M201634200; Xu D, 2007, J BIOL CHEM, V282, P8356, DOI 10.1074/jbc.M608062200; Yamamoto-Hino M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001254; Yamamoto-Hino M., 2012, GLYCANS BIOCH CHARAC, P165; Yamamoto-Hino M, 2013, GENES-BASEL, V4, P646, DOI 10.3390/genes4040646; Zhu XJ, 2005, DEVELOPMENT, V132, P3813, DOI 10.1242/dev.01962	83	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	JUN	2015	20	6					521	542		10.1111/gtc.12246		22	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CJ7RT	WOS:000355697000006		
J	Ju, YS; Tubio, JMC; Mifsud, W; Fu, BY; Davies, HR; Ramakrishna, M; Li, YL; Yates, L; Gundem, G; Tarpey, PS; Behjati, S; Papaemmanuil, E; Martin, S; Fullam, A; Gerstung, M; Nangalia, J; Green, AR; Caldas, C; Borg, A; Tutt, A; Lee, MTM; van't Veer, LJ; Tan, BKT; Aparicio, S; Span, PN; Martens, JWM; Knappskog, S; Vincent-Salomon, A; Borresen-Dale, AL; Eyfjord, JE; Flanagan, AM; Foster, C; Neal, DE; Cooper, C; Eeles, R; Lakhani, SR; Desmedt, C; Thomas, G; Richardson, AL; Purdie, CA; Thompson, AM; McDermott, U; Yang, FT; Nik-Zainal, S; Campbell, PJ; Stratton, MR				Ju, Young Seok; Tubio, Jose M. C.; Mifsud, William; Fu, Beiyuan; Davies, Helen R.; Ramakrishna, Manasa; Li, Yilong; Yates, Lucy; Gundem, Gunes; Tarpey, Patrick S.; Behjati, Sam; Papaemmanuil, Elli; Martin, Sancha; Fullam, Anthony; Gerstung, Moritz; Nangalia, Jyoti; Green, Anthony R.; Caldas, Carlos; Borg, Ake; Tutt, Andrew; Lee, Ming Ta Michael; van't Veer, Laura J.; Tan, Benita K. T.; Aparicio, Samuel; Span, Paul N.; Martens, John W. M.; Knappskog, Stian; Vincent-Salomon, Anne; Borresen-Dale, Anne-Lise; Eyfjoerd, Jorunn Erla; Flanagan, Adrienne M.; Foster, Christopher; Neal, David E.; Cooper, Colin; Eeles, Rosalind; Lakhani, Sunil R.; Desmedt, Christine; Thomas, Gilles; Richardson, Andrea L.; Purdie, Colin A.; Thompson, Alastair M.; McDermott, Ultan; Yang, Fengtang; Nik-Zainal, Serena; Campbell, Peter J.; Stratton, Michael R.		ICGC Prostate Cancer Working Grp; ICGC Bone Canc Working Grp; ICGC Breast Canc Working Grp	Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells	GENOME RESEARCH			English	Article							HUMAN GENETIC-DISEASE; FOREIGN DNA; SEQUENCES; CHROMOSOMES; MECHANISMS; EVOLUTION; REARRANGEMENTS; INSERTIONS; LANDSCAPE; AUTOPHAGY	Mitochondrial genomes are separated from the nuclear genome for most of the cell cycle by the nuclear double membrane, intervening cytoplasm, and the mitochondrial double membrane. Despite these physical barriers, we show that somatically acquired mitochondrial-nuclear genome fusion sequences are present in cancer cells. Most occur in conjunction with intranuclear genomic rearrangements, and the features of the fusion fragments indicate that nonhomologous end joining and/or replication-dependent DNA double-strand break repair are the dominant mechanisms involved. Remarkably, mitochondrial-nuclear genome fusions occur at a similar rate per base pair of DNA as interchromosomal nuclear rearrangements, indicating the presence of a high frequency of contact between mitochondrial and nuclear DNA in some somatic cells. Transmission of mitochondrial DNA to the nuclear genome occurs in neoplastically transformed cells, but we do not exclude the possibility that some mitochondrial-nuclear DNA fusions observed in cancer occurred years earlier in normal somatic cells.	[Ju, Young Seok; Tubio, Jose M. C.; Mifsud, William; Davies, Helen R.; Ramakrishna, Manasa; Li, Yilong; Yates, Lucy; Gundem, Gunes; Tarpey, Patrick S.; Behjati, Sam; Papaemmanuil, Elli; Martin, Sancha; Fullam, Anthony; Gerstung, Moritz; Nangalia, Jyoti; McDermott, Ultan; Nik-Zainal, Serena; Campbell, Peter J.; Stratton, Michael R.] Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England; [Fu, Beiyuan; Yang, Fengtang] Wellcome Trust Sanger Inst, Cytogenet Facil, Cambridge CB10 1SA, England; [Nangalia, Jyoti; Green, Anthony R.; Caldas, Carlos] Cambridge Univ Hosp, NHS Fdn Trust, Cambridge CB2 0QQ, England; [Nangalia, Jyoti; Green, Anthony R.] Univ Cambridge, Dept Haematol, Cambridge CB2 0XY, England; [Caldas, Carlos] Univ Cambridge, CRUK Cambridge Inst, Cambridge CB2 0RE, England; [Borg, Ake] BioCare, Strateg Canc Res Program, SE-22381 Lund, Sweden; [Borg, Ake] CREATE Hlth, Strateg Ctr Translat Canc Res, SE-22100 Lund, Sweden; [Borg, Ake] Lund Univ, Ctr Canc, Dept Pathol & Oncol, SE-22185 Lund, Sweden; [Tutt, Andrew] Kings Coll London, Guys Hosp, Res Oncol, Breakthrough Breast Canc Res Unit, London SE1 9RT, England; [Lee, Ming Ta Michael] RIKEN, Ctr Integrat Med Sci, Lab Int Alliance Genom Res, Yokohama, Kanagawa 2300045, Japan; [Lee, Ming Ta Michael] Acad Sinica, Inst Biomed Sci, Natl Ctr Genome Med, Taipei 115, Taiwan; [van't Veer, Laura J.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Lab Med, San Francisco, CA 94158 USA; [van't Veer, Laura J.] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Tan, Benita K. T.] Singapore Gen Hosp, Dept Gen Surg, Singapore 169608, Singapore; [Aparicio, Samuel] British Columbia Canc Agcy, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada; [Span, Paul N.] Radboud Univ Nijmegen, Dept Radiat Oncol, Med Ctr, NL-6525 HP Nijmegen, Netherlands; [Span, Paul N.] Radboud Univ Nijmegen, Dept Lab Med, Med Ctr, NL-6525 HP Nijmegen, Netherlands; [Martens, John W. M.] Erasmus Univ, Med Ctr, Dept Med Oncol, Erasmus MC Canc Inst, NL-3015 CE Rotterdam, Netherlands; [Knappskog, Stian] Univ Bergen, Dept Clin Sci, Sect Oncol, N-5020 Bergen, Norway; [Knappskog, Stian] Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway; [Vincent-Salomon, Anne] INSERM, Inst Curie, U934, F-75248 Paris 05, France; [Vincent-Salomon, Anne] Dept Tumor Biol, F-75248 Paris 05, France; [Borresen-Dale, Anne-Lise] Norwegian Radium Hosp, Oslo Univ Hosp, Inst Canc Res, Dept Genet, N-0310 Oslo, Norway; [Borresen-Dale, Anne-Lise] Univ Oslo, Fac Med, Inst Clin Med, KG Jebsen Ctr Breast Canc Res, N-0450 Oslo, Norway; [Eyfjoerd, Jorunn Erla] Univ Iceland, Canc Res Lab, IS-101 Reykjavik, Iceland; [Flanagan, Adrienne M.] Royal Natl Orthopaed Hosp, Stanmore HA7 4LP, Middx, England; [Flanagan, Adrienne M.] UCL, UCL Canc Inst, London WC1E 6DD, England; [Foster, Christopher] Univ Liverpool, London WC1E 6JA, England; [Foster, Christopher] HCA Pathol Labs, London WC1E 6JA, England; [Neal, David E.] Canc Res UK Cambridge Res Inst, Urol Res Lab, Cambridge CB2 0RE, England; [Neal, David E.] Univ Cambridge, Addenbrookes Hosp, Dept Surg Oncol, Cambridge CB2 0QQ, England; [Cooper, Colin] Sutton, Inst Canc Res, London SM2 5NG, England; [Cooper, Colin] Univ E Anglia, Dept Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Cooper, Colin] Univ E Anglia, Sch Med, Norwich NR4 7TJ, Norfolk, England; [Eeles, Rosalind] Inst Canc Res, Div Genet & Epidemiol, Sutton SM2 5NG, Surrey, England; [Eeles, Rosalind] Royal Marsden NHS Fdn Trust, London SW3 6JJ, England; [Lakhani, Sunil R.] Univ Queensland, Sch Med, Brisbane, Qld 4006, Australia; [Lakhani, Sunil R.] Royal Brisbane & Womens Hosp, Pathol Queensland, Brisbane, Qld 4029, Australia; [Lakhani, Sunil R.] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld 4029, Australia; [Desmedt, Christine] Univ Libre Bruxelles, Breast Canc Translat Res Lab, Inst Jules Bordet, B-1000 Brussels, Belgium; [Thomas, Gilles] Univ Lyon 1, Inst Natl Canc INCa Synergie, F-69008 Lyon, France; [Richardson, Andrea L.] Dana Farber Canc Inst, Boston, MA 02215 USA; [Richardson, Andrea L.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02215 USA; [Purdie, Colin A.] Ninewells Hosp, Dept Pathol, Dundee DD1 9SY, Scotland; [Purdie, Colin A.] Sch Med, Dundee DD1 9SY, Scotland; [Thompson, Alastair M.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA	Stratton, MR (reprint author), Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England.	mrs@sanger.ac.uk	Span, Paul/G-4710-2012; Tubio, Jose/H-5076-2015; Ju, Young Seok/E-1324-2012; 	Tubio, Jose/0000-0003-3540-2459; Ju, Young Seok/0000-0002-5514-4189; Fullam, Anthony/0000-0002-0884-8124; Gerstung, Moritz/0000-0001-6709-963X	Wellcome Trust; European Molecular Biology Organization long-term fellowship [LTF 1203_2012]; Marie Curie Fellowship FP7-PEOPLE-IEF [328264]; National Institute for Health Research (NIHR) UCLH Biomedical Research Centre; European Union (BASIS); Cancer Research UK; Dallaglio Foundation [C5047/A14835]; National Institute for Health Research; Royal Marsden NHS Foundation Trust; National Cancer Research Prostate Cancer Mechanisms of Progression and Treatment (PROMPT) collaborative in Cambridge [G0500966/75466]; Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award; Breakthrough Breast Cancer Research [ICGC 08/09, KCL]	We thank Thomas Bleazard at the Faculty of Medical and Human Sciences, University of Manchester for discussion and assistance with manuscript preparation. We also thank The Cancer Genome Atlas (TCGA) Project Team and their specimen donors for providing sequencing data used in this study. This work was supported by the Wellcome Trust. Y.S.J is supported by a European Molecular Biology Organization long-term fellowship (LTF 1203_2012). J.M. C.T. is supported by Marie Curie Fellowship FP7-PEOPLE-2012-IEF (project number 328264). P.J.C. is a Wellcome Trust Senior Clinical Fellow. Support was provided to A.M.F. by the National Institute for Health Research (NIHR) UCLH Biomedical Research Centre. The ICGC Breast Cancer Consortium was supported by a grant from the European Union (BASIS) and the Wellcome Trust. The ICGC Prostate Cancer Consortium was funded by Cancer Research UK with a grant from the Dallaglio Foundation (grant number C5047/A14835). R.E. is supported by National Institute for Health Research support to the Biomedical Research Centre at The Institute of Cancer Research and Royal Marsden NHS Foundation Trust. We also thank the National Cancer Research Prostate Cancer Mechanisms of Progression and Treatment (PROMPT) collaborative (grant code G0500966/75466) which has funded tissue and urine collections in Cambridge. The authors also acknowledge financial support from the Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust and Breakthrough Breast Cancer Research (ICGC 08/09 and KCL) (A.T.).	Andrews RM, 1999, NAT GENET, V23, P147; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; THORSNESS PE, 1990, NATURE, V346, P376, DOI 10.1038/346376a0; Higgins GC, 2014, BRIT J PHARMACOL, V171, P1917, DOI 10.1111/bph.12503; Ricchetti M, 1999, NATURE, V402, P96, DOI 10.1038/47076; Eiyama A, 2013, FEBS LETT, V587, P1787, DOI 10.1016/j.febslet.2013.04.030; Yu X, 1999, MOL CELL, V4, P873, DOI 10.1016/S1097-2765(00)80397-4; Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Dayama G, 2014, NUCLEIC ACIDS RES, V42, P12640, DOI 10.1093/nar/gku1038; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Huang CY, 2003, NATURE, V422, P72, DOI 10.1038/nature01435; Forment JV, 2012, NAT REV CANCER, V12, P663, DOI 10.1038/nrc3352; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Chen JM, 2005, HUM MUTAT, V25, P207, DOI 10.1002/humu.20133; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; DROST JB, 1995, ENVIRON MOL MUTAGEN, V25, P48, DOI 10.1002/em.2850250609; Gherman A, 2007, PLOS GENET, V3, P1223, DOI 10.1371/journal.pgen.0030119; Goldin E, 2004, HUM MUTAT, V24, P460, DOI 10.1002/humu.20094; Gribble SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060482; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Ju YS, 2014, ELIFE, V3, DOI 10.7554/eLife.02935; Lenglez S, 2010, GENOME RES, V20, P1250, DOI 10.1101/gr.104513.109; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Millar David S, 2010, Hum Genomics, V4, P384; Mishmar D, 2004, HUM MUTAT, V23, P125, DOI 10.1002/humu.10304; Oeggerli M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041664; Paternoster SF, 2002, AM J PATHOL, V160, P1967, DOI 10.1016/S0002-9440(10)61146-7; Schneider JS, 2014, STEM CELLS DEV, V23, P2712, DOI 10.1089/scd.2013.0630; SHAY JW, 1991, ONCOGENE, V6, P1869; Simone D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-517; Tubio JMC, 2014, SCIENCE, V345, P531, DOI 10.1126/science.1251343; Turner C, 2003, HUM GENET, V112, P303, DOI 10.1007/s00439-002-0892-2	48	2	2	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JUN	2015	25	6					814	824		10.1101/gr.190470.115		11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	CJ5XF	WOS:000355565900004		
J	Lu, JC; Kobayashi, Y; Deeming, DC; Liu, YQ				Lu, Junchang; Kobayashi, Yoshitsugu; Deeming, D. Charles; Liu, Yongqing			Post-natal parental care in a Cretaceous diapsid from northeastern China	GEOSCIENCES JOURNAL			English	Article						parental care; choristodera; diapsid; Cretaceous	PHYLOGENETIC-RELATIONSHIPS; SEMIAQUATIC REPTILE; LIAONING-PROVINCE; CHORISTODERA; DINOSAUR; INTERRELATIONSHIPS; VIVIPARITY; OSTEOLOGY; AMNIOTES; BIRTH	Post-natal parental care seems to have evolved numerous times in vertebrates. Among extant amniotes, it is present in crocodilians, birds, and mammals. However, evidence of this behavior is extremely rare in the fossil record and is only reported for two types of dinosaurs, and a varanopid 'pelycosaur'. Here we report new evidence for post-natal parental care in Philydrosaurus, a choristodere, from the Yixian Formation of western Liaoning Province, China. We review the fossil record of reproduction in choristoderes, and this represents the oldest record of post-natal parental care in diapsids to our knowledge.	[Lu, Junchang; Liu, Yongqing] Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China; [Lu, Junchang; Liu, Yongqing] Minist Land & Resources China, Key Lab Stratig & Paleontol, Beijing 100037, Peoples R China; [Kobayashi, Yoshitsugu] Hokkaido Univ, Hokkaido Univ Museum, Sapporo, Hokkaido 0600810, Japan; [Deeming, D. Charles] Lincoln Univ, Sch Life Sci, Joseph Banks Labs, Brayford Pool LN6 7DL, Lincoln, England	Lu, JC (reprint author), Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China.	lujc2008@126.com		Deeming, Denis Charles/0000-0002-9587-6149	National Natural Science Foundation of China [41272022, 90914003]; China Geological Survey [12120114026801]; JSPS KAKENHI [24540494]	We thank Louis Jacobs (SMU, USA) and Xiao-Chun Wu (Canadian Museum of Nature, Canada) who reviewed the first draft of the paper and made constructive suggestions. Marcello Ruta helped with the use of Mesquite in the estimation of ancestral behavior patterns. Zhenyuan Sun offered the specimen for scientific research. The specimen was prepared by Zhang Y-Q (CAGS). The living scene of Philydrosaurus was drawn by Zhao Chuang. J. Lu was supported by grants from the National Natural Science Foundation of China (Grant No. 41272022, 90914003) and the China Geological Survey (Grant 12120114026801). Y. K was financially supported by JSPS KAKENHI Grant Number 24540494.	Andrews R.M., 1982, Biology of Reptilia, V13, P273; Meng QJ, 2004, NATURE, V431, P145, DOI 10.1038/431145a; Cheng YN, 2004, NATURE, V432, P383, DOI 10.1038/nature03050; Pineiro G, 2012, HIST BIOL, V24, P620, DOI 10.1080/08912963.2012.662230; Caldwell MW, 2001, P ROY SOC B-BIOL SCI, V268, P2397, DOI 10.1098/rspb.2001.1796; Varricchio DJ, 2007, P ROY SOC B-BIOL SCI, V274, P1361, DOI 10.1098/rspb.2006.0443; Varricchio DJ, 2008, SCIENCE, V322, P1826, DOI 10.1126/science.1163245; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420; Dilkes DW, 1998, PHILOS T ROY SOC B, V353, P501, DOI 10.1098/rstb.1998.0225; Muller J, 2003, NATURWISSENSCHAFTEN, V90, P473, DOI 10.1007/s00114-003-0461-0; MAGNUSSON WE, 1980, COPEIA, P359, DOI 10.2307/1444019; deBraga M, 1997, ZOOL J LINN SOC-LOND, V120, P281, DOI 10.1111/j.1096-3642.1997.tb01280.x; Gao KQ, 1998, ZOOL J LINN SOC-LOND, V124, P303, DOI 10.1111/j.1096-3642.1998.tb00580.x; Gao KQ, 2000, J VERTEBR PALEONTOL, V20, P417, DOI 10.1671/0272-4634(2000)020[0417:EFMOAS]2.0.CO;2; O'Keefe FR, 2011, SCIENCE, V333, P870, DOI 10.1126/science.1205689; Bertram B.C.R., 1992, OSTRICH COMMUNAL NES; Birchard G. F., 2013, BIOL LETT; Botha-Brink J, 2007, P R SOC B, V274, P2829, DOI 10.1098/rspb.2007.0803; Buffetaut E, 2007, BIOL LETT-UK, V3, P80, DOI 10.1098/rsbl.2006.0580; Bureau of Geology and Mineral Resource of Liaoning Province, 1989, REG GEOL LIAON PROV, P33; CINTRA R, 1989, J HERPETOL, V23, P320, DOI 10.2307/1564464; Deeming D. Charles, 1993, Modern Geology, V18, P423; Endo R., 1940, Bulletin of the Central National Museum of Manchoukuo, V2, P1; Gao KQ, 2005, ZOOL J LINN SOC-LOND, V145, P427, DOI 10.1111/j.1096-3642.2005.00191.x; Gao Ke-Qin, 2007, Historical Biology, V19, P215, DOI 10.1080/08912960601106391; [高克勤 Gao Keqin], 2007, [古地理学报, Journal of Palaeogeography], V9, P541; Gao KQ, 2007, CRETACEOUS RES, V28, P261, DOI 10.1016/j.cretres.2006.07.001; Gao KQ, 2013, CRETACEOUS RES, V45, P91, DOI 10.1016/j.cretres.2013.08.003; GAUTHIER J, 1989, HIERARCHY LIFE, V824, P337; Griebeler Eva Maria, 2011, P263; Hou LH, 2010, P ROY SOC B-BIOL SCI, V277, P1235, DOI 10.1098/rspb.2009.2035; Burt D. Brent, 2007, P295; Ji Qiang, 2006, Journal of the Paleontological Society of Korea, V22, P111; Ji Q, 2010, NATURWISSENSCHAFTEN, V97, P423, DOI 10.1007/s00114-010-0654-2; Lockley Martin G., 1994, P347; Maddison W. P., 2011, MESQUITE MODULAR SYS; Muller J, 2010, P NATL ACAD SCI USA, V107, P2118, DOI 10.1073/pnas.0912622107; Renesto S, 2003, J VERTEBR PALEONTOL, V23, P957, DOI 10.1671/1840-21; Timothy S., 2009, PALAEOGEOGR PALAEOCL, V274, P96; Wang XL, 2005, CHINESE SCI BULL, V50, P281, DOI 10.1360/982004-647; [张伟 Zhang Wei], 2014, [古地理学报, Journal of Palaeogeography], V16, P205	41	1	1	GEOLOGICAL SOCIETY KOREA	SEOUL	NEW BLD RM 813, KSTC, 835-4, YEOKSAM-DONG, KANGNAM-GU, SEOUL, 135-703, SOUTH KOREA	1226-4806	1598-7477		GEOSCI J	Geosci. J.	JUN	2015	19	2					273	280		10.1007/s12303-014-0047-1		8	Geosciences, Multidisciplinary	Geology	CJ3ZB	WOS:000355422200007		
J	Iwabuchi, K; Masuda, H; Kaga, N; Nakayama, H; Matsumoto, R; Iwahara, C; Yoshizaki, F; Tamaki, Y; Kobayashi, T; Hayakawa, T; Ishii, K; Yanagida, M; Ogawa, H; Takamori, K				Iwabuchi, Kazuhisa; Masuda, Hiromi; Kaga, Naoko; Nakayama, Hitoshi; Matsumoto, Ryo; Iwahara, Chihiro; Yoshizaki, Fumiko; Tamaki, Yuuki; Kobayashi, Toshihide; Hayakawa, Tomohiro; Ishii, Kumiko; Yanagida, Mitsuaki; Ogawa, Hideoki; Takamori, Kenji			Properties and functions of lactosylceramide from mouse neutrophils	GLYCOBIOLOGY			English	Article						chemotaxis; lactosylceramide; mouse neutrophils; phagocytosis	BETA-GLUCAN; MASS-SPECTROMETRY; MEMBRANE DOMAINS; NADPH OXIDASE; LIPID RAFTS; ACTIVATION; BINDING; CELLS; GLYCOSPHINGOLIPIDS; DIFFERENTIATION	Lactosylceramide (LacCer), which is essential for many cellular processes, is highly expressed on the plasma membranes of human neutrophils and mediates innate immune functions. Less is known, however, about the properties and biological functions of LacCer in mouse neutrophils. This study therefore analyzed the properties of mouse neutrophil LacCer. LacCer was observed on the surface of these cells, with flow cytometry indicating that mouse neutrophil LacCer could be detected by the anti-LacCer mAb T5A7, but not by the anti-LacCer antibodies Huly-m13 and MEM-74. The molecular species of LacCer were nearly identical in mouse and human neutrophils, including C24:0 and C24:1 fatty acid chain-containing species, although the LacCer content in plasma membranes was similar to 20-fold lower in mouse than in human neutrophils. Surface plasmon resonance analysis revealed that T5A7 bound to a lipid monolayer composed of LacCer, DOPC, cholesterol and sphingomyelin (molar ratio 0.1 : 10 : 10 : 1), whereas Huly-m13 did not. T5A7 induced neutrophil migration, which was abolished by inhibitors of Src-family kinases, PI-3 kinases, and trimeric G (o/i) proteins. T5A7 also inhibited phagocytosis of non-opsonized zymosans by neutrophils. Taken together, these findings suggest that in mouse neutrophils, (i) LacCer is expressed as LacCer-enriched microdomains in cell surface plasma membranes, (ii) these microdomains are recognized by T5A7 but not by other known anti-LacCer antibodies and (iii) LacCer is involved in cell migration and phagocytosis.	[Iwabuchi, Kazuhisa; Masuda, Hiromi; Nakayama, Hitoshi; Matsumoto, Ryo; Iwahara, Chihiro; Yoshizaki, Fumiko; Tamaki, Yuuki; Yanagida, Mitsuaki; Ogawa, Hideoki; Takamori, Kenji] Juntendo Univ, Grad Sch Med, Inst Environm & Gender Specif Med, Urayasu, Chiba, Japan; [Iwabuchi, Kazuhisa; Nakayama, Hitoshi] Juntendo Univ, Fac Hlth Care & Nursing, Biochem Lab, Chiba, Japan; [Iwabuchi, Kazuhisa] Juntendo Univ, Infect Control Nursing, Grad Sch Hlth Care & Nursing, Chiba, Japan; [Kaga, Naoko] Biomed Res Ctr, Div Prote & Biomol Sci, Tokyo, Japan; [Kobayashi, Toshihide; Hayakawa, Tomohiro; Ishii, Kumiko] RIKEN, Lipid Biol Lab, Saitama, Japan; [Kobayashi, Toshihide; Hayakawa, Tomohiro; Ishii, Kumiko] Juntendo Univ, Grad Sch Med, Tokyo, Japan	Iwabuchi, K (reprint author), Juntendo Univ, Grad Sch Med, Inst Environm & Gender Specif Med, 2-1-1 Tomioka, Urayasu, Chiba, Japan.	iwabuchi@juntendo.ac.jp			Foundation of Strategic Research Projects in Private Universities [S1201013, S1311011]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [24659293]	This study was supported in part by a Grant-in-Aid (S1201013, S1311011) from the Foundation of Strategic Research Projects in Private Universities and by a Grant-in-Aid for Exploratory Research (24659293) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Abul-Milh M, 1999, INFECT IMMUN, V67, P4983; Angstrom J, 1998, GLYCOBIOLOGY, V8, P297, DOI 10.1093/glycob/8.4.297; Houde M, 2012, INFECT IMMUN, V80, P506, DOI 10.1128/IAI.05734-11; DICARLO FJ, 1958, SCIENCE, V127, P756, DOI 10.1126/science.127.3301.756-a; Iwabuchi K, 1998, J BIOL CHEM, V273, P33766, DOI 10.1074/jbc.273.50.33766; Babiychuk VS, 2000, ACTA BIOCHIM POL, V47, P579; LEW DP, 1985, NATURE, V315, P509, DOI 10.1038/315509a0; Ichikawa N, 2009, J CELL SCI, V122, P289, DOI 10.1242/jcs.030338; Sonnino S, 2006, CHEM REV, V106, P2111, DOI 10.1021/cr0100446; Mestas J, 2004, J IMMUNOL, V172, P2731; Yoshizaki F, 2008, BBA-GEN SUBJECTS, V1780, P383, DOI 10.1016/j.bbagen.2007.11.004; Degroote S, 2004, SEMIN CELL DEV BIOL, V15, P375, DOI 10.1016/j.semedb.2004.03.007; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Iwabuchi K, 2002, BLOOD, V100, P1454; Papo N, 2003, BIOCHEMISTRY-US, V42, P458, DOI 10.1021/bi0267846; Nagafuku M, 2012, P NATL ACAD SCI USA, V109, pE336, DOI 10.1073/pnas.1114965109; Chatterjee S, 1998, ARTERIOSCL THROM VAS, V18, P1523; Ito K, 2005, JPN J APPL PHYS 1, V44, P8684, DOI 10.1143/JJAP.44.8684; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Nakayama H, 2008, J LEUKOCYTE BIOL, V83, P728, DOI 10.1189/jlb.0707478; Zimmerman JW, 1998, J BIOL CHEM, V273, P22014, DOI 10.1074/jbc.273.34.22014; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Zola H, 2007, J IMMUNOL METHODS, V319, P1, DOI 10.1016/j.jim.2006.11.001; RINDER HM, 1991, BLOOD, V78, P1760; KARLSSON KA, 1986, CHEM PHYS LIPIDS, V42, P153, DOI 10.1016/0009-3084(86)90050-2; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; HUANG TC, 1993, J APPL CRYSTALLOGR, V26, P180, DOI 10.1107/S0021889892009762; Hua J, 2002, J LEUKOCYTE BIOL, V71, P632; Vaissiere C, 1999, J LEUKOCYTE BIOL, V65, P629; Kaga N, 2005, ANAL BIOCHEM, V337, P316, DOI 10.1016/j.ab.2004.11.003; HESTDAL K, 1991, J IMMUNOL, V147, P22; Seino K, 1998, J IMMUNOL, V161, P4484; Hakomori S, 2003, CURR OPIN HEMATOL, V10, P16, DOI 10.1097/00062752-200301000-00004; Boettcher JM, 2011, BIOCHEMISTRY-US, V50, P2264, DOI 10.1021/bi1013694; Hahn PY, 2003, J BIOL CHEM, V278, P2043, DOI 10.1074/jbc.M209715200; HAUSER H, 1975, EUR J BIOCHEM, V58, P133, DOI 10.1111/j.1432-1033.1975.tb02357.x; HICKSTEIN DD, 1987, J BIOL CHEM, V262, P5576; Iwabuchi Kazuhisa, 2008, Glycoconj J, V25, P357, DOI 10.1007/s10719-007-9084-6; Iwabuchi K, 2012, BIOFACTORS, V38, P275, DOI 10.1002/biof.1017; Kina K, 2011, J IMMUNOL, V186, P5323, DOI 10.4049/jimmunol.1002100; Koshy KM, 1999, BIOPHYS J, V77, P306, DOI 10.1016/S0006-3495(99)76891-8; Makino A, 2015, FASEB J, V29, P477, DOI 10.1096/fj.13-247585; Mizukami H, 2002, J CLIN INVEST, V109, P1215, DOI 10.1172/JCI200214530; Nishie T, 2010, GLYCOBIOLOGY, V20, P1311, DOI 10.1093/glycob/cwq098; Ohta Y, 2004, COLLOID SURFACE B, V34, P147, DOI 10.1016/j.colsurfb.2003.11.005; RAHMANN H, 1992, NEUROCHEM INT, V20, P323, DOI 10.1016/0197-0186(92)90047-U; Sato T, 2006, J LEUKOCYTE BIOL, V80, P204, DOI 10.1189/jlb.0106069; SAUKKONEN K, 1992, P NATL ACAD SCI USA, V89, P118, DOI 10.1073/pnas.89.1.118; Silliman CC, 2003, J LEUKOCYTE BIOL, V73, P511, DOI 10.1189/jlb.0402179; STAIN C, 1987, BLOOD, V70, P1872; SYMINGTON FW, 1985, J IMMUNOL, V134, P2498; Takaya N, 2005, J MOL CELL CARDIOL, V39, P856, DOI 10.1016/j.yjmcc.2005.07.006	52	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	JUN	2015	25	6					655	668		10.1093/glycob/cwv008		14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CJ7IM	WOS:000355668400007		
J	Urashima, T; Inamori, H; Fukuda, K; Saito, T; Messer, M; Oftedal, OT				Urashima, Tadasu; Inamori, Hiroaki; Fukuda, Kenji; Saito, Tadao; Messer, Michael; Oftedal, Olav T.			4-O-Acetyl-sialic acid (Neu4,5Ac(2)) in acidic milk oligosaccharides of the platypus (Ornithorhynchus anatinus) and its evolutionary significance	GLYCOBIOLOGY			English	Article						evolution; milk oligosaccharides; monotreme; platypus; sialic acid	TACHYGLOSSUS-ACULEATUS-SETOSUS; CHEMICAL-CHARACTERIZATION; MAMMARY-GLAND; ECHIDNA MILK; COLOSTRUM; LACTOSE; GALACTOSIDASE; MARSUPIALS; PROTECTION; DIARRHEA	Monotremes (echidnas and platypus) retain an ancestral form of reproduction: egg-laying followed by secretion of milk onto skin and hair in a mammary patch, in the absence of nipples. Offspring are highly immature at hatching and depend on oligosaccharide-rich milk for many months. The primary saccharide in long-beaked echidna milk is an acidic trisaccharide Neu4,5Ac(2)(alpha 2-3)Gal(beta 1-4)Glc (4-O-acetyl 3'-sialyllactose), but acidic oligosaccharides have not been characterized in platypus milk. In this study, acidic oligosaccharides purified from the carbohydrate fraction of platypus milk were characterized by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and H-1-nuclear magnetic resonance spectroscopy. All identified structures, except Neu5Ac(alpha 2-3)Gal(beta 1-4)Glc (3'-sialyllactose) contained Neu4,5Ac(2) (4-O-acetyl-sialic acid). These include the trisaccharide 4-O-acetyl 3'-sialyllactose, the pentasaccharide Neu4,5Ac(2)(alpha 2-3)Gal(beta 1-4)GlcNAc(beta 1-3)Gal(beta 1-4)Glc (4-O-acetyl-3'-sialyllacto-N-tetraose d) and the hexasaccharide Neu4,5Ac(2)(alpha 2-3)Gal(beta 1-4)[Fuc(alpha 1-3)]GlcNAc(beta 1-3)Gal(beta 1-4)Glc (4-O-acetyl-3'-sialyllacto-N-fucopentaose III). At least seven different octa- to deca-oligosaccharides each contained a lacto-N-neohexaose core (LNnH) and one or two Neu4,5Ac(2) and one to three fucose residues. We conclude that platypus milk contains a diverse (a parts per thousand yen20) array of neutral and acidic oligosaccharides based primarily on lactose, lacto-N-neotetraose (LNnT) and LNnH structural cores and shares with echidna milk the unique feature that all identified acidic oligosaccharides (other than 3'-sialyllactose) contain the 4-O-acetyl-sialic acid moiety. We propose that 4-O-acetylation of sialic acid moieties protects acidic milk oligosaccharides secreted onto integumental surfaces from bacterial hydrolysis via steric interference with bacterial sialidases. This may be of evolutionary significance since taxa ancestral to monotremes and other mammals are thought to have secreted milk, or a milk-like fluid containing oligosaccharides, onto skin surfaces.	[Urashima, Tadasu; Inamori, Hiroaki; Fukuda, Kenji] Obihiro Univ Agr & Vet Med, Grad Sch Anim & Food Hyg, Obihiro, Hokkaido 0808555, Japan; [Saito, Tadao] Tohoku Univ, Grad Sch Agr, Sendai, Miyagi 9818555, Japan; [Messer, Michael] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Oftedal, Olav T.] Smithsonian Inst, Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA	Oftedal, OT (reprint author), Smithsonian Inst, Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA.	oftedalo@si.edu			Yotsuba Milk Products Co., Hokkaido, Japan	We acknowledge financial support for laboratory research from the Yotsuba Milk Products Co., Hokkaido, Japan.	Amano J., 1985, Glycoconjugate Journal, V2, P121, DOI 10.1007/BF01050469; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Luo ZX, 2011, NATURE, V476, P442, DOI 10.1038/nature10291; Oftedal OT, 2002, J MAMMARY GLAND BIOL, V7, P225, DOI 10.1023/A:1022896515287; Urashima T, 2000, BBA-GEN SUBJECTS, V1475, P395, DOI 10.1016/S0304-4165(00)00103-3; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; Kawasaki K, 2011, MOL BIOL EVOL, V28, P2053, DOI 10.1093/molbev/msr020; STRECKER G, 1989, GLYCOCONJUGATE J, V6, P67, DOI 10.1007/BF01047891; Phillips MJ, 2009, P NATL ACAD SCI USA, V106, P17089, DOI 10.1073/pnas.0904649106; Shennan DB, 2000, PHYSIOL REV, V80, P925; Urashima T, 2001, GLYCOCONJUGATE J, V18, P357, DOI 10.1023/A:1014881913541; Vorbach C, 2003, TRENDS IMMUNOL, V24, P512, DOI 10.1016/S1471-4906(03)00237-0; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Newburg DS, 2004, GLYCOBIOLOGY, V14, P253, DOI 10.1093/glycob/cwh020; Urashima T, 2004, COMP BIOCHEM PHYS B, V139, P587, DOI 10.1016/j.cbpc.2004.07.012; Ramakrishnan B, 2001, J MOL BIOL, V310, P205, DOI 10.1006/jmbi.2001.4757; Oftedal OT, 2012, ANIMAL, V6, P355, DOI 10.1017/S1751731111001935; JOURDIAN GW, 1971, J BIOL CHEM, V246, P430; Uemura Y, 2006, COMP BIOCHEM PHYS A, V145, P468, DOI 10.1016/j.cbpa.2006.08.001; Morrow AL, 2005, J NUTR, V135, P1304; van Leeuwen SS, 2014, GLYCOBIOLOGY, V24, P728, DOI 10.1093/glycob/cwu036; Urashima T, 2014, GLYCOCONJUGATE J, V31, P387, DOI 10.1007/s10719-014-9533-y; Rinninger A, 2006, GLYCOCONJUGATE J, V23, P73, DOI 10.1007/s10719-006-5439-7; Urashima T, 2005, COMP BIOCHEM PHYS A, V142, P461, DOI 10.1016/j.cbpa.2005.09.015; Bisana S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053686; Brew K., 2003, ADV DAIRY CHEM, V1, P387; Brockhausen I., 2014, IMMUNOTHERAPIES VACC, V5, P492; Camens AB, 2010, P NATL ACAD SCI USA, V107, pE12, DOI 10.1073/pnas.0912404107; Duncan PI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008241; Enjapoori AK, 2014, GENOME BIOL EVOL, V6, P2754, DOI 10.1093/gbe/evu209; Garido D, 2013, MICROBIOLOGY, V159, P649, DOI [10.1099/mic.0.064113-0, DOI 10.1099/MIC.0.064113-0]; Grant T, 1984, THE PLATYPUS; Grant T.R., 1992, P80; Griffiths M., 1978, BIOL MONOTREMES; GRONBERG G, 1990, ARCH BIOCHEM BIOPHYS, V278, P297, DOI 10.1016/0003-9861(90)90264-Y; Hughes RL, 1998, PHILOS T ROY SOC B, V353, P1101, DOI 10.1098/rstb.1998.0269; HUGHES RL, 1993, J EXP ZOOL, V266, P480, DOI 10.1002/jez.1402660602; Iwersen M, 2003, BIOL CHEM, V384, P1035, DOI 10.1515/BC.2003.116; JENKINS GA, 1984, CARBOHYD RES, V126, P157, DOI 10.1016/0008-6215(84)85132-0; JENNESS R, 1964, COMP BIOCHEM PHYSIOL, V13, P339, DOI 10.1016/0010-406X(64)90028-3; KAMERLING JP, 1982, CARBOHYD RES, V100, P331, DOI 10.1016/S0008-6215(00)81046-0; Manger PR, 1998, PHILOS T ROY SOC B, V353, P1115, DOI 10.1098/rstb.1998.0270; MESSER M, 1974, BIOCHEM J, V139, P415; MESSER M, 1977, AUST J BIOL SCI, V30, P379; MESSER M, 1973, SCIENCE, V180, P201, DOI 10.1126/science.180.4082.201; Messer Michael, 1998, Journal of Mammalian Evolution, V5, P95, DOI 10.1023/A:1020523120739; Messer M, 2002, TRENDS GLYCOSCI GLYC, V14, P153; MESSER M, 1983, AUST J BIOL SCI, V36, P129; Miwa M, 2010, GLYCOBIOLOGY, V20, P1402, DOI 10.1093/glycob/cwq101; Morrow G, 2009, AUST J ZOOL, V57, P275, DOI 10.1071/ZO09037; Morrow G. E., 2013, AUSTR J ZOOLOGY, V60, P289, DOI DOI 10.1071/ZO12066; Oftedal O. T., 2013, ADV DAIRY CHEM A, V1A, P1, DOI DOI 10.1007/978-1-4614-4714-6_1; Oftedal OT, 2014, GLYCOBIOLOGY, V24, P826, DOI 10.1093/glycob/cwu041; Oftedal OT, 2013, J MAMMARY GLAND BIOL, V18, P105, DOI 10.1007/s10911-013-9290-8; Schauer R, 2008, GLYCOCONJUGATE J, V25, P625, DOI 10.1007/s10719-008-9109-9; Schauer R, 2009, CARBOHYD RES, V344, P1494, DOI 10.1016/j.carres.2009.05.020; Schauer Roland, 2011, Adv Exp Med Biol, V705, P525, DOI 10.1007/978-1-4419-7877-6_28; STEWART IM, 1983, AUST J BIOL SCI, V36, P139; Taufik E, 2012, GLYCOCONJUGATE J, V29, P119, DOI 10.1007/s10719-012-9370-9; Taufik E, 2013, ANIM SCI J, V84, P569, DOI 10.1111/asj.12040; Urashima T., 2007, COMPREHENSIVE GLYCOS, V4, P695; Urashima T, 2011, ANIMAL, V6, P369; Urashima T, 2013, GLYCOCONJUGATE J, V30, P801, DOI 10.1007/s10719-013-9484-8; Urashima T, 2009, GLYCOBIOLOGY, V19, P499, DOI 10.1093/glycob/cwp006; Urashima T, 1999, COMP BIOCHEM PHYS C, V124, P295, DOI 10.1016/S0742-8413(99)00080-8; Urashima T, 2002, COMP BIOCHEM PHYS B, V132, P611, DOI 10.1016/S1096-4959(02)00083-0; Urashima T., 2014, EVOLUTIONARY BIOL GE, P3; Urashima T, 2012, ADV NUTR, V3, p473S, DOI 10.3945/an.111.001412	68	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	JUN	2015	25	6					683	697		10.1093/glycob/cwv010		15	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CJ7IM	WOS:000355668400009		
J	Uchida, Y; Clough, TJ				Uchida, Yoshitaka; Clough, Timothy J.			Nitrous oxide emissions from pastures during wet and cold seasons	GRASSLAND SCIENCE			English	Review						Grazing; nitrous oxide; pasture; winter	NITRIFICATION INHIBITOR DICYANDIAMIDE; SOIL PHYSICAL-PROPERTIES; DAIRY-CATTLE SLURRY; NEW-ZEALAND; N2O EMISSIONS; GRAZED PASTURES; URINE PATCHES; MANAGEMENT-PRACTICES; NITRIFIER DENITRIFICATION; MITIGATION OPTIONS	Grazed pastures contribute significantly to the global nitrous oxide (N2O) budget. In grazed pastures, the highest N2O emission rates are often reported during winter when soils are wet. This review discusses the current knowledge about factors controlling winter N2O emissions in grazed pastures. High N2O emissions from pastures during winter are also observed from winter-housed animal feeding systems. At near-zero temperature, N2O producing microbial activity is limited but some soil microbial communities adjust to low temperature better than others. Soil microbiological studies focusing on the identification of cold-tolerant denitrifiers and/or changes in microbial community structures under cold conditions are required. In winter-grazed pastures, the availability of substrates, such as nitrate (NO3-) and labile organic carbon (C), for soil microbes producing N2O is influenced by factors such as animal wintering system, effluent management systems and plant activity. When animals are housed, N2O emissions during the winter storage of manures and the emissions after their application are important contributors to N2O inventories. The activity of pasture during winter and its relationship to N2O emissions requires further study in order to understand the competition between plants and N2O producing microbes for nitrogen, and the role of root exudation. Additionally, the effect of low temperatures on nutrient availability under urine patches is still not well known. The reduction of N2O to dinitrogen is regulated by an enzyme N2O reductase and its encoding gene (nosZ) expression needs to be studied in more detail to investigate the mechanisms behind winter N2O emissions. To mitigate N2O emissions during winter, restricted grazing regimes and the use of nitrification inhibitors have been studied; however, little is known about the effectiveness of these methods in mitigating N2O emissions during freeze/thaw cycles and during periods of snow-cover.	[Uchida, Yoshitaka] Hokkaido Univ, Res Fac Agr, Task Force Innovat Life Resources & Environm Sci, Sapporo, Hokkaido 0608589, Japan; [Clough, Timothy J.] Lincoln Univ, Fac Agr & Life Sci, Lincoln, New Zealand	Uchida, Y (reprint author), Hokkaido Univ, Res Fac Agr, Task Force Innovat Life Resources & Environm Sci, Kita Ku, Kita9,Nishi9, Sapporo, Hokkaido 0608589, Japan.	uchiday@chem.agr.hokudai.ac.jp					Anger M, 2003, SOIL USE MANAGE, V19, P104, DOI 10.1079/SUM2003175; Park S, 2012, NAT GEOSCI, V5, P261, DOI [10.1038/ngeo1421, 10.1038/NGEO1421]; Nemeth DD, 2014, SOIL BIOL BIOCHEM, V73, P1, DOI 10.1016/j.soilbio.2014.02.007; Sommer SG, 2004, NUTR CYCL AGROECOSYS, V69, P143, DOI 10.1023/B:FRES.0000029678.25083.fa; Bell LW, 2011, SOIL TILL RES, V113, P19, DOI 10.1016/j.still.2011.02.003; Velthof GL, 1998, ENVIRON POLLUT, V102, P173, DOI 10.1016/S0269-7491(98)80030-4; Henry S, 2008, ENVIRON MICROBIOL, V10, P3082, DOI 10.1111/j.1462-2920.2008.01599.x; Schimel JP, 2004, SOIL BIOL BIOCHEM, V36, P217, DOI 10.1016/j.soilbio.2003.09.008; Luo J, 2010, AGR ECOSYST ENVIRON, V136, P282, DOI 10.1016/j.agee.2009.12.003; Zhu BA, 2011, GLOBAL CHANGE BIOL, V17, P2172, DOI 10.1111/j.1365-2486.2010.02354.x; Muller C, 2002, SOIL BIOL BIOCHEM, V34, P1325, DOI 10.1016/S0038-0717(02)00076-7; Longhurst RD, 2000, NEW ZEAL J AGR RES, V43, P7; DENDOOVEN L, 1994, SOIL BIOL BIOCHEM, V26, P1501, DOI 10.1016/0038-0717(94)90091-4; Holtan-Hartwig L, 2002, SOIL BIOL BIOCHEM, V34, P1797, DOI 10.1016/S0038-0717(02)00169-4; Smith KA, 1998, ATMOS ENVIRON, V32, P3301, DOI 10.1016/S1352-2310(97)00492-5; Balaine N, 2013, SOIL SCI SOC AM J, V77, P1496, DOI 10.2136/sssaj2013.04.0141; Greenwood KL, 2001, AUST J EXP AGR, V41, P1231, DOI 10.1071/EA00102; GOODROAD LL, 1984, CAN J SOIL SCI, V64, P187; Teepe R, 2000, SOIL BIOL BIOCHEM, V32, P1807, DOI 10.1016/S0038-0717(00)00078-X; Sordi A, 2014, AGR ECOSYST ENVIRON, V190, P94, DOI 10.1016/j.agee.2013.09.004; Menneer JC, 2005, SOIL BIOL BIOCHEM, V37, P1625, DOI 10.1016/j.soilbio.2005.01.023; Baily A, 2012, NUTR CYCL AGROECOSYS, V94, P287, DOI 10.1007/s10705-012-9541-x; Simek M, 2006, AGR ECOSYST ENVIRON, V112, P186, DOI 10.1016/j.agee.2005.08.018; Nie ZN, 2001, AUST J AGR RES, V52, P37, DOI 10.1071/AR00063; Kuzyakov Y, 2007, PLANT SOIL, V290, P293, DOI 10.1007/s11104-006-9162-8; Drewry JJ, 2008, AUST J SOIL RES, V46, P237, DOI 10.1071/SR07125; van der Weerden TJ, 2011, AGR ECOSYST ENVIRON, V141, P426, DOI 10.1016/j.agee.2011.04.007; BURTON DL, 1994, SOIL SCI SOC AM J, V58, P115; Di HJ, 2007, SOIL USE MANAGE, V23, P1, DOI 10.1111/j.1475-2743.2006.00057.x; Groffman PM, 2006, GLOBAL CHANGE BIOL, V12, P1748, DOI 10.1111/j.1365-2486.2006.01194.x; Maag M, 1996, APPL SOIL ECOL, V4, P5, DOI 10.1016/0929-1393(96)00106-0; Flechard CR, 2005, GLOBAL CHANGE BIOL, V11, P2114, DOI 10.1111/j.1365-2486.2005.01056.x; Sommer SG, 2013, ANIMAL MANURE RECYCLING: TREATMENT AND MANAGEMENT, P177; Ball BC, 1999, SOIL TILL RES, V52, P191, DOI 10.1016/S0167-1987(99)00081-1; Wagner-Riddle C, 1998, NUTR CYCL AGROECOSYS, V52, P151, DOI 10.1023/A:1009788411566; Dalal RC, 2003, AUST J SOIL RES, V41, P165, DOI 10.1071/SR02064; Di HJ, 2002, NUTR CYCL AGROECOSYS, V64, P237, DOI 10.1023/A:1021471531188; Davidson EA, 2009, NAT GEOSCI, V2, P659, DOI 10.1038/NGEO608; Luo J, 1999, SOIL BIOL BIOCHEM, V31, P913, DOI 10.1016/S0038-0717(99)00013-9; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Di HJ, 2010, FEMS MICROBIOL ECOL, V72, P386, DOI 10.1111/j.1574-6941.2010.00861.x; Grayston SJ, 2001, SOIL BIOL BIOCHEM, V33, P533, DOI 10.1016/S0038-0717(00)00194-2; Wrage N, 2001, SOIL BIOL BIOCHEM, V33, P1723, DOI 10.1016/S0038-0717(01)00096-7; Rafique R, 2011, ECOSYSTEMS, V14, P563, DOI 10.1007/s10021-011-9434-x; Kelliher FM, 2008, SOIL BIOL BIOCHEM, V40, P1878, DOI 10.1016/j.soilbio.2008.03.013; Ellis S, 1998, PLANT SOIL, V202, P15, DOI 10.1023/A:1004332209345; WEIER KL, 1993, SOIL SCI SOC AM J, V57, P66; Kelliher FM, 2014, AGR ECOSYST ENVIRON, V186, P201, DOI 10.1016/j.agee.2014.01.026; Ball BC, 2012, SOIL USE MANAGE, V28, P194, DOI 10.1111/j.1475-2743.2012.00389.x; Sherlock RR, 2002, J ENVIRON QUAL, V31, P1491; Hansen M, 2014, SOIL BIOL BIOCHEM, V69, P17, DOI 10.1016/j.soilbio.2013.10.031; Amon B, 2006, AGR ECOSYST ENVIRON, V112, P153, DOI 10.1016/j.agee.2005.08.030; Li KH, 2012, GLOBAL CHANGE BIOL, V18, P2546, DOI 10.1111/j.1365-2486.2012.02704.x; Bolan NS, 2004, ADV AGRON, V84, P37, DOI 10.1016/S0065-2113(04)84002-1; Saggar S, 2004, NUTR CYCL AGROECOSYS, V68, P243, DOI 10.1023/B:FRES.0000019463.92440.a3; Wolf B, 2010, NATURE, V464, P881, DOI 10.1038/nature08931; Saggar S, 2008, PLANT SOIL, V309, P25, DOI 10.1007/s11104-007-9421-3; Saggar S, 2004, NEW ZEAL J AGR RES, V47, P513; Clough TJ, 2009, SOIL BIOL BIOCHEM, V41, P2222, DOI 10.1016/j.soilbio.2009.07.032; Matzner E, 2008, EUR J SOIL SCI, V59, P274, DOI 10.1111/j.1365-2389.2007.00992.x; Zhu X, 2013, P NATL ACAD SCI USA, V110, P6328, DOI 10.1073/pnas.1219993110; Rover M, 1998, SOIL BIOL BIOCHEM, V30, P1859, DOI 10.1016/S0038-0717(98)00080-7; CUTTLE SP, 1993, PLANT SOIL, V150, P77, DOI 10.1007/BF00779178; Oenema O, 2005, NUTR CYCL AGROECOSYS, V72, P51, DOI 10.1007/s10705-004-7354-2; Bhandral R, 2007, SOIL TILL RES, V94, P482, DOI 10.1016/j.still.2006.10.006; Ball BC, 2013, EUR J SOIL SCI, V64, P357, DOI 10.1111/ejss.12013; Li DJ, 2013, J ENVIRON MANAGE, V128, P893, DOI 10.1016/j.jenvman.2013.06.026; van Groenigen JW, 2005, PLANT SOIL, V273, P15, DOI 10.1007/s11104-004-6261-2; SCHOLEFIELD D, 1993, J SOIL SCI, V44, P601; Freney JR, 1997, NUTR CYCL AGROECOSYS, V49, P1, DOI 10.1023/A:1009702832489; Katayanagi N, 2012, SOIL SCI PLANT NUTR, V58, P261, DOI 10.1080/00380768.2012.670810; GRAHAM D, 1982, ANNU REV PLANT PHYS, V33, P347, DOI 10.1146/annurev.pp.33.060182.002023; Luo J, 1999, SOIL BIOL BIOCHEM, V31, P903, DOI 10.1016/S0038-0717(99)00012-7; Rudaz AO, 1999, AGR ECOSYST ENVIRON, V73, P83, DOI 10.1016/S0167-8809(99)00005-5; Bilbrough CJ, 2000, ARCT ANTARCT ALP RES, V32, P404, DOI 10.2307/1552389; Burchill W, 2014, GLOBAL CHANGE BIOL, V20, P3137, DOI 10.1111/gcb.12595; Cameron KC, 2014, NZ J AGR RES, V57, P1; CARRAN RA, 1995, AUST J SOIL RES, V33, P341, DOI 10.1071/SR9950341; Ciais P, 2013, CLIMATE CHANGE 2013, P465, DOI DOI 10.1017/CBO9781107415324.014; Das BT, 2012, NEW ZEAL J AGR RES, V55, P319, DOI 10.1080/00288233.2012.697068; DAVIDSSON TE, 1997, WETLANDS ECOLOGY MAN, V5, P111, DOI 10.1023/A:1008297609079; desKlein CAM, 2006, AGR ECOSYST ENVIRON, V112, P192; Dietzel R, 2011, SOIL BIOL BIOCHEM, V43, P1989, DOI 10.1016/j.soilbio.2011.05.017; DORLAND S, 1991, CAN J SOIL SCI, V71, P293; Douglas JT, 1998, GRASS FORAGE SCI, V53, P31; Drewry JJ, 2001, NEW ZEAL J AGR RES, V44, P181; Giltrap DL, 2010, AGR ECOSYST ENVIRON, V136, P310, DOI 10.1016/j.agee.2009.08.007; Hamonts K, 2013, SOIL BIOL BIOCHEM, V65, P1, DOI 10.1016/j.soilbio.2013.05.006; He ZL, 1997, BIOL FERT SOILS, V24, P421, DOI 10.1007/s003740050267; Kariyapperuma KA, 2012, CAN J SOIL SCI, V92, P315, DOI 10.4141/CJSS2011-059; Kelln B. M., 2011, Professional Animal Scientist, V27, P410; Klein CAMd, 2003, SOIL RES, V41, P381; Koops JG, 1997, PLANT SOIL, V191, P57, DOI 10.1023/A:1004285221368; Kulling DR, 2001, J AGR SCI, V137, P235; Ledgard SF, 1996, PLANT SOIL, V181, P65, DOI 10.1007/BF00011293; Ledgard SF, 2014, NZ J AGR RES, V27, P1; Luo J, 2007, NEW ZEAL J AGR RES, V50, P1; Maggiotto S, 2001, WATER AIR SOIL POLL, V1, P89, DOI 10.1023/A:1013174214957; Malcolm BJ, 2014, SOIL USE MANAGE, V30, P58, DOI 10.1111/sum.12101; Meyer DM, 1997, J DAIRY SCI, V80, P1841; Monaghan RM, 2013, AGR ECOSYST ENVIRON, V175, P29, DOI 10.1016/j.agee.2013.04.019; Mosier A, 1998, NUTR CYCL AGROECOSYS, V52, P225, DOI 10.1023/A:1009740530221; Pal P, 2012, J ENVIRON QUAL, V41, P444, DOI 10.2134/jeq2011.0277; Pal P, 2014, NEW ZEAL J AGR RES, V57, P202, DOI 10.1080/00288233.2014.918547; Paul JW, 1997, CAN J SOIL SCI, V77, P231; Phillips RL, 2007, J ENVIRON QUAL, V36, P23, DOI 10.2134/jeq2006.0205; Phillips RL, 2012, SOIL BIOL BIOCHEM, V45, P14, DOI 10.1016/j.soilbio.2011.09.012; Qiu WH, 2010, J SOIL SEDIMENT, V10, P1229, DOI 10.1007/s11368-010-0242-2; Risk N, 2013, CAN J SOIL SCI, V93, P401, DOI [10.4141/CJSS2012-071, 10.4141/cjss2012-071]; RUZJEREZ BE, 1994, SOIL BIOL BIOCHEM, V26, P29, DOI 10.1016/0038-0717(94)90192-9; Shima E, 2002, WATER SCI TECHNOL, V45, P63; SIMPSON JR, 1962, AUST J AGR RES, V13, P1059, DOI 10.1071/AR9621059; SOMMER SG, 1991, J ENVIRON QUAL, V20, P679; Teepe R, 2001, SOIL BIOL BIOCHEM, V33, P1269, DOI 10.1016/S0038-0717(01)00084-0; Uchida Y, 2011, PLANT SOIL, V345, P171, DOI 10.1007/s11104-011-0769-z; Vallentine JF, 2001, GRAZING MANAGEMENT, V2nd, P93, DOI 10.1016/B978-012710001-2/50244-6; van der Weerden TJ, 2012, PR N Z GRASSL ASSOC, V74, P57; van dersWeerden TJ, 2014, NZ J AGR RES, V57, P1; vansBochove E, 1996, HYDROL PROCESS, V10, P1545; Velthof GL, 1996, PLANT SOIL, V181, P263, DOI 10.1007/BF00012061; Virkajarvi P, 2010, AGR ECOSYST ENVIRON, V137, P59, DOI 10.1016/j.agee.2009.12.015; Watanabe T, 1997, NUTR CYCL AGROECOSYS, V49, P35, DOI 10.1023/A:1009794705731; WILLIAMS PH, 1989, NEW ZEAL J AGR RES, V32, P415	123	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-6961	1744-697X		GRASSL SCI	Grassl. Sci.	JUN	2015	61	2					61	74		10.1111/grs.12093		14	Agriculture, Multidisciplinary; Agronomy	Agriculture	CJ7OO	WOS:000355686200001		
J	Anzoua, KG; Suzuki, K; Fujita, S; Toma, Y; Yamada, T				Anzoua, Kossonou G.; Suzuki, Kenji; Fujita, Shinichi; Toma, Yo; Yamada, Toshihiko			Evaluation of morphological traits, winter survival and biomass potential in wild Japanese Miscanthus sinensis Anderss. populations in northern Japan	GRASSLAND SCIENCE			English	Article						Biomass productivity; cold environment; genetic variability; Miscanthus sinensis; morphological traits	COLD TOLERANCE; ENERGY CROP; YIELD; GENOTYPES; EUROPE; GIGANTEUS; NITROGEN; PRODUCTIVITY; GRASSES; GROWTH	Miscanthus xgiganteus has potential as a biomass feedstock for bioenergy production in cold environments. However, its sterility, high cost propagation and relative lack of cold tolerance constrain its cultivation especially during its first winter. Diploid Miscanthus sinensis is a closely related species with substantial genetic diversity, amenable to seed propagation and broadly distributed across a range of environments in eastern Asia including Japan. Forty-three wild Japanese M.sinensis populations collected across a range of latitudes (from N31 degrees 30 in southern to N44 degrees 30 northern Japan) and altitudes (0-1375m) were evaluated in Sapporo (N43 degrees; 56m), Japan to assess morphological traits, winter survival and biomass productivity (BP). Seventy percent of M.sinensis from Hokkaido Island and 67% from other areas of Japan survived over three winter seasons in Sapporo. M.sinensis populations from cooler climates and higher elevations in other areas of Japan showed greater number of tillers, plant height and leaf length whose characteristics were associated with high BP. BP varied among accessions with higher potential productivity in plants from other areas of Japan than from Hokkaido, but annual biomass yield increase is less in the other Japan group. The present study concludes that wild M.sinensis populations from other areas of Japan could be used for domestication as an energy crop in cold environment areas such as Hokkaido. With the observed variability that exists among wild populations, further genetic improvement of M.sinensis for high yield and stability in BP is feasible.	[Anzoua, Kossonou G.; Suzuki, Kenji; Fujita, Shinichi; Yamada, Toshihiko] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Sapporo, Hokkaido 0600811, Japan; [Toma, Yo] Ehime Univ, Fac Agr, Matsuyama, Ehime 790, Japan	Yamada, T (reprint author), Hokkaido Univ, Field Sci Ctr Northern Biosphere, Kita Ku, Kita 11,Nishi 10, Sapporo, Hokkaido 0600811, Japan.	yamada@fsc.hokudai.ac.jp	Yamada, Toshihiko/A-5111-2012	Yamada, Toshihiko/0000-0002-7845-6556	New Energy and Industrial Technology Development Organization; Ministry of Agriculture, Forestry and Fisheries, Japan	We gratefully acknowledge Professor John A. Juvik, Department of Crop Science, University of Illinois at Urbana-Champaign for careful and critical review of this manuscript. We also would like to express appreciation to Ms. Maiko Ohta and staff members at the Experimental Farm of the Field Science Center for Northern Biosphere, Hokkaido University for assisting with the research. This work was supported by the New Energy and Industrial Technology Development Organization and the Ministry of Agriculture, Forestry and Fisheries, Japan.	Huang CL, 2011, BIOMASS BIOENERG, V35, P1873, DOI 10.1016/j.biombioe.2011.01.032; Zub HW, 2010, AGRON SUSTAIN DEV, V30, P201, DOI 10.1051/agro/2009034; Clifton-Brown JC, 2002, EUR J AGRON, V16, P97, DOI 10.1016/S1161-0301(01)00120-4; Stewart JR, 2009, GCB BIOENERGY, V1, P126, DOI 10.1111/j.1757-1707.2009.01010.x; Aust C, 2014, GCB BIOENERGY, V6, P521, DOI 10.1111/gcbb.12083; Lewandowski I, 2003, BIOMASS BIOENERG, V25, P335, DOI 10.1016/S0961-9534(03)00030-8; Maughan M, 2012, GCB BIOENERGY, V4, P253, DOI 10.1111/j.1757-1707.2011.01144.x; LINDELAURSEN I, 1993, HEREDITAS, V119, P297, DOI 10.1111/j.1601-5223.1993.00297.x; Tuck G, 2006, BIOMASS BIOENERG, V30, P183, DOI 10.1016/j.biombioe.2005.11.019; Hastings A, 2009, GCB BIOENERGY, V1, P154, DOI 10.1111/j.1757-1707.2009.01007.x; Borland AM, 2009, J EXP BOT, V60, P2879, DOI 10.1093/jxb/erp118; Jezowski S, 2008, IND CROP PROD, V27, P65, DOI 10.1016/j.indcrop.2007.07.013; Chou CH, 2009, RENEW ENERG, V34, P1908, DOI 10.1016/j.renene.2008.12.027; Heaton E, 2004, BIOMASS BIOENERG, V27, P21, DOI 10.1016/j.biombioe.2003.10.005; Clifton-Brown JC, 2004, GLOBAL CHANGE BIOL, V10, P509, DOI 10.1111/j.1529-8817.2003.00749.x; Clifton-Brown JC, 2000, NEW PHYTOL, V148, P287, DOI 10.1046/j.1469-8137.2000.00764.x; Lewandowski I, 2000, BIOMASS BIOENERG, V19, P209, DOI 10.1016/S0961-9534(00)00032-5; Lewandowski I, 2003, AGRON J, V95, P1274; Lewandowski I, 2006, AGR ECOSYST ENVIRON, V112, P335, DOI 10.1016/j.agee.2005.08.003; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Farrell AD, 2006, ANN APPL BIOL, V149, P337, DOI 10.1111/j.1744-7348.2006.00099.x; Danalatos NG, 2007, BIOMASS BIOENERG, V31, P145, DOI 10.1016/j.biombioe.2006.07.004; Clifton-Brown JC, 2001, AGRON J, V93, P1013; Christian DG, 2005, IND CROP PROD, V21, P109, DOI 10.1016/j.indcrop.2004.01.004; Clifton-Brown JC, 2007, GLOBAL CHANGE BIOL, V13, P2296, DOI 10.1111/j.1365-2486.2007.01438.x; Clifton-Brown John, 2008, P273, DOI 10.1007/978-0-387-70805-8_10; Gowacka K, 2011, BIOMASS BIOENERG, V35, P2445, DOI DOI 10.1016/J.BIOMBIOE.2011.01.041; Greef M, 1993, ANGEW BOT, V67, P87; Hodkinson Trevor R., 2001, Kew Bulletin, V56, P759, DOI 10.2307/4117709; Joseph GR, 2010, BIOMASS BIOENERG, V34, P500; Luciana GA, 2009, BIOMASS BIOENERG, V33, P635; Matumura M, 1985, RES B FACULTY AGR, V50, P423; McVicker IFG, 1946, J I HEATING VENTILAT, V14, P256; Numata M, 1969, PLANT ECOL, V19, P96; Sacks E. J., 2013, GENOMICS SACCHARINAE, V11, P73; Waramit N, 2014, GCB BIOENERGY, V6, P534, DOI 10.1111/gcbb.12086	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-6961	1744-697X		GRASSL SCI	Grassl. Sci.	JUN	2015	61	2					83	91		10.1111/grs.12085		9	Agriculture, Multidisciplinary; Agronomy	Agriculture	CJ7OO	WOS:000355686200003		
J	Thaikua, S; Ebina, M; Kouki, K; Inafuku, M; Akamine, H; Shimoda, K; Suenaga, K; Kawamoto, Y				Thaikua, Sarayut; Ebina, Masumi; Kouki, Kaori; Inafuku, Masahito; Akamine, Hikaru; Shimoda, Katsuhisa; Suenaga, Kazuhiro; Kawamoto, Yasuhiro			Preliminary evaluation on digestibility and the relation to morphology and water content of Brachiaria spp. and their heritability	GRASSLAND SCIENCE			English	Article						Brachiaria spp; correlation; digestibility; heritability; selection criteria	SELECTION CRITERION; QUALITY; STRENGTH; PASTURE; FORAGES	In vitro dry matter digestibility (IVDMD) is one of the most important traits for grass quality improvement. Analysis of IVDMD in laboratory with a large number of breeding populations is very laborious. The objectives of this study were to evaluate IVDMD of brachiariagrass germplasm as material in breeding program, and also to determine the appropriate selection criteria for high digestibility. IVDMD (pepsin-cellulase method), morphology traits and water content of 17 genotypes of Brachiaria spp. (B.brizantha, B.decumbens, B.ruziziensis and Brachiaria hybrid) were evaluated at two harvesting times, winter and early summer seasons. The correlations among traits were determined, and their heritability were also estimated. IVDMD ranged from 48.9 to 59.0% in winter, and 42.9 to 54.4% in early summer. Among morphological traits, leaf-stem index (ratio of leaf width/stem diameter) showed the highest correlation with whole plant IVDMD (r=0.74) followed by leaf-shape ratio (leaf width/leaf length; r=0.72), and leaf water content also highly correlated with whole plant IVDMD (r=0.79). The broad sense heritability of IVDMD and the related traits of two harvests combination were high with the range of 0.75-0.93. The results demonstrate that leaf-stem index, leaf-shape ratio and water content could be the useful selection criteria for the breeding of brachiariagrass for high digestibility.	[Thaikua, Sarayut] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan; [Ebina, Masumi] Natl Agr & Food Res Org NARO, Inst Livestock & Grassland Sci, Nasushiobara, Tochigi, Japan; [Kouki, Kaori; Inafuku, Masahito] Okinawa Prefectural Livestock & Grassland Res Ctr, Nakijin, Okinawa, Japan; [Akamine, Hikaru; Kawamoto, Yasuhiro] Univ Ryukyus, Fac Agr, Nishihara, Okinawa 9030213, Japan; [Shimoda, Katsuhisa; Suenaga, Kazuhiro] Japan Int Res Ctr Agr Sci JIRCAS, Tsukuba, Ibaraki, Japan	Kawamoto, Y (reprint author), Univ Ryukyus, Fac Agr, Nishihara, Okinawa 9030213, Japan.	yasuk@agr.u-ryukyu.ac.jp			Royal Thai Government	The study was the part of PhD program of the United Graduate School of Agricultural Sciences, Kagoshima University by the scholarship from Royal Thai Government. We thank for the Research Training Program of National Agriculture and Food Research Organization (NARO) Institute of Livestock and Grassland Science of Japan (NILGS), Japan. We wish to thank International Center for Tropical Agriculture (CIAT) and Miyazaki University for kindly providing some germplasms and information of Brachiaria spp. and 'Miyaokikoku', respectively. We thank all students in Tropical grassland science laboratory, University of the Ryukuys for supporting this study. Lastly, we wish to thank Associate Professor Md. Amzad Hossain, Subtropical Field Science Center, University of the Ryukuys, for kindly reviewing the manuscript.	Buxton DR, 1996, ANIM FEED SCI TECH, V59, P37, DOI 10.1016/0377-8401(95)00885-3; JUNG HG, 1989, AGRON J, V81, P33; BURTON GW, 1953, AGRON J, V45, P478; Casler MD, 1999, CROP SCI, V39, P12; Ishigaki Genki, 2009, Grassland Science, V55, P164, DOI 10.1111/j.1744-697X.2009.00153.x; Argel PJ, 2007, CULTIVAR MULATO, P1; Batistoti C, 2012, ANIM FEED SCI TECH, V171, P173, DOI 10.1016/j.anifeedsci.2011.11.008; BUCKNER RC, 1979, CROP SCI, V19, P93; BUXTON DR, 1993, FORAGE CELL WALL STRUCTURE AND DIGESTIBILITY, P685; Buxton DR, 1997, J NUTR, V127, p814S; dosValle CB, 1996, BRACHIARIA BIOL AGRO, P147; Figueiredo UJ, 2012, CROP BREED APPL BIOT, V12, P237; Fisher MJ, 1996, BRACHIARIA BIOL AGRO, P43; Goering H. D., 1970, USDA AGR HDB, V379, P1; GOTO I, 1977, ANIM FEED SCI TECH, V2, P247, DOI 10.1016/0377-8401(77)90028-1; Hanson WD, 1963, STAT GENETICS PLANT, P125; Herrero M, 2001, ANIM FEED SCI TECH, V92, P149, DOI 10.1016/S0377-8401(01)00261-9; Hughes NRG, 2000, J AGR SCI-CAMBRIDGE, V135, P123, DOI 10.1017/S0021859699008084; Jungmann L, 2009, MOLECULAR BREEDING OF FORAGE AND TURF, P103, DOI 10.1007/978-0-387-79144-9_9; Lascano CE, 1996, BRACHIARIA BIOL AGRO, P106; LENTZ EM, 1991, CROP SCI, V31, P1555; Levetin E, 2008, PLANTS AND SOC, V5th, P1; Miles JW, 2004, WARM SEASON C4 GRASS, P745, DOI 10.2134/agronmonogr45.c22; SENANAYAKE SGJN, 1994, TROP AGR, V71, P327; Smith KF, 1997, GRASS FORAGE SCI, V52, P167, DOI 10.1046/j.1365-2494.1997.00067.x; THEANDER O, 1993, FORAGE CELL WALL STRUCTURE AND DIGESTIBILITY, P83; VANSOEST PJ, 1967, J ANIM SCI, V26, P119	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-6961	1744-697X		GRASSL SCI	Grassl. Sci.	JUN	2015	61	2					92	100		10.1111/grs.12082		9	Agriculture, Multidisciplinary; Agronomy	Agriculture	CJ7OO	WOS:000355686200004		
J	Lim, J; Kawamura, K; Lee, HJ; Yoshitoshi, R; Kurokawa, Y; Tsumiyama, Y; Watanabe, N				Lim, Jihyun; Kawamura, Kensuke; Lee, Hyo-Jin; Yoshitoshi, Rena; Kurokawa, Yuzo; Tsumiyama, Yoshimasa; Watanabe, Nariyasu			Evaluating a hand-held crop-measuring device for estimating the herbage biomass, leaf area index and crude protein content in an Italian ryegrass field	GRASSLAND SCIENCE			English	Article						Bi-directional passive sensor; forage crop; proximal sensing; saturation effect; vegetation index	ADJUSTED VEGETATION INDEX; PASTURE BIOMASS; SENSORS; RADIOMETER; QUALITY; PARAMETERS; MODIS; TOOL	The objective of this study is to evaluate the ability of a newly developed hand-held crop-measuring device and vegetation indices (VIs) to estimate the herbage biomass (BM), leaf area index (LAI) and forage crude protein mass (CPmass) in an Italian ryegrass (Lolium multiflorum Lam.) field, Japan. The device uses bi-directional passive sensors (550, 650 and 880nm) upward and downward to overcome the major drawback of optical remote sensing as influenced by weather conditions. The canopy reflectance and plant sample data were collected 11 times during two winter growing seasons in 2010-11 and 2011-12. Seven VIs were compared to estimate the forage parameters in the normal and logarithmic forms. The predictive ability of the VIs was assessed by the cross-validated coefficient of determination (R-cv(2)) and the residual prediction (RPD) values. Acceptable RPD values (>1.5) were found in most of the log-transformed forage parameters with all of the VIs but not in most of the normal-form. The highest R-cv(2) and RPD were obtained in the normalized difference vegetation index (NDVI) for the ln BM (R-cv(2) = 0.76, RPD = 2.04) and ln LAI (R-cv(2) = 0.80, RPD = 2.25), and the highest modified soil-adjusted vegetation index (MSAVI) was obtained for the ln CPmass (R-cv(2) = 0.78, RPD = 2.16). By evaluating the limitation of NDVI or MSAVI sensitivity with ranges of cumulative data, the log-transformed forage parameters showed good R-cv(2) values in the ln BM (0.76-0.79), ln LAI (0.80-0.84) and ln CPmass (0.71-0.84) with acceptable RPD values throughout most of the range, whereas in the normal-form, the NDVI or MSAVI was saturated at moderate-high BM, LAI or CPmass, causing the R-cv(2) and RPD values to decrease with increasing plant parameters. These results suggest that this device is applicable in log-transformed BM, LAI and CPmass throughout the growing season without cloud effect.	[Lim, Jihyun; Kawamura, Kensuke; Lee, Hyo-Jin; Yoshitoshi, Rena] Hiroshima Univ, Grad Sch Int Dev & Cooperat, Higashihiroshima, Hiroshima 7398529, Japan; [Kurokawa, Yuzo; Tsumiyama, Yoshimasa] Hiroshima Univ, Grad Sch Biosphere Sci, Setouchi Field Sci Ctr, Higashihiroshima, Hiroshima 7398529, Japan; [Watanabe, Nariyasu] Natl Agr & Food Res Org NARO, Hokkaido Agr Res Ctr, Sapporo, Hokkaido, Japan	Lim, J (reprint author), Hiroshima Univ, Grad Sch Int Dev & Cooperat, Higashihiroshima, Hiroshima 7398529, Japan.	limjihyun7@gmail.com	Kawamura, Kensuke/E-2431-2011	Kawamura, Kensuke/0000-0002-2824-1266	Japan Society for the Promotion of Science (JSPS) [21880030, 23780266]	We are grateful to all the staff of the Setouchi Field Science Center, Saijo Station, Hiroshima University, for their assistance in the field experiments. We also thank Mr. Hideyuki Ichiki and Ms. Chika Yoshino, National Agriculture and Food Research Organization (NARO) Bio-oriented Technology Research Advancement Institution, for their support in using the hand-held measuring device. This work was partially supported by the Japan Society for the Promotion of Science (JSPS) through the Grant-in-Aid for Research Activity Start-up (No. 21880030) and the Grant-in-Aid for Young Scientists (B) (No. 23780266).	Chen JM, 1996, REMOTE SENS ENVIRON, V55, P153, DOI 10.1016/0034-4257(95)00195-6; Gitelson AA, 2002, REMOTE SENS ENVIRON, V80, P76, DOI 10.1016/S0034-4257(01)00289-9; Biewer S, 2009, CROP SCI, V49, P1917, DOI 10.2135/cropsci2008.11.0653; Kokaly RF, 2001, REMOTE SENS ENVIRON, V75, P153, DOI 10.1016/S0034-4257(00)00163-2; Erdle K, 2011, FIELD CROP RES, V124, P74, DOI 10.1016/j.fcr.2011.06.007; Kawamura K, 2010, GRASSL SCI, V56, P205, DOI 10.1111/j.1744-697X.2010.00196.x; Park RS, 1997, ANIM FEED SCI TECH, V68, P235, DOI 10.1016/S0377-8401(97)00055-2; Gitelson AA, 2004, J PLANT PHYSIOL, V161, P165, DOI 10.1078/0176-1617-01176; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; QI J, 1994, REMOTE SENS ENVIRON, V48, P119, DOI 10.1016/0034-4257(94)90134-1; Thenkabail PS, 2000, REMOTE SENS ENVIRON, V71, P158, DOI 10.1016/S0034-4257(99)00067-X; Gitelson AA, 1996, REMOTE SENS ENVIRON, V58, P289, DOI 10.1016/S0034-4257(96)00072-7; MYNENI RB, 1995, IEEE T GEOSCI REMOTE, V33, P481, DOI 10.1109/36.377948; JORDAN CF, 1969, ECOLOGY, V50, P663, DOI 10.2307/1936256; Chida H, 2006, TOHOKU J CROP SCI, V46, P75; Fitzgerald GJ, 2010, INT J REMOTE SENS, V31, P4335, DOI 10.1080/01431160903258217; Flynn ES, 2008, AGRON J, V100, P114, DOI 10.2134/agronj2006.0363; Gutman GG, 1999, J GEOPHYS RES-ATMOS, V104, P6241, DOI 10.1029/1998JD200106; Hong SD, 2007, COMMUN SOIL SCI PLAN, V38, P2209, DOI 10.1080/00103620701549157; Horio M, 2007, FARMING MECH, V3077, P10; Horio M., 2007, Journal of the Japanese Society of Agricultural Machinery, V69, P8; HUETE AR, 1988, REMOTE SENS ENVIRON, V25, P295, DOI 10.1016/0034-4257(88)90106-X; Jasper J, 2009, PRECISION AGR 09, P23; Kaneda T, 2007, HOKURIKU CROP SCI, V42, P97; Kawamura K, 2009, NEW ZEAL J AGR RES, V52, P417; Kawamura K, 2011, J APPL REMOTE SENS, V5, DOI 10.1117/1.3659893; Kawamura K, 2013, GRASSL SCI, V59, P166, DOI 10.1111/grs.12026; Kawamura K, 2011, INT J REMOTE SENS, V32, P103, DOI 10.1080/01431160903439908; Li ZQ, 1996, IEEE T GEOSCI REMOTE, V34, P1308, DOI 10.1109/36.544556; Makino T, 2006, JPN J GRASSL SCI, V52, P38; Ministry of Agriculture Forestry and Fisheries (MAFF), 2008, ANN STAT; ROUJEAN JL, 1995, REMOTE SENS ENVIRON, V51, P375, DOI 10.1016/0034-4257(94)00114-3; Rouse JW, 1973, MONITORING VERNAL AD, P1; Shaver TM, 2011, PRECIS AGRIC, V12, P892, DOI 10.1007/s11119-011-9229-2; Tremblay N, 2009, PRECIS AGRIC, V10, P145, DOI 10.1007/s11119-008-9080-2; TUCKER CJ, 1981, SCIENCE, V211, P281, DOI 10.1126/science.211.4479.281; Vina A, 2004, REMOTE ESTIMATION LE; Watanabe N, 2014, GRASSL SCI, V60, P214, DOI 10.1111/grs.12064; Williams P. C., 2001, NEAR INFRARED TECHNO, V2, P145	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-6961	1744-697X		GRASSL SCI	Grassl. Sci.	JUN	2015	61	2					101	108		10.1111/grs.12083		8	Agriculture, Multidisciplinary; Agronomy	Agriculture	CJ7OO	WOS:000355686200005		
J	Mori, A; Hojito, M				Mori, Akinori; Hojito, Masayuki			Methane and nitrous oxide emissions due to excreta returns from grazing cattle in Nasu, Japan	GRASSLAND SCIENCE			English	Article						Emission factor; grassland; greenhouse gas; volcanic soil	GRAZED GRASSLAND; SOILS; FLUXES; N2O; MANURE; CH4; DEPOSITION; OXIDATION; PATTERNS; ANIMALS	To quantify emissions of methane (CH4) and nitrous oxide (N2O) from the excreta returns of grazing cattle, we used a closed-chamber method to quantify the fluxes of CH4 and N2O from patches of dung, urine and untreated grassland (control) within an experimental site. Fresh dung or urine of beef cattle was applied five times at different times of year to simulate excreta deposition from year-round grazing. CH4 fluxes were greatest immediately after dung deposition and returned to control fluxes within 10-35days. When precipitation occurred following dung deposition, CH4 fluxes temporarily increased. Once CH4 emission ceased, however, later rewetting did not lead to a resumption of CH4 emission. CH4 emission factors for dung (CH4EFdung) averaged 0.052%. During the normal grazing period from May to October, the mean CH4EFdung was estimated to be 0.076%. The CH4 fluxes were not significantly affected by urine deposition. However, N2O fluxes increased only slightly following dung deposition. During the grass-growing period, N2O fluxes increased after urine deposition, reached a maximum within 3-14days, and then returned to the levels measured from untreated controls within 28-35days. During the winter, N2O fluxes increased slightly after urine deposition. However, relatively small N2O fluxes, typically less than 100gNm(-2)h(-1), were observed intermittently following rainfall events. The N2O emission factors for dung (N2O EFdung) averaged 0.013%, and those for urine (N2O EFurine) averaged 0.570%. During the normal grazing period from May to October, the mean N2O EFdung and N2O EFurine were estimated to be 0.024% and 0.684%, respectively. These results suggest that CH4 and N2O emissions from manure could be reduced by grazing cattle and leaving their manure in the field as opposed to housing cattle and composting their manure.	[Mori, Akinori; Hojito, Masayuki] Natl Agr & Food Res Org NARO, Inst Livestock & Grassland Sci, Nasushiobara, Tochigi, Japan	Mori, A (reprint author), NARO Inst Livestock & Grassland Sci, 768 Senbonmatsu, Nasushiobara, Tochigi 3292793, Japan.	amori@affrc.go.jp					Akiyama H, 2009, SOIL SCI PLANT NUTR, V55, P435, DOI 10.1111/j.1747-0765.2009.00379.x; TIEDJE JM, 1984, PLANT SOIL, V76, P197, DOI 10.1007/BF02205580; Bodelier PLE, 2004, FEMS MICROBIOL ECOL, V47, P265, DOI 10.1016/S0168-6496(03)00304-0; Flessa H, 1996, J ENVIRON QUAL, V25, P1366; Fukumoto Y, 2003, BIORESOURCE TECHNOL, V89, P109, DOI 10.1016/S0960-8524(03)00060-9; Allen AG, 1996, SOIL BIOL BIOCHEM, V28, P597, DOI 10.1016/0038-0717(95)00186-7; HAYNES RJ, 1993, ADV AGRON, V49, P119, DOI 10.1016/S0065-2113(08)60794-4; van der Weerden TJ, 2011, AGR ECOSYST ENVIRON, V141, P426, DOI 10.1016/j.agee.2011.04.007; Akiyama H, 2006, SOIL SCI PLANT NUTR, V52, P774, DOI 10.1111/j.1747-0765.2006.00097.x; OJIMA DS, 1993, CHEMOSPHERE, V26, P675, DOI 10.1016/0045-6535(93)90452-B; Maag M, 1996, APPL SOIL ECOL, V4, P5, DOI 10.1016/0929-1393(96)00106-0; Chadwick DR, 2000, J ENVIRON QUAL, V29, P277; MOSIER A, 1991, NATURE, V350, P330, DOI 10.1038/350330a0; Shimizu M, 2010, SOIL SCI PLANT NUTR, V56, P676, DOI 10.1111/j.1747-0765.2010.00496.x; Davidson EA, 2000, BIOSCIENCE, V50, P667, DOI 10.1641/0006-3568(2000)050[0667:TACMOS]2.0.CO;2; Conrad R, 1996, MICROBIOL REV, V60, P609; Oenema O, 1997, SOIL USE MANAGE, V13, P288, DOI 10.1111/j.1475-2743.1997.tb00600.x; Saggar S, 2004, NEW ZEAL J AGR RES, V47, P513; Dobbie KE, 1999, J GEOPHYS RES-ATMOS, V104, P26891, DOI 10.1029/1999JD900378; Mori A, 2008, SOIL SCI PLANT NUTR, V54, P606, DOI 10.1111/j.1747-0765.2008.00270.x; BALL PR, 1984, PLANT SOIL, V76, P23, DOI 10.1007/BF02205564; Boon A, 2014, AGR ECOSYST ENVIRON, V186, P23, DOI 10.1016/j.agee.2014.01.008; Castaldi S, 2000, BIOL FERT SOILS, V32, P67, DOI 10.1007/s003740000218; Cicerone RJ, 1987, SCIENCE, V237, P37; desKlein CAM, 2003, AUS J SOIL RES, V41, P381; GIO, 2014, NAT GREENH GAS INV R; Greenhouse Gas Inventory Office of Japan (GIO) Center for Global Invironmental Research National Institute for Environmental Research National Institute for Environmental Studies, 2013, GHGS EM DAT JAP; Haga K, 1998, JARQ-JPN AGR RES Q, V32, P203; HAKAMATA T, 1980, Grassland Science, V26, P201; Holter P, 1997, SOIL BIOL BIOCHEM, V29, P31, DOI 10.1016/S0038-0717(96)00267-2; Intergovernmental Panel for Climate Change (IPCC), 2000, IPCC GOOD PRACT GUID; Intergovernmental Panel on Climate Change, 2007, CLIMATE CHANGE 2007; IPCC, 2006, IPCC GUIDELINES NATL; Jarvis SC, 1995, SOIL BIOL BIOCHEM, V27, P1581, DOI 10.1016/0038-0717(95)00092-S; Kurashima K, 1993, MISC PUBL NATL GRASS, V3, P1; Lantinga E. A., 1987, Animal manure on grassland and fodder crops. Fertilizer or waste? (Editors: Meer, H.G. van der; Unwin, R.J.; Dijk, T.A.van; Ennik, G.C.)., P103; Matsuura S, 2012, GRASSL SCI, V58, P79, DOI 10.1111/j.1744-697X.2012.00245.x; Ministry of Agriculture Forestry and Fisheries (MAFF), 2013, LOVT A, P1; National Grassland Research Institute (NGRI), 2001, MISCELLANEOUS PUBLIC, V4, P1; National Institute of Animal Health (NIAH), 2000, NAT SURV CATTL GRAZ, P1; Osada T., 2005, 4th International Symposium on non-CO 2 greenhouse gases (NCGG-4), science, control, policy and implementation, Utrecht, Netherlands, 4-6 July 2005, P105; Soil Survey Staff, 2014, KEYS SOIL TAX, P1; Takata Y., 2009, Japanese Journal of Soil Science and Plant Nutrition, V80, P502; vansGroenigen JW, 2005, PLANT SOIL, V273, P15; WILLIAMS DJ, 1993, CHEMOSPHERE, V26, P179, DOI 10.1016/0045-6535(93)90420-A; Yamulki S, 1998, SOIL BIOL BIOCHEM, V30, P491, DOI 10.1016/S0038-0717(97)00145-4; Yamulki S, 1999, J ENVIRON QUAL, V28, P676	47	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-6961	1744-697X		GRASSL SCI	Grassl. Sci.	JUN	2015	61	2					109	120		10.1111/grs.12081		12	Agriculture, Multidisciplinary; Agronomy	Agriculture	CJ7OO	WOS:000355686200006		
J	Chen, J; Shiyomi, M; Wuyunna; Hori, Y; Yamamura, Y				Chen, Jun; Shiyomi, Masae; Wuyunna; Hori, Yoshimichi; Yamamura, Yasuo			Vegetation and its spatial pattern analysis on salinized grasslands in the semiarid Inner Mongolia steppe	GRASSLAND SCIENCE			English	Article						Halophyte; occurrence of species; remediation; species composition; species richness	HEILONGJIANG STEPPE; SPECIES RICHNESS; SOIL-SALINITY; POWER-LAW; CHINA; WATER; HETEROGENEITY; DYNAMICS; GROWTH; RESTORATION	We determined how the vegetation and spatial heterogeneity (spatial variation) in species richness and species composition in salinized grasslands are affected by soil salinity level, and whether the Grime's hypothesis regarding species richness is accepted, to understand vegetation on salinized soil. To address these questions, we surveyed three grassland sites in Inner Mongolia. All sites had been degraded heavily by livestock grazing, and had different salinity levels: heavy (electrical conductivity 1.18-8.15dSm(-1)), intermediate (0.38-0.70dSm(-1)) and non-salinized (0.07-0.20dSm(-1)). We set 50 square quadrats (0.25m(2) per quadrat), divided into four sub-quadrats (0.0625m(2) each), along two 25m transects in each site, and recorded all plant species in each sub-quadrat. The species richness of the sites per 0.25m(2) was in the order: intermediate salinity > non-salinized > heavy salinity. At the heavy and intermediate sites, the spatial heterogeneity of vegetation per sub-quadrat was higher than expected from a random pattern, but not at the non-salinized site. At the heavily salinized site, the spatial patterns of two halophytes with the highest occurrences drove the high spatial heterogeneity in species richness. In contrast, at the non-salinized site, two low-level halophytes with the highest occurrences determined the random pattern. The intermediate salinity site, where high- and low-level halophytes could coexist in accordance with small-scale spatial changes in salinity, had the highest species richness with relatively high spatial heterogeneity (which accepted the Grime's hypothesis). Our working hypothesis for remediating vegetation and soil in salinized grasslands is to inhibit grazing, and to grow species that accumulate organic matter in soil. For this, halophyte species with large spatial heterogeneity/body size would be effective.	[Chen, Jun] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China; [Shiyomi, Masae] Open Univ Japan, Ibaraki Study Ctr, Mito, Ibaraki, Japan; [Shiyomi, Masae; Hori, Yoshimichi] Ibaraki Univ, Mito, Ibaraki, Japan; [Wuyunna] Dalian Nationalities Univ, Coll Environm & Resource Sci, Dalian, Liaoning, Peoples R China; [Yamamura, Yasuo] Ibaraki Univ, Coll Sci, Mito, Ibaraki, Japan	Chen, J (reprint author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China.	chen_jun2008@nwsuaf.edu.cn			Institute for Global Change Adaptation Science, Ibaraki University, Japan (ICAS); Ministry of Education, Culture, Sports, Science, and Technology of Japan [11490015]; National Science Foundation of China [31470504]	This study was funded by the Institute for Global Change Adaptation Science, Ibaraki University, Japan (ICAS) for a research on land-use and agricultural systems under the climate change, and by the Ministry of Education, Culture, Sports, Science, and Technology of Japan for a research project of "The indices for evaluating sustainable production of cropland, forest land and grassland" (11490015); this study is also supported by The National Science Foundation of China for a research project "Ecophysiological mechanisms underlying the expansion of Allium polyrhizum population during the degradation of Stipa krylovii steppe (31470504). The survey sites were determined with the assistance of the Yijinhuoluo-Qi Grassland Station, Ordos City, China. The species identification was made under the guidance of Prof. Yizhi Zhao, Inner Mongolia University. We thank these organizations and individuals involved therein.	Allaby M, 1996, CONCISE OXFORD DICT, P1; Ravindran KC, 2007, SOIL BIOL BIOCHEM, V39, P2661, DOI 10.1016/j.soilbio.2007.02.005; Wang YS, 2002, AGR ECOSYST ENVIRON, V90, P217, DOI 10.1016/S0167-8809(01)00217-1; Chhabra R, 2005, ARID LAND RES MANAG, V19, P61, DOI 10.1080/15324980590887344; Mallants D, 1996, SOIL SCI, V161, P167, DOI 10.1097/00010694-199603000-00003; Jobbagy EG, 2004, GLOBAL CHANGE BIOL, V10, P1299, DOI 10.1111/j.1365-2486.2004.00806.x; Shiyomi M, 2001, ECOL RES, V16, P487, DOI 10.1046/j.1440-1703.2001.00411.x; Akiyama Tsuyoshi, 2007, Grassland Science, V53, P1, DOI 10.1111/j.1744-697X.2007.00073.x; Crain CM, 2004, ECOLOGY, V85, P2539, DOI 10.1890/03-0745; Chen Jun, 2006, Grassland Science, V52, P167, DOI 10.1111/j.1744-697X.2006.00065.x; Guo QF, 1998, ECOLOGY, V79, P2555, DOI 10.1890/0012-9658(1998)079[2555:SRABDO]2.0.CO;2; Chen J, 2007, LANDSCAPE URBAN PLAN, V82, P222, DOI 10.1016/j.landurbplan.2007.02.011; Chaneton EJ, 1996, J RANGE MANAGE, V49, P182, DOI 10.2307/4002692; HUSTON MA, 1994, AM NAT, V144, P954, DOI 10.1086/285720; Zhao KF, 2002, PLANT SCI, V163, P491, DOI 10.1016/S0168-9452(02)00160-7; Khamzina A, 2009, AGR FOREST METEOROL, V149, P1865, DOI 10.1016/j.agrformet.2009.06.015; Cui YL, 2005, GROUND WATER, V43, P471, DOI 10.1111/j.1745-6584.2005.0063.x; ALMUFTI MM, 1977, J ECOL, V65, P759, DOI 10.2307/2259378; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Beare M.H., 1997, SOIL ECOLOGY SUSTAIN, P37; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Chen J, 2014, ECOL INFORM, V24, P124, DOI 10.1016/j.ecoinf.2014.08.001; Chen J, 2008, JPN J GRASSL SCI, V53, P282; Chen J, 2008, ECOL MODEL, V211, P403, DOI 10.1016/j.ecolmodel.2007.09.017; Dwivedi RS, 1998, INT J REMOTE SENS, V19, P605, DOI 10.1080/014311698215883; Fan LY, 2011, PLANT SOIL, V340, P169, DOI 10.1007/s11104-010-0448-5; Funk Dale W., 2004, Wetlands Ecology and Management, V12, P215, DOI 10.1023/B:WETL.0000034074.81373.65; Garia LV, 1993, J VEG SCI, V4, P417; Ghassemi FA, 1995, HUMAN CAUSES EXTENT, P1; Gokalp Z, 2010, AFR J AGR RES, V5, P1127; Grime JP, 1979, PLANT STRATEGIES VEG, P1; Hou XY, 2001, VISUAL BASIC 6 0 PRO, P1; Institute of Botany Chinese Academy of Science (IBCAS), 2002, IC CORM SIN, VI-V; Jiang D, 2001, CHIN J APPL ECOL S, V12, P39; Kawanabe S, 2001, CHIN J APPL ECOL, V12, P103; Kawanabe Sukeo, 1999, Grassland Science, V45, P149; Kubo S, 1975, B NATL GRASSLAND RES, V7, P33; Li XY, 2007, ENVIRON MONIT ASSESS, V131, P421, DOI 10.1007/s10661-006-9487-z; Ma DongMei, 2013, Acta Agrestia Sinica, V21, P1144; PECK AJ, 1978, AUST J SOIL RES, V16, P157, DOI 10.1071/SR9780157; Perelman SB, 2001, J ECOL, V89, P562, DOI 10.1046/j.0022-0477.2001.00579.x; Ren J, 2008, ENCY GRASSLAND SCI, P1; Rosenzweig M., 1993, SPECIES DIVERS ECOL, V1993, P52; Schmalz B, 2002, J HYDROL, V267, P217, DOI 10.1016/S0022-1694(02)00152-X; Shiyomi M, 2000, J VEG SCI, V11, P627, DOI 10.2307/3236569; Shiyomi M, 2010, GRASSL SCI, V56, P153, DOI 10.1111/j.1744-697X.2010.00188.x; SINHA A, 1986, PLANT SOIL, V95, P411, DOI 10.1007/BF02374621; Taboada MA, 2006, THESIS I NAT POL TOU; Tsuiki M, 2005, J INTEGR PLANT BIOL, V47, P917, DOI 10.1111/j.1744-7909.2005.00121.x; UNGER PW, 1991, SOIL TILL RES, V20, P219, DOI 10.1016/0167-1987(91)90041-U; Wang ZQ, 1993, SALINE SOIL CHINA, P1; Wuyunna Nakamura T, 1999, GRASSLAND SCI, V45, P140; Xie XM, 2009, WEED SCI, V57, P248, DOI 10.1614/WS-08-124.1; [易津 Yi Jin], 2003, [草地学报, Acta agrestia sinica], V11, P110; Yiruhan, 2001, GRASSLAND SCI, V47, P362; Yuan JF, 2010, J ARID LAND, V2, P190, DOI 10.3724/SP.J.1227.2010.00190; Zhang JF, 2010, P INT C MECH AUT CON, P1349; Zhang K, 2012, J ARID LAND, V4, P330, DOI 10.3724/SP.J.1227.2012.00330; Zhang S, 2001, CHIN J APPL ECOL S, V12, P90; Zhu HuiSen, 2010, Acta Agrestia Sinica, V18, P383	61	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-6961	1744-697X		GRASSL SCI	Grassl. Sci.	JUN	2015	61	2					121	130		10.1111/grs.12084		10	Agriculture, Multidisciplinary; Agronomy	Agriculture	CJ7OO	WOS:000355686200007		
J	Khaleda, S; Murayama, Y				Khaleda, Syeda; Murayama, Yuji			Identification of Suitability of Sites for Microenterprises for Value Chain Development: A Study in Gazipur District, Bangladesh	GROWTH AND CHANGE			English	Article							DECISION-MAKING; MULTICRITERIA; GIS	In recent years, many commercial poultry farm microenterprises (MEs) have flourished in rural areas with the help of an extensive microfinance program in Bangladesh. These poultry MEs are in a key position for the profitable operation of other actors in the poultry subsector value chain. But not all these MEs are located in suitable places, which results in poor input supply and marketing facilities for their products and thus cause higher costs and less profit. The government, nongovernment organizations (NGOs) and donor agencies apply the same policy for providing support services to all these poultry farmers, irrespective of their locations. Thus, this paper tries to explain the poultry value chain in Gazipur District, where the concentration of poultry farms is highest, and to delineate suitable sites for poultry MEs using the multicriteria evaluation technique within a Geographic Information System context, utilizing factors such as flood-free land, and infrastructures related to the poultry business-enabling environment of the value chain. The delineation of suitable land areas for farms can help NGOs, as well as the government, to design interventions and appropriate policy development for farmers in different locations, and thus help all farmers to increase their profit and sustainability.	[Khaleda, Syeda; Murayama, Yuji] Univ Tsukuba, Grad Sch Life & Environm Sci, Div Spatial Informat Sci, Tsukuba, Ibaraki, Japan	Khaleda, S (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Div Spatial Informat Sci, Tsukuba, Ibaraki, Japan.	syedakhaleda@yahoo.com; mura@geoenv.tsukuba.ac.jp	Murayama, Yuji/B-3161-2014	Murayama, Yuji/0000-0003-4397-6882	Japan Society for Promotion of Science	Syeda Khaleda is a research fellow for Division of Spatial Information Science, Graduate School of Life and Environmental Science, University of Tsukuba, Tsukuba, Japan. Her e-mail address is: syedakhaleda@yahoo.com. Yuji Murayama is a professor for Division of Spatial Information Science, Graduate School of Life and Environmental Science, University of Tsukuba, Tsukuba, Japan. His e-mail address is: mura@geoenv.tsukuba.ac.jp. The authors are grateful to Professor Kazutoshi Abe of Aichi University of Education, Japan, for his valuable comments. The authors are thankful to the editors of the journal and anonymous reviewers for their constructive comments on earlier draft of this article and to their colleagues in the University of Tsukuba, especially Dr. Ko Ko Lwin and Ronald Estoque. The authors extend their appreciation to the Japan Society for Promotion of Science for awarding the fellowship that made undertaking the research possible.	Aguilar M., 1998, STRATEGIC REASSESSME; Thapa RB, 2008, LAND USE POLICY, V25, P225, DOI 10.1016/j.landusepol.2007.06.004; Jankowski P, 2001, INT J GEOGR INF SCI, V15, P101, DOI 10.1080/13658810010005525; Hossain MS, 2009, LANDSCAPE URBAN PLAN, V90, P119, DOI 10.1016/j.landurbplan.2008.10.020; PEREIRA JMC, 1993, INT J GEOGR INF SYST, V7, P407, DOI 10.1080/02693799308901971; Ceballos-Silva A, 2003, AGR ECOSYST ENVIRON, V95, P371, DOI 10.1016/S0167-8809(02)00180-9; SAATY TL, 1977, J MATH PSYCHOL, V15, P234, DOI 10.1016/0022-2496(77)90033-5; Neumann K, 2009, LANDSCAPE ECOL, V24, P1207, DOI 10.1007/s10980-009-9357-5; Barredo C., 1996, AGR SYST, V77, P117; BBS, 2001, COMM SER GAZ ZIL GLA; Brata A., 2007, 12622 PERS REPEC ARC; CARVER SJ, 1991, INT J GEOGR INF SYST, V5, P321, DOI 10.1080/02693799108927858; Coe N M, 2007, EC GEOGRAPHY CONT IN; Daley-Harris S., 2007, STATE MICROCREDIT SU; Danida International Business Development, 2009, VAL CHAINS; EASTMAN JR, 1995, PHOTOGRAMM ENG REM S, V61, P539; Environment Protection Authority, 1998, GUID EST OP FARMS S; Haggblade J., 1991, FIELD MANUAL SUBSECT; Jun C., 2000, URISA J, V12, P5; Kapetsky J.M., 1994, 27 CIFA FAO; Khaleda S., 2007, REGIONAL DEV STUDIES, V11, P55; Khaleda S, 2013, LAND USE POLICY, V30, P642, DOI 10.1016/j.landusepol.2012.05.010; Khan A., 2000, VILLAGE INFRASTRUCTU, P67; Ledgerwood J., 2000, MICROFINANCE HDB I F; McLeod A., 2007, POULTRY 21 CENTURY A; Mendoza G. A., 1997, 7 S SYST AN FOR RES; Milliman J., 1989, BANGLADESH QUEST, V1, P11; Prabakaran R., 2003, 159 FAO AN PROD HLTH; Ravindran V., 2010, POULTRY DEV REC; Rhyne E., 1994, 40 WORLD BANK; Roduner D., 2007, WORKING PAPER; Saaty T., 1990, ANAL HIERARCHY PROCE; Salam M., 2004, AQUACULTURE AMSTERDA, V245, P75; United States Agency for International Development, 2006, 42 USAID AMAP BDS US; Voogd H., 1983, MULTICRITERIA EVALUA; Wittlinger B., 2006, ACCION INSIGHTS, V19, P1; World Bank, 2006, MICR S AS	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-4815	1468-2257		GROWTH CHANGE	Growth Change	JUN	2015	46	2					274	291		10.1111/grow.12082		18	Planning & Development	Public Administration	CJ8BX	WOS:000355725300007		
J	Kon, M; Nakagaki, K; Ebi, Y; Nishiyama, T; Russell, AP				Kon, Michihiro; Nakagaki, Kohei; Ebi, Yoshiko; Nishiyama, Tetsunari; Russell, Aaron P.			Hormonal and metabolic responses to repeated cycling sprints under different hypoxic conditions	GROWTH HORMONE & IGF RESEARCH			English	Article						Growth hormone; Lipolysis; Supramaximal exercise; Systemic hypoxia	INTENSITY RESISTANCE EXERCISE; GROWTH-HORMONE; ADIPOSE-TISSUE; REPEATED BOUTS; MEN; LIPOLYSIS; IMPACT	Objective: Sprint exercise and hypoxic stimulus during exercise are potent factors affecting hormonal and metabolic responses. However, the effects of different hypoxic levels on hormonal and metabolic responses during sprint exercise are not known. Here, we examined the effect of different hypoxic conditions on hormonal and metabolic responses during sprint exercise. Design: Seven male subjects participated in three experimental trials: I) sprint exercise under normoxia (NSE); 2) sprint exercise under moderate normobaric hypoxia (16.4% oxygen) (HSE 16.4); and 3) sprint exercise under severe normobaric hypoxia (13.6% oxygen) (HSE 13.6). The sprint exercise consisted of four 30 sail-out cycling bouts with 4-min rest between bouts. Glucose, free fatty acids (FFA), blood lactate, growth hormone (GH), epinephrine (E), norepinephrine (NE), and insulin concentrations in the HSE trials were measured before exposure to hypoxia (pre 1), 15 min after exposure to hypoxia (pre 2), and at 0, 15, 30, 60, 120, and 180 min after the exercise performed in hypoxia. The blood samples in the NSE trial were obtained in normoxia at the same time points as the HSE trials. Results: Circulating levels of glucose, FFA, lactate, GH, E, NE, and insulin significantly increased after all three exercise trials (P < 0.05). The area under the curve (AUC) for GH was significantly higher in the HSE 13.6 trial than in the NSE and HSE 16.4 trials (P < 0.05). A maximal increase in FFA concentration was observed at 180 min after exercise and was not different between trials. Conclusion: These findings suggest that severe hypoxia may be an important factor for the enhancement of GH response to all-out sprint exercise. (C) 2015 Elsevier Ltd. All rights reserved.	[Kon, Michihiro] Chukyo Univ, Sch Int Liberal Studies, Showa Ku, Nagoya, Aichi 4668666, Japan; [Kon, Michihiro; Nakagaki, Kohei; Ebi, Yoshiko] Japan Inst Sports Sci, Dept Sports Sci, Kita Ku, Tokyo 1150056, Japan; [Nishiyama, Tetsunari] Nippon Sport Sci Univ, Dept Phys Educ, Setagaya Ku, Tokyo 1588508, Japan; [Russell, Aaron P.] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Activ & Nutr Res, Burwood, Vic 3125, Australia	Kon, M (reprint author), Chukyo Univ, Sch Int Liberal Studies, Showa Ku, 101-2 Yagotohonmachi, Nagoya, Aichi 4668666, Japan.	kon.michihiro@gmail.com			Ministry of Education, Culture, Sports, Science, and Technology of Japan [26750319]; Japan Institute of Sports Sciences	We thank members of the hypoxic research project in Japan Institute of Sports Sciences for their excellent technical support. We also thank clinical laboratory technicians in Japan Institute of Sports Sciences and University of Tsukuba for help with conduct of the clinical portion of this study. We also thank Yusuke Ikeda and Wataru Takashima for their excellent experimental assistances. This work was supported by a grant-in-aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (No. 26750319; M. K), and a grant-in-aid for Scientific Research from the Japan Institute of Sports Sciences.	Amer P., 1990, J CLIN INVEST, V85, P893; Gravholt CH, 1999, AM J PHYSIOL-ENDOC M, V277, pE848; Smith KJ, 2010, EUR J APPL PHYSIOL, V109, P989, DOI 10.1007/s00421-010-1444-4; Stokes KA, 2013, EUR J APPL PHYSIOL, V113, P775, DOI 10.1007/s00421-012-2487-5; Stokes KA, 2002, J SPORT SCI, V20, P487, DOI 10.1080/02640410252925152; Takarada Y, 2000, J APPL PHYSIOL, V88, P61; Katayama K, 2010, METABOLISM, V59, P959, DOI 10.1016/j.metabol.2009.10.017; Wee J, 2005, GROWTH HORM IGF RES, V15, P397, DOI 10.1016/j.ghir.2005.08.003; GORDON SE, 1994, J APPL PHYSIOL, V76, P821; Bowtell JL, 2014, J SCI MED SPORT, V17, P399, DOI 10.1016/j.jsams.2013.05.016; Pritzlaff CJ, 1999, J APPL PHYSIOL, V87, P498; Beaumont Coste M., 2004, CHRONOBIOL INT, V21, P419; Enevoldsen LH, 2007, CLIN PHYSIOL FUNCT I, V27, P320, DOI 10.1111/j.1475-097X.2007.00754.x; Faiss R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056522; Goto K, 2005, MED SCI SPORT EXER, V37, P955, DOI 10.1249/01.mss.0000170470.98084.39; Ho JY, 2014, RES SPORTS MED, V22, P240, DOI 10.1080/15438627.2014.915834; Kon M., 2014, PHYS REP, V6; Kon M, 2012, J STRENGTH COND RES, V26, P611, DOI 10.1519/JSC.0b013e3182281c69; Kon M, 2010, MED SCI SPORT EXER, V42, P1279, DOI 10.1249/MSS.0b013e3181ce61a5; Kurobe K, 2015, CLIN PHYSIOL FUNCT I, V35, P197, DOI 10.1111/cpf.12147; Oopik V, 2014, GROWTH HORM IGF RES, V24, P2, DOI 10.1016/j.ghir.2013.10.001; Salgueiro R.B., 2014, 5ROWTH HORMON IGF RE, V24, P268; Stallknecht B, 2001, J PHYSIOL-LONDON, V536, P283, DOI 10.1111/j.1469-7793.2001.00283.x; Stokes K, 2005, J APPL PHYSIOL, V99, P1254, DOI 10.1152/japplphysiol.00839.2004; Stokes KA, 2008, J APPL PHYSIOL, V104, P724, DOI 10.1152/japplphysiol.00534.2007; SUTTON JR, 1977, J APPL PHYSIOL, V42, P587	26	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1096-6374	1532-2238		GROWTH HORM IGF RES	Growth Horm. IGF Res.	JUN	2015	25	3					121	126		10.1016/j.ghir.2015.03.002		6	Cell Biology; Endocrinology & Metabolism	Cell Biology; Endocrinology & Metabolism	CJ7WR	WOS:000355711600004		
J	Fujino, H; Kimura, T; Aikata, H; Miyaki, D; Kawaoka, T; Kan, H; Fukuhara, T; Kobayashi, T; Naeshiro, N; Honda, Y; Tsuge, M; Hiramatsu, A; Imamura, M; Kawakami, Y; Hyogo, H; Takahashi, S; Yoshimatsu, R; Yamagami, T; Kenjo, M; Nagata, Y; Awai, K; Chayama, K				Fujino, Hatsue; Kimura, Tomoki; Aikata, Hiroshi; Miyaki, Daisuke; Kawaoka, Tomokazu; Kan, Hiromi; Fukuhara, Takayuki; Kobayashi, Tomoki; Naeshiro, Noriaki; Honda, Yohji; Tsuge, Masataka; Hiramatsu, Akira; Imamura, Michio; Kawakami, Yoshiiku; Hyogo, Hideyuki; Takahashi, Shoichi; Yoshimatsu, Rika; Yamagami, Takuji; Kenjo, Masahiro; Nagata, Yasushi; Awai, Kazuo; Chayama, Kazuaki			Role of 3-D conformal radiotherapy for major portal vein tumor thrombosis combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma	HEPATOLOGY RESEARCH			English	Article						hepatic arterial infusion chemotherapy; hepatocellular carcinoma; portal vein tumor thrombosis; radiotherapy	ENDOTHELIAL GROWTH-FACTOR; RADIATION-THERAPY; TRANSARTERIAL CHEMOEMBOLIZATION; SORAFENIB; 5-FLUOROURACIL; CISPLATIN; EFFICACY; CANCER; SURVIVAL; ABLATION	AimTo evaluate the response, survival and safety on 3-D conformal radiotherapy (3D-CRT) for major portal vein tumor thrombosis (PVTT) combined with hepatic arterial infusion chemotherapy (HAIC) for advanced hepatocellular carcinoma (HCC). MethodsIn this retrospective study, 83 advanced HCC patients treated with HAIC who met the following criteria were enrolled: (i) PVTT of the main trunk or first branch of the portal vein; (ii) no extrahepatic metastasis; (iii) Child-Pugh score of 5-7; (iv) performance status of 0 or 1; and (v) no history of sorafenib treatment. The response, overall survival (OS), time to treatment failure (TTF), post-progression survival (PPS) and safety were compared between HAIC combined with 3D-CRT for PVTT (RT group, n=41) and HAIC alone (non-RT group, n=42). ResultsThe objective response of PVTT was significantly higher in the RT group (56.1%) than in the non-RT group (33.3%), while that of intrahepatic tumor and OS were not significantly different between groups. Median OS, TTF and PPS were significantly longer in the RT group than in the non-RT group (8.6 and 5.0 months, 5.0 and 2.7 months, and 5.3 and 1.5 months, respectively) among intrahepatic tumor non-responders to HAIC, whereas those were not significantly different between groups among intrahepatic tumor responders to HAIC. By multivariate analysis, the combination of 3D-CRT with HAIC was an independent contributing factor for OS (hazard ratio, 3.2; 95% confidence interval, 1.692-6.021; P<0.001) among intrahepatic HCC non-responders to HAIC. Conclusion3D-CRT for PVTT combined with HAIC could provide survival benefit to non-responder to HAIC.	[Fujino, Hatsue; Aikata, Hiroshi; Miyaki, Daisuke; Kawaoka, Tomokazu; Kan, Hiromi; Fukuhara, Takayuki; Kobayashi, Tomoki; Naeshiro, Noriaki; Honda, Yohji; Tsuge, Masataka; Hiramatsu, Akira; Imamura, Michio; Kawakami, Yoshiiku; Hyogo, Hideyuki; Takahashi, Shoichi; Chayama, Kazuaki] Hiroshima Univ, Inst Biomed & Hlth Sci, Appl Life Sci, Dept Gastroenterol & Metab, Hiroshima 7348551, Japan; [Kimura, Tomoki; Kenjo, Masahiro; Nagata, Yasushi] Hiroshima Univ, Grad Sch Biomed Sci, Dept Radiat Oncol, Hiroshima 7348551, Japan; [Yoshimatsu, Rika; Yamagami, Takuji; Awai, Kazuo] Hiroshima Univ, Grad Sch Biomed Sci, Dept Diagnost Radiol, Hiroshima 7348551, Japan	Aikata, H (reprint author), Hiroshima Univ, Appl Life Sci Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	aikata@hiroshima-u.ac.jp					Abou-Alfa Ghassan K, 2011, Gastrointest Cancer Res, V4, P40; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Hollebecque A, 2011, ALIMENT PHARM THER, V34, P1193, DOI 10.1111/j.1365-2036.2011.04860.x; Pawlik TM, 2005, SURGERY, V137, P403, DOI 10.1016/j.surg.2004.12.012; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Miyahara K, 2011, J GASTROEN HEPATOL, V26, P1604, DOI 10.1111/j.1440-1746.2011.06887.x; Yamashita T, 2011, ONCOLOGY-BASEL, V81, P281, DOI 10.1159/000334439; Bruix J, 2012, J HEPATOL, V57, P821, DOI 10.1016/j.jhep.2012.06.014; Sugimoto K, 2013, LIVER INT, V33, P605, DOI 10.1111/liv.12098; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Yoon S, 2012, INT J RADIAT ONCOL, V82, P2004, DOI 10.1016/j.ijrobp.2011.03.019; Ando E, 1997, CANCER, V79, P1890, DOI 10.1002/(SICI)1097-0142(19970515)79:10<1890::AID-CNCR8>3.0.CO;2-K; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Jeong SW, 2013, GUT LIVER, V7, P696, DOI 10.5009/gnl.2013.7.6.696; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Ueshima K, 2010, ONCOLOGY-BASEL, V78, P148, DOI 10.1159/000315244; Katamura Y, 2009, J GASTROENTEROL, V44, P492, DOI 10.1007/s00535-009-0033-y; Hasegawa K, 2013, J HEPATOL, V58, P724, DOI 10.1016/j.jhep.2012.11.009; Toya R, 2007, RADIOTHER ONCOL, V84, P266, DOI 10.1016/j.radonc.2007.07.005; Sakon M, 2002, CANCER, V94, P435, DOI 10.1002/cncr.10246; Huang YJ, 2009, INT J RADIAT ONCOL, V73, P1155, DOI 10.1016/j.ijrobp.2008.06.1486; Llovet JM, 2012, CLIN CANCER RES, V18, P2290, DOI 10.1158/1078-0432.CCR-11-2175; Kawaoka T, 2012, ONCOLOGY-BASEL, V83, P192, DOI 10.1159/000341347; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Tsuchiya K, 2014, CANCER-AM CANCER SOC, V120, P229, DOI 10.1002/cncr.28384; Hans KH, 2008, CANCER, V113, P995; Itamoto T, 2002, J SURG ONCOL, V80, P143, DOI 10.1002/jso.10116; Kims DY, 2005, CANCER, V103, P2419; Kims TH, 2006, AM J CLIN ONCOL-CANC, V29, P568; Liver Cancer study Group of Japan, 2013, GUID EV BAS CLIN PRA; Niizeki T, 2012, J GASTROENTEROL, V47, P686, DOI 10.1007/s00535-012-0555-6; Obis S, 2006, CANCER, V106, P1990; Okita K, 2006, J GASTROENTEROL, V41, P100, DOI 10.1007/s00535-005-1763-0; Otas H, 2005, BRIT J CANCER, V93, P557; Pans CC, 2010, INT J RADIAT ONCOL, V76, pS94; Rossi S, 1996, AM J ROENTGENOL, V167, P759; Takayasu K, 2012, J HEPATOL, V56, P886, DOI 10.1016/j.jhep.2011.10.021; Tanaka Y, 2014, J GASTROEN HEPATOL, V29, P352, DOI 10.1111/jgh.12333; Ukas K, 2007, LIVER INT, V27, P1209; Yamasakis T, 2011, HEPATOL RES, V42, P340; Zeng ZC, 2008, CANCER SCI, V99, P2510, DOI 10.1111/j.1349-7006.2008.00981.x	41	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	JUN	2015	45	6					607	617		10.1111/hepr.12392		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CJ7EL	WOS:000355657100001		
J	Komatsu, H; Inui, A; Fujisawa, T; Takano, T; Tajiri, H; Murakami, J; Suzuki, M				Komatsu, Haruki; Inui, Ayano; Fujisawa, Tomoo; Takano, Tomoko; Tajiri, Hitoshi; Murakami, Jun; Suzuki, Mitsuyoshi			Transmission route and genotype of chronic hepatitis B virus infection in children in Japan between 1976 and 2010: A retrospective, multicenter study	HEPATOLOGY RESEARCH			English	Article						genotype; hepatitis B immunoglobulin; immunoprophylaxis; mother-to-child transmission; vaccine	INDUCED ESCAPE MUTANT; PERINATAL TRANSMISSION; VERTICAL TRANSMISSION; HOUSEHOLD CONTACTS; VIRAL-HEPATITIS; VACCINATION; PREVENTION; IMMUNIZATION; IMPLEMENTATION; KNOWLEDGE	AimThe aim of this study was to clarify the trends of the infectious source of chronic hepatitis B virus (HBV) infection and the HBV genotype in the Japanese pediatric population over the last three decades. MethodsThe present study was a retrospective, nationwide, multicenter study. Patients who were under 20 years of age when diagnosed with chronic HBV infection were eligible for enrollment in this study. A total of 430 patients (male/female, 256/174; age at the time of writing, 1-37 years; median age, 14 years; birth year, 1976-2010) from 11 hospitals were evaluated. ResultsThe incidence of chronic HBV infection from 1976 to 1980, 1981-1985, 1986-1990, 1991-1995, 1996-2000, 2001-2005 and 2006-2010 was 56, 52, 34, 37, 81, 92 and 78, respectively. Of the 430 patients, 304 (71%), 61 (14%), 11 (3%) and 54 (13%) were infected via mother-to-child transmission, close contact, blood transfusion and unknown source, respectively. After the introduction of perinatal immunoprophylaxis, the rate of mother-to-child transmission increased from 62% during the 1991-1995 period to 86% during the 2006-2010 period. The distributions of genotypes A, B, C, D and F were 3%, 9%, 86%, 2% and 1%, respectively. No obvious change was observed in the distribution of genotypes. Genotype C was significantly associated with mother-to-child transmission. ConclusionMother-to-child transmission remains the primary source of chronic HBV infection after the introduction of immunoprophylaxis. Taking measures to prevent immunoprophylaxis failure is essential to reduce pediatric chronic HBV infection in Japan.	[Komatsu, Haruki; Inui, Ayano; Fujisawa, Tomoo] Toho Univ, Sakura Med Ctr, Dept Pediat, Shimoshizu, Sakura, Japan; [Komatsu, Haruki] Saiseikai Yokohama City Tobu Hosp, Dept Pediat Hepatol & Gastroenterol, Yokohama, Kanagawa, Japan; [Takano, Tomoko; Tajiri, Hitoshi] Osaka Gen Med Ctr, Dept Pediat, Osaka, Japan; [Murakami, Jun] Tottori Univ, Fac Med, Div Pediat & Perinatol, Tottori 680, Japan; [Suzuki, Mitsuyoshi] Juntendo Univ, Sch Med, Dept Pediat, Tokyo 113, Japan	Komatsu, H (reprint author), Toho Univ, Sakura Med Ctr, Dept Pediat, 564-1 Shimoshizu Sakura, Chiba 2858741, Japan.	haruki-komatsu@chive.ocn.ne.jp			Ministry of Health, Labor and Welfare of Japan [H23-Jutuyouka-Ippan-005]	THIS WORK WAS supported by a Grant-in-Aid for hepatitis research from the Ministry of Health, Labor and Welfare of Japan (H23-Jutuyouka-Ippan-005). The authors would like to thank the following participating physicians for collaborating with data collection: Daiki Abukawa (Miyagi Children's Hospital), Hiroshi Kimura (Department of Pediatrics, Nagoya University Graduate School of Medicine), Takayuki Hoshina (Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University), Tsuyoshi Endo (Department of Pediatrics and Neonatology, Nagoya City University), Yoko Miyoshi (Department of Pediatrics, Osaka University Graduate School of Medicine), Yuko Yoto (Department of Pediatrics, Sapporo Medical University School of Medicine) and Yuri Etani (Department of Pediatric Gastroenterology and Nutrition, Osaka Medical Center and Research Institute for Maternal and Child Health).	WATERS JA, 1992, J CLIN INVEST, V90, P2543, DOI 10.1172/JCI116148; Ragheb M, 2012, J MED VIROL, V84, P587, DOI 10.1002/jmv.23234; Tanaka J, 2011, INTERVIROLOGY, V54, P185, DOI 10.1159/000324525; Zuckerman J, 2007, LANCET INFECT DIS, V7, P410, DOI 10.1016/S1473-3099(07)70136-6; Tamada Y, 2012, GUT, V61, P765, DOI 10.1136/gutjnl-2011-300832; Song YM, 2007, EUR J PEDIATR, V166, P813, DOI 10.1007/s00431-006-0327-5; Takahashi K, 2012, J PUBLIC HEALTH POL, V33, P136, DOI 10.1057/jphp.2011.53; Yano K, 2010, INTERVIROLOGY, V53, P70, DOI 10.1159/000252788; CARMAN WF, 1990, LANCET, V336, P325, DOI 10.1016/0140-6736(90)91874-A; Tajiri H, 2007, J MED VIROL, V79, P922, DOI 10.1002/jmv.20916; Tadokoro K, 2006, J VIROL METHODS, V138, P30, DOI 10.1016/j.jviromet.2006.07.014; Chang MH, 2000, JAMA-J AM MED ASSOC, V284, P3040, DOI 10.1001/jama.284.23.3040; Shimizu I, 2007, WORLD J GASTROENTERO, V13, P4295; Brouard C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-576; Bzowej N. H., 2012, Current Hepatitis Reports, V11, P82, DOI 10.1007/s11901-012-0130-x; Yoshikura H, 2001, JPN J INFECT DIS, V54, P201; Crutzen Rik, 2012, J Infect Public Health, V5, P195, DOI 10.1016/j.jiph.2011.12.001; Francois Guido, 2002, Vaccine, V21, P1, DOI 10.1016/S0264-410X(02)00440-1; Guos Z, 2013, J VIRAL HEPATITUS, V20, P317; Hahne S, 2012, VACCINE, V30, P1715, DOI 10.1016/j.vaccine.2011.12.071; Hans GR, 2011, J HEPATOL, V55, P1215; Houweling H, 2011, VACCINE, V29, P8960, DOI 10.1016/j.vaccine.2011.09.042; Hus Y, 2012, BMC INFECT DIS, V12, P221; Iitsuka T, 2010, HEPATOL RES, V40, P878, DOI 10.1111/j.1872-034X.2010.00694.x; Inui A, 2007, J MED VIROL, V79, P670, DOI 10.1002/jmv.20884; Itos K, 2014, HEPATOLOGY, V59, P89; Jonas Maureen M, 2010, Hepatology, V52, P2192, DOI 10.1002/hep.23934; Komatsu H, 2009, HEPATOL RES, V39, P569, DOI 10.1111/j.1872-034X.2009.00496.x; Komatsu H, 2011, J INFECT CHEMOTHER, V17, P272, DOI 10.1007/s10156-010-0107-z; Lins CL, 2005, CLIN INFECT DIS, V41, P1576; Lis F, 2012, VACCINE, V30, P7118; LONDON WT, 1977, P NATL ACAD SCI USA, V74, P2561, DOI 10.1073/pnas.74.6.2561; Mereckienes J, 2009, VACCINE, V28, P4470; Moriya T, 2002, J CLIN MICROBIOL, V40, P877, DOI 10.1128/JCM.40.3.877-880-2002; Mus SC, 2011, J MED VIROL, V83, P783; Pans CQ, 2012, CLIN GASTROENTEROL H, V10, P520; Pans CQ, 2012, CLIN GASTROENTEROL H, V10, P452; Pans CQ, 2013, CLIN GASTROENTEROL H, V11, P1349; Raimondo G, 2007, DIGEST LIVER DIS, V39, P257, DOI 10.1016/j.dld.2006.12.010; Richardson G, 2001, J EPIDEMIOL COMMUN H, V55, P934, DOI 10.1136/jech.55.12.934; Schenkel K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-132; Scognamiglio P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-86; Shiraki K, 2000, J GASTROEN HEPATOL, V15, pE11, DOI 10.1046/j.1440-1746.2000.02098.x; Shis Z, 2010, OBSTET GYNECOL, V116, P147; Siddiqui MR, 2011, VACCINE, V29, P466, DOI 10.1016/j.vaccine.2010.10.075; Singh AE, 2011, J VIRAL HEPATITIS, V18, P468, DOI 10.1111/j.1365-2893.2010.01333.x; vans Steenbergens JE, 2004, J HEPATOL, V40, P979; Wens WH, 2013, J HEPATOL, V59, P24; Wens WH, 2011, HEPATOLOGY, V53, P429; Willis BC, 2010, PEDIATRICS, V125, P704, DOI 10.1542/peds.2009-1831; World Health Organization, 2013, HEP B; Yins Y, 2013, J INFECTION, V66, P447; Zous H, 2012, J VIRAL HEPATITUS, V19, pe18	53	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	JUN	2015	45	6					629	637		10.1111/hepr.12396		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CJ7EL	WOS:000355657100003		
J	Takahashi, A; Ohira, H; Abe, K; Miyake, Y; Abe, M; Yamamoto, K; Suzuki, Y; Onji, M; Tsubouchi, H				Takahashi, Atsushi; Ohira, Hiromasa; Abe, Kazumichi; Miyake, Yasuhiro; Abe, Masanori; Yamamoto, Kazuhide; Suzuki, Yoshiyuki; Onji, Morikazu; Tsubouchi, Hirohito		Intractable Liver Biliary Dis	Rapid corticosteroid tapering: Important risk factor for type 1 autoimmune hepatitis relapse in Japan	HEPATOLOGY RESEARCH			English	Article						autoimmune hepatitis; corticosteroid taper rate; relapse; risk factors	CHRONIC ACTIVE HEPATITIS; TREATMENT WITHDRAWAL; SUSTAINED REMISSION; PROGNOSIS; THERAPY; CLASSIFICATION; DIAGNOSIS; FEATURES	AimPatients with autoimmune hepatitis (AIH) sometimes relapse after immunosuppressive therapies are discontinued or sometimes even while they are still being administrated. Furthermore, relapse often occurs in the absence of AIH relapse risk factors. This study aimed to identify the frequency of relapse and to analyze the risk factors associated with relapse in type 1 AIH patients. MethodsClinical characteristics and therapeutic processes were assessed in 129 type 1 AIH patients. ResultsRelapse was identified in 39 (30.2%) type 1 AIH patients after alanine aminotransferase (ALT) level normalization. ALT levels significantly increased when corticosteroid treatment was initiated in relapsed patients compared with that in patients with sustained remission. The reduction dose and rate of corticosteroid taper were significantly increased in relapsed patients compared with those in sustained remission patients. Moreover, positive correlations were identified between the reduction dose/taper rate and initial corticosteroid dose, and ALT levels, total bilirubin levels and hepatitis activity. Multivariate logistic regression analysis identified the corticosteroid reduction rate as significantly associated with AIH relapse. ConclusionCorticosteroid reduction taper rate until ALT normalization is an important AIH relapse risk factor.	[Takahashi, Atsushi; Ohira, Hiromasa; Abe, Kazumichi] Fukushima Med Univ, Dept Gastroenterol & Rheumatol, Sch Med, Fukushima 9601295, Japan; [Miyake, Yasuhiro; Yamamoto, Kazuhide] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama 7008530, Japan; [Abe, Masanori; Onji, Morikazu] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Japan; [Suzuki, Yoshiyuki] Toranomon Gen Hosp, Dept Hepatol, Tokyo, Japan; [Tsubouchi, Hirohito] Kagoshima City Hosp, Kagoshima, Japan	Takahashi, A (reprint author), Fukushima Med Univ, Dept Gastroenterol & Rheumatol, 1 Hikarigaoka, Fukushima 9601295, Japan.	junior@fmu.ac.jp			MINISTRY OF Health, Labor and Welfare of Japan	THE MINISTRY OF Health, Labor and Welfare of Japan supported this study as a project of the Intractable Liver Diseases Study Group of Japan from April 2011 through March 2014.	Alvarez F., 1999, Journal of Hepatology, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Czaja AJ, 2003, LIVER INT, V23, P116, DOI 10.1034/j.1600-0676.2003.00810.x; Czaja AJ, 2002, HEPATOLOGY, V35, P890, DOI 10.1053/jhep.2002.32485; CZAJA AJ, 1980, GASTROENTEROLOGY, V78, P518; CZAJA AJ, 1984, HEPATOLOGY, V4, P622, DOI 10.1002/hep.1840040409; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; HEGARTY JE, 1983, HEPATOLOGY, V3, P685; Al-Chalabi T, 2007, AM J GASTROENTEROL, V102, P1013, DOI 10.1111/j.1572-0241.2007.01147.x; Miyake Y, 2005, J HEPATOL, V43, P951, DOI 10.1016/j.jhep.2005.06.006; Montano-Loza AJ, 2007, AM J GASTROENTEROL, V102, P1005, DOI 10.1111/j.1572-0241.2007.01153.x; Yokokawa J, 2011, HEPATOL RES, V41, P641, DOI 10.1111/j.1872-034X.2011.00812.x; Czaja AJ, 1987, GASTROENTEROLOGY, V92, P215; CZAJA AJ, 1981, NEW ENGL J MED, V304, P5, DOI 10.1056/NEJM198101013040102; Verma S, 2004, AM J GASTROENTEROL, V99, P1510, DOI 10.1111/j.1572.0241.2004.30457.x; Manns MP, 2010, HEPATOLOGY, V51, P2193, DOI 10.1002/hep.23584; Yoshizawa K, 2012, HEPATOLOGY, V56, P668, DOI 10.1002/hep.25658; Hoeroldt B, 2011, GASTROENTEROLOGY, V140, P1980, DOI 10.1053/j.gastro.2011.02.065; Montano-Loza AJ, 2007, LIVER INT, V27, P507, DOI 10.1111/j.1478-3231.2007.01444.x; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1016/0270-9139(94)90250-X; Kanzlers S, 2013, J HEPATOL, V58, P141; vans Gervens NM, 2001, J HEPATOL, V34, P354	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	JUN	2015	45	6					638	644		10.1111/hepr.12397		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CJ7EL	WOS:000355657100004		
J	Fujiwara, N; Tateishi, R; Nakagawa, H; Nakagomi, R; Kondo, M; Minami, T; Sato, M; Uchino, K; Enooku, K; Kondo, Y; Asaoka, Y; Shiina, S; Yoshida, H; Koike, K				Fujiwara, Naoto; Tateishi, Ryosuke; Nakagawa, Hayato; Nakagomi, Ryo; Kondo, Mayuko; Minami, Tatsuya; Sato, Masaya; Uchino, Koji; Enooku, Kenichiro; Kondo, Yuji; Asaoka, Yoshinari; Shiina, Shuichiro; Yoshida, Haruhiko; Koike, Kazuhiko			Slight elevation of high-sensitivity C-reactive protein to predict recurrence and survival in patients with early stage hepatitis C-related hepatocellular carcinoma	HEPATOLOGY RESEARCH			English	Article						curative treatment; hepatocellular carcinoma; high-sensitivity C-reactive protein; prognosis; recurrence	COMPUTED-TOMOGRAPHY; RADIOFREQUENCY ABLATION; PROGNOSTIC BIOMARKERS; GENE-EXPRESSION; SERUM; INFLAMMATION; MARKERS; RISK; INTERLEUKIN-6; STATISTICS	AimHepatocellular carcinoma (HCC) is associated with chronic inflammation derived from various origins. We investigated whether high-sensitivity C-reactive protein (hsCRP) could predict recurrence and survival after curative treatment for early stage hepatitis C virus-related HCC (C-HCC). MethodsWe enrolled 387 patients with three or fewer C-HCC nodules, none of which exceeded 3cm, and of Child-Pugh class A or B who underwent radiofrequency ablation. We divided the patients into high and low hsCRP groups based on the optimal cut-off value for recurrence using a split-sample method and maximally selected rank statistics. Differences in recurrence and survival rates were evaluated by the Kaplan-Meier method and the log-rank test. Hazard ratios of hsCRP were adjusted with confounding factors using a multiple Cox regression model. We also assessed the correlations between hsCRP levels and clinical parameters. ResultsThe optimal hsCRP cut-off value was 0.08mg/dL. The cumulative recurrence rates after 5 years in the high and low hsCRP groups were 90.0% and 82.2%, respectively (P=0.028), and the corresponding survival rates were 50.9% and 71.8%, respectively (P<0.001). Higher hsCRP was an independent predictor for recurrence (adjusted hazard ratio [aHR], 1.32; 95% confidence interval [CI], 1.03-1.67; P=0.026) and survival (aHR, 1.59; 95% CI, 1.14-2.22; P=0.007). hsCRP was correlated with central obesity as well as tumor burden and liver dysfunction. ConclusionSlight elevation of the hsCRP level, even within the normal range, can predict recurrence and survival after curative treatment among patients with early stage C-HCC.	[Fujiwara, Naoto; Tateishi, Ryosuke; Nakagawa, Hayato; Nakagomi, Ryo; Kondo, Mayuko; Minami, Tatsuya; Sato, Masaya; Uchino, Koji; Enooku, Kenichiro; Kondo, Yuji; Asaoka, Yoshinari; Yoshida, Haruhiko; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo 1138655, Japan; [Shiina, Shuichiro] Juntendo Univ, Dept Gastroenterol, Tokyo, Japan	Tateishi, R (reprint author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tateishi-tky@umin.ac.jp	Nakagawa, Hayato/I-2837-2012		Ministry of Health, Labor and Welfare of Japan	This work was supported by Health Sciences Research Grants of The Ministry of Health, Labor and Welfare of Japan (Research on Hepatitis). No additional external funding was received for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Nakagawa H, 2009, INT J CANCER, V125, P2264, DOI 10.1002/ijc.24720; Proctor MJ, 2013, CANCER-AM CANCER SOC, V119, P2325, DOI 10.1002/cncr.28018; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Jang JW, 2012, CYTOKINE, V60, P686, DOI 10.1016/j.cyto.2012.07.017; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Ridker PM, 2001, CIRCULATION, V103, P1813; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Raoul JL, 2012, J HEPATOL, V56, P1080, DOI 10.1016/j.jhep.2011.12.009; EDMONDSON HA, 1954, CANCER, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Nault JC, 2013, CANCER EPIDEM BIOMAR, V22, P1343, DOI 10.1158/1055-9965.EPI-13-0179; GANTER U, 1989, EMBO J, V8, P3773; Jonsson JR, 2008, HEPATOLOGY, V48, P80, DOI 10.1002/hep.22311; Torzilli G, 1999, HEPATOLOGY, V30, P889, DOI 10.1002/hep.510300411; Sharma D, 2010, HEPATOLOGY, V52, P1713, DOI 10.1002/hep.23892; Villasenor A, 2014, CANCER EPIDEM BIOMAR, V23, P189, DOI 10.1158/1055-9965.EPI-13-0852; Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933; Siemes C, 2006, J CLIN ONCOL, V24, P5216, DOI 10.1200/JCO.2006.07.1381; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Tateishi R, 2006, HEPATOLOGY, V44, P1518, DOI 10.1002/hep.21408; Sherman M, 2008, NEW ENGL J MED, V359, P2045, DOI 10.1056/NEJMe0807581; Hashimoto K, 2005, CANCER-AM CANCER SOC, V103, P1856, DOI 10.1002/cncr.20976; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Saxena NK, 2010, GASTROENTEROLOGY, V139, P1762, DOI 10.1053/j.gastro.2010.07.001; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Tsuchiya K, 2014, CANCER-AM CANCER SOC, V120, P229, DOI 10.1002/cncr.28384; Ans HJ, 2012, LIVER TRANSPLANT, V18, P1406; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Dufour JF, 2013, HEPATOLOGY, V57, P2103, DOI 10.1002/hep.26250; Fujishima T, 2005, J GASTROENTEROL, V40, P266, DOI 10.1007/s00535-004-1533-4; LAUSEN B, 1992, BIOMETRICS, V48, P73, DOI 10.2307/2532740; Omata M, 2004, GASTROENTEROLOGY, V127, pS159, DOI 10.1053/j.gastro.2004.09.030; Pang RWC, 2012, NAT REV GASTRO HEPAT, V9, P691, DOI 10.1038/nrgastro.2012.208; Rhodes B, 2011, NAT REV RHEUMATOL, V7, P283, DOI 10.1038/nrrheum.2011.37; Sieghart W, 2013, HEPATOLOGY, V57, P2224, DOI 10.1002/hep.26057; Teratani T, 2004, LIVER INT, V24, P619, DOI 10.1111/j.1478-3231.2004.0959.x; Zhao BS, 2006, J COMPUT ASSIST TOMO, V30, P777, DOI 10.1097/01.rct.0000228164.08968.e8	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	JUN	2015	45	6					645	655		10.1111/hepr.12398		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CJ7EL	WOS:000355657100005		
J	Naeshiro, N; Aikata, H; Hyogo, H; Kan, H; Fujino, H; Kobayashi, T; Fukuhara, T; Honda, Y; Nakahara, T; Ohno, A; Miyaki, D; Murakami, E; Kawaoka, T; Tsuge, M; Hiraga, N; Hiramatsu, A; Imamura, M; Kawakami, Y; Ochi, H; Chayama, K				Naeshiro, Noriaki; Aikata, Hiroshi; Hyogo, Hideyuki; Kan, Hiromi; Fujino, Hatsue; Kobayashi, Tomoki; Fukuhara, Takayuki; Honda, Yohji; Nakahara, Takashi; Ohno, Atsushi; Miyaki, Daisuke; Murakami, Eisuke; Kawaoka, Tomokazu; Tsuge, Masataka; Hiraga, Nobuhiko; Hiramatsu, Akira; Imamura, Michio; Kawakami, Yoshiiku; Ochi, Hidenori; Chayama, Kazuaki			Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis	HEPATOLOGY RESEARCH			English	Article						anticoagulation; danaparoid sodium; liver cirrhosis; portal vein thrombosis	BUDD-CHIARI-SYNDROME; FACTOR-V-LEIDEN; PLACED MESENTERIC CATHETER; VENOUS THROMBOSIS; RISK-FACTORS; MUTATION; HEPARIN; THROMBOEMBOLISM; THROMBOPHILIA; THROMBOLYSIS	AimTo assess the efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis (PVT) in patients with liver cirrhosis. MethodsA consecutive 26 cirrhotic patients with PVT were enrolled in this retrospective cohort study. The etiologies of cirrhosis were hepatitis B virus-related, hepatitis C virus-related, alcoholic and cryptogenic in five, 14, three and four patients, respectively. Child-Pugh grade A, B and C was noted in 13, eight and five patients, respectively. Patients were treated with 2 weeks' administration of danaparoid sodium followed by the evaluation of PVT reduction and adverse events. ResultsAll patients experienced reduction of PVT through the treatment. The median volume of PVT before and after treatment was 2.40cm(3) (range, 0.18-16.63) and 0.37cm(3) (range, 0-5.74), respectively. The median reduction rate of PVT volume was 77.3% (range, 18-100%). According to the reduction rate, complete reduction (CR), partial reduction (PR, 50%) and stable disease (SD, <50%) were observed in four (15%), 16 (62%) and six patients (23%), respectively. The median volume of PVT before treatment was significantly different between CR+PR and SD (2.09 vs 4.35cm(3), P=0.045). No severe adverse events such as bleeding symptoms (e.g. gastrointestinal bleeding and cerebral hemorrhage) and thrombocytopenia were encountered. ConclusionDanaparoid sodium for the treatment of PVT in patients with liver cirrhosis was safe and effective. Therefore, anticoagulation therapy with danaparoid sodium could have potential as one of the treatment options in PVT accompanied by cirrhosis.	[Naeshiro, Noriaki; Aikata, Hiroshi; Hyogo, Hideyuki; Kan, Hiromi; Fujino, Hatsue; Kobayashi, Tomoki; Fukuhara, Takayuki; Honda, Yohji; Nakahara, Takashi; Ohno, Atsushi; Miyaki, Daisuke; Murakami, Eisuke; Kawaoka, Tomokazu; Tsuge, Masataka; Hiraga, Nobuhiko; Hiramatsu, Akira; Imamura, Michio; Kawakami, Yoshiiku; Ochi, Hidenori; Chayama, Kazuaki] Hiroshima Univ Hosp, Dept Gastroenterol & Metab, Hiroshima 7348551, Japan	Aikata, H (reprint author), Hiroshima Univ Hosp, Dept Gastroenterol & Metab, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	aikata@hiroshima-u.ac.jp					Amitrano L, 2001, AM J GASTROENTEROL, V96, P146; Condat B, 2000, HEPATOLOGY, V32, P466, DOI 10.1053/jhep.2000.16597; Amitrano L, 2010, J CLIN GASTROENTEROL, V44, P448, DOI 10.1097/MCG.0b013e3181b3ab44; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Janssen HLA, 2000, BLOOD, V96, P2364; Mahmoud AEA, 1997, GUT, V40, P798; Denninger MH, 2000, HEPATOLOGY, V31, P587, DOI 10.1002/hep.510310307; Primignani M, 2005, HEPATOLOGY, V41, P603, DOI 10.1002/hep.20591; Ferro C, 2007, CARDIOVASC INTER RAD, V30, P1070, DOI 10.1007/s00270-007-9137-z; Parikh S, 2010, AM J MED, V123, P111, DOI 10.1016/j.amjmed.2009.05.023; Mohanty D, 2001, HEPATOLOGY, V34, P666, DOI 10.1053/jhep.2001.27948; Bhattacharyya M, 2004, AM J CLIN PATHOL, V121, P844, DOI 10.1309/F2U1XBV4RXYUAYG0; Chamouard P, 1999, GASTROENTEROLOGY, V116, P144, DOI 10.1016/S0016-5085(99)70238-6; Amitrano L, 2004, J HEPATOL, V40, P736, DOI 10.1016/j.jhep.2004.01.001; Kearon C, 2007, CURR OPIN PULM MED, V13, P398; Ahuja V, 1999, J GASTROEN HEPATOL, V14, P1210, DOI 10.1046/j.1440-1746.1999.02030.x; Egesel T, 2000, J CLIN GASTROENTEROL, V30, P66, DOI 10.1097/00004836-200001000-00013; DeLeve LD, 2009, HEPATOLOGY, V49, P1729, DOI 10.1002/hep.22772; Breddin HK, 2001, NEW ENGL J MED, V344, P626, DOI 10.1056/NEJM200103013440902; HOBBELEN PMJ, 1987, THROMB RES, V48, P549, DOI 10.1016/0049-3848(87)90386-0; IDEZUKI Y, 1995, WORLD J SURG, V19, P420; Kaplan JL, 2004, AM SURGEON, V70, P600; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Lais W, 2012, WORLD J GASTROENTERO, V18, P3443; Lius FY, 2010, HEPATO-GASTROENTEROL, V57, P1367; MEULEMAN DG, 1992, HAEMOSTASIS, V22, P58; Ozdogan M, 2006, SURG TODAY, V36, P846, DOI 10.1007/s00595-006-3243-4; Semiz-Oysu A, 2007, CARDIOVASC INTER RAD, V30, P688, DOI 10.1007/s00270-007-9097-3; Valla Dominique-Charles, 2002, J Gastroenterol Hepatol, V17 Suppl 3, pS224, DOI 10.1046/j.1440-1746.17.s3.4.x; VISSER A, 1990, THROMB RES, V58, P469, DOI 10.1016/0049-3848(91)90252-R	30	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	JUN	2015	45	6					656	662		10.1111/hepr.12400		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CJ7EL	WOS:000355657100006		
J	Arai, H; Abe, T; Takayama, H; Toyoda, M; Ueno, T; Kakizaki, S; Sato, K				Arai, Hirotaka; Abe, Takehiko; Takayama, Hisashi; Toyoda, Mitsuo; Ueno, Takashi; Kakizaki, Satoru; Sato, Ken			Safety and efficacy of balloon-occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma	HEPATOLOGY RESEARCH			English	Article						balloon-occluded transcatheter arterial chemoembolization; hepatocellular carcinoma; miriplatin	SUSPENSION	AimBalloon-occluded transcatheter arterial chemoembolization (B-TACE) using a microballoon catheter was performed to administrate miriplatin, and the early therapeutic efficacy and safety of the procedure were evaluated. MethodsOut of 158 patients who received miriplatin using B-TACE for hepatocellular carcinoma, 49 patients with a single lesion at either stage I or II (according to the Liver Cancer Study Group of Japan) were evaluated in comparison with 48 matched patients who received miriplatin using conventional TACE (C-TACE). ResultsThe mean total dose and median dose of miriplatin in each group were 32.531.7mg and 20mg (C-TACE) and 50.1 +/- 31.3mg and 40mg (B-TACE), respectively (P<0.01). The treatment effect (TE) on the target nodule classified as TE4, TE3, TE2 or TE1 was 39.6%, 33.3%, 25.0% and 2.1%, respectively, in the C-TACE group, and 55.1%, 38.8%, 4.1% and 2.0%, respectively, in the B-TACE group. Therefore, the TE was significantly higher in the B-TACE group (P<0.05). Although abdominal blood tests revealed adverse, increased levels of serum alanine aminotransferase (ALT) in a significantly higher number of B-TACE-treated patients, serum ALT levels returned to baseline levels in all patients within 1 month. There were no significant differences in clinical symptoms between the two groups. ConclusionCompared with C-TACE, B-TACE significantly improved cancer nodule control, and it was satisfactory in terms of safety. B-TACE is an effective procedure that enhances the effects of catheterization with miriplatin.	[Arai, Hirotaka; Abe, Takehiko; Takayama, Hisashi; Toyoda, Mitsuo; Ueno, Takashi] Maebashi Red Cross Hosp, Dept Gastroenterol, Maebashi, Gunma 3710014, Japan; [Kakizaki, Satoru; Sato, Ken] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 371, Japan	Arai, H (reprint author), Maebashi Red Cross Hosp, Dept Gastroenterol, 3-21-36 Asahi Cho, Maebashi, Gunma 3710014, Japan.	h-arai@maebashi.jrc.or.jp					Miyayama S, 2007, J VASC INTERV RADIOL, V18, P365, DOI 10.1016/j.jvir.2006.12.004; Irie T, 2013, CARDIOVASC INTER RAD, V36, P706, DOI 10.1007/s00270-012-0476-z; Imai N, 2012, JPN J CLIN ONCOL, V42, P175, DOI 10.1093/jjco/hyr189; Iries T, 2011, JPN J INTERVENT RADI, V26, P49; Okabe K, 2011, ANTICANCER RES, V31, P2983; Okusaka T, 2004, INVEST NEW DRUG, V22, P169, DOI 10.1023/B:DRUG.0000011793.72775.d1; The Japan Clinical Oncology Group (JCOG)/Japan Society of Clinical Oncology (JSCO), 2010, JAP TRANSL COMM TERM; The Liver Cancer Study Group of Japan, 1999, 13 LIV CANC STUD GRO, V40, P288; The Liver Cancer Study Group of Japan, 2009, 5 SUPPL ED GEN RUL C; The Liver Cancer Study Group of Japan, 2000, 14 LIV CANC STUD GRO, V41, P799	10	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	JUN	2015	45	6					663	666		10.1111/hepr.12403		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CJ7EL	WOS:000355657100007		
J	Takahashi, Y; Kurosaki, M; Tamaki, N; Yasui, Y; Hosokawa, T; Tsuchiya, K; Nakanishi, H; Itakura, J; Izumi, N				Takahashi, Yuka; Kurosaki, Masayuki; Tamaki, Nobuharu; Yasui, Yutaka; Hosokawa, Takanori; Tsuchiya, Kaoru; Nakanishi, Hiroyuki; Itakura, Jun; Izumi, Namiki			Non-alcoholic fatty liver disease fibrosis score and FIB-4 scoring system could identify patients at risk of systemic complications	HEPATOLOGY RESEARCH			English	Article						cerebral-cardiovascular diseases; FIB-4; diabetes; non-alcoholic fatty liver disease; non-alcoholic fatty liver disease fibrosis score	METABOLIC SYNDROME; HEPATITIS-C; STEATOHEPATITIS; POPULATION; PREVALENCE; MORTALITY; BIOPSY; INDEX; MEN	AimTo investigate the relation between systemic complications of non-alcoholic fatty liver disease (NAFLD) and non-invasive fibrosis scores. MethodsThe NAFLD fibrosis score (NFS) and FIB-4 were measured in 1559 people who underwent a complete medical checkup at our hospital and were followed for more than 3 years. Correlation between these scores and prevalence and new incidence rates of diabetes or cerebral-cardiovascular diseases were analyzed. ResultsThe 1559 cases were classified into two groups using the low cut-off values of NFS and FIB-4: group 1 (low cut-off score with fatty liver) and group 2 (the others). In group 1, the prevalence of diabetes and cerebral-cardiovascular diseases at baseline and additional incidences during the observation period was higher compared with group 2. Diabetes at baseline in group 1 versus group 2 were 31.5% versus 3.1% (NFS, P<0.0001), 17.0% versus 4.7% (FIB-4, P<0.0001), and cerebral-cardiovascular diseases at baseline were 7.7% versus 2.3% (NFS, P=0.002) and 9.0% versus 2.3% (FIB-4, P=0.0012). New incidences of diabetes were 4.5% versus 1.2% (NFS, P=0.034) and 3.6% versus 1.2% (FIB-4, P=0.11), and of cerebral-cardiovascular diseases were 5.0% versus 0.9% (NFS, P=0.0019) and 5.4% versus 0.9% (FIB-4, P=0.0034). ConclusionNFS and FIB-4 are useful to extract cases with high risk of systemic complications of NAFLD in the public.	[Takahashi, Yuka; Izumi, Namiki] Musashino Red Cross Hosp, Dept Med Hlth Checkup Ctr, Musashino, Tokyo 1808610, Japan; [Takahashi, Yuka; Kurosaki, Masayuki; Tamaki, Nobuharu; Yasui, Yutaka; Hosokawa, Takanori; Tsuchiya, Kaoru; Nakanishi, Hiroyuki; Itakura, Jun; Izumi, Namiki] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Musashino, Tokyo 1808610, Japan	Izumi, N (reprint author), Musashino Red Cross Hosp, Dept Med Hlth Checkup Ctr, 1-26-1 Kyonan Cho, Musashino, Tokyo 1808610, Japan.	kensin@musashino.jrc.or.jp					Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI 10.1016/S0002-9270(03)00265-X; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Bruce KD, 2009, POSTGRAD MED J, V85, P614, DOI 10.1136/pgmj.2008.078014; Sanyal AJ, 2006, HEPATOLOGY, V43, P682, DOI 10.1002/hep.21103; Dixon JB, 2001, GASTROENTEROLOGY, V121, P91, DOI 10.1053/gast.2001.25540; Jimba S, 2005, DIABETIC MED, V22, P1141, DOI 10.1111/j.1464-5491.2005.01582.x; Fans JG, 2008, J DIGEST DIS, V9, P63; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Ohnuki T, 2013, INTERNAL MED, V52, P523, DOI 10.2169/internalmedicine.52.8858; Sumida Y, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-2; Takeuchi H, 2005, HYPERTENS RES, V28, P203, DOI 10.1291/hypres.28.203	19	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	JUN	2015	45	6					667	675		10.1111/hepr.12405		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CJ7EL	WOS:000355657100008		
J	Kishikawa, N; Kanno, K; Sugiyama, A; Yokobayashi, K; Mizooka, M; Tazuma, S				Kishikawa, Nobusuke; Kanno, Keishi; Sugiyama, Akiko; Yokobayashi, Kenichi; Mizooka, Masafumi; Tazuma, Susumu			Clinical evaluation of ezetimibe on bile lithogenicity in humans: Use of transnasal endoscopy for bile sampling	HEPATOLOGY RESEARCH			English	Article						bile sampling; biliary lipids; ezetimibe; lithogenicity; transnasal endoscopy	NONCHOLESTEROL STEROLS; CHOLESTEROL ABSORPTION; DEHYDROCHOLIC ACID; GALLSTONES; HYPERCHOLESTEROLEMIA; SIMVASTATIN; DISSOLUTION; PREVENTION; METABOLISM	AimEzetimibe inhibits cholesterol absorption by blocking Niemann-Pick C1-like 1 proteins (NPC1L1) expressed in the small intestine. Because NPC1L1 is also expressed in human liver, ezetimibe conceivably alters biliary lipid compositions. Here, we performed a clinical trial investigating the effect of ezetimibe on biliary lipids using transnasal endoscopy for bile collection. MethodsEight patients with dyslipidemia enrolled in this study completed blood and bile sampling before and at 3 months after ezetimibe treatment (10mg/day), and the samples are analyzed. ResultsEndoscopic bile sampling was performed safely and painlessly. Serum sterol-based biomarkers declared decreased cholesterol absorption and increased synthesis. On analysis of biliary lipids, four of the eight patients showed relative decrease of cholesterol and increase of bile acids with improved lithogenicity while the remainder exhibited the symmetrical changes. ConclusionOur data suggests that biliary lithogenicity is not worsened by ezetimibe. The regulation of biliary cholesterol is presumably multifactorial such as body cholesterol pool size and biliary cholesterol reabsorption by NPC1L1 in the liver.	[Kishikawa, Nobusuke; Kanno, Keishi; Sugiyama, Akiko; Yokobayashi, Kenichi; Mizooka, Masafumi; Tazuma, Susumu] Hiroshima Univ Hosp, Dept Gen Internal Med, Hiroshima 7348551, Japan	Tazuma, S (reprint author), Hiroshima Univ Hosp, Dept Gen Internal Med, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	stazuma@hiroshima-u.ac.jp			Ministry of Health, Labor and Welfare of Japan	THIS WORK WAS supported by a Grant-in-Aid from the Ministry of Health, Labor and Welfare of Japan to S. Tazuma. The authors thank Mika Nakashima for technical assistance.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Wang HH, 2008, GASTROENTEROLOGY, V134, P2101, DOI 10.1053/j.gastro.2008.03.011; Wang HH, 2013, EUR J CLIN INVEST, V43, P413, DOI 10.1111/eci.12058; CAREY MC, 1993, AM J SURG, V165, P410, DOI 10.1016/S0002-9610(05)80932-8; Cuis W, 2010, LIPIDS HLTH DIS, V9, P17; EINARSSON K, 1975, LANCET, V1, P484; Hiramitsu S, 2010, J ATHEROSCLER THROMB, V17, P106; Miettinen TA, 2000, ARTERIOSCL THROM VAS, V20, P1340; Sakai Y, 2008, HEPATO-GASTROENTEROL, V55, P17; SOLOWAY RD, 1973, J CLIN INVEST, V52, P715, DOI 10.1172/JCI107233; Tazuma S, 1998, CLIN THER, V20, P477, DOI 10.1016/S0149-2918(98)80057-X; Tazuma S, 1998, J CLIN GASTROENTEROL, V26, P287, DOI 10.1097/00004836-199806000-00015; THOMAS PJ, 1973, GASTROENTEROLOGY, V65, P698; UUSITUPA MIJ, 1992, ARTERIOSCLER THROMB, V12, P807	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	JUN	2015	45	6					693	697		10.1111/hepr.12402		5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CJ7EL	WOS:000355657100011		
J	Matsui, T; Kang, JH; Matsubayashi, K; Yamazaki, H; Nagai, K; Sakata, H; Tsuji, K; Maguchi, H				Matsui, Takeshi; Kang, Jong-Hon; Matsubayashi, Keiji; Yamazaki, Hajime; Nagai, Kazumasa; Sakata, Hidekatsu; Tsuji, Kunihiko; Maguchi, Hiroyuki			Rare case of transfusion-transmitted hepatitis E from the blood of a donor infected with the hepatitis E virus genotype 3 indigenous to Japan: Viral dynamics from onset to recovery	HEPATOLOGY RESEARCH			English	Article						genotype; hepatitis E virus; hepatitis E virus RNA; transfusion-transmitted hepatitis	POSTTRANSFUSION HEPATITIS; FULMINANT; HOKKAIDO; PATIENT	AimThe transfusion transmission of hepatitis E can occur even in non-endemic areas in the world as autochthonous hepatitis E has been increasingly reported in developed countries where the hepatitis E virus (HEV) is not prevalent. We investigated the post-transfusion transmission of hepatitis E in a patient by molecularly confirming its presence, and characterized the viral kinetics of HEV in this case. MethodsA Japanese man underwent re-thoracotomy for hemostasis followed by platelet transfusion. After the transfusion, the blood donor was found to be HEV positive. The donated blood was re-examined and was found to contain HEV. Throughout the prospective follow up of the patient, we analyzed the viral kinetics, chronological anti-HEV antibody level changes and disease progression during the entire course of HEV infection from transfusion until the end of viremia. ResultsSequence analysis of the strains isolated from both the donor and the patient who contracted acute hepatitis E showed an identical match for 326nucleotides in open reading frame 1. Two strains belonged to HEV genotype 3 indigenous to Japan. ConclusionTo the best of our knowledge, this is the first detailed report on the entire natural course of hepatitis E from viral transmission, then clearance, to replication preceding liver injury caused by HEV genotype 3, which is responsible for autochthonous infection in developed countries. The findings provide valuable insights into the mechanism of the transfusion transmission of HEV and subsequent viral dynamics.	[Matsui, Takeshi; Kang, Jong-Hon; Yamazaki, Hajime; Nagai, Kazumasa; Tsuji, Kunihiko; Maguchi, Hiroyuki] Teine Keijinkai Hosp, Ctr Gastroenterol, Sapporo, Hokkaido, Japan; [Matsui, Takeshi] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan; [Matsubayashi, Keiji; Sakata, Hidekatsu] Japanese Red Cross Hokkaido Block Blood Ctr, Sapporo, Hokkaido, Japan	Matsui, T (reprint author), 1 Jo 12 Chome,Teine Ku, Sapporo, Hokkaido 0068555, Japan.	mtake0402@gmail.com					Boxall E, 2006, TRANSFUSION MED, V16, P79, DOI 10.1111/j.1365-3148.2006.00652.x; Schlauder GG, 1998, J GEN VIROL, V79, P447; Takahashi M, 2010, J MED VIROL, V82, P271, DOI 10.1002/jmv.21678; Matsubayashi K, 2004, TRANSFUSION, V44, P934, DOI 10.1111/j.1537-2995.2004.03300.x; Inoue J, 2006, J MED VIROL, V78, P476, DOI 10.1002/jmv.20565; Miyashita K, 2012, HEPATOL RES, V42, P870, DOI 10.1111/j.1872-034X.2012.01006.x; Colson P, 2007, EMERG INFECT DIS, V13, P648; Matsubayashi K, 2008, TRANSFUSION, V48, P1368, DOI 10.1111/j.1537-2995.2008.01722.x; Mizuo H, 2002, J CLIN MICROBIOL, V40, P3209, DOI 10.1128/JCM.40.9.3209-3218.2002; Arankalle VA, 2000, VOX SANG, V79, P72, DOI 10.1159/000031215; Khuroo MS, 2004, J GASTROEN HEPATOL, V19, P778, DOI 10.1111/j.1400-1746.2004.03437.x; Pavio N, 2010, VET RES, V41, DOI 10.1051/vetres/2010018; Takahashis K, 2001, VIROLOGY, V15, P9; Takahashis K, 2002, J INFECT DIS, V1, P1342; Tamura A, 2007, HEPATOL RES, V37, P113, DOI 10.1111/j.1872-034X.2007.00024.x; Wangs CH, 1993, LANCET, V27, P825; WANG JT, 1994, J INFECT DIS, V169, P229; Worms HC, 1998, NEW ENGL J MED, V19, P1554	18	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	JUN	2015	45	6					698	704		10.1111/hepr.12390		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CJ7EL	WOS:000355657100012		
J	Honda, Y; Kawaoka, T; Aikata, H; Kan, H; Fujino, H; Kobayashi, T; Fukuhara, T; Naeshiro, N; Hiramatsu, A; Imamura, M; Kawakami, Y; Hyogo, H; Arihiro, K; Chayama, K				Honda, Yohji; Kawaoka, Tomokazu; Aikata, Hiroshi; Kan, Hiromi; Fujino, Hatsue; Kobayashi, Tomoki; Fukuhara, Takayuki; Naeshiro, Noriaki; Hiramatsu, Akira; Imamura, Michio; Kawakami, Yoshiiki; Hyogo, Hideyuki; Arihiro, Koji; Chayama, Kazuaki			Disseminated carcinomatosis of the bone marrow originating from hepatocellular carcinoma. A case report	HEPATOLOGY RESEARCH			English	Article						bone marrow metastasis; disseminated intravascular coagulation; disseminated carcinomatosis of the bone marrow; hepatocellular carcinoma	METASTASIS; CRITERIA	A 50-year-old male patient was admitted to the hospital for persistent high fever and back pain. He was diagnosed with hepatocellular carcinoma (HCC), bone marrow metastasis and disseminated intravascular coagulation (DIC). Despite the diagnosis and treatment, the general condition deteriorated rapidly and he died of cerebral hemorrhage associated with generalized bleeding tendency. Autopsy showed multiple HCC in the liver and systemic metastasis including bone marrow. The case describes a rare complication of HCC with disseminated carcinomatosis of the bone marrow (DCBM) complicated with DIC, with rapid deterioration and death. This is the first case of DCBM from HCC. Physicians need to be aware of DCBM in patients with HCC.	[Honda, Yohji; Kawaoka, Tomokazu; Aikata, Hiroshi; Kan, Hiromi; Fujino, Hatsue; Kobayashi, Tomoki; Fukuhara, Takayuki; Naeshiro, Noriaki; Hiramatsu, Akira; Imamura, Michio; Kawakami, Yoshiiki; Hyogo, Hideyuki; Chayama, Kazuaki] Hiroshima Univ Hosp, Dept Gastroenterol & Metab, Hiroshima, Japan; [Arihiro, Koji] Hiroshima Univ Hosp, Dept Anat Pathol, Hiroshima, Japan	Aikata, H (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Med & Mol Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	aikata@hiroshima-u.ac.jp					Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327; Bastons OV, 1940, ANN SURG, V112, P138; Hayashis H, 1979, JPN J CANC CLIN, V25, P329; Ichida F, 1996, INT HEPATOL COMMUN, V6, P112, DOI 10.1016/S0928-4346(96)00325-8; Jarcho S, 1936, ARCH PATHOL, V22, P674; Nakanishis M, 1984, NIHON SHOKAKIGEKA GA, V17, P1532; Okada T, 1995, INT J CANCER, V63, P823, DOI 10.1002/ijc.2910630613; OKAZAKI N, 1985, CANCER, V55, P1991, DOI 10.1002/1097-0142(19850501)55:9<1991::AID-CNCR2820550927>3.0.CO;2-F; Sasada Shinsuke, 2008, Gan To Kagaku Ryoho, V35, P1611; Shiozakis M, 2008, NIHON SHOKAKIBYO GAK, V101, P879; Ukas K, 2008, ONCOLOGY, V75, P8; Yamamuras Y, 1985, NIPPON SHOKAKI GEKA, V18, P2288	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	JUN	2015	45	6					705	710		10.1111/hepr.12391		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CJ7EL	WOS:000355657100013		
J	Zhang, Z; Nishimura, H; Fujioka, S; Arikawa, Y; Ikenouchi, T; Nakai, M; Nagatomo, H; Chen, H; Park, J; Williams, GJ; Ozaki, T; Shiraga, H; Kojima, S; Hosoda, H; Miyanaga, N; Kawanaka, J; Nakata, Y; Jitsuno, T; Azechi, H				Zhang, Z.; Nishimura, H.; Fujioka, S.; Arikawa, Y.; Ikenouchi, T.; Nakai, M.; Nagatomo, H.; Chen, H.; Park, J.; Williams, G. J.; Ozaki, T.; Shiraga, H.; Kojima, S.; Hosoda, H.; Miyanaga, N.; Kawanaka, J.; Nakata, Y.; Jitsuno, T.; Azechi, H.			Quantitative K alpha line spectroscopy for energytransport in fast ignition plasma driven with LFEX PW laser	HIGH ENERGY DENSITY PHYSICS			English	Article						X-ray spectroscopy; Laser-plasma interaction; Hard X-rays; Fast ignition	RAY; TRANSMISSION; SPECTRA	Quantitative high-energy X-ray spectroscopy is applied for the laser plasma interaction in the fast ignition scheme. A double tracer layer target is designed for the absolute measurement of hot electron temperature and laser energy transfer efficiency. The hot electron temperature is determined from the ratio of the number of K alpha photons from the first and second tracers. Consequently, the energy transfer efficiency from incident laser beams to hot electrons, as the energy transfer mechanism, is derived. In a cone-guide geometry, we simultaneously measured the hot electron temperature and the energy transfer efficiency from the incident LFEX, a kJ-class PW laser, which were measured to be 5.3 MeV and 37%, respectively. (C) 2015 Elsevier B.V. All rights reserved.	[Zhang, Z.; Nishimura, H.; Fujioka, S.; Arikawa, Y.; Ikenouchi, T.; Nakai, M.; Nagatomo, H.; Shiraga, H.; Kojima, S.; Hosoda, H.; Miyanaga, N.; Kawanaka, J.; Nakata, Y.; Jitsuno, T.; Azechi, H.] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan; [Zhang, Z.] Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China; [Chen, H.; Park, J.; Williams, G. J.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Ozaki, T.] Natl Inst Fus Sci, LHD, High Temp Plasma G, Toki, Gifu 5095292, Japan	Zhang, Z (reprint author), Osaka Univ, Inst Laser Engn, 2-6 Yamada Oka, Suita, Osaka 5650871, Japan.	zhang-z@ile.osaka-u.ac.jp	Azechi, Hiroshi/H-5876-2015; Nakai, Mitsuo/I-6758-2015; Nishimura, Hiroaki/I-4908-2015; Shiraga, Hiroyuki/I-9565-2015; Fujioka, Shinsuke/J-5530-2015; Nakata, Yoshiki/L-4957-2015; Arikawa, Yasunobu/L-8760-2015; Jitsuno, Takahisa/M-6056-2015; Kawanaka, Junji/P-8065-2015	Nakai, Mitsuo/0000-0001-6076-756X; Fujioka, Shinsuke/0000-0001-8406-1772; Nakata, Yoshiki/0000-0002-0680-999X; Arikawa, Yasunobu/0000-0002-3142-3060; Kawanaka, Junji/0000-0001-5655-7981	JSPS [26246043]	The authors would like to thank the Gekko-XII and LFEX laser operation crew, the target fabrication group, the plasma diagnostics group, and the computer operation staffs for their great contribution to this work. This work was partly supported by JSPS KAKENHI Grant Number 26246043.	Seely JF, 2007, HIGH ENERG DENS PHYS, V3, P263, DOI 10.1016/j.hedp.2007.02.022; Kodama R, 2001, NATURE, V412, P798, DOI 10.1038/35090525; Myatt J, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2472371; BAMBYNEK W, 1972, REV MOD PHYS, V44, P716, DOI 10.1103/RevModPhys.44.716; Salzmann D, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036402; MIYAHARA J, 1986, NUCL INSTRUM METH A, V246, P572, DOI 10.1016/0168-9002(86)90156-7; Fujioka S, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/12/124042; Sato T, 2013, J NUCL SCI TECHNOL, V50, P913, DOI 10.1080/00223131.2013.814553; Cauchois Y, 1932, J PHYS-PARIS, V3, P320, DOI 10.1051/jphysrad:0193200307032000; Patoary MAR, 2009, INT J QUANTUM CHEM, V109, P897, DOI 10.1002/qua.21902; Shiraga H, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/12/124029; Szabo CI, 2011, OPT LETT, V36, P1335, DOI 10.1364/OL.36.001335; Welch D.R., 2006, PHYS PLASMAS, V13, P6; Zhang Z, 2013, HIGH ENERG DENS PHYS, V9, P435, DOI 10.1016/j.hedp.2013.04.001; Zhang Z, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4717677	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1574-1818	1878-0563		HIGH ENERG DENS PHYS	High Energy Density Phys.	JUN	2015	15						78	81		10.1016/j.hedp.2015.04.001		4	Physics, Fluids & Plasmas	Physics	CJ6DL	WOS:000355583500012		
J	Sato, A				Sato, Atsuhisa			The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy	HYPERTENSION RESEARCH			English	Review						aldosterone; aldosterone breakthrough; diabetic nephropathy; mineralocorticoid receptor antagonists; renin-angiotensin system	CONVERTING ENZYME-INHIBITOR; OBSTRUCTIVE SLEEP-APNEA; SALT-SENSITIVE HYPERTENSION; RENIN-ANGIOTENSIN BLOCKADE; CHRONIC RENAL-DISEASE; BLOOD-PRESSURE; METABOLIC SYNDROME; RESISTANT HYPERTENSION; INSULIN-RESISTANCE; ALDOSTERONE BREAKTHROUGH	Diabetes mellitus is a major cause of chronic kidney disease (CKD), and diabetic nephropathy is the most common primary disease necessitating dialysis treatment in the world including Japan. Major guidelines for treatment of hypertension in Japan, the United States and Europe recommend the use of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers, which suppress the renin-angiotensin system (RAS), as the antihypertensive drugs of first choice in patients with coexisting diabetes. However, even with the administration of RAS inhibitors, failure to achieve adequate anti-albuminuric, renoprotective effects and a reduction in cardiovascular events has also been reported. Inadequate blockade of aldosterone may be one of the reasons why long-term administration of RAS inhibitors may not be sufficiently effective in patients with diabetic nephropathy. This review focuses on treatment in diabetic nephropathy and discusses the significance of aldosterone blockade. In pre-nephropathy without overt nephropathy, a mineralocorticoid receptor antagonist can be used to enhance the blood pressure-lowering effects of RAS inhibitors, improve insulin resistance and prevent clinical progression of nephropathy. In CKD categories A2 and A3, the addition of a mineralocorticoid receptor antagonist to an RAS inhibitor can help to maintain 'long-term' antiproteinuric and anti-albuminuric effects. However, in category G3a and higher, sufficient attention must be paid to hyperkalemia. Mineralocorticoid receptor antagonists are not currently recommended as standard treatment in diabetic nephropathy. However, many studies have shown promise of better renoprotective effects if mineralocorticoid receptor antagonists are appropriately used.	[Sato, Atsuhisa] Int Univ Hlth & Welf, Mita Hosp, Dept Internal Med, Tokyo 1088329, Japan	Sato, A (reprint author), Int Univ Hlth & Welf, Mita Hosp, Dept Internal Med, Minato Ku, 1-4-3 Mita, Tokyo 1088329, Japan.	atsu-sa@iuhw.ac.jp					Shiuchi T, 2002, HYPERTENSION, V40, P329, DOI 10.1161/01.HYP.0000028979.98877.0C; Fujisawa G, 2004, KIDNEY INT, V66, P1493, DOI 10.1111/j.1523-1755.2004.00913.x; Giacchetti G, 2007, J HYPERTENS, V25, P177, DOI 10.1097/HJH.0b013e3280108e6f; Davies JI, 2004, DIABETOLOGIA, V47, P1687, DOI 10.1007/s00125-004-1510-8; Rachmani R, 2004, DIABETIC MED, V21, P471, DOI 10.1111/j.1464-5491.2004.01194.x; Kumagai E, 2011, HYPERTENSION, V58, P1043, DOI 10.1161/HYPERTENSIONAHA.111.180521; Sato A, 2005, AM J HYPERTENS, V18, P44, DOI 10.1016/j.amjhyper.2004.06.029; Imai E, 2013, HYPERTENS RES, V36, P1051, DOI 10.1038/hr.2013.86; Fallo F, 2006, J CLIN ENDOCR METAB, V91, P454, DOI 10.1210/jc.2005-1733; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Hitomi H, 2007, HYPERTENSION, V50, P750, DOI 10.1161/HYPERTENSIONAHA.107.093955; Epstein M, 2006, CLIN J AM SOC NEPHRO, V1, P940, DOI 10.2215/CJN.00240106; Oxlund CS, 2013, J HYPERTENS, V31, P2094, DOI 10.1097/HJH.0b013e3283638b1a; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Shibata S, 2011, J CLIN INVEST, V121, P3233, DOI 10.1172/JCI43124; Schjoedt KJ, 2005, KIDNEY INT, V68, P2829, DOI 10.1111/j.1523-1755.2005.00756.x; Kidambi S, 2007, HYPERTENSION, V49, P704, DOI 10.1161/01.HYP.0000253258.36141.c7; WILLIAMSON JR, 1993, DIABETES, V42, P801, DOI 10.2337/diabetes.42.6.801; Schjoedt KJ, 2006, KIDNEY INT, V70, P536, DOI 10.1038/sj.ki.5001580; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Naruse M, 2002, HYPERTENSION, V40, P28, DOI 10.1161/01.HYP.0000022606.52221.2F; Fallo F, 2007, AM J HYPERTENS, V20, P855, DOI 10.1016/j.amjhyper.2007.03.012; Gaddam K, 2010, J HUM HYPERTENS, V24, P532, DOI 10.1038/jhh.2009.96; Nakai S, 2012, THER APHER DIAL, V16, P11, DOI 10.1111/j.1744-9987.2011.01050.x; Luther JM, 2011, DIABETOLOGIA, V54, P2152, DOI 10.1007/s00125-011-2158-9; Mehdi UF, 2009, J AM SOC NEPHROL, V20, P2641, DOI 10.1681/ASN.2009070737; Casas JP, 2005, LANCET, V366, P2026, DOI 10.1016/S0140-6736(05)67814-2; Yoneda T, 2007, AM J HYPERTENS, V20, P1329, DOI 10.1016/j.amjhyper.2007.09.001; Sato A, 2010, J HUM HYPERTENS, V24, P387, DOI 10.1038/jhh.2009.81; Pratt-Ubunama MN, 2007, CHEST, V131, P453, DOI 10.1378/chest.06-1442; Sowers JR, 2009, ANN INTERN MED, V150, P776; Kosugi T, 2010, AM J PATHOL, V176, P619, DOI 10.2353/ajpath.2010.090578; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Ip MSM, 2002, AM J RESP CRIT CARE, V165, P670, DOI 10.1164/rccm.2103001; Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274; Fried LF, 2013, NEW ENGL J MED, V369, P1892, DOI 10.1056/NEJMoa1303154; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492; Sato A, 2003, HYPERTENSION, V41, P64, DOI 10.1161/01.HYP.0000044937.95080.E9; Wada T, 2009, ENDOCRINOLOGY, V150, P1662, DOI 10.1210/en.2008-1018; Haller H, 2011, NEW ENGL J MED, V364, P907, DOI 10.1056/NEJMoa1007994; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Guo C, 2006, ENDOCRINOLOGY, V147, P5363, DOI 10.1210/en.2006-0944; Chrysostomou A, 2001, NEW ENGL J MED, V345, P925, DOI 10.1056/NEJM200109203451215; van den Meiracker AH, 2006, J HYPERTENS, V24, P2285, DOI 10.1097/01.hjh.0000249708.44016.5c; Taira M, 2008, EUR J PHARMACOL, V589, P264, DOI 10.1016/j.ejphar.2008.06.019; Davies CWH, 2000, THORAX, V55, P736, DOI 10.1136/thorax.55.9.736; Liu GH, 2006, BIOCHEM BIOPH RES CO, V342, P1291, DOI 10.1016/j.bbrc.2006.02.065; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Krug AW, 2008, HYPERTENSION, V51, P1252, DOI 10.1161/HYPERTENSIONAHA.107.109439; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Sato A, 2002, HYPERTENS RES, V25, P837; Go AS, 2014, HYPERTENSION, V63, P878, DOI 10.1161/HYP.0000000000000003; Bouchud M, 2006, HYPERTENSION, V48, P239; Campion J, 2002, CELL BIOCHEM FUNCT, V20, P237, DOI 10.1002/cbf.970; Catena C, 2006, J CLIN ENDOCR METAB, V91, P3457, DOI 10.1210/jc.2006-0736; Cerezo C, 2011, J HYPERTENS, V30, P204; Colussi Gianluca, 2007, Diabetes Care, V30, P2349, DOI 10.2337/dc07-0525; Fujita T, 2008, CURR HYPERTENS REP, V10, P421, DOI 10.1007/s11906-008-0078-y; Fujita T, 2007, NEPHROL DIAL TRANSPL, V22, P3102, DOI 10.1093/ndt/gfm409; GOODFRIEND TL, 1995, HYPERTENSION, V25, P30; Gustafsson F, 2010, J HYPERTENS, V28, P1595, DOI 10.1097/HJH.0b013e32833984b8; Ido Y, 1997, DIABETOLOGIA, V40, pS115, DOI 10.1007/s001250051422; Jawa A, 2006, J CLIN ENDOCR METAB, V91, P31, DOI 10.1210/jc.2005-1632; Lastra G, 2010, NAT REV CARDIOL, V7, P577, DOI 10.1038/nrcardio.2010.123; Liu YJ, 2000, KIDNEY INT, V57, P2064, DOI 10.1046/j.1523-1755.2000.00055.x; Luft FC, 1988, HYPERTENSION, V11, P1229; MACGREGOR GA, 1985, J CARDIOVASC PHARM, V7, pS92, DOI 10.1097/00005344-198507004-00018; Matsumoto Y, 2014, J AM COLL CARDIOL, V63, P529, DOI 10.1016/j.jacc.2013.09.056; Nielsen SE, 2012, DIABETIC MED, V29, pE184, DOI 10.1111/j.1464-5491.2012.03585.x; Oxlund CS, 2015, J HUM HYPERTENS, V29, P28, DOI 10.1038/jhh.2014.27; Pierdomenico Sante D, 2010, Blood Press Monit, V15, P1, DOI 10.1097/MBP.0b013e3283360ed1; Robles NR, 2011, J RENIN-ANGIO-ALDO S, V12, P333, DOI 10.1177/1470320310374215; Saruta Takao, 2004, J Clin Hypertens (Greenwich), V6, P175, DOI 10.1111/j.1524-6175.2004.03146.x; Sato A, 2006, HYPERTENS RES, V29, P211, DOI 10.1291/hypres.29.211; Sato A, 2001, J INT MED RES, V29, P13; Sato A, 2003, AM J HYPERTENS, V16, P781, DOI 10.1016/S0895-7061(03)00913-0; Sato A, 1996, ENDOCRINOLOGY, V137, P4145, DOI 10.1210/en.137.10.4145; Sato A, 2013, HYPERTENS RES, V36, P879, DOI 10.1038/hr.2013.74; SCHERSTEN B, 1980, HYPERTENSION, V2, P672; Shibata H, 2012, AM J HYPERTENS, V25, P514, DOI 10.1038/ajh.2011.245; Shimamoto Kazuaki, 2014, Hypertens Res, V37, P253, DOI 10.1038/hr.2014.20; Swaminathan K, 2008, DIABETOLOGIA, V51, P762, DOI 10.1007/s00125-008-0972-5; Taheri Shahram, 2009, Saudi J Kidney Dis Transpl, V20, P392; Takebayashi K, 2006, J CLIN ENDOCR METAB, V91, P2214, DOI 10.1210/jc.2005-1718; Uzu T, 2009, CLIN EXP NEPHROL, V13, P300, DOI 10.1007/s10157-009-0157-7; Vogt B, 2007, SEMIN NEPHROL, V27, P529, DOI 10.1016/j.semnephrol.2007.07.009; Yamashita R, 2004, ENDOCR J, V51, P243, DOI 10.1507/endocrj.51.243; Yano Y, 2011, J RENIN-ANGIO-ALDO S, V12, P340, DOI 10.1177/1470320310390404; Yilmaz MI, 2008, NEPHROL DIAL TRANSPL, V23, P1621, DOI 10.1093/ndt/gfm828; Yoshida S, 2014, NEPHRON EXP NEPHROL, V126, P16, DOI 10.1159/000358758; Yuan J, 2007, J RENIN-ANGIO-ALDO S, V8, P118, DOI 10.3317/jraas.2007.014	94	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	JUN	2015	38	6					367	374		10.1038/hr.2015.19		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CJ7TE	WOS:000355701800001		
J	Kawahata, H; Sotobayashi, D; Aoki, M; Shimizu, H; Nakagami, H; Ogihara, T; Morishita, R				Kawahata, Hirohisa; Sotobayashi, Daisuke; Aoki, Motokuni; Shimizu, Hideo; Nakagami, Hironori; Ogihara, Toshio; Morishita, Ryuichi			Continuous infusion of angiotensin II modulates hypertrophic differentiation and apoptosis of chondrocytes in cartilage formation in a fracture model mouse	HYPERTENSION RESEARCH			English	Article						Angiotensin II; angiotensin receptor blocker; apoptosis; AT1R; hypertrophic chondrocyte	CONVERTING ENZYME-INHIBITOR; NF-KAPPA-B; GROWTH-PLATE; ESTROGEN-RECEPTOR; IN-VIVO; OSTEOBLAST DIFFERENTIATION; ENDOCHONDRAL OSSIFICATION; TYPE-1 RECEPTOR; BLOOD-VESSELS; BONE MASS	Although components of the renin-angiotensin system (RAS) are reported to be expressed in cultured chondrocytes and cartilage, little is known about the precise function of Angiotensin II (Ang II) in chondrocytes. In this study, we employed a rib fracture model mouse to investigate the effect of Ang II on chondrocytes. Ang II type 1 receptor (AT1R) was expressed in chondrocytes in the growth plate of mouse tibia. Continuous infusion of Ang II to rib-fractured mice resulted in a significant increase in the volume of cartilage, suggesting Ang II-induced hypertrophic differentiation of chondrocytes. It was also confirmed by a significant increase in the mRNA expression of Sox9 and runt-related transcription factor 2 (Runx2), which are genes related to chondrocyte differentiation, and type X collagen, matrix metalloproteinase (MMP)-13 and Indian hedgehog (Ihh), which are hypertrophic chondrocyte-specific molecular markers. Chondrocyte hypertrophy with upregulation of these genes was attenuated by administration of olmesartan, an AT1R blocker, but not by hydralazine. Moreover, Ang II infusion significantly suppressed apoptosis of chondrocytes, accompanied by significant induction of mRNA expression of bcl-2 and bcl-xL. Olmesartan, but not hydralazine, significantly attenuated the reduction of apoptotic cells and the increase in anti-apoptotic genes induced by Ang II infusion. Overall, the present study demonstrated that Ang II promoted hypertrophic differentiation of chondrocytes and reduced apoptosis of hypertrophic chondrocytes independently of high blood pressure. The present data indicate the role of Ang II in cartilage, and might provide a new concept for treatment of cartilage diseases.	[Kawahata, Hirohisa; Morishita, Ryuichi] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Osaka 5650871, Japan; [Kawahata, Hirohisa; Sotobayashi, Daisuke; Aoki, Motokuni; Ogihara, Toshio] Morinomiya Univ Med Sci, Grad Sch Hlth Sci, Osaka 5598611, Japan; [Shimizu, Hideo; Nakagami, Hironori] Osaka Univ, United Grad Sch Child Dev, Div Vasc Med & Epigenet, Osaka, Japan	Aoki, M (reprint author), Morinomiya Univ Med Sci, Grad Sch Hlth Sci, Suminoe Ku, 1-26-16 Nanko Kita, Osaka 5598611, Japan.	aoki@morinomiya-u.ac.jp; morishit@cgt.med.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [24590906]	We wish to thank Touru Yutani, Hiroshi Kawanami and Miyuki Mori for their excellent technical assistance. Olmesartan was kindly provided by Daiichi Sankyo. This study was supported by the Japan Society for the Promotion of Science (JSPS; grant number: 24590906) (http://www.jsps.go.jp/english/index.html). JSPS and Daiichi Sankyo had no participation in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alique M, J RENIN ANGIOTENSIN; Price A, 2007, ARTHRITIS RHEUM, V56, P441, DOI 10.1002/art.22335; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Ding M, 2012, J CELL PHYSIOL, V227, P3446, DOI 10.1002/jcp.24045; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Liu SS, 2013, INT J MOL SCI, V14, P24029, DOI 10.3390/ijms141224029; Takarada T, 2012, J BIOL CHEM, V287, P36081, DOI 10.1074/jbc.M112.408963; Garcia P, 2010, BRIT J PHARMACOL, V159, P1672, DOI 10.1111/j.1476-5381.2010.00651.x; Lynn H, 2006, BONE, V38, P584, DOI 10.1016/j.bone.2005.09.011; Yao XF, 2006, MED MOL MORPHOL, V39, P193, DOI 10.1007/s00795-006-0336-5; Yoshida T, 2014, J BIOL CHEM, V289, P26239, DOI 10.1074/jbc.M114.585521; Hatton R, 1997, J ENDOCRINOL, V152, P5, DOI 10.1677/joe.0.1520005; PEACH MJ, 1977, PHYSIOL REV, V57, P313; Perez-Castrillon JL, 2003, AM J HYPERTENS, V16, P453, DOI 10.1016/S0895-7061(03)00845-8; Sagawa K, 2005, ARTHRITIS RHEUM, V52, P1920, DOI 10.1002/art.21040; Nilsson O, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730407; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/job.200211089; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Chagin AS, 2006, J ENDOCRINOL, V188, P193, DOI 10.1677/joe.1.06364; Mezzano SA, 2001, HYPERTENSION, V38, P635, DOI 10.1161/hy09t1.094234; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Yasuda N, 2008, N-S ARCH PHARMACOL, V377, P393, DOI 10.1007/s00210-007-0215-1; Asaba Y, 2009, J BONE MINER RES, V24, P241, DOI [10.1359/jbmr.081006, 10.1359/JBMR.081006]; Kaneko K, 2011, J BONE MINER RES, V26, P2959, DOI 10.1002/jbmr.501; Vidal O, 2000, P NATL ACAD SCI USA, V97, P5474, DOI 10.1073/pnas.97.10.5474; Kita K, 2008, GENES CELLS, V13, P839, DOI 10.1111/j.1365-2443.2008.01209.x; Shimizu H, 2008, FASEB J, V22, P2465, DOI 10.1096/fj.07-098954; Mancini GBJ, 2006, J AM COLL CARDIOL, V47, P2554, DOI 10.1016/j.jacc.2006.04.039; Zhao YB, 2014, J CELL PHYSIOL, V229, P1855, DOI 10.1002/jcp.24639; Balakumar P, 2014, CELL SIGNAL, V26, P2147, DOI 10.1016/j.cellsig.2014.06.011; Franses RE, 2010, OSTEOARTHR CARTILAGE, V18, P563, DOI 10.1016/j.joca.2009.11.015; Shimizu H, 2009, HYPERTENS RES, V32, P786, DOI 10.1038/hr.2009.99; Izu Y, 2009, J BIOL CHEM, V284, P4857, DOI 10.1074/jbc.M807610200; Aoki M, 2014, GERIATR GERONTOL INT, V3, P12406; Chauhan VP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3516; Cuesta-Dominguez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032451; Emons J, 2010, J ENDOCRINOL, V205, P61, DOI 10.1677/JOE-09-0337; Fu HH, 2007, J BIOMED MATER RES A, V83A, P770, DOI 10.1002/jbm.a.31356; Hiruma Y, 1997, BIOCHEM BIOPH RES CO, V230, P176, DOI 10.1006/bbrc.1996.5914; Huang Y, 2012, J ORTHOP RES, V30, P304, DOI 10.1002/jor.21505; Jansen H, 2010, ANN ANAT, V194, P452; Karsenty G, 2001, ENDOCRINOLOGY, V142, P2731, DOI 10.1210/en.142.7.2731; Kawahata Hirohisa, 2003, J Orthop Sci, V8, P102, DOI 10.1007/s007760300017; Kawakami Y, 2012, ARTHRITIS, V2012, P1; Kehoe PG, 2012, J ALZHEIMERS DIS, V30, pS251, DOI 10.3233/JAD-2012-111376; Maeda A., 2014, BIOMED RES INT, V2014; Pattacini L, 2007, RHEUMATOLOGY, V46, P1252, DOI 10.1093/rheumatology/kem092; Platten M, 2009, P NATL ACAD SCI USA, V106, P14948, DOI 10.1073/pnas.0903958106; Rahman MM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002624; Rodd C, 2004, CALCIFIED TISSUE INT, V75, P214, DOI 10.1007/s00223-004-0197-7; Rundle CH, 2008, BONE, V43, P880, DOI 10.1016/j.bone.2008.07.239; Schurman SJ, 2004, PEDIATR NEPHROL, V19, P33, DOI 10.1007/s00467-003-1361-4; Speth RC, 2014, BRAIN RES, V2, P132; Tsukamoto, 2013, FEBS OPEN BIO, V3, P279; Tsukamoto I, 2014, Eur J Histochem, V58, P2387, DOI 10.4081/ejh.2014.2387; TURNER RT, 1994, ENDOCRINOLOGY, V134, P461, DOI 10.1210/en.134.1.461; Wang AW, 2014, AM HYPERTENS, V31, P194; Wang SJ, 2012, J ENDOCRINOL, V213, P163, DOI 10.1530/JOE-11-0353; Wang YW, 2013, IRAN RED CRESCENT ME, V15, DOI 10.5812/ircmj.8303; Yutani Toru, 2013, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V13, P122; Zhao X, 2010, PLOS ONE, V7; Zheng XY, 2013, DIFFERENTIATION, V85, P41, DOI 10.1016/j.diff.2012.11.003	63	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	JUN	2015	38	6					382	393		10.1038/hr.2015.18		12	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CJ7TE	WOS:000355701800004		
J	Obara, T; Ubeda, SRG; Ohkubo, T; Matsuura, H; Ishimitsu, T; Takata, M; Rakugi, H; Imai, Y				Obara, Taku; Ubeda, Sergio Ramon Gutierrez; Ohkubo, Takayoshi; Matsuura, Hideo; Ishimitsu, Toshihiko; Takata, Masanobu; Rakugi, Hiromi; Imai, Yutaka		Japanese Soc Hypertension	Awareness of the Japanese Society of Hypertension Guidelines for the Management of Hypertension and their use in clinical practices: 2009 survey results	HYPERTENSION RESEARCH			English	Article						awareness; guidelines; practice	BLOOD-PRESSURE-MEASUREMENT; ARTERIAL-HYPERTENSION; TASK-FORCE; PHYSICIANS; ESC	The objective of this study was to investigate physicians' awareness and use of the Japanese Society of Hypertension (JSH) Guidelines for the Management of Hypertension (JSH2004 and JSH2009), and determine what changes need to be implemented in the future. A questionnaire was used to survey physicians' awareness and their use of JSH2004 and JSH2009. Physicians attending educational seminars on hypertension that were held during the months after the publication of JSH2009 (January-April 2009) were asked to participate in the survey. Of the 5795 respondents, 88% were aware of the JSH2009 publication. Furthermore, physicians were also aware of JSH2004, with about 90% using JSH2004 in their practice. A hypertension blood pressure (BP) reference value of 140/90 mm Hg was used by 55% in office BP, whereas 31% used 135/85 mm Hg for home BP. Target BP levels used by physicians were 130/80 mm Hg for patients with diabetes or kidney disease (52%) and for elderly patients with diabetes or kidney disease (45%), whereas 140/90 mm Hg was used for elderly patients with low cardiovascular disease risk (44%) and for patients with chronic-phase stroke (27%). Answers to the questionnaire varied among physicians according to sex, age, workplace and specialty. The majority of the participating Japanese physicians were familiar with both JSH2004 and JSH2009, with many following the guidelines in their practice. However, some physicians use different reference values for hypertension and target BP levels. Physicians' adherence to and use of the guidelines should be regularly examined and promoted.	[Obara, Taku] Tohoku Univ, Tohoku Med Megabank Org, Dept Prevent Med & Epidemiol, Sendai, Miyagi 9808575, Japan; [Obara, Taku] Tohoku Univ, Grad Sch Med, Dept Mol Epidemiol, Sendai, Miyagi 9808575, Japan; [Ubeda, Sergio Ramon Gutierrez] Tohoku Univ, Grad Sch Med, Dept Geriatr Behav Neurol, Sendai, Miyagi 9808575, Japan; [Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan; [Matsuura, Hideo] Saiseikai Kure Hosp, Kure, Japan; [Ishimitsu, Toshihiko] Dokkyo Med Univ, Dept Cardiol & Nephrol, Mibu, Tochigi, Japan; [Takata, Masanobu] Toyama Teishin Hosp, Toyama, Japan; [Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Osaka, Japan; [Imai, Yutaka] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi 9808575, Japan	Imai, Y (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Planning Drug Dev & Clin Evaluat, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.	dontaku@mail.tains.tohoku.ac.jp			Japanese Society of Hypertension	This work was supported by directors, councilors and members of the Japanese Society of Hypertension.	James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Kobayashi M, 2010, HYPERTENS RES, V33, P960, DOI 10.1038/hr.2010.89; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Graham R, 2011, CLIN PRACTICE GUIDEL, P1; Ikeda N, 2006, J HUM HYPERTENS, V20, P263, DOI 10.1038/sj.jhh.1001977; Japanese Society of Hypertension, 2006, HYPERTENS RES, V29, pS1; Fujishima M, 2001, HYPERTENS RES, V24, P613; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Obara T, 2010, HYPERTENS RES, V33, P428, DOI 10.1038/hr.2010.10; Shimamoto Kazuaki, 2014, Hypertens Res, V37, P253, DOI 10.1038/hr.2014.20	12	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	JUN	2015	38	6					400	404		10.1038/hr.2015.21		5	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CJ7TE	WOS:000355701800006		
J	Otsuka, T; Kachi, Y; Takada, H; Kato, K; Kodani, E; Ibuki, C; Kusama, Y; Kawada, T				Otsuka, Toshiaki; Kachi, Yuko; Takada, Hirotaka; Kato, Katsuhito; Kodani, Eitaro; Ibuki, Chikao; Kusama, Yoshiki; Kawada, Tomoyuki			Development of a risk prediction model for incident hypertension in a working-age Japanese male population	HYPERTENSION RESEARCH			English	Article						blood pressure; preventive medicine; risk prediction model; working-age Japanese male population	RANDOMIZED CONTROLLED-TRIALS; NORMAL BLOOD-PRESSURE; BODY-MASS INDEX; ALCOHOL-CONSUMPTION; SODIUM REDUCTION; WEIGHT-LOSS; SCORE; METAANALYSIS; PREVENTION; SOCIETY	The aim of this study was to develop a risk prediction model for incident hypertension in a Japanese male population. Study participants included 15 025 nonhypertensive Japanese male workers (mean age, 38.8 +/- 8.9 years) who underwent an annual medical checkup at a company. The participants were followed-up for a median of 4.0 years to determine new-onset hypertension, defined as a systolic blood pressure (BP) >= 140 mm Hg, a diastolic BP >= 90 mm Hg, or the initiation of antihypertensive medication. Participants were divided into the following two cohorts for subsequent analyses: the derivation cohort (n = 12 020, 80% of the study population) and the validation cohort (n = 3005, the remaining 20% of the study population). In the derivation cohort, a multivariate Cox proportional hazards model demonstrated that age, body mass index, systolic and diastolic BP, current smoking status, excessive alcohol intake and parental history of hypertension were independent predictors of incident hypertension. Using these variables, a risk prediction model was constructed to estimate the 4-year risk of incident hypertension. In the validation cohort, the risk prediction model demonstrated high discrimination ability and acceptable calibration, with a C-statistic of 0.861 (95% confidence interval 0.844, 0.877) and a modified Hosmer-Lemeshow chi(2) statistic of 15.2 (P = 0.085). A risk score sheet was constructed to enable the simple calculation of the approximate 4-year probability of incident hypertension. In conclusion, a practical risk prediction model for incident hypertension was successfully developed in a working-age Japanese male population.	[Otsuka, Toshiaki; Kachi, Yuko; Kato, Katsuhito; Kawada, Tomoyuki] Nippon Med Sch, Dept Hyg & Publ Hlth, Tokyo 1138602, Japan; [Takada, Hirotaka] Canon Inc, Ind Safety & Hlth Ctr, Tokyo, Japan; [Kodani, Eitaro; Kusama, Yoshiki] Tama Nagayama Hosp, Nippon Med Sch, Dept Internal Med & Cardiol, Tokyo, Japan; [Ibuki, Chikao] Chiba Hokusoh Hosp, Nippon Med Sch, Cardiovasc Ctr, Chiba, Japan	Otsuka, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	otsuka@nms.ac.jp					Bowman TS, 2007, J AM COLL CARDIOL, V50, P2085, DOI 10.1016/j.jacc.2007.08.017; Bozorgmanesh M, 2011, J HYPERTENS, V29, P1486, DOI 10.1097/HJH.0b013e328348fdb2; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Kshirsagar AV, 2010, J CLIN HYPERTENS, V12, P800, DOI 10.1111/j.1751-7176.2010.00343.x; Neter JE, 2003, HYPERTENSION, V42, P878, DOI 10.1161/01.HYP.0000094221.86888.AE; Lewington S, 2002, LANCET, V360, P1903; Matsuo T, 2011, INT J OBESITY, V35, P1056, DOI 10.1038/ijo.2010.226; Shihab HM, 2012, CIRCULATION, V126, P2983, DOI 10.1161/CIRCULATIONAHA.112.117333; He JA, 2000, HYPERTENSION, V35, P544; Whelton SP, 2002, ANN INTERN MED, V136, P493; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Miura K, 2013, CIRC J, V77, P2226, DOI 10.1253/circj.CJ-13-0847; Chien KL, 2011, J HUM HYPERTENS, V25, P294, DOI 10.1038/jhh.2010.63; Grotto I, 2008, CURR OPIN CARDIOL, V23, P335, DOI 10.1097/HCO.0b013e3283021c70; Diaz KM, 2013, CURR HYPERTENS REP, V15, P659, DOI 10.1007/s11906-013-0386-8; Paynter NP, 2009, AM J MED, V122, P464, DOI 10.1016/j.amjmed.2008.10.034; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c; Whelton PK, 1997, ARCH INTERN MED, V157, P657; Parikh NI, 2008, ANN INTERN MED, V148, P102; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Xin X, 2001, HYPERTENSION, V38, P1112, DOI 10.1161/hy1101.093424; Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560; Sesso HD, 2008, HYPERTENSION, V51, P1080, DOI 10.1161/HYPERTENSIONAHA.107.104968; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Sasazuki S, 2011, J EPIDEMIOL, V21, P417, DOI 10.2188/jea.JE20100180; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499; Guffey D, HOSMER LEMESHOW GOOD; Halperin RO, 2008, AM J HYPERTENS, V21, P148, DOI 10.1038/ajh.2007.36; HUNT SC, 1986, J CHRON DIS, V39, P809, DOI 10.1016/0021-9681(86)90083-4; Kawada T, 2012, OCCUP ENVIRON MED, V69, P606, DOI 10.1136/oemed-2011-100565; Kivimaki M, 2009, HYPERTENSION, V54, P496, DOI 10.1161/HYPERTENSIONAHA.109.132373; Lim NK, 2013, J CLIN HYPERTENS, V15, P344, DOI 10.1111/jch.12080; Ohmori S, 2002, ALCOHOL CLIN EXP RES, V26, P1010, DOI 10.1097/01.ALC.0000021147.31338.C2; Okubo Y, 2014, HYPERTENSION, V63, P41, DOI 10.1161/HYPERTENSIONAHA.113.01585; Otsuka T, 2013, INTERN MED J, V43, P1316, DOI 10.1111/imj.12259; Volzke H, 2013, J HYPERTENS, V31, P2142, DOI 10.1097/HJH.0b013e328364a16d; White N, 2013, TLS-TIMES LIT SUPPL, P6	39	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	JUN	2015	38	6					419	425		10.1038/hr.2014.159		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CJ7TE	WOS:000355701800009		
J	Fujii, M; Ohnishi, H; Saitoh, S; Akasaka, H; Miura, T; Mori, M				Fujii, Mizue; Ohnishi, Hirofumi; Saitoh, Shigeyuki; Akasaka, Hiroshi; Miura, Tetsuji; Mori, Mitsuru			The combination of abdominal obesity and high-sensitivity C-reactive protein predicts new-onset hypertension in the general Japanese population: the Tanno-Sobetsu study	HYPERTENSION RESEARCH			English	Article							CORONARY-HEART-DISEASE; AORTIC ENDOTHELIAL-CELLS; CARDIOVASCULAR RISK; ADIPOSE-TISSUE; BLOOD-PRESSURE; INSULIN-RESISTANCE; METABOLIC SYNDROME; INFLAMMATION; INDIVIDUALS; BIOMARKERS	The aim of this study was to examine whether the combination of abdominal obesity and high serum levels of high-sensitivity C-reactive protein (hsCRP) improves the prediction of new-onset hypertension in the general Japanese population. Participants in the Tanno-Sobetsu study, a prospective cohort study, were enrolled. Of 1516 subjects aged 30 years or older in 2002, those with hypertension or abnormal hsCRP levels were excluded, and the remaining 705 subjects were included in the present analyses. Abdominal obesity (AO) and high hsCRP levels were defined by the Japanese criteria of waist circumference and median hsCRP values, respectively. Subjects were followed up on for a maximum of 4.5 years, and the hazard ratio (HR) for new-onset hypertension was calculated using the Cox proportional hazard model. The HR for new-onset hypertension after adjustment for age, sex, fasting plasma glucose, alcohol intake, smoking, treatment for dyslipidemia and high normal blood pressure at baseline was significantly higher in the group with AO and high hsCRP (HR = 1.44, 95% CI: 1.00-2.07) compared with the reference group, a group with no AO and low hsCRP; AO alone or high hsCRP alone was not associated with a significant increase in the HR. Similar trends for the increase in the HR by AO and high hsCRP were observed in separate analyses of men and women, although the differences did not reach statistical significance. Co-presence of AO and a high level of hsCRP is associated with a high risk for new-onset hypertension in the general population.	[Fujii, Mizue; Ohnishi, Hirofumi; Mori, Mitsuru] Sapporo Med Univ, Sch Med, Dept Publ Hlth, Sapporo, Hokkaido, Japan; [Fujii, Mizue] Sapporo City Univ, Sch Nursing, Dept Nursing, Sapporo, Hokkaido 0600011, Japan; [Ohnishi, Hirofumi; Akasaka, Hiroshi; Miura, Tetsuji] Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Sapporo, Hokkaido, Japan; [Saitoh, Shigeyuki] Sapporo Med Univ, Sch Hlth Sci, Dept Basics & Clin Med, Sapporo, Hokkaido, Japan	Fujii, M (reprint author), Sapporo City Univ, Sch Nursing, Dept Nursing, Chuo Ku, Nishi 13 Chome,Kita 11 Jyo, Sapporo, Hokkaido 0600011, Japan.	m.fujii@scu.ac.jp					Verma S, 2002, CIRCULATION, V106, P913, DOI 10.1161/01.CIR.0000029802.88087.5E; Buckley DI, 2009, ANN INTERN MED, V151, P483; Verma S, 2002, CIRCULATION, V105, P1890, DOI 10.1161/01.CIR.0000015126.83143.B4; Neter JE, 2003, HYPERTENSION, V42, P878, DOI 10.1161/01.HYP.0000094221.86888.AE; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Vasan RS, 2001, LANCET, V358, P1682, DOI 10.1016/S0140-6736(01)06710-1; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Huang ZP, 1998, ANN INTERN MED, V128, P81; Hwang JJ, 2008, NUTR METAB CARDIOVAS, V18, P671, DOI 10.1016/j.numecd.2007.11.006; [Anonymous], 2011, J JAPAN SOC STUDY OB; Mattace-Raso FUS, 2010, J HYPERTENS, V28, P892, DOI 10.1097/HJH.0b013e328336ed26; Wilson PWF, 2008, CIRC-CARDIOVASC QUAL, V1, P92, DOI 10.1161/CIRCOUTCOMES.108.831198; Venugopal SK, 2002, CIRCULATION, V106, P1439, DOI 10.1161/01.CIR.0000033116.22237.F9; Landsberg L, 2013, J CLIN HYPERTENS, V15, P14, DOI 10.1111/jch.12049; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972; Devaraj S, 2003, CIRCULATION, V107, P398, DOI 10.1161/01.CIR.0000052617.91920.FD; Arima H, 2008, ARTERIOSCL THROM VAS, V28, P1385, DOI 10.1161/ATVBAHA.107.157164; Pitsavos C, 2008, HEART VESSELS, V23, P96, DOI 10.1007/s00380-007-1018-5; Niskanen L, 2004, HYPERTENSION, V44, P859, DOI 10.1161/01.HYP.0000146691.51307.84; Nishimura S, 2008, J CLIN INVEST, V118, P710, DOI 10.1172/JCI33328; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Wang TJ, 2012, CIRCULATION, V126, P1596, DOI 10.1161/CIRCULATIONAHA.112.129437; Sesso HD, 2003, JAMA-J AM MED ASSOC, V290, P2945, DOI 10.1001/jama.290.22.2945; Sakurai M, 2006, HYPERTENS RES, V29, P75, DOI 10.1291/hypres.29.75; Nakamura K, 2007, EUR J EPIDEMIOL, V22, P691, DOI 10.1007/s10654-007-9168-4; Kong H, 2012, HYPERTENS RES, V35, P1019, DOI 10.1038/hr.2012.89; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Davey Smith G., 2005, ARTERIOSCLER THROMB, V25, P1051; Henson J, 2013, PLOS MED, V8; Ikeda N, 2012, PLOS MED, V9; Li HM, 2012, HYPERTENS RES, V35, P513, DOI 10.1038/hr.2011.229; Mitsumata K, 2012, HYPERTENSION, V60, P1124, DOI 10.1161/HYPERTENSIONAHA.112.201129; Nishimura S, 2010, J JPN BIOCH SOC, V82, P832; Ohnishi H, 2008, HYPERTENS RES, V31, P1385, DOI 10.1291/hypres.31.1385; Rabkin SW, 2013, HYPERTENS RES, V36, P550, DOI 10.1038/hr.2012.214; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Shafi Dar M, 2010, J CLIN BIOCH, V25, P208; TODD ME, 1992, CAN J PHYSIOL PHARM, V70, P536; Verma S, 2001, Cardiol Rev, V9, P250, DOI 10.1097/00045415-200109000-00003; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624; Yoshihara M, 2013, PLOS MED, V8	44	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	JUN	2015	38	6					426	432		10.1038/hr.2015.27		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CJ7TE	WOS:000355701800010		
J	Kruusamae, K; Mukai, K; Sugino, T; Asaka, K				Kruusamaee, Karl; Mukai, Ken; Sugino, Takushi; Asaka, Kinji			Electroactive Shape-Fixing of Bucky-Gel Actuators	IEEE-ASME TRANSACTIONS ON MECHATRONICS			English	Article						Actuator; bucky-gel; carbon nanotube; electroactive polymer; ionic liquid (IL); morphing; shape memory	DIELECTRIC ELASTOMER; POLYMER ACTUATORS; CARBON NANOTUBE; TRANSISTORS; DISPLAY; MEMORY	Electromechanically active polymers (EAP) behave as actuators, i.e., temporarily change their shape when subjected to electric stimulus. However, in applications where a steady state of an actuator is required for an extended period of time (e.g., displaying characters of Braille text), EAPs need an active driving signal. Shape memory polymers, on the other hand, can be fixed to a preferred shape using appropriate stimuli such as temperature change and mechanical stress. Combining the electromechanical properties with the shape memory functionality could increase the efficiency and utility of EAP materials. As bucky-gel actuators-a subtype of EAPs-have been reported to possess a quite characteristic viscoelastic response, this paper proposes to implement them as shape-fixable EAPs. We employ four different shape-fixing techniques, out of which two allow programming the bucky-gel actuator in a controlled direction without any external stress or temperature change. These shape-fixing methods utilize composite driving signal consisting of high-frequency section to generate Joule heating within the material while low-frequency rectangular component deforms the bucky-gel laminate. It is concluded that bucky-gel actuators can achieve steady deformation by using solely the electrical input. By using the proposed methods for adding the shape-fixing functionality to an existing EAP device, no constructional changes of the system are required.	[Kruusamaee, Karl; Mukai, Ken; Sugino, Takushi; Asaka, Kinji] Natl Inst Adv Ind Sci & Technol, Osaka 5638577, Japan	Kruusamae, K (reprint author), Natl Inst Adv Ind Sci & Technol, Osaka 5638577, Japan.	karl.kruusamae@aist.go.jp; mukai-ken@aist.go.jp; takushi-sugino@aist.go.jp; asaka-kinji@aist.go.jp					Yun S, 2014, IEEE-ASME T MECH, V19, P1463, DOI 10.1109/TMECH.2013.2292956; Kong LR, 2014, ADV MATER, V26, P1025, DOI 10.1002/adma.201303432; Imaizumi S, 2012, J PHYS CHEM B, V116, P5080, DOI 10.1021/jp301501c; Conn AT, 2012, IEEE-ASME T MECH, V17, P968, DOI 10.1109/TMECH.2011.2153867; Kato Y, 2007, IEEE T ELECTRON DEV, V54, P202, DOI 10.1109/TED.2006.888678; Koh JS, 2013, IEEE-ASME T MECH, V18, P419, DOI 10.1109/TMECH.2012.2211033; Krossing I, 2006, J AM CHEM SOC, V128, P13427, DOI 10.1021/ja0619612; Asaka K, 2013, POLYM INT, V62, P1263, DOI 10.1002/pi.4562; Onal CD, 2013, IEEE-ASME T MECH, V18, P430, DOI 10.1109/TMECH.2012.2210239; Fukuda K, 2011, ADV FUNCT MATER, V21, P4019, DOI 10.1002/adfm.201101050; Son SI, 2012, APPL OPTICS, V51, P2987, DOI 10.1364/AO.51.002987; Xie T, 2010, NATURE, V464, P267, DOI 10.1038/nature08863; Niu XF, 2012, ADV MATER, V24, P6513, DOI 10.1002/adma.201202876; Lendlein A, 2010, J MATER CHEM, V20, P3332, DOI 10.1039/c004361n; Ghamsari AK, 2013, ACS APPL MATER INTER, V5, P5408, DOI 10.1021/am400106q; Araromi OA, 2015, IEEE-ASME T MECH, V20, P438, DOI 10.1109/TMECH.2014.2329367; Feng G.-H., 2014, SMART MATER STRUCT, V23; Ghamsari A. K., 2012, SMART MATER STRUCT, V21; Kosidlo U., 2013, SMART MATER STRUCT, V22; Kruusamae K., 2014, P SOC PHOTO-OPT INS, V9056; Kruusamae K, 2014, J INTEL MAT SYST STR, V25, P2235, DOI 10.1177/1045389X14538538; Kruusamae K., 2014, SMART MATER STRUCT, V23; Li S. L., 2011, SMART MATER STRUCT, V20; Liu Y., 2010, APPL PHYS LETT, V96; McPherson T, 2014, IEEE-ASME T MECH, V19, P755, DOI 10.1109/TMECH.2013.2257827; Meng H., 2013, SMART MATER STRUCT, V22; Must I, 2015, ADV ENG MATER, V17, P84, DOI 10.1002/adem.201400246; Rossiter J., 2012, SMART MATER STRUCT, V21; Vunder V., 2011, P SOC PHOTO-OPT INS, V7977; Yu Z., 2009, APPL PHYS LETT, V95	30	2	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1083-4435	1941-014X		IEEE-ASME T MECH	IEEE-ASME Trans. Mechatron.	JUN	2015	20	3					1108	1116		10.1109/TMECH.2014.2362917		9	Automation & Control Systems; Engineering, Manufacturing; Engineering, Electrical & Electronic; Engineering, Mechanical	Automation & Control Systems; Engineering	CJ3VT	WOS:000355413000012		
J	Kanno, T; Haraguchi, D; Yamamoto, M; Tadano, K; Kawashima, K				Kanno, Takahiro; Haraguchi, Daisuke; Yamamoto, Masayoshi; Tadano, Kotaro; Kawashima, Kenji			A Forceps Manipulator With Flexible 4-DOF Mechanism for Laparoscopic Surgery	IEEE-ASME TRANSACTIONS ON MECHATRONICS			English	Article						Forceps manipulator; pneumatic system; surgical robot; wire-driven mechanism	ROBOTIC FORCEPS; SYSTEM; DEEP	In this paper, a forceps manipulator for minimally invasive surgery is developed. The developed forceps has 4-DOF inside the abdominal cavity so that pivoting motion around the entry point is reduced, avoiding the interference with other manipulators or surgeons. The 4-DOF motion is realized using flexible joints that are driven by push-pull wire of superelastic alloy, which make the mechanism of the forceps simple and, thus, low cost and reliable. Since the wires of the forceps are driven by compact pneumatic cylinders, the manipulator is lightweight and achieves high power-to-weight ratio. Kinematic and dynamic models of the proposed forceps are derived considering the flexibility of the joints and friction of the wires. A position control law of the endpoint of the forceps is shown and tracking performance is confirmed by an experiment.	[Kanno, Takahiro; Kawashima, Kenji] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan; [Haraguchi, Daisuke; Tadano, Kotaro] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan; [Yamamoto, Masayoshi] Toyota Motor Co Ltd, Toyota 4718571, Japan	Kanno, T (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.	tak.kanno@gmail.com; haraguchi.d.aa@m.titech.ac.jp; ta.k.ka.nno@gmail.com; tadano@pi.titech.ac.jp; kkawa.bmc@tmd.ac.jp			Japan Science and Technology Agency	This work was supported by the Japan Science and Technology Agency, "Creation of Human-Harmonized Information Technology for Convivial Society."	Jourdan IC, 2004, BRIT J SURG, V91, P879, DOI 10.1002/bjs.4549; Tadano K, 2010, ADV ROBOTICS, V24, P1763, DOI 10.1163/016918610X522559; Harada K, 2005, IEEE INT CONF ROBOT, P502; Taylor RH, 2003, IEEE T ROBOTIC AUTOM, V19, P765, DOI 10.1109/TRA.2003.817058; Hagn U, 2010, INT J COMPUT ASS RAD, V5, P183, DOI [10.1007/s11548-009-0372-4, 10.1007/s11548-009-0372-41]; Xu K, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P5546, DOI 10.1109/IROS.2009.5354028; Ishii C, 2010, IEEE-ASME T MECH, V15, P671, DOI 10.1109/TMECH.2009.2031641; Arata J, 2010, IEEE INT CONF ROBOT, P1041, DOI 10.1109/ROBOT.2010.5509705; Davies B, 2000, P I MECH ENG H, V214, P129, DOI 10.1243/0954411001535309; Haraguchi D, 2011, IEEE INT C INT ROBOT, P931, DOI 10.1109/IROS.2011.6048226; Haraguchi D, 2013, PROC CIRP, V5, P61, DOI 10.1016/j.procir.2013.01.012; Ghodoussi M, 2002, IEEE INT C ROBOT AUT, V2, P1882; Goldman R., 2010, P IEEE INT C ROB AUT, P1053; Guthart G. S., 2000, IEEE ICRA 2000, V1, P618; Ikuta K, 2002, LECT NOTES COMPUT SC, V2488, P163; Ikuta K, 2003, IEEE INT CONF ROBOT, P1098; Kim KY, 2013, IEEE-ASME T MECH, V18, P200, DOI 10.1109/TMECH.2011.2164929; Kim K.-Y., 2010, P 4 INT C SENS TECHN, P90; Kitagawa M., 2002, P 5 INT C MED IM COM, V2488, P155; Low S. C., 2004, IEEE C ROB AUT MECH, V1, P37; Lum MJH, 2006, P IEEE RAS EMBS INT, P841; Rosen J, 2006, IEEE SPECTRUM, V43, P34, DOI 10.1109/MSPEC.2006.1705774; Tadano K., 2007, P SICE ANN C, P2871; Tadano K, 2010, J ROBOTICS MECHATRON, V22, P179; Tobergte A, 2009, P IEEE INT C ROB AUT, P4225; XU K, 2006, P IEEE INT C ROB AUT, P4148; Yamashita H, 2003, P 2003 IEEE RSJ INT, V3, P2577, DOI 10.1109/IROS.2003.1249258	27	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1083-4435	1941-014X		IEEE-ASME T MECH	IEEE-ASME Trans. Mechatron.	JUN	2015	20	3					1170	1178		10.1109/TMECH.2014.2327223		9	Automation & Control Systems; Engineering, Manufacturing; Engineering, Electrical & Electronic; Engineering, Mechanical	Automation & Control Systems; Engineering	CJ3VT	WOS:000355413000018		
J	Lafitte, N; Haddab, Y; Le Gorrec, Y; Guillou, H; Kumemura, M; Jalabert, L; Collard, D; Fujita, H				Lafitte, Nicolas; Haddab, Yassine; Le Gorrec, Yann; Guillou, Herve; Kumemura, Momoko; Jalabert, Laurent; Collard, Dominique; Fujita, Hiroyuki			Improvement of Silicon Nanotweezers Sensitivity for Mechanical Characterization of Biomolecules Using Closed-Loop Control	IEEE-ASME TRANSACTIONS ON MECHATRONICS			English	Article						Biosensor; MEMS tweezers; parameter detection; sensitivity improvement; state feedback	COMB-DRIVE ACTUATORS; FORCE SENSOR; DNA; MANIPULATION; MICROMANIPULATION	In this paper, we show that closed-loop control can be advantageously used for the characterization of mechanical properties of biomolecules using silicon nanotweezers (SNT). SNT have already been used in open-loop mode for the characterization of mechanical properties of DNA molecules. Up to now, such an approach allows the detection of stiffness variations equivalent to about 15 DNA molecules. Here, it is shown that this resolution is inversely proportional to the resonance frequency of the whole system and that real-time feedback control with state observer can drastically improve the performances of the tweezers used as biosensors. Such improvement is experimentally validated in the case of the manipulation of fibronectin molecules. The results are promising for the accurate characterization of biopolymers such as DNA molecules.	[Lafitte, Nicolas; Guillou, Herve; Kumemura, Momoko; Jalabert, Laurent; Collard, Dominique] Univ Tokyo, Inst Ind Sci, LIMMS CNRS IIS, UMI 2820, Tokyo 1538505, Japan; [Haddab, Yassine; Le Gorrec, Yann] UFC ENSMM UTBM CNRS, FEMTO ST, F-25044 Besancon, France; [Fujita, Hiroyuki] Univ Tokyo, Inst Ind Sci, Ctr Int Res Micromechatron, Tokyo 1538505, Japan	Lafitte, N (reprint author), Univ Tokyo, Inst Ind Sci, LIMMS CNRS IIS, UMI 2820, Tokyo 1538505, Japan.	lafitte@iis.u-tokyo.ac.jp; yassine.haddab@ens2m.fr; Yann.Le.Gorrec@ens2m.fr; herveg@iis.u-tokyo.ac.jp; momo@iis.u-tokyo.ac.jp; jalabert@iis.u-tokyo.ac.jp; collard@iis.u-tokyo.ac.jp; fujita@iis.u-tokyo.ac.jp	Collard, Dominique/A-6002-2013		LABEX ACTION [ANR-11-LABX-01-01]; NANOROBUST Project [ANR-2011 NANO 006]	The work of Y. Haddab and Y. Le Gorrec was supported in part by the LABEX ACTION under Grant ANR-11-LABX-01-01 and the NANOROBUST Project (ANR-2011 NANO 006).	Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Bao G, 2002, J MECH PHYS SOLIDS, V50, P2237, DOI 10.1016/S0022-5096(02)00035-2; Simmons RM, 1996, BIOPHYS J, V70, P1813; Collard D, 2007, IEEJ T ELECTR ELECTR, V2, P262, DOI 10.1002/tee.20154; Hashiguchi G, 2003, ANAL CHEM, V75, P4347, DOI 10.1021/ac034501p; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Beyeler F, 2007, J MICROELECTROMECH S, V16, P7, DOI 10.1109/JMEMS.2006.885853; Gosse C, 2002, BIOPHYS J, V82, P3314; WASHIZU M, 1990, IEEE T IND APPL, V26, P1165, DOI 10.1109/28.62403; Sun Y, 2002, J MICROMECH MICROENG, V12, P832, DOI 10.1088/0960-1317/12/6/314; Hawkins T, 2010, J BIOMECH, V43, P23, DOI 10.1016/j.jbiomech.2009.09.005; Gore J, 2006, NATURE, V439, P100, DOI 10.1038/nature04319; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Amblard F, 1996, REV SCI INSTRUM, V67, P818, DOI 10.1063/1.1146816; Yamahata C, 2008, J MICROELECTROMECH S, V17, P623, DOI 10.1109/JMEMS.2008.922080; Sun Y, 2005, J MICROELECTROMECH S, V14, P4, DOI 10.1109/JMEMS.2004.839028; Cluzel P, 1996, SCIENCE, V271, P792, DOI 10.1126/science.271.5250.792; Zhou GY, 2003, J MICROMECH MICROENG, V13, P178, DOI 10.1088/0960-1317/13/2/303; Chaudhuri O, 2007, NATURE, V445, P295, DOI 10.1038/nature05459; Bancaud A, 2006, NAT STRUCT MOL BIOL, V13, P444, DOI 10.1038/nsmb1087; Bao M., 2005, ANAL DESIGN PRINCIPL; Clark T., 1999, IEEE J SOLID-ST CIRC, V34, P440; Collard Dominique, 2013, Front Biosci (Elite Ed), V5, P955; ISHIJIMA A, 1991, NATURE, V352, P301, DOI 10.1038/352301a0; Kim K, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/5/055013; Kumemura M, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/5/054020; Kumemura M, 2010, PROC IEEE MICR ELECT, P915; Lafitte N., 2011, P 15 INT C MIN SYST, P389; Lafitte N., 2012, THESIS U FRANCHE COM; Legtenberg R, 1996, J MICROMECH MICROENG, V6, P320, DOI 10.1088/0960-1317/6/3/004; TANG WC, 1989, SENSOR ACTUATOR, V20, P25, DOI 10.1016/0250-6874(89)87098-2; Tarhan M. C., 2012, P 16 INT C MIN SYST, P1897	33	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1083-4435	1941-014X		IEEE-ASME T MECH	IEEE-ASME Trans. Mechatron.	JUN	2015	20	3					1418	1427		10.1109/TMECH.2014.2351415		10	Automation & Control Systems; Engineering, Manufacturing; Engineering, Electrical & Electronic; Engineering, Mechanical	Automation & Control Systems; Engineering	CJ3VT	WOS:000355413000040		
J	Song, SSC; Shang, HL; Ikeda, S				Song, Stanley S. C.; Shang, Huiling; Ikeda, Shuji			Special Issue on Variation Aware Technology and Circuit Co-Design Foreword	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Editorial Material									[Shang, Huiling] IBM Semicond Res & Dev Ctr, CMOS Technol Dev, Yorktown Hts, NY USA; [Ikeda, Shuji] Hitachi Ltd, Semicond & Integrated Circuit Grp, Tokyo, Japan								0	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	JUN	2015	62	6					1680	1681		10.1109/TED.2015.2425031		2	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CJ3TB	WOS:000355405800001		
J	Noda, T; Vrancken, C; Vandervorst, W				Noda, Taiji; Vrancken, Christa; Vandervorst, Wilfried			Atomistic Modeling of Pocket Dopant Deactivation and Its Impact on V-th Variation in Scaled Si Planar Devices Using an Atomistic Kinetic Monte Carlo Approach	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Diffusion; kinetic Monte Carlo (KMC); MOSFETs; semiconductor; ultrashallow junctions (USJs); V-th variation	ENHANCED DIFFUSION; SILICON; TECHNOLOGIES; TRANSISTORS; EVOLUTION; BORON	An analysis of pocket dopant deactivation and its impact on V-th variation for scaled Si devices using an atomistic kinetic Monte Carlo approach are shown in this paper. B 5 keV, 5 x 10(13)/cm(2) + As 1 keV, 1 x 10(15)/cm(2) implants were used for B pocket deactivation study. An effect of laser annealing (LA) before spike-Rapid Thermal Annealing (RTA) was investigated. In case of B pocket implant, a stable B cluster configuration is changed from B3I (>1020 degrees C) to BI2 at spike-RTA temperature similar to 1020 degrees C. BI2 is a source of B pocket deactivation with lower temperature than 1020 degrees C. LA before low-temperature spike-RTA (<1020 degrees C) is useful to improve B pocket activation. The Vth mismatch figure of merit extracted from Pelgrom plot (Avt) degradation in nFET is shown as spike-RTA temperature is reduced. LA before spike-RTA shows a better short channel effect with lower drain-induced barrier lowering in nFET. LA + spike-RTA at 1000 degrees C shows better Avt than spike-RTA-only. The difference of pocket deactivation is one of possible important reasons for the higher Vth mismatch for nFET than for pFET.	[Noda, Taiji] Panasonic Corp, Osaka 5406233, Japan; [Vrancken, Christa; Vandervorst, Wilfried] IMEC, B-3001 Leuven, Belgium; [Vandervorst, Wilfried] Katholieke Univ Leuven, B-3001 Leuven, Belgium	Noda, T (reprint author), Panasonic Corp, Osaka 5406233, Japan.	noda.taiji@jp.panasonic.com; christa.vrancken@imec.be; wilfried.vandervorst@imec.be					Roy G, 2006, IEEE T ELECTRON DEV, V53, P3063, DOI 10.1109/TED.2006.885683; Pelaz L, 1999, APPL PHYS LETT, V74, P3657, DOI 10.1063/1.123213; De Salvador D, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2402905; Noda T, 2002, J APPL PHYS, V91, P639, DOI 10.1063/1.1421213; Takeuchi K, 2007, INT EL DEVICES MEET, P467, DOI 10.1109/IEDM.2007.4418975; [Anonymous], 2010, SENT PROC US GUID; Yuan XB, 2011, IEEE T ELECTRON DEV, V58, P335, DOI 10.1109/TED.2010.2090159; PELGROM MJM, 1989, IEEE J SOLID-ST CIRC, V24, P1433, DOI 10.1109/JSSC.1989.572629; Cristiano F, 2000, J APPL PHYS, V87, P8420, DOI 10.1063/1.373557; Duffy R, 2006, IEEE T ELECTRON DEV, V53, P71, DOI 10.1109/TED.2005.860651; Harrison SA, 2006, ELECTROCHEM SOLID ST, V9, pG354, DOI 10.1149/1.2359084; Hoffmann T. Y., 2007, P IWJT JUN, P137; Noda T., 2010, P IEEE IEDM SAN FRAN, P383; Noda T, 2008, INT EL DEVICES MEET, P539; Noda T, 2010, S VLSI TECH, P73, DOI 10.1109/VLSIT.2010.5556177; Noda T., 2006, P INT EL DEV M, P377; Noda T, 2007, INT EL DEVICES MEET, P955, DOI 10.1109/IEDM.2007.4419111; Ortolland C, 2008, 2008 SYMPOSIUM ON VLSI TECHNOLOGY, DIGEST OF TECHNICAL PAPERS, P186, DOI 10.1109/VLSIT.2008.4588612; Pawlak BJ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2227863; Ramamoorthy M, 1996, PHYS REV LETT, V76, P4753, DOI 10.1103/PhysRevLett.76.4753; Rousseau PM, 1997, IEEE ELECTR DEVICE L, V18, P42, DOI 10.1109/55.553038; Severi S., 2006, P IEDM, P859; Vandervorst W., 2008, P MAT RES SOC S, V1070	23	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	JUN	2015	62	6					1789	1795		10.1109/TED.2015.2419876		7	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CJ3TB	WOS:000355405800017		
J	Takahashi, T; Sato, M; Nakasha, Y; Hara, N				Takahashi, Tsuyoshi; Sato, Masaru; Nakasha, Yasuhiro; Hara, Naoki			Sensitivity Improvement in GaAsSb-Based Heterojunction Backward Diodes by Optimized Doping Concentration	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Backward diode; GaAsSb; interband tunneling; lattice match; millimeter wave; nonlinearity; sensitivity; zero bias	MILLIMETER-WAVE DETECTORS; NOISE EQUIVALENT POWER; DOPED BARRIER DIODES; TEMPERATURE-DEPENDENCE; PERFORMANCE; TUNNEL; BIAS	An impedance-matched voltage sensitivity (beta(v, opt)) of 20 400 V/W at 94 GHz was achieved at zero bias and room temperature using heterojunction backward diodes that were based on a p(+)-GaAsSb/i-InAlAs/n-InGaAs that was lattice matched to an InP substrate. Doping concentrations in the diodes were adjusted to optimize the sensitivity and its nonlinear characteristic. The proper donor doping concentration in n-InGaAs to increase its sensitivity was determined to be 1x10(18) cm(-3). Meanwhile, the proper acceptor doping concentration in a p-GaAsSb layer was 5 x 10(18) cm(-3) to achieve a large nonlinearity as a curvature coefficient (gamma) of -49.4 V-1, which exceeded that of ideal Schottky diode. The dependence of doping concentration on noise performance was also considered. The lattice-matched GaAsSb-based backward diodes are applicable in millimeter wave detectors and mixers.	[Takahashi, Tsuyoshi; Sato, Masaru; Nakasha, Yasuhiro; Hara, Naoki] Fujitsu Labs Ltd, Fujitsu Ltd, Atsugi, Kanagawa 2430197, Japan	Takahashi, T (reprint author), Fujitsu Labs Ltd, Fujitsu Ltd, Atsugi, Kanagawa 2430197, Japan.	takahashi.tsuyo@jp.fujitsu.com; sato.masaru@jp.fujitsu.com; nakasha-y@jp.fujitsu.com; hara.naoki@jp.fujitsu.com			Ministry of Internal Affairs and Communications, Japan	This work was supported by the Ministry of Internal Affairs and Communications, Japan. The review of this paper was arranged by Editor G. Niu.	Su N, 2008, IEEE ELECTR DEVICE L, V29, P536, DOI 10.1109/LED.2008.922986; Meyers RG, 2004, IEEE ELECTR DEVICE L, V25, P4, DOI 10.1109/LED.2003.821601; Schulman JN, 2000, IEEE ELECTR DEVICE L, V21, P353, DOI 10.1109/55.847378; KANE EO, 1961, J APPL PHYS, V32, P83, DOI 10.1063/1.1735965; Ito H, 2008, JPN J APPL PHYS, V47, P6256, DOI 10.1143/JJAP.47.6256; ESAKI L, 1976, IEEE T ELECTRON DEV, V23, P644, DOI 10.1109/T-ED.1976.18466; Bahl I. J., 1988, MICROWAVE SOLID STAT, P549; Fay P, 2002, IEEE ELECTR DEVICE L, V23, P585, DOI 10.1109/LED.2002.803760; KAJIYAMA K, 1979, IEEE T ELECTRON DEV, V26, P244, DOI 10.1109/T-ED.1979.19417; KARLOVSK.J, 1967, SOLID STATE ELECTRON, V10, P1109, DOI 10.1016/0038-1101(67)90131-1; KEARNEY MJ, 1991, ELECTRON LETT, V27, P721, DOI 10.1049/el:19910448; Morgan M, 2001, IEEE MTT-S, P99, DOI 10.1109/MWSYM.2001.966848; Sato K. F., 1998, MICR S 1998 IEEE MTT, V3, P1695; Sato M., 2007, IEEE MTT S INT MICR, P1775; Su N, 2007, IEEE ELECTR DEVICE L, V28, P336, DOI 10.1109/LED.2007.895377; Sze S. M., 2007, PHYS SEMICONDUCTOR D, V3rd, P436; Takahashi T, 2009, ELECTRON LETT, V45, P1269, DOI 10.1049/el.2009.2496; Takahashi T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.104101; Takahashi T., 2012, P INT C IND PHOSPH R, P95; Takahashi T., 2013, P APEMC 2013 IEEE ME, P1; TEMKIN H, 1989, APPL PHYS LETT, V55, P1668, DOI 10.1063/1.102231; Vo VT, 2004, ELECTRON LETT, V40, P343, DOI 10.1049/el:20040217; Zhang Z, 2011, IEEE MICROW WIREL CO, V21, P267, DOI 10.1109/LMWC.2011.2123878	23	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	JUN	2015	62	6					1891	1897		10.1109/TED.2015.2423851		7	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CJ3TB	WOS:000355405800031		
J	Kumabe, M; Suzuki, T				Kumabe, Masahiro; Suzuki, Toshio			Resource-bounded martingales and computable Dowd-type generic sets	INFORMATION AND COMPUTATION			English	Article						Dowd-type generic set; Resource-bounded randomness; Martingale	ONE-QUERY TAUTOLOGIES; RANDOM ORACLE; TRUTH-TABLE; RANDOMNESS; COMPLEXITY; REDUCE	Martin-Lof defined algorithmic randomness, the use of martingales in this definition and several variants were explored by Schnorr, and Lutz introduced resource-bounded randomness. Ambos-Spies et al. have studied resource-bounded randomness under time-bounds and have shown that resource-bounded randomness implies resource-bounded genericity. While the genericity of Ambos-Spies is based on time-bound on finite-extension strategy, the genericity of Dowd, the main topic of this paper, is based on an analogy of the forcing theorem. For a positive integer r, an oracle D is r-generic in the sense of Dowd (r-Dowd) if the following holds: If a certain formula F on an exponential-sized portion of D is a tautology then a polynomial-sized subfunction of D forces F to be a tautology. Here, r is the number of occurrences of query symbols in F. The relationship between resource-bounded randomness and Dowd-type genericity has been not clear so far. We show that there exists a primitive recursive function t(n) with the following property: Every t(n)-random set is r-Dowd for each positive integer r. A proof is done by means of constructing resource-bounded martingales. In our former paper, we left an open problem whether there exists a primitive recursive set which is r-Dowd for every positive integer r. In our recent work, we give an affirmative answer to the problem. The main theorem of the present paper gives an alternative proof of the affirmative answer. (C) 2015 Elsevier Inc. All rights reserved.	[Kumabe, Masahiro] Open Univ Japan, Fac Liberal Arts, Mihama Ku, Chiba 2618586, Japan; [Suzuki, Toshio] Tokyo Metropolitan Univ, Dept Math & Informat Sci, Hachioji, Tokyo 1920397, Japan	Suzuki, T (reprint author), Tokyo Metropolitan Univ, Dept Math & Informat Sci, Hachioji, Tokyo 1920397, Japan.	kumabe@ouj.ac.jp; toshio-suzuki@tmu.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [22540146, 19340019]	We are deeply grateful to Klaus Ambos-Spies for his comments on our talk at the 11th Asian Logic Conference. The comments were very helpful in formulating the statement of our main theorem. We are also grateful to Andre Nies and anonymous referees. Their kind advices allowed us to improve the manuscript. We would like to thank Akitoshi Kawamura and Stephen A. Cook for their encouragement. This work was partially supported by Japan Society for the Promotion of Science (JSPS) KAKENHI (C) 22540146 and (B) 19340019.	Ambos-Spies K., 1988, LECT NOTES COMPUTER, V329, P1; Ambos-Spies K., 1996, LECT NOTES COMPUTER, V1046, P63; Hella L, 2006, THEOR COMPUT SCI, V355, P197, DOI 10.1016/j.tcs.2006.01.009; [Anonymous], 1990, LECT NOTES COMPUT SC; AmbosSpies K, 1996, THEOR COMPUT SCI, V168, P3, DOI 10.1016/0304-3975(96)89424-2; Suzuki T, 2010, PROCEEDINGS OF THE 10TH ASIAN LOGIC CONFERENCE, P322, DOI 10.1142/9789814293020_0013; Suzuki T, 2005, ARCH MATH LOGIC, V44, P751, DOI 10.1007/s00153-005-0283-1; [Anonymous], 1997, LECT NOTES PURE APPL; Suzuki T, 2002, INFORM COMPUT, V176, P66, DOI 10.1006/inco.2002.3149; Kumabe M, 2008, ARCH MATH LOGIC, V47, P159, DOI 10.1007/s00153-008-0076-4; LUTZ JH, 1990, SIAM J COMPUT, V19, P1100, DOI 10.1137/0219076; AmbosSpies K, 1997, THEOR COMPUT SCI, V172, P195, DOI 10.1016/S0304-3975(95)00260-X; DOWD M, 1992, INFORM COMPUT, V96, P65, DOI 10.1016/0890-5401(92)90055-K; Downey RG, 2010, THEOR APPL COMPUT, P401, DOI 10.1007/978-0-387-68441-3; Downey R, 2006, B SYMB LOG, V12, P411, DOI 10.2178/bsl/1154698741; Kumabe M., 2009, P 11 AS LOG C NAT U, P128; LUTZ JH, 1992, J COMPUT SYST SCI, V44, P220, DOI 10.1016/0022-0000(92)90020-J; MARTINLO.P, 1966, INFORM CONTROL, V9, P602, DOI 10.1016/S0019-9958(66)80018-9; Nies A., 2009, COMPUTABILITY RANDOM; Schnorr C.-P., 1971, LECT NOTES MATH, V218; Schnorr C. P., 1971, Mathematical Systems Theory, V5, DOI 10.1007/BF01694181; Suzuki T., 1999, THESIS U TSUKUBA TSU; Suzuki T., 2001, Notre Dame Journal of Formal Logic, V42, DOI 10.1305/ndjfl/1054837938; Suzuki T., 1998, KOBE J MATH, V15, P91; Suzuki T., 2000, Notre Dame Journal of Formal Logic, V41, DOI 10.1305/ndjfl/1038234608	25	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0890-5401	1090-2651		INFORM COMPUT	Inf. Comput.	JUN	2015	242						227	248		10.1016/j.ic.2015.03.004		22	Computer Science, Theory & Methods; Mathematics, Applied	Computer Science; Mathematics	CJ7HH	WOS:000355664900010		
J	Indarto, J; Kaneko, S; Kawata, K				Indarto, J.; Kaneko, S.; Kawata, K.			Do forest permits cause deforestation in Indonesia?	INTERNATIONAL FORESTRY REVIEW			English	Article						forest cover loss; deforestation; forest concession or permit; the forest moratorium policy; the forest tariff policy; Indonesia	ENVIRONMENTAL KUZNETS CURVE; TROPICAL DEFORESTATION; CARBON EMISSIONS; EAST KALIMANTAN; ASIA; MANAGEMENT; POLICY; COVER; FRAGMENTATION; BIODIVERSITY	Deforestation is the most critical issue of climate change in Indonesia, as well as in other tropical countries, meanwhile major forests is managed under concession or permit system. This paper investigates the effect of forest permits on deforestation in Indonesia. Two major forest permits are taken into analysis, resulting that logging permit is insignificantly correlated to forest cover loss, whereas plantation conversion permit diminishes more forest cover in Indonesia. These results pose a question on the effectiveness of the current forest moratorium policy as well as the forest tariff policy to the attempts in mitigating deforestation. At the end, this paper summarises possible alternative forest policies derived from the empirical findings, from both short and long term perspectives.	[Indarto, J.; Kaneko, S.; Kawata, K.] Hiroshima Univ, Grad Sch Int Dev & Cooperat IDEC, Higashihiroshima, Hiroshima 7398529, Japan; [Indarto, J.] Natl Dev Planning Agcy BAPPENAS, Dki Jakarta 10310, Indonesia	Indarto, J (reprint author), Hiroshima Univ, Grad Sch Int Dev & Cooperat IDEC, 1-5-1 Kagamiyama, Higashihiroshima, Hiroshima 7398529, Japan.	j.indarto@gmail.com; kshinji@hiroshima-u.ac.jp; keisuke@hiroshima-u.ac.jp	Kawata, Keisuke/M-4488-2013; Kaneko, Shinji/G-5913-2012	Kaneko, Shinji/0000-0002-9026-5728	BAPPENAS, Indonesia; JICA, Japan	This research was partially supported by the Capacity Development for Climate Change Strategies in Indonesia as a collaborative project between BAPPENAS, Indonesia and JICA, Japan. The authors are indebted to two anonymous referees whose insightful comments, suggestions and directions improved this paper considerably.	ABOOD S.A., 2014, CONSERV LETT, P1; ANDERSON J., 2013, CONVERSATION NIRARTA; Carlson KM, 2012, P NATL ACAD SCI USA, V109, P7559, DOI 10.1073/pnas.1200452109; SKOLE D, 1993, SCIENCE, V260, P1905, DOI 10.1126/science.260.5116.1905; Barbier EB, 2010, LAND USE POLICY, V27, P98, DOI 10.1016/j.landusepol.2009.02.001; Damette O, 2011, ECOL ECON, V70, P1211, DOI 10.1016/j.ecolecon.2011.01.025; Hansen MC, 2013, SCIENCE, V342, P850, DOI 10.1126/science.1244693; Margono BA, 2014, NAT CLIM CHANGE, V4, P730, DOI [10.1038/nclimate2277, 10.1038/NCLIMATE2277]; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Meijaard E, 2007, NATURE, V446, P974, DOI 10.1038/446974a; Obidzinski K, 2013, LAND USE POLICY, V30, P952, DOI 10.1016/j.landusepol.2012.06.018; VERISSIMO A, 1992, FOREST ECOL MANAG, V55, P169, DOI 10.1016/0378-1127(92)90099-U; Sist P, 2003, ENVIRON CONSERV, V30, P364, DOI 10.1017/S0376892903000389; Jepson P, 2001, SCIENCE, V292, P859, DOI 10.1126/science.1061727; Fearnside PM, 2005, CONSERV BIOL, V19, P680, DOI 10.1111/j.1523-1739.2005.00697.x; Singer B, 2008, INT FOREST REV, V10, P523, DOI 10.1505/ifor.10.3.523; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Smith J, 2003, INT FOREST REV, V5, P293, DOI 10.1505/IFOR.5.3.293.19138; DAUVERGNE P, 1994, PAC AFF, V66, P497; Brockhaus M, 2012, FOREST POLICY ECON, V18, P30, DOI [10.1016/j.forpol.2011.09.004, 10.1016/j.forpol.2012.03.001]; Rudel T, 1997, WORLD DEV, V25, P53, DOI 10.1016/S0305-750X(96)00086-1; Busch J, 2012, P NATL ACAD SCI USA, V109, P1062, DOI 10.1073/pnas.1109034109; Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Obidzinski K, 2009, INT FOREST REV, V11, P79, DOI 10.1505/ifor.11.1.79; Koop G, 1999, J DEV ECON, V58, P231, DOI 10.1016/S0304-3878(98)00110-2; Abdullah SA, 2007, FOREST ECOL MANAG, V241, P39, DOI 10.1016/j.foreco.2006.12.016; Bull GQ, 2006, FOREST POLICY ECON, V9, P13, DOI 10.1016/j.forpol.2005.01.004; Gaveau DLA, 2012, CONSERV LETT, V5, P142, DOI 10.1111/j.1755-263X.2011.00220.x; Bhattarai M, 2001, WORLD DEV, V29, P995, DOI 10.1016/S0305-750X(01)00019-5; Culas RJ, 2007, ECOL ECON, V61, P429, DOI 10.1016/j.ecolecon.2006.03.014; Griscom B, 2014, GLOBAL CHANGE BIOL, V20, P923, DOI 10.1111/gcb.12386; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Fisher B, 2011, CONSERV LETT, V4, P443, DOI 10.1111/j.1755-263X.2011.00198.x; Culas RJ, 2012, ECOL ECON, V79, P44, DOI 10.1016/j.ecolecon.2012.04.015; Amacher GS, 2012, J ENVIRON ECON MANAG, V63, P92, DOI 10.1016/j.jeem.2011.05.007; Arbainsyah, 2014, BIODIVERS CONSERV, V23, P2445, DOI 10.1007/s10531-014-0732-4; Barber C. V., 2000, TRIAL FIRE FOREST FI; Barbier EB, 2001, J ECON SURV, V15, P413, DOI 10.1111/1467-6419.00144; Barr C, 2001, BANKING SUSTAINABILI; Barr C., 2002, WHICH WAY FORWARD PE, P191; Barr C., 2006, DECENTRALIZATION FOR; Barr CM, 2012, BIOL CONSERV, V154, P9, DOI 10.1016/j.biocon.2012.03.020; BILSBORROW R., 1994, CAUSES TROPICAL DEFO, P106; BLAIR M.M., 2007, J CORPORATE LAW, V33, P325; BPS, 2010, LAJ PERT PEND MEN PR; BURGESS R., 2012, Q J ECON, P1707; CASSON A., 2000, HESITANT BOOM INDONE, V62; Choumert J, 2013, ECOL ECON, V90, P19, DOI 10.1016/j.ecolecon.2013.02.016; CIFOR, 2004, GEN EC GROWTH RUR LI; Cossalter C., 2003, FAST WOOD FORESTRY M; CROPPER M, 1994, AM ECON REV, V84, P250; DENNIS R.A., 2008, ECOLOGY SOC, V13, P1; FAO, 2001, GOV PRINC CONC CONTR; Food and Agriculture Organization [FAO], 2010, GLOB FOR RES ASS 201; Fuller DO, 2004, CONSERV BIOL, V18, P249, DOI 10.1111/j.1523-1739.2004.00018.x; GAUTAM M., 2000, INDONESIA CHALLENGES; Gaveau D., 2013, NEARLY Q JUNE FIRES; GAVEAU D.L.A., 2013, PLOS ONE, V8, P1; GAVEAU D.L.A., 2014, PLOS ONE, V9, P1; GRAY J.A., 2002, FOREST CONCESSION PO; HANSEN M.C., 2013, HANSEN UMD GOOGLE US; HOFFMAN A.A., 1999, FIRE DAMAGE E KALIMA; HOLMES D.A., 2002, HAVE ALL FORESTS GON; Hunt C, 2010, B INDONES ECON STUD, V46, P187, DOI 10.1080/00074918.2010.503563; Iskandar H, 2006, FOREST ECOL MANAG, V237, P83, DOI 10.1016/j.foreco.2006.09.079; Kaimowitz David, 1998, EC MODELS TROPICAL D; Karsenty A, 2008, FOREST ECOL MANAG, V256, P1498, DOI 10.1016/j.foreco.2008.07.001; KARTODIHARDJO H., 2000, IMPACT SECTORAL DEV, V26; LAURANCE W.F., 2012, BIOL CONSERV, V151, P41; LOPEZ R.E., 1998, ANN WORLD BANK C DEV; Mahapatra K, 2005, FOREST POLICY ECON, V7, P1, DOI 10.1016/S1389-9341(03)00064-9; Margono BA, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034010; MATTHEWS E, 2002, STATE FOREST INDONES; McAllister RRJ, 2007, FOREST POLICY ECON, V9, P1079, DOI 10.1016/j.forpol.2006.10.004; Merry F. D., 2003, ITTO Tropical Forest Update, V13, P7; Ministry of Environment [MoE], 2010, IND 2 NAT COMM UN FR; MOF, 2008, IFCA CONS REP RED EM; MOF, 2013, DAT INF DITJ PLAN KE; MOF, 2012, DAT INF PEM HUT TAH; MOF, 2011, MOF POLICY BRIEF, V5, P1; MOF, 2014, STAT KEH; MOLNAR A, 2011, LARGE ACQUISITION RI; Murdiyarso Daniel, 2011, INDONESIAS FOREST MO; NAWIR A.A, 2008, REHABILITASI HUTAN I; PALMER C, 2000, EXTENT CAUSES ILLEGA; PALO M, 1994, CAUSES TROPICAL DEFO, P42; Poffenberger M, 1997, ASIAN SURV, V37, P453, DOI 10.1525/as.1997.37.5.01p0246u; Repetto R., 1988, PUBLIC POLICIES MISU; RESOSUDARMO B.P., 2012, WORKING PAPERS TRADE; RRI, 2012, IND COUNTR DAT; Tacconi L., 2004, Journal of Sustainable Forestry, V19, P137, DOI 10.1300/J091v19n01_07; Thiele R., 1994, Intereconomics, V29, P184, DOI 10.1007/BF02926437; VON AMSBERG J., 1994, EC PARAMETERS DEFORE; WALKER R, 1993, J REGIONAL SCI, V33, P387, DOI 10.1111/j.1467-9787.1993.tb00232.x; Wheeler D, 2013, ECOL ECON, V85, P85, DOI 10.1016/j.ecolecon.2012.11.005	95	0	0	COMMONWEALTH FORESTRY ASSOC	CRAVEN ARRMS	CRIB, DINCHOPE, CRAVEN ARRMS SY7 9JJ, SHROPSHIRE, ENGLAND	1465-5489	2053-7778		INT FOREST REV	Int. For. Rev.	JUN	2015	17	2					165	181				17	Forestry	Forestry	CJ8GE	WOS:000355737400005		
J	Harih, G; Tada, M				Harih, Gregor; Tada, Mitsunori			Finite element evaluation of the effect of fingertip geometry on contact pressure during flat contact	INTERNATIONAL JOURNAL FOR NUMERICAL METHODS IN BIOMEDICAL ENGINEERING			English	Article						fingertip geometry; contact pressure; contact simulation; finite element method; pressure discomfort threshold; pressure pain threshold	HAND-HANDLE INTERFACE; BIOMECHANICAL PROPERTIES; VISCOELASTIC PROPERTIES; HUMAN SKIN; IN-VIVO; COMFORT; SURFACE; RECOMMENDATIONS; DESIGN; SYSTEM	Several studies investigated the mechanical loads developing in the hands during the use of various products in order to enhance user's performance, increase satisfaction and lower the risk of acute and cumulative trauma disorders. Values of pressure discomfort (PDT) and pressure-pain threshold (PPT) were, hence, provided. PDT and PPT may differ significantly for each subject and area of the hand because of psychological and physiological factors. A finite element study of the effect of fingertip anthropometry and anatomy geometry on mechanical loads developed during grasping is carried out in this research in order to assess physiological aspects behind variations of PDT and PPT existing between different subjects. It is found that the underlying anatomical structure and geometry (especially of the bone) significantly affect contact pressure distributions and pressure peak values. The largest difference in peak contact pressure between two different fingertips was in fact 27% for the same applied force. Furthermore, contact pressure distributions varied significantly between different subjects. The findings of this research provide novel insight into the phenomena of human grasping and the variation of contact pressure from subject to subject. Copyright (c) 2015John Wiley & Sons, Ltd.	[Harih, Gregor] Univ Maribor, Fac Mech Engn, Lab Intelligent CAD Syst, SI-2000 Maribor, Slovenia; [Tada, Mitsunori] Natl Inst Adv Ind Sci & Technol, Digital Human Res Ctr, Tsukuba, Ibaraki, Japan	Harih, G (reprint author), Univ Maribor, Fac Mech Engn, LICADS Lab Intelligent CAD Syst, SI-2000 Maribor, Slovenia.	gregor.harih@um.si					ABAS WAB, 1994, BIOMED MAT ENG, V4, P473; Ali Aidy, 2010, American Journal of Engineering and Applied Sciences, V3, DOI 10.3844/ajeassp.2010.232.239; Aldien Y, 2005, INT J IND ERGONOM, V35, P267, DOI 10.1016/j.ergon.2004.09.005; Mundermann A, 2001, MED SCI SPORT EXER, V33, P1939; Vesenjak M, 2013, MATER LETT, V110, P201, DOI 10.1016/j.matlet.2013.08.026; Clark JA, 1996, BURNS, V22, P443, DOI 10.1016/0305-4179(96)00038-1; Annett J, 2002, ERGONOMICS, V45, P966, DOI 10.1080/00140130210166951; Pawluk DTV, 1999, J BIOMECH ENG-T ASME, V121, P605, DOI 10.1115/1.2800860; Zheng YP, 1996, IEEE T BIO-MED ENG, V43, P912, DOI 10.1109/10.532125; Kuijt-Evers LFM, 2004, APPL ERGON, V35, P453, DOI 10.1016/j.apergo.2004.04.001; Xiong SP, 2011, ERGONOMICS, V54, P282, DOI 10.1080/00140139.2011.552736; Wilhelmi BJ, 1998, ANN PLAS SURG, V41, P215, DOI 10.1097/00000637-199808000-00019; Wongsriruksa S, 2012, MATER DESIGN, V42, P238, DOI 10.1016/j.matdes.2012.05.054; Lemerle P, 2008, ERGONOMICS, V51, P168, DOI 10.1080/00140130701528602; DELOOZE MP, 2003, TERG ERGONOMICS, V46, P985; Wu JZ, 2005, P I MECH ENG H, V219, P89, DOI 10.1243/095441105X9327; Edwards C, 1995, CLIN DERMATOL, V13, P375, DOI 10.1016/0738-081X(95)00078-T; FRANSSONHALL C, 1993, APPL ERGON, V24, P181, DOI 10.1016/0003-6870(93)90006-U; Goonetilleke RS, 1994, P HUM FACT ERG SOC A, V38, P688; Harih G, 2014, APPL ERGON, V45, P943, DOI 10.1016/j.apergo.2013.11.011; Harih G, 2013, BIOMED RES INT, V2013, P1; Harih G, 2014, 3 INT DIG HUM MOD S; Harih G, 2013, INT J IND ERGONOM, V43, P288, DOI 10.1016/j.ergon.2013.05.002; Harih G, 2014, APPL ERGON, V45, P577, DOI 10.1016/j.apergo.2013.07.014; Harih G, 2014, INT J SIMUL MODEL, V13, P5, DOI 10.2507/IJSIMM13(1)1.234; Kaljun J, 2012, S AFR J IND ENG, V23, P215; Kinchington M, 2012, PHYS THER SPORT, V13, P27, DOI 10.1016/j.ptsp.2011.02.001; Kuijt-Evers LFM, 2007, INT J IND ERGONOM, V37, P73, DOI 10.1016/j.ergon.2006.09.019; Pan L, 1998, ULTRASOUND MED BIOL, V24, P995, DOI 10.1016/S0301-5629(98)00071-4; Reinvee M., 2014, Agronomy Research, V12, P907; Tada M, 2006, EUROHAPTICS 2006; Vesenjak M, 2013, POLYM TEST, V32, P1538, DOI 10.1016/j.polymertesting.2013.10.005; Wu JZ, 2002, MED ENG PHYS, V24, P253, DOI 10.1016/S1350-4533(02)00018-8; Wu JZ, 2007, SKIN RES TECHNOL, V13, P34, DOI 10.1111/j.1600-0846.2007.00182.x	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-7939	2040-7947		INT J NUMER METH BIO	Int. J. Numer. Meth. Biomed.	JUN	2015	31	6							e02712	10.1002/cnm.2712		13	Engineering, Biomedical; Mathematical & Computational Biology; Mathematics, Interdisciplinary Applications	Engineering; Mathematical & Computational Biology; Mathematics	CJ7HE	WOS:000355664600001		
J	Fatichah, C; Tangel, ML; Yan, F; Betancourt, JP; Widyanto, MR; Dong, FY; Hirota, K				Fatichah, Chastine; Tangel, Martin L.; Yan, Fei; Betancourt, Janet P.; Widyanto, M. Rahmat; Dong, Fangyan; Hirota, Kaoru			Fuzzy Feature Representation for White Blood Cell Differential Counting in Acute Leukemia Diagnosis	INTERNATIONAL JOURNAL OF CONTROL AUTOMATION AND SYSTEMS			English	Article						Feature extraction; fuzzy decision tree; fuzzy logic; leukemia diagnosis	CLASSIFICATION; SEGMENTATION; IMAGES; LOGIC	A fuzzy feature representation for white blood cell differential counting is proposed to diagnose types of acute leukemia. The accuracy of diagnosis is higher than that by numerical features by dealing with uncertainty of white blood cell features and inflexibility of diagnosing. Experiments on acute leukemia diagnosis use 120 acute leukemia images and fuzzy decision tree method with the accuracy rate of diagnosis is 84% using fuzzy features and 76.6% using numerical features. Given the importance of accurate diagnosis of acute leukemia in patients, this proposal is essential and planned to be introduced in an Indonesian hospital.	[Fatichah, Chastine] Inst Technol Sepuluh Nopember, Dept Informat, Surabaya, Indonesia; [Tangel, Martin L.; Betancourt, Janet P.; Dong, Fangyan; Hirota, Kaoru] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Tokyo 152, Japan; [Yan, Fei] Changchun Univ Sci & Technol, Sch Comp Sci & Technol, Changchun, Peoples R China; [Widyanto, M. Rahmat] Univ Indonesia, Fac Comp Sci, Jawa Barat, Indonesia	Fatichah, C (reprint author), Inst Technol Sepuluh Nopember, Dept Informat, Surabaya, Indonesia.	chastine@csits.ac.id; martin@hrt.dis.titech.ac.jp; yanfei@cust.edu.cn; janet@hrt.dis.titech.ac.jp; widyanto@cs.ui.ac.id; tou@hrt.dis.titech.ac.jp; hirota@hrt.dis.titech.ac.jp			Directorate General of the Ministry of Higher Education, Indonesia Government (DIKTI)	This journal was supported by the Directorate General of the Ministry of Higher Education, Indonesia Government (DIKTI).	Guo NN, 2007, COMPUT BIOL MED, V37, P70, DOI 10.1016/j.compbiomed.2005.10.003; Gomez-Gil P, 2008, MEX INT CONF ARTIF I, P227, DOI 10.1109/MICAI.2008.41; Phuong NH, 2001, INT J MED INFORM, V62, P165, DOI 10.1016/S1386-5056(01)00160-5; Angulo J, 2006, CELL MOL BIOL, V52, P2, DOI 10.1170/T732; Lee TK, 2003, MED IMAGE ANAL, V7, P47, DOI 10.1016/S1361-8415(02)00090-7; Auer J., 1986, AM J MED SCI, V131, P1002; Baldwin JF, 2005, INT FED INFO PROC, V163, P175, DOI 10.1007/0-387-23152-8_23; Caponetti L, 2006, LECT NOTES ARTIF INT, V4252, P340; Eom S, 2006, LECT NOTES COMPUT SC, V4179, P867; Fatichah C., 2012, J ADV COMPUTATIONAL, V16, P76; Gonzalez R. C., 2004, DIGITAL IMAGE PROCES; Gorzalczany M. B., 2002, STUD FUZZ SOFT COMP, V86, P1; Reta C., 2010, P 23 INT FLOR ART IN, P86; Rezatofighi SH, 2010, LECT NOTES COMPUT SC, V6112, P161, DOI 10.1007/978-3-642-13775-4_17; Riley R. S., 1999, LEUKEMIA MULTIPLE MY; Rokach L., 2008, SERIES MACHINE PERCE, V69, P159; Scotti F, 2005, Proceedings of the 2005 IEEE International Conference on Computational Intelligence for Measurement Systems and Applications, P96; Theera-Umpon N, 2007, IEEE T INF TECHNOL B, V11, P353, DOI 10.1109/TITB.2007.892694; Yuan Y., 2005, FUSSY SETS SYSTEMS, V69, P125; Zadeh L. A., 1996, ADV FUZZY SYSTEMS AP, V6, P1	20	0	0	INST CONTROL ROBOTICS & SYSTEMS, KOREAN INST ELECTRICAL ENGINEERS	BUCHEON	BUCHEON TECHNO PARK 401-1506, 193 YAKDAE-DONG WONMI-GU, BUCHEON, GYEONGGI-DO 420-734, SOUTH KOREA	1598-6446	2005-4092		INT J CONTROL AUTOM	Int. J. Control Autom. Syst.	JUN	2015	13	3					742	752		10.1007/s12555-012-0393-6		11	Automation & Control Systems	Automation & Control Systems	CJ1KO	WOS:000355242700029		
J	Tanaka, S; Harada, K; Ida, Y; Tomita, K; Kato, I; Arai, F; Ueta, T; Noda, Y; Sugita, N; Mitsuishi, M				Tanaka, Shinichi; Harada, Kanako; Ida, Yoshiki; Tomita, Kyohei; Kato, Ippei; Arai, Fumihito; Ueta, Takashi; Noda, Yasuo; Sugita, Naohiko; Mitsuishi, Mamoru			Quantitative assessment of manual and robotic microcannulation for eye surgery using new eye model	INTERNATIONAL JOURNAL OF MEDICAL ROBOTICS AND COMPUTER ASSISTED SURGERY			English	Article						robotic surgery; regulatory science; eye surgery; microelectromechanical systems		BackgroundMicrocannulation, a surgical procedure for the eye that requires drug injection into a 60-90 mu m retinal vein, is difficult to perform manually. Robotic assistance has been proposed; however, its effectiveness in comparison to manual operation has not been quantified. MethodsAn eye model has been developed to quantify the performance of manual and robotic microcannulation. The eye model, which is implemented with a force sensor and microchannels, also simulates the mechanical constraints of the instrument's movement. Ten subjects performed microcannulation using the model, with and without robotic assistance. ResultsThe results showed that the robotic assistance was useful for motion stability when the drug was injected, whereas its positioning accuracy offered no advantage. ConclusionsAn eye model was used to quantitatively assess the robotic microcannulation performance in comparison to manual operation. This approach could be valid for a better evaluation of surgical robotic assistance. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Tanaka, Shinichi; Harada, Kanako; Ida, Yoshiki; Sugita, Naohiko; Mitsuishi, Mamoru] Univ Tokyo, Dept Mech Engn, Tokyo 1138654, Japan; [Tomita, Kyohei; Kato, Ippei; Arai, Fumihito] Nagoya Univ, Dept Mech Sci & Engn, Nagoya, Aichi 4648601, Japan; [Ueta, Takashi; Noda, Yasuo] Univ Tokyo, Dept Ophthalmol, Tokyo 1138654, Japan	Tanaka, S (reprint author), Room 71C1,Engn Bldg 2,7-3-1,Bunkyo Ku, Tokyo To 1138656, Japan.	tanaka@nml.t.u-tokyo.ac.jp			Global Centre of Excellence for Mechanical Systems Innovation (GMSI) at the University of Tokyo;  [23226006]	This study was partially supported by the Global Centre of Excellence for Mechanical Systems Innovation (GMSI) at the University of Tokyo and a Grant-in-Aid for Scientific Research (S) 23226006.	ALLF BE, 1987, GRAEF ARCH CLIN EXP, V225, P221, DOI 10.1007/BF02175453; Angs WT, 2000, LECT NOTES COMPUT SC, V1935, P878; Jensen PS, 1997, GRAEF ARCH CLIN EXP, V235, P696, DOI 10.1007/BF01880668; Fleming Ioana, 2008, Med Image Comput Comput Assist Interv, V11, P543; Fribergs TR, 1998, EXP EYE RES, V47, P429; Idas Y, 2012, INT J COMPUT ASSIST, V7, P27; Kameis Y, 2013, P COMP ASS RAD SURG, pS127; Nakano T, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3523471; Nakano T, 2009, INT J COMPUT ASS RAD, V4, P517, DOI 10.1007/s11548-009-0374-2; Noda Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054116; Singh SPN, 2002, PROCEEDINGS OF THE IEEE 28TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, P171, DOI 10.1109/NEBC.2002.999520; uneris A, 2010, P IEEE RAS EMBS INT, P26; Yangs S, 1946, P IEEE INT C ROB AUT	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1478-5951	1478-596X		INT J MED ROBOT COMP	Int. J. Med. Robot. Comput. Assist. Surg.	JUN	2015	11	2					210	217		10.1002/rcs.1586		8	Surgery	Surgery	CJ8HS	WOS:000355741400013		
J	Yang, LJ; Wang, JC; Kobayashi, E; Ando, T; Yamashita, H; Sakuma, I; Chiba, T				Yang, Liangjing; Wang, Junchen; Kobayashi, Etsuko; Ando, Takehiro; Yamashita, Hiromasa; Sakuma, Ichiro; Chiba, Toshio			Image mapping of untracked free-hand endoscopic views to an ultrasound image-constructed 3D placenta model	INTERNATIONAL JOURNAL OF MEDICAL ROBOTICS AND COMPUTER ASSISTED SURGERY			English	Article						surgical navigation; image mapping; mosaic; minimally invasive fetal endoscopic surgery; twin-to-twin transfusion syndrome	TWIN TRANSFUSION SYNDROME; SURGERY; TRACKING	BackgroundThis study presents a tracker-less image-mapping framework for surgical navigation motivated by the clinical need for intuitive visual guidance during minimally invasive fetoscopic surgery. MethodsA navigation framework mapping 2D endoscopic vision to a 3D ultrasound image model is proposed. This maps an endoscopic image onto a 3D placenta model through a one-time ultrasound image-based localization method followed by a series of concurrent image alignments and texture mapping of the untracked endoscopic video stream. ResultsThe mean absolute error of our ultrasound image-based localization method was (1.63mm, 0.93 degrees). The simulation analysis reveals an upper bound mapping performance with a mean error of 1.53mm. In a phantom experiment, the overall mapping performance is close to this accuracy and achieves a mean absolute error of 2mm, thereby supporting the feasibility of this method. ConclusionThis novel integration of intraoperative visual guidance has potential contributions to innovative fusions of image guidance techniques for effective navigation in minimally invasive fetoscopic surgery. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Yang, Liangjing; Wang, Junchen; Kobayashi, Etsuko; Ando, Takehiro; Sakuma, Ichiro] Univ Tokyo, Grad Sch Engn, Tokyo, Japan; [Yamashita, Hiromasa; Chiba, Toshio] Natl Ctr Child Hlth & Dev, Clin Res Ctr, Tokyo, Japan	Yang, LJ (reprint author), Univ Tokyo, Grad Sch Engn, Tokyo, Japan.	yl.liangjing@gmail.com	Wang, Junchen/D-2421-2014	Wang, Junchen/0000-0002-0916-9932	JSPS KAKENHI [20345268]; Grant for Translational Systems Biology and Medicine Initiative (TSBMI)	This work was supported by JSPS KAKENHI (Grant Numbers 20345268) and Grant for Translational Systems Biology and Medicine Initiative (TSBMI).	VILLE Y, 1995, NEW ENGL J MED, V332, P224, DOI 10.1056/NEJM199501263320404; Rossi AC, 2008, AM J OBSTET GYNECOL, V198, P147, DOI 10.1016/j.ajog.2007.09.043; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Ville Y, 1998, BRIT J OBSTET GYNAEC, V105, P446, DOI 10.1111/j.1471-0528.1998.tb10132.x; Rosten E, 2006, LECT NOTES COMPUT SC, V3951, P430; Mountney P, 2010, LECT NOTES COMPUT SC, V6362, P496; Atasoy S, 2008, LECT NOTES COMPUT SC, V5241, P850, DOI 10.1007/978-3-540-85988-8_101; Azzari P, 2008, LECT NOTES COMPUT SC, V5259, P89, DOI 10.1007/978-3-540-88458-3_9; Baud D, 2013, AM J OBSTET GYNECOL, V208, P165; Brown D. C., 1966, PHOTOGRAMMETRIC ENG, V32, P444; Bruner JP, 1998, PLACENTA, V19, P81, DOI 10.1016/S0143-4004(98)90102-3; Carroll RE, 2009, INT J COMPUT VISION, V85, P307, DOI 10.1007/s11263-009-0264-7; Cleary K, 2012, ANNU REV BIOMED ENG, V12, P119; Fowler SF, 2002, J PEDIATR SURG, V37, P1700, DOI 10.1053/jpsu.2002.36699; Grasa OG, 2009, P AMI ARCS 5 WORKSH, P102; Hartley R. I., 2004, MULTIPLE VIEW GEOMET; Heikkila J, 1997, PROC CVPR IEEE, P1106, DOI 10.1109/CVPR.1997.609468; Liao H, 2009, WORLD C MED PHYS BIO, V25, P206, DOI 10.1007/978-3-642-03904-1_58; Liao H, 2009, MINIM INVASIV THER, V18, P332, DOI 10.3109/13645700903201217; RAUSKOLB R, 1979, ENDOSCOPY, V11, P107; Reeff M, 2006, GL JAHRESTAGUNG, V93, P467; Richa R, 2010, LECT NOTES COMPUT SC, V6361, P267; Richa Rogerio BZ, 2012, LECT NOTES COMPUTER, V7510, P397; Sato I, 2013, INT J COMPUT ASS RAD, V8, P379, DOI 10.1007/s11548-012-0789-z; Seshamani S, 2009, P SOC PHOTO-OPT INS, V7261; Wang X, 2010, MED IMAG IEEE T, V29, P1213; Yang L, 2013, INT J CARS S1, V8, pS152; Yang LJ, 2013, LECT NOTES COMPUT SC, V8090, P107; Yang L, 2007, P 35 ANN INT C IEEE, P1411	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1478-5951	1478-596X		INT J MED ROBOT COMP	Int. J. Med. Robot. Comput. Assist. Surg.	JUN	2015	11	2					223	234		10.1002/rcs.1592		12	Surgery	Surgery	CJ8HS	WOS:000355741400015		
J	Kobayashi, Y; Sekiguchi, Y; Noguchi, T; Takahashi, Y; Liu, Q; Oguri, S; Toyoda, K; Uemura, M; Ieiri, S; Tomikawa, M; Ohdaira, T; Hashizume, M; Fujie, MG				Kobayashi, Yo; Sekiguchi, Yuta; Noguchi, Takehiko; Takahashi, Yu; Liu, Quanquan; Oguri, Susumu; Toyoda, Kazutaka; Uemura, Munenori; Ieiri, Satoshi; Tomikawa, Morimasa; Ohdaira, Takeshi; Hashizume, Makoto; Fujie, Masaktsu G.			Development of a robotic system with six-degrees-of-freedom robotic tool manipulators for single-port surgery	INTERNATIONAL JOURNAL OF MEDICAL ROBOTICS AND COMPUTER ASSISTED SURGERY			English	Article						surgical robot; surgical manipulator; master-slave; endoscopic; single-port surgery	LAPAROSCOPIC SURGERY	BackgroundCurrent robotic systems have limitations for single-port surgery (SPS) because the instruments are large, the arms collide and the field of vision requires manual readjustment. We have developed an SPS robotic system that manipulates the vision field. MethodsThe master-slave system included a six degrees of freedom (DOFs) tool manipulator, an easy set-up mechanism, a flexible shaft drive with sufficient DOFs and a vertical arrangement for improved vision. The robot manipulates an endoscope within the body. After assembly, the system was tested in vitro and in vivo. ResultsIn vitro testing showed that the tool manipulators resected tissue precisely, with the range of motion required. In vivo testing indicated that an abdominal organ is accurately approached and diseased tissue removed by combined endoscopy and robotics. ConclusionsOur robotics allowed the operator to adjust the vision field intuitively. The tool manipulator approached and resected diseased tissue precisely. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Kobayashi, Yo; Sekiguchi, Yuta; Noguchi, Takehiko; Takahashi, Yu; Liu, Quanquan; Oguri, Susumu; Fujie, Masaktsu G.] Waseda Univ, Res Inst Sci & Engn, Fac Sci & Engn, Tokyo 1698555, Japan; [Toyoda, Kazutaka; Uemura, Munenori; Ieiri, Satoshi; Tomikawa, Morimasa; Ohdaira, Takeshi; Hashizume, Makoto] Kyushu Univ Hosp, Dept Adv Med & Innovat Technol, Fukuoka, Japan	Kobayashi, Y (reprint author), Waseda Univ, Res Inst Sci & Engn, Fac Sci & Engn, Shinjuku Ku, 59-309,3-4-1 Okubo, Tokyo 1698555, Japan.	you-k@fuji.waseda.jp		Kobayashi, Yo/0000-0003-4358-6294	Global Centres of Excellence (COE) Programme 'Global Robot Academia', from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Grant for Scientific Research, Japan [21240056]; High-Tech Research Centre Project from MEXT; Mizuho Foundation for the Promotion of Sciences	This work was supported by: the Global Centres of Excellence (COE) Programme 'Global Robot Academia', from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; a Grant for Scientific Research (No. 21240056), Japan; the High-Tech Research Centre Project from MEXT; and the Mizuho Foundation for the Promotion of Sciences.	Abbott D.J., 2007, P IEEE RSJ INT C INT, P410, DOI DOI 10.1109/IR0S.2007.4399536; Taylor RH, 2003, IEEE T ROBOTIC AUTOM, V19, P765, DOI 10.1109/TRA.2003.817058; Zhang XL, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P5540, DOI 10.1109/IROS.2009.5354446; Horgan S, 2001, J LAPAROENDOSC ADV A, V11, P415, DOI 10.1089/10926420152761950; Kaouk JH, 2009, BJU INT, V103, P366, DOI 10.1111/j.1464-410X.2008.07949.x; Xu K, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION (ICRA), P3367; Hubens G, 2003, SURG ENDOSC, V17, P1595, DOI 10.1007/s00464-002-9248-1; Xu K, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P5546, DOI 10.1109/IROS.2009.5354028; Ding JA, 2010, IEEE INT CONF ROBOT, P1053; Rentschler ME, 2007, SURG ENDOSC, V21, P1212, DOI 10.1007/s00464-007-9400-z; Dario P, 2003, IEEE T ROBOTIC AUTOM, V19, P782, DOI 10.1109/TRA.2003.817071; Autorino R, 2011, EUR UROL, V59, P26, DOI 10.1016/j.eururo.2010.08.030; Bardou B, 2009, IEEE ENG MED BIO, P5577, DOI 10.1109/IEMBS.2009.5333486; Gumbs AA, 2008, J GASTROINTESTINAL S, V23, P2242; Guthart GS, 2000, P IEEE INT C ROB AUT, DOI 10.1109/ROBOT.2000.844121; Hashizume M, 2008, INT J COMPUT ASS RAD, V2, P317, DOI 10.1007/s11548-007-0146-9; Horise Y, 2012, INT J COMPUT ASS RAD, V7, P289, DOI 10.1007/s11548-011-0658-1; Ishii C, 2007, IEEE INT CONF ROBOT, P238, DOI 10.1109/ROBOT.2007.363793; Kim YJ, 2013, IEEE T ROBOT, V99, P1; Kobayashi Y, 2010, INT J MED ROBOT COMP, V6, P454, DOI 10.1002/rcs.355; Liu Q, 2013, 35 ANN INT C IEEE EM, P6261; Min BS, 2014, SINGLE INCISION LAPA, P49; Navarra G, 1997, BRIT J SURG, V84, P695, DOI 10.1002/bjs.1800840536; Noguchi T, 2012, P COMP ASS RAD SURG, pS395; Petroni G, 2013, SURG ENDOSC, V27, P1932, DOI 10.1007/s00464-012-2690-9; Phee SJ, 2009, IEEE ENG MED BIO, P1192, DOI 10.1109/IEMBS.2009.5333413; Sekiguchi Y, 2011, J ROBOTICS MECHATRON, V23, P1115; Shi ZY, 2014, INT J MED ROBOT COMP, V10, P474, DOI 10.1002/rcs.1558; Vitiello Valentina, 2013, IEEE Rev Biomed Eng, V6, P111, DOI 10.1109/RBME.2012.2236311	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1478-5951	1478-596X		INT J MED ROBOT COMP	Int. J. Med. Robot. Comput. Assist. Surg.	JUN	2015	11	2					235	246		10.1002/rcs.1600		12	Surgery	Surgery	CJ8HS	WOS:000355741400016		
J	Kaneko, T; Tada, Y; Maruya, S; Takeishi, E; Miura, K; Masubuchi, T; Fushimi, C; Hasegawa, H; Kamata, S				Kaneko, T.; Tada, Y.; Maruya, S.; Takeishi, E.; Miura, K.; Masubuchi, T.; Fushimi, C.; Hasegawa, H.; Kamata, S.			Intra-arterial chemoradiation therapy with weekly low-dose cisplatin for squamous cell carcinoma of the maxillary sinus	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						superficial temporal artery; occipital artery; sodium thiosulphate; definitive irradiation; orbital invasion	SUPERFICIAL TEMPORAL ARTERY; NECK-CANCER; PARANASAL SINUSES; REGIONAL CHEMOTHERAPY; ADVANCED HEAD; NASAL CAVITY; RADIOTHERAPY; INFUSION; SURGERY; TUMORS	A new intra-arterial chemoraliation regimen that involves infusing low-dose cisplatin in combination with definitive irradiation was used in 36 patients diagnosed with squamous cell carcinoma of the maxillary sinus. The safety and therapeutic efficacy of this regimen were reviewed retrospectively. An intra-arterial catheter was inserted in a retrograde manner into the target artery via the superficial temporal artery or occipital artery. Intra-arterial infusion was performed using cisplatin at a dose of 20-50 mg/m(2) per week for 6-8 weeks. At the same time, sodium thiosulphate was infused as a neutralizing agent. Irradiation was performed at 60 Gy in 30 fractions. All 36 patients completed treatment. Grade 3 adverse events occurred in only seven patients (19.4%) and no grade 4 events were noted. As a primary therapy, the complete response rate was 83.3%, the partial response rate was 16.7%, and the overall response rate was 100%. The 2-year local control rate was 63.0%, and the 2-year overall survival rate was 75.5%. The 2-year preservation rate of the hard palate was 97.1%, that of the eyeball was 97.2%, and that of visual function was 94.4%. This treatment regimen can contribute to improving the quality of life of patients without reducing the curability of the therapy.	[Kaneko, T.; Tada, Y.; Maruya, S.; Takeishi, E.; Miura, K.; Masubuchi, T.; Fushimi, C.; Kamata, S.] Int Univ Hlth & Welf, Head & Neck Oncol Ctr, Mita Hosp, Tokyo 1088329, Japan; [Hasegawa, H.] Fukushima Med Univ, Sch Med, Dept Dent & Oral Surg, Fukushima, Japan	Kaneko, T (reprint author), Int Univ Hlth & Welf, Head & Neck Oncol Ctr, Mita Hosp, Minato Ku, 1-4-3 Mita, Tokyo 1088329, Japan.	testu1277@yahoo.co.jp					Turner JH, 2012, HEAD NECK-J SCI SPEC, V34, P877, DOI 10.1002/hed.21830; Homma A, 2009, CANCER, V115, P4705, DOI 10.1002/cncr.24515; Thorup C, 2010, ACTA ONCOL, V49, P389, DOI 10.3109/02841860903428176; Robbins KT, 2000, HEAD NECK-J SCI SPEC, V22, P687, DOI 10.1002/1097-0347(200010)22:7<687::AID-HED8>3.0.CO;2-W; Ganly I, 2005, HEAD NECK-J SCI SPEC, V27, P575, DOI 10.1002/hed.20165; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Sanghvi S, 2014, LARYNGOSCOPE, V124, P76, DOI 10.1002/lary.24264; Yoshimura RI, 2002, INT J RADIAT ONCOL, V53, P656, DOI 10.1016/S0360-3016(02)02771-2; Ashraf M, 2010, WORLD J ONCOL, V1, P28; Foote RL, 2005, CANCER, V103, P559, DOI 10.1002/cncr.20803; Fuwa N, 2008, BRIT J CANCER, V98, P1039, DOI 10.1038/sj.bjc.6604272; Fuwa N, 2008, ORAL SURG ORAL MED O, V105, P783, DOI 10.1016/j.tripleo.2007.07.031; GIRI SPG, 1992, CANCER, V69, P657, DOI 10.1002/1097-0142(19920201)69:3<657::AID-CNCR2820690310>3.0.CO;2-7; Hasegawa H, 2008, INT J ORAL MAX SURG, V37, P82, DOI 10.1016/j.ijom.2007.05.008; Macey David, 2006, JPN J HEAD NECK CANC, V138, P15; Nakamura T, 2011, ORAL ONCOL, V47, P387, DOI 10.1016/j.oraloncology.2011.03.010; Nakashima Torahiko, 2011, Case Rep Oncol, V4, P492, DOI 10.1159/000332759; Nakatani Hiroaki, 2010, ORL J Otorhinolaryngol Relat Spec, V71 Suppl 1, P116, DOI 10.1159/000265123; National Cancer Institute, CANC THER EV PROGR C; National Comprehensive Cancer Network, 2013, NCCN CLIN PRACT GUID; Nibu K, 2002, CANCER, V94, P1474; Nishino H, 2000, CANCER, V89, P1925, DOI 10.1002/1097-0142(20001101)89:9<1925::AID-CNCR8>3.3.CO;2-8; Ohba S, 2012, ORAL ONCOL, V48, P1101, DOI 10.1016/j.oraloncology.2012.08.007; Papadimitrakopoulou VA, 2003, CANCER, V98, P2214, DOI 10.1002/cncr.11771; Paulino AC, 1998, CANCER, V83, P457, DOI 10.1002/(SICI)1097-0142(19980801)83:3<457::AID-CNCR14>3.0.CO;2-V; ROBBINS KT, 1994, J CLIN ONCOL, V12, P2113; SATO Y, 1970, CANCER, V25, P571, DOI 10.1002/1097-0142(197003)25:3<571::AID-CNCR2820250312>3.0.CO;2-N	27	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	JUN	2015	44	6					697	704		10.1016/j.ijom.2015.03.009		8	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CJ8SX	WOS:000355774900004		
J	Lee, C; Park, J; Kinoshita, M; Jeong, H				Lee, Changsuk; Park, Jaehong; Kinoshita, Masaharu; Jeong, Haedo			Analysis of pressure distribution and verification of pressure signal by changes load and velocity in chemical mechanical polishing	INTERNATIONAL JOURNAL OF PRECISION ENGINEERING AND MANUFACTURING			English	Article						Intelligent pad; Monitoring system; Pressure distribution; Pressure signal; Polishing condition; Chemical mechanical polishing	TEMPERATURE; FRICTION; CMP	The Preston's equation which was known as the governing equation of the polishing results in CMP process is caused by the wafer pressure and velocity. It is very important for the pressure and velocity to examine the fundamental characteristics which have effects on the polishing results. In this study, the intelligent pad which can measure the pressure distribution delivered to the wafer by the independent change of the pressure and velocity in real-time was used. The intelligent pad has sheet shape of embedded pressure sensor and functions of pressure signal processing, saving and transmitting in real-time. The average and the deviation of pressure signals were calculated by extracting the signal value from the measured pressure distribution, and the quantitative analysis was conducted by using the full width at half maximum (FWHM) value of the probability density function. The suitability of pressure signal was confirmed by polishing the oxide wafer in the same experiment conditions. So, the average and deviation of the pressure signal value correspond with the material removal rate (MRR) and non-uniformity of the polishing result. In conclusion, the intelligent pad system will be a good monitoring tool to understand various phenomena in CMP process.	[Lee, Changsuk; Jeong, Haedo] Pusan Natl Univ, Grad Sch Mech Engn, Busan 609735, South Korea; [Park, Jaehong; Kinoshita, Masaharu] Nitta Haas Inc, Res & Dev Solut Ctr, Kyotanabe, Kyoto 6100333, Japan	Jeong, H (reprint author), Pusan Natl Univ, Grad Sch Mech Engn, 2 Busandaehak Ro 63beon Gil, Busan 609735, South Korea.	hdjeong@pusan.ac.kr			Basic Science Research Program through the National Research Foundation of Korea - ministry of Education, Science and Technology [NRF-2012A1A1A2008146]	This work supported by Nitta Haas, Inc. help to develop pressure sensor and Basic Science Research Program through the National Research Foundation of Korea (NRF-2012A1A1A2008146) funded by the ministry of Education, Science and Technology.	Kim HJ, 2002, J MATER PROCESS TECH, V130, P334, DOI 10.1016/S0924-0136(02)00820-8; Hocheng H, 1999, J ELECTROCHEM SOC, V146, P4236, DOI 10.1149/1.1392620; Jeong H., 2004, P 1 PAC RIM INT C PL, P54; Kim H., 2003, THESIS PUSAN NATL U; Lee H., 2010, THESIS PUSAN NATL U; Li Y., 2008, MICROELECTRONIC APPL, P94; Lu J, 2004, J ELECTROCHEM SOC, V151, pG241, DOI 10.1149/1.1649986; Preston F. W., 1927, J SOC GLASS TECHNOL, V11, P214; Sorooshian J, 2004, ELECTROCHEM SOLID ST, V7, pG222, DOI 10.1149/1.1792240; Yu T. K., 1994, P INT WORKSH NUM MOD, P29	10	0	0	KOREAN SOC PRECISION ENG	SEOUL	RM 306, KWANGMYUNG BLDG, 5-4 NONHYUN-DONG, KANGNAM-GU, SEOUL, 135-010, SOUTH KOREA	2234-7593	2005-4602		INT J PRECIS ENG MAN	Int. J. Precis. Eng. Manuf.	JUN	2015	16	6					1061	1066		10.1007/s12541-015-0137-7		6	Engineering, Manufacturing; Engineering, Mechanical	Engineering	CK0DG	WOS:000355874300002		
J	Kimura, T; Katayama, J				Kimura, Tsukasa; Katayama, Jun'ichi			Approach of visual stimuli modulates spatial expectations for subsequent somatosensory stimuli	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Multimodal interaction; Expectation; ERP	EVOKED POTENTIALS; P300 AMPLITUDE; DUAL-TASK; TOUCH; VISION; ATTENTION; SURPRISE; SPACE; HAND; EXPECTANCIES	To examine how the approach of visual stimuli toward the body influences expectations regarding subsequent somatosensory stimuli, we recorded event-related brain potentials (ERPs; nose reference) during a simple reaction time to somatosensory stimuli task Twelve participants were asked to place their arms on a desk, and three LEDs were placed between their arms at equal intervals. Electrical stimuli were presented to the left (or right) wrist at a high probability (80%) or to the opposite wrist at a low probability (20%). Each trial was composed of three visual stimuli followed by one electrical stimulus. In Experiment 1, the right, center, and left (or left, center, and right) LEDs were turned on sequentially toward the wrist to which the high probability somatosensory stimuli was presented (congruent condition), or the center LED were presented three times (neutral condition). Experiment 2 was composed of the congruent condition and the inverse of the congruent condition (incongruent condition). In both experiments, the reaction times to low probability stimuli were longer than those to high probability stimuli. Moreover, the low probability stimuli elicited a larger P3 amplitude than the high probability stimuli. In addition, the P3 amplitude was higher under the visual approach condition (i.e., the congruent condition in each experiment) than under the control condition (i.e., the neutral and incongruent conditions). Furthermore, no effect on the CNV amplitude before the somatosensory stimuli was found. These results suggest that visual stimuli directed toward the body induce an automatic spatial expectation for subsequent somatosensory stimuli. (C) 2015 Elsevier B.V. All rights reserved.	[Kimura, Tsukasa; Katayama, Jun'ichi] Kwansei Gakuin Univ, Dept Psychol Sci, Nishinomiya, Hyogo 6628501, Japan; [Katayama, Jun'ichi] Kwansei Gakuin Univ, Ctr Appl Psychol Sci, Nishinomiya, Hyogo 6628501, Japan	Kimura, T (reprint author), Kwansei Gakuin Univ, Dept Psychol Sci, Nishinomiya, Hyogo 6628501, Japan.	ts.kimura2011@kwansei.ac.jp; jkatayama@kwansei.ac.jp			Japan Society for the Promotion of Science (JSPS) [25285206]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), JAPAN [S1001050]	A part of this study was supported by a Grant-in-Aid for Scientific Research (B) (25285206) from the Japan Society for the Promotion of Science (JSPS) awarded to Jun'ichi Katayama. The experiment was conducted as a part of the project supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), JAPAN, for the Strategic Research Foundation at Private Universities (2010-2014; Project number S1001050) to the Center for Applied Psychological Science (CAPS), Kwansei Gakuin University.	DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Sommer W, 1998, BEHAV BRAIN SCI, V21, P149; Eimer M, 2002, J COGNITIVE NEUROSCI, V14, P254, DOI 10.1162/089892902317236885; Spence C, 2000, J EXP PSYCHOL HUMAN, V26, P1298, DOI 10.1037//0096-1523.26.4.1298; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Spence C, 2003, PERCEPT PSYCHOPHYS, V65, P318, DOI 10.3758/BF03194803; GIBSON JJ, 1962, PSYCHOL REV, V69, P477, DOI 10.1037/h0046962; Spence C, 2002, BEHAV BRAIN RES, V135, P57, DOI 10.1016/S0166-4328(02)00155-9; GRAZIANO MSA, 1993, EXP BRAIN RES, V97, P96; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DUNCANJOHNSON CC, 1977, PSYCHOPHYSIOLOGY, V14, P456, DOI 10.1111/j.1469-8986.1977.tb01312.x; Reed CL, 2006, J EXP PSYCHOL HUMAN, V32, P166, DOI 10.1037/0096-1523.32.1.166; Katayama J, 1998, PSYCHOPHYSIOLOGY, V35, P23, DOI 10.1017/S0048577298961479; Cosman JD, 2010, PSYCHOL SCI, V21, P1254, DOI 10.1177/0956797610380697; Spence C, 2000, EXP BRAIN RES, V134, P42, DOI 10.1007/s002210000442; Macaluso E, 2010, NEUROPSYCHOLOGIA, V48, P782, DOI 10.1016/j.neuropsychologia.2009.10.010; Abrams RA, 2008, COGNITION, V107, P1035, DOI 10.1016/j.cognition.2007.09.006; Craig C.J., 2005, PERCEPTION, V34, P357; Craig C.J., 2006, PERCEPTION, V35, P351; Damme S., 2009, BRAIN RES, V1253, P100; Forster B, 2009, BIOL PSYCHOL, V82, P227, DOI 10.1016/j.biopsycho.2009.08.001; Gray R, 2002, EXP BRAIN RES, V145, P50, DOI 10.1007/s00221-002-1085-x; Graziano M. S., 1993, SCIENCE, V266, P1054; Kida T, 2012, CLIN NEUROPHYSIOL, V123, P1123, DOI 10.1016/j.clinph.2011.10.001; Kida T, 2012, EXP BRAIN RES, V216, P575, DOI 10.1007/s00221-011-2961-z; Kida T., 2003, ADV EXERC SPORTS PHY, V9, P105; Kida T, 2004, CLIN NEUROPHYSIOL, V115, P2616, DOI 10.1016/j.clinph.2004.06.013; Montoya P, 2006, BRAIN RES, V1068, P205, DOI 10.1016/j.brainres.2005.11.019; Nadtanen R., 2007, CLIN NEUROPHYSIOL, V118, P2544; OYAMA T, 1982, PSYCHOLOGIA, V25, P131; Reed CL, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00420; Sambo CF, 2011, THESCIENTIFICWORLDJO, V11, P199, DOI 10.1100/tsw.2011.34; SHAFFER JP, 1986, J AM STAT ASSOC, V81, P826, DOI 10.2307/2289016; VERLEGER R, 1994, PSYCHOPHYSIOLOGY, V31, P359, DOI 10.1111/j.1469-8986.1994.tb02444.x; Wesslein AK, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00084	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	JUN	2015	96	3					176	182		10.1016/j.ijpsycho.2015.04.002		7	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	CJ7VE	WOS:000355707600008		
J	Okamoto, T; Sakamaki, MS; Min, SK; Yoshida, S; Watanabe, Y; Ogasawara, R				Okamoto, T.; Sakamaki, M. S.; Min, S. K.; Yoshida, S.; Watanabe, Y.; Ogasawara, R.			Repeated Cessation and Resumption of Resistance Training Attenuates Increases in Arterial Stiffness	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						resistance training; arterial stiffness; training cessation; training resumption		Although high-intensity resistance training (RT) increases arterial stiffness, removing weightlifting stimuli returns arterial stiffness to baseline levels within relatively short periods during 4-8 weeks. This study investigates the effects of repeated RT cessation and resumption on arterial stiffness. Eighteen young healthy subjects were randomly assigned to a group that performed continuous RT (CRT, n=9) and a group that performed periodic RT (PRT, n=9). Both groups performed RT at 75% of one repetition maximum for 3 days per week. The CRT group continuously trained for 16 weeks, whereas the PRT group performed 3 cycles of 4 weeks training, with 2 weeks detraining intervals between cycles. The carotid-femoral pulse wave velocity in the CRT group significantly increased (P<0.05) at 4, 6, 10, 12, 16 and 20 weeks from baseline, whereas in the PRT group it significantly increased (P<0.05) after 4, 10 and 16 weeks from baseline, and was significantly lower (P<0.05) than that of the CRT group after 6, 10, 12, 16 and 20 weeks. Muscle mass and strength in the both groups significantly increased after 16 weeks from baseline and persisted for 20 weeks (P<0.05). These results suggest that PRT, including short-term repeated cessation and resumption, attenuates increases in arterial stiffness.	[Okamoto, T.; Sakamaki, M. S.; Yoshida, S.; Watanabe, Y.] Nippon Sport Sci Univ, Dept Exercise Physiol, Tokyo 1588508, Japan; [Min, S. K.] Korea Inst Sport Sci, Dept Sport Sci, Seoul, South Korea; [Ogasawara, R.] Univ Tokyo, Dept Life Sci, Tokyo, Japan	Okamoto, T (reprint author), Nippon Sport Sci Univ, Dept Exercise Physiol, Setagaya Ku, 7-1-1 Fukasawa, Tokyo 1588508, Japan.	tokamoto@nittai.ac.jp			Nippon Sport Science University	This research was supported by the Nippon Sport Science University grant for academic research.		0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	JUN	2015	36	6					440	445		10.1055/s-0034-1398584		6	Sport Sciences	Sport Sciences	CJ8PG	WOS:000355764800002		
J	Kubo, K				Kubo, K.			Effects of Repeated Concentric and Eccentric Contractions on Tendon Blood Circulation	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						blood volume; oxygen saturation; tendon; human	CHRONIC ACHILLES TENDINOSIS; RED LASER LIGHTS; OXYGEN-SATURATION; HUMAN MUSCLE; IN-VIVO; EXERCISE; VOLUME; STIFFNESS; FLOW	Previous studies demonstrated that treatment involving eccentric training was effective in the conservative management of chronic tendinosis. However, the mechanisms for these phenomena are unknown. The purpose of this study was to compare changes in blood circulation of the tendons after the repeated concentric and eccentric contractions. 11 healthy males volunteered for this study. Subjects performed the repeated concentric (CON) and eccentric (ECC) contractions (5 sets of 10 maximal voluntary contractions) of the plantar flexors. During and after repeated contractions, oxyhemoglobin (Oxy), deoxyhemoglobin (Deoxy), total hemoglobin (THb), and oxygen saturation (StO(2)) of the Achilles tendons were measured using red laser lights. Oxy and THb increased during and after ECC, but not CON. Deoxy decreased during both CON and ECC. Increase in StO(2) during and after ECC was greater than that during and after CON. These results suggested that changes in blood circulation of the Achilles tendon during and after repeated eccentric contractions were more remarkable than those during and after repeated concentric contractions.	Univ Tokyo, Life Sci Sports Sci, Tokyo, Japan	Kubo, K (reprint author), Univ Tokyo, Life Sci Sports Sci, Komaba 3-8-1, Tokyo, Japan.	kubo@idaten.c.u-tokyo.ac.jp			Japan Society for the Promotion of Science [21680047]	This study was supported by a Grant-in-Aid for Young Scientists (A) (21680047 to K. Kubo) from the Japan Society for the Promotion of Science.	Harriss DJ, 2013, INT J SPORTS MED, V34, P1025, DOI 10.1055/s-0033-1358756; Duclay J, 2009, MUSCLE NERVE, V39, P819, DOI 10.1002/mus.21297; Foure A, 2013, J APPL PHYSIOL, V114, P523, DOI 10.1152/japplphysiol.01313.2011; Alfredson H, 1998, AM J SPORT MED, V26, P360; Kubo K, 2010, EUR J APPL PHYSIOL, V109, P545, DOI 10.1007/s00421-010-1368-z; Ohberg L, 2004, KNEE SURG SPORT TR A, V12, P465, DOI 10.1007/s00167-004-0494-8; Langberg H, 2007, SCAND J MED SCI SPOR, V17, P61, DOI 10.1111/j.1600-0838.2006.00522.x; Mafi N, 2001, KNEE SURG SPORT TR A, V9, P42, DOI 10.1007/s001670000148; ARCHAMBAULT JM, 1995, SPORTS MED, V20, P77, DOI 10.2165/00007256-199520020-00003; Babault N, 2001, J APPL PHYSIOL, V91, P2628; Jarvinen M, 1997, SCAND J MED SCI SPOR, V7, P86; Jozsa L, 1998, EUR SURG RES, V30, P125, DOI 10.1159/000008567; Kashima S, 2003, OPT LASER TECHNOL, V35, P485, DOI 10.1016/S0030-3992(03)00066-5; Knoblock K, 2007, J ORTHOP SPORT PHYS, V37, P269, DOI 10.2519/jospt.2007.2296; Kubo K, 2009, EUR J APPL PHYSIOL, V106, P445, DOI 10.1007/s00421-009-1037-2; Kubo K, 2009, J APPL PHYSIOL, V106, P412, DOI 10.1152/japplphysiol.91381.2008; Kubo K, 2008, ACTA PHYSIOL, V193, P257, DOI 10.1111/j.1748-1716.2008.01841.x; Kubo K, 2008, EUR J APPL PHYSIOL, V104, P859, DOI 10.1007/s00421-008-0841-4; Kubo K, 2012, J STRENGTH COND RES, V26, P2765, DOI 10.1519/JSC.0b013e31826791da; Kubo K, 2012, RES Q EXERCISE SPORT, V83, P49; Mahieu NN, 2008, MED SCI SPORT EXER, V40, P117, DOI 10.1249/mss.0b013e3181599254; Perrey S, 2001, J APPL PHYSIOL, V91, P2135; Yin NH, 2014, J ORTHOP SPORT PHYS, V44, P304, DOI 10.2519/jospt.2014.4872	23	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	JUN	2015	36	6					481	484		10.1055/s-0034-1398649		4	Sport Sciences	Sport Sciences	CJ8PG	WOS:000355764800008		
J	Hobara, H; Kobayashi, Y; Mochimaru, M				Hobara, H.; Kobayashi, Y.; Mochimaru, M.			Spatiotemporal Variables of Able-bodied and Amputee Sprinters in Men's 100-m Sprint	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						prosthetic sprinting; step frequency; step length	RUNNING-SPECIFIC PROSTHESES; STIFFNESS	The difference in world records set by able-bodied sprinters and amputee sprinters in the men's 100-m sprint is still approximately 1s (as of 28 March 2014). Theoretically, forward velocity in a 100-m sprint is the product of step frequency and step length. The goal of this study was to examine the hypothesis that differences in the sprint performance of able-bodied and amputee sprinters would be due to a shorter step length rather than lower step frequency. Men's elite-level 100-m races with a total of 36 able-bodied, 25 unilateral and 17 bilateral amputee sprinters were analyzed from the publicly available internet broadcasts of 11 races. For each run of each sprinter, the average forward velocity, step frequency and step length over the whole 100-m distance were analyzed. The average forward velocity of able-bodied sprinters was faster than that of the other 2 groups, but there was no significant difference in average step frequency among the 3 groups. However, the average step length of able-bodied sprinters was significantly longer than that of the other 2 groups. These results suggest that the differences in sprint performance between 2 groups would be due to a shorter step length rather than lower step frequency.	[Hobara, H.; Kobayashi, Y.; Mochimaru, M.] Natl Inst Adv Ind Sci & Technol, Digital Human Res Ctr, Tokyo 1350064, Japan	Hobara, H (reprint author), Natl Inst Adv Ind Sci & Technol, Digital Human Res Ctr, Koto Ku, Waterfront 3F,2-3-26 Aomi, Tokyo 1350064, Japan.	hobara-hiroaki@aist.go.jp			DESCENT; ISHIMOTO Foundation for the Promotion of Sports Science	This study received grant support from DESCENT and the ISHIMOTO Foundation for the Promotion of Sports Science.	Harriss DJ, 2013, INT J SPORTS MED, V34, P1025, DOI 10.1055/s-0033-1358756; Scholz MS, 2011, COMPOS SCI TECHNOL, V71, P1791, DOI 10.1016/j.compscitech.2011.08.017; Webster JB, 2001, ARCH PHYS MED REHAB, V82, pS38, DOI 10.1053/apmr.2001.22243; McGowan CP, 2012, J R SOC INTERFACE, V9, P1975, DOI 10.1098/rsif.2011.0877; Salo AIT, 2011, MED SCI SPORT EXER, V43, P1055, DOI 10.1249/MSS.0b013e318201f6f8; Weyand PG, 2009, J APPL PHYSIOL, V107, P903, DOI 10.1152/japplphysiol.00174.2009; Hunter JP, 2004, MED SCI SPORT EXER, V36, P261, DOI 10.1249/01.MSS.0000113664.15777.53; Bruggemann GP, 2009, SPORTS TECHNOL, V1, P220; Grabowski AM, 2010, BIOL LETTERS, V6, P201, DOI 10.1098/rsbl.2009.0729; Hay JG, 1994, BIOMECHANICS SPORTS; Hobara H, 2013, J BIOMECH, V46, P2483, DOI 10.1016/j.jbiomech.2013.07.009; Lechler K, 2008, SPORTS TECHNOL, V1, P229, DOI 10.1002/jst.57; Nolan Lee, 2008, Foot Ankle Surg, V14, P125, DOI 10.1016/j.fas.2008.05.007; Stewart AM, 2000, MED SCI SPORT EXER, V32, P997; Tweedy S, IPC ATHLETICS CLASSI; Weyand PG, 2000, J APPL PHYSIOL, V89, P1991	16	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	JUN	2015	36	6					494	497		10.1055/s-0034-1387794		4	Sport Sciences	Sport Sciences	CJ8PG	WOS:000355764800011		
J	Sakamoto, S				Sakamoto, Shinichi			Editorial Comment to Prostate-specific antigen-based prostate cancer screening: Past and future	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material							JAPANESE UROLOGICAL ASSOCIATION; MORTALITY		Chiba Univ, Grad Sch Med, Dept Urol, Chiba, Japan	Sakamoto, S (reprint author), Chiba Univ, Grad Sch Med, Dept Urol, Chiba, Japan.	rbatbat1@yahoo.co.jp					Alberts AR, 2015, INT J UROL, V22, P524, DOI 10.1111/iju.12750; Mufarrij P, 2010, UROLOGY, V76, P689, DOI 10.1016/j.urology.2009.12.075; Schroder FH, 2010, EUR UROL, V58, P46, DOI 10.1016/j.eururo.2010.03.033; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; [Anonymous], 2010, INT J UROL, V17, P830; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Ito K, 2014, NAT REV UROL, V11, P197, DOI 10.1038/nrurol.2014.42; Fujimoto H, 2005, INT J UROL, V12, P46	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUN	2015	22	6					532	533		10.1111/iju.12783		2	Urology & Nephrology	Urology & Nephrology	CJ9PU	WOS:000355835500002		
J	Miyake, H; Fujisawa, M				Miyake, Hideaki; Fujisawa, Masato			Editorial Comment to Venous tumor thrombus consistency is not predictive of survival in patients with renal cell carcinoma: A retrospective study of 147 patients	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material									[Miyake, Hideaki; Fujisawa, Masato] Kobe Univ, Div Urol, Grad Sch Med, Kobe, Hyogo 657, Japan	Miyake, H (reprint author), Kobe Univ, Div Urol, Grad Sch Med, Kobe, Hyogo 657, Japan.	hmiyake@med.kobe-u.ac.jp					Bertini R, 2011, EUR UROL, V60, P358, DOI 10.1016/j.eururo.2011.05.029; Antonelli A, 2015, INT J UROL, V22, P534, DOI 10.1111/iju.12738; Pouliot F, 2010, J UROLOGY, V184, P833, DOI 10.1016/j.juro.2010.04.071; Weiss VL, 2014, BJU INT, V113, P209, DOI 10.1111/bju.12322	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUN	2015	22	6					540	540		10.1111/iju.12740		1	Urology & Nephrology	Urology & Nephrology	CJ9PU	WOS:000355835500004		
J	Miyake, M; Gotoh, D; Shimada, K; Tatsumi, Y; Nakai, Y; Anai, S; Torimoto, K; Aoki, K; Tanaka, N; Konishi, N; Fujimoto, K				Miyake, Makito; Gotoh, Daisuke; Shimada, Keiji; Tatsumi, Yoshihiro; Nakai, Yasushi; Anai, Satoshi; Torimoto, Kazumasa; Aoki, Katsuya; Tanaka, Nobumichi; Konishi, Noboru; Fujimoto, Kiyohide			Exploration of risk factors predicting outcomes for primary T1 high-grade bladder cancer and validation of the Spanish Urological Club for Oncological Treatment scoring model: Long-term follow-up experience at a single institute	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						bladder cancer; broad base; high grade; infiltrative pattern; Spanish Urological Club for Oncological Treatment scoring model	BACILLUS-CALMETTE-GUERIN; UROTHELIAL CARCINOMA; PROGNOSTIC-FACTORS; CLINICAL-SIGNIFICANCE; JAPANESE PATIENTS; GROWTH-PATTERNS; STAGE TA; PROGRESSION; RECURRENCE; EXPRESSION	ObjectiveTo determine the prognostic factors of primary T1 high-grade bladder cancer and to validate the Spanish Urological Club for Oncological Treatment model in Japanese patients with T1 high-grade bladder cancer treated at a single institution. MethodsRecords of 106 patients with T1 high-grade bladder cancer treated from 1998 to 2013 were retrospectively reviewed. Variables included various clinicopathological parameters, including lymphovascular invasion and tumor growth pattern at the invasion front. Recurrence-free survival and progression-free survival were analyzed. Multivariate Cox proportional regression analysis was used to verify the prognostic significance of the variables. Scores for recurrence and progression were calculated using the Spanish Urological Club for Oncological Treatment model. ResultsOf 106 patients, 44 (42%) had recurrence and 16 (15%) developed progression after a median (interquartile range) follow-up period of 54months (range 32-81months). Non-papillary shape was the only independent predictor for recurrence, while broad-based tumor stalk and infiltrative tumor growth pattern at the invasion front were determined to be independent predictors for progression. Stratification of patients according to the number of progression risk factors yielded hazard ratios of 10.1 and 13.1 in patients having one and two risks, respectively, compared with those without any risks. The Spanish Urological Club for Oncological Treatment model successfully stratified our patients with a trend toward different probabilities of recurrence and progression. ConclusionsThe results of the present study might be helpful for counseling certain patients towards intensive treatment, such as radical cystectomy and/or platinum-based systemic chemotherapy. In addition, the Spanish Urological Club for Oncological Treatment model might be applicable to Japanese patients with T1 high-grade bladder cancer.	[Miyake, Makito; Gotoh, Daisuke; Tatsumi, Yoshihiro; Nakai, Yasushi; Anai, Satoshi; Torimoto, Kazumasa; Aoki, Katsuya; Tanaka, Nobumichi; Fujimoto, Kiyohide] Nara Med Univ, Dept Urol, Nara 6348522, Japan; [Shimada, Keiji; Tatsumi, Yoshihiro; Konishi, Noboru] Nara Med Univ, Dept Pathol, Nara 6348522, Japan	Fujimoto, K (reprint author), Nara Med Univ, Dept Urol, 840 Shijo Cho, Nara 6348522, Japan.	kiyokun@naramed-u.ac.jp					Fernandez-Gomez J, 2008, EUR UROL, V53, P992, DOI 10.1016/j.eururo.2007.10.006; Segal R, 2012, BJU INT, V109, P1026, DOI 10.1111/j.1464-410X.2011.10462.x; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Kikuchi E, 2009, INT J UROL, V16, P279, DOI 10.1111/j.1442-2042.2008.02235.x; Babjuk M, 2011, EUR UROL, V59, P997, DOI 10.1016/j.eururo.2011.03.017; Shahin O, 2003, J UROLOGY, V169, P96, DOI 10.1097/01.ju.0000035543.69161.58; Jimenez RE, 2000, AM J SURG PATHOL, V24, P980, DOI 10.1097/00000478-200007000-00009; Baumgart E, 2007, CLIN CANCER RES, V13, P1685, DOI 10.1158/1078-0432.CCR-06-2330; Zlotta AR, 1999, J UROLOGY, V161, P792, DOI 10.1016/S0022-5347(01)61770-1; Denzinger S, 2009, SCAND J UROL NEPHROL, V43, P282, DOI 10.1080/00365590902854354; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brimo F, 2013, HUM PATHOL, V44, P95, DOI 10.1016/j.humpath.2012.04.020; Cho KS, 2009, J UROLOGY, V182, P2625, DOI 10.1016/j.juro.2009.08.083; Barski Dimitri, 2014, Cent European J Urol, V67, P333, DOI 10.5173/ceju.2014.04.art3; Dalbagni G, 2010, BJU INT, V106, P1502, DOI 10.1111/j.1464-410X.2010.09347.x; Kim HS, 2014, UROL ONCOL; Kohjimoto Y, 2014, INT J UROL, V21, P1201, DOI 10.1111/iju.12572; Koskela LR, 2012, NITRIC OXIDE-BIOL CH, V27, P185, DOI 10.1016/j.niox.2012.07.001; Matsuda T, 2008, JPN J CLIN ONCOL, V38, P85, DOI 10.1093/jjco/hyn006; Miyake M, 2011, BMC UROL, V11, DOI 10.1186/1471-2490-11-17; Miyake M, 2010, UROL INT, V85, P355, DOI 10.1159/000317785; Nepple Kenneth G, 2009, Can Urol Assoc J, V3, pS188; Sakano S, 2011, BJU INT, V107, P1598, DOI 10.1111/j.1464-410X.2010.09850.x; Schmitz-Drager BJ, 2000, EUR UROL, V38, P691, DOI 10.1159/000020364; Shariat SF, 2005, J UROLOGY, V173, P1518, DOI 10.1097/01.ju.0000154696.48217.75; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208	26	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUN	2015	22	6					541	547		10.1111/iju.12749		7	Urology & Nephrology	Urology & Nephrology	CJ9PU	WOS:000355835500005		
J	Yashi, M				Yashi, Masahiro			Editorial Comment to Importance of prostate volume in the stratification of patients with intermediate-risk prostate cancer	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material							RADICAL PROSTATECTOMY; SIZE		Dokkyo Med Univ, Dept Urol, Mibu, Tochigi, Japan	Yashi, M (reprint author), Dokkyo Med Univ, Dept Urol, Mibu, Tochigi, Japan.	yashima@dokkyomed.ac.jp					Hong SK, 2014, UROLOGY, V84, P153, DOI 10.1016/j.urology.2014.04.006; Ngo TC, 2012, J UROLOGY, V187, P477, DOI 10.1016/j.juro.2011.10.042; Klein EA, 2015, EUR UROL, V67, P778, DOI 10.1016/j.eururo.2014.10.036; Koie T, 2015, INT J UROL, V22, P70, DOI 10.1111/iju.12597; Moschini M, 2015, INT J UROL, V22, P555, DOI 10.1111/iju.12748	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUN	2015	22	6					561	562		10.1111/iju.12764		2	Urology & Nephrology	Urology & Nephrology	CJ9PU	WOS:000355835500009		
J	Shoji, S; Hashimoto, A; Nakamoto, M; Fukuda, N; Fujikawa, H; Endo, K; Tomonaga, T; Nakano, M; Terachi, T; Uchida, T				Shoji, Sunao; Hashimoto, Akio; Nakamoto, Masahiko; Fukuda, Norio; Fujikawa, Hiroshi; Endo, Kazuyuki; Tomonaga, Tetsuro; Nakano, Mayura; Terachi, Toshiro; Uchida, Toyoaki			Morphological analysis of the effects of intraoperative transrectal compression of the prostate during high-intensity focused ultrasound for localized prostate cancer	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						high-intensity focused ultrasound; magnetic resonance imaging; prostate cancer; transrectal compression; transrectal ultrasound	FOCAL THERAPY; IN-VIVO; OUTCOMES; EDEMA	ObjectivesTo evaluate the effects of transrectal compression of the prostate for intra-operative prostatic swelling and intraprostatic point shift during high-intensity focused ultrasound treatment of localized prostate cancer. MethodsPatients treated with whole-gland high-intensity focused ultrasound as primary monotherapy for localized prostate cancer were enrolled in the study. Using the standard and compression method, the volumes of degassed water in the balloon covering the high-intensity focused ultrasound probe were 50 mL and 80-160 mL, respectively. To identify prostatic swelling and shift during high-intensity focused ultrasound and the volume occupied by the non-enhanced area, three-dimensional prostate models were reconstructed using ultrasound and contrast-enhanced magnetic resonance imaging. ResultsIn comparison with the standard (n=40) and compression (n=48) methods, intraoperative increase in the prostate volume (21% vs 5.3%; P=0.044), intraprostatic point shift (4mm vs 2mm, P=0.040 in the transition zone; 3mm vs 0mm; P=0.001 in the peripheral zone) and the volume occupied by the non-enhanced area (89% vs 96%; P=0.001) were significantly suppressed. The biochemical disease-free survival rate in patients treated using the compression method was significantly improved relative to the standard method (92.6% vs 76.5%; P=0.038). Regarding complications, there was no significant difference in the rate of urethral stricture (P=0.9), urinary tract infection (P=0.9), incontinence (P=0.3), erectile dysfunction (P=0.9) or recto-urethral fistula between the patients treated using the standard and compression methods. ConclusionsIntraoperative transrectal compression suppresses intraoperative increase in the prostate volume and intraprostatic point shift during high-intensity focused ultrasound, having the potential to achieve precise whole-gland and lesion-targeted focal therapy.	[Shoji, Sunao; Tomonaga, Tetsuro; Nakano, Mayura; Uchida, Toyoaki] Tokai Univ, Dept Urol, Hachioji Hosp, Hachioji, Tokyo 1920032, Japan; [Hashimoto, Akio; Fujikawa, Hiroshi; Endo, Kazuyuki] Tokai Univ, Dept Radiol, Hachioji Hosp, Hachioji, Tokyo 1920032, Japan; [Nakamoto, Masahiko; Fukuda, Norio] Osaka Univ, Dept Radiol, Grad Sch Med, Suita, Osaka, Japan; [Terachi, Toshiro] Tokai Univ, Sch Med, Dept Urol, Isehara, Kanagawa 25911, Japan	Shoji, S (reprint author), Tokai Univ, Dept Urol, Hachioji Hosp, 1838 Ishikawa Machi, Hachioji, Tokyo 1920032, Japan.	sunashoj@mail.goo.ne.jp					MADERSBACHER S, 1995, CANCER RES, V55, P3346; Hynynen K, 1996, ULTRASOUND MED BIOL, V22, P193, DOI 10.1016/0301-5629(95)02044-6; Shoji S, 2010, INT J UROL, V17, P715, DOI 10.1111/j.1442-2042.2010.02568.x; Eggener SE, 2007, J UROLOGY, V178, P2260, DOI 10.1016/j.juro.2007.08.072; Shoji S, 2013, J UROLOGY, V190, P1224, DOI 10.1016/j.juro.2013.03.116; Suehiro K, 2014, CIRC J, V78, P1733, DOI 10.1253/circj.CJ-13-1599; Ahmed HU, 2011, J UROLOGY, V185, P1246, DOI 10.1016/j.juro.2010.11.079; Muto S, 2008, JPN J CLIN ONCOL, V38, P192, DOI 10.1093/jjco/hym173; Van Leenders GJLH, 2000, J CLIN PATHOL, V53, P391, DOI 10.1136/jcp.53.5.391; Curiel L, 2004, MED BIOL ENG COMPUT, V42, P44, DOI 10.1007/BF02351010; Shoji S, 2014, INT J UROL, V21, P942, DOI 10.1111/iju.12515; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; El Fegoun AB, 2011, INT BRAZ J UROL, V37, P213, DOI 10.1590/S1677-55382011000200008; Hynynen K, 1998, ULTRASOUND MED BIOL, V24, P275, DOI 10.1016/S0301-5629(97)00269-X; Walz J, 2010, EUR UROL, V57, P179, DOI 10.1016/j.eururo.2009.11.009; Roach M, 2006, INT J RADIAT ONCOL, V65, P965, DOI 10.1016/j.ijrobp.2006.04.029; Ahmed HU, 2012, LANCET ONCOL, V13, P622, DOI 10.1016/S1470-2045(12)70121-3; Crouzet S, 2014, EUR UROL, V65, P907, DOI 10.1016/j.eururo.2013.04.039; Kirkham APS, 2008, RADIOLOGY, V246, P833, DOI 10.1148/radiol.2463062080; Gelet A, 2000, J ENDOUROL, V14, P519, DOI 10.1089/end.2000.14.519; Chapelon J Y, 1999, Eur J Ultrasound, V9, P31, DOI 10.1016/S0929-8266(99)00005-1; Chaussy C, 2000, MOL UROL, V4, P179; Fox M, 2011, DIGESTION, V83, P46, DOI 10.1159/000314588; Illing R, 2006, EXPERT REV MED DEVIC, V3, P717, DOI 10.1586/17434440.3.6.717; Rivens I H, 1999, Eur J Ultrasound, V9, P89, DOI 10.1016/S0929-8266(99)00008-7; Shoji S, 2014, J UROLOGY, V191, pE104; Trayes KP, 2013, AM FAM PHYSICIAN, V88, P102; Uchida T, 2012, INT J UROL, V19, P187, DOI 10.1111/j.1442-2042.2011.02936.x; Uchida T, 2015, J UROLOGY, V193, P103, DOI 10.1016/j.juro.2014.07.096; Watanabe H, 1998, PROSTATE, V37, P116, DOI 10.1002/(SICI)1097-0045(19981001)37:2<116::AID-PROS8>3.0.CO;2-E	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUN	2015	22	6					563	571		10.1111/iju.12747		9	Urology & Nephrology	Urology & Nephrology	CJ9PU	WOS:000355835500010		
J	Makiyama, K; Yamanaka, H; Ueno, D; Ohsaka, K; Sano, F; Nakaigawa, N; Yao, M; Kubota, Y				Makiyama, Kazuhide; Yamanaka, Hiroyuki; Ueno, Daiki; Ohsaka, Kimito; Sano, Futoshi; Nakaigawa, Noboru; Yao, Masahiro; Kubota, Yoshinobu			Validation of a patient-specific simulator for laparoscopic renal surgery	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						kidney; laparoscopy; patient-specific; simulator; validation	VIRTUAL-REALITY SIMULATION; OPERATING-ROOM; NEPHRECTOMY SIMULATOR; SURGICAL SIMULATION; MEDICAL SIMULATION; SKILLS; PERFORMANCE; TRIAL	ObjectivesTo describe and to validate a novel patient-specific virtual-reality based simulator for laparoscopic surgery. MethodsThree surgeons carried out 13 preoperative simulations at Yokohama City University Hospital, Yokohama, Kanagawa, Japan, from 2011 to 2012. The procedures included seven nephrectomies, four partial nephrectomies and two pyeloplasties. We evaluated whether the anatomies reproduced by the simulator matched those encountered during the actual operations. Furthermore, the surgeons were asked to use visual analog scales (from 1 to 5; higher scores are better) to evaluate the anatomical integrity and utility of the simulations, and their intraoperative confidence during the subsequent surgical procedures. ResultsThe simulator reproduced the patients' anatomies almost perfectly. Only a few minor mistakes were identified. Regarding the surgeons' evaluations of the system, the mean scores for the anatomical integrity and utility of the simulations, and the surgeons' intraoperative confidence were 3.4, 4.2 and 4.1, respectively. In all 13 cases, the surgeons were able to carry out preoperative training with ease, and they stated that the simulator was useful for producing preoperative images. ConclusionsA patient-specific simulator for laparoscopic renal surgery has been successfully developed. This system correctly reproduces anatomical structures, and it seems to be a useful preoperative training tool.	[Makiyama, Kazuhide; Yamanaka, Hiroyuki; Ueno, Daiki; Ohsaka, Kimito; Sano, Futoshi; Nakaigawa, Noboru; Yao, Masahiro; Kubota, Yoshinobu] Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa 2360004, Japan	Makiyama, K (reprint author), Yokohama City Univ, Grad Sch Med, Dept Urol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	makiya@yokohama-cu.ac.jp					Aggarwal R, 2009, SURGERY, V145, P1, DOI 10.1016/j.surg.2008.07.010; Wignall GR, 2008, J UROLOGY, V179, P1690, DOI 10.1016/j.juro.2008.01.014; Grantcharov TP, 2004, BRIT J SURG, V91, P146, DOI 10.1002/bjs.4407; Seymour NE, 2002, ANN SURG, V236, P458, DOI 10.1097/01.SLA.0000028969.51489.B4; Fried GM, 1999, SURG ENDOSC-ULTRAS, V13, P1077, DOI 10.1007/s004649901176; Palter VN, 2014, ANN SURG, V259, P443, DOI 10.1097/SLA.0000000000000254; Haque S, 2006, IEEE T INF TECHNOL B, V10, P51, DOI 10.1109/TITB.2005.855529; Brewin J, 2010, BJU INT, V106, P850, DOI 10.1111/j.1464-410X.2009.09193.x; Scott DJ, 2008, J GASTROINTEST SURG, V12, P213, DOI 10.1007/s11605-007-0357-y; Aggarwal R, 2007, ANN SURG, V246, P771, DOI 10.1097/SLA.0b013e3180f61b09; Korndorffer JR, 2006, AM J SURG, V191, P17, DOI 10.1016/j.amjsurg.2005.05.048; Hamilton EC, 2002, SURG ENDOSC, V16, P406, DOI 10.1007/s00464-001-8149-z; Le CQ, 2007, J UROLOGY, V177, P288, DOI 10.1016/j.juro.2006.08.106; Makiyama K, 2012, UROLOGY, V80, P1375, DOI 10.1016/j.urology.2012.08.054; Makiyama K, 2012, INT J UROL, V19, P829, DOI 10.1111/j.1442-2042.2012.03053.x; Matsuda T, 2006, J UROLOGY, V176, P2168, DOI 10.1016/j.juro.2006.07.034; Soler L, 2008, WORLD J SURG, V32, P208, DOI 10.1007/s00268-007-9329-3; Suzuki S, 2007, ST HEAL T, V125, P464; Wijn RPWF, 2010, J ENDOUROL, V24, P117, DOI 10.1089/end.2009.0219; Willaert WIM, 2012, WORLD J SURG, V36, P1703, DOI 10.1007/s00268-012-1489-0; Yamanaka Hiroyuki, 2012, J Med Case Rep, V6, P338, DOI 10.1186/1752-1947-6-338	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUN	2015	22	6					572	576		10.1111/iju.12737		5	Urology & Nephrology	Urology & Nephrology	CJ9PU	WOS:000355835500011		
J	Tomoe, H				Tomoe, Hikaru			Improvement of overactive bladder symptoms after tension-free vaginal mesh operation in women with pelvic organ prolapse: Correlation with preoperative urodynamic findings	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						detrusor overactivity; overactive bladder; pelvic organ prolapse; tension-free vaginal mesh operation; urodynamic study	URINARY-TRACT SYMPTOMS; INCONTINENCE; POPULATION; PREVALENCE; REPAIR; SCORE	ObjectivesTo further elucidate the mechanisms of overactive bladder coexisting with pelvic organ prolapse. MethodsA total of 100 consecutive women with stage2 or greater pelvic organ prolapse associated with cystocele were enrolled in the present prospective study. They underwent urodynamic studies and then received tension-free vaginal mesh operation. Urodynamic studies were carried out before and after the correction of pelvic organ prolapse using a single gauze pack in the vagina in the sitting position. The overactive bladder symptom score and International Prostate Symptom Score were collected before and 3months after surgery. ResultsIn 53 of 100 cases, pelvic organ prolapse was accompanied with overactive bladder, and detrusor overactivity was observed in 28 out of 53 pelvic organ prolapse with overactive bladder cases (52.8%). Detrusor overactivity was resolved in 18 and reduced in four out of 28 cases after the correction of pelvic organ prolapse by the gauze packing method. Of 53 patients who had overactive bladder preoperatively, overactive bladder symptoms disappeared in 35 cases (66.0%) and improved in six additional cases (11.3%) after tension-free vaginal mesh operation. A total of 20 of 25 cases whose overactive bladder symptoms disappeared or improved after surgery coincided with those who had shown either disappearance (n=16) or improvement (n=4) of detrusor overactivity after intravaginal gauze pack insertion in preoperative urodynamic studies. All scores in the overactive bladder symptom score decreased significantly after tension-free vaginal mesh, as well as the International Prostate Symptom Score, except for night-time frequency. ConclusionsPelvic organ prolapse-associated overactive bladder or detrusor overactivity conditions can be reversed in most cases within a short period of time after surgical correction of pelvic organ prolapse.	Tokyo Womens Med Univ, Dept Pelv Reconstruct Surg Urol, Med Ctr East, Arakawa Ku, Tokyo 1168567, Japan	Tomoe, H (reprint author), Tokyo Womens Med Univ, Dept Pelv Reconstruct Surg Urol, Med Ctr East, Arakawa Ku, 2-1-10 Nishiogu, Tokyo 1168567, Japan.	tomoeur@dnh.twmu.ac.jp					Weber AM, 2001, AM J OBSTET GYNECOL, V185, P1299, DOI 10.1067/mob.2001.119081; Gammie A, 2014, NEUROUROL URODYNAM, V33, P370, DOI 10.1002/nau.22546; Brading AF, 1997, UROLOGY, V50, P57, DOI 10.1016/S0090-4295(97)00591-8; Ferguson DR, 1997, J PHYSIOL-LONDON, V505, P503, DOI 10.1111/j.1469-7793.1997.503bb.x; Homma Y, 2006, UROLOGY, V68, P318, DOI 10.1016/j.urology.2006.02.042; Kaplan SA, 2008, BJU INT, V102, P1133, DOI 10.1111/j.1464-410X.2008.07761.x; Lawrence JM, 2008, OBSTET GYNECOL, V111, P678, DOI 10.1097/AOG.0b013e3181660c1b; de Boer TA, 2010, NEUROUROL URODYNAM, V29, P30, DOI 10.1002/nau.20858; Fernando RJ, 2006, OBSTET GYNECOL, V108, P93, DOI 10.1097/01.AOG.0000222903.38684.cc; Digesu GA, 2005, BJOG-INT J OBSTET GY, V112, P971, DOI 10.1111/j.1471-0528.2005.00568.x; Debodinance P, 2004, J Gynecol Obstet Biol Reprod (Paris), V33, P577; Digesu GA, 2007, INT UROGYNECOL J, V18, P1439, DOI 10.1007/s00192-007-0375-z; DUNN M, 1975, BRIT J UROL, V47, P67, DOI 10.1111/j.1464-410X.1975.tb03919.x; Foster RT, 2007, AM J OBSTET GYNECOL, V197; GHONIEM GM, 1994, J UROLOGY, V152, P931; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Nguyen JK, 2001, J UROLOGY, V166, P2263, DOI 10.1016/S0022-5347(05)65547-4; Takeda M, 2013, UROLOGY, V82, P887, DOI 10.1016/j.urology.2013.05.008; Takeyama M, 2007, INT UROGYNECOL J, V18, pS46; Takeyama M, 2011, INT J UROL, V18, P555, DOI 10.1111/j.1442-2042.2011.02805.x; Tegerstedt G, 2005, INT UROGYNECOL J, V16, P497, DOI 10.1007/s00192-005-1326-1	21	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUN	2015	22	6					577	580		10.1111/iju.12744		4	Urology & Nephrology	Urology & Nephrology	CJ9PU	WOS:000355835500012		
J	Kitta, T				Kitta, Takeya			Editorial Comment to Improvement of overactive bladder symptoms after tension-free vaginal mesh operation in women with pelvic organ prolapse: Correlation with preoperative urodynamic findings	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material									Hokkaido Univ, Grad Sch Med, Dept Renal & Genitourinary Surg, Sapporo, Hokkaido, Japan	Kitta, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Renal & Genitourinary Surg, Sapporo, Hokkaido, Japan.	kitta@fb3.so-net.ne.jp					FitzGerald MP, 2000, AM J OBSTET GYNECOL, V183, P1361, DOI 10.1067/mob.2000.110956; Kitta T, 2015, INT J UROL, V22, P201, DOI 10.1111/iju.12656; Tomoe H, 2015, INT J UROL, V22, P577, DOI 10.1111/iju.12744	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUN	2015	22	6					581	581		10.1111/iju.12756		1	Urology & Nephrology	Urology & Nephrology	CJ9PU	WOS:000355835500013		
J	Oh-oka, H				Oh-oka, Hitoshi			Editorial Comment from Dr Oh-oka to Treatment satisfaction and clinically meaningful symptom improvement in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: Secondary results from a 6-month, randomized, double-blind study comparing finasteride plus tadalafil with finasteride plus placebo	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material							THERAPY		Kobe Med Ctr, Dept Urol, Kobe, Hyogo, Japan	Oh-oka, H (reprint author), Kobe Med Ctr, Dept Urol, Kobe, Hyogo, Japan.	bighill@zeus.eonet.ne.jp					Roehrborn CG, 2008, J UROLOGY, V179, P616, DOI 10.1016/j.juro.2007.09.084; Roehrborn CG, 2015, INT J UROL, V22, P582, DOI 10.1111/iju.12741; Kaplan SA, 2011, J UROLOGY, V185, P1369, DOI 10.1016/j.juro.2010.11.060; Lepor H, 1998, J UROLOGY, V160, P1358, DOI 10.1016/S0022-5347(01)62536-9; Lepor H, 1996, NEW ENGL J MED, V335, P533, DOI 10.1056/NEJM199608223350801	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUN	2015	22	6					588	588		10.1111/iju.12757		1	Urology & Nephrology	Urology & Nephrology	CJ9PU	WOS:000355835500015		
J	Masumori, N				Masumori, Naoya			Editorial Comment from Dr Masumori to Treatment satisfaction and clinically meaningful symptom improvement in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: Secondary results from a 6-month, randomized, double-blind study comparing finasteride plus tadalafil with finasteride plus placebo	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material							COMBINATION; THERAPY		Sapporo Med Univ, Dept Urol, Sapporo, Hokkaido, Japan	Masumori, N (reprint author), Sapporo Med Univ, Dept Urol, Sapporo, Hokkaido, Japan.	masumori@sapmed.ac.jp					Roehrborn CG, 2015, INT J UROL, V22, P582, DOI 10.1111/iju.12741; Casabe A, 2014, J UROLOGY, V191, P727, DOI 10.1016/j.juro.2013.09.059; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; Gacci M, 2012, EUR UROL, V61, P994, DOI 10.1016/j.eururo.2012.02.033; Roehrborn CG, 2010, EUR UROL, V57, P123, DOI 10.1016/j.eururo.2009.09.035; Takeda M, 2014, INT J UROL, V21, P670, DOI 10.1111/iju.12410	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUN	2015	22	6					589	589		10.1111/iju.12765		1	Urology & Nephrology	Urology & Nephrology	CJ9PU	WOS:000355835500016		
J	Sawada, Y; Omoto, K; Kohei, N; Sakaguchi, K; Miura, M; Tanabe, K				Sawada, Yugo; Omoto, Kazuya; Kohei, Naoki; Sakaguchi, Kengo; Miura, Masahiko; Tanabe, Kazunari			Sulfoquinovosylacylpropanediol is a novel potent radiosensitizer in prostate cancer	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						oxygenation; prostate cancer; radiation therapy; radiosensitizer; vascular normalization	BORON NEUTRON-CAPTURE; ALPHA-SULFOQUINOVOSYLMONOACYLGLYCEROL; IONIZING-RADIATION; PHASE-I; THERAPY; CELLS; ANGIOGENESIS; BEVACIZUMAB; INHIBITOR; TRIAL	ObjectivesTo examine the effects of combined treatment with sulfoquinovosylacylpropanediol and X-ray irradiation on the remodeling of the prostate cancer microenvironment, including angiogenic and hypoxic characteristics. MethodsHuman prostate cancer cells (DU145 and PC3) were implanted subcutaneously into the right hind legs of athymic nude mice. After the tumor volume reached 100-300mm(3), 2mg/kg/day sulfoquinovosylacylpropanediol was given intravenously from day0 to day4, and cells were exposed to 4Gy X-ray irradiation on days0 and 3 (for a total of 8Gy). Tumors were fixed and stained for pathological analyses and immunohistochemical evaluations. To analyze vascular normalization, 60mg/kg pimonidazole dissolved in saline was injected intraperitoneally. ResultsCombined treatment with sulfoquinovosylacylpropanediol plus X-ray irradiation enhanced growth inhibition in DU145 xenografts. The tumor vessel density in DU145 cells significantly decreased after the combined treatment. Staining for smooth muscle actin in vessels was significantly increased. Pimonidazole staining, showing hypoxic lesions, was negative from 72h, but positive at 6 and 24h after the first combined treatment. In contrast, no enhancement of the microenvironment in PC3 xenografts was observed with sulfoquinovosylacylpropanediol plus X-ray irradiation. ConclusionSulfoquinovosylacylpropanediol could be a novel potent radiosensitizing agent targeting angiogenesis in prostate cancer.	[Sawada, Yugo; Omoto, Kazuya; Kohei, Naoki; Tanabe, Kazunari] Tokyo Womens Med Univ, Dept Urol, Tokyo 1628666, Japan; [Sakaguchi, Kengo] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol, Chiba, Japan; [Miura, Masahiko] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Restitut, Oral Radiat Oncol, Tokyo, Japan	Tanabe, K (reprint author), Tokyo Womens Med Univ, Dept Urol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	tanabe@kc.twmu.ac.jp			MEXT, the Support Program for the Strategic Research Foundation at Private Universities	This study was supported by MEXT, the Support Program for the Strategic Research Foundation at Private Universities.	Ohta K, 2010, ANTICANCER RES, V30, P4397; Sakimoto I, 2006, CANCER RES, V66, P2287, DOI 10.1158/0008-5472.CAN-05-2209; Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4; Vincenzi B, 2009, CANCER, V115, P4849, DOI 10.1002/cncr.24540; Sahara H, 1997, BRIT J CANCER, V75, P324, DOI 10.1038/bjc.1997.54; Ni XH, 2011, J CLIN INVEST, V121, P2383, DOI 10.1172/JCI45109; Yasui L, 2012, APPL RADIAT ISOTOPES, V70, P6, DOI 10.1016/j.apradiso.2011.07.001; Harada H, 2009, J BIOL CHEM, V284, P5332, DOI 10.1074/jbc.M806653200; Mauceri HJ, 1998, NATURE, V394, P287; Ward JF, 2005, NAT CLIN PRACT UROL, V2, P174, DOI 10.1038/ncpuro.0145; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gifford I, 2014, INT J RADIAT BIOL, V90, P480, DOI 10.3109/09553002.2014.901579; Hottinger AF, 2014, BRIT J CANCER, V110, P2655, DOI 10.1038/bjc.2014.209; Hsu CH, 2010, BRIT J CANCER, V102, P981, DOI 10.1038/sj.bjc.6605580; Kindler HL, 2010, J CLIN ONCOL, V28, P3617, DOI 10.1200/JCO.2010.28.1386; Baade Peter D, 2013, Prostate Int, V1, P47, DOI 10.12954/PI.12014; Bonkhoff H, 2012, PROSTATE CANC, V2012; Chang L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.415; El Kaffas A, 2014, MICROVASC RES, V92, P1, DOI 10.1016/j.mvr.2013.10.008; Han Sumin, 2013, Neoplasia, V15, P1207; Jastaniyah N, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-38; Jayakumar S, 2014, BBA-GEN SUBJECTS, V1840, P485, DOI 10.1016/j.bbagen.2013.10.006; Kuenen BC, 2003, J CLIN ONCOL, V21, P2192, DOI 10.1200/JCO.2003.08.046; Mizushina Y, 1998, BIOCHEM PHARMACOL, V55, P537, DOI 10.1016/S0006-2952(97)00536-4; Murakami C, 2003, BBA-PROTEINS PROTEOM, V1645, P72, DOI 10.1016/S1570-9639(02)00521-6; Ohta K, 1998, CHEM PHARM BULL, V46, P684; Sahara H, 2002, JPN J CANCER RES, V93, P85	28	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUN	2015	22	6					590	595		10.1111/iju.12753		6	Urology & Nephrology	Urology & Nephrology	CJ9PU	WOS:000355835500017		
J	Miyata, Y; Sakai, H				Miyata, Yasuyoshi; Sakai, Hideki			Editorial Comment from Dr Miyata and Dr Sakai to Sulfoquinovosylacylpropanediol is a novel potent radiosensitizer in prostate cancer	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material									[Miyata, Yasuyoshi; Sakai, Hideki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Urol, Nagasaki 852, Japan	Miyata, Y (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Urol, Nagasaki 852, Japan.	int.doc.miya@m3.dion.ne.jp					Ohta K, 2010, ANTICANCER RES, V30, P4397; Ischia J, 2013, INT J UROL, V20, P290, DOI 10.1111/iju.12069; Sawada Y, 2015, INT J UROL, V22, P590, DOI 10.1111/iju.12753; Mizushina Y, 2003, LIPIDS, V38, P1065, DOI 10.1007/s11745-006-1162-1; Murakami C, 2003, BBA-PROTEINS PROTEOM, V1645, P72, DOI 10.1016/S1570-9639(02)00521-6	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUN	2015	22	6					597	597		10.1111/iju.12776		1	Urology & Nephrology	Urology & Nephrology	CJ9PU	WOS:000355835500019		
J	Kuroda, N				Kuroda, Naoto			Editorial Comment to ImmunoglobulinG4-related disease in the urinary bladder	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material							IGG4-RELATED DISEASE		Kochi Red Cross Hosp, Dept Diagnost Pathol, Kochi, Japan	Kuroda, N (reprint author), Kochi Red Cross Hosp, Dept Diagnost Pathol, Kochi, Japan.	kurochankochi@yahoo.co.jp					Dropkin BM, 2015, INT J UROL, V22, P605, DOI 10.1111/iju.12769; Fujii M, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-41; Karashima T, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0225-5; Kuroda N, 2014, INT J CLIN EXP PATHO, V7, P6379; Montironi R, 2013, EUR UROL, V64, P865, DOI 10.1016/j.eururo.2012.11.056; Park S, 2013, ANN DIAGN PATHOL, V17, P540, DOI 10.1016/j.anndiagpath.2013.01.004	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUN	2015	22	6					607	608		10.1111/iju.12777		2	Urology & Nephrology	Urology & Nephrology	CJ9PU	WOS:000355835500023		
J	Hara, R; Nagai, A; Fujii, T; Fukumoto, K; Ohira, S; Jo, Y; Yokoyama, T; Miyaji, Y				Hara, Ryoei; Nagai, Atsushi; Fujii, Tomohiro; Fukumoto, Kazuhiko; Ohira, Shin; Jo, Yoshimasa; Yokoyama, Teruhiko; Miyaji, Yoshiyuki			Practical application of color Doppler ultrasonography in patients with ejaculatory dysfunction	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						anorgasmia; collagen injection; color Doppler ultrasonography; ejaculatory dysfunction; retrograde ejaculation	RETROGRADE EJACULATION; COLLAGEN INJECTION; ANTEGRADE	We describe two cases in which dynamic analysis of ejaculation using color Doppler ultrasonography was useful in diagnosis of ejaculatory dysfunction and planning of therapy. The first patient was a 32-year-old man with a diagnosis of retrograde ejaculation. A bladder neck collagen injection was carried out, as the main cause was thought to be the bladder neck remaining open during ejaculation. The patient had antegrade ejaculation 1week later. The second patient was a 48-year-old man with a diagnosis of anorgasmia accompanied by decreased seminal emission and insufficient function of the rhythmic pelvic striated muscles. The patient was prescribed etilefrine hydrochloride 15mg/day. The symptom improved 2weeks after starting this drug. These cases suggest that the use of color Doppler ultrasonography during ejaculation can improve the understanding of ejaculatory dysfunction and therapy for this condition.	[Hara, Ryoei; Nagai, Atsushi; Fujii, Tomohiro; Fukumoto, Kazuhiko; Ohira, Shin; Jo, Yoshimasa; Yokoyama, Teruhiko; Miyaji, Yoshiyuki] Kawasaki Med Univ, Dept Urol, Kurashiki, Okayama 7010192, Japan	Hara, R (reprint author), Kawasaki Med Univ, Dept Urol, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	ryoeih@med.kawasaki-m.ac.jp					Safarinejad MR, 2009, INT J IMPOT RES, V21, P213, DOI 10.1038/ijir.2009.19; McMahon CG, 2013, J SEX MED, V10, P204, DOI 10.1111/j.1743-6109.2012.02824.x; Nagai A, 2004, INT J IMPOT RES, V16, P456, DOI 10.1038/sj.ijir.3901202; Paduch DA, 2012, BJU INT, V109, P1060, DOI 10.1111/j.1464-410X.2011.10504.x; Hisasue S, 2006, INT J UROL, V13, P1311, DOI 10.1111/j.1442-2042.2006.01535.x; Reynolds JC, 1998, J UROLOGY, V159, P1303, DOI 10.1016/S0022-5347(01)63592-4; Haaga JR, 2006, INT J IMPOT RES, V19, P110; Nagai A, 2005, UROLOGY, V65, P365, DOI 10.1016/j.urology.2004.09.016; Nagai A, 2008, INT J UROL, V15, P915, DOI 10.1111/j.1442-2042.2008.02136.x	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUN	2015	22	6					609	611		10.1111/iju.12754		3	Urology & Nephrology	Urology & Nephrology	CJ9PU	WOS:000355835500024		
J	Shimizu, Y; Kanamaru, S; Ito, N				Shimizu, Yousuke; Kanamaru, Sojun; Ito, Noriyuki			Simultaneous chylothorax and chylous ascites in a patient with castration-resistant prostate cancer after docetaxel chemotherapy: An unusual manifestation	INTERNATIONAL JOURNAL OF UROLOGY			English	Letter									[Shimizu, Yousuke; Kanamaru, Sojun; Ito, Noriyuki] Nishi Kobe Med Ctr, Dept Urol, Kobe, Hyogo, Japan	Shimizu, Y (reprint author), Nishi Kobe Med Ctr, Dept Urol, Kobe, Hyogo, Japan.	yousuke@kuhp.kyoto-u.ac.jp					Amin Rajni, 2002, Urology, V59, P773, DOI 10.1016/S0090-4295(02)01536-4; Cigarral C, 2009, CLIN TRANSL ONCOL, V11, P767, DOI 10.1007/s12094-009-0441-8; Khosravi Adnan, 2009, Hematol Oncol Stem Cell Ther, V2, P431; Motta G, 2003, AM J MED, V114, P772, DOI 10.1016/S0002-9343(03)00159-1	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUN	2015	22	6					614	614		10.1111/iju.12767		1	Urology & Nephrology	Urology & Nephrology	CJ9PU	WOS:000355835500026		
J	Watanabe, H; Takahashi, S; Ukimura, O				Watanabe, Hiroki; Takahashi, Satoru; Ukimura, Osamu			There is a possibility that the urethra opens actively and independently by the lateral movement of the urethral muscles themselves	INTERNATIONAL JOURNAL OF UROLOGY			English	Letter							MICTURITION		[Watanabe, Hiroki] Watanabe Mem Choumei Res Lab, Omihachiman, Shiga, Japan; [Takahashi, Satoru] Nihon Univ, Sch Med, Dept Urol, Tokyo, Japan; [Ukimura, Osamu] Univ So Calif, Norris Cotton Canc Ctr, Dept Urol, Los Angeles, CA USA	Watanabe, H (reprint author), Watanabe Mem Choumei Res Lab, Omihachiman, Shiga, Japan.	watanabe.choumei.rl@shoshikai.or.jp					LEGRICE IJ, 1995, AM J PHYSIOL-HEART C, V269, pH571; Napadow VJ, 2002, J BIOMECH ENG-T ASME, V124, P547, DOI 10.1115/1.1503794; Petros P, 2014, INT J UROL, V21, P1292, DOI 10.1111/iju.12575; Petros PEP, 1990, ACTA OBSTET GYN SCAN, V69, P69, DOI 10.1111/j.1600-0412.1990.tb08035.x; Watanabe H, 2014, INT J UROL, V21, P208, DOI 10.1111/iju.12212	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	JUN	2015	22	6					615	615		10.1111/iju.12763		1	Urology & Nephrology	Urology & Nephrology	CJ9PU	WOS:000355835500027		
J	Murayama, T; Ohnishi, H; Mori, T; Okazaki, Y; Sujita, K; Sakai, A				Murayama, Takashi; Ohnishi, Hideo; Mori, Toshiharu; Okazaki, Yuichi; Sujita, Kenji; Sakai, Akinori			A novel non-invasive mechanical technique of cup and stem placement and leg length adjustment in total hip arthroplasty for dysplastic hips	INTERNATIONAL ORTHOPAEDICS			English	Article						Mechanical technique; Cup placement; Leg length; Total hip arthroplasty; Dysplastic hip	TOMOGRAPHY-BASED NAVIGATION; ACETABULAR COMPONENT; COMPUTED-TOMOGRAPHY; DISCREPANCY; ACCURACY; ORIENTATION; CT; DISLOCATION	Purpose This study assessed the accuracy of cup and stem positioning and limb length adjustment for developmental dysplasia of the hip (DDH) using our new mechanical technique compared with imageless navigation or a computed tomography (CT)-based navigation system. Methods One hundred thirteen primary total hip arthroplasties (THAs) for DDH were evaluated. At pre-operative positioning, patients were placed in a precise lateral decubitus position by tilting the surgical table using simple ready-made devices (two shot pipe, metal chain, level gauge and goniometer). During surgery, cups were intentionally placed at 45A degrees inclination and 15A degrees anteversion on radiograph by using a level gauge and goniometer. Results Cup inclination was 44.2 degrees +/- 3.4 degrees (range, 32.0-51.2 degrees), cup anteversion was 19.6 degrees +/- 6.1 degrees (range, 3.0-33.1 degrees), stem alignment was 0.04 degrees +/- 0.8 degrees valgus (range, 2.1 degrees varus to 1.9 degrees valgus), and leg length discrepancy was -0.37 +/- 3.7 mm (range, -12.8 to 8.8 mm) in postoperative radiographs. Outliers (outside +/- 10 degrees from intentional position) occurred in 15 cases (13.3 %) in inclination or anteversion. Postoperative dislocation did not occur in any cases. Conclusions Cup and stem positioning in THAs with our new mechanical technique yielded satisfactory results compared with previously reported imageless navigation or CT-based navigation. Our results were superior with regard to being non-invasive and low cost and involving minimum radiation exposure.	[Murayama, Takashi; Okazaki, Yuichi; Sujita, Kenji] Makiyama Cent Hosp, Orthopaed Surg, Tobata Ku, Kitakyushu, Fukuoka 8040066, Japan; [Ohnishi, Hideo] Moji Med Ctr, Orthopaed Surg, Kitakyushu, Fukuoka, Japan; [Mori, Toshiharu; Sakai, Akinori] Univ Occupat & Environm Hlth, Sch Med, Orthopaed Surg, Kitakyushu, Fukuoka 807, Japan	Murayama, T (reprint author), Makiyama Cent Hosp, Orthopaed Surg, Tobata Ku, 13-13 Hatsunechou, Kitakyushu, Fukuoka 8040066, Japan.	muraya-t@clnc.uoeh-u.ac.jp					Hohmann E, 2011, J ARTHROPLASTY, V26, P1078, DOI 10.1016/j.arth.2010.11.009; Georgiades G, 2010, J ARTHROPLASTY, V25, P1143, DOI 10.1016/j.arth.2009.12.016; Widmer KH, 2004, J ARTHROPLASTY, V19, P387, DOI 10.1016/j.arth.2003.10.016; Kalteis T, 2006, J BONE JOINT SURG BR, V88B, P163, DOI 10.1302/0301-620X.88B2.17163; MURRAY DW, 1993, J BONE JOINT SURG BR, V75, P228; Kulkarni NM, 2012, RADIOLOGY, V265, P158, DOI 10.1148/radiol.12112470; Kitada M, 2011, J ARTHROPLASTY, V26, P674, DOI 10.1016/j.arth.2010.08.001; Maloney WJ, 2004, J ARTHROPLASTY, V19, P108, DOI 10.1016/j.arth.2004.02.018; Sendtner E, 2011, INT ORTHOP, V35, P809, DOI 10.1007/s00264-010-1042-4; CROWE JF, 1979, J BONE JOINT SURG AM, V61, P15; Saxler G, 2004, INT ORTHOP, V28, P198, DOI 10.1007/s00264-004-0542-5; Aravid SD, 2013, CURR REV MUSCULOSKEL, V6, P336; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Digeoia AM, 2002, J ARTHROPLASTY, V17, P359; Hassan DM, 1998, J ARTHROPLASTY, V13, P80, DOI 10.1016/S0883-5403(98)90079-1; Honl M, 2006, J BONE JOINT SURG BR, V88B, P1401, DOI 10.1302/0301-620X.88B10.17587; Irie S, 2002, PROSTHET ORTHOT INT, V26, P253, DOI 10.1080/03093640208726656; Jingushi S, 2007, J ARTHROPLASTY, V22, P1074, DOI 10.1016/j.arth.2007.04.022; Leeders T, 2002, COMPUT AIDED SURG, V7, P99; Licini DJ, 2013, ORTHOPEDICS, V36, pE543, DOI 10.3928/01477447-20130426-13; Lin F, 2011, J ARTHROPLASTY, V26, P596, DOI 10.1016/j.arth.2010.05.027; Nishikubo Y, 2011, J ARTHROPLASTY, V26, P1088, DOI 10.1016/j.arth.2011.05.011; Satoh M, 2009, ARCH ORTHOP TRAUM SU, V129, P1707, DOI 10.1007/s00402-009-0906-9; Simon DS, 2011, CLIN ORTHOP RELAT R, V469, P423	24	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	JUN	2015	39	6					1057	1064		10.1007/s00264-014-2613-6		8	Orthopedics	Orthopedics	CJ8MK	WOS:000355755600004		
J	Koshino, T; Sato, K; Umemoto, Y; Akamatsu, Y; Kumagai, K; Saito, T				Koshino, Tomihisa; Sato, Koji; Umemoto, Yusuke; Akamatsu, Yasushi; Kumagai, Ken; Saito, Tomoyuki			Clinical results of unicompartmental arthroplasty for knee osteoarthritis using a tibial component with screw fixation	INTERNATIONAL ORTHOPAEDICS			English	Article						Unicompartmental knee arthroplasty; Knee osteoarthritis; Tibial component with screw fixation; High knee flexion; Importance of postoperative limb alignment	MINIMUM FOLLOW-UP; REPLACEMENT; OSTEOTOMY; WEAR	Purpose Unicompartmental knee prostheses with screw fixation into the proximal tibia were employed and postoperative clinical results for osteoarthritis of the knee, especially regarding relief of pain, range of motion and satisfactory limb alignment are reported and discussed. Methods A total of 140 knees (131 medial and 9 lateral) of 85 patients (21 men and 64 women) were followed up for two to 17 years with an average of 7.0 +/- 3.0 years. Results In spite of loss to follow-up in three knees of two patients and revision to total knee arthroplasty in one knee of one patient, in the remaining 136 knees (82 patients) the mean knee score of the Knee Society Clinical Rating System was 41.0 +/- 14.7 pre-operatively, which improved to 93.1 +/- 5.7 at follow-up, while the mean functional score similarly improved from 36.9 +/- 8.1 to 88.5 +/- 6.3 (p < 0.001 respectively). One knee developed a fracture in the medial proximal part of the tibia, but no knee developed loosening of the prosthesis or infection. The mean pre-operative knee flexion was 122.6 +/- 15.9A degrees, which improved to 132.9 A +/- 13.4A degrees (p < 0.001) at follow-up. The limb alignment showed 4.8 A +/- 4.5A degrees anatomical varus angulation pre-operatively, which was corrected to 5.8 A +/- 3.3A degrees valgus at follow-up in the medial unicompartmental replacement group (127 knees), and 19 A +/- 6.1A degrees valgus pre-operatively, which was corrected to 6.7 A +/- 3.0A degrees valgus at follow-up in the lateral unicompartmental replacement group (nine knees). Conclusions The clinical results of arthroplasty with screw fixation were concluded to be promising.	[Koshino, Tomihisa; Sato, Koji; Umemoto, Yusuke; Akamatsu, Yasushi; Kumagai, Ken; Saito, Tomoyuki] Yokohama City Univ, Sch Med, Orthopaed Surg, Yokohama, Kanagawa 232, Japan	Koshino, T (reprint author), Yokohama City Univ, Sch Med, Orthopaed Surg, Yokohama, Kanagawa 232, Japan.	koshino@med.yokohama-cu.ac.jp					Ahlback S, 1968, ACTA RADIOL STOCKH S, P7; LASKIN RS, 1978, J BONE JOINT SURG AM, V60, P182; Luscombe KL, 2007, INT ORTHOP, V31, P321, DOI 10.1007/s00264-006-0202-z; Cartier P, 1996, J ARTHROPLASTY, V11, P782, DOI 10.1016/S0883-5403(96)80177-X; Argenson JNA, 2002, J BONE JOINT SURG AM, V84A, P2235; Niinimaki TT, 2011, KNEE, V18, P432, DOI 10.1016/j.knee.2010.08.004; Kendrick BJL, 2011, J BONE JOINT SURG BR, V93B, P470, DOI 10.1302/0301-620X.93B4.25605; Price AJ, 2005, CLIN ORTHOP RELAT R, P171, DOI 10.1097/01.blo.0000155347.89533.c5; Emerson RH, 2008, J BONE JOINT SURG AM, V90A, P118, DOI 10.2106/JBJS.F.00739; Mercier N, 2010, INT ORTHOP, V34, P1137, DOI 10.1007/s00264-009-0869-z; Lisowski LA, 2011, KNEE SURG SPORT TR A, V19, P277, DOI 10.1007/s00167-010-1213-2; Cross MB, 2014, INT ORTHOP, V38, P443, DOI 10.1007/s00264-013-2214-9; Pandit H, 2011, J BONE JOINT SURG BR, V93B, P198, DOI 10.1302/0301-620X.93B2.25767; Murray DW, 1998, J BONE JOINT SURG BR, V80B, P983, DOI 10.1302/0301-620X.80B6.8177; Citak M, 2014, INT ORTHOP, V38, P961, DOI 10.1007/s00264-013-2263-0; Hasegawa Y, 1998, ARCH ORTHOP TRAUM SU, V117, P183, DOI 10.1007/s004020050226; INSALL J, 1976, CLIN ORTHOP RELAT R, P83; Jonsson GT, 1982, ACTA ORTHOP SCAND S, V193, P60; Keys GW, 2004, KNEE, V11, P375, DOI 10.1016/j.knee.2004.03.007; KNUTSON K, 1981, ACTA ORTHOP SCAND, V52, P667; Koshinen E, 2009, ARCH ORTHOP TRAUMA S, V129, P617; KOSHINO T, 1991, B HOSP JOINT DIS ORT, V51, P119; Koshino T, 1987, HIGH TECH CERAMICS, P351; Koshino T, 2004, KNEE, V11, P439, DOI 10.1016/j.knee.2004.03.005; KOSHINO T, 1979, INT ORTHOP, V3, P37; Koshino T, 1997, UNICOMPARTMENTAL KNE, P200; MARMOR L, 1976, CLIN ORTHOP RELAT R, P86; Psychoyios V, 1998, J BONE JOINT SURG BR, V80B, P976, DOI 10.1302/0301-620X.80B6.8176	28	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	JUN	2015	39	6					1085	1091		10.1007/s00264-014-2564-y		7	Orthopedics	Orthopedics	CJ8MK	WOS:000355755600008		
J	Hashiguchi, H; Iwashita, S; Ohkubo, A; Takai, S				Hashiguchi, Hiroshi; Iwashita, Satoshi; Ohkubo, Atsushi; Takai, Shinro			The outcome of hemiarthroplasty for proximal humeral fractures is dependent on the status of the rotator cuff	INTERNATIONAL ORTHOPAEDICS			English	Article						Proximal humeral fracture; Hemiarthroplasty; Radiological evaluation; Humeral offset	REVERSE SHOULDER ARTHROPLASTY; DISPLACED FRACTURES; FOLLOW-UP; FIXATION; PROSTHESIS	Purpose The purpose of this study was to evaluate clinical and radiological outcomes of hemiarthroplasty for proximal humerus fractures. Methods Thirty-five patients (33 women and two men), average age at the time of surgery of 75.1 (range, 64-92) years, who underwent hemiarthroplasty for proximal humerus fracture or fracture-dislocation of the shoulder were enrolled in this study. The Constant score was used for clinical evaluation of outcomes, and X-rays were performed after a minimum follow-up period of 12 months postoperatively. Parameters for radiological evaluation were as follows: value of acromiohumeral interval (AHI), humeral offset, medial and lateral projection, and the existence of subacromial spur, a radiolucent zone around humeral stem and an osteolytic change of the greater tuberosity. Results The average follow-up after surgery was 45.8 (range, 13-114) months. The average postoperative Constant score was 76.2 (range, 53-96) points. The mean values of AHI and humeral offset were 8.4 and 28.3 mm, respectively. A subacromial spur was observed in ten patients, and an osteolytic change of the greater tuberosity in seven patients. There was a significant correlation between Constant score and values of AHI or humeral offset. The Constant score in patients with a subacromial spur or radiolucent zone around humeral stem was markedly lower than that in patients without them. Conclusions The clinical outcome of hemiarthroplasty was influenced by factors reflecting function and conditions of the rotator cuff. Anatomical reconstruction and bone union of the tuberosities need to ensure clinical success in hemiarthroplasty.	[Hashiguchi, Hiroshi; Iwashita, Satoshi; Ohkubo, Atsushi] Nippon Med Sch, Chiba Hokusoh Hosp, Dept Orthopaed Surg, Tokyo 113, Japan; [Takai, Shinro] Nippon Med Coll Hosp, Dept Orthopaed Surg, Tokyo, Japan	Hashiguchi, H (reprint author), Nippon Med Sch, Chiba Hokusoh Hosp, Dept Orthopaed Surg, 1-1-5 Sendagi, Tokyo 113, Japan.	hashi.h@ac.auone-net.jp					Krishnan SG, 2008, ORTHOP CLIN N AM, V39, P441, DOI 10.1016/j.ocl.2008.05.004; Boyle MJ, 2013, J SHOULDER ELB SURG, V22, P32, DOI 10.1016/j.jse.2012.03.006; Bufquin T, 2007, J BONE JOINT SURG BR, V89B, P516, DOI 10.1302/0301-620X.89B4.18435; Li FL, 2013, INT ORTHOP, V37, P2259, DOI 10.1007/s00264-013-2061-8; Farng E, 2011, J SHOULDER ELB SURG, V20, P557, DOI 10.1016/j.jse.2010.11.005; Harrison AK, 2012, J BONE JOINT SURG AM, V94A, P1223, DOI 10.2106/JBJS.J.01371; Spross C, 2012, J TRAUMA ACUTE CARE, V72, P783, DOI 10.1097/TA.0b013e31822c1b5b; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1077; Levy JC, 2011, J ORTHOP TRAUMA, V25, P318, DOI 10.1097/BOT.0b013e3181f22088; Boileau P, 2002, J SHOULDER ELB SURG, V11, P401, DOI 10.1067/mse.2002.124527; Antuna SA, 2008, J SHOULDER ELB SURG, V17, P202, DOI 10.1016/j.jse.2007.06.025; Connor P M, 1997, Instr Course Lect, V46, P25; Gerber C, 2004, J BONE JOINT SURG BR, V86B, P848, DOI 10.1302/0301-620X.86B6.14577; Goldman R T, 1995, J Shoulder Elbow Surg, V4, P81, DOI 10.1016/S1058-2746(05)80059-X; Gradl G, 2015, INT ORTHOP, V39, P329, DOI 10.1007/s00264-014-2630-5; Hettrich CM, 2012, J ORTHOP TRAUMA, V26, P212, DOI 10.1097/BOT.0b013e318243909c; Klein M, 2008, J ORTHOP TRAUMA, V25, P318; Kontakis G, 2008, J BONE JOINT SURG BR, V90B, P1407, DOI 10.1302/0301-620X.90B11.21070; Liu J, 2011, J ORTHOP SCI, V16, P565, DOI 10.1007/s00776-011-0113-8; Nighell MA, 2003, J SHOULDER ELB SURG, V12, P569; Olsson C, 2006, CLIN ORTHOP RELAT R, P93, DOI 10.1097/01.blo.0000194673.56764.0e; Popescu D, 2009, ARCH ORTHOP TRAUM SU, V129, P1239, DOI 10.1007/s00402-008-0789-1; RIETVELD ABM, 1988, J BONE JOINT SURG BR, V70, P561	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	JUN	2015	39	6					1115	1119		10.1007/s00264-015-2758-y		5	Orthopedics	Orthopedics	CJ8MK	WOS:000355755600012		
J	Kanayama, M; Oha, F; Iwata, A; Hashimoto, T				Kanayama, Masahiro; Oha, Fumihiro; Iwata, Akira; Hashimoto, Tomoyuki			Does balloon kyphoplasty improve the global spinal alignment in osteoporotic vertebral fracture?	INTERNATIONAL ORTHOPAEDICS			English	Article						Balloon kyphoplasty; Osteoporosis; Vertebral compression fracture; Global spinal alignment	COMPRESSION FRACTURES; VERTEBROPLASTY; OSTEOTOMY; COLLAPSE; KYPHOSIS; SURGERY	Purpose Balloon kyphoplasty (BKP) has been a well-accepted procedure in the treatment of osteoporotic vertebral compression fracture (OVCF), whereas it remains unclear whether or not this procedure has an impact on the global spinal alignment. The purpose of this study is to evaluate the effect of BKP on the global spinal alignment in OVCF. Methods Fifty-six consecutive patients who had undergone BKP for symptomatic OVCF were retrospectively reviewed with a mean follow-up of 32 months. They were seven males and 49 females with a mean age of 75 years. Radiographic assessment was performed using upright whole spine radiographs. The parameters included vertebral kyphosis, mid-vertebral body height and global sagittal spinal alignment (C7 plumb line deviation). Clinical outcomes were evaluated using visual analog scale of back pain. Results Fifty-one of 56 patients (91.1 %) achieved immediate pain relief. Vertebral kyphosis significantly decreased from 18 to 14 degrees, but 43 patients (76.8 %) still had more than 10 degrees of local kyphosis. Subsequent vertebral compression fractures were observed in seven patients (12.5 %). Anterior deviation of a C7 plumb line (C7PL) was 3.1 cm pre-operatively, 3.1 cm postoperatively, and significantly increased to 5.9 cm at the final follow-up. Consistent results were obtained in those with pre-operative sagittal imbalance (> 5 cm anterior deviation of C7PL) and with pre-existing OVCFs. Conclusions BKP contributed to immediate pain relief, but did not improve the global sagittal spinal alignment after OVCF. This procedure should be solely indicated for painful OVCF or non-union, and could not be expected to restore the global sagittal alignment.	[Kanayama, Masahiro; Oha, Fumihiro; Iwata, Akira; Hashimoto, Tomoyuki] Hakodate Cent Gen Hosp, Spine Ctr, Hakodate, Hokkaido 0408585, Japan; [Kanayama, Masahiro; Hashimoto, Tomoyuki] Hokkaido Univ, Grad Sch Med, Clin Collaborat Dept, Sapporo, Hokkaido, Japan	Kanayama, M (reprint author), Hakodate Cent Gen Hosp, Spine Ctr, Hon Cho 33-2, Hakodate, Hokkaido 0408585, Japan.	mkanayama@aol.com					Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8; Voggenreiter G, 2005, SPINE, V30, P2806, DOI 10.1097/01.brs.0000190885.85675.a0; Chen LA, 2011, SPINE, V36, P534, DOI 10.1097/BRS.0b013e3181f99d70; Pradhan BB, 2006, SPINE, V31, P435, DOI 10.1097/01.brs.0000200036.08679.1e; Lindsay R, 2001, JAMA-J AM MED ASSOC, V285, P320, DOI 10.1001/jama.285.3.320; Suk SI, 2003, SPINE, V28, P2170, DOI 10.1097/01.BRS.0000090889.45158.5A; Li XG, 2012, J SPINAL DISORD TECH, V25, P142, DOI 10.1097/BSD.0b013e318213c113; ROSS PD, 1991, ANN INTERN MED, V114, P919; Garfin SR, 2001, SPINE, V26, P1511, DOI 10.1097/00007632-200107150-00002; Lieberman IH, 2001, SPINE, V26, P1631, DOI 10.1097/00007632-200107150-00026; Wang G, 2010, J BONE JOINT SURG BR, V92B, P1553, DOI 10.1302/0301-620X.92B11.24671; Jensen ME, 1997, AM J NEURORADIOL, V18, P1897; Chung HJ, 2008, INT ORTHOP, V32, P817, DOI 10.1007/s00264-007-0439-1; Berlemann U, 2004, EUR SPINE J, V13, P496, DOI 10.1007/s00586-004-0691-7; Biino G, 2011, AM J EPIDEMIOL, V174, P432, DOI 10.1093/aje/kwr106; Bornemann R, 2013, J SPINAL DISORD TECH; Cagli S, 2010, TURK NEUROSURG, V20, P464, DOI 10.5137/1019-5149.JTN.2954-10.0; Crandall Dennis, 2004, Spine J, V4, P418, DOI 10.1016/j.spinee.2004.01.003; Dong RB, 2009, INT ORTHOP, V33, P1689, DOI 10.1007/s00264-008-0680-2; Erkan S, 2009, ACTA ORTHOP BELG, V75, P396; Han SL, 2011, INT ORTHOP, V35, P1349, DOI 10.1007/s00264-011-1283-x; Jalava T, 2003, J BONE MINER RES, V18, P1254, DOI 10.1359/jbmr.2003.18.7.1254; Kanayama M, 2010, J SPINAL DISORD TECH, V23, P53, DOI 10.1097/BSD.0b013e318193e3a5; Kanayama M, 2013, J NEUROSURG-SPINE, V19, P507, DOI 10.3171/2013.7.SPINE121162; KANEDA K, 1992, SPINE, V17, pS295, DOI 10.1097/00007632-199208001-00015; Klezl Z, 2012, ACTA CHIR ORTHOP TR, V78, P551; Korovessis P, 2008, J SPINAL DISORD TECH, V21, P293, DOI 10.1097/BSD.0b013e31812e6295; Mengmeng Zhang, 2012, Arch Osteoporos, V7, P31, DOI 10.1007/s11657-011-0066-8; Munting Everard, 2010, Eur Spine J, V19 Suppl 1, pS69, DOI 10.1007/s00586-009-1117-3; Patil S, 2012, EUR SPINE J, V22, P883; Phillips FM, 2003, SPINE, V28, P2260, DOI 10.1097/01.BRS.0000085092.84097.7B; Saracen A, 2014, INT ORTHOP, V38, P2309, DOI 10.1007/s00264-014-2470-3; Shen GW, 2010, J BONE JOINT SURG BR, V92B, P1282, DOI 10.1302/0301-620X.92B9.23739; Yokoyama K, 2013, AM J NEURORADIOL, V34, P1474, DOI 10.3174/ajnr.A3424	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	JUN	2015	39	6					1137	1143		10.1007/s00264-015-2737-3		7	Orthopedics	Orthopedics	CJ8MK	WOS:000355755600015		
J	Sawada, K; Yoshida, R; Yasuda, K; Yamaguchi, S; Yusa, Y				Sawada, Kota; Yoshida, Ryuta; Yasuda, Keiko; Yamaguchi, Sachi; Yusa, Yoichi			Dwarf males in the epizoic barnacle Octolasmis unguisiformis and their implications for sexual system evolution	INVERTEBRATE BIOLOGY			English	Article						androdioecy; hermaphroditism; Crustacea; Cirripedia; Thoracica	SCALPELLUM-SCALPELLUM; CIRRIPEDIA THORACICA; LIFE-HISTORY; DEEP-SEA; HERMAPHRODITES; CRUSTACEA; MACROPHTHALMUS; LEPADOMORPHA; ANDRODIOECY; ALLOCATION	Descriptions of the diversity of sexual systems in animal taxa such as the thoracican barnacles are needed to study the evolution of sexual systems. Androdioecious systems (coexistence of hermaphrodites and males) are particularly important due to their possible role as evolutionary intermediates in transitions between hermaphroditism and dioecy. In this study, we used histology to examine the sexual system of the crab-epizoic barnacle Octolasmis unguisiformis to determine if dwarf males were present or not; a previous study reported the existence of conspecific-attached individuals, but did not investigate their sexuality. All conspecific-attached individuals were dwarf males, irrespective of their attachment site. However, crab-attached individuals never acted as dwarf males even if they were small and lived together with large individuals. The result emphasizes the importance of attachment to conspecifics, but not to specific sites on conspecifics, in the evolution of dwarf males. Other individuals were hermaphroditic, indicating androdioecy in this species. However, their functional sexuality (that is, whether they actually do act as males) requires further study. The presence of dwarf males in this species supports theoretical predictions that small group size, short-lived habitats, or spatial limitation favor the evolution of dwarf males.	[Sawada, Kota] SOKENDAI Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa 2400193, Japan; [Yoshida, Ryuta] Univ Ryukyus, Dept Chem Biol & Marine Sci, Fac Sci, Nishihara, Okinawa 9030213, Japan; [Yasuda, Keiko; Yusa, Yoichi] Nara Womens Univ, Fac Sci, Nara 6308506, Japan; [Yamaguchi, Sachi] Kanagawa Univ, Dept Informat Syst Creat, Fac Engn, Yokohama, Kanagawa 2218686, Japan	Sawada, K (reprint author), SOKENDAI Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa 2400193, Japan.	sawada@anet.soken.ac.jp			Research Institute of Marine Invertebrates	We thank Makoto Kato, Euichi Hirose, and Rie Nakano for their assistance during sample collection, Masato Aoyama for histological support, and Nobuyuki Kutsukake and two anonymous reviewers for their helpful comments on the manuscript. This work was funded by the Research Institute of Marine Invertebrates.	ALBERT A, 1984, BIOMETRIKA, V71, P1; Weeks SC, 2012, EVOLUTION, V66, P3670, DOI 10.1111/j.1558-5646.2012.01714.x; Weeks SC, 2006, INTEGR COMP BIOL, V46, P449, DOI 10.1093/icb/icj048; Vollrath F, 1998, TRENDS ECOL EVOL, V13, P159, DOI 10.1016/S0169-5347(97)01283-4; GHISELIN MT, 1969, Q REV BIOL, V44, P189, DOI 10.1086/406066; Barnes RSK, 2010, RAFFLES B ZOOL, V58, P31; Buhl-Mortensen L, 2013, ORG DIVERS EVOL, V13, P545, DOI 10.1007/s13127-013-0137-3; Buhl-Mortensen L, 2006, MAR BIOL, V149, P829, DOI 10.1007/s00227-006-0263-y; Callan HG, 1941, NATURE, V148, P258, DOI 10.1038/148258a0; Charnov E., 1987, BARNACLE BIOL CRUSTA, V5, P89; CHARNOV E L, 1982; CRISP DJ, 1983, MAR BIOL LETT, V4, P281; CRISP DJ, 1983, BIOL J LINN SOC, V20, P73, DOI 10.1111/j.1095-8312.1983.tb01590.x; Darwin C, 1852, MONOGRAPH SUBCLASS C; Erisman BE, 2013, INTEGR COMP BIOL, V53, P736, DOI 10.1093/icb/ict077; GOMEZ E D, 1975, Crustaceana (Leiden), V28, P105; Hoeg J.T., 1995, NEW FRONTIERS BARNAC, P195; Kato M, 2012, THREATENED ANIMALS J, P174; Kelly MW, 2010, J EXP MAR BIOL ECOL, V392, P37, DOI 10.1016/j.jembe.2010.04.009; Kobayashi C, 2003, J MAR BIOL ASSOC UK, V83, P925, DOI 10.1017/S0025315403008075h; Leonard Janet L., 2010, P15; Leonard JL, 2013, INTEGR COMP BIOL, V53, P671, DOI 10.1093/icb/ict088; Mathers TC, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-30; NEWMAN W A, 1980, Tethys, V9, P379; Spremberg U, 2012, J EXP MAR BIOL ECOL, V422, P39, DOI 10.1016/j.jembe.2012.04.004; SVANE I, 1986, MAR BIOL, V90, P249, DOI 10.1007/BF00569135; WILLIAMS R, 1988, J CRUSTACEAN BIOL, V8, P177, DOI 10.2307/1548310; Yamaguchi S, 2014, MAR BIOL RES, V10, P635; Yamaguchi S, 2013, THEOR POPUL BIOL, V85, P49, DOI 10.1016/j.tpb.2013.02.001; Yamaguchi S, 2013, J THEOR BIOL, V334, P101, DOI 10.1016/j.jtbi.2013.05.027; Yamaguchi S, 2008, J THEOR BIOL, V253, P61, DOI 10.1016/j.jtbi.2008.01.025; Yamaguchi S, 2013, J THEOR BIOL, V320, P1, DOI 10.1016/j.jtbi.2012.12.001; Yamaguchi S, 2012, INTEGR COMP BIOL, V52, P356, DOI 10.1093/icb/ics046; Yusa Y, 2015, CRUSTACEANA, V88, P273, DOI 10.1163/15685403-00003414; Yusa Y, 2013, INTEGR COMP BIOL, V53, P701, DOI 10.1093/icb/ict016; Yusa Y, 2012, P ROY SOC B-BIOL SCI, V279, P959, DOI 10.1098/rspb.2011.1554; Yusa Y, 2010, BIOL BULL-US, V218, P259	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1077-8306	1744-7410		INVERTEBR BIOL	Invertebr. Biol.	JUN	2015	134	2					162	167		10.1111/ivb.12083		6	Marine & Freshwater Biology; Zoology	Marine & Freshwater Biology; Zoology	CJ7TR	WOS:000355703100006		
J	Nagayama, T; Araki, M				Nagayama, Toshiki; Araki, Makoto			Habituation of LG-mediated tailflip in the crayfish	INVERTEBRATE NEUROSCIENCE			English	Article						Chemical synapse; Modulation; Biogenic amines; Second messengers	TERMINAL ABDOMINAL-GANGLION; DOMINANCE HIERARCHY FORMATION; GIANT ESCAPE REACTION; NONSPIKING LOCAL INTERNEURONS; INDUCED SYNAPTIC ENHANCEMENT; SEROTONIN RECEPTOR; MECHANOSENSORY AFFERENTS; PROPRIOCEPTIVE AFFERENTS; CHOLINERGIC TRANSMISSION; ASCENDING INTERNEURONS	Crayfish escape from threatening stimuli by tailflipping. If a stimulus is applied to the rear, crayfish escape up and forwards in a summersault maneuver that is mediated by the activation of lateral giant (LG) interneurons. The occurrence probability of LG-mediated tailflip, however, diminishes and habituates if a stimulus is repeatedly applied. Since crayfish have a relatively simple CNS with many identifiable neurons, crayfish represent a good animal to analyze the cellular basis of habituation. A reduction in the amplitude of the EPSP in the LGs, caused by direct chemical synaptic connection from sensory afferents by repetitive stimulations, is essential to bring about an inactivation of the LGs. The spike response of the LGs recovers within several minutes of habituation, but the LGs subsequently fail to spike when an additional stimulus is applied after specific periods following habituation. These results indicate that a decline in synaptic efficacy from the mechanosensory afferents recovers readily after a short delay, but then the excitability of the LGs themselves decreases. Furthermore, the processes underlying habituation are modulated depending on a social status. When two crayfish encounter each other, a winner-loser relationship is established. With a short interstimulus interval of 5 s, the rate of habituation of the LG in both socially dominant and subordinate crayfish becomes lower than in socially isolated animals. Serotonin and octopamine affect this social status-dependent modulation of habituation by means of activation of downstream second messenger system of cAMP and IP3 cascades, respectively.	[Nagayama, Toshiki] Yamagata Univ, Fac Sci, Dept Biol, Yamagata 9908560, Japan; [Araki, Makoto] Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Sapporo, Hokkaido 0600810, Japan	Nagayama, T (reprint author), Yamagata Univ, Fac Sci, Dept Biol, Yamagata 9908560, Japan.	nagayama@sci.kj.yamagata-u.ac.jp	Araki, Makoto/G-5455-2015	Araki, Makoto/0000-0002-6941-2842	Ministry of Education, Science, Sport, Culture and Technology	This work was supported by grants from the Ministry of Education, Science, Sport, Culture and Technology to T.N. We are grateful to Dr. H. Aonuma for his assistance of this work.	KRASNE FB, 1973, SCIENCE, V182, P590, DOI 10.1126/science.182.4112.590; Kandel ER, 2009, J NEUROSCI, V29, P12748, DOI 10.1523/JNEUROSCI.3958-09.2009; WINE JJ, 1975, J EXP BIOL, V62, P771; EATON RC, 1981, J COMP PHYSIOL, V144, P521; BRAUN G, 1992, J NEUROPHYSIOL, V67, P588; Araki M, 2012, J COMP PHYSIOL A, V198, P607, DOI 10.1007/s00359-012-0733-2; Fujimoto S, 2011, J EXP BIOL, V214, P2718, DOI 10.1242/jeb.057752; VU ET, 1992, SCIENCE, V255, P1710, DOI 10.1126/science.1553559; Araki M, 2013, J EXP BIOL, V216, P681, DOI 10.1242/jeb.075689; WINE JJ, 1972, J EXP BIOL, V56, P1; KRASNE FB, 1995, P NATL ACAD SCI USA, V92, P3362, DOI 10.1073/pnas.92.8.3362; Huber R, 1997, P NATL ACAD SCI USA, V94, P5939, DOI 10.1073/pnas.94.11.5939; Hammer M, 1998, LEARN MEMORY, V5, P146; Shirinyan D, 2006, J NEUROPHYSIOL, V95, P2721, DOI 10.1152/jn.00914.2005; Yeh SR, 1997, J NEUROSCI, V17, P697; NAGAYAMA T, 1986, EXP BIOL, V46, P75; Araki M, 2005, J NEUROPHYSIOL, V94, P2644, DOI 10.1152/jn.00502.2005; NAGAYAMA T, 1994, HISTOL HISTOPATHOL, V9, P791; WINE JJ, 1984, J EXP BIOL, V112, P283; Van Harreveld A, 1936, P SOC EXP BIOL MED, V34, P428; Huber R, 1998, J COMP PHYSIOL A, V182, P573, DOI 10.1007/s003590050204; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; KENNEDY D, 1965, J EXP BIOL, V43, P211; HOYER D, 1994, PHARMACOL REV, V46, P157; Ueno R, 2012, J EXP BIOL, V215, P2841, DOI 10.1242/jeb.072520; Spitzer N, 2005, J COMP NEUROL, V484, P261, DOI 10.1002/cne.20456; Sato D, 2012, J EXP BIOL, V215, P1210, DOI 10.1242/jeb.066191; Aonuma H, 1999, J COMP NEUROL, V410, P677; Roeder T, 1999, PROG NEUROBIOL, V59, P533, DOI 10.1016/S0301-0082(99)00016-7; Edwards DH, 1999, TRENDS NEUROSCI, V22, P153, DOI 10.1016/S0166-2236(98)01340-X; Antonsen BL, 2007, J NEUROPHYSIOL, V98, P3494, DOI 10.1152/jn.00331.2007; Araki M, 2005, J COMP PHYSIOL A, V191, P481, DOI 10.1007/s00359-005-0607-y; Araki M, 2003, J COMP PHYSIOL A, V189, P731, DOI 10.1007/s00359-003-0456-5; BRYAN JS, 1977, J PHYSIOL-LONDON, V271, P351; EDWARDS DH, 1994, J NEUROPHYSIOL, V72, P890; Edwards DH, 2009, J EXP BIOL, V212, P749, DOI 10.1242/jeb.021972; Edwards DH, 2002, BRAIN BEHAV EVOLUT, V60, P360, DOI 10.1159/000067789; FRICKE RA, 1984, BRAIN RES, V322, P139, DOI 10.1016/0006-8993(84)91193-4; Gerhardt CC, 1997, MOL PHARMACOL, V51, P293; GLANZMAN DL, 1983, J NEUROSCI, V3, P2263; Herberholz J, 2001, J NEUROSCI, V21, P2759; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KRASNE FB, 1969, ANIM BEHAV, V17, P416, DOI 10.1016/0003-3472(69)90141-9; KRASNE FB, 1975, J EXP BIOL, V63, P433; KRASNE FB, 1969, J EXP BIOL, V50, P29; Krasne FB, 1997, J NEUROSCI, V17, P709; Lee SHC, 2008, J NEUROPHYSIOL, V100, P1113, DOI 10.1152/jn.90267.2008; MARCHAND AR, 1992, EUR J NEUROSCI, V4, P521, DOI 10.1111/j.1460-9568.1992.tb00902.x; MILLER MW, 1992, J NEUROPHYSIOL, V68, P2174; Miyata H, 1997, J NEUROPHYSIOL, V77, P1213; Momohara Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074489; Nagayama T, 2005, J EXP ZOOL PART A, V303A, P66, DOI 10.1002/jez.a.135; NAGAYAMA T, 1993, J COMP NEUROL, V337, P584, DOI 10.1002/cne.903370405; Nagayama T, 2004, J COMP NEUROL, V474, P123, DOI 10.1002/cne.20124; Nagayama T, 2011, J COMP PHYSIOL A, V197, P1073, DOI 10.1007/s00359-011-0668-z; Nagayama T, 2008, INSECT MIMETICS, P533; Nagayama T, 1997, J NEUROPHYSIOL, V77, P2826; NAGAYAMA T, 1993, J COMP NEUROL, V332, P155, DOI 10.1002/cne.903320203; Nagayama T, 1997, J COMP NEUROL, V389, P139, DOI 10.1002/(SICI)1096-9861(19971208)389:1<139::AID-CNE10>3.0.CO;2-G; Newland PL, 1997, J COMP PHYSIOL A, V181, P103, DOI 10.1007/s003590050097; Roberts AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029132; Sosa MA, 2004, J COMP NEUROL, V473, P526, DOI 10.1002/cne.20092; Spitzer N, 2008, J EXP BIOL, V211, P92, DOI 10.1242/jeb.012450; Ushizawa T, 1996, J COMP PHYSIOL A, V179, P1; VU ET, 1993, J NEUROSCI, V13, P4379; VU ET, 1993, J NEUROSCI, V13, P4394; WIERSMA CAG, 1947, J NEUROPHYSIOL, V10, P23; ZUCKER RS, 1972, J NEUROPHYSIOL, V35, P599; ZUCKER RS, 1971, SCIENCE, V173, P645, DOI 10.1126/science.173.3997.645; ZUCKER RS, 1972, J NEUROPHYSIOL, V35, P621	70	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1354-2516	1439-1104		INVERTEBR NEUROSCI	Invertebr. Neurosci.	JUN	2015	15	2							2	10.1007/s10158-015-0178-8		12	Neurosciences	Neurosciences & Neurology	CJ5TY	WOS:000355554500001		
J	Bagheri, M; Dong, YP; Ono, M				Bagheri, Mozhdeh; Dong, Yupeng; Ono, Masao			Molecular Diversity of Macrophages in Allergic Reaction: Comparison between the Allergenic Modes; Th1-and-Th2-Derived Immune Conditions	IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY			English	Article						Cell Markers; Complete Freund Adjuvant; Cytokines; Hypersensitivity; Inflammatory; Macrophages; Ovalbumin-alum; Th1 cells; Th2 cells	ALTERNATIVE ACTIVATION; MOUSE; INFLAMMATION; POLARIZATION; RESPONSES; MICE; EMR4	Activated macrophages have been classified into classical (M1) and alternative (M2) macrophages. We aimed to establish a method to yield enough number of macrophages to analyze their molecular, biological and immunological functions. We used drugs; adjuvant albumin from chicken egg whites-Imject Alum (OVA-Alum) and OVA Complete Freund Adjuvant (OVA-CFA), to induce macrophages to M2 and M1 respectively. We analyzed the phenotype of purified macrophages induced under these immune conditions, using flow cytometry (FACS) to detect cell-surface molecules and the enzyme-linked immunosorbent assay (ELISA) was used to detect cytokines. The cDNA microarray was employed to measure changes in expression level of cell surface protein between M1 and M2 macrophages. Phenotype analysis of purified macrophages, induced under these immune conditions, showed macrophages induced by OVA-Alum was almost M2 while the proportion of M1 macrophages induced by OVA-CFA was significantly higher. The results also showed higher expression level of macrophage galactose N-acetyl-galactosamine specific lectin-2 protein (MGL1/2-PE), a known M2 macrophage marker, on the surface of Alum-induced macrophages. On the basis of these preliminary data, ELISA results revealed that after macrophage stimulation with lipopolysaccharides (LPS), the level of interleukin (IL)-10 produced by Alum-induced macrophages was higher than the level of IL-10 produced by CFA-induced macrophages. In contrast, the level of tumor necrosis factor-alpha (TNF-alpha) produced by CFA-induced macrophages was higher than Alum-induced macrophages. The cDNA microarray confirmed previous results and suggest immunoglobulin-like type 2 receptor alpha (Pilra) as a new marker for M1, macrophage galactose N-acetylgalactosamine-specific lectin 2 (Mgl2) as M2 macrophages marker.	[Bagheri, Mozhdeh; Dong, Yupeng; Ono, Masao] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 980, Japan; [Bagheri, Mozhdeh] Tohoku Univ, Grad Sch Med, Dept Stem Cell Biol & Histol, Sendai, Miyagi 980, Japan; [Dong, Yupeng] Tohoku Univ, Grad Sch Med, Dept Disabil Sci, Adv Interdisciplinary Biomed Funct, Sendai, Miyagi 980, Japan	Dong, YP (reprint author), Tohoku Univ, Grad Sch Med, Immunol & Histopathol Dept, Moved Disabil Sci Adv Interdisciplinary Biomed Fu, Sendai, Miyagi 9808575, Japan.	dongypeng7@gmail.com			Tohoku University Graduate School of Medicine, Sendai, Japan	This study was fully supported by Tohoku University Graduate School of Medicine, Sendai, Japan. We would like to thank Dr. Nosei Inuie and Mr. Zhongbo Li for their assistance.	Raes G, 2005, J LEUKOCYTE BIOL, V77, P321, DOI 10.1189/jlb.0304212; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Bobbie MW, 2010, INVEST OPHTH VIS SCI, V51, P3758, DOI 10.1167/iovs.09-4489; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Takai T, 2005, IMMUNOLOGY, V115, P433, DOI 10.1111/j.1365-2567.2005.02177.x; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Fujisaka S, 2011, ENDOCRINOLOGY, V152, P1789, DOI 10.1210/en.2010-1312; Wan YSY, 2010, IMMUNOLOGY, V130, P166, DOI 10.1111/j.1365-2567.2010.03289.x; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Oh JY, 2012, EMBO MOL MED, V4, P435, DOI 10.1002/emmm.201200221; BOREK F, 1963, P SOC EXP BIOL MED, V114, P266; Ebihara S, 2007, INFLAMM RES, V56, P112, DOI 10.1007/s00011-006-6063-5; Ford AQ, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-6; Hamann J, 2003, EUR J IMMUNOL, V33, P1365, DOI 10.1002/eji.200323881; Jaeger K, 2008, HISTOCHEM CELL BIOL, V129, P321, DOI 10.1007/s00418-007-0367-6; Kidd Parris, 2003, Altern Med Rev, V8, P223; Kitching AR, 2000, HISTOL HISTOPATHOL, V15, P993; Nagai K, 2003, J BIOL CHEM, V278, P18229, DOI 10.1074/jbc.M213266200; Stacey M, 2002, J BIOL CHEM, V277, P29283, DOI 10.1074/jbc.M204306200; Taubes Gary, 2012, Science, V335, P29, DOI 10.1126/science.335.6064.29	24	0	0	IRANIAN SCIENTIFIC SOCIETY MEDICAL ENTOMOLOGY	TEHRAN	SCHOOL PUBLIC HEALTH & INST HEALTH RESEARCH, TEHRAN UNIV MEDICAL SCIENCES, P O BOX  6446-14155, TEHRAN, 00000, IRAN	1735-1502	1735-5249		IRAN J ALLERGY ASTHM	Iran. J. Allergy Asthma Immunol.	JUN	2015	14	3					261	272				12	Allergy; Immunology	Allergy; Immunology	CJ9SL	WOS:000355842600004		
J	Shirzadfar, H; Nadi, M; Kourtiche, D; Yamada, S; Hauet, T				Shirzadfar, H.; Nadi, M.; Kourtiche, D.; Yamada, S.; Hauet, T.			Needle-type GMR sensor to estimate the magnetic properties of diluted ferrofluid for biomedicine application	IRBM			English	Article							IRON-OXIDE NANOPARTICLES	This paper proposes a needle-type giant magnetoresistance (GMR) sensor for very low magnetic fluid weight density of ferrofluid estimation. The magnetic fluids or ferrofluids due to their biocompatibility are used for various applications in medicine such as cancer treatment, magnetic resonance imagining (MRI), cell separation and also to detect the bacteria. The high sensitivity of GMR sensor gives us to accurately measure the magnetic properties of ferrofluid in a weak magnetic field. The results were obtained by GMR sensor are compared by theoretical results and show that the GMR sensor has a good ability for biofluid magnetic characterization. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Shirzadfar, H.; Nadi, M.; Kourtiche, D.; Hauet, T.] Univ Lorraine, CNRS, UMR 7198, Inst Jean Lamour, Vandoeuvre Les Nancy, France; [Yamada, S.] Kanazawa Univ, Inst Nat & Environm Technol, Kanazawa, Ishikawa 9201192, Japan	Shirzadfar, H (reprint author), Univ Lorraine, CNRS, UMR 7198, Inst Jean Lamour, Vandoeuvre Les Nancy, France.	h.shirzadfar@gmail.com			Institut Jean Lamour in University of Lorraine; Institute of Nature and Environmental Technology of Kanazawa University	This research by supported by Institut Jean Lamour in University of Lorraine in corroboration with Institute of Nature and Environmental Technology of Kanazawa University.	Ahmadi R, 2012, COLLOID SURF A, V424, P113; Silva AC, 2011, INT J NANOMED, V6, P591, DOI 10.2147/IJN.S14737; Li GX, 2006, SENSOR ACTUAT A-PHYS, V126, P98, DOI 10.1016/j.sna.2005.10.001; Mahdavi M, 2013, MOLECULES, V18, P7533, DOI 10.3390/molecules18077533; OSBORN JA, 1945, PHYS REV, V67, P351, DOI 10.1103/PhysRev.67.351; Kobayashi T, 2011, BIOTECHNOL J, V6, P1342, DOI 10.1002/biot.201100045; Mukhopadhyay SC, 2007, IEEE SENS J, V7, P401, DOI 10.1109/JSEN.2007.891929; Alexiou C, 2000, CANCER RES, V60, P6641; Chomsuwan K, 2005, IEEE T MAGN, V41, P3619, DOI 10.1109/TMAG.2005.855173; Feng J, 2011, J PHYS C SER; Gooneratne CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081227; Kyrtatos P, 2010, CELL TARGETING IMAGI; Lekawa A, 2008, J JAPAN SOC APPL ELE, V16, P221; Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201; Shirzadfar H., 2014, DESIGN EVALUATION GM; Shirzadfar H, 2014, 13 MED C MED BIOL EN, P833; Singh VR, 2008, IRBM, V29, P326, DOI 10.1016/j.rbmret.2008.03.007	17	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1959-0318	1876-0988		IRBM	IRBM	JUN	2015	36	3					178	184		10.1016/j.irbm.2015.01.014		7	Engineering, Biomedical	Engineering	CJ8UZ	WOS:000355780300005		
J	Kobayashi, T; Oshima, Y				Kobayashi, Toshiyuki; Oshima, Yoshiki			Classification of symmetric pairs with discretely decomposable restrictions of (g, K)-modules	JOURNAL FUR DIE REINE UND ANGEWANDTE MATHEMATIK			English	Article							REDUCTIVE SUBGROUPS; BRANCHING LAWS; REPRESENTATIONS; RESPECT; SPACES; ORBIT; A(Q)(LAMBDA); MODULES	We give a complete classification of reductive symmetric pairs (g, h) with the following property: there exists at least one infinite-dimensional irreducible (g, K)-module X that is discretely decomposable as an (h, H boolean AND K)-module. We investigate further if such X can be taken to be a minimal representation, a Zuckerman derived functor module A(q)(lambda) or some other unitarizable (g, K)-module. The tensor product pi(1) circle times pi(2) of two infinite-dimensional irreducible (g, K)-modules arises as a very special case of our setting. In this case, we prove that pi(1) circle times pi(2) is discretely decomposable if and only if pi(1) and pi(2) are simultaneously highest weight modules.	[Kobayashi, Toshiyuki] Univ Tokyo, Kavli IPMU WPI, Meguro Ku, Tokyo 1538914, Japan; [Kobayashi, Toshiyuki] Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan; [Oshima, Yoshiki] Univ Tokyo, Kavli IPMU WPI, Kashiwa, Chiba 2778583, Japan	Kobayashi, T (reprint author), Univ Tokyo, Kavli IPMU WPI, Meguro Ku, 3-8-1 Komaba, Tokyo 1538914, Japan.	toshi@ms.u-tokyo.ac.jp; yoshiki.oshima@ipmu.jp			Japan Society for the Promotion of Science (JSPS) [25247006]	The first author was partially supported by Grant-in-Aid for Scientific (A) (25247006), Japan Society for the Promotion of Science (JSPS). The second author was supported by Grant-in-Aid for JSPS Fellows.	JOSEPH A, 1976, ANN SCI ECOLE NORM S, V9, P1; Kobayashi T, 2008, PROG MATH, V255, P45; Kobayashi T, 2011, J FUNCT ANAL, V260, P1682, DOI 10.1016/j.jfa.2010.12.008; KOSTANT B, 1971, AM J MATH, V93, P753, DOI 10.2307/2373470; KOBAYASHI T, 1994, INVENT MATH, V117, P181, DOI 10.1007/BF01232239; Berger M., 1957, ANN SCI ECOLE NORM S, V74, P85; Duflo M, 2010, P JPN ACAD A-MATH, V86, P49, DOI 10.3792/pjaa.86.49; Eisenbud D., 1995, GRAD TEXTS MATH, V150; Gross B., 2000, P S PURE MATH, V68, P255; Helgason S., 2001, GRAD STUD MATH, V34; Huang J.-S., 1999, LECT REPRESENTATION; Kassel F, 2011, CR MATH, V349, P29, DOI 10.1016/j.crma.2010.11.023; Kobayashi T., 2000, ADV STUDY PURE MATH, V26, P98; Kobayashi T., 1993, P JAPAN ACAD A, V69; Kobayashi T, 1998, J FUNCT ANAL, V152, P100, DOI 10.1006/jfan.1997.3128; Kobayashi T, 1998, INVENT MATH, V131, P229, DOI 10.1007/s002220050203; Kobayashi T, 1998, COMMENT MATH HELV, V73, P45, DOI 10.1007/s000140050045; Kobayashi T, 2012, ADV MATH, V231, P2013, DOI 10.1016/j.aim.2012.07.006; Kobayashi T, 1998, ANN MATH, V147, P709; Kobayashi T., 2013, CONT MATH, V598, P141; Kobayashi T, 2003, ADV MATH, V180, P513, DOI 10.1016/S0001-8708(03)00013-6; Okuda T., SMALLEST COMPL UNPUB; SEKIGUCHI J, 1987, J MATH SOC JPN, V39, P127; Speh B, 2011, CONTEMP MATH, V557, P371; Torasso P, 1997, DUKE MATH J, V90, P261, DOI 10.1215/S0012-7094-97-09009-8; Vogan D, 1981, LECT NOTES MATH, V880, P506; Vogan D. A., 1991, PROGR MATH, V101, P315	27	1	1	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0075-4102	1435-5345		J REINE ANGEW MATH	J. Reine Angew. Math.	JUN	2015	703						201	223		10.1515/crelle-2013-0045		23	Mathematics	Mathematics	CJ3XS	WOS:000355418400008		
J	Tanaka, K; Okamoto, NL; Fujio, S; Sakamoto, H; Inui, H				Tanaka, Katsushi; Okamoto, Norihiko L.; Fujio, Satoshi; Sakamoto, Hiroki; Inui, Haruyuki			Appropriate zone-axis orientations for the determination of crystal polarity by convergent-beam electron diffraction	JOURNAL OF APPLIED CRYSTALLOGRAPHY			English	Article						polarity; enantiomorphs; convergent-beam electron diffraction; Bijvoet pairs; nonpolar axes	TRANSITION-METAL DISILICIDES; ENERGY-LOSS SPECTROSCOPY; ENANTIOMORPH IDENTIFICATION; EPITAXIAL LAYERS; C40 STRUCTURE; POINT GROUPS; THIN-FILMS; GAN FILMS; MICROSCOPY; SCATTERING	A convergent-beam electron diffraction (CBED) method is proposed for polarity determination, in which polarity is determined from the intensity asymmetry of any of the hkl-(hkl) over bar Friedel pairs appearing in a zone-axis CBED pattern with a symmetric arrangement of Bijvoet pairs of reflections. The intensity asymmetry occurs as a result of multiple scattering among Bijvoet pairs of reflections in the CBED pattern. The appropriate zone-axis orientations for polarity determination are deduced for 19 of the 25 polar point groups from symmetry considerations so as to observe Bijvoet pairs of reflections symmetrically in a single CBED pattern. These appropriate zone-axis orientations deduced for the 19 polar point groups coincide with nonpolar directions. This is because the nonpolar directions for these point groups are perpendicular to an even-fold rotation axis, which guarantees the symmetric arrangement of Bijvoet pairs of reflections with respect to the symmetry (m-m') line in a CBED pattern taken along any of the appropriate zone-axis orientations. The m-m' line in the CBED pattern is proved to be perpendicular to the trace of the even-fold rotation axis. On the other hand, if the nonpolar direction is either perpendicular to a mirror plane or parallel to a roto-inversion axis as in the four point groups m, 3m1, 31m, (6) over bar, the nonpolar direction cannot be used as the appropriate zone-axis orientation for polarity determination because the Bijvoet pairs of reflections are not arranged symmetrically in the CBED pattern. The validity of the CBED method is confirmed both by experiment and by calculation of CBED patterns.	[Tanaka, Katsushi; Okamoto, Norihiko L.; Fujio, Satoshi; Sakamoto, Hiroki; Inui, Haruyuki] Kobe Univ, Dept Mech, Nada Ku, Kobe, Hyogo 6578501, Japan	Tanaka, K (reprint author), Kobe Univ, Dept Mech, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	k-tanaka@mech.kobe-u.ac.jp			JSPS KAKENHI [24246113, 25709066]; Elements Strategy Initiative for Structural Materials (ESISM) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Advanced Low Carbon Technology Research and Development Program (ALCA) from the Japan Science and Technology Agency (JST)	This work was supported by JSPS KAKENHI grant Nos. 24246113 and 25709066, and the Elements Strategy Initiative for Structural Materials (ESISM) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and in part by the Advanced Low Carbon Technology Research and Development Program (ALCA) from the Japan Science and Technology Agency (JST).	Hong SK, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.115331; Dick KA, 2007, NANO LETT, V7, P1817, DOI 10.1021/nl0705900; Daudin B, 1996, APPL PHYS LETT, V69, P2480, DOI 10.1063/1.117504; TAFTO J, 1982, J APPL CRYSTALLOGR, V15, P60, DOI 10.1107/S0021889882011352; Wang Y, 2004, PHYS LETT A, V320, P322, DOI 10.1016/j.physleta.2003.11.032; COWLEY JM, 1959, ACTA CRYSTALLOGR, V12, P360, DOI 10.1107/S0365110X59001104; Inui H, 2003, ACTA CRYSTALLOGR B, V59, P802, DOI 10.1107/S010876810302411X; Kong X, 2002, APPL PHYS LETT, V81, P1990, DOI 10.1063/1.1504876; Ponce FA, 1996, APPL PHYS LETT, V69, P337, DOI 10.1063/1.118052; Jiang N, 2002, APPL PHYS LETT, V80, P389, DOI 10.1063/1.1433919; BIJVOET JM, 1951, NATURE, V168, P271, DOI 10.1038/168271a0; TAFTO J, 1983, PHYS REV LETT, V51, P654, DOI 10.1103/PhysRevLett.51.654; Ayers J. E., 2007, HETEROEPITAXY SEMICO; Burns G., 1990, SPACE GROUPS SOLIDS, V2nd; Cao JF, 2013, ACTA CRYSTALLOGR B, V69, P556, DOI 10.1107/S2052519213028881; Cherns D, 1998, PHILOS MAG A, V77, P273; Cowley J. M., 1986, DIFFRACTION PHYS; Fasol G., 1997, BLUE LASER DIODE; Fujii A, 2007, INTERMETALLICS, V15, P154, DOI 10.1016/j.intermet.2006.05.001; Fujio S, 2007, INTERMETALLICS, V15, P245, DOI 10.1016/j.intermet.2006.05.010; Fujio S, 2009, J APPL CRYSTALLOGR, V42, P433, DOI 10.1107/S0021889809015702; GLANVILL SR, 1989, J APPL PHYS, V66, P619, DOI 10.1063/1.343527; GOODMAN P, 1968, ACTA CRYSTALL A-CRYS, VA 24, P339, DOI 10.1107/S0567739468000677; Harris G.L., 1995, PROPERTIES SILICON C; Inui H, 2007, MATER SCI FORUM, V539-543, P1457; Inui H, 2007, J APPL CRYSTALLOGR, V40, P241, DOI 10.1107/S0021889806055877; ISHIZUKA K, 1984, ACTA CRYSTALLOGR B, V40, P332, DOI 10.1107/S010876818400224X; Ishizuka K., 1998, P INT S HYBR AN FUNC, P69; Jansen J, 2002, ULTRAMICROSCOPY, V90, P291, DOI 10.1016/S0304-3991(01)00136-X; Klapper H., 2011, INT TABLES CRYSTALLO, VA, P786; Koch CT, 2003, J PHYS A-MATH GEN, V36, P803, DOI 10.1088/0305-4470/36/3/314; Komiyama J, 2007, J CRYST GROWTH, V298, P223, DOI 10.1016/j.jcrysgro.2006.10.022; Mader W, 1998, PHYS STATUS SOLIDI A, V166, P381, DOI 10.1002/(SICI)1521-396X(199803)166:1<381::AID-PSSA381>3.0.CO;2-R; Mata M., 2012, NANO LETT, V12, P2579; Mead C. A., 1974, SYMMETRY CHIRALITY; Mitate T, 2002, PHYS STATUS SOLIDI A, V192, P383, DOI 10.1002/1521-396X(200208)192:2<383::AID-PSSA383>3.0.CO;2-A; MOODIE AF, 1972, Z NATURFORSCH PT A, VA 27, P437; Sakamoto H, 2005, ACTA MATER, V53, P41, DOI 10.1016/j.actamat.2004.08.001; SPENCE JCH, 1983, J MICROSC-OXFORD, V130, P147; Tanaka K, 2009, Journal of Physics: Conference Series, V165, DOI 10.1088/1742-6596/165/1/012017; Vermaut P, 1997, PHILOS MAG A, V76, P1215; Villars P., 1985, PEARSONS HDB CRYSTAL; WRIGHT AC, 1988, PHIL MAG LETT, V57, P107, DOI 10.1080/09500838808229618; Zandbergen HW, 2000, J CRYST GROWTH, V210, P167, DOI 10.1016/S0022-0248(99)00672-7; Zhang XZ, 2008, J ELECTRON MICROSC, V57, P7, DOI 10.1093/jmicro/dfm035	45	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8898	1600-5767		J APPL CRYSTALLOGR	J. Appl. Crystallogr.	JUN	2015	48		3				736	746		10.1107/S1600576715004884		11	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	CJ5WB	WOS:000355562000014		
J	Bressler, I; Pauw, BR; Thunemann, AF				Bressler, I.; Pauw, B. R.; Thuenemann, A. F.			McSAS: software for the retrieval of model parameter distributions from scattering patterns	JOURNAL OF APPLIED CRYSTALLOGRAPHY			English	Article						small-angle scattering; Monte Carlo; data analysis software; disperse samples	SMALL-ANGLE SCATTERING; SYSTEMS; WATER	A user-friendly open-source Monte Carlo regression package (McSAS) is presented, which structures the analysis of small-angle scattering (SAS) using uncorrelated shape-similar particles (or scattering contributions). The underdetermined problem is solvable, provided that sufficient external information is available. Based on this, the user picks a scatterer contribution model (or 'shape') from a comprehensive library and defines variation intervals of its model parameters. A multitude of scattering contribution models are included, including prolate and oblate nanoparticles, core-shell objects, several polymer models, and a model for densely packed spheres. Most importantly, the form-free Monte Carlo nature of McSAS means it is not necessary to provide further restrictions on the mathematical form of the parameter distribution; without prior knowledge, McSAS is able to extract complex multimodal or odd-shaped parameter distributions from SAS data. When provided with data on an absolute scale with reasonable uncertainty estimates, the software outputs model parameter distributions in absolute volume fraction, and provides the modes of the distribution (e.g. mean, variance etc.). In addition to facilitating the evaluation of (series of) SAS curves, McSAS also helps in assessing the significance of the results through the addition of uncertainty estimates to the result. The McSAS software can be integrated as part of an automated reduction and analysis procedure in laboratory instruments or at synchrotron beamlines.	[Bressler, I.; Thuenemann, A. F.] BAM Fed Inst Mat Res & Testing, D-12205 Berlin, Germany; [Pauw, B. R.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan	Bressler, I (reprint author), BAM Fed Inst Mat Res & Testing, D-12205 Berlin, Germany.	ingo.bressler@bam.de; brian@stack.nl	Pauw, Brian/C-8392-2013; Thunemann, Andreas/B-8700-2009	Pauw, Brian/0000-0002-8605-838X; Thunemann, Andreas/0000-0002-9883-6134	MIS program of BAM	We would like to acknowledge Peter Hoghoj and Xenocs for their provision of the dense spheres data set. Furthermore, the editor and referees are thanked for their insightful comments. IB acknowledges financial support by the MIS program of BAM.	Pauw BR, 2013, J APPL CRYSTALLOGR, V46, P365, DOI 10.1107/S0021889813001295; Hura G, 2000, J CHEM PHYS, V113, P9140, DOI 10.1063/1.1319614; Meli F, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/12/125005; DEBYE P, 1947, J PHYS COLLOID CHEM, V51, P18, DOI 10.1021/j150451a002; Hansen S, 2000, J APPL CRYSTALLOGR, V33, P1415, DOI 10.1107/S0021889800012930; Pedersen JS, 1997, ADV COLLOID INTERFAC, V70, P171, DOI 10.1016/S0001-8686(97)00312-6; Jacques DA, 2012, ACTA CRYSTALLOGR D, V68, P620, DOI 10.1107/S0907444912012073; Abecassis B, 2015, NANO LETT, V15, P2620, DOI 10.1021/acs.nanolett.5b00199; Song C, 2008, NATURE, V453, P629, DOI 10.1038/nature06981; Schnepp Z, 2013, J MATER CHEM A, V1, P13576, DOI 10.1039/c3ta12996a; Meir Y, 2013, MATERIALS, V6, P4011, DOI 10.3390/ma6094011; GLATTER O, 1977, J APPL CRYSTALLOGR, V10, P415, DOI 10.1107/S0021889877013879; Pauw BR, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/38/383201; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; KINNING DJ, 1984, MACROMOLECULES, V17, P1712, DOI 10.1021/ma00139a013; Botet R, 2012, J APPL CRYSTALLOGR, V45, P406, DOI 10.1107/S0021889812012812; Bressler I., 2015, SASFIT COMPREH UNPUB; Brown D., 2015, NEUTRON ACTIVATION S; EU, 2011, L275 EU OJ; FEDOROVA IS, 1978, J APPL CRYSTALLOGR, V11, P405, DOI 10.1107/S0021889878013503; HANSEN S, 1991, J APPL CRYSTALLOGR, V24, P541, DOI 10.1107/S0021889890013322; ISO, 2014, 178672014E ISOFDIS; Kestens V., 2014, ERMFD102; KHOLODENKO AL, 1993, MACROMOLECULES, V26, P4179, DOI 10.1021/ma00068a017; Kieffer J, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/20/202012; Klein T, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/9/094002; Lak A, 2015, J MAGN MAGN MATER, V380, P140, DOI 10.1016/j.jmmm.2014.08.050; Pauw B. R., 2013, ARXIV13032903; POROD G, 1952, KOLLOID Z Z POLYM, V125, P108, DOI 10.1007/BF01526289; Rosalie JM, 2014, ACTA MATER, V66, P150, DOI 10.1016/j.actamat.2013.11.029; SVERGUN DI, 1991, J APPL CRYSTALLOGR, V24, P485, DOI 10.1107/S0021889891001280	31	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8898	1600-5767		J APPL CRYSTALLOGR	J. Appl. Crystallogr.	JUN	2015	48		3				962	969		10.1107/S1600576715007347		8	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	CJ5WB	WOS:000355562000043		
J	Koga, S; Barstow, TJ; Okushima, D; Rossiter, HB; Kondo, N; Ohmae, E; Poole, DC				Koga, Shunsaku; Barstow, Thomas J.; Okushima, Dai; Rossiter, Harry B.; Kondo, Narihiko; Ohmae, Etsuko; Poole, David C.			Validation of a high-power, time-resolved, near-infrared spectroscopy system for measurement of superficial and deep muscle deoxygenation during exercise	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						heterogeneity; kinetics; oxygen delivery; oxygen utilization; oxygen consumption	PULMONARY O-2 UPTAKE; DIFFERENT FIBER TYPES; CYCLE EXERCISE; BLOOD-FLOW; DYNAMIC HETEROGENEITY; UPTAKE KINETICS; RAMP EXERCISE; RAT MUSCLES; OXYGENATION; QUADRICEPS	Near-infrared assessment of skeletal muscle is restricted to superficial tissues due to power limitations of spectroscopic systems. We reasoned that understanding of muscle deoxygenation may be improved by simultaneously interrogating deeper tissues. To achieve this, we modified a high-power (similar to 8 mW), time-resolved, near-infrared spectroscopy system to increase depth penetration. Precision was first validated using a homogenous optical phantom over a range of inter-optode spacings (OS). Coefficients of variation from 10 measurements were minimal (0.5-1.9%) for absorption (mu(a)), reduced scattering, simulated total hemoglobin, and simulated O-2 saturation. Second, a dual-layer phantom was constructed to assess depth sensitivity, and the thickness of the superficial layer was varied. With a superficial layer thickness of 1, 2, 3, and 4 cm (mu(a) = 0.149 cm(-1)), the proportional contribution of the deep layer (mu(a) = 0.250 cm(-1)) to total mu(a) was 80.1, 26.9, 3.7, and 0.0%, respectively (at 6-cm OS), validating penetration to similar to 3 cm. Implementation of an additional superficial phantom to simulate adipose tissue further reduced depth sensitivity. Finally, superficial and deep muscle spectroscopy was performed in six participants during heavy-intensity cycle exercise. Compared with the superficial rectus femoris, peak deoxygenation of the deep rectus femoris (including the superficial intermedius in some) was not significantly different (deoxyhemoglobin and deoxymyoglobin concentration: 81.3 +/- 20.8 vs. 78.3 +/- 13.6 +/- M, P > 0.05), but deoxygenation kinetics were significantly slower (mean response time: 37 +/- 10 vs. 65 +/- 9 s, P <= 0.05). These data validate a high-power, time-resolved, near-infrared spectroscopy system with large OS for measuring the deoxygenation of deep tissues and reveal temporal and spatial disparities in muscle deoxygenation responses to exercise.	[Koga, Shunsaku; Okushima, Dai] Kobe Design Univ, Appl Physiol Lab, Kobe, Hyogo 6512196, Japan; [Barstow, Thomas J.; Poole, David C.] Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA; [Barstow, Thomas J.; Poole, David C.] Kansas State Univ, Dept Kinesiol, Manhattan, KS 66506 USA; [Rossiter, Harry B.] Harbor UCLA Med Ctr, Rehabil Clin Trials Ctr, Div Resp & Crit Care Physiol & Med, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Kondo, Narihiko] Kobe Univ, Kobe, Hyogo 657, Japan; [Ohmae, Etsuko] Hamamatsu Photon KK, Hamamatsu, Shizuoka, Japan	Koga, S (reprint author), Kobe Design Univ, Appl Physiol Lab, Nishi Ku, 8-1-1 Gakuennishi Machi, Kobe, Hyogo 6512196, Japan.	s-koga@kobe-du.ac.jp			Japan Society for the Promotion of Science [KAKENHI-24247046, 26560362]; UK-Japan Partnering Award from Biotechnology and Biological Sciences Research Council [BB/I024798/1]	S. Koga was supported by grants from Japan Society for the Promotion of Science (KAKENHI-24247046, 26560362). H. B. Rossiter and S. Koga were supported by a UK-Japan Partnering Award from Biotechnology and Biological Sciences Research Council, UK (BB/I024798/1).	Hamaoka T, 2000, J BIOMED OPT, V5, P102, DOI 10.1117/1.429975; Koga S, 2011, AM J PHYSIOL-REG I, V301, pR534, DOI 10.1152/ajpregu.00101.2011; Murias JM, 2012, AM J PHYSIOL-REG I, V303, pR815, DOI 10.1152/ajpregu.00306.2012; DeLorey DS, 2003, J APPL PHYSIOL, V95, P113, DOI 10.1152/japplphysiol.00956.2002; McAllister RM, 2003, J APPL PHYSIOL, V94, P1777, DOI 10.1152/japplphysiol.00901.2002; Heinonen I, 2010, J APPL PHYSIOL, V108, P378, DOI 10.1152/japplphysiol.00745.2009; Behnke BJ, 2011, AM J PHYSIOL-REG I, V301, pR783, DOI 10.1152/ajpregu.00205.2011; Grassi B, 2003, J APPL PHYSIOL, V95, P149, DOI 10.1152/japplphysiol.00695.2002; McDonough P, 2005, J PHYSIOL-LONDON, V563, P903, DOI 10.1113/jphysiol.2004.079533; Koga S, 2014, MED SCI SPORT EXER, V46, P860, DOI 10.1249/MSS.0000000000000178; CHANCE B, 1992, AM J PHYSIOL, V262, pC766; Jones AM, 2006, J APPL PHYSIOL, V101, P1432, DOI 10.1152/japplphysiol.00436.2006; Behnke BJ, 2003, J PHYSIOL-LONDON, V549, P597, DOI 10.1113/jphysiol.2002.035915; Richardson RS, 2001, J APPL PHYSIOL, V91, P1845; Bowen TS, 2013, EXP PHYSIOL, V98, P1585, DOI 10.1113/expphysiol.2013.073270; Ferrari M, 2011, PHILOS T R SOC A, V369, P4577, DOI 10.1098/rsta.2011.0230; Boone J, 2010, MED SCI SPORT EXER, V42, P935, DOI 10.1249/MSS.0b013e3181c0ecea; Koga S, 2012, J APPL PHYSIOL, V112, P26, DOI 10.1152/japplphysiol.00925.2011; Koga S, 2007, J APPL PHYSIOL, V103, P2049, DOI 10.1152/japplphysiol.00627.2007; Copp SW, 2010, J PHYSIOL-LONDON, V588, P5077, DOI 10.1113/jphysiol.2010.198382; Cannon DT, 2013, J APPL PHYSIOL, V115, P839, DOI 10.1152/japplphysiol.00510.2013; Chin LMK, 2011, J APPL PHYSIOL, V111, P1259, DOI 10.1152/japplphysiol.01216.2010; Ohmae E, 2006, NEUROIMAGE, V29, P697, DOI 10.1016/j.neuroimage.2005.08.008; Celie B, 2012, EUR J APPL PHYSIOL, V112, P2369, DOI 10.1007/s00421-011-2183-x; Ferrari M, 2012, J NEAR INFRARED SPEC, V20, P1, DOI 10.1255/jnirs.973; Ferreira LF, 2007, J APPL PHYSIOL, V102, P358, DOI 10.1152/japplphysiol.00920.2005; Goodwin ML, 2012, J APPL PHYSIOL, V112, P9, DOI 10.1152/japplphysiol.01480.2010; Ijichi S, 2005, J BIOMED OPT, V10, P1; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; Kalliokoski KK, 2006, EXERC SPORT SCI REV, V34, P164, DOI 10.1249/01.jes.0000240018.07502.48; Laaksonen MS, 2013, EUR J APPL PHYSIOL, V113, P1775, DOI 10.1007/s00421-013-2609-8; Niwayama M, 2000, REV SCI INSTRUM, V71, P4571, DOI 10.1063/1.1322578; Oda M, 1999, P SOC PHOTO-OPT INS, V3597, P611, DOI 10.1117/12.356809; Poole DC, 2000, J APPL PHYSIOL, V88, P186; Saitoh T, 2009, AM J PHYSIOL-REG I, V297, pR615, DOI 10.1152/ajpregu.00048.2009; Spencer MD, 2014, J APPL PHYSIOL, V117, P1199, DOI 10.1152/japplphysiol.00060.2014; Suzuki H, 2014, P SOC PHOTO-OPT INS, V8928; Whipp B., 2005, OXYGEN UPTAKE KINETI, P62	38	1	1	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587	1522-1601		J APPL PHYSIOL	J. Appl. Physiol.	JUN 1	2015	118	11					1435	1442		10.1152/japplphysiol.01003.2014		8	Physiology; Sport Sciences	Physiology; Sport Sciences	CJ5YE	WOS:000355569200012		
J	Takenaka, S; Miyatake, A; Tanaka, K; Kuntiya, A; Techapun, C; Leksawasdi, N; Seesuriyachan, P; Chaiyaso, T; Watanabe, M; Yoshida, K				Takenaka, Shinji; Miyatake, Ayaka; Tanaka, Kosei; Kuntiya, Ampin; Techapun, Charin; Leksawasdi, Noppol; Seesuriyachan, Phisit; Chaiyaso, Thanongsak; Watanabe, Masanori; Yoshida, Ken-ichi			Characterization of the native form and the carboxy-terminally truncated halotolerant form of -amylases from Bacillus subtilis strain FP-133	JOURNAL OF BASIC MICROBIOLOGY			English	Article						Bacillus subtilis; Halotolerant enzyme; -Amylase; Carboxy-terminal truncation	ALPHA-AMYLASE; PURIFICATION; BACTERIUM; PROTEASE; ENZYMES; BINDING; GENE	Two amylases, amylase I and amylase II from Bacillus subtilis strain FP-133, were purified to homogeneity and characterized. Their stabilities toward temperature, pH, and organic solvents, and their substrate specificities toward polysaccharides and oligosaccharides were similar. Under moderately high salt conditions, both amylases were more stable than commercial B. licheniformis amylase, and amylase I retained higher amylase activity than amylase II. The N-terminal amino acid sequence, genomic southern blot analysis, and MALDI-TOFF-MS analysis indicated that the halotolerant amylase I was produced by limited carboxy-terminal truncation of the amylase II peptide. The deduced amino acid sequence of amylase II was >95% identical to that of previously reported B. subtilis -amylases, but their carboxy-terminal truncation points differed. Three recombinant amylases full-length amylase corresponding to amylase II, an artificially truncated amylase corresponding to amylase I, and an amylase with a larger artificial C-terminal truncation were expressed in B. subtilis. The artificially truncated recombinant amylases had the same high amylase activity as amylase I under moderately high salt conditions. Sequence comparisons indicated that an increased ratio of Asp/Glu residues in the enzyme may be one factor responsible for increasing halotolerance.	[Takenaka, Shinji; Miyatake, Ayaka; Tanaka, Kosei; Yoshida, Ken-ichi] Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Kobe, Hyogo 6578501, Japan; [Kuntiya, Ampin; Techapun, Charin; Leksawasdi, Noppol; Seesuriyachan, Phisit; Chaiyaso, Thanongsak] Chiang Mai Univ, Fac Agroind, Sch Agroind, Bioproc Res Cluster, Chiang Mai, Thailand; [Watanabe, Masanori] Yamagata Univ, Fac Agr, Dept Food Life & Environm Sci, Yamagata 990, Japan	Takenaka, S (reprint author), Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	stakenaka@people.kobe-u.ac.jp			Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe; iBioK); Scientific Cooperation Program of the Japan Society for the Promotion of Science (JSPS); National Research Council of Thailand (NRCT); Project of National Research University (NRU) under the Office of Higher Education Commission (OHEC), Ministry of Education, Thailand	This work was partially supported by the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe; iBioK) and was carried out as collaborative research in the Core to Core Program (A. Advanced Research Networks), which was supported by the Scientific Cooperation Program of the Japan Society for the Promotion of Science (JSPS), the National Research Council of Thailand (NRCT) and universities involved in the program. Financial support from the Project of National Research University (NRU) under the Office of Higher Education Commission (OHEC), Ministry of Education, Thailand for Thai Researchers is also acknowledged.	Albert J. L., 1993, CHEM REV, V93, P1281; Graziano G, 2014, BBA-PROTEINS PROTEOM, V1844, P850, DOI 10.1016/j.bbapap.2014.02.018; Vagner V, 1998, MICROBIOL-UK, V144, P3097; van den Burg B, 2003, CURR OPIN MICROBIOL, V6, P213, DOI 10.1016/S1369-5274(03)00060-2; Prakash B, 2009, PROCESS BIOCHEM, V44, P210, DOI 10.1016/j.procbio.2008.10.013; Setyorini E, 2006, BIOSCI BIOTECH BIOCH, V70, P433, DOI 10.1271/bbb.70.433; Machius M, 1998, STRUCTURE, V6, P281, DOI 10.1016/S0969-2126(98)00032-X; Madern D, 2000, EXTREMOPHILES, V4, P91, DOI 10.1007/s007920050142; Yamaguchi R, 2011, APPL MICROBIOL BIOT, V89, P673, DOI 10.1007/s00253-010-2882-y; Sanoja RR, 2000, APPL ENVIRON MICROB, V66, P3350, DOI 10.1128/AEM.66.8.3350-3356.2000; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Toyokawa Y, 2010, APPL MICROBIOL BIOT, V86, P1867, DOI 10.1007/s00253-009-2434-5; Yan BQ, 2009, EXTREMOPHILES, V13, P725, DOI 10.1007/s00792-009-0263-1; Nielsen JE, 2000, BBA-PROTEIN STRUCT M, V1543, P253, DOI 10.1016/S0167-4838(00)00240-5; Castro R. E., 2005, FEMS MICROBIOL REV, V30, P17; Chambert R, 2003, J BIOCHEM, V134, P655, DOI 10.1093/jb/mvg189; Cheng MY, 2009, J BIOSCI BIOENG, V107, P373, DOI 10.1016/j.jbiosc.2008.12.010; Cho HY, 2000, BBA-PROTEIN STRUCT M, V1478, P333, DOI 10.1016/S0167-4838(00)00037-6; Easwaran N, 2015, J BASIC MICROB, V55, P579, DOI 10.1002/jobm.201400013; Kalpana BJ, 2014, J BASIC MICROB, V54, P802, DOI 10.1002/jobm.201200732; Kobayashi K, 2002, INT CONGR SER, V1246, P15, DOI 10.1016/S0531-5131(02)01126-3; MACGREGOR EA, 1988, J PROTEIN CHEM, V7, P399, DOI 10.1007/BF01024888; Marco JL, 1996, APPL MICROBIOL BIOT, V44, P746, DOI 10.1007/s002530050627; Nisha M, 2013, APPL MICROBIOL BIOT, V97, P6279, DOI 10.1007/s00253-012-4538-6; Ohdan K, 1999, APPL ENVIRON MICROB, V65, P4652; Phrommao E, 2011, J APPL MICROBIOL, V110, P191, DOI 10.1111/j.1365-2672.2010.04871.x; Setyorini E, 2006, J BASIC MICROB, V46, P294, DOI 10.1002/jobm.200510086; Shafiei M, 2012, EXTREMOPHILES, V16, P627, DOI 10.1007/s00792-012-0462-z; Takenaka S, 2011, BIOSCI BIOTECH BIOCH, V75, P148, DOI 10.1271/bbb.100588; TAKKINEN K, 1983, J BIOL CHEM, V258, P1007; VIHINEN M, 1994, PROTEIN ENG, V7, P1255, DOI 10.1093/protein/7.10.1255; Wang CH, 2014, BIOTECHNOL APPL BIOC, V61, P93, DOI 10.1002/bab.1150	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0233-111X	1521-4028		J BASIC MICROB	J. Basic Microbiol.	JUN	2015	55	6					780	789		10.1002/jobm.201400813		10	Microbiology	Microbiology	CJ7SR	WOS:000355700400010		
J	Mizuno, M; Yamada, A; Fukunaga, K; Kojima, H				Mizuno, Maya; Yamada, Akira; Fukunaga, Kaori; Kojima, Hiroaki			Far-infrared spectroscopy of salt penetration into a collagen fiber scaffold	JOURNAL OF BIOLOGICAL PHYSICS			English	Article						Collagen fiber; Salt; Penetration; Absorbance spectrum	PEPSIN-SOLUBILIZED COLLAGEN; CONNECTIVE-TISSUE; PURIFICATION; PEPTIDES; SKIN; NMR	We employed far-infrared spectroscopy to observe the amount of salt that penetrates into collagen fiber masses. The absorption properties of collagen sheets prepared from tilapia skin, bovine skin, rat tail, and sea cucumber dermis were measured using a transmission Fourier transform spectrometer in a band from approximately 100 to 700 cm(-1). We confirmed that the absorbance spectra of the four types of dried collagen sheet show good agreement, even though the amino acid compositions differed. The absorbance peaks observed in the band corresponded to collective vibrations of plural functional groups such as methylene and imino groups in collagen. When salt solution was added to the collagen sheets and then dried, the spectral shapes of the sheets at approximately 166 cm(-1) were clearly different from those of the plain collagen sheets. The differential absorbance between wavenumbers 166 cm(-1) and 250 cm(-1) sensitively reflected the difference between higher-order structures, and the salt diffusion (crystallization) depended on the collagen fiber condition. From these results, we consider that spectral changes can be used for the numerical evaluation of salt penetration into a collagen fiber scaffold.	[Mizuno, Maya; Fukunaga, Kaori] Natl Inst Informat & Commun Technol, Appl Electromagnet Res Inst, Koganei, Tokyo 1848795, Japan; [Yamada, Akira; Kojima, Hiroaki] Natl Inst Informat & Commun Technol, Adv ICT Res Inst, Kobe, Hyogo 6512492, Japan; [Mizuno, Maya] Natl Inst Informat & Commun Technol, Appl Electromagnet Res Inst, Electromagnet Compatibil Lab, Koganei, Tokyo 1848795, Japan	Mizuno, M (reprint author), Natl Inst Informat & Commun Technol, Appl Electromagnet Res Inst, Electromagnet Compatibil Lab, 4-2-1 Nukuikitamachi, Koganei, Tokyo 1848795, Japan.	mmizuno@nict.go.jp					Acbas G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4076; Adibzadeh N, 2014, APPL BIOCHEM BIOTECH, V173, P143, DOI 10.1007/s12010-014-0823-4; Freudenberg U, 2007, BIOPHYS J, V92, P2108, DOI 10.1529/biophysj.106.094284; Stewart JJP, 2013, J MOL MODEL, V19, P1, DOI 10.1007/s00894-012-1667-x; Vidal BD, 2011, MICRON, V42, P283, DOI 10.1016/j.micron.2010.09.010; DeMoor S, 2003, MAR BIOTECHNOL, V5, P45, DOI 10.1007/s10126-002-0049-2; Falconer RJ, 2012, J INFRARED MILLIM TE, V33, P973, DOI 10.1007/s10762-012-9915-9; BERENDSEN HJC, 1962, J CHEM PHYS, V36, P3297, DOI 10.1063/1.1732460; Gullekson C, 2011, BIOPHYS J, V100, P1837, DOI 10.1016/j.bpj.2011.02.026; Ding T, 2011, J PHYS CHEM A, V115, P11559, DOI 10.1021/jp200553d; Brown EM, 1999, J AM LEATHER CHEM AS, V94, P59; FUNG BM, 1971, BIOPOLYMERS, V10, P391, DOI 10.1002/bip.360100213; Liu ZY, 2010, J AGR FOOD CHEM, V58, P1270, DOI 10.1021/jf9032415; Markelz AG, 2000, CHEM PHYS LETT, V320, P42, DOI 10.1016/S0009-2614(00)00227-X; MARTIN TP, 1970, PHYS REV B, V1, P3480, DOI 10.1103/PhysRevB.1.3480; Mayne J, 2002, J CELL BIOCHEM, V84, P567; Mayo KH, 1996, BIOPOLYMERS, V40, P359, DOI 10.1002/(SICI)1097-0282(1996)40:4<359::AID-BIP2>3.0.CO;2-V; Potaros T., 2009, Kasetsart Journal, Natural Sciences, V43, P584; Nishizawa S, 2005, TOP APPL PHYS, V97, P203, DOI 10.1007/10828028_7; Stewart J. J. P., MOPAC2012; Suenaga M., 2008, J COMPUT CHEM JPN, V7, P33, DOI 10.2477/jccj.H1920; Tamori M, 2006, J EXP BIOL, V209, P1594, DOI 10.1242/jeb.02178	22	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0092-0606	1573-0689		J BIOL PHYS	J. Biol. Phys.	JUN	2015	41	3					293	301		10.1007/s10867-015-9379-y		9	Biophysics	Biophysics	CJ9DN	WOS:000355802800005		
J	Kah, WS; Moorthy, K; Mohamad, MS; Kasim, S; Deris, S; Omatu, S; Yoshioka, M				Kah, Wong Sou; Moorthy, Kohbalan; Mohamad, Mohd Saberi; Kasim, Shahreen; Deris, Safaai; Omatu, Sigeru; Yoshioka, Michifumi			BIOLOGICAL ANALYSIS OF MICROARRAY DATA USING ORTHOGONAL FORWARD SELECTION WITH A CLUSTERING APPROACH	JOURNAL OF BIOLOGICAL SYSTEMS			English	Article						Microarray Data; Functional Profiling; Orthogonal Forward Selection; FunCluster	WHITE ADIPOSE-TISSUE; GENE-EXPRESSION DATA; OBESE SUBJECTS; WEIGHT-LOSS; INFLAMMATION	DNA microarray technology allows researchers to monitor the expression level of thousands of genes under various conditions in microarray experiments. However, high-dimensional data in microarray is a major challenge as the irrelevant genes often reduce the detection capability and increase the computation time. Many learning algorithms are not specifically developed to deal with the noisy genes, thus, incorporating them with gene selection techniques has become a necessity. In this paper, we propose a combined method of Gram-Schmidt orthogonal forward selection (OFS) and FunCluster to search for putatively co-regulated biological processes that share the co-expressed genes. There were two datasets used in this research: human white adipose tissue and human skeletal muscle. This study aimed to find a small subset of strongly correlated genes from the raw datasets to maximize the detection capability of cluster analysis. This method was found able to detect the clusters of biological categories that were overlooked in the previous research. Some clusters represented minor functions of the datasets and indicated more specific biological processes. Further, the computation time for both datasets was reduced using this proposed method, as the Gram-Schmidt OFS significantly reduced the dimensionality of the datasets.	[Kah, Wong Sou; Moorthy, Kohbalan; Mohamad, Mohd Saberi; Deris, Safaai] Univ Teknol Malaysia, Fac Comp, Artificial Intelligence & Bioinformat Res Grp, Skudai 81310, Johor, Malaysia; [Kasim, Shahreen] Univ Tun Hussein Onn Malaysia, Fac Informat Technol & Multimedia, Dept Informat Syst, Batu Pahat 86400, Malaysia; [Omatu, Sigeru] Osaka Inst Technol, Dept Elect Informat & Commun Engn, Osaka 5358585, Japan; [Yoshioka, Michifumi] Osaka Prefecture Univ, Fac Engn, Naka Ku, Sakai, Osaka 5998531, Japan	Mohamad, MS (reprint author), Univ Teknol Malaysia, Fac Comp, Artificial Intelligence & Bioinformat Res Grp, Skudai 81310, Johor, Malaysia.	skwong5@live.utm.my; kohbalan2@live.utm.my; saberi@utm.my; shahreen@uthm.edu.my; safaai@utm.my; omatu@rsh.oit.ac.jp; yoshioka@cs.osakafu-u.ac.jp			Malaysian Ministry of Education by Exploratory Research through RACE research grant [1447]; Matching grant from Universiti Teknologi Malaysia [Q.J130000.3007.00M27]; GUP grant from Universiti Teknologi Malaysia [Q.J130000.2507.05H50]	We would like to thank the Malaysian Ministry of Education for supporting this research by the Exploratory Research through RACE research grant (Grant No.: 1447). This research is also funded by Matching grant (Grant No.: Q.J130000.3007.00M27) and GUP grant (Grant No.: Q.J130000.2507.05H50) from Universiti Teknologi Malaysia.	Rome S, 2003, J BIOL CHEM, V278, P18063, DOI 10.1074/jbc.M300293200; Clement K, 2004, FASEB J, V18, P1657, DOI 10.1096/fj.04-2204com; Mitra P, 2002, IEEE T PATTERN ANAL, V24, P301, DOI 10.1109/34.990133; Kusminski CM, 2012, TRENDS ENDOCRIN MET, V23, P435, DOI 10.1016/j.tem.2012.06.004; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Curat CA, 2004, DIABETES, V53, P1285, DOI 10.2337/diabetes.53.5.1285; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Dash M, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P115, DOI 10.1109/ICDM.2002.1183893; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Jiang DX, 2004, IEEE T KNOWL DATA EN, V16, P1370; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Dy JG, 2004, J MACH LEARN RES, V5, P845; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Henegar Corneliu, 2006, Journal of Bioinformatics and Computational Biology, V4, P833, DOI 10.1142/S0219720006002181; Hwe Jen Lin, 2005, TAMKANG J SCI ENG, V8, P113; Jain KK, 2004, CURR OPIN DRUG DISC, V7, P285; Kim Y., 2000, P 6 ACM SIGKDD INT C, P365, DOI 10.1145/347090.347169; Liu H, 2005, IEEE T KNOWL DATA EN, V17, P491; Liu Huan, 2010, J MACH LEARN RES, V10, P4; Liu R, 2011, INT J INF TECH DECIS, V10, P967, DOI 10.1142/S0219622011004671; Thomas FL, 1993, AM J HYPERTENS, V6, P2835; Zhang Z, 2012, INT J PATTERN RECOGN, V26, P1	23	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0218-3390	1793-6470		J BIOL SYST	J. Biol. Syst.	JUN	2015	23	2					275	288		10.1142/S021833901550014X		14	Biology; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology	CJ3JP	WOS:000355379500006		
J	Oktaviani, NA; Risor, MW; Lee, YH; Megens, RP; de Jong, DH; Otten, R; Scheek, RM; Enghild, JJ; Nielsen, NC; Ikegami, T; Mulder, FAA				Oktaviani, Nur Alia; Risor, Michael W.; Lee, Young-Ho; Megens, Rik P.; de Jong, Djurre H.; Otten, Renee; Scheek, Ruud M.; Enghild, Jan J.; Nielsen, Niels Chr.; Ikegami, Takahisa; Mulder, Frans A. A.			Optimized co-solute paramagnetic relaxation enhancement for the rapid NMR analysis of a highly fibrillogenic peptide	JOURNAL OF BIOMOLECULAR NMR			English	Article						Paramagnetic relaxation enhancement; Intrinsically disordered proteins; Fe(DO3A); alpha(1)-Antitrypsin; Amyloid beta-peptides; NMR spectroscopy	SENSITIVITY ENHANCEMENT; FIBRIL FORMATION; SPECTROSCOPY; PROTEINS; IDENTIFICATION; SPECTRA; DESIGN	Co-solute paramagnetic relaxation enhancement (PRE) is an attractive way to speed up data acquisition in NMR spectroscopy by shortening the T (1) relaxation time of the nucleus of interest and thus the necessary recycle delay. Here, we present the rationale to utilize high-spin iron(III) as the optimal transition metal for this purpose and characterize the properties of its neutral chelate form Fe(DO3A) as a suitable PRE agent. Fe(DO3A) effectively reduces the T (1) values across the entire sequence of the intrinsically disordered protein alpha-synuclein with negligible impact on line width. The agent is better suited than currently used alternatives, shows no specific interaction with the polypeptide chain and, due to its high relaxivity, is effective at low concentrations and in 'proton-less' NMR experiments. By using Fe(DO3A) we were able to complete the backbone resonance assignment of a highly fibrillogenic peptide from alpha(1)-antitrypsin by acquiring the necessary suite of multidimensional NMR datasets in 3 h.	[Oktaviani, Nur Alia; de Jong, Djurre H.; Otten, Renee; Scheek, Ruud M.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [Risor, Michael W.; Enghild, Jan J.; Nielsen, Niels Chr.; Mulder, Frans A. A.] Univ Aarhus, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark; [Risor, Michael W.; Nielsen, Niels Chr.; Mulder, Frans A. A.] Univ Aarhus, Dept Chem, DK-8000 Aarhus C, Denmark; [Lee, Young-Ho; Ikegami, Takahisa] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan; [Megens, Rik P.] Univ Groningen, Stratingh Inst Chem, Groningen, Netherlands; [Enghild, Jan J.] Univ Aarhus, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark	Mulder, FAA (reprint author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands.	fmulder@chem.au.dk			Osaka Frontier Labs Program; VIDI grant from the Netherlands Organization for Scientific Research; Danish National Research Foundation [DNRF 0059]	Prof. Gerard Roelfes is acknowledged for access to organic synthesis facilities. Prof. Yuji Goto and Dr. Hisashi Yagi for their help with alpha-synuclein production. The Osaka Frontier Labs Program is gratefully acknowledged for a visiting scholarship to NAO. This work was supported by a VIDI grant from the Netherlands Organization for Scientific Research to FAAM, and by the Danish National Research Foundation (DNRF 0059).	Abragam A., 1961, INT SERIES MONOGRAPH; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Cai S, 2006, J AM CHEM SOC, V128, P13474, DOI 10.1021/ja0634526; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; Hsu STD, 2009, J AM CHEM SOC, V131, P7222, DOI 10.1021/ja902307q; Kupce E, 2004, J BIOMOL NMR, V28, P391, DOI 10.1023/B:JNMR.0000015421.60023.e5; Schanda P, 2006, J AM CHEM SOC, V128, P9042, DOI 10.1021/ja062025p; Huskens J, 1997, INORG CHEM, V36, P1495, DOI 10.1021/ic961131x; Elliott PR, 2000, PROTEIN SCI, V9, P1274; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fawzi NL, 2010, J AM CHEM SOC, V132, P9948, DOI 10.1021/ja1048253; Gil S, 2013, ANGEW CHEM INT EDIT, V52, P11808, DOI 10.1002/anie.201304272; Sakhaii P, 2013, J MAGN RESON, V233, P92, DOI 10.1016/j.jmr.2013.05.008; Peterson DW, 2008, BIOCHEMISTRY-US, V47, P7393, DOI 10.1021/bi702466a; Pervushin K, 2002, J AM CHEM SOC, V124, P12898, DOI 10.1021/ja027149q; Svane ASP, 2008, BIOPHYS J, V95, P366, DOI 10.1529/biophysj.107.122895; KUMAR K, 1994, INORG CHEM, V33, P3567, DOI 10.1021/ic00094a021; Hocking HG, 2013, CHEMPHYSCHEM, V14, P3082, DOI 10.1002/cphc.201300219; Bermel W, 2006, J AM CHEM SOC, V128, P3918, DOI 10.1021/ja0582206; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Bermel W, 2006, PROG NUCL MAG RES SP, V48, P25, DOI 10.1016/j.pnmrs.2005.09.002; CHANG CA, 1993, INORG CHEM, V32, P3501, DOI 10.1021/ic00068a020; Sekhar A, 2013, P NATL ACAD SCI USA, V110, P12867, DOI 10.1073/pnas.1305688110; Theillet FX, 2011, J BIOMOL NMR, V51, P487, DOI 10.1007/s10858-011-9577-2; Schmit JD, 2011, BIOPHYS J, V100, P450, DOI 10.1016/j.bpj.2010.11.041; Tamiola K, 2012, BIOCHEM SOC T, V40, P1014, DOI 10.1042/BST20120171; Takeuchi K, 2010, J BIOMOL NMR, V47, P271, DOI 10.1007/s10858-010-9430-z; Diercks T, 2005, J BIOMOL NMR, V33, P243, DOI 10.1007/s10858-005-3868-4; FREED JH, 1978, J CHEM PHYS, V68, P4034, DOI 10.1063/1.436302; Bertini I., 2001, SOLUTION NMR PARAMAG, V2; Caravan P, 2009, ACCOUNTS CHEM RES, V42, P851, DOI 10.1021/ar800220p; Dichtl Wolfgang, 2000, Molecular Cell Biology Research Communications, V4, P50, DOI 10.1006/mcbr.2000.0256; Ernst RR, 1987, INT SERIES MONOGRAPH, V14; Goddard TD, 2003, SPARKY 3; JANCIAUSKIENE S, 1995, BIOL CHEM H-S, V376, P415, DOI 10.1515/bchm3.1995.376.7.415; JOHANSSON J, 1992, FEBS LETT, V299, P146, DOI 10.1016/0014-5793(92)80234-8; Kay LE, 1992, J AM CHEM SOC, V114, P10633; Marion D, 2005, J BIOMOL NMR, V32, P141, DOI 10.1007/s10858-005-5977-5; Peters JA, 1996, PROG NUCL MAGN RESON, V28, P221; Pintacuda G, 2002, J AM CHEM SOC, V124, P372, DOI 10.1021/ja016985h; Uversky V, 2010, INSTRUMENTAL ANAL IN	41	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-2738	1573-5001		J BIOMOL NMR	J. Biomol. NMR	JUN	2015	62	2					129	142		10.1007/s10858-015-9925-8		14	Biochemistry & Molecular Biology; Spectroscopy	Biochemistry & Molecular Biology; Spectroscopy	CJ6TM	WOS:000355626800002		
J	Yagi, H; Nakamura, M; Yokoyama, J; Zhang, Y; Yamaguchi, T; Kondo, S; Kobayashi, J; Kato, T; Park, EY; Nakazawa, S; Hashii, N; Kawasaki, N; Kato, K				Yagi, Hirokazu; Nakamura, Masatoshi; Yokoyama, Jun; Zhang, Ying; Yamaguchi, Takumi; Kondo, Sachiko; Kobayashi, Jun; Kato, Tatsuya; Park, Enoch Y.; Nakazawa, Shiori; Hashii, Noritaka; Kawasaki, Nana; Kato, Koichi			Stable isotope labeling of glycoprotein expressed in silkworms using immunoglobulin G as a test molecule	JOURNAL OF BIOMOLECULAR NMR			English	Article						Silkworm; Isotope labeling; Glycoprotein; Artificial diet; Immunoglobulin G; Fc	CYSTEINE-PROTEASE-DEFICIENT; INSECT CELLS; BOMBYX-MORI; NMR-SPECTROSCOPY; N-GLYCOSYLATION; FUSION PROTEIN; SYSTEM; GLYCANS; LARVAE; PATHWAY	Silkworms serve as promising bioreactors for the production of recombinant proteins, including glycoproteins and membrane proteins, for structural and functional protein analyses. However, lack of methodology for stable isotope labeling has been a major deterrent to using this expression system for nuclear magnetic resonance (NMR) structural biology. Here we developed a metabolic isotope labeling technique using commercially available silkworm larvae. The fifth instar larvae were infected with baculoviruses for co-expression of recombinant human immunoglobulin G (IgG) as a test molecule, with calnexin as a chaperone. They were subsequently reared on an artificial diet containing N-15-labeled yeast crude protein extract. We harvested 0.1 mg of IgG from larva with a N-15-enrichment ratio of approximately 80 %. This allowed us to compare NMR spectral data of the Fc fragment cleaved from the silkworm-produced IgG with those of an authentic Fc glycoprotein derived from mammalian cells. Therefore, we successfully demonstrated that our method enables production of isotopically labeled glycoproteins for NMR studies.	[Yagi, Hirokazu; Kondo, Sachiko; Kato, Koichi] Nagoya City Univ, Fac & Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Nakamura, Masatoshi] Natl Inst Agrobiol Sci, Genet Resources Conservat Res Unit, Genet Resources Ctr, Yamanashi 4080044, Japan; [Yokoyama, Jun] Taiyo Nippon Sanso Corp, Tsukuba Labs, Tsukuba, Ibaraki 3002611, Japan; [Zhang, Ying; Yamaguchi, Takumi; Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan; [Zhang, Ying; Yamaguchi, Takumi; Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Kondo, Sachiko; Kato, Koichi] Med & Biol Labs Co Ltd, Chikusa Ku, Nagoya, Aichi 4640858, Japan; [Kobayashi, Jun] Yamaguchi Univ, Dept Biol & Environm Sci, Fac Agr, Yamaguchi 16771, Japan; [Kato, Tatsuya; Park, Enoch Y.] Shizuoka Univ, Res Inst Green Sci & Technol, Biotechnol Lab, Suruga Ku, Shizuoka 4228529, Japan; [Nakazawa, Shiori; Hashii, Noritaka; Kawasaki, Nana] Natl Inst Hlth Sci, Div Biol Chem & Biologicals, Setagaya Ku, Tokyo 1588501, Japan; [Kato, Koichi] Ochanomizu Univ, Glycosci Inst, Bunkyo Ku, Tokyo 1128610, Japan	Kato, K (reprint author), Nagoya City Univ, Fac & Grad Sch Pharmaceut Sci, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	kkato@phar.nagoya-cu.ac.jp	Kobayashi, Junjiro/J-8547-2015; Kato, Tatsuya/E-3095-2010		Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); Ministry of Education, Culture, Sports, Science and Technology (MEXT) [24249002, 25102008, 25860053]; Nanotechnology Platform Program (Molecule and Material Synthesis) of MEXT	This study was supported in part by the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) and by Grants-in-Aid for Scientific Research (24249002, 25102008, and 25860053) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). This study was partly also supported by the Nanotechnology Platform Program (Molecule and Material Synthesis) of MEXT. We also thank Ms. Kiyomi Senda and Ms. Kumiko Hattori (Nagoya City University) for their help in purification of IgG.	Aburatani T, 2002, J BIOCHEM, V132, P775; Dojima T, 2010, BIOTECHNOL PROGR, V26, P232, DOI 10.1002/btpr.313; Hiyoshi M, 2007, J VIROL METHODS, V144, P91, DOI 10.1016/j.jviromet.2007.04.005; Demain AL, 2009, BIOTECHNOL ADV, V27, P297, DOI 10.1016/j.biotechadv.2009.01.008; Kato T, 2010, APPL MICROBIOL BIOT, V85, P459, DOI 10.1007/s00253-009-2267-2; Ailor E, 2000, GLYCOBIOLOGY, V10, P837, DOI 10.1093/glycob/10.8.837; Breitbach K, 2001, BIOTECHNOL BIOENG, V74, P230, DOI 10.1002/bit.1112; Palmberger D, 2011, J BIOTECHNOL, V153, P160, DOI 10.1016/j.jbiotec.2011.02.009; Sasaki K, 2009, BIOCHEM BIOPH RES CO, V387, P575, DOI 10.1016/j.bbrc.2009.07.065; de Wildt RMT, 2000, NAT BIOTECHNOL, V18, P989, DOI 10.1038/79494; YAMAGUCHI Y, 1995, J IMMUNOL METHODS, V181, P259, DOI 10.1016/0022-1759(95)00010-8; Zhu JW, 2012, BIOTECHNOL ADV, V30, P1158, DOI 10.1016/j.biotechadv.2011.08.022; Harrison RL, 2006, ADV VIRUS RES, V68, P159, DOI 10.1016/S0065-3527(06)68005-6; Hollister JR, 2001, GLYCOBIOLOGY, V11, P1; Takahashi N, 2003, TRENDS GLYCOSCI GLYC, V15, P235; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; COHEN SA, 1993, ANAL BIOCHEM, V211, P279, DOI 10.1006/abio.1993.1270; Matsumiya S, 2007, J MOL BIOL, V368, P767, DOI 10.1016/j.jmb.2007.02.034; Skrisovska L, 2010, J BIOMOL NMR, V46, P51, DOI 10.1007/s10858-009-9362-7; Saxena K, 2012, METHODS MOL BIOL, V831, P37, DOI 10.1007/978-1-61779-480-3_3; Motohashi T, 2005, BIOCHEM BIOPH RES CO, V326, P564, DOI 10.1016/j.bbrc.2004.11.060; Yagi H, 2012, J BIOL CHEM, V287, P24356, DOI 10.1074/jbc.M112.365643; Yamaguchi Y, 2006, BBA-GEN SUBJECTS, V1760, P693, DOI 10.1016/j.bbagen.2005.10.002; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Park EY, 2009, J BIOTECHNOL, V139, P108, DOI 10.1016/j.jbiotec.2008.09.013; Dojima T, 2009, J BIOTECHNOL, V143, P27, DOI 10.1016/j.jbiotec.2009.06.013; Kamiya Y, 2014, CURR OPIN STRUC BIOL, V26, P44, DOI 10.1016/j.sbi.2014.03.008; Park EY, 2008, BIOTECHNOL APPL BIOC, V49, P135, DOI 10.1042/BA20070098; Hollister J, 2002, BIOCHEMISTRY-US, V41, P15093, DOI 10.1021/bi026455d; Jarvis DL, 2009, METHOD ENZYMOL, V463, P191, DOI 10.1016/S0076-6879(09)63014-7; Kato K, 2010, PROG NUCL MAG RES SP, V56, P346, DOI 10.1016/j.pnmrs.2010.03.001; Yagi H, 2015, PLANT CELL REP, V34, P959, DOI 10.1007/s00299-015-1757-1; Takahashi H, 2010, J BIOMOL NMR, V46, P3, DOI 10.1007/s10858-009-9377-0; DeLano W. L., 2002, PYMOL MOL GRAPHICS S; Dutta A, 2012, METHODS MOL BIOL, V831, P55, DOI 10.1007/978-1-61779-480-3_4; Hirayama C, 1996, J INSECT PHYSIOL, V42, P983, DOI 10.1016/0022-1910(96)00009-1; Horie Y, 1966, B SERICULT EXP STN, V20, P393; Kamiya Yukiko, 2013, Biomolecules, V3, P108, DOI 10.3390/biom3010108; Kato K, 2011, ENCY MAGNET IN PRESS, DOI [10.1002/9780470034590, DOI 10.1002/9780470034590]; Kneller D, 1993, SPARKY 3; de Marco A, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-26; Ohki S, 2008, J BIOMOL NMR, V42, P271, DOI 10.1007/s10858-008-9283-x; Yagi H, 2010, CARBOHYD RES, V345, P442, DOI 10.1016/j.carres.2009.12.002; Yagi H, 2014, BIOMOL NMR ASSIGN, DOI [10.1007/s12104-014-9586-7, DOI 10.1007/S12104-014-9586-7]; Yamaguchi Y, 2010, METHOD ENZYMOL, V478, P305, DOI 10.1016/S0076-6879(10)78015-0	45	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-2738	1573-5001		J BIOMOL NMR	J. Biomol. NMR	JUN	2015	62	2					157	167		10.1007/s10858-015-9930-y		11	Biochemistry & Molecular Biology; Spectroscopy	Biochemistry & Molecular Biology; Spectroscopy	CJ6TM	WOS:000355626800004		
J	Isoda, S; Imoto, K; Uchida, K; Nishimura, K; Karube, N; Suzuki, S; Masuda, M				Isoda, Susumu; Imoto, Kiyotaka; Uchida, Keiji; Nishimura, Kenji; Karube, Norihisa; Suzuki, Shinichi; Masuda, Munetaka			"Sandwich Technique" via a Right Ventricle Incision to Repair Postinfarction Ventricular Septal Defects	JOURNAL OF CARDIAC SURGERY			English	Article							SURGICAL REPAIR; INFARCTION	BackgroundResidual shunting and mortality are problems associated with the current surgical repair techniques for postinfarction ventricular septal defects (VSD). We developed the sandwich technique via a right ventricle incision and assessed the surgical outcome of 13 years of experience with this technique. MethodsBetween June 2001 and March 2013, 25 consecutive patients with postinfarction VSD underwent surgical repair using this technique. This technique includes the following: Application of direct ultrasonography to the right ventricular (RV) wall enables the surgeon to visualize the lesion, perform an appropriate incision into the RV, and perform a trabecular resection. One patch is placed on the left ventricular (LV) side and the other on the RV side of the VSD. The VSD is sealed with gelatin-resorcin-formalin (GRF) glue between the two patches. ResultsThirty-day mortality was 0% (0/25 case). A postoperative major shunt occurred in three patients (12%, 3/25) and two of them required reoperation (8%, 2/25). Hospital mortality was 28% (seven patients). Mean follow-up period was 4.23.7 years. The overall survival at one, five, and 10 years was 71 +/- 9%, 65 +/- 10%, and 56 +/- 12%, respectively. There was no cardiac death during follow-up in the patients who survived for six months after the surgery. No tissue degeneration related to GRF glue was noted. ConclusionThe sandwich technique via a right ventricle incision results in a low incidence of postoperative leak and good short- and mid-term survival.	[Isoda, Susumu; Imoto, Kiyotaka; Uchida, Keiji; Karube, Norihisa] Yokohama City Univ, Med Ctr, Dept Cardiovasc Surg, Minami Ku, Yokohama, Kanagawa 2320024, Japan; [Nishimura, Kenji] Natl Def Med Coll, Dept Cardiovasc Surg, Tokorozawa, Saitama 359, Japan; [Suzuki, Shinichi; Masuda, Munetaka] Yokohama City Univ, Dept Surg, Yokohama, Kanagawa 2320024, Japan	Isoda, S (reprint author), Yokohama City Univ, Med Ctr, Dept Cardiovasc Surg, Minami Ku, 4-57 Urafune, Yokohama, Kanagawa 2320024, Japan.	isoda@yokohama-cu.ac					Deja MA, 2000, EUR J CARDIO-THORAC, V18, P194, DOI 10.1016/S1010-7940(00)00482-6; Asai T, 2012, SEMIN THORAC SURG, V62; Caimmi PP, 2010, ANN THORAC SURG, V89, P1679, DOI 10.1016/j.athoracsur.2009.06.064; Hosoba S, 2013, EUR J CARDIO-THORAC, V43, pE116, DOI 10.1093/ejcts/ezt027; Isoda S, 2004, J CARDIAC SURG, V19, P149, DOI 10.1111/j.0886-0440.2004.04028.x; Isoda S, 2013, ANN THORAC CARDIOVAS, V19, P95, DOI 10.5761/atcs.ra.12.02201; Isoda S, 2012, ANN THORAC CARDIOVAS, V18, P318, DOI 10.5761/atcs.oa.11.01703; Isoda S, 2011, GEN THORAC CARDIOVAS, V59, P326; KOMEDA M, 1990, CIRCULATION, V82, P243; LUNDBERG S, 1962, ACTA MED SCAND, V172, P413; Madsen JC, 1977, CARDIAC SURG ADULT, P629; Musumeci F, 1996, ANN THORAC SURG, V62, P486, DOI 10.1016/0003-4975(96)00313-X; Yamamoto Nobuyuki, 2002, Jpn J Thorac Cardiovasc Surg, V50, P294	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0886-0440	1540-8191		J CARDIAC SURG	J. Card. Surg.	JUN	2015	30	6					488	493		10.1111/jocs.12546		6	Cardiac & Cardiovascular Systems; Surgery	Cardiovascular System & Cardiology; Surgery	CJ7DL	WOS:000355654300002		
J	Hattori, R; Uchiyama, H				Hattori, Reiji; Uchiyama, Hirotomo			Multiple Coronary Artery-Pulmonary Artery-Bronchial Artery Fistulas	JOURNAL OF CARDIAC SURGERY			English	Editorial Material									[Hattori, Reiji] Hino Hosp, Dept Cardiovasc Surg, Sakai, Osaka 5998123, Japan; [Uchiyama, Hirotomo] Tokyo Med Univ, Hachioji Med Ctr, Dept Cardiovasc Surg, Tokyo 1608402, Japan	Hattori, R (reprint author), Hino Hosp, Dept Cardiovasc Surg, Higashi Ku, 626 Kitanoda, Sakai, Osaka 5998123, Japan.	hattorireiji@yahoo.co.jp						0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0886-0440	1540-8191		J CARDIAC SURG	J. Card. Surg.	JUN	2015	30	6					518	519		10.1111/jocs.12515		2	Cardiac & Cardiovascular Systems; Surgery	Cardiovascular System & Cardiology; Surgery	CJ7DL	WOS:000355654300010		
J	Matsushima, S; Oshima, Y; Maruo, A; Hasegawa, T; Matsuhisa, H; Noda, R; Iwaki, R				Matsushima, Shunsuke; Oshima, Yoshihiro; Maruo, Ayako; Hasegawa, Tomomi; Matsuhisa, Hironori; Noda, Rei; Iwaki, Ryuma			A Left Anterior Extrapleural Approach to Adjust Right Ventricle-Pulmonary Artery Shunt Flow Using Hemostatic Clips After the Norwood Operation	JOURNAL OF CARDIAC SURGERY			English	Article							LEFT-HEART SYNDROME; MANAGEMENT	Adjusting right ventricle-pulmonary artery shunt flow with placement of hemostatic clips in the Norwood operation is a useful technique for precise control of pulmonary blood flow in the acute postoperative period. This report describes our technique for optimizing right ventricle-pulmonary artery shunt flow with metal clips through a left anterior extrapleural approach, which can be performed safely and minimally invasively without sternal reopening. This procedure may decrease morbidity and contribute to long-term clinical improvement in patients undergoing the Norwood operation.	[Matsushima, Shunsuke; Oshima, Yoshihiro; Maruo, Ayako; Hasegawa, Tomomi; Matsuhisa, Hironori; Noda, Rei; Iwaki, Ryuma] Kobe Childrens Hosp, Dept Cardiovasc Surg, Kobe, Hyogo 6540081, Japan	Matsushima, S (reprint author), Kobe Childrens Hosp, Dept Cardiovasc Surg, Suma Ku, 1-1-1 Takakuradai, Kobe, Hyogo 6540081, Japan.	matsushima_kch@hp.pref.hyogo.jp					Ohye RG, 2010, NEW ENGL J MED, V362, P1980, DOI 10.1056/NEJMoa0912461; Feinstein JA, 2012, J AM COLL CARDIOL, V59, pS1, DOI 10.1016/j.jacc.2011.09.022; Bradley SM, 2008, ANN THORAC SURG, V86, P183, DOI 10.1016/j.athoracsur.2008.03.047; Januszewska K, 2011, EUR J CARDIO-THORAC, V40, P584, DOI 10.1016/j.ejcts.2010.10.038; Nakano T, 2004, ANN THORAC SURG, V77, P908, DOI 10.1016/j.athoracsur.2003.09.025; Reinhardt Z, 2014, CARDIOL YOUNG, V24, P212, DOI 10.1017/S1047951113000024; Sano S, 2012, OPERAT TECH THORAC C, V17, P66; YAO JKY, 1969, J CARDIOVASC SURG, V10, P273	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0886-0440	1540-8191		J CARDIAC SURG	J. Card. Surg.	JUN	2015	30	6					532	534		10.1111/jocs.12545		3	Cardiac & Cardiovascular Systems; Surgery	Cardiovascular System & Cardiology; Surgery	CJ7DL	WOS:000355654300013		
J	Suehiro, K; Tanaka, K; Mikawa, M; Uchihara, Y; Matsuyama, T; Matsuura, T; Funao, T; Yamada, T; Mori, T; Nishikawa, K				Suehiro, Koichi; Tanaka, Katsuaki; Mikawa, Mika; Uchihara, Yuriko; Matsuyama, Taiki; Matsuura, Tadashi; Funao, Tomoharu; Yamada, Tokuhiro; Mori, Takashi; Nishikawa, Kiyonobu			Improved Performance of the Fourth-Generation FloTrac/Vigileo System for Tracking Cardiac Output Changes	JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA			English	Article						FloTrac/Vigileo system; cardiac output; systemic vascular resistance; pulmonary artery catheter; thermodilution	CRITICALLY-ILL PATIENTS; VASCULAR-RESISTANCE; VIGILEO-FLOTRAC; SURGERY; IMPACT; PHENYLEPHRINE; METAANALYSIS; AGREEMENT; MONITORS; ABILITY	Objectives: The aims of this study were to compare cardiac output (CO) measured by the new fourth-generation FloTrac (TM)/Vigileo (TM) system (Version 4.00) (COFvs) with that measured by a pulmonary artery catheter (COREF), and to investigate the ability of COFVS to track CO changes induced by increased peripheral resistance. Design: Prospective study. Setting: University Hospital. Participants: Twenty-three patients undergoing cardiac surgery. Interventions: Phenylephrine (100 mu g) was administered. Measurements and Main Results: Hemodynamic variables, including COREF and COFVS, were measured before and after phenylephrine administration. Bland-Altman analysis was used to assess the discrepancy between COREF and COFVS. Four-quadrant plot and polar-plot analyses were utilized to evaluate the trending ability of COFVS against COREF after phenylephrine boluses. One hundred thirty-six hemodynamic interventions were performed. The bias shown by the Bland-Altman analysis was -0.66 L/min, and the percentage error was 55.4%. The bias was significantly correlated with the systemic vascular resistance index (SVRI) before phenylephrine administration (p < 0.001, r(2) = 0.420). The concordance rate determined by four-quadrant plot analysis and the angular concordance rate calculated using polar-plot analysis were 87.0% and 83.0%, respectively. Additionally, this trending ability was not affected by SVRI state. Conclusions: The trending ability of the new fourth-generation FloTra (TM)/Vigileo (TM) system after increased vasomotor tone was greatly improved compared with previous versions; however, the discrepancy of the new system in CO measurement was not clinically acceptable, as in previous versions. For clinical application in critically ill patients, this vasomotor tone-dependent disagreement must be decreased. (C) 2015 Elsevier Inc. All rights reserved.	[Suehiro, Koichi; Tanaka, Katsuaki; Mikawa, Mika; Uchihara, Yuriko; Matsuyama, Taiki; Matsuura, Tadashi; Funao, Tomoharu; Yamada, Tokuhiro; Mori, Takashi; Nishikawa, Kiyonobu] Osaka City Univ, Dept Anesthesiol, Grad Sch Med, Osaka 5458586, Japan	Suehiro, K (reprint author), Osaka City Univ, Dept Anaesthesiol, Grad Sch Med, Abeno Ku, 1-5-7 Asahimachi, Osaka 5458586, Japan.	suehirokoichi@yahoo.co.jp					Critchley LA, 2010, ANESTH ANALG, V111, P1180, DOI 10.1213/ANE.0b013e3181f08a5b; Monnet X, 2012, BRIT J ANAESTH, V108, P615, DOI 10.1093/bja/aer491; Suehiro K, 2013, BRIT J ANAESTH, V111, P170, DOI 10.1093/bja/aet022; Critchley LAH, 1999, J CLIN MONITOR COMP, V15, P85, DOI 10.1023/A:1009982611386; Cannesson M, 2012, J APPL PHYSIOL, V113, P281, DOI 10.1152/japplphysiol.00126.2012; Finfer S, 2006, BRIT MED J, V333, P930, DOI 10.1136/bmj.39017.459907.BE; Hofer CK, 2009, EUR J ANAESTH, V26, P996, DOI 10.1097/EJA.0b013e3283300d55; Biancofiore G, 2011, ANESTH ANALG, V113, P515, DOI 10.1213/ANE.0b013e31822401b2; Myles PS, 2007, BRIT J ANAESTH, V99, P309, DOI 10.1093/bja/aem214; Connors AF, 1996, JAMA-J AM MED ASSOC, V276, P889, DOI 10.1001/jama.276.11.889; Meng LZ, 2011, ANESTH ANALG, V113, P751, DOI 10.1213/ANE.0b013e31822649fb; Critchley LA, 2011, J CARDIOTHOR VASC AN, V25, P536, DOI 10.1053/j.jvca.2011.01.003; Arulkumaran N, 2014, BRIT J ANAESTH, V112, P648, DOI 10.1093/bja/aet466; BLAND JM, 1986, LANCET, V1, P307; Cecconi M, 2013, CRIT CARE, V17, DOI 10.1186/cc11823; Grensemann J, 2012, ANESTH ANALG, V116, P820; Kapoor Poonam Malhotra, 2008, Ann Card Anaesth, V11, P27; Krejci V, LIVER TRANSPL, V16, P773; LILJESTRAND G., 1928, ZEITSCHR GES EXP MED, V59, P105, DOI 10.1007/BF02608853; Mutoh Tatsushi, 2012, Surg Neurol Int, V3, P99, DOI 10.4103/2152-7806.100195; Sander M, 2006, CRIT CARE, V10, DOI 10.1186/cc5103; Sotomi Y, 2013, J CLIN MONIT COMPUT, V27, P639, DOI 10.1007/s10877-013-9481-2	22	3	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1053-0770	1532-8422		J CARDIOTHOR VASC AN	J. Cardiothorac. Vasc. Anesth.	JUN	2015	29	3					656	662		10.1053/j.jvca.2014.07.022		7	Anesthesiology; Cardiac & Cardiovascular Systems; Respiratory System; Peripheral Vascular Disease	Anesthesiology; Cardiovascular System & Cardiology; Respiratory System	CJ6ZK	WOS:000355643500018		
J	Takahashi, K; Okumura, Y; Watanabe, I; Nagashima, K; Sonoda, K; Sasaki, N; Kogawa, R; Iso, K; Ohkubo, K; Nakai, T; Hirayama, A				Takahashi, Keiko; Okumura, Yasuo; Watanabe, Ichiro; Nagashima, Koichi; Sonoda, Kazumasa; Sasaki, Naoko; Kogawa, Rikitake; Iso, Kazuki; Ohkubo, Kimie; Nakai, Toshiko; Hirayama, Atsushi			Relation Between Left Atrial Wall Thickness in Patients with Atrial Fibrillation and Intracardiac Electrogram Characteristics and ATP-Provoked Dormant Pulmonary Vein Conduction	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Article						atrial fibrillation; left atrial wall thickness; PA-LA junction wall thickness	CATHETER ABLATION; MYOCARDIUM; RECURRENCE; ADENOSINE; DISEASE	LA Wall Thickness, LA Electrogram, and Dormant PV Conduction IntroductionAtrial remodeling plays a key role in development of the substrate for atrial fibrillation (AF). Whether the wall thicknesses of the left atrium (LA) and pulmonary vein (PV)-LA junction affect remodeling and AF ablation is unknown. We investigated the relationship between wall thicknesses, electrogram characteristics, and adenosine triphosphate (ATP)-provoked dormant PV conduction as they pertain to AF. MethodsIn 50 patients with AF and 25 patients without AF, wall thicknesses of the LA and PV-LA junction were measured on 320-slice computed tomography images. For the AF patients, NavX-based voltage maps generated during sinus rhythm were obtained, and ATP-provoked dormant PV conduction after PV isolation was evaluated. ResultsWalls of the LA and PV-LA junction were significantly thicker in the AF patients than in the control patients (1.83 0.29 mm vs. 1.59 +/- 0.28 mm, respectively; P = 0.0010; and 0.88 +/- 0.14 mm vs. 0.65 +/- 0.11 mm, P<0.0001, respectively). Wall thickness at the PV-LA junction was independently associated with AF ( = 0.40, P = 0.0002). In AF patients, the walls of the PV-LA junction showed stepwise thickening across bipolar voltages indicative of severe (bipolar voltage <33rd percentile) to moderate (33rd-66th percentiles) to mild fibrosis/scarring (66th percentile). Walls of the PV-LA junction with dormant PV conduction were significantly thicker than those without it (0.94 +/- 0.19 mm vs. 0.86 +/- 0.21 mm, respectively; P = 0.0025). ConclusionsTogether, the association between thickened PV-LA junction walls and AF and the increased bipolar voltage suggests that such wall thickening increases PV electrical activities, leading to initiation and maintenance of AF and perhaps to ATP-provoked dormant PV conduction.	[Takahashi, Keiko; Okumura, Yasuo; Watanabe, Ichiro; Nagashima, Koichi; Sonoda, Kazumasa; Sasaki, Naoko; Kogawa, Rikitake; Iso, Kazuki; Ohkubo, Kimie; Nakai, Toshiko; Hirayama, Atsushi] Nihon Univ, Sch Med, Dept Med, Div Cardiol, Tokyo, Japan	Okumura, Y (reprint author), 30-1 Ohyaguchi Kamicho,Itabashi Ku, Tokyo 1738610, Japan.	yasuwo128@yahoo.co.jp			Alumni Association; Nihon University School of Medicine; Fukuda Foundation for the Medical Technology of Japan	This study was supported in part by the Alumni Association, Nihon University School of Medicine and the Fukuda Foundation for the Medical Technology of Japan.	Okumura Y, 2014, J INTERV CARD ELECTR, V40, P39, DOI 10.1007/s10840-013-9869-4; Dewland TA, 2013, PACE, V36, P55, DOI 10.1111/pace.12028; Abhayaratna WP, 2006, J AM COLL CARDIOL, V47, P2357, DOI 10.1016/j.jacc.2006.02.048; Sanchez-Quintana D, 2005, CIRCULATION, V112, P1400, DOI 10.1161/CIRCULATIONHA.105.551291; Beinart R, 2011, J CARDIOVASC ELECTR, V22, P1232, DOI 10.1111/j.1540-8167.2011.02100.x; Gerstenfeld ER, 2003, J CARDIOVASC ELECTR, V14, P685; Datino T, 2010, CIRCULATION, V121, P963, DOI 10.1161/CIRCULATIONAHA.109.893107; Ouyang FF, 2005, CIRCULATION, V111, P127, DOI 10.1161/01.CIR.0000151289.73085.36; Lee G, 2012, LANCET, V380, P1509, DOI 10.1016/S0140-6736(12)61463-9; Arentz T, 2004, J CARDIOVASC ELECTR, V15, P1041, DOI 10.1046/j.1540-8167.2004.04031.x; Ausma J, 1997, CIRCULATION, V96, P3157; Matsuo S, 2007, J CARDIOVASC ELECTR, V18, P704, DOI 10.1111/j.1540-8167.2007.00842.x; Kholova I, 2003, PACE, V26, P1348, DOI 10.1046/j.1460-9592.2003.t01-1-00193.x; Teh AW, 2012, J CARDIOVASC ELECTR, V23, P232, DOI 10.1111/j.1540-8167.2011.02178.x; Becker AE, 2004, HEART RHYTHM, V1, P627, DOI 10.1016/j.hrthm.2004.09.009; Corradi D, 2005, HUM PATHOL, V36, P1080, DOI 10.1016/j.humpath.2005.07.018; Hall B, 2006, J INTERV CARD ELECTR, V17, P127, DOI 10.1007/s10840-006-9052-2; Kumagai K, 2010, J CARDIOVASC ELECTR, V21, P494, DOI 10.1111/j.1540-8167.2009.01667.x; Nakamura K, 2011, INT J CARDIOL, V148, P139, DOI 10.1016/j.ijcard.2009.10.032; Okumura Y, 2011, J CARDIOVASC ELECTR, V22, P987, DOI 10.1111/j.1540-8167.2011.02059.x; Park J, 2014, INT J CARDIOL, V172, pE411, DOI 10.1016/j.ijcard.2013.12.255; Platonov PG, 2008, J CARDIOVASC ELECTR, V19, P689, DOI 10.1111/j.1540-8167.2008.01102.x; Sih HJ, 2000, J AM COLL CARDIOL, V36, P924, DOI 10.1016/S0735-1097(00)00788-9	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	JUN	2015	26	6					597	605		10.1111/jce.12660		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CK1VG	WOS:000355995200001		
J	Miyazaki, S; Hachiya, H; Taniguchi, H; Nakamura, H; Ichihara, N; Usui, E; Kuroi, A; Takagi, T; Iwasawa, J; Hirao, K; Iesaka, Y				Miyazaki, Shinsuke; Hachiya, Hitoshi; Taniguchi, Hiroshi; Nakamura, Hiroaki; Ichihara, Noboru; Usui, Eisuke; Kuroi, Akio; Takagi, Takamitsu; Iwasawa, Jin; Hirao, Kenzo; Iesaka, Yoshito			Prospective Evaluation of Bilateral Diaphragmatic Electromyograms During Cryoballoon Ablation of Atrial Fibrillation	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Article						atrial fibrillation; catheter ablation; compound motor action potential; cryoballoon; phrenic nerve injury	PHRENIC-NERVE INJURY; PULMONARY VEIN ISOLATION; 2ND-GENERATION CRYOBALLOON; RADIOFREQUENCY ABLATION; CATHETER ABLATION	Bilateral Diaphragmatic CMAPs During Cryoablation BackgroundLeft phrenic nerve injury (PNI) can occur during cryoballoon ablation of the left pulmonary veins (PVs). This study aimed to evaluate the feasibility of monitoring the bilateral phrenic nerve function during cryoballoon ablation of atrial fibrillation (AF). MethodsFifty consecutive paroxysmal AF patients undergoing cryoballoon ablation using one 28-mm second-generation balloon were prospectively enrolled. Bilateral diaphragmatic compound motor action potentials (CMAPs) were obtained from modified surface electrodes by pacing from the bilateral subclavian veins, and monitored during 3-minute cryoballoon applications at the ipsilateral PVs. ResultsOne hundred ninety of 202 PVs were successfully isolated exclusively using 28-mm cryoballoons. CMAPs could be obtained in all except 3 cases with catheter inaccessibility in the left subclavian vein. The left and right CMAP amplitudes were similar at baseline (1.04 0.41 mV vs. 1.01 +/- 0.43 mV, P = 0.49). Among 105 left and 132 right PV applications while monitoring CMAPs, 2 (1.9%) and 13 (9.8%) applications were interrupted for a decreased CMAP amplitude (P = 0.01). Among them, CMAPs decreased due to right PNI in 4 applications/patients and to catheter dislodgement in the remaining applications. PNI remained in 1 and recovered in the remaining 3 patients one day after the procedure. Applications without requiring interruptions exhibited no significant CMAP amplitude changes throughout the applications, and the time-course pattern was similar between the bilateral CMAPs (P = 0.292). ConclusionsA stable bilateral diaphragmatic CMAP could be similarly obtained during cryoballoon applications in the vast majority of patients. Monitoring CMAPs might be useful to anticipate not only right but also left PNI during cryoballoon ablation.	[Miyazaki, Shinsuke; Hachiya, Hitoshi; Taniguchi, Hiroshi; Nakamura, Hiroaki; Ichihara, Noboru; Usui, Eisuke; Kuroi, Akio; Takagi, Takamitsu; Iwasawa, Jin; Iesaka, Yoshito] Tsuchiura Kyodo Gen Hosp, Ctr Cardiovasc, Tsuchiura, Ibaraki 3000053, Japan; [Hirao, Kenzo] Tokyo Med & Dent Univ, Heart Rhythm Ctr, Tokyo, Japan	Miyazaki, S (reprint author), Tsuchiura Kyodo Gen Hosp, Div Cardiol, Ctr Cardiovasc, 11-7 Manabeshin Machi, Tsuchiura, Ibaraki 3000053, Japan.	mshinsuke@k3.dion.ne.jp					Metzner A, 2014, J CARDIOVASC ELECTR, V25, P466, DOI 10.1111/jce.12358; Lakhani M, 2012, J CARDIOVASC ELECTR, V23, P874, DOI 10.1111/j.1540-8167.2012.02302.x; Arentz T, 2007, CIRCULATION, V115, P3057, DOI 10.1161/CIRCULATIONAHA.107.690578; Andrie RP, 2012, PACE, V35, pe334, DOI 10.1111/j.1540-8159.2012.03470.x; Mondesert B, 2014, CIRC-ARRHYTHMIA ELEC, V7, P605, DOI 10.1161/CIRCEP.113.001238; Liu XP, 2006, J CARDIOVASC ELECTR, V17, P1263, DOI 10.1111/j.1540-8167.2006.00621.x; Sanchez-Quintana D, 2009, HEART RHYTHM, V6, P764, DOI 10.1016/j.hrthm.2009.02.029; Franceschi F, 2011, HEART RHYTHM, V8, P1068, DOI 10.1016/j.hrthm.2011.01.047; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Kojodjojo P, 2010, HEART, V96, P1379, DOI 10.1136/hrt.2009.192419; Nault I, 2010, EUR HEART J, V31, P1046, DOI 10.1093/eurheartj/ehq079; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Andrade JG, 2014, J CARDIOVASC ELECTR, V25, P187, DOI 10.1111/jce.12296; Sacher F, 2006, J AM COLL CARDIOL, V47, P2498, DOI 10.1016/j.jacc.2006.02.050; Dionne A, 2009, MUSCLE NERVE, V40, P37, DOI 10.1002/mus.21290; Furnkranz A, 2014, J CARDIOVASC ELECTR, V25, P840, DOI 10.1111/jce.12417; Hachiya H, 2007, J CARDIOVASC ELECTR, V18, P1; Hermida JS, 2013, EUROPACE, V15, P514, DOI 10.1093/europace/eus296; Kowalski M, 2014, HEART RHYTHM, V11, P1839, DOI 10.1016/j.hrthm.2014.06.019; Lakhani M, 2014, HEART RHYTHM, V11, P369, DOI 10.1016/j.hrthm.2013.11.015; Lee JC, 2009, HEART RHYTHM, V6, P1186, DOI 10.1016/j.hrthm.2009.03.056; Linhart M, 2014, J CARDIOVASC ELECTR, V25, P859, DOI 10.1111/jce.12431; Martins RP, 2014, HEART RHYTHM, V11, P386, DOI 10.1016/j.hrthm.2014.01.002; Miyazaki S, 2015, J CARDIOVASC ELECTR, V26, P260, DOI 10.1111/jce.12571; Miyazaki S, 2014, AM HEART J, V168, P846, DOI 10.1016/j.ahj.2014.09.011	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	JUN	2015	26	6					622	628		10.1111/jce.12671		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CK1VG	WOS:000355995200005		
J	Aiba, T; Noda, T; Hidaka, I; Inagaki, M; Katare, RG; Ando, M; Sunagawa, K; Sato, T; Sugimachi, M				Aiba, Takeshi; Noda, Takashi; Hidaka, Ichiro; Inagaki, Masashi; Katare, Rajesh G.; Ando, Motonori; Sunagawa, Kenji; Sato, Takayuki; Sugimachi, Masaru			Acetylcholine Suppresses Ventricular Arrhythmias and Improves Conduction and Connexin-43 Properties During Myocardial Ischemia in Isolated Rabbit Hearts	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Article						acetylcholine; conduction; connexin-43; gap junction; ischemia; optical mapping; ventricular arrhythmias	EPICARDIAL BORDER ZONE; SUDDEN CARDIAC DEATH; PROTEIN-KINASE-C; VAGAL-STIMULATION; GAP-JUNCTION; NITRIC-OXIDE; 2,3-BUTANEDIONE MONOXIME; PAPILLARY-MUSCLE; INFARCTION; FIBRILLATION	ACh Prevents Ischemic Loss of Gj and Arrhythmias IntroductionAcetylcholine (ACh), a vagal efferent neurotransmitter, markedly improves survival in rats with myocardial ischemia (MI) by preventing ischemic loss of gap junction (Gj) and by inducing anti-apoptotic cascades. However, electrophysiological mechanisms of the antiarrhythmic effect of ACh after acute MI are still unclear. MethodsAcute MI was induced by ligation of the left anterior descending (LAD) coronary artery in Langendorff-perfused rabbit hearts with (ACh(+):n = 11) or without (ACh(-):n = 12) 10 mol/L ACh delivered continuously starting at 5 minutes before LAD ligation. Action potentials on the left ventricular (LV) anterior surface (approximate to 2x2 cm) were recorded by optical mapping during pacing from the LV epicardium (BCL = 500 milliseconds). Conduction velocities (CVs) at 256 sites were calculated and the ventricular tachycardia/ventricular fibrillation (VT/VF) susceptibility was also assessed by programmed electrical stimulation before and 30 minutes after MI. The amount and distribution of Gj protein connexin-43 was analyzed by immunoblotting and immunohistochemistry. ResultsAveraged CV in the ischemic border zone (IBZ) was significantly slower in ACh(-) than in ACh(+) (21 7 vs. 34 +/- 6 cm/s; P < 0.01). Short-coupled extra stimulus further decreased CV of IBZ in ACh(-) (13 +/- 4 cm/s) but did not change that in ACh(+) (34 +/- 5 cm/s), leading to a high incidence of conduction block in IBZ in ACh(-) but not in ACh(+) (83% vs. 0%). VT/VF after MI were induced in ACh(-) but suppressed in ACh(+) (10/12 vs. 3/11; P < 0.01). Connexin-43 in the LV anterior wall was significantly reduced after MI in ACh(-) but not in ACh(+). ConclusionACh may suppress VT/VF by preventing loss of Gj and improving CV in IBZ during acute MI.	[Aiba, Takeshi; Noda, Takashi] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Div Arrhythmia & Electrophysiol, Suita, Osaka 5658565, Japan; [Hidaka, Ichiro; Inagaki, Masashi; Sugimachi, Masaru] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Res Inst, Suita, Osaka 5658565, Japan; [Katare, Rajesh G.; Ando, Motonori; Sato, Takayuki] Kochi Med Sch, Dept Cardiovasc Control, Nankoku, Kochi, Japan; [Sunagawa, Kenji] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 812, Japan	Aiba, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Div Arrhythmia & Electrophysiol, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	aiba@hsp.ncvc.go.jp			Japan Science and Technology Agency; Ministry of Health, Labor and Welfare of Japan [H20-katsudo-Shitei-007, H21-trans-Ippan-013]	This study was supported by the Japan Science and Technology Agency and a Health and Labour Sciences Research grant for research on medical devices for analyzing, supporting, and substituting the function of the human body and by Health and Labor Sciences Research Grants (H20-katsudo-Shitei-007 and H21-trans-Ippan-013) from the Ministry of Health, Labor and Welfare of Japan.	Danik SB, 2004, CIRC RES, V95, P1035, DOI 10.1161/01.RES.0000148664.33695.2a; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; Liu YB, 2004, J CARDIOVASC ELECTR, V15, P1433, DOI 10.1046/j.1540-8167.2004.04337.x; Lerner DL, 2000, CIRCULATION, V101, P547; MYERS RW, 1974, CIRCULATION, V49, P943; Zhao JL, 2010, BRIT J PHARMACOL, V159, P1217, DOI 10.1111/j.1476-5381.2009.00606.x; ZUANETTI G, 1987, CIRC RES, V61, P429; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; Seo K, 2010, CIRC RES, V106, P176, DOI 10.1161/CIRCRESAHA.109.203828; Cabo C, 2006, CARDIOVASC RES, V72, P241, DOI 10.1016/j.cardiores.2006.07.005; Zaitsev AV, 2003, CIRC RES, V92, P546, DOI 10.1161/01.RES.0000061917.23107.F7; VANOLI E, 1991, CIRC RES, V68, P1471; Li M, 2004, CIRCULATION, V109, P120, DOI 10.1161/01.CIR.0000105721.71640.DA; Kakinuma Y, 2005, FEBS LETT, V579, P2111, DOI 10.1016/j.febslet.2005.02.065; ROSENSHTRAUKH L, 1994, CIRC RES, V75, P722; Beardslee MA, 2000, CIRC RES, V87, P656; Ando M, 2005, CIRCULATION, V112, P164, DOI 10.1161/CIRCULATIONAHA.104.525493; Aiba T, 2006, J AM COLL CARDIOL, V47, P2074, DOI 10.1016/j.jacc.2005.12.064; Zhang Y, 2006, J PHARMACOL SCI, V101, P214, DOI 10.1254/jphs.FP0051023; Zipes DP, 2006, HEART RHYTHM, V3, P108, DOI 10.1016/j.hrthm.2005.09.021; Zipes DP, 1998, CIRCULATION, V98, P2334; Brack KE, 2007, J PHYSIOL-LONDON, V583, P695, DOI 10.1113/jphysiol.2007.138461; Akar FG, 2007, AM J PHYSIOL-HEART C, V293, pH1223, DOI 10.1152/ajpheart.00079.2007; Betsuyaku T, 2004, CARDIOVASC PATHOL, V13, P156, DOI 10.1016/S1054-8807(03)00152-2; BOBAN M, 1993, J THORAC CARDIOV SUR, V105, P532; Chou CC, 2007, J PHYSIOL-LONDON, V580, P895, DOI 10.1113/jphysiol.2006.120659; Chowdhary S, 1999, CLIN SCI, V97, P5, DOI 10.1042/CS19980399; Dekker LRC, 1996, CIRC RES, V79, P237; DesGroot JR, 2004, CARDIOVASC RES, V62, P323; Gilleron J, 2006, J CELL PHYSIOL, V209, P153, DOI 10.1002/jcp.20716; Hund TJ, 2007, HEART RHYTHM, V4, P1183, DOI 10.1016/j.hrthm.2007.05.030; Inagaki M, 2004, Conf Proc IEEE Eng Med Biol Soc, V5, P3578; Liu HP, 2001, AM J PHYSIOL-HEART C, V281, pH191; Nygren Anders, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS113, DOI 10.1111/j.1540-8167.2006.00392.x; Ohara T, 2001, CIRCULATION, V103, P1465; Peters NS, 2000, J CARDIOVASC ELECTR, V11, P488, DOI 10.1111/j.1540-8167.2000.tb00348.x; Remme WJ, 1998, EUR HEART J, V19, pF62; ROSENSHTRAUKH LV, 1989, CIRC RES, V64, P213; Rueckschloss U, 2001, J PHYSIOL-LONDON, V537, P363, DOI 10.1111/j.1469-7793.2001.00363.x; Saffitz JE, 2004, CARDIAC ELECTROPHYSI, P181; Shinlapawittayatorn K, 2014, HEART RHYTHM, V11, P2278, DOI 10.1016/j.hrthm.2014.08.001; Sims JJ, 2003, AM J PHYSIOL-HEART C, V285, pH10, DOI 10.1152/ajpheart.01074.2002; TAKAHASHI N, 1992, CIRCULATION, V86, P1987; Verrecchia F, 1997, AM J PHYSIOL-CELL PH, V272, pC875; YAN GX, 1992, CIRC RES, V71, P460; Yao JA, 2003, CIRC RES, V92, P437, DOI 10.1161/01.RES.0000059301.81035.06; Zeevi-Levin N, 2005, CARDIOVASC RES, V66, P64, DOI 10.1016/j.cardiores.2005.01.014; Zheng C, 2005, P ANN INT IEEE EMBS, P7072	48	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	JUN	2015	26	6					678	685		10.1111/jce.12663		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CK1VG	WOS:000355995200014		
J	Nakahara, S; Tsutsumi, K; Zuinen, T; Ohta, Y				Nakahara, Shinichiro; Tsutsumi, Koji; Zuinen, Takuya; Ohta, Yasutaka			FilGAP, a Rho-ROCK-regulated GAP for Rac, controls adherens junctions in MDCK cells	JOURNAL OF CELL SCIENCE			English	Article						Rac; Rho; Adherens junctions; E-cadherin; EMT	EPITHELIAL ZONULA ADHERENS; SMALL G-PROTEINS; E-CADHERIN; ADHESION; ENDOCYTOSIS; GTPASES; GROWTH; LOCALIZATION; INTEGRITY; MIGRATION	Rho family small GTPases are essential for the formation of adherens junctions in epithelial cells. Here, we found that FilGAP (also known as ARHGAP24), a Rac-specific Rho GTPase-activating protein, promoted the formation of adherens junctions in Madin-Darby canine kidney (MDCK) cells. Knockdown of FilGAP by siRNA stimulated the disassembly and migration of MDCK cells induced by hepatocyte growth factor (HGF). By contrast, forced expression of FilGAP induced accumulation of E-cadherin at adherens junctions. Endogenous FilGAP colocalized with E-cadherin at adherens junctions, and depletion of FilGAP reduced the amount of E-cadherin expressed at the surface. The Rac GAP domain of FilGAP was necessary for the suppression of cell scattering induced by HGF. In agreement with this, siRNA-mediated knockdown of both Rac1 and FilGAP suppressed cell scattering induced by HGF. Forced expression of Rho kinase (ROCK, of which there are two isoforms ROCK1 and ROCK2) induced the accumulation of E-cadherin at the adherens junction, and depletion of FilGAP prevented the accumulation of E-cadherin. Moreover, wild-type FilGAP but not a non-phosphorylatable FilGAP mutant rescued the accumulation of E-cadherin at adherens junctions. These results suggest that FilGAP might regulate cell-cell adhesion through inactivation of Rac downstream of Rho-ROCK-signaling in MDCK cells.	[Nakahara, Shinichiro; Tsutsumi, Koji; Zuinen, Takuya; Ohta, Yasutaka] Kitasato Univ, Dept Biosci, Div Cell Biol, Sagamihara, Kanagawa 2520373, Japan	Ohta, Y (reprint author), Kitasato Univ, Dept Biosci, Div Cell Biol, Sagamihara, Kanagawa 2520373, Japan.	yohta@kitasato-u.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Kitasato University Research Grant for Young Researchers; Grant for All Kitasato Project Study	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant for All Kitasato Project Study, and Kitasato University Research Grant for Young Researchers.	Ratheesh A, 2012, NAT CELL BIOL, V14, P818, DOI 10.1038/ncb2532; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Kawaguchi K, 2014, J BIOL CHEM, V289, P9675, DOI 10.1074/jbc.M113.546051; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Kodama A, 2000, MOL BIOL CELL, V11, P2565; Akhtar N, 2001, MOL BIOL CELL, V12, P847; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Nakamura F, 2013, BIOCHEM J, V453, P17, DOI 10.1042/BJ20130290; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Matsuda M, 2008, EXP CELL RES, V314, P939, DOI 10.1016/j.yexcr.2007.11.009; Niessen CM, 2011, PHYSIOL REV, V91, P691, DOI 10.1152/physrev.00004.2010; Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Izumi G, 2004, J CELL BIOL, V166, P237, DOI 10.1083/jcb.200401078; RIDLEY AJ, 1995, MOL CELL BIOL, V15, P1110; Laser-Azogui A, 2014, ONCOGENE, V33, P1788, DOI 10.1038/onc.2013.138; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Brieher WM, 2013, CURR OPIN CELL BIOL, V25, P39, DOI 10.1016/j.ceb.2012.10.010; Lozano E, 2003, BIOESSAYS, V25, P452, DOI 10.1002/bies.10262; Saito K, 2012, MOL BIOL CELL, V23, P4739, DOI 10.1091/mbc.E12-04-0310; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Gentile A, 2008, ONCOGENE, V27, P5590, DOI 10.1038/onc.2008.173; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Bright MD, 2009, CELL SIGNAL, V21, P1738, DOI 10.1016/j.cellsig.2009.07.005; McCormack J, 2013, J CELL SCI, V126, P379, DOI 10.1242/jcs.097923; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Graveel CR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009209; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; Jia ZJ, 2006, BIOL CELL, V98, P337, DOI 10.1042/BC20050088; Lau KM, 2011, EXP CELL RES, V317, P539, DOI 10.1016/j.yexcr.2010.12.005; Ngok S. P., J CELL SCI, V127, P3205; Ngok SP, 2013, J CELL SCI, V126, P3271, DOI 10.1242/jcs.123869; Noren NK, 2003, J BIOL CHEM, V278, P13615, DOI 10.1074/jbc.C200657200; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881	39	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0021-9533	1477-9137		J CELL SCI	J. Cell Sci.	JUN 1	2015	128	11					2047	2056		10.1242/jcs.160192		10	Cell Biology	Cell Biology	CJ5VG	WOS:000355559600005		
J	Hyder, CL; Kemppainen, K; Isoniemi, KO; Imanishi, SY; Goto, H; Inagaki, M; Fazeli, E; Eriksson, JE; Tornquist, K				Hyder, Claire L.; Kemppainen, Kati; Isoniemi, Kimmo O.; Imanishi, Susumu Y.; Goto, Hidemasa; Inagaki, Masaki; Fazeli, Elnaz; Eriksson, John E.; Toernquist, Kid			Sphingolipids inhibit vimentin-dependent cell migration	JOURNAL OF CELL SCIENCE			English	Article						S1P; SPC; Vimentin; ROCK; Phosphorylation; Sphingosine 1-phosphate; Sphingosylphosphorylcholine; migration; S1P(2); S1PR2; Intermediate filament	INTERMEDIATE-FILAMENTS; RHO-KINASE; POSTTRANSLATIONAL MODIFICATIONS; SPHINGOSINE 1-PHOSPHATE; KERATIN REORGANIZATION; BREAST-CANCER; LIVING CELLS; TUMOR-CELLS; PHOSPHORYLATION; SPHINGOSYLPHOSPHORYLCHOLINE	The sphingolipids, sphingosine 1-phosphate (S1P) and sphingosylphosphorylcholine (SPC), can induce or inhibit cellular migration. The intermediate filament protein vimentin is an inducer of migration and a marker for epithelial-mesenchymal transition. Given that keratin intermediate filaments are regulated by SPC, with consequences for cell motility, we wanted to determine whether vimentin is also regulated by sphingolipid signalling and whether it is a determinant for sphingolipid-mediated functions. In cancer cells where S1P and SPC inhibited migration, we observed that S1P and SPC induced phosphorylation of vimentin on S71, leading to a corresponding reorganization of vimentin filaments. These effects were sphingolipid-signalling-dependent, because inhibition of either the S1P2 receptor (also known as S1PR2) or its downstream effector Rho-associated kinase (ROCK, for which there are two isoforms ROCK1 and ROCK2) nullified the sphingolipid-induced effects on vimentin organization and S71 phosphorylation. Furthermore, the anti-migratory effect of S1P and SPC could be prevented by expressing S71-phosphorylation-deficient vimentin. In addition, we demonstrated, by using wild-type and vimentin-knockout mouse embryonic fibroblasts, that the sphingolipid-mediated inhibition of migration is dependent on vimentin. These results imply that this newly discovered sphingolipid-vimentin signalling axis exerts brake-and-throttle functions in the regulation of cell migration.	[Hyder, Claire L.; Isoniemi, Kimmo O.; Imanishi, Susumu Y.; Eriksson, John E.] Univ Turku, Turku Ctr Biotechnol, FIN-20521 Turku, Finland; [Hyder, Claire L.; Isoniemi, Kimmo O.; Imanishi, Susumu Y.; Eriksson, John E.] Abo Akad Univ, FIN-20521 Turku, Finland; [Hyder, Claire L.; Kemppainen, Kati; Isoniemi, Kimmo O.; Fazeli, Elnaz; Eriksson, John E.; Toernquist, Kid] Abo Akad Univ, Dept Biosci, FI-20520 Turku, Finland; [Imanishi, Susumu Y.] Meijo Univ, Environm Sci Lab, Fac Pharm, Tempaku Ku, Nagoya, Aichi 4688503, Japan; [Goto, Hidemasa; Inagaki, Masaki] Aichi Canc Ctr, Res Inst, Div Biochem, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Goto, Hidemasa; Inagaki, Masaki] Nagoya Univ, Grad Sch Med, Dept Cellular Oncol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Toernquist, Kid] Biomedicum, Minerva Fdn, Inst Med Res, Helsinki 00290, Finland	Eriksson, JE (reprint author), Univ Turku, Turku Ctr Biotechnol, POB 123, FIN-20521 Turku, Finland.	john.eriksson@abo.fi; ktornqvi@abo.fi	Imanishi, Susumu/B-8697-2014	Imanishi, Susumu/0000-0002-3641-4390	Sigrid Juselius Foundation; Liv och Halsa Foundation; Academy of Finland; Centre of Excellence in Cell Stress and Molecular Ageing (Abo Akademi University); Abo Akademi University; Finnish Cultural Foundation; Ida Montin Foundation; K. Albin Johansson Foundation; Tor, Joe and Pentti Borg Foundation; Arvid and Greta Olin Foundation; Receptor Research Program (Abo Akademi University); Receptor Research Program (University of Turku)	This study was supported by the Sigrid Juselius Foundation; the Liv och Halsa Foundation; The Academy of Finland; the Centre of Excellence in Cell Stress and Molecular Ageing (Abo Akademi University); Abo Akademi University; Finnish Cultural Foundation; Ida Montin Foundation; the K. Albin Johansson Foundation; the Tor, Joe and Pentti Borg Foundation; the Arvid and Greta Olin Foundation; and the Receptor Research Program (Abo Akademi University and the University of Turku).	Alewijnse AE, 2006, BRIT J PHARMACOL, V147, P347, DOI 10.1038/sj.bjp.0706602; Alix-Panabieres C, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2326; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Chung BM, 2013, CURR OPIN CELL BIOL, V25, P600, DOI 10.1016/j.ceb.2013.06.008; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Kankaanpaa P, 2012, NAT METHODS, V9, P683, DOI [10.1038/nmeth.2047, 10.1038/NMETH.2047]; Sellappan S, 2004, CANCER RES, V64, P3479, DOI 10.1158/0008-5472.CAN-3299-2; Adada M, 2013, FEBS J, V280, P6354, DOI 10.1111/febs.12446; Pan YR, 2011, J CELL BIOL, V195, P113, DOI 10.1083/jcb.201103016; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Sin WC, 1998, MOL CELL BIOL, V18, P6325; Shi JJ, 2007, ARCH IMMUNOL THER EX, V55, P61, DOI 10.1007/s00005-007-0009-7; Hyder CL, 2011, J CELL SCI, V124, P1363, DOI 10.1242/jcs.041244; Lepley D, 2005, CANCER RES, V65, P3788, DOI 10.1158/0008-5472.CAN-04-2311; Kim H, 2010, AM J PHYSIOL-CELL PH, V298, pC221, DOI 10.1152/ajpcell.00323.2009; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Nixon GF, 2008, PROG LIPID RES, V47, P62, DOI 10.1016/j.plipres.2007.11.001; Eckes B, 1998, J CELL SCI, V111, P1897; Busch T, 2012, J CELL SCI, V125, P2148, DOI 10.1242/jcs.080127; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Helfand BT, 2011, MOL BIOL CELL, V22, P1274, DOI 10.1091/mbc.E10-08-0699; Bauer PO, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-43; Izawa I, 2006, CANCER SCI, V97, P167, DOI 10.1111/j.1349-7006.2006.00161.x; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Eckes B, 2000, J CELL SCI, V113, P2455; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Goto H, 1998, J BIOL CHEM, V273, P11728, DOI 10.1074/jbc.273.19.11728; Beil M, 2003, NAT CELL BIOL, V5, P803, DOI 10.1038/ncb1037; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Hyder CL, 2008, FEBS LETT, V582, P2140, DOI 10.1016/j.febslet.2008.04.064; Park MK, 2011, BBA-MOL CELL BIOL L, V1811, P1021, DOI 10.1016/j.bbalip.2011.07.007; Lund N, 2010, BIOCHEM BIOPH RES CO, V395, P401, DOI 10.1016/j.bbrc.2010.04.033; Svitkina TM, 1996, J CELL BIOL, V135, P991, DOI 10.1083/jcb.135.4.991; Asghar MY, 2012, ENDOCR-RELAT CANCER, V19, P667, DOI 10.1530/ERC-12-0092; Robert A, 2014, FASEB J, V28, P2879, DOI 10.1096/fj.14-250019; Barberis L, 2009, EUR J IMMUNOL, V39, P1136, DOI 10.1002/eji.200838884; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chernoivanenko I S, 2013, Ontogenez, V44, P186; Dave JM, 2013, J BIOL CHEM, V288, P30720, DOI 10.1074/jbc.M113.512467; Fois G, 2013, FASEB J, V27, P1322, DOI 10.1096/fj.12-215632; Imanishi SY, 2007, MOL CELL PROTEOMICS, V6, P1380, DOI 10.1074/mcp.M600480-MCP200; Inada H, 1999, J BIOL CHEM, V274, P34932, DOI 10.1074/jbc.274.49.34932; Ivaska J, 2011, SMALL GTPASES, V2, P51, DOI DOI 10.4161/SGTP.2.1.15114; Iyer SV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053532; Jakobs KH, 2007, BIOCHIM BIOPHYS ACTA, V1768, P923, DOI DOI 10.1016/J.BBAMEM.2006.09.026.PUBMED:17078925; Lei S, 2013, CELL BIOCHEM BIOPHYS, V67, P1333, DOI 10.1007/s12013-013-9665-x; Li Jing, 2013, J Mol Signal, V8, P6, DOI 10.1186/1750-2187-8-6; Nakamura Y, 2000, GENES CELLS, V5, P823, DOI 10.1046/j.1365-2443.2000.00372.x; Pallari HM, 2006, SCI STKE, V2006, pe53; Pallari HM, 2011, MOL BIOL CELL, V22, P1539, DOI 10.1091/mbc.E10-07-0568; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Tobo M, 2007, CELL SIGNAL, V19, P1745, DOI 10.1016/j.cellsig.2007.03.009; Yokoyama T, 2005, GENES CELLS, V10, P127, DOI 10.1111/j.1365-2443.2005.00824.x; Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147	58	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0021-9533	1477-9137		J CELL SCI	J. Cell Sci.	JUN 1	2015	128	11					2057	2069		10.1242/jcs.160341		13	Cell Biology	Cell Biology	CJ5VG	WOS:000355559600006		
J	Ibuka, S; Matsumoto, S; Fujii, S; Kikuchi, A				Ibuka, Souji; Matsumoto, Shinji; Fujii, Shinsuke; Kikuchi, Akira			The P2Y(2) receptor promotes Wnt3a-and EGF-induced epithelial tubular formation by IEC6 cells by binding to integrins	JOURNAL OF CELL SCIENCE			English	Article						Fibronectin; Integrins; Tubulogenesis; P2Y(2)R; Wnt; EGF	PRIMARY CORTICAL-NEURONS; BRANCHING MORPHOGENESIS; TGF-BETA; UP-REGULATION; GROWTH; ACTIVATION; EXPRESSION; SIGNAL; WNT; RGD	Epithelial tubular structures are essential units in various organs. Here, we used rat intestinal epithelial IEC6 cells to investigate tubulogenesis and we found that tubular formation was induced by a combination of Wnt3a and EGF signaling during three-dimensional culture. Wnt3a and EGF induced the expression of the P2Y(2) receptor (P2Y(2)R, also known as P2RY2), and knockdown of P2Y(2)R suppressed tubular formation. A P2Y(2)R mutant that lacks nucleotide responsiveness rescued the phenotypes resulting from P2Y(2)R knockdown, suggesting that nucleotide-dependent responses are not required for P2Y(2)R functions in tubular formation. The Arg-Gly-Asp (RGD) sequence of P2Y(2)R has been shown to interact with integrins, and a P2Y(2)R mutant lacking integrin-binding activity was unable to induce tubular formation. P2Y(2)R expression inhibited the interaction between integrins and fibronectin, and induced cell morphological changes and proliferation. Inhibition of integrin and fibronectin binding by treatment with the cyclic RGD peptide and fibronectin knockdown induced tubular formation in the presence of EGF alone, but a fibronectin coat suppressed Wnt3a- and EGF-induced tubular formation. These results suggest that Wnt3a- and EGF-induced P2Y(2)R expression causes tubular formation by preventing the binding of integrins and fibronectin rather than by mediating nucleotide responses.	[Ibuka, Souji; Matsumoto, Shinji; Fujii, Shinsuke; Kikuchi, Akira] Osaka Univ, Dept Mol Biol & Biochem, Grad Sch Med, Suita, Osaka 5650871, Japan; [Ibuka, Souji] Osaka Univ, Grad Sch Med, Dept Pediat Surg, Suita, Osaka 5650871, Japan	Kikuchi, A (reprint author), Osaka Univ, Dept Mol Biol & Biochem, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	akikuchi@molbiobc.med.osaka-u.ac.jp			Ministry of Education, Science, and Culture of Japan [25250018, 25861669, 25860211, 26861547, 23112004]; Uehara Memorial Foundation	This work was supported by Ministry of Education, Science, and Culture of Japan Grants-in-Aid for Scientific Research [grant numbers 25250018 to A.K., 25861669 to S.I., 25860211 to S.M., 26861547 to S.F.] and Grants-in-Aid for Scientific Research on Innovative Areas [grant number 23112004 to A.K.]; and by grants from the Uehara Memorial Foundation (2014).	Komekado H, 2007, GENES CELLS, V12, P521, DOI 10.1111/j.1365-2443.2007.01068.x; Chorna NE, 2007, J CELL PHYSIOL, V211, P410, DOI 10.1002/jcp.20946; Hillmann P, 2009, J MED CHEM, V52, P2762, DOI 10.1021/jm801442p; Moore DJ, 2001, BBA-GENE STRUCT EXPR, V1521, P107, DOI 10.1016/S0167-4781(01)00291-3; Kong Q, 2009, J NEUROCHEM, V109, P1300, DOI 10.1111/j.1471-4159.2009.06048.x; Erb L, 2001, J CELL BIOL, V153, P491, DOI 10.1083/jcb.153.3.491; Grbic DM, 2008, J IMMUNOL, V180, P2659; Bagchi S, 2005, J BIOL CHEM, V280, P39050, DOI 10.1074/jbc.M504819200; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Lu PF, 2008, SCIENCE, V322, P1506, DOI 10.1126/science.1162783; McCarthy TL, 2010, MOL ENDOCRINOL, V24, P587, DOI 10.1210/me.2009-0379; Burnstock G, 2006, BRIT J PHARMACOL, V147, pS172, DOI 10.1038/sj.bjp.0706429; Peterson TS, 2013, J NEUROCHEM, V125, P885, DOI 10.1111/jnc.12252; Uttamsingh S, 2008, ONCOGENE, V27, P2626, DOI 10.1038/sj.onc.1210915; Miyoshi H, 1998, J VIROL, V72, P8150; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Kim HJ, 2012, J NEUROCHEM, V121, P228, DOI 10.1111/j.1471-4159.2012.07700.x; Steinberg Z, 2005, DEVELOPMENT, V132, P1223, DOI 10.1242/dev.01690; Miyazono K, 2004, ONCOGENE, V23, P4232, DOI 10.1038/sj.onc.1207131; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Zegers MMP, 2003, TRENDS CELL BIOL, V13, P169, DOI 10.1016/S0962-8924(03)00036-9; Kishida S, 2004, MOL CELL BIOL, V24, P4487, DOI 10.1128/.24.10.4487-4501.2004; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Datta A, 2011, CURR BIOL, V21, pR126, DOI 10.1016/j.cub.2010.12.003; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; PFAFF M, 1994, J BIOL CHEM, V269, P20233; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; ANZANO MA, 1982, CANCER RES, V42, P4776; Burd CG, 2004, TRENDS CELL BIOL, V14, P687, DOI 10.1016/j.tcb.2004.10.004; Degagne E, 2013, J CELL PHYSIOL, V228, P99, DOI 10.1002/jcp.24109; ERB L, 1995, J BIOL CHEM, V270, P4185; GUMBINER BM, 1992, CELL, V69, P385, DOI 10.1016/0092-8674(92)90440-N; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Jiang ST, 2000, KIDNEY INT, V57, P1860, DOI 10.1046/j.1523-1755.2000.00035.x; Komoszynski M, 1996, BBA-MOL CELL RES, V1310, P233, DOI 10.1016/0167-4889(95)00135-2; Liao ZJ, 2007, J CELL SCI, V120, P1654, DOI 10.1242/jcs.03441; Matsumoto S, 2014, EMBO J, V33, P702, DOI 10.1002/embj.201386942; Ohtsuka N, 2001, DEV DYNAM, V222, P263, DOI 10.1002/dvdy.1206; Patel BA, 2011, BIOSENS BIOELECTRON, V26, P2890, DOI 10.1016/j.bios.2010.11.033; Qi AD, 2005, J BIOL CHEM, V280, P29169, DOI 10.1074/jbc.M501301200; SANTOS OFP, 1993, DEV BIOL, V160, P293, DOI 10.1006/dbio.1993.1308; Singh Anurag, 2010, J Mol Signal, V5, P11, DOI 10.1186/1750-2187-5-11; Xu J., 2011, FIBRONECTIN OTHER AD; Xu YR, 2010, MOL BIOL CELL, V21, P29, DOI 10.1091/mbc.E09-08-0710; Yan S, 2000, J CELL PHYSIOL, V185, P107, DOI 10.1002/1097-4652(200010)185:1<107::AID-JCP10>3.0.CO;2-D; Zhang Xing, 2012, Methods Mol Biol, V886, P13, DOI 10.1007/978-1-61779-851-1_2	49	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0021-9533	1477-9137		J CELL SCI	J. Cell Sci.	JUN 1	2015	128	11					2156	2168		10.1242/jcs.169060		13	Cell Biology	Cell Biology	CJ5VG	WOS:000355559600014		
J	Holland, PR; Searcy, JL; Salvadores, N; Scullion, G; Chen, GQ; Lawson, G; Scott, F; Bastin, ME; Ihara, M; Kalaria, R; Wood, ER; Smith, C; Wardlaw, JM; Horsburgh, K				Holland, Philip R.; Searcy, James L.; Salvadores, Natalia; Scullion, Gillian; Chen, Guiquan; Lawson, Greig; Scott, Fiona; Bastin, Mark E.; Ihara, Masafumi; Kalaria, Rajesh; Wood, Emma R.; Smith, Colin; Wardlaw, Joanna M.; Horsburgh, Karen			Gliovascular disruption and cognitive deficits in a mouse model with features of small vessel disease	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						cognition; diffusion-tensor imaging; hypoperfusion; magnetic resonance imaging; small vessel disease	WHITE-MATTER LESIONS; SPONTANEOUSLY HYPERTENSIVE RATS; BLOOD-BRAIN-BARRIER; CEREBRAL HYPOPERFUSION; VASCULAR DEMENTIA; LACUNAR STROKE; RISK-FACTORS; ACTIVATION; MECHANISMS; INTEGRITY	Cerebral small vessel disease (SVD) is a major cause of age-related cognitive impairment and dementia. The pathophysiology of SVD is not well understood and is hampered by a limited range of relevant animal models. Here, we describe gliovascular alterations and cognitive deficits in a mouse model of sustained cerebral hypoperfusion with features of SVD (microinfarcts, hemorrhage, white matter disruption) induced by bilateral common carotid stenosis. Multiple features of SVD were determined on T2-weighted and diffusion-tensor magnetic resonance imaging scans and confirmed by pathologic assessment. These features, which were absent in sham controls, included multiple T2-hyperintense infarcts and T2-hypointense hemosiderin-like regions in subcortical nuclei plus increased cerebral atrophy compared with controls. Fractional anisotropy was also significantly reduced in several white matter structures including the corpus callosum. Investigation of gliovascular changes revealed a marked increase in microvessel diameter, vascular wall disruption, fibrinoid necrosis, hemorrhage, and blood brain barrier alterations. Widespread reactive gliosis, including displacement of the astrocytic water channel, aquaporin 4, was observed. Hypoperfused mice also demonstrated deficits in spatial working and reference memory tasks. Overall, gliovascular disruption is a prominent feature of this mouse, which could provide a useful model for early-phase testing of potential SVD treatment strategies.	[Holland, Philip R.; Horsburgh, Karen] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Ctr Neuroregenerat, Edinburgh EH16 4SB, Midlothian, Scotland; [Searcy, James L.; Salvadores, Natalia; Scullion, Gillian; Chen, Guiquan; Lawson, Greig; Scott, Fiona] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh EH16 4SB, Midlothian, Scotland; [Bastin, Mark E.; Wardlaw, Joanna M.] Univ Edinburgh, Ctr Clin Brain Sci, Platform Sci Collaborat SINAPSE, Ctr Cognit Ageing & Cognit Epidemiol,Scottish Ima, Edinburgh EH16 4SB, Midlothian, Scotland; [Ihara, Masafumi] Natl Cerebral & Cardiovasc Ctr Hosp, Dept Stroke & Cerebrovasc Dis, Osaka, Japan; [Kalaria, Rajesh] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wood, Emma R.] Univ Edinburgh, Ctr Cognit & Neural Syst, Edinburgh EH16 4SB, Midlothian, Scotland; [Wood, Emma R.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH16 4SB, Midlothian, Scotland; [Smith, Colin] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh EH16 4SB, Midlothian, Scotland	Horsburgh, K (reprint author), Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Ctr Neuroregenerat, Chancellors Bldg,49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland.	karen.horsburgh@ed.ac.uk		Ihara, Masafumi/0000-0002-7102-4048	Help the Aged/Age UK (Disconnected Mind programme); Alzheimer Society; Alzheimer Research UK; AXA Research Fund; University of Edinburgh Centre for Cognitive Aging and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative [G0700704/84698]	This work was supported by grants from Help the Aged/Age UK (Disconnected Mind programme), the Alzheimer Society, Alzheimer Research UK, AXA Research Fund, and The University of Edinburgh Centre for Cognitive Aging and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (G0700704/84698). The Scottish Funding Council and the British Heart Foundation provided the MRI scanner (BHF CI/05/004).	TAGAMI M, 1987, STROKE, V18, P733; Dichgans M, 2002, STROKE, V33, P67, DOI 10.1161/hs0102.100885; van Norden AGW, 2012, BBA-MOL BASIS DIS, V1822, P401, DOI 10.1016/j.bbadis.2011.04.008; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Brittain JF, 2013, J CEREBR BLOOD F MET, V33, P760, DOI 10.1038/jcbfm.2013.14; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Steiner E, 2012, GLIA, V60, P1646, DOI 10.1002/glia.22383; Wang MH, 2012, J NEUROSCI, V32, P17948, DOI 10.1523/JNEUROSCI.1860-12.2012; Fernando MS, 2006, STROKE, V37, P1391, DOI 10.1161/01.STR.0000221308.94473.14; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7; Kalaria RN, 2012, STROKE, V43, P2526, DOI 10.1161/STROKEAHA.112.655803; Fernando MS, 2004, J NEUROL SCI, V226, P13, DOI 10.1016/j.jns.2004.09.004; Gouw AA, 2011, J NEUROL NEUROSUR PS, V82, P126, DOI 10.1136/jnnp.2009.204685; Farkas E, 2004, ACTA NEUROPATHOL, V108, P57, DOI 10.1007/s00401-004-0864-9; Maniega SM, 2015, NEUROBIOL AGING, V36, P909, DOI 10.1016/j.neurobiolaging.2014.07.048; Bailey EL, 2009, STROKE, V40, pE451, DOI 10.1161/STROKEAHA.108.528430; van Dijk EJ, 2008, STROKE, V39, P2712, DOI 10.1161/STROKEAHA.107.513176; TAGAMI M, 1990, STROKE, V21, P1064; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Reimer MM, 2011, J NEUROSCI, V31, P18185, DOI 10.1523/JNEUROSCI.4936-11.2011; Wardlaw JM, 2014, NEUROLOGY, V82, P1331, DOI 10.1212/WNL.0000000000000312; Hainsworth AH, 2008, J CEREBR BLOOD F MET, V28, P1877, DOI 10.1038/jcbfm.2008.91; Benavente OR, 2013, LANCET, V382, P507, DOI 10.1016/S0140-6736(13)60852-1; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Nishio K, 2010, STROKE, V41, P1278, DOI 10.1161/STROKEAHA.110.581686; Wolburg-Buchholz K, 2009, ACTA NEUROPATHOL, V118, P219, DOI 10.1007/s00401-009-0558-4; Bailey EL, 2011, NEUROPATH APPL NEURO, V37, P711, DOI 10.1111/j.1365-2990.2011.01170.x; Roman GC, 2002, LANCET NEUROL, V1, P426, DOI 10.1016/S1474-4422(02)00190-4; Braun H, 2012, J NEUROL SCI, V322, P71, DOI 10.1016/j.jns.2012.06.013; Coltman R, 2011, NEUROBIOL AGING, V32, p[2324, e2327]; Craggs LJL, 2014, BRAIN PATHOL, V24, P495, DOI 10.1111/bpa.12177; Dong YF, 2011, HYPERTENSION, V58, P635, DOI 10.1161/HYPERTENSIONAHA.111.173534; Fuchtemeier M, 2015, J CEREBR BLOOD F MET, V35, P476, DOI 10.1038/jcbfm.2014.221; Holland PR, 2011, NEUROBIOL AGING, V32, p[2325, e2321]; Holland PR, 2015, J CEREBR BLOOD F MET, V35, P188, DOI 10.1038/jcbfm.2014.201; Niklass Solveig, 2014, Exp Transl Stroke Med, V6, P1, DOI 10.1186/2040-7378-6-1; Potter GM, 2012, CEREBROVASC DIS, V33, P378, DOI 10.1159/000336762	37	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JUN	2015	35	6					1005	1014		10.1038/jcbfm.2015.12		10	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	CJ6AO	WOS:000355575600015		
J	Giannou, AD; Marazioti, A; Spella, M; Kanellakis, NI; Apostolopoulou, H; Psallidas, L; Prijovich, ZM; Vreka, M; Zazara, DE; Lilis, L; Papaleonidopoulos, V; Kairi, CA; Patmanidi, AL; Giopanou, J; Spiropoulou, N; Harokopos, V; Aidinis, V; Spyratos, D; Teliousi, S; Papadaki, H; Taraviras, S; Snyder, LA; Eickelberg, O; Kardamakis, D; Iwakura, V; Feyerabend, TB; Rodewald, HR; Kalomenidis, L; Blackwell, TS; Agalloti, T; Stathopoulos, GT				Giannou, Anastasios D.; Marazioti, Antonia; Spella, Magda; Kanellakis, Nikolaos I.; Apostolopoulou, Hara; Psallidas, Loannis; Prijovich, Zeljko M.; Vreka, Malamati; Zazara, Dimitra E.; Lilis, Loannis; Papaleonidopoulos, Vassilios; Kairi, Chrysoula A.; Patmanidi, Alexandra L.; Giopanou, Joanna; Spiropoulou, Nikolitsa; Harokopos, Vaggelis; Aidinis, Vassilis; Spyratos, Dionisios; Teliousi, Stamatia; Papadaki, Helen; Taraviras, Stavros; Snyder, Linda A.; Eickelberg, Oliver; Kardamakis, Dimitrios; Iwakura, Voichiro; Feyerabend, Thorsten B.; Rodewald, Hans-Reimer; Kalomenidis, Loannis; Blackwell, Timothy S.; Agalloti, Theodora; Stathopoulos, Georgios T.			Mast cells mediate malignant pleural effusion formation	JOURNAL OF CLINICAL INVESTIGATION			English	Article							FACTOR-KAPPA-B; C-KIT GENE; LUNG ADENOCARCINOMA; TUMOR PROGRESSION; BONE-MARROW; MOUSE MODEL; STEM-CELLS; CANCER; MICE; INFLAMMATION	Mast cells (MCs) have been identified in various tumors; however, the role of these cells in tumorigenesis remains controversial. Here, we quantified MCs in human and murine malignant pleural effusions (MPEs) and evaluated the fate and function of these cells in MPE development. Evaluation of murine MPE-competent lung and colon adenocarcinomas revealed that these tumors actively attract and subsequently degranulate MCs in the pleural space by elaborating CCL2 and osteopontin. MCs were required for effusion development, as MPEs did not form in mice lacking MCs, and pleural infusion of MCs with MPE-incompetent cells promoted MPE formation. Once homed to the pleural space, MCs released tryptase AB1 and IL-1 beta, which in turn induced pleural vasculature leakiness and triggered NF-kappa B activation in pleural tumor cells, thereby fostering pleural fluid accumulation and tumor growth. Evaluation of human effusions revealed that MCs are elevated in MPEs compared with benign effusions. Moreover, MC abundance correlated with MPE formation in a human cancer cell-induced effusion model. Treatment of mice with the c-KIT inhibitor imatinib mesylate limited effusion precipitation by mouse and human adenbcarcinoma cells. Together, the results of this study indicate that MCs are required for MPE formation and suggest that MC-dependent effusion formation is therapeutically addressable.	[Giannou, Anastasios D.; Marazioti, Antonia; Spella, Magda; Apostolopoulou, Hara; Psallidas, Loannis; Prijovich, Zeljko M.; Vreka, Malamati; Zazara, Dimitra E.; Lilis, Loannis; Papaleonidopoulos, Vassilios; Kairi, Chrysoula A.; Giopanou, Joanna; Spiropoulou, Nikolitsa; Agalloti, Theodora] Univ Patras, Fac Med, Dept Physiol, Lab Mol Resp Carcinogenesis, Rion, Achaia, Greece; [Kanellakis, Nikolaos I.; Patmanidi, Alexandra L.; Taraviras, Stavros] Univ Patras, Fac Med, Dept Physiol, Stem Cell Biol Lab, Rion, Achaia, Greece; [Psallidas, Loannis] Churchill Hosp, Oxford Ctr Resp Med, Oxford OX3 7LJ, England; [Kairi, Chrysoula A.; Kalomenidis, Loannis; Stathopoulos, Georgios T.] Univ Athens, Gen Hosp Evangelismos, Sch Med, Dept Crit Care & Pulm Med 1, Athens, Attica, Greece; [Harokopos, Vaggelis] Biomed Sci Res Ctr BSRC, Express Profiling Unit, Vari, Attica, Greece; [Aidinis, Vassilis] Biomed Sci Res Ctr BSRC, Div Immunol, Vari, Attica, Greece; [Spyratos, Dionisios] Aristotle Univ Thessaloniki, Hosp G Papanikolaau, Fac Med, Dept Pulm Med, GR-54006 Thessaloniki, Greece; [Teliousi, Stamatia] Hosp G Papanikolaou, Dept Cytol, Thessaloniki, Greece; [Papadaki, Helen] Univ Patras, Fac Med, Dept Anat, Rion, Achaia, Greece; [Snyder, Linda A.] Janssen R&D LLC, Oncol Discovery Res, Spring House, PA USA; [Eickelberg, Oliver; Stathopoulos, Georgios T.] Univ Munich, Univ Hosp, CPC, Munich, Germany; [Eickelberg, Oliver; Stathopoulos, Georgios T.] Helmholtz Zentrum Munchen, Munich, Germany; [Kardamakis, Dimitrios] Univ Patras, Fac Med, Dept Radiat Oncol & Stereotact Radiotherapy, Rion, Achaia, Greece; [Iwakura, Voichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Tokyo 162, Japan; [Feyerabend, Thorsten B.; Rodewald, Hans-Reimer] Deutsch Krebsforsch Zentrum DKFZ, Div Cellular Immunol, Heidelberg, Baden Wurttembe, Germany; [Blackwell, Timothy S.; Stathopoulos, Georgios T.] Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37212 USA	Stathopoulos, GT (reprint author), Univ Patras, Fac Med, 1 Asklepiou St,Univ Campus, Rion 26504, Greece.	amarazioti@upatras.gr; gstathop@upatras.gr		Psallidas, Ioannis/0000-0001-7284-0111; MARAZIOTI, ANTONIA/0000-0002-1978-1121	European Research Council [260524, 233074]; Hellenic Thoracic Society; European Respiratory Society; Romain Pauwels Research Awards; European Respiratory Society Long Term Research Fellowship; Thorax Foundation (Athens, Greece); US NIH [HL61419]; VA Merit Review Grants; Ruprecht-Karls-University Heidelberg [SFB 938]	This work was supported by European Research Council 2010 Starting Independent (260524 to G.T. Stathopoulos) and 2009 Advanced (233074 to H.R. Rodewald) Investigator Grants, by a Hellenic Thoracic Society 2012 Research Award (to A.D. Giannou and G.T. Stathopoulos), by European Respiratory Society 2009 Maurizio Vignola and 2013 Romain Pauwels Research Awards (to G.T. Stathopoulos), by a 2013 European Respiratory Society Long Term Research Fellowship (1824 to I. Psallidas), by a Thorax Foundation (Athens, Greece) 2006 Fellowship (to G.T. Stathopoulos), by US NIH (HL61419) and VA Merit Review Grants (to T.S. Blackwell), and by Ruprecht-Karls-University Heidelberg SFB 938 Project L (to H.R. Rodewald). The authors thank the University of Patras Center for Animal Models of Disease and Advanced Light Microscopy Core for experimental support, Panagiota Stamou and Alexandros Spiridonidis for flow cytometry support, Charis Roussos and Androniki Kollintza for insightful discussions, and Georgia Papaspyrou for editorial assistance.	Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Stathopoulos GT, 2012, AM J RESP CRIT CARE, V186, P487, DOI 10.1164/rccm.201203-0465PP; Yeh HH, 2006, ONCOGENE, V25, P4300, DOI 10.1038/sj.onc.1209464; Prieto-Garcia A, 2012, J BIOL CHEM, V287, P7834, DOI 10.1074/jbc.M111.325712; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Blair RJ, 1997, J CLIN INVEST, V99, P2691, DOI 10.1172/JCI119458; Floor SL, 2012, TRENDS MOL MED, V18, P509, DOI 10.1016/j.molmed.2012.06.005; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Chen CC, 2005, P NATL ACAD SCI USA, V102, P11408, DOI 10.1073/pnas.0504197102; Wu SG, 2013, EUR RESPIR J, V41, P1409, DOI 10.1183/09031936.00069812; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; Chen RY, 2001, J CLIN INVEST, V108, P1151; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Postmus PE, 2007, J THORAC ONCOL, V2, P686, DOI 10.1097/JTO.0b013e31811f4703; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Brickshawana A, 2011, J IMMUNOL, V187, P5795, DOI [10.4049/jimmunol.1102242, 10.4049/jiminunol.1102242]; TONO T, 1992, BLOOD, V80, P1448; Stathopoulos GT, 2008, J NATL CANCER I, V100, P1464, DOI 10.1093/jnci/djn325; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Kitaura J, 2005, BLOOD, V105, P3222, DOI 10.1182/blood-2004-11-4205; Balkwill FR, 2012, SEMIN CANCER BIOL, V22, P33, DOI 10.1016/j.semcancer.2011.12.005; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Theoharides TC, 2007, IMMUNOL REV, V217, P65, DOI 10.1111/j.1600-065X.2007.00519.x; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; Sinnamon MJ, 2008, CARCINOGENESIS, V29, P880, DOI 10.1093/carcin/bgn040; Swamy M, 2010, NAT IMMUNOL, V11, P656, DOI 10.1038/ni.1905; Wolters PJ, 2005, CLIN EXP ALLERGY, V35, P82, DOI 10.1111/j.1365-2222.2005.02136.x; Ryu JS, 2014, J CLIN ONCOL, V32, P960, DOI 10.1200/JCO.2013.50.5453; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Chen J, 2009, AM J PATHOL, V174, P701, DOI 10.2353/ajpath.2009.080606; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Stathopoulos GT, 2006, AM J RESP CELL MOL, V34, P142, DOI 10.1165/rcmb.2005-0130OC; Dalton DK, 2012, CANCER IMMUNOL IMMUN, V61, P1511, DOI 10.1007/s00262-012-1246-0; Burgers JA, 2008, EUR RESPIR J, V32, P1321, DOI 10.1183/09031936.00165607; Coussens LM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003285; Davies HE, 2013, CURR OPIN PULM MED, V19, P374, DOI 10.1097/MCP.0b013e3283615b67; Dong G, 1999, CANCER RES, V59, P3495; FUJIWARA M, 1987, ANAL BIOCHEM, V166, P72, DOI 10.1016/0003-2697(87)90547-1; Maaninka K, 2013, J ALLERGY CLIN IMMUN, V132, P463, DOI 10.1016/j.jaci.2013.02.011; Marazioti A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071207; Marazioti A, 2014, AM J RESP CRIT CARE, V189, P626, DOI 10.1164/rccm.201401-0140ED; Nakamura Y, 2012, IMMUNITY, V37, P85, DOI 10.1016/j.immuni.2012.04.013; Pittoni P, 2012, CANCER RES, V72, P831, DOI 10.1158/0008-5472.CAN-11-3110; Psallidas I, 2013, ONCOGENE, V32, P528, DOI 10.1038/onc.2012.57; Roberts Mark E, 2010, Thorax, V65 Suppl 2, pii32, DOI 10.1136/thx.2010.136994; Stathopoulos GT, 2010, AM J RESP CRIT CARE, V182, P1273, DOI [10.1164/rccm.201001-0001OC, 10.1164/rccm.201001.0001OC]; Stathopoulos GT, 2007, CANCER RES, V67, P9825, DOI 10.1158/0008-5472.CAN-07-1064; Theoharides TC, 2008, NEW ENGL J MED, V358, P1860, DOI 10.1056/NEJMcibr0801519; Tilley SL, 2000, J CLIN INVEST, V105, P361, DOI 10.1172/JCI8253; Tsui Ping, 2007, Human Antibodies, V16, P117; Voehringer D, 2008, J IMMUNOL, V180, P4742; YAMAZAKI M, 1994, BLOOD, V83, P3509; ZHANG Y, 1991, J CLIN INVEST, V88, P841, DOI 10.1172/JCI115385	59	3	3	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	JUN	2015	125	6					2317	2334		10.1172/JCI79840		18	Medicine, Research & Experimental	Research & Experimental Medicine	CJ5ZX	WOS:000355573900020		
J	Strougo, A; Yassen, A; Danhof, M; Freijer, J				Strougo, A.; Yassen, A.; Danhof, M.; Freijer, J.			Mechanistic Versus Allometric Models for the Prediction of Drug Clearance in Neonates (< 3 Months of Age) Response	JOURNAL OF CLINICAL PHARMACOLOGY			English	Letter							EXPONENT		[Strougo, A.; Danhof, M.] Leiden Univ, Div Pharmacol, NL-2300 RA Leiden, Netherlands; [Yassen, A.; Freijer, J.] Astellas Pharma, Global Clin Pharmacol & Exploratory Dev, Tokyo, Japan	Strougo, A (reprint author), Leiden Univ, Div Pharmacol, NL-2300 RA Leiden, Netherlands.						Strougo A, 2012, J PHARMACOKINET PHAR, V39, P195, DOI 10.1007/s10928-012-9241-9; Strougo A, 2011, DRUG METAB DISPOS, V39, P1278, DOI 10.1124/dmd.110.037838; Wang CG, 2013, CLIN DRUG INVEST, V33, P523, DOI 10.1007/s40261-013-0097-6; Strougo A, 2014, J CLIN PHARMACOL, V54, P1006, DOI 10.1002/jcph.294; Wang CG, 2014, BRIT J CLIN PHARMACO, V77, P149, DOI 10.1111/bcp.12180	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0091-2700	1552-4604		J CLIN PHARMACOL	J. Clin. Pharmacol.	JUN	2015	55	6					721	721		10.1002/jcph.490		1	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CK0BO	WOS:000355869100014		
J	Doneray, H; Usui, T; Kaya, A; Donmez, AS				Doneray, Hakan; Usui, Takeshi; Kaya, Avni; Donmez, Ayse Sena			The First Turkish Case of Hypoparathyroidism, Deafness and Renal Dysplasia (HDR) Syndrome	JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY			English	Article						HDR syndrome; infant; p.R367X mutation	GATA3 TRANSCRIPTION FACTOR; MUTATION; FAMILY; GENE	Hypoparathyroidism, deafness and renal dysplasia (HDR) syndrome is an autosomal dominant genetic disorder characterized by hypoparathyroidism, sensorineural deafness and renal dysplasia. We herein present the first Turkish patient with HDR syndrome, who has a p.R367X mutation. This report indicates that p.R367X is not a mutation specific for the Far Eastern populations and also that urological findings in infants with hypoparathyroidism should be carefully examined because clinical findings relating to the p.R367X mutation may show a variable age of onset.	[Doneray, Hakan; Kaya, Avni] Ataturk Univ, Fac Med, Dept Pediat Endocrinol, Erzurum, Turkey; [Usui, Takeshi] Kyoto Med Ctr, Natl Hosp Org, Clin Res Inst, Kyoto, Japan; [Donmez, Ayse Sena] Ataturk Univ, Fac Med, Dept Pediat, Erzurum, Turkey	Doneray, H (reprint author), Ataturk Univ, Fac Med, Dept Pediat Endocrinol, Erzurum, Turkey.	hdoneray@hotmail.com	Kaya, Avni/O-6540-2014				Ali A, 2007, HUM MOL GENET, V16, P265, DOI 10.1093/hmg/ddl454; Zahirieh A, 2005, J CLIN ENDOCR METAB, V90, P2445, DOI 10.1210/jc.2004-1969; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; Nesbit MA, 2004, J BIOL CHEM, V279, P22624, DOI 10.1074/jbc.M401797200; Ferraris S, 2009, AM J MED GENET A, V149A, P770, DOI 10.1002/ajmg.a.32689; BILOUS RW, 1992, NEW ENGL J MED, V327, P1069, DOI 10.1056/NEJM199210083271506; Hernandez AM, 2007, AM J MED GENET A, V143A, P757, DOI 10.1002/ajmg.a.31617; Muroya K, 2001, J MED GENET, V38, P374, DOI 10.1136/jmg.38.6.374; OOSTERWEGEL M, 1992, DEV IMMUNOL, V3, P1, DOI 10.1155/1992/27903; Sun Y, 2009, AM J MED GENET A, V149A, P776, DOI 10.1002/ajmg.a.32706	10	0	0	GALENOS YAYINCILIK	FINDIKZADE	ERKAN MOR, MOLLA GURANI CAD 21-1, FINDIKZADE, ISTANBUL 34093, TURKEY	1308-5727	1308-5735		J CLIN RES PEDIATR E	J. Clin Res. Pediatr. Endocrinol.	JUN	2015	7	2					140	143		10.4274/jcrpe.1874		4	Endocrinology & Metabolism; Pediatrics	Endocrinology & Metabolism; Pediatrics	CK1AD	WOS:000355936400009		
J	Jinnin, M				Jinnin, Masatoshi			Recent progress in studies of miRNA and skin diseases	JOURNAL OF DERMATOLOGY			English	Review						melanoma; miRNA; psoriasis; scleroderma	DOWN-REGULATION; COLLAGEN EXPRESSION; MALIGNANT-MELANOMA; DERMAL FIBROBLASTS; PSORIASIS-VULGARIS; SYSTEMIC-SCLEROSIS; SERUM-LEVELS; I COLLAGEN; HAIR SHAFT; MICRORNAS	miRNA is a family of small non-coding RNA that consists of 22 nucleotides on average. miRNA are implicated in various cellular activities such as cell proliferation or migration via the modulation of gene expression, and also are linked to the pathogenesis of human diseases. This paper reviews recent research progress about the contribution of miRNA to the pathogenesis of various skin diseases, and possible application of miRNA as the disease markers in each disease. For example, downregulated miR-424-5p in psoriatic skin causes the overexpression of MEK1 and cyclin E1 in psoriatic keratinocytes, resulting in the keratinocyte overgrowth and hyperproliferation seen in the disease. Although there was no significant difference in the serum miR-424-5p levels between psoriasis patients and healthy controls, serum miR-1266-5p levels were significantly upregulated in psoriasis patients, and showed weak and inverse correlation with disease activity. Furthermore, combination of serum levels of miR-146a-5p and -203a-3p was more reliable to distinguish psoriasis patients and normal subjects, than each miRNA alone. Hair shaft miR-424-5p levels were significantly higher in psoriasis patients than normal subjects, while hair root miR-19a-3p levels in psoriasis patients were inversely correlated with the duration between symptom onset and the first visit to the hospital. Future researches of miRNA will enable the advances of their clinical applications including the clarification of pathogenesis, disease markers and novel treatments.	Kumamoto Univ, Fac Life Sci, Dept Dermatol & Plast Surg, Kumamoto 8608556, Japan	Jinnin, M (reprint author), Kumamoto Univ, Fac Life Sci, Dept Dermatol & Plast Surg, 1-1-1 Honjo, Kumamoto 8608556, Japan.	mjin@kumamoto-u.ac.jp					Wang ZZ, 2013, J DERMATOL SCI, V72, P134, DOI 10.1016/j.jdermsci.2013.06.018; Philippidou D, 2010, CANCER RES, V70, P4163, DOI 10.1158/0008-5472.CAN-09-4512; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; van Dommelen SM, 2012, J CONTROL RELEASE, V161, P635, DOI 10.1016/j.jconrel.2011.11.021; Furer V, 2010, CLIN IMMUNOL, V136, P1, DOI 10.1016/j.clim.2010.02.005; Ikuta Y, 2005, CLIN CANCER RES, V11, P8079, DOI 10.1158/1078-0432.CCR-05-1074; Kanemaru H, 2011, J DERMATOL SCI, V61, P187, DOI 10.1016/j.jdermsci.2010.12.010; Honda N, 2012, J IMMUNOL, V188, P3323, DOI 10.4049/jimmunol.1100876; Nazari-Jahantigh M, 2012, THROMB HAEMOSTASIS, V107, P611, DOI 10.1160/TH11-12-0826; Pivarcsi A, 2013, BRIT J DERMATOL, V169, P563, DOI 10.1111/bjd.12381; Takemoto R, 2013, EXP DERMATOL, V22, P832, DOI 10.1111/exd.12245; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Li P, 2014, J DERMATOL, V41, P903, DOI 10.1111/1346-8138.12600; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Bertino JR, 2007, PHARMACOGENOMICS, V8, P1625, DOI 10.2217/14622416.8.12.1625; Inoue K, 2013, J DERMATOL, V40, P715, DOI 10.1111/1346-8138.12218; Makino K, 2013, J IMMUNOL, V190, P3905, DOI 10.4049/jimmunol.1200822; Chen X, 2012, PROTEIN CELL, V3, P28, DOI 10.1007/s13238-012-2003-z; Shiiyama R, 2013, MELANOMA RES, V23, P366, DOI 10.1097/CMR.0b013e328363e485; Zibert JR, 2010, J DERMATOL SCI, V58, P177, DOI 10.1016/j.jdermsci.2010.03.004; Koba S, 2013, EXP DERMATOL, V22, P489, DOI 10.1111/exd.12173; Hanke Merle, 2010, Urol Oncol, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Greenberg E, 2013, BIOMARKERS, V18, P502, DOI 10.3109/1354750X.2013.816777; Makino K, 2012, CLIN EXP DERMATOL, V37, P34, DOI 10.1111/j.1365-2230.2011.04158.x; Sing T, 2012, RHEUMATOLOGY, V51, P1550, DOI 10.1093/rheumatology/kes120; Yamashita J, 2013, MELANOMA RES, V23, P13, DOI 10.1097/CMR.0b013e32835c5b30; IHN H, 1992, ARCH DERMATOL RES, V284, P391, DOI 10.1007/BF00372068; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Cheng J, 2013, AM J MED SCI, V346, P98, DOI 10.1097/MAJ.0b013e318267680d; Chinnathambi S, 2012, J DERMATOL, V39, P617, DOI 10.1111/j.1346-8138.2012.01553.x; Friedman EB, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-155; Hirao H, 2013, EUR J DERMATOL, V23, P807, DOI 10.1684/ejd.2013.2190; Ichihara A, 2014, J ALLERGY CLIN IMMUN, V133, P1065, DOI 10.1016/j.jaci.2013.09.019; Ichihara A, 2011, BRIT J DERMATOL, V165, P1003, DOI 10.1111/j.1365-2133.2011.10497.x; Ichihara A, 2012, EUR J DERMATOL, V22, P68, DOI 10.1684/ejd.2011.1600; Igawa K, 2009, BRIT J DERMATOL, V160, P1124, DOI 10.1111/j.1365-2133.2009.09070.x; Inada T, 2015, J DERMATOL, V42, P198, DOI 10.1111/1346-8138.12730; Inoue K, 2013, EUR J DERMATOL, V23, P160, DOI 10.1684/ejd.2013.1959; Inoue M, 2015, INT J DERMA IN PRESS; Kawashita Y, 2011, J DERMATOL SCI, V61, P67, DOI 10.1016/j.jdermsci.2010.11.007; Koga Y, 2014, J DERMATOL SCI, V74, P170, DOI 10.1016/j.jdermsci.2014.01.005; Lefkowitz GK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027603; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Okada Y, 2014, INT J DERMATOL, V53, P300, DOI 10.1111/j.1365-4632.2012.05739.x; Oshikawa Y, 2012, ACTA DERM-VENEREOL, V93, P273; Oyama R, 2011, J DERMATOL SCI, V61, P209, DOI 10.1016/j.jdermsci.2010.12.008; Shimada S, 2013, CLIN EXP RHEUMATOL, V31, P161; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Tamai Katsuto, 2005, Nihon Rinsho, V63 Suppl 12, P659; Tsuru Y, 2014, J DERMATOL, V41, P382, DOI 10.1111/1346-8138.12460; vansRooij E, 2008, P NATL ACAD SCI USA, V105, P13027; Wang Y, 2015, J DERMATOL, V42, P193, DOI 10.1111/1346-8138.12725	54	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JUN	2015	42	6					551	558		10.1111/1346-8138.12904		8	Dermatology	Dermatology	CJ9PW	WOS:000355835700001		
J	Kamiya, K; Aoyama, Y; Yamaguchi, M; Ukida, A; Mizuno-Ikeda, K; Fujii, K; Hamada, T; Tokura, Y; Iwatsuki, K				Kamiya, Koji; Aoyama, Yumi; Yamaguchi, Mari; Ukida, Aya; Mizuno-Ikeda, Kazuko; Fujii, Kazuyasu; Hamada, Toshihisa; Tokura, Yoshiki; Iwatsuki, Keiji			Clues to diagnosis for unusual mucosal pemphigus demonstrating undetectable anti-desmoglein 3 serum antibodies by routine tests	JOURNAL OF DERMATOLOGY			English	Article						anti-desmoglein 3 antibody; desmoglein 3 distribution; highly sensitive enzyme-linked immunoassay; immunostaining; pemphigus vulgaris	LINKED-IMMUNOSORBENT-ASSAY; CALCIUM-DEPENDENT EPITOPES; VULGARIS-IGG; RECOMBINANT DESMOGLEINS; AUTOANTIBODIES; DESMOSOMES; KERATINOCYTES; PATHOGENICITY; DEPLETION; CADHERINS	Pemphigus is an autoimmune blistering disease caused by immunoglobulin (Ig)G autoantibodies against desmogleins (Dsg). In mucosal-dominant pemphigus vulgaris (PV), anti-Dsg3 antibodies play a critical role in acantholysis. We followed two mucosal-dominant PV cases who suffered from refractory oral mucosal erosions. In these cases, anti-Dsg3 serum antibodies were not detected by indirect immunofluorescence and enzyme-linked immunosorbent assay (ELISA). However, direct immunofluorescence showed the intercellular IgG deposition in the epidermis and histopathological findings revealed suprabasal acantholysis. In order to analyze the pathomechanisms in these cases, we first examined the Dsg3 expression patterns in lesional sites and compared them with those of typical mucosal-dominant PV cases. In typical PV cases, the alteration of Dsg3 distribution was observed in lesional sites by immunostaining. The aggregation of Dsg3, which is the characteristic change in PV mucosal lesions, was observed as the initial change prior to acantholysis. In our cases, a clustering of Dsg3 was observed at mucosal lesions, and the expression levels of Dsg3 in acantholytic lesions were decreased, as observed in typical mucosal-dominant PV cases. Although anti-Dsg3 serum antibodies could not be detected by routine tests, anti-Dsg3 serum antibodies were detected by Dsg3 ELISA using 10-times more concentrated sera (highly sensitive ELISA). Moreover, purified and concentrated PV IgG showed high pathogenicity when examined by dissociation assay. In conclusion, the detection of morphological changes in Dsg3 distribution and highly sensitive ELISA method could be useful for the early diagnosis of PV recurrence.	[Kamiya, Koji; Tokura, Yoshiki] Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan; [Kamiya, Koji; Aoyama, Yumi; Yamaguchi, Mari; Ukida, Aya; Mizuno-Ikeda, Kazuko; Hamada, Toshihisa; Iwatsuki, Keiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dermatol, Okayama 7008558, Japan; [Fujii, Kazuyasu] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Dermatol, Kagoshima 890, Japan	Aoyama, Y (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dermatol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	ymaoyama@cc.okayama-u.ac.jp			Ministry of Health, Labor and Welfare (Research for Intractable Diseases); Ministry of Education, Culture, Sports, Science and Technology	This work was supported by a grant from the Ministry of Health, Labor and Welfare (Research for Intractable Diseases), and a Ministry of Education, Culture, Sports, Science and Technology. We thank Ms Hiroko Katayama, Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences for her technical assistance.	AMAGAI M, 1995, J INVEST DERMATOL, V104, P146, DOI 10.1111/1523-1747.ep12613668; Waschke J, 2008, HISTOCHEM CELL BIOL, V130, P21, DOI 10.1007/s00418-008-0420-0; Yamamoto Y, 2007, J BIOL CHEM, V282, P17866, DOI 10.1074/jbc.M607963200; Stanley JR, 2006, NEW ENGL J MED, V355, P1800, DOI 10.1056/NEJMra061111; Ishii K, 1997, J IMMUNOL, V159, P2010; Huen AC, 2002, J CELL BIOL, V159, P1005, DOI 10.1083/jcb.200206098; Sato M, 2000, LAB INVEST, V80, P1583; Cheng SW, 2002, BRIT J DERMATOL, V147, P261, DOI 10.1046/j.1365-2133.2002.04838.x; Kwon EJ, 2008, J EUR ACAD DERMATOL, V22, P1070, DOI 10.1111/j.1468-3083.2008.02715.x; Oktarina DAM, 2011, BRIT J DERMATOL, V165, P552, DOI 10.1111/j.1365-2133.2011.10463.x; Koga H, 2012, BRIT J DERMATOL, V166, P976, DOI 10.1111/j.1365-2133.2012.10827.x; Kamiya K, 2012, BRIT J DERMATOL, V167, P252, DOI 10.1111/j.1365-2133.2012.10929.x; Aoyama Y, 1999, J INVEST DERMATOL, V112, P67, DOI 10.1046/j.1523-1747.1999.00463.x; Jennings JM, 2011, J INVEST DERMATOL, V131, P706, DOI 10.1038/jid.2010.389; Ishii K, 2005, J INVEST DERMATOL, V124, P939, DOI 10.1111/j.0022-202X.2005.23714.x; Amagai M, 1999, BRIT J DERMATOL, V140, P351; Calkins CC, 2006, J BIOL CHEM, V281, P7623, DOI 10.1074/jbc.M512447200; Rosenbach M, 2009, J INVEST DERMATOL, V129, P2404, DOI 10.1038/jid.2009.72; Spindler V, 2009, J BIOL CHEM, V284, P30556, DOI 10.1074/jbc.M109.024810; Muller EJ, 2008, J INVEST DERMATOL, V128, P501, DOI 10.1038/sj.jid.5701248; Aoyama Y, 2010, BRIT J DERMATOL, V162, P1049, DOI 10.1111/j.1365-2133.2010.09672.x; BURGE SM, 1993, BRIT J DERMATOL, V128, P363, DOI 10.1111/j.1365-2133.1993.tb00192.x; Kamiya K, 2013, J DERMATOL SCI, V70, P190, DOI 10.1016/j.jdermsci.2013.02.011; KITAJIMA Y, 1987, J INVEST DERMATOL, V89, P167, DOI 10.1111/1523-1747.ep12470554; Mao XM, 2010, AM J PATHOL, V177, P2724, DOI 10.2353/ajpath.2010.100483; Rafei D, 2011, AM J PATHOL, V178, P718, DOI 10.1016/j.ajpath.2010.10.016; Shu E, 2007, ARCH DERMATOL RES, V299, P165, DOI 10.1007/s00403-007-0754-9	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JUN	2015	42	6					572	579		10.1111/1346-8138.12872		8	Dermatology	Dermatology	CJ9PW	WOS:000355835700004		
J	Kaminaka, C; Uede, M; Matsunaka, H; Furukawa, F; Yamamoto, Y				Kaminaka, Chikako; Uede, Mikiko; Matsunaka, Hiroshi; Furukawa, Fukumi; Yamamoto, Yuki			Clinical studies of the treatment of facial atrophic acne scars and acne with a bipolar fractional radiofrequency system	JOURNAL OF DERMATOLOGY			English	Article						3-D imaging analysis; acne vulgaris; atrophic acne scars; bipolar fractional radiofrequency; Skindex-16	QUALITY-OF-LIFE; JAPANESE VERSION; EFFICACY; SKIN; SKINDEX-16; VULGARIS; DEVICE; PORES; LASER	Few clinical studies have examined the utility of bipolar fractional radiofrequency (FRF) therapy as a treatment for atrophic acne scars and active acne in people with darker skin. This study was designed to compare the safety and efficacy of bipolar FRF therapy as a treatment for atrophic acne scars and acne vulgaris. Twenty-three Japanese patients with atrophic acne scars and mild to severe acne on both cheeks were treated with a bipolar FRF system (eMatrix; Syneron, Yokneam Illit, Israel). Five treatment sessions were carried out at 1-month intervals, and the patients were followed up for 3months after the final treatment. Assessments of scar severity and the number of acne lesions and 3-D in vivo imaging analysis were performed. Evaluations of the treatment outcomes and their effects on the patients' quality of life (QOL) were also carried out. We demonstrated that the improvement in scar volume was marked in the patients with mild scars and was at least moderate in 23 (57.5%) of the treated areas. With regard to the number of acne lesions, the treated areas exhibited significantly fewer lesions compared with the baseline at each time point (P<0.05). The patients' assessments of the treatment outcomes and their QOL indicated that both had improved significantly by the end of the study. Furthermore, significant reductions in the patients' sebum levels, skin roughness and scar depth were observed. Bipolar FRF treatment significantly improved the atrophic acne scars and acne of Japanese patients and had minimal side-effects.	[Kaminaka, Chikako; Uede, Mikiko; Matsunaka, Hiroshi; Furukawa, Fukumi; Yamamoto, Yuki] Wakayama Med Univ, Dept Dermatol, Wakayama 6410012, Japan; [Kaminaka, Chikako; Yamamoto, Yuki] Wakayama Med Univ, Dept Cosmet Dermatol & Photomed, Wakayama 6410012, Japan	Kaminaka, C (reprint author), Wakayama Med Univ, Dept Dermatol, 811-1 Kimiidera, Wakayama 6410012, Japan.	kamikami@wakayama-med.ac.jp			JMEC (Tokyo, Japan)	This study was funded by JMEC (Tokyo, Japan). The sponsor of the study had no role in the study design, the performance of the study, the data collection or interpretation, or the preparation of the report.	El-Domyati M, 2011, J AM ACAD DERMATOL, V64, P524, DOI 10.1016/j.jaad.2010.06.045; Gollnick H, 2003, J AM ACAD DERMATOL, V49, pS1, DOI 10.1067/mjd.2003.618; Lolis MS, 2012, DERMATOL SURG, V38, P1765, DOI 10.1111/j.1524-4725.2012.02547.x; Goodman GJ, 2006, DERMATOL SURG, V32, P1458, DOI 10.1111/j.1524-4725.2006.32354.x; Bloemen MCT, 2011, J AM ACAD DERMATOL, V64, P706, DOI 10.1016/j.jaad.2010.03.006; Hayashi N, 2008, J DERMATOL, V35, P255, DOI 10.1111/j.1346-8138.2008.00462.x; LAYTON AM, 1994, CLIN EXP DERMATOL, V19, P303, DOI 10.1111/j.1365-2230.1994.tb01200.x; Atiyeh BS, 2009, AESTHET PLAST SURG, V33, P283, DOI 10.1007/s00266-009-9361-9; Peterson JD, 2011, DERMATOL SURG, V37, P1260, DOI 10.1111/j.1524-4725.2011.02110.x; Cho SI, 2012, DERMATOL SURG, V38, P1017, DOI 10.1111/j.1524-4725.2012.02402.x; Alster TS, 2007, CLIN DERMATOL, V25, P487, DOI 10.1016/j.clindermatol.2007.05.005; Manuskiatti W, 2010, J AM ACAD DERMATOL, V63, P274, DOI 10.1016/j.jaad.2009.08.051; Zhang Z, 2013, DERMATOL SURG, V39, P559, DOI 10.1111/dsu.12103; Gold MH, 2012, J COSMET LASER THER, V14, P172, DOI 10.3109/14764172.2012.687824; Brightman L, 2009, J DRUGS DERMATOL, V8, P9; Cho Sung Bin, 2009, Dermatol Surg, V35, P108, DOI 10.1111/j.1524-4725.2008.34399.x; Goodman GJ, 2011, INT J DERMATOL, V50, P1179, DOI 10.1111/j.1365-4632.2011.05029.x; Hayashi N, 2004, J DERMATOL, V31, P971; Higaki Y, 2002, J DERMATOL, V29, P693; Hruza George, 2009, J Drugs Dermatol, V8, P259; Huzaira M, 2003, LASERS SURG MED S15, V32, P17; Kaminaka C, 2014, J DERMATOL, V41, P435, DOI 10.1111/1346-8138.12483; Kim JE, 2014, DERMATOL SURG, V40, P988, DOI 10.1097/01.DSS.0000452625.01889.c3; Kim ST, 2014, J DERMATOL, V41, P586, DOI 10.1111/1346-8138.12471; Lee SJ, 2012, DERMATOL SURG, V38, P400, DOI 10.1111/j.1524-4725.2011.02267.x; Omi T, 2014, J CLIN EXP DERMATOL, V5, P1; Ong MWS, 2012, BRIT J DERMATOL, V166, P1160, DOI 10.1111/j.1365-2133.2012.10870.x; Rongsaard N, 2014, DERMATOL SURG, V40, P14, DOI 10.1111/dsu.12372; Thiboutot D, 2009, JAAD, V60, P1	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JUN	2015	42	6					580	587		10.1111/1346-8138.12864		8	Dermatology	Dermatology	CJ9PW	WOS:000355835700005		
J	Sugawara, M; Ishii, N; Nakanaga, K; Suzuki, K; Umebayashi, Y; Makigami, K; Aihara, M				Sugawara, Mariko; Ishii, Norihisa; Nakanaga, Kazue; Suzuki, Koichi; Umebayashi, Yoshihiro; Makigami, Kuniko; Aihara, Michiko			Exploration of a standard treatment for Buruli ulcer through a comprehensive analysis of all cases diagnosed in Japan	JOURNAL OF DERMATOLOGY			English	Article						Buruli ulcer; clarithromycin; levofloxacin; Mycobacterium ulcerans; rifampicin; treatment	MYCOBACTERIUM-ULCERANS; RIFAMPIN-STREPTOMYCIN; CLINICAL-EFFICACY; INFECTION; CLARITHROMYCIN; COMBINATION; DISEASE; PHARMACOKINETICS; RIFABUTIN; BENIN	Buruli ulcer (BU) is a refractory skin ulcer caused by Mycobacterium ulcerans or M.ulcerans ssp. shinshuense, a subspecies thought to have originated in Japan or elsewhere in Asia. Although BU occurs most frequently in tropical and subtropical areas such as Africa and Australia, the occurrence in Japan has gradually increased in recent years. The World Health Organization recommends multidrug therapy consisting of a combination of oral rifampicin (RFP) and i.m. streptomycin (SM) for the treatment of BU. However, surgical interventions are often required when chemotherapy alone is ineffective. As a first step in developing a standardized regimen for BU treatment in Japan, we analyzed detailed records of treatments and prognoses in 40 of the 44 BU cases that have been diagnosed in Japan. We found that a combination of RFP (450mg/day), levofloxacin (LVFX; 500mg/day) and clarithromycin (CAM; at a dose of 800mg/day instead of 400mg/day) was superior to other chemotherapies performed in Japan. This simple treatment with oral medication increases the probability of patient adherence, and may often eliminate the need for surgery.	[Sugawara, Mariko; Ishii, Norihisa; Aihara, Michiko] Yokohama City Univ, Grad Sch Med, Dept Environm Immunodermatol, Yokohama, Kanagawa 2360004, Japan; [Sugawara, Mariko] West Yokohama Sugawara Dermatol Clin, Yokohama, Kanagawa, Japan; [Ishii, Norihisa; Nakanaga, Kazue; Suzuki, Koichi] Natl Inst Infect Dis, Leprosy Res Ctr, Tokyo, Japan; [Umebayashi, Yoshihiro] Akita Univ, Grad Sch Med, Dept Dermatol & Plast Surg, Akita 010, Japan; [Makigami, Kuniko] Tsubasa Home Care Clin, Funabashi, Chiba, Japan	Sugawara, M (reprint author), Yokohama City Univ, Grad Sch Med, Dept Environm Immunodermatol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	mariko@sugawara-clinic.jp					ALANGADEN GJ, 1995, ANTIMICROB AGENTS CH, V39, P1700; Alffenaar JWC, 2010, ANTIMICROB AGENTS CH, V54, P3878, DOI 10.1128/AAC.00099-10; Almeida D, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000933; Sarfo FS, 2010, ANTIMICROB AGENTS CH, V54, P3678, DOI 10.1128/AAC.00299-10; Phillips RO, 2014, ANTIMICROB AGENTS CH, V58, P1161, DOI 10.1128/AAC.02165-13; Etuaful S, 2005, ANTIMICROB AGENTS CH, V49, P3182, DOI 10.1128/AAC.49.8.3182-3186.; Wansbrough-Jones M, 2006, LANCET, V367, P1849, DOI 10.1016/S0140-6736(06)68807-7; Onoe H, 2012, J DERMATOL, V39, P869, DOI 10.1111/j.1346-8138.2011.01430.x; Chauty A, 2007, ANTIMICROB AGENTS CH, V51, P4029, DOI 10.1128/AAC.00175-07; WALLACE RJ, 1995, J INFECT DIS, V171, P747; Nakanaga K, 2013, JPN J INFECT DIS, V66, P83; Nakanaga K, 2011, J CLIN MICROBIOL, V49, P3829, DOI 10.1128/JCM.00783-11; Chauty A, 2011, CLIN INFECT DIS, V52, P94, DOI 10.1093/cid/ciq072; Yotsu RR, 2012, J DERMATOL, V39, P587, DOI 10.1111/j.1346-8138.2012.01543.x; O'Brien DP, 2014, MED J AUSTRALIA, V200, P267, DOI 10.5694/mja13.11331; Nienhuis WA, 2010, LANCET, V375, P664, DOI 10.1016/S0140-6736(09)61962-0; Benedetti MS, 1995, PHARMACOL RES, V32, P177, DOI 10.1016/S1043-6618(05)80021-0; Chen Jiezhong, 2006, Ann Clin Microbiol Antimicrob, V5, P3, DOI 10.1186/1476-0711-5-3; Global Buruli Ulcer Initiative (GBUI), 2011, BUR ULC END COUNTR; Hasegawa N, 2009, PULM PHARMACOL THER, V22, P190, DOI 10.1016/j.pupt.2008.11.004; Hasumi J, 2011, J PEDIAT INFECT DIS, V23, P383; O'Brien DP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001473; Pommelet V, 2014, CLIN INFECT DIS, V59, P1256, DOI 10.1093/cid/ciu584; Portaels F, 1998, ANTIMICROB AGENTS CH, V42, P2070; Vouking Marius Zambou, 2013, Pan Afr Med J, V15, P155, DOI 10.11604/pamj.2013.15.155.2341; WHO, 2012, TREATM MYC ULC DIS B; World Health Organization, 2014, LEPROSY; World Health Organization, 2014, TUBERCULOSIS	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JUN	2015	42	6					588	595		10.1111/1346-8138.12851		8	Dermatology	Dermatology	CJ9PW	WOS:000355835700006		
J	Sugaya, M; Morimura, S; Suga, H; Kawaguchi, M; Miyagaki, T; Ohmatsu, H; Fujita, H; Sato, S				Sugaya, Makoto; Morimura, Sohshi; Suga, Hiraku; Kawaguchi, Makiko; Miyagaki, Tomomitsu; Ohmatsu, Hanako; Fujita, Hideki; Sato, Shinichi			CCR4 is expressed on infiltrating cells in lesional skin of early mycosis fungoides and atopic dermatitis	JOURNAL OF DERMATOLOGY			English	Article						atopic dermatitis; CCR4; mycosis fungoides; psoriasis; Sezary syndrome	CHEMOKINE RECEPTORS; T-CELLS; THYMUS	CCR4 is expressed on tumor cells of mycosis fungoides (MF) and Sezary syndrome (SS). In MF, most infiltrating cells in patches and plaques express CXCR3, while tumor cells express CCR4 in advanced stages. Poteligeo Test IHC (CCR4 staining kit) is a newly developed staining kit that can examine the presence of CCR4 expressed on tumor cells of adult T-cell leukemia/lymphoma, peripheral T-cell lymphoma and cutaneous T-cell lymphoma before treatment of anti-CCR4 antibody using paraffin-embedded samples. In this study, we analyzed CCR4 expression in lesional skin of MF, SS, atopic dermatitis (AD) and psoriasis with this new kit. CCR4 was expressed on infiltrating cells in lesional skin of patch, plaque, tumor MF and SS, and the number of positive cells increased as the disease progressed. Immunohistochemistry with frozen sections also showed some positive cells scattered in the dermis, although the quality was not high enough to quantify positive cells. There were significant positive correlations between CCR4(+) cells and serum lactate dehydrogenase levels. Interestingly, CCR4(+) cells were also detected in AD skin, whose number was larger than that in psoriatic skin. Previous studies showed only scattered CCR4(+) cells in skin samples by standard immunohistochemical staining. The new, sensitive CCR4 staining kit has revealed that CCR4 is expressed on infiltrating cells in lesional skin of early MF and AD as well as advanced MF and SS. These cells can be therapeutic targets for patients who are resistant to standard treatments.	[Sugaya, Makoto; Morimura, Sohshi; Suga, Hiraku; Kawaguchi, Makiko; Miyagaki, Tomomitsu; Ohmatsu, Hanako; Fujita, Hideki; Sato, Shinichi] Univ Tokyo, Dept Dermatol, Fac Med, Tokyo 1138655, Japan	Sugaya, M (reprint author), Univ Tokyo, Dept Dermatol, Fac Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	sugayam-der@h.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan	We thank Tamami Kaga for technical assistance. This study was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology in Japan.	Guttman-Yassky E, 2011, J ALLERGY CLIN IMMUN, V127, P1420, DOI 10.1016/j.jaci.2011.01.054; Ishii T, 2010, CLIN CANCER RES, V16, P1520, DOI 10.1158/1078-0432.CCR-09-2697; Sugaya M, 2010, J DERMATOL SCI, V59, P81, DOI 10.1016/j.jdermsci.2010.05.005; Saeki H, 2006, J DERMATOL SCI, V43, P75, DOI 10.1016/j.jdermsci.2006.06.002; Yoshie O, 2002, BLOOD, V99, P1505, DOI 10.1182/blood.V99.5.1505; Kakinuma T, 2003, J AM ACAD DERMATOL, V48, P23, DOI 10.1067/mjd.2003.132; Kallinich T, 2003, J INVEST DERMATOL, V121, P1045, DOI 10.1046/j.1523-1747.2003.12555.x; Morimura S, 2014, ARCH DERMATOL RES, V306, P843, DOI 10.1007/s00403-014-1501-7; Sokolowska-Wojdyo M, 2005, BRIT J DERMATOL, V152, P258, DOI 10.1111/J.1365-2133.2004.06325.X; Yamaguchi T, 2006, BRIT J DERMATOL, V154, P904, DOI 10.1111/j.1365-2133.2005.07039.x	10	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JUN	2015	42	6					613	615		10.1111/1346-8138.12852		3	Dermatology	Dermatology	CJ9PW	WOS:000355835700010		
J	Misago, N; Kuwashiro, M; Tsuruta, N; Narisawa, Y				Misago, Noriyuki; Kuwashiro, Maki; Tsuruta, Noriko; Narisawa, Yutaka			Sebaceous carcinoma in association with actinic keratosis: A report of two cases with an immunohistochemical study	JOURNAL OF DERMATOLOGY			English	Article						adipophilin; atrophic type actinic keratosis; bowenoid type actinic keratosis; cytokeratin 1; sebaceous carcinoma	BOWENS-DISEASE; EXPRESSION; ADIPOPHILIN; INVOLUCRIN	We report two cases of sebaceous carcinoma associated with actinic keratosis (AK) with an immunohistochemical study, which suggests the possibility that sebaceous carcinoma really does develop within AK. Case 1 had sebaceous carcinoma arising within the atrophic type AK and case 2 had sebaceous carcinoma associated with bowenoid AK in the periphery and some parts of the overlying epidermis of the lesion.	[Misago, Noriyuki; Kuwashiro, Maki; Tsuruta, Noriko; Narisawa, Yutaka] Saga Univ, Fac Med, Dept Internal Med, Div Dermatol, Saga 8498501, Japan	Misago, N (reprint author), Saga Univ, Fac Med, Dept Internal Med, Div Dermatol, 5-1-1 Nabeshima, Saga 8498501, Japan.	misago@post.saga-med.ac.jp					Ostler DA, 2010, MODERN PATHOL, V23, P567, DOI 10.1038/modpathol.2010.1; Muthusamy K, 2006, J CLIN PATHOL, V59, P1166, DOI 10.1136/jcp.2005.033381; Ansai S, 2011, AM J DERMATOPATH, V33, P579, DOI 10.1097/DAD.0b013e31820a2027; WATANABE S, 1995, BRIT J DERMATOL, V132, P730; Ansai S, 2011, J DERMATOL, V38, P951, DOI 10.1111/j.1346-8138.2011.01274.x; Ansai S, 2000, EUR J DERMATOL, V10, P385; Aung PP, 2014, J CUTAN PATHOL, V41, P592, DOI 10.1111/cup.12351; Currie GP, 2014, AM J DERMATOPATH, V36, P673, DOI 10.1097/DAD.0000000000000045; HEID HW, 1988, DIFFERENTIATION, V37, P137, DOI 10.1111/j.1432-0436.1988.tb00805.x; ICHIKAWA E, 1995, AM J DERMATOPATH, V17, P151, DOI 10.1097/00000372-199504000-00007; Ishida M, 2012, J CUTAN PATHOL, V39, P731, DOI 10.1111/j.1600-0560.2012.01881.x; Leibovitch I, 2006, J CUTAN PATHOL, V33, P303, DOI 10.1111/j.0303-6987.2006.00423.x; Nakashima K, 2010, ACTA DERM-VENEREOL, V90, P196, DOI 10.2340/00015555-0761; Takayama A, 1997, JPN J DERMATOL, V107, P851	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JUN	2015	42	6					616	620		10.1111/1346-8138.12840		5	Dermatology	Dermatology	CJ9PW	WOS:000355835700011		
J	Takamura, S; Teraki, Y				Takamura, Saori; Teraki, Yuichi			Case of clear cell sarcoma in the left buttock in which serum neuron-specific enolase was a useful marker for monitoring disease progression	JOURNAL OF DERMATOLOGY			English	Article						clear cell sarcoma; neuron-specific enolase; serum neuron-specific enolase	SOFT PARTS; APONEUROSES; FEATURES; TENDONS; TUMOR	We report a case of clear cell sarcoma (CCS) in the left buttock in which serum neuron-specific enolase (NSE) was useful as a biomarker of CCS progression. A 40-year-old man had a subcutaneous tumor, 1.7cm in diameter, in the left buttock. Histopathology revealed that the tumor consisted of nests of polygonal or spindle-shaped cells with abundant clear cytoplasm delineated by fibrous septa in the subcutaneous tissue. There was cellular atypia but no melanin deposits. Immunohistochemically, the tumor cells were positive for HMB-45, Melan-A, S-100 protein and NSE. Reverse transcription polymerase chain reaction demonstrated Ewing's sarcoma oncogene-activating transcription factor 1 fusion transcripts in the tumor cells. CCS was diagnosed. There was no metastasis to the lymph nodes and viscera, and the patient was treated by surgical wide resection. The serum NSE levels increased before detection of distant metastasis and further increased in parallel with the expansion of metastasis. The present case suggests that serum NSE could be used as a biochemical marker in the clinical follow up of patients with CCS.	[Takamura, Saori; Teraki, Yuichi] Saitama Med Univ, Saitama Med Ctr, Dept Dermatol, Kawagoe, Saitama 3508550, Japan	Teraki, Y (reprint author), Saitama Med Univ, Saitama Med Ctr, Dept Dermatol, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.	teraki@saitama-med.ac.jp					SWANSON PE, 1989, ARCH PATHOL LAB MED, V113, P55; CARNEY DN, 1982, LANCET, V1, P583; Dim DC, 2007, ARCH PATHOL LAB MED, V131, P152; Riley RD, 2004, CLIN CANCER RES, V10, P4, DOI 10.1158/1078-0432.CCR-1051-2; KAISER E, 1989, CLIN CHIM ACTA, V183, P13, DOI 10.1016/0009-8981(89)90268-4; Hocar O, 2012, DERMATOL RES PRACT, V2012, P1; Kosemehmetoglu K, 2010, J CLIN PATHOL, V63, P416, DOI 10.1136/jcp.2008.057471; LEADER M, 1986, J CLIN PATHOL, V39, P1186, DOI 10.1136/jcp.39.11.1186; LUCAS DR, 1992, AM J SURG PATHOL, V16, P1197, DOI 10.1097/00000478-199212000-00006; Mavrogenis AF, 2013, HIPPOKRATIA, V17, P298	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JUN	2015	42	6					621	624		10.1111/1346-8138.12854		4	Dermatology	Dermatology	CJ9PW	WOS:000355835700012		
J	Wu, CY; Asano, Y; Taniguchi, T; Sato, S; Yu, HS				Wu, Ching-Ying; Asano, Yoshihide; Taniguchi, Takashi; Sato, Shinichi; Yu, Hsin-Su			Serum heparanase levels: A protective marker against digital ulcers in patients with systemic sclerosis	JOURNAL OF DERMATOLOGY			English	Article						angiogenesis; digital ulcers; heparanase; systemic sclerosis; vascular endothelial growth factor	ENDOTHELIAL GROWTH-FACTOR; CLASSIFICATION; ACTIVATION	Heparanase is an endo--D-glucuronidase cleaving heparan sulfate side-chains of heparin sulfate proteoglycans, which is involved in wound healing, inflammation, neovascularization and tumor progression through the degradation and remodeling of the extracellular matrix and the release of sequestered pro-angiogenic factors. Because heparanase-mediated biological processes seem to be involved in the development of systemic sclerosis (SSc), we investigated the clinical correlation of serum heparanase levels in patients with this disease. Serum heparanase levels were significantly higher in SSc patients than in healthy individuals, while comparable between diffuse cutaneous SSc and limited cutaneous SSc subgroups. On the other hand, SSc patients with digital ulcers had serum heparanase levels significantly lower than those without. These results suggest that serum heparanase levels may be elevated in SSc patients reflecting the contribution of heparanase-dependent biological processes to the development of SSc. SSc patients with high serum heparanase levels may be protected from the development of digital ulcers due to the increased release of sequestered pro-angiogenic factors such as vascular endothelial growth factor. Therefore, serum heparanase levels may serve as a protective marker against digital ulcers in SSc patients.	[Wu, Ching-Ying; Asano, Yoshihide; Taniguchi, Takashi; Sato, Shinichi] Univ Tokyo, Grad Sch Med, Dept Dermatol, Tokyo 1138655, Japan; [Wu, Ching-Ying; Yu, Hsin-Su] Kaohsiung Med Univ, Dept Dermatol, Kaohsiung, Taiwan; [Wu, Ching-Ying; Yu, Hsin-Su] Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan	Asano, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Dermatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yasano-tky@umin.ac.jp					Noda S, 2013, ARCH DERMATOL RES, V305, P325, DOI 10.1007/s00403-012-1307-4; LEROY EC, 1988, J RHEUMATOL, V15, P202; VLODAVSKY I, 1987, P NATL ACAD SCI USA, V84, P2292, DOI 10.1073/pnas.84.8.2292; Distler JHW, 2006, RHEUMATOLOGY, V45, P26, DOI 10.1093/rheumatology/kel295; Choi JJ, 2003, J RHEUMATOL, V30, P1529; Asano Y, 2010, J DERMATOL, V37, P54, DOI 10.1111/j.1346-8138.2009.00758.x; Yamaguchi Y, 2013, HISTOL HISTOPATHOL, V28, P175; Maurer B, 2014, ANN RHEUM DIS, V73, P1880, DOI 10.1136/annrheumdis-2013-203535; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; FOLKMAN J, 1988, AM J PATHOL, V130, P393; Meirovitz A, 2013, FEBS J, V280, P2307, DOI 10.1111/febs.12184; Asano Y, 2010, AM J PATHOL, V176, P1983, DOI 10.2353/ajpath.2010.090593; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Taniguchi T, 2015, ARTHRITIS RHEUMATOL, V67, P517, DOI 10.1002/art.38948; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JUN	2015	42	6					625	628		10.1111/1346-8138.12842		4	Dermatology	Dermatology	CJ9PW	WOS:000355835700013		
J	Kawakami, Y; Gokita, M; Fukunaga, A; Nishigori, C				Kawakami, Yukari; Gokita, Mari; Fukunaga, Atsushi; Nishigori, Chikako			Refractory case of adrenergic urticaria successfully treated with clotiazepam	JOURNAL OF DERMATOLOGY			English	Article						adrenergic urticaria; anxiolytic drug; beta-blocker; clotiazepam; noradrenaline test	CHOLINERGIC URTICARIA; PATIENT; STRESS	Adrenergic urticaria (AU) is a rare type of stress-induced physical urticaria characterized by widespread pruritic urticarial papules. Diagnosis can be made by i.d. injection of adrenaline or noradrenaline, which produces the characteristic rash. Although the lesions of AU typically respond to beta-blockers such as propranolol, the therapeutic options for AU are limited. Here, we report a case of AU that was resistant to beta-blockers and successfully treated with clotiazepam. The clinical picture of AU resembles that of cholinergic urticaria (CU), however, positive noradrenaline test and negative acetylcholine skin test were useful for the differential diagnosis of AU and CU. Although his symptoms were resistant to several therapeutic methods including olopatadine (H-1 antagonist), lafutidine (H-2 antagonist) and propranolol, the severity and frequency of his attacks and his subjective symptoms were reduced by oral clotiazepam, an anxiolytic benzodiazepine. Dermatologists should be aware that anxiolytic benzodiazepines may be a therapeutic option in AU.	[Kawakami, Yukari; Gokita, Mari; Fukunaga, Atsushi; Nishigori, Chikako] Kobe Univ, Grad Sch Med, Dept Internal Related, Div Dermatol, Kobe, Hyogo 6500017, Japan	Fukunaga, A (reprint author), Kobe Univ, Grad Sch Med, Dept Internal Related, Div Dermatol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	atsushi@med.kobe-u.ac.jp					SHELLEY WB, 1985, LANCET, V2, P1031; Morilak DA, 2005, PROG NEURO-PSYCHOPH, V29, P1214, DOI 10.1016/j.pnpbp.2005.08.007; Chedraoui A, 2008, ACTA DERM-VENEREOL, V88, P263, DOI 10.2340/00015555-0435; Feinberg JH, 2008, MIL MED, V173, P217; Hogan SR, 2014, J AM ACAD DERMATOL, V70, P763, DOI 10.1016/j.jaad.2013.10.062; Horikawa T, 2009, CURR ALLERGY ASTHM R, V9, P273, DOI 10.1007/s11882-009-0038-x; Mihara S, 2008, BRIT J DERMATOL, V158, P629, DOI 10.1111/j.1365-2133.2007.08366.x; VITHAYASAI P, 1989, Journal of the Medical Association of Thailand, V72, P478	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JUN	2015	42	6					635	637		10.1111/1346-8138.12855		3	Dermatology	Dermatology	CJ9PW	WOS:000355835700016		
J	Suga, Y; Tsuda, T; Nagai, M; Sakaguchi, Y; Jitsukawa, O; Yamamoto, M; Hitomi, K; Yamanishi, K				Suga, Yasushi; Tsuda, Tatsuya; Nagai, Makoto; Sakaguchi, Yoshiko; Jitsukawa, Orie; Yamamoto, Masaaki; Hitomi, Kiyotaka; Yamanishi, Kiyofumi			Lamellar ichthyosis with pseudoexon activation in the transglutaminase 1 gene	JOURNAL OF DERMATOLOGY			English	Article						lamellar ichthyosis; mutation; next-generation sequencing; pseudoexon; transglutaminase 1	SKIN	We report a case of a 12-year-old boy who was born as a collodion baby after which thick scales developed on his entire body surface. His younger brother showed a similar skin condition. Arcuate-shaped, large, brownish scales covered his face with ectropion. His lower legs were also covered with larger thick, brownish, plate-like scales, but other areas were covered with smaller scales. Next-generation sequencing for exons and splice sites detected a stop-gain TGM1 mutation leading to p.R71* in transglutaminase 1 (TG1). Another mutation identified was a cryptic mutation in intron 3 that activated a pseudoexon, which was detected by RNA-based analysis of hair bulbs. The deep intronic mutation caused another truncation mutation, p.N171Tfs(*)45, in TG1. An insitu TG1 assay demonstrated that TG1 activity was totally lost in this case. Thus, we conclude that the severe phenotype of the patient developed due to those novel compound heterozygous null truncation mutations in TGM1.	[Suga, Yasushi] Juntendo Univ, Urayasu Hosp, Dept Dermatol, Urayasu, Japan; [Tsuda, Tatsuya; Nagai, Makoto; Sakaguchi, Yoshiko; Jitsukawa, Orie; Yamamoto, Masaaki; Yamanishi, Kiyofumi] Hyogo Coll Med, Dept Dermatol, Nishinomiya, Hyogo 6638501, Japan; [Hitomi, Kiyotaka] Nagoya Univ, Grad Sch Pharmaceut Sci, Dept Basic Med Sci, Nagoya, Aichi 4648601, Japan	Yamanishi, K (reprint author), Hyogo Coll Med, Dept Dermatol, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	kyamanis@hyo-med.ac.jp			JSPS KAKENHI [26461668]; Ministry of Health, Labor and Welfare, Japan [H23-028]	The authors thank members of the Joint-Use Research Facilities of the Hyogo College of Medicine for their technical assistance. This work was supported in part by JSPS KAKENHI (grant no. 26461668) and by a grant from the "Research on Measures for Intractable Diseases" Project: matching fund subsidy (no. H23-028) from the Ministry of Health, Labor and Welfare, Japan.	Flanagan SE, 2013, AM J HUM GENET, V92, P131, DOI 10.1016/j.ajhg.2012.11.017; Grall A, 2012, NAT GENET, V44, P140, DOI 10.1038/ng.1056; Oji V, 2010, J AM ACAD DERMATOL, V63, P607, DOI 10.1016/j.jaad.2009.11.020; Takeichi T, 2015, BRIT J DERMATOL, V172, P1407, DOI 10.1111/bjd.13473; Hiiragi T, 1999, J BIOL CHEM, V274, P34148, DOI 10.1074/jbc.274.48.34148; Sugimura Y, 2008, FEBS J, V275, P5667, DOI 10.1111/j.1742-4658.2008.06692.x; Inoue Y, 2015, ACTA DERM-VENEREOL, V95, P747, DOI 10.2340/00015555-2062; Radner FPW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003536; Scott CA, 2013, J INVEST DERMATOL, V133, P573, DOI 10.1038/jid.2012.332; Tsuda T, 2008, BRIT J DERMATOL, V159, P730, DOI 10.1111/j.1365-2133.2008.08684.x	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JUN	2015	42	6					642	645		10.1111/1346-8138.12846		4	Dermatology	Dermatology	CJ9PW	WOS:000355835700018		
J	Ohata, C; Matsuda, M; Hamada, T; Shintani, T; Muto, I; Nagata, H; Furumura, M; Nakama, T				Ohata, Chika; Matsuda, Mitsuhiro; Hamada, Takahiro; Shintani, Takako; Muto, Ikko; Nagata, Hiroshi; Furumura, Minao; Nakama, Takekuni			Loss of heterozygosity in a case of glomuvenous malformations	JOURNAL OF DERMATOLOGY			English	Letter							GLOMULIN		[Ohata, Chika; Matsuda, Mitsuhiro; Hamada, Takahiro; Shintani, Takako; Muto, Ikko; Nagata, Hiroshi; Furumura, Minao; Nakama, Takekuni] Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 8300011, Japan	Ohata, C (reprint author), Kurume Univ, Sch Med, Dept Dermatol, 67 Asahimachi, Kurume, Fukuoka 8300011, Japan.	ohata@med.kurume-u.ac.jp	Ohata, Chika/F-3277-2015	Ohata, Chika/0000-0001-8341-7300			Amyere M, 2013, AM J HUM GENET, V92, P188, DOI 10.1016/j.ajhg.2012.12.017; Brouillard P, 2002, AM J HUM GENET, V70, P866, DOI 10.1086/339492; Borroni RG, 2011, EXP DERMATOL, V20, P1032, DOI 10.1111/j.1600-0625.2011.01387.x; Brouillard P, 2013, Mol Syndromol, V4, P157, DOI 10.1159/000348675	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JUN	2015	42	6					646	647		10.1111/1346-8138.12849		2	Dermatology	Dermatology	CJ9PW	WOS:000355835700019		
J	Kurashige, Y; Kishida, K; Minemura, T; Nagatani, T				Kurashige, Yuta; Kishida, Kosuke; Minemura, Tokuya; Nagatani, Tetsuo			Patient delay in skin cancer: Influence of clinical characteristics and questionnaire results	JOURNAL OF DERMATOLOGY			English	Letter									[Kurashige, Yuta; Kishida, Kosuke; Minemura, Tokuya; Nagatani, Tetsuo] Tokyo Med Univ, Hachioji Med Ctr, Dept Dermatol, Tokyo 1608402, Japan	Kurashige, Y (reprint author), Tokai Univ, Sch Med, Dept Dermatol, 143 Shimokasuya, Isehara, Kanagawa 2591131, Japan.	kurasige@is.icc.u-tokai.ac.jp					Betti R, 2003, EUR J DERMATOL, V13, P183; Kakagia D, 2013, ONKOLOGIE, V36, P738, DOI 10.1159/000356834; Takenouchi T, 2003, JPN J CLIN DERMATOL, V57, P8	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JUN	2015	42	6					647	648		10.1111/1346-8138.12868		2	Dermatology	Dermatology	CJ9PW	WOS:000355835700020		
J	Nakagawa, K; Kishida, M; Okabayashi, A; Shimizu, N; Taguchi, M; Kinoshita, R; Tanaka, M; Imanishi, H; Tsuruta, D				Nakagawa, Koichi; Kishida, Masaru; Okabayashi, Aya; Shimizu, Nami; Taguchi, Mari; Kinoshita, Rie; Tanaka, Masaru; Imanishi, Hisayoshi; Tsuruta, Daisuke			Spitz nevus on the palm with crista transverse dots/dotted lines revealed by dermoscopic examination	JOURNAL OF DERMATOLOGY			English	Letter									[Nakagawa, Koichi; Kishida, Masaru; Okabayashi, Aya; Shimizu, Nami; Taguchi, Mari; Kinoshita, Rie] Saiseikai Tondabayashi Hosp, Dept Dermatol, Tondabayashi City, Osaka 5840082, Japan; [Tanaka, Masaru] Tokyo Womens Med Univ, Med Ctr East, Dept Dermatol, Tokyo, Japan; [Imanishi, Hisayoshi; Tsuruta, Daisuke] Osaka City Univ, Grad Sch Med, Dept Dermatol, Osaka 558, Japan	Nakagawa, K (reprint author), Saiseikai Tondabayashi Hosp, Dept Dermatol, 1-3-36 Koyodai, Tondabayashi City, Osaka 5840082, Japan.	yama_and_sawa@tonbyo.org					Banba K, 2000, J Dermatol, V27, P333; Kerner M, 2013, DERMATOL CLIN, V31, P327, DOI 10.1016/j.det.2012.12.009; Mackie RM, 1998, TXB DERMATOLOGY, P1717; Vaccaro M, 2015, J AM ACAD DERMATOL, V72, pS11, DOI 10.1016/j.jaad.2014.03.036; Yasuma A, 2006, J EUR ACAD DERMATOL, V20, P1362, DOI 10.1111/j.1468-3083.2006.01718.x	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JUN	2015	42	6					649	650		10.1111/1346-8138.12860		2	Dermatology	Dermatology	CJ9PW	WOS:000355835700021		
J	Mori, T; Hiraiwa, T; Ohtsuka, M; Yamamoto, T				Mori, Tatsuhiko; Hiraiwa, Tomoko; Ohtsuka, Mikio; Yamamoto, Toshiyuki			Late-onset pyoderma gangrenosum following surgical operation in a patient with malignant melanoma	JOURNAL OF DERMATOLOGY			English	Letter									[Mori, Tatsuhiko; Hiraiwa, Tomoko; Ohtsuka, Mikio; Yamamoto, Toshiyuki] Fukushima Med Univ, Dept Dermatol, Fukushima, Fukushima 9601247, Japan	Mori, T (reprint author), Fukushima Med Univ, Dept Dermatol, 1 Hikarigaoka, Fukushima, Fukushima 9601247, Japan.	mtatsu@fmu.ac.jp					Ruocco E, 2009, J EUR ACAD DERMATOL, V23, P1008, DOI 10.1111/j.1468-3083.2009.03199.x; Crowson AN, 2003, J CUTAN PATHOL, V30, P97; Lyon CC, 2000, J AM ACAD DERMATOL, V42, P992, DOI 10.1016/S0190-9622(00)90292-5; Momeni A, 2015, ANN PLAS SURG, V74, P284, DOI 10.1097/SAP.0b013e318296b7ae; Wollina U, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-19	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JUN	2015	42	6					650	651		10.1111/1346-8138.12850		2	Dermatology	Dermatology	CJ9PW	WOS:000355835700022		
J	Koga, M; Koga, K; Tatsukawa, R; Imafuku, S				Koga, Monji; Koga, Kaori; Tatsukawa, Ryoko; Imafuku, Shinichi			Favorable response to composite treatment including infliximab in a case of granulomatous cheilitis with Crohn's disease	JOURNAL OF DERMATOLOGY			English	Letter							OROFACIAL GRANULOMATOSIS		[Koga, Monji; Tatsukawa, Ryoko; Imafuku, Shinichi] Fukuoka Univ, Fac Med, Dept Dermatol, Fukuoka 8140180, Japan; [Koga, Kaori] Fukuoka Univ Hosp, Dept Pathol, Fukuoka, Japan	Koga, M (reprint author), Fukuoka Univ, Sch Med, Dept Dermatol, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	mob3mob3@yahoo.co.jp					Barry O, 2005, ARCH DERMATOL, V141, P1080, DOI 10.1001/archderm.141.9.1080; Macaigne G, 2011, CLIN RES HEPATOL GAS, V35, P147, DOI 10.1016/j.clinre.2010.10.001; Ruiz VR, 2012, INT J DERMATOL, V51, P118; Tilakaratne WM, 2008, J ORAL PATHOL MED, V37, P191, DOI 10.1111/j.1600-0714.2007.00591.x; van de Scheur MR, 2003, J AM ACAD DERMATOL, V49, P952, DOI 10.1067/S0190-9622(03)01560-3	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JUN	2015	42	6					651	652		10.1111/1346-8138.12847		2	Dermatology	Dermatology	CJ9PW	WOS:000355835700023		
J	Takeoka, S; Tada, Y; Ohnishi, T; Watanabe, S				Takeoka, Shintaro; Tada, Yayoi; Ohnishi, Takamitsu; Watanabe, Shinichi			Case of lichen planus pigmentosus with unique distribution	JOURNAL OF DERMATOLOGY			English	Letter									[Takeoka, Shintaro; Tada, Yayoi; Ohnishi, Takamitsu; Watanabe, Shinichi] Teikyo Univ, Sch Med, Dept Dermatol, Tokyo 1738605, Japan	Tada, Y (reprint author), Teikyo Univ, Sch Med, Dept Dermatol, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	ytada-tky@umin.ac.jp					Al-Mutairi N, 2010, J EUR ACAD DERMATOL, V24, P535, DOI 10.1111/j.1468-3083.2009.03460.x; BHUTANI LK, 1974, DERMATOLOGICA, V149, P43; Bourra Hayat, 2013, Pan Afr Med J, V15, P55, DOI 10.11604/pamj.2013.15.55.2976; Kanwar AJ, 2003, CLIN EXP DERMATOL, V28, P5; Seo JK, 2010, ANN DERMATOL, V22, P323, DOI 10.5021/ad.2010.22.3.323	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JUN	2015	42	6					652	654		10.1111/1346-8138.12870		3	Dermatology	Dermatology	CJ9PW	WOS:000355835700024		
J	Taguchi, R; Sugawara, K; Tsuruta, D				Taguchi, Rieko; Sugawara, Koji; Tsuruta, Daisuke			Case of pseudolymphoma with bald patches on the scalp	JOURNAL OF DERMATOLOGY			English	Letter							ALOPECIA NEOPLASTICA		[Taguchi, Rieko; Sugawara, Koji; Tsuruta, Daisuke] Osaka City Univ, Grad Sch Med, Dept Dermatol, Osaka 5458585, Japan	Sugawara, K (reprint author), Osaka City Univ, Grad Sch Med, Dept Dermatol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	sugawara@med.osaka-cu.ac.jp					COHEN I, 1961, ARCH DERMATOL, V84, P490; Castelli E, 2008, AM J DERMATOPATH, V30, P241, DOI 10.1097/DAD.0b013e3181676b60; Garg Sunny, 2012, Int J Trichology, V4, P169, DOI 10.4103/0974-7753.100085; Kim JH, 2014, ANN DERMATOL, V26, P624, DOI 10.5021/ad.2014.26.5.624; Sperling LC, 2012, ATLAS OF HAIR PATHOLOGY WITH CLINICAL CORRELATIONS, 2ND EDITION, P1	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JUN	2015	42	6					654	655		10.1111/1346-8138.12867		2	Dermatology	Dermatology	CJ9PW	WOS:000355835700025		
J	Morita, R; Oiso, N; Ishii, N; Tatebayashi, M; Matsuda, H; Hashimoto, T; Kawada, A				Morita, Ryoko; Oiso, Naoki; Ishii, Norito; Tatebayashi, Megumi; Matsuda, Hiromasa; Hashimoto, Takashi; Kawada, Akira			Case of burn-associated bullous pemphigoid caused by anti-BP230 immunoglobulin G autoantibodies	JOURNAL OF DERMATOLOGY			English	Letter							SITES		[Morita, Ryoko; Oiso, Naoki; Tatebayashi, Megumi; Matsuda, Hiromasa; Kawada, Akira] Kinki Univ, Fac Med, Dept Dermatol, Osaka, Osaka 5898511, Japan; [Ishii, Norito; Hashimoto, Takashi] Kurume Univ, Sch Med, Dept Dermatol, Inst Cutaneous Cell Biol, Kurume, Fukuoka 830, Japan	Oiso, N (reprint author), Kinki Univ, Fac Med, Dept Dermatol, 377-2 Ohno Higashi, Osaka, Osaka 5898511, Japan.	naoiso@med.kindai.ac.jp					Girao L, 2000, J EUR ACAD DERMATOL, V14, P507, DOI 10.1046/j.1468-3083.2000.00158.x; Neri I, 2013, J DTSCH DERMATOL GES, V11, P675, DOI 10.1111/ddg.12094; QUARTEYPAPAFIO CM, 1994, CLIN EXP DERMATOL, V19, P281, DOI 10.1111/j.1365-2230.1994.tb01192.x; Sasai S, 2014, ACTA DERM-VENEREOL, V94, P734, DOI 10.2340/00015555-1848; Wagner G H, 1995, Australas J Dermatol, V36, P17, DOI 10.1111/j.1440-0960.1995.tb00918.x	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JUN	2015	42	6					657	658		10.1111/1346-8138.12848		2	Dermatology	Dermatology	CJ9PW	WOS:000355835700027		
J	Kasuya, A; Kaneko, Y; Enomoto, N; Suda, T; Tokura, Y				Kasuya, Akira; Kaneko, Yasuhito; Enomoto, Noriyuki; Suda, Takafumi; Tokura, Yoshiki			Simultaneous reactivation of cytomegalovirus in an adult patient with varicella	JOURNAL OF DERMATOLOGY			English	Letter							DIAGNOSIS		[Kasuya, Akira; Kaneko, Yasuhito; Tokura, Yoshiki] Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan; [Enomoto, Noriyuki; Suda, Takafumi] Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka 4313192, Japan	Kasuya, A (reprint author), Hamamatsu Univ Sch Med, Dept Dermatol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	casuaki@hama-med.ac.jp					Kasuya A, 2014, J DERMATOL, V41, P542, DOI 10.1111/1346-8138.12479; Cook CH, 2011, ANTIVIR RES, V90, P151, DOI 10.1016/j.antiviral.2011.03.179; Desmons A, 2013, J CLIN VIROL, V58, P486, DOI 10.1016/j.jcv.2013.08.007; GONDO H, 1994, BRIT J HAEMATOL, V86, P130, DOI 10.1111/j.1365-2141.1994.tb03263.x; Komura K, 2005, J DERMATOL, V32, P976	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JUN	2015	42	6					658	659		10.1111/1346-8138.12858		2	Dermatology	Dermatology	CJ9PW	WOS:000355835700028		
J	Belloni, A; Chernozhukov, V; Chetverikov, D; Kato, K				Belloni, Alexandre; Chernozhukov, Victor; Chetverikov, Denis; Kato, Kengo			Some new asymptotic theory for least squares series: Pointwise and uniform results	JOURNAL OF ECONOMETRICS			English	Article						Least squares series; Strong approximations; Uniform confidence bands	POLYNOMIAL SPLINE REGRESSION; MAJORIZING MEASURES; CONVERGENCE-RATES; NORMALITY; ESTIMATORS; MODELS	In econometric applications it is common that the exact form of a conditional expectation is unknown and having flexible functional forms can lead to improvements over a pre-specified functional form, especially if they nest some successful parametric economically-motivated forms. Series method offers exactly that by approximating the unknown function based on k basis functions, where k is allowed to grow with the sample size n to balance the trade off between variance and bias. In this work we consider series estimators for the conditional mean in light of four new ingredients: (i) sharp LLNs for matrices derived from the non-commutative Khinchin inequalities, (ii) bounds on the Lebesgue factor that controls the ratio between the L-infinity and L-2-norms of approximation errors, (iii) maximal inequalities for processes whose entropy integrals diverge at some rate, and (iv) strong approximations to series-type processes. These technical tools allow us to contribute to the series literature, specifically the seminal work of Newey (1997), as follows. First, we weaken considerably the condition on the number k of approximating functions used in series estimation from the typical k(2)/n -> 0 to k/n -> 0, up to log factors, which was available only for spline series before. Second, under the same weak conditions we derive L-2 rates and pointwise central limit theorems results when the approximation error vanishes. Under an incorrectly specified model, i.e. when the approximation error does not vanish, analogous results are also shown. Third, under stronger conditions we derive uniform rates and functional central limit theorems that hold if the approximation error vanishes or not. That is, we derive the strong approximation for the entire estimate of the nonparametric function. Finally and most importantly, from a point of view of practice, we derive uniform rates, Gaussian approximations, and uniform confidence bands for a wide collection of linear functionals of the conditional expectation function, for example, the function itself, the partial derivative function, the conditional average partial derivative function, and other similar quantities. All of these results are new. (C) 2015 Elsevier B.V. All rights reserved.	[Belloni, Alexandre] Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA; [Chernozhukov, Victor] MIT, Dept Econ, Cambridge, MA 02139 USA; [Chetverikov, Denis] Univ Calif Los Angeles, Dept Econ, Los Angeles, CA 90024 USA; [Kato, Kengo] Univ Tokyo, Grad Sch Econ, Tokyo 1138654, Japan	Chetverikov, D (reprint author), Univ Calif Los Angeles, Dept Econ, Los Angeles, CA 90024 USA.	chetverikov@econ.ucla.edu					Angrist J, 2006, ECONOMETRICA, V74, P539, DOI 10.1111/j.1468-0262.2006.00671.x; ANDREWS DWK, 1991, ECONOMETRICA, V59, P307, DOI 10.2307/2938259; STONE CJ, 1994, ANN STAT, V22, P118, DOI 10.1214/aos/1176325361; Newey WK, 1999, ECONOMETRICA, V67, P565, DOI 10.1111/1468-0262.00037; Huang JHZ, 2003, ANN STAT, V31, P1600, DOI 10.1214/aos/1065705120; STONE CJ, 1982, ANN STAT, V10, P1040, DOI 10.1214/aos/1176345969; Huang JHZ, 1998, ANN STAT, V26, P242; Cattaneo MD, 2013, J ECONOMETRICS, V174, P127, DOI 10.1016/j.jeconom.2013.02.002; Chernozhukov V, 2013, ECONOMETRICA, V81, P667, DOI 10.3982/ECTA8718; Gine E, 2006, ANN PROBAB, V34, P1143, DOI 10.1214/009117906000000070; Belloni A., 2011, WORKING PAPER; Chen X., 2007, HDB ECONOMETRICS B, V6B; Chen X. B., 2013, WORKING PAPER; Chernozhukov V, 2014, ANN STAT, V42, P1787, DOI 10.1214/14-AOS1235; Chernozhukov V., 2012, ARXIV12126906; Cohen A., 1993, Applied and Computational Harmonic Analysis, V1, DOI 10.1006/acha.1993.1005; de Boor C., 2001, PRACTICAL GUIDE SPLI; DeVore R.A., 1993, CONSTRUCTIVE APPROXI; Dudley R. M., 1967, J FUNCT ANAL, V1, P290, DOI 10.1016/0022-1236(67)90017-1; EASTWOOD BJ, 1991, ECONOMET THEOR, V7, P307; GALLANT AR, 1991, J ECONOMETRICS, V50, P329, DOI 10.1016/0304-4076(91)90024-8; Guedon O, 2007, ADV MATH, V208, P798, DOI 10.1016/j.aim.2006.03.013; Hansen B., 2014, WORKING PAPER; Hardle W., 1990, APPL NONPARAMETRIC R; Horn R. A., 1990, MATRIX ANAL; Huang JHZ, 2003, STAT PROBABIL LETT, V65, P207, DOI 10.1016/j.spl.2003.09.003; Johnstone I.M., 2011, GAUSSIAN ESTIM UNPUB; Kato K, 2013, ANN STAT, V41, P2359, DOI 10.1214/13-AOS1150; Lust-Picard L., 1991, ARK MAT, V29, P241; Mallat S, 2009, WAVELET TOUR OF SIGNAL PROCESSING: THE SPARSE WAY, P1; Newey WK, 1997, J ECONOMETRICS, V79, P147, DOI 10.1016/S0304-4076(97)00011-0; Pollard D., 2002, CAMBRIDGE SERIES STA; Rudelson M., 1999, J FUNCT ANAL, V164, P60, DOI 10.1006/jfan.1998.3384; Talagrand M, 1996, ANN PROBAB, V24, P1049, DOI 10.1214/aop/1065725175; Tropp J.A., 2012, ARXIV150101571; Tsybakov AB, 2009, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-79052-7_1; VANDEGEER S, 1990, ANN STAT, V18, P907, DOI 10.1214/aos/1176347632; van der Vaart A. W., 1996, WEAK CONVERGENCE EMP; van de Geer S, 2002, J STAT PLAN INFER, V108, P55, DOI 10.1016/S0378-3758(02)00270-7; Wasserman L., 2006, ALL NONPARAMETRIC ST; Zygmund A., 2002, TRIGONOMETRIC SERIES	41	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0304-4076	1872-6895		J ECONOMETRICS	J. Econom.	JUN	2015	186	2					345	366		10.1016/j.jeconom.2015.02.014		22	Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods	Business & Economics; Mathematics; Mathematical Methods In Social Sciences	CJ3AT	WOS:000355356500006		
J	Mizuno, S; Imai, H; Takaki, H; Tanemura, A; Kuriyama, N; Sakurai, H; Yamakado, K; Sakuma, H; Isaji, S				Mizuno, Shugo; Imai, Hiroshi; Takaki, Haruyuki; Tanemura, Akihiro; Kuriyama, Naohisa; Sakurai, Hiroyuki; Yamakado, Koichiro; Sakuma, Hajime; Isaji, Shuji			SPONTANEOUS RUPTURE OF AN INTRASPLENIC ANEURYSM AFTER PANCREATICODUODENECTOMY FOR PANCREATIC DUCTAL ADENOCARCINOMA	JOURNAL OF EMERGENCY MEDICINE			English	Letter									[Mizuno, Shugo; Tanemura, Akihiro; Kuriyama, Naohisa; Sakurai, Hiroyuki; Isaji, Shuji] Mie Univ, Sch Med, Dept Hepatobiliary Pancreat & Transplant Surg, Tsu, Mie 514, Japan; [Imai, Hiroshi] Mie Univ, Sch Med, Emergency & Crit Care Ctr, Tsu, Mie 514, Japan; [Takaki, Haruyuki; Yamakado, Koichiro; Sakuma, Hajime] Mie Univ, Sch Med, Dept Radiol, Tsu, Mie 514, Japan	Mizuno, S (reprint author), Mie Univ, Sch Med, Dept Hepatobiliary Pancreat & Transplant Surg, Tsu, Mie 514, Japan.						Burg MD, 2001, J EMERG MED, V20, P349, DOI 10.1016/S0736-4679(01)00310-9; Gupta R, 2002, J EMERG MED, V22, P421, DOI 10.1016/S0736-4679(02)00444-4; Windham TC, 2000, NEW ENGL J MED, V342, P1999, DOI 10.1056/NEJM200006293422616	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	JUN	2015	48	6					729	730		10.1016/j.jemermed.2014.11.025		2	Emergency Medicine	Emergency Medicine	CJ2UU	WOS:000355341000025		
J	Tan, YL; Tokonami, S; Hosoda, M				Tan, Yanliang; Tokonami, Shinji; Hosoda, Masahiro			On the calibration of a radon exhalation monitor based on the electrostatic collection method and accumulation chamber	JOURNAL OF ENVIRONMENTAL RADIOACTIVITY			English	Article						Radon exhalation monitor; Electrostatic collection method; Accumulation chamber; Calibration	BUILDING-MATERIALS; CARBON-DIOXIDE; SOIL; ATMOSPHERE; TRANSPORT; SAMPLES; MODEL; CELL	The radon exhalation rate can be obtained quickly and easily from the evolution of radon concentration over time in the accumulation chamber. Radon monitoring based on the electrostatic collection method is not interfered with by Rn-220. In this paper, we propose that the difference between radon and Po-218 concentrations in the measurement cell of this kind of radon exhalation monitor is the main system error, and it changes with time and different effective decay constants. Based on the results of simulation experiments, we propose that the calibration factor obtained from the suitable experiment cannot completely correct the system error, even if it is useful to reduce the measurement error. The better way for reducing measurement error is to use the new measurement model which we have proposed in recent years. (C) 2015 Elsevier Ltd. All rights reserved.	[Tan, Yanliang] Hengyang Normal Univ, Dept Phys & Elect, Hengyang 421008, Hunan, Peoples R China; [Tokonami, Shinji] Hirosaki Univ, Inst Radiat Emergency Med, Dept Radiat Phys, Hirosaki, Aomori 0368564, Japan; [Hosoda, Masahiro] Hirosaki Univ, Grad Sch Hlth Sci, Hirosaki, Aomori 0368564, Japan	Tan, YL (reprint author), Hengyang Normal Univ, Dept Phys & Elect, Hengyang 421008, Hunan, Peoples R China.	hytyl@163.com			National Natural Science Foundation of China [11075049, 11375058]; Excellent Talents Program of Hengyang Normal University of China; Cooperative Innovation Center for Digitalization of Cultural Heritage in Ancient Villages and Towns; Construct Program of the Key Discipline in Hunan Province	This work was supported by the National Natural Science Foundation of China (Grants # 11075049, 11375058), the Excellent Talents Program of Hengyang Normal University of China, Cooperative Innovation Center for Digitalization of Cultural Heritage in Ancient Villages and Towns, and the Construct Program of the Key Discipline in Hunan Province. The authors appreciate Ms. Stephany for providing the language editing service.	Abdallah AM, 2012, RADIAT PHYS CHEM, V81, P1710, DOI 10.1016/j.radphyschem.2012.07.004; Kumar A, 2014, J ENVIRON RADIOACTIV, V127, P50, DOI 10.1016/j.jenvrad.2013.10.004; Tan YL, 2013, ENVIRON MONIT ASSESS, V185, P8759, DOI 10.1007/s10661-013-3210-7; Tait DR, 2013, ENVIRON SCI TECHNOL, V47, P3099, DOI 10.1021/es304538g; Tuccimei P, 2008, RADIAT MEAS, V43, P102, DOI 10.1016/j.radmeas.2007.05.056; Saad AF, 2013, APPL RADIAT ISOTOPES, V72, P163, DOI 10.1016/j.apradiso.2012.11.006; Evangeliou N, 2013, ENVIRON SCI TECHNOL, V47, P5803, DOI 10.1021/es400372u; Tuccimei P, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042134; Sahoo BK, 2011, SCI TOTAL ENVIRON, V409, P2635, DOI 10.1016/j.scitotenv.2011.03.031; Tan YL, 2011, IEEE T NUCL SCI, V58, P209, DOI 10.1109/TNS.2010.2090897; Imme G, 2014, RADIAT PHYS CHEM, V95, P349, DOI 10.1016/j.radphyschem.2013.02.033; Atwood CH, 2006, J CHEM EDUC, V83, P1436; Bavarnegin E, 2013, J ENVIRON RADIOACTIV, V117, P36, DOI 10.1016/j.jenvrad.2011.12.022; Deynse A.V., 1999, RADIAT MEAS, V31, P325; Hanson D.J., 1989, RES CHEM ENG NEWS AR, V67, P7; Huxol S, 2013, ENVIRON SCI TECHNOL, V47, P14044, DOI 10.1021/es4026529; Jayaratne ER, 2011, ENVIRON SCI TECHNOL, V45, P6350, DOI 10.1021/es201152g; Kakati RK, 2013, APCBEE PROC, V5, P186, DOI 10.1016/j.apcbee.2013.05.033; Kotrappa P., 1996, 1996 INT RAD S AARST; Mahur AK, 2013, RADIAT MEAS, V50, P130, DOI 10.1016/j.radmeas.2012.09.008; Quindos-Poncela LS, 2003, NUCL INSTRUM METH A, V512, P606, DOI 10.1016/S0168-9002(03)02049-7; Reddy D.V., 2004, GEOPHYS RES LETT, V31; Roca V, 2004, APPL RADIAT ISOTOPES, V61, P243, DOI 10.1016/j.apradiso.2004.03.053; Rottger S, 2001, NUCL INSTRUM METH A, V466, P475, DOI 10.1016/S0168-9002(01)00227-3; Santos IR, 2012, ENVIRON SCI TECHNOL, V46, P7685, DOI 10.1021/es301961b; SHEETS RW, 1993, J CHEM EDUC, V70, P1040; Tan Y, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/08/T08004; Tan YL, 2013, J RADIOANAL NUCL CH, V295, P2295, DOI 10.1007/s10967-012-2294-9; Tan YL, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3572271; Ujic P, 2008, RADIAT MEAS, V43, P1396, DOI 10.1016/j.radmeas.2008.03.003; Wang JX, 1999, NUCL INSTRUM METH A, V421, P601, DOI 10.1016/S0168-9002(98)01230-3	31	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0265-931X	1879-1700		J ENVIRON RADIOACTIV	J. Environ. Radioact.	JUN	2015	144						9	14		10.1016/j.jenvrad.2015.02.012		6	Environmental Sciences	Environmental Sciences & Ecology	CJ4ZN	WOS:000355497300002		
J	Sakai, M; Gomi, T; Naito, RS; Negishi, JN; Sasaki, M; Toda, H; Nunokawa, M; Murase, K				Sakai, Masaru; Gomi, Takashi; Naito, Risa S.; Negishi, Juniiro N.; Sasaki, Michiko; Toda, Hiroto; Nunokawa, Masanori; Murase, Kaori			Radiocesium leaching from contaminated litter in forest streams	JOURNAL OF ENVIRONMENTAL RADIOACTIVITY			English	Article						Cryptomeria japonica; Fukushima Daiichi Nuclear Power Plant accident; Japanese cedar; Organic matter; Potassium; Radiation contamination	NUCLEAR-POWER-PLANT; LEAF-LITTER; MICACEOUS MINERALS; FUKUSHIMA; JAPAN; SOIL; ACCIDENT; FALLOUT; CESIUM; RADIONUCLIDES	In Japanese forests suffering from the Fukushima Daiichi Nuclear Power Plant accident, litter fall provides a large amount of radiocesium from forests to streams. Submerged litter is processed to become a vital food resource for various stream organisms through initial leaching and subsequent decomposition. Although leaching from litter can detach radiocesium similarly to potassium, radiocesium leaching and its migration are poorly understood. We examined both radiocesium and potassium leaching to the water column and radiocesium allocation to minerals (glass beads, silica sand, and vermiculite) in the laboratory using soaked litter with and without minerals on a water column. The mineral types did not affect radiocesium leaching from litter, but soaking in water for 1, 7, and 30 days decreased the radiocesium concentration in litter by x0.71, x0.66, and x0.56, respectively. Meanwhile, the 1-, 7-, and 30-day experiments decreased potassium concentration in litter by x0.17, x0.11, and x0.09, respectively. Leached radiocesium remained in a dissolved form when there was no mineral phases present in the water, whereas there was sorption onto the minerals when they were present. In particular, vermiculite adsorbed radiocesium by two to three orders of magnitude more effectively than the other minerals. Because radiocesium forms (such as that dissolved or adsorbed to organic matter or minerals) can further mobilize to ecosystems, our findings will increase our understanding regarding the dynamics of radiocesium in stream ecosystems. (C) 2015 Elsevier Ltd. All rights reserved.	[Sakai, Masaru; Gomi, Takashi; Naito, Risa S.; Sasaki, Michiko; Toda, Hiroto] Tokyo Univ Agr & Technol, Grad Sch Agr, Fuchu, Tokyo 1838509, Japan; [Negishi, Juniiro N.] Hokkaido Univ, Fac Environm Earth Sci, Kita Ku, Sapporo, Hokkaido 0600860, Japan; [Nunokawa, Masanori] Hokkaido Univ, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan; [Murase, Kaori] Nagoya City Univ, Grad Sch Nat Sci, Mizuho Ku, Nagoya, Aichi 4678501, Japan	Sakai, M (reprint author), Tokyo Univ Agr & Technol, Grad Sch Agr, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	boundary.0008@gmail.com	Gomi, Takashi/E-3504-2010		Ministry of the Environment, Japan [ZD-1202]; Japan Society for the Promotion of Science [24248058]	Invaluable comment for the improvement of this manuscript was provided by Editor-in-Chief S. C. Sheppard, and the anonymous reviewers. We also thank Mr. Shoichi Yokoyama for technical support on potassium measurement. A portion of this study was supported by the Environmental Research Fund (ZD-1202) of the Ministry of the Environment, Japan, and a Grant-in-Aid for Scientific Research (A) (#24248058) from the Japan Society for the Promotion of Science.	Tanaka K, 2013, J RADIOANAL NUCL CH, V295, P2007, DOI 10.1007/s10967-012-2192-1; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; SAWHNEY BL, 1972, CLAY CLAY MINER, V20, P93, DOI 10.1346/CCMN.1972.0200208; Avery SV, 1996, J ENVIRON RADIOACTIV, V30, P139, DOI 10.1016/0265-931X(96)89276-9; Yasunari TJ, 2011, P NATL ACAD SCI USA, V108, P19530, DOI 10.1073/pnas.1112058108; FRANCIS CW, 1976, NATURE, V260, P511, DOI 10.1038/260511a0; Nagao S, 2013, BIOGEOSCIENCES, V10, P6215, DOI 10.5194/bg-10-6215-2013; Driscoll CT, 2007, BIOSCIENCE, V57, P17, DOI 10.1641/B570106; Ueda S, 2013, J ENVIRON RADIOACTIV, V118, P96, DOI 10.1016/j.jenvrad.2012.11.009; Kato H, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052928; Richardson JS, 2007, FOREST SCI, V53, P131; Walters DM, 2008, ECOL APPL, V18, P1835, DOI 10.1890/08-0354.1; Kanasashi T, 2015, J ENVIRON RADIOACTIV, V139, P398, DOI 10.1016/j.jenvrad.2014.06.018; CUMMINS KW, 1989, BIOSCIENCE, V39, P24, DOI 10.2307/1310804; Bock R.A., 1979, HDB DECOMPOSITION ME; FAWARIS BH, 1995, SCI TOTAL ENVIRON, V170, P221, DOI 10.1016/0048-9697(95)04710-3; Gastberger M, 2000, J ENVIRON RADIOACTIV, V49, P217, DOI 10.1016/S0265-931X(99)00106-X; GESSNER MO, 1991, FRESHWATER BIOL, V26, P387, DOI 10.1111/j.1365-2427.1991.tb01406.x; Hashimoto S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00416; HILTON J, 1994, WATER RES, V28, P975, DOI 10.1016/0043-1354(94)90107-4; Iwamoto A., 2014, THESIS TOKYO U AGR T; Ministry of Education Culture Sports Science and Technology Japan (MEXT), 2012, RES 5 AIRCR MON AIR; Murakami M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03599; Nakao A, 2008, SOIL SCI PLANT NUTR, V54, P479, DOI 10.1111/j.1747-0765.2008.00262.x; Nakao A., 2012, SANSAI ENV J GLOB CO, V6, P17; R Development Core Team, 2013, R LANG ENV STAT COMP; Rosen K, 2006, SCI TOTAL ENVIRON, V368, P795, DOI 10.1016/j.scitotenv.2006.03.009; Sakai M, 2014, ENVIRON POLLUT, V187, P112, DOI 10.1016/j.envpol.2014.01.002; Schreeg LA, 2013, ECOLOGY, V94, P94, DOI 10.1890/11-1958.1; SHAND CA, 1994, J ENVIRON RADIOACTIV, V23, P285, DOI 10.1016/0265-931X(94)90067-1; SHEPPARD SC, 1990, J ENVIRON QUAL, V19, P464; Teramage MT, 2014, SCI TOTAL ENVIRON, V490, P435, DOI 10.1016/j.scitotenv.2014.05.034; Whicker FW, 2002, HEALTH PHYS, V82, P680, DOI 10.1097/00004032-200205000-00014; Yoshimura M, 2014, HYDROBIOLOGIA, V722, P19, DOI 10.1007/s10750-013-1672-9	34	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0265-931X	1879-1700		J ENVIRON RADIOACTIV	J. Environ. Radioact.	JUN	2015	144						15	20		10.1016/j.jenvrad.2015.03.001		6	Environmental Sciences	Environmental Sciences & Ecology	CJ4ZN	WOS:000355497300003		
J	Ochiai, S; Ueda, S; Hasegawa, H; Kakiuchi, H; Akata, N; Ohtsuka, Y; Hisamatsu, S				Ochiai, Shinya; Ueda, Shinji; Hasegawa, Hidenao; Kakiuchi, Hideki; Akata, Naofumi; Ohtsuka, Yoshihito; Hisamatsu, Shun'ichi			Effects of radiocesium inventory on Cs-137 concentrations in river waters of Fukushima, Japan, under base-flow conditions	JOURNAL OF ENVIRONMENTAL RADIOACTIVITY			English	Article						Fukushima Dai-ichi Nuclear Power Plant accident; Radiocesium; River water; Base-flow; Catchment inventory	NUCLEAR-POWER-PLANT; ATMOSPHERICALLY DEPOSITED RADIONUCLIDES; ACCIDENT; SYSTEMS; TIME	To investigate the behavior of nuclear accident-derived Cs-137 in river water under base-flow conditions, concentrations of dissolved and particulate Cs-137 were measured at 16 sampling points in seven rivers of Fukushima Prefecture, Japan, in 2012 and 2013. The concentration of dissolved Cs-137 was significantly correlated with the mean Cs-137 inventory in the catchment area above each sampling point in both sampling years. These results suggest that the concentration of dissolved Cs-137 under base-flow conditions is primarily determined by the Cs-137 inventory of the catchment area above the sampling point. However, the concentration of particulate Cs-137 did not show a clear relationship with either the mean Cs-137 inventory or the dissolved Cs-137 concentration, thus indicating that particulate and dissolved forms do not effectively interact in rivers. To evaluate the contribution of the Cs-137 inventory within catchment areas, we analyzed relations between the Cs-137 concentration and the mean Cs-137 inventory over the area within certain flow path lengths that were traced along the river and slope above the sampling point. Coefficients of determination for dissolved Cs-137 concentrations were highest for the longest flow path, i.e., the whole catchment area, and lower for shorter flow paths. Coefficients of determination for particulate Cs-137 concentrations were only moderately high for the shortest flow path in 2012, whereas the values were quite low for all flow paths in 2013. These results suggest that dissolved Cs-137 can originate from a larger area of the catchment even under base-flow conditions; however, particulate Cs-137 did not show such behavior. The results also show that under base-flow conditions, dissolved and particulate Cs-137 behave independently during their transport from river catchments to the ocean. (C) 2015 Elsevier Ltd. All rights reserved.	[Ochiai, Shinya; Ueda, Shinji; Hasegawa, Hidenao; Kakiuchi, Hideki; Akata, Naofumi; Ohtsuka, Yoshihito; Hisamatsu, Shun'ichi] Inst Environm Sci, Dept Radioecol, Kamikita, Aomori 0393212, Japan; [Akata, Naofumi] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Ochiai, S (reprint author), Inst Environm Sci, Dept Radioecol, 1-7 Ienomae, Kamikita, Aomori 0393212, Japan.	sochiai@ies.or.jp			government of Aomori Prefecture, Japan	We are grateful to H. Kakimoto and S. Takaya (Zax Co. Ltd.) for their technical help in sample pretreatment. This work was performed under a contract with the government of Aomori Prefecture, Japan.	MITASOVA H, 1993, MATH GEOL, V25, P657, DOI 10.1007/BF00893172; Tsuji H, 2014, WATER RES, V60, P15, DOI 10.1016/j.watres.2014.04.024; Smith JT, 2004, ENVIRON SCI TECHNOL, V38, P850, DOI 10.1021/es0300463; Ueda S, 2013, J ENVIRON RADIOACTIV, V118, P96, DOI 10.1016/j.jenvrad.2012.11.009; SMALL H, 1975, ANAL CHEM, V47, P1801, DOI 10.1021/ac60361a017; Phillips JM, 2000, HYDROL PROCESS, V14, P2589, DOI 10.1002/1099-1085(20001015)14:14<2589::AID-HYP94>3.3.CO;2-4; Sakaguchi A, 2015, J ENVIRON RADIOACTIV, V139, P379, DOI 10.1016/j.jenvrad.2014.05.011; Garcia-Sanchez L, 2008, J ENVIRON RADIOACTIV, V99, P563, DOI 10.1016/j.jenvrad.2007.11.013; Geospatial Information Authority of Japan, 2014, FUND GEOSP; GRIMSHAW DL, 1980, J HYDROL, V47, P151, DOI 10.1016/0022-1694(80)90053-0; HELTON JC, 1985, HEALTH PHYS, V48, P757, DOI 10.1097/00004032-198506000-00004; KIMURA T, 1980, ANAL CHIM ACTA, V120, P419, DOI 10.1016/S0003-2670(01)84392-0; Mikami S, 2015, J ENVIRON RADIOACTIV, V139, P320, DOI 10.1016/j.jenvrad.2014.09.010; Ministry of Education Culture Sports Science and Technology (MEXT), 2013, 1 RES 6 AIRB MON 2 A; Ministry of Education Culture Sports Science and Technology (MEXT), 2012, RES 1 5 AIRB MON SUR; Ministry of Land Infrastructure Transport and Tourism Japan (MLIT), 2014, INFORM SYSTEM; Ministry of Land Infrastructure Transport and Tourism Japan (MLIT), 2014, NAT LAND NUM INF; MONTE L, 1995, J ENVIRON RADIOACTIV, V26, P71, DOI 10.1016/0265-931X(95)91634-G; Nagao S., 2013, BIOGEOSCI DISCUSS, V10, P2767, DOI DOI 10.5194/BGD-10-2767-2013; Nuclear Emergency Response Headquarters Government of Japan, 2011, IAEA MIN C NUCL SAF; Nuclear Regulation Authority Japan, 2013, MON AIR DOS RAT SER; Saito K, 2015, J ENVIRON RADIOACTIV, V139, P308, DOI 10.1016/j.jenvrad.2014.02.014; Yamamoto M, 1998, J RADIOANAL NUCL CH, V227, P81, DOI 10.1007/BF02386435; Yamashiki Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep03714; Yoshimura K, 2015, J ENVIRON RADIOACTIV, V139, P370, DOI 10.1016/j.jenvrad.2014.08.021	25	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0265-931X	1879-1700		J ENVIRON RADIOACTIV	J. Environ. Radioact.	JUN	2015	144						86	95		10.1016/j.jenvrad.2015.03.005		10	Environmental Sciences	Environmental Sciences & Ecology	CJ4ZN	WOS:000355497300013		
J	Ohnuki, T; Sakamoto, F; Yamasaki, S; Kozai, N; Shiotsu, H; Utsunomiya, S; Watanabe, N; Kozaki, T				Ohnuki, Toshihiko; Sakamoto, Fuminori; Yamasaki, Shinya; Kozai, Naofumi; Shiotsu, Hiroyuki; Utsunomiya, Satoshi; Watanabe, Naoko; Kozaki, Tamotsu			Effect of minerals on accumulation of Cs by fungus Saccaromyces cerevisiae	JOURNAL OF ENVIRONMENTAL RADIOACTIVITY			English	Article						Radioactive Cs; Fungi; Migration; Mineral; Accumulation	NUCLEAR-POWER-PLANT; CESIUM ACCUMULATION; SOILS; ADSORPTION; ACCIDENT; SORPTION; RELEASE; I-131; CD; MICROORGANISMS	The accumulation of Cs by unicellular fungus of Saccharomyces cerevisiae in the presence of minerals has been studied to elucidate the role of microorganisms in the migration of radioactive Cs in the environment. Two different types of experiments were employed: experiments using stable Cs to examine the effect of a carbon source on the accumulation of Cs, and accumulation experiments of radioactive Cs from agar medium containing Cs-137 and zeolite, vermiculite, phlogopite, smectite, mica, or illite as mineral supplements. In the former type of experiments, the Cs-accumulated cells were analyzed by scanning electron microscopy equipped with energy dispersive X-ray analysis (SEM-EDS). In the latter type, the radioactivity in the yeast cells was measured by an autoradiography technique. When a carbon source was present, higher amounts of Cs accumulated in the cells than in the resting condition without a carbon source. Analyses with SEM-EDS showed that no mineral formed on the cell surface. These results indicate that the yeast cells accumulate Cs by adsorption on the cell surface and intracellular accumulation. In the presence of minerals in the agar medium, the radioactivity in the yeast cells was in the order of mica > smectite, illite >> vermiculite, phlogopite, zeolite. This order is inversely correlated to the ratio of the concentration of radioactive Cs between the minerals and the medium solution. These results strongly suggest that the yeast accumulates radioactive Cs competitively with minerals. (C) 2015 Elsevier Ltd. All rights reserved.	[Ohnuki, Toshihiko; Sakamoto, Fuminori; Yamasaki, Shinya; Kozai, Naofumi] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan; [Ohnuki, Toshihiko] Univ Fukui, Res Inst Nucl Engn, Fukui 9140055, Japan; [Yamasaki, Shinya] Univ Tsukuba, Grad Sch Pure & Appl Sci, Div Chem, Tsukuba, Ibaraki 3058577, Japan; [Shiotsu, Hiroyuki; Utsunomiya, Satoshi] Kyushu Univ, Dept Chem, Higashi Ku, Fukuoka 8128581, Japan; [Watanabe, Naoko; Kozaki, Tamotsu] Hokkaido Univ, Grad Sch Engn, Div Energy & Environm Syst, Kita Ku, Sapporo, Hokkaido 0608628, Japan	Ohnuki, T (reprint author), Japan Atom Energy Agcy, Adv Sci Res Ctr, 2-4 Shirakata, Tokai, Ibaraki 3191195, Japan.	ohnuki.toshihiko@jaea.go.jp			JST Initiatives for Atomic Energy Basic and Generic Strategic Research	This study is partially supported by JST Initiatives for Atomic Energy Basic and Generic Strategic Research.	Tanaka K, 2013, J RADIOANAL NUCL CH, V295, P2007, DOI 10.1007/s10967-012-2192-1; Naeem A, 2006, ENVIRON SCI TECHNOL, V40, P5724, DOI 10.1021/es0606935; Ginn BR, 2008, GEOCHIM COSMOCHIM AC, V72, P3939, DOI 10.1016/j.gca.2008.05.063; TOMIOKA N, 1994, APPL ENVIRON MICROB, V60, P2227; Tanaka K, 2012, GEOCHEM J, V46, P73; Botha A, 2011, SOIL BIOL BIOCHEM, V43, P1, DOI 10.1016/j.soilbio.2010.10.001; COMANS RNJ, 1991, GEOCHIM COSMOCHIM AC, V55, P433; Parekh NR, 2008, J ENVIRON RADIOACTIV, V99, P841, DOI 10.1016/j.jenvrad.2007.10.017; Tanaka K, 2014, J NUCL SCI TECHNOL, V51, P1032, DOI 10.1080/00223131.2014.921583; Yee N, 2001, GEOCHIM COSMOCHIM AC, V65, P2037, DOI 10.1016/S0016-7037(01)00587-7; Kozai N, 2012, J NUCL SCI TECHNOL, V49, P473, DOI [10.1080/002231312012677131, 10.1080/00223131.2012.677131]; Kobayashi T, 2013, J NUCL SCI TECHNOL, V50, P255, DOI 10.1080/00223131.2013.772449; AVERY SV, 1995, J IND MICROBIOL, V14, P76, DOI 10.1007/BF01569888; BORCHARDT G, 1989, SSSA BOOK SER, V1, P675; Borrok DM, 2005, J COLLOID INTERF SCI, V286, P110, DOI 10.1016/j.jcis.2005.01.015; Chino M, 2011, J NUCL SCI TECHNOL, V48, P1129, DOI 10.3327/jnst.48.1129; Fanning D.S., 1989, SSSA BOOK SER, V1, P551; FAWARIS BH, 1995, SCI TOTAL ENVIRON, V170, P221, DOI 10.1016/0048-9697(95)04710-3; GOULDING KWT, 1986, ACS SYM SER, V323, P327; Hirao S, 2013, J NUCL SCI TECHNOL, V50, P139, DOI 10.1080/00223131.2013.757454; JONES RP, 1990, ENZYME MICROB TECH, V12, P402, DOI 10.1016/0141-0229(90)90051-Q; Kuwahara C, 2011, J ENVIRON RADIOACTIV, V102, P138, DOI 10.1016/j.jenvrad.2010.11.004; MING DW, 1989, SSSA BOOK SERIES, V1, P873; YOSHIDA S, 1994, J ENVIRON RADIOACTIV, V22, P141, DOI 10.1016/0265-931X(94)90019-1; Nakao A, 2008, SOIL SCI PLANT NUTR, V54, P479, DOI 10.1111/j.1747-0765.2008.00262.x; Nakao A., 2005, J NUCL RADIOCHEM SCI, V6, P107; OHNUKI T, 1994, RADIOCHIM ACTA, V64, P237; Ohnuki T, 2013, J NUCL SCI TECHNOL, V50, P369, DOI 10.1080/00223131.2013.773164; OLSEN RA, 1990, TRANSFER OF RADIONUCLIDES IN NATURAL AND SEMI-NATURAL ENVIRONMENTS, P657; Phillips RB, 2009, PHYS BIOL CELL; Saito K., 2014, J ENVIRON RADIOACTIV, V139, P308; Sanchez AL, 2000, SOIL BIOL BIOCHEM, V32, P2091, DOI 10.1016/S0038-0717(00)00099-7; Sawney B.L., 1970, CLAY CLAY MINER, V18, P47; SCHULZE DG, 1989, SSSA BOOK SER, V1, P1; SERRANO R, 1984, CURR TOP CELL REGUL, V23, P87; Stemmer M, 2005, J ENVIRON RADIOACTIV, V79, P107, DOI 10.1016/j.jenvrad.2004.04.010; Sugiyama H, 2008, J AGR FOOD CHEM, V56, P9641, DOI 10.1021/jf801269t; Tamura T., 1989, HEALTH PHYS, V12, P391; Walker G, 1998, YEAST PHYSL BIOTECHN; Wang H.L., 2006, BIOTECHNOL ADV, V24, P427	40	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0265-931X	1879-1700		J ENVIRON RADIOACTIV	J. Environ. Radioact.	JUN	2015	144						127	133		10.1016/j.jenvrad.2015.02.018		7	Environmental Sciences	Environmental Sciences & Ecology	CJ4ZN	WOS:000355497300018		
J	Malins, A; Machida, M; Saito, K				Malins, Alex; Machida, Masahiko; Saito, Kimiaki			Comment on 'Update of K-40 and Ra-226 and Th-232 series gamma-to-dose conversion factors for soil'	JOURNAL OF ENVIRONMENTAL RADIOACTIVITY			English	Letter							SYSTEM	A comment on the recent Journal of Environmental Radioactivity article titled 'Update of K-40 and Ra-226 and Th-232 series gamma-to-dose conversion factors for soil'. (C) 2015 Elsevier Ltd. All rights reserved.	[Malins, Alex; Machida, Masahiko] Japan Atom Energy Agcy, Ctr Computat Sci & E Syst, Kashiwa, Chiba 2770871, Japan; [Saito, Kimiaki] Japan Atom Energy Agcy, Sect Fukushima Res & Dev, Fukushima Environm Safety Ctr, Chiyoda Ku, Tokyo 1008577, Japan	Malins, A (reprint author), Japan Atom Energy Agcy, Ctr Computat Sci & E Syst, 178-4-4 Wakashiba, Kashiwa, Chiba 2770871, Japan.	malins.alex@jaea.go.jp	Malins, Alex/D-8405-2013	Malins, Alex/0000-0003-1922-4496			SAITO K, 1995, RADIAT PROT DOSIM, V58, P29; Sato T, 2013, J NUCL SCI TECHNOL, V50, P913, DOI 10.1080/00223131.2013.814553; Namito Y, 2012, J NUCL SCI TECHNOL, V49, P167, DOI 10.1080/00223131.2011.649079; Askri B, 2015, RADIAT MEAS, V72, P1, DOI 10.1016/j.radmeas.2014.11.006; Beck H., 1972, HASL258 AEC; Eckerman K.F., 1993, 12 US EPA; Gasser E, 2014, J ENVIRON RADIOACTIV, V138, P68, DOI 10.1016/j.jenvrad.2014.08.002; ICRP, 2008, ANN ICRP, V38, P119; ICRU, 1994, ICRU PUBL, V53; NEA, 1994, 13 NEA JEF OECD NUCL; UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiations), 2000, SOURC EFF RISKS ION, V1	11	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0265-931X	1879-1700		J ENVIRON RADIOACTIV	J. Environ. Radioact.	JUN	2015	144						179	180		10.1016/j.jenvrad.2015.01.009		2	Environmental Sciences	Environmental Sciences & Ecology	CJ4ZN	WOS:000355497300025		
J	Ito, E; Yamagishi, M; Hatakeyama, D; Watanabe, T; Fujito, Y; Dyakonova, V; Lukowiak, K				Ito, Etsuro; Yamagishi, Miki; Hatakeyama, Dai; Watanabe, Takayuki; Fujito, Yutaka; Dyakonova, Varvara; Lukowiak, Ken			Memory block: a consequence of conflict resolution	JOURNAL OF EXPERIMENTAL BIOLOGY			English	Article						Conditioned taste aversion; Context; Food deprivation; Long-term memory; Lymnaea	CONDITIONED TASTE-AVERSION; POND SNAIL LYMNAEA; LONG-TERM-MEMORY; HUMAN INSULIN-RECEPTOR; MONOCLONAL-ANTIBODIES; STAGNALIS; STIMULI; ACQUISITION; EPITOPES; NEURONS	Food deprivation for 1 day in the pond snail Lymnaea stagnalis before aversive classical conditioning results in optimal conditioned taste aversion (CTA) and long-term memory (LTM) formation, whereas 5-day food deprivation before training does not. We hypothesize that snails do in fact learn and form LTM when trained after prolonged food deprivation, but that severe food deprivation blocks their ability to express memory. We trained 5-day food-deprived snails under various conditions, and found that memory was indeed formed but is overpowered by severe food deprivation. Moreover, CTA-LTM was context dependent and was observed only when the snails were in a context similar to that in which the training occurred.	[Ito, Etsuro; Yamagishi, Miki; Hatakeyama, Dai] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Lab Funct Biol, Sanuki 7692193, Japan; [Watanabe, Takayuki] Hokkaido Univ, Res Inst Elect Sci, Lab Neurocybernet, Sapporo, Hokkaido 0600812, Japan; [Fujito, Yutaka] Sapporo Med Univ, Sch Med, Dept Syst Neurosci, Sapporo, Hokkaido 0608556, Japan; [Dyakonova, Varvara] RAS, Inst Dev Biol, Comparat Physiol Lab, Moscow 119909, Russia; [Lukowiak, Ken] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada	Ito, E (reprint author), Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Lab Funct Biol, Sanuki 7692193, Japan.	eito@kph.bunri-u.ac.jp			Japanese Society for the Promotion of Science [24657055, 25291074]; Canadian Institutes of Health Research [MOP 64339]	This work was supported by KAKENHI from the Japanese Society for the Promotion of Science [24657055, 25291074 to E.I.] and a grant from Canadian Institutes of Health Research [MOP 64339 to K.L.].	TAYLOR R, 1987, BIOCHEM J, V242, P123; Azami S, 2006, J NEUROSCI RES, V84, P1610, DOI 10.1002/jnr.21045; Takigami S, 2014, NEUROBIOL LEARN MEM, V107, P79, DOI 10.1016/j.nlm.2013.10.022; [Anonymous], 1989, LYMNAEA J NEUROCYTOL; [Anonymous], 2015, BIOPHYSICS-USSR; Kawai R, 2004, NEUROBIOL LEARN MEM, V82, P164, DOI 10.1016/j.nlm.2004.06.003; Kojima S, 1996, ZOOL SCI, V13, P803, DOI 10.2108/zsj.13.803; Mita K, 2014, NEUROBIOL LEARN MEM, V107, P1, DOI 10.1016/j.nlm.2013.10.013; Sugai R, 2007, J EXP BIOL, V210, P1225, DOI 10.1242/jeb.02735; Dyakonova VE, 2015, J EXP BIOL, V218, P1151, DOI 10.1242/jeb.111930; [Anonymous], 2015, BIOPHYSICS-USSR; Ito E, 2013, CAN J ZOOL, V91, P405, DOI 10.1139/cjz-2012-0292; Benjamin PR, 2000, LEARN MEMORY, V7, P124, DOI 10.1101/lm.7.3.124; Takigami S, 2013, NEUROSCI LETT, V555, P149, DOI 10.1016/j.neulet.2013.09.042; Sugai R, 2006, J EXP BIOL, V209, P826, DOI 10.1242/jeb.02069; Kawai R, 2011, ZOOL SCI, V28, P517, DOI 10.2108/zsj.28.517; Ito E, 1999, ZOOL SCI, V16, P711, DOI 10.2108/zsj.16.711; Wagatsuma A, 2004, ACTA BIOL HUNG, V55, P149, DOI 10.1556/ABiol.55.2004.1-4.18; Murakami J, 2013, J NEUROSCI, V33, P371, DOI 10.1523/JNEUROSCI.0679-12.2013; Ito E, 2015, J EXP BIOL, V218, P336, DOI 10.1242/jeb.113266; BUCKETT KJ, 1990, J NEUROPHYSIOL, V63, P1413; Chistopol'skii I A, 2003, Neurosci Behav Physiol, V33, P295, DOI 10.1023/A:1022163701311; Dalesman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079561; D'yakonova V. E., 2001, Doklady Akademii Nauk, V376, P267; Dyakonova V E, 2001, Dokl Biol Sci, V378, P230, DOI 10.1023/A:1019258523049; Dyakonova V. E., 2014, NEUROSCI BEHAV PHYSL, V44, P256; Haney J, 2001, LEARN MEMORY, V8, P35, DOI 10.1101/lm.34701; Hatakeyama D, 1999, BIOIMAGES, V7, P1; Ito E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043151; Lukowiak K, 2014, J EXP BIOL, V217, P76, DOI 10.1242/jeb.089441; Mita K, 2014, NEUROBIOL LEARN MEM, V116, P132, DOI 10.1016/j.nlm.2014.10.006; Otsuka E., 2013, BIOPHYSICS-USSR, V9, P161; Palmer CR, 2011, CURR OPIN NEUROBIOL, V21, P520, DOI 10.1016/j.conb.2011.05.003; Shors TJ, 2004, LEARN MEMORY, V11, P137, DOI 10.1101/lm.66604; SOOS MA, 1986, BIOCHEM J, V235, P199; Sunada H., 2014, BIOPHYSICS-USSR, V10, P121; Takahashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075276; Watabe S., 2014, BIOPHYSICS-USSR, V10, P49; Yamanaka M, 2000, NEUROSCI LETT, V278, P113, DOI 10.1016/S0304-3940(99)00916-7	39	1	1	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0022-0949	1477-9145		J EXP BIOL	J. Exp. Biol.	JUN	2015	218	11					1699	1704		10.1242/jeb.120329		6	Biology	Life Sciences & Biomedicine - Other Topics	CJ6KF	WOS:000355602000018		
J	Stewart, FJ; Kinoshita, M; Arikawa, K				Stewart, Finlay J.; Kinoshita, Michiyo; Arikawa, Kentaro			The roles of visual parallax and edge attraction in the foraging behaviour of the butterfly Papilio xuthus	JOURNAL OF EXPERIMENTAL BIOLOGY			English	Article						Parallax; Vision; Motion; Flight; Virtual reality; Butterfly	DROSOPHILA-MELANOGASTER; OPTIC FLOW; VIRTUAL-REALITY; MOTION PARALLAX; FRUIT-FLIES; HONEYBEES; DISTANCES; VISION; LOCUSTS; SPEED	Several examples of insects using visual motion to measure distance have been documented, from locusts peering to gauge the proximity of prey, to honeybees performing visual odometry en route between the hive and a flower patch. However, whether the use of parallax information is confined to specialised behaviours like these or represents a more general purpose sensory capability, is an open question. We investigate this issue in the foraging swallowtail butterfly Papilio xuthus, which we trained to associate a target presented on a monitor with a food reward. We then tracked the animal's flight in real-time, allowing us to manipulate the size and/or position of the target in a closed-loop manner to create the illusion that it is situated either above or below the monitor surface. Butterflies are less attracted to (i.e. slower to approach) targets that appear, based on motion parallax, to be more distant. Furthermore, we found that the number of abortive descent manoeuvres performed prior to the first successful target approach varies according to the depth of the virtual target, with expansion and parallax cues having effects of opposing polarity. However, we found no evidence that Papilio modulate the kinematic parameters of their descents according to the apparent distance of the target. Thus, we argue that motion parallax is used to identify a proximal target object, but that the subsequent process of approaching it is based on stabilising its edge in the 2D space of the retina, without estimating its distance.	[Stewart, Finlay J.; Kinoshita, Michiyo; Arikawa, Kentaro] Sokendai Grad Univ Adv Studies, Sch Adv Sci, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa 2400193, Japan	Stewart, FJ (reprint author), Sokendai Grad Univ Adv Studies, Sch Adv Sci, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa 2400193, Japan.	stewart@soken.ac.jp			JSPS (Japanese Society for Promotion of Science) [26650116, 24570084, 26251036]	This work was supported in part by the JSPS (Japanese Society for Promotion of Science) Grants-in-Aid for Scientific Research to F.J.S. [26650116], M.K. [24570084] and K.A. [26251036].	Fry SN, 2009, J EXP BIOL, V212, P1120, DOI 10.1242/jeb.020768; Baird E, 2013, P NATL ACAD SCI USA, V110, P18686, DOI 10.1073/pnas.1314311110; Straw AD, 2010, CURR BIOL, V20, P1550, DOI 10.1016/j.cub.2010.07.025; Boeddeker N, 2010, P ROY SOC B-BIOL SCI, V277, P1209, DOI 10.1098/rspb.2009.1928; SRINIVASAN MV, 1991, VISUAL NEUROSCI, V6, P519; Arikawa K, 2003, J COMP PHYSIOL A, V189, P791, DOI 10.1007/s00359-003-0454-7; Takeuchi Y, 2006, J EXP BIOL, V209, P2873, DOI 10.1242/jeb.02311; Chahl JS, 2004, INT J ROBOT RES, V23, P101, DOI 10.1177/0278364904041320; Maimon G, 2008, CURR BIOL, V18, P464, DOI 10.1016/j.cub.2008.02.054; WALLACE GK, 1959, J EXP BIOL, V36, P512; Riabinina O, 2014, J EXP BIOL, V217, P2633, DOI 10.1242/jeb.102897; MCBEATH MK, 1995, SCIENCE, V268, P569, DOI 10.1126/science.7725104; SOBEL EC, 1990, J COMP PHYSIOL A, V167, P579; Kinoshita M, 2014, J COMP PHYSIOL A, V200, P513, DOI 10.1007/s00359-014-0903-5; Boeddeker N, 2003, P ROY SOC B-BIOL SCI, V270, P393, DOI 10.1098/rspb.2002.2240; Schuster S, 2002, CURR BIOL, V12, P1591, DOI 10.1016/S0960-9822(02)01141-7; Fry SN, 2008, J NEUROSCI METH, V171, P110, DOI 10.1016/j.jneumeth.2008.02.016; Esch HE, 2001, NATURE, V411, P581, DOI 10.1038/35079072; Franceschini N, 2007, CURR BIOL, V17, P329, DOI 10.1016/j.cub.2006.12.032; Koshitaka H, 2011, J COMP PHYSIOL A, V197, P1105, DOI 10.1007/s00359-011-0671-4; Kral K, 1997, J INSECT BEHAV, V10, P145, DOI 10.1007/BF02765480; SRINIVASAN MV, 1989, J COMP PHYSIOL A, V165, P605, DOI 10.1007/BF00610992; LEHRER M, 1993, J COMP PHYSIOL A, V173, P23; NAKAGAWA T, 1994, ZOOL SCI, V11, P759; RONACHER B, 1995, J COMP PHYSIOL A, V177, P21; Strauss R, 1998, J COMP PHYSIOL A, V182, P411, DOI 10.1007/s003590050190; van Breugel F, 2012, J EXP BIOL, V215, P1783, DOI 10.1242/jeb.066498; van Breugel F, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/2/025002; von Frisch K, 1914, FARBENSINN FORMENSIN; ZHANG SW, 1995, P NATL ACAD SCI USA, V92, P3029, DOI 10.1073/pnas.92.7.3029	30	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0022-0949	1477-9145		J EXP BIOL	J. Exp. Biol.	JUN	2015	218	11					1725	1732		10.1242/jeb.115063		8	Biology	Life Sciences & Biomedicine - Other Topics	CJ6KF	WOS:000355602000021		
J	Wilson, RP; Ives, ML; Rao, G; Lau, A; Payne, K; Kobayashi, M; Arkwright, PD; Peake, J; Wong, M; Adelstein, S; Smart, JM; French, MA; Fulcher, DA; Picard, C; Bustamante, J; Boisson-Dupuis, S; Gray, P; Stepensky, P; Warnatz, K; Freeman, AF; Rossjohn, J; McCluskey, J; Holland, SM; Casanova, JL; Uzel, G; Ma, CS; Tangye, SG; Deenick, EK				Wilson, Robert P.; Ives, Megan L.; Rao, Geetha; Lau, Anthony; Payne, Kathryn; Kobayashi, Masao; Arkwright, Peter D.; Peake, Jane; Wong, Melanie; Adelstein, Stephen; Smart, Joanne M.; French, Martyn A.; Fulcher, David A.; Picard, Capucine; Bustamante, Jacinta; Boisson-Dupuis, Stephanie; Gray, Paul; Stepensky, Polina; Warnatz, Klaus; Freeman, Alexandra F.; Rossjohn, Jamie; McCluskey, James; Holland, Steven M.; Casanova, Jean-Laurent; Uzel, Gulbu; Ma, Cindy S.; Tangye, Stuart G.; Deenick, Elissa K.			STAT3 is a critical cell-intrinsic regulator of human unconventional T cell numbers and function	JOURNAL OF EXPERIMENTAL MEDICINE			English	Article							HYPER-IGE SYNDROME; ROR-GAMMA-T; EFFECTOR FUNCTIONS; CLINICAL-FEATURES; MAIT CELLS; MUTATIONS; DOMINANT; RECEPTOR; DIFFERENTIATION; DEFICIENCY	Unconventional T cells such as gamma delta T cells, natural killer T cells (NKT cells) and mucosal-associated invariant T cells (MAIT cells) are a major component of the immune system; however, the cytokine signaling pathways that control their development and function in humans are unknown. Primary immunodeficiencies caused by single gene mutations provide a unique opportunity to investigate the role of specific molecules in regulating human lymphocyte development and function. We found that individuals with loss-of-function mutations in STAT3 had reduced numbers of peripheral blood MAIT and NKT but not gamma delta T cells. Analysis of STAT3 mosaic individuals revealed that this effect was cell intrinsic. Surprisingly, the residual STAT3-deficient MAIT cells expressed normal levels of the transcription factor ROR gamma t. Despite this, they displayed a deficiency in secretion of IL-17A and IL-17F, but were able to secrete normal levels of cytokines such as IFN gamma and TNF The deficiency in MAIT and NKT cells in STAT3-deficient patients was mirrored by loss-of-function mutations in IL12RB1 and IL21R, respectively. Thus, these results reveal for the first time the essential role of STAT3 signaling downstream of IL-23R and IL-21R in controlling human MAIT and NKT cell numbers.	[Wilson, Robert P.; Lau, Anthony] Univ Bath, Bath BA2 7AY, Avon, England; [Wilson, Robert P.; Ives, Megan L.; Rao, Geetha; Lau, Anthony; Payne, Kathryn; Ma, Cindy S.; Tangye, Stuart G.; Deenick, Elissa K.] Garvan Inst Med Res, Immunol Div, Sydney, NSW 2010, Australia; [Ives, Megan L.; Ma, Cindy S.; Tangye, Stuart G.; Deenick, Elissa K.] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW 2052, Australia; [Gray, Paul] Univ New S Wales, Sch Womens & Childrens Hlth, Sydney, NSW 2052, Australia; [Kobayashi, Masao] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pediat, Hiroshima 7398511, Japan; [Arkwright, Peter D.] Univ Manchester, Royal Manchester Childrens Hosp, Manchester M13 9WL, Lancs, England; [Peake, Jane] Royal Childrens Hosp, Dept Paediat & Child Hlth, Brisbane, Qld 4006, Australia; [Wong, Melanie] Childrens Hosp, Dept Allergy & Immunol, Westmead, NSW 2145, Australia; [Adelstein, Stephen] Royal Prince Alfred Hosp, Dept Clin Immunol, Camperdown, NSW 2050, Australia; [Smart, Joanne M.] Royal Childrens Hosp Melbourne, Dept Allergy & Immunol, Parkville, Vic 3052, Australia; [French, Martyn A.] Royal Perth Hosp, Dept Clin Immunol, Perth, WA 6000, Australia; [French, Martyn A.] Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA 6009, Australia; [Fulcher, David A.] Westmead Hosp, Inst Clin Pathol & Med Res, Dept Immunol, Westmead, NSW 2006, Australia; [Picard, Capucine; Bustamante, Jacinta; Boisson-Dupuis, Stephanie; Casanova, Jean-Laurent] Necker Hosp Sick Children, Lab Human Genet Infect Dis, Necker Branch, French Inst Hlth & Med Res INSERM,U1163, F-75015 Paris, France; [Casanova, Jean-Laurent] Necker Hosp Sick Children, Pediat Hematol & Immunol Unit, F-75015 Paris, France; [Picard, Capucine; Bustamante, Jacinta] Hop Necker Enfants Malad, AP HP, Study Ctr Primary Immunodeficiencies, F-75015 Paris, France; [Picard, Capucine; Bustamante, Jacinta; Casanova, Jean-Laurent] Paris Descartes Univ, Imagine Inst, F-75015 Paris, France; [Boisson-Dupuis, Stephanie; Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA; [Stepensky, Polina] Hebrew Univ Jerusalem, Med Ctr, Hadassah Med Ctr, Dept Pediat Hematol Oncol & Bone Marrow, IL-91120 Jerusalem, Israel; [Warnatz, Klaus] Univ Freiburg, Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, D-79106 Freiburg, Germany; [Freeman, Alexandra F.; Holland, Steven M.; Uzel, Gulbu] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Rossjohn, Jamie] Monash Univ, Ctr Excellence Adv Mol Imaging, Australian Res Council ARC, Clayton, Vic 3800, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales; [McCluskey, James] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia; [Casanova, Jean-Laurent] Howard Hughes Med Inst, New York, NY 10065 USA	Deenick, EK (reprint author), Garvan Inst Med Res, Immunol Div, Sydney, NSW 2010, Australia.	s.tangye@garvan.org.au; e.deenick@garvan.org.au	McCluskey, James/A-1291-2007; Peake, Jane/B-4488-2011; 	Lau, Anthony/0000-0002-7338-7176; Arkwright, Peter/0000-0002-7411-5375	National Health and Medical Research Council (NHMRC) of Australia [1016953, 1066694, 1027400]; Rockefeller University Center for 541 Clinical and Translational Science [5UL1RR024143]; Career Development Fellowship [1008820]; NHMRC of Australia [1042925]	This work was funded by project and program grants from the National Health and Medical Research Council (NHMRC) of Australia (1016953, 1066694, and 1027400 to E.K. Deenick and S.G. Tangye) and the Rockefeller University Center for 541 Clinical and Translational Science (5UL1RR024143 to J.-L. Casanova). C.S. Ma is a recipient of a Career Development Fellowship (1008820), and S.G. Tangye is a recipient of a Principal Research Fellowship (1042925) from the NHMRC of Australia.	de Beaucoudrey L, 2010, MEDICINE, V89, P381, DOI 10.1097/MD.0b013e3181fdd832; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Corbett AJ, 2014, NATURE, V509, P361, DOI 10.1038/nature13160; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Chandesris MO, 2012, MEDICINE, V91, pE1, DOI 10.1097/MD.0b013e31825f95b9; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; de Beaucoudrey L, 2008, J EXP MED, V205, P1543, DOI 10.1084/jem.20080321; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Gold MC, 2013, NAT REV MICROBIOL, V11, P14, DOI 10.1038/nrmicro2918; Shibata K, 2011, BLOOD, V118, P586, DOI 10.1182/blood-2011-02-334995; Deenick EK, 2013, J EXP MED, V210, P2739, DOI 10.1084/jem.20130323; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Kotlarz D, 2013, J EXP MED, V210, P433, DOI 10.1084/jem.20111229; Fenoglio D, 2009, BLOOD, V113, P6611, DOI 10.1182/blood-2009-01-198028; Siegel AM, 2011, IMMUNITY, V35, P806, DOI 10.1016/j.immuni.2011.09.016; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; Dorman SE, 2004, LANCET, V364, P2113, DOI 10.1016/S0140-6736(04)17552-1; Cypowyj S, 2012, EUR J IMMUNOL, V42, P2246, DOI 10.1002/eji.201242605; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Ives ML, 2013, J ALLERGY CLIN IMMUN, V132, P400, DOI 10.1016/j.jaci.2013.05.029; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Coquet JM, 2008, P NATL ACAD SCI USA, V105, P11287, DOI 10.1073/pnas.0801631105; Le Bourhis L, 2013, CURR OPIN IMMUNOL, V25, P174, DOI 10.1016/j.coi.2013.01.005; Hsu AP, 2013, J ALLERGY CLIN IMMUN, V131, P1586, DOI 10.1016/j.jaci.2013.02.038; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Constantinides MG, 2013, CURR OPIN IMMUNOL, V25, P161, DOI 10.1016/j.coi.2013.01.003; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Kane A, 2014, CURR OPIN IMMUNOL, V28, P49, DOI 10.1016/j.coi.2014.01.015; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Eidson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024441; Li BQ, 1996, J IMMUNOL, V157, P4222; Ness-Schwickerath KJ, 2010, J IMMUNOL, V184, P7268, DOI 10.4049/jimmunol.1000600; PARKER CM, 1990, J EXP MED, V171, P1597, DOI 10.1084/jem.171.5.1597; Stepensky P, 2015, HAEMATOLOGICA, V100, pE72, DOI 10.3324/haematol.2014.112508	43	4	4	ROCKEFELLER UNIV PRESS	NEW YORK	950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA	0022-1007	1540-9538		J EXP MED	J. Exp. Med.	JUN 1	2015	212	6					855	864		10.1084/jem.20141992		10	Immunology; Medicine, Research & Experimental	Immunology; Research & Experimental Medicine	CJ5YF	WOS:000355569300003		
J	Tachibana, R; Noguchi, Y				Tachibana, Ryosuke; Noguchi, Yasuki			Unconscious Analyses of Visual Scenes Based on Feature Conjunctions	JOURNAL OF EXPERIMENTAL PSYCHOLOGY-HUMAN PERCEPTION AND PERFORMANCE			English	Article						misbinding; preattentive feature integration; statistic scene analysis; color-shape conjunction	STATISTICAL PROPERTIES; PSYCHOPHYSICS TOOLBOX; FEATURE BINDING; COLOR; ATTENTION; AWARENESS; CONSCIOUSNESS; SUPPRESSION; PERCEPTION; MOTION	To efficiently process a cluttered scene, the visual system analyzes statistical properties or regularities of visual elements embedded in the scene. It is controversial, however, whether those scene analyses could also work for stimuli unconsciously perceived. Here we show that our brain performs the unconscious scene analyses not only using a single featural cue (e.g., orientation) but also based on conjunctions of multiple visual features (e.g., combinations of color and orientation information). Subjects foveally viewed a stimulus array (duration: 50 ms) where 4 types of bars (red-horizontal, red-vertical, green-horizontal, and green-vertical) were intermixed. Although a conscious perception of those bars was inhibited by a subsequent mask stimulus, the brain correctly analyzed the information about color, orientation, and color-orientation conjunctions of those invisible bars. The information of those features was then used for the unconscious configuration analysis (statistical processing) of the central bars, which induced a perceptual bias and illusory feature binding in visible stimuli at peripheral locations. While statistical analyses and feature binding are normally 2 key functions of the visual system to construct coherent percepts of visual scenes, our results show that a high-level analysis combining those 2 functions is correctly performed by unconscious computations in the brain.	[Tachibana, Ryosuke; Noguchi, Yasuki] Kobe Univ, Grad Sch Humanities, Dept Psychol, Kobe, Hyogo 6578501, Japan	Noguchi, Y (reprint author), Kobe Univ, Grad Sch Humanities, Dept Psychol, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	ynoguchi@lit.kobe-u.ac.jp			KAKENHI from the Japan Society for the Promotion of Science (JSPS) [22680022, 26700011]	This work was supported by KAKENHI Grants (22680022 and 26700011) from the Japan Society for the Promotion of Science (JSPS).	Koch C, 2012, TRENDS COGN SCI, V16, P103, DOI 10.1016/j.tics.2011.11.012; Almeida J, 2008, P NATL ACAD SCI USA, V105, P15214, DOI 10.1073/pnas.0805867105; Enns JT, 2000, TRENDS COGN SCI, V4, P345, DOI 10.1016/S1364-6613(00)01520-5; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Holcombe AO, 2001, NAT NEUROSCI, V4, P127, DOI 10.1038/83945; Kanai R, 2010, CONSCIOUS COGN, V19, P1045, DOI 10.1016/j.concog.2010.06.003; Simons DJ, 2000, TRENDS COGN SCI, V4, P147, DOI 10.1016/S1364-6613(00)01455-8; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Vul E, 2006, NAT NEUROSCI, V9, P873, DOI 10.1038/nn1723; Oliva A, 2007, TRENDS COGN SCI, V11, P520, DOI 10.1016/j.tics.2007.09.009; Van Opstal F, 2011, COGNITION, V120, P136, DOI 10.1016/j.cognition.2011.03.005; Mudrik L, 2011, PSYCHOL SCI, V22, P764, DOI 10.1177/0956797611408736; Blaser E, 2005, EUR J NEUROSCI, V21, P2040, DOI 10.1111/j.1460-9568.2005.04032.x; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Bauer B, 2009, PSYCHOL REC, V59, P171; Seymour K, 2009, CURR BIOL, V19, P177, DOI 10.1016/j.cub.2008.12.050; Chong SC, 2003, VISION RES, V43, P393, DOI 10.1016/S0042-6989(02)00596-5; WILLIAMS DW, 1984, VISION RES, V24, P55, DOI 10.1016/0042-6989(84)90144-5; HOUCK MR, 1986, J EXP PSYCHOL HUMAN, V12, P186, DOI 10.1037//0096-1523.12.2.186; Jiang Y, 2007, PSYCHOL SCI, V18, P349, DOI 10.1111/j.1467-9280.2007.01902.x; Kim CY, 2005, TRENDS COGN SCI, V9, P381, DOI 10.1016/j.tics.2005.06.012; Seymour K, 2010, CEREB CORTEX, V20, P1946, DOI 10.1093/cercor/bhp265; Harris JJ, 2011, PSYCHOL SCI, V22, P399, DOI 10.1177/0956797611399293; Lin ZC, 2009, PROG NEUROBIOL, V87, P195, DOI 10.1016/j.pneurobio.2008.09.002; Ariely D, 2001, PSYCHOL SCI, V12, P157, DOI 10.1111/1467-9280.00327; Cohen MA, 2012, TRENDS COGN SCI, V16, P411, DOI 10.1016/j.tics.2012.06.013; FAVREAU OE, 1972, SCIENCE, V176, P78, DOI 10.1126/science.176.4030.78; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; Bouvier S, 2010, PSYCHOL SCI, V21, P200, DOI 10.1177/0956797609357858; Alvarez GA, 2011, TRENDS COGN SCI, V15, P122, DOI 10.1016/j.tics.2011.01.003; Parkes L, 2001, NAT NEUROSCI, V4, P739, DOI 10.1038/89532; Wu DA, 2004, NATURE, V429, P262, DOI 10.1038/429262a; Wolfe JM, 2011, TRENDS COGN SCI, V15, P77, DOI 10.1016/j.tics.2010.12.001; de Gardelle V, 2011, P NATL ACAD SCI USA, V108, P13341, DOI 10.1073/pnas.1104517108; Montoro PR, 2014, CONSCIOUS COGN, V25, P1, DOI 10.1016/j.concog.2014.01.004; Di Lollo V, 2000, J EXP PSYCHOL GEN, V129, P481, DOI 10.1037//0096-3445.129.4.481; Sobel KV, 2002, PERCEPTION, V31, P813, DOI 10.1068/p3279; Humphrey GK, 1998, CONSCIOUS COGN, V7, P494, DOI 10.1006/ccog.1998.0369; BREITMEYER BG, 1976, PSYCHOL REV, V83, P1, DOI 10.1037/0033-295X.83.1.1; Chung CYL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00195; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Koivisto M, 2011, CONSCIOUS COGN, V20, P1293, DOI 10.1016/j.concog.2011.02.008; MCCOLLOU.C, 1965, SCIENCE, V149, P1115, DOI 10.1126/science.149.3688.1115; Melcher D, 2005, NEURON, V46, P723, DOI 10.1016/j.neuron.2005.04.023; Moore CM, 1997, J EXP PSYCHOL HUMAN, V23, P339, DOI 10.1037/0096-1523.23.2.339; Noguchi Y, 2011, PSYCHOL SCI, V22, P153, DOI 10.1177/0956797610393743; Rajimehr R, 2004, NEURON, V41, P663, DOI 10.1016/S0896-6273(04)00041-8; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037//0096-1523.18.3.849; Schwarzkopf DS, 2011, P ROY SOC B-BIOL SCI, V278, P2207, DOI 10.1098/rspb.2010.1909; Suzuki M, 2013, VISION RES, V82, P58, DOI 10.1016/j.visres.2013.02.011; Tsuchiya N, 2012, TRENDS COGN SCI, V16, P527, DOI 10.1016/j.tics.2012.09.004; Wang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040106; WATAMANIUK SNJ, 1992, VISION RES, V32, P931, DOI 10.1016/0042-6989(92)90036-I	54	0	0	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0096-1523	1939-1277		J EXP PSYCHOL HUMAN	J. Exp. Psychol.-Hum. Percept. Perform.	JUN	2015	41	3					639	648		10.1037/xhp0000045		10	Psychology; Psychology, Experimental	Psychology	CJ2IG	WOS:000355306900008		
J	Taguchi, T				Taguchi, Takeo			Special issue: International Conference on Fluorine Chemistry 2014 Tokyo (ICFC2014TOKYO) Preface	JOURNAL OF FLUORINE CHEMISTRY			English	Editorial Material									Sagami Chem Res Inst, Comm 155, JSPS, Ayase, Kanagawa 2521193, Japan	Taguchi, T (reprint author), Sagami Chem Res Inst, Comm 155, JSPS, Ayase, Kanagawa 2521193, Japan.							0	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	JUN	2015	174				SI		1	1		10.1016/j.jfluchem.2015.04.009		1	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CJ2ZO	WOS:000355353400001		
J	Matsumoto, K; Matsui, T; Nohira, T; Hagiwara, R				Matsumoto, Kazuhiko; Matsui, Toshifumi; Nohira, Toshiyuki; Hagiwara, Rika			Crystal structure of Na[N(SO2CF3)(2)] and coordination environment of alkali metal cation in the M[N(SO2CF3)(2)] (M+ = Li+, Na+, K+, and Cs+) structures	JOURNAL OF FLUORINE CHEMISTRY			English	Article						TFSA; Bis(trifluoromethylsulfonyl)amide; Structure; Alkali metal	TEMPERATURE IONIC LIQUIDS; BOND-VALENCE PARAMETERS; XENON-NITROGEN BONDS; MOLTEN-SALTS; ELECTROLYTES; ANION; IMIDAZOLIUM; BATTERIES; VISCOSITY; COMPOUND	Crystal structure of Na[TFSA] (TFSA(-) bis(trifluoromethylsulfonyl)amide anion (N(SO2CF3)(2)(-))) has been determined by single-crystal X-ray diffraction. This compound crystallizes in a monoclinic cell (space group: P2(1)/n) with Z = 8 and two ion pairs in the asymmetric unit. Both the crystallographically independent TFSA(-) anions adopt a cis configuration with the C-S center dot center dot center dot S-C torsion angle of -25.2(2)degrees and 25.1(2)degrees The Na+ cations have contacts primarily with five neighboring O atoms (2.344(3)-2.415(3) angstrom for Na1 center dot center dot center dot O and 2337(3)-2.451(3) angstrom for Na2 center dot center dot center dot O) and secondarily with one O atom and one N atom (2.843(3) for Na1 center dot center dot center dot O, 2.929(3) for Na1 center dot center dot center dot N, 2.806(3) for Na2 center dot center dot center dot O and 2.907(3) for Na2 center dot center dot center dot N). Comparison of the present structure with the previously reported M[TFSA] (M+ = Li+, K+, and Cs+) structures revealed that all of them have layered structures composed of the cationic and anionic layers. Coordination environment of M+ in the M[TFSA] structures is discussed based on bond valence sum calculations. (C) 2014 Elsevier B.V. All rights reserved.	[Matsumoto, Kazuhiko; Matsui, Toshifumi; Nohira, Toshiyuki; Hagiwara, Rika] Kyoto Univ, Grad Sch Energy Sci, Sakyo Ku, Kyoto 6068501, Japan	Matsumoto, K (reprint author), Kyoto Univ, Grad Sch Energy Sci, Sakyo Ku, Kyoto 6068501, Japan.	k-matsumoto@energy.kyoto-u.ac.jp					Tsunashima K, 2007, ELECTROCHEM COMMUN, V9, P2353, DOI 10.1016/j.elecom.2007.07.003; Dias FB, 2000, J POWER SOURCES, V88, P169, DOI 10.1016/S0378-7753(99)00529-7; Bonhote P, 1996, INORG CHEM, V35, P1168, DOI 10.1021/ic951325x; [Anonymous], 2004, RAPID XRD VERS 2 3 3; Haas A, 1996, INORG CHEM, V35, P1918, DOI 10.1021/ic9507934; Xue LX, 2002, SOLID STATE SCI, V4, P1535, DOI 10.1016/S1293-2558(02)00050-X; NOWINSKI JL, 1994, J MATER CHEM, V4, P1579, DOI 10.1039/jm9940401579; ALTOMARE A, 1993, J APPL CRYSTALLOGR, V26, P343, DOI 10.1107/S0021889892010331; Lopes JNC, 2004, J PHYS CHEM B, V108, P16893, DOI 10.1021/jp0476545; Fujii K, 2006, J PHYS CHEM B, V110, P8179, DOI 10.1021/jp0612477; Tokuda H, 2006, J PHYS CHEM B, V110, P2833, DOI 10.1021/jp053396f; BROWN ID, 1985, ACTA CRYSTALLOGR B, V41, P244, DOI 10.1107/S0108768185002063; Noda A, 2001, J PHYS CHEM B, V105, P4603, DOI 10.1021/jp004132q; Pringle JM, 2010, J MATER CHEM, V20, P2056, DOI 10.1039/b920406g; Nohira T, 2012, J POWER SOURCES, V205, P506, DOI 10.1016/j.jpowsour.2011.11.086; [Anonymous], 2006, RAPID AUTO VERS 2 40; MacFarlane DR, 1999, NATURE, V402, P792, DOI 10.1038/45514; Holbrey JD, 2004, DALTON T, P2267, DOI 10.1039/b405901h; MacFarlane DR, 1999, J PHYS CHEM B, V103, P4164, DOI 10.1021/jp984145s; Golding JJ, 1998, CHEM COMMUN, P1593, DOI 10.1039/a802745e; BRESE NE, 1991, ACTA CRYSTALLOGR B, V47, P192, DOI 10.1107/S0108768190011041; Earle MJ, 2004, CHEM COMMUN, P1368, DOI 10.1039/b403650f; Farrugia L.J., 1999, J APPL CRYSTALLOGR, V32, P837; FOROPOULOS J, 1982, J FLUORINE CHEM, V21, P9, DOI 10.1016/S0022-1139(00)85329-4; FOROPOULOS J, 1982, J AM CHEM SOC, V104, P4260, DOI 10.1021/ja00379a042; Forsyth CM, 2002, CHEM MATER, V14, P2103, DOI 10.1021/cm0107777; Hagiwara R, 2008, J CHEM ENG DATA, V53, P355, DOI 10.1021/je700368r; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Watarai A, 2008, J POWER SOURCES, V183, P724, DOI 10.1016/j.jpowsour.2008.05.054; Xue LX, 2005, SOLID STATE SCI, V7, P311, DOI 10.1016/j.solidstatesciences.2004.10.029; Zak Z, 1998, Z KRISTALLOGR, V213, P217, DOI 10.1524/zkri.1998.213.4.217	31	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	JUN	2015	174				SI		42	48		10.1016/j.jfluchem.2014.07.021		7	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CJ2ZO	WOS:000355353400008		
J	Mizuhata, M; Katayama, A; Maki, H				Mizuhata, Minoru; Katayama, Akihito; Maki, Hideshi			On-site fabrication and charge-discharge property of TiO2 coated porous silicon electrode by the liquid phase deposition with anodic oxidation	JOURNAL OF FLUORINE CHEMISTRY			English	Article						LPD; PSi; Lithium ion battery; Anodization; Titanium oxide; Etching	LITHIUM-ION BATTERIES; OXIDE THIN-FILMS; AQUEOUS-SOLUTION; NEGATIVE ELECTRODES; MESOPOROUS SILICON; METAL-DEPOSITION; SURFACE; PERFORMANCE; NANOSTRUCTURE; MECHANISMS	TiO2/porous Si (PSi) nanocomposites were fabricated by liquid-phase deposition with anodization of PSI. Scanning electron microscopy-energy-dispersive X-ray spectroscopy showed that TiO2 was only deposited in the fine pores of anodized PSi (ca. 7.4 nm) when the PSi surface was anodized in the presence of Ti ions as F- scavengers. The TiO2/PSi nanocomposites were fabricated by anodization of PSi in a H2TiF6 electrolyte at a constant potential. The amount of Ti deposited was maximum at 300 mV vs. Ag/AgCl electrode, and the deposition process was controlled by varying the applied potential for PSi anodization. The charge/discharge capacities of the fabricated TiO2/PSi nanocomposites as Li-ion battery anodes were determined. Improvements in the charge/discharge capacity were achieved by improving the PSi wettability by TiO2 deposition and activation of Si on the surface of the anodized PSi fine pores. TiO2/PSi fabricated by anodization maintained a high charge/discharge capacity without rapid degradation, because SiO2, which causes rapid degradation of the charge/discharge capacity, was reduced by Li metal. (C) 2014 Elsevier B.V. All rights reserved.	[Mizuhata, Minoru; Katayama, Akihito; Maki, Hideshi] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, Kobe, Hyogo 6578501, Japan	Mizuhata, M (reprint author), Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	mizuhata@kobe-u.ac.jp; maki@kobe-u.ac.jp	Mizuhata, Minoru/F-2309-2010	Mizuhata, Minoru/0000-0002-4496-2215	JST Core Research for Evolutional Science and Technology (CREST) [12101607]	This study is supported by the research project of No. 12101607 in "Phase Interface Science for Highly Efficient Energy Utilization" of JST Core Research for Evolutional Science and Technology (CREST). We would like to thank Professors Takeshi Abe and Masahiro Yamamoto and their colleagues for discussion of electrochemical evaluation of the electrode sample.	Angermann H, 2014, APPL SURF SCI, V312, P3, DOI 10.1016/j.apsusc.2014.05.087; Riikonen J, 2012, LANGMUIR, V28, P10573, DOI 10.1021/la301642w; Qu YQ, 2009, NANO LETT, V9, P4539, DOI 10.1021/nl903030h; Anglin EJ, 2004, LANGMUIR, V20, P11264, DOI 10.1021/la048105t; Maki H, 2013, MATER CHEM PHYS, V141, P445, DOI 10.1016/j.matchemphys.2013.05.043; Philippe B, 2012, CHEM MATER, V24, P1107, DOI 10.1021/cm2034195; Harraz FA, 2002, J ELECTROCHEM SOC, V149, pC456, DOI 10.1149/1.1498841; Lin LH, 2010, NANOSCALE RES LETT, V5, P1822, DOI 10.1007/s11671-010-9719-6; Shin HC, 2005, J POWER SOURCES, V139, P314, DOI 10.1016/j.jpowsour.2004.06.073; Kavan L, 2004, CHEM MATER, V16, P477, DOI 10.1021/cm035046g; Maki H, 2014, J PHYS CHEM C, V118, P11964, DOI 10.1021/jp501162a; Chan CK, 2008, NAT NANOTECHNOL, V3, P31, DOI 10.1038/nnano.2007.411; Huang JJ, 2013, SURF COAT TECH, V231, P257, DOI 10.1016/j.surfcoat.2012.04.078; Djenizian T, 2011, J MATER CHEM, V21, P9925, DOI 10.1039/c0jm04205f; Kato Y, 2012, APPL SURF SCI, V258, P5689, DOI 10.1016/j.apsusc.2012.02.063; Chen JS, 2011, J MATER CHEM, V21, P9912, DOI 10.1039/c0jm04163g; Astrova EV, 2011, TECH PHYS LETT+, V37, P731, DOI 10.1134/S1063785011080037; To WK, 2011, NANO LETT, V11, P5252, DOI 10.1021/nl202674t; Harraz FA, 2005, J ELECTROCHEM SOC, V152, pC213, DOI 10.1149/1.1864292; Jiang YM, 2012, J POWER SOURCES, V214, P298, DOI 10.1016/j.jpowsour.2012.04.091; Arigane T, 1999, SURF SCI, V427-28, P304, DOI 10.1016/S0039-6028(99)00294-0; Bal JK, 2012, MATER CHEM PHYS, V134, P549, DOI 10.1016/j.matchemphys.2012.03.033; Deki S, 2002, SOLID STATE IONICS, V151, P1, DOI 10.1016/S0167-2738(02)00597-0; Deki S, 1996, CHEM LETT, P433, DOI 10.1246/cl.1996.433; Dudley ME, 2009, ELECTROCHEM SOLID ST, V12, pD22, DOI 10.1149/1.3074333; El-Sheikh SM, 2012, J NON-CRYST SOLIDS, V358, P2816, DOI 10.1016/j.jnoncrysol.2012.07.007; Foll H, 2011, J ELECTROCHEM SOC, V158, pD357, DOI 10.1149/1.3563752; Fukami K, 2009, ELECTROCHIM ACTA, V54, P2197, DOI 10.1016/j.electacta.2008.10.024; Hasegawa T, 2012, CHEM LETT, V41, P1262, DOI 10.1246/cl.2012.1262; Kolasinski KW, 2010, J PHYS CHEM C, V114, P22098, DOI 10.1021/jp108169b; Li H, 1999, SOLID STATE LETT, V2, P547; Lu M, 2012, INT J ELECTROCHEM SC, V7, P6180; Mizuhata M, 2008, MICROELECTRON ENG, V85, P355, DOI 10.1016/j.mee.2007.07.006; Nishio K, 2012, ELECTROCHEM SOLID ST, V15, pA41, DOI 10.1149/2.002204esl; SMITH RL, 1992, J APPL PHYS, V71, pR1, DOI 10.1063/1.350839; TURNER DR, 1960, J ELECTROCHEM SOC, V107, P810, DOI 10.1149/1.2427519; ZOUBIR NH, 1995, THIN SOLID FILMS, V255, P228, DOI 10.1016/0040-6090(94)05659-2	37	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	JUN	2015	174				SI		62	69		10.1016/j.jfluchem.2014.12.001		8	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CJ2ZO	WOS:000355353400010		
J	Ie, Y; Jinnai, S; Karakawa, M; Saeki, A; Seki, S; Aso, Y				Ie, Yutaka; Jinnai, Seihou; Karakawa, Makoto; Saeki, Akinori; Seki, Shu; Aso, Yoshio			Synthesis, properties, and semiconducting characteristics of electron-transporting three-dimensional pi-conjugated compounds containing dicyanomethylene-substituted difluorocyclopenta[b]thiophene	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Structure-property relationship; Electron mobility; Organic solar cell; Three-dimensional structure; Electron-transporting material	HETEROJUNCTION SOLAR-CELLS; NON-FULLERENE; TRANSISTORS; ACCEPTOR	The design and synthesis of three-dimensional pi-conjugated compounds containing dicyanomethylene-substituted difluorocyclopenta[b]thiophene for application as acceptor materials in organic photovoltaic devices are reported. Photophysical and electrochemical measurements, as well as semiconducting performance evaluations were performed to investigate the characteristic properties derived from the three-dimensional structure. (C) 2014 Elsevier B.V. All rights reserved.	[Ie, Yutaka; Jinnai, Seihou; Karakawa, Makoto; Aso, Yoshio] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan; [Ie, Yutaka; Saeki, Akinori] Japan Sci & Technol Agcy JST PRESTO, Kawaguchi, Saitama 3330012, Japan; [Saeki, Akinori; Seki, Shu] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan	Ie, Y (reprint author), Osaka Univ, Inst Sci & Ind Res, 8-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.	yutakaie@sanken.osaka-u.ac.jp; aso@sanken.osaka-u.ac.jp	Saeki, Akinori/B-7756-2011; Seki, Shu/E-5346-2010	Seki, Shu/0000-0001-7851-4405	Ministry of Education, Culture, Sports, Science and Technology, Japan; Sumitomo Chemical Co., Ltd.; Japan Society for the Promotion of Science for Young Scientists	This work was supported by a Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by cooperative Research with Sumitomo Chemical Co., Ltd. We acknowledge Mr. Takeo Makino for the support of synthesis. S. J. acknowledges research fellowship of Japan Society for the Promotion of Science for Young Scientists. Thanks are extended to the CAC, ISIR, for assistance in obtaining elemental analyses.	Lin YZ, 2012, CHEM COMMUN, V48, P4773, DOI 10.1039/c2cc31511d; Heeger AJ, 2014, ADV MATER, V26, P10, DOI 10.1002/adma.201304373; Ie Y, 2013, CHEM COMMUN, V49, P8386, DOI 10.1039/c3cc43925a; Wang CL, 2012, CHEM REV, V112, P2208, DOI 10.1021/cr100380z; Holliday S, 2014, CHEM MATER, V26, P647, DOI 10.1021/cm402421p; Dennler G, 2009, ADV MATER, V21, P1323, DOI 10.1002/adma.200801283; Saeki A, 2012, ACCOUNTS CHEM RES, V45, P1193, DOI 10.1021/ar200283b; Eftaiha AF, 2014, J MATER CHEM A, V2, P1201, DOI 10.1039/c3ta14236a; Park SH, 2009, NAT PHOTONICS, V3, P297, DOI 10.1038/NPHOTON.2009.69; POMMEREHNE J, 1995, ADV MATER, V7, P551, DOI 10.1002/adma.19950070608; Ie Y, 2014, CHEM COMMUN, V50, P4123, DOI 10.1039/c4cc00940a; Faulkner L.A., 1984, ELECTROCHEMICAL METH; Ie Y, 2011, J ORG CHEM, V76, P6604, DOI 10.1021/jo200890b; Ie Y, 2011, CHEM-EUR J, V17, P4750, DOI 10.1002/chem.201002995; Nakayama J, 1997, TETRAHEDRON LETT, V38, P6043, DOI 10.1016/S0040-4039(97)01356-7; Thompson BC, 2008, ANGEW CHEM INT EDIT, V47, P58, DOI 10.1002/anie.200702506; Li YF, 2012, ACCOUNTS CHEM RES, V45, P723, DOI 10.1021/ar2002446	17	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	JUN	2015	174				SI		75	80		10.1016/j.jfluchem.2014.07.023		6	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CJ2ZO	WOS:000355353400012		
J	Watanabe, Y; Konno, T				Watanabe, Yusuke; Konno, Tsutomu			Copper(0)-mediated tetrafluoroethylenation of various aromatic compounds	JOURNAL OF FLUORINE CHEMISTRY			English	Article						4-Bromo-3,3,4,4-tetrafluorobut-1-ene; Aromatics; Copper; Cross-coupling reaction	SANDMEYER TRIFLUOROMETHYLATION; ENANTIOSELECTIVE SYNTHESIS; FLUOROALKYLATION; ARYL; DERIVATIVES; BROMIDES; IODIDES; ACIDS	Treatment of 4-bromo-3,3,4,4-tetrafluorobut-1-ene with 6.0 equiv. of various aryl halides in the presence of 9.0 equiv. of copper metal in DMSO at 160 degrees C for 24 h in a sealed tube gave the corresponding (1,1,2,2-tetrafluoro-3-buten-1-yl) group-substituted aromatics in acceptable yields. (C) 2015 Elsevier B.V. All rights reserved.	[Watanabe, Yusuke; Konno, Tsutomu] Kyoto Inst Technol, Dept Chem & Mat Technol, Sakyo Ku, Kyoto 6068585, Japan	Konno, T (reprint author), Kyoto Inst Technol, Dept Chem & Mat Technol, Sakyo Ku, Kyoto 6068585, Japan.	konno@kit.ac.jp					Ye YD, 2010, J AM CHEM SOC, V132, P14682, DOI 10.1021/ja107780w; Mejia E, 2012, ACS CATAL, V2, P521, DOI 10.1021/cs300089y; Li Y, 2013, CHEM COMMUN, V49, P2628, DOI 10.1039/c2cc36554e; Uneyama K, 2004, ORG LETT, V6, P2733, DOI 10.1021/ol049055m; Huang XT, 2001, J ORG CHEM, V66, P4651, DOI 10.1021/jo010178j; ZHOU QL, 1988, J FLUORINE CHEM, V39, P87, DOI 10.1016/S0022-1139(00)82739-6; Xie J, 2014, ORG LETT, V16, P1768, DOI 10.1021/ol500469a; Wiehn MS, 2010, J FLUORINE CHEM, V131, P951, DOI 10.1016/j.jfluchem.2010.06.020; Qi QQ, 2012, J AM CHEM SOC, V134, P6548, DOI 10.1021/ja301705z; Biffinger JC, 2004, CHEMBIOCHEM, V5, P622, DOI 10.1002/cbic.200300910; Wang X, 2013, J AM CHEM SOC, V135, P10330, DOI 10.1021/ja4056239; Morimoto H, 2011, ANGEW CHEM INT EDIT, V50, P3793, DOI 10.1002/anie.201100633; Danoun G, 2013, ANGEW CHEM INT EDIT, V52, P7972, DOI 10.1002/anie.201304276; Nagib DA, 2011, NATURE, V480, P224, DOI 10.1038/nature10647; Zhu JM, 2010, J ORG CHEM, V75, P5505, DOI 10.1021/jo1005262; Timofte RS, 2008, ORG LETT, V10, P3673, DOI 10.1021/ol801272e; Mormino MG, 2014, ORG LETT, V16, P1744, DOI 10.1021/ol500422t; Hassan J, 2002, CHEM REV, V102, P1359, DOI 10.1021/cr000664r; Dai JJ, 2013, J AM CHEM SOC, V135, P8436, DOI 10.1021/ja404217t; Tomashenko OA, 2011, CHEM REV, V111, P4475, DOI 10.1021/cr1004293; Bonnac L, 2010, ORG BIOMOL CHEM, V8, P1445, DOI 10.1039/b922442d; Browwne DL., 2014, ANGEW CHEM INT EDIT, V53, P1482; Ceretta F, 2012, J FLUORINE CHEM, V135, P220, DOI 10.1016/j.jfluchem.2011.11.006; Chang C. T., 1998, U.S. Patent, Patent No. [5, 747, 525, 5747525]; Chernykh Y, 2011, EUR J ORG CHEM, P4528, DOI 10.1002/ejoc.201100667; Dmowski W, 2010, J FLUORINE CHEM, V131, P746, DOI 10.1016/j.fluchem.2010.01.009; FANTA PE, 1964, CHEM REV, V64, P613, DOI 10.1021/cr60232a002; Furin G.G., 2000, RUSS CHEM REV, V69, P491, DOI DOI 10.1070/RC2000V069N06ABEH000353; Kim HW, 1998, J AM CHEM SOC, V120, P9082, DOI 10.1021/ja9803714; Konno T, 2011, SYNTHESIS-STUTTGART, P33, DOI 10.1055/s-0030-1258330; Konno T, 2013, J FLUORINE CHEM, V152, P106, DOI 10.1016/j.jfluchem.2013.02.013; Linclau B, 2009, ORG BIOMOL CHEM, V7, P803, DOI 10.1039/b817260a; Boydell AJ, 2004, ANGEW CHEM INT EDIT, V43, P5677, DOI 10.1002/anie.200460746; Liu Z., 2014, CHEM REV; loannou A., 2011, CHEM COMMUN, V47, P11228; McLaughlin V.C.R., 1969, TETRAHEDRON, V25, P5921; Oishi M, 2009, CHEM COMMUN, P1909, DOI 10.1039/b823249k; Saijo H., 2014, J AM CHEM SOC; Zhu J., 2014, J FLUORINE CHEM	39	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	JUN	2015	174				SI		102	107		10.1016/j.jfluchem.2014.12.008		6	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CJ2ZO	WOS:000355353400016		
J	Yanai, H; Taguchi, T				Yanai, Hikaru; Taguchi, Takeo			Synthesis of superacidic carbon acid and its derivatives	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Carbon acids; Carbanions; Triflyl group; Acid catalysis	FLUOROCARBON ACIDS; GAS-PHASE; ORGANOMETALLIC CHEMISTRY; BRONSTED ACIDS; ACIDITIES; CATALYSTS; SULFONES; METHIDE; YLIDES; BIS(TRIFLUOROMETHANESULFONYL)METHIDE	In this review, we provide an outline of synthetic efforts for carbon acids (C-H acids) bearing (RfSO2)(2)CH group as an acidic functionality. Unlike conventional active methylene compounds such as acetoacetates and malonates are not enough acidic to work as acid catalysts, (RfSO2)(2)CH-type carbon acids are superacidic in gas phase and catalyze organic reactions in organic solvents. (C) 2014 Elsevier B.V. All rights reserved.	[Yanai, Hikaru; Taguchi, Takeo] Tokyo Univ Pharm & Life Sci, Sch Pharm, Hachioji, Tokyo 1920392, Japan; [Taguchi, Takeo] Sagami Chem Res Inst, Ayase, Kanagawa 2521193, Japan	Yanai, H (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	yanai@toyaku.ac.jp			MEXT	This work was partially supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Advanced Molecular Transformations by Organocatalysts" from the MEXT. The authors greatly acknowledge Prof. Takashi Matsumoto (Tokyo University of Pharmacy and Life Sciences) for his helpful discussions.	ALTHOFF W, 1973, Z NATURFORSCH B, VB 28, P98; SIEDLE AR, 1986, INORG CHEM, V25, P1345, DOI 10.1021/ic00229a010; Saadi J, 2011, J AM CHEM SOC, V133, P14248, DOI 10.1021/ja2066169; Gutowski KE, 2006, J PHYS CHEM A, V110, P12044, DOI 10.1021/jp065243d; Waller FJ, 1999, J ORG CHEM, V64, P2910, DOI 10.1021/jo9800917; Yanai H, 2013, ASIAN J ORG CHEM, V2, P989, DOI 10.1002/ajoc.201300157; Chen JW, 2012, ANGEW CHEM INT EDIT, V51, P5897, DOI 10.1002/anie.201200378; Ishihara K, 2001, ANGEW CHEM INT EDIT, V40, P4077, DOI 10.1002/1521-3773(20011105)40:21<4077::AID-ANIE4077>3.0.CO;2-1; Raamat E, 2013, J PHYS ORG CHEM, V26, P162, DOI 10.1002/poc.2946; KOPPEL IA, 1994, J AM CHEM SOC, V116, P3047, DOI 10.1021/ja00086a038; FOROPOULOS J, 1984, INORG CHEM, V23, P3720, DOI 10.1021/ic00191a011; Hasegawa A, 2006, ORG LETT, V8, P3175, DOI 10.1021/ol060939a; Barrett AGM, 2000, SYNLETT, P847; Barrett AGM, 2002, TETRAHEDRON, V58, P3835, DOI 10.1016/S0040-4020(02)00210-7; BENRABAH D, 1993, SOLID STATE IONICS, V60, P87, DOI 10.1016/0167-2738(93)90279-C; BORDWELL FG, 1988, ACCOUNTS CHEM RES, V21, P456, DOI 10.1021/ar00156a004; Brice T. J, 1956, U. S. Patent, Patent No. [2 732 398, 2732398]; Engelbrecht V.A., 1977, ANORG ALLG CHEM, V433, P19; EUGENE F, 1994, J FLUORINE CHEM, V66, P301, DOI 10.1016/0022-1139(93)02909-X; GRAMSTAD T, 1957, J CHEM SOC, P4069, DOI 10.1039/jr9570004069; HACKENBERG J, 1991, J CHEM SOC CHEM COMM, P470, DOI 10.1039/c39910000470; HANACK M, 1994, SYNTHESIS-STUTTGART, P249; HANACK M, 1991, SYNTHESIS-STUTTGART, P1205; Hasegawa A, 2005, B CHEM SOC JPN, V78, P1401, DOI 10.1246/bcsj.78.1401; HASZELDINE RN, 1954, J CHEM SOC, P4228, DOI 10.1039/jr9540004228; HENDRICK.JB, 1974, J AM CHEM SOC, V96, P2275, DOI 10.1021/ja00814a061; HOWELLS RD, 1977, CHEM REV, V77, P69, DOI 10.1021/cr60305a005; Ishihara K, 2002, SYNLETT, P1296; Ishihara K, 2000, SYNLETT, P80; Ishihara K, 2002, SYNLETT, P1299; Ishihara K, 2000, J FLUORINE CHEM, V106, P139, DOI 10.1016/S0022-1139(00)00318-3; KLOTER G, 1980, ANGEW CHEM INT EDIT, V19, P942, DOI 10.1002/anie.198009421; Kohar R.J, 1976, U.S. Patent, Patent No. [3 932 526, 3932526, 3,932,526]; Koshar R. J., 1977, U.S. Patent, Patent No. [4,053,519, 4053519, 4 053 519]; Koshar R. J., 1976, U.S. Patent, Patent No. [3 962 346, 3962346]; KOSHAR RJ, 1973, J ORG CHEM, V38, P3358, DOI 10.1021/jo00959a026; Lamanna W.M., 1996, U.S. Patent, Patent No. [5 554 664, 5554664]; Le Guillanton G., 1991, TETRAHEDRON LETT, V31, P3149; Leito I, 2009, J PHYS CHEM A, V113, P8421, DOI 10.1021/jp903780k; Maletina I.I., 1979, J ORG CHEM USSR, V15, p[2416, 2187]; Nagamori, 2009, [No title captured], Patent No. [WO 113 508, 113508]; Nishikido J, 1999, SYNLETT, P1990; Ochiai M, 2011, HETEROATOM CHEM, V22, P325, DOI 10.1002/hc.20683; Ochiai M, 2008, J AM CHEM SOC, V130, P2118, DOI 10.1021/ja074624h; Ochiai M, 2011, J AM CHEM SOC, V133, P3342, DOI 10.1021/ja200479p; Ochiai M, 2006, J AM CHEM SOC, V128, P9608, DOI 10.1021/ja063492+; Olah G. A., 2009, SUPERACID CHEM; Robins J., 1985, ACS SYM SER, V286, P263; Sidle A.R., 1984, J AM CHEM SOC, V106, P1510; SIEDLE AR, 1986, ORGANOMETALLICS, V5, P38, DOI 10.1021/om00132a007; SIEDLE AR, 1986, J AM CHEM SOC, V108, P767, DOI 10.1021/ja00264a032; SIEDLE AR, 1986, INORG CHEM, V25, P3412, DOI 10.1021/ic00239a019; Suzuki K., 2011, [No title captured], Patent No. [WO 102 327, 102327]; Takahashi A., 2014, [No title captured], Patent No. [WO 050 814, 050814]; Takahashi A, 2010, J ORG CHEM, V75, P1259, DOI 10.1021/jo902641g; Terui Y., 2009, [No title captured], Patent No. [WO 151 074, 151074]; TORDEUX M, 1989, J ORG CHEM, V54, P2452, DOI 10.1021/jo00271a041; TUROWSKY L, 1988, INORG CHEM, V27, P2135, DOI 10.1021/ic00285a025; Winter RW, 2006, J FLUORINE CHEM, V127, P1324, DOI 10.1016/j.jfluchem.2006.05.023; Yagupolskii Yu.L., 1990, J ORG CHEM USSR, V26, p[682, 584]; Yamamoto H., 2008, ACID CATALYSIS MODER, V1, P35; Yamamoto T., 2001, JP Patent, Patent No. [039 942, 039942]; Yanai H, 2011, CHEM COMMUN, V47, P7245, DOI 10.1039/c1cc12093j; Yanai H, 2010, J ORG CHEM, V75, P5375, DOI 10.1021/jo100915e; Yanai H, 2014, ASIAN J ORG CHEM, V3, P556, DOI 10.1002/ajoc.201402010; Yanai H, 2013, ANGEW CHEM INT EDIT, V52, P1560, DOI 10.1002/anie.201208809; Yanai H, 2013, CHEM COMMUN, V49, P10091, DOI 10.1039/c3cc46171h; Yanai H, 2013, TETRAHEDRON LETT, V54, P2160, DOI 10.1016/j.tetlet.2013.02.039; Yanai H, 2013, MOLECULES, V18, P15531, DOI 10.3390/molecules181215531; Yanai H, 2007, TETRAHEDRON, V63, P12149, DOI 10.1016/j.tet.2007.09.061; Yanai H, 2011, CHEM-EUR J, V17, P11747, DOI 10.1002/chem.201102023; Yanai H, 2012, CHEM COMMUN, V48, P8967, DOI 10.1039/c2cc33606e; Yanai H, 2014, J SYN ORG CHEM JPN, V72, P158; Young C.I., 1983, U.S. Patent, Patent No. [4 405 497, 4405497]; Zhang M., 2014, J PHYS ORG IN PRESS; ZHU SZ, 1990, J CHEM SOC CHEM COMM, P1459, DOI 10.1039/c39900001459; ZHU SZ, 1993, J FLUORINE CHEM, V64, P47, DOI 10.1016/S0022-1139(00)80062-7; Zhu SZ, 1999, HETEROATOM CHEM, V10, P147, DOI 10.1002/(SICI)1098-1071(1999)10:2<147::AID-HC8>3.0.CO;2-2; Zhu S.-Z., 1995, INORG CHEM, V34, P192; ZHU SZ, 1993, INORG CHEM, V32, P223, DOI 10.1021/ic00054a018; ZHU SZ, 1994, SYNTHESIS-STUTTGART, P261; ZHU SZ, 1994, HETEROATOM CHEM, V5, P9, DOI 10.1002/hc.520050104; ZHU SZ, 1993, J FLUORINE CHEM, V62, P31, DOI 10.1016/S0022-1139(00)80078-0	83	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	JUN	2015	174				SI		108	119		10.1016/j.jfluchem.2014.11.006		12	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CJ2ZO	WOS:000355353400017		
J	Okazoe, T				Okazoe, Takashi			Development of the "PERFECT" direct fluorination method and its industrial applications	JOURNAL OF FLUORINE CHEMISTRY			English	Article						The PERFECT' method; Acyl fluoride; Direct fluorination; Perfluorination; Fluorine	PHASE DIRECT FLUORINATION; PERFLUORINATED COMPOUNDS; ELEMENTAL FLUORINE; MONOMER; CHEMISTRY; MEMBRANE; ROUTE	The "PERFECT" direct fluorination method for the preparation of perfluorinated compounds, which has been developed and is beeing used for manufacturing in Asahi Glass Co., Ltd., and the comparison with other liquid-phase direct fluorination methods are reviewed. A key step in the synthetic route is a liquid-phase direct fluorination reaction with elemental fluorine. Direct fluorination of a partially-fluorinated ester, which was prepared from a hydrocarbon alcohol and a perfluoroacyl fluoride, followed by thermolysis, gave a corresponding perfluorinated product and the starting perfluoroacyl fluoride recovered. The perfluorinated product is a precursor of various perfluorinated building blocks. (C) 2014 Elsevier B.V. All rights reserved.	Asahi Glass Co Ltd, Technol Planning Off, Chiyoda Ku, Tokyo 1008405, Japan	Okazoe, T (reprint author), Asahi Glass Co Ltd, Technol Planning Off, Chiyoda Ku, Shin Marunouchi Bldg,1-5-1 Marunouchi, Tokyo 1008405, Japan.	takashi-okazoe@agc.com					Abe T., 1982, PREPARATION PROPERTI, P19; [Anonymous], 2002, [No title captured], Patent No. 266779; Shirakawa D, 2008, IEEE T MAGN, V44, P3710, DOI 10.1109/TMAG.2008.2001674; Okazoe T, 2001, J FLUORINE CHEM, V112, P109, DOI 10.1016/S0022-1139(01)00474-2; SIMONS JH, 1949, J ELECTROCHEM SOC, V95, P47, DOI 10.1149/1.2776733; KASAI PH, 1992, MACROMOLECULES, V25, P6791, DOI 10.1021/ma00051a011; Ruff O, 1931, Z ANORG ALLG CHEM, V201, P245, DOI 10.1002/zaac.19312010122; Chambers RD, 2000, J FLUORINE CHEM, V101, P97, DOI 10.1016/S0022-1139(99)00218-3; Kobayashi M, 2003, J FLUORINE CHEM, V120, P105, DOI 10.1016/S0022-1139(02)00317-2; Sandford G, 2007, J FLUORINE CHEM, V128, P90, DOI 10.1016/j.jfluchem.2006.10.019; Okazoe T, 2004, J FLUORINE CHEM, V125, P1695, DOI 10.1016/j.jfluchem.2004.09.024; Costello M.G., 1990, PCT Int. Appl, Patent No. [WO 6296, 69364]; Feiring A.E., 1994, ORGANOFLUORINE CHEM, P339; Galimberti M., 2012, PCT Int. Appl, Patent No. [WO 69364, 75545]; Hatchinson J., 1997, TOP CURR CHEM, V193, P1; Hintzer K., 1997, MODERN FLUOROPOLYMER, P223; Howell JL, 2011, LUBR SCI, V23, P61, DOI 10.1002/ls.144; Iwaya M., 2001, P 25 FLUOR C JAP, P36; Joyner B.D., 1986, J FLUORINE CHEM, V33, P337; Lagow R.J., 1999, METHODEN ORG CHE E A, VE10a, P194; Lagow R.J., 1979, PROG INORG CHEM, V26, P161, DOI 10.1002/9780470166277.ch3; Lui N., 1999, MODERN ORG CHEM HO B, VE10b, P699; Marchionni G., 2010, PCT Int. Appl, Patent No. [WO 3931, 52832]; Matsuura K., 2008, PCT Int. Appl, Patent No. [WO 75545, 85303]; McPake CB, 2012, ORG PROCESS RES DEV, V16, P844, DOI 10.1021/op200331s; MODENA S, 1988, J FLUORINE CHEM, V40, P349, DOI 10.1016/S0022-1139(00)83073-0; Murata K, 2006, J FLUORINE CHEM, V127, P1125, DOI 10.1016/j.jfluchem.2006.06.001; Murata K, 1998, J AM CHEM SOC, V120, P7117, DOI 10.1021/ja980727b; Murotani E, 2007, J FLUORINE CHEM, V128, P1131, DOI 10.1016/j.jfluchem.2007.08.009; Nakamura M., 2001, J CHEM SOC JAP CHEM, V2001, P659; Niedzielsky E.L., 1967, US Patent, Patent No. [3 307 330, 37885]; Okamoto H., 2002, PCT Int. Appl. WO, Patent No. [266779, 3307330]; Okazoe T, 2012, APPL SCI-BASEL, V2, P327, DOI 10.3390/app2020327; Okazoe T., 2004, PCT Int. Appl., Patent No. [WO 52832, 6296]; Okazoe T, 2007, B CHEM SOC JPN, V80, P1611, DOI 10.1246/bcsj.80.1611; Okazoe T, 2009, P JPN ACAD B-PHYS, V85, P276, DOI 10.2183/pjab.85.276; Okazoe T, 2001, ADV SYNTH CATAL, V343, P215, DOI 10.1002/1615-4169(20010226)343:2<215::AID-ADSC215>3.3.CO;2-Z; Okazoe T, 2005, J FLUORINE CHEM, V126, P521, DOI 10.1016/j.jfluchem.2004.12.002; Okazoe T., 2003, PCT Int. Appl., Patent No. [WO 37885, 37818]; SCHERER KV, 1990, J FLUORINE CHEM, V50, P47, DOI 10.1016/S0022-1139(00)82178-8; Shirakawa D., 2002, P 26 FLUOR C JAP, P82; Shirakawa D., 2003, 4 INT C TRIB INF STO, P21; Sugiyama N., 2005, PCT Int. Appl, Patent No. [WO 85303, 87946]; Sugiyama N., 2005, PCT Int. Appl, Patent No. [WO 37818, 3931]; Suzuki H., 2013, P 22 POL MAT FOR JAP, P76; Takagi H., 2008, P 1 INT WORKSH FLUOR, pPA3; Tortelli V., 2012, 20 INT S FLUOR CHEM, p1A; Wakselman C., 1995, CHEM ORGANIC FLUOR 2, P446; Yamabe M., 1994, ORGANOFLUORINE CHEM, P403	49	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	JUN	2015	174				SI		120	131		10.1016/j.jfluchem.2014.09.020		12	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CJ2ZO	WOS:000355353400018		
J	Funabiki, K; Yagi, K; Nomoto, M; Kubota, Y; Matsui, M				Funabiki, Kazumasa; Yagi, Kazutaka; Nomoto, Masayuki; Kubota, Yasuhiro; Matsui, Masaki			Improvement of the thermal stability of near-infrared-absorbing heptamethinecyanine dyes by anion-exchange from an iodide to fluorine-containing anions	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Near-infrared-absorbing dyes; Bis(trifluoromethanesulfonyl)imide; Hexafluorophosphate; Trifluoromethanesulfonate; Thermal stability	OXIDE SOLAR-CELL; CYANINE DYES; IONIC LIQUIDS	Anion exchange in a near-infrared-absorbing heptamethinecyanine dye from an iodide to fluorine-containing anions proceeded smoothly at room temperature to give the corresponding heptamethinecyanine dyes carrying bis(trifluoromethanesulfonyl)imide ((CF3SO2)(2)N-), hexafluorophosphate (PF6-) and trifluoromethanesulfonate (CF3SO3-) in good yields. Heptamethinecyanine dyes carrying (CF3SO2)(2)N-, PF6-, and CF3SO3- showed better thermal stabilities than the dye carrying an iodide as a counter anion. (C) 2015 Elsevier B.V. All rights reserved.	[Funabiki, Kazumasa; Yagi, Kazutaka; Nomoto, Masayuki; Kubota, Yasuhiro; Matsui, Masaki] Gifu Univ, Fac Engn, Dept Chem & Biomol Sci, Gifu 5011193, Japan	Funabiki, K (reprint author), Gifu Univ, Fac Engn, Dept Chem & Biomol Sci, 1-1 Yanagido, Gifu 5011193, Japan.	funabiki@gifu-u.ac.jp					FABIAN J, 1992, CHEM REV, V92, P1197, DOI 10.1021/cr00014a003; Ngo HL, 2000, THERMOCHIM ACTA, V357, P97, DOI 10.1016/S0040-6031(00)00373-7; Huddleston JG, 2001, GREEN CHEM, V3, P156, DOI 10.1039/b103275p; Castro FA, 2006, SYNTHETIC MET, V156, P973, DOI 10.1016/j.synthmet.2006.06.010; Fujiwara M., [No title captured], Patent No. [WO2012/063964A1, 2012063964]; Funabiki K, 2011, ENERG ENVIRON SCI, V4, P2186, DOI 10.1039/c1ee01141c; Matsui M, 2005, SYNTHETIC MET, V148, P147, DOI 10.1016/j.synthmet.2004.09.026; Matsuoka M., 1990, INFRARED ABSORBING D; Nakamura I., 2004, Jpn. Kokai Tokkyo Koho, Patent No. [JP49 A20042196, 20042196]; NARAYANAN N, 1995, J ORG CHEM, V60, P2391, DOI 10.1021/jo00113a018; Otsuka A, 2008, CHEM LETT, V37, P176, DOI 10.1246/cl.2008.176; Sakai T., 2011, Jpn. Koka Tokkyo Koho, Patent No. [JP201138007A, 201138007]; Shershov VE, 2013, DYES PIGMENTS, V97, P353, DOI 10.1016/j.dyepig.2012.12.031; Tang PG, 2011, DYES PIGMENTS, V90, P253, DOI 10.1016/j.dyepig.2011.01.007	14	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	JUN	2015	174				SI		132	136		10.1016/j.jfluchem.2015.02.008		5	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CJ2ZO	WOS:000355353400019		
J	Mori, S; Yoshiyama, H; Tokunaga, E; Iida, N; Hayashi, M; Obata, T; Tanaka, M; Shibata, N				Mori, Satoru; Yoshiyama, Hideyuki; Tokunaga, Etsuko; Iida, Norihito; Hayashi, Masamichi; Obata, Tohru; Tanaka, Motohiro; Shibata, Norio			Design, synthesis, spectral investigations and biological activity of fluorinated phthalocyanine conjugated with galactose and comparison to its non-fluorinated counterpart	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Fluorine; Phthalocyanine; Photodynamic therapy; Galactose; Amphipathicity	VITRO PHOTODYNAMIC ACTIVITY; SPECTROSCOPIC PROPERTIES; BASIC PRINCIPLES; THERAPY; COMPLEXES; DEOXYRIBONUCLEOSIDES; PHOTOSENSITIZERS; DERIVATIVES; SENSITIZERS; PORPHYRINS	Photofrin is a clinically useful photosensitizer of photodynamic therapy (PDT) used for cancer treatment, but has some disadvantages, including its weak absorbance when excited at 630 nm. Hence, the development of novel photosensitizers with greater than 630 nm absorbance is required. In addition, photosensitizers must have suitable balance between lipophilicity and hydrophilicity to allow for selective accumulation in tumor cells. Herein, we describe the design and synthesis of a novel perfluorinated phthalocyanine/galactose conjugate 1a suitable for use as a PDT agent. Our novel phthalocyanine/galactose conjugate 1a displays absorption at 600-750 nm. Four of its peripheral galactopyranosyl moieties resulted in improved water solubility confirmed by a 1-octanol/water partition coefficient log P value. Moreover, 12 fluorine atoms at the peripheral position of 1a simultaneously endowed the macrocycle with suitable hydrophobicity. In vitro biological activity of our perfluorinated phthalocyanine/galactose conjugate 1a showed a much more efficient photo-dynamic effect than the non-fluorinated phthalocyanine/galactose counterpart 1b. This is one of the clear examples of fluorine effect on biological activity. (C) 2014 Elsevier B.V. All rights reserved.	[Mori, Satoru; Tokunaga, Etsuko; Shibata, Norio] Nagoya Inst Technol, Dept Nanopharmaceut Sci, Showa Ku, Nagoya, Aichi 4668555, Japan; [Yoshiyama, Hideyuki; Iida, Norihito; Hayashi, Masamichi; Shibata, Norio] Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan; [Obata, Tohru; Tanaka, Motohiro] Aichi Gakuin Univ, Sch Pharm, Dept Bioorgan Chem, Chikusa Ku, Nagoya, Aichi 4648650, Japan	Shibata, N (reprint author), Nagoya Inst Technol, Dept Nanopharmaceut Sci, Showa Ku, Nagoya, Aichi 4668555, Japan.	nozshiba@nitech.ac.jp			MEXT Japan [25288045, 25670055]	This research was financially supported in part by the Platform for Drug Discovery, Informatics, and Structural Life Science, and Scientific Research (B) (25288045) from MEXT Japan, Exploratory Research (25670055).	ROSENTHAL I, 1991, PHOTOCHEM PHOTOBIOL, V53, P859; Ribeiro AO, 2006, TETRAHEDRON LETT, V47, P6129, DOI 10.1016/j.tetlet.2006.06.068; O'Hagan D, 2008, CHEM SOC REV, V37, P308, DOI 10.1039/b711844a; Anabuki S, 2012, ORG LETT, V14, P2778, DOI 10.1021/ol301005b; Sharman WM, 1999, DRUG DISCOV TODAY, V4, P507, DOI 10.1016/S1359-6446(99)01412-9; Rajput VK, 2006, TETRAHEDRON LETT, V47, P5939, DOI 10.1016/j.tetlet.2006.06.050; Sibrian-Vazquez M, 2007, BIOCONJUGATE CHEM, V18, P410, DOI 10.1021/bc060297b; Liang T, 2013, ANGEW CHEM INT EDIT, V52, P8214, DOI 10.1002/anie.201206566; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Sharman WM, 1996, TETRAHEDRON LETT, V37, P5831, DOI 10.1016/0040-4039(96)01243-9; WOHRLE D, 1980, MAKROMOL CHEM, V181, P2127; Lee PPS, 2005, TETRAHEDRON LETT, V46, P1551, DOI 10.1016/j.tetlet.2004.12.137; Reddy MR, 2006, ANGEW CHEM INT EDIT, V45, P8163, DOI 10.1002/anie.200603590; Allen CM, 2001, J PORPHYR PHTHALOCYA, V5, P161, DOI 10.1002/jpp.324; Fujimoto K, 2014, ORG LETT, V16, P972, DOI 10.1021/ol4037049; Sol V, 2006, BIOORGAN MED CHEM, V14, P1364, DOI 10.1016/j.bmc.2005.09.071; MAILLARD P, 1989, J AM CHEM SOC, V111, P9125, DOI 10.1021/ja00207a033; Sternberg ED, 1998, TETRAHEDRON, V54, P4151, DOI 10.1016/S0040-4020(98)00015-5; BOSSARD GE, 1995, INORG CHEM, V34, P1524, DOI 10.1021/ic00110a034; Alvarez-Mico X, 2006, TETRAHEDRON LETT, V47, P3283, DOI 10.1016/j.tetlet.2006.03.029; Ali H, 1999, CHEM REV, V99, P2379, DOI 10.1021/cr980439y; VINCETT PS, 1971, J CHEM PHYS, V55, P4131, DOI 10.1063/1.1676714; Ribeiro AO, 2006, TETRAHEDRON LETT, V47, P9177, DOI 10.1016/j.tetlet.2006.10.155; Berg K, 2005, J MICROSC-OXFORD, V218, P133, DOI 10.1111/j.1365-2818.2005.01471.x; Soares ARM, 2009, CARBOHYD RES, V344, P507, DOI 10.1016/j.carres.2008.12.009; MacDonald IJ, 2001, J PORPHYR PHTHALOCYA, V5, P105, DOI 10.1002/jpp.328; BERNAUER K, 1961, HELV CHIM ACTA, V44, P1287, DOI 10.1002/hlca.19610440516; BOYLE RW, 1995, SYNTHESIS-STUTTGART, P1079; Choi CF, 2004, CHEM COMMUN, P2236, DOI 10.1039/b405868b; Dabak S, 1997, J CHEM RES-S, P8, DOI 10.1039/a604638j; Das B, 2010, EUR J ORG CHEM, P2878, DOI 10.1002/ejoc.201000179; Filippis M.P.D., 2000, TETRAHEDRON LETT, V41, P9143; Fu J, 2002, LANGMUIR, V18, P3843, DOI 10.1021/la011764a; Iids N., 2014, J FLUORINE CHEM, V168, P93; Kessel D., 1990, PHOTODYNAMIC THERAPY, V1; Kudrevich SV, 1996, J ORG CHEM, V61, P5706, DOI 10.1021/jo9605354; Leznoff C.C., 1996, PHTHALOCYANINES PROP, V4; Lutsenko OG, 2004, RUSS J GEN CHEM+, V74, P446, DOI 10.1023/B:RUGC.0000030405.21990.b5; Muller K., 2007, SCIENCE, V317, P1880; Nemykin VN, 2000, J PORPHYR PHTHALOCYA, V4, P551, DOI 10.1002/1099-1409(200008)4:5<551::AID-JPP270>3.3.CO;2-C; Phillips D, 1997, PROG REACT KINET, V22, P175; Seotsanyana-Mokhosi I, 2006, J PHOTOCH PHOTOBIO B, V83, P55, DOI 10.1016/j.jphotobiol.2005.12.004; Shibata N, 2014, CHEM COMMUN, V50, P3040, DOI 10.1039/c3cc49831j; Sugimori T, 2004, CHEM LETT, V33, P1014, DOI 10.1246/cl.2004.1014; Vicente M. G. H., 2001, Current Medicinal Chemistry - Anti-Cancer Agents, V1, P175, DOI 10.2174/1568011013354769; Yoshiyama H, 2008, CHEM COMMUN, P1977, DOI 10.1039/b800918j	47	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	JUN	2015	174				SI		137	141		10.1016/j.jfluchem.2014.11.003		5	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CJ2ZO	WOS:000355353400020		
J	Yoshida, K; Kawabata, H				Yoshida, Kiyoshi; Kawabata, Hidehiko			The Prognostic Value of Concurrent Phrenic Nerve Palsy in Newborn Babies With Neonatal Brachial Plexus Palsy	JOURNAL OF HAND SURGERY-AMERICAN VOLUME			English	Article						Obstetric brachial plexus palsy; phrenic nerve palsy; prognostic value	BREECH DELIVERY; NATURAL-HISTORY; CHILDREN; INJURIES; INFANTS	Purpose To investigate the prognostic value of concurrent phrenic nerve palsy for predicting spontaneous motor recovery in neonatal brachial plexus palsy. Methods We reviewed the records of 366 neonates with brachial plexus palsy. The clinical and follow-up data of patients with and without phrenic nerve palsy were compared. Results Of 366 newborn babies with neonatal brachial plexus palsy, 21 (6%) had concurrent phrenic nerve palsy. Sixteen of these neonates had upper-type palsy and 5 had total-type palsy. Poor spontaneous motor recovery was observed in 13 neonates with concurrent phrenic nerve palsy (62%) and in 129 without concurrent phrenic nerve palsy (39%). Among neonates born via vertex delivery, poor motor recovery was observed in 7 of 9 (78%) neonates with concurrent phrenic nerve palsy and 115 of 296 (39%) without concurrent phrenic nerve palsy. Conclusions Concurrent phrenic nerve palsy in neonates with brachial plexus palsy has prognostic value in predicting poor spontaneous motor recovery of the brachial plexus, particularly after vertex delivery. Copyright (C) 2015 by the American Society for Surgery of the Hand. All rights reserved.	[Yoshida, Kiyoshi] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka 5650871, Japan; Osaka Med Ctr & Res, Dept Orthopaed Surg, Osaka, Japan	Yoshida, K (reprint author), Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yoshida-kiyoshi@umin.ac.jp					Al-Qattan MM, 1998, J HAND SURG-BRIT EUR, V23B, P225, DOI 10.1016/S0266-7681(98)80179-4; ALVORD EC, 1990, J CHILD NEUROL, V5, P205; NARAKAS AO, 1987, ORTHOPADE, V16, P81; Waters PM, 1999, J BONE JOINT SURG AM, V81A, P649; Al-Qattan MM, 2003, ANN PLAS SURG, V51, P257, DOI 10.1097/01.SAP.0000063750.16982.E4; Borshel OH, 2009, PLAST RECONSTR SURG, V124, P144; Bowerson M, 2010, PEDIATR NEUROL, V42, P234, DOI 10.1016/j.pediatrneurol.2009.11.005; CLARKE HM, 1995, HAND CLIN, V11, P563; Escande B, 2000, ARCH PEDIATRIE, V7, P965, DOI 10.1016/S0929-693X(00)90012-5; Geutjens G, 1996, J BONE JOINT SURG BR, V78B, P303; Gilbert A., 1993, HAND, P575; Joyner Benny, 2006, Pediatr Rev, V27, P238, DOI 10.1542/pir.27-6-238; Kennedy R, 1903, Br Med J, V1, P298; LANGER JC, 1988, J PEDIATR SURG, V23, P749, DOI 10.1016/S0022-3468(88)80417-2; Marcus JR, 2003, CLIN PLAST SURG, V30, P289, DOI 10.1016/S0094-1298(02)00100-1; MICHELOW BJ, 1994, PLAST RECONSTR SURG, V93, P675, DOI 10.1097/00006534-199404000-00001; Stramrood CAI, 2009, J PERINAT MED, V37, P293, DOI 10.1515/JPM.2009.040; Tsugawa C, 1997, J PEDIATR SURG, V32, P1643, DOI 10.1016/S0022-3468(97)90473-5; van Overbeeke A J, 1983, Ned Tijdschr Geneeskd, V127, P1945	19	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0363-5023	1531-6564		J HAND SURG-AM	J. Hand Surg.-Am. Vol.	JUN	2015	40	6					1166	1169		10.1016/j.jhsa.2015.01.039		4	Orthopedics; Surgery	Orthopedics; Surgery	CJ6BK	WOS:000355577800015		
J	Kobori, H; Tanigawa, M; Maeda, S; Hori, H; Yubisui, T; Nagata, Y				Kobori, Hiroki; Tanigawa, Minoru; Maeda, Shintaro; Hori, Hiroshi; Yubisui, Toshitsugu; Nagata, Yoko			Methemoglobin reduction mediated by D-amino acid dehydrogenase in Propsilocerus akamusi (Tokunaga) larvae	JOURNAL OF INSECT PHYSIOLOGY			English	Article						D-Alanine; D-Amino acid dehydrogenase; Electron-transfer; Methemoglobin; Propsilocerus akamusi	ESCHERICHIA-COLI; ENZYME; CYTOCHROME-B5; PURIFICATION; HEMOGLOBIN; HISTIDINE; BACTERIA; PROTEINS	A methemoglobin (metHb) reduction system is required for aerobic respiration. In humans, Fe(III)-heme-bearing metHb (the oxidized form of hemoglobin), which cannot bind oxygen, is converted to Fe(II)heme-bearing oxyhemoglobin (oxyHb, the reduced form), which can bind oxygen, in a system comprising NADH, NADH-cytochrome b(5) reductase, and cytochrome b(5). However, the mechanism of metHb reduction in organisms that inhabit oxygen-deficient environments is unknown. In the coelomic fluid of the larvae of Propsilocerus akamusi, which inhabit a microaerobic environment, we found that metHb was reduced by D-alanine. We purified an FAD-containing enzyme, D-amino acid dehydrogenase (DAD), and component V hemoglobin from the larvae. Using the purified components and spectrophotometric analyses, we showed a novel function of DAD: DAD-mediation of P. akamusi component V metHb reduction with using D-alanine as an electron donor. P. akamusi larvae possess this D-alanine-DAD metHb reduction system in addition to a previously discovered NADH-NADH-cytochrome b(5) reductase system. This is the first report of the presence of DAD in a multicellular organism. The molecular mass of DAD was estimated to be 45 kDa. The optimal pH and temperature of the enzyme were 7.4 and 20 degrees C, respectively, and the optimal substrate was D-alanine. The enzyme activity was inhibited by benzoate and sulfhydryl-binding reagents. (C) 2015 Elsevier Ltd. All rights reserved.	[Kobori, Hiroki; Tanigawa, Minoru; Maeda, Shintaro; Nagata, Yoko] Nihon Univ, Coll Sci & Technol, Dept Mat & Appl Chem, Chiyoda Ward, Tokyo 1018308, Japan; [Hori, Hiroshi] Osaka Univ, Grad Sch Engn Sci, Div Bioengn, Osaka 5608531, Japan; [Yubisui, Toshitsugu] Okayama Univ Sci, Fac Sci, Dept Biochem, Okayama 7000005, Japan	Nagata, Y (reprint author), Nihon Univ, Coll Sci & Technol, Dept Mat & Appl Chem, Chiyoda Ward, Tokyo 1018308, Japan.	ocean_nagata@axel.ocn.ne.jp					OMURA T, 1970, J BIOCHEM-TOKYO, V67, P249; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOBOCKA M, 1994, J BACTERIOL, V176, P1500; JONES H, 1983, FEBS LETT, V151, P189, DOI 10.1016/0014-5793(83)80066-0; Burmester T, 2007, J INSECT PHYSIOL, V53, P285, DOI 10.1016/j.jinsphys.2006.12.006; Nagata Y, 1998, BBA-GEN SUBJECTS, V1379, P76, DOI 10.1016/S0304-4165(97)00084-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Burmester T, 2006, FEBS J, V273, P468, DOI 10.1111/j.1742-4658.2005.05073.x; EDER HA, 1949, J CLIN INVEST, V28, P265, DOI 10.1172/JCI102067; FRANKLIN FCH, 1976, MOL GEN GENET, V149, P229, DOI 10.1007/BF00332894; FUKUDA M, 1993, BIOCHIM BIOPHYS ACTA, V1157, P185, DOI 10.1016/0304-4165(93)90063-E; HULTQUIS.DE, 1971, NATURE-NEW BIOL, V229, P252; Kamimura S, 2003, EUR J BIOCHEM, V270, P1424, DOI 10.1046/j.1432-1033.2003.03498.x; MARSHALL VP, 1968, J BACTERIOL, V95, P1419; Nagata Y, 2001, J MOL CATAL B-ENZYM, V12, P109, DOI 10.1016/S1381-1177(00)00210-1; OLSIEWSKI PJ, 1980, J BIOL CHEM, V255, P4487; Sasa M., 1978, JPN J SANIT ZOOL, V29, P98; Schieber A, 1999, BIOMED CHROMATOGR, V13, P46, DOI 10.1002/(SICI)1099-0801(199902)13:1<46::AID-BMC808>3.0.CO;2-4; Tanigawa M, 2010, AMINO ACIDS, V38, P247, DOI 10.1007/s00726-009-0240-0; Tojo M., 2011, J CHROMATOGR, V49, P810; TSUKADA K, 1966, J BIOL CHEM, V241, P4522; WILD J, 1974, MOL GEN GENET, V128, P131, DOI 10.1007/BF02654486	22	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-1910	1879-1611		J INSECT PHYSIOL	J. Insect Physiol.	JUN	2015	77						33	38		10.1016/j.jinsphys.2015.04.002		6	Entomology; Physiology; Zoology	Entomology; Physiology; Zoology	CJ7WX	WOS:000355712200005		
J	Makishima, S; Boonvisut, S; Ishizuka, Y; Watanabe, K; Nakayama, K; Iwamoto, S				Makishima, Saho; Boonvisut, Supichaya; Ishizuka, Yuumi; Watanabe, Kazuhisa; Nakayama, Kazuhiro; Iwamoto, Sadahiko			Sin3A-associated protein, 18 kDa, a novel binding partner of TRIB1, regulates MTTP expression	JOURNAL OF LIPID RESEARCH			English	Article						very low density lipoprotein; cholesterol; triglycerides; lipoproteins/assembly; lipid transfer proteins; fatty liver; chromatin immunoprecipitation assay; molecular interaction; tribbles homolog 1; microsomal triglyceride transfer protein	TRIGLYCERIDE TRANSFER PROTEIN; HISTONE DEACETYLASES; HEPATIC LIPOGENESIS; LIVER; MICE; TRIBBLES; LOCI; ASSOCIATION; POPULATION; INHIBITION	Mammalian tribbles homolog 1 (TRIB1) is a human locus that has been shown to significantly impact plasma lipid levels across several ethnic groups. In addition, the gene has been associated with the occurrence of nonalcoholic fatty liver disease. In the present study, a yeast-two-hybrid system was used to screen for novel molecular targets of TRIB1 binding. Loci corresponding to clones that were positive for TRIB1 binding subsequently were assessed for roles in lipid metabolism in mice using adenoviral constructs to induce knockdown or overexpression. Sin3A-associated protein, 18 kDa (SAP18) was identified as a novel binding partner of TRIB1. Knockdown of the Sap18 in mouse liver decreased plasma lipid levels and increased hepatic lipid levels; SAP18 overexpression showed the opposite effects. Transcriptome analysis of the mouse liver revealed that Sap18 knockdown decreased and SAP18 overexpression increased microsomal TG transfer protein (MTTP) expression levels. Chromatin immunoprecipitation analysis showed that halo-tagged SAP18, halo-tagged TRIB1, and anti-mSin3A antibody enriched precipitates for regulatory sequences of the MTTP gene. Enforced expression of SAP18 enhanced and SAP18 knockdown conversely attenuated the enrichment of MTTP regulatory sequences seen with anti-mSin3A antibody. These studies indicated that SAP18 expression enhanced the recruitment of mSin3A in coordination with TRIB1 to MTTP regulatory elements and increased MTTP expression.	[Makishima, Saho; Boonvisut, Supichaya; Ishizuka, Yuumi; Watanabe, Kazuhisa; Nakayama, Kazuhiro; Iwamoto, Sadahiko] Jichi Med Univ, Ctr Mol Med, Div Human Genet, Shimotsuke, Tochigi 3290498, Japan	Iwamoto, S (reprint author), Jichi Med Univ, Ctr Mol Med, Div Human Genet, Shimotsuke, Tochigi 3290498, Japan.	siwamoto@jichi.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [25461377]; MEXT; Takeda Science Foundation, Osaka, Japan [3-2313-004]	This study was supported by a Grant-in-Aid (25461377) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT), and the MEXT supported program for the strategic research foundation at private universities (2013-2017), and by a grant from the Takeda Science Foundation (3-2313-004), Osaka, Japan. The authors have no conflicts of interest that could be perceived as prejudicing the impartiality of the reported research.	Cuchel M, 2013, LANCET, V381, P40, DOI 10.1016/S0140-6736(12)61731-0; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Song CP, 2006, PLANT MOL BIOL, V60, P241, DOI 10.1007/s11103-005-3880-9; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0; Sung HY, 2006, IMMUNOL LETT, V104, P171, DOI 10.1016/j.imlet.2005.11.010; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Nakayama K, 2009, J MED GENET, V46, P370, DOI 10.1136/jmg.2008.064063; Singh KK, 2010, RNA, V16, P2442, DOI 10.1261/rna.2304410; Kirpich I, 2012, ALCOHOL CLIN EXP RES, V36, P1578, DOI 10.1111/j.1530-0277.2012.01751.x; Burkhardt R, 2010, J CLIN INVEST, V120, P4410, DOI [10.1172/JCI44213, 10.1172/JC144213]; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Murachelli AG, 2012, NAT STRUCT MOL BIOL, V19, P378, DOI 10.1038/nsmb.2242; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Yokoyama T, 2011, CANCER SCI, V102, P1115, DOI 10.1111/j.1349-7006.2011.01914.x; Sacks FM, 2014, JAMA INTERN MED, V174, P443, DOI 10.1001/jamainternmed.2013.13309; Kitamoto A, 2014, ENDOCR J, V61, P683, DOI 10.1507/endocrj.EJ14-0052; Rahman SM, 2007, HEPATOLOGY, V45, P1108, DOI 10.1002/hep.21614; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; Hegedus Z, 2007, CELL SIGNAL, V19, P238, DOI 10.1016/j.cellsig.2006.06.010; Baltus GA, 2009, J BIOL CHEM, V284, P6998, DOI 10.1074/jbc.M807670200; Costa E, 2011, FEBS LETT, V585, P275, DOI 10.1016/j.febslet.2010.11.058; *ENCODE PROJ CONS, 2011, PLOS BIOL, V0009; Gellert P, 2009, BIOINFORMATICS, V25, P3323, DOI 10.1093/bioinformatics/btp577; Ishizuka Y, 2014, J MOL ENDOCRINOL, V52, P145, DOI 10.1530/JME-13-0243; Jiang XT, 2014, J MOL ENDOCRINOL, V53, P191, DOI 10.1530/JME-14-0066; Lee J, 2014, J INHERIT METAB DIS, V37, P333, DOI 10.1007/s10545-013-9665-4; Xin X, 2007, BIOCHEM BIOPH RES CO, V362, P120, DOI 10.1016/j.bbre.2007.07.156	29	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0022-2275	1539-7262		J LIPID RES	J. Lipid Res.	JUN	2015	56	6					1145	1152		10.1194/jlr.M057802		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CJ5MR	WOS:000355532400007		
J	Kinai, E; Gatanaga, H; Kikuchi, Y; Oka, S; Kato, S				Kinai, Ei; Gatanaga, Hiroyuki; Kikuchi, Yoshimi; Oka, Shinichi; Kato, Shingo			Ultrasensitive method to quantify intracellular zidovudine mono-, di- and triphosphate concentrations in peripheral blood mononuclear cells by liquid chromatography-tandem mass spectrometry	JOURNAL OF MASS SPECTROMETRY			English	Article						LC-MS/MS; ultrasensitive; zidovudine; phosphates; intracellular	PERSISTENT MITOCHONDRIAL DYSFUNCTION; VIRUS-INFECTED INDIVIDUALS; TENOFOVIR-DIPHOSPHATE; SIMULTANEOUS QUANTITATION; LAMIVUDINE; METABOLITES; PHARMACOKINETICS; ANABOLITES; STAVUDINE; CARBOVIR	Although zidovudine (AZT) is not the preferred antiretroviral drug for adult HIV-infected patients, it is still widely used in infants for both prevention of mother-to-infant HIV-1 transmission and treatment of HIV-infected children. However, it is difficult to measure intracellular concentrations of AZT metabolites in small blood samples due to their extremely low concentrations in peripheral blood mononuclear cells and interference by endogenous nucleotide triphosphates, residual plasma phosphates and electrolytes. We developed an ultrasensitive assay using liquid chromatography-tandem mass spectrometry (LC-MS/MS) for measurement of intracellular concentrations of zidovudine (AZT)-monophosphate (AZT-MP), -diphosphate (AZT-DP) and - triphosphate (AZT-TP). The high sensitivity was due to the improvement of peripheral blood mononuclear cells extraction for complete removal of plasma and electrolytes, alkalization of LC buffer and use of alkaline-stable high performance liquid chromatography column and tetrabutylammoniumhydroxide as the ion pair. Using this method, the lower limits of quantification of AZT, AZT-MP, -DP and -TP were 6, 6, 10 and 10 fmol per sample, respectively. Accuracy ranged 89-115% and precision was lower than 15% in the quantification range of 6-6000 fmol/sample for plasma AZT and intracellular AZT-MP and 10-10 000 fmol/sample for AZT-DP and -TP. The validation parameters met the international requirements. Among nine AZT-treated HIV-infected adult patients, five had low AZT-TP levels (< 10fmol/10(6) cells). Our assay has high sensitivity and is advantageous for evaluation of AZT phosphates in children and infants based on minimum blood sampling requirement. Copyright (C) 2015 John Wiley & Sons, Ltd.	[Kinai, Ei; Gatanaga, Hiroyuki; Kikuchi, Yoshimi; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo 1628655, Japan; [Kato, Shingo] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan	Kinai, E (reprint author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	ekinai@acc.ncgm.go.jp					Becher F, 2002, RAPID COMMUN MASS SP, V16, P555, DOI 10.1002/rcm.605; Lavie A, 1997, NAT MED, V3, P922, DOI 10.1038/nm0897-922; Durand-Gasselin L, 2008, ANTIMICROB AGENTS CH, V52, P2555, DOI 10.1128/AAC.01130-07; Blanche S, 1999, LANCET, V354, P1084, DOI 10.1016/S0140-6736(99)07219-0; Font E, 1999, ANTIMICROB AGENTS CH, V43, P2964; SHIRASAKA T, 1993, P NATL ACAD SCI USA, V90, P562, DOI 10.1073/pnas.90.2.562; King T, 2006, J CHROMATOGR B, V843, P147, DOI 10.1016/j.jchromb.2006.05.043; Barret B, 2003, AIDS, V17, P1769, DOI 10.1097/01.aids.0000076284.54156.44; Chen JM, 2012, JAIDS-J ACQ IMM DEF, V61, P593, DOI 10.1097/QAI.0b013e3182717c98; Compain S, 2007, J MASS SPECTROM, V42, P389, DOI 10.1002/jms.1176; Flynn PM, 2007, ANTIMICROB AGENTS CH, V51, P3516, DOI 10.1128/AAC.01626-06; GAO WY, 1994, J BIOL CHEM, V269, P12633; Jorajuria Sylvie, 2004, Antivir Ther, V9, P519; Moore JD, 2000, J AM SOC MASS SPECTR, V11, P1134, DOI 10.1016/S1044-0305(00)00178-1; NAKATA H, 2007, J MASS SPECTROM, V51, P2701; Pruvost A, 2008, J MASS SPECTROM, V43, P224, DOI 10.1002/jms.1294; Pruvost A, 2001, RAPID COMMUN MASS SP, V15, P1401, DOI 10.1002/rcm.384; Robbins BL, 2007, J CHROMATOGR B, V850, P310, DOI 10.1016/j.jchromb.2006.12.015; Rodriguez JF, 2000, ANTIMICROB AGENTS CH, V44, P3097, DOI 10.1128/AAC.44.11.3097-3100.2000; TANAKA R, 2008, J MASS SPECTROM, V52, P782; US Department of Health and Human Services, 2014, GUIDELINES USE ANTIR	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1076-5174	1096-9888		J MASS SPECTROM	J. Mass Spectrom.	JUN	2015	50	6					783	791		10.1002/jms.3577		9	Biochemical Research Methods; Chemistry, Analytical; Spectroscopy	Biochemistry & Molecular Biology; Chemistry; Spectroscopy	CJ6QO	WOS:000355618600001		
J	Jiang, XF; Weng, QH; Wang, XB; Li, X; Zhang, J; Golberg, D; Bando, Y				Jiang, Xiang-Fen; Weng, Qunhong; Wang, Xue-Bin; Li, Xia; Zhang, Jun; Golberg, Dmitri; Bando, Yoshio			Recent Progress on Fabrications and Applications of Boron Nitride Nanomaterials: A Review	JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY			English	Review						Boron nitride; Nanoparticle; Nanotube; Nanosheet; Porous boron nitride	CHEMICAL-VAPOR-DEPOSITION; HIGH-YIELD SYNTHESIS; FULLERENE-LIKE NANOPARTICLES; DOUBLE-LAYER GRAPHENE; HYDROGEN STORAGE; THERMAL-CONDUCTIVITY; POLYMERIC COMPOSITES; BN NANOTUBES; SUBSTITUTION-REACTION; CARBON NANOTUBES	Boron nitride (BN) nanostructures with complementary functions to their carbon counterparts are one of the most intriguing nanomaterials. Here we devote a compact review on the syntheses of BN nanomaterials: typical zero-dimensional (0D) fullerenes and nanoparticles, one-dimensional (1D) nanotubes and nanoribbons, two-dimensional (2D) nanosheets as well as three-dimensional (3D) nanoporous BN. Combining low-dimensional quantum confinement and surface effects with unique physical and chemical properties of BN, e.g. excellent electric insulation, wide band gap, and high chemical and thermal stability, BN nanomaterials have drawn particular attention in a variety of potential applications, e.g. luminescence, functional composites, hydrogen accumulators, and advanced insulators, which are also reviewed. Copyright (C) 2015, The editorial office of Journal of Materials Science & Technology. Published by Elsevier Limited. All rights reserved.	[Jiang, Xiang-Fen; Weng, Qunhong; Wang, Xue-Bin; Li, Xia; Golberg, Dmitri; Bando, Yoshio] NIMS, World Premier Int Ctr Mat Nanoarchitecton WPI MAN, Tsukuba, Ibaraki 3050044, Japan; [Wang, Xue-Bin] NIMS, ICYS, Tsukuba, Ibaraki 3050044, Japan; [Wang, Xue-Bin] Nanjing Univ, Coll Engn & Appl Sci, Nanjing 210093, Jiangsu, Peoples R China; [Zhang, Jun] Hebei Univ Technol, Sch Mat Sci & Engn, Tianjin 300130, Peoples R China	Wang, XB (reprint author), NIMS, World Premier Int Ctr Mat Nanoarchitecton WPI MAN, Namiki 1-1, Tsukuba, Ibaraki 3050044, Japan.	WANGXB@fuji.waseda.jp; zhang.jun@hebut.edu.cn; GOLBERG.Dmitri@nims.go.jp	Golberg, Dmitri/H-2776-2011; WANG, Xue-Bin/H-8061-2013	Golberg, Dmitri/0000-0003-2298-6539; WANG, Xue-Bin/0000-0002-7894-1922	International Center for Young Scientists (ICYS); World Premier International Center for Materials Nanoarchitectonics (WPI-MANA) in National Institute for Materials Science (NIMS); KAKENHI project of Japan Society for the Promotion of Science (JSPS) [26820322]	The authors acknowledge financial support of International Center for Young Scientists (ICYS), and World Premier International Center for Materials Nanoarchitectonics (WPI-MANA) in National Institute for Materials Science (NIMS). The authors thank Drs. Kenjiro Miyano, Jie Tang, Masanori Mitome, Yusuke Ide, Naoyuki Kawamoto, Akihiko Nukui, Xi Wang, Daiming Tang, Amir Pakdel, and Ms. Kanako Takahashi for their kind assistances. X.B. Wang also thanks the financial support from KAKENHI project (Grant-in-Aid for Young Scientists, 26820322) of Japan Society for the Promotion of Science (JSPS).	Wang XB, 2011, ADV MATER, V23, P4072, DOI 10.1002/adma.201101788; Wang JS, 2010, NANOSCALE, V2, P2028, DOI 10.1039/c0nr00335b; Wei XL, 2010, ADV MATER, V22, P4895, DOI 10.1002/adma.201001829; Kim KS, 2014, ACS NANO, V8, P6211, DOI 10.1021/nn501661p; Wang XZ, 2007, ELECTROCHIM ACTA, V52, P2841, DOI 10.1016/j.electacta.2006.08.047; Nag A, 2010, ACS NANO, V4, P1539, DOI 10.1021/nn9018762; Pakdel A, 2012, J MATER CHEM, V22, P4818, DOI 10.1039/c2jm15109j; Watanabe K, 2009, NAT PHOTONICS, V3, P591, DOI 10.1038/NPHOTON.2009.167; Ghose S, 2008, COMPOS SCI TECHNOL, V68, P1843, DOI 10.1016/j.compscitech.2008.01.016; Lian G, 2012, ENERG ENVIRON SCI, V5, P7072, DOI 10.1039/c2ee03240f; Bosak A, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.041402; Yu DP, 1998, APPL PHYS LETT, V72, P1966, DOI 10.1063/1.121236; Gao R, 2009, J PHYS CHEM C, V113, P15160, DOI 10.1021/jp904246j; Gorbachev RV, 2012, NAT PHYS, V8, P896, DOI [10.1038/nphys2441, 10.1038/NPHYS2441]; Sinitskii A, 2014, ACS NANO, V8, P9867, DOI 10.1021/nn504809n; Chen W, 2009, J CHEM THEORY COMPUT, V5, P3088, DOI 10.1021/ct900388x; Lourie OR, 2000, CHEM MATER, V12, P1808, DOI 10.1021/cm000157q; Wang XB, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/31/314205; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Pan Y, 2005, SMALL, V1, P1199, DOI 10.1002/smll.200500218; Zhi CY, 2009, ADV FUNCT MATER, V19, P1857, DOI 10.1002/adfm.200801435; Chen Y, 1999, CHEM PHYS LETT, V299, P260, DOI 10.1016/S0009-2614(98)01252-4; Zhi CY, 2005, SOLID STATE COMMUN, V135, P67, DOI 10.1016/j.ssc.2005.03.062; Huang XY, 2013, ADV FUNCT MATER, V23, P1824, DOI 10.1002/adfm.201201824; Warner JH, 2010, ACS NANO, V4, P1299, DOI 10.1021/nn901648q; Lee C, 2010, SCIENCE, V328, P76, DOI 10.1126/science.1184167; He CY, 2010, J AM CHEM SOC, V132, P4843, DOI 10.1021/ja910874x; Qi JS, 2012, NANO LETT, V12, P1224, DOI 10.1021/nl2035749; Weng QH, 2013, ACS NANO, V7, P1558, DOI 10.1021/nn305320v; Wu HS, 2006, J MOL MODEL, V12, P537, DOI 10.1007/s00894-005-0042-6; Vinu A, 2005, CHEM MATER, V17, P5887, DOI 10.1021/cm051780j; Golberg D, 1998, APPL PHYS LETT, V73, P2441, DOI 10.1063/1.122475; Wang XJ, 2013, J PHYS CONF SER, V418, DOI 10.1088/1742-6596/418/1/012003; Han WQ, 2004, NANO LETT, V4, P173, DOI 10.1021/nl034843a; Malenfant PRL, 2007, NAT NANOTECHNOL, V2, P43, DOI 10.1038/nnano.2006.168; Wang XB, 2014, ACS NANO, V8, P9081, DOI 10.1021/nn502486x; CHOPRA NG, 1995, SCIENCE, V269, P966, DOI 10.1126/science.269.5226.966; Meyer JC, 2009, NANO LETT, V9, P2683, DOI 10.1021/nl9011497; NAGASHIMA A, 1995, PHYS REV LETT, V75, P3918, DOI 10.1103/PhysRevLett.75.3918; Cao F, 2012, J MATER SCI TECHNOL, V28, P956; Chen SS, 2012, NAT MATER, V11, P203, DOI [10.1038/nmat3207, 10.1038/NMAT3207]; Ponomarenko LA, 2011, NAT PHYS, V7, P958, DOI [10.1038/nphys2114, 10.1038/NPHYS2114]; Zhou WY, 2007, MATER RES BULL, V42, P1863, DOI 10.1016/j.materresbull.2006.11.047; Chen W, 2010, J AM CHEM SOC, V132, P1699, DOI 10.1021/ja908475v; Huo KF, 2003, J PHYS CHEM B, V107, P11316, DOI 10.1021/jp035375w; Watanabe K, 2004, NAT MATER, V3, P404, DOI 10.1038/nmat1134; Jo I, 2013, NANO LETT, V13, P550, DOI 10.1021/nl304060g; Dibandjo P, 2005, ADV MATER, V17, P571, DOI 10.1002/adma.200401501; Li X, 2014, CHEM COMMUN, V50, P4371, DOI 10.1039/c4cc00990h; Erickson KJ, 2011, NANO LETT, V11, P3221, DOI 10.1021/nl2014857; Shi YM, 2010, NANO LETT, V10, P4134, DOI 10.1021/nl1023707; Suenaga K, 1997, SCIENCE, V278, P653, DOI 10.1126/science.278.5338.653; Qiu NX, 2014, INT J HYDROGEN ENERG, V39, P9307, DOI 10.1016/j.ijhydene.2014.04.063; Chen Y, 1999, APPL PHYS LETT, V74, P2960, DOI 10.1063/1.123979; Pakdel A, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/21/215601; Zhi CY, 2009, ADV MATER, V21, P2889, DOI 10.1002/adma.200900323; Jin CH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.195505; Kim KK, 2012, NANO LETT, V12, P161, DOI 10.1021/nl203249a; Tian YJ, 2013, NATURE, V493, P385, DOI 10.1038/nature11728; Golberg D, 2002, CHEM PHYS LETT, V359, P220, DOI 10.1016/S0009-2614(02)00536-5; Rushton B, 2008, J MATER CHEM, V18, P235, DOI 10.1039/b713740k; Alauzun JG, 2011, J MATER CHEM, V21, P14025, DOI 10.1039/c1jm12751a; Rao CNR, 2012, DALTON T, V41, P5089, DOI 10.1039/c2dt12266a; Golberg D, 2000, SOLID STATE COMMUN, V116, P1, DOI 10.1016/S0038-1098(00)00281-7; Barone V, 2008, NANO LETT, V8, P2210, DOI 10.1021/nl080745j; Corso M, 2004, SCIENCE, V303, P217, DOI 10.1126/science.1091979; Han WQ, 1998, APPL PHYS LETT, V73, P3085, DOI 10.1063/1.122680; Shi G, 2014, NANO LETT, V14, P1739, DOI 10.1021/nl4037824; Loiseau A, 1996, PHYS REV LETT, V76, P4737, DOI 10.1103/PhysRevLett.76.4737; Lin Y, 2012, NANOSCALE, V4, P6908, DOI 10.1039/c2nr32201c; Park CH, 2008, NANO LETT, V8, P2200, DOI 10.1021/nl080695i; Tang C, 2002, CHEM COMMUN, P1290, DOI 10.1039/b202177c; Tang CC, 2002, J AM CHEM SOC, V124, P14550, DOI 10.1021/ja028051e; Li L, 2013, ANGEW CHEM INT EDIT, V52, P4212, DOI 10.1002/anie.201209597; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Li XL, 2012, ACS NANO, V6, P4104, DOI 10.1021/nn300495t; Yu J, 2010, ACS NANO, V4, P414, DOI 10.1021/nn901204c; Stephan O, 1998, APPL PHYS A-MATER, V67, P107, DOI 10.1007/s003390050745; Han WQ, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3041639; Pacile D, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2903702; Dai J, 2014, J PHYS CHEM LETT, V5, P393, DOI 10.1021/jz4026535; Zhang ZH, 2011, J AM CHEM SOC, V133, P14831, DOI 10.1021/ja206703x; Smith MW, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/50/505604; Chen ZG, 2008, ACS NANO, V2, P2183, DOI 10.1021/nn8004922; Huo KF, 2002, APPL PHYS LETT, V80, P3611, DOI 10.1063/1.1479213; Pakdel A, 2013, ACTA MATER, V61, P1266, DOI 10.1016/j.actamat.2012.11.002; Wang JS, 2005, NANO LETT, V5, P2528, DOI 10.1021/nl051859n; Chadderton LT, 1999, PHYS LETT A, V263, P401, DOI 10.1016/S0375-9601(99)00731-8; Chatterjee S, 2012, CHEM MATER, V24, P2872, DOI 10.1021/cm3006088; Dibandjo P, 2005, J MATER CHEM, V15, P1917, DOI 10.1039/b417891b; Arenal R, 2007, J AM CHEM SOC, V129, P16183, DOI 10.1021/ja076135n; Golberg D, 2007, ADV MATER, V19, P2413, DOI 10.1002/adma.200700179; Lian G, 2010, J MATER CHEM, V20, P3736, DOI 10.1039/b920881j; Fathalizadeh A, 2014, NANO LETT, V14, P4881, DOI 10.1021/nl5022915; Weng QH, 2014, ACS NANO, V8, P6123, DOI 10.1021/nn5014808; Britnell L, 2012, NANO LETT, V12, P1707, DOI 10.1021/nl3002205; Song L, 2010, NANO LETT, V10, P3209, DOI 10.1021/nl1022139; Schlienger S, 2012, CHEM MATER, V24, P88, DOI 10.1021/cm201938h; Lopez-Bezanilla A, 2011, NANO LETT, V11, P3267, DOI 10.1021/nl201616h; Coleman JN, 2011, SCIENCE, V331, P568, DOI 10.1126/science.1194975; Pupysheva OV, 2008, NANO LETT, V8, P767, DOI 10.1021/nl071436g; Zeng HB, 2010, NANO LETT, V10, P5049, DOI 10.1021/nl103251m; Li J, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/36/365605; Tang CC, 2008, ADV FUNCT MATER, V18, P3653, DOI 10.1002/adfm.200800493; Fu JJ, 2004, NANOTECHNOLOGY, V15, P727, DOI 10.1088/0957-4484/15/7/003; Golberg D, 1996, APPL PHYS LETT, V69, P2045, DOI 10.1063/1.116874; Rousseas M, 2013, ACS NANO, V7, P8540, DOI 10.1021/nn402452p; Tenne R, 2006, NAT NANOTECHNOL, V1, P103, DOI 10.1038/nnano.2006.62; Golberg D, 1999, CHEM PHYS LETT, V308, P337, DOI 10.1016/S0009-2614(99)00591-6; BANHART F, 1994, CHEM PHYS LETT, V231, P98, DOI 10.1016/0009-2614(94)01215-6; Bernard S, 2014, MATER TODAY, V17, P443, DOI 10.1016/j.mattod.2014.07.006; Celik-Aktas A, 2005, ACTA CRYSTALLOGR A, V61, P533, DOI 10.1107/S0108767305026723; Chen Y. J., 2006, NANOTECHNOLOGY, V17, P786, DOI 10.1088/0957-4484/17/3/028; GLEIZE P, 1994, J MATER SCI, V29, P1575, DOI 10.1007/BF00368928; Golberg D, 2003, APPL PHYS A-MATER, V76, P499, DOI 10.1007/s00339-002-2047-7; Gyawali G, 2014, J MATER SCI TECHNOL, V30, P796, DOI 10.1016/j.jmst.2014.05.008; Han WQ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2363980; Han WQ, 1999, JPN J APPL PHYS 2, V38, pL755, DOI 10.1143/JJAP.38.L755; Huang Q., 2007, P 16 INT C COMP MAT, P810; Huang Y, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/8/085705; Huang Y, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/14/145602; Kim MJ, 2008, NANO LETT, V8, P3298, DOI 10.1021/nl8016835; Lai L, 2009, J PHYS CHEM C, V113, P2273, DOI 10.1021/jp8079827; Lei WW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2818; Li C, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/38/385707; Li J., 2013, NATURE, V3, P3208; Li L, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-417; Li X., 2015, ADV MAT UNPUB; Li XL, 2013, ADV MATER, V25, P2200, DOI 10.1002/adma.201204031; Lin Y., 2010, J PHYS CHEM C, V115, P2679; LINDQUIST DA, 1991, J AM CERAM SOC, V74, P3126, DOI 10.1111/j.1151-2916.1991.tb04310.x; Liu F, 2014, SCI REP-UK, V4, DOI 10.1038/srep04211; Liu Z, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3541; Loh KP, 2004, CHEM PHYS LETT, V387, P40, DOI 10.1016/j.cplett.2004.01.093; Pruss EA, 2000, CHEM MATER, V12, P19, DOI 10.1021/cm990562l; Qiu NX, 2014, CHEMPHYSCHEM, V15, P3015, DOI 10.1002/cphc.201402246; Shimizu Y, 1999, APPL PHYS LETT, V75, P929, DOI 10.1063/1.124557; Slawinska J, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.155433; Suryavanshi U, 2014, PHYS CHEM CHEM PHYS, V16, P23554, DOI 10.1039/c4cp04210g; Tang CC, 2002, CHEM COMMUN, P2826, DOI 10.1039/b208785e; Tang CC, 2002, CHEM PHYS LETT, V362, P185, DOI 10.1016/S0009-2614(02)00973-9; Wang XB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3905; Wang XB, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-662; Yamaguchi M, 2012, ACTA MATER, V60, P6213, DOI 10.1016/j.actamat.2012.07.066; Zhang H, 2009, 2009 IEEE INTERNATIONAL SYMPOSIUM ON RADIO-FREQUENCY INTEGRATION TECHNOLOGY (RFIT 2009), P20; Zhi CY, 2011, ACS NANO, V5, P6571, DOI 10.1021/nn201946x; Zhi CY, 2013, J APPL PHYS, V114, DOI 10.1063/1.4817430	147	1	1	JOURNAL MATER SCI TECHNOL	SHENYANG	72 WENHUA RD, SHENYANG 110015, PEOPLES R CHINA	1005-0302			J MATER SCI TECHNOL	J. Mater. Sci. Technol.	JUN	2015	31	6					589	598		10.1016/j.jmst.2014.12.008		10	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CJ5UJ	WOS:000355556100007		
J	Katahira, K				Katahira, Kentaro			The relation between reinforcement learning parameters and the influence of reinforcement history on choice behavior	JOURNAL OF MATHEMATICAL PSYCHOLOGY			English	Article						Reinforcement learning; History dependence; Regression model; Model-based analysis	HUMAN DECISION-MAKING; MIXED-STRATEGY GAME; MATCHING BEHAVIOR; PREFRONTAL CORTEX; REWARD; MODELS; PREDICTION; REPRESENTATION; VARIABILITY; STRIATUM	Reinforcement learning (RL) models have been widely used to analyze the choice behavior of humans and other animals in a broad range of fields, including psychology and neuroscience. Linear regression-based models that explicitly represent how reward and choice history influences future choices have also been used to model choice behavior. While both approaches have been used independently, the relation between the two models has not been explicitly described. The aim of the present study is to describe this relation and investigate how the parameters in the RL model mediate the effects of reward and choice history on future choices. To achieve these aims, we performed analytical calculations and numerical simulations. First, we describe a special case in which the RL and regression models can provide equivalent predictions of future choices. The general properties of the RL model are discussed as a departure from this special case. We clarify the role of the RL-model parameters, specifically, the learning rate, inverse temperature, and outcome value (also referred to as the reward value, reward sensitivity, or motivational value), in the formation of history dependence. (C) 2015 The Author. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	Nagoya Univ, Grad Sch Environm Studies, Dept Psychol, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Katahira, K (reprint author), Nagoya Univ, Grad Sch Environm Studies, Dept Psychol, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	katahira@lit.nagoya-u.ac.jp			KAKENHI [24700238, 26118506]	This work was supported in part by the Grants-in-Aid for Scientific Research (KAKENHI) grants 24700238 and 26118506.	Akaishi R, 2014, NEURON, V81, P195, DOI 10.1016/j.neuron.2013.10.018; Ito M, 2009, J NEUROSCI, V29, P9861, DOI 10.1523/JNEUROSCI.6157-08.2009; Lindstrom B, 2014, PSYCHOL SCI, V25, P711, DOI 10.1177/0956797613514093; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Yechiam E, 2005, PSYCHOL SCI, V16, P973, DOI 10.1111/j.1467-9280.2005.01646.x; Kovach CK, 2012, J NEUROSCI, V32, P8434, DOI 10.1523/JNEUROSCI.5468-11.2012; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Niv Y, 2009, J MATH PSYCHOL, V53, P139, DOI 10.1016/j.jmp.2008.12.005; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sakai Y, 2008, NEURAL COMPUT, V20, P227, DOI 10.1162/neco.2008.20.1.227; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Gershman SJ, 2009, J NEUROSCI, V29, P13524, DOI 10.1523/JNEUROSCI.2469-09.2009; O'Doherty JP, 2007, ANN NY ACAD SCI, V1104, P35, DOI 10.1196/annals.1390.022; Seo H, 2009, J NEUROSCI, V29, P3627, DOI 10.1523/JNEUROSCI.4726-08.2009; Seymour B, 2012, J NEUROSCI, V32, P5833, DOI 10.1523/JNEUROSCI.0053-12.2012; Corrado G, 2007, J NEUROSCI, V27, P8178, DOI 10.1523/JNEUROSCI.1590-07.2007; [Anonymous], DECISION MAKING AFFE; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Corrado GS, 2005, J EXP ANAL BEHAV, V84, P581, DOI 10.1901/jeab.2005.23-05; Huys QJM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002028; Katahira K, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00311; Katahira K, 2012, NEURAL COMPUT, V24, P1230, DOI 10.1162/NECO_a_00264; Katahira K., 2015, J NEUROPHYS IN PRESS; Katahira K, 2014, BIOL PSYCHOL, V103, P322, DOI 10.1016/j.biopsycho.2014.10.007; Kunisato Y, 2012, J BEHAV THER EXP PSY, V43, P1088, DOI 10.1016/j.jbtep.2012.05.007; Saito H., 2014, FRONTIERS COMPUTATIO, V8; Seo H, 2009, J NEUROSCI, V29, P7278, DOI 10.1523/JNEUROSCI.1479-09.2009; Sutton R., 1998, REINFORCEMENT LEARNI	32	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-2496	1096-0880		J MATH PSYCHOL	J. Math. Psychol.	JUN	2015	66						59	69		10.1016/j.jmp.2015.03.006		11	Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods; Psychology, Mathematical	Mathematics; Mathematical Methods In Social Sciences; Psychology	CJ7ZD	WOS:000355718000007		
J	Harasawa, S; Sato, M				Harasawa, S.; Sato, M.			HELICAL BUCKLING OF SLENDER BEAM STRUCTURES SURROUNDED BY AN ELASTIC MEDIUM	JOURNAL OF MECHANICS			English	Article						Helical buckling; Helix; Strain; Elastic medium	PIPE CROSS-SECTIONS; ROD; MODEL	The goal of this study was to investigate analytically the buckling phenomena of slender beam structures embedded in an elastic medium. In such cases, there is a possibility that spiral-shaped buckling modes can occur due to the restraining effect of the surrounding medium. As a result of analytical investigations, helical buckling occurs radically. Furthermore the pitch of the helix does not fluctuate as the radius of the helix increases. The interesting mechanical implications of the embedding effect are demonstrated by the theoretical approach established in this study.	[Harasawa, S.] Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido, Japan; [Sato, M.] Hokkaido Univ, Fac Engn, Sapporo, Hokkaido 060, Japan	Sato, M (reprint author), Hokkaido Univ, Fac Engn, North 13,West 8, Sapporo, Hokkaido 060, Japan.	tayu@eng.hokudai.ac.jp	Sato, Motohiro/D-6788-2012		JSPS KAKENHI [24686096]	This work was supported by JSPS KAKENHI (Grant Number 24686096).	He XQ, 2005, J MECH PHYS SOLIDS, V53, P303, DOI 10.1016/j.jmps.2004.08.003; Silverberg JL, 2012, P NATL ACAD SCI USA, V109, P16794, DOI 10.1073/pnas.1209287109; Brush D. O., 1975, BUCKLING BARS PLATES; Foster D, 2012, P ROY SOC A-MATH PHY, V468, P3172, DOI 10.1098/rspa.2012.0132; Huang NC, 2000, INT J NONLINEAR MECH, V35, P911, DOI 10.1016/S0020-7462(99)00067-0; Sato M, 2008, STRUCT ENG MECH, V30, P263; Sato M, 2007, J MAR SCI TECHNOL, V12, P251, DOI 10.1007/s00773-007-0244-y; Sun C, 2006, J PETROL SCI ENG, V50, P78, DOI 10.1016/j.petrol.2005.10.001; Svensek D, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.031808; Tanaka S., 1983, J I ELECT INFORM COM, V66, P943; Thompson JMT, 2012, P ROY SOC A-MATH PHY, V468, P1591, DOI 10.1098/rspa.2011.0558; Valverde J, 2012, INT J NONLIN MECH, V47, P38, DOI 10.1016/j.ijnonlinmec.2011.12.005	12	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1727-7191	1811-8216		J MECH	J. Mech.	JUN	2015	31	3					241	247		10.1017/jmech.2014.92		7	Mechanics	Mechanics	CK1QU	WOS:000355982900001		
J	Janak, M; Froitzheim, N; Yoshida, K; Sasinkova, V; Nosko, M; Kobayashi, T; Hirajima, T; Vrabec, M				Janak, M.; Froitzheim, N.; Yoshida, K.; Sasinkova, V.; Nosko, M.; Kobayashi, T.; Hirajima, T.; Vrabec, M.			Diamond in metasedimentary crustal rocks from Pohorje, Eastern Alps: a window to deep continental subduction	JOURNAL OF METAMORPHIC GEOLOGY			English	Article						diamond; fluid inclusions; moissanite; Raman spectroscopy; UHP metamorphism	ULTRAHIGH-PRESSURE METAMORPHISM; O-H FLUIDS; RAMAN-SPECTRUM; SM-ND; TECTONOMETAMORPHIC EVOLUTION; EXPERIMENTAL CONSTRAINTS; MANTLE XENOLITHS; SILICON-CARBIDE; OROGENIC BELTS; EARTHS MANTLE	We report the first finding of diamond and moissanite in metasedimentary crustal rocks of Pohorje Mountains (Slovenia) in the Austroalpine ultrahigh-pressure (UHP) metamorphic terrane of the Eastern Alps. Microscopic observations and Raman spectroscopy show that diamond occurs in situ as inclusions in garnet, being heterogeneously distributed. Under the optical microscope, diamond-bearing inclusions are of cuboidal to rounded shape and of pinkish, yellow to brownish colour. The Raman spectra of the investigated diamond show a sharp, first order peak of sp(3)-bonded carbon, in most cases centred between 1332 and 1330cm(-1), with a full width at half maximum between 3 and 5cm(-1). Several spectra show Raman bands typical for disordered graphitic (sp(2)-bonded) carbon. Detailed observations show that diamond occurs either as a monomineralic, single-crystal inclusion or it is associated with SiC (moissanite), CO2 and CH4 in polyphase inclusions(.) This rare record of diamond occurring with moissanite as fluid-inclusion daughter minerals implies the crystallization of diamond and moissanite from a supercritical fluid at reducing conditions. Thermodynamic modelling suggests that diamond-bearing gneisses attained P-T conditions of 3.5GPa and 800-850 degrees C, similar to eclogites and garnet peridotites. We argue that diamond formed when carbonaceous sediment underwent UHP metamorphism at mantle depth exceeding 100km during continental subduction in the Late Cretaceous (c. 95-92Ma). The finding of diamond confirms UHP metamorphism in the Pohorje Mountains, the most deeply subducted part of Austroalpine units.	[Janak, M.] Slovak Acad Sci, Inst Geol, Bratislava 84005 45, Slovakia; [Froitzheim, N.] Univ Bonn, Steinmann Inst, D-53115 Bonn, Germany; [Yoshida, K.; Hirajima, T.] Kyoto Univ, Grad Sch Sci, Dept Geol & Mineral, Kyoto 6068502, Japan; [Sasinkova, V.] Slovak Acad Sci, Inst Chem, Bratislava 84005, Slovakia; [Nosko, M.] Slovak Acad Sci, Inst Mat & Machine Mech, Bratislava 84005, Slovakia; [Kobayashi, T.] Nagoya Gakuin Univ, Fac Hlth & Sports, Nagoya, Aichi 4801298, Japan; [Vrabec, M.] Univ Ljubljana, Dept Geol, Ljubljana 10000, Slovenia	Janak, M (reprint author), Slovak Acad Sci, Inst Geol, Dubravska 9,POB 106, Bratislava 84005 45, Slovakia.	marian.janak@savba.sk			Slovak Research and Development Agency [APVV-0080-11]; Slovak Scientific Grant Agency VEGA [2/0013/12]; DFG [FR700/17-1]	We thank C. Chopin and an anonymous reviewer for their constructive reviews and D. Robinson for editorial handling of the manuscript. This work was financially supported by the Slovak Research and Development Agency (project APVV-0080-11 to M.J.), the Slovak Scientific Grant Agency VEGA (grant no. 2/0013/12 to M.J.) and DFG grant no. FR700/17-1 to N.F.	Akaishi M, 2000, J CRYST GROWTH, V209, P999, DOI 10.1016/S0022-0248(99)00756-3; ALTHERR R, 1995, MINER PETROL, V54, P225, DOI 10.1007/BF01162863; Schmid SM, 2004, ECLOGAE GEOL HELV, V97, P93, DOI 10.1007/s00015-004-1113-x; Perraki M, 2014, LITHOS, V202, P157, DOI 10.1016/j.lithos.2014.05.025; Perraki M, 2009, AM MINERAL, V94, P546, DOI 10.2138/am.2009.2973; Janak M, 2006, J METAMORPH GEOL, V24, P19, DOI 10.1111/j.1525-1314.2005.00619.x; Connolly JAD, 2005, EARTH PLANET SC LETT, V236, P524, DOI 10.1016/j.epsl.2005.04.033; Deines P, 2002, EARTH-SCI REV, V58, P247, DOI 10.1016/S0012-8252(02)00064-8; Okamoto K, 1999, AM MINERAL, V84, P362; Janak M, 2004, TECTONICS, V23, DOI 10.1029/2004TC001641; Shirey SB, 2013, REV MINERAL GEOCHEM, V75, P355, DOI 10.2138/rmg.2013.75.12; Kurz W, 2003, INT GEOL REV, V45, P1100, DOI 10.2747/0020-6814.45.12.1100; El Atrassi F, 2011, EUR J MINERAL, V23, P157, DOI 10.1127/0935-1221/2011/0023-2094; Frezzotti ML, 2011, NAT GEOSCI, V4, P703, DOI [10.1038/ngeo1246, 10.1038/NGEO1246]; TUINSTRA F, 1970, J CHEM PHYS, V53, P1126, DOI 10.1063/1.1674108; Hermann J, 2001, EARTH PLANET SC LETT, V188, P149, DOI 10.1016/S0012-821X(01)00321-1; Smith DC, 2011, ELSEV INSIGHT, P43, DOI 10.1016/B978-0-12-385144-4.00001-1; Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095; Kohn MJ, 2000, GEOLOGY, V28, P1127, DOI 10.1130/0091-7613(2000)028<1127:RNTRIF>2.3.CO;2; Sokol AG, 2009, GEOCHIM COSMOCHIM AC, V73, P5820, DOI 10.1016/j.gca.2009.06.010; THOMPSON JB, 1979, AM MINERAL, V64, P57; Wojdyr M, 2010, J APPL CRYSTALLOGR, V43, P1126, DOI 10.1107/S0021889810030499; LEUNG IS, 1990, AM MINERAL, V75, P1110; Coggon R, 2002, J METAMORPH GEOL, V20, P683, DOI 10.1046/j.1525-1314.2002.00395.x; Whitney DL, 2010, AM MINERAL, V95, P185, DOI 10.2138/am.2010.3371; White RW, 2007, J METAMORPH GEOL, V25, P511, DOI 10.1111/j.1525-1314.2007.00711.x; Smith DC, 2013, J METAMORPH GEOL, V31, P19, DOI 10.1111/jmg.12007; Frost DJ, 2008, ANNU REV EARTH PL SC, V36, P389, DOI 10.1146/annurev.earth.36.031207.124322; SMITH DC, 1984, NATURE, V310, P641, DOI 10.1038/310641a0; Day HW, 2012, AM MINERAL, V97, P52, DOI 10.2138/am.2011.3763; Hoinkes G, 1999, SCHWEIZ MINER PETROG, V79, P155; Stockhert B, 2001, GEOLOGY, V29, P391, DOI 10.1130/0091-7613(2001)029<0391:MDCPFS>2.0.CO;2; LESPADE P, 1982, CARBON, V20, P427, DOI 10.1016/0008-6223(82)90043-4; Holland TJB, 1998, J METAMORPH GEOL, V16, P309, DOI 10.1111/j.1525-1314.1998.00140.x; Liou JG, 2014, J ASIAN EARTH SCI, V96, P386, DOI 10.1016/j.jseaes.2014.09.011; De Hoog JCM, 2009, LITHOS, V109, P209, DOI 10.1016/j.lithos.2008.05.006; WANG Y, 1990, CHEM MATER, V2, P557, DOI 10.1021/cm00011a018; Ruiz-Cruz MD, 2013, LITHOS, V177, P184, DOI 10.1016/j.lithos.2013.06.004; Burke EAJ, 2001, LITHOS, V55, P139, DOI 10.1016/S0024-4937(00)00043-8; Hermann J, 2008, J PETROL, V49, P717, DOI 10.1093/petrology/egm073; KAWASHIMA Y, 1995, PHYS REV B, V52, P10053, DOI 10.1103/PhysRevB.52.10053; THONI M, 1992, GEOCHIM COSMOCHIM AC, V56, P347, DOI 10.1016/0016-7037(92)90138-9; Handy MR, 2010, EARTH-SCI REV, V102, P121, DOI 10.1016/j.earscirev.2010.06.002; SOLIN SA, 1970, PHYS REV B, V1, P1687, DOI 10.1103/PhysRevB.1.1687; NEMANICH RJ, 1979, PHYS REV B, V20, P392, DOI 10.1103/PhysRevB.20.392; NEWTON RC, 1980, GEOCHIM COSMOCHIM AC, V44, P933, DOI 10.1016/0016-7037(80)90283-5; CONNOLLY JAD, 1990, AM J SCI, V290, P666; BALLHAUS C, 1995, EARTH PLANET SC LETT, V132, P75, DOI 10.1016/0012-821X(95)00047-G; CHOPIN C, 1984, CONTRIB MINERAL PETR, V86, P107, DOI 10.1007/BF00381838; De Corte K, 1998, GEOCHIM COSMOCHIM AC, V62, P3765, DOI 10.1016/S0016-7037(98)00266-X; De Hoog JCM, 2011, ELSEV INSIGHT, P399, DOI 10.1016/B978-0-12-385144-4.00012-6; Di Pierro S, 2003, AM MINERAL, V88, P1817; Dobrzhinetskaya LF, 2012, GONDWANA RES, V21, P207, DOI 10.1016/j.gr.2011.07.014; Dobrzhinetskaya LF, 2007, INT GEOL REV, V49, P389, DOI 10.2747/0020-6814.49.5.389; Dobrzhinetskaya LF, 2013, J METAMORPH GEOL, V31, P5, DOI 10.1111/jmg.12010; Dobrzhinetskaya LF, 2004, GEOLOGY, V32, P869, DOI 10.1130/G20582.1; FABRE D, 1986, CR ACAD SCI II, V303, P1305; Fodor Laszlo I., 2008, Swiss Journal of GeoSciences, V101, DOI 10.1007/s00015-008-1286-9; Fodor L., 2003, ANN U SCI BUDAPEST G, V35, P118; Fodor L., 2002, GEOL CARPATH, V53, P199; Frezzotti ML, 2014, GEOCHIM COSMOCHIM AC, V143, P68, DOI 10.1016/j.gca.2013.12.022; Frezzotti ML, 2007, EARTH PLANET SC LETT, V262, P273, DOI 10.1016/j.epsl.2007.08.001; Gilotti JA, 2013, ELEMENTS, V9, P255, DOI 10.2113/gselements.9.4.255; Hacker BR, 2013, ELEMENTS, V9, P289, DOI 10.2113/gselements.9.4.289; Haggerty SE, 1999, SCIENCE, V285, P851, DOI 10.1126/science.285.5429.851; Hinterlechner-Ravnik A., 1991, RENDICONTI FISICHE A, V2, P175, DOI 10.1007/BF03001420; HOINKES G, 1991, MINER PETROL, V43, P237, DOI 10.1007/BF01164529; HOKE L., 1990, JB GEOL B A, V133, P5; Hurai V, 2010, CONTRIB MINERAL PETR, V160, P203, DOI 10.1007/s00410-009-0473-7; Janak M, 2009, EUR J MINERAL, V21, P1191, DOI 10.1127/0935-1221/2009/0021-1966; Kirst F, 2010, GEOL CARPATH, V61, P451, DOI 10.2478/v10096-010-0027-y; Krenn E, 2009, AM MINERAL, V94, P801, DOI 10.2138/am.2009.2981; Kurz W, 2002, J STRUCT GEOL, V24, P1957, DOI 10.1016/S0191-8141(02)00008-1; MATHEZ EA, 1995, GEOCHIM COSMOCHIM AC, V59, P781, DOI 10.1016/0016-7037(95)00002-H; Miller C., 1990, SCHWEIZ MINER PETROG, V70, P287; Miller C, 1997, CHEM GEOL, V137, P283, DOI 10.1016/S0009-2541(96)00165-9; Miller C, 2005, CONTRIB MINERAL PETR, V150, P70, DOI 10.1007/s00410-005-0004-0; Missoni S, 2011, INT J EARTH SCI, V100, P1605, DOI 10.1007/s00531-010-0552-z; Mizukami T, 2008, GEOLOGY, V36, P219, DOI 10.1130/G24350A.1; Moissan H, 1905, CR HEBD ACAD SCI, V140, P405; Neubauer F., 2000, MITTEILUNGEN OSTERRE, V92, P7; Pal'yanov YN, 2005, RUSS GEOL GEOPHYS+, V46, P1271; Schmidt M. W., 2014, PROGR EARTH PLANETAR, V1, P27; Schuster R., 2004, MITTEILUNGEN OSTERRE, V149, P175; Shiryaev AA, 2014, EUR J MINERAL, V26, P53, DOI 10.1127/0935-1221/2013/0025-2339; SOBOLEV NV, 1990, NATURE, V343, P742, DOI 10.1038/343742a0; Spear F., 1993, METAMORPHIC PHASE EQ; Stuwe K, 2010, GEOLOGY, V38, P175, DOI 10.1130/G30528.1; Tajcmanova L, 2009, J METAMORPH GEOL, V27, P153, DOI 10.1111/j.1525-1314.2009.00812.x; Thoni M, 1996, J METAMORPH GEOL, V14, P453, DOI 10.1046/j.1525-1314.1996.05995.x; Thoni M, 2002, CHEM GEOL, V185, P255, DOI 10.1016/S0009-2541(01)00410-7; Trajanova M, 2008, GEOL CARPATH, V59, P247; Trumbull RB, 2009, LITHOS, V113, P612, DOI 10.1016/j.lithos.2009.06.033; Uher P, 2014, GEOL CARPATH, V65, P131, DOI 10.2478/geoca-2014-0009; Vrabec M, 2012, LITHOS, V144, P40, DOI 10.1016/j.lithos.2012.04.004	95	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0263-4929	1525-1314		J METAMORPH GEOL	J. Metamorph. Geol.	JUN	2015	33	5					495	512		10.1111/jmg.12130		18	Geology	Geology	CJ8IB	WOS:000355742300003		
J	Li, J; Feng, W; Liu, B; Sun, B; Han, XC; Du, J; Sun, J; Yimin; Cui, J; Guo, J; Kudo, A; Amizuka, N; Li, MQ				Li, Juan; Feng, Wei; Liu, Bo; Sun, Bao; Han, Xiuchun; Du, Juan; Sun, Jing; Yimin; Cui, Jian; Guo, Jie; Kudo, Akira; Amizuka, Norio; Li, Minqi			Altered distribution of HMGB1 in the periodontal ligament of periostin-deficient mice subjected to Waldo's orthodontic tooth movement	JOURNAL OF MOLECULAR HISTOLOGY			English	Article						Periostin; HMGB1; Orthodontic tooth movement; Periodontal ligament	CYTOKINE; DANGER; REPAIR	Periostin is essential for the integrity and function of the periodontal ligament (PDL), and periostin knockout is related to an enhanced inflammatory status in PDL. High mobility group box 1 (HMGB1), a late inflammatory cytokine, is up-regulated in PDL cells in response to mechanical stress. This study aimed to investigate the effect of periostin deficiency (Pn-/-) on HMGB1 expression in PDL during orthodontic tooth movement. We used 8-week-old male mice homozygous for the disrupted periostin gene and their wild-type (WT) littermates. Tooth movement was performed according to Waldo's method, in which 0.5-mm-thick elastic bands were inserted between the first and second upper molars of anesthetized mice. After 3 days of mechanical loading, mice were fixed by transcardial perfusion of 4 % paraformaldehyde in phosphate buffer, and the maxilla was extracted for histochemical analyses. Compared with the WT group, Pn-/- mice showed higher basal expression of HMGB1 in the absence of mechanical loading. Following 3 days of orthodontic tooth movement, the PDL in the compression side of both groups was almost replaced by cell-free hyaline zones, and Pn-/- mice showed a much wider residual PDL than WT mice. In the tension side, the number of HMGB1-positive cells in PDL in both Pn-/- and WT groups increased remarkably without a significant difference between the two groups. Our findings suggest an inhibitory effect of periostin on HMGB1 production by PDL and confirmed the critical role of periostin in integrity of PDL collagen fibrils during orthodontic tooth movement, although mechanical loading is the predominant stimulant of HMGB1 expression relative to periostin deficiency.	[Li, Juan; Feng, Wei; Liu, Bo; Sun, Bao; Han, Xiuchun; Du, Juan; Sun, Jing; Cui, Jian; Guo, Jie; Li, Minqi] Shandong Univ, Sch Stomatol, Dept Bone Metab, Shandong Prov Key Lab Oral Biomed, Jinan 250012, Peoples R China; [Yimin] Hokkaido Univ, Grad Sch Med, Dept Adv Med, Sapporo, Hokkaido, Japan; [Kudo, Akira] Tokyo Inst Technol, Dept Biol Informat, Yokohama, Kanagawa 227, Japan; [Amizuka, Norio] Hokkaido Univ, Grad Sch Dent Med, Dept Dev Biol Hard Tissue, Sapporo, Hokkaido, Japan	Li, MQ (reprint author), Shandong Univ, Sch Stomatol, Dept Bone Metab, Shandong Prov Key Lab Oral Biomed, Wenhua West Rd 44-1, Jinan 250012, Peoples R China.	liminqi@sdu.edu.cn			National Nature Science Foundation of China [81271965, 81470719, 81311140173]; Specialized Research Fund for the Doctoral Program of Higher Education [20120131110073]; Shandong Province Science and Technique Foundation, China [2014GSF118093]	This study was partially supported by the National Nature Science Foundation of China (Nos. 81271965; 81470719; 81311140173) and Specialized Research Fund for the Doctoral Program of Higher Education (No. 20120131110073) to Li M. The Shandong Province Science and Technique Foundation, China (No. 2014GSF118093) to Guo J.	Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Lv SY, 2014, J MOL HISTOL, V45, P303, DOI 10.1007/s10735-013-9548-x; TAKESHITA S, 1993, BIOCHEM J, V294, P271; Kim YS, 2010, J CELL BIOCHEM, V111, P1310, DOI 10.1002/jcb.22858; Yang H, 2002, J ENDOTOXIN RES, V8, P469, DOI 10.1179/096805102125001091; Wilde J, 2003, CELL TISSUE RES, V312, P345, DOI 10.1007/s00441-002-0664-2; Andersson U, 2002, J LEUKOCYTE BIOL, V72, P1084; Norris RA, 2008, ANN NY ACAD SCI, V1123, P30, DOI 10.1196/annals.1420.005; Rios HF, 2008, J PERIODONTOL, V79, P1480, DOI 10.1902/jop.2008.070624 ; Choi JW, 2011, J PERIODONTAL RES, V46, P513, DOI 10.1111/j.1600-0765.2011.01351.x; KUITERT R B, 1988, Acta Morphologica Neerlando-Scandinavica, V26, P191; Lv SY, 2015, J MOL HISTOL, V46, P107, DOI 10.1007/s10735-014-9606-z; Noda K, 2009, EUR J ORTHODONT, V31, P37, DOI 10.1093/ejo/cjn075; PACKMAN H, 1977, J PERIODONTOL, V48, P194; RYGH P, 1973, ACTA ODONTOL SCAND, V31, P109, DOI 10.3109/00016357309004617; Wolf M, 2013, J OROFAC ORTHOP, V74, P420, DOI 10.1007/s00056-013-0167-7; Wolf M, 2013, CLIN ORAL INVEST, V17, P989, DOI 10.1007/s00784-012-0777-2; Wolf M, 2014, EUR J ORTHODONT, V36, P624, DOI 10.1093/ejo/cjt037; Yamada S, 2014, J DENT RES, V93, P891, DOI 10.1177/0022034514543015	23	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-2379	1567-2387		J MOL HISTOL	J. Mol. Histol.	JUN	2015	46	3					303	311		10.1007/s10735-015-9619-2		9	Cell Biology	Cell Biology	CJ9ZA	WOS:000355861800008		
J	Liu, HR; Cui, J; Sun, J; Du, J; Feng, W; Sun, B; Li, J; Han, XC; Liu, B; Yimin; Oda, K; Amizuka, N; Li, MQ				Liu, Hongrui; Cui, Jian; Sun, Jing; Du, Juan; Feng, Wei; Sun, Bao; Li, Juan; Han, Xiuchun; Liu, Bo; Yimin; Oda, Kimimitsu; Amizuka, Norio; Li, Minqi			Histochemical evidence of zoledronate inhibiting c-src expression and interfering with CD44/OPN-mediated osteoclast adhesion in the tibiae of mice	JOURNAL OF MOLECULAR HISTOLOGY			English	Article						Zoledronate; Osteoblasts; Osteoclasts; C-src; Adhesion	NITROGEN-CONTAINING BISPHOSPHONATES; BONE-RESORPTION; RUFFLED BORDERS; CELLS; CD44; RAT; OSTEOPONTIN; MATRIX; DIFFERENTIATION; OSTEOPETROSIS	The purpose of this study was to investigate the effect of zoledronate (ZA) on osteoclast functions and viability in the tibiae of 8-week-old male mice. After weekly intravenous administration of ZA (125 mu g/kg body weight) for 8 weeks, the mice were fixed by transcardial perfusion of 4 % paraformaldehyde under anesthesia, and their tibiae were extracted for histochemical analysis. Compared with the control group, many tartrate-resistant acidic phosphatase-positive osteoclasts were found on the surface of the trabecular bone, but cartilage cores were obviously increased in the metaphysis of the ZA group. Osteoclasts of both groups showed similar expression of cathepsin K and matrix metalloproteinase-9. However, hardly any expression of c-src, a gene necessary for ruffled border formation and bone resorption, was found in osteoclasts of the ZA group. Moreover, no expression of CD44 or osteopontin (OPN) was observed in osteoclasts of the ZA group. Taken together, our findings suggest that ZA administration decreases the bone resorption ability of osteoclasts by inhibiting c-src expression and suppressing osteoclast adhesion by interfering with CD44/OPN binding.	[Liu, Hongrui; Cui, Jian; Sun, Jing; Du, Juan; Feng, Wei; Sun, Bao; Li, Juan; Han, Xiuchun; Liu, Bo; Li, Minqi] Shandong Univ, Sch Stomatol, Dept Bone Metab, Shandong Prov Key Lab Oral Biomed, Jinan 250012, Peoples R China; [Yimin] Hokkaido Univ, Grad Sch Med, Dept Adv Med, Sapporo, Hokkaido, Japan; [Oda, Kimimitsu] Niigata Univ, Grad Sch Med & Dent Sci, Div Biochem, Niigata, Japan; [Amizuka, Norio] Hokkaido Univ, Grad Sch Dent Med, Dept Dev Biol Hard Tissue, Sapporo, Hokkaido, Japan	Li, MQ (reprint author), Shandong Univ, Sch Stomatol, Dept Bone Metab, Shandong Prov Key Lab Oral Biomed, Wenhua West Rd 44-1, Jinan 250012, Peoples R China.	liminqi@sdu.edu.cn			National Nature Science Foundation of China [81271965, 81470719, 81311140173]; Specialized Research Fund for the Doctoral Program of Higher Education [20120131110073]	This study was partially supported by the National Nature Science Foundation of China (Grant Nos. 81271965; 81470719; 81311140173) and Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 20120131110073) to Li M.	Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Schwartzberg PL, 1997, GENE DEV, V11, P2835, DOI 10.1101/gad.11.21.2835; Oda K, 1999, J BIOCHEM-TOKYO, V126, P694; Delaisse JM, 2000, CLIN CHIM ACTA, V291, P223, DOI 10.1016/S0009-8981(99)00230-2; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Standal T, 2004, EXP ONCOL, V26, P179; Passarelli MN, 2013, J BONE MINER RES, V28, P2043, DOI 10.1002/jbmr.1930; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; SAKIYAMA H, 1994, CELL TISSUE RES, V277, P239, DOI 10.1007/s004410050151; Yu XF, 2003, CONNECT TISSUE RES, V44, P79, DOI 10.1080/03008200390152133; Li MQ, 2013, HISTOL HISTOPATHOL, V28, P327; Jobke B, 2014, BONE, V59, P37, DOI 10.1016/j.bone.2013.10.024; Allen MR, 2011, BONE, V49, P56, DOI 10.1016/j.bone.2010.10.159; Chellaiah MA, 2003, CALCIFIED TISSUE INT, V72, P197, DOI 10.1007/s00223-002-1025-6; Rodan GA, 1998, ANNU REV PHARMACOL, V38, P375, DOI 10.1146/annurev.pharmtox.38.1.375; Suzuki K, 2002, J BONE MINER RES, V17, P1486, DOI 10.1359/jbmr.2002.17.8.1486; MURAKAMI H, 1995, BONE, V17, P137, DOI 10.1016/S8756-3282(95)00150-6; Giuliani N, 1998, SCAND J RHEUMATOL, V27, P38; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; HUGHES DE, 1989, J CLIN INVEST, V83, P1930, DOI 10.1172/JCI114100; SATO M, 1991, J CLIN INVEST, V88, P2095, DOI 10.1172/JCI115539; NAKAMURA H, 1995, CELL TISSUE RES, V280, P225, DOI 10.1007/s004410050348; Coxon FP, 2000, J BONE MINER RES, V15, P1467, DOI 10.1359/jbmr.2000.15.8.1467; Dedes PG, 2012, BBA-GEN SUBJECTS, V1820, P1926, DOI 10.1016/j.bbagen.2012.07.013; Itoh F, 2003, EUR J PHARMACOL, V477, P9, DOI 10.1016/j.ejphar.2003.08.011; Dunford JE, 2001, J PHARMACOL EXP THER, V296, P235; Reinholz GG, 2000, CANCER RES, V60, P6001; Brown DL, 1999, J CLIN PHARMACOL, V39, P651, DOI 10.1177/00912709922008272; CECCHINI MG, 1987, J BONE MINER RES, V2, P135; Chabadel A, 2007, MOL BIOL CELL, V18, P4899, DOI 10.1091/mbc.E07-04-0378; FLANAGAN AM, 1991, CALCIFIED TISSUE INT, V49, P407, DOI 10.1007/BF02555852; Green JR, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.37421; Li MQ, 2006, MICROSC RES TECHNIQ, V69, P73, DOI 10.1002/jemt.20272; LOWE C, 1993, P NATL ACAD SCI USA, V90, P4485, DOI 10.1073/pnas.90.10.4485; Mayahara M, 2003, ANAT REC PART A, V274A, P817, DOI 10.1002/ar.a.10092; MILLER SC, 1979, ANAT REC, V193, P439, DOI 10.1002/ar.1091930309; Ralte S, 2011, ANN ANAT, V193, P509, DOI 10.1016/j.aanat.2011.03.009; Rogers MJ, 1997, CANCER, V80, P1652, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1652::AID-CNCR15>3.0.CO;2-Z; Rogers Michael J., 2000, Cancer, V88, P2961, DOI 10.1002/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L; Rogers MJ, 1996, BIOCHEM BIOPH RES CO, V224, P863, DOI 10.1006/bbrc.1996.1113; Schmidt A, 1996, P NATL ACAD SCI USA, V93, P3068, DOI 10.1073/pnas.93.7.3068; Vora SR, 2013, THESIS; Weinstein RS, 2009, NEW ENGL J MED, V360, P1677	43	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-2379	1567-2387		J MOL HISTOL	J. Mol. Histol.	JUN	2015	46	3					313	323		10.1007/s10735-015-9620-9		11	Cell Biology	Cell Biology	CJ9ZA	WOS:000355861800009		
J	Tsukiyama, K; Ogi, Y				Tsukiyama, K.; Ogi, Y.			The fluorescence lifetimes of the gerade states of HD near the second dissociation limit	JOURNAL OF MOLECULAR SPECTROSCOPY			English	Article						HD; Term value; Fluorescence lifetime; Gerade state	VACUUM-ULTRAVIOLET; SPECTROSCOPY; H-2; ENERGY; D-2; NM	An extreme ultraviolet-visible two step excitation scheme has been employed to populate rovibronic levels of the EF1 Sigma g(+), GK(1)Sigma g(+), H-1 Sigma g(+), I-1 Pi g, and J(1)Delta g states of HD near the second dissociation limit. Term values and fluorescence lifetimes are determined for the newly identified 17 rovibronic levels. In addition to the overall g-u symmetry breakdown in the wide energy range covering the excitation energies of the EF1 Sigma g(+) and B-1 Sigma u(+) states, a strong accidental g-u mixing is observed between GK(1)Sigma g(+)(v = 9, J = 1) and B'(1)Sigma u(+)(v = 7,J = 1). (C) 2015 Elsevier Inc. All rights reserved.	[Tsukiyama, K.] Tokyo Univ Sci, Dept Chem, Fac Sci, Shinjuku Ku, Tokyo 1628601, Japan; [Ogi, Y.] RIKEN, Ctr Adv Photon, Wako, Saitama 3510198, Japan	Tsukiyama, K (reprint author), Tokyo Univ Sci, Dept Chem, Fac Sci, Shinjuku Ku, Tokyo 1628601, Japan.	tsuki@rs.kagu.tus.ac.jp					Ivanov TI, 2010, MOL PHYS, V108, P771, DOI 10.1080/00268971003649307; Sprecher D, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3483462; BALAKRISHNAN A, 1992, J MOL SPECTROSC, V156, P517, DOI 10.1016/0022-2852(92)90253-K; DABROWSKI I, 1976, CAN J PHYS, V54, P525; De Lange A, 2002, INT REV PHYS CHEM, V21, P257, DOI 10.1080/01442350210124515; de Lange A, 2000, CAN J PHYS, V78, P567; Dickenson GD, 2012, J PHYS B-AT MOL OPT, V45, DOI 10.1088/0953-4075/45/14/145101; HINNEN PC, 1995, PHYS REV A, V52, P4425, DOI 10.1103/PhysRevA.52.4425; Niu ML, 2014, J MOL SPECTROSC, V300, P44, DOI 10.1016/j.jms.2014.03.011; Pielage TGP, 2002, CHEM PHYS LETT, V366, P583, DOI 10.1016/S0009-2614(02)01617-2; QUADRELLI P, 1990, J CHEM PHYS, V92, P7461, DOI 10.1063/1.458181; Reinhold E, 1999, PHYS REV A, V60, P1258, DOI 10.1103/PhysRevA.60.1258; Ross SC, 2010, MOL PHYS, V108, P109, DOI 10.1080/00268970903521186; Yoshinari T, 2004, J PHYS CHEM A, V108, P7915, DOI 10.1021/jp0401022	14	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-2852	1096-083X		J MOL SPECTROSC	J. Mol. Spectrosc.	JUN	2015	312						87	89		10.1016/j.jms.2015.04.001		3	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CJ6XR	WOS:000355639000012		
J	Abe, M; Sera, H; Sasada, H				Abe, Masashi; Sera, Hideyuki; Sasada, Hiroyuki			A(1)-A(2) splitting of CH3D	JOURNAL OF MOLECULAR SPECTROSCOPY			English	Article						Isotope methane; A(1)-A(2) splitting; Mid-infrared; Sub-Doppler resolution; Optical frequency comb; Difference frequency generation	TRANSITION FREQUENCY LIST; SPECTROSCOPY; METHANE; SPECTRUM; CM(-1)	Sub-Doppler resolution spectroscopy of CH3D has been carried out from 88.6 to 93.1 THz. Thirty transitions of the v(1) and v(4) bands from the low-J and K = 3 levels are observed, and the A(1)-A(2) splitting is resolved for twenty-three of the thirty transitions. The absolute frequencies are determined with a typical uncertainty of 4 kHz. The effective A(1)-A(2) splitting constant of the K = 3 levels is 2h(3,v=0) = (1.5641 +/- 0.0026) Hz for the ground vibrational state, and those of the K = 3 levels for the v(1) = 1 state and of the (K = 2, l = -1) and (K = 4, l = +1) levels for the v(4) = 1 state are also determined. (C) 2015 Elsevier Inc. All rights reserved.	[Abe, Masashi; Sera, Hideyuki; Sasada, Hiroyuki] Keio Univ, Fac Sci & Technol, Dept Phys, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Abe, M (reprint author), Keio Univ, Fac Sci & Technol, Dept Phys, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	masashi.abe@z3.keio.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Exploratory Research for Advanced Technology Intelligent Optical Synthesizer program of the Japan Science and Technology Agency, JST	One of the authors (H. Sera) thanks Dr. Kana Iwakuni of Keio University and Drs Sho Okubo and Hajime Inaba of Advanced Institute of Standard and Technology for their help in the construction of a novel optical frequency comb. We are grateful for a Grand-in-Aid for Scientific Research (A) and the Photon Frontier Network Program of the Ministry of Education, Culture, Sports, Science and Technology, Japan. This research is partially supported by Exploratory Research for Advanced Technology Intelligent Optical Synthesizer program of the Japan Science and Technology Agency, JST.	Ulenikov ON, 1999, J MOL SPECTROSC, V193, P249, DOI 10.1006/jmsp.1998.7729; Abe M, 2013, J OPT SOC AM B, V30, P1027, DOI 10.1364/JOSAB.30.001027; Nikitin A, 2002, J MOL SPECTROSC, V216, P225, DOI 10.1006/jmsp.2002.8566; OKA T, 1967, J CHEM PHYS, V47, P5410, DOI 10.1063/1.1701809; Rothman LS, 2013, J QUANT SPECTROSC RA, V130, P4, DOI 10.1016/j.jqsrt.2013.07.002; Iwakuni K, 2013, OPT EXPRESS, V21, P14832, DOI 10.1364/OE.21.014832; Abe M, 2014, OPT LETT, V39, P5277, DOI 10.1364/OL.39.005277; Dreyer RWP, 1983, APPL PHYS B, V31, P97, DOI DOI 10.1007/BF00702605; Drouin BJ, 2009, J QUANT SPECTROSC RA, V110, P2077, DOI 10.1016/j.jqsrt.2009.05.014; Iwakuni K, 2014, J MOL SPECTROSC, V306, P19, DOI 10.1016/j.jms.2014.09.013; Lattanzi V, 2008, J QUANT SPECTROSC RA, V109, P580, DOI 10.1016/j.jqsrt.2007.09.002; NIELSEN HH, 1947, PHYS REV, V72, P1101, DOI 10.1103/PhysRev.72.1101; Nikitin A, 2000, J MOL STRUCT, V517, P1, DOI 10.1016/S0022-2860(99)00235-5; Okubo S, 2011, OPT EXPRESS, V19, P23878, DOI 10.1364/OE.19.023878; Okubo S, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.012505; WOFSY SC, 1970, J CHEM PHYS, V53, P4005, DOI 10.1063/1.1673872; Wolfram Research Inc., 2010, MATH VERS 8 0	17	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-2852	1096-083X		J MOL SPECTROSC	J. Mol. Spectrosc.	JUN	2015	312						90	96		10.1016/j.jms.2015.04.003		7	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CJ6XR	WOS:000355639000013		
J	Kaneko, YS; Takayanagi, T; Nagasaki, H; Kodani, Y; Nakashima, A; Mori, K; Suzuki, A; Itoh, M; Kondo, K; Nagatsu, T; Ota, M; Ota, A				Kaneko, Yoko S.; Takayanagi, Takeshi; Nagasaki, Hiroshi; Kodani, Yu; Nakashima, Akira; Mori, Keiji; Suzuki, Atsushi; Itoh, Mitsuyasu; Kondo, Kazunao; Nagatsu, Toshiharu; Ota, Miyuki; Ota, Akira			Aripiprazole increases NAD(P)H-quinone oxidoreductase-1 and heme oxygenase-1 in PC12 cells	JOURNAL OF NEURAL TRANSMISSION			English	Article						Aripiprazole; Clozapine; Haloperidol; NAD(P)H-quinone oxidoreductase-1; Heme oxygenase-1; Nrf2; Keap1; beta-TrCP; Akt; Glycogen synthase kinase-3 beta; Acetylation; Pentose phosphate pathway	TRANSCRIPTION FACTOR NRF2; ANTIOXIDANT RESPONSE ELEMENT; PROTEIN-KINASE-C; OXIDATIVE STRESS; GENE-EXPRESSION; NF-E2-RELATED FACTOR-2; NUCLEAR IMPORT; RAT-BRAIN; PHOSPHORYLATION; ACTIVATION	We previously showed that aripiprazole increases intracellular NADPH and glucose-6-phosphate dehydrogenase mRNA in PC12 cells. Aripiprazole presumably activates a system that concurrently detoxifies reactive oxygen species and replenishes NADPH. Nrf2, a master transcriptional regulator of redox homeostasis genes, also activates the pentose phosphate pathway, including NADPH production. Therefore, our aim was to determine whether aripiprazole activates Nrf2 in PC12 cells. Aripiprazole increased mRNA expression of Nrf2-dependent genes (NAD(P)H-quinone oxidoreductase-1, Nqo1; heme oxygenase-1, HO1; and glutamate-cysteine ligase catalytic subunit) and protein expression of Nqo1 and HO1 in these cells (p < 0.05). To maintain increased Nrf2 activity, it is necessary to inhibit Nrf2 degradation; this is done by causing Nrf2 to dissociate from Keap1 or beta-TrCP. However, in aripiprazole-treated cells, the relative amount of Nrf2 anchored to Keap1 or beta-TrCP was unaffected and Nrf2 in the nuclear fraction decreased (p < 0.05). Aripiprazole did not affect phosphorylation of Nrf2 at Ser40 and decreased the relative amount of acetylated Nrf2 (p < 0.05). The increase in Nqo1 and HO1 in aripiprazole-treated cells cannot be explained by the canonical Nrf2-degrading pathways. Further experiments are needed to determine the biochemical mechanisms underlying the aripiprazole-induced increase in these enzymes.	[Kaneko, Yoko S.; Nagasaki, Hiroshi; Kodani, Yu; Nakashima, Akira; Ota, Akira] Fujita Hlth Univ, Dept Physiol, Sch Med, Toyoake, Aichi 4701192, Japan; [Takayanagi, Takeshi; Suzuki, Atsushi; Itoh, Mitsuyasu] Fujita Hlth Univ, Div Endocrinol & Metab, Dept Internal Med, Sch Med, Toyoake, Aichi 4701192, Japan; [Mori, Keiji] Kinjo Univ, Dept Hlth Sci, Haku San 9248511, Japan; [Kondo, Kazunao; Nagatsu, Toshiharu] Fujita Hlth Univ, Dept Pharmacol, Sch Med, Toyoake, Aichi 4701192, Japan; [Ota, Miyuki] Tosei Gen Hosp, Dept Psychiat, Seto 4898642, Japan	Ota, A (reprint author), Fujita Hlth Univ, Dept Physiol, Sch Med, Toyoake, Aichi 4701192, Japan.	aota@fujita-hu.ac.jp			Fujita Health University; Kinjo University	This work was supported by grants-in-aid from Fujita Health University to AO and YSK and by grants-in-aid from Kinjo University to KM.	Sasaki H, 2002, J BIOL CHEM, V277, P44765, DOI 10.1074/jbc.M208704200; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Rojo AI, 2008, J NEUROCHEM, V105, P192, DOI 10.1111/j.1471-4159.2007.05124.x; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; Kawai Y, 2011, J BIOL CHEM, V286, P7629, DOI 10.1074/jbc.M110.208173; Wu JQ, 2013, PROG NEURO-PSYCHOPH, V46, P200, DOI 10.1016/j.pnpbp.2013.02.015; Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Nakaso K, 2003, FEBS LETT, V546, P181, DOI 10.1016/S0014-5793(03)00517-9; Salazar M, 2006, J BIOL CHEM, V281, P14841, DOI 10.1074/jbc.M513737200; Sun Z, 2009, MOL CELL BIOL, V29, P2658, DOI 10.1128/MCB.01639-08; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Pillai A, 2007, J PSYCHIATR RES, V41, P372, DOI 10.1016/j.jpsychires.2006.01.011; Theodore M, 2008, J BIOL CHEM, V283, P8984, DOI 10.1074/jbc.M709040200; Eren I, 2007, NEUROCHEM RES, V32, P1188, DOI 10.1007/s11064-007-9289-x; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Singh A, 2013, J CLIN INVEST, V123, P2921, DOI 10.1172/JCI66353; Jain AK, 2005, J BIOL CHEM, V280, P29158, DOI 10.1074/jbc.M502083200; Xu CJ, 2006, MOL CANCER THER, V5, P1918, DOI 10.1158/1535-7163.MCT-05-0497; McMahon M, 2001, CANCER RES, V61, P3299; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Chowdhry S, 2013, ONCOGENE, V32, P3765, DOI 10.1038/onc.2012.388; Huang HC, 2000, P NATL ACAD SCI USA, V97, P12475, DOI 10.1073/pnas.220418997; Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; KIKUCHI T, 1995, J PHARMACOL EXP THER, V274, P329; Qi HY, 2012, NEUROPHARMACOLOGY, V62, P1659, DOI 10.1016/j.neuropharm.2011.11.012; So HS, 2006, CELL DEATH DIFFER, V13, P1763, DOI 10.1038/sj.cdd.4401863; Moinova HR, 1999, BIOCHEM BIOPH RES CO, V261, P661, DOI 10.1006/bbrc.1999.1109; Keum YS, 2006, CANCER RES, V66, P8804, DOI 10.1158/0008-5472.CAN-05-3513; Rojo AI, 2008, MOL CELL NEUROSCI, V39, P125, DOI 10.1016/j.mcn.2008.06.007; Harrison EM, 2006, FEBS J, V273, P2345, DOI 10.1111/j.1742-4658.2006.05224; Oshiro Y, 1998, J MED CHEM, V41, P658, DOI 10.1021/jm940608g; Mahadik SP, 2003, PSYCHIAT CLIN N AM, V26, P85, DOI 10.1016/S0193-953X(02)00033-3; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754; Emiliani FE, 2014, CURR OPIN PSYCHIATR, V27, P185, DOI 10.1097/YCO.0000000000000054; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Singh A, 2008, CANCER RES, V68, P7975, DOI 10.1158/0008-5472.CAN-08-1401; BANNO K, 1988, CHEM PHARM BULL, V36, P4377; Berg J. M., 2007, BIOCHEMISTRY; Horrobin DF, 1999, PROSTAG LEUKOTR ESS, V60, P431, DOI 10.1016/S0952-3278(99)80024-6; Miljevic C, 2013, HUM PSYCHOPHARM CLIN, V28, P1, DOI 10.1002/hup.2272; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Nagasaki H, 2014, J NEURAL TRANSM, V121, P91, DOI 10.1007/s00702-013-1075-0; Ota A, 2012, J NEURAL TRANSM, V119, P1327, DOI 10.1007/s00702-012-0782-2; Park SW, 2011, NEUROSCI RES, V69, P283, DOI 10.1016/j.neures.2011.01.004; Rotblat B, 2014, P NATL ACAD SCI USA, V111, P3032, DOI 10.1073/pnas.1314421111; Sun Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006588; Takami G, 2010, J NEURAL TRANSM, V117, P1139, DOI 10.1007/s00702-010-0457-9	55	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564	1435-1463		J NEURAL TRANSM	J. Neural Transm.	JUN	2015	122	6					757	772		10.1007/s00702-014-1350-8		16	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CJ2VY	WOS:000355344000004		
J	Jitoku, D; Yamamoto, N; Iwayama, Y; Toyota, T; Miyagi, M; Enokida, T; Tasaka, Y; Umino, M; Umino, A; Uezato, A; Iwata, Y; Suzuki, K; Kikuchi, M; Hashimoto, T; Kanahara, N; Kurumaji, A; Yoshikawa, T; Nishikawa, T				Jitoku, Daisuke; Yamamoto, Naoki; Iwayama, Yoshimi; Toyota, Tomoko; Miyagi, Momo; Enokida, Takeshi; Tasaka, Yuri; Umino, Masakazu; Umino, Asami; Uezato, Akihito; Iwata, Yasuhide; Suzuki, Katsuaki; Kikuchi, Mitsuru; Hashimoto, Tasuku; Kanahara, Nobuhisa; Kurumaji, Akeo; Yoshikawa, Takeo; Nishikawa, Toru			Association study of H2AFZ with schizophrenia in a Japanese case-control sample	JOURNAL OF NEURAL TRANSMISSION			English	Article						H2AFZ; Histone acetylation; miRNA; Phencyclidine; SNP; Schizophrenia	PREFRONTAL CORTEX; POPULATION-STRUCTURE; MICRORNA EXPRESSION; HAPLOTYPE BLOCKS; COMMON VARIANTS; SAP97 GENE; INDIVIDUALS; LINKAGE; GENOME; POLYMORPHISMS	It is widely accepted that malfunction of the N-methyl-d-aspartate (NMDA)-type glutamate receptor may be involved in the pathophysiology of schizophrenia. Several recent microRNA (miRNA) studies have demonstrated that the expression of the glutamate system-related miR-132 and miR-212 is changed in postmortem schizophrenic brains. Here we attempted to obtain further insight into the relationships among schizophrenia, the NMDA receptor, the molecular cascades controlled by these miRNAs and commonly predicted target genes of the two miRNAs. We focused on the H2AFZ (encoding H2A histone family, member Z) gene, whose expression was shown in our screening study to be modified by a schizophrenomimetic NMDA antagonist, phencyclidine. By performing polymerase chain reaction with fluorescent signal detention using the TaqMan system, we examined four tag single nucleotide polymorphisms (SNPs; SNP01-04) located around and within the H2AFZ gene for their genetic association with schizophrenia. The subjects were a Japanese cohort (2,012 patients with schizophrenia and 2,170 control subjects). We did not detect any significant genetic association of these SNPs with schizophrenia in this cohort. However, we observed a significant association of SNP02 (rs2276939) in the male patients with schizophrenia (allelic P = 0.003, genotypic P = 0.008). A haplotype analysis revealed that haplotypes consisting of SNP02-SNP03 (rs10014424)-SNP04 (rs6854536) also showed a significant association in the male patients with schizophrenia (P = 0.018). These associations remained significant even after correction for multiple testing. The present findings suggest that the H2AFZ gene may be a susceptibility factor in male subjects with schizophrenia, and that modification of the H2AFZ signaling pathway warrants further study in terms of the pathophysiology of schizophrenia.	[Jitoku, Daisuke; Yamamoto, Naoki; Miyagi, Momo; Enokida, Takeshi; Tasaka, Yuri; Umino, Masakazu; Umino, Asami; Uezato, Akihito; Kurumaji, Akeo; Yoshikawa, Takeo; Nishikawa, Toru] Tokyo Med & Dent Univ, Grad Sch, Dept Psychiat & Behav Sci, Tokyo 1130034, Japan; [Iwayama, Yoshimi; Toyota, Tomoko; Yoshikawa, Takeo] RIKEN Brain Sci Inst, Lab Mol Psychiat, Wako, Saitama, Japan; [Iwata, Yasuhide; Suzuki, Katsuaki] Hamamatsu Univ Sch Med, Dept Psychiat & Neurol, Shizuoka, Japan; [Kikuchi, Mitsuru] Kanazawa Univ, Dept Psychiat & Neurobiol, Grad Sch Med, Kanazawa, Ishikawa, Japan; [Hashimoto, Tasuku; Kanahara, Nobuhisa] Chiba Univ, Dept Psychiat, Grad Sch Med, Chiba, Japan	Nishikawa, T (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Psychiat & Behav Sci, Tokyo 1130034, Japan.	tnis.psyc@tmd.ac.jp					Hennah W, 2003, HUM MOL GENET, V12, P3151, DOI 10.1093/hmg/ddg341; Yamada K, 2006, BIOL PSYCHIAT, V60, P192, DOI 10.1016/j.biopsych.2005.11.008; Bahari-Javan S, 2012, J NEUROSCI, V32, P5062, DOI 10.1523/JNEUROSCI.0079-12.2012; Sato J, 2008, J NEURAL TRANSM, V115, P1355, DOI 10.1007/s00702-008-0085-9; Hattori E, 2009, AM J MED GENET B, V150B, P1110, DOI 10.1002/ajmg.b.30941; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Miller BH, 2012, P NATL ACAD SCI USA, V109, P3125, DOI 10.1073/pnas.1113793109; Pritchard JK, 2000, GENETICS, V155, P945; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Beveridge NJ, 2008, HUM MOL GENET, V17, P1156, DOI 10.1093/hmg/ddn005; Yamada K, 2004, BIOL PSYCHIAT, V56, P683, DOI 10.1016/j.biopsych.2004.08.015; Sharma RP, 2008, SCHIZOPHR RES, V98, P111, DOI 10.1016/j.schres.2007.09.020; Kurita M, 2012, NAT NEUROSCI, V15, P1245, DOI 10.1038/nn.3181; Benes FM, 2007, P NATL ACAD SCI USA, V104, P10164, DOI 10.1073/pnas.0703806104; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Kim AH, 2010, SCHIZOPHR RES, V124, P183, DOI 10.1016/j.schres.2010.07.002; Draker R, 2009, BIOCHEM CELL BIOL, V87, P19, DOI 10.1139/O08-117; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Balan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070302; Clemmensen L, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-150; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kim B, 2010, PSYCHIAT RES, V179, P121, DOI 10.1016/j.psychres.2008.08.009; Kirov G, 2005, J CLIN INVEST, V115, P1440, DOI 10.1172/JCI24759; Leung A, 2000, ACTA PSYCHIAT SCAND, V101, P3; Shifman S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040028; Takebayashi H, 2009, INT J NEUROPSYCHOPH, V12, P1111, DOI 10.1017/S1461145709009997; Takebayashi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097955; The Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium, 2011, NAT GENET, V43, P969; Torrey EF, 2000, SCHIZOPHR RES, V44, P151, DOI 10.1016/S0920-9964(99)00192-9; Tsukada S, 2006, MOL ENDOCRINOL, V20, P1104, DOI 10.1210/me.2005-0311; Uezato A, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-2	44	2	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564	1435-1463		J NEURAL TRANSM	J. Neural Transm.	JUN	2015	122	6					915	923		10.1007/s00702-014-1332-x		9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CJ2VY	WOS:000355344000022		
J	Hirono, S; Iwadate, Y; Higuchi, Y; Serizawa, T; Nagano, O; Matsutani, T; Saeki, N				Hirono, Seiichiro; Iwadate, Yasuo; Higuchi, Yoshinori; Serizawa, Toru; Nagano, Osamu; Matsutani, Tomoro; Saeki, Naokatsu			Stereotactic radiosurgery in combination with up-front high-dose methotrexate as a first-line treatment for newly diagnosed primary central nervous system lymphoma	JOURNAL OF NEURO-ONCOLOGY			English	Article						Stereotactic radiosurgery; Newly diagnosed primary central nervous system lymphoma; High-dose methotrexate; Whole brain radiotherapy; Gamma knife radiosurgery	PRIMARY CNS LYMPHOMA; WHOLE-BRAIN RADIOTHERAPY; QUALITY-OF-LIFE; CHEMOTHERAPY; THERAPY; PROCARBAZINE; VINCRISTINE; RADIATION; SINGLE; TRIAL	The efficacy of stereotactic radiosurgery (SRS) instead of whole brain radiotherapy (WBRT) following high-dose methotrexate (HD-MTX) for primary central nervous system lymphoma (PCNSL) is unclear. To clarify whether SRS in combination with up-front HD-MTX supplements the effect of HD-MTX in remaining or refractory lesions after initial HD-MTX treatment. The authors conducted a retrospective review for newly diagnosed PCNSL patients who underwent SRS after HD-MTX as a first-line treatment. The local control (LC), the progression-free survival (PFS), the recurrence patterns, the salvage treatments, the overall survival (OS), the Karnofsky Performance Status (KPS), the activities of daily living (ADL) were analyzed as well as radiosurgical parameters. Twenty patients underwent SRS for 51 lesions with the median volume of 0.45 cm(3). The median age at SRS was 67 (range 37-82). The median KPS at SRS was 90. The LC rate at 2 years was 86.0 %, the median PFS after SRS was 17 months, necessitating additional SRS and chemotherapy. The median OS was 52 months. No significant side effects related to SRS were observed. During follow-up period, the good ADL preservation was achieved for 13 months from SRS. Patients with KPS a parts per thousand yen 90 at SRS demonstrated longer ADL preservation (32 months from SRS). SRS following up-front HD-MTX without WBRT provided excellent LC, acceptable OS and the long ADL preservation period. These benefits may be more emphasized especially in patients with good KPS, but should be validated in a large patient population.	[Hirono, Seiichiro; Iwadate, Yasuo; Higuchi, Yoshinori; Matsutani, Tomoro; Saeki, Naokatsu] Chiba Univ, Grad Sch Med, Dept Neurol Surg, Chuo Ku, Chiba 2608670, Japan; [Serizawa, Toru] Tsukiji Neurol Clin, Tokyo Gamma Unit Ctr, Chuo Ku, Tokyo 1040045, Japan; [Nagano, Osamu] Chiba Cerebral & Cardiovasc Ctr, Dept Neurosurg, Ichihara, Chiba 2900512, Japan	Hirono, S (reprint author), Chiba Univ, Grad Sch Med, Dept Neurol Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	s-hirono@umin.ac.jp					Batchelor T, 2003, J CLIN ONCOL, V21, P1044, DOI 10.1200/JCO.2003.03.036; Citterio G, 2013, EXPERT REV ANTICANC, V13, P1327, DOI 10.1586/14737140.2013.851007; Kondziolka D, 2015, NEURO-ONCOLOGY, V17, P29, DOI 10.1093/neuonc/nou284; Dalia S, 2014, INT J HEMATOL, V99, P450, DOI 10.1007/s12185-014-1540-z; Herrlinger U, 2005, ANN NEUROL, V57, P843, DOI 10.1002/ana.20495; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Omuro AMP, 2005, ARCH NEUROL-CHICAGO, V62, P1595, DOI 10.1001/archneur.62.10.1595; Pollock BE, 2012, CANCER-AM CANCER SOC, V118, P1048, DOI 10.1002/cncr.26362; Correa DD, 2012, NEURO-ONCOLOGY, V14, P101, DOI 10.1093/neuonc/nor186; Villano JL, 2011, BRIT J CANCER, V105, P1414, DOI 10.1038/bjc.2011.357; Morris PG, 2013, J CLIN ONCOL, V31, P3971, DOI 10.1200/JCO.2013.50.4910; Thiel E, 2010, LANCET ONCOL, V11, P1036, DOI 10.1016/S1470-2045(10)70229-1; Ferreri AJM, 2014, NEUROLOGY, V82, P1370, DOI 10.1212/WNL.0000000000000314; Rubenstein JL, 2013, J CLIN ONCOL, V31, P3061, DOI 10.1200/JCO.2012.46.9957; Doolittle ND, 2013, NEUROLOGY, V81, P84, DOI 10.1212/WNL.0b013e318297eeba; Gerstner ER, 2008, NEUROLOGY, V70, P401, DOI 10.1212/01.wnl.0000300671.37279.0e; Guha-Thakurta N, 1999, J NEURO-ONCOL, V43, P259, DOI 10.1023/A:1006210703827; Kenai H, 2006, J NEUROSURG, V105, P133; Kim YR, 2014, ANN HEMATOL, V93, P211, DOI 10.1007/s00277-013-1853-7; Matsumoto Y, 2007, INT J HEMATOL, V85, P333, DOI 10.1532/IJH97.06205; Roth P, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-013-0277-y; Sakamoto M, 2006, J NEURO-ONCOL, V77, P53, DOI 10.1007/s11060-005-7698-8	22	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-594X	1573-7373		J NEURO-ONCOL	J. Neuro-Oncol.	JUN	2015	123	2					237	244		10.1007/s11060-015-1786-1		8	Oncology; Clinical Neurology	Oncology; Neurosciences & Neurology	CJ6VJ	WOS:000355632800005		
